[["Aging and physical inactivity are two factors that favors the development of cardiovascular disease, metabolic syndrome, obesity, diabetes, and sleep dysfunction.", {"entities": [[121, 128, "DISEASE"], [111, 119, "DISEASE"]]}], ["In contrast, the adoption a habitual of moderate exercise may present a non-pharmacological treatment alternative for sleep and metabolic disorders.", {"entities": []}], ["We aimed to assess the effects of moderate exercise training on sleep quality and on the metabolic profile of elderly people with a sedentary lifestyle.", {"entities": []}], ["Fourteen male sedentary, healthy, elderly volunteers performed moderate training for 60 minutes/day, 3 days/week for 24 wk at a work rate equivalent to the ventilatory aerobic threshold.", {"entities": []}], ["The environment was kept at a temperature of 23 \u00b1 2\u00b0C, with an air humidity 60 \u00b1 5%.", {"entities": []}], ["Blood and polysomnographs analysis were collected 3 times: at baseline (1 week before training began), 3 and 6 months (after 3 and 6 months of training).", {"entities": []}], ["Training promoted increasing aerobic capacity (relative VO 2 , time and velocity to VO 2 max ; p < 0.05), and reduced serum NEFA, and insulin concentrations as well as improved HOMA index (p < 0.05), and increased adiponectin levels (p < 0.05), after 3 months of training when compared with baseline data.", {"entities": [[89, 92, "GENE"]]}], ["The sleep parameters, awake time and REM sleep latency were decreased after 6 months exercise training (p < 0.05) in relation baseline values.", {"entities": []}], ["Our results demonstrate that the moderate exercise training protocol improves the sleep profile in older people, but the metabolism adaptation does not persist.", {"entities": []}], ["Suggesting that this population requires training strategy modifications as to ensure consistent alterations regarding metabolism.", {"entities": []}], ["Isoquercitrin, (IQ, quercetin-3- O -\u03b2- d -glucopyranoside) is known for strong chemoprotectant activities.", {"entities": []}], ["Acylation of flavonoid glucosides with carboxylic acids containing an aromatic ring brings entirely new properties to these compounds.", {"entities": []}], ["Here, we describe the chemical and enzymatic synthesis of a series of IQ derivatives at the C-6\u2033.", {"entities": []}], ["IQ benzoate, phenylacetate, phenylpropanoate and cinnamate were prepared from respective vinyl esters using Novozym 435 (Lipase B from Candida antarctica immobilized on acrylic resin).", {"entities": []}], ["The enzymatic procedure gave no products with \u201chydroxyaromatic\u201d acids, their vinyl esters nor with their benzyl-protected forms.", {"entities": []}], ["A chemical protection/deprotection method using Steglich reaction yielded IQ 4-hydroxybenzoate, vanillate and gallate.", {"entities": []}], ["In case of p -coumaric, caffeic, and ferulic acid, the deprotection lead to the saturation of the double bonds at the phenylpropanoic moiety and yielded 4-hydroxy-, 3,4-dihydroxy- and 3-methoxy-4-hydroxy-phenylpropanoates.", {"entities": []}], ["Reducing capacity of the cinnamate, gallate and 4-hydroxyphenylpropanoate towards Folin-Ciocalteau reagent was significantly lower than that of IQ, while other derivatives displayed slightly better or comparable capacity.", {"entities": []}], ["Compared to isoquercitrin, most derivatives were less active in 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging, but they showed significantly better 2,2\u2032-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid, ABTS) scavenging activity and were substantially more active in the inhibition of tert -butylhydroperoxide induced lipid peroxidation of rat liver microsomes.", {"entities": [[295, 299, "GENE"]]}], ["The most active compounds were the hydroxyphenylpropanoates.", {"entities": []}], ["Combretum hereroense and Canthium mundianum are two plants commonly used by traditional healers in the Northern region of Limpopo, South Africa for the treatment of diarrhea and inflammation.", {"entities": [[165, 173, "DISEASE"]]}], ["In the present study, the effects of their water extracts on the production and expression of interleukin-4 by peripheral blood mononuclear cells (PBMC\u2019S) from HIV positive and negative individuals was evaluated.", {"entities": []}], ["Blood samples were collected from both HIV positive and HIV negative volunteers and were used for the purification of Peripheral blood mononuclear cells ( PBMC ).", {"entities": []}], ["The PBMCs were cultured together with the water extracts after activation with phytohemagglutinin (PHA) for three days.", {"entities": []}], ["Solid-phase sandwich ELISA (MABTECH) kit was used to detect IL-4 on un-stimulated and stimulated PBMC\u2019S with phytohemaglutinin (PHA) and plant extracts, followed by the isolation of RNA using RNAesy Qiagen mini kit from the cells.", {"entities": []}], ["Reverse transcriptase real time PCR was used to evaluate IL-4 gene expression by the cells.", {"entities": []}], ["Combretum hereroense showed higher production of IL-4 at three different concentrations and a significant expression of mRNA with 4-fold amplification increase at 300\u03bcg/ml and 2-fold amplification increase at 20\u03bcg/ml.", {"entities": []}], ["Canthium mundianum also showed increased production of IL-4 at 300\u03bcg/ml, but inhibited its production at 20\u03bcg/ml.", {"entities": []}], ["Both extracts showed no expression at 50\u03bcg/ml.", {"entities": []}], ["The response of the PBMCs from HIV negative individuals was more pronounced than that of HIV positive individuals who mostly increased production of IL4 at smaller concentrations unlike their HIV negative counterparts.", {"entities": [[149, 152, "GENE"]]}], ["Although in vitro studies do not necessarily predict in vivo outcomes, the plant extracts modulated the immune system by enhancing the production and expression of IL-4 in both HIV- and HIV+ individuals at different concentrations.", {"entities": []}], ["For the first time we have shown that the immunomodulatory effect of medicinal plants may depend on the clinical status of the individual.", {"entities": []}], ["The present study revealed that the effect of the water extracts from the two plants on IL-4 expression and production is dependent on the microbiological state of the individual and is dose dependent.", {"entities": []}], ["Further studies are needed to identify the active components in the extracts and also characterize the patients further for a better understanding of the mechanisms of action of these extracts.", {"entities": []}], ["Surfactant proteins are produced predominantly by alveolar type II (ATII) cells, and the expression of these proteins can be altered by cytokines and growth factors.", {"entities": []}], ["Th1/Th2 cytokine imbalance is suggested to be important in the pathogenesis of several adult lung diseases.", {"entities": []}], ["Recently, we developed a culture system for maintaining differentiated adult human ATII cells.", {"entities": []}], ["Therefore, we sought to determine the effects of IL-13 and IFN-\u03b3 on the expression of surfactant proteins in adult human ATII cells in vitro .", {"entities": []}], ["Additional studies were done with rat ATII cells.", {"entities": []}], ["Adult human ATII cells were isolated from deidentified organ donors whose lungs were not suitable for transplantation and donated for medical research.", {"entities": []}], ["The cells were cultured on a mixture of Matrigel and rat-tail collagen for 8 d with differentiation factors and human recombinant IL-13 or IFN-\u03b3.", {"entities": []}], ["IL-13 reduced the mRNA and protein levels of surfactant protein (SP)-C, whereas IFN-\u03b3 increased the mRNA level of SP-C and proSP-C protein but not mature SP-C.", {"entities": []}], ["Neither cytokine changed the mRNA level of SP-B but IFN-\u03b3 slightly decreased mature SP-B.", {"entities": []}], ["IFN-\u03b3 reduced the level of the active form of cathepsin H. IL-13 also reduced the mRNA and protein levels of SP-D, whereas IFN-\u03b3 increased both mRNA and protein levels of SP-D. IL-13 did not alter SP-A, but IFN-\u03b3 slightly increased the mRNA levels of SP-A.", {"entities": []}], ["We demonstrated that IL-13 and IFN-\u03b3 altered the expression of surfactant proteins in human adult ATII cells in vitro .", {"entities": []}], ["IL-13 decreased SP-C and SP-D in human ATII cells, whereas IFN-\u03b3 had the opposite effect.", {"entities": []}], ["The protein levels of mature SP-B were decreased by IFN-\u03b3 treatment, likely due to the reduction in active form cathpesin H. Similarly, the active form of cathepsin H was relatively insufficient to fully process proSP-C as IFN-\u03b3 increased the mRNA levels for SP-C and proSP-C protein, but there was no increase in mature SP-C.", {"entities": []}], ["These observations suggest that in disease states with an overexpression of IL-13, there would be some deficiency in mature SP-C and SP-D.", {"entities": []}], ["In disease states with an excess of IFN-\u03b3 or therapy with IFN-\u03b3, these data suggest that there might be incomplete processing of SP-B and SP-C.", {"entities": []}], ["Cats can be carriers of infected arthropods and be infected with several vector-borne pathogens (VBP) but there is limited knowledge about their pathogenic role in cats.", {"entities": []}], ["A cross-sectional controlled study investigated the clinical status and antibody ( Bartonella henselae , Rickettsia conorii , Ehrlichia canis , Anaplasma phagocytophilum , Babesia microti and Leishmania infantum ) and/or blood PCR ( Mycoplasma spp., Bartonella spp., Rickettsia spp., Ehrlichia/Anaplasma spp., piroplasmids, L. infantum , Hepatozoon felis ) prevalence in 197 cats.", {"entities": []}], ["Outdoor cats lacking ectoparasiticide treatment or hosting ectoparasites (study group [SG], n = 134) and indoor cats treated against ectoparasites (control group [CG], n = 63) were enrolled.", {"entities": []}], ["Clinical data and retroviral co-infections were compared between the two groups.", {"entities": []}], ["Multivariable analysis tested associations between variables and VBP exposure.", {"entities": []}], ["Lymphadenia, stomatitis, and various haematological abnormalities were statistically more frequent in SG.", {"entities": [[13, 23, "DISEASE"]]}], ["Antibodies against R. conorii , B. henselae , A. phagocytophylum , B. microti , E. canis and L. infantum were detected.", {"entities": []}], ["Bartonella henselae , Bartonella clarridgeiae , Mycoplasma haemofelis , \u201c Candidatus Mycoplasma haemominutum\u201d and \u201c Candidatus Mycoplasma turicensis\u201d DNA were identified.", {"entities": []}], ["Very high antibody (87.8%) and PCR (40.1%) positivity to at least one pathogen were detected and were significantly higher in SG.", {"entities": []}], ["Co-infections were confirmed in about one-third of the cats and were more frequent in SG cats.", {"entities": []}], ["Molecular and overall (antibody and PCR) positivity to Bartonella and antibody positivity to R. conorii were higher in SG.", {"entities": []}], ["Multivariable analysis found significant associations of Bartonella spp.", {"entities": []}], ["infection with Feline Immunodeficiency Virus (FIV) infection and increased globulins, and of Mycoplasma spp.", {"entities": []}], ["infection with adult age, FIV infection, anaemia, and increased creatinine.", {"entities": []}], ["A very high prevalence of exposure to zoonotic VBP was found in cats, with Rickettsia and Bartonella infections being most prevalent.", {"entities": []}], ["Some risk factors were documented namely for Mycoplasma spp.", {"entities": []}], ["and Bartonella spp.", {"entities": []}], ["The lifestyle of cats is clinically relevant and requires specific preventative measures to protect their health.", {"entities": []}], ["The online version of this article (10.1186/s13071-018-2725-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A 45-year-old man presented with a six-month history of progressive dyspnea with productive cough and wheezing.", {"entities": []}], ["The patient was a heavy smoker and had a history of tongue cancer, hypertension, and asthma.", {"entities": [[67, 79, "DISEASE"], [85, 91, "DISEASE"], [52, 65, "DISEASE"], [59, 65, "DISEASE"]]}], ["Chest X-ray and computed tomography showed a mass lesion in the left hilar region and total collapse of the upper left lobe of the lung.", {"entities": []}], ["Bronchoscopy revealed a whitish solid tumor obstructing the left upper lobe bronchus.", {"entities": []}], ["Positron emission tomography showed increased tracer uptake in the lesion.", {"entities": []}], ["A thoracoscopic lobectomy of the left upper lobe of the lung was performed.", {"entities": []}], ["The final pathologic diagnosis was inflammatory myofibroblastic tumor.", {"entities": []}], ["DNA methylation of the Th1 and Th2 cytokine genes is altered during cow\u2019s milk allergy (CMA).", {"entities": []}], ["Forkhead box transcription factor 3 ( FoxP3 ) is essential for the development and function of regulatory T cells (Tregs) and is involved in oral tolerance acquisition.", {"entities": [[38, 43, "GENE"]]}], ["We assessed whether tolerance acquisition in children with IgE-mediated CMA is associated with DNA demethylation of the Treg-specific demethylated region (TSDR) of FoxP3 .", {"entities": [[164, 169, "GENE"]]}], ["Forty children (aged 3\u201318\u00a0months) were enrolled: 10 children with active IgE-mediated CMA (group 1), 10 children who outgrew CMA after dietary treatment with an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG (group 2), 10 children who outgrew CMA after treatment with other formulas (group 3), and 10 healthy controls (group 4).", {"entities": []}], ["FoxP3 TSDR demethylation and expression were measured in mononuclear cells purified from peripheral blood of the four groups of children.", {"entities": [[0, 5, "GENE"]]}], ["FoxP3 TSDR demethylation was significantly lower in children with active IgE-mediated CMA than in either children who outgrew CMA or in healthy children.", {"entities": [[0, 5, "GENE"]]}], ["Formula selection influenced the FoxP3 TSDR demethylation profile.", {"entities": [[33, 38, "GENE"]]}], ["The FoxP3 TSDR demethylation rate and expression level were correlated.", {"entities": [[4, 9, "GENE"]]}], ["Tolerance acquisition in children with IgE-mediated CMA involves epigenetic regulation of the FoxP3 gene.", {"entities": [[94, 99, "GENE"]]}], ["This feature could be a new target for preventive and therapeutic strategies against CMA.", {"entities": []}], ["Empathy has been re-discovered as a desirable quality in doctors.", {"entities": []}], ["A number of approaches using the medical humanities have been advocated to teach empathy to medical students.", {"entities": []}], ["This paper describes a new approach using the medium of creative writing and a new narrative genre: clinical realism.", {"entities": []}], ["Third year students were offered a four week long Student Selected Component (SSC) in Narrative Medicine and Creative Writing.", {"entities": []}], ["The creative writing element included researching and creating a character with a life-changing physical disorder without making the disorder the focus of the writing.", {"entities": [[96, 113, "DISEASE"]]}], ["The age, gender, social circumstances and physical disorder of a character were randomly allocated to each student.", {"entities": [[42, 59, "DISEASE"]]}], ["The students wrote repeated assignments in the first person, writing as their character and including details of living with the disorder in all of their narratives.", {"entities": []}], ["This article is based on the work produced by the 2013 cohort of students taking the course, and on their reflections on the process of creating their characters.", {"entities": []}], ["Their output was analysed thematically using a constructivist approach to meaning making.", {"entities": []}], ["This preliminary analysis suggests that the students created convincing and detailed narratives which included rich information about living with a chronic disorder.", {"entities": []}], ["Although the writing assignments were generic, they introduced a number of themes relating to illness, including stigma, personal identity and narrative wreckage.", {"entities": []}], ["Some students reported that they found it difficult to relate to \u201ctheir\u201d character initially, but their empathy for the character increased as the SSC progressed.", {"entities": []}], ["Clinical realism combined with repeated writing exercises about the same character is a potential tool for helping to develop empathy in medical students and merits further investigation.", {"entities": []}], ["Asthma is a global health problem with increasing prevalence.", {"entities": [[0, 6, "DISEASE"]]}], ["The airway epithelium is the initial barrier against inhaled noxious agents or aeroallergens.", {"entities": []}], ["In asthma, the airway epithelium suffers from structural and functional abnormalities and as such, is more susceptible to normally innocuous environmental stimuli.", {"entities": [[3, 9, "DISEASE"]]}], ["The epithelial structural and functional impairments are now recognised as a significant contributing factor to asthma pathogenesis.", {"entities": [[112, 118, "DISEASE"]]}], ["Both genetic and environmental risk factors play important roles in the development of asthma with an increasing number of genes associated with asthma susceptibility being expressed in airway epithelium.", {"entities": [[87, 93, "DISEASE"], [145, 151, "DISEASE"]]}], ["Epigenetic factors that regulate airway epithelial structure and function are also an attractive area for assessment of susceptibility to asthma.", {"entities": [[138, 144, "DISEASE"]]}], ["In this review we provide a comprehensive discussion on genetic factors; from using linkage designs and candidate gene association studies to genome-wide association studies and whole genome sequencing, and epigenetic factors; DNA methylation, histone modifications, and non-coding RNAs (especially microRNAs), in airway epithelial cells that are functionally associated with asthma pathogenesis.", {"entities": [[376, 382, "DISEASE"]]}], ["Our aims were to introduce potential predictors or therapeutic targets for asthma in airway epithelium.", {"entities": [[75, 81, "DISEASE"]]}], ["Overall, we found very small overlap in asthma susceptibility genes identified with different technologies.", {"entities": [[40, 46, "DISEASE"]]}], ["Some potential biomarkers are IRAKM , PCDH1 , ORMDL3 / GSDMB , IL - 33 , CDHR3 and CST1 in airway epithelial cells.", {"entities": [[38, 43, "GENE"], [46, 52, "GENE"], [55, 60, "GENE"], [73, 78, "GENE"], [83, 87, "GENE"]]}], ["Recent studies on epigenetic regulatory factors have further provided novel insights to the field, particularly their effect on regulation of some of the asthma susceptibility genes (e.g.", {"entities": [[154, 160, "DISEASE"]]}], ["methylation of ADAM33 ).", {"entities": [[15, 21, "GENE"]]}], ["Among the epigenetic regulatory mechanisms, microRNA networks have been shown to regulate a major portion of post-transcriptional gene regulation.", {"entities": []}], ["Particularly, miR-19a may have some therapeutic potential.", {"entities": [[14, 21, "GENE"]]}], ["Background : Pre-eclampsia (PE) is a major pregnancy disorder complicating up to 8% of pregnancies.", {"entities": [[17, 26, "DISEASE"]]}], ["Increasing evidence indicates a sex-specific interplay between the mother, placenta and fetus.", {"entities": []}], ["This may lead to different adaptive mechanisms during pregnancy.", {"entities": []}], ["Methods: We performed an individual participant data meta-analysis to determine associations of fetal sex and PE, with specific focus on gestational age at delivery in PE.", {"entities": []}], ["This was done on 219\u2009575 independent live-born singleton pregnancies, with a gestational age at birth between 22.0 and 43.0 weeks of gestation, from 11 studies participating in a worldwide consortium of international research groups focusing on pregnancy.", {"entities": []}], ["Results: Of the women, 9033 (4.1%) experienced PE in their pregnancy and 48.8% of the fetuses were female versus 51.2% male.", {"entities": []}], ["No differences in the female/male distribution were observed with respect to term PE (delivered\u2009\u2265\u200937 weeks).", {"entities": []}], ["Preterm PE (delivered\u2009<\u200937 weeks) was slightly more prevalent among pregnancies with a female fetus than in pregnancies with a male fetus [odds ratio (OR) 1.11, 95% confidence interval (CI) 1.02\u20131.21].", {"entities": []}], ["Very preterm PE (delivered\u2009<\u200934 weeks) was even more prevalent among pregnancies with a female fetus as compared with pregnancies with a male fetus (OR 1.36, 95% CI 1.17\u20131.59).", {"entities": []}], ["Conclusions: Sexual dimorphic differences in the occurrence of PE exist, with preterm PE being more prevalent among pregnancies with a female fetus as compared with pregnancies with a male fetus and with no differences with respect to term PE.", {"entities": []}], ["Asthma is a chronic respiratory disease characterized by airway inflammation and remodeling, resulting in a substantial economic burden on both patients and society.", {"entities": [[0, 6, "DISEASE"]]}], ["Deguelin, a constituent of the Leguminosae family, exhibits anti-proliferative and anti-inflammatory activities in cancer mice models via inhibiting phosphatidylinositol 3-kinases and the NF-\u03baB pathway.", {"entities": [[115, 121, "DISEASE"]]}], ["We demonstrated that deguelin effectively reduced OVA-induced inflammatory cell recruitment, decreased lung tissue inflammation and mucus production, suppressed airway hyperresponsiveness, and inhibited serum immunoglobulin and Th2 cytokine levels in a dose-dependent manner in asthmatic mice.", {"entities": []}], ["In addition, we found that deguelin reduced inflammatory gene expressions both in vivo and in vitro , which were closely associated with activation of the NF-\u03baB signaling pathway.", {"entities": []}], ["Thus, we further explored the underlying mechanisms of deguelin in normal human bronchial epithelial cells (BEAS-2B).", {"entities": []}], ["Our results suggested that deguelin inhibited NF-\u03baB binding activity by enhancing the ability of I\u03baB\u03b1 to maintain NF-\u03baB in an inactive form in the cytoplasm and preventing the TNF-\u03b1 induced translocation of p65 to the nucleus.", {"entities": []}], ["In conclusion, our research indicates that deguelin attenuates allergic airway inflammation via inhibition of NF-\u03baB pathway in mice model and may act as a potential therapeutic agent for patients with allergic airway inflammation.", {"entities": []}], ["Psychiatric symptoms of anxiety, depression and cognitive dysfunction often occur in patients suffering from somatic conditions such as asthma and chronic obstructive pulmonary disease (COPD) which constitute a major and growing public health problem.", {"entities": [[147, 184, "DISEASE"], [136, 142, "DISEASE"]]}], ["In the present study we therefore aimed at analyzing depressive symptoms as well as symptoms of anxiety and cognitive problems in patients with mild to moderate asthma and COPD.", {"entities": [[161, 167, "DISEASE"]]}], ["59 participants\u201417 with asthma, 24 with COPD and 18 healthy controls were enrolled.", {"entities": [[24, 30, "DISEASE"]]}], ["Depressiveness was assessed with the beck depression inventory (BDI); anxiety symptoms were measured with the State-Trait Anxiety Inventory Part 1 and 2, and cognitive function levels were estimated with the Trail Making Test Part A and B.", {"entities": []}], ["A score above the threshold indicative for depression was found by 33\u00a0% ( n \u00a0=\u00a08) of COPD patients, 29\u00a0% ( n \u00a0=\u00a05) of asthma patients compared to 0.05\u00a0% ( n \u00a0=\u00a01) of the control group.", {"entities": [[118, 124, "DISEASE"]]}], ["Clinically relevant anxiety levels were found in 42\u00a0% ( n \u00a0=\u00a010) of the COPD group, 41\u00a0% ( n \u00a0=\u00a07) of the asthma patients and 17\u00a0% ( n \u00a0=\u00a03) of the controls.", {"entities": [[106, 112, "DISEASE"]]}], ["Patients with COPD performed significantly worse on the TMT than other groups.", {"entities": []}], ["Psychoemotional state and cognitive functions were found to be correlated with exposure to tobacco smoke (measured in pack-years) and airway obstruction (measured with FEV1).", {"entities": []}], ["In conclusion, patients with mild to moderate asthma and COPD exhibit significantly higher levels of depressive and anxiety symptoms as well as cognitive dysfunctions than controls.", {"entities": [[46, 52, "DISEASE"]]}], ["The prevalence of these symptoms is related to the amount of exposure to tobacco smoke and the severity of airflow obstruction.", {"entities": []}], ["The purpose of this study was the effect of epithelium damage on mechanical responses of airway smooth muscles under different resting tension.", {"entities": []}], ["We performed acetylcholine (ACh) (10(-5) M)-induced contraction on tracheal strips from 30 rabbits in five groups (0.5, 1, 1.5, 2 and 2.5 g) before and after epithelium removal.", {"entities": []}], ["At low resting tension (0.5-1.5 g), the epithelium removal decreased the ACh-induced contractions.", {"entities": []}], ["At 2 g resting tension, the epithelium removal increased the ACh-induced contractions of airways with intact epithelium about 20%.", {"entities": []}], ["At 2.5 g resting tension, the elevation of contraction is about 25% (P<0.01).", {"entities": []}], ["Consequently, after epithelium loss, the resting tension determines the airway smooth muscles responsiveness.", {"entities": []}], ["In asthma, mediators such as ACh act on already contracted inflammatory airways, which results in additional increase of contraction.", {"entities": [[3, 9, "DISEASE"]]}], ["In contrast, low resting tension, a condition that simulates normal tidal breathing, protects from bronchoconstriction even when the epithelium is damaged.", {"entities": []}], ["Yoga is a holistic therapy of expanding popularity, which has the potential to produce a range of physical, mental and social benefits.", {"entities": []}], ["This trial evaluated the feasibility and effects of an adapted yoga programme on physical function and health-related quality of life in physically-inactive older adults.", {"entities": []}], ["In this randomised controlled pilot trial, 52 older adults (90% female; mean age 74.8\u00a0years, SD 7.2) were randomised 1:1 to a yoga programme or wait-list control.", {"entities": []}], ["The yoga group ( n \u00a0=\u00a025) received a physical activity education booklet and were invited to attend ten yoga sessions during a 12-week period.", {"entities": []}], ["The control group ( n \u00a0=\u00a027) received the education booklet only.", {"entities": []}], ["Measures of physical function (e.g., Short Physical Performance Battery; SPPB), health status (EQ-5D) and mental well-being (Warwick-Edinburgh Mental Well-being Scale; WEMWBS) were assessed at baseline and 3\u00a0months.", {"entities": []}], ["Feasibility was assessed using course attendance and adverse event data, and participant interviews.", {"entities": []}], ["Forty-seven participants completed follow-up assessments.", {"entities": []}], ["Median class attendance was 8 (range 3 to 10).", {"entities": []}], ["At the 3-month follow-up, the yoga group had a higher SPPB total score compared with the control group (mean difference 0.9, 95% confidence interval [CI] -0.3 to 2.0), a faster time to rise from a chair five times (mean difference\u00a0\u2212\u00a01.73\u00a0s, 95% CI \u22124.08 to 0.62), and better performance on the chair sit-and-reach lower-limb flexibility test (mean difference 5\u00a0cm, 95% CI 0 to 10).", {"entities": []}], ["The yoga group also had superior health status and mental well-being (vs. control) at 3\u00a0months, with mean differences in EQ-5D and WEMWBS scores of 0.12 (95% CI, 0.03 to 0.21) and 6 (95% CI, 1 to 11), respectively.", {"entities": []}], ["The interviews indicated that participants valued attending the yoga programme, and that they experienced a range of benefits.", {"entities": []}], ["The adapted yoga programme appeared to be feasible and potentially beneficial in terms of improving mental and social well-being and aspects of physical function in physically-inactive older adults.", {"entities": []}], ["An appropriately-powered trial is required to confirm the findings of the present study and to determine longer-term effects.", {"entities": []}], ["ClinicalTrials.gov NCT02663726 .", {"entities": []}], ["Objective : To explore the associations between decreased pulse oximetry values (SpO 2 ) and clinical, laboratory, and demographic variables in general practice patients diagnosed with asthma or chronic obstructive pulmonary disease (COPD), including those with both COPD and asthma in combination.", {"entities": [[195, 232, "DISEASE"], [185, 191, "DISEASE"], [276, 282, "DISEASE"]]}], ["Design/setting : A cross-sectional study in seven Norwegian general practices of patients aged 40 years or over who were diagnosed by their general practitioner (GP) with asthma and/or COPD.", {"entities": [[171, 177, "DISEASE"]]}], ["The patients were examined during a stable phase of their disease.", {"entities": []}], ["Patients diagnosed with COPD (including those with combined COPD/asthma) and those diagnosed with asthma only were analysed separately.", {"entities": [[65, 71, "DISEASE"], [98, 104, "DISEASE"]]}], ["Main outcome measures : Decreased SpO 2 values (\u2264\u200995% and\u2009\u2264\u200992%).", {"entities": []}], ["Results : Of 372 patients included (mean age 61.5 years, 62% women), 82 (22.0%) had SpO 2 \u2009\u2264\u200995%, of which 11 had SpO 2 \u2009\u2264\u200992%.", {"entities": []}], ["In both asthma and COPD patients, SpO 2 \u2009\u2264\u200995% was significantly associated with reduced lung function (spirometry), a diagnosis of coronary heart disease and older age (\u2265\u200965 years).", {"entities": [[141, 154, "DISEASE"], [132, 154, "DISEASE"], [8, 14, "DISEASE"]]}], ["In the COPD group, haemoglobin above normal was associated with SpO 2 \u2009\u2264\u200995%.", {"entities": []}], ["These associations were confirmed by multivariable logistic regression, where FEV 1 % predicted\u2009<\u200950 was the strongest predictor of SpO 2 \u2009\u2264\u200995% (odds ratio 6.8, 95% confidence interval 2.8\u201316.4).", {"entities": [[78, 81, "GENE"]]}], ["Conclusion.", {"entities": []}], ["Pulse oximetry represents a useful diagnostic adjunct for assessing the severity of obstructive pulmonary disease.", {"entities": []}], ["Decreased pulse oximetry values in stable-phase patients with asthma and/or COPD should prompt the GP to consider revising the diagnosis and treatment and to look for co-morbidities.", {"entities": [[62, 68, "DISEASE"]]}], ["Key Points Despite its common use in general practice, the diagnostic benefits of pulse oximetry remain to be established.", {"entities": []}], ["Decreased pulse oximetry values are associated with both reduced lung function (spirometry) and with a diagnosis of coronary heart disease.", {"entities": [[125, 138, "DISEASE"], [116, 138, "DISEASE"]]}], ["Decreased pulse oximetry values may reflect suboptimal treatment and/or undiagnosed comorbidity.", {"entities": []}], ["Pulse oximetry may therefore be a useful measure in the follow-up of asthma and COPD patients in general practice.", {"entities": [[69, 75, "DISEASE"]]}], ["Despite its common use in general practice, the diagnostic benefits of pulse oximetry remain to be established.", {"entities": []}], ["Decreased pulse oximetry values are associated with both reduced lung function (spirometry) and with a diagnosis of coronary heart disease.", {"entities": [[125, 138, "DISEASE"], [116, 138, "DISEASE"]]}], ["Decreased pulse oximetry values may reflect suboptimal treatment and/or undiagnosed comorbidity.", {"entities": []}], ["Pulse oximetry may therefore be a useful measure in the follow-up of asthma and COPD patients in general practice.", {"entities": [[69, 75, "DISEASE"]]}], ["Despite the growing number of point-of-care (POC) tests available, little research has assessed primary care clinician need for such tests.", {"entities": []}], ["We therefore aimed to determine which POC tests they actually use or would like to use (if not currently available in their practice).", {"entities": []}], ["Cross-sectional survey.", {"entities": []}], ["Primary care in Australia, Belgium (Flanders region only), the Netherlands, the UK and the USA.", {"entities": []}], ["Primary care doctors (general practitioners, family physicians).", {"entities": []}], ["We asked respondents to (1) identify conditions for which a POC test could help inform diagnosis, (2) from a list of tests provided: evaluate which POC tests they currently use (and how frequently) and (3) determine which tests (from that same list) they would like to use in the future (and how frequently).", {"entities": []}], ["2770 primary care clinicians across five countries responded.", {"entities": []}], ["Respondents in all countries wanted POC tests to help them diagnose acute conditions (infections, acute cardiac disease, pulmonary embolism/deep vein thrombosis), and some chronic conditions (diabetes, anaemia).", {"entities": [[121, 139, "DISEASE"]]}], ["Based on the list of POC tests provided, the most common tests currently used were: urine pregnancy, urine leucocytes or nitrite and blood glucose.", {"entities": []}], ["The most commonly reported tests respondents expressed a wish to use in the future were: D-dimer, troponin and chlamydia.", {"entities": []}], ["The UK and the USA reported a higher actual and desired use for POC tests than Australia, Belgium and the Netherlands.", {"entities": []}], ["Our limited data suggest (but do not confirm) representativeness.", {"entities": []}], ["Primary care clinicians in all five countries expressed a desire for POC tests to help them diagnose a range of acute and chronic conditions.", {"entities": []}], ["Rates of current reported use and desired future use were generally high for a small selection of POC tests, but varied across countries.", {"entities": []}], ["Future research is warranted to explore how specific POC tests might improve primary care.", {"entities": []}], ["Previous studies have demonstrated the ability of an eicosapentaenoic acid (EPA)-derived endogenous cyclopentenone prostaglandin (CyPG) metabolite, \u0394 3 , to selectively target leukemic stem cells, but not the normal hematopoietic stems cells, in in vitro and in vivo models of chronic myelogenous leukemia (CML).", {"entities": [[297, 305, "DISEASE"]]}], ["Here we evaluated the stability, bioavailability, and hypersensitivity of \u0394 3 .", {"entities": []}], ["The stability of \u0394 3 was evaluated under simulated conditions using artificial gastric and intestinal juice.", {"entities": []}], ["The bioavailability of \u0394 3 in systemic circulation was demonstrated upon intraperitoneal injection into mice by LC-MS/MS.", {"entities": []}], ["\u0394 3 being a downstream metabolite of PGD 3 was tested in vitro using primary mouse bone marrow-derived mast cells (BMMCs) and in vivo mouse models for airway hypersensitivity.", {"entities": [[37, 40, "GENE"]]}], ["ZK118182, a synthetic PG analog with potent PGD 2 receptor (DP)-agonist activity and a drug candidate in current clinical trials, was used for toxicological comparison.", {"entities": [[44, 47, "GENE"]]}], ["\u0394 3 was relatively more stable in simulated gastric juice than in simulated intestinal juice that followed first-order kinetics of degradation.", {"entities": []}], ["Intraperitoneal injection into mice revealed that \u0394 3 was bioavailable and well absorbed into systemic circulation with a C max of 263 \u00b5g/L at 12 h. Treatment of BMMCs with ZK118182 for 12 h resulted in increased production of histamine, while \u0394 3 did not induce degranulation in BMMCs nor increase histamine.", {"entities": [[124, 127, "GENE"]]}], ["In addition, in vivo testing for hypersensitivity in mice showed that ZK118182 induces higher airways hyperresponsiveness when compared \u0394 3 and/or PBS control.", {"entities": []}], ["Based on the stability studies, our data indicates that intraperitoneal route of administration of \u0394 3 was favorable than oral administration to achieve effective pharmacological levels in the plasma against leukemia.", {"entities": [[208, 216, "DISEASE"]]}], ["\u0394 3 failed to increase histamine and IL-4 in BMMCs, which is in agreement with reduced airway hyperresponsiveness in mice.", {"entities": []}], ["In summary, our studies suggest \u0394 3 to be a promising bioactive metabolite for further evaluation as a potential drug candidate for treating CML.", {"entities": []}], ["Engineered nanoparticles (NPs) are widely used in many sectors, such as food, medicine, military, and sport, but their unique characteristics may cause deleterious health effects.", {"entities": [[26, 29, "GENE"]]}], ["Close attention is being paid to metal NP genotoxicity; however, NP genotoxic/carcinogenic effects and the underlying mechanisms remain to be elucidated.", {"entities": []}], ["In this review, we address some metal and metal oxide NPs of interest and current genotoxicity tests in vitro and in vivo.", {"entities": [[54, 57, "GENE"]]}], ["Metal NPs can cause DNA damage such as chromosomal aberrations, DNA strand breaks, oxidative DNA damage, and mutations.", {"entities": [[6, 9, "GENE"]]}], ["We also discuss several parameters that may affect genotoxic response, including physicochemical properties, widely used assays/end point tests, and experimental conditions.", {"entities": []}], ["Although potential biomarkers of nanogenotoxicity or carcinogenicity are suggested, inconsistent findings in the literature render results inconclusive due to a variety of factors.", {"entities": []}], ["Advantages and limitations related to different methods for investigating genotoxicity are described, and future directions and recommendations for better understanding genotoxic potential are addressed.", {"entities": []}], ["To investigate the role of Acylation Stimulating Protein (ASP) receptor C5L2 in skeletal muscle fatty acid accumulation and metabolism as well as insulin sensitivity in both mice and human models of diet-induced insulin resistance.", {"entities": []}], ["Male wildtype (WT) and C5L2 knockout (KO) mice were fed a low (LFD) or a high (HFD) fat diet for 10 weeks.", {"entities": []}], ["Intramyocellular lipid (IMCL) accumulation (by oil red O staining) and beta-oxidation HADH enzyme activity were determined in skeletal muscle.", {"entities": [[86, 90, "GENE"]]}], ["Mitochondria were isolated from hindleg muscles for high-resolution respirometry.", {"entities": []}], ["Muscle C5L2 protein content was also determined in obese type 2 diabetics and age- and BMI matched men.", {"entities": []}], ["IMCL levels were increased by six-fold in C5L2KO-HFD compared to WT-HFD mice (p<0.05) and plasma insulin levels were markedly increased in C5L2KO-HFD mice (twofold, p<0.05).", {"entities": []}], ["Muscle HADH activity was elevated in C5L2KO-LFD mice (+75%, p<0.001 vs. WT-LFD) and C5L2KO-HFD displayed increased mitochondrial fatty acid oxidative capacity compared to WT-HFD mice (+23%, p<0.05).", {"entities": [[7, 11, "GENE"]]}], ["In human subjects, C5L2 protein content was reduced (\u221248%, p<0.01) in type 2 diabetic patients when compared to obese controls.", {"entities": []}], ["Further, exercise training increased C5L2 (+45%, p\u200a=\u200a0.0019) and ASP (+80%, p<0.001) in obese insulin-resistant men.", {"entities": []}], ["The results suggest that insulin sensitivity may be permissive for coupling of C5L2 levels to lipid storage and utilization.", {"entities": []}], ["HIV replication is closely regulated by a complex pathway of host factors, many of them being determinants of cell tropism and host susceptibility to HIV infection.", {"entities": []}], ["These host factors are known to exert a positive or negative influence on the replication of the two major types of HIV, HIV-1 and HIV-2, thereby modulating virus infectivity, host response to infection and ultimately disease progression profiles characteristic of these two types.", {"entities": []}], ["Understanding the differential regulation of host cellular factors in response to HIV-1 and HIV-2 infections will help us to understand the apparent differences in rates of disease progression and pathogenesis.", {"entities": []}], ["This knowledge would aid in the discovery of new biomarkers that may serve as novel targets for therapy and diagnosis.", {"entities": []}], ["The objective of this study was to determine the differential expression of host genes in response to HIV-1/HIV-2 infection.", {"entities": []}], ["To achieve this, we analyzed the effects of HIV-1 (MN) and HIV-2 (ROD) infection on the expression of host factors in PBMC at the RNA level using the Agilent Whole Human Genome Oligo Microarray.", {"entities": []}], ["Differentially expressed genes were identified and their biological functions determined.", {"entities": []}], ["Host gene expression profiles were significantly changed.", {"entities": []}], ["Gene expression profiling analysis identified a subset of differentially expressed genes in HIV-1 and HIV-2 infected cells.", {"entities": []}], ["Genes involved in cellular metabolism, apoptosis, immune cell proliferation and activation, cytokines, chemokines, and transcription factors were differentially expressed in HIV-1 infected cells.", {"entities": []}], ["Relatively few genes were differentially expressed in cells infected with HIV-2.", {"entities": []}], ["Validated measures to assess the severity of airway obstruction in patients with obstructive airway disease are limited.", {"entities": []}], ["Changes in the pulse oximeter plethysmograph waveform represent fluctuations in arterial flow.", {"entities": []}], ["Analysis of these fluctuations might be useful clinically if they represent physiologic perturbations resulting from airway obstruction.", {"entities": []}], ["We tested the hypothesis that the severity of airway obstruction could be estimated using plethysmograph waveform data.", {"entities": []}], ["Using a closed airway circuit with adjustable inspiratory and expiratory pressure relief valves, airway obstruction was induced in a prospective convenience sample of 31 healthy adult subjects.", {"entities": []}], ["Maximal change in airway pressure at the mouthpiece was used as a surrogate measure of the degree of obstruction applied.", {"entities": []}], ["Plethysmograph waveform data and mouthpiece airway pressure were acquired for 60 seconds at increasing levels of inspiratory and expiratory obstruction.", {"entities": []}], ["At each level of applied obstruction, mean values for maximal change in waveform area under the curve and height as well as maximal change in mouth pressure were calculated for sequential 7.5 second intervals.", {"entities": []}], ["Correlations of these waveform variables with mouth pressure values were then performed to determine if the magnitude of changes in these variables indicates the severity of airway obstruction.", {"entities": []}], ["There were significant relationships between maximal change in area under the curve (P < .0001) or height (P < 0.0001) and mouth pressure.", {"entities": []}], ["The findings suggest that mathematic interpretation of plethysmograph waveform data may estimate the severity of airway obstruction and be of clinical utility in objective assessment of patients with obstructive airway diseases.", {"entities": []}], ["Contrast media (CM) are used in imaging techniques to enhance the differences between body tissues on images.", {"entities": []}], ["The ideal contrast medium should achieve very high concentration in the tissues without producing any adverse effects.", {"entities": []}], ["Unfortunately, this has not been possible so far and all CM have adverse effects.", {"entities": []}], ["The increasing use of CM is likely to give rise to a wide range of pitfalls, including compliance with and appropriateness of indications for the use of CM themselves, the choice of the \u2018best\u2019 contrast agent, off-label use, evaluation of special populations of patients, and competence to tackle emergency scenarios following the administration of CM.", {"entities": []}], ["Even more prominent, and potentially more important, is the issue of informed consent which brings with it a duty to inform patients awaiting the administration of CM with regard to the nature of the procedure, the existence of alternative procedures, the extent of the risks relating to the use of CM and, finally, the risks relating to refusal of the procedure.", {"entities": []}], ["All these issues may give rise to concerns about liability for failure to offer adequate information to patients or to carefully evaluate and balance the potential risks and benefits of the procedure or, finally, for being unprepared in the event of adverse reactions to CM, especially when these are severe and life-threatening.", {"entities": []}], ["Educational and training programmes for radiologists are likely to shape change in the medical liability environment in the coming years.", {"entities": []}], ["Although studies have demonstrated that air pollution is associated with exacerbation of asthma symptoms in children with asthma, little is known about the susceptibility of subgroups, particularly those with atopy.", {"entities": [[89, 95, "DISEASE"], [122, 128, "DISEASE"]]}], ["This study was designed to evaluate our a priori hypothesis that identifiable subgroups of asthmatic children are more likely to wheeze with exposure to ambient air pollution.", {"entities": []}], ["A cohort of 315 children with asthma, 6\u201311 years of age, was recruited for longitudinal follow-up in Fresno, California (USA).", {"entities": [[30, 36, "DISEASE"]]}], ["During the baseline visit, children were administered a respiratory symptom questionnaire and allergen skin-prick test.", {"entities": []}], ["Three times a year, participants completed 14-day panels during which they answered symptom questions twice daily.", {"entities": []}], ["Ambient air quality data from a central monitoring station were used to assign exposures to the following pollutants: particulate matter \u2264 2.5 \u03bcm in aerodynamic diameter, particulate matter between 2.5 and 10 \u03bcm in aerodynamic diameter (PM 10\u20132.5 ), elemental carbon, nitrogen dioxide (NO 2 ), nitrate, and O 3 .", {"entities": []}], ["For the group as a whole, wheeze was significantly associated with short-term exposures to NO 2 [odds ratio (OR) = 1.10 for 8.7-ppb increase; 95% confidence interval (CI), 1.02\u20131.20] and PM 10\u20132.5 (OR = 1.11 for 14.7-\u03bcg/m A pollutant associated with traffic emissions, NO 2 , and a pollutant with bioactive constituents, PM 10\u20132.5 , were associated with increased risk of wheeze in asthmatic children living in Fresno, California.", {"entities": []}], ["Children with atopy to cat or common fungi and boys with mild intermittent asthma were the subgroups for which we observed the largest associations.", {"entities": [[75, 81, "DISEASE"]]}], ["Pooled estimates of air pollution health effects are important drivers of environmental risk communications and political willingness.", {"entities": []}], ["In China, there is a lack of review studies to provide such estimates for health impact assessments.", {"entities": []}], ["We systematically searched the MEDLINE database using keywords of 80 major Chinese cities in Mainland China, Hong Kong and Taiwan on 30 June 2012, yielding 350 abstracts with 48 non-duplicated reports either in English or Chinese after screening.", {"entities": []}], ["We pooled the relative risks (RR) per 10\u00a0\u03bcg/m 10 ), nitrogen dioxide (NO 2 ), sulphur dioxide (SO 2 ) and ozone (O 3 ).", {"entities": []}], ["For short-term effects, the pooled RR (p\u2009<\u20090.05) ranges were: 1.0031 (PM 10 ) to 1.0140 (NO 2 ) for all-cause mortality, 1.0034 (cardiopulmonary, PM 10 ) to 1.0235 (influenza and pneumonia, SO 2 ) for 9 specific-causes mortality, 1.0021 (cardiovascular, PM 10 ) to 1.0162 (asthma, O 3 ) for 5 specific-causes hospital admissions.", {"entities": [[165, 174, "DISEASE"], [179, 188, "DISEASE"], [273, 279, "DISEASE"]]}], ["For birth outcomes, the RR (p\u2009<\u20090.05) ranged from 1.0051 (stillbirth, O 3 ) to 1.1189 (preterm-birth, SO 2 ) and for long-term effect on mortality from 1.0150 (respiratory, SO 2 ) to 1.0297 (respiratory, NO 2 ).", {"entities": []}], ["Publication bias was absent (Egger test: p\u2009=\u20090.326 to 0.624).", {"entities": []}], ["Annual PM 10 and NO 2 concentrations were inversely associated with RR of mortality (p\u2009=\u20090.017-0.028).", {"entities": []}], ["Evidence on short-term effects of air pollution is consistent and sufficient for health impact assessment but that on long-term effects is still insufficient.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) often have poor health-related quality of life (HRQoL) that is disproportionate to their degree of airflow limitation.", {"entities": [[14, 51, "DISEASE"]]}], ["This study evaluated the association between St George\u2019s Respiratory Questionnaire for COPD (SGRQ-C) score and forced expiratory volume in one second and investigated the factors responsible for high SGRQ-C score according to severity of airflow limitation.", {"entities": []}], ["Data from 1,264 COPD patients were obtained from the Korean COPD Subgroup Study (KOCOSS) cohort.", {"entities": []}], ["Patients were categorized into two groups according to severity of airflow limitation: mild-to-moderate and severe-to-very severe COPD groups.", {"entities": []}], ["We evaluated the clinical factors associated with high SGRQ-C score (\u226525) in each COPD patient group.", {"entities": []}], ["Of the 1,264 COPD patients, 902 (71.4%) had mild-to-moderate airflow limitation and 362 (28.6%) had severe-to-very severe airflow limitation.", {"entities": []}], ["Of the mild-to-moderate COPD patients, 59.2% (534/902) had high SGRQ-C score, while 80.4% (291/362) of the severe-to-very severe COPD patients had high SGRQ-C score.", {"entities": []}], ["The association between SGRQ-C score and post-bronchodilator forced expiratory volume in one second (% predicted) was very weak in the mild-to-moderate COPD patients ( r =\u22120.103, p =0.002) and weak in the severe-to-very severe COPD patients ( r =\u22120.219, p <0.001).", {"entities": []}], ["Multiple logistic regression analysis revealed that age, being an ex- or current smoker, lower level of education, cough, dyspnea, and number of comorbidities with congestive heart failure, hyperlipidemia, and depression were significantly associated with high SGRQ-C score in mild-to-moderate COPD patients.", {"entities": [[164, 188, "DISEASE"]]}], ["In comparison, being an ex-smoker and having respiratory symptoms including sputum and dyspnea were significant factors associated with high SGRQ-C score in severe-to-very severe COPD patients.", {"entities": []}], ["In addition to the respiratory symptoms of dyspnea and cough, high SGRQ-C score was associated with extra-pulmonary comorbidities in mild-to-moderate COPD patients.", {"entities": []}], ["However, only respiratory symptoms such as sputum and dyspnea were significantly associated with high SGRQ-C score in severe-to-very severe COPD patients.", {"entities": []}], ["This indicates the need for an improved management strategy for relieving respiratory symptoms in COPD patients with poor HRQoL.", {"entities": []}], ["In addition, attention should be paid to extra-pulmonary comorbidities, especially in mild-to-moderate COPD patients with poor HRQoL.", {"entities": []}], ["Asthma is a chronic inflammatory disease characterised by airways remodelling.", {"entities": [[0, 6, "DISEASE"]]}], ["In mouse models IL-9 and IL-13 have been implicated in airways remodelling including mucus hypersecretion and goblet cell hyperplasia.", {"entities": []}], ["Their role, especially that of IL-9, has been much less studied in authentic human ex vivo models of the bronchial epithelium from normal and asthmatic children.", {"entities": []}], ["We assessed the effects of IL-9, IL-13 and an IL-9/IL-13 combination, during differentiation of bronchial epithelial cells from normal (n\u200a=\u200a6) and asthmatic (n\u200a=\u200a8) children.", {"entities": []}], ["Cultures were analysed for morphological markers and factors associated with altered differentiation (MUC5AC, SPDEF and MMP-7).", {"entities": [[110, 115, "GENE"]]}], ["IL-9, IL-9/IL-13 combination and IL-13 stimulated bronchial epithelial cells from normal children had fewer ciliated cells [14.8% (SD 8.9), p\u200a=\u200a0.048, 12.4 (SD 6.1), p\u200a=\u200a0.016 and 7.3% (SD 6.6), p\u200a=\u200a0.031] respectively compared with unstimulated [(21.4% (SD 9.6)].", {"entities": []}], ["IL-9 stimulation had no effect on goblet cell number in either group whereas IL-9/IL-13 combination and IL-13 significantly increased goblet cell number [24.8% (SD 8.8), p\u200a=\u200a0.02), 32.9% (SD 8.6), p\u200a=\u200a0.007] compared with unstimulated normal bronchial cells [(18.6% (SD 6.2)].", {"entities": []}], ["All stimulations increased MUC5AC mRNA in bronchial epithelial cells from normal children and increased MUC5AC mucin secretion.", {"entities": []}], ["MMP-7 localisation was dysregulated in normal bronchial epithelium stimulated with Th2 cytokines which resembled the unstimulated bronchial epithelium of asthmatic children.", {"entities": []}], ["All stimulations resulted in a significant reduction in transepithelial electrical resistance values over time suggesting a role in altered tight junction formation.", {"entities": []}], ["We conclude that IL-9 does not increase goblet cell numbers in bronchial epithelial cell cultures from normal or asthmatic children.", {"entities": []}], ["IL-9 and IL-13 alone and in combination, reduce ciliated cell numbers and transepithelial electrical resistance during differentiation of normal epithelium, which clinically could inhibit mucociliary clearance and drive an altered repair mechanism.", {"entities": []}], ["This suggests an alternative role for IL-9 in airways remodelling and reaffirms IL-9 as a potential therapeutic target.", {"entities": []}], ["Irrational drug use results in drug interactions, treatment noncompliance, and drug resistance.", {"entities": []}], ["Rational pharmacotherapy education is being implemented in many faculties of medicine.", {"entities": []}], ["Our aim is to introduce rational pharmacotherapy education by clinicians and to evaluate task-based rational drug therapy education in the clinical context.", {"entities": []}], ["The Kirkpatrick's evaluation model was used for the evaluation of the program.", {"entities": []}], ["The participants evaluated the program in terms of constituents of the program, utilization, and contribution to learning.", {"entities": []}], ["Voluntary participants responded to the evaluation forms after the educational program.", {"entities": []}], ["Data are evaluated using both quantitative and qualitative tools.", {"entities": []}], ["SPSS (version 21) used for quantitative data for determining mean and standard deviation values.", {"entities": []}], ["Descriptive qualitative analysis approach is used for the analysis of open-ended questions.", {"entities": []}], ["It was revealed that the program and its components have been favorable.", {"entities": []}], ["A total 95.9% of the students consider the education to be beneficial.", {"entities": []}], ["Simulated patients practice and personal drug choice/problem-based learning sessions were appreciated by the students in particular.", {"entities": []}], ["93.9% of the students stated that all students of medicine should undergo this educational program.", {"entities": []}], ["Among the five presentations contained in the program, \u201cThe Principles of Prescribing\u201d received the highest points (9 \u00b1 1.00) from participating students in general evaluation of the educational program.", {"entities": []}], ["This study was carried out to improve task-based rational drug therapy education.", {"entities": []}], ["According to feedback from the students concerning content, method, resource, assessment, and program design; some important changes, especially in number of facilitators and indications, are made in rational pharmacotherapy education in clinical task-based learning program.", {"entities": []}], ["The age of an individual is an important, independent risk factor for many of the most common diseases afflicting modern societies.", {"entities": []}], ["Interleukin-7 (IL-7) plays a central, critical role in the homeostasis of the immune system.", {"entities": []}], ["Recent studies support a critical role for IL-7 in the maintenance of a vigorous healthspan.", {"entities": []}], ["We describe the role of IL-7 and its receptor in immunosenescence, the aging of the immune system.", {"entities": []}], ["An understanding of the role that IL-7 plays in aging may permit parsimonious preventative or therapeutic solutions for diverse conditions.", {"entities": []}], ["Perhaps IL-7 might be used to \u201ctune\u201d the immune system to optimize human healthspan and longevity.", {"entities": []}], ["Familial hypocalciuric hypercalcemia is a rare autosomal dominant disorder characterized by asymptomatic and non-progressive hypercalcemia due to mutations of the calcium-sensing receptor gene.", {"entities": [[23, 36, "DISEASE"], [125, 138, "DISEASE"]]}], ["Disorders of calcium metabolism are very common in the elderly, and they can coexist with familial hypocalciuric hypercalcemia in affected families.", {"entities": [[113, 126, "DISEASE"]]}], ["We describe an Irish family with hypercalcemia and hypocalciuria.", {"entities": [[33, 46, "DISEASE"]]}], ["The proband, an 80-year-old Irish woman, presented with hypercalcemia, relative hypocalciuria, and an elevated parathormone level.", {"entities": [[56, 69, "DISEASE"]]}], ["She also had chronic kidney disease stage 3 and vitamin D deficiency.", {"entities": [[21, 35, "DISEASE"]]}], ["Two of her sons were also found to be hypercalcemic and hypocalciuric.", {"entities": []}], ["DNA sequencing identified a novel missense inactivating mutation in the calcium sensing-receptor gene of the proband and her two hypercalcemic sons.", {"entities": []}], ["Familial hypocalciuric hypercalcemia due to a novel mutation in the calcium-sensing receptor gene was diagnosed in the proband and her two sons.", {"entities": [[23, 36, "DISEASE"]]}], ["Disorders of calcium metabolism can be multifarious in the elderly.", {"entities": []}], ["We suggest that testing first degree relatives for calcium levels and DNA sequencing may have a role in the assessment of elderly patients with parathormone-related hypercalcemia.", {"entities": [[165, 178, "DISEASE"]]}], ["Irreversible airflow obstruction in Chronic Obstructive Pulmonary Disease (COPD) is thought to result from airway remodelling associated with aberrant inflammation.", {"entities": []}], ["Patients who experience frequent episodes of acute deterioration in symptoms and lung function, termed exacerbations, experience a faster decline in their lung function, and thus over time greater disease severity However the mechanisms by which these episodes may contribute to decreased lung function are poorly understood.", {"entities": []}], ["This study has prospectively examined changes in sputum levels of inflammatory cells, MMP-9 and TIMP-1 during exacerbations comparing with paired samples taken prior to exacerbation.", {"entities": []}], ["Nineteen COPD patients ((median, [IQR]) age 69 [63 to 74], forced expiratory volume in one second (FEV1) 1.0 [0.9 to1.2], FEV1% predicted 37.6 [27.3 to 46.2]) provided sputa at exacerbation.", {"entities": []}], ["Of these, 12 were paired with a samples collected when the patient was stable, a median 4 months [2 to 8 months] beforehand.", {"entities": []}], ["MMP-9 levels increased from 10.5 \u03bcg/g [1.2 to 21.1] prior to exacerbation to 17.1 \u03bcg/g [9.3 to 48.7] during exacerbation ( P < 0.01).", {"entities": []}], ["TIMP-1 levels decreased from 3.5 \u03bcg/g [0.6 to 7.8] to 1.5 \u03bcg/g [0.3 to 4.9] ( P = 0.16).", {"entities": []}], ["MMP-9/TIMP-1 Molar ratio significantly increased from 0.6 [0.2 to 1.1] to 3.6 [2.0 to 25.3] ( P < 0.05).", {"entities": []}], ["Neutrophil, eosinophil and lymphocyte counts all showed significant increase during exacerbation compared to before ( P < 0.05).", {"entities": []}], ["Macrophage numbers remained level.", {"entities": []}], ["MMP-9 levels during exacerbation showed highly significant correlation with both neutrophil and lymphocyte counts (Rho = 0.7, P < 0.01).", {"entities": []}], ["During exacerbation, increased inflammatory burden coincides with an imbalance of the proteinase MMP-9 and its cognate inhibitor TIMP-1.", {"entities": []}], ["This may suggest a pathway connecting frequent exacerbations with lung function decline.", {"entities": []}], ["Oral leukoplakias are histopathologically-diagnosed as Candida leukoplakia or non- Candida leukoplakia by the presence or absence of hyphae in the superficial epithelium.", {"entities": []}], ["Candida leukoplakia lesions have significantly increased malignant potential.", {"entities": []}], ["Candida albicans is the most prevalent fungal species associated with oral leukoplakia and may contribute to malignant transformation of Candida leukoplakia.", {"entities": []}], ["To date, no detailed population analysis of C. albicans isolates from oral leukoplakia patients has been undertaken.", {"entities": []}], ["This study investigated whether specific C. albicans genotypes were associated with Candida leukoplakia and non- Candida leukoplakia in a cohort of Irish patients.", {"entities": []}], ["Patients with histopathologically-defined Candida leukoplakia (n\u200a=\u200a31) or non- Candida leukoplakia (n\u200a=\u200a47) were screened for Candida species by culture of oral rinse and lesional swab samples.", {"entities": []}], ["Selected C. albicans isolates from Candida leukoplakia patients (n\u200a=\u200a25), non- Candida leukoplakia patients (n\u200a=\u200a19) and oral carriage isolates from age and sex matched healthy subjects without leukoplakia (n\u200a=\u200a34) were subjected to multilocus sequence typing (MLST) and ABC genotyping.", {"entities": []}], ["MLST revealed that the clade distribution of C. albicans from both Candida leukoplakia and non- Candida leukoplakia lesions overlapped with the corresponding clade distributions of oral carriage isolates and global reference isolates from the MLST database indicating no enrichment of leukoplakia-associated clones.", {"entities": []}], ["Oral leukoplakia isolates were significantly enriched with ABC genotype C (12/44, 27.3%), particularly Candida leukoplakia isolates (9/25, 36%), relative to oral carriage isolates (3/34, 8.8%).", {"entities": []}], ["Genotype C oral leukoplakia isolates were distributed in MLST clades 1,3,4,5,8,9 and 15, whereas genotype C oral carriage isolates were distributed in MLST clades 4 and 11.", {"entities": []}], ["Background: Cadmium (Cd) is an embryotoxic and teratogenic metal in a variety of animal species, but data from humans are limited.", {"entities": []}], ["Objectives: The aim of the present study was to assess the effects of maternal Cd exposure in pregnancy on size at birth.", {"entities": []}], ["Methods: This prospective cohort study was nested in a population-based nutritional supplementation trial in pregnancy conducted in rural Bangladesh.", {"entities": []}], ["We selected women recruited from February 2002 through January 2003 who had a singleton birth with measurements of size at birth and had donated a urine sample in early pregnancy for Cd analyses ( n = 1,616).", {"entities": []}], ["Urinary Cd was measured with inductively coupled plasma mass spectrometry and adjusted for specific gravity.", {"entities": []}], ["Results: Multiple linear regression analyses adjusted for sex and other potential confounders showed that maternal urinary Cd (median, 0.63 \u03bcg/L) was significantly negatively associated with birth weight [unstandardized regression coefficient B = \u201331.0; 95% confidence interval (CI): \u201359, \u20132.8] and head circumference (B = \u20130.15; 95% CI: \u20130.27, \u20130.026).", {"entities": []}], ["However, associations appeared to be limited to girls, with little evidence of effects in boys.", {"entities": []}], ["A 1-\u03bcg/L increase in Cd in maternal urine was associated with a 0.26-cm (95% CI: \u20130.43, \u20130.088 cm) and 0.24-cm (95% CI: \u20130.44, \u20130.030 cm) decrease in girls\u2019 head and chest circumferences, respectively, and a 45-g (95% CI: \u201382.5, 7.3 g) decrease in birth weight.", {"entities": []}], ["Quantile regression analyses indicated that associations with maternal Cd were similar for girls of smaller (25th percentile) and larger (50th and 75th percentiles) sizes at birth.", {"entities": []}], ["Conclusion: We found evidence of a sex difference in the association between maternal Cd exposure and birth size, which was apparent only in girls.", {"entities": []}], ["Results add support for the need to reduce Cd pollution to improve public health.", {"entities": []}], ["Low concentrations of hemoglobin have previously been demonstrated in many patients with COPD.", {"entities": []}], ["There is evidence of anemia as a prognostic factor in acute exacerbations, but the detailed relationship between concentrations of hemoglobin and mortality is not known.", {"entities": [[21, 27, "DISEASE"]]}], ["A register-based cohort of patients admitted for the first time to Danish hospitals for acute exacerbations of COPD from 2007 through 2012 was established.", {"entities": []}], ["Age, sex, comorbidities, medication, renal function, and concentrations of hemoglobin were retrieved.", {"entities": []}], ["Sex-specific survival analyses were fitted for different rounded concentrations of hemoglobin.", {"entities": []}], ["The cohort encompassed 6,969 patients.", {"entities": []}], ["Hemoglobin below 130 g/L was present in 39% of males and below 120 g/L in 24% of females.", {"entities": []}], ["The in-hospital mortality rates for patients with hemoglobin below or above these limits were 11.6% and 5.4%, respectively.", {"entities": []}], ["After discharge, compared to hemoglobin 130 g/L, the hazard ratio (HR) for males with hemoglobin 120 g/L was 1.45 (95% confidence interval [CI] 1.22\u20131.73), adjusted HR 1.37 (95% CI 1.15\u20131.64).", {"entities": [[67, 69, "GENE"], [165, 167, "GENE"], [67, 69, "GENE"], [165, 167, "GENE"]]}], ["Compared to hemoglobin 120 g/L, the HR for females with hemoglobin 110 g/L was 1.4 (95% CI 1.17\u20131.68), adjusted HR 1.28 (95% CI 1.06\u20131.53).", {"entities": [[36, 38, "GENE"], [112, 114, "GENE"], [36, 38, "GENE"], [112, 114, "GENE"]]}], ["In conclusion, low concentrations of hemoglobin are frequent in COPD patients with acute exacerbations, and predict long-term mortality.", {"entities": []}], ["Bronchoscopic balloon dilatation (BBD) is a common strategy in the treatment of bronchostenosis.", {"entities": []}], ["However, the longer dilating time in each inflation cycle (approximately 3\u20135\u00a0min) without mechanical ventilation is not possible for the treatment of tracheal stenosis.", {"entities": [[150, 167, "DISEASE"]]}], ["In this study, we reported our experience of BBD with shorter dilating time (10\u00a0s or 1\u00a0min) and intermittent ventilation for the repair of tuberculous-associated tracheal stenosis in two cases of our hospital.", {"entities": [[162, 179, "DISEASE"]]}], ["After the surgeries, the physical examinations and pulmonary function were tested.", {"entities": []}], ["In case 1, the cough and dyspnea syndromes subsided, wheeze and strid or in lungs were remarkably reduced, tracheal lumen was considerably expanded and pulmonary function was improved following the treatment.", {"entities": []}], ["For the case 2, her chest tightness, shortness of breath symptoms were alleviated after the treatment.", {"entities": []}], ["The middle and lower trachea stenosis was dilated and patent, but the right main bronchus stenosis was slightly improved.", {"entities": []}], ["No restenosis occurred in the two patients in 1\u00a0year outpatient follow-up.", {"entities": []}], ["These findings suggest that our modification in BBD is safe and effective for treating this patient with tracheal stenosis caused by tuberculosis, but the longer-term effect of the surgery in a large number of patients with longer follow-up remains to be seen.", {"entities": [[133, 145, "DISEASE"], [105, 122, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s13019-016-0417-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Children who were <1000 g (ELBW extremely low birth weight) at birth more frequently present with wheezing which is the most common reason that pediatric consultation is sought.", {"entities": []}], ["Therefore asthma is diagnosed very often.", {"entities": [[10, 16, "DISEASE"]]}], ["However is the asthma that is diagnosed in ELBW subjects atopic in origin, or is there a different etiology?", {"entities": [[15, 21, "DISEASE"]]}], ["To determine if ELBW infants are at higher risk for the development of allergic and respiratory symptoms and to establish if there were any specific risk factors for these symptoms.", {"entities": []}], ["81 children born with a mean birthweight of 845 g (91% of available cohort) were evaluated at the mean age 6.7 years.", {"entities": []}], ["The control group included 40 full-term children.", {"entities": []}], ["The children were examined for clinical signs of allergy, and were subjected to the following tests: serum total IgE, skin prick tests (SPT), exhaled nitric oxide measurement (FeNO) and spirometry.", {"entities": []}], ["ELBW children had wheezing episodes more often (64% vs. 25%; OR (odds ratio): 5.38; 95% CI (confidence interval): 2.14-13.8) and were diagnosed more frequently with asthma (32% vs. 7.5%; OR: 5.83, 95% CI: 1.52-26) than their term born peers.", {"entities": [[165, 171, "DISEASE"]]}], ["The most important risk factors for wheezing persistence were hospitalization and wheezing episodes in first 24 months of life.", {"entities": []}], ["Mean serum tIgE level (geometric mean: 32+/\u22124 vs. 56+/\u22124 kU/L; p=0.002) was higher and the number of children with positive results of tIgE level (12% vs. 32%; p=0.02) were more frequent in the control group.", {"entities": []}], ["Children from the control group also more frequently had SPT, however this data was not statistically significant (11% vs. 24%; p=0.09).", {"entities": []}], ["All of the ELBW had normal FeNO level (<=20 ppb), but 5 children from the control group had abnormal results (p=0.02).", {"entities": []}], ["There was no difference between the groups in the occurrence of allergic symptoms.", {"entities": []}], ["ELBW children have more frequent respiratory, but not allergic problems at the age of 6\u20137 years compared to children born at term.", {"entities": []}], ["The need for rehospitalization in the first 2 years of life, was a more important risk factor of future respiratory problems at the age of 7 than perinatal factors, the diagnosis of bronchopulmonary dysplasia or allergy.", {"entities": []}], ["Helium/oxygen therapies have been studied as a means to reduce the symptoms of obstructive lung diseases with inconclusive results in clinical trials.", {"entities": []}], ["To better understand this variability in results, an exploratory physiological study was performed comparing the effects of helium/oxygen mixture (78%/22%) to that of medical air.", {"entities": []}], ["The gas mixtures were administered to healthy, asthmatic, and chronic obstructive pulmonary disease (COPD) participants, both moderate and severe (6 participants in each disease group, a total of 30); at rest and during submaximal cycling exercise with equivalent work rates.", {"entities": [[62, 99, "DISEASE"]]}], ["Measurements of ventilatory parameters, forced spirometry, and ergospirometry were obtained.", {"entities": []}], ["There was no statistical difference in ventilatory and cardiac responses to breathing helium/oxygen during submaximal exercise.", {"entities": []}], ["For asthmatics, but not for the COPD participants, there was a statistically significant benefit in reduced metabolic cost, determined through measurement of oxygen uptake, for the same exercise work rate.", {"entities": []}], ["However, the individual data show that there were a mixture of responders and nonresponders to helium/oxygen in all of the groups.", {"entities": []}], ["The inconsistent response to helium/oxygen between individuals is perhaps the key drawback to the more effective and widespread use of helium/oxygen to increase exercise capacity and for other therapeutic applications.", {"entities": []}], ["The aim of the present work was to investigate the relative importance of socio-demographic and physical health status factors for subjective functioning, as well as to examine the role of social support.", {"entities": []}], ["A cross-sectional health survey was carried out in a Greek municipality.", {"entities": []}], ["1356 adults of the general population were included in the study.", {"entities": []}], ["Personal interviews were conducted with house-to-house visits.", {"entities": []}], ["The response rate was 91.2%.", {"entities": []}], ["Functioning has been measured by five indexes: 'The Social Roles and Mobility' scale ( SORM ), 'The Self-Care Restrictions' scale ( SCR ), 'The Serious Limitations' scale ( SL ), 'The Minor Self-care Limitations' scale ( MSCR ) and 'The Minor Limitations in Social Roles and Mobility' scale ( MSORM ).", {"entities": []}], ["Among the two sets of independent variables, the socio-demographic ones had significant influence on the functional status, except for MSORM.", {"entities": []}], ["Allowing for these variables, the physical health status indicators had also significant effects on all functioning scales.", {"entities": []}], ["Living arrangements and marital status had significant effects on four out of five indexes, while arthritis, Parkinson's disease, past stroke and kidney stones had significant effects on the SCR and SL scales.", {"entities": [[98, 107, "DISEASE"]]}], ["These results suggest that socio-demographic factors are as important as physical health variables in affecting a person's ability to function normally in their everyday life.", {"entities": []}], ["Social support appears to play a significant role in explaining differences in subjective functioning: people living alone or only with the spouse, particularly the elderly, seem to be in greater risk for disability problems and should be targeted by preventive programs in the community.", {"entities": []}], ["Although heart disease is a major cause of morbidity and mortality the majority of patients do not access existing rehabilitation programs and patient resources are not designed to facilitate patient choice and decision-making.", {"entities": [[9, 22, "DISEASE"]]}], ["The objective of this study was to develop and test a series of risk factor modules and corresponding patient information leaflets for secondary prevention of CHD.", {"entities": []}], ["In phase one, a series of risk factor modules and management options were developed following analysis of literature and interviews with health professionals.", {"entities": []}], ["In phase two, module information leaflets were developed using published guidelines and interviews of people with CHD.", {"entities": []}], ["In phase three, the leaflets were tested for quality (DISCERN), readability (Flesch) and suitability (SAM) and were compared to the existing cardiac rehabilitation (CR) information leaflet.", {"entities": []}], ["Finally, the patients assessed the leaflets for content and relevance.", {"entities": []}], ["Four key risk factors identified were cholesterol, blood pressure, smoking and physical inactivity.", {"entities": []}], ["Choice management options were selected for each risk factor and included medical consultation, intensive health professional led program, home program and self direction.", {"entities": []}], ["Patient information needs were then identified and leaflets were developed.", {"entities": []}], ["DISCERN quality scores were high for cholesterol (62/80), blood pressure (59/80), smoking (62/80) and physical activity (62/80), all scoring 4/5 for overall rating.", {"entities": []}], ["The mean Flesch readability score was 75, representing \"fairly easy to read\", all leaflets scored in the superior category for suitability and were reported to be easy to understand, useful and motivating by persons with CHD risk factors.", {"entities": []}], ["The developed leaflets scored higher on each assessment than the existing CR leaflets.", {"entities": []}], ["Using a progressive three phase approach, a series of risk factor modules and information leaflets were successfully developed and tested.", {"entities": []}], ["The leaflets will contribute to shared-decision making and empowerment for persons with CHD.", {"entities": []}], ["COPD is a complex, heterogeneous condition.", {"entities": []}], ["Even in the early clinical stages, COPD carries a significant burden, with breathlessness frequently leading to a reduction in exercise capacity and changes that correlate with long-term patient outcomes and mortality.", {"entities": []}], ["Implementation of an effective management strategy is required to reduce symptoms, preserve lung function, quality of life, and exercise capacity, and prevent exacerbations.", {"entities": []}], ["However, current clinical practice frequently differs from published guidelines on the management of COPD.", {"entities": []}], ["This review focuses on the current scientific evidence and expert opinion on the management of moderate COPD: the symptoms arising from moderate airflow obstruction and the burden these symptoms impose, how physical activity can improve disease outcomes, the benefits of dual bronchodilation in COPD, and the limited evidence for the benefits of inhaled corticosteroids in this disease.", {"entities": []}], ["We emphasize the importance of maximizing bronchodilation in COPD with inhaled dual-bronchodilator treatment, enhancing patient-related outcomes, and enabling the withdrawal of inhaled corticosteroids in COPD in well-defined patient groups.", {"entities": []}], ["The gastrointestinal barrier is - with approximately 400 m via activation of protease activated receptors.", {"entities": []}], ["In addition, proteases regulate the activity and availability of cytokines and growth factors, which are also known modulators of intestinal permeability.", {"entities": []}], ["This review aims at outlining the mechanisms by which proteases alter the intestinal permeability.", {"entities": []}], ["More knowledge on the role of proteases in mucosal homeostasis and gastrointestinal barrier function will definitely contribute to the identification of new therapeutic targets for permeability-related diseases.", {"entities": []}], ["Resistance to triazoles was recently reported in Aspergillus fumigatus isolates cultured from patients with invasive aspergillosis.", {"entities": [[117, 130, "DISEASE"], [108, 130, "DISEASE"]]}], ["The prevalence of azole resistance in A. fumigatus is unknown.", {"entities": []}], ["We investigated the prevalence and spread of azole resistance using our culture collection that contained A. fumigatus isolates collected between 1994 and 2007.", {"entities": []}], ["We investigated the prevalence of itraconazole (ITZ) resistance in 1,912 clinical A. fumigatus isolates collected from 1,219 patients in our University Medical Centre over a 14-y period.", {"entities": []}], ["The spread of resistance was investigated by analyzing 147 A. fumigatus isolates from 101 patients, from 28 other medical centres in The Netherlands and 317 isolates from six other countries.", {"entities": []}], ["The isolates were characterized using phenotypic and molecular methods.", {"entities": []}], ["The electronic patient files were used to determine the underlying conditions of the patients and the presence of invasive aspergillosis.", {"entities": [[123, 136, "DISEASE"], [114, 136, "DISEASE"]]}], ["ITZ-resistant isolates were found in 32 of 1,219 patients.", {"entities": []}], ["All cases were observed after 1999 with an annual prevalence of 1.7% to 6%.", {"entities": []}], ["The ITZ-resistant isolates also showed elevated minimum inhibitory concentrations of voriconazole, ravuconazole, and posaconazole.", {"entities": []}], ["A substitution of leucine 98 for histidine in the cyp51A gene, together with two copies of a 34-bp sequence in tandem in the gene promoter (TR/L98H), was found to be the dominant resistance mechanism.", {"entities": []}], ["Microsatellite analysis indicated that the ITZ-resistant isolates were genetically distinct but clustered.", {"entities": []}], ["The ITZ-sensitive isolates were not more likely to be responsible for invasive aspergillosis than the ITZ-resistant isolates.", {"entities": [[79, 92, "DISEASE"], [70, 92, "DISEASE"]]}], ["ITZ resistance was found in isolates from 13 patients (12.8%) from nine other medical centres in The Netherlands, of which 69% harboured the TR/L98H substitution, and in six isolates originating from four other countries.", {"entities": []}], ["Azole resistance has emerged in A. fumigatus and might be more prevalent than currently acknowledged.", {"entities": []}], ["The presence of a dominant resistance mechanism in clinical isolates suggests that isolates with this mechanism are spreading in our environment.", {"entities": []}], ["Aspergillosis is a group of lung diseases caused by infection with Aspergillus , a mold (fungus) that grows on decaying plant matter.", {"entities": [[0, 13, "DISEASE"]]}], ["Because Aspergillus is widespread in the environment, people often breathe in its spores.", {"entities": []}], ["For most people, this is not a problem\u2014their immune system rapidly kills the fungal spores.", {"entities": []}], ["However, people with asthma or cystic fibrosis sometimes develop allergic bronchopulmonary aspergillosis, a condition in which the spores trigger an allergic reaction in the lungs that causes coughing, wheezing.", {"entities": [[91, 104, "DISEASE"], [31, 46, "DISEASE"], [21, 27, "DISEASE"], [65, 104, "DISEASE"]]}], ["and breathlessness.", {"entities": []}], ["Other people can develop an aspergilloma\u2014a fungus ball that grows in cavities in the lung caused by other illnesses such as tuberculosis.", {"entities": [[124, 136, "DISEASE"]]}], ["However, the most serious form of aspergillosis is invasive aspergillosis.", {"entities": [[34, 47, "DISEASE"], [60, 73, "DISEASE"], [51, 73, "DISEASE"]]}], ["This pneumonia-like infection, which is fatal if left untreated, affects people who have a weakened immune system (for example, people with leukemia) and can spread from the lungs into the heart, brain, and other parts of the body.", {"entities": [[5, 14, "DISEASE"], [140, 148, "DISEASE"]]}], ["Aspergillosis is usually treated with triazole drugs, which inhibit an enzyme that the fungus needs to make its cell membranes; this enzyme is encoded by a gene called cyp51A .", {"entities": [[0, 13, "DISEASE"]]}], ["Voriconazole is the first-line therapy for aspergillosis but itraconazole and posaconazole are also sometimes used and ravuconazole is in clinical development.", {"entities": [[43, 56, "DISEASE"]]}], ["About half of patients with invasive aspergillosis recover if they are given triazoles.", {"entities": [[37, 50, "DISEASE"], [28, 50, "DISEASE"]]}], ["Worryingly, however, strains of Aspergillus fumigatus (the type of Aspergillus usually involved in invasive aspergillosis) with resistance to several triazoles have recently been isolated from some patients in The Netherlands.", {"entities": [[108, 121, "DISEASE"], [99, 121, "DISEASE"]]}], ["If multi-azole resistant strains of A. fumigatus become common, they could have a serious impact on the management of invasive aspergillosis.", {"entities": [[127, 140, "DISEASE"], [118, 140, "DISEASE"]]}], ["However, noone knows what proportion of A. fumigatus strains isolated from patients with aspergillosis are resistant to several azole drugs.", {"entities": [[89, 102, "DISEASE"]]}], ["That is, noone knows the \u201cprevalence\u201d of multi-azole resistance.", {"entities": []}], ["In this study, the researchers investigate the prevalence and development of azole resistance in A. fumigatus .", {"entities": []}], ["Since 1994, all fungal isolates from patients at the Radboud University Nijmegen Medical Center in the Netherlands have been stored.", {"entities": []}], ["The researchers' search of this collection yielded 1,908 A. fumigatus isolates that had been collected from 1,219 patients over a 14-year period.", {"entities": []}], ["Of these, the isolates from 32 patients grew in the presence of itraconazole.", {"entities": []}], ["All the itraconazole-resistant isolates (which also had increased resistance to voriconazole, ravuconazole, and posaconazole) were collected after 1999; the annual prevalence of itraconazole-resistant isolates ranged from 1.7% to 6%.", {"entities": []}], ["The researchers then sequenced the cyp51A gene in each resistant isolate.", {"entities": []}], ["Thirty had a genetic alteration represented as TR/L98H.", {"entities": []}], ["This \u201cdominant resistance mechanism\u201d consisted of a single amino acid change in the cyp51A gene and an alteration in the gene's promoter region (the region that controls how much protein is made from a gene).", {"entities": []}], ["The researchers also analyzed A. fumigatus isolates from patients admitted to 28 other hospitals in the Netherlands.", {"entities": []}], ["Itraconazole resistance was present in isolates from 13 patients (out of 101 patients) from nine hospitals; the TR/L98H genetic alteration was present in 69% of the itraconazole-resistant isolates.", {"entities": []}], ["Finally, itraconazole resistance was present in six isolates from four other countries (out of 317 isolates from six countries); only one Norwegian isolate had the TR/L98H genetic alteration.", {"entities": []}], ["These findings indicate that azole resistance is emerging in A. fumigatus and may already be more prevalent than generally thought.", {"entities": []}], ["Given the dominance of the TR/L98H genetic alteration in the azole-resistant clinical isolates, the researchers suggest that A. fumigatus isolates harboring this alteration might be present and spreading in the environment rather than being selected for during azole treatment of patients.", {"entities": []}], ["Why azole resistance should develop in A. fumigatus in the environment is unclear but might be caused by the use of azole-containing fungicides.", {"entities": []}], ["Further studies are now urgently needed to find out if this is the case, to measure the international prevalence and spread of A. fumigatus isolates harboring the TR/L98H genetic alteration, and, most importantly, to develop alternative treatments for patients with azole-resistant aspergillosis.", {"entities": [[282, 295, "DISEASE"]]}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0050219 .", {"entities": []}], ["The MedlinePlus Medical Encyclopedia has a page on aspergillosis (in English and Spanish) The UK National Health Service Direct health encyclopedia has detailed information about all aspects of aspergillosis The US Centers for Disease Control and Prevention also has information about aspergillosis Paul Verweij and colleagues show that azole resistance has emerged in Aspergillus fumigatus in The Netherlands and that a dominant resistance mechanism is present in clinical isolates.", {"entities": [[51, 64, "DISEASE"], [194, 207, "DISEASE"], [285, 298, "DISEASE"]]}], ["We review the major linkages between the oceans and public health, focusing on exposures and potential health effects due to anthropogenic and natural factors including: harmful algal blooms, microbes, and chemical pollutants in the oceans; consumption of seafood; and flooding events.", {"entities": []}], ["We summarize briefly the current state of knowledge about public health effects and their economic consequences; and we discuss priorities for future research.", {"entities": []}], ["We find that: \u2022 There are numerous connections between the oceans, human activities, and human health that result in both positive and negative exposures and health effects (risks and benefits); and the study of these connections comprises a new interdisciplinary area, \"oceans and human health.\"", {"entities": []}], ["\u2022 The state of present knowledge about the linkages between oceans and public health varies.", {"entities": []}], ["Some risks, such as the acute health effects caused by toxins associated with shellfish poisoning and red tide, are relatively well understood.", {"entities": []}], ["Other risks, such as those posed by chronic exposure to many anthropogenic chemicals, pathogens, and naturally occurring toxins in coastal waters, are less well quantified.", {"entities": []}], ["Even where there is a good understanding of the mechanism for health effects, good epidemiological data are often lacking.", {"entities": []}], ["Solid data on economic and social consequences of these linkages are also lacking in most cases.", {"entities": []}], ["\u2022 The design of management measures to address these risks must take into account the complexities of human response to warnings and other guidance, and the economic tradeoffs among different risks and benefits.", {"entities": []}], ["Future research in oceans and human health to address public health risks associated with marine pathogens and toxins, and with marine dimensions of global change, should include epidemiological, behavioral, and economic components to ensure that resulting management measures incorporate effective economic and risk/benefit tradeoffs.", {"entities": []}], ["The pathogenesis of intraocular tuberculosis remains poorly understood partly due to the lack of adequate animal models that accurately simulate human disease.", {"entities": [[32, 44, "DISEASE"]]}], ["Using a recently developed model of ocular tuberculosis following aerosol infection of guinea pigs with Mycobacterium tuberculosis , we studied the microbiological, histological, and clinical features of intraocular tuberculosis infection.", {"entities": [[43, 55, "DISEASE"], [118, 130, "DISEASE"], [216, 228, "DISEASE"]]}], ["Viable tubercle bacilli were cultivated from all eyes by Day 56 after aerosol delivery of \u223c200 bacilli to guinea pig lungs.", {"entities": []}], ["Choroidal tuberculous granulomas showed reduced oxygen tension, as evidenced by staining with the hypoxia-specific probe pimonidazole, and expression of vascular endothelial growth factor (VEGF) was detected in the retinal pigment epithelium (RPE) and photoreceptors.", {"entities": [[243, 246, "GENE"]]}], ["Fundoscopic examination of M. tuberculosis -infected guinea pig eyes revealed altered vascular architecture and chorioretinal hemorrhage by Day 56 after infection.", {"entities": [[30, 42, "DISEASE"]]}], ["This model may be useful in further elucidating the pathogenesis of ocular tuberculosis, as well as in developing tools for diagnosis and assessment of antituberculosis treatment responses in the eye.", {"entities": [[75, 87, "DISEASE"]]}], ["We propose a novel framework for management of cancer survivorship: electronic patient Self-Assessment and Management (SAM).", {"entities": [[47, 53, "DISEASE"]]}], ["SAM is a framework for transfer of information to and from patients in such a way as to increase both the patient's and the health care provider's understanding of the patient's progress, and to help ensure that patient care follows best practice.", {"entities": []}], ["Patients who participate in the SAM system are contacted by email at regular intervals and asked to complete validated questionnaires online.", {"entities": []}], ["Patient responses on these questionnaires are then analyzed in order to provide patients with real-time, online information about their progress and to provide them with tailored and standardized medical advice.", {"entities": []}], ["Patient-level data from the questionnaires are ported in real time to the patient's health care provider to be uploaded to clinic notes.", {"entities": []}], ["An initial version of SAM has been developed at Memorial Sloan-Kettering Cancer Center (MSKCC) and the University of California, San Francisco (UCSF) for aiding the clinical management of patients after surgery for prostate cancer.", {"entities": [[73, 79, "DISEASE"], [224, 230, "DISEASE"], [215, 230, "DISEASE"]]}], ["Pilot testing at MSKCC and UCSF suggests that implementation of SAM systems are feasible, with no major problems with compliance (> 70% response rate) or security.", {"entities": []}], ["SAM is a conceptually simple framework for passing information to and from patients in such a way as to increase both the patient's and the health care provider's understanding of the patient's progress, and to help ensure that patient care follows best practice.", {"entities": []}], ["ADAM10, as the sheddase of the low affinity IgE receptor (CD23), promotes IgE production and thus is a unique target for attenuating allergic disease.", {"entities": [[0, 6, "GENE"]]}], ["Herein, we describe that B cell levels of ADAM10, specifically, are increased in allergic patients and Th2 prone WT mouse strains (Balb/c and A/J).", {"entities": [[42, 48, "GENE"]]}], ["While T cell help augments ADAM10 expression, Balb WT B cells exhibit increased ADAM10 in the na\u00efve state and even more dramatically increased ADAM10 after anti-CD40/IL4 stimulation compared C57 (Th1 prone) WT B cells.", {"entities": [[27, 33, "GENE"], [80, 86, "GENE"], [143, 149, "GENE"], [27, 33, "GENE"], [80, 86, "GENE"], [143, 149, "GENE"], [27, 33, "GENE"], [80, 86, "GENE"], [143, 149, "GENE"]]}], ["Furthermore, ADAM17 and TNF are reduced in allergic patients and Th2 prone mouse strains (Balb/c and A/J) compared to Th1 prone controls.", {"entities": [[13, 19, "GENE"], [24, 27, "GENE"]]}], ["To further understand this regulation, ADAM17 and TNF were studied in C57Bl/6 and Balb/c mice deficient in ADAM10.", {"entities": [[39, 45, "GENE"], [50, 53, "GENE"], [107, 113, "GENE"]]}], ["Since first described by Paul Ehrlich in 1878, mast cells have been mostly viewed as effectors of allergy.", {"entities": []}], ["It has been only in the past two decades that mast cells have gained recognition for their involvement in other physiological and pathological processes.", {"entities": []}], ["Mast cells have a widespread distribution and are found predominantly at the interface between the host and the external environment.", {"entities": []}], ["Mast cell maturation, phenotype and function are a direct consequence of the local microenvironment and have a marked influence on their ability to specifically recognize and respond to various stimuli through the release of an array of biologically active mediators.", {"entities": []}], ["These features enable mast cells to act as both first responders in harmful situations as well as to respond to changes in their environment by communicating with a variety of other cells implicated in physiological and immunological responses.", {"entities": []}], ["Therefore, the critical role of mast cells in both innate and adaptive immunity, including immune tolerance, has gained increased prominence.", {"entities": []}], ["Conversely, mast cell dysfunction has pointed to these cells as the main offenders in several chronic allergic/inflammatory disorders, cancer and autoimmune diseases.", {"entities": [[135, 141, "DISEASE"]]}], ["This review summarizes the current knowledge of mast cell function in both normal and pathological conditions with regards to their regulation, phenotype and role.", {"entities": []}], ["Whether Web-based technologies can improve disease self-management is uncertain.", {"entities": []}], ["My Asthma Portal (MAP) is a Web-based self-management support system that couples evidence-based behavioral change components (self-monitoring of symptoms, physical activity, and medication adherence) with real-time monitoring, feedback, and support from a nurse case manager.", {"entities": [[3, 9, "DISEASE"]]}], ["The aim of this study was to compare the impact of access to a Web-based asthma self-management patient portal linked to a case-management system (MAP) over 6 months compared with usual care on asthma control and quality of life.", {"entities": [[73, 79, "DISEASE"], [194, 200, "DISEASE"]]}], ["A multicenter, parallel, 2-arm, pilot, randomized controlled trial was conducted with 100 adults with confirmed diagnosis of asthma from 2 specialty clinics.", {"entities": [[125, 131, "DISEASE"]]}], ["Asthma control was measured using an algorithm based on overuse of fast-acting bronchodilators and emergency department visits, and asthma-related quality of life was assessed using the Mini-Asthma Quality of Life Questionnaire (MAQLQ).", {"entities": [[0, 6, "DISEASE"], [132, 138, "DISEASE"], [191, 197, "DISEASE"]]}], ["Secondary mediating outcomes included asthma symptoms, depressive symptoms, self-efficacy, and beliefs about medication.", {"entities": [[38, 44, "DISEASE"]]}], ["Process evaluations were also included.", {"entities": []}], ["A total of 49 individuals were randomized to MAP and 51 to usual care.", {"entities": []}], ["Compared with usual care, participants in the intervention group reported significantly higher asthma quality of life (mean change 0.61, 95% CI 0.03 to 1.19), and the change in asthma quality of life for the intervention group between baseline and 3 months (mean change 0.66, 95% CI 0.35 to 0.98) was not seen in the control group.", {"entities": [[95, 101, "DISEASE"], [177, 183, "DISEASE"]]}], ["No significant differences in asthma quality of life were found between the intervention and control groups at 6 (mean change 0.46, 95% CI \u20130.12 to 1.05) and 9 months (mean change 0.39, 95% CI \u20130.2 to 0.98).", {"entities": [[30, 36, "DISEASE"]]}], ["For poor control status, there was no significant effect of group, time, or group by time.", {"entities": []}], ["For all self-reported measures, the intervention group had a significantly higher proportion of individuals, demonstrating a minimal clinically meaningful improvement compared with the usual care group.", {"entities": []}], ["This study supported the use of MAP to enhance asthma quality of life but not asthma control as measured by an administrative database.", {"entities": [[47, 53, "DISEASE"], [78, 84, "DISEASE"]]}], ["Implementation of MAP beyond 6 months with tailored protocols for monitoring symptoms and health behaviors as individuals\u2019 knowledge and self-management skills improve may result in long-term gains in asthma control.", {"entities": [[201, 207, "DISEASE"]]}], ["International Standard Randomized Controlled Trial Number (ISRCTN): 34326236; http://www.isrctn.com/ISRCTN34326236 (Archived by Webcite at http://www.webcitation.org/6mGxoI1R7).", {"entities": []}], ["There are many anatomical, physiopathological, and cognitive changes that occur in the elderly that affect different components of airway management: intubation, ventilation, oxygenation, and risk of aspiration.", {"entities": []}], ["Anatomical changes occur in different areas of the airway from the oral cavity to the larynx.", {"entities": []}], ["Common changes to the airway include tooth decay, oropharyngeal tumors, and significant decreases in neck range of motion.", {"entities": []}], ["These changes may make intubation challenging by making it difficult to visualize the vocal cords and/or place the endotracheal tube.", {"entities": []}], ["Also, some of these changes, including but not limited to, atrophy of the muscles around the lips and an edentulous mouth, affect bag mask ventilation due to a difficult face-mask seal.", {"entities": []}], ["Physiopathologic changes may impact airway management as well.", {"entities": []}], ["Common pulmonary issues in the elderly (eg, obstructive sleep apnea and COPD) increase the risk of an oxygen desaturation event, while gastrointestinal issues (eg, achalasia and gastroesophageal reflux disease) increase the risk of aspiration.", {"entities": [[178, 209, "DISEASE"], [164, 173, "DISEASE"]]}], ["Finally, cognitive changes (eg, dementia) not often seen as related to airway management may affect patient cooperation, especially if an awake intubation is required.", {"entities": [[32, 40, "DISEASE"]]}], ["Overall, degradation of the airway along with other physiopathologic and cognitive changes makes the elderly population more prone to complications related to airway management.", {"entities": []}], ["When deciding which airway devices and techniques to use for intubation, the clinician should also consider the difficulty associated with ventilating the patient, the patient\u2019s risk of oxygen desaturation, and/or aspiration.", {"entities": []}], ["For patients who may be difficult to bag mask ventilate or who have a risk of aspiration, a specialized supralaryngeal device may be preferable over bag mask for ventilation.", {"entities": []}], ["Patients with tumors or decreased neck range of motion may require a device with more finesse and maneuverability, such as a flexible fiberoptic broncho-scope.", {"entities": []}], ["Overall, geriatric-focused airway management is necessary to decrease complications in this patient population.", {"entities": []}], ["Background .", {"entities": []}], ["Classification of pulmonary disease into obstructive, restrictive, and mixed patterns is based on 2005 ATS/ERS guidelines and modified GOLD criteria by Mannino et al.", {"entities": []}], ["(2003), but these guidelines are of limited use for simple spirometry in situations involving mass casualties.", {"entities": []}], ["The purpose of this study was to apply these guidelines to patients who underwent simple spirometry following high concentration of chlorine gas inhalation after a train derailment in Graniteville, South Carolina.", {"entities": []}], ["We retrospectively investigated lung functions in ten patients.", {"entities": []}], ["In order to classify pulmonary disease pattern, we used 2005 ATS/ERS guidelines and modified GOLD criteria along with our own criteria developed using available simple spirometry data.", {"entities": []}], ["We found predominant restrictive pattern in our patients with both modified GOLD and our criteria, which is in contrast to other chlorine exposure studies where obstructive pattern was more common.", {"entities": []}], ["When compared to modified GOLD and our criteria, 2005 ATS/ERS guidelines underestimated the frequency of restrictive disease.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Diagnosis of pulmonary disease patterns is of importance after irritant gas inhalation.", {"entities": []}], ["Acceptable criteria need to be developed to evaluate pulmonary disease through simple spirometry in events leading to mass casualty and patient surge in hospitals.", {"entities": []}], ["Asthma often progresses from early episodes of insults.", {"entities": [[0, 6, "DISEASE"]]}], ["How early life events connect to long-term airway dysfunction remains poorly understood.", {"entities": []}], ["We demonstrated previously that increased neurotrophin 4 (NT4) levels following early life allergen exposure cause persistent changes in airway smooth muscle (ASM) innervation and airway hyper-reactivity (AHR) in mice.", {"entities": [[205, 208, "GENE"]]}], ["Herein, we identify pulmonary mast cells as a key source of aberrant NT4 expression following early insults.", {"entities": []}], ["NT4 is selectively expressed by ASM and mast cells in mice, nonhuman primates and humans.", {"entities": []}], ["We show in mice that mast cell-derived NT4 is dispensable for ASM innervation during development.", {"entities": []}], ["However, upon insults, mast cells expand in number and degranulate to release NT4 and thus become the major source of NT4 under pathological condition.", {"entities": []}], ["Adoptive transfer of wild type mast cells, but not NT4 mast cells restores ASM hyperinnervation and AHR in Kit mice following early life insults.", {"entities": [[100, 103, "GENE"]]}], ["Notably, an infant nonhuman primate model of asthma also exhibits ASM hyperinnervation associated with the expansion and degranulation of mast cells.", {"entities": [[45, 51, "DISEASE"]]}], ["Together, these findings identify an essential role of mast cells in mediating ASM hyperinnervation following early life insults by producing NT4.", {"entities": []}], ["This role may be evolutionarily conserved in linking early insults to long-term airway dysfunction.", {"entities": []}], ["Tuberculosis (TB) remains an important health problem in the Roma population in Serbia.", {"entities": []}], ["Recent studies have highlighted the importance of increasing awareness of TB and reducing the associated stigmas to reduce the incidence of TB and enable earlier diagnosis and effective treatment.", {"entities": []}], ["This study investigated the knowledge and beliefs about transmission, symptoms and treatment of TB as well as attitudes towards patients with TB among the Roma population in Belgrade.", {"entities": []}], ["The focus-group method was considered to be appropriate for investigating knowledge and beliefs about TB.", {"entities": []}], ["A total of 24 Roma people aged 19-55 years participated in three focus-group discussions.", {"entities": []}], ["All participants knew that TB was a pulmonary disease and could be contagious.", {"entities": []}], ["Saliva was the most commonly mentioned mode of transmission.", {"entities": []}], ["Some individuals thought, albeit hesitantly, that TB could be transmitted by shaking hands with an infected individual.", {"entities": []}], ["Of factors contributing to TB, participants mentioned bad living conditions, low quality and lack of food, and stress.", {"entities": []}], ["Participants quoted chest pain, cough, haemoptysis, loss of appetite, loss of weight, weakness and sweating as basic symptoms of TB.", {"entities": []}], ["Participants believed that effective treatment should include resting, taking prescribed medicines, inhaling fresh air and eating \"strong\" food such as bacon and pork; these approaches were considered as important as taking antibiotics).", {"entities": []}], ["In addition, participants mentioned that they use some folk medicines.", {"entities": []}], ["Relatives and friends, and to a lesser extent television, were the main sources of information about TB.", {"entities": []}], ["Participants most appreciate personal contact with doctors as a source of information.", {"entities": []}], ["We concluded that participants were aware of the seriousness TB as well as some of the modes of transmission; however, they had some misconceptions.", {"entities": []}], ["An important finding was the confidence in doctors expressed by the Roma people.", {"entities": []}], ["BACKGROUND: In contrast to cellular receptors, soluble receptors do not enhance the cellular activation because they do not have transmembranic and cytoplasmic parts, acting thereby as endogenous regulatory mechanisms against systemic functions of cytokines.", {"entities": []}], ["AIM: To measure serum concentrations of the soluble interleukin-2 receptor (sIL2R), soluble interleukin-4 receptor (sIL4R), soluble interleukin-6 receptor (sIL6R), and soluble tumor necrosis factor-alpha receptor I and soluble tumor necrosis factor-alpha receptor II, during the perinatal and early neonatal period, in order to evaluate their role in activation of immune response in labor and the first days postpartum.", {"entities": []}], ["METHODS: Soluble receptor serum concentrations were determined by enzyme-linked immunosorbent assay, in 45 healthy, full-termed neonates during the first and fifth days after birth, in 25 of their mothers (MS), in 25 samples of umbilical cords (UC) and in 25 healthy adult donors age-matched with the mothers (controls).", {"entities": []}], ["RESULTS: Soluble receptor serum concentrations showed considerable changes during labor and early neonatal life, being significantly higher both in MS (except sIL6R) and in neonatal sample UC, first and fifth days after birth, compared with controls (p<0.0001).", {"entities": []}], ["Neonatal serum sIL2R and sIL6R increased significantly from birth to the fifth day, while the remaining receptors showed a rapid increase in the first day (p<0.0001), declining significantly thereafter (p<0.0001).", {"entities": []}], ["CONCLUSION: Our findings suggest that the elevated concentrations of all studied soluble cytokine receptors reflect the activation of immune response, and represent also regulatory protective mechanisms for mother and fetus-neonate against the systemic function of cytokines during labor and early neonatal life.", {"entities": []}], ["Conducting health surveys with community-based random samples are essential to capture an otherwise unreachable population, but these surveys can be biased if the effort to reach participants is insufficient.", {"entities": []}], ["This study determines the desirable amount of effort to minimise such bias.", {"entities": []}], ["A household-based health survey with random sampling and face-to-face interviews.", {"entities": []}], ["Up to 11 visits, organised by canvassing rounds, were made to obtain an interview.", {"entities": []}], ["Single-family homes in an underserved and understudied population in North Miami-Dade County, Florida, USA.", {"entities": []}], ["Of a probabilistic sample of 2200 household addresses, 30 corresponded to empty lots, 74 were abandoned houses, 625 households declined to participate and 265 could not be reached and interviewed within 11 attempts.", {"entities": []}], ["Analyses were performed on the 1206 remaining households.", {"entities": []}], ["Each household was asked if any of their members had been told by a doctor that they had high blood pressure, heart disease including heart attack, cancer, diabetes, anxiety/ depression, obesity or asthma.", {"entities": [[110, 123, "DISEASE"], [187, 194, "DISEASE"], [198, 204, "DISEASE"], [148, 154, "DISEASE"]]}], ["Responses to these questions were analysed by the number of visit attempts needed to obtain the interview.", {"entities": []}], ["Return per visit fell below 10% after four attempts, below 5% after six attempts and below 2% after eight attempts.", {"entities": []}], ["As the effort increased, household size decreased, while household income and the percentage of interviewees active and employed increased; proportion of the seven health conditions decreased, four of which did so significantly: heart disease 20.4\u20139.2%, high blood pressure 63.5\u201358.1%, anxiety/depression 24.4\u20139.2% and obesity 21.8\u201312.6%.", {"entities": [[229, 242, "DISEASE"], [319, 326, "DISEASE"]]}], ["Beyond the fifth attempt, however, cumulative percentages varied by less than 1% and precision varied by less than 0.1%.", {"entities": []}], ["In spite of the early and steep drop, sustaining at least five attempts to reach participants is necessary to reduce selection bias.", {"entities": []}], ["Asthmatics are known to have esophageal hypomotility.", {"entities": []}], ["Vagal hypofunction and prolonged intra-esophageal acidification cause esophageal hypomotility.", {"entities": []}], ["The contribution of gastroesophageal reflux (GER) and vagal function to esophageal motility in asthmatics is unclear.", {"entities": []}], ["We studied the relationship between esophageal motility, GER and vagal function in a cohort of adult asthmatics.", {"entities": []}], ["Thirty mild, stable asthmatics (ATS criteria) and 30 healthy volunteers underwent 24-hour ambulatory esophageal monitoring, manometry, autonomic function testing and GER symptom assessment.", {"entities": []}], ["27 asthmatics underwent gastroscopy.", {"entities": []}], ["A vagal function score calculated from 3 tests (valsalva maneuver, heart rate response to deep breathing and to standing from supine position) was correlated with esophageal function parameters.", {"entities": []}], ["Asthmatics (mean age 34.8 (SD 8.4), 60% female) had more frequent GERD symptoms than controls (mean age 30.9 (SD 7.7), 50% female).", {"entities": []}], ["10/27 asthmatics had esophageal mucosal damage, 22 showed hypervagal response, none had a hyperadrenergic response.", {"entities": []}], ["14 asthmatics had ineffective esophageal motility.", {"entities": []}], ["Higher GERD-score asthmatics had significantly fewer peristaltic and more simultaneous contractions than controls, and higher esophageal acid contact times than those with lower scores.", {"entities": []}], ["All reflux parameters were significantly higher and acid clearance time prolonged in asthmatics than controls (p\u2009<\u20090.001, Mann\u2013Whitney U test).", {"entities": []}], ["There was no correlation between vagal function score and esophageal function parameters.", {"entities": []}], ["A cohort of adult asthmatics was found to have peristaltic dysfunction and pathological GER, but otherwise normal esophageal motility.", {"entities": []}], ["The peristaltic dysfunction seems to be associated with vagal hyperreactivity rather than vagal hypofunction.", {"entities": []}], ["Non-communicable diseases (NCDs) continue to pose threats to human health and development worldwide.", {"entities": []}], ["Though preventable, NCDs kill more people annually than all other diseases combined.", {"entities": []}], ["The four major NCDs namely cardiovascular diseases, chronic respiratory diseases, diabetes and cancers share common modifiable risk factors.", {"entities": []}], ["In order to prevent and control NCDs, Ghana has adopted the World Health Organisation Package for Essential NCD (WHO-PEN) intervention, to be piloted in selected districts before a nationwide scale-up.", {"entities": []}], ["We assessed the capacity of these facilities for the implementation of the WHO-PEN pilot.", {"entities": []}], ["We conducted a cross-sectional health facility-based survey using a multistage sampling technique.", {"entities": []}], ["We collected data on human resource, equipment, service utilization, medicines availability and health financing through interviews and observation.", {"entities": []}], ["Descriptive data analysis was performed and expressed in frequencies and relative frequencies.", {"entities": []}], ["In all, 23 health facilities comprising two regional hospitals, three district hospitals, nine health centres and nine Community-based Health Planning and Services (CHPS) compounds from three regions were surveyed.", {"entities": []}], ["All the hospitals had medical officers whilst 4 (44.4%) of the health centres had physician assistants.", {"entities": []}], ["Health financing is mainly by the National Health Insurance Scheme (NHIS).", {"entities": []}], ["None of the health facilities had spacers and only one health centre had oxygen cylinder, glucometer and nebulizer.", {"entities": []}], ["Gaps exist in the human resource capacity and service delivery at the primary care levels, the focus of WHO-PEN intervention.", {"entities": []}], ["Adequately equipping the primary health care level with trained health workers, basic equipment, medications and diagnostics will optimize the performance of WHO-PEN intervention when implemented.", {"entities": []}], ["Interleukin-33 (IL-33) is a new cytokine of interleukin-1 family, whose specific receptor is ST2.", {"entities": []}], ["IL-33 exerts its functions via its target cells and plays different roles in diseases.", {"entities": []}], ["ST2 deletion and exclusion of IL-33/ST2 axis are accompanied by enhanced susceptibility to dominantly T cell-mediated organ-specific autoimmune diseases.", {"entities": []}], ["It has been reported that IL-33/ST2 pathway plays a key role in host defense and immune regulation in inflammatory and infectious diseases.", {"entities": []}], ["This review focuses on new findings in the roles of IL-33 and ST2 in several kinds of T cell-mediated autoimmune diseases.", {"entities": []}], ["Upon stimulation, activation of NADPH oxidase complexes in neutrophils produces a burst of superoxide anions contributing to oxidative stress and the development of inflammatory process.", {"entities": []}], ["Store-operated calcium entry (SOCE), whereby the depletion of intracellular stores induces extracellular calcium influx, is known to be a crucial element of NADPH oxidase regulation.", {"entities": []}], ["However, the mechanistic basis mediating SOCE is still only partially understood, as is the signal-coupling pathway leading to modulation of store-operated channels.", {"entities": []}], ["This review emphasizes the role of calcium influx in the control of the NADPH oxidase and summarizes the current knowledge of pathways mediating this extracellular calcium entry in neutrophils.", {"entities": []}], ["Such investigations into the cross-talk between NADPH oxidase and calcium might allow the identification of novel pharmacological targets with clinical use, particularly in inflammatory diseases.", {"entities": []}], ["A recent preclinical study has shown that not only maternal smoking but also grandmaternal smoking is associated with elevated pediatric asthma risk.", {"entities": [[137, 143, "DISEASE"]]}], ["Using a well-established rat model of in utero nicotine exposure, Rehan et al .", {"entities": []}], ["have now demonstrated multigenerational effects of nicotine that could explain this 'grandmother effect'.", {"entities": []}], ["F1 offspring of nicotine-treated pregnant rats exhibited asthma-like changes to lung function and associated epigenetic changes to DNA and histones in both lungs and gonads.", {"entities": [[57, 63, "DISEASE"]]}], ["These alterations were blocked by co-administration of the peroxisome proliferator-activated receptor-\u03b3 agonist, rosiglitazone, implicating downregulation of this receptor in the nicotine effects.", {"entities": []}], ["F2 offspring of F1 mated animals exhibited similar changes in lung function to that of their parents, even though they had never been exposed to nicotine.", {"entities": [[0, 2, "GENE"]]}], ["Thus epigenetic mechanisms appear to underlie the multigenerational transmission of a nicotine-induced asthma-like phenotype.", {"entities": [[103, 109, "DISEASE"]]}], ["These findings emphasize the need for more effective smoking cessation strategies during pregnancy, and cast further doubt on the safety of using nicotine replacement therapy to reduce tobacco use in pregnant women.", {"entities": []}], ["Please see related article: http://www.biomedcentral.com/1741-7015/10/129", {"entities": []}], ["Necrotizing enterocolitis (NEC) is a devastating neonatal gastrointestinal disease that primarily affects premature infants.", {"entities": []}], ["It is characterized by bowel inflammation and necrosis.", {"entities": []}], ["In spite of extensive research, there has been little progress in decreasing the incidence or mortality of NEC over the past three decades.", {"entities": []}], ["The exact etiology of NEC has not been identified.", {"entities": []}], ["However, it is believed to result from an inappropriate immune response to gut microbiota.", {"entities": []}], ["Using 454-pyrosequencing analyses of 16S rRNA genes that were PCR-amplified from stool DNA specimens, we compared the gut microbiota of infants with NEC to matched controls without NEC.", {"entities": []}], ["The infants with NEC were then categorized into three subgroups based on severity: mild, severe, and lethal.", {"entities": []}], ["We compared the microbiota among these subgroups and between each severity group and appropriate controls.", {"entities": []}], ["Bacterial diversity and the relative abundance of Actinobacteria and Clostridia were significantly lower in NEC specimens compared to controls.", {"entities": []}], ["The absence of Clostridia was significantly associated with NEC.", {"entities": []}], ["Microbial diversity and Clostridia abundance and prevalence decreased with increasing severity of NEC.", {"entities": []}], ["Low bacterial diversity in stool specimens may be indicative of NEC and the severity of NEC.", {"entities": []}], ["The low bacterial diversity, and the lack of Clostridia in lethal specimens, could indicate that the presence of a diverse bacterial population in the gut as well as the presence of taxa such as Clostridia may play a role in attenuating inflammation leading to NEC.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-015-0075-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["46 U.S. states and the District of Columbia have passed laws and regulations mandating that health insurance plans cover diabetes treatment and preventive care.", {"entities": []}], ["Previous research on state mandates suggested that these policies had little impact, since many health plans already covered the benefits.", {"entities": []}], ["Here, we analyze the contents of and model the effect of state mandates.", {"entities": []}], ["We examined how state mandates impacted the likelihood of using three types of diabetes preventive care: annual eye exams, annual foot exams, and performing daily self-monitoring of blood glucose (SMBG).", {"entities": []}], ["We collected information on diabetes benefits specified in state mandates and time the mandates were enacted.", {"entities": []}], ["To assess impact, we used data that the Behavioral Risk Factor Surveillance System gathered between 1996 and 2000.", {"entities": []}], ["4,797 individuals with self-reported diabetes and covered by private insurance were included; 3,195 of these resided in the 16 states that passed state mandates between 1997 and 1999; 1,602 resided in the 8 states or the District of Columbia without state mandates by 2000.", {"entities": []}], ["Multivariate logistic regression models (with state fixed effect, controlling for patient demographic characteristics and socio-economic status, state characteristics, and time trend) were used to model the association between passing state mandates and the usage of the forms of diabetes preventive care, both individually and collectively.", {"entities": []}], ["All 16 states that passed mandates between 1997 and 1999 required coverage of diabetic monitors and strips, while 15 states required coverage of diabetes self management education.", {"entities": []}], ["Only 1 state required coverage of periodic eye and foot exams.", {"entities": []}], ["State mandates were positively associated with a 6.3 (P = 0.04) and a 5.8 (P = 0.03) percentage point increase in the probability of privately insured diabetic patient's performing SMBG and simultaneous receiving all three preventive care, respectively; state mandates were not significantly associated with receiving annual diabetic eye (0.05 percentage points decrease, P = 0.92) or foot exams (2.3 percentage points increase, P = 0.45).", {"entities": []}], ["Effects of state mandates varied by preventive care type, with state mandates being associated with a small increase in SMBG.", {"entities": []}], ["We found no evidence that state mandates were effective in increasing receipt of annual eye or foot exams.", {"entities": []}], ["The small or non-significant effects might be attributed to small numbers of insured people not having the benefits prior to the mandates' passage.", {"entities": []}], ["If state mandates' purpose is to provide improved benefits to many persons, policy makers should consider determining the number of people who might benefit prior to passing the mandate.", {"entities": []}], ["To promote the health and quality of life of United States residents, the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) \u2013 with 54 state and territorial health agencies \u2013 has supported population surveillance of health-related quality of life (HRQOL).", {"entities": []}], ["HRQOL was defined as \"perceived physical and mental health over time.\"", {"entities": []}], ["Commonly-used measures of health status and activity limitation were identified and a set of \"Healthy Days\" HRQOL measures was developed and validated.", {"entities": []}], ["A core set of these measures (the CDC HRQOL-4) asks about self-rated general health and the number of recent days when a person was physically unhealthy, mentally unhealthy, or limited in usual activities.", {"entities": []}], ["A summary measure combines physically and mentally unhealthy days.", {"entities": []}], ["From 1993 to 2001, more than 1.2 million adults responded to the CDC HRQOL-4 in each state-based Behavioral Risk Factor Surveillance System (BRFSS) telephone interview.", {"entities": []}], ["More than one fifth of all BRFSS respondents also responded to a set of related questions \u2013 including five items that assess the presence, main cause and duration of a current activity limitation, and the need for activity-related personal and routine care; as well as five items that ask about recent days of pain, depression, anxiety, sleeplessness, and vitality.", {"entities": []}], ["The Healthy Days surveillance data are particularly useful for finding unmet health needs, identifying disparities among demographic and socioeconomic subpopulations, characterizing the symptom burden of disabilities and chronic diseases, and tracking population patterns and trends.", {"entities": []}], ["The full set of 14 Healthy Days Measures (the CDC HRQOL-14) has shown good measurement properties in several populations, languages, and settings.", {"entities": []}], ["The brief standard CDC HRQOL-4 is now often used in surveys, surveillance systems, prevention research, and population health report cards.", {"entities": []}], ["Ethnic groups can display differential genetic susceptibility to infectious diseases.", {"entities": []}], ["The arthropod-born viral dengue disease is one such disease, with empirical and limited genetic evidence showing that African ancestry may be protective against the haemorrhagic phenotype.", {"entities": [[25, 39, "DISEASE"]]}], ["Global ancestry analysis based on high-throughput genotyping in admixed populations can be used to test this hypothesis, while admixture mapping can map candidate protective genes.", {"entities": []}], ["A Cuban dengue fever cohort was genotyped using a 2.5 million SNP chip.", {"entities": []}], ["Global ancestry was ascertained through ADMIXTURE and used in a fine-matched corrected association study, while local ancestry was inferred by the RFMix algorithm.", {"entities": []}], ["The expression of candidate genes was evaluated by RT-PCR in a Cuban dengue patient cohort and gene set enrichment analysis was performed in a Thai dengue transcriptome.", {"entities": []}], ["OSBPL10 and RXRA candidate genes were identified, with most significant SNPs placed in inferred weak enhancers, promoters and lncRNAs.", {"entities": [[0, 7, "GENE"], [12, 16, "GENE"]]}], ["OSBPL10 had significantly lower expression in Africans than Europeans, while for RXRA several SNPs may differentially regulate its transcription between Africans and Europeans.", {"entities": [[0, 7, "GENE"], [81, 85, "GENE"]]}], ["Their expression was confirmed to change through dengue disease progression in Cuban patients and to vary with disease severity in a Thai transcriptome dataset.", {"entities": [[49, 63, "DISEASE"]]}], ["These genes interact in the LXR/RXR activation pathway that integrates lipid metabolism and immune functions, being a key player in dengue virus entrance into cells, its replication therein and in cytokine production.", {"entities": []}], ["Knockdown of OSBPL10 expression in THP-1 cells by two shRNAs followed by DENV2 infection tests led to a significant reduction in DENV replication, being a direct functional proof that the lower OSBPL10 expression profile in Africans protects this ancestry against dengue disease.", {"entities": [[264, 278, "DISEASE"], [13, 20, "GENE"], [194, 201, "GENE"], [13, 20, "GENE"], [194, 201, "GENE"]]}], ["Dengue is a concern of worldwide health authorities given the increase on virus and vector dispersions.", {"entities": []}], ["So far only one traditional GWAS survey has been performed in Vietnamese children.", {"entities": []}], ["This disease is also epidemic in tropical and subtropical regions of the Americas, where most populations descend from a dynamic admixture between African, European and Native American backgrounds.", {"entities": []}], ["Empirical evidence claimed that African descent was protective against dengue haemorrhagic phenotype in the Cuban population, and this study is the first to apply admixture mapping to identify candidate genes that confer African protection.", {"entities": []}], ["We also present evidence that two candidate genes, OSBPL10 and RXRA , are differentially expressed along dengue disease progression in Cuban patients and in a Thai dengue transcriptome dataset, and directly show that knockdown of OSBPL10 gene expression leads to a significant reduction in DENV2 replication.", {"entities": [[105, 119, "DISEASE"], [51, 58, "GENE"], [230, 237, "GENE"], [63, 67, "GENE"], [51, 58, "GENE"], [230, 237, "GENE"]]}], ["A very important overall result of our work is that it provides a unifying framework for many genes that have been said to be protective in dengue.", {"entities": []}], ["Our evidence places the LXR/RXR activation pathway at the center of natural dengue protection, and supports pursuing therapeutic techniques involving synthetic ligands of nuclear receptor genes or kinases inhibitors that interact with proteins involved in lipid metabolism.", {"entities": []}], ["Self-care practices for patients with hypertension include adherence to medication, use of blood pressure self-monitoring and use of complementary and alternative therapies (CAM) The prevalence of CAM use and blood pressure self-monitoring have not been described in a UK secondary care population of patients with hypertension and their impact on adherence to medication has not been described.", {"entities": [[38, 50, "DISEASE"], [315, 327, "DISEASE"]]}], ["Adherence to medication is important for blood pressure control, but poor adherence is common.", {"entities": []}], ["The study aimed to determine the prevalence of self-care behaviours in patients attending a secondary care hypertension clinic.", {"entities": [[107, 119, "DISEASE"]]}], ["Cross-sectional questionnaire survey.", {"entities": []}], ["196 patients attending a secondary care hypertension clinic in a teaching hospital serving a multiethnic population, Birmingham, UK.", {"entities": [[40, 52, "DISEASE"]]}], ["Main outcome measures: Prevalence of use of CAM, home monitors, adherence to anti-hypertensive medication.", {"entities": []}], ["CAM use in previous 12 months was reported by 66 (43.1%) respondents.", {"entities": []}], ["CAM users did not differ statistically from non-CAM users by age, gender, marital status or education.", {"entities": []}], ["Vitamins, prayer a dietary supplements were the most commonly used CAM.", {"entities": []}], ["Nine (12.7%) women reported using herbal CAM compared to one man (1.2%), (p = 0.006).", {"entities": []}], ["Ten (6.7%) respondents reported ever being asked by a doctor about CAM use.", {"entities": []}], ["Perfect adherence to anti-hypertensive medication was reported by 26 (44.8%) CAM-users and 46 (60.5%) non-CAM users (p = 0.07).", {"entities": []}], ["Being female and a CAM user was significantly associated with imperfect adherence to anti-hypertensive medication.", {"entities": []}], ["Older and white British respondents were significantly more likely to report perfect adherence.", {"entities": []}], ["Blood pressure monitors were used by 67 (43.8%) respondents, which was not associated with gender, CAM use or adherence to medication.", {"entities": []}], ["Hypertensive patients use a variety of self-care methods, including CAM, home blood pressure monitors, and adherence to prescribed medication.", {"entities": []}], ["This study found the prevalence of CAM use in hypertensive patients was higher than in the UK population.", {"entities": []}], ["It is important to acknowledge the self-care behaviour of hypertensive patients, in order to assess potential harm, and encourage effective methods of self-care.", {"entities": []}], ["IgE-associated food allergy affects approximately 3% of the population and has severe effects on the daily life of patients\u2014manifestations occur not only in the gastrointestinal tract but also affect other organ systems.", {"entities": [[15, 27, "DISEASE"]]}], ["Birth cohort studies have shown that allergic sensitization to food allergens develops early in childhood.", {"entities": []}], ["Mechanisms of pathogenesis include cross-linking of mast cell\u2013 and basophil-bound IgE and immediate release of inflammatory mediators, as well as late-phase and chronic allergic inflammation, resulting from T-cell, basophil, and eosinophil activation.", {"entities": []}], ["Researchers have begun to characterize the molecular features of food allergens and have developed chip-based assays for multiple allergens.", {"entities": []}], ["These have provided information about cross-reactivity among different sources of food allergens, identified disease-causing food allergens, and helped us to estimate the severity and types of allergic reactions in patients.", {"entities": []}], ["Importantly, learning about the structure of disease-causing food allergens has allowed researchers to engineer synthetic and recombinant vaccines.", {"entities": []}], ["Understanding co-morbidity of depression and tuberculosis (TB) has been limited by challenges in measurement of depression due to overlapping symptoms, use of small hospital samples and uncontrolled analysis.", {"entities": [[45, 57, "DISEASE"]]}], ["This study was conducted to better understand the burden and presentation of depression, and associated factors in people with TB in primary care settings in Ethiopia.", {"entities": []}], ["We conducted a cross-sectional survey among 657 people newly diagnosed with TB.", {"entities": []}], ["Symptoms of depression were measured using the Patient Health Questionnaire (PHQ-9).", {"entities": []}], ["TB symptoms and other factors were captured using standardised questionnaires.", {"entities": []}], ["The factor structure of PHQ-9 was examined.", {"entities": []}], ["Multivariable analysis was carried out to estimate prevalence ratios.", {"entities": []}], ["The prevalence of probable depression was 54.0%.", {"entities": []}], ["The PHQ-9 had one factor structure (alpha\u2009=\u20090.81).", {"entities": []}], ["Little interest or pleasure in doing things (73.0%) was the commonest depressive symptom.", {"entities": []}], ["Older age (Adjusted Prevalence ratio (APR)\u2009=\u20091.19; 95%CI\u2009=\u20091.06, 1.33), female sex (APR\u2009=\u20091.23; 95%CI\u2009=\u20091.18, 1.27), night sweating (APR\u2009=\u20091.25; 95%CI\u2009=\u20091.16, 1.35), pain (APR\u2009=\u20091.69; 95%CI\u2009=\u20091.24, 2.29), being underweight (APR\u2009=\u20091.10; 95%CI\u2009=\u20091.07, 1.13), duration of illness (APR\u2009=\u20091.35; 95%CI\u2009=\u20091.22, 1.50), level of education (APR\u2009=\u20090.93; 95%CI\u2009=\u20090.90, 0.95), and social support (APR\u2009=\u20090.89; 95%CI\u2009=\u20090.85, 0.93) were independently associated with probable depression.", {"entities": []}], ["Depression appears highly prevalent in people with TB and PHQ-9 seems to be a useful instrument to detect depression in the context of TB.", {"entities": []}], ["The frequency of depressive symptoms would suggest that the occurrence of the symptoms in people with TB is in the usual manifestation of the disorder.", {"entities": []}], ["Prospective studies are needed to understand the longitudinal relationship between TB and depression.", {"entities": []}], ["The childhood Asthma-Control Test (C-ACT) is validated for assessing asthma control in paediatric asthma.", {"entities": [[14, 20, "DISEASE"], [69, 75, "DISEASE"], [98, 104, "DISEASE"]]}], ["Among children aged 4\u201311 years, the C-ACT requires the simultaneous presence of both parent and child.", {"entities": []}], ["There is an unmet need for a tool that can be used to assess asthma control in children when parents or caregivers are not present such as in the school setting.", {"entities": [[61, 67, "DISEASE"]]}], ["We assessed the psychometric properties and estimated the minimally important difference (MID) of the C-ACT and a modified version, comprising only the child responses (C-ACTc).", {"entities": []}], ["Asthma patients aged 6\u201311 years ( n =161) from a previously completed multicenter randomised trial were included.", {"entities": [[0, 6, "DISEASE"]]}], ["Demographic information, spirometry and questionnaire scores were obtained at baseline and during follow-up.", {"entities": []}], ["Participants or their guardians kept a daily asthma diary.", {"entities": [[45, 51, "DISEASE"]]}], ["Internal consistency reliabilities of the C-ACT and C-ACTc were 0.76 and 0.67 (Cronbach\u2019s \u03b1 ), respectively.", {"entities": []}], ["Test\u2013retest reliabilities of the C-ACT and C-ACTc were 0.72 and 0.66 (intra-class correlation), respectively.", {"entities": []}], ["Significant correlations were noted between C-ACT scores and ACQ scores (Spearman\u2019s correlation r =\u22120.56, 95% CI (\u22120.66, \u22120.44), P <0.001).", {"entities": []}], ["The strength of the correlation between C-ACTc scores and ACQ scores was weaker (Spearman\u2019s correlation r =\u22120.46, 95% CI (\u22120.58, \u22120.33), P <0.001).", {"entities": []}], ["We estimated the MID for the C-ACT and C-ACTc to be 2 points and 1 point, respectively.", {"entities": []}], ["Among asthma patients aged 6\u201311 years, the C-ACT had good psychometric properties.", {"entities": [[6, 12, "DISEASE"]]}], ["The psychometric properties of a shortened child-only version (C-ACTc), although acceptable, are not as strong.", {"entities": []}], ["The prevalence of renal diseases is rising and reaching 5\u201315% of the adult population.", {"entities": []}], ["Renal damage is associated with disturbances of body homeostasis and the loss of equilibrium between exogenous and endogenous elements including drugs and metabolites.", {"entities": []}], ["Studies indicate that renal diseases are influenced not only by environmental but also by genetic factors.", {"entities": []}], ["In some cases the disease is caused by mutation in a single gene and at that time severity depends on the presence of one or two mutated alleles.", {"entities": []}], ["In other cases, renal disease is associated with the presence of alteration within a gene or genes, but environmental factors are also necessary for the development of disease.", {"entities": []}], ["Therefore, it seems that the analysis of genetic aspects should be a natural component of clinical and experimental studies.", {"entities": []}], ["The goal of personalized medicine is to determine the right drug, for the right patient, at the right time.", {"entities": []}], ["Whole-genome examinations may help to change the approach to the disease and the patient resulting in the creation of \u201cpersonalized medicine\u201d with new diagnostic and treatment strategies designed on the basis of genetic background of each individual.", {"entities": []}], ["The identification of high-risk patients in pharmacogenomics analyses will help to avoid many unwarranted side effects while optimizing treatment efficacy for individual patients.", {"entities": []}], ["Personalized therapies for kidney diseases are still at the preliminary stage mainly due to high costs of such analyses and the complex nature of human genome.", {"entities": []}], ["This review will focus on several areas of interest: renal disease pathogenesis, diagnosis, treatment, rate of progression and the prediction of prognosis.", {"entities": []}], ["To comprehensively examine the relationship between current sleep duration and past suicidal idea or attempt among Korean adolescents.", {"entities": []}], ["Data came from the 2009 Korea Youth Risk Behavior Web-based Survey with 75 066 participants (with the participation rate of 97.6%) in 800 middle and high schools.", {"entities": []}], ["Binary logistic regression was conducted by gender and depressed mood to identify significant factors for suicidal ideation/attempt.", {"entities": []}], ["The dependent variable was the log odds of suicidal ideation/attempt, while the independent/control variables were sleep duration and other demographic, socio-economic and health-related factors.", {"entities": []}], ["A negative association between sleep duration and suicidal ideation or attempt was weaker for those with depressed mood than for those without such experience in Korea for Year 2009.", {"entities": []}], ["The odds ratio of suicidal ideation/attempt regarding less than 4 hours of sleep compared to 6 to 7 hours of sleep, was smaller in a group with depressed mood than in a group without such experience, for example, 1.64 (95% confidence interval [CI], 1.29 to 2.08) vs. 2.06 (95% CI, 1.34 to 3.17) for men's suicidal ideation, 2.50 (95% CI, 1.69 to 3.69) vs. 3.89 (95% CI, 1.74 to 8.66) for men's suicidal attempt.", {"entities": []}], ["A negative association between age (or self-rated health) and suicidal ideation/attempt was also weaker for those with depressed mood than for those without such experience in the nation for the year.", {"entities": []}], ["There was a negative association between sleep duration and suicidal ideation/attempt in Korea for Year 2009 and this association was weaker for those with depressed mood than for those without such experience.", {"entities": []}], ["Based on the findings of this study, adolescents' better mental health and longer, more comfortable sleep might help to prevent their suicidal ideation and attempt in Korea.", {"entities": []}], ["Human respiratory patterns at chest and abdomen are associated with both physical and emotional states.", {"entities": []}], ["Accurate measurement of the respiratory patterns provides an approach to assess and analyze the physical and emotional states of the subject persons.", {"entities": []}], ["Not many research efforts have been made to wirelessly assess different respiration patterns, largely due to the inaccuracy of the conventional continuous-wave radar sensor to track the original signal pattern of slow respiratory movements.", {"entities": []}], ["This paper presents the accurate assessment of different respiratory patterns based on noncontact Doppler radar sensing.", {"entities": []}], ["This paper evaluates the feasibility of accurately monitoring different human respiration patterns via noncontact radar sensing.", {"entities": []}], ["A 2.4 GHz DC coupled multi-radar system was used for accurate measurement of the complete respiration patterns without any signal distortion.", {"entities": []}], ["Experiments were carried out in the lab environment to measure the different respiration patterns when the subject person performed natural breathing, chest breathing and diaphragmatic breathing.", {"entities": []}], ["The experimental results showed that accurate assessment of different respiration patterns is feasible using the proposed noncontact radar sensing technique.", {"entities": []}], ["Conotruncal heart defects (CTDs) are among the most severe birth defects worldwide.", {"entities": []}], ["Studies of CTDs indicate both lifestyle behaviors and genetic variation contribute to the risk of CTDs.", {"entities": []}], ["Based on a hybrid design using data from 616 case-parental and 1645 control-parental triads recruited for the National Birth Defects Prevention Study between 1997 and 2008, we investigated whether the occurrence of CTDs is associated with interactions between 921 maternal and/or fetal single nucleotide polymorphisms (SNPs) and maternal obesity and tobacco use.", {"entities": [[338, 345, "DISEASE"]]}], ["The maternal genotypes of the variants in the glutamate-cysteine ligase, catalytic subunit ( GCLC ) gene and the fetal genotypes of the variants in the glutathione S-transferase alpha 3 ( GSTA3 ) gene were associated with an elevated risk of CTDs among obese mothers.", {"entities": [[93, 97, "GENE"], [188, 193, "GENE"]]}], ["The risk of delivering infants with CTDs among obese mothers carrying AC genotype for a variant in the GCLC gene (rs6458939) was 2.00 times the risk among those carrying CC genotype (95% confidence interval: 1.41, 2.38).", {"entities": [[103, 107, "GENE"]]}], ["The maternal genotypes of several variants in the glutathione-S-transferase ( GST ) family of genes and the fetal genotypes of the variants in the GCLC gene interacted with tobacco exposures to increase the risk of CTDs.", {"entities": [[147, 151, "GENE"]]}], ["Our study suggests that the genetic basis underlying susceptibility of the developing heart to the adverse effects of maternal obesity and tobacco use involve both maternal and embryonic genetic variants.", {"entities": [[127, 134, "DISEASE"]]}], ["These results may provide insights into the underlying pathophysiology of CTDs, and ultimately lead to novel prevention strategies.", {"entities": []}], ["Stem cell factor (SCF), also known as mast cell growth factor, kit ligand, and steel factor, is the ligand for the tyrosine kinase receptor (SCFR) that is encoded by the c-kit proto-oncogene.", {"entities": []}], ["We analyzed the effects of recombinant human SCF (r-hSCF, 5-50 micrograms/kg/day, injected subcutaneously) on mast cells and melanocytes in a phase I study of 10 patients with advanced breast carcinoma.", {"entities": [[192, 201, "DISEASE"], [185, 201, "DISEASE"]]}], ["A wheal and flare reaction developed at each r-hSCF injection site; by electron microscopy, most dermal mast cells at these sites exhibited extensive, anaphylactic-type degranulation.", {"entities": []}], ["A 14-d course of r-hSCF significantly increased dermal mast cell density at sites distant to those injected with the cytokine and also increased both urinary levels of the major histamine metabolite, methyl- histamine, and serum levels of mast cell alpha-tryptase.", {"entities": []}], ["Five subjects developed areas of persistent hyperpigmentation at r-hSCF injection sites; by light microscopy, these sites exhibited markedly increased epidermal melanization and increased numbers of melanocytes.", {"entities": []}], ["The demonstration that r-hSCF can promote both the hyperplasia and the functional activation of human mast cells and melanocytes in vivo has implications for our understanding of the role of endogenous SCF in health and disease.", {"entities": []}], ["These findings also indicate that the interaction between SCF and its receptor represents a potential therapeutic target for regulating the numbers and functional activity of both mast cells and cutaneous melanocytes.", {"entities": []}], ["Respiratory effects of ozone in the workplace have not been extensively studied.", {"entities": []}], ["Our aim was to explore the relationship between daily average ozone levels and compensated acute respiratory problems among workers in Quebec between 2003 and 2010 using a time-stratified case-crossover design.", {"entities": []}], ["Health data came from the Workers\u2019 Compensation Board.", {"entities": []}], ["Daily concentrations of ozone were estimated using a spatiotemporal model.", {"entities": []}], ["Conditional logistic regressions, with and without adjustment for temperature, were used to estimate odds ratios (ORs, per 1 ppb increase of ozone), and lag effects were assessed.", {"entities": []}], ["Relationships with respiratory compensations in all industrial sectors were essentially null.", {"entities": []}], ["Positive non-statistically significant associations were observed for outdoor sectors, and decreased after controlling for temperature (ORs of 0.98; 1.01 and 1.05 at Lags 0, 1 and 2 respectively).", {"entities": []}], ["Considering the predicted increase of air pollutant concentrations in the context of climate change, closer investigation should be carried out on outdoor workers.", {"entities": []}], ["Eicosapentaenoic acid (EPA) is an omega-3 fatty acid with immunomodulatory and anti-inflammatory effects.", {"entities": []}], ["Beyond its direct effects, the metabolic products of EPA also regulate various immune responses.", {"entities": []}], ["Animal experiments demonstrated that EPA reduces adipose inflammation in high fat diet-induced obese mouse.", {"entities": []}], ["However, the effects of EPA on infiltrated immune cell populations in adipose tissue and underlying mechanisms remain to be elucidated.", {"entities": []}], ["We performed flow cytometry of stromal vascular fraction of epididymal adipose tissues from C57BL/6J and ob/ob mice fed normal chow mixed with or without 5% EPA.", {"entities": []}], ["The numbers of hematopoietic cells, including Tregs, were higher in both C57BL/6J and ob/ob mice fed EPA diet compared with control diet.", {"entities": []}], ["EPA enhanced the induction of Tregs in co-cultures of adipose tissue macrophages (ATMs) and na\u00efve T cells.", {"entities": []}], ["Among EPA metabolites, 5-HEPE was the most potent inducer of Tregs.", {"entities": []}], ["GPR119 and GPR120 are receptors for 5-HEPE and EPA, respectively, and antagonist of GPR119 blocked Treg induction by EPA in the presence of ATMs.", {"entities": [[0, 6, "GENE"], [84, 90, "GENE"], [11, 17, "GENE"], [0, 6, "GENE"], [84, 90, "GENE"]]}], ["Alox5 gene encodes 5-lipoxygenase enzyme catalyzing EPA into 5-HEPE, and inhibitor of 5-lipoxygenase down-regulated EPA-mediated induction of adipose tissue Tregs in ob/ob mice.", {"entities": [[0, 5, "GENE"]]}], ["The study findings demonstrated that both EPA and 5-HEPE enhance ATM-mediated Treg induction.", {"entities": []}], ["Natural products have always been exploited to promote health and served as a valuable source for the discovery of new drugs.", {"entities": []}], ["In this review, the great potential of natural compounds and medicinal plants for the treatment or prevention of cardiovascular and metabolic disorders, global health problems with rising prevalence, is addressed.", {"entities": []}], ["Special emphasis is laid on natural products for which efficacy and safety have already been proven and which are in clinical trials, as well as on plants used in traditional medicine.", {"entities": []}], ["Potential benefits from certain dietary habits and dietary constituents, as well as common molecular targets of natural products, are also briefly discussed.", {"entities": []}], ["A glimpse at the history of statins and biguanides, two prominent representatives of natural products (or their derivatives) in the fight against metabolic disease, is also included.", {"entities": []}], ["The present review aims to serve as an \u201copening\u201d of this special issue of Molecules , presenting key historical developments, recent advances, and future perspectives outlining the potential of natural products for prevention or therapy of cardiovascular and metabolic disease.", {"entities": []}], ["The parameters R N (Newtonian resistance), G (tissue damping), and H (tissue elastance) of the constant phase model of respiratory mechanics provide information concerning the site of altered mechanical properties of the lung.", {"entities": []}], ["The aims of this study were to compare the site of allergic airway narrowing implied from respiratory mechanics to a direct assessment by morphometry and to evaluate the effects of exogenous surfactant administration on the site and magnitude of airway narrowing.", {"entities": []}], ["We induced airway narrowing by ovalbumin sensitization and challenge and we tested the effects of a natural surfactant lacking surfactant proteins A and D (Infasurf\u00ae) on airway responses.", {"entities": []}], ["Sensitized, mechanically ventilated Brown Norway rats underwent an aerosol challenge with 5% ovalbumin or vehicle.", {"entities": []}], ["Other animals received nebulized surfactant prior to challenge.", {"entities": []}], ["Three or 20 minutes after ovalbumin challenge, airway luminal areas were assessed on snap-frozen lungs by morphometry.", {"entities": []}], ["At 3 minutes, R N and G detected large airway narrowing whereas at 20 minutes G and H detected small airway narrowing.", {"entities": []}], ["Surfactant inhibited R N at the peak of the early allergic response and ovalbumin-induced increase in bronchoalveolar lavage fluid cysteinyl leukotrienes and amphiregulin but not IgE-induced mast cell activation in vitro .", {"entities": []}], ["Allergen challenge triggers the rapid onset of large airway narrowing, detected by R N and G, and subsequent peripheral airway narrowing detected by G and H. Surfactant inhibits airway narrowing and reduces mast cell-derived mediators.", {"entities": []}], ["Little is known from developing countries about the effects of maternal morbidities diagnosed in the postpartum period on children's development.", {"entities": []}], ["The study aimed to document the relationships of such morbidities with care-giving practices by mothers, children's developmental milestones and their language, mental and psychomotor development.", {"entities": []}], ["Maternal morbidities were identified through physical examination at 6-9 weeks postpartum (n=488).", {"entities": []}], ["Maternal care-giving practices and postnatal depression were assessed also at 6-9 weeks postpartum.", {"entities": []}], ["Children's milestones of development were measured at six months, and their mental (MDI) and psychomotor (PDI) development, language comprehension and expression, and quality of psychosocial stimulation at home were assessed at 12 months.", {"entities": []}], ["Several approaches were used for identifying the relationships among different maternal morbidities, diagnosed by physicians, with children's development.", {"entities": []}], ["After controlling for the potential confounders, maternal anaemia diagnosed postpartum showed a small but significantly negative effect on children's language expression while the effects on language comprehension did not reach the significance level (p=0.085).", {"entities": []}], ["Children's development at 12 months was related to psychosocial stimulation at home, nutritional status, education of parents, socioeconomic status, and care-giving practices of mothers at six weeks of age.", {"entities": []}], ["Only a few mothers experienced each specific morbidity, and with the exception of anaemia, the sample-size was insufficient to make a conclusion regarding each specific morbidity.", {"entities": []}], ["Further research with a sufficient sample-size of individual morbidities is required to determine the association of postpartum maternal morbidities with children's development.", {"entities": []}], ["Caregivers of individuals with COPD have a key role in maintaining patient adherence and optimizing patient function.", {"entities": []}], ["However, no systematic review has examined how the caregiver role has been operationalized in interventions to improve outcomes of individuals with COPD or the quality or effectiveness of these interventions.", {"entities": []}], ["The aims of this review were to 1) determine whether caregivers have been involved as part of interventions to improve outcomes of individuals with COPD; 2) determine the risk of bias within included intervention studies; and 3) examine the effectiveness of interventions that have involved caregivers in improving outcomes of individuals with COPD.", {"entities": []}], ["The electronic databases of Medline, Embase, PsycINFO, and Cochrane Library were searched from January 2000 to November 2015.", {"entities": []}], ["Experimental studies testing interventions that involved a caregiver to improve COPD patient outcomes were eligible.", {"entities": []}], ["Nine studies involving caregivers met inclusion criteria.", {"entities": []}], ["No studies reported any intervention components targeted solely at caregivers, with most instead including caregivers in dyadic or group education sessions about COPD delivered by health care professionals.", {"entities": []}], ["The risk of bias identified in included studies was mixed.", {"entities": []}], ["Seven of the nine studies were effective in improving a broad range of outcomes.", {"entities": []}], ["These findings highlight that there is an urgent need for methodologically rigorous interventions to examine the effectiveness of strategies to assist caregivers to provide direct care, encourage adherence to health care provider recommendations, act as a health care advocate, and provide emotional and psychosocial support to individuals with COPD.", {"entities": []}], ["Genome-wide associations have shown a lot of promise in dissecting the genetics of complex traits in humans with single variants, yet a large fraction of the genetic effects is still unaccounted for.", {"entities": []}], ["Analyzing genetic interactions between variants (epistasis) is one of the potential ways forward.", {"entities": []}], ["We investigated the abundance and functional impact of a specific type of epistasis, namely the interaction between regulatory and protein-coding variants.", {"entities": []}], ["Using genotype and gene expression data from the 210 unrelated individuals of the original four HapMap populations, we have explored the combined effects of regulatory and protein-coding single nucleotide polymorphisms (SNPs).", {"entities": []}], ["We predict that about 18% (1,502 out of 8,233 nsSNPs) of protein-coding variants are differentially expressed among individuals and demonstrate that regulatory variants can modify the functional effect of a coding variant in cis .", {"entities": []}], ["Furthermore, we show that such interactions in cis can affect the expression of downstream targets of the gene containing the protein-coding SNP.", {"entities": []}], ["In this way, a cis interaction between regulatory and protein-coding variants has a trans impact on gene expression.", {"entities": []}], ["Given the abundance of both types of variants in human populations, we propose that joint consideration of regulatory and protein-coding variants may reveal additional genetic effects underlying complex traits and disease and may shed light on causes of differential penetrance of known disease variants.", {"entities": []}], ["The ultimate goal of genome-wide association studies (GWAS) is to explain the proportion of variation in a phenotypic trait that can be attributed to genetic factors.", {"entities": []}], ["The past two years have seen a plethora of successes in this field, yet, for most traits, a large fraction of variation remains unexplained.", {"entities": []}], ["Epistasis, or interaction between genetic variants, is a largely under-explored factor, which may shed some light in this area.", {"entities": []}], ["We use the HapMap populations to investigate interactions between regulatory and protein-coding variants and their impact on gene expression.", {"entities": []}], ["We show that if a specific protein-coding variant has a functional impact, this can be modified by a co-segregating regulatory variant ( cis interaction).", {"entities": []}], ["Furthermore, the authors demonstrate that such modification effects between variants at one locus may affect the expression of other genes in the cell in a trans manner.", {"entities": []}], ["The aim of this article is to present a framework though which variation can be considered in the context of GWAS.", {"entities": []}], ["Viewing variation from this underappreciated angle may, in some cases, provide an explanation for differential penetrance of complex disease traits, but also for non-replication of GWAS results that may arise as a consequence of such interactions.", {"entities": []}], ["The global epidemiology of many infectious diseases is changing, but little attention has been paid to whether the timing of seasonal influenza epidemics changed in recent years.", {"entities": [[134, 143, "DISEASE"]]}], ["This study investigated whether the timing of the peak of influenza epidemics has changed in countries of the World Health Organization (WHO) European Region between 1996 and 2016.", {"entities": [[58, 67, "DISEASE"]]}], ["Methods: Surveillance data were obtained from the WHO FluNet database.", {"entities": []}], ["For each country and season (July to June of the next year), the peak was defined as the week with the highest 3-week moving average for reported cases.", {"entities": []}], ["Linear regression models were used to test for temporal trends in the timing of the epidemic peak in each country and to determine whether this differed geographically.", {"entities": []}], ["Results: More than 600,000 influenza cases were included from 38 countries of the WHO European Region.", {"entities": [[27, 36, "DISEASE"]]}], ["The timing of the epidemic peak changed according to a longitudinal gradient, occurring progressively later in Western Europe (e.g.", {"entities": []}], ["by 2.8 days/season in Spain) and progressively earlier in Eastern Europe (e.g.", {"entities": []}], ["by 3.5 days/season in the Russian Federation).", {"entities": []}], ["Discussion: These results were confirmed in several sensitivity analyses.", {"entities": []}], ["Our findings have implications for influenza control and prevention measures in the WHO European Region, for instance for the implementation of influenza vaccination campaigns.", {"entities": [[35, 44, "DISEASE"], [144, 153, "DISEASE"]]}], ["Interleukin (IL)\u201037 is a newly identified member of the IL\u20101 family, and shows a growing role in a variety of diseases.", {"entities": []}], ["This review aims at summarizing and discussing the role of IL\u201037 in cardiovascular diseases.", {"entities": []}], ["Data for this review were identified by searches of MEDLINE, Embase, and PubMed using appropriate search terms.", {"entities": []}], ["IL\u201037 is a newly identified cytokine belonging to the IL\u20101 family and is expressed in inflammatory immune cells and several parenchymal cells.", {"entities": []}], ["It has potent anti\u2010inflammatory and immunosuppressive properties, with two mechanisms underlying this function.", {"entities": []}], ["IL\u201037 is produced as a precursor and then cleaved into mature form in the cytoplasm by caspase\u20101, translocating to nucleus and suppressing the transcription of several pro\u2010inflammatory genes by binding SMAD\u20103.", {"entities": []}], ["Besides, IL\u201037 can be secreted extracellularly, and binds to IL\u201018Ra chain and recruits Toll/IL\u20101R (TIR)\u20108 for transducing anti\u2010inflammatory signaling.", {"entities": []}], ["IL\u201037 is upregulated in an inducible manner and negatively regulates signaling mediated by TLR agonists and pro\u2010inflammatory cytokines.", {"entities": []}], ["The cytokine has been shown to inhibit both innate and adaptive immunological responses, exert antitumor effects, and act as a prognostic marker in a variety of autoimmune diseases.", {"entities": []}], ["Recent studies have suggested that IL\u201037 plays a role in cardiovascular diseases.", {"entities": []}], ["In this review, we provide an overview of the cytokine biology, discuss recent advances made in unraveling its cardio\u2010protective effects, and suggest guidelines for future research.", {"entities": []}], ["Background Individuals with a mental health disorder appear to be at increased risk of medical illness.", {"entities": []}], ["Aims To examine rates of medical illnesses in patients with bipolar disorder ( n = 1720) and to examine the clinical course of the bipolar illness according to lifetime medical illness burden.", {"entities": [[60, 76, "DISEASE"]]}], ["Method Participants recruited within the UK were asked about the lifetime occurrence of 20 medical illnesses, interviewed using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) and diagnosed according to DSM-IV criteria.", {"entities": []}], ["Results We found significantly increased rates of several medical illnesses in our bipolar sample.", {"entities": []}], ["A high medical illness burden was associated with a history of anxiety disorder, rapid cycling mood episodes, suicide attempts and mood episodes with a typically acute onset.", {"entities": [[63, 79, "DISEASE"]]}], ["Conclusions Bipolar disorder is associated with high rates of medical illness.", {"entities": [[12, 28, "DISEASE"]]}], ["This comorbidity needs to be taken into account by services in order to improve outcomes for patients with bipolar disorder and also in research investigating the aetiology of affective disorder where shared biological pathways may play a role.", {"entities": [[107, 123, "DISEASE"]]}], ["The importance of the patients point of view on their health status is widely recognised.", {"entities": []}], ["Patient-reported outcomes is a broad term encompassing a large variety of different health data reported by patients, as symptoms, functional status, Quality of Life and Health-Related Quality of Life.", {"entities": []}], ["Measurements of Health-Related Quality of Life have been developed during many years of researches, and a lot of validated questionnaires exist.", {"entities": []}], ["However, few attempts have been made to standardise the evaluation of instruments characteristics, no recommendations are made about interpretation on Health-Related Quality of Life results, especially regarding the clinical significance of a change leading a therapeutic approach.", {"entities": []}], ["Moreover, the true value of Health-Related Quality of Life evaluations in clinical trials has not yet been completely defined.", {"entities": []}], ["An important step towards a more structured and frequent use of Patient-Reported Outcomes in drug development is represented by the FDA Guidance, issued on February 2006.", {"entities": []}], ["In our paper we aim to report some considerations on this Guidance.", {"entities": []}], ["Our comments focus especially on the characteristics of instruments to use, the Minimal Important Difference, and the methods to calculate it.", {"entities": []}], ["Furthermore, we present the advantages and opportunities of using the Patient-Reported Outcomes in drug development, as seen by a pharmaceutical company.", {"entities": []}], ["The Patient-Reported Outcomes can provide additional data to make a drug more competitive than others of the same pharmacological class, and a well demonstrated positive impact on the patient' health status and daily life might allow a higher price and/or the inclusion in a reimbursement list.", {"entities": []}], ["Applying extensively the FDA Guidance in the next trials could lead to a wider culture of subjective measurement, and to a greater consideration for the patient's opinions on his/her care.", {"entities": []}], ["Moreover, prescribing doctors and payers could benefit from subjective information to better define the value of drugs.", {"entities": []}], ["The etiology of bioaerosol-related pulmonary diseases remains poorly understood.", {"entities": []}], ["Recently, archaea emerged as prominent airborne components of agricultural environments, but the consequences of airway exposure to archaea remain unknown.", {"entities": []}], ["Since subcomponents of archaea can be immunogenic, we used a murine model to study the pulmonary immune responses to two archaeal species found in agricultural facilities: Methanobrevibacter smithii (MBS) and Methanosphaera stadtmanae (MSS).", {"entities": []}], ["Mice were administered intranasally with 6.25, 25 or 100 \u00b5g of MBS or MSS, once daily, 3 days a week, for 3 weeks.", {"entities": []}], ["MSS induced more severe histopathological alterations than MBS with perivascular accumulation of granulocytes, pronounced thickening of the alveolar septa, alveolar macrophages accumulation and increased perivascular mononucleated cell accumulation.", {"entities": []}], ["Analyses of bronchoalveolar lavage fluids revealed up to 3 times greater leukocyte accumulation with MSS compared to MBS.", {"entities": []}], ["Instillation of 100 \u00b5g of MBS or MSS caused predominant accumulation of monocyte/macrophages (4.5\u00d710", {"entities": []}], ["Evidence-based diabetes guidelines generally neglect comorbidity, which may interfere with diabetes management.", {"entities": []}], ["The prevalence of comorbidity described in patients with type 2 diabetes (T2D) shows a wide range depending on the population selected and the comorbid diseases studied.", {"entities": []}], ["This exploratory study aimed to establish comorbidity rates in an unselected primary-care population of patients with T2D.", {"entities": []}], ["This was a cohort study of 714 adult patients with newly diagnosed T2D within the study period (1985-2007) in a practice-based research network in the Netherlands.", {"entities": []}], ["The main outcome measures were prevalence and incidence density rates of chronic comorbid diseases and disease clusters.", {"entities": []}], ["All chronic disease episodes registered in the practice-based research network were considered as comorbidities.", {"entities": []}], ["We categorised comorbidity into 'concordant' (that is, shared aetiology, risk factors, and management plans with diabetes) and 'discordant' comorbidity.", {"entities": []}], ["Prevalence and incidence density were assessed for both categories of comorbidity.", {"entities": []}], ["The mean observation period was 17.3 years.", {"entities": []}], ["At the time of diabetes diagnosis, 84.6% of the patients had one or more chronic comorbid disease of 'any type', 70.6% had one or more discordant comorbid disease, and 48.6% and 27.2% had three or more chronic comorbid diseases of 'any type' or of 'discordant only', respectively.", {"entities": []}], ["A quarter of those without any comorbid disease at the time of their diabetes diagnosis developed at least one comorbid disease in the first year afterwards.", {"entities": []}], ["Cardiovascular diseases (considered concordant comorbidity) were the most common, but there were also high rates of musculoskeletal and mental disease.", {"entities": []}], ["Discordant comorbid diseases outnumbered concordant diseases.", {"entities": []}], ["We found high prevalence and incidence density rates for both concordant and discordant comorbidity.", {"entities": []}], ["The latter may interfere with diabetes management, thus future research and clinical practice should take discordant comorbidity in patients with T2D into account.", {"entities": []}], ["OBJECTIVE \u2014To examine whether diabetes is a risk factor for hospitalization with pneumonia and to assess the impact of A1C level on such risk.", {"entities": [[81, 90, "DISEASE"]]}], ["RESEARCH DESIGN AND METHODS \u2014In this population-based, case-control study we identified patients with a first-time pneumonia-related hospitalization between 1997 and 2005, using health care databases in northern Denmark.", {"entities": [[115, 124, "DISEASE"]]}], ["For each case, 10 sex- and age-matched population control subjects were selected from Denmark's Civil Registration System.", {"entities": []}], ["We used conditional logistic regression to compute relative risk (RR) for pneumonia-related hospitalization among subjects with and without diabetes, controlling for potential confounding factors.", {"entities": [[74, 83, "DISEASE"]]}], ["RESULTS \u2014The study included 34,239 patients with a pneumonia-related hospitalization and 342,390 population control subjects.", {"entities": [[51, 60, "DISEASE"]]}], ["The adjusted RR for pneumonia-related hospitalization among subjects with diabetes was 1.26 (95% CI 1.21\u20131.31) compared with nondiabetic individuals.", {"entities": [[20, 29, "DISEASE"]]}], ["The adjusted RR was 4.43 (3.40\u20135.77) for subjects with type 1 diabetes and 1.23 (1.19\u20131.28) for subjects with type 2 diabetes.", {"entities": []}], ["Diabetes duration \u226510 years increased the risk of a pneumonia-related hospitalization (1.37 [1.28\u20131.47]).", {"entities": [[52, 61, "DISEASE"]]}], ["Compared with subjects without diabetes, the adjusted RR was 1.22 (1.14\u20131.30) for diabetic subjects whose A1C level was <7% and 1.60 (1.44\u20131.76) for diabetic subjects whose A1C level was \u22659%.", {"entities": []}], ["CONCLUSIONS \u2014Type 1 and type 2 diabetes are risk factors for a pneumonia-related hospitalization.", {"entities": [[63, 72, "DISEASE"]]}], ["Poor long-term glycemic control among patients with diabetes clearly increases the risk of hospitalization with pneumonia.", {"entities": [[112, 121, "DISEASE"]]}], ["Background to the debate: Only two industrialized countries, the United States and New Zealand, allow direct-to-consumer advertising (DTCA) of prescription medicines, although New Zealand is planning a ban [ Proponents of such advertising say that it informs the public and stimulates appropriate use of drugs, but critics argue that the adverts are misleading and raise prescribing costs without net evidence of health benefits.", {"entities": []}], ["c-CBL ( CBL ) encodes a member of the Cbl family of proteins, which functions as an E3 ubiquitin ligase.", {"entities": [[2, 5, "GENE"], [8, 11, "GENE"], [38, 41, "GENE"], [2, 5, "GENE"], [8, 11, "GENE"], [38, 41, "GENE"]]}], ["We describe a dominant developmental disorder resulting from germline missense CBL mutations, which is characterized by constitutional anomalies that include impaired growth, developmental delay, cryptorchidism, and a predisposition to juvenile myelomonocytic leukemia (JMML).", {"entities": [[196, 210, "DISEASE"], [236, 268, "DISEASE"], [260, 268, "DISEASE"], [79, 82, "GENE"]]}], ["Some individuals experienced spontaneous regression of their JMML but developed vasculitis later in life.", {"entities": [[80, 90, "DISEASE"]]}], ["Importantly, JMML specimens from affected children show loss of the normal CBL allele through acquired isodisomy.", {"entities": [[75, 78, "GENE"]]}], ["Consistent with these genetic data, the common p.Y371H mutant Cbl protein induces cytokine-independent growth and constitutive phosphorylation of ERK, AKT, and S6 only in hematopoietic cells in which normal Cbl expression is reduced by RNA interference.", {"entities": [[62, 65, "GENE"], [207, 210, "GENE"], [62, 65, "GENE"], [207, 210, "GENE"]]}], ["We conclude that germline CBL mutations have developmental, tumorigenic, and functional consequences that are reminiscent of disorders that are caused by hyperactive Ras/Raf/MEK/ERK signaling and include neurofibromatosis type 1, and Noonan, Costello, cardiofaciocutaneous, and Legius syndromes.", {"entities": [[204, 221, "DISEASE"], [26, 29, "GENE"]]}], ["Recent studies have explored the potential for swimming pool disinfection by-products (DBPs), which are respiratory irritants, to cause asthma in young children.", {"entities": [[136, 142, "DISEASE"]]}], ["Here we describe the state of the science on methods for understanding children\u2019s exposure to DBPs and biologics at swimming pools and associations with new-onset childhood asthma and recommend a research agenda to improve our understanding of this issue.", {"entities": [[173, 179, "DISEASE"]]}], ["A workshop was held in Leuven, Belgium, 21\u201323 August 2007, to evaluate the literature and to develop a research agenda to better understand children\u2019s exposures in the swimming pool environment and their potential associations with new-onset asthma.", {"entities": [[242, 248, "DISEASE"]]}], ["Participants, including clinicians, epidemiologists, exposure scientists, pool operations experts, and chemists, reviewed the literature, prepared background summaries, and held extensive discussions on the relevant published studies, knowledge of asthma characterization and exposures at swimming pools, and epidemiologic study designs.", {"entities": [[248, 254, "DISEASE"]]}], ["Childhood swimming and new-onset childhood asthma have clear implications for public health.", {"entities": [[43, 49, "DISEASE"]]}], ["If attendance at indoor pools increases risk of childhood asthma, then concerns are warranted and action is necessary.", {"entities": [[58, 64, "DISEASE"]]}], ["If there is no such relationship, these concerns could unnecessarily deter children from indoor swimming and/or compromise water disinfection.", {"entities": []}], ["Current evidence of an association between childhood swimming and new-onset asthma is suggestive but not conclusive.", {"entities": [[76, 82, "DISEASE"]]}], ["Important data gaps need to be filled, particularly in exposure assessment and characterization of asthma in the very young.", {"entities": [[99, 105, "DISEASE"]]}], ["Participants recommended that additional evaluations using a multidisciplinary approach are needed to determine whether a clear association exists.", {"entities": []}], ["Clinical studies of the associations of vitamin E with lung function have reported conflicting results.", {"entities": []}], ["However, these reports primarily examine the \u03b1-tocopherol isoform of vitamin E and have not included the isoform \u03b3-tocopherol which we recently demonstrated in vitro opposes the function of \u03b1-tocopherol.", {"entities": []}], ["We previously demonstrated, in vitro and in animal studies, that the vitamin E isoform \u03b1-tocopherol protects, but the isoform \u03b3-tocopherol promotes lung inflammation and airway hyperresponsiveness.", {"entities": []}], ["To translate these findings to humans, we conducted analysis of 4526 adults in the Coronary Artery Risk Development in Young Adults (CARDIA) multi-center cohort with available spirometry and tocopherol data in blacks and whites.", {"entities": []}], ["Spirometry was obtained at years 0, 5, 10, and 20 and serum tocopherol was from years 0, 7 and 15 of CARDIA.", {"entities": []}], ["In cross-sectional regression analysis at year 0, higher \u03b3-tocopherol associated with lower FEV 1 (p\u2009=\u20090.03 in blacks and p\u2009=\u20090.01 in all participants) and FVC (p\u2009=\u20090.01 in blacks, p\u2009=\u20090.05 in whites, and p\u2009=\u20090.005 in all participants), whereas higher \u03b1-tocopherol associated with higher FVC (p\u2009=\u20090.04 in blacks and whites and p\u2009=\u20090.01 in all participants).", {"entities": [[92, 95, "GENE"]]}], ["In the lowest quartile of \u03b1-tocopherol, higher \u03b3-tocopherol associated with a lower FEV 1 (p\u2009=\u20090.05 in blacks and p\u2009=\u20090.02 in all participants).", {"entities": [[84, 87, "GENE"]]}], ["In contrast, in the lowest quartile of \u03b3-tocopherol, higher \u03b1-tocopherol associated with a higher FEV 1 (p\u2009=\u20090.03) in blacks.", {"entities": [[98, 101, "GENE"]]}], ["Serum \u03b3-tocopherol >10\u00a0\u03bcM was associated with a 175\u2013545\u00a0ml lower FEV 1 and FVC at ages 21\u201355\u00a0years.", {"entities": [[65, 68, "GENE"]]}], ["Increasing serum concentrations of \u03b3-tocopherol were associated with lower FEV1 or FVC, whereas increasing serum concentrations of \u03b1-tocopherol was associated with higher FEV1 or FVC.", {"entities": []}], ["Based on the prevalence of serum \u03b3-tocopherol >10\u00a0\u03bcM in adults in CARDIA and the adult U.S. population in the 2011 census, we expect that the lower FEV 1 and FVC at these concentrations of serum \u03b3-tocopherol occur in up to 4.5 million adults in the population.", {"entities": [[148, 151, "GENE"]]}], ["Baguio City, Philippines experienced its first influenza A(H1N1)pdm09 [A(H1)pdm09] case in May 2009.", {"entities": [[47, 56, "DISEASE"]]}], ["In spite of numerous reports describing the epidemiological and clinical features of A(H1)pdm09 cases, there are no studies about A(H1)pdm09 epidemiology in the Philippines, where year-round influenza activity was observed.", {"entities": [[191, 200, "DISEASE"]]}], ["We aimed to investigate the epidemiological and clinical features of A(H1)pdm09 in pandemic and post-pandemic periods.", {"entities": []}], ["Data were collected under enhanced surveillance of influenza-like illness (ILI) and severe acute respiratory infection (SARI) from January 2009 to December 2010.", {"entities": [[51, 60, "DISEASE"]]}], ["RT-PCR was used to detect A(H1)pdm09, following the protocol of the United States Centers for Disease Control and Prevention.", {"entities": []}], ["The reproduction number was computed as a simple exponential growth rate.", {"entities": []}], ["Differences in proportional and categorical data were examined using chi-square test or Fishers\u2019 exact test.", {"entities": []}], ["The outbreak was observed from week 25 to 35 in 2009 and from week 24 to 37 in 2010.", {"entities": []}], ["The highest proportion of cases was among children aged 5\u201314 years.", {"entities": []}], ["The number of ILI outpatients was 2.3-fold higher in 2009 than in 2010, while the number of inpatients was 1.8-fold higher in 2009.", {"entities": []}], ["No significant difference in gender was observed during the two periods.", {"entities": []}], ["The clinical condition of all patients was generally mild and self-limiting, with only 2 mortalities among inpatients in 2009.", {"entities": []}], ["The basic reproduction number was estimated as 1.16 in 2009 and 1.05 in 2010 in the assumption of mean generation time as 2.6 days.", {"entities": []}], ["School children played a significant role in facilitating influenza transmission.", {"entities": [[58, 67, "DISEASE"]]}], ["Despite the reported high prevalence of osteoporosis in India, there have been no previous studies examining the risk factors for hip fracture in the Indian population.", {"entities": [[40, 52, "DISEASE"]]}], ["We carried out a case control investigation comprising 100 case subjects (57 women and 43 men) admitted with a first hip fracture into one of three hospitals across New Delhi.", {"entities": []}], ["The 100 controls were age and sex matched subjects who were either healthy visitors not related to the case patients or hospital staff.", {"entities": []}], ["Information from all subjects was obtained through a questionnaire based interview.", {"entities": []}], ["There was a significant increase in the number of cases of hip fracture with increasing age.", {"entities": []}], ["There were significantly more women (57%) than men (43%).", {"entities": []}], ["Univariate analysis identified protective effects for increased activity, exercise, calcium and vitamin supplements, almonds, fish, paneer (cottage cheese), curd (plain yogurt), and milk.", {"entities": []}], ["However, tea and other caffeinated beverages were significant risk factors.", {"entities": []}], ["In women, hormone/estrogen therapy appeared to have a marginal protective effect.", {"entities": []}], ["For all cases, decreased agility, visual impairment, long term medications, chronic illnesses increased the risk of hip fracture.", {"entities": []}], ["The multivariate analysis confirmed a protective effect of increased activity and also showed a decrease in hip fracture risk with increasing body mass index (odds ratio (OR) 0.024, 95% confidence interval (CI) 0.006-0.10 & OR 0.81, 95% CI 0.68-0.97 respectively).", {"entities": []}], ["Individuals who take calcium supplements have a decreased risk of hip fracture (OR 0.076; CI 0.017-0.340), as do individuals who eat fish (OR 0.094; CI 0.020-0.431), and those who eat paneer (OR 0.152; 0.031-0.741).", {"entities": []}], ["Tea drinkers have a higher risk of hip fracture (OR 22.8; 95% CI 3.73-139.43).", {"entities": []}], ["Difficulty in getting up from a chair also appears to be an important risk factor for hip fractures (OR 14.53; 95% CI 3.86-54.23).", {"entities": []}], ["In the urban Indian population, dietary calcium, vitamin D, increased body mass index, and higher activity levels have a significant protective effect on hip fracture.", {"entities": []}], ["On the other hand, caffeine intake and decreased agility increase the risk of hip fracture.", {"entities": []}], ["Future studies should be done in order to direct primary preventive programs for hip fracture in India.", {"entities": []}], ["The U.S. Clean Air Act (CAA) explicitly guarantees the protection of sensitive human subpopulations from adverse health effects associated with air pollution exposure.", {"entities": []}], ["Identified subpopulations, such as asthmatics, may carry multiple genetic susceptibilities to disease onset and progression and thus qualify for special protection under the CAA.", {"entities": []}], ["Scientific advances accelerated as a result of the ground-breaking Human Genome Project enable the quantification of genetic information that underlies such human variability in susceptibility and the cellular mechanisms of disease.", {"entities": []}], ["In epidemiology and regulatory toxicology, genetic information can more clearly elucidate human susceptibility essential to risk assessment, such as in support of air quality regulation.", {"entities": []}], ["In an effort to encourage the incorporation of genomic information in regulation, the U.S. Environmental Protection Agency (EPA) has issued an Interim Policy on Genomics .", {"entities": []}], ["Additional research strategy and policy documents from the National Academy of Science, the U.S. EPA, and the U.S. Department of Health and Human Services further promote the expansion of asthma genetics research for human health risk assessment.", {"entities": [[188, 194, "DISEASE"]]}], ["Through a review of these government documents, we find opportunities for the inclusion of genetic information in the regulation of air pollutants.", {"entities": []}], ["In addition, we identify sources of information in recent scientific research on asthma genetics relevant to regulatory standard setting.", {"entities": [[81, 87, "DISEASE"]]}], ["We conclude with recommendations on how to integrate these approaches for the improvement of regulatory health science and the prerequisites for inclusion of genetic information in decision making.", {"entities": []}], ["Platinum-metal oxidation catalysts are to be introduced in exhaust systems of many 1975 model-year automobiles in the U.S. to meet Clean Air Act standards.", {"entities": []}], ["Small quantities of finely divided catalyst have been found issuing from prototype systems; platinum and palladium compounds may be found also.", {"entities": []}], ["Although platinum exhibits a remarkable resistance to oxidation and chemical attack, it reacts chemically under some conditions producing coordination complex compounds.", {"entities": []}], ["Palladium reacts more readily than platinum.", {"entities": []}], ["Some platinum-metal complexes interact with biological systems as bacteriostatic, bacteriocidal, viricidal, and immunosuppressive agents.", {"entities": []}], ["Workers chronically exposed to platinum complexes often develop asthma-like respiratory distress and skin reactions called platinosis.", {"entities": [[64, 70, "DISEASE"]]}], ["Platinum complexes used alone and in combination therapy with other drugs have recently emerged as effective agents in cancer chemotherapy.", {"entities": [[119, 125, "DISEASE"]]}], ["Understanding toxic and favorable interactions of metal species with living organisms requires basic information on quantities and chemical characteristics of complexes at trace concentrations in biological materials.", {"entities": []}], ["Some basic chemical kinetic and thermodynamic data are presented to characterize the chemical behavior of the complex cis-[Pt(NH3)2Cl2] used therapeutically.", {"entities": []}], ["A brief discussion of platinum at manogram levels in biological tissue is discussed.", {"entities": []}], ["MicroRNA are small noncoding RNA molecules that are involved in the control of gene expression.", {"entities": []}], ["To investigate the role of microRNA in multiple sclerosis (MS), we performed genome-wide expression analyses of mRNA and microRNA in T-cells from MS patients and controls.", {"entities": [[39, 57, "DISEASE"]]}], ["Heparin-anticoagulated peripheral blood was collected from MS-patients and healthy controls followed by isolation of T-cells.", {"entities": []}], ["MicroRNA and RNA from T-cells was prepared and hybridized to Affymetrix miR 2.0 array and Affymetrix U133Plus 2.0 Human Genome array (Santa Clara, CA), respectively.", {"entities": []}], ["Verifications were performed with real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["We identified 2,452 differentially expressed genes and 21 differentially expressed microRNA between MS patients and controls.", {"entities": []}], ["By Kolmogorov-Smirnov test, 20 of 21 differentially expressed microRNA were shown to affect the expression of their target genes, many of which were involved in the immune system.", {"entities": []}], ["Tumor necrosis factor ligand superfamily member 14 ( TNFSF14 ) was a microRNA target gene significantly decreased in MS.", {"entities": [[53, 60, "GENE"]]}], ["The differential expression of mir-494 , mir-197 and the predicted microRNA target gene TNFSF14 was verified by real-time PCR and ELISA.", {"entities": [[31, 38, "GENE"], [41, 48, "GENE"], [88, 95, "GENE"]]}], ["These findings indicate that microRNA may be important regulatory molecules in T-cells in MS.", {"entities": []}], ["Outdoor allergens are an important part of the exposures that lead to allergic disease.", {"entities": []}], ["Understanding the role of outdoor allergens requires a knowledge of the nature of outdoor allergen-bearing particles, the distributions of their source, and the nature of the aerosols (particle types, sizes, dynamics of concentrations).", {"entities": []}], ["Primary sources for outdoor allergens include vascular plants (pollen, fern spores, soy dust), and fungi (spores, hyphae).", {"entities": []}], ["Nonvascular plants, algae, and arthropods contribute small numbers of allergen-bearing particles.", {"entities": []}], ["Particles are released from sources into the air by wind, rain, mechanical disturbance, or active discharge mechanisms.", {"entities": []}], ["Once airborne, they follow the physical laws that apply to all airborne particles.", {"entities": []}], ["Although some outdoor allergens penetrate indoor spaces, exposure occurs mostly outdoors.", {"entities": []}], ["Even short-term peak outdoor exposures can be important in eliciting acute symptoms.", {"entities": []}], ["Monitoring of airborne biological particles is usually by particle impaction and microscopic examination.", {"entities": []}], ["Centrally located monitoring stations give regional-scale measurements for aeroallergen levels.", {"entities": []}], ["Evidence for the role of outdoor allergens in allergic rhinitis is strong and is rapidly increasing for a role in asthma.", {"entities": [[46, 63, "DISEASE"], [55, 63, "DISEASE"], [114, 120, "DISEASE"]]}], ["Pollen and fungal spore exposures have both been implicated in acute exacerbations of asthma, and sensitivity to some fungal spores predicts the existence of asthma.", {"entities": [[86, 92, "DISEASE"], [158, 164, "DISEASE"]]}], ["Synergism and/or antagonism probably occurs with other outdoor air particles and gases.", {"entities": []}], ["Control involves avoidance of exposure (staying indoors, preventing entry of outdoor aerosols) as well as immunotherapy, which is effective for pollen but of limited effect for spores.", {"entities": []}], ["Outdoor allergens have been the subject of only limited studies with respect to the epidemiology of asthma.", {"entities": [[100, 106, "DISEASE"]]}], ["Much remains to be studied with respect to prevalence patterns, exposure and disease relationships, and control.", {"entities": []}], ["Misfolding and aggregation of copper\u2013zinc superoxide dismutase (Sod1) are observed in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).", {"entities": [[121, 150, "DISEASE"], [133, 150, "DISEASE"], [64, 68, "GENE"]]}], ["Mutations in Sod1 lead to familial ALS (FALS), which is a late-onset disease.", {"entities": [[13, 17, "GENE"]]}], ["Since oxidative damage to proteins increases with age, it had been proposed that oxidation of Sod1 mutants may trigger their misfolding and aggregation in FALS.", {"entities": [[94, 98, "GENE"]]}], ["However, over 90% of ALS cases are sporadic (SALS) with no obvious genetic component.", {"entities": []}], ["We hypothesized that oxidation could also trigger the misfolding and aggregation of wild-type Sod1 and sought to confirm this in a cellular environment.", {"entities": [[94, 98, "GENE"]]}], ["Using quiescent, stationary-phase yeast cells as a model for non-dividing motor neurons, we probed for post-translational modification (PTM) and aggregation of wild-type Sod1 extracted from these cells.", {"entities": [[170, 174, "GENE"]]}], ["By size-exclusion chromatography (SEC), we isolated two populations of Sod1 from yeast: a low-molecular weight (LMW) fraction that is catalytically active and a catalytically inactive, high-molecular weight (HMW) fraction.", {"entities": [[71, 75, "GENE"]]}], ["High-resolution mass spectrometric analysis revealed that LMW Sod1 displays no PTMs but HMW Sod1 is oxidized at Cys146 and His71, two critical residues for the stability and folding of the enzyme.", {"entities": [[62, 66, "GENE"], [92, 96, "GENE"], [79, 83, "GENE"], [62, 66, "GENE"], [92, 96, "GENE"]]}], ["HMW Sod1 is also oxidized at His120, a copper ligand, which will promote loss of this catalytic metal cofactor essential for SOD activity.", {"entities": [[4, 8, "GENE"]]}], ["Monitoring the fluorescence of a Sod1-green-fluorescent-protein fusion (Sod1-GFP) extracted from yeast chromosomally expressing this fusion, we find that HMW Sod1-GFP levels increase up to 40-fold in old cells.", {"entities": []}], ["Thus, we speculate that increased misfolding and inclusion into soluble aggregates is a consequence of elevated oxidative modifications of wild-type Sod1 as cells age.", {"entities": [[149, 153, "GENE"]]}], ["Our observations argue that oxidative damage to wild-type Sod1 initiates the protein misfolding mechanisms that give rise to SALS.", {"entities": [[58, 62, "GENE"]]}], ["\u2022 Key Sod1 catalytic and structure-stabilizing residues (Cys146, His120, His71) are oxidized in stationary-phase yeast.", {"entities": [[6, 10, "GENE"]]}], ["\u2022 Oxidized Sod1 is isolated in an inactive, high-molecular-weight, soluble aggregate.", {"entities": [[11, 15, "GENE"]]}], ["\u2022 Sod1 with native mass isolated from the same samples is not oxidized and is catalytically active.", {"entities": [[2, 6, "GENE"]]}], ["\u2022 Our results argue that oxidation triggers the\u00a0formation of soluble Sod1-containing aggregates that may contribute to sporadic ALS development.", {"entities": []}], ["Key Sod1 catalytic and structure-stabilizing residues (Cys146, His120, His71) are oxidized in stationary-phase yeast.", {"entities": [[4, 8, "GENE"]]}], ["Oxidized Sod1 is isolated in an inactive, high-molecular-weight, soluble aggregate.", {"entities": [[9, 13, "GENE"]]}], ["Sod1 with native mass isolated from the same samples is not oxidized and is catalytically active.", {"entities": [[0, 4, "GENE"]]}], ["Our results argue that oxidation triggers the\u00a0formation of soluble Sod1-containing aggregates that may contribute to sporadic ALS development.", {"entities": []}], ["Previous studies on the association between adiposity and mood disorder have produced contradictory results, and few have used measurements other than body mass index (BMI).", {"entities": [[58, 71, "DISEASE"]]}], ["We examined the association between probable major depression and several measurements of adiposity: BMI, waist circumference (WC), waist-hip-ratio (WHR), and body fat percentage (BF%).", {"entities": []}], ["We conducted a cross-sectional study using baseline data on the sub-group of UK Biobank participants who were assessed for mood disorder.", {"entities": [[123, 136, "DISEASE"]]}], ["Multivariate logistic regression models were used, adjusting for potential confounders including: demographic and life-style factors, comorbidity and psychotropic medication.", {"entities": []}], ["Of the 140,564 eligible participants, evidence of probable major depression was reported by 30,145 (21.5%).", {"entities": []}], ["The fully adjusted odds ratios (OR) for obese participants were 1.16 (95% confidence interval (CI) 1.12, 1.20) using BMI, 1.15 (95% CI 1.11, 1.19) using WC, 1.09 (95% CI 1.05, 1.13) using WHR and 1.18 (95% CI 1.12, 1.25) using BF% (all p\u2009<\u20090.001).", {"entities": []}], ["There was a significant interaction between adiposity and gender (p\u2009=\u20090.001).", {"entities": []}], ["Overweight women were at increased risk of depression with a dose response relationship across the overweight (25.0-29.9\u00a0kg/m Adiposity was associated with probable major depression, irrespective of the measurement used.", {"entities": []}], ["The association was stronger in women than men.", {"entities": []}], ["Physicians managing overweight and obese women should be alert to this increased risk.", {"entities": []}], ["Since the passage of the environmental legislation in the early 1970's, critics have attacked these laws as being unnecessary and for contributing significantly to the problem of inflation in the United States.", {"entities": []}], ["This paper is an attempt to put the inflationary costs of air pollution into perspective by considering them in light of the cost, especially to public health, of not proceeding with pollution control.", {"entities": []}], ["There is now a great deal of evidence that the concentration of certain pollutants in the air can contribute significantly to the incidence of respiratory and cardiovascular diseases and to certain forms of cancer.", {"entities": [[207, 213, "DISEASE"]]}], ["On the basis of the results of a recent study of the impacts of pollution control on inflation, the annual reduction in purchasing power of the average family is calculated to be $31 per family.", {"entities": []}], ["To determine the average costs of air pollution on human health, research by Lave and Seskin is utilized.", {"entities": []}], ["First, the implications of air pollution for mortality and morbidity rates are determined.", {"entities": []}], ["Then, the reduction in direct health costs and indirect costs (lost productivity of workers) as a result of pollution abatement is estimated.", {"entities": []}], ["These annual health costs from pollution total approximately $250 per family.", {"entities": []}], ["The results suggest that the inflationary costs of air pollution control are more than offset by the damages to public health from unabated air pollution.", {"entities": []}], ["There is a need to increase flu vaccination rates in England particularly among those under 65 years of age and at risk because of other conditions and treatments.", {"entities": []}], ["Patients in at risk groups are eligible for free vaccination on the National Health Service (NHS) in England, but despite this, some choose to pay privately.", {"entities": [[93, 96, "GENE"]]}], ["This paper explores how prevalent this is and why people choose to do it.", {"entities": []}], ["There is moderate to good evidence from several countries that community pharmacies can safely provide a range of vaccinations, largely seasonal influenza Immunisation.", {"entities": [[145, 154, "DISEASE"]]}], ["Pharmacy-based services can extend the reach of immunisation programmes.", {"entities": []}], ["User, doctor and pharmacist satisfaction with these services is high.", {"entities": []}], ["Data were collected during the 2012\u201313 flu season as part of a community pharmacy private flu vaccination service to help identify whether patients were eligible to have their vaccination free of charge on the NHS.", {"entities": [[210, 213, "GENE"]]}], ["Additional data were collected from a sample of patients accessing the private service within 13 pharmacies to help identify the reasons patients paid when they were eligible for free vaccination.", {"entities": []}], ["Data were captured from 89,011 privately paying patients across 479 pharmacies in England, of whom 6% were eligible to get the vaccination free.", {"entities": []}], ["921 patients completed a survey in the 13 pharmacies selected.", {"entities": []}], ["Of these, 199 (22%) were eligible to get their flu vaccination for free.", {"entities": []}], ["131 (66%) were female.", {"entities": []}], ["Average age was 54 years.", {"entities": []}], ["Of the 199 patients who were eligible for free treatment, 100 (50%) had been contacted by their GP surgery to go for their vaccination, but had chosen not to go.", {"entities": []}], ["Reasons given include accessibility, convenience and preference for pharmacy environment.", {"entities": []}], ["While people at risk can access flu vaccinations free via the NHS, some choose to pay privately because they perceive that community pharmacy access is easier.", {"entities": [[62, 65, "GENE"]]}], ["There are opportunities for pharmacy to support the NHS in delivering free flu vaccinations to patients at risk by targeting people unlikely to access the service at GP surgeries.", {"entities": [[52, 55, "GENE"]]}], ["Humans are increasingly exposed via the diet to Ag nanoparticles (NP) used in the food industry.", {"entities": []}], ["Because of their anti-bacterial activity, ingested Ag NP might disturb the gut microbiota that is essential for local and systemic homeostasis.", {"entities": []}], ["We explored here the possible impact of dietary Ag NP on the gut microbiota in mice at doses relevant for currently estimated human intake.", {"entities": []}], ["Mice were orally exposed to food (pellets) supplemented with increasing doses of Ag NP (0, 46, 460 or 4600\u00a0ppb) during 28 d. Body weight, systemic inflammation and gut integrity were investigated to determine overall toxicity, and feces DNA collected from the gut were analyzed by Next Generation Sequencing (NGS) to assess the effect of Ag NP on the bacterial population.", {"entities": []}], ["Ag NP were characterized alone and in the supplemented pellets by scanning transmission electron microscopy (STEM) and energy dispersive X-ray analysis (EDX).", {"entities": []}], ["No overall toxicity was recorded in mice exposed to Ag NP.", {"entities": []}], ["Ag NP disturbed bacterial evenness (\u03b1-diversity) and populations (\u03b2-diversity) in a dose-dependent manner.", {"entities": []}], ["Ag NP increased the ratio between Firmicutes (F) and Bacteroidetes (B) phyla.", {"entities": []}], ["At the family level, Lachnospiraceae and the S24-7 family mainly accounted for the increase in Firmicutes and decrease in Bacteroidetes, respectively.", {"entities": []}], ["Similar effects were not observed in mice identically exposed to the same batch of Ag NP-supplemented pellets aged during 4 or 8\u00a0months and the F/B ratio was less or not modified.", {"entities": []}], ["Analysis of Ag NP-supplemented pellets showed that freshly prepared pellets released Ag ions faster than aged pellets.", {"entities": []}], ["STEM-EDX analysis also showed that Ag sulfidation occurred in aged Ag NP-supplemented pellets.", {"entities": []}], ["Our data indicate that oral exposure to human relevant doses of Ag NP can induce microbial alterations in the gut.", {"entities": []}], ["The bacterial disturbances recorded after Ag NP are similar to those reported in metabolic and inflammatory diseases, such as obesity.", {"entities": [[126, 133, "DISEASE"]]}], ["It also highlights that Ag NP aging in food, and more specifically sulfidation, can reduce the effects of Ag NP on the microbiota by limiting the release of toxic Ag ions.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-016-0149-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Epidemiology studies have linked exposure to pollutant particles to increased cardiovascular mortality and morbidity, but the mechanisms remain unknown.", {"entities": []}], ["We tested the hypothesis that the ultrafine fraction of ambient pollutant particles would cause endothelial cell dysfunction.", {"entities": []}], ["We profiled gene expression of human pulmonary artery endothelial cells (HPAEC) exposed to ultrafine particles (UFPs; 100 \u03bcg/mL) from Chapel Hill, North Carolina, or vehicle for 4 hr with Affymetrix HG U133 Plus 2.0 chips ( n = 4 each).", {"entities": [[180, 182, "GENE"]]}], ["We found 320 up-regulated genes and 106 down-regulated genes ( p < 0.01, 5% false discovery rate).", {"entities": []}], ["We noted up-regulation of genes related to coagulation [tissue factor ( F3 ) and coagulation factor II receptor-like 2 ( F2RL2 )] and differential regulation of genes related to F3 signaling ( FOS, JUN, and NFKBIA ).", {"entities": [[72, 74, "GENE"], [178, 180, "GENE"], [121, 126, "GENE"], [72, 74, "GENE"], [178, 180, "GENE"], [193, 196, "GENE"], [198, 201, "GENE"], [207, 213, "GENE"]]}], ["Results of quantitative polymerase chain reaction show a significant up-regulation of F3 after 10 and 100 \u03bcg/mL UFP exposures.", {"entities": [[86, 88, "GENE"]]}], ["Additionally, the water-soluble fractions of UFPs were sufficient to induce the expression of F3, F2RL2, and heme oxygenase 1 ( HMOX1 ).", {"entities": [[94, 96, "GENE"], [98, 103, "GENE"], [128, 133, "GENE"]]}], ["Treatment of HPAEC with UFPs for 16 hr increased the release of interleukin (IL)-6 and IL-8.", {"entities": [[36, 38, "GENE"]]}], ["Pretreatment of HPAEC with a blocking antibody against F3 attenuated IL-6 and IL-8 release by 30 and 70%, respectively.", {"entities": [[55, 57, "GENE"]]}], ["Using gene profiling, we discovered that UFPs may induce vascular endothelial cells to express genes related to clotting.", {"entities": []}], ["These results indicate that PM may cause adverse cardiovascular health effects by activating coagulation-inflammation circuitry.", {"entities": []}], ["Sanfu acupoint herbal patching (SAHP) is a unique traditional Chinese medicine therapy, which has become popular for preventing acute attack of respiratory diseases such as asthma and chronic obstructive pulmonary disease, in many regions of mainland China.", {"entities": [[184, 221, "DISEASE"], [173, 179, "DISEASE"]]}], ["However, the knowledge about its users is lacking, especially the characteristics of the users and their experience and perspectives.", {"entities": []}], ["To investigate the demographics of users, conditions for its use and the previous experience of SAHP, as well as users\u2019 perspectives to provide baseline information for its practice.", {"entities": []}], ["A cross-sectional consecutive-sample survey was conducted at outpatient departments from 3 traditional Chinese medicine hospitals in northern China.", {"entities": []}], ["Each participant completed a questionnaire, after informed consent.", {"entities": []}], ["Data description and analyses were done using SPSS 20.0.", {"entities": []}], ["Among 949 SAHP users from 3 hospitals, female was predominant (n = 592; 62.4%), aged from 2 to 96 years (median = 52 years).", {"entities": []}], ["64.7% (380/587) of regular users have applied consecutively for 3 years or over, and the self-perceived satisfaction rates of respiratory diseases were from 45.9% to 77.7%.", {"entities": []}], ["Positive attitude toward traditional Chinese medicine was the top reason for choosing SAHP.", {"entities": []}], ["42.4% of users held a motivation of being cured by SAHP and with great outcome expectancy on SAHP (70.8%).", {"entities": []}], ["SAHP users were mainly female adults or elderly population; more than half were regular users, who predominantly used SAHP for various chronic respiratory diseases during their stable stage.", {"entities": []}], ["The majority of users expressed satisfaction to previous SAHP for their respiratory diseases.", {"entities": []}], ["42.4% of users held a motivation of being cured by SAHP and with great outcome expectancy on SAHP (70.8%).", {"entities": []}], ["The findings from this survey deserve further clinical trials for their clinical effectiveness.", {"entities": []}], ["Cost-benefit analysis is a transparent tool to inform policy makers about the potential effect of regulatory interventions, nevertheless its use to evaluate clean-up interventions in polluted industrial sites is limited.", {"entities": []}], ["The two industrial areas of Gela and Priolo in Italy were declared \"at high risk of environmental crisis\" in 1990.", {"entities": []}], ["Since then little has been done to clean the polluted sites and reduce the health outcomes attributable to pollution exposure.", {"entities": []}], ["This study, aims to quantify the monetary benefits resulting from clean-up interventions in the contaminated sites of Gela and Priolo.", {"entities": []}], ["A damage function approach was used to estimate the number of health outcomes attributable to industrial pollution exposure.", {"entities": []}], ["Extensive one way analyses and probabilistic analyses were conducted to investigate the sensitivity of results to different model assumptions.", {"entities": []}], ["It has been estimated that, on average, 47 cases of premature death, 281 cases of cancer and 2,702 cases of non-cancer hospital admission could be avoided each year by removing environmental exposure in these two areas.", {"entities": [[82, 88, "DISEASE"], [112, 118, "DISEASE"]]}], ["Assuming a 20 year cessation lag and a 4% discount rate we calculate that the potential monetary benefit of removing industrial pollution is \u20ac3,592 million in Priolo and \u20ac6,639 million in Gela.", {"entities": []}], ["Given the annual number of health outcomes attributable to pollution exposure the effective clean-up of Gela and Priolo should be prioritised.", {"entities": []}], ["This study suggests that clean-up policies costing up to \u20ac6,639 million in Gela and \u20ac3,592 million in Priolo would be cost beneficial.", {"entities": []}], ["These two amounts are notably higher than the funds allocated thus far to clean up the two sites, \u20ac127.4 million in Gela and \u20ac774.5 million in Priolo, implying that further economic investments - even considerable ones - could still prove cost beneficial.", {"entities": []}], ["We compared 2 sociocultural cohorts with different duration of exposure to graphic health warning labels (GHWL), to investigate a possible desensitisation to their use.", {"entities": []}], ["We further studied how a differing awareness and emotional impact of smoking-associated risks could be used to prevent this.", {"entities": []}], ["Structured interviews of patients from the general respiratory department were undertaken between 2012 and 2013 in 2 tertiary hospitals in Singapore and London.", {"entities": []}], ["266 participants were studied, 163 Londoners (35% smokers, 54% male, age 52\u00b118\u2005years) and 103 Singaporeans (53% smokers, p=0.003; 78% male, p<0.001; age 58\u00b115\u2005years, p=0.012).", {"entities": []}], ["50 items assessed demographics, smoking history, knowledge and the deterring impact of smoking-associated risks.", {"entities": []}], ["After showing 10 GHWL, the impact on emotional response, cognitive processing and intended smoking behaviour was recorded.", {"entities": []}], ["Singaporeans scored lower than the Londoners across all label processing constructs, and this was consistent for the smoking and non-smoking groups.", {"entities": []}], ["Londoners experienced more \u2018disgust\u2019 and felt GHWL were more effective at preventing initiation of, or quitting, smoking.", {"entities": []}], ["Singaporeans had a lower awareness of lung cancer (82% vs 96%, p<0.001), despite ranking it as the most deterring consequence of smoking.", {"entities": [[38, 49, "DISEASE"], [43, 49, "DISEASE"]]}], ["Overall, \u2018blindness\u2019 was the least known potential risk (28%), despite being ranked as more deterring than \u2018stroke\u2019 and \u2018oral cancer\u2019 in all participants.", {"entities": [[10, 19, "DISEASE"], [126, 132, "DISEASE"]]}], ["The length of exposure to GHWL impacts on the effectiveness.", {"entities": []}], ["However, acknowledging the different levels of awareness and emotional impact of smoking-associated risks within different sociocultural cohorts could be used to maintain their impact.", {"entities": []}], ["The pathogenicity of staphylococcus aureus is dependent largely upon its ability to secrete a number of virulence factors, therefore, anti-virulence strategy to combat S. aureus -mediated infections is now gaining great interest.", {"entities": []}], ["It is widely recognized that some plant essential oils could affect the production of staphylococcal exotoxins when used at subinhibitory concentrations.", {"entities": []}], ["Perilla [ Perilla frutescens (L.) Britton], a natural medicine found in eastern Asia, is primarily used as both a medicinal and culinary herb.", {"entities": []}], ["Its essential oil (perilla oil) has been previously demonstrated to be active against S. aureus .", {"entities": []}], ["However, there are no data on the influence of perilla oil on the production of S. aureus exotoxins.", {"entities": []}], ["A broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) of perilla oil against S. aureus strains.", {"entities": []}], ["Hemolysis, tumour necrosis factor (TNF) release, Western blot, and real-time RT-PCR assays were performed to evaluate the effects of subinhibitory concentrations of perilla oil on exotoxins production in S. aureus .", {"entities": [[35, 38, "GENE"]]}], ["The data presented here show that perilla oil dose-dependently decreased the production of \u03b1-toxin, enterotoxins A and B (the major staphylococcal enterotoxins), and toxic shock syndrome toxin 1 (TSST-1) in both methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA).", {"entities": [[178, 186, "DISEASE"], [166, 186, "DISEASE"]]}], ["The production of \u03b1-toxin, SEA, SEB, and TSST-1 in S. aureus was decreased by perilla oil.", {"entities": []}], ["These data suggest that perilla oil may be useful for the treatment of S. aureus infections when used in combination with \u03b2-lactam antibiotics, which can increase exotoxins production by S. aureus at subinhibitory concentrations.", {"entities": []}], ["Furthermore, perilla oil could be rationally applied in food systems as a novel food preservative both to inhibit the growth of S. aureus and to repress the production of exotoxins, particularly staphylococcal enterotoxins.", {"entities": []}], ["The serious feeding- and microbiota-associated intestinal disease, necrotizing enterocolitis (NEC), occurs mainly in infants born prematurely (5-10% of all newborns) and most frequently after formula-feeding.", {"entities": [[47, 65, "DISEASE"]]}], ["We hypothesized that changes in gene methylation is involved in the prenatal maturation of the intestine and its response to the first days of formula feeding, potentially leading to NEC in preterm pigs used as models for preterm infants.", {"entities": []}], ["Reduced Representation Bisulfite Sequencing (RRBS) was used to assess if changes in intestinal DNA methylation are associated with formula-induced NEC outbreak and advancing age from 10\u00a0days before birth to 4\u00a0days after birth.", {"entities": []}], ["Selected key genes with differentially methylated gene regions (DMRs) between groups were further validated by HiSeq-based bisulfite sequencing PCR and RT-qPCR to assess methylation and expression levels.", {"entities": []}], ["Consistent with the maturation of many intestinal functions in the perinatal period, methylation level of most genes decreased with advancing pre- and postnatal age.", {"entities": []}], ["The highest number of DMRs was identified between the newborn and 4 d-old preterm pigs.", {"entities": []}], ["There were few intestinal DMR differences between unaffected pigs and pigs with initial evidence of NEC.", {"entities": []}], ["In the 4 d-old formula-fed preterm pigs, four genes associated with intestinal metabolism (CYP2W1, GPR146, TOP1MT, CEND1) showed significant hyper-methylation in their promoter CGIs, and thus, down-regulated transcription.", {"entities": [[91, 97, "GENE"], [99, 105, "GENE"], [107, 113, "GENE"], [115, 120, "GENE"]]}], ["Methylation-driven down-regulation of such genes may predispose the immature intestine to later metabolic dysfunctions and severe NEC lesions.", {"entities": []}], ["Pre- and postnatal changes in intestinal DNA methylation may contribute to high NEC sensitivity in preterm neonates.", {"entities": []}], ["Optimizing gene methylation changes via environmental stimuli (e.g.", {"entities": []}], ["diet, nutrition, gut microbiota), may help to make immature newborn infants more resistant to gut dysfunctions, both short and long term.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2164-15-716) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Randomised controlled trials (RCTs) are perceived as the gold-standard method for evaluating healthcare interventions, and increasingly include quality of life (QoL) measures.", {"entities": []}], ["The observed results are susceptible to bias if a substantial proportion of outcome data are missing.", {"entities": []}], ["The review aimed to determine whether imputation was used to deal with missing QoL outcomes.", {"entities": []}], ["A random selection of 285 RCTs published during 2005/6 in the British Medical Journal, Lancet, New England Journal of Medicine and Journal of American Medical Association were identified.", {"entities": []}], ["QoL outcomes were reported in 61 (21%) trials.", {"entities": []}], ["Six (10%) reported having no missing data, 20 (33%) reported \u2264 10% missing, eleven (18%) 11%\u201320% missing, and eleven (18%) reported >20% missing.", {"entities": []}], ["Missingness was unclear in 13 (21%).", {"entities": []}], ["Missing data were imputed in 19 (31%) of the 61 trials.", {"entities": []}], ["Imputation was part of the primary analysis in 13 trials, but a sensitivity analysis in six.", {"entities": []}], ["Last value carried forward was used in 12 trials and multiple imputation in two.", {"entities": []}], ["Following imputation, the most common analysis method was analysis of covariance (10 trials).", {"entities": []}], ["The majority of studies did not impute missing data and carried out a complete-case analysis.", {"entities": []}], ["For those studies that did impute missing data, researchers tended to prefer simpler methods of imputation, despite more sophisticated methods being available.", {"entities": []}], ["The inhibition of activated macrophages has been used to develop anti\u2010inflammatory agents for therapeutic intervention to human diseases that cause excessive inflammatory responses.", {"entities": []}], ["Antofine, a phenanthroindolizidine alkaloid, has a potent anti\u2010inflammatory effect.", {"entities": []}], ["However, the molecular mechanisms of its anti\u2010inflammatory activity have not yet been fully detailed.", {"entities": []}], ["In this study, we comprehensively explored the anti\u2010inflammatory effects of antofine on endotoxin\u2010induced inflammation in macrophages using cDNA microarray analysis, thereby elucidating the potential mechanism by which antofine suppresses inflammation.", {"entities": []}], ["Antofine significantly suppressed the secretion of proinflammatory cytokines such as TNF \u03b1 and IL \u20101 \u03b2 and the production of iNOS in LPS \u2010activated Raw264.7 macrophage cells.", {"entities": [[85, 88, "GENE"]]}], ["In addition, antofine can suppress the expressions of several inflammation\u2010related genes (such as ARG \u20101, IL 1F9, IL \u201010, and IL \u201033) and extracellular matrix genes (such as TNC and HYAL 1), as well as a vasopressor gene ( EDN 1) in activated macrophage cells, that are induced by LPS stimulation.", {"entities": [[174, 177, "GENE"]]}], ["The gene expression profiles analyzed by Gene MANIA software showed that antofine not only contributed anti\u2010inflammatory activity but also modulated the cellular metabolism via AMPK .", {"entities": []}], ["Furthermore, antofine also modulated the activation of AMPK and caspase\u20101, the key regulator in inflammasome\u2010mediated IL \u20101 \u03b2 maturation, in activated macrophage cells.", {"entities": []}], ["In conclusion, these data indicated that antofine potentially can not only contribute an anti\u2010inflammatory effect but can also attenuate the metabolic disorders induced by inflammation via AMPK.", {"entities": []}], ["In 2001, the Institute of Medicine\u2019s (IOM) report, \u201cExploring the Biological Contributions to Human Health: Does Sex Matter?\u201d advocated for better understanding of the differences in human diseases between the sexes, with translation of these differences into clinical practice.", {"entities": []}], ["Sex differences are well documented in the prevalence of cardiovascular (CV) risk factors, the clinical manifestation and incidence of cardiovascular disease (CVD), and the impact of risk factors on outcomes.", {"entities": []}], ["There are also physiologic and psychosocial factors unique to women that may affect CVD risk, such as issues related to reproduction.", {"entities": []}], ["The Society for Women\u2019s Health Research (SWHR) CV Network compiled an inventory of sex-specific strategies and methods for the study of women and CV health and disease across the lifespan.", {"entities": []}], ["References for methods and strategy details are provided to gather and evaluate this information.", {"entities": []}], ["Some items comprise robust measures; others are in development.", {"entities": []}], ["To address female-specific CV health and disease in population, physiology, and clinical trial research, data should be collected on reproductive history, psychosocial variables, and other factors that disproportionately affect CVD in women.", {"entities": []}], ["Variables related to reproductive health include the following: age of menarche, menstrual cycle regularity, hormone levels, oral contraceptive use, pregnancy history/complications, polycystic ovary syndrome (PCOS) components, menopause age, and use and type of menopausal hormone therapy.", {"entities": [[182, 207, "DISEASE"], [199, 207, "DISEASE"]]}], ["Other factors that differentially affect women\u2019s CV risk include diabetes mellitus, autoimmune inflammatory disease, and autonomic vasomotor control.", {"entities": [[65, 82, "DISEASE"]]}], ["Sex differences in aging as well as psychosocial variables such as depression and stress should also be considered.", {"entities": []}], ["Women are frequently not included/enrolled in mixed-sex CVD studies; when they are included, information on these variables is generally not collected.", {"entities": []}], ["These omissions limit the ability to determine the role of sex-specific contributors to CV health and disease.", {"entities": []}], ["Lack of sex-specific knowledge contributes to the CVD health disparities that women face.", {"entities": []}], ["The purpose of this review is to encourage investigators to consider ways to increase the usefulness of physiological and psychosocial data obtained from clinical populations, in an effort to improve the understanding of sex differences in clinical CVD research and health-care delivery for women and men.", {"entities": []}], ["Informal caregivers play an integral part in the management of amyotrophic lateral sclerosis (ALS).", {"entities": [[63, 92, "DISEASE"], [75, 92, "DISEASE"]]}], ["The objective of this study was to explore the journey from first problem symptoms to diagnosis from the perspective of informal caregivers providing care to people with ALS.", {"entities": []}], ["As part of a semistructured interview, information was collected on a range of caregiver demographic details, and from an open-ended question their experiences of the time of symptom onset to diagnosis.", {"entities": []}], ["We carried out descriptive statistical analysis and thematic analysis of qualitative data.", {"entities": []}], ["Home interviews with informal caregivers (n=74) of people with ALS attending the National ALS/Motor Neuron Disease Clinic at Beaumont Hospital, Dublin, Ireland.", {"entities": []}], ["This was a largely female and spousal cohort of caregivers, living with the patient for whom they provided informal care.", {"entities": []}], ["The majority of patients were men and were spinal onset.", {"entities": []}], ["Caregivers described the time from first symptoms to diagnosis.", {"entities": []}], ["Using a primarily inductive approach, the coding was data driven and the codes and themes derived from the content of these descriptions.", {"entities": []}], ["Two main themes were identified (1) problem signs and symptoms (A) noticing and (B) reaction; (2) interaction with the health services.", {"entities": []}], ["Exploring the perspectives of caregivers from first problem symptoms to diagnosis provides valuable insights into the development of the condition, impediments to its recognition, help-seeking behaviours and interactions with healthcare services.", {"entities": []}], ["The journey from early symptoms to diagnosis is important for future decision-making, affects readiness for caregiving and could negatively impact on caregiver health and well-being.", {"entities": []}], ["The early acknowledgement by healthcare professionals of stressors along the journey to diagnosis, and appreciation of their possible impact on caregivers is important.", {"entities": []}], ["The separate needs of caregivers should be assessed on a regular basis.", {"entities": []}], ["This retrospective chart review describes the epidemiology and clinical features of 40 patients with culture-proven Mycoplasma pneumoniae infections at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.", {"entities": []}], ["Patients with positive M. pneumoniae cultures from respiratory specimens from January 1997 through December 1998 were identified through the Microbiology records.", {"entities": []}], ["Charts of patients were reviewed.", {"entities": []}], ["40 patients were identified, 33 (82.5%) of whom required admission.", {"entities": []}], ["Most infections (92.5%) were community-acquired.", {"entities": []}], ["The infection affected all age groups but was most common in infants (32.5%) and pre-school children (22.5%).", {"entities": []}], ["It occurred year-round but was most common in the fall (35%) and spring (30%).", {"entities": []}], ["More than three-quarters of patients (77.5%) had comorbidities.", {"entities": []}], ["Twenty-four isolates (60%) were associated with pneumonia, 14 (35%) with upper respiratory tract infections, and 2 (5%) with bronchiolitis.", {"entities": [[48, 57, "DISEASE"], [125, 138, "DISEASE"]]}], ["Cough (82.5%), fever (75%), and malaise (58.8%) were the most common symptoms, and crepitations (60%), and wheezes (40%) were the most common signs.", {"entities": []}], ["Most patients with pneumonia had crepitations (79.2%) but only 25% had bronchial breathing.", {"entities": [[19, 28, "DISEASE"]]}], ["Immunocompromised patients were more likely than non-immunocompromised patients to present with pneumonia (8/9 versus 16/31, P = 0.05).", {"entities": [[96, 105, "DISEASE"]]}], ["Of the 24 patients with pneumonia, 14 (58.3%) had uneventful recovery, 4 (16.7%) recovered following some complications, 3 (12.5%) died because of M pneumoniae infection, and 3 (12.5%) died due to underlying comorbidities.", {"entities": [[24, 33, "DISEASE"]]}], ["The 3 patients who died of M pneumoniae pneumonia had other comorbidities.", {"entities": [[40, 49, "DISEASE"]]}], ["our results were similar to published data except for the finding that infections were more common in infants and preschool children and that the mortality rate of pneumonia in patients with comorbidities was high.", {"entities": [[164, 173, "DISEASE"]]}], ["Pharmacodynamic effects and safety of single\u2010dose inhaled loxapine administered via the Staccato IM ) lorazepam in combination versus each agent alone were compared in a randomized, double\u2010blind, crossover study in healthy volunteers.", {"entities": []}], ["Subjects received: inhaled loxapine 10\u00a0mg\u00a0+\u00a0IM lorazepam 1\u00a0mg; inhaled loxapine 10\u00a0mg\u00a0+\u00a0 IM placebo; IM lorazepam 1\u00a0mg\u00a0+\u00a0Staccato placebo in random order, each separated by a 3\u2010day washout.", {"entities": []}], ["Primary endpoints were maximum effect ( minimum value) and area under the curve ( AUC ) from baseline to 2\u00a0h post treatment for respirations/min and pulse oximetry.", {"entities": []}], ["Least\u2010squares means (90% confidence interval [ CI ]) for concomitant treatment versus each agent alone were derived and equivalence (no difference) confirmed if the 90% CI was within 0.8\u20131.25.", {"entities": []}], ["Blood pressure ( BP ), heart rate ( HR ), sedation (100\u2010mm visual analog scale), and adverse events ( AE s) were recorded.", {"entities": [[36, 38, "GENE"]]}], ["All 18 subjects (mean age, 20.4\u00a0years; 61% male) completed the study.", {"entities": []}], ["There was no difference between inhaled loxapine\u00a0+\u00a0 IM lorazepam and either agent alone on respiration or pulse oximetery during the 12\u2010h postdose period, confirmed by 90% CI s for AUC and C min ratios.", {"entities": []}], ["BP and HR were no different for inhaled loxapine\u00a0+\u00a0 IM lorazepam and each agent alone over a 12\u2010h postdose period.", {"entities": [[7, 9, "GENE"]]}], ["Although the central nervous system sedative effects were observed for each treatment in healthy volunteers, the effect was greater following concomitant lorazepam 1\u00a0mg IM \u00a0+\u00a0inhaled loxapine 10\u00a0mg administration.", {"entities": []}], ["There were no deaths, serious AE s, premature discontinuations due to AE s, or treatment\u2010related AE s.", {"entities": []}], ["Human Immunodeficiency Virus-1 (HIV-1)-associated neurocognitive disorders (HAND) occur, in part, due to the inflammatory response to viral proteins, such as the HIV-1 transactivator of transcription (Tat), in the central nervous system (CNS).", {"entities": []}], ["Given the need for novel adjunctive therapies for HAND, we hypothesized that ibudilast would inhibit Tat-induced excess production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF\u03b1) in microglial cells.", {"entities": []}], ["Ibudilast is a non-selective cyclic AMP phosphodiesterase inhibitor that has recently shown promise as a treatment for neuropathic pain via its ability to attenuate glial cell activation.", {"entities": []}], ["Accordingly, here we demonstrate that pre-treatment of both human and mouse microglial cells with increasing doses of ibudilast inhibited Tat-induced synthesis of TNF\u03b1 by microglial cells in a manner dependent on serine/threonine protein phosphatase activity.", {"entities": []}], ["Ibudilast had no effect on Tat-induced p38 MAP kinase activation, and blockade of adenosine A 2A receptor activation did not reverse ibudilast's inhibition of Tat-induced TNF\u03b1 production.", {"entities": []}], ["Interestingly, ibudilast reduced Tat-mediated transcription of TNF\u03b1, via modulation of nuclear factor-kappa B (NF-\u03baB) signaling, as shown by transcriptional activity of NF-\u03baB and analysis of inhibitor of kappa B alpha (I\u03baB\u03b1) stability.", {"entities": []}], ["Together, our findings shed light on the mechanism of ibudilast's inhibition of Tat-induced TNF\u03b1 production in microglial cells and may implicate ibudilast as a potential novel adjunctive therapy for the management of HAND.", {"entities": []}], ["Soluble IgE receptors are potential in vivo modulators of IgE-mediated immune responses and are thus important for our basic understanding of allergic responses.", {"entities": []}], ["We here characterize a novel soluble version of the IgE-binding alpha-chain of Fc-epsilon-RI (sFc\u03b5RI), the high affinity receptor for IgE.", {"entities": []}], ["sFc\u03b5RI immunoprecipitates as a protein of \u223c40 kDa and contains an intact IgE-binding site.", {"entities": []}], ["In human serum, sFc\u03b5RI is found as a soluble free IgE receptor as well as a complex with IgE.", {"entities": []}], ["Using a newly established ELISA, we show that serum sFc\u03b5RI levels correlate with serum IgE in patients with elevated IgE.", {"entities": []}], ["We also show that serum of individuals with normal IgE levels can be found to contain high levels of sFc\u03b5RI.", {"entities": []}], ["After IgE-antigen-mediated crosslinking of surface Fc\u03b5RI, we detect sFc\u03b5RI in the exosome-depleted, soluble fraction of cell culture supernatants.", {"entities": []}], ["We further show that sFc\u03b5RI can block binding of IgE to Fc\u03b5RI expressed at the cell surface.", {"entities": []}], ["In summary, we here describe the alpha-chain of Fc\u03b5RI as a circulating soluble IgE receptor isoform in human serum.", {"entities": []}], ["Residential clusters of non-communicable diseases are a source of enduring public concern, and at times, controversy.", {"entities": []}], ["Many clusters reported to public health agencies by concerned citizens are accompanied by expectations that investigations will uncover a cause of disease.", {"entities": []}], ["While goals, methods and conclusions of cluster studies are debated in the scientific literature and popular press, investigations of reported residential clusters rarely provide definitive answers about disease etiology.", {"entities": []}], ["Further, it is inherently difficult to study a cluster for diseases with complex etiology and long latency (e.g., most cancers).", {"entities": []}], ["Regardless, cluster investigations remain an important function of local, state and federal public health agencies.", {"entities": []}], ["Challenges limiting the ability of cluster investigations to uncover causes for disease include the need to consider long latency, low statistical power of most analyses, uncertain definitions of cluster boundaries and population of interest, and in- and out-migration.", {"entities": []}], ["A multi-disciplinary Workshop was held to discuss innovative and/or under-explored approaches to investigate cancer clusters.", {"entities": [[109, 115, "DISEASE"]]}], ["Several potentially fruitful paths forward are described, including modern methods of reconstructing residential history, improved approaches to analyzing spatial data, improved utilization of electronic data sources, advances using biomarkers of carcinogenesis, novel concepts for grouping cases, investigations of infectious etiology of cancer, and \u201comics\u201d approaches.", {"entities": [[339, 345, "DISEASE"]]}], ["Continuous respiratory monitoring is an important tool for clinical monitoring.", {"entities": []}], ["Associated with the development of biomedical technology, it has become more and more important, especially in the measuring of gas flow and CO 2 concentration, which can reflect the status of the patient.", {"entities": []}], ["In this paper, a new type of biomedical device is presented, which uses low-power sensors with a piezoresistive silicon differential pressure sensor to measure gas flow and with a pyroelectric sensor to measure CO 2 concentration simultaneously.", {"entities": []}], ["For the portability of the biomedical device, the sensors and low-power measurement circuits are integrated together, and the airway tube also needs to be miniaturized.", {"entities": []}], ["Circuits are designed to ensure the stability of the power source and to filter out the existing noise.", {"entities": []}], ["Modulation technology is used to eliminate the fluctuations at the trough of the waveform of the CO 2 concentration signal.", {"entities": []}], ["Statistical analysis with the coefficient of variation was performed to find out the optimal driving voltage of the pressure transducer.", {"entities": []}], ["Through targeted experiments, the biomedical device showed a high accuracy, with a measuring precision of 0.23 mmHg, and it worked continuously and stably, thus realizing the real-time monitoring of the status of patients.", {"entities": []}], ["Asthma affects a large number of patients in China, but comprehensive evaluation of risks associated with poor asthma control in asthmatic patients with nasal diseases was still limited.", {"entities": [[0, 6, "DISEASE"], [111, 117, "DISEASE"]]}], ["We conducted this study to provide a comprehensive estimate of asthma control in Chinese asthma patients with combined nasal diseases, to explore the effect of kinds of nasal diseases on the asthma control, and to identify risk factors associated with uncontrolled asthmatic patients with combined nasal diseases.", {"entities": [[63, 69, "DISEASE"], [89, 95, "DISEASE"], [191, 197, "DISEASE"]]}], ["1756 asthma patients concomitant with nasal diseases aged \u226517 years and representing all regions of mainland China were surveyed.", {"entities": [[5, 11, "DISEASE"]]}], ["Multivariate logistic regression model with all related demographic characteristics and disease characteristics factors entered was used to identify risk factors associated with uncontrolled asthma.", {"entities": [[191, 197, "DISEASE"]]}], ["56.4% of asthmatic patients with combined allergic rhinitis or rhinosinusitis or rhinopolyp remained uncontrolled.", {"entities": [[42, 59, "DISEASE"], [51, 59, "DISEASE"]]}], ["Concomitant without allergic rhinitis, younger age, better treatment adherence and higher education level might positively impact asthma control among asthmatic patients with combined nasal diseases.", {"entities": [[20, 37, "DISEASE"], [29, 37, "DISEASE"], [130, 136, "DISEASE"]]}], ["Perennial allergic rhinitis (OR = 1.5, P = 0.021), moderate-severe allergic rhinitis (OR = 2.2, P = 0.001) were all found to significantly increase the risk of uncontrolled asthma among asthma patients with combined allergic rhinitis.", {"entities": [[10, 27, "DISEASE"], [67, 84, "DISEASE"], [216, 233, "DISEASE"], [19, 27, "DISEASE"], [76, 84, "DISEASE"], [225, 233, "DISEASE"], [173, 179, "DISEASE"], [186, 192, "DISEASE"]]}], ["The high prevalence of uncontrolled asthma indicates that asthma management among adult Chinese asthmatic patients comorbid with nasal disease is still a challenge.", {"entities": [[36, 42, "DISEASE"], [58, 64, "DISEASE"]]}], ["Efforts should be made to raise the awareness of asthma management and to provide sufficient treatment will greatly contribute to improved quality of asthma management.", {"entities": [[49, 55, "DISEASE"], [150, 156, "DISEASE"]]}], ["It is possible to minimize the influence of allergic rhinitis on asthma control by improving nasal function, especially for more severe allergic rhinitis and perennial allergic rhinitis.", {"entities": [[44, 61, "DISEASE"], [136, 153, "DISEASE"], [168, 185, "DISEASE"], [53, 61, "DISEASE"], [145, 153, "DISEASE"], [177, 185, "DISEASE"], [65, 71, "DISEASE"]]}], ["Supplemental Digital Content is available in the text Irritable bowel syndrome (IBS) and bipolar disorder (BD) are 2 distinct diseases but may share a similar pathophysiology.", {"entities": [[89, 105, "DISEASE"], [70, 78, "DISEASE"]]}], ["However, the comorbidity rate of these 2 diseases is unclear.", {"entities": []}], ["Also, the current practice guidelines suggest prescribing antidepressants to IBS patients.", {"entities": []}], ["However, this practice may increase the risk of phase-shift to manic episodes in IBS patients comorbid with BD.", {"entities": []}], ["This study aimed to determine the relationship between IBS and BD through a meta-analysis.", {"entities": []}], ["Electronic research through PubMed, Medline, ScienceDirect online, ClinicalTrials.gov, and additional resources.", {"entities": []}], ["The inclusion criteria were studies investigating the prevalence rate of BD in subjects with IBS and control subjects; and articles on clinical trials on humans.", {"entities": []}], ["Data from included studies were pooled by a random effects model, and possible confounding variables were examined by meta-regression and subgroup analysis.", {"entities": []}], ["The current study consists of a total of 177,117 IBS patients and 192,092 control subjects extracted from 6 included studies.", {"entities": []}], ["The prevalence rate of BD was significantly higher in the IBS patients than in the controls (odds ratio = 2.48, 95% confidence interval: 2.35\u20132.61, P \u200a < \u200a0.001).", {"entities": []}], ["However, the significance persists only in studies from database research, but not from primary studies.", {"entities": []}], ["In addition, there was no significant association between the prevalence rate of BD in IBS and several clinical variables, including age, female proportion, prevalence of comorbid diabetes, or hypertension.", {"entities": [[193, 205, "DISEASE"]]}], ["The total number of included studies is small.", {"entities": []}], ["Moreover, apparently different results from database research and primary research limit the generalization of our findings to a broad population.", {"entities": []}], ["Also, we could only perform meta-regression on limited clinical variables.", {"entities": []}], ["Our results support a significantly higher prevalence rate of BD in IBS patients than in controls.", {"entities": []}], ["Clinicians should be cautious about the risk of phase-shift to manic episodes when prescribing antidepressants in IBS patients under current practice guidelines.", {"entities": []}], ["Objective .", {"entities": []}], ["The objective of this study was to quantify and describe the distribution of the 36 molds that make up the Environmental Relative Moldiness Index (ERMI).", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["As part of the 2006 American Healthy Homes Survey, settled dust samples were analyzed by mold-specific quantitative PCR (MSQPCR) for the 36 ERMI molds.", {"entities": []}], ["Each species' geographical distribution pattern was examined individually, followed by partitioning analysis in order to identify spatially meaningful patterns.", {"entities": []}], ["For mapping, the 36 mold populations were divided into disjoint clusters on the basis of their standardized concentrations, and First Principal Component (FPC) scores were computed.", {"entities": []}], ["Results and Conclusions .", {"entities": []}], ["The partitioning analyses failed to uncover a valid partitioning that yielded compact, well-separated partitions with systematic spatial distributions, either on global or local criteria.", {"entities": []}], ["Disjoint variable clustering resulted in seven mold clusters.", {"entities": []}], ["The 36 molds and ERMI values themselves were found to be heterogeneously distributed across the United States of America (USA).", {"entities": []}], ["During development of disease, complex intracellular signaling pathways regulate an intricate series of events, including resistance to external toxins, the secretion of cytokines and the production of pathological phenomena.", {"entities": []}], ["Adenosine 3\u2032,5\u2032-cyclic monophosphate (cAMP) is a nucleotide that acts as a key second messenger in numerous signal transduction pathways.", {"entities": []}], ["cAMP regulates various cellular functions, including cell growth and differentiation, gene transcription and protein expression.", {"entities": []}], ["This review aimed to provide an understanding of the effects of the cAMP signaling pathway and the associated factors on disease occurrence and development by examining the information from a new perspective.", {"entities": []}], ["These novel insights aimed to promote the development of novel therapeutic approaches and aid in the development of new drugs.", {"entities": []}], ["Respiratory syncytial virus (RSV) is an important causative agent of lower respiratory tract infections in infants and elderly individuals.", {"entities": []}], ["Its fusion (F) protein is critical for virus infection.", {"entities": []}], ["It is targeted by several investigational antivirals and by palivizumab, a humanized monoclonal antibody used prophylactically in infants considered at high risk of severe RSV disease.", {"entities": []}], ["ALX-0171 is a trimeric Nanobody that binds the antigenic site II of RSV F protein with subnanomolar affinity.", {"entities": []}], ["ALX-0171 demonstrated in vitro neutralization superior to that of palivizumab against prototypic RSV subtype A and B strains.", {"entities": []}], ["Moreover, ALX-0171 completely blocked replication to below the limit of detection for 87% of the viruses tested, whereas palivizumab did so for 18% of the viruses tested at a fixed concentration.", {"entities": []}], ["Importantly, ALX-0171 was highly effective in reducing both nasal and lung RSV titers when delivered prophylactically or therapeutically directly to the lungs of cotton rats.", {"entities": []}], ["ALX-0171 represents a potent novel antiviral compound with significant potential to treat RSV-mediated disease.", {"entities": []}], ["In the conventional pathway of protein secretion, leader sequence-containing proteins leave the cell following processing through the endoplasmic reticulum (ER) and Golgi body.", {"entities": []}], ["However, leaderless proteins also enter the extracellular space through mechanisms collectively known as unconventional secretion.", {"entities": []}], ["Unconventionally secreted proteins often have vital roles in cell and organism function such as inflammation.", {"entities": []}], ["Amongst the best-studied inflammatory unconventionally secreted proteins are interleukin (IL)-1\u03b2, IL-1\u03b1, IL-33 and high-mobility group box 1 (HMGB1).", {"entities": [[142, 147, "GENE"]]}], ["In this review we discuss the current understanding of the unconventional secretion of these proteins and highlight future areas of research such as the role of nuclear localisation.", {"entities": []}], ["An important immunopathological hallmark of allergic disease is tissue eosinophilic and basophilic inflammation, a phenomenon which originates from hemopoietic progenitors (HP).", {"entities": [[173, 175, "GENE"]]}], ["The fate of HP is determined by local inflammatory cytokines that permit \u201cin situ hemopoiesis,\u201d which leads to the accumulation of eosinophils and basophils (Eo/B).", {"entities": [[12, 14, "GENE"]]}], ["Given that recent evidence supports a critical immunomodulatory role for thymic stromal lymphopoietin (TSLP) in allergic inflammation, as well as TSLP effects on CD34+ progenitor cytokine and chemokine secretion, we investigated the role of TSLP in mediating eosinophilo- and basophilopoiesis, the mechanisms involved, and the association of these processes with atopic sensitisation.", {"entities": [[103, 107, "GENE"], [146, 150, "GENE"], [241, 245, "GENE"], [103, 107, "GENE"], [146, 150, "GENE"], [241, 245, "GENE"], [103, 107, "GENE"], [146, 150, "GENE"], [241, 245, "GENE"]]}], ["In the studies presented herein, we demonstrate a direct role for TSLP in Eo/B differentiation from human peripheral blood CD34+ cells.", {"entities": [[66, 70, "GENE"]]}], ["In the presence of IL-3, TSLP significantly promoted the formation of Eo/B colony forming units (CFU) (including both eosinophils and basophils) from human HP (HHP), which was dependent on TSLP\u2013TSLPR interactions.", {"entities": [[25, 29, "GENE"], [189, 193, "GENE"], [156, 158, "GENE"]]}], ["IL-3/TSLP-stimulated HHP actively secreted an array of cytokines/chemokines, key among which was TNF\u03b1, which, together with IL-3, enhanced surface expression of TSLPR.", {"entities": []}], ["Moreover, pre-stimulation of HHP with IL-3/TNF\u03b1 further promoted TSLP-dependent Eo/B CFU formation.", {"entities": []}], ["HHP isolated from atopic individuals were functionally and phenotypically more responsive to TSLP than those from nonatopic individuals.", {"entities": [[93, 97, "GENE"]]}], ["This is the first study to demonstrate enhanced TSLP-mediated hemopoiesis ex vivo in relation to clinical atopic status.", {"entities": []}], ["The capacity of HHP to participate in TSLP-driven allergic inflammation points to the potential importance of \u201cin situ hemopoiesis\u201d in allergic inflammation initiated at the epithelial surface.", {"entities": []}], ["To determine adherence to dimensions of physical wellness among medical students of public and private medical colleges in Pakistan.", {"entities": []}], ["This cross-sectional study was carried out from January to July 2011 among 820 students of private and public medical colleges in Karachi, Pakistan.", {"entities": []}], ["Overall, medical students scored low in dimensions of physical wellness.", {"entities": []}], ["Private medical colleges students were fond of vigorous activities such as aerobics and swimming, whereas public medical colleges students were involved in moderate intensity activities such as walking and use of stairs ( p <0.0001).", {"entities": []}], ["Private students reported to consume more fast food ( p =0.0001), had less sleep ( p =0.0001), but attended regular annual medical checkups ( p =0.009) as compared with their public institute counterparts.", {"entities": []}], ["Safe practices such as avoidance of tobacco were almost the same.", {"entities": []}], ["Comprehensive adherence to all dimensions of physical wellness was lacking among medical students.", {"entities": []}], ["Ricin, a plant-derived toxin originating from the seeds of Ricinus communis (castor beans), is one of the most lethal toxins known, particularly if inhaled.", {"entities": []}], ["Ricin is considered a potential biological threat agent due to its high availability and ease of production.", {"entities": []}], ["The clinical manifestation of pulmonary ricin intoxication in animal models is closely related to acute respiratory distress syndrome (ARDS), which involves pulmonary proinflammatory cytokine upregulation, massive neutrophil infiltration and severe edema.", {"entities": [[125, 133, "DISEASE"]]}], ["Currently, the only post-exposure measure that is effective against pulmonary ricinosis at clinically relevant time-points following intoxication in pre-clinical studies is passive immunization with anti-ricin neutralizing antibodies.", {"entities": []}], ["The efficacy of this antitoxin treatment depends on antibody affinity and the time of treatment initiation within a limited therapeutic time window.", {"entities": []}], ["Small-molecule compounds that interfere directly with the toxin or inhibit its intracellular trafficking may also be beneficial against ricinosis.", {"entities": []}], ["Another approach relies on the co-administration of antitoxin antibodies with immunomodulatory drugs, thereby neutralizing the toxin while attenuating lung injury.", {"entities": []}], ["Immunomodulators and other pharmacological-based treatment options should be tailored according to the particular pathogenesis pathways of pulmonary ricinosis.", {"entities": []}], ["This review focuses on the current treatment options for pulmonary ricin intoxication using anti-ricin antibodies, disease-modifying countermeasures, anti-ricin small molecules and their various combinations.", {"entities": []}], ["Mast cells are found in connective and mucosal tissues throughout the body.", {"entities": []}], ["Their activation via immunoglobulin E (IgE)\u2013antigen interactions is promoted by T helper cell type 2 (Th2) cytokines and leads to the sequelae of allergic disease.", {"entities": []}], ["We now report a mechanism by which Th2 cytokines can regulate mast cell survival.", {"entities": []}], ["Specifically, we find that interleukin (IL)-4 and IL-10 induce apoptosis in IL-3\u2013dependent bone marrow\u2013derived mast cells and peritoneal mast cells.", {"entities": []}], ["This process required 6 d of costimulation with IL-3, IL-4, and IL-10, and expression of signal transducer and activator of transcription 6 (Stat6).", {"entities": [[141, 146, "GENE"]]}], ["Apoptosis was coupled with decreased expression of bcl-x L and bcl-2 .", {"entities": []}], ["While this process occurred independent of the Fas pathway, culture in IL-3+IL-4+IL-10 greatly sensitized mast cells to Fas-mediated death.", {"entities": [[47, 50, "GENE"], [120, 123, "GENE"]]}], ["Additionally, we found that IgE cross-linkage or stimulation with stem cell factor enhanced the apoptotic abilities of IL-4 and IL-10.", {"entities": []}], ["Finally, IL-3\u2013independent mastocytomas and mast cell lines were resistant to apoptosis induced by IL-3+IL-4+IL-10.", {"entities": []}], ["These data offer evidence of Th2 cytokine\u2013mediated homeostasis whereby these cytokines both elicit and limit allergic responses.", {"entities": []}], ["Dysregulation of this pathway may play a role in allergic disease and mast cell tumor survival.", {"entities": []}], ["Pharmaceutical company representatives likely influence the prescribing habits and professional behaviors of physicians.", {"entities": []}], ["The objective of this study was to systematically review the association between physicians\u2019 interactions with pharmaceutical companies and their clinical practices.", {"entities": []}], ["We used the standard systematic review methodology.", {"entities": []}], ["Observational and experimental study designs examining any type of targeted interaction between practicing physicians and pharmaceutical companies were eligible.", {"entities": []}], ["The search strategy included a search of MEDLINE and EMBASE databases up to July 2016.", {"entities": []}], ["Two reviewers selected studies, abstracted data, and assessed risk of bias in duplicate and independently.", {"entities": []}], ["We assessed the quality of evidence using the GRADE approach.", {"entities": []}], ["Twenty articles reporting on 19 studies met our inclusion criteria.", {"entities": []}], ["All of these studies were conducted in high-income countries and examined different types of interactions, including detailing, industry-funded continuing medical education, and receiving free gifts.", {"entities": []}], ["While all included studies assessed prescribing behaviors, four studies also assessed financial outcomes, one assessed physicians\u2019 knowledge, and one assessed their beliefs.", {"entities": []}], ["None of the studies assessed clinical outcomes.", {"entities": []}], ["Out of the 19 studies, 15 found a consistent association between interactions promoting a medication, and inappropriately increased prescribing rates, lower prescribing quality, and/or increased prescribing costs.", {"entities": []}], ["The remaining four studies found both associations and lack of significant associations for the different types of exposures and drugs examined in the studies.", {"entities": []}], ["A meta-analysis of six of these studies found a statistically significant association between exposure and physicians\u2019 prescribing behaviors (OR = 2.52; 95% CI 1.82\u20133.50).", {"entities": []}], ["The quality of evidence was downgraded to moderate for risk of bias and inconsistency.", {"entities": []}], ["Sensitivity analysis excluding studies at high risk of bias did not substantially change these results.", {"entities": []}], ["A subgroup analysis did not find a difference by type of exposure.", {"entities": []}], ["There is moderate quality evidence that physicians\u2019 interactions with pharmaceutical companies are associated with their prescribing patterns and quality.", {"entities": []}], ["The goal of this study is to develop, test, and compare multinomial logistic regression (MLR) and support vector machines (SVM) in classifying preschool-aged children physical activity data acquired from an accelerometer.", {"entities": []}], ["In this study, 69 children aged 3\u20135 years old were asked to participate in a supervised protocol of physical activities while wearing a triaxial accelerometer.", {"entities": []}], ["Accelerometer counts, steps, and position were obtained from the device.", {"entities": []}], ["We applied K -means clustering to determine the number of natural groupings presented by the data.", {"entities": []}], ["We used MLR and SVM to classify the six activity types.", {"entities": []}], ["Using direct observation as the criterion method, the 10-fold cross-validation (CV) error rate was used to compare MLR and SVM classifiers, with and without sleep.", {"entities": []}], ["Altogether, 58 classification models based on combinations of the accelerometer output variables were developed.", {"entities": []}], ["In general, the SVM classifiers have a smaller 10-fold CV error rate than their MLR counterparts.", {"entities": []}], ["Including sleep, a SVM classifier provided the best performance with a 10-fold CV error rate of 24.70%.", {"entities": []}], ["Without sleep, a SVM classifier-based triaxial accelerometer counts, vector magnitude, steps, position, and 1- and 2-min lag and lead values achieved a 10-fold CV error rate of 20.16% and an overall classification error rate of 15.56%.", {"entities": []}], ["SVM supersedes the classical classifier MLR in categorizing physical activities in preschool-aged children.", {"entities": []}], ["Using accelerometer data, SVM can be used to correctly classify physical activities typical of preschool-aged children with an acceptable classification error rate.", {"entities": []}], ["Current literature suggests that dipeptidyl peptidase IV (DPP-IV; CD26) plays an essential role in T-dependent immune responses, a role that could have important clinical consequences.", {"entities": []}], ["To rigorously define the role of DPP-IV in the immune system, we evaluated genetic and pharmacological inhibition of the enzyme on T-dependent immune responses in vivo .", {"entities": []}], ["The DPP-IV null animals mounted robust primary and secondary antibody responses to the T dependent antigens, 4-hydroxy-3-nitrophenylacetyl-ovalbumin (NP-Ova) and 4-hydroxy-3-nitrophenylacetyl-chicken gamma globulin (NP-CGG), which were comparable to wild type mice.", {"entities": []}], ["Serum levels of antigen specific IgM, IgG1, IgG2a, IgG2b and IgG3 were similar between the two groups of animals.", {"entities": []}], ["DPP-IV null animals mounted an efficient germinal center reaction by day 10 after antigen stimulation that was comparable to wild type mice.", {"entities": []}], ["Moreover, the antibodies produced by DPP-IV null animals after repeated antigenic challenge were affinity matured.", {"entities": []}], ["Similar observations were made using wild type animals treated with a highly selective DPP-IV inhibitor during the entire course of the experiments.", {"entities": []}], ["T cell recall responses to ovalbumin and MOG peptide, evaluated by measuring proliferation and IL-2 release from cells isolated from draining lymph nodes, were equivalent in DPP-IV null and wild type animals.", {"entities": []}], ["Furthermore, mice treated with DPP-IV inhibitor had intact T-cell recall responses to MOG peptide.", {"entities": []}], ["In addition, female DPP-IV null and wild type mice treated with DPP-IV inhibitor exhibited normal and robust in vivo cytotoxic T cell responses after challenge with cells expressing the male H-Y minor histocompatibility antigen.", {"entities": []}], ["These data indicate Selective inhibition of DPP-IV does not impair T dependent immune responses to antigenic challenge.", {"entities": []}], ["Here we show that iNOS-deficient mice display enhanced classically activated M1 macrophage polarization without major effects on alternatively activated M2 macrophages.", {"entities": []}], ["eNOS and nNOS mutant mice show comparable M1 macrophage polarization compared with wild-type control mice.", {"entities": []}], ["Addition of N6-(1-iminoethyl)-L-lysine dihydrochloride, an iNOS inhibitor, significantly enhances M1 macrophage polarization while S-nitroso-N-acetylpenicillamine, a NO donor, suppresses M1 macrophage polarization.", {"entities": []}], ["NO derived from iNOS mediates nitration of tyrosine residues in IRF5 protein, leading to the suppression of IRF5-targeted M1 macrophage signature gene activation.", {"entities": [[64, 68, "GENE"], [108, 112, "GENE"]]}], ["Computational analyses corroborate a circuit that fine-tunes the expression of IL-12 by iNOS in macrophages, potentially enabling versatile responses based on changing microenvironments.", {"entities": []}], ["Finally, studies of an experimental model of endotoxin shock show that iNOS deficiency results in more severe inflammation with an enhanced M1 macrophage activation phenotype.", {"entities": []}], ["These results suggest that NO derived from iNOS in activated macrophages suppresses M1 macrophage polarization.", {"entities": []}], ["In response to microbial ligands, IRF5 promotes pro-inflammatory M1 macrophage activation and production of nitrous oxide.", {"entities": [[34, 38, "GENE"]]}], ["Here the authors show that nitrous oxide modifies IRF5 tyrosine residues as a negative feedback, limiting the inflammatory response and protecting from endotoxin shock.", {"entities": [[50, 54, "GENE"]]}], ["Asthma outcomes are generally worse for ethnic minority children.", {"entities": [[0, 6, "DISEASE"]]}], ["Cultural competence training is an instrument for improving healthcare for ethnic minority patients.", {"entities": []}], ["To develop effective training, we explored the mechanisms in paediatric asthma care for ethnic minority patients that lead to deficiencies in the care process.", {"entities": [[72, 78, "DISEASE"]]}], ["We conducted semi-structured interviews on care for ethnic minority children with asthma (aged 4-10 years) with paediatricians (n\u2009=\u200913) and nurses (n\u2009=\u20093) in three hospitals.", {"entities": [[82, 88, "DISEASE"]]}], ["Interviews were analysed qualitatively with a framework method, using a cultural competence model.", {"entities": []}], ["Respondents mentioned patient non-adherence as the central problem in asthma care.", {"entities": [[70, 76, "DISEASE"]]}], ["They related non-adherence in children from ethnic minority backgrounds to social context factors, difficulties in understanding the chronic nature of asthma, and parents\u2019 language barriers.", {"entities": [[151, 157, "DISEASE"]]}], ["Reactions reported by respondents to patients\u2019 non-adherence included retrieving additional information, providing biomedical information, occasionally providing referrals for social context issues, and using informal interpreters.", {"entities": []}], ["This study provides keys to improve the quality of specialist paediatric asthma care to ethnic minority children, mainly related to non-adherence.", {"entities": [[73, 79, "DISEASE"]]}], ["Care providers do not consciously recognise all the mechanisms that lead to deficiencies in culturally competent asthma care they provide to ethnic minority children (e.g.", {"entities": [[113, 119, "DISEASE"]]}], ["communicating mainly from a biomedical perspective and using mostly informal interpreters).", {"entities": []}], ["Therefore, the learning objectives of cultural competence training should reflect issues that care providers are aware of as well as issues they are unaware of.", {"entities": []}], ["TGF-\u03b2 has been postulated to play an important role in the maintenance of epithelial homeostasis and the development of epithelium-derived cancers.", {"entities": []}], ["However, most of previous studies are mainly focused on the function of TGF-\u03b2 in immune cells to the development of allergic asthma and how TGF-\u03b2 signaling in airway epithelium itself in allergic inflammation is largely unknown.", {"entities": [[116, 131, "DISEASE"], [125, 131, "DISEASE"]]}], ["Furthermore, the in vivo TGF-\u03b2 function specifically in the airway epithelium during lung cancer development has been largely elusive.", {"entities": [[85, 96, "DISEASE"], [90, 96, "DISEASE"]]}], ["To evaluate the in vivo contribution of TGF-\u03b2 signaling in lung epithelium to the development of allergic disease and lung cancer, we generated a transgenic mouse model with Smad7, an intracellular inhibitor of TGF-\u03b2 signaling, constitutively expressed in mouse airway Clara cells using a mouse CC10 promoter.", {"entities": [[118, 129, "DISEASE"], [123, 129, "DISEASE"], [174, 179, "GENE"]]}], ["The mice were subjected to the development of OVA-induced allergic asthma and urethane-induced lung cancer.", {"entities": [[95, 106, "DISEASE"], [58, 73, "DISEASE"], [67, 73, "DISEASE"], [100, 106, "DISEASE"]]}], ["The Smad7 transgenic animals significantly protected from OVA-induced asthma, with reduced airway inflammation, airway mucus production, extracellular matrix deposition, and production of OVA-specific IgE.", {"entities": [[70, 76, "DISEASE"], [4, 9, "GENE"]]}], ["Further analysis of cytokine profiles in lung homogenates revealed that the Th2 cytokines including IL-4, IL-5 and IL-13, as well as other cytokines including IL-17, IL-1, IL-6, IP10, G-CSF, and GM-CSF were significantly reduced in the transgenic mice upon OVA induction.", {"entities": []}], ["In contrast, the Smad7 transgenic animals had an increased incidence of lung carcinogenesis when subjected to urethane treatment.", {"entities": [[17, 22, "GENE"]]}], ["These studies, therefore, demonstrate for the first time the in vivo function of TGF-\u03b2 signaling specifically in airway epithelium during the development of allergic asthma and lung cancer.", {"entities": [[177, 188, "DISEASE"], [157, 172, "DISEASE"], [166, 172, "DISEASE"], [182, 188, "DISEASE"]]}], ["Atopic dermatitis (AD) is a chronic skin disease which has been known to negatively influence the mental health of patients.", {"entities": [[36, 48, "DISEASE"], [7, 17, "DISEASE"]]}], ["However, only a few studies have explored the prevalence of psychiatric problems among AD patients, particularly among adolescents.", {"entities": []}], ["In this study, we aimed to assess the association of AD with depressive symptoms and suicidal behaviors among adolescents by analyzing data from the 2013 Korean Youth Risk Behavior Survey, a nationwide web-based survey.", {"entities": []}], ["Data from 72,435 adolescent middle and high school students in Korea were analyzed.", {"entities": []}], ["Students self-reported AD diagnosed by a doctor and yes-or-no answers to questions about depressive symptoms and suicide ideation, suicide planning, and suicide attempts were analyzed.", {"entities": []}], ["Relationships between AD and depressive symptoms or suicidal behaviors were tested by logistic regression models after controlling for potential confounding factors.", {"entities": []}], ["The proportion of adolescents who had AD was 6.8%.", {"entities": []}], ["The proportion of adolescents reporting depressive feelings was 31.0%, suicide ideation was 16.3%, suicide planning was 5.8%, and suicide attempts was 4.2%.", {"entities": []}], ["Compared to adolescents without AD, adolescents with AD were significantly more likely to experience depressive feelings (odds ratio [OR]: 1.27, 95% confidence interval [Cl]: 1.19-1.36), suicide ideation (OR: 1.34, 95% Cl: 1.24-1.45), suicide planning (OR: 1.46, 95% Cl: 1.32-1.65), and suicide attempts (OR: 1.51, 95% Cl: 1.33-1.72).", {"entities": []}], ["In the multivariate model, the relationships between AD and suicide ideation (OR: 1.26, 95% Cl:1.16-1.36), suicide planning (OR: 1.28, 95% Cl:1.14-1.44), and suicide attempt (OR: 1.29, 95% Cl:1.13-1.49) were statistically significant.", {"entities": []}], ["Adolescents who have AD are associated with a higher prevalence of depression symptoms and suicidal behaviors.", {"entities": []}], ["Adolescent AD patients may need interventions from clinicians and caregivers that use a holistic approach to prevent psychological comorbidities, although further research is needed to clarify this relationship.", {"entities": []}], ["Metals cause nephrotoxicity with acute and/or chronic exposure; however, few epidemiological studies have examined impacts of exposure to metal fumes on renal injury in welding workers.", {"entities": []}], ["In total, 66 welding workers and 12 office workers were recruited from a shipyard located in southern Taiwan.", {"entities": []}], ["Urine samples from each subject were collected at the beginning (baseline) and end of the work week (1-week exposure).", {"entities": []}], ["Personal exposure to PM 2.5 was measured.", {"entities": []}], ["The 8-h mean PM 2.5 was 50.3\u2009\u03bcg/m 2.5 in the urine, suggesting that extracellular matrix (ECM)-receptor interactions are a critical mechanism.", {"entities": []}], ["ECM-receptor interaction-related biomarkers for renal injury, kidney injury molecule (KIM)-1 and neutrophil gelatinase-associated lipocalin (NGAL), were significantly elevated in welding workers post-exposure, as well as were urinary Al, Cr, Mn, Fe, Co, and Ni levels.", {"entities": []}], ["NGAL was more significantly associated with Al (r\u2009=\u20090.737, p\u2009<\u20090.001), Cr (r\u2009=\u20090.705, p\u2009<\u20090.001), Fe (r\u2009=\u20090.709, p\u2009<\u20090.001), and Ni (r\u2009=\u20090.657, p\u2009<\u20090.001) than was KIM-1, suggesting that NGAL may be a urinary biomarker for welding PM 2.5 exposure.", {"entities": []}], ["Nephrotoxicity (e.g., renal tubular injury) may be an emerging concern in occupational health.", {"entities": []}], ["Additional biomarkers in sepsis are needed to tackle the challenges of determining prognosis and optimizing selection of high-risk patients for application of therapy.", {"entities": []}], ["In the present study, conducted in a cohort of medical intensive care unit patients, our aim was to compare the prognostic value of mid-regional pro-atrial natriuretic peptide (ANP) levels with those of other biomarkers and physiological scores.", {"entities": []}], ["Blood samples obtained in a prospective observational study conducted in 101 consecutive critically ill patients admitted to the intensive care unit were analyzed.", {"entities": []}], ["The prognostic value of pro-ANP levels was compared with that of the Acute Physiology and Chronic Health Evaluation (APACHE) II score and with those of various biomarkers (i.e.", {"entities": []}], ["C-reactive protein, IL-6 and procalcitonin).", {"entities": []}], ["Mid-regional pro-ANP was detected in EDTA plasma from all patients using a new sandwich immunoassay.", {"entities": []}], ["On admission, 53 patients had sepsis, severe sepsis, or septic shock, and 68 had systemic inflammatory response syndrome.", {"entities": [[112, 120, "DISEASE"]]}], ["The median pro-ANP value in the survivors was 194 pmol/l (range 20\u20132000 pmol/l), which was significantly lower than in the nonsurvivors (median 853.0 pmol/l, range 100\u20132000 pmol/l; P < 0.001).", {"entities": []}], ["On the day of admission, pro-ANP levels, but not levels of other biomarkers, were significantly higher in surviving than in nonsurviving sepsis patients ( P = 0.001).", {"entities": []}], ["In a receiver operating characteristic curve analysis for the survival of patients with sepsis, the area under the curve (AUC) for pro-ANP was 0.88, which was significantly greater than the AUCs for procalcitonin and C-reactive protein, and similar to the AUC for the APACHE II score.", {"entities": []}], ["Pro-ANP appears to be a valuable tool for individual risk assessment in sepsis patients and for stratification of high-risk patients in future intervention trials.", {"entities": []}], ["Further studies are needed to validate our results.", {"entities": []}], ["Sargassum naozhouense is a brown seaweed used in folk medicine and applied for thousands of years in Zhanjiang, Guangdong province, China.", {"entities": []}], ["This study is the first time to investigate its chemical composition and antiviral activity.", {"entities": []}], ["On the dry weight basis, this seaweed was constituted of ca.", {"entities": []}], ["35.18% ash, 11.20% protein, 1.06% lipid and 47.73% total carbohydrate, and the main carbohydrate was water-soluble polysaccharide.", {"entities": []}], ["The protein analysis indicated the presence of essential amino acids, which accounted for 36.35% of the protein.", {"entities": []}], ["The most abundant fatty acids were C14:0, C16:0, C18:1 and C20:4.", {"entities": []}], ["The ash fraction analysis indicated that essential minerals and trace elements, such as Fe, Zn and Cu, were present in the seaweed.", {"entities": []}], ["IR analysis revealed that polysaccharides from cultivated S. naozhouense may be alginates and fucoidan.", {"entities": []}], ["The polysaccharides possessed strong antiviral activity against HSV-1 in vitro with EC 50 of 8.92 \u03bcg/mL.", {"entities": []}], ["These results demonstrated cultivated S. naozhouense has a potential for its use in functional foods and antiviral new drugs.", {"entities": []}], ["Genome-wide association studies (GWASs) identify single nucleotide polymorphisms (SNPs) that are enriched in individuals suffering from a given disease.", {"entities": []}], ["Most disease-associated SNPs fall into non-coding regions, so that it is not straightforward to infer phenotype or function; moreover, many SNPs are in tight genetic linkage, so that a SNP identified as associated with a particular disease may not itself be causal, but rather signify the presence of a linked SNP that is functionally relevant to disease pathogenesis.", {"entities": []}], ["Here, we present an analysis method that takes advantage of the recent rapid accumulation of epigenomics data to address these problems for some SNPs.", {"entities": []}], ["Using asthma as a prototypic example; we show that non-coding disease-associated SNPs are enriched in genomic regions that function as regulators of transcription, such as enhancers and promoters.", {"entities": [[6, 12, "DISEASE"]]}], ["Identifying enhancers based on the presence of the histone modification marks such as H3K4me1 in different cell types, we show that the location of enhancers is highly cell-type specific.", {"entities": []}], ["We use these findings to predict which SNPs are likely to be directly contributing to disease based on their presence in regulatory regions, and in which cell types their effect is expected to be detectable.", {"entities": []}], ["Moreover, we can also predict which cell types contribute to a disease based on overlap of the disease-associated SNPs with the locations of enhancers present in a given cell type.", {"entities": []}], ["Finally, we suggest that it will be possible to re-analyze GWAS studies with much higher power by limiting the SNPs considered to those in coding or regulatory regions of cell types relevant to a given disease.", {"entities": []}], ["It is still unclear whether signs of neutrophil mobilization in the blood of patients with chronic obstructive pulmonary disease represent true systemic events and how these relate to bacterial colonization in the airways.", {"entities": [[91, 128, "DISEASE"]]}], ["In this study, we evaluated these issues during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease and chronic bronchitis (OPD-CB).", {"entities": [[157, 167, "DISEASE"]]}], ["Over a period of 60 weeks for each subject, blood samples were repeatedly collected from 60 smokers with OPD-CB during clinically stable periods, as well as during and after exacerbations.", {"entities": []}], ["Myeloperoxidase (MPO) and neutrophil elastase (NE) protein and mRNA, growth of bacteria in sputum, and clinical parameters were analyzed.", {"entities": [[17, 20, "GENE"]]}], ["Ten asymptomatic smokers and ten never-smokers were included as controls.", {"entities": []}], ["We found that, during clinically stable periods, neutrophil and NE protein concentrations were increased in smokers with OPD-CB and in the asymptomatic smokers when compared with never-smokers.", {"entities": []}], ["During exacerbations, neutrophil and MPO protein concentrations were further increased in smokers with OPD-CB, without a detectable increase in the corresponding mRNA during exacerbations.", {"entities": [[37, 40, "GENE"]]}], ["However, MPO and NE protein and mRNA displayed positive correlations.", {"entities": [[9, 12, "GENE"]]}], ["During exacerbations, only increased neutrophil concentrations were associated with growth of bacteria in sputum.", {"entities": []}], ["Among patients with low transcutaneous oxygen saturation during exacerbations, PaO 2 (partial oxygen pressure) correlated with concentrations of MPO and NE protein and neutrophils in a negative manner.", {"entities": [[145, 148, "GENE"]]}], ["There are signs of systemic neutrophil mobilization during clinically stable periods and even more so during exacerbations in chronic obstructive pulmonary disease.", {"entities": [[126, 163, "DISEASE"]]}], ["In this condition, MPO and NE may share a cellular origin, but its location remains uncertain.", {"entities": [[19, 22, "GENE"]]}], ["Factors other than local bacteria, including hypoxemia, may be important for driving systemic signs of neutrophil mobilization.", {"entities": []}], ["This study analyzed the lifetime health care expenditures and life years lost associated with diabetes in the U.S. Data from the National Health Interview Survey (NHIS), the Medical Expenditure Panel Survey from 1997 to 2000, and the NHIS Linked Mortality Public-use Files with a mortality follow-up to 2006 were used to estimate age-, race-, sex-, and BMI-specific risk of diabetes, mortality, and annual health care expenditures for both patients with diabetes and those without diabetes.", {"entities": []}], ["A Markov model populated by the risk and cost estimates was used to compute life years and total lifetime health care expenditures by age, race, sex, and BMI classifications for patients with diabetes and without diabetes.", {"entities": []}], ["Predicted life expectancy for patients with diabetes and without diabetes demonstrated an inverted U shape across most BMI classifications, with highest life expectancy being for the overweight.", {"entities": []}], ["Lifetime health care expenditures were higher for whites than blacks and for females than males.", {"entities": []}], ["Using U.S. adults aged 50 years as an example, we found that diabetic white females with a BMI >40 kg/m Our results show that diabetes is associated with large decreases in life expectancy and large increases in lifetime health care expenditures.", {"entities": []}], ["In addition to decreasing life expectancy by 3.3 to 18.7 years, diabetes increased lifetime health care expenditures by $8,946 to $159,380 depending on age-race-sex-BMI classification groups.", {"entities": []}], ["The HLA - G gene displays several peculiarities that are distinct from those of classical HLA class I genes.", {"entities": [[4, 7, "GENE"], [90, 93, "GENE"], [4, 7, "GENE"], [90, 93, "GENE"]]}], ["The unique structure of the HLA-G molecule permits a restricted peptide presentation and allows the modulation of the cells of the immune system.", {"entities": [[28, 33, "GENE"]]}], ["Although polymorphic sites may potentially influence all biological functions of HLA-G, those present at the promoter and 3\u2032 untranslated regions have been particularly studied in experimental and pathological conditions.", {"entities": [[81, 86, "GENE"]]}], ["The relatively low polymorphism observed in the MHC-G coding region both in humans and apes may represent a strong selective pressure for invariance, whereas, in regulatory regions several lines of evidence support the role of balancing selection.", {"entities": []}], ["Since HLA-G has immunomodulatory properties, the understanding of gene regulation and the role of polymorphic sites on gene function may permit an individualized approach for the future use of HLA-G for therapeutic purposes.", {"entities": [[6, 11, "GENE"], [193, 198, "GENE"], [6, 11, "GENE"], [193, 198, "GENE"]]}], ["Hemipelvectomy is a major orthopedic surgical procedure indicated in specific situations.", {"entities": []}], ["Although many studies discuss surgical techniques for hemipelvectomy, few studies have presented survival data, especially in underdeveloped countries.", {"entities": []}], ["Additionally, there is limited information on anesthesia for orthopedic oncologic surgeries.", {"entities": []}], ["The primary aim of this study was to determine the survival rate after hemipelvectomy, and the secondary aims were to evaluate anesthesia and perioperative care associated with hemipelvectomy and determine the influence of the surgical technique (external hemipelvectomy [amputation] or internal hemipelvectomy [limb sparing surgery]) on anesthesia and perioperative care in Brazil.", {"entities": []}], ["This retrospective case series collected data from 35 adult patients who underwent hemipelvectomy between 2000 and 2013.", {"entities": []}], ["Survival rates after surgery were determined, and group comparisons were performed using the Kaplan\u2013Meier method and the log-rank test.", {"entities": []}], ["Mantel\u2013Cox test and multiple linear regression analysis with stepwise forward selection were performed for univariate and multivariate analyses, respectively.", {"entities": []}], ["Mean survival time was 32.8\u2009\u00b1\u20094.6\u00a0months and 5-year survival rate was 27\u00a0%.", {"entities": []}], ["Of the 35 patients, 23 patients (65.7\u00a0%) underwent external hemipelvectomy and 12 patients (34.3\u00a0%) underwent internal hemipelvectomy.", {"entities": []}], ["The survival rate was significantly higher in patients with bone tumors than in those with soft tissue sarcomas ( P \u2009=\u20090.024).", {"entities": []}], ["The 5-year cumulative probability of survival was significantly lower in patients who underwent external hemipelvectomy than in those who underwent internal hemipelvectomy ( P \u2009=\u20090.043).", {"entities": []}], ["In the univariate and multivariate analyses, only advanced disease stage (3 and 4) was identified as a significant independent predictor of reduced survival ( P \u2009=\u20090.0003).", {"entities": []}], ["Balanced general anesthesia combined with epidural block was the most frequent anesthesia technique.", {"entities": []}], ["Median intraoperative crystalloid volume and red blood cell transfusions were 3500\u00a0mL and 2\u00a0units, respectively.", {"entities": []}], ["Overall mean survival time after hemipelvectomy was 32.8\u00a0months.", {"entities": []}], ["Advanced disease stage might be independently associated with reduced survival.", {"entities": []}], ["Smaller amounts of fluids and transfusions were administered and time to discharge was shorter.", {"entities": []}], ["Acute and chronic pain as well as wound complications are still important challenges in hemipelvectomy.", {"entities": []}], ["Interest in developing physically active pediculicides has identified new active substances.", {"entities": []}], ["The objective was to evaluate a new treatment for clinical efficacy.", {"entities": []}], ["We describe the selection of 1,2-octanediol as a potential pediculicide.", {"entities": []}], ["Clinical studies were community based.", {"entities": []}], ["The main outcome measure was no live lice, after two treatments, with follow up visits over 14 days.", {"entities": []}], ["Study 1 was a proof of concept with 18/20 (90%) participants cured.", {"entities": []}], ["Study 2 was a multicentre, parallel, randomised, observer-blind study (520 participants) that compared 0.5% malathion liquid with 1,2-octanediol lotion (20% alcohol) applied 2\u20132.5 hours or 8 hours/overnight.", {"entities": []}], ["1,2-octanediol lotion was significantly (p<0.0005) more effective with success for 124/175 (70.9%) RR\u200a=\u200a1.50 (97.5% CI, 1.22 to 1.85) for 2\u20132.5 hours, and 153/174 (87.9%) RR\u200a=\u200a1.86 (97.5% CI, 1.54 to 2.26) for 8 hours/overnight compared with 81/171 (47.4%) for malathion.", {"entities": []}], ["Study 3, a two centre, parallel, randomised, observer-blind study (121 participants), compared 1,2-octanediol lotion, 2\u20132.5 hours with 1,2-octanediol alcohol free mousse applied for 2\u20132.5 hours or 8 hours/overnight.", {"entities": []}], ["The mousse applied for 8 hours/overnight cured 31/40 (77.5%), compared with 24/40 (60.0%) for lotion (RR\u200a=\u200a1.29, 95% CI, 0.95 to 1.75; NNT\u200a=\u200a5.7) but mousse applied for 2\u20132.5 hours 17/41 (41.5%) was less effective than lotion (RR\u200a=\u200a0.69, 95% CI, 0.44 to 1.08).", {"entities": [[135, 138, "GENE"]]}], ["Adverse events were more common using 1,2-octanediol lotion at both 2\u20132.5 hours (12.0%, p\u200a=\u200a0.001) and 8 hours/overnight (14.9%, p<0.0005), compared with 0.5% malathion (2.3%).", {"entities": []}], ["Similar reactions were more frequent (p<0.045) using lotion compared with mousse.", {"entities": []}], ["1,2-octanediol was found to eliminate head louse infestation.", {"entities": []}], ["It is believed to disrupt the insect's cuticular lipid, resulting in dehydration.", {"entities": []}], ["The alcohol free mousse is more acceptable exhibiting significantly fewer adverse reactions.", {"entities": []}], ["Controlled-Trials.com ISRCTN66611560 , ISRCTN91870666 , ISRCTN28722846", {"entities": []}], ["Inflammation and cancer have a profound yet ambiguous relationship.", {"entities": [[17, 23, "DISEASE"]]}], ["Inflammation - especially chronic inflammation - has protumorigenic effects, but inflammatory cells also mediate an immune response against the tumor and immunosuppression is known to increase the risk for certain tumors.", {"entities": []}], ["This article reviews current literature on the role of inflammation in cancer and the cancer risk in immune-mediated inflammatory diseases (IMIDs).", {"entities": [[71, 77, "DISEASE"], [86, 92, "DISEASE"]]}], ["We discuss the effect on cancer risk of different drug classes used in the treatment of IMIDs treatment, including biologicals such as tumor necrosis factor (TNF) inhibitors.", {"entities": [[25, 31, "DISEASE"], [158, 161, "GENE"]]}], ["Overall cancer incidence and mortality risk are similar to the general population in inflammatory bowel disease (IBD), and slightly increased for rheumatoid arthritis and psoriasis, with risk profiles differing for different tumor types.", {"entities": [[85, 111, "DISEASE"], [146, 166, "DISEASE"], [171, 180, "DISEASE"], [157, 166, "DISEASE"], [8, 14, "DISEASE"]]}], ["Increased risk for non-melanoma skin cancer is associated with thiopurine treatment in IBD, with the combination of anti-TNF and methotrexate in rheumatoid arthritis and with PUVA, cyclosporine and anti-TNF treatment in psoriasis.", {"entities": [[145, 165, "DISEASE"], [220, 229, "DISEASE"], [32, 43, "DISEASE"], [156, 165, "DISEASE"], [23, 31, "DISEASE"], [37, 43, "DISEASE"]]}], ["Data on the safety of using biologic or immunosuppressant therapy in IMID patients with a history of cancer are scarce.", {"entities": [[101, 107, "DISEASE"]]}], ["This review provides clinicians with a solid background to help them in making decisions about treatment of immune-mediated diseases in patients with a tumor history.", {"entities": []}], ["This article is related to another review article in Molecular Cancer: http://www.molecular-cancer.com/content/12/1/86 .", {"entities": [[63, 69, "DISEASE"], [92, 98, "DISEASE"]]}], ["Genetic variation among Aedes aegypti populations can greatly influence their vector competence for human pathogens such as the dengue virus (DENV).", {"entities": []}], ["While intra-species transcriptome differences remain relatively unstudied when compared to coding sequence polymorphisms, they also affect numerous aspects of mosquito biology.", {"entities": []}], ["Comparative molecular profiling of mosquito strain transcriptomes can therefore provide valuable insight into the regulation of vector competence.", {"entities": []}], ["We established a panel of A. aegypti strains with varying levels of susceptibility to DENV, comprising both laboratory-maintained strains and field-derived colonies collected from geographically distinct dengue-endemic regions spanning South America, the Caribbean, and Southeast Asia.", {"entities": []}], ["A comparative genome-wide gene expression microarray-based analysis revealed higher basal levels of numerous immunity-related gene transcripts in DENV-refractory mosquito strains than in susceptible strains, and RNA interference assays further showed different degrees of immune pathway contribution to refractoriness in different strains.", {"entities": []}], ["By correlating transcript abundance patterns with DENV susceptibility across our panel, we also identified new candidate modulators of DENV infection in the mosquito, and we provide functional evidence for two potential DENV host factors and one potential restriction factor.", {"entities": []}], ["Our comparative transcriptome dataset thus not only provides valuable information about immune gene regulation and usage in natural refractoriness of mosquito populations to dengue virus but also allows us to identify new molecular interactions between the virus and its mosquito vector.", {"entities": []}], ["Genetic variations among Aedes aegypti mosquito populations can greatly influence their ability to transmit human pathogens such as the dengue virus (DENV).", {"entities": []}], ["Some of these variations between mosquito populations are represented by differences in the expression of specific genes that control susceptibility to a pathogen.", {"entities": []}], ["We have compared susceptibilities to dengue virus infection and the genome-wide gene expression patterns between laboratory-maintained Aedes aegypti strains as well as field-derived colonies collected from geographically-distinct dengue-endemic regions spanning South America, the Caribbean, and Southeast Asia.", {"entities": []}], ["These analyses in conjunction with functional gene silencing assays showed that the basal immune activity is a likely determinant of resistance to the dengue virus, along with other novel factors.", {"entities": []}], ["Our study also identified two potential DENV host factors and one potential restriction factor, thereby elucidating novel aspects of dengue virus \u2013 mosquito interactions.", {"entities": []}], ["The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in many developed countries appears to be increasing.", {"entities": []}], ["There is some evidence from Latin America that COPD is a growing cause of death, but information on prevalence is scant.", {"entities": []}], ["It is possible that, due to the high frequency of smoking in these countries, this disease may represent a major public health problem that has not yet been recognized as such.", {"entities": []}], ["The PLATINO study is aimed at measuring COPD prevalence in major cities in Latin America.", {"entities": []}], ["A multi-country survey is being carried out in major cities in Latin America.", {"entities": []}], ["In each metropolitan area, a population-based sample of approximately 1,000 individuals aged 40 years or older is being interviewed using standardized questionnaires.", {"entities": []}], ["Eligible subjects are submitted to pre- and post-bronchodilator spirometry, and classified according to several criteria for COPD.", {"entities": []}], ["Anthropometric examinations are also performed.", {"entities": []}], ["Several risk factors are being studied, including smoking, socioeconomic factors, exposure to domestic biomass pollution, occupational exposure to dust and hospital admissions due to respiratory conditions during childhood.", {"entities": []}], ["Whether or not subjects affected by COPD are aware of their disease, and if so how it is being managed by health services, is also being investigated, as are the consequences of this condition on quality of life and work performance.", {"entities": []}], ["At the present time, the study is completed in S\u00e3o Paulo, Mexico City and Montevideo; Chile has started the study in March 2004 and it will be followed by Venezuela; two other metropolitan areas could still join the PLATINO project.", {"entities": []}], ["Similar sampling procedures, with stratification for socio-economic status, are being used in all sites.", {"entities": []}], ["Strict coordination, training and standardization procedures have been used to ensure comparability of results across sites.", {"entities": []}], ["Overall 92% of the pre-bronchodilator spirometry tests fulfilled ATS criteria of quality in the three first sites (97% in Montevideo, 91% in Mexico and 89% in Sao Paulo).", {"entities": []}], ["The PLATINO project will provide a detailed picture of the global distribution of COPD in Latin America.", {"entities": []}], ["This project shows that studies from Latin America can be carried out with adequate quality and be of scientific value.", {"entities": []}], ["We designed a program called MolGridCal that can be used to screen small molecule database in grid computing on basis of JPPF grid environment.", {"entities": []}], ["Based on MolGridCal program, we proposed an integrated strategy for virtual screening and binding mode investigation by combining molecular docking, molecular dynamics (MD) simulations and free energy calculations.", {"entities": []}], ["To test the effectiveness of MolGridCal, we screened potential ligands for \u03b2 2 adrenergic receptor (\u03b2 2 AR) from a database containing 50,000 small molecules.", {"entities": []}], ["MolGridCal can not only send tasks to the grid server automatically, but also can distribute tasks using the screensaver function.", {"entities": []}], ["As for the results of virtual screening, the known agonist BI-167107 of \u03b2 2 AR is ranked among the top 2% of the screened candidates, indicating MolGridCal program can give reasonable results.", {"entities": []}], ["To further study the binding mode and refine the results of MolGridCal, more accurate docking and scoring methods are used to estimate the binding affinity for the top three molecules (agonist BI-167107, neutral antagonist alprenolol and inverse agonist ICI 118,551).", {"entities": []}], ["The results indicate agonist BI-167107 has the best binding affinity.", {"entities": []}], ["MD simulation and free energy calculation are employed to investigate the dynamic interaction mechanism between the ligands and \u03b2 2 AR.", {"entities": []}], ["The results show that the agonist BI-167107 also has the lowest binding free energy.", {"entities": []}], ["This study can provide a new way to perform virtual screening effectively through integrating molecular docking based on grid computing, MD simulations and free energy calculations.", {"entities": []}], ["The source codes of MolGridCal are freely available at http://molgridcal.codeplex.com .", {"entities": []}], ["Measurement of biomarkers is a potential approach to early assessment and prediction of mortality in patients with sepsis.", {"entities": []}], ["The aim of the present study was to evaluate the prognostic value of mid-regional pro-adrenomedullin (MR-proADM) levels in a cohort of medical intensive care patients and to compare it with other biomarkers and physiological scores.", {"entities": []}], ["We evaluated blood samples from 101 consecutive critically ill patients admitted to the intensive care unit and from 160 age-matched healthy control individuals.", {"entities": []}], ["The patients had initially been enrolled in a prospective observational study investigating the prognostic value of endocrine dysfunction in critically ill patients (\"PEDCRIP\" Study).", {"entities": []}], ["The prognostic value of MR-proADM levels was compared with those of two physiological scores and of various biomarkers (for example C-reactive Protein, IL-6, procalcitonin).", {"entities": []}], ["MR-proADM was measured in EDTA plasma from all patients using a new sandwich immunoassay.", {"entities": []}], ["On admission, 53 patients had sepsis, severe sepsis, or septic shock, and 48 had systemic inflammatory response syndrome.", {"entities": [[112, 120, "DISEASE"]]}], ["Median MR-proADM levels on admission (nmol/l [range]) were 1.1 (0.3\u20133.7) in patients with systemic inflammatory response syndrome, 1.8 (0.4\u20135.8) in those with sepsis, 2.3 (1.0\u201317.6) in those with severe sepsis and 4.5 (0.9\u201321) in patients with septic shock.", {"entities": [[121, 129, "DISEASE"]]}], ["In healthy control individuals the median MR-proADM was 0.4 (0.21\u20130.97).", {"entities": []}], ["On admission, circulating MR-proADM levels in patients with sepsis, severe sepsis, or septic shock were significantly higher in nonsurvivors (8.5 [0.8\u201321.0]; P < 0.001) than in survivors (1.7 [0.4\u201317.6]).", {"entities": []}], ["In a receiver operating curve analysis of survival of patients with sepsis, the area under the curve (AUC) for MR-proADM was 0.81, which was similar to the AUCs for IL-6, Acute Physiology and Chronic Health Evaluation II score and Simplified Acute Physiology Score II.", {"entities": []}], ["The prognostic value of MR-proADM was independent of the sepsis classification system used.", {"entities": []}], ["MR-proADM may be helpful in individual risk assessment in septic patients.", {"entities": []}], ["Individual lifestyles are key drivers of both environmental change and chronic disease.", {"entities": []}], ["We undertook a scoping review of peer-reviewed studies which examined associations between environmental and health behaviors of individuals in high-income countries.", {"entities": []}], ["We searched EconLit, Medline, BIOSIS and the Social Science Citation Index.", {"entities": []}], ["A total of 136 studies were included.", {"entities": []}], ["The majority were USA-based cross-sectional studies using self-reported measures.", {"entities": []}], ["Most of the evidence related to travel behavior, particularly active travel (walking and cycling) and physical activity (92 studies) or sedentary behaviors (19 studies).", {"entities": []}], ["Associations of public transport use with physical activity were examined in 18 studies, and with sedentary behavior in one study.", {"entities": []}], ["Four studies examined associations between car use and physical activity.", {"entities": []}], ["A small number included other environmental behaviors (food-related behaviors (n = 14), including organic food, locally-sourced food and plate waste) and other health behaviors ((n = 20) smoking, dietary intake, alcohol).", {"entities": []}], ["These results suggest that research on individual environmental and health behaviors consists largely of studies examining associations between travel mode and levels of physical activity.", {"entities": []}], ["There appears to be less research on associations between other behaviors with environmental and health impacts, and very few longitudinal studies in any domain.", {"entities": []}], ["The mucosal pathogen Chlamydia trachomatis affects hundreds of millions of people worldwide and is a significant cause of sexually transmitted disease.", {"entities": []}], ["Although most acute infections can be easily managed, complications often occur that can be especially severe in women.", {"entities": []}], ["It has been proposed that increased exposure to conserved chlamydial antigens, such as through reinfection or persistent infection, results in chronic inflammation and tissue scarring and contributes to the pathogenesis of endometrial and fallopian tube damage.", {"entities": []}], ["This immunopathologic damage is believed to be a principal cause of ectopic pregnancy and tubal factor infertility.", {"entities": [[103, 114, "DISEASE"]]}], ["The chlamydial heat shock protein Hsp60, a homolog of Escherichia coli GroEL, has been identified as one protein capable of eliciting intense mononuclear inflammation.", {"entities": []}], ["Furthermore, several studies have revealed a correlation between Hsp60 responses and the immunopathologic manifestations of human chlamydial disease.", {"entities": []}], ["The role of additional antigens in the immunopathologic response to chlamydiae is currently undefined.", {"entities": []}], ["A prime candidate, however, is the chlamydial GroES homolog Hsp10, which is genetically and physiologically linked to Hsp60.", {"entities": []}], ["Recent studies provide data to suggest that immune reactivity to Hsp10 is significantly associated with tubal infertility in a chlamydiae-exposed population.", {"entities": [[110, 121, "DISEASE"]]}], ["Chlamydia pneumoniae is a more recently defined chlamydial species that has been implicated in a variety of ways with chronic disease processes, such as adult onset asthma and atherosclerosis.", {"entities": [[176, 191, "DISEASE"], [165, 171, "DISEASE"]]}], ["Evidence indicates that Hsp60 is present in human atheroma and may play a role in lesion development by direct activation of macrophages.", {"entities": []}], ["Hsp60 causes the elaboration of inflammatory cytokines, the induction of metalloproteinase, and the oxidation of low density lipoprotein.", {"entities": []}], ["Each of these events is directly associated with the progress of atherosclerosis.", {"entities": [[65, 80, "DISEASE"]]}], ["Thus, chlamydial heat shock proteins may function in at least two ways to promote chronic disease: first by direct antigenic stimulation and second as signal transducers that result in macrophage activation.", {"entities": []}], ["These concepts in disease pathology are discussed in the context of chlamydial infections.", {"entities": []}], ["Gecko proteins have long been used as anti-tumor agents in oriental medicine, without any scientific background.", {"entities": []}], ["Although anti-tumor effects of Gecko proteins on several cancers were recently reported, their effect on bladder cancer has not been investigated.", {"entities": [[113, 119, "DISEASE"]]}], ["Thus, we explored the anti-tumor effect of Gecko proteins and its cellular mechanisms in human bladder cancer 5637 cells.", {"entities": [[103, 109, "DISEASE"]]}], ["Gecko proteins significantly reduced the viability of 5637 cells without any cytotoxic effect on normal cells.", {"entities": []}], ["These proteins increased the Annexin-V staining and the amount of condensed chromatin, demonstrating that the Gecko proteinsinduced cell death was caused by apoptosis.", {"entities": []}], ["Gecko proteins suppressed Akt activation, and the overexpression of constitutively active form of myristoylated Akt prevented Gecko proteins-induced death of 5637 cells.", {"entities": []}], ["Furthermore, Gecko proteins activated caspase 9 and caspase 3/7.", {"entities": []}], ["Taken together, our data demonstrated that Gecko proteins suppressed the Akt pathway and activated the intrinsic caspase pathway, leading to the apoptosis of bladder cancer cells.", {"entities": [[166, 172, "DISEASE"]]}], ["[BMB Reports 2015; 48(9): 531-536]", {"entities": []}], ["We compared the inflammatory and cytotoxic responses caused by household mold and bacteria in human and mouse cell lines.", {"entities": []}], ["We studied the fungi Aspergillus versicolor, Penicillium spinulosum, and Stachybotrys chartarum and the bacteria Bacillus cereus, Pseudomonas fluorescens, and Streptomyces californicus for their cytotoxicity and ability to stimulate the production of inflammatory mediators in mouse RAW264.7 and human 28SC macrophage cell lines and in the human A549 lung epithelial cell line in 24-hr exposure to 10(5), 10(6), and 10(7) microbes/mL.", {"entities": []}], ["We studied time dependency by terminating the exposure to 10(6) microbes/mL after 3, 6, 12, 24, and 48 hr.", {"entities": [[103, 105, "GENE"]]}], ["We analyzed production of the cytokines tumor necrosis factor-alpha and interleukins 6 and 1ss (TNF-alpha, IL-6, IL-1ss, respectively) and measured nitric oxide production using the Griess method, expression of inducible NO-synthase with Western Blot analysis, and cytotoxicity with the MTT-test.", {"entities": []}], ["All bacteria strongly induced the production of TNF-alpha, IL-6 and, to a lesser extent, the formation of IL-1ss in mouse macrophages.", {"entities": []}], ["Only the spores of Str.", {"entities": []}], ["californicus induced the production of NO and IL-6 in both human and mouse cells.", {"entities": []}], ["In contrast, exposure to fungal strains did not markedly increase the production of NO or any cytokine in the studied cell lines except for Sta.", {"entities": []}], ["chartarum, which increased IL-6 production somewhat in human lung epithelial cells.", {"entities": []}], ["These microbes were less cytotoxic to human cells than to mouse cells.", {"entities": []}], ["On the basis of equivalent numbers of bacteria and spores of fungi added to cell cultures, the overall potency to stimulate the production of proinflammatory mediators decreased in the order Ps.", {"entities": []}], ["fluorescens > Str.", {"entities": []}], ["californicus > B. cereus > Sta.", {"entities": []}], ["chartarum > A. versicolor > P. spinulosum.", {"entities": []}], ["These data suggest that bacteria in water-damaged buildings should also be considered as causative agents of adverse inflammatory effects.", {"entities": []}], ["The aim of this study was to investigate the attitudes and use of complementary and alternative medicine (CAM) among Saudi Arabian adolescents.", {"entities": []}], ["A multistage stratified sampling method was used to select 736 adolescents (358 males, 378 females) aged 15\u201319 years from secondary schools.", {"entities": []}], ["The study was carried out in Al-Khobar city, Eastern region of Saudi Arabia.", {"entities": []}], ["The findings revealed that the use of CAM by adolescents in their lifetime ranged from 1.6% for acupuncture to 58.6% for honey treatment, with significant differences between genders, except in the use of dietary supplements, black cumin, and acupuncture therapies.", {"entities": []}], ["Females were more likely to use CAM for treating abdominal pains, cold and flu, and cough than males (P < 0.000).", {"entities": []}], ["Family members and friends (67.7%) were the main source of CAM usage, followed by television (10%), and Internet (8%).", {"entities": []}], ["Religious and medicinal herb healers were the CAM healers most commonly visited by adolescents.", {"entities": []}], ["Nearly 21\u201343% of adolescents had positive attitudes toward CAM, with some significant differences between males and females.", {"entities": []}], ["It can be concluded that CAM is widely used by Saudi adolescents, but caution should be exercised for the safe usage of some CAM treatments.", {"entities": []}], ["CAM should not be ignored; however there is an urgent need to establish regulations for CAM usage.", {"entities": []}], ["The differentiation of naive CD8 T cells into effector cytotoxic T lymphocytes upon antigen stimulation is necessary for successful antiviral, and antitumor immune responses.", {"entities": []}], ["Here, using a mouse model, we describe a dual role for the let-7 microRNAs in the regulation of CD8 T cell responses, where maintenance of the naive phenotype in CD8 T cells requires high levels of let-7 expression, while generation of cytotoxic T lymphocytes depends upon T cell receptor-mediated let-7 downregulation.", {"entities": []}], ["Decrease of let-7 expression in activated T cells enhances clonal expansion and the acquisition of effector function through derepression of the let-7 targets, including Myc and Eomesodermin.", {"entities": [[170, 173, "GENE"]]}], ["Ultimately, we have identified a novel let-7-mediated mechanism, which acts as a molecular brake controlling the magnitude of CD8 T cell responses.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.26398.001", {"entities": []}], ["Due to the difficult geographic terrain with lack of roads and transport, the Sikkim State in India finds difficulties in contending the respiratory diseases especially during the rainy seasons.", {"entities": []}], ["A case\u2013control study was conducted for two months at the Central Referral Hospital of East Sikkim involving 110 individuals in the age group of 10\u00a0years and above.", {"entities": []}], ["Due to feasibility constraints, 55 cases and 55 controls were selected by applying the non-probability sampling method with age and sex matching.", {"entities": []}], ["The collected data were tabulated and analyzed by using the SPSS (Statistical Package for Social Sciences) version 10.0 for windows.", {"entities": []}], ["Findings were expressed in terms of proportion, Chi Square Test and Multiple Logistic Regression Analysis.", {"entities": []}], ["Here, p -value <0.05 was considered as statistically significant.", {"entities": []}], ["This study revealed that the presence of overcrowding, chronic exposure to allergens, smoking habits, chronic respiratory illnesses within last 5\u00a0years, family history of chronic respiratory illnesses and mental illnesses were independently associated with respiratory diseases.", {"entities": []}], ["This study should be replicated in other parts of Sikkim to obtain more confirmatory evidence on determinants of respiratory diseases.", {"entities": []}], ["Sickle cell disease (SCD) is the most frequent hemoglobinopathy worldwide but remains a rare blood disorder in most western countries.", {"entities": [[47, 63, "DISEASE"], [21, 24, "GENE"]]}], ["Recommendations for standard of care have been produced in the United States, the United Kingdom and France, where this disease is relatively frequent because of earlier immigration from Africa.", {"entities": []}], ["These recommendations have changed the clinical course of SCD but can be difficult to apply in other contexts.", {"entities": [[58, 61, "GENE"]]}], ["The Italian Association of Pediatric Hematology Oncology (AIEOP) decided to develop a common national response to the rising number of SCD patients in Italy with the following objectives: 1) to create a national working group focused on pediatric SCD, and 2) to develop tailored guidelines for the management of SCD that could be accessed and practiced by those involved in the care of children with SCD in Italy.", {"entities": [[135, 138, "GENE"], [247, 250, "GENE"], [312, 315, "GENE"], [400, 403, "GENE"], [135, 138, "GENE"], [247, 250, "GENE"], [312, 315, "GENE"], [400, 403, "GENE"], [135, 138, "GENE"], [247, 250, "GENE"], [312, 315, "GENE"], [400, 403, "GENE"], [135, 138, "GENE"], [247, 250, "GENE"], [312, 315, "GENE"], [400, 403, "GENE"]]}], ["Guidelines, adapted to the Italian social context and health system, were developed by 22 pediatric hematologists representing 54 AIEOP centers across Italy.", {"entities": []}], ["The group met five times for a total of 128\u00a0hours in 22\u00a0months; documents and opinions were circulated via web.", {"entities": []}], ["Recommendations regarding the prevention and treatment of the most relevant complications of SCD in childhood adapted to the Italian context and health system were produced.", {"entities": [[93, 96, "GENE"]]}], ["For each topic, a pathway of diagnosis and care is detailed, and a selection of health management issues crucial to Italy or different from other countries is described (i.e., use of alternatives for infection prophylaxis because of the lack of oral penicillin in Italy).", {"entities": []}], ["Creating a network of physicians involved in the day-to-day care of children with SCD is feasible in a country where it remains rare.", {"entities": [[82, 85, "GENE"]]}], ["Providing hematologists, primary and secondary care physicians, and caregivers across the country with web-based guidelines for the management of SCD tailored to the Italian context is the first step in building a sustainable response to a rare but emerging childhood blood disorder and in implementing the World Health Organization\u2019s suggestion \u201cto design (and) implement \u2026 comprehensive national integrated programs for the prevention and management of SCD\".", {"entities": [[146, 149, "GENE"], [455, 458, "GENE"], [146, 149, "GENE"], [455, 458, "GENE"]]}], ["Trichophyton rubrum and Trichophyton mentagrophytes complex, or Trichophyton spp.", {"entities": []}], ["are the main etiologic agents of dermatophytosis, whose treatment is limited by the high cost of antifungal treatments, their various side effects, and the emergence of resistance amongst these species.", {"entities": [[33, 48, "DISEASE"]]}], ["This study evaluated the in vitro antidermatophytic activity of 23 crude extracts from nine plant species of semiarid vegetation ( caatinga ) found in Brazil.", {"entities": []}], ["The extracts were tested at concentrations ranging from 1.95 to 1,000.0 mg/mL by broth microdilution assay against the reference strains T. rubrum ATCC 28189 and T. mentagrophytes ATCC 11481, and 33 clinical isolates of dermatophytes.", {"entities": []}], ["All plants showed a fungicidal effect against both fungal species, with MIC/MFC values of the active extracts ranging from 15.6 to 250.0 \u00b5g/mL.", {"entities": []}], ["Selected extracts of Eugenia uniflora (AcE), Libidibia ferrea (AE), and Persea americana (AcE) also exhibited a fungicidal effect against all clinical isolates of T. rubrum and T. mentagrophytes complex.", {"entities": []}], ["This is the first report of the antifungal activity of Schinus terebinthifolius , Piptadenia colubrina , Parapiptadenia rigida , Mimosa ophthalmocentra, and Persea americana against both dermatophyte species.", {"entities": []}], ["Background : Sustained high temperatures, specifically heat waves (HW), increase the risk of dying, especially among risk populations, which are highly vulnerable to its additional effect.", {"entities": []}], ["In developing countries, there are only a few studies which focused on the magnitude of the risks attributed to HWs.", {"entities": []}], ["Objectives : This study explored the HW effects using 15 HW definitions through the combination of duration (> 2, > 4, and > 7 consecutive days) and intensity (at the \u2265 90th, \u2265 95th, \u2265 97th, \u2265 98th, and \u2265 99th temperature percentiles).", {"entities": []}], ["Methods : Daily mortality count data from 2006\u20132010 were obtained from the four tropical cities of the Philippines, and were further stratified by mortality sub-groups, such as cause of death, sex, and age.", {"entities": []}], ["The same period of daily maximum temperature and relative humidity were also collected.", {"entities": []}], ["We used a distributed lag non-linear model to determine the risks associated with the main temperature effects, as well as the added HW effects.", {"entities": []}], ["Results : It has been observed that the main temperature effects comprise a substantial portion of the risks compared to the HW effects, even across the mortality sub-groups.", {"entities": []}], ["Further stratification by the sub-groups showed significant HW effects among the young and male populations.", {"entities": []}], ["Conclusions : Results of this study can be of use to improve (1) candidate HW definition identification/selection, and (2) risk population-specific strategies, taking into consideration the risk attributions.", {"entities": []}], ["In urban Guinea-Bissau, adults with a vaccinia scar had better survival but also a higher prevalence of HIV-2 infection.", {"entities": [[38, 46, "DISEASE"]]}], ["We therefore investigated the association between vaccinia scar and survival and HIV infection in a rural area of Guinea-Bissau.", {"entities": [[50, 58, "DISEASE"]]}], ["In connection with a study of HIV in rural Guinea-Bissau, we assessed vaccinia and BCG scars in 193 HIV-1 or HIV-2 infected and 174 uninfected participants.", {"entities": [[70, 78, "DISEASE"]]}], ["Mortality was assessed after 2\u00bd\u20133 years of follow-up.", {"entities": []}], ["The analyses were adjusted for age, sex, village, and HIV status.", {"entities": []}], ["The prevalence of vaccinia scar was associated with age, village, and HIV-2 status but not with sex and schooling.", {"entities": [[18, 26, "DISEASE"]]}], ["Compared with individuals without any scar, individuals with a vaccinia scar had better survival (mortality rate ratio (MR)\u200a=\u200a0.22 (95% CI 0.08\u20130.61)), the MR being 0.19 (95% CI 0.06\u20130.57) for women and 0.40 (95% CI 0.04\u20133.74) for men.", {"entities": [[63, 71, "DISEASE"]]}], ["Estimates were similar for HIV-2 infected and HIV-1 and HIV-2 uninfected individuals.", {"entities": []}], ["The HIV-2 prevalence was higher among individuals with a vaccinia scar compared to individuals without a vaccinia scar (RR\u200a=\u200a1.57 (95% CI 1.02\u20132.36)).", {"entities": [[57, 65, "DISEASE"], [105, 113, "DISEASE"]]}], ["The present study supports the hypothesis that vaccinia vaccination may have a non-specific beneficial effect on adult survival.", {"entities": [[47, 55, "DISEASE"]]}], ["Objective \u00a0To estimate the benefits and harms of using corticosteroids as an adjunct treatment for sore throat.", {"entities": []}], ["Design \u00a0Systematic review and meta-analysis of randomised control trials.", {"entities": []}], ["Data sources \u00a0Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), trial registries up to May 2017, reference lists of eligible trials, related reviews.", {"entities": []}], ["Study selection \u00a0Randomised controlled trials of the addition of corticosteroids to standard clinical care for patients aged 5 or older in emergency department and primary care settings with clinical signs of acute tonsillitis, pharyngitis, or the clinical syndrome of sore throat.", {"entities": [[257, 265, "DISEASE"], [215, 226, "DISEASE"], [228, 239, "DISEASE"]]}], ["Trials were included irrespective of language or publication status.", {"entities": []}], ["Review methods \u00a0Reviewers identified studies, extracted data, and assessed the quality of the evidence, independently and in duplicate.", {"entities": []}], ["A parallel guideline committee ( BMJ \u00a0Rapid Recommendation) provided input on the design and interpretation of the systematic review, including the selection of outcomes important to patients.", {"entities": []}], ["Random effects model was used for meta-analyses.", {"entities": []}], ["Quality of evidence was assessed with the GRADE approach.", {"entities": []}], ["Results \u00a010 eligible trials enrolled 1426 individuals.", {"entities": []}], ["Patients who received single low dose corticosteroids (the most common intervention was oral dexamethasone with a maximum dose of 10 mg) were twice as likely to experience pain relief after 24 hours (relative risk 2.2, 95% confidence interval 1.2 to 4.3; risk difference 12.4%; moderate quality evidence) and 1.5 times more likely to have no pain at 48 hours (1.5, 1.3 to 1.8; risk difference 18.3%; high quality).", {"entities": []}], ["The mean time to onset of pain relief in patients treated with corticosteroids was 4.8 hours earlier (95% confidence interval \u22121.9 to \u22127.8; moderate quality) and the mean time to complete resolution of pain was 11.1 hours earlier (\u22120.4 to \u221221.8; low quality) than in those treated with placebo.", {"entities": []}], ["The absolute pain reduction at 24 hours (visual analogue scale 0-10) was greater in patients treated with corticosteroids (mean difference 1.3, 95% confidence interval 0.7 to 1.9; moderate quality).", {"entities": []}], ["Nine of the 10 trials sought information regarding adverse events.", {"entities": []}], ["Six studies reported no adverse effects, and three studies reported few adverse events, which were mostly complications related to disease, with a similar incidence in both groups.", {"entities": []}], ["Conclusion \u00a0Single low dose corticosteroids can provide pain relief in patients with sore throat, with no increase in serious adverse effects.", {"entities": []}], ["Included trials did not assess the potential risks of larger cumulative doses in patients with recurrent episodes of acute sore throat.", {"entities": []}], ["Systematic review registration \u00a0PROSPERO CRD42017067808.", {"entities": []}], ["The central nervous, immune, and endocrine systems communicate through multiple common messengers.", {"entities": []}], ["Over evolutionary time, what may be termed integrated defense system(s) (IDS) have developed to coordinate these communications for specific contexts; these include the stress response, acute-phase response, nonspecific immune response, immune response to antigen, kindling, tolerance, time-dependent sensitization, neurogenic switching, and traumatic dissociation (TD).", {"entities": [[73, 76, "GENE"]]}], ["These IDSs are described and their overlap is examined.", {"entities": []}], ["Three models of disease production are generated: damage, in which IDSs function incorrectly; inadequate/inappropriate, in which IDS response is outstripped by a changing context; and evolving/learning, in which the IDS learned response to a context is deemed pathologic.", {"entities": [[129, 132, "GENE"], [216, 219, "GENE"], [129, 132, "GENE"], [216, 219, "GENE"]]}], ["Mechanisms of multiple chemical sensitivity (MCS) are developed from several IDS disease models.", {"entities": [[14, 43, "DISEASE"], [77, 80, "GENE"]]}], ["Model 1A is pesticide damage to the central nervous system, overlapping with body chemical burdens, TD, and chronic zinc deficiency; model 1B is benzene disruption of interleukin-1, overlapping with childhood developmental windows and hapten-antigenic spreading; and model 1C is autoimmunity to immunoglobulin-G (IgG), overlapping with spreading to other IgG-inducers, sudden spreading of inciters, and food-contaminating chemicals.", {"entities": []}], ["Model 2A is chemical and stress overload, including comparison with the susceptibility/sensitization/triggering/spreading model; model 2B is genetic mercury allergy, overlapping with: heavy metals/zinc displacement and childhood/gestational mercury exposures; and model 3 is MCS as evolution and learning.", {"entities": []}], ["Remarks are offered on current MCS research.", {"entities": []}], ["Problems with clinical measurement are suggested on the basis of IDS models.", {"entities": [[65, 68, "GENE"]]}], ["Large-sample patient self-report epidemiology is described as an alternative or addition to clinical biomarker and animal testing.", {"entities": []}], ["In some situations, practice guidelines do not provide firm evidence-based guidance regarding COPD treatment choices, especially when large trials have failed to identify subgroups of particularly good or poor responders to available medications.", {"entities": []}], ["This observational cross-sectional study explored the yield of four types of multidimensional analyses to assess the associations between the clinical characteristics of COPD patients and pharmacological and non-pharmacological treatments prescribed by lung specialists in a real-life context.", {"entities": []}], ["Altogether, 2494 patients were recruited by 515 respiratory physicians.", {"entities": []}], ["Multiple correspondence analysis and hierarchical clustering identified 6 clinical subtypes and 6 treatment subgroups .", {"entities": []}], ["Strong bi-directional associations were found between clinical subtypes and treatment subgroups in multivariate logistic regression.", {"entities": []}], ["However, although the overall frequency of prescriptions varied from one clinical subtype to the other for all types of pharmacological treatments, clinical subtypes were not associated with specific prescription profiles.", {"entities": []}], ["When canonical analysis of redundancy was used, the proportion of variation in pharmacological treatments that was explained by clinical characteristics remained modest: 6.23%.", {"entities": []}], ["This proportion was greater (14.29%) for non-pharmacological components of care.", {"entities": []}], ["This study shows that, although pharmacological treatments of COPD are quantitatively very well related to patients\u2019 clinical characteristics, there is no particular patient profile that could be qualitatively associated to prescriptions.", {"entities": []}], ["This underlines uncertainties perceived by physicians for differentiating the respective effects of available pharmacological treatments.", {"entities": []}], ["The methodology applied here is useful to identify areas of uncertainty requiring further research and/or guideline clarification.", {"entities": []}], ["Many studies report significant associations between PM 2.5 (particulate matter <2.5 micrometers) and hospital admissions.", {"entities": []}], ["These studies mostly rely on a limited number of monitors which introduces exposure error, and excludes rural and suburban populations from locations where monitors are not available, reducing generalizability and potentially creating selection bias.", {"entities": []}], ["Using prediction models developed by our group, daily PM2.5 exposure was estimated across the Mid-Atlantic (Washington D.C., and the states of Delaware, Maryland, New Jersey, Pennsylvania, Virginia, New York and West Virginia).", {"entities": []}], ["We then investigated the short-term effects of PM 2.5 exposures on emergency hospital admissions of the elderly in the Mid-Atlantic region.We performed case-crossover analysis for each admission type, matching on day of the week, month and year and defined the hazard period as lag01 (a moving average of day of admission exposure and previous day exposure).", {"entities": []}], ["We observed associations between short-term exposure to PM 2.5 and hospitalization for all outcomes examined.", {"entities": []}], ["For example, for every 10-\u00b5g/m 2.5 there was a 2.2% increase in respiratory diseases admissions (95% CI\u200a=\u200a1.9 to 2.6), and a 0.78% increase in cardiovascular disease (CVD) admission rate (95% CI\u200a=\u200a0.5 to 1.0).", {"entities": []}], ["We found differences in risk for CVD admissions between people living in rural and urban areas.", {"entities": []}], ["For every10-\u00b5g/m 2.5 exposure in the \u2018rural\u2019 group there was a 1.0% increase (95% CI\u200a=\u200a0.6 to 1.5), while for the \u2018urban\u2019 group the increase was 0.7% (95% CI\u200a=\u200a0.4 to 1.0).", {"entities": []}], ["Our findings showed that PM 2.5 exposure was associated with hospital admissions for all respiratory, cardio vascular disease, stroke, ischemic heart disease and chronic obstructive pulmonary disease admissions.", {"entities": [[135, 157, "DISEASE"], [144, 157, "DISEASE"], [162, 199, "DISEASE"], [109, 125, "DISEASE"]]}], ["In addition, we demonstrate that our AOD (Aerosol Optical Depth) based exposure models can be successfully applied to epidemiological studies investigating the health effects of short-term exposures to PM 2.5.", {"entities": []}], ["The health status of the young people is an important indicator for future health and health care needs of the next generation.", {"entities": []}], ["In order to understand the health risk factors of Saudi youth, we analyzed data from a large national survey in the Kingdom of Saudi Arabia.", {"entities": []}], ["The Saudi Health Information Survey sample included 2382 youths aged 15 to 24\u00a0years old.", {"entities": []}], ["The questionnaire included information on socio-demographic characteristics, risk factors, risky behaviors, chronic conditions, functional status, health care utilization, and anthropometric and blood pressure measurements.", {"entities": []}], ["Only 45.9\u00a0% of men and 48.4\u00a0% of women had normal body mass index (BMI).", {"entities": []}], ["Men were more likely than women to smoke cigarettes or shisha.", {"entities": []}], ["The prevalence of daily consumption of at least five servings of fruits and vegetables was 6.6\u00a0%.", {"entities": []}], ["The prevalence of no or insufficient physical activity was 41.8\u00a0% in men and 75.6\u00a0% in women ( P\u2009< \u20090.001).", {"entities": []}], ["Around 40\u00a0% of men and 25\u00a0% of women had abnormal blood pressure.", {"entities": []}], ["Mean BMI and prevalence of insufficient physical activity, current smoking, and hypertension was higher in 20-to 24-year-olds than younger ages.", {"entities": [[80, 92, "DISEASE"]]}], ["Women were more likely to report that they never use seatbelts (82.2\u00a0% vs. 65.4\u00a0%).", {"entities": []}], ["The prevalence of modifiable risk factors and risky driving behaviors is very high among Saudi youth.", {"entities": []}], ["If these current behaviors are not reversed during this crucial age period, the burden of disease and injuries will rise in the future.", {"entities": []}], ["Our findings call for developing health prevention programs for youths in Saudi Arabia.", {"entities": []}], ["The objective of our study was to examine various existing chronic disease models, their elements and their role in the management of Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Cardiovascular diseases (CVD).", {"entities": []}], ["A literature search was performed using PubMed and CINHAL during a period of January 2003- March 2011.", {"entities": []}], ["Following key terms were used either in single or in combination such as \u201cChronic Disease Model\u201d AND \u201cDiabetes Mellitus\u201d OR \u201cCOPD\u201d OR \u2018CVD\u201d.", {"entities": []}], ["A total of 23 studies were included in the final analysis.", {"entities": []}], ["Majority of the studies were US-based.", {"entities": []}], ["Five chronic disease models included Chronic Care Model (CCM), Improving Chronic Illness Care (ICIC), and Innovative Care for Chronic Conditions (ICCC), Stanford Model (SM) and Community based Transition Model (CBTM).", {"entities": []}], ["CCM was the most studied model.", {"entities": []}], ["Elements studied included delivery system design and self-management support (87%), clinical information system and decision support (57%) and health system organization (52%).", {"entities": []}], ["Elements including center care on the patient and family (13%), patient safety (4%), community policies (4%), built integrated health care (4%) and remote patient monitoring (4%) have not been well studied.", {"entities": []}], ["Other elements including support paradigm shift, manage political environment, align sectoral policies for health, use healthcare personnel more effectively, support patients in their communities, emphasize prevention, identify patient specific concerns related to the transition process, and health literacy between visits and treatments have also not been well studied in the existing literature.", {"entities": []}], ["It was unclear to what extent the results generated is applicable to different populations and locations and therefore is an area of future research.", {"entities": []}], ["Future studies are also needed to test chronic disease models in settings where more racially and ethnically representative patients receive chronic care.", {"entities": []}], ["Future program development should also include information on other barriers including transportation issues, finances and lack of services.", {"entities": []}], ["Chronic stress, known to contribute to negative physical and mental health outcomes, is closely associated with broader issues of material hardship, poor neighborhood conditions, residential instability, and inadequate housing conditions.", {"entities": []}], ["However, few studies have comprehensively explored pathways to stress in a low-income housing environment.", {"entities": []}], ["A mixed-methods pilot study investigated the concept of energy insecurity by looking at the impacts of weatherization and energy efficiency interventions on low-income households in the South Bronx neighborhood of New York City.", {"entities": []}], ["In-depth interviews were conducted with 20 low-income heads of household; participants also completed health, housing and budget assessments.", {"entities": []}], ["Physical deficiencies, economic hardship, and health issues all interacted to directly and indirectly produce living conditions that contribute to chronic stress.", {"entities": []}], ["Households with higher stress reported more health problems.", {"entities": []}], ["Poor quality housing led to coping responses that increased expenses, which in turn increased stress around housing and energy affordability.", {"entities": []}], ["This study provides further support for the connections between both health and the built environment and between low socio-economic status populations and net negative health outcomes.", {"entities": []}], ["Energy insecurity is an important contributor to chronic stress in low-income households, and isolating pathways to stress where there is potential for interventions is important for future policy and housing-based strategies.", {"entities": []}], ["Exposure of humans to air pollutants such as ozone and particulate matter (PM) may result in airway and systemic inflammation and altered immune function.", {"entities": []}], ["One putative mechanism may be through modification of cell-surface costimulatory molecules.", {"entities": []}], ["We examined whether changes in expression of costimulatory molecules on circulating cells are associated with ambient levels of fine PM [aerodynamic diameter \u2264 2.5 \u03bcm (PM 2.5 )] in a susceptible population of diabetic individuals.", {"entities": []}], ["Twenty subjects were studied for 4 consecutive days.", {"entities": []}], ["Daily measurements of PM 2.5 and meteorologic data were acquired on the rooftop of the exam site.", {"entities": []}], ["Circulating cell-surface markers that mediate innate immune and inflammatory responses were assessed by flow cytometry on each day.", {"entities": []}], ["Sensitivity analysis was conducted on glutathione S -transferase M1 ( GSTM1 ) genotype, body mass index, and glycosylated hemoglobin A1c (HbA1c) levels to determine their role as effect modifiers.", {"entities": [[70, 75, "GENE"]]}], ["Data were analyzed using random effects models adjusting for season, weekday, and meteorology.", {"entities": []}], ["We found significantly increased monocyte expression (mean fluorescent intensity) of CD80, CD40, CD86, HLA-DR, and CD23 per 10-\u03bcg/m 2.5 at 2- to 4-day lag times after exposure.", {"entities": [[85, 89, "GENE"], [91, 95, "GENE"], [97, 101, "GENE"]]}], ["These findings were significantly higher in obese individuals, in individuals with HbA1c > 7%, and in participants who were GSTM1 null.", {"entities": [[124, 129, "GENE"]]}], ["Exposure to PM 2.5 can enhance antigen-presenting cell phenotypes on circulating cells, which may have consequences in the development of allergic or autoimmune diseases.", {"entities": []}], ["These effects are amplified in diabetic individuals with characteristics that are associated with insulin resistance or with oxidative stress.", {"entities": []}], ["Over the past decade, there has been a cohesive effort from patients, physicians, clinical and basic scientists, and the pharmaceutical industry to find definitive treatments for idiopathic pulmonary fibrosis (IPF).", {"entities": [[190, 208, "DISEASE"], [179, 208, "DISEASE"]]}], ["As understanding of disease behavior and pathogenesis has improved, the aims of those treating IPF have shifted from reversing the disease to slowing or preventing progression of this chronic fibrotic illness.", {"entities": []}], ["It is to be hoped that by slowing disease progression, survival will be improved from the current dismal median of 3.5 years following diagnosis.", {"entities": []}], ["In Europe and Asia, a milestone has recently been reached with the licensing of the first IPF-specific drug, pirfenidone.", {"entities": []}], ["This review assesses the current treatment modalities available for IPF, including pirfenidone.", {"entities": []}], ["It also turns an eye to the future and discusses the growing number of promising compounds currently in development that it is hoped, in time, will make their way into the clinic as treatments for IPF.", {"entities": []}], ["Several materials have been used for tissue engineering purposes, since the ideal matrix depends on the desired tissue.", {"entities": []}], ["Silk biomaterials have come to focus due to their great mechanical properties.", {"entities": []}], ["As untreated silkworm silk has been found to be quite immunogenic, an alternative could be spider silk.", {"entities": []}], ["Not only does it own unique mechanical properties, its biocompatibility has been shown already in vivo.", {"entities": []}], ["In our study, we used native spider dragline silk which is known as the strongest fibre in nature.", {"entities": []}], ["Steel frames were originally designed and manufactured and woven with spider silk, harvesting dragline silk directly out of the animal.", {"entities": []}], ["After sterilization, scaffolds were seeded with fibroblasts to analyse cell proliferation and adhesion.", {"entities": []}], ["Analysis of cell morphology and actin filament alignment clearly revealed adherence.", {"entities": []}], ["Proliferation was measured by cell count as well as determination of relative fluorescence each after 1, 2, 3, and 5 days.", {"entities": []}], ["Cell counts for native spider silk were also compared with those for trypsin-digested spider silk.", {"entities": []}], ["Spider silk specimens displayed less proliferation than collagen- and fibronectin-coated cover slips, enzymatic treatment reduced adhesion and proliferation rates tendentially though not significantly.", {"entities": []}], ["Nevertheless, proliferation could be proven with high significance (p<0.01).", {"entities": []}], ["Native spider silk does not require any modification to its application as a biomaterial that can rival any artificial material in terms of cell growth promoting properties.", {"entities": []}], ["We could show adhesion mechanics on intracellular level.", {"entities": []}], ["Additionally, proliferation kinetics were higher than in enzymatically digested controls, indicating that spider silk does not require modification.", {"entities": []}], ["Recent findings concerning reduction of cell proliferation after exposure could not be met.", {"entities": []}], ["As biotechnological production of the hierarchical composition of native spider silk fibres is still a challenge, our study has a pioneer role in researching cellular mechanics on native spider silk fibres.", {"entities": []}], ["To document anxiety and depression from pretreatment till 5-year follow-up in 299 men with localized prostate cancer.", {"entities": [[110, 116, "DISEASE"], [101, 116, "DISEASE"]]}], ["To assess, if baseline scores were predictive for anxiety and depression at 1-year follow-up.", {"entities": []}], ["Respondents completed four assessments (pretreatment, at 6 and 12 months, and at 5-year follow-up) on anxiety, depression and mental health.", {"entities": []}], ["Respondents were subdivided according to therapy (prostatectomy or radiotherapy) and high vs low-anxiety.", {"entities": []}], ["Pretreatment 28% of all patients were classified as \u2018high-anxiety'; their average anxiety scores decreased significantly post-treatment, that is towards less anxiety.", {"entities": []}], ["At all assessments, high-anxiety men treated by prostatectomy reported less depression than high-anxiety men treated by radiotherapy.", {"entities": []}], ["Of men treated by radiotherapy, 27% reported clinical significant levels of depression while 20% is expected in a general population.", {"entities": []}], ["The improvement in mental health at 6-months follow-up was statistically significant and clinically meaningful in all respondent groups.", {"entities": []}], ["Sensitivity of anxiety at baseline as a screening tool was 71% for anxiety and 60% for symptoms of depression.", {"entities": []}], ["We recommend clinicians to attempt early detection of patients at risk of high levels of anxiety and depression after prostate cancer diagnosis since prevalence is high.", {"entities": [[127, 133, "DISEASE"], [118, 133, "DISEASE"]]}], ["STAI-State can be a useful screening tool but needs further development.", {"entities": []}], ["Using data collected from 25,780 Hong Kong citizens in a household survey, this study aimed to investigate the association between having regular source of primary care and hospitalization amongst people with and without multimorbidity (two or more chronic conditions).", {"entities": []}], ["Potential interaction effects of regular primary care with multimorbidity were also examined.", {"entities": []}], ["Results revealed a significant association between having regular source of primary care from General Practitioners and reduced hospitalization amongst respondents with multimorbidity (RR\u2009=\u20090.772; 95% CI\u2009=\u20090.667\u20130.894), adjusting for other potential confounding factors (i.e., socio-demographic factors and medical insurance and benefits).", {"entities": []}], ["In contrast, having regular Specialist care was significantly associated with increased risk of hospitalization among both people with multimorbidity (RR\u2009=\u20091.619; 95% CI\u2009=\u20091.256\u20132.087) and without multimorbidity (RR\u2009=\u20091.981; 95% CI\u2009=\u20091.246\u20133.149), adjusting for potential confounders.", {"entities": []}], ["A dose-response relationship between the number of chronic diseases and hospitalization was also observed, regardless of whether participants had regular source of primary care or not; relative risks and predicted probabilities for hospitalization were generally greater for those without regular source of primary care.", {"entities": []}], ["Further studies are warranted to explore the role of healthcare system, informatics, organizational and practice-related factors on healthcare and functional outcomes.", {"entities": []}], ["The fruit of Stauntonia hexaphylla is commonly used as a traditional anthelmintic in Korea, Japan, and China.", {"entities": []}], ["However, its anti-inflammatory activity and the underlying mechanisms have not been studied systematically.", {"entities": []}], ["In the present study, we examined the anti-inflammatory activities of an aqueous extract of S. hexaphylla fruit (SHF) in lipopolysaccharide (LPS)-activated RAW 264.7 cells.", {"entities": [[113, 116, "GENE"]]}], ["The SHF extract contained anti-inflammatory compounds, such as neochlorogenic acid, chlorogenic acid, and cryptochlorogenic acid.", {"entities": [[4, 7, "GENE"]]}], ["The extract inhibited protein levels of inducible nitric oxide synthase and the activity of cyclooxygenase enzyme, with concomitant reductions in the production of nitric oxide and prostaglandin E 2 in LPS-activated RAW 264.7 cells.", {"entities": []}], ["Additionally, the SHF extract reduced the production of pro-inflammatory cytokines, including tumor necrosis factor-\u03b1, interleukin (IL)-1\u03b2, and IL-6.", {"entities": [[18, 21, "GENE"]]}], ["The SHF extract attenuated LPS-induced nuclear factor-\u03baB (NF-\u03baB) activation by decreasing the phosphorylation of its inhibitor, I\u03baB\u03b1.", {"entities": [[4, 7, "GENE"]]}], ["Furthermore, the SHF extract showed a significant anti-inflammatory effect in vivo by reducing the volume of carrageenan-induced paw edema in rats.", {"entities": [[17, 20, "GENE"]]}], ["Our results suggest that the SHF extract exerts potential anti-inflammatory properties against LPS-activated RAW 254.7 cells, and in an animal model of inflammation.", {"entities": [[29, 32, "GENE"]]}], ["We aimed to investigate the relationship between increased free fatty acid (FFA) level and early postoperative hypoxemia after coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB).", {"entities": []}], ["Ninety-eight consecutive patients undergoing CABG were enrolled.", {"entities": []}], ["Early postoperative hypoxemia was defined as the lowest of the ratio of arterial oxygen tension (PaO 2 ) to inspired oxygen fraction (FiO 2 )\u2009\u2264\u2009200\u00a0mm Hg within 24\u00a0h without pleural effusion and pneumothorax.", {"entities": [[195, 207, "DISEASE"]]}], ["The 26 perioperative factors, serum levels of FFA and inflammatory cytokines between the hypoxemia and non-hypoxemia groups were recorded or detected using autoanalyzer and enzyme-linked immunosorbent assay, respectively.", {"entities": []}], ["Additionally, the risk factors for early postoperative hypoxemia were evaluated using multiple logistic regression analysis.", {"entities": []}], ["The incidence rate of early postoperative hypoxemia was 37.8\u00a0%.", {"entities": []}], ["Serum FFA levels were significantly higher in the hypoxemia group than in the non-hypoxemia group ( P \u2009<\u20090.001).", {"entities": []}], ["Further, postoperative serum FFA levels were inversely related to the lowest of the ratio of PaO 2 /FiO 2 at 24\u00a0h after CABG (r\u2009=\u2009\u2212 0.367, P \u2009<\u20090.001).", {"entities": []}], ["Multiple logistic regression analysis confirmed that age, body mass index and postoperative serum FFA concentrations were independently associated with early postoperative hypoxemia.", {"entities": []}], ["Notably, patients with hypoxemia had markedly higher serum intercellular adhesion molecule-1 (ICAM-1) levels than those without ( P \u2009<\u20090.001).", {"entities": []}], ["Moreover, serum FFA levels at 2\u00a0h after CABG correlated positively with ICAM-1 concentrations (r\u2009=\u20090.492, P \u2009<\u20090.001).", {"entities": []}], ["Elevated FFA concentration is a risk factor for early postoperative hypoxemia after on-pump CABG, which may be closely associated with endothelial activation.", {"entities": []}], ["Mucous gland adenoma is an extremely rare benign tumor predominately presented in central bronchus.", {"entities": [[13, 20, "DISEASE"]]}], ["Thus far, only six cases located in the periphery have been reported in English literature.", {"entities": []}], ["Herein, we report a case located in periphery of the lung with parenchymal involvement in a 59-year-old female.", {"entities": []}], ["Histologically, the tumor appeared as peripheral lobulated and solid mass with the pushing border.", {"entities": []}], ["The tumor was composed of abundant irregular glands, mucus-filled acini and tubules lined by bland cuboidal to columnar mucus-secreting epithelial cells lacking cellular atypia and mitotic activities.", {"entities": []}], ["Moreover, the tumor contained fibromyxoid stroma with smooth muscular bundles and prominent lymph follicles, which has not been reported in previous cases.", {"entities": []}], ["Based on the morphological profile and immunohistochemical staining, the tumor was diagnosed as a mucous gland adenoma.", {"entities": [[111, 118, "DISEASE"]]}], ["The patient then underwent wedge resection in our hospital.", {"entities": []}], ["The patient was alive with no tumor recurrence or metastasis within 16\u200amonths of follow-up.", {"entities": []}], ["We report a peculiar case of mucous gland adenoma that occurred in the periphery of the lung and involved the parenchyma.", {"entities": [[42, 49, "DISEASE"]]}], ["The present case reported the smooth muscular bundles presenting in the stroma, which could broaden the histologic profile of the tumor.", {"entities": []}], ["The aim of this study was to investigate the association between systemic inflammatory mediators and peripheral muscle mass and strength in COPD patients.", {"entities": []}], ["Fifty-five patients (69% male; age: 64\u00b19 years) with mild/very severe COPD (defined as forced expiratory volume in the first second [FEV 1 ] =54%\u00b123%) were evaluated.", {"entities": [[133, 136, "GENE"]]}], ["We evaluated serum concentrations of IL-8, CRP, and TNF-\u03b1.", {"entities": [[43, 46, "GENE"]]}], ["Peripheral muscle mass was evaluated by computerized tomography (CT); midthigh cross-sectional muscle area (MTCSA) and midarm cross-sectional muscle area (MACSA) were obtained.", {"entities": []}], ["Quadriceps, triceps, and biceps strength were assessed through the determination of the one-repetition maximum.", {"entities": []}], ["The multiple regression results, adjusted for age, sex, and FEV 1 %, showed positive significant association between MTCSA and leg extension (0.35 [0.16, 0.55]; P =0.001), between MACSA and triceps pulley (0.45 [0.31, 0.58]; P =0.001), and between MACSA and biceps curl (0.34 [0.22, 0.47]; P =0.001).", {"entities": [[60, 63, "GENE"]]}], ["Plasma TNF-\u03b1 was negatively associated with leg extension (\u22123.09 [\u22125.99, \u22120.18]; P =0.04) and triceps pulley (\u22121.31 [\u22122.35, \u22120.28]; P =0.01), while plasma CRP presented negative association with biceps curl (\u22120.06 [\u22120.11, \u22120.01]; P =0.02).", {"entities": [[155, 158, "GENE"]]}], ["Our results showed negative association between peripheral muscle mass (evaluated by CT) and muscle strength and that systemic inflammation has a negative influence in the strength of specific groups of muscles in individuals with stable COPD.", {"entities": []}], ["This is the first study showing association between systemic inflammatory markers and strength in upper limb muscles.", {"entities": []}], ["Interplay among immune activation and cancer pathogenesis provides the framework for a novel subspecialty known as immunooncology.", {"entities": [[38, 44, "DISEASE"]]}], ["In the rapidly evolving field of immunooncology, understanding the tumor-specific immune response enhances understanding of cancer resistance.", {"entities": [[124, 130, "DISEASE"]]}], ["This review highlights the fundamentals of incorporating precision medicine to discover new immune biomarkers and predictive signatures.", {"entities": []}], ["Using a personalized approach may have a significant, positive impact on the use of oncolytics to better guide safer and more effective therapies.", {"entities": []}], ["RC-3095, a selective GRPR antagonist, has been shown to have anti-inflammatory properties in different models of inflammation.", {"entities": [[21, 25, "GENE"]]}], ["However, its protective effect on lungs submitted to lung ischemia-reperfusion injury has not been addressed before.", {"entities": [[58, 66, "DISEASE"]]}], ["Then, we administrated RC-3095 intravenously before and after lung reperfusion using an animal model of lung ischemia-reperfusion injury (LIRI) by clamping the pulmonary hilum.", {"entities": [[109, 117, "DISEASE"]]}], ["Twenty Wistar rats were subjected to an experimental model in four groups: SHAM, ischemia-reperfusion (IR), RC-Pre, and RC-Post.", {"entities": [[81, 89, "DISEASE"]]}], ["The final mean arterial pressure significantly decreased in IR and RC-Pre compared to their values before reperfusion ( P < 0.001).", {"entities": []}], ["The RC-Post group showed significant decrease of partial pressure of arterial oxygen at the end of the observation when compared to baseline ( P = 0.005).", {"entities": []}], ["Caspase-9 activity was significantly higher in the RC-Post as compared to the other groups ( P < 0.013).", {"entities": []}], ["No significant differences were observed in eNOS activity among the groups.", {"entities": []}], ["The groups RC-Pre and RC-Post did not show any significant decrease in IL-1 \u03b2 ( P = 0.159) and TNF- \u03b1 ( P = 0.260), as compared to IR.", {"entities": []}], ["The histological score showed no significant differences among the groups.", {"entities": []}], ["In conclusion, RC-3095 does not demonstrate a protective effect in our LIRI model.", {"entities": []}], ["Additionally, its use after reperfusion seems to potentiate cell damage, stimulating apoptosis.", {"entities": []}], ["An innovative program, the Practice Support Program (PSP), for full-service family physicians and their medical office assistants in primary care practices was recently introduced in British Columbia, Canada.", {"entities": []}], ["The PSP was jointly approved by both government and physician groups, and is a dynamic, interactive, educational and supportive program that offers peer-to-peer training to physicians and their office staff.", {"entities": []}], ["Topic areas range from clinical tools/skills to office management relevant to General Practitioner (GP) practices and \u201cdoable in real GP time\u201d.", {"entities": []}], ["PSP learning modules consist of three half-day learning sessions interspersed with 6\u20138 week action periods.", {"entities": []}], ["At the end of the third learning session, all participants were asked to complete a pen-and-paper survey that asked them to rate (a) their satisfaction with the learning module components, including the content and (b) the perceived impact the learning has had on their practices and patients.", {"entities": []}], ["A total of 887 GPs (response rates ranging from 26.0% to 60.2% across three years) and 405 MOAs (response rates from 21.3% to 49.8%) provided responses on a pen-and-paper survey administered at the last learning session of the learning module.", {"entities": []}], ["The survey asked respondents to rate (a) their satisfaction with the learning module components, including the content and (b) the perceived impact the learning has had on their practices and patients.", {"entities": []}], ["The psychometric properties (Chronbach\u2019s alphas) of the satisfaction and impact scales ranged from .82 to .94.", {"entities": []}], ["Evaluation findings from the first three years of the PSP indicated consistently high satisfaction ratings and perceived impact on GP practices and patients, regardless of physician characteristics (gender, age group) or work-related variables (e.g., time worked in family practice).", {"entities": []}], ["The Advanced Access Learning Module, which offers tools to improve office efficiencies, decreased wait times for urgent, regular and third next available appointments by an average of 1.2, 3.3, and by 3.4 days across all physicians.", {"entities": []}], ["For the Chronic Disease Management module, over 87% of all GP respondents developed a CDM patient registry and reported being able to take better care of their patients.", {"entities": []}], ["After attending the Adult Mental Health module: 94.1% of GPs agreed that they felt more comfortable helping patients who required mental health care; over 82% agreed that their skills and their confidence in diagnosing and treating mental health conditions had improved; and 41.0% agreed that their frequency of prescribing medications, if appropriate, had decreased.", {"entities": []}], ["Additionally for the Adult Mental Health module, a 3\u20136 month follow-up survey of the GPs indicated that the implemented changes were sustained over time.", {"entities": []}], ["GP and medical office assistant participant ratings show that the PSP learning modules were consistently successful in providing GPs and their staff with new learning that was relevant and could be implemented and used in \u201creal-GP-time\u201d.", {"entities": []}], ["Cancer is a major disease worldwide, and many patients use complementary and alternative treatments.", {"entities": [[0, 6, "DISEASE"]]}], ["The purpose of this study was to identify the herbal remedies and functional foods used as complementary medicine by prostate, breast and colorectal cancer patients at speciality care facilities in Trinidad.", {"entities": [[138, 155, "DISEASE"], [149, 155, "DISEASE"]]}], ["We also sought to determine how patients rated the efficacy of these modalities compared with conventional treatment.", {"entities": []}], ["A descriptive, cross-sectional survey was conducted using an interviewer-administered pilot-tested de novo questionnaire during the period June to August 2012 at two speciality treatment centres on the island.", {"entities": []}], ["Data was analysed using \u03c7 Among the 150 patients who reported use of herbal remedies/functional foods, soursop ( Annona muricata L.) was the most popular; with 80.7\u00a0% using the leaves, bark, fruit and seeds on a regular basis.", {"entities": []}], ["Other common herbal remedies/functional foods included wheatgrass ( Triticum aestivum L.), saffron ( Crocus sativus L.) and Aloe vera (L.) Burm.", {"entities": []}], ["f. The most commonly used functional foods were beetroot ( Beta vulgaris L.), carrots ( Daucus carata L.) and papaya ( Carica papaya L.) used by 43.3\u00a0% of patients; and these were mostly blended as a mixture.", {"entities": []}], ["Herbal remedies and functional foods were used on a daily basis and patients believed that this modality was equally (32.0\u00a0%) or more efficacious (14.7\u00a0%) than conventional treatment.", {"entities": []}], ["This survey identified the most common herbal remedies and functional foods used among prostate, breast and colorectal cancer patients in Trinidad.", {"entities": [[108, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["Although functional foods rarely pose a problem, herbs may interact with conventional chemotherapy and physicians need to inform patients regarding probable herb-drug interactions.", {"entities": []}], ["The online version of this article (doi:10.1186/s12906-016-1380-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Intensity and duration of physical activity are associated with the achievement of health benefits.", {"entities": []}], ["Our aim was to characterize physical activity behavior in terms of intensity, duration pattern, and adherence to the WHO physical activity recommendations in a population-based sample of adults from southern Germany.", {"entities": []}], ["Further, we investigated associations between physical activity and sex, age, and body mass index (BMI), considering also common chronic diseases.", {"entities": []}], ["We analyzed 475 subjects (47% males, mean age 58 years, range 48\u201368 years) who wore ActiGraph accelerometers for up to seven days.", {"entities": []}], ["Measured accelerations per minute obtained from the vertical axis (uniaxial) and the vector magnitude of all three axes (triaxial) were classified as sedentary, light or moderate-to-vigorous physical activity (MVPA) according to predefined acceleration count cut-offs.", {"entities": []}], ["The average minutes/day spent in each activity level per subject served as outcome.", {"entities": []}], ["Associations of sex, age, BMI, and seven chronic diseases or health limitations, with the activity levels were analyzed by negative binomial regression.", {"entities": []}], ["Most of the wear time was spent in sedentarism (median 61%/day), whereas the median time spent in MVPA was only 3%, with men achieving more MVPA than women (35 vs. 28 minutes/day, p<0.05).", {"entities": []}], ["Almost two thirds of MVPA was achieved in short bouts of less than 5 minutes, and 35% of the subjects did not achieve a single 10-minute bout.", {"entities": []}], ["Hence, only 14% adhered to the WHO recommendation of 2.5 hours of MVPA/week in at least 10-minute bouts.", {"entities": []}], ["Females, older subjects and obese subjects spent less time in MVPA (p<0.05), but no clear association with hypertension, asthma, diabetes, chronic obstructive pulmonary disease, anxiety/depression, pain or walking difficulties was observed in regression analyses with MVPA as outcome.", {"entities": [[107, 119, "DISEASE"], [139, 176, "DISEASE"], [121, 127, "DISEASE"]]}], ["Activity behavior among middle-aged German adults was highly insufficient, indicating a further need for physical activity promotion in order to gain health benefits.", {"entities": []}], ["Underdiagnosis of chronic obstructive pulmonary disease (COPD) is widespread.", {"entities": [[18, 55, "DISEASE"]]}], ["Early detection of COPD may improve the outcome by timely smoking cessation, a change in lifestyle, and treatment with an inhaled bronchodilator (BD).", {"entities": []}], ["The objective of this study was to evaluate the diagnostic role of BD reversibility testing in early COPD case finding.", {"entities": []}], ["General practitioners (n=241) consecutively recruited subjects aged \u226535 years with relevant exposure (history of smoking, and/or occupational exposure) and at least one respiratory symptom.", {"entities": []}], ["Information on age, smoking status, body mass index, dyspnea score (Medical Research Council scale), and spirometry was obtained.", {"entities": []}], ["Individuals with airway obstruction (forced expiratory volume in one second [FEV 1 ]/forced vital capacity [FVC] <0.70) underwent a BD test with an inhaled \u03b2 2 agonist, which was considered positive if \u0394FEV 1 was >0.20 L and >12%.", {"entities": [[77, 80, "GENE"]]}], ["Asthma and COPD were, respectively, defined as an FEV 1 increase >0.50 L and a post-BD FEV 1 /FVC <0.70.", {"entities": [[50, 53, "GENE"], [87, 90, "GENE"], [50, 53, "GENE"], [87, 90, "GENE"]]}], ["In total, 4,049 subjects (51% male) were included (mean age 58 years, body mass index 27, 32 pack-years of smoking).", {"entities": []}], ["A significant BD response was found in 143 (15%) of the 937 subjects (23%) with airway obstruction at screening spirometry.", {"entities": []}], ["In 59% of these subjects, the post-BD FEV 1 /FVC remained <0.70.", {"entities": [[38, 41, "GENE"]]}], ["In 24% of the subjects with pre-BD airway obstruction, the post-BD FEV 1 /FVC ratio was within the reference range.", {"entities": [[67, 70, "GENE"]]}], ["In subjects with confirmed COPD, the mean increase in FEV 1 following BD was 0.11 L\u00b10.10 L. The subjects with COPD and a significant BD response were characterized by a higher prevalence of dyspnea (72% versus 57%, P =0.02) but less cough (55% versus 75%, P =0.001) when compared with COPD subjects without BD reversibility.", {"entities": [[54, 57, "GENE"]]}], ["Administration of a BD in COPD case finding is important in order to determine the post-BD FEV 1 /FVC ratio.", {"entities": [[91, 94, "GENE"]]}], ["Exclusion of subjects with a significant BD response may result in underdiagnosis of COPD, and we question the need for the BD reversibility test in the diagnostic screening algorithm in early COPD case finding.", {"entities": []}], ["Rapid and accurate diagnosis and management can be lifesaving for patients with acute dyspnea.", {"entities": []}], ["However, making a differential diagnosis and selecting early treatment for patients with acute dyspnea in the emergency setting is a clinical challenge that requires complex decision-making in order to achieve hemodynamic balance, improve functional capacity, and decrease mortality.", {"entities": []}], ["In the present study, we examined the screening potential of rapid evaluation by lung-cardiac-inferior vena cava (LCI) integrated ultrasound for differentiating acute heart failure syndromes (AHFS) from primary pulmonary disease in patients with acute dyspnea in the emergency setting.", {"entities": []}], ["Between March 2011 and March 2012, 90 consecutive patients (45 women, 78.1\u2009\u00b1\u20099.9\u2009years) admitted to the emergency room of our hospital for acute dyspnea were enrolled.", {"entities": []}], ["Within 30\u2009minutes of admission, all patients underwent conventional physical examination, rapid ultrasound (lung-cardiac-inferior vena cava [LCI] integrated ultrasound) examination with a hand-held device, routine laboratory tests, measurement of brain natriuretic peptide, and chest X-ray in the emergency room.", {"entities": []}], ["The final diagnosis was acute dyspnea due to AHFS in 53 patients, acute dyspnea due to pulmonary disease despite a history of heart failure in 18 patients, and acute dyspnea due to pulmonary disease in 19 patients.", {"entities": []}], ["Lung ultrasound alone showed a sensitivity, specificity, negative predictive value, and positive predictive value of 96.2, 54.0, 90.9, and 75.0%, respectively, for differentiating AHFS from pulmonary disease.", {"entities": []}], ["On the other hand, LCI integrated ultrasound had a sensitivity, specificity, negative predictive value, and positive predictive value of 94.3, 91.9, 91.9, and 94.3%, respectively.", {"entities": []}], ["Our study demonstrated that rapid evaluation by LCI integrated ultrasound is extremely accurate for differentiating acute dyspnea due to AHFS from that caused by primary pulmonary disease in the emergency setting.", {"entities": []}], ["It has recently been proposed that B lymphocytes are involved in sepsis pathogenesis.", {"entities": []}], ["The goal of this study is to investigate potential abnormalities in a subset distribution and activation of circulating B lymphocytes in patients with septic shock.", {"entities": []}], ["This observational prospective study was conducted in a medical-surgical ICU.", {"entities": []}], ["All patients with septic shock were eligible for inclusion.", {"entities": []}], ["B-cell phenotypes (CD19+CD69+, CD19+CD23+, CD19+CD5+, CD19+CD80, CD19+CD86+, CD19+CD40 and CD19+CD95+) were assessed by quantitative flow cytometry upon admission to the ICU and 3, 7, 14 and 28 d later.", {"entities": []}], ["Fifty-two patients were included.", {"entities": []}], ["Thirty-six healthy volunteers matched for age and sex were used as controls.", {"entities": []}], ["The patients had lymphopenia that was maintained during 28 d of follow-up.", {"entities": [[17, 28, "DISEASE"]]}], ["In patients with septic shock who died, the percentage of CD19+CD23+ was lower during the 7 d of follow-up than it was in survival patients.", {"entities": []}], ["Moreover, the percentage of CD80+ and CD95+ expression on B cells was higher in patients who died than in survivors.", {"entities": []}], ["Receiver operating characteristic curve analysis showed that a CD19+CD23+ value of 64.6% at ICU admission enabled discrimination between survivors and nonsurvivors with a sensitivity of 90.9% and a specificity of 80.0% ( P = 0.0001).", {"entities": []}], ["Patients with septic shock who survive and those who don't have different patterns of abnormalities in circulating B lymphocytes.", {"entities": []}], ["At ICU admission, a low percentage of CD23+ and a high of CD80+ and CD95+ on B cells were associated with increased mortality of patients with septic shock.", {"entities": []}], ["Moreover, a drop in circulating B cells persisted during 28 d of ICU follow-up.", {"entities": []}], ["Computer-aided drug design has a long history of being applied to discover new molecules to treat various cancers, but it has always been focused on single targets.", {"entities": []}], ["The development of systems biology has let scientists reveal more hidden mechanisms of cancers, but attempts to apply systems biology to cancer therapies remain at preliminary stages.", {"entities": [[137, 143, "DISEASE"]]}], ["Our lab has successfully developed various systems biology models for several cancers.", {"entities": []}], ["Based on these achievements, we present the first attempt to combine multiple-target therapy with systems biology.", {"entities": []}], ["In our previous study, we identified 28 significant proteins--i.e., common core network markers--of four types of cancers as house-keeping proteins of these cancers.", {"entities": []}], ["In this study, we ranked these proteins by summing their carcinogenesis relevance values (CRVs) across the four cancers, and then performed docking and pharmacophore modeling to do virtual screening on the NCI database for anti-cancer drugs.", {"entities": [[228, 234, "DISEASE"]]}], ["We also performed pathway analysis on these proteins using Panther and MetaCore to reveal more mechanisms of these cancer house-keeping proteins.", {"entities": [[115, 121, "DISEASE"]]}], ["We designed several approaches to discover targets for multiple-target cocktail therapies.", {"entities": []}], ["In the first one, we identified the top 20 drugs for each of the 28 cancer house-keeping proteins, and analyzed the docking pose to further understand the interaction mechanisms of these drugs.", {"entities": [[68, 74, "DISEASE"]]}], ["After screening for duplicates, we found that 13 of these drugs could target 11 proteins simultaneously.", {"entities": []}], ["In the second approach, we chose the top 5 proteins with the highest summed CRVs and used them as the drug targets.", {"entities": []}], ["We built a pharmacophore and applied it to do virtual screening against the Life-Chemical library for anti-cancer drugs.", {"entities": [[107, 113, "DISEASE"]]}], ["Based on these results, wet-lab bio-scientists could freely investigate combinations of these drugs for multiple-target therapy for cancers, in contrast to the traditional single target therapy.", {"entities": []}], ["Combination of systems biology with computer-aided drug design could help us develop novel drug cocktails with multiple targets.", {"entities": []}], ["We believe this will enhance the efficiency of therapeutic practice and lead to new directions for cancer therapy.", {"entities": [[99, 105, "DISEASE"]]}], ["Flavoring a facemask with a lip balm for inhalational induction in children is a common practice.", {"entities": []}], ["However, most anesthesia providers are unaware of potential complications and the management of allergic reactions caused by lip balm.", {"entities": []}], ["We describe the occurrence of allergic reaction to lip balm\u2013flavored facemask in a child who underwent an inhalational anesthetic induction.", {"entities": []}], ["The facial rash resolved completely without complications after administration of an antihistamine and steroid.", {"entities": []}], ["Human or animals lacking either JAK3 or the common gamma chain (\u03b3c) expression display severe combined immunodeficiency disease, indicating the crucial role of JAK3 in T-cell development and the homeostasis of the immune system.", {"entities": [[87, 119, "DISEASE"], [32, 36, "GENE"], [160, 164, "GENE"], [32, 36, "GENE"], [160, 164, "GENE"]]}], ["JAK3 has also been suggested to contribute to the pathogenesis of tumorigenesis.", {"entities": [[0, 4, "GENE"]]}], ["Recent studies identified activating JAK3 mutations in patients with various hematopoietic malignancies, including acute megakaryoblastic leukemia.", {"entities": [[138, 146, "DISEASE"], [37, 41, "GENE"]]}], ["Importantly, functional analyses of some of those JAK3 mutations have been shown to cause lethal hematopoietic malignancies in animal models.", {"entities": [[50, 54, "GENE"]]}], ["These observations make JAK3 an ideal therapeutic target for the treatment of various human diseases.", {"entities": [[24, 28, "GENE"]]}], ["To identify novel small molecule inhibitors of JAK3, we performed structure-based virtual screen using the 3D structure of JAK3 kinase domain and the NCI diversity set of compounds.", {"entities": [[47, 51, "GENE"], [123, 127, "GENE"], [47, 51, "GENE"], [123, 127, "GENE"]]}], ["We identified NSC114792 as a lead compound.", {"entities": []}], ["This compound directly blocked the catalytic activity of JAK3 but not that of other JAK family members in vitro .", {"entities": [[57, 61, "GENE"]]}], ["In addition, treatment of 32D/IL-2R\u03b2 cells with the compound led to a block in IL-2-dependent activation of JAK3/STAT5 but not IL-3-dependent activation of JAK2/STAT5.", {"entities": []}], ["Consistent with the specificity of NSC114792 for JAK3, it selectively inhibited persistently-activated JAK3, but failed to affect the activity of other JAK family members and other oncogenic kinases in various cancer cell lines.", {"entities": [[210, 216, "DISEASE"], [49, 53, "GENE"], [103, 107, "GENE"], [49, 53, "GENE"], [103, 107, "GENE"]]}], ["Finally, we showed that NSC114792 decreases cell viability by inducing apoptosis through down-regulating anti-apoptotic gene expression only in cancer cells harboring persistently-active JAK3.", {"entities": [[144, 150, "DISEASE"], [187, 191, "GENE"]]}], ["NSC114792 is a lead compound that selectively inhibits JAK3 activity.", {"entities": [[55, 59, "GENE"]]}], ["Therefore, our study suggests that this small molecule inhibitor of JAK3 can be used as a starting point to develop a new class of drugs targeting JAK3 activity, and may have therapeutic potential in various diseases that are caused by aberrant JAK3 activity.", {"entities": [[68, 72, "GENE"], [147, 151, "GENE"], [245, 249, "GENE"], [68, 72, "GENE"], [147, 151, "GENE"], [245, 249, "GENE"], [68, 72, "GENE"], [147, 151, "GENE"], [245, 249, "GENE"]]}], ["Individuals of low socioeconomic status experience a disproportionate burden of chronic conditions; however it is unclear whether chronic condition burden affects survival differently across socioeconomic strata.", {"entities": []}], ["This retrospective cohort study used health administrative data from all residents of Ontario, Canada aged 65 to 105 with at least one of 16 chronic conditions on April 1, 2009 (n\u00a0=\u00a01,518,939).", {"entities": []}], ["Chronic condition burden and unadjusted mortality were compared across neighborhood income quintiles.", {"entities": []}], ["Multivariable Cox proportional hazards models were used to examine the effect of number of chronic conditions on two-year survival across income quintiles.", {"entities": []}], ["Prevalence of five or more chronic conditions was significantly higher among older adults in the poorest neighborhoods (18.2%) than the wealthiest (14.3%) (Standardized difference\u00a0>\u00a00\u00b71).", {"entities": []}], ["There was also a socioeconomic gradient in unadjusted mortality over two years: 10.1% of people in the poorest neighborhoods died compared with 7.6% of people in the wealthiest neighborhoods.", {"entities": []}], ["In adjusted analyses, having more chronic conditions was associated with a statistically significant increase in hazard of death over two years, however the magnitude of this effect was comparable across income quintiles.", {"entities": []}], ["Individuals in the poorest neighborhoods with four chronic conditions had 2.07 times higher hazard of death (95% CI: 1.97\u20132.19) than those with one chronic condition, but this was comparable to the hazard associated with four chronic conditions in the wealthiest neighborhoods (HR: 2.29, 95% CI: 2.16\u20132.43).", {"entities": [[278, 280, "GENE"]]}], ["Among older adults with universal access to health care, the deleterious effect of increasing chronic condition burden on two-year hazard of death was consistent across neighborhood income quintiles once baseline differences in condition burden were accounted for.", {"entities": []}], ["This may be partly attributable to equal access to, and utilization of, health care.", {"entities": []}], ["Alternate explanations for these findings, including study limitations, are also discussed.", {"entities": []}], ["\u2022 Older Canadians in poor neighborhoods have more chronic conditions than those in wealthy ones.", {"entities": []}], ["\u2022 Survival among older Canadians with two or more chronic conditions is comparable across wealthy and poor neighborhoods.", {"entities": []}], ["\u2022 Universal health care may flatten socioeconomic gradients in occurrence of \u2013 and survival with \u2013 chronic disease.", {"entities": []}], ["Older Canadians in poor neighborhoods have more chronic conditions than those in wealthy ones.", {"entities": []}], ["Survival among older Canadians with two or more chronic conditions is comparable across wealthy and poor neighborhoods.", {"entities": []}], ["Universal health care may flatten socioeconomic gradients in occurrence of \u2013 and survival with \u2013 chronic disease.", {"entities": []}], ["Even in a population of older adults with universal access to health care, significantly more people in low-income neighborhoods have multiple chronic conditions than those in wealthy neighborhoods.", {"entities": []}], ["But once older adults have two, three, four, or five-plus chronic conditions, their survival over two years is comparable, regardless of the neighborhood in which they live.", {"entities": []}], ["We conclude that access to universal health care does not eliminate socioeconomic disparities in the occurrence of chronic conditions; however, once older adults are diagnosed with multiple chronic conditions, universal health care may flatten socioeconomic gradients in health care utilization and survival.", {"entities": []}], ["Helicobacter pylori , a lifelong and typically asymptomatic infection of the stomach, profoundly alters gastric immune responses, and may benefit the host in protection against other pathogens.", {"entities": []}], ["We explored the hypothesis that H. pylori contributes to the control of infection with Mycobacterium tuberculosis .", {"entities": [[101, 113, "DISEASE"]]}], ["We first examined M. tuberculosis -specific IFN-\u03b3 and H. pylori antibody responses in 339 healthy Northern Californians undergoing routine tuberculin skin testing.", {"entities": [[21, 33, "DISEASE"]]}], ["Of 97 subjects (29%) meeting criteria for latent tuberculosis (TB) infection (LTBI), 45 (46%) were H. pylori seropositive.", {"entities": [[49, 61, "DISEASE"]]}], ["Subjects with LTBI who were H. pylori -seropositive had 1.5-fold higher TB antigen-induced IFN-\u03b3 responses ( p\u200a=\u200a0.04 , ANOVA), and a more Th-1 like cytokine profile in peripheral blood mononuclear cells, compared to those who were H. pylori seronegative.", {"entities": []}], ["To explore an association between H. pylori infection and clinical outcome of TB exposure, we evaluated H. pylori seroprevalence in baseline samples from two high risk TB case-contact cohorts, and from cynomolgus macaques experimentally challenged with M. tuberculosis .", {"entities": [[256, 268, "DISEASE"]]}], ["Compared to 513 household contacts who did not progress to active disease during a median 24 months follow-up, 120 prevalent TB cases were significantly less likely to be H. pylori infected (AOR: 0.55, 95% CI 0.0.36\u20130.83, p\u200a=\u200a0.005 ), though seroprevalence was not significantly different from non-progressors in 37 incident TB cases (AOR: 1.35 [95% CI 0.63\u20132.9] p\u200a=\u200a0.44 ).", {"entities": []}], ["Cynomolgus macaques with natural H. pylori infection were significantly less likely to progress to TB 6 to 8 months after M. tuberculosis challenge (RR: 0.31 [95% CI 0.12\u20130.80], p\u200a=\u200a0.04 ).", {"entities": [[125, 137, "DISEASE"]]}], ["H. pylori infection may induce bystander effects that modify the risk of active TB in humans and non-human primates.", {"entities": []}], ["That immunity to TB may be enhanced by exposure to other microbial agents may have important implications for vaccine development and disease control.", {"entities": []}], ["Identifying relatedness among diseases could help deepen understanding for the underlying pathogenic mechanisms of diseases, and facilitate drug repositioning projects.", {"entities": []}], ["A number of methods for computing disease similarity had been developed; however, none of them were designed to utilize information of the entire protein interaction network, using instead only those interactions involving disease causing genes.", {"entities": []}], ["Most of previously published methods required gene-disease association data, unfortunately, many diseases still have very few or no associated genes, which impeded broad adoption of those methods.", {"entities": []}], ["In this study, we propose a new method (MedNetSim) for computing disease similarity by integrating medical literature and protein interaction network.", {"entities": []}], ["MedNetSim consists of a network-based method (NetSim), which employs the entire protein interaction network, and a MEDLINE-based method (MedSim), which computes disease similarity by mining the biomedical literature.", {"entities": []}], ["Among function-based methods, NetSim achieved the best performance.", {"entities": []}], ["Its average AUC (area under the receiver operating characteristic curve) reached 95.2\u00a0%.", {"entities": []}], ["MedSim, whose performance was even comparable to some function-based methods, acquired the highest average AUC in all semantic-based methods.", {"entities": []}], ["Integration of MedSim and NetSim (MedNetSim) further improved the average AUC to 96.4\u00a0%.", {"entities": []}], ["We further studied the effectiveness of different data sources.", {"entities": []}], ["It was found that quality of protein interaction data was more important than its volume.", {"entities": []}], ["On the contrary, higher volume of gene-disease association data was more beneficial, even with a lower reliability.", {"entities": []}], ["Utilizing higher volume of disease-related gene data further improved the average AUC of MedNetSim and NetSim to 97.5\u00a0% and 96.7\u00a0%, respectively.", {"entities": []}], ["Integrating biomedical literature and protein interaction network can be an effective way to compute disease similarity.", {"entities": []}], ["Lacking sufficient disease-related gene data, literature-based methods such as MedSim can be a great addition to function-based algorithms.", {"entities": []}], ["It may be beneficial to steer more resources torward studying gene-disease associations and improving the quality of protein interaction data.", {"entities": []}], ["Disease similarities can be computed using the proposed methods at http:// www.digintelli.com:8000/ .", {"entities": []}], ["The online version of this article (doi:10.1186/s12859-016-1205-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Periostin, a novel matricellular protein, is recently reported to play a crucial role in tissue remodeling and is highly expressed under fibrotic conditions.", {"entities": []}], ["This study was undertaken to assess the role of periostin in scleroderma.", {"entities": [[61, 72, "DISEASE"]]}], ["Using skin from patients and healthy donors, the expression of periostin was assessed by immunohistochemistry and immunoblotting analyses.", {"entities": []}], ["Furthermore, we investigated periostin in vivo and in vitro .", {"entities": []}], ["To determine the downstream pathway involved in periostin signaling, receptor neutralizing antibody and signal transduction inhibitors were used in vitro .", {"entities": []}], ["Elevated expression of periostin was observed in the lesional skin of patients with scleroderma compared with healthy donors.", {"entities": [[84, 95, "DISEASE"]]}], ["Although WT mice showed marked cutaneous sclerosis with increased expression of periostin and increased numbers of myofibroblasts after bleomycin treatment, PN In vitro , dermal fibroblasts from PN in vitro , and this effect was inhibited by blocking the \u03b1v integrin-mediated PI3K/Akt signaling either with anti-\u03b1v functional blocking antibody or with the PI3K/Akt kinase inhibitor LY294002.", {"entities": []}], ["Periostin plays an essential role in the pathogenesis of Bleomycin-induced scleroderma in mice.", {"entities": [[75, 86, "DISEASE"]]}], ["Periostin may represent a potential therapeutic target for human scleroderma.", {"entities": [[65, 76, "DISEASE"]]}], ["Tanzania is East Africa\u2019s largest country.", {"entities": []}], ["Although it is socially diverse, it has experienced general political stability since independence in 1964.", {"entities": []}], ["Despite gradual economic development and Tanzania\u2019s status as one of the biggest recipients of aid in Africa, health status remains poor.", {"entities": []}], ["This paper explores Tanzania\u2019s science-based health innovation system, and highlights areas which can be strengthened.", {"entities": []}], ["Qualitative case study research methodology was used.", {"entities": []}], ["Data were collected through reviews of academic literature and policy documents, and through open-ended, face-to-face interviews with 52 people from across the science-based health innovation system over two visits to Tanzania from July to October 2007.", {"entities": []}], ["Tanzania has a rich but complex S&T governance landscape, with the public sector driving the innovation agenda through a series of different bodies which are not well-coordinated.", {"entities": []}], ["It has some of the leading health research on the continent at the University of Dar es Salaam, Muhimbili University of Health and Applied Sciences, the National Institute for Medical Research and the Ifakara Medical Institute, with strong donor support.", {"entities": []}], ["Tanzania has found developing an entrepreneurial culture difficult; nevertheless projects such as the clusters initiative at the University of Dar es Salaam are encouraging low-tech innovation and overcoming knowledge-sharing barriers.", {"entities": []}], ["In the private sector, one generics company has developed a South-South collaboration to enable technology transfer and hence the local production of anti-retrovirals.", {"entities": []}], ["Local textile company A to Z Textiles is now manufacturing 30 million insecticide impregnated bednets a year.", {"entities": []}], ["To have a coherent vision for innovation, Tanzania may wish to address some key issues: coordination across stakeholders involved with health research, increasing graduates in health-related disciplines, and building capabilities in biological testing, preclinical testing, formulation and standardization, and related areas important to moving from basic research to applications.", {"entities": []}], ["The private sector can be encouraged to innovate through improved access to financing, and incentives for R&D.", {"entities": []}], ["The diaspora community represents an untapped source for partnerships and access to other developing world markets and technology.", {"entities": []}], ["The government may wish to set up mechanisms to encourage south-south collaborations, and to bring the public and private sector together around specific projects to help realize the country\u2019s innovation potential.", {"entities": []}], ["Angiotensin II receptor blockers (ARBs) play a key role in hypertension therapy.", {"entities": [[59, 71, "DISEASE"]]}], ["Recently, fimasartan, the ninth ARB, was developed, but its safety and efficacy have not been well established.", {"entities": []}], ["The objective of this study was to determine whether age, sex, concomitant disease, and current antihypertensive medications affect the safety and efficacy of fimasartan in patients with arterial hypertension.", {"entities": [[196, 208, "DISEASE"]]}], ["This was a large-scale, open-label observational study to determine the safety and efficacy of fimasartan in patients with hypertension.", {"entities": [[123, 135, "DISEASE"]]}], ["Patients who were treated for more than 2\u00a0months with fimasartan (60 or 120\u00a0mg, once daily) were recruited, and the data were systematically collected using electronic case report forms.", {"entities": []}], ["Written informed consent forms were obtained from all patients.", {"entities": []}], ["A total of 14,151 patients (50.7\u00a0% males; mean age 59\u00a0\u00b1\u00a012\u00a0years) were evaluated, of whom 37.9\u00a0% were never treated with fimasartan, 53.5\u00a0% were switched to fimasartan, and 8.5\u00a0% had fimasartan added to their treatment.", {"entities": []}], ["Overall, fimasartan reduced systolic blood pressure (SBP) from 145.4\u00a0\u00b1\u00a018.1 to 126.8\u00a0\u00b1\u00a012.6\u00a0mmHg and diastolic blood pressure (DBP) from 88.7\u00a0\u00b1\u00a011.8 to 79.0\u00a0\u00b1\u00a08.7\u00a0mmHg (all p \u00a0<\u00a00.001).", {"entities": [[127, 130, "GENE"]]}], ["The pulse rate decreased from 74.4\u00a0\u00b1\u00a010.3 to 71.9\u00a0\u00b1\u00a09.2\u00a0beats/min in comparison with before treatment ( p \u00a0<\u00a00.001).", {"entities": []}], ["The reductions were similar between sexes, age groups, and patients with and without co-morbidities, and were not dependent on prior or concomitant treatment with other antihypertensive drugs.", {"entities": []}], ["Adverse events were reported in 3.31\u00a0% (treatment-emergent) and 2.35\u00a0% (drug-related) of patients; there were no dose differences for adverse events.", {"entities": []}], ["The most frequent adverse events were dizziness (1.55\u00a0%) and headache (0.52\u00a0%); other adverse events were rare.", {"entities": []}], ["The responder rate (DBP to <90\u00a0mmHg or a reduction of \u226510\u00a0mmHg) and the goal rate (combined SBP/DBP <140/90\u00a0mmHg) were 85.0 and 75.6\u00a0%, respectively.", {"entities": [[20, 23, "GENE"], [96, 99, "GENE"]]}], ["Global drug compliance was rated as excellent, very good, good, and poor in 68.1, 26.9, 3.4, and 1.7\u00a0% of patients, respectively.", {"entities": []}], ["The safety, efficacy, and compliance of fimasartan were found to be excellent in a large patient population that included patients potentially at higher risk for adverse events.", {"entities": []}], ["The online version of this article (doi:10.1007/s40256-013-0004-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["COPD is a globally significant public health problem and is the second leading cause of mortality.", {"entities": []}], ["This study presents the health burden of COPD in Nepal using the Global Burden of Disease (GBD) study 2016 dataset.", {"entities": []}], ["This study used the data from the GBD repository presenting morbidity and mortality attributed to COPD, by sex and age.", {"entities": []}], ["In GBD 2016, due to a lack of the primary source of data in Nepal, estimations on morbidity and mortality of COPD were based on its predictive covariates.", {"entities": []}], ["Years of life lost (YLLs) were calculated based on the cause of death estimations, applying GBD\u2019s Cause of Death Ensemble modeling.", {"entities": []}], ["Likewise, years lived with disability (YLDs) were calculated by multiplying the prevalence of each sequela by the disability weight.", {"entities": []}], ["Disability-adjusted life years (DALYs) were derived as the sum of YLLs and YLDs.", {"entities": []}], ["Between 1990 and 2016, the estimated age-standardized mortality rate due to COPD was decreasing for both genders, but the decline was much higher among males.", {"entities": []}], ["Unlike the high rate of incidence among males, the age-standardized DALYs were found to be high among females (2,274.9 [95% UI: 1,702.0\u20132,881.5] per 100,000).", {"entities": []}], ["YLLs contributed around 80% of DALYs due to COPD in 2016.", {"entities": []}], ["Age-standardized YLLs rate was higher among females, with a value of 1,860 (95% uncertainty interval (UI): 1,282.8\u20132,472.8) vs 1,547.6 (95% UI: 992.1\u20132,018.5) among the males per 100,000 population.", {"entities": []}], ["The prevalence and incidence of COPD remained almost stationary over the years, but still very high.", {"entities": []}], ["Though the incidence and prevalence of disease were high among males, the death rate and DALYs were more significant among females throughout the years.", {"entities": []}], ["If the current situation prevails, the burden of COPD will continue to increase in the country.", {"entities": []}], ["Hence, comprehensive social, environmental, and behavioral approaches to curtail the risk factors along with early identification, treatment, and management of COPD is of utmost importance.", {"entities": []}], ["The Norwegian Food Allergy Register was established at the Norwegian Institute of Public Health in 2000.", {"entities": [[14, 26, "DISEASE"]]}], ["The purpose of the register is to gain information about severe allergic reactions to food in Norway and to survey food products in relation to allergen labelling and contamination.", {"entities": []}], ["Cases are reported on a voluntary basis by first line doctors, and submitted together with a serum sample for specific IgE analysis.", {"entities": []}], ["The register has received a total of 877 reports from 1 July, 2000 to 31 December, 2010.", {"entities": []}], ["Two age groups, small children and young adults are over-represented, and the overall gender distribution is 40:60 males-females.", {"entities": []}], ["The legumes lupine and fenugreek have been identified as two \u201cnew\u201d allergens in processed foods and cases of contamination and faults in production of processed foods have been revealed.", {"entities": []}], ["The highest frequency of food specific IgE is to hazelnuts and peanuts, with a marked increase in reactions to hazelnuts during the last three years.", {"entities": []}], ["The Food Allergy Register has improved our knowledge about causes and severity of food allergic reactions in Norway.", {"entities": [[4, 16, "DISEASE"]]}], ["The results show the usefulness of population based national food allergy registers in providing information for health authorities and to secure safe food for individuals with food allergies.", {"entities": [[61, 73, "DISEASE"]]}], ["Studying the mechanism(s) of uterine relaxation is important and will be helpful in the prevention of obstetric difficulties such as preterm labour, which remains a major cause of perinatal mortality and morbidity.", {"entities": []}], ["Multiple signalling pathways regulate the balance between maintaining relative uterine quiescence during gestation, and the transition to the contractile state at the onset of parturition.", {"entities": []}], ["Elevation of intracellular cyclic AMP promotes myometrial relaxation, and thus quiescence, via effects on multiple intracellular targets including calcium channels, potassium channels and myosin light chain kinase.", {"entities": []}], ["A complete understanding of cAMP regulatory pathways (synthesis and hydrolysis) would assist in the development of better tocolytics to delay or inhibit preterm labour.", {"entities": []}], ["Here we review the enzymes involved in cAMP homoeostasis (adenylyl cyclases and phosphodiesterases) and possible myometrial substrates for the cAMP dependent protein kinase.", {"entities": []}], ["We must emphasise the need to identify novel pharmacological targets in human pregnant myometrium to achieve safe and selective uterine relaxation when this is indicated in preterm labour or other obstetric complications.", {"entities": []}], ["The A-DROP scoring system was originally designed to assess clinical severity of community acquired pneumonia using the following parameters: advanced Age, Dehydration, Respiratory failure, Orientation disturbance (confusion); and, low blood Pressure.", {"entities": [[100, 109, "DISEASE"]]}], ["Total A-DROP score ranges zero to five assigning one point for each component, wherein five indicates the poorest prognosis.", {"entities": []}], ["The purpose of this single-center retrospective study was to determine whether A-DROP could predict the risk for death in patients with pulmonary tuberculosis.", {"entities": [[146, 158, "DISEASE"], [136, 158, "DISEASE"]]}], ["We reviewed consecutive HIV-negative, non-multidrug-resistant smear-positive adult pulmonary tuberculosis patients.", {"entities": [[93, 105, "DISEASE"], [83, 105, "DISEASE"]]}], ["The cohort consisted of 134 men (38.8%), 211 women (61.2%), 272 who discharged alive (28.8%), and 73 who died in-hospital (21.2%) with a median age of 72 (IQR: 54\u201382) years.", {"entities": []}], ["A one-point increase in the A-DROP score was associated with a higher risk for in-hospital mortality with odds ratio of 3.8 (95% confidence interval 2.8\u20135.2, P\u2009<\u20090.001).", {"entities": []}], ["The area under receiver operating characteristics curve was 0.86.", {"entities": []}], ["The total score cutoff of 1.5 provided the best Youden Index of 0.61.", {"entities": []}], ["Using this criteria, total score >1.5, sensitivity was 85% and specificity was 76%.", {"entities": []}], ["Kaplan-Meier curve clearly indicated that in-hospital mortality increased with higher A-DROP scores (Log-rank test <0.001).", {"entities": []}], ["In conclusion, A-DROP score clearly indicate pulmonary tuberculosis in-hospital mortality.", {"entities": [[55, 67, "DISEASE"], [45, 67, "DISEASE"]]}], ["Genetic variations in toll-like receptors (TLRs) and IL-17A have been widely connected to different diseases.", {"entities": []}], ["Associations between susceptibility and resistance to different infections and single nucleotide polymorphisms (SNPs) in TLR1 to TLR4 and IL17A have been found.", {"entities": [[121, 125, "GENE"], [129, 133, "GENE"], [138, 143, "GENE"]]}], ["In this study, we aimed to develop a rapid and high throughput method to detect functional SNPs of above mentioned proteins.", {"entities": []}], ["The following most studied and clinically important SNPs: TLR1 (rs5743618), TLR2 (rs5743708), TLR3 (rs3775291), TLR4 (rs4986790) and IL17 (rs2275913) were tested.", {"entities": [[58, 62, "GENE"], [76, 80, "GENE"], [94, 98, "GENE"], [112, 116, "GENE"]]}], ["High resolution melting analysis (HRMA) based on real-time PCR combined with melting analysis of a saturating double stranded-DNA binding dye was developed and used.", {"entities": []}], ["The obtained results were compared to the \u201cstandard\u201d sequencing method.", {"entities": []}], ["A total of 113 DNA samples with known genotypes were included.", {"entities": []}], ["The HRMA method correctly identified all genotypes of these five SNPs.", {"entities": []}], ["Co-efficient values of variation of intra- and inter-run precision repeatability ranged from 0.04 to 0.23%.", {"entities": []}], ["The determined limit of qualification for testing samples was from 0.5 to 8.0 ng/\u03bcl.", {"entities": []}], ["The identical genotyping result was obtained from the same sample with these concentrations.", {"entities": []}], ["Compared to \u201cstandard\u201d sequencing methods HRMA is cost-effective, rapid and simple.", {"entities": []}], ["All the five SNPs can be analyzed separately or in combination.", {"entities": []}], ["Molecular changes involved in cell differentiation are only partially known.", {"entities": []}], ["Circulating inflammatory cells need to differentiate to perform specialized functions in target tissues.", {"entities": []}], ["Here, we hypothesized that low-density lipoprotein receptor\u2013related protein 5 (LRP5) is involved, through its participation in the canonical Wnt/\u03b2-catenin signalling, in the differentiation process of monocytic cells.", {"entities": [[79, 83, "GENE"]]}], ["To this aim, we characterized differentiation mechanisms of HL60 cells and primary human monocytes.", {"entities": []}], ["We show that silencing the LRP5 gene increased differentiation of HL60 cells and human monocytes, suggesting that LRP5 signalling abrogates differentiation.", {"entities": [[27, 31, "GENE"], [114, 118, "GENE"], [27, 31, "GENE"], [114, 118, "GENE"]]}], ["We demonstrate that the mechanisms behind this blockade include sequestration of \u03b2-catenin at the cellular membrane, inhibition of the Wnt signalling and increase of apoptosis.", {"entities": []}], ["We further demonstrate the involvement of LRP5 and the Wnt/\u03b2-catenin signalling in the process because cellular differentiation can be rescued by the addition of downstream Wnt target genes to the monocytic cells.", {"entities": [[42, 46, "GENE"]]}], ["The airway epithelium is the first place, where a defense mechanism is initiated against environmental stimuli.", {"entities": []}], ["Mucociliary transport (MCT), which is the defense mechanism of the airway and the role of airway epithelium as mechanical barriers are essential in innate immunity.", {"entities": []}], ["To maintain normal physiologic function, normal oxygenation is critical for the production of energy for optimal cellular functions.", {"entities": []}], ["Several pathologic conditions are associated with a decrease in oxygen tension in airway epithelium and chronic sinusitis is one of the airway diseases, which is associated with the hypoxic condition, a potent inflammatory stimulant.", {"entities": [[112, 121, "DISEASE"]]}], ["We have observed the overexpression of the hypoxia-inducible factor 1 (HIF-1), an essential factor for oxygen homeostasis, in the epithelium of sinus mucosa in sinusitis patients.", {"entities": [[160, 169, "DISEASE"]]}], ["In a series of previous reports, we have found hypoxia-induced mucus hyperproduction, especially by MUC5AC hyperproduction, disruption of epithelial barrier function by the production of VEGF, and down-regulation of junctional proteins such as ZO-1 and E-cadherin.", {"entities": []}], ["Furthermore, hypoxia-induced inflammation by HMGB1 translocation into the cytoplasm results in the release of IL-8 through a ROS-dependent mechanism in upper airway epithelium.", {"entities": [[45, 50, "GENE"]]}], ["In this mini-review, we briefly introduce and summarize current progress in the pathogenesis of sinusitis related to hypoxia.", {"entities": [[96, 105, "DISEASE"]]}], ["The investigation of hypoxia-related pathophysiology in airway epithelium will suggest new insights on airway inflammatory diseases, such as rhinosinusitis for clinical application and drug development.", {"entities": []}], ["Background: Little is known about the environmental and public health impact of unconventional natural gas extraction activities, including hydraulic fracturing, that occur near residential areas.", {"entities": []}], ["Objectives: Our aim was to assess the relationship between household proximity to natural gas wells and reported health symptoms.", {"entities": []}], ["Methods: We conducted a hypothesis-generating health symptom survey of 492 persons in 180 randomly selected households with ground-fed wells in an area of active natural gas drilling.", {"entities": []}], ["Gas well proximity for each household was compared with the prevalence and frequency of reported dermal, respiratory, gastrointestinal, cardiovascular, and neurological symptoms.", {"entities": []}], ["Results: The number of reported health symptoms per person was higher among residents living < 1 km (mean \u00b1 SD, 3.27 \u00b1 3.72) compared with > 2 km from the nearest gas well (mean \u00b1 SD, 1.60 \u00b1 2.14; p = 0.0002).", {"entities": []}], ["In a model that adjusted for age, sex, household education, smoking, awareness of environmental risk, work type, and animals in house, reported skin conditions were more common in households < 1 km compared with > 2 km from the nearest gas well (odds ratio = 4.1; 95% CI: 1.4, 12.3; p = 0.01).", {"entities": []}], ["Upper respiratory symptoms were also more frequently reported in persons living in households < 1 km from gas wells (39%) compared with households 1\u20132 km or > 2 km from the nearest well (31 and 18%, respectively) ( p = 0.004).", {"entities": []}], ["No equivalent correlation was found between well proximity and other reported groups of respiratory, neurological, cardiovascular, or gastrointestinal conditions.", {"entities": []}], ["Conclusion: Although these results should be viewed as hypothesis generating, and the population studied was limited to households with a ground-fed water supply, proximity of natural gas wells may be associated with the prevalence of health symptoms including dermal and respiratory conditions in residents living near natural gas extraction activities.", {"entities": []}], ["Further study of these associations, including the role of specific air and water exposures, is warranted.", {"entities": []}], ["Citation: Rabinowitz PM, Slizovskiy IB, Lamers V, Trufan SJ, Holford TR, Dziura JD, Peduzzi PN, Kane MJ, Reif JS, Weiss TR, Stowe MH.", {"entities": []}], ["Proximity to natural gas wells and reported health status: results of a household survey in Washington County, Pennsylvania.", {"entities": []}], ["Environ Health Perspect 123:21\u201326;\u2002 http://dx.doi.org/10.1289/ehp.1307732", {"entities": []}], ["Accumulating evidence shows that functional impairment in subjects with coal workers\u2019 pneumoconiosis (CWP) is principally due to emphysema and airflow obstruction, rather than underlying restrictive mechanisms.", {"entities": [[86, 100, "DISEASE"]]}], ["However, cigarette smoking has remained a major confounder.", {"entities": []}], ["The aim of this study was to assess whether coal dust exposure was associated with emphysema and/or airflow obstruction in the absence of smoking history.", {"entities": []}], ["The subjects evaluated for possible pneumoconiosis between 2013 and 2015 were retrospectively enrolled into this study.", {"entities": [[36, 50, "DISEASE"]]}], ["After excluding those with history of smoking, tuberculosis, or lung cancer, the study population was a total of 57 subjects.", {"entities": [[64, 75, "DISEASE"], [47, 59, "DISEASE"], [69, 75, "DISEASE"]]}], ["The emphysema severity and airflow obstruction were quantified by computed tomographic densitometry analysis and spirometry, respectively.", {"entities": []}], ["For comparability regarding emphysema, 9 age- and sex-matched nonsmoker (n=9) control subjects without known lung disease were randomly selected from a radiology database.", {"entities": [[109, 121, "DISEASE"]]}], ["Emphysema severity was significantly higher in the CWP group compared with the control group (15% vs. 4%, p<0.001).", {"entities": []}], ["The median percent emphysema and percentage of those with FEV1/FVC <0.7 was 13% and 37% in subjects with simple CWP and 18% and 67% in subjects with complicated CWP, respectively.", {"entities": []}], ["Percent emphysema and Perc15 (15 Our results support the observation that coal dust exposure is associated with emphysema and airflow obstruction, independent of smoking status.", {"entities": []}], ["There is much evidence to suggest that risk for common clinical disorders begins in foetal life.", {"entities": []}], ["Exposure to environmental risk factors however is often not random.", {"entities": []}], ["Many commonly used indices of prenatal adversity (e.g.", {"entities": []}], ["maternal gestational stress, gestational diabetes, smoking in pregnancy) are influenced by maternal genes and genetically influenced maternal behaviour.", {"entities": [[29, 49, "DISEASE"]]}], ["As mother provides the baby with both genes and prenatal environment, associations between prenatal risk factors and offspring disease maybe attributable to true prenatal risk effects or to the \"confounding\" effects of genetic liability that are shared by mother and offspring.", {"entities": []}], ["Cross-fostering designs, including those that involve embryo transfer have proved useful in animal studies.", {"entities": []}], ["However disentangling these effects in humans poses significant problems for traditional genetic epidemiological research designs.", {"entities": []}], ["We present a novel research strategy aimed at disentangling maternally provided pre-natal environmental and inherited genetic effects.", {"entities": []}], ["Families of children aged 5 to 9 years born by assisted reproductive technologies, specifically homologous IVF, sperm donation, egg donation, embryo donation and gestational surrogacy were contacted through fertility clinics and mailed a package of questionnaires on health and mental health related risk factors and outcomes.", {"entities": []}], ["Further data were obtained from antenatal records.", {"entities": []}], ["To date 741 families from 18 fertility clinics have participated.", {"entities": []}], ["The degree of association between maternally provided prenatal risk factor and child outcome in the group of families where the woman undergoing pregnancy and offspring are genetically related (homologous IVF, sperm donation) is compared to association in the group where offspring are genetically unrelated to the woman who undergoes the pregnancy (egg donation, embryo donation, surrogacy).", {"entities": []}], ["These comparisons can be then examined to infer the extent to which prenatal effects are genetically and environmentally mediated.", {"entities": []}], ["A study based on children born by IVF treatment and who differ in genetic relatedness to the woman undergoing the pregnancy is feasible.", {"entities": []}], ["The present report outlines a novel experimental method that permits disaggregation of maternally provided inherited genetic and post-implantation prenatal effects.", {"entities": []}], ["Guidelines support health care decision-making and high quality care and outcomes.", {"entities": []}], ["However, their implementation is sub-optimal.", {"entities": []}], ["Theory-informed, tailored implementation is associated with guideline use.", {"entities": []}], ["Few guideline implementation studies published up to 1998 employed theory.", {"entities": []}], ["This study aimed to describe if and how theory is now used to plan or evaluate guideline implementation among physicians.", {"entities": []}], ["A scoping review was conducted.", {"entities": []}], ["MEDLINE, EMBASE, and The Cochrane Library were searched from 2006 to April 2016.", {"entities": []}], ["English language studies that planned or evaluated guideline implementation targeted to physicians based on explicitly named theory were eligible.", {"entities": []}], ["Screening and data extraction were done in duplicate.", {"entities": []}], ["Study characteristics and details about theory use were analyzed.", {"entities": []}], ["A total of 1244 published reports were identified, 891 were unique, and 716 were excluded based on title and abstract.", {"entities": []}], ["Among 175 full-text articles, 89 planned or evaluated guideline implementation targeted to physicians; 42 (47.2%) were based on theory and included.", {"entities": []}], ["The number of studies using theory increased yearly and represented a wide array of countries, guideline topics and types of physicians.", {"entities": []}], ["The Theory of Planned Behavior (38.1%) and the Theoretical Domains Framework (23.8%) were used most frequently.", {"entities": []}], ["Many studies rationalized choice of theory (83.3%), most often by stating that the theory described implementation or its determinants, but most failed to explicitly link barriers with theoretical constructs.", {"entities": []}], ["The majority of studies used theory to inform surveys or interviews that identified barriers of guideline use as a preliminary step in implementation planning (76.2%).", {"entities": []}], ["All studies that evaluated interventions reported positive impact on reported physician or patient outcomes.", {"entities": []}], ["While the use of theory to design or evaluate interventions appears to be increasing over time, this review found that one half of guideline implementation studies were based on theory and many of those provided scant details about how theory was used.", {"entities": []}], ["This limits interpretation and replication of those interventions, and seems to result in multifaceted interventions, which may not be feasible outside of scientific investigation.", {"entities": []}], ["Further research is needed to better understand how to employ theory in guideline implementation planning or evaluation.", {"entities": []}], ["The online version of this article (doi:10.1186/s13012-017-0557-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Many toxic compounds found in air emissions may induce bronchoconstriction.", {"entities": []}], ["In the workplace, workers are exposed to these compounds, often in much higher concentrations.", {"entities": []}], ["Some of these compounds act as sensitizers.", {"entities": []}], ["Of these, some compounds induce asthma by producing specific IgE antibodies to the compound or its protein conjugate, while others induce asthma through yet unidentified immunologic mechanisms.", {"entities": [[32, 38, "DISEASE"], [138, 144, "DISEASE"]]}], ["Some compounds, when inhaled in high concentrations, act as irritants and produce bronchoconstriction probably by inducing acute airway inflammation.", {"entities": []}], ["The latter condition is called Reactive Airways Dysfunction Syndrome (RADS) or irritant-induced asthma.", {"entities": [[96, 102, "DISEASE"]]}], ["Occupational asthma is an excellent model to study the pathogenesis and the natural history of adult onset asthma because the responsible agent can be identified, complete avoidance is possible, and exposure can be measured or estimated.", {"entities": [[13, 19, "DISEASE"], [107, 113, "DISEASE"]]}], ["Background: Inhaling fine particles (particulate matter with diameter \u2264 2.5 \u03bcm; PM 2.5 ) can induce oxidative stress and inflammation, and may contribute to onset of preterm labor and other adverse perinatal outcomes.", {"entities": []}], ["Objectives: We examined whether outdoor PM 2.5 was associated with adverse birth outcomes among 22 countries in the World Health Organization Global Survey on Maternal and Perinatal Health from 2004 through 2008.", {"entities": []}], ["Methods: Long-term average (2001\u20132006) estimates of outdoor PM 2.5 were assigned to 50-km\u2013radius circular buffers around each health clinic where births occurred.", {"entities": []}], ["We used generalized estimating equations to determine associations between clinic-level PM 2.5 levels and preterm birth and low birth weight at the individual level, adjusting for seasonality and potential confounders at individual, clinic, and country levels.", {"entities": []}], ["Country-specific associations were also investigated.", {"entities": []}], ["Results: Across all countries, adjusting for seasonality, PM 2.5 was not associated with preterm birth, but was associated with low birth weight [odds ratio (OR) = 1.22; 95% CI: 1.07, 1.39 for fourth quartile of PM 2.5 (> 20.2 \u03bcg/m 2.5 range, preterm birth and low birth weight both were associated with the highest quartile of PM 2.5 only, which suggests a possible threshold effect (OR = 2.54; CI: 1.42, 4.55 and OR = 1.99; CI: 1.06, 3.72 for preterm birth and low birth weight, respectively, for PM 2.5 \u2265 36.5 \u03bcg/m 2.5 < 12.5 \u03bcg/m Conclusions: Outdoor PM 2.5 concentrations were associated with low birth weight but not preterm birth.", {"entities": []}], ["In rapidly developing countries, such as China, the highest levels of air pollution may be of concern for both outcomes.", {"entities": []}], ["Citation: Fleischer NL, Merialdi M, van Donkelaar A, Vadillo-Ortega F, Martin RV, Betran AP, Souza JP, O\u00b4Neill MS. 2014.", {"entities": []}], ["Outdoor air pollution, preterm birth, and low birth weight: analysis of the World Health Organization Global Survey on Maternal and Perinatal Health.", {"entities": []}], ["Environ Health Perspect 122:425\u2013430;\u2002 http://dx.doi.org/10.1289/ehp.1306837", {"entities": []}], ["Fungal spores and mycelium fragments are particles which become and remain airborne and have been subjects of aerobiological studies.", {"entities": []}], ["The presence and the abundance of taxa in aerobiological samples can be very variable and impaired by changeable climatic conditions.", {"entities": []}], ["Because many fungi produce mycotoxins and both their mycelium fragments and spores are potential allergens, monitoring the presence of these taxa is of key importance.", {"entities": []}], ["So far data on exposure and sensitization to fungal allergens are mainly based on the assessment of few, easily identifiable taxa and focused only on certain environments.", {"entities": []}], ["The microscopic method used to analyze aerobiological samples and the inconspicuous fungal characters do not allow a in depth taxonomical identification.", {"entities": []}], ["Here, we present a first assessment of fungal diversity from airborne samples using a DNA metabarcoding analysis.", {"entities": []}], ["The nuclear ITS2 region was selected as barcode to catch fungal diversity in mixed airborne samples gathered during two weeks in four sites of North-Eastern and Central Italy.", {"entities": []}], ["We assessed the taxonomic composition and diversity within and among the sampled sites and compared the molecular data with those obtained by traditional microscopy.", {"entities": []}], ["The molecular analyses provide a tenfold more comprehensive determination of the taxa than the traditional morphological inspections.", {"entities": []}], ["Our results prove that the metabarcoding analysis is a promising approach to increases quality and sensitivity of the aerobiological monitoring.", {"entities": []}], ["The laboratory and bioinformatic workflow implemented here is now suitable for routine, high-throughput, regional analyses of airborne fungi.", {"entities": []}], ["Lung cancer is characterized by a high mortality rate probably attributable to early metastasis.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"]]}], ["Oxidative stress is involved in development and progression of lung cancer, through cellular and molecular mechanisms which at least in part overlap with proinflammatory pathways.", {"entities": [[63, 74, "DISEASE"], [68, 74, "DISEASE"]]}], ["Simvastatin is a statin with pleiotropic effects that can also act as an anti-oxidant agent, and these pharmacologic properties may contribute to its potential anti-cancer activity.", {"entities": [[165, 171, "DISEASE"]]}], ["Therefore, the aim of this study was to evaluate, in the human lung adenocarcinoma cell line GLC-82, the effects of a 24-hour treatment with simvastatin on hydrogen peroxide (H 2 O 2 )-induced changes in cell viability, ERK phosphorylation, matrix metalloproteinase (MMP) expression, innate immunity signaling, NF-\u03baB activation and IL-8 secretion.", {"entities": [[68, 82, "DISEASE"], [63, 82, "DISEASE"]]}], ["Cell counting was performed after trypan blue staining, cell proliferation was assessed using MTT assay, and apoptosis was evaluated through caspase-3 activation and Tunel assay.", {"entities": []}], ["Western blotting was used to analyze protein extracts, and IL-8 release into cell culture supernatants was assessed by ELISA.", {"entities": []}], ["Our results show that simvastatin (30\u00a0\u03bcM) significantly (P <0.01) inhibited the proliferative effect of H 2 O 2 (0.5\u00a0mM) and its stimulatory actions on ERK1/2 phosphorylation, NF-\u03baB activation and IL-8 production.", {"entities": []}], ["Furthermore, simvastatin decreased H 2 O 2 -mediated induction of the cellular expression of MMP-2 and MMP-9, as well as of several components of the signaling complex activated by innate immune responses, including MyD88, TRAF2, TRAF6 and TRADD.", {"entities": [[216, 221, "GENE"], [223, 228, "GENE"], [230, 235, "GENE"], [240, 245, "GENE"]]}], ["In conclusion, these findings suggest that simvastatin could play a role in prevention and treatment of lung cancer via modulation of important proinflammatory and tumorigenic events promoted by oxidative stress.", {"entities": [[104, 115, "DISEASE"], [109, 115, "DISEASE"]]}], ["This investigation evaluated the distributions of airborne adenovirus and Mycoplasma pneumoniae in public areas in the pediatric department of Children's Hospital in northern Taiwan.", {"entities": []}], ["The airborne viral and bacterial concentrations were evaluated twice a week for a year using filter sampling with an airflow rate of 12 liters per minute for eight hours in the pediatric outpatient department and 24 hours in the pediatric emergency room.", {"entities": []}], ["Real-time polymerase chain reaction assays were conducted for analysis.", {"entities": []}], ["Approximately 18% of the air samples from the pediatric emergency room were found to contain adenovirus.", {"entities": []}], ["Approximately forty-six percent of the air samples from the pediatric outpatient department contained Mycoplasma pneumoniae DNA products.", {"entities": []}], ["High detection rates of airborne adenovirus DNA were obtained in July and August in the pediatric public areas.", {"entities": []}], ["Airborne Mycoplasma pneumoniae was detected only in July in the pediatric emergency room and the peak levels were found from August to January in the pediatric outpatient department.", {"entities": []}], ["Airborne particles that contained adenovirus and Mycoplasma pneumoniae were the most prevalent in the pediatric public areas.", {"entities": []}], ["The potential relationship between these airborne viral/bacterial particles and human infection should be examined further.", {"entities": []}], ["Keywords: adenovirus; Mycoplasma pneumoniae ; filter sampling; real-time polymerase chain reaction; hospital; pediatric public areas.", {"entities": []}], ["This article presents design issues of high-sensitive laser absorption spectroscopy systems for nitrogen oxides (NO x ) detection.", {"entities": []}], ["Examples of our systems and their investigation results are also described.", {"entities": []}], ["The constructed systems use one of the most sensitive methods, cavity enhanced absorption spectroscopy (CEAS).", {"entities": []}], ["They operate at different wavelength ranges using a blue\u2014violet laser diode (410 nm) as well as quantum cascade lasers (5.27 \u03bcm and 4.53 \u03bcm).", {"entities": []}], ["Each of them is configured as a one or two channel measurement device using, e.g., time division multiplexing and averaging.", {"entities": []}], ["During the testing procedure, the main performance features such as detection limits and measurements uncertainties have been determined.", {"entities": []}], ["The obtained results are 1 ppb NO 2 , 75 ppb NO and 45 ppb N 2 O.", {"entities": []}], ["For all systems, the uncertainty of concentration measurements does not exceed a value of 13%.", {"entities": []}], ["Some experiments with explosives are also discussed.", {"entities": []}], ["A setup equipped with a concentrator of explosives vapours was used.", {"entities": []}], ["The detection method is based either on the reaction of the sensors to the nitrogen oxides directly emitted by the explosives or on the reaction to the nitrogen oxides produced during thermal decomposition of explosive vapours.", {"entities": []}], ["For TNT, PETN, RDX and HMX a detection limit better than 1 ng has been achieved.", {"entities": [[15, 18, "GENE"]]}], ["Mycobacterium tuberculosis (MTB) remains a significant global health burden despite the availability of antimicrobial chemotherapy.", {"entities": [[14, 26, "DISEASE"]]}], ["Increasing evidence indicates a critical role of the complement system in the development of host protection against the bacillus, but few studies have specifically explored the function of the terminal complement factors.", {"entities": []}], ["Mice deficient in complement C7 and wild-type C57BL/6 mice were aerosol challenged with MTB Erdman and assessed for bacterial burden, histopathology, and lung cytokine responses at days 30 and 60 post-infection.", {"entities": [[29, 31, "GENE"]]}], ["Macrophages isolated from C7 \u2212/\u2212 and wild-type mice were evaluated for MTB proliferation and cytokine production.", {"entities": [[26, 28, "GENE"]]}], ["C7 \u2212/\u2212 mice had significantly less liver colony forming units (CFUs) at day 30; no differences were noted in lung CFUs.", {"entities": [[0, 2, "GENE"]]}], ["The C7 deficient mice had markedly reduced lung occlusion with significantly increased total lymphocytes, decreased macrophages, and increased numbers of CD4+ cells 60 days post-infection.", {"entities": [[4, 6, "GENE"]]}], ["Expression of lung IFN- \u03b3 and TNF- \u03b1 was increased at day 60 compared to wild-type mice.", {"entities": []}], ["There were no differences in MTB-proliferation in macrophages isolated from wild-type and knock-out mice.", {"entities": []}], ["These results indicate a role for complement C7 in the development of MTB induced immunopathology which warrants further investigation.", {"entities": [[45, 47, "GENE"]]}], ["Infection by the intracellular bacterial pathogen Mycobacterium tuberculosis (Mtb) is a major cause of morbidity and mortality worldwide.", {"entities": [[64, 76, "DISEASE"]]}], ["Slow progress has been made in lessening the impact of tuberculosis (TB) on human health, especially in parts of the world where Mtb is endemic.", {"entities": [[55, 67, "DISEASE"]]}], ["Due to the complexity of TB disease, there is still an urgent need to improve diagnosis, prevention, and treatment strategies to control global spread of disease.", {"entities": []}], ["Active research targeting avenues to prevent infection or transmission through vaccination, to diagnose asymptomatic carriers of Mtb, and to improve antimicrobial drug treatment responses is ongoing.", {"entities": []}], ["However, this research is hampered by a relatively poor understanding of the pathogenesis of early infection and the factors that contribute to host susceptibility, protection, and the development of active disease.", {"entities": []}], ["There is increasing interest in the development of adjunctive therapy that will aid the host in responding to Mtb infection appropriately thereby improving the effectiveness of current and future drug treatments.", {"entities": []}], ["In this review, we summarize what is known about the host response to Mtb infection in humans and animal models and highlight potential therapeutic targets involved in TB granuloma formation and resolution.", {"entities": []}], ["Strategies designed to shift the balance of TB granuloma formation toward protective rather than destructive processes are discussed based on our current knowledge.", {"entities": []}], ["These therapeutic strategies are based on the assumption that granuloma formation, although thought to prevent the spread of the tubercle bacillus within and between individuals contributes to manifestations of active TB disease in human patients when left unchecked.", {"entities": []}], ["This effect of granuloma formation favors the spread of infection and impairs antimicrobial drug treatment.", {"entities": []}], ["By gaining a better understanding of the mechanisms by which Mtb infection contributes to irreversible tissue damage, down regulates protective immune responses, and delays tissue healing, new treatment strategies can be rationally designed.", {"entities": []}], ["Granuloma-targeted therapy is advantageous because it allows for the repurpose of existing drugs used to treat other communicable and non-communicable diseases as adjunctive therapies combined with existing and future anti-TB drugs.", {"entities": []}], ["Thus, the development of adjunctive, granuloma-targeted therapy, like other host-directed therapies, may benefit from the availability of approved drugs to aid in treatment and prevention of TB.", {"entities": []}], ["In this review, we have attempted to summarize the results of published studies in the context of new innovative approaches to host-directed therapy that need to be more thoroughly explored in pre-clinical animal studies and in human clinical trials.", {"entities": []}], ["Endometriosis is one of the most common gynecological diseases.", {"entities": [[0, 13, "DISEASE"]]}], ["It is still a chameleon in many aspects and urges intense research activities in the fields of diagnosis, therapy and prevention.", {"entities": []}], ["Despite the need to foster research in this area, no in-depth analysis of the global architecture of endometriosis research exists yet.", {"entities": [[101, 114, "DISEASE"]]}], ["We here used the NewQIS platform to conduct a density equalizing mapping study, using the Web of Science as database with endometriosis related entries between 1900 and 2009.", {"entities": [[122, 135, "DISEASE"]]}], ["Density equalizing maps of global endometriosis research encompassing country-specific publication activities, and semi-qualitative indices such as country specific citations, citation rates, h-Indices were created.", {"entities": [[34, 47, "DISEASE"]]}], ["In total, 11,056 entries related to endometriosis were found.", {"entities": [[36, 49, "DISEASE"]]}], ["The USA was leading the field with 3705 publications followed by the United Kingdom (952) and Japan (846).", {"entities": []}], ["Concerning overall citations and country-specific h-Indices, the USA again was the leading nation with 74,592 citations and a modified h-Index of 103, followed by the UK with 15,175 citations (h-Index 57).", {"entities": []}], ["Regarding the citation rate, Sweden and Belgium were at top positions with rates of 22.46 and 22.26, respectively.", {"entities": []}], ["Concerning collaborative studies, there was a steep increase in numbers present; analysis of the chronological evolution indicated a strong increase in international collaborations in the past 10\u00a0years.", {"entities": []}], ["This study is the first analysis that illustrates the global endometriosis research architecture.", {"entities": [[61, 74, "DISEASE"]]}], ["It shows that endometriosis research is constantly gaining importance but also underlines the need for further efforts and investments to foster research and ultimately improve endometriosis management on a global scale.", {"entities": [[14, 27, "DISEASE"], [177, 190, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12905-016-0336-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Children make up a significant proportion of the global tuberculosis (TB) caseload, and experience considerable TB-related morbidity and mortality.", {"entities": [[56, 68, "DISEASE"]]}], ["Unfortunately, it is not easy to diagnose TB in the first years of life because of the diversity of its clinical presentation and the non-specific nature of most of its symptoms.", {"entities": []}], ["A 26-month-old male child was admitted to hospital because of the sudden onset of rapidly increasing swelling of the neck, face and upper trunk a few hours before.", {"entities": []}], ["Upon admission, his temperature was 36.5\u00b0C, pulse rate 120/min, respiratory rate 36/min, and O 2 saturation 97% in air.", {"entities": []}], ["Palpation revealed subcutaneous emphysema (SE) over the swollen skin areas, and an examination of the respiratory system revealed crepitations in the left part of the chest without any significant suggestion of mediastinal shift.", {"entities": []}], ["Chest radiography showed enlargement of the left lung hilum with pneumomediastinum and diffuse SE.", {"entities": []}], ["Bronchoscopy was carried out because of the suspicion that the SE may have been due to the inhalation of a peanut.", {"entities": []}], ["This excluded the presence of a foreign body but showed that the left main bronchus was partially obstructed with caseous material and showed significant signs of granulomatous inflammation on the wall.", {"entities": []}], ["Contrast-enhanced computed tomography of the lungs confirmed the SE and pneumomediastinum, and revealed bilateral hilum lymph node disease with infiltration of the adjacent anatomical structure and a considerable breach in the left primary bronchus wall conditioning the passage of air in the mediastinum and subcutaneous tissue.", {"entities": [[120, 138, "DISEASE"]]}], ["As a tuberculin skin test and polymerase chain reaction for Mycobacterium tuberculosis on bronchial material and gastric aspirate were positive, a diagnosis of TB was made and oral anti-TB therapy was started, which led to the elimination of M. tuberculosis and a positive clinical outcome.", {"entities": [[74, 86, "DISEASE"], [245, 257, "DISEASE"]]}], ["This is the first case in which SE was the first relevant clinical manifestation of TB and arose from infiltration of the bronchial wall secondary to caseous necrosis of the hilum lymph nodes.", {"entities": []}], ["Physicians should be aware of the fact that SE is one of the possible initial signs and symptoms of early TB infection, and act accordingly.", {"entities": []}], ["Puumala hantavirus (PUUV) causes a hemorrhagic fever with renal syndrome called nephropathia epidemica (NE).", {"entities": [[80, 102, "DISEASE"], [64, 72, "DISEASE"], [35, 72, "DISEASE"]]}], ["The aim of the present study was to evaluate plasma cell-free DNA (cf-DNA) levels and urinary cf-DNA excretion in acute NE as well as their associations with the severity of the disease.", {"entities": []}], ["Total plasma cf-DNA was quantified directly in plasma of 61 patients and urine of 20 patients with acute NE.", {"entities": []}], ["We also carried out a qualitative high-sensitivity lab-on-a-chip DNA assay in 20 patients to elucidate the appearance of cf-DNA in plasma and urine.", {"entities": []}], ["The maximum plasma cf-DNA values taken during acute NE were significantly higher than the control values taken after the hospitalization period (median 1.33 \u00b5g/ml, range 0.94\u20133.29 \u00b5g/ml vs. median 0.77 \u00b5g/ml, range 0.55\u20130.99 \u00b5g/ml, P <0.001).", {"entities": []}], ["The maximum plasma cf-DNA levels correlated positively with maximum blood leukocyte count ( r \u200a=\u200a0.388, P \u200a=\u200a0.002) and the length of hospital stay ( r \u200a=\u200a0.376, P \u200a=\u200a0.003), and inversely with minimum blood platelet count ( r \u200a=\u200a\u22120.297, P \u200a=\u200a0.020).", {"entities": []}], ["Qualitative analysis of plasma cf-DNA revealed that in most of the patients cf-DNA displayed a low-molecular weight appearance, corresponding to the size of apoptotic DNA (150\u2013200 bp).", {"entities": []}], ["The visually graded maximum cf-DNA band intensity correlated positively with the maximum quantity of total plasma cf-DNA ( r \u200a=\u200a0.513, P \u200a=\u200a0.021).", {"entities": []}], ["Maximum urinary excretion of cf-DNA in turn was not markedly increased during the acute phase of NE and did not correlate with any of the variables reflecting severity of the disease or with the maximum plasma cf-DNA level.", {"entities": []}], ["The plasma levels of cf-DNA are elevated during acute PUUV infection and correlate with the apoptotic cf-DNA-band intensity.", {"entities": []}], ["The plasma cf-DNA concentration correlates with some variables reflecting the severity of the disease.", {"entities": []}], ["The urinary excretion of cf-DNA does not reflect the degree of inflammation in the kidney.", {"entities": []}], ["The neuropeptide S (NPS) system was discovered as a novel neurotransmitter system a decade ago and has since been identified as a key player in the modulation of fear and anxiety.", {"entities": [[20, 23, "GENE"]]}], ["Genetic variations of the human NPS receptor (NPSR1) have been associated with pathologies like panic disorders.", {"entities": [[32, 35, "GENE"], [46, 51, "GENE"]]}], ["However, details on the molecular fundamentals of NPSR1 activity in neurons remained elusive.", {"entities": [[50, 55, "GENE"]]}], ["We expressed NPSR1 in primary hippocampal cultures.", {"entities": [[13, 18, "GENE"]]}], ["Using single-cell calcium imaging we found that NPSR1 stimulation induced calcium mobilization from the endoplasmic reticulum via activation of IP 3 and ryanodine receptors.", {"entities": [[48, 53, "GENE"]]}], ["Store-operated calcium channels were activated in a downstream process mediating entry of extracellular calcium.", {"entities": []}], ["We provide the first detailed analysis of NPSR1 activity and the underlying intracellular pathways with respect to calcium mobilization in neurons.", {"entities": [[42, 47, "GENE"]]}], ["Fetal and early postnatal life represent critical periods in vertebrate immune system development.", {"entities": []}], ["Disruption of such development by perinatal immunotoxic chemical exposure has been widely described in experimental animal models.", {"entities": []}], ["The resultant inhibited postnatal immune responses in such animals are often more dramatic and persistent than those after exposure during adult life.", {"entities": []}], ["Further, recent reports suggest that prenatal exposure to immunotoxicants may exacerbate postnatal aberrant immune responses (e.g., hypersensitivity disorders and autoimmune disease) in genetically predisposed rodents.", {"entities": []}], ["Limited information is available regarding the possibility of inhibited postnatal immune capacity in humans as a result of developmental immunotoxicant exposure.", {"entities": []}], ["The multifactorial nature of hypersensitivity and autoimmune responses will further complicate the elucidation of possible relationships between chemical exposure during ontogeny of the human immune system and immune-mediated disease later in life.", {"entities": []}], ["Taken together, however, the available animal data suggest the potential for altered postnatal immune function in humans exposed to immunotoxicants (e.g., environmental chemicals and therapeutic agents) during fetal and/or early postnatal life.", {"entities": []}], ["Most atopic dermatitis (AD) patients have elevated serum immunoglobulin E (IgE).", {"entities": [[5, 22, "DISEASE"], [12, 22, "DISEASE"]]}], ["Impaired folic acid (FA) metabolism was found to reduce the intracellular methyl donor pool, associated with a higher prevalence of atopy.", {"entities": []}], ["To assess serum IgE and FA in AD patients and to correlate their levels with the disease severity, and with each other.", {"entities": []}], ["Twenty patients with AD were assessed for serum FA and IgE, compared with 20 age- and sex-matched controls.", {"entities": []}], ["Patients were classified into three groups (mild, moderate, and severe AD) based on clinical severity according to Nottingham index.", {"entities": []}], ["In both patients and controls, serum IgE was measured using Enzyme-linked immunosorbent assay technique and serum FA was measured using Microparticle Enzyme Immunoassay technique.", {"entities": []}], ["Serum FA levels were lower in AD patients compared with controls, but the difference was not statistically significant.", {"entities": []}], ["FA levels did not show statistically significant difference among disease severity groups and did not correlate with serum IgE levels.", {"entities": []}], ["On the other hand, serum IgE levels were significantly elevated in AD patients compared with controls, and among AD patients, its levels were significantly elevated in severe AD compared with mild and moderate disease.", {"entities": []}], ["Serum IgE is useful in assessment of AD severity and activity.", {"entities": []}], ["FA contribution to AD needs further investigations.", {"entities": []}], ["When faced with uncertainties about the effects of medical interventions regulatory agencies, guideline developers, clinicians, and researchers commonly ask for more research, and in particular for more randomized trials.", {"entities": []}], ["The conduct of additional randomized trials is, however, sometimes not the most efficient way to reduce uncertainty.", {"entities": []}], ["Instead, approaches such as value of information analysis or other approaches should be used to prioritize research that will most likely reduce uncertainty and inform decisions.", {"entities": []}], ["In situations where additional research for specific interventions needs to be prioritized, we propose the use of quantitative benefit\u2013harm assessments that illustrate how the benefit\u2013harm balance may change as a consequence of additional research.", {"entities": []}], ["The example of roflumilast for patients with chronic obstructive pulmonary disease shows that additional research on patient preferences (e.g., how important are exacerbations relative to psychiatric harms?)", {"entities": [[45, 82, "DISEASE"]]}], ["or outcome risks (e.g., what is the incidence of psychiatric outcomes in patients with chronic obstructive pulmonary disease without treatment?)", {"entities": [[87, 124, "DISEASE"]]}], ["is sometimes more valuable than additional randomized trials.", {"entities": []}], ["We propose that quantitative benefit\u2013harm assessments have the potential to explore the impact of additional research and to identify research priorities Our approach may be seen as another type of value of information analysis and as a useful approach to stimulate specific new research that has the potential to change current estimates of the benefit\u2013harm balance and decision making.", {"entities": []}], ["The analysis describes trends in the levels and social distribution of total life expectancy and healthy life expectancy in South Australia from 1999 to 2008.", {"entities": []}], ["South Australian Burden of Disease series for the period 1999-2001 to 2006-2008 and across statistical local areas according to relative socioeconomic disadvantage were analyzed for changes in total life expectancy and healthy life expectancy by sex and area level disadvantage, with further decomposition of healthy life expectancy change by age, cause of death, and illness.", {"entities": []}], ["Total life expectancy at birth increased in South Australia for both sexes (2.0 years [2.6%] among males; 1.5 years [1.8%] among females).", {"entities": []}], ["Healthy life expectancy also increased (1.4 years [2.1%] among males; 1.2 years [1.5%] among females).", {"entities": []}], ["Total life and healthy life expectancy gains were apparent in all socioeconomic groups, with the largest increases in areas of most and least disadvantage.", {"entities": []}], ["While the least disadvantaged areas consistently had the best health outcomes, they also experienced the largest increase in the amount of life expectancy lived with disease and injury-related illness.", {"entities": []}], ["While overall gains in both total life and healthy life expectancy were apparent in South Australia, gains were greater for total life expectancy.", {"entities": []}], ["Additionally, the proportion of expected life lived with disease and injury-related illness increased as disadvantage decreased.", {"entities": []}], ["This expansion of morbidity occurred in both sexes and across all socio-economic groups.", {"entities": []}], ["This analysis outlines the continuing improvements to population health outcomes within South Australia.", {"entities": []}], ["It also highlights the challenge of reducing population morbidity so that gains to healthy life match those of total life expectancy.", {"entities": []}], ["Obesity and type 2 diabetes (T2D) lead to various life-threatening diseases such as coronary heart disease, stroke, osteoarthritis, asthma, and neurodegeneration.", {"entities": [[93, 106, "DISEASE"], [84, 106, "DISEASE"], [0, 7, "DISEASE"], [116, 130, "DISEASE"], [132, 138, "DISEASE"]]}], ["Therefore, extensive research is ongoing to identify novel pathways that can be targeted in obesity/T2D.", {"entities": [[92, 99, "DISEASE"]]}], ["Deletion of the inositol pyrophosphate (5-IP7) biosynthetic enzyme, inositol hexakisphosphate kinase-1 (IP6K1), protects mice from high fat diet (HFD) induced obesity (DIO) and insulin resistance.", {"entities": [[159, 166, "DISEASE"], [104, 109, "GENE"]]}], ["Yet, whether this pathway is a valid pharmacologic target in obesity/T2D is not known.", {"entities": [[61, 68, "DISEASE"]]}], ["Here, we demonstrate that TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine], a pan-IP6K inhibitor, has strong anti-obesity and anti-diabetic effects in DIO mice.", {"entities": [[120, 127, "DISEASE"]]}], ["Q-NMR, GTT, ITT, food intake, energy expenditure, QRT-PCR, ELISA, histology, and immunoblot studies were conducted in short (2.5-week)- and long (10-week)-term TNP treated DIO C57/BL6 WT and IP6K1-KO mice, under various diet and temperature conditions.", {"entities": []}], ["TNP, when injected at the onset of HFD-feeding, decelerates initiation of DIO and insulin resistance.", {"entities": []}], ["Moreover, TNP facilitates weight loss and restores metabolic parameters, when given to DIO mice.", {"entities": []}], ["However, TNP does not reduce weight gain in HFD-fed IP6K1-KO mice.", {"entities": []}], ["TNP specifically enhances insulin sensitivity in DIO mice via Akt activation.", {"entities": []}], ["TNP decelerates weight gain primarily by enhancing thermogenic energy expenditure in the adipose tissue.", {"entities": []}], ["Accordingly, TNP's effect on body weight is partly abolished whereas its impact on glucose homeostasis is preserved at thermoneutral temperature.", {"entities": []}], ["Pharmacologic inhibition of the inositol pyrophosphate pathway has strong therapeutic potential in obesity, T2D, and other metabolic diseases.", {"entities": [[99, 106, "DISEASE"]]}], ["\u2022 Pharmacologic inhibition of IP6K by TNP, at the onset of high fat feeding, decelerates initiation of DIO and insulin resistance in mice.", {"entities": []}], ["\u2022 TNP, when treated to DIO mice, promotes weight loss and restores metabolic homeostasis.", {"entities": []}], ["\u2022 TNP does not reduce high fat diet induced weight gain in IP6K1-KO mice.", {"entities": []}], ["\u2022 TNP promotes insulin sensitivity by stimulating Akt activity, whereas it reduces body weight primarily by enhancing thermogenic energy expenditure.", {"entities": []}], ["\u2022 Long-term TNP treatment does not display deleterious side effects.", {"entities": []}], ["Pharmacologic inhibition of IP6K by TNP, at the onset of high fat feeding, decelerates initiation of DIO and insulin resistance in mice.", {"entities": []}], ["TNP, when treated to DIO mice, promotes weight loss and restores metabolic homeostasis.", {"entities": []}], ["TNP does not reduce high fat diet induced weight gain in IP6K1-KO mice.", {"entities": []}], ["TNP promotes insulin sensitivity by stimulating Akt activity, whereas it reduces body weight primarily by enhancing thermogenic energy expenditure.", {"entities": []}], ["Long-term TNP treatment does not display deleterious side effects.", {"entities": []}], ["Asthma is a chronic life-threatening disease of worldwide importance.", {"entities": [[0, 6, "DISEASE"]]}], ["Although allergic asthma and related atopic conditions correlate strongly with immune sensitization to house dust mites, it is unclear why antigens from mites provoke such powerful allergic immune responses.", {"entities": [[9, 24, "DISEASE"], [18, 24, "DISEASE"]]}], ["We have characterized the protease activity of Der p I, the group I protease allergen of the house dust mite Dermatophagoides pteronyssinus, and here report that it cleaves the low-affinity immunoglobulin (Ig) E Fc receptor (CD23) from the surface of human B lymphocytes.", {"entities": []}], ["Der p I selectively cleaves CD23 and has no effect on the expression of any other B cell surface molecules tested.", {"entities": []}], ["We speculate that this loss of cell surface CD23 from IgE-secreting B cells may promote and enhance IgE immune responses by ablating an important feedback inhibitory mechanism that normally limits IgE synthesis.", {"entities": []}], ["Furthermore, since soluble CD23 is reported to promote IgE production, fragments of CD23 released by Der p I may directly enhance the synthesis of IgE.", {"entities": []}], ["alpha 1-Antiprotease, a pulmonary antiprotease, is also shown to inhibit the cleavage of CD23 by Der p I.", {"entities": []}], ["This may be significant in the etiopathogenesis of asthma, because other indoor pollutants associated with asthma are known to potently inhibit this antiprotease.", {"entities": [[51, 57, "DISEASE"], [107, 113, "DISEASE"]]}], ["These data suggest that the proteolytic activity of Der p I, the group I allergen of the house dust mite D. pteronyssinus, is mechanistically linked to the potent allergenicity of house dust mites.", {"entities": []}], ["Furthermore, inhibition of Der p I by alpha 1-antiprotease suggests a mechanism by which confounding factors, such as tobacco smoke, may act as a risk factor for allergic asthma.", {"entities": [[162, 177, "DISEASE"], [171, 177, "DISEASE"]]}], ["Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that have been shown to possess immunomodulatory properties in recent years.", {"entities": []}], ["Initially met with much skepticism, MSC immunomodulation has now been well reproduced across tissue sources and species to be clinically relevant.", {"entities": [[36, 39, "GENE"]]}], ["This has opened up the use of these versatile cells for application as 3rd party/allogeneic use in cell replacement/tissue regeneration, as well as for immune- and inflammation-mediated disease entities.", {"entities": []}], ["Most surprisingly, use of MSCs for in immune-/inflammation-mediated diseases appears to yield more efficacy than for regenerative medicine, since engraftment of the exogenous cell does not appear necessary.", {"entities": []}], ["In this review, we focus on this non-traditional clinical use of a tissue-specific stem cell, and highlight important findings and trends in this exciting area of stem cell therapy.", {"entities": []}], ["The world is undergoing a massive urban transition, which is now both the greatest driver of global environmental change and the most significant influence on human health.", {"entities": []}], ["Cities offer real opportunities for improving health, but managed poorly, they can also create or reinforce significant health deficits while putting severe stresses on the natural systems which support human civilization.", {"entities": []}], ["Management of urban problems is rarely straightforward, as complexity across scales and sectors, in causal structures, actors and incentives, can lead to ineffective policies and unintended consequences.", {"entities": []}], ["Systems thinking offers a promising way forward in its ability to deal with non-linear relationships and simultaneous actions and outcomes.", {"entities": []}], ["Encompassing, on the one hand, analytic frameworks and methods that can provide important causal insights and a test bed for urban policy, and on the other, broad processes of inter- and trans-disciplinary engagement to better define problems and feasible solutions, systems approaches are critical to the current and future design and management of sustainable healthy cities.", {"entities": []}], ["The evaluation of patient-reported outcomes (PROs) in health care has seen greater use in recent years, and methods to improve the reliability and validity of PRO instruments are advancing.", {"entities": []}], ["This paper discusses the cognitive interviewing procedures employed by the Patient Reported Outcomes Measurement Information System (PROMIS) pediatrics group for the purpose of developing a dynamic, electronic item bank for field testing with children and adolescents using novel computer technology.", {"entities": []}], ["The primary objective of this study was to conduct cognitive interviews with children and adolescents to gain feedback on items measuring physical functioning, emotional health, social health, fatigue, pain, and asthma-specific symptoms.", {"entities": [[212, 218, "DISEASE"]]}], ["A total of 88 cognitive interviews were conducted with 77 children and adolescents across two sites on 318 items.", {"entities": []}], ["From this initial item bank, 25 items were deleted and 35 were revised and underwent a second round of cognitive interviews.", {"entities": []}], ["A total of 293 items were retained for field testing.", {"entities": []}], ["Children as young as 8 years of age were able to comprehend the majority of items, response options, directions, recall period, and identify problems with language that was difficult for them to understand.", {"entities": []}], ["Cognitive interviews indicated issues with item comprehension on several items which led to alternative wording for these items.", {"entities": []}], ["Children ages 8\u201317 years were able to comprehend most item stems and response options in the present study.", {"entities": []}], ["Field testing with the resulting items and response options is presently being conducted as part of the PROMIS Pediatric Item Bank development process.", {"entities": []}], ["Staphylococcus aureus releases virulence factors (VF) that may impair the innate protective functions of airway cells.", {"entities": []}], ["The aim of this study was to determine whether a long-acting \u03b2 2 adrenergic receptor agonist (salmeterol hydroxynaphthoate, Sal) combined with a corticosteroid (fluticasone propionate, FP) was able to regulate ion content and cytokine expression by airway glandular cells after exposure to S. aureus supernatant.", {"entities": []}], ["A human airway glandular cell line was incubated with S. aureus supernatant for 1 h and then treated with the combination Sal/FP for 4 h. The expression of actin and CFTR proteins was analyzed by immunofluorescence.", {"entities": [[166, 170, "GENE"]]}], ["Videomicroscopy was used to evaluate chloride secretion and X-ray microanalysis to measure the intracellular ion and water content.", {"entities": []}], ["The pro-inflammatory cytokine expression was assessed by RT-PCR and ELISA.", {"entities": []}], ["When the cells were incubated with S. aureus supernatant and then with Sal/FP, the cellular localisation of CFTR was apical compared to the cytoplasmic localisation in cells incubated with S. aureus supernatant alone.", {"entities": [[108, 112, "GENE"]]}], ["The incubation of airway epithelial cells with S. aureus supernatant reduced by 66% the chloride efflux that was fully restored by Sal/FP treatment.", {"entities": []}], ["We also observed that Sal/FP treatment induced the restoration of ion (Cl and S) and water content within the intracellular secretory granules of airway glandular cells and reduced the bacterial supernatant-dependent increase of pro-inflammatory cytokines IL8 and TNF\u03b1.", {"entities": [[256, 259, "GENE"]]}], ["Our results demonstrate that treatment with the combination of a corticosteroid and a long-acting \u03b2 2 adrenergic receptor agonist after bacterial infection restores the airway glandular cell function.", {"entities": []}], ["Abnormal mucus induced by defective ion transport during pulmonary infection could benefit from treatment with a combination of \u03b2 2 adrenergic receptor agonist and glucocorticoid.", {"entities": []}], ["There are few alternatives to glucocorticosteroids for treatment of asthma.", {"entities": [[68, 74, "DISEASE"]]}], ["We assessed the activity of a novel protein drug designated ISU201, the extracellular domain of the human cell surface protein BST2, stabilised by fusion with the Fc region of IgG, in mouse models of mild chronic asthma and an acute exacerbation of asthma.", {"entities": [[213, 219, "DISEASE"], [249, 255, "DISEASE"], [127, 131, "GENE"]]}], ["The ability of ISU201 to suppress airway inflammation and remodelling was compared with that of dexamethasone.", {"entities": []}], ["Female BALB/c mice were systemically sensitised with ovalbumin, then received controlled low-level challenge with aerosolised ovalbumin for 6 weeks, which induced lesions of mild chronic asthma, and were treated with drugs during the final 2 weeks.", {"entities": [[187, 193, "DISEASE"]]}], ["Alternatively, sensitised mice received 4 weeks of chronic low-level challenge and were treated 24 and 2 hours before a final single moderate-level challenge, which triggered acute airway inflammation simulating an asthmatic exacerbation.", {"entities": []}], ["Inflammation and remodelling were quantified, as was the expression of pro-inflammatory cytokines in bronchoalveolar lavage fluid and tissues.", {"entities": []}], ["To identify cellular targets of ISU201, we assessed the effects of the drug on activated lymphocytes, macrophages and airway epithelial cells.", {"entities": []}], ["In the model of mild chronic asthma, ISU201 was as effective as dexamethasone in suppressing airway inflammation and most changes of remodelling.", {"entities": [[29, 35, "DISEASE"]]}], ["In the model of an allergen-induced acute exacerbation of chronic asthma, ISU201 was also an effective anti-inflammatory agent, although it was less active than dexamethasone.", {"entities": [[66, 72, "DISEASE"]]}], ["The drug acted on multiple cellular targets, suppressing production of pro-inflammatory cytokines by lymphocytes and macrophages.", {"entities": []}], ["ISU201 significantly reduced acetylation of histone H4 in airway epithelial cells, suggesting at least one potential mechanism of action.", {"entities": []}], ["We conclude that in these models of asthma, ISU201 is a broad-spectrum inhibitor of both airway inflammation and remodelling.", {"entities": [[36, 42, "DISEASE"]]}], ["Thus, unlike drugs which target specific mediators, it could potentially be an alternative or an adjunct to glucocorticoids for the treatment of asthma.", {"entities": [[145, 151, "DISEASE"]]}], ["To examine the association of life events and social support in the broadly defined category of depression in late life.", {"entities": []}], ["Negative life events and lack of social support are associated with depression in the elderly.", {"entities": []}], ["Currently, there are limited studies examining the association between life events, social support and late-life depression in Brazil.", {"entities": []}], ["We estimated the frequency of late-life depression within a household community sample of 367 subjects aged 60 years or greater with associated factors.", {"entities": []}], ["\u201cOld age symptomatic depression\u201d was defined using the Composite International Diagnostic Interview 1.1 tool.", {"entities": []}], ["This diagnostic category included only late-life symptoms and consisted of the diagnoses of depression and dysthymia as well as a subsyndromal definition of depression, termed \u201clate subthreshold depression\u201d.", {"entities": []}], ["Social support and life events were assessed using the Comprehensive Assessment and Referral Evaluation (SHORT-CARE) inventory.", {"entities": []}], ["\u201cOld age symptomatic depression\u201d occurred in 18.8% of the patients in the tested sample.", {"entities": []}], ["In univariate analyses, this condition was associated with female gender, lifetime anxiety disorder and living alone.", {"entities": [[83, 99, "DISEASE"]]}], ["In multivariate models, \u201cold age symptomatic depression\u201d was associated with a perceived lack of social support in men and life events in women.", {"entities": []}], ["Social support and life events were determined to be associated with late-life depression, but it is important to keep in mind the differences between genders.", {"entities": []}], ["Also, further exploration of the role of lifetime anxiety disorder in late-life depression may be of future importance.", {"entities": [[50, 66, "DISEASE"]]}], ["We believe that this study helps to provide insight into the role of psychosocial factors in late-life depression.", {"entities": []}], ["Despite its use since the 1960s, the safety or effectiveness of adrenaline as a treatment for cardiac arrest has never been comprehensively evaluated in a clinical trial.", {"entities": []}], ["Although most studies have found that adrenaline increases the chance of return of spontaneous circulation for short periods, many studies found harmful effects on the brain and raise concern that adrenaline may reduce overall survival and/or good neurological outcome.", {"entities": []}], ["The PARAMEDIC-2 trial seeks to determine if adrenaline is safe and effective in out-of-hospital cardiac arrest.", {"entities": []}], ["This is a pragmatic, individually randomised, double blind, controlled trial with a parallel economic evaluation.", {"entities": []}], ["Participants will be eligible if they are in cardiac arrest in the out-of-hospital environment and advanced life support is initiated.", {"entities": []}], ["Exclusions are cardiac arrest as a result of anaphylaxis or life threatening asthma, and patient known or appearing to be under 16 or pregnant.", {"entities": [[77, 83, "DISEASE"]]}], ["8000 participants treated by 5 UK ambulance services will be randomised between December 2014 and August 2017 to adrenaline (intervention) or placebo (control) through opening pre-randomised drug packs.", {"entities": []}], ["Clinical outcomes are survival to 30 days (primary outcome), hospital discharge, 3, 6 and 12 months, health related quality of life, and neurological and cognitive outcomes (secondary outcomes).", {"entities": []}], ["Trial registration (ISRCTN73485024).", {"entities": []}], ["The Internet provides new opportunities for parents of children with difficult illnesses and disabilities to find information and support.", {"entities": []}], ["The Internet is particularly important for caregivers of children with special needs due to numerous health-related decisions they face.", {"entities": []}], ["For at-risk populations, online support communities can become key settings and channels for health promotion and communication.", {"entities": []}], ["This study is an initial exploration of the information-seeking and information-provision processes present in an online support community, which is an area of opportunity and interest for Internet-based medical research and practice.", {"entities": []}], ["The aim of this study was to explore and describe information-related processes of uncertainty management in relationship to clubfoot.", {"entities": [[125, 133, "DISEASE"]]}], ["Specifically, the study explored interpersonal communication (information seeking and provision) in an online support community serving the needs of parents of children with clubfoot.", {"entities": [[174, 182, "DISEASE"]]}], ["The study population consisted of messages posted to an online community by caregivers (parents) of children with clubfoot.", {"entities": [[114, 122, "DISEASE"]]}], ["The theoretical framework informing the study was the Uncertainty Management Theory (UMT).", {"entities": []}], ["The study used content analysis to explore and categorize the content of 775 messages.", {"entities": []}], ["Women authored 664 of 775 messages (86%) and men authored 47 messages (6%).", {"entities": []}], ["Caregivers managed uncertainty through information seeking and provision behaviors that were dynamic and multilayered.", {"entities": []}], ["The ratio of information-seeking messages to information-provision responses was 1 to 4.", {"entities": []}], ["All five types of information-seeking behaviors proposed by Brashers\u2019 schema were identified, most of them being correlated.", {"entities": []}], ["Information seeking using direct questions was found to be positively correlated to self-disclosure ( r =.538), offering of a candidate answer ( r =.318), and passive information seeking ( r =.253).", {"entities": []}], ["Self-disclosure was found to be positively correlated to provision of a candidate answer (r=.324), second-guessing ( r =.149), and passive information seeking ( r =.366).", {"entities": []}], ["Provision of a candidate answer was found to be positively correlated with second-guessing ( r =.193) and passive information seeking ( r =.223).", {"entities": []}], ["Second-guessing was found to be positively correlated to passive information seeking ( r =.311).", {"entities": []}], ["All correlations reported above were statistically significant ( P <0.01).", {"entities": []}], ["Of the 775 messages analyzed, 255 (33%) identified a medical professional or institution by name.", {"entities": []}], ["Detailed medical information was provided in 101 (13%) messages, with the main source of information identified being personal experience rather than medical sources.", {"entities": []}], ["Online communities can be an effective channel for caregivers, especially women, to seek and offer information required for managing clubfoot-related uncertainty.", {"entities": [[133, 141, "DISEASE"]]}], ["To enhance communication with parents, health care institutions may need to invest additional resources in user-friendly online information sources and online interactions with caregivers of children with special illnesses such as clubfoot.", {"entities": [[231, 239, "DISEASE"]]}], ["Furthermore, explorations of information-seeking and information-provision behaviors in online communities can provide valuable data for interdisciplinary health research and practice.", {"entities": []}], ["Matrix stiffness strongly influences growth, differentiation and function of adherent cells", {"entities": []}], ["Age-related changes in DNA methylation occurring in blood leukocytes during early childhood may reflect epigenetic maturation.", {"entities": []}], ["We hypothesized that some of these changes involve gene networks of critical relevance in leukocyte biology and conducted a prospective study to elucidate the dynamics of DNA methylation.", {"entities": []}], ["Serial blood samples were collected at 3, 6, 12, 24, 36, 48 and 60\u00a0months after birth in ten healthy girls born in Finland and participating in the Type 1 Diabetes Prediction and Prevention Study.", {"entities": []}], ["DNA methylation was measured using the HumanMethylation450 BeadChip.", {"entities": []}], ["After filtering for the presence of polymorphisms and cell-lineage-specific signatures, 794 CpG sites showed significant DNA methylation differences as a function of age in all children (41.6% age-methylated and 58.4% age-demethylated, Bonferroni-corrected P value <0.01).", {"entities": []}], ["Age-methylated CpGs were more frequently located in gene bodies and within +5 to +50 kilobases (kb) of transcription start sites (TSS) and enriched in developmental, neuronal and plasma membrane genes.", {"entities": []}], ["Age-demethylated CpGs were associated to promoters and DNAse-I hypersensitivity sites, located within \u22125 to +5\u00a0kb of the nearest TSS and enriched in genes related to immunity, antigen presentation, the polycomb-group protein complex and cytoplasm.", {"entities": []}], ["This study reveals that susceptibility loci for complex inflammatory diseases (for example, IRF5 , NOD2 , and PTGER4 ) and genes encoding histone modifiers and chromatin remodeling factors (for example, HDAC4 , KDM2A , KDM2B , JARID2 , ARID3A , and SMARCD3 ) undergo DNA methylation changes in leukocytes during early childhood.", {"entities": [[92, 96, "GENE"], [99, 103, "GENE"], [110, 116, "GENE"], [203, 208, "GENE"], [211, 216, "GENE"], [219, 224, "GENE"], [227, 233, "GENE"], [236, 242, "GENE"], [249, 256, "GENE"]]}], ["These results open new perspectives to understand leukocyte maturation and provide a catalogue of CpG sites that may need to be corrected for age effects when performing DNA methylation studies in children.", {"entities": []}], ["The online version of this article (doi:10.1186/s13148-015-0064-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We sought to analyse the impacts found, and the methods used, in a series of assessments of programmes and portfolios of health research consisting of multiple projects.", {"entities": []}], ["We analysed a sample of 36 impact studies of multi-project research programmes, selected from a wider sample of impact studies included in two narrative systematic reviews published in 2007 and 2016.", {"entities": []}], ["We included impact studies in which the individual projects in a programme had been assessed for wider impact, especially on policy or practice, and where findings had been described in such a way that allowed them to be collated and compared.", {"entities": []}], ["Included programmes were highly diverse in terms of location (11 different countries plus two multi-country ones), number of component projects (8 to 178), nature of the programme, research field, mode of funding, time between completion and impact assessment, methods used to assess impact, and level of impact identified.", {"entities": []}], ["Thirty-one studies reported on policy impact, 17 on clinician behaviour or informing clinical practice, three on a combined category such as policy and clinician impact, and 12 on wider elements of impact (health gain, patient benefit, improved care or other benefits to the healthcare system).", {"entities": []}], ["In those multi-programme projects that assessed the respective categories, the percentage of projects that reported some impact was policy 35% (range 5\u2013100%), practice 32% (10\u201369%), combined category 64% (60\u201367%), and health gain/health services 27% (6\u201348%).", {"entities": []}], ["Variations in levels of impact achieved partly reflected differences in the types of programme, levels of collaboration with users, and methods and timing of impact assessment.", {"entities": []}], ["Most commonly, principal investigators were surveyed; some studies involved desk research and some interviews with investigators and/or stakeholders.", {"entities": []}], ["Most studies used a conceptual framework such as the Payback Framework.", {"entities": []}], ["One study attempted to assess the monetary value of a research programme\u2019s health gain.", {"entities": []}], ["The widespread impact reported for some multi-project programmes, including needs-led and collaborative ones, could potentially be used to promote further research funding.", {"entities": []}], ["Moves towards greater standardisation of assessment methods could address existing inconsistencies and better inform strategic decisions about research investment; however, unresolved issues about such moves remain.", {"entities": []}], ["The online version of this article (doi:10.1186/s12961-017-0191-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mucosal leishmaniasis (ML) is a progressive disease that affects cartilage and bone structures of the nose and other upper respiratory tract structures.", {"entities": [[8, 21, "DISEASE"]]}], ["Complications associated with ML have been described, but there is a lack of studies that evaluate the structural changes of the nose and paranasal sinuses in ML using radiological methods.", {"entities": []}], ["In this study, we aimed to assess the opacification of the paranasal sinuses in patients with treated ML and any anatomical changes in the face associated with ML using multidetector computed tomography scans (MDCT) of the sinuses.", {"entities": []}], ["We compared the findings with a control group.", {"entities": []}], ["We evaluated 54 patients with treated ML who underwent CT scans of the sinuses and compared them with a control group of 40 patients who underwent orbital CT scans.", {"entities": []}], ["The degree of sinus disease was assessed according to the Lund-Mackay criteria.", {"entities": []}], ["Forty of the 54 patients with a history of ML (74.1%) had a tomographic score compatible with chronic sinusitis (Lund-Mackay \u22654).", {"entities": [[102, 111, "DISEASE"]]}], ["CT scans in the leishmaniasis and control groups demonstrated significant differences in terms of facial structure alterations.", {"entities": [[16, 29, "DISEASE"]]}], ["Patients from the ML group showed more severe levels of partial opacification and pansinus mucosal thickening (42.6%) and a greater severity of total opacification.", {"entities": []}], ["Patients from the ML group with a Lund-Mackay score \u22654 presented longer durations of disease before treatment and more severe presentations of the disease at diagnosis.", {"entities": []}], ["CT scans of the sinuses of patients with ML presented several structural alterations, revealing a prominent destructive feature of the disease.", {"entities": []}], ["The higher prevalence in this study of chronic rhinosinusitis observed in CT scans of patients with treated ML than in those of the control group suggests that ML can be considered a risk factor for chronic rhinosinusitis in this population (p<0.05).", {"entities": []}], ["Mucosal leishmaniasis (ML) is mainly caused by the agent Leishmania (V.) brasiliensis and usually occurs months or years after symptomatic or asymptomatic skin infection.", {"entities": [[8, 21, "DISEASE"]]}], ["Approximately 5% of patients with untreated cutaneous leishmaniasis will develop ML, a presentation that causes significant morbidity in patients.", {"entities": [[54, 67, "DISEASE"], [44, 67, "DISEASE"]]}], ["This important but often neglected anthropozoonosis also presents direct health care costs and several indirect losses in terms of impaired daily functioning.", {"entities": []}], ["In this study, we aimed to assess the degree of opacification of the paranasal sinuses in patients with treated ML and any anatomical changes in the face associated with ML using multidetector computed tomography scans (MDCT) of the sinuses.", {"entities": []}], ["We compared the findings in this population with those from a control group.", {"entities": []}], ["We evaluated 54 patients with treated ML who were subjected to MDCT of the sinuses and compared them with a control group of 40 patients who underwent MDCT of the orbit.", {"entities": []}], ["CT scans of the sinus of patients with ML presented several structural alterations, revealing a prominent destructive feature of the disease.", {"entities": []}], ["The higher prevalence of chronic rhinosinusitis observed in CT scans of patients with treated ML in this study also suggests that ML can be considered a risk factor for chronic rhinosinusitis in this population.", {"entities": []}], ["Hair testing is a useful tool to investigate the prevalence of unsuspected chronic exposure to drugs of abuse in pediatric populations and it has been applied to three different cohorts of children from Barcelona, Spain along fifteen years to evaluate eventual changes in this exposure.", {"entities": []}], ["Children were recruited from three independent studies performed at Hospital del Mar (Barcelona, Spain) and approved by the local Ethics Committee.", {"entities": []}], ["Hair samples were collected from the first 187 children cohort (around 4 years of age) in 1998, from the second 90 children cohort (1.5\u20135 years of age) in 2008 and from the third 114 children cohort (5\u201314 years of age) in 2013.", {"entities": []}], ["Hair samples were analysed for the presence of opiates, cocaine, amphetamines, and cannabis by validated methodologies using gas or liquid chromatography-mass spectrometry.", {"entities": []}], ["Familiar sociodemographics and eventual consumption of drugs of abuse by parents, and caregivers were recorded.", {"entities": []}], ["Hair samples from 24.6% children in 1998 were positive for any drug of abuse (23.0% cocaine), 25.5% in 2008 (23.3% cocaine), and 28.1% in 2013 (20.1% cocaine and 11.4% cannabis).", {"entities": []}], ["In none of the cohorts, parental sociodemographics were associated with children exposure to drugs of abuse.", {"entities": []}], ["The results of the three study cohorts demonstrated a significant prevalence of unsuspected pediatric exposure to drugs of abuse which mainly involved cocaine maintained along fifteen years in Barcelona, Spain.", {"entities": []}], ["We recommend to be aware about unsuspected passive exposure to drugs of abuse in general population and to use general or selected hair screening to disclose exposure to drugs of abuse in children from risky environments to provide the basis for specific social and health interventions.", {"entities": []}], ["To identify risk factors for spontaneous preterm birth (birth <37 weeks gestation) with intact membranes (SPTB-IM) and SPTB after prelabour rupture of the membranes (SPTB-PPROM) for nulliparous pregnant women.", {"entities": [[106, 110, "GENE"], [119, 123, "GENE"], [166, 170, "GENE"]]}], ["Prospective international multicentre cohort.", {"entities": []}], ["3234 healthy nulliparous women with a singleton pregnancy, follow up was complete in 3184 of participants (98.5%).", {"entities": []}], ["Of the 3184 women, 156 (4.9%) had their pregnancy complicated by SPTB; 96 (3.0%) and 60 (1.9%) in the SPTB-IM and SPTB-PPROM categories, respectively.", {"entities": [[65, 69, "GENE"], [102, 106, "GENE"], [114, 118, "GENE"]]}], ["Independent risk factors for SPTB-IM were shorter cervical length, abnormal uterine Doppler flow, use of marijuana pre-pregnancy, lack of overall feeling of well being, being of Caucasian ethnicity, having a mother with diabetes and/or a history of preeclampsia, and a family history of low birth weight babies.", {"entities": []}], ["Independent risk factors for SPTB-PPROM were shorter cervical length, short stature, participant\u2019s not being the first born in the family, longer time to conceive, not waking up at night, hormonal fertility treatment (excluding clomiphene), mild hypertension, family history of recurrent gestational diabetes, and maternal family history of any miscarriage (risk reduction).", {"entities": [[246, 258, "DISEASE"], [288, 308, "DISEASE"]]}], ["Low BMI (<20) nearly doubled the risk for SPTB-PPROM (odds ratio 2.64; 95% CI 1.07\u20136.51).", {"entities": []}], ["The area under the receiver operating characteristics curve (AUC), after internal validation, was 0.69 for SPTB-IM and 0.79 for SPTB-PPROM.", {"entities": []}], ["The ability to predict PTB in healthy nulliparous women using clinical characteristics is modest.", {"entities": []}], ["The dissimilarity of risk factors for SPTB-IM compared with SPTB-PPROM indicates different pathophysiological pathways underlie these distinct phenotypes.", {"entities": []}], ["ACTR.org.au ACTRN12607000551493", {"entities": []}], ["Viral and bacterial respiratory tract infections in early-life are linked to the development of allergic airway inflammation and asthma.", {"entities": [[129, 135, "DISEASE"]]}], ["However, the mechanisms involved are not well understood.", {"entities": []}], ["We have previously shown that neonatal and infant, but not adult, chlamydial lung infections in mice permanently alter inflammatory phenotype and physiology to increase the severity of allergic airway disease by increasing lung interleukin (IL)-13 expression, mucus hyper-secretion and airway hyper-responsiveness.", {"entities": []}], ["This occurred through different mechanisms with infection at different ages.", {"entities": []}], ["Neonatal infection suppressed inflammatory responses but enhanced systemic dendritic cell:T-cell IL-13 release and induced permanent alterations in lung structure (i.e., increased the size of alveoli).", {"entities": []}], ["Infant infection enhanced inflammatory responses but had no effect on lung structure.", {"entities": []}], ["Here we investigated the role of hematopoietic cells in these processes using bone marrow chimera studies.", {"entities": []}], ["Neonatal (<24-hours-old), infant (3-weeks-old) and adult (6-weeks-old) mice were infected with C. muridarum .", {"entities": []}], ["Nine weeks after infection bone marrow was collected and transferred into recipient age-matched irradiated na\u00efve mice.", {"entities": []}], ["Allergic airway disease was induced (8 weeks after adoptive transfer) by sensitization and challenge with ovalbumin.", {"entities": []}], ["Reconstitution of irradiated na\u00efve mice with bone marrow from mice infected as neonates resulted in the suppression of the hallmark features of allergic airway disease including mucus hyper-secretion and airway hyper-responsiveness, which was associated with decreased IL-13 levels in the lung.", {"entities": []}], ["In stark contrast, reconstitution with bone marrow from mice infected as infants increased the severity of allergic airway disease by increasing T helper type-2 cell cytokine release (IL-5 and IL-13), mucus hyper-secretion, airway hyper-responsiveness and IL-13 levels in the lung.", {"entities": []}], ["Reconstitution with bone marrow from infected adult mice had no effects.", {"entities": []}], ["These results suggest that an infant chlamydial lung infection results in long lasting alterations in hematopoietic cells that increases the severity of allergic airway disease in later-life.", {"entities": []}], ["After stroke, pneumonia is a relevant medical complication that can be precipitated by aspiration of saliva, liquids, or solid food.", {"entities": [[14, 23, "DISEASE"]]}], ["Swallowing difficulty and aspiration occur in a significant proportion of stroke survivors.", {"entities": []}], ["Cough, an important mechanism protecting the lungs from inhaled materials, can be impaired in stroke survivors, and the likely cause for this impairment is central weakness of the respiratory musculature.", {"entities": []}], ["Thus, respiratory muscle training in acute stroke may be useful in the recovery of respiratory muscle and cough function, and may thereby reduce the risk of pneumonia.", {"entities": [[157, 166, "DISEASE"]]}], ["The present study is a pilot study, aimed at investigating the validity and feasibility of this approach by exploring effect size, safety, and patient acceptability of the intervention.", {"entities": []}], ["Adults with moderate to severe stroke impairment (National Institutes of Health Stroke Scale (NIHSS) score 5 to 25 at the time of admission) are recruited within 2\u00a0weeks of stroke onset.", {"entities": []}], ["Participants must be able to perform voluntary respiratory maneuvers.", {"entities": []}], ["Excluded are patients with increased intracranial pressure, uncontrolled hypertension, neuromuscular conditions other than stroke, medical history of asthma or chronic obstructive pulmonary disease, and recent cardiac events.", {"entities": [[73, 85, "DISEASE"], [160, 197, "DISEASE"], [150, 156, "DISEASE"]]}], ["Participants are randomized to receive inspiratory, expiratory, or sham respiratory training over a 4-week period, by using commercially available threshold resistance devices.", {"entities": []}], ["Participants and caregivers, but not study investigators, are blind to treatment allocation.", {"entities": []}], ["All participants receive medical care and stroke rehabilitation according to the usual standard of care.", {"entities": []}], ["The following assessments are conducted at baseline, 4\u00a0weeks, and 12\u00a0weeks: Voluntary and reflex cough flow measurements, forced spirometry, respiratory muscle strength tests, incidence of pneumonia, assessments of safety parameters, and self-reported activity of daily living.", {"entities": [[189, 198, "DISEASE"]]}], ["The primary outcome is peak expiratory cough flow of voluntary cough, a parameter indicating the effectiveness of cough.", {"entities": []}], ["Secondary outcomes are incidence of pneumonia, peak expiratory cough flow of reflex cough, and maximum inspiratory and expiratory mouth pressures.", {"entities": [[36, 45, "DISEASE"]]}], ["Various novel pharmacologic and nonpharmacologic approaches for preventing stroke-associated pneumonia are currently being researched.", {"entities": [[93, 102, "DISEASE"]]}], ["This study investigates a novel strategy based on an exercise intervention for cough rehabilitation.", {"entities": []}], ["Current Controlled Trials ISRCTN40298220", {"entities": []}], ["Asthma is prevalent in children and cats, and needs means of noninvasive diagnosis.", {"entities": [[0, 6, "DISEASE"]]}], ["We sought to distinguish noninvasively the differences in 53 cats before and soon after induction of allergic asthma, using NMR spectra of exhaled breath condensate (EBC).", {"entities": [[101, 116, "DISEASE"], [110, 116, "DISEASE"]]}], ["Statistical pattern recognition was improved considerably by preprocessing the spectra with probabilistic quotient normalization and glog transformation.", {"entities": []}], ["Classification of the 106 preprocessed spectra by principal component analysis and partial least squares with discriminant analysis (PLS-DA) appears to be impaired by variances unrelated to eosinophilic asthma.", {"entities": [[203, 209, "DISEASE"]]}], ["By filtering out confounding variances, orthogonal signal correction (OSC) PLS-DA greatly improved the separation of the healthy and early asthmatic states, attaining 94% specificity and 94% sensitivity in predictions.", {"entities": []}], ["OSC enhancement of multi-level PLS-DA boosted the specificity of the prediction to 100%.", {"entities": []}], ["OSC-PLS-DA of the normalized spectra suggest the most promising biomarkers of allergic asthma in cats to include increased acetone, metabolite(s) with overlapped NMR peaks near 5.8 ppm, and a hydroxyphenyl-containing metabolite, as well as decreased phthalate.", {"entities": [[78, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["Acetone is elevated in the EBC of 74% of the cats with early asthma.", {"entities": [[61, 67, "DISEASE"]]}], ["The noninvasive detection of early experimental asthma, biomarkers in EBC, and metabolic perturbation invite further investigation of the diagnostic potential in humans.", {"entities": [[48, 54, "DISEASE"]]}], ["Objective To investigate the association between genus \u03b2 human papillomaviruses and the incidence of non-melanocytic skin cancer in the general population.", {"entities": [[117, 128, "DISEASE"], [122, 128, "DISEASE"]]}], ["Design Population based case-control study.", {"entities": []}], ["Setting New Hampshire, USA.", {"entities": []}], ["Participants 2366 skin cancer cases and controls from the general population aged 25 to 74 years (663 squamous cell carcinoma, 898 basal cell carcinoma, 805 controls), with plasma samples tested for L1 antibodies to 16 genus \u03b2 human papillomaviruses by multiplex serology.", {"entities": [[116, 125, "DISEASE"], [142, 151, "DISEASE"], [131, 151, "DISEASE"], [18, 29, "DISEASE"], [102, 125, "DISEASE"], [23, 29, "DISEASE"]]}], ["Main outcome measures Odds ratios for squamous cell carcinoma and basal cell carcinoma associated with seropositivity to \u03b2 human papillomaviruses.", {"entities": [[52, 61, "DISEASE"], [77, 86, "DISEASE"], [66, 86, "DISEASE"], [38, 61, "DISEASE"]]}], ["Results Squamous cell carcinoma, but not basal cell carcinoma, cases had a higher prevalence of each of the individual \u03b2 human papillomaviruses assayed compared with controls.", {"entities": [[22, 31, "DISEASE"], [52, 61, "DISEASE"], [41, 61, "DISEASE"], [8, 31, "DISEASE"]]}], ["The odds ratios for squamous cell carcinoma increased with the number of \u03b2 types positive (odds ratio for one type positive 0.99 (95% confidence interval 0.74 to 1.33); two to three types positive 1.44 (1.03 to 2.01); four to eight types positive 1.51 (1.03 to 2.20); more than eight types positive 1.71 (1.12 to 2.62); P for trend (categorical)<0.001; P for trend (continuous)=0.003).", {"entities": [[34, 43, "DISEASE"], [20, 43, "DISEASE"]]}], ["With limited statistical power, the association was stronger among long term users of systemic glucocorticoids (odds ratio 3.21, 1.22 to 8.44) than among non-users (1.23, 0.97 to 1.55).", {"entities": []}], ["Conclusions These findings support a relation between genus \u03b2 human papillomavirus infection and the incidence of squamous cell carcinoma of the skin in the general population, as well as potential enhancement of risk by immunosuppression.", {"entities": [[128, 137, "DISEASE"], [114, 137, "DISEASE"]]}], ["Limited research addresses links between obesity and cognitive function in young adults.", {"entities": [[41, 48, "DISEASE"]]}], ["Objective .", {"entities": []}], ["To investigate the relationship between obesity and cognitive function in young women.", {"entities": [[40, 47, "DISEASE"]]}], ["This cross-sectional study recruited healthy, young (18\u201335\u2009y) women of normal (NW: BMI\u2009=\u200918.5\u201324.9\u2009kg\u00b7m z -scores (mean \u00b1 SD), and group comparisons were assessed via ANOVA.", {"entities": []}], ["Potential confounding from questionnaire and blood variables were evaluated using ANCOVA.", {"entities": []}], ["299 women (NW: n \u2009=\u2009157; OB: n \u2009=\u2009142) aged 25.8\u2009\u00b1\u20095.1\u2009y were enrolled.", {"entities": []}], ["Cognition scores were within normal range (\u00b11 z -score), but OB had lower attention (NW: 0.31\u2009\u00b1\u20091.38; OB: \u22120.25\u2009\u00b1\u20091.39; ES: 0.41, CI: 0.17\u20130.64; p < 0.001) and higher impulsivity (NW: 0.36\u2009\u00b1\u20091.14; OB: \u22120.07\u2009\u00b1\u20091.07; ES: 0.39, CI: 0.15\u20130.62; p =0.033).", {"entities": []}], ["Confounder adjustment had minimal impact on results.", {"entities": []}], ["Conclusion .", {"entities": []}], ["The OB group had normal but significantly lower performance on attention and were more impulsive compared to NW participants.", {"entities": []}], ["This may indicate early cognitive decline, but longitudinal research confirming these findings is warranted.", {"entities": []}], ["Air pollution is an important public health problem in Europe and there is evidence that it exacerbates health inequities.", {"entities": []}], ["This calls for effective strategies and targeted interventions.", {"entities": []}], ["In this study, we conducted a systematic review to evaluate the effectiveness of strategies relating to air pollution control on public health and health equity in Europe.", {"entities": []}], ["Three databases, Web of Science, PubMed, and Trials Register of Promoting Health Interventions (TRoPHI), were searched for scientific publications investigating the effectiveness of strategies on outdoor air pollution control, public health and health equity in Europe from 1995 to 2015.", {"entities": []}], ["A total of 15 scientific papers were included in the review after screening 1626 articles.", {"entities": []}], ["Four groups of strategy types, namely, general regulations on air quality control, road traffic related emission control interventions, energy generation related emission control interventions and greenhouse gas emission control interventions for climate change mitigation were identified.", {"entities": []}], ["All of the strategies reviewed reported some improvement in air quality and subsequently in public health.", {"entities": []}], ["The reduction of the air pollutant concentrations and the reported subsequent health benefits were more significant within the geographic areas affected by traffic related interventions.", {"entities": []}], ["Among the various traffic related interventions, low emission zones appeared to be more effective in reducing ambient nitrogen dioxide (NO 2 ) and particulate matter levels.", {"entities": []}], ["Only few studies considered implications for health equity, three out of 15, and no consistent results were found indicating that these strategies could reduce health inequity associated with air pollution.", {"entities": []}], ["Particulate matter (particularly fine particulate matter) and NO 2 were the dominant outdoor air pollutants examined in the studies in Europe in recent years.", {"entities": []}], ["Health benefits were gained either as a direct, intended objective or as a co-benefit from all of the strategies examined, but no consistent impact on health equity from the strategies was found.", {"entities": []}], ["The strategy types aiming to control air pollution in Europe and the health impact assessment methodology were also discussed in this review.", {"entities": []}], ["Historically, only partial assessments of data quality have been performed in clinical trials, for which the most common method of measuring database error rates has been to compare the case report form (CRF) to database entries and count discrepancies.", {"entities": []}], ["Importantly, errors arising from medical record abstraction and transcription are rarely evaluated as part of such quality assessments.", {"entities": []}], ["Electronic Data Capture (EDC) technology has had a further impact, as paper CRFs typically leveraged for quality measurement are not used in EDC processes.", {"entities": []}], ["The National Institute on Drug Abuse Treatment Clinical Trials Network has developed, implemented, and evaluated methodology for holistically assessing data quality on EDC trials.", {"entities": []}], ["We characterize the average source-to-database error rate (14.3 errors per 10,000 fields) for the first year of use of the new evaluation method.", {"entities": []}], ["This error rate was significantly lower than the average of published error rates for source-to-database audits, and was similar to CRF-to-database error rates reported in the published literature.", {"entities": []}], ["We attribute this largely to an absence of medical record abstraction on the trials we examined, and to an outpatient setting characterized by less acute patient conditions.", {"entities": []}], ["Historically, medical record abstraction is the most significant source of error by an order of magnitude, and should be measured and managed during the course of clinical trials.", {"entities": []}], ["Source-to-database error rates are highly dependent on the amount of structured data collection in the clinical setting and on the complexity of the medical record, dependencies that should be considered when developing data quality benchmarks.", {"entities": []}], ["Comprehensive analyses of results from genome-wide association studies (GWAS) have demonstrated that complex disease/trait-associated loci are enriched in gene regulatory regions of the genome.", {"entities": []}], ["The search for causal regulatory variation has focused primarily on transcriptional elements, such as promoters and enhancers.", {"entities": []}], ["microRNAs (miRNAs) are now widely appreciated as critical posttranscriptional regulators of gene expression and are thought to impart stability to biological systems.", {"entities": []}], ["Naturally occurring genetic variation in the miRNA regulome is likely an important contributor to phenotypic variation in the human population.", {"entities": []}], ["However, the extent to which polymorphic miRNA-mediated gene regulation underlies GWAS signals remains unclear.", {"entities": []}], ["In this study, we have developed the most comprehensive bioinformatic analysis pipeline to date for cataloging and prioritizing variants in the miRNA regulome as functional candidates in GWAS.", {"entities": []}], ["We highlight specific findings, including a variant in the promoter of the miRNA let-7 that may contribute to human height variation.", {"entities": []}], ["We also provide a discussion of how our approach can be expanded in the future.", {"entities": []}], ["Overall, we believe that the results of this study will be valuable for researchers interested in determining whether GWAS signals implicate the miRNA regulome in their disease/trait of interest.", {"entities": []}], ["Genome-wide association studies (GWAS) have generated a wealth of valuable genotyping data for complex diseases/traits.", {"entities": []}], ["A large proportion of these data are embedded with many weakly associated markers that have been missed in traditional single marker analyses, but they may provide valuable insights in dissecting the genetic components of diseases.", {"entities": []}], ["Gene set analysis (GSA) augmented by protein-protein interaction network data provides a promising way to examine GWAS data by analyzing the combined effects of multiple genes/markers, each of which may have only individually weak to moderate association effects.", {"entities": []}], ["A critical issue in GSA of GWAS data is the definition of gene-wise P values based on multiple SNPs mapped to a gene.", {"entities": []}], ["In this study, we proposed an alternative restricted search approach based on our previously developed dense module search algorithm, and we demonstrated it in the CATIE GWAS dataset for schizophrenia.", {"entities": [[187, 200, "DISEASE"]]}], ["Specifically, we explored three ways of computing gene-wise P values and examined their effects on the resultant module genes.", {"entities": []}], ["These methods calculate gene-wise P values based on all the SNPs, the top ranked SNPs, or the most significant SNP among all the SNPs mapped to a gene.", {"entities": []}], ["We applied the restricted search approach and identified a module gene set for each of the gene-wise P value data set.", {"entities": []}], ["In our evaluation using an independent method, ALIGATOR, we showed that although each of these input datasets generated a unique set of module genes, all of them were significant in the GWAS dataset.", {"entities": []}], ["Further functional enrichment analysis of these module genes showed that at the pathway level, they were all consistently related to neuro- and immune-related pathways.", {"entities": []}], ["Finally, we compared our method with a previously reported method.", {"entities": []}], ["Our results showed that the approaches to computing gene-wise P values in GWAS data are critical in GSA.", {"entities": []}], ["This work is useful for evaluating key factors in GSA of GWAS data.", {"entities": []}], ["Oxidative damage and inflammation are closely associated with the pathogenesis of acute lung injury (ALI).", {"entities": []}], ["Thus, we explored the protective effect of isovitexin (IV), a glycosylflavonoid, in the context of ALI.", {"entities": []}], ["To accomplish this, we created in vitro and in vivo models by respectively exposing macrophages to lipopolysaccharide (LPS) and using LPS to induce ALI in mice.", {"entities": []}], ["In vitro, our results showed that IV treatment reduced LPS-induced pro-inflammatory cytokine secretion, iNOS and COX-2 expression and decreased the generation of ROS.", {"entities": []}], ["Consistent findings were obtained in vivo.", {"entities": []}], ["Additionally, IV inhibited H 2 O 2 -induced cytotoxicity and apoptosis.", {"entities": []}], ["However, these effects were partially reversed following the use of an HO-1 inhibitor in vitro.", {"entities": []}], ["Further studies revealed that IV significantly inhibited MAPK phosphorylation, reduced NF-\u03baB nuclear translocation, and upregulated nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1) expression in RAW 264.7 cells.", {"entities": []}], ["In vivo, pretreatment with IV attenuated histopathological changes, infiltration of polymorphonuclear granulocytes and endothelial activation, decreased the expression of ICAM-1 and VCAM-1, reduced the levels of MPO and MDA, and increased the content of GSH and SOD in ALI.", {"entities": [[212, 215, "GENE"]]}], ["Furthermore, IV treatment effectively increased Nrf2 and HO-1 expression in lung tissues.", {"entities": []}], ["Therefore, IV may offer a protective role against LPS-induced ALI by inhibiting MAPK and NF-\u03baB and activating HO-1/Nrf2 pathways.", {"entities": []}], ["A neuroimmune crosstalk between dendritic cells (DCs) and airway nerves in the lung has recently been reported.", {"entities": []}], ["However, the presence of DCs in airway sensory ganglia under normal and allergic conditions has not been explored so far.", {"entities": []}], ["Therefore, this study aims to investigate the localisation, distribution and proliferation of DCs in airway sensory ganglia under allergic airway inflammation.", {"entities": []}], ["Using the house dust mite (HDM) model for allergic airway inflammation BALB/c mice were exposed to HDM extract intranasally (25\u00a0\u03bcg/50\u00a0\u03bcl) for 5 consecutive days a week over 7\u00a0weeks.", {"entities": []}], ["With the help of the immunohistochemistry, vagal jugular-nodose ganglia complex (JNC) sections were analysed regarding their expression of DC-markers (MHC II, CD11c, CD103), the neuronal marker PGP 9.5 and the neuropeptide calcitonin gene-related peptide (CGRP) and glutamine synthetase (GS) as a marker for satellite glia cells (SGCs).", {"entities": [[194, 197, "GENE"]]}], ["To address the original source of DCs in sensory ganglia, a proliferation experiment was also carried in this study.", {"entities": []}], ["Immune cells with characteristic DC-phenotype were found to be closely located to SGCs and vagal sensory neurons under physiological conditions.", {"entities": []}], ["The percentage of DCs in relation to neurons was significantly increased by allergic airway inflammation in comparison to the controls (HDM 51.38\u2009\u00b1\u20092.38% vs. control 28.16\u2009\u00b1\u20092.86%, p\u2009<\u20090.001).", {"entities": []}], ["The present study also demonstrated that DCs were shown to proliferate in jugular-nodose ganglia, however, the proliferation rate of DCs is not significantly changed in the two treated animal groups (proliferating DCs/ total DCs: HDM 0.89\u2009\u00b1\u20090.38%, vs. control 1.19\u2009\u00b1\u20090.54%, p\u2009=\u20090.68).", {"entities": []}], ["Also, increased number of CGRP-positive neurons was found in JNC after allergic sensitisation and challenge (HDM 31.16\u2009\u00b1\u20095.41% vs. control 7.16\u2009\u00b1\u20091.53%, p\u2009<\u20090.001).", {"entities": []}], ["The present findings suggest that DCs may migrate from outside into the ganglia to interact with sensory neurons enhancing or protecting the allergic airway inflammation.", {"entities": []}], ["The increase of DCs as well as CGRP-positive neurons in airway ganglia by allergic airway inflammation indicate that intraganglionic DCs and neurons expressing CGRP may contribute to the pathogenesis of bronchial asthma.", {"entities": [[213, 219, "DISEASE"]]}], ["To understand this neuroimmune interaction in allergic airway inflammation further functional experiments should be carried out in future studies.", {"entities": []}], ["Despite indoor home environments being where people spend most time, involving residents in testing those environments has been very limited, especially in marginalized communities.", {"entities": []}], ["We piloted participatory testing and reporting that combined relatively simple tests with actionable reporting to empower residents in Main South/Piedmont neighborhoods of Worcester, Massachusetts.", {"entities": []}], ["We answered: 1) How do we design and implement the approach for neighborhood and household environments using participatory methods?", {"entities": []}], ["2) What do pilot tests reveal?", {"entities": []}], ["3) How does our experience inform testing practice?", {"entities": []}], ["The approach was designed and implemented with community partners using community-based participatory research.", {"entities": []}], ["Residents and researchers tested fourteen homes for: lead in dust indoors, soil outdoors, paint indoors and drinking water; radon in basement air; PM2.5 in indoor air; mold spores in indoor/outdoor air; and drinking water quality.", {"entities": []}], ["Monitoring of neighborhood particulates by residents and researchers used real-time data to stimulate dialogue.", {"entities": []}], ["Given the newness of our partnership and unforeseen conflicts, we achieved moderate-high success overall based on process and outcome criteria: methods, test results, reporting, lessons learned.", {"entities": []}], ["The conflict burden we experienced may be attributable less to generic university-community differences in interests/culture, and more to territoriality and interpersonal issues.", {"entities": []}], ["Lead-in-paint touch-swab results were poor proxies for lead-in-dust.", {"entities": []}], ["Of eight units tested in summer, three had very high lead-in-dust (>1000 \u03bc g/ft Timely reporting back home-toxics' results to residents is ethical but it must be empowering.", {"entities": []}], ["Future work should fund the active participation of a few motivated residents as representatives of the target population.", {"entities": []}], ["Although difficult and demanding in time and effort, the approach can educate residents and inform exposure assessment.", {"entities": []}], ["It should be considered as a core ingredient of comprehensive household toxics' testing, and has potential to improve participant retention and the overall positive impact of long-term environmental health research efforts.", {"entities": []}], ["Chronic glucocorticoid (GC) treatment represents a widely-prescribed therapy for several diseases in consideration of both anti-inflammatory and immunosuppressive activity but, if used at high doses for prolonged periods, it can determine the systemic effects characteristic of Cushing\u2019s syndrome.", {"entities": [[288, 296, "DISEASE"], [24, 26, "GENE"]]}], ["In addition to signs and symptoms of hypercortisolism, patients on chronic GC therapy are at risk to develop tertiary adrenal insufficiency after the reduction or the withdrawal of corticosteroids or during acute stress.", {"entities": [[75, 77, "GENE"]]}], ["This effect is mediated by the negative feedback loop on the hypothalamus-pituitary-adrenal (HPA) axis, which mainly involves corticotropin-release hormone (CRH), which represents the most important driver of adrenocorticotropic hormone (ACTH) release.", {"entities": [[157, 160, "GENE"]]}], ["In fact, after withdrawal of chronic GC treatment, reactivation of CRH secretion is a necessary prerequisite for the recovery of the HPA axis.", {"entities": [[37, 39, "GENE"], [67, 70, "GENE"]]}], ["In addition to the well-known factors which regulate the degree of inhibition of the HPA during synthetic GC therapy (type of compound, method of administration, cumulative dose, duration of the treatment, concomitant drugs which can increase the bioavailability of GCs), there is a considerable variation in individual physiology, probably related to different genetic profiles which regulate GC receptor activity.", {"entities": [[106, 108, "GENE"], [394, 396, "GENE"], [106, 108, "GENE"], [394, 396, "GENE"]]}], ["This may represent an interesting basis for possible future research fields.", {"entities": []}], ["We introduced video-based teaching in pediatrics.", {"entities": []}], ["We evaluated the impact of a pediatric video program on student performance in assessing pediatric patients presented as video cases.", {"entities": []}], ["The program consisted of a library of pediatric videos, and inclusion of these in the teaching and examination for pediatric medicine.", {"entities": []}], ["Medical students on a pediatric clerkship at the University of Copenhagen assessed eight short pediatric video cases during autumn 2011 and spring 2012.", {"entities": []}], ["Two independent observers evaluated a subset of records in a pilot study.", {"entities": []}], ["A blind evaluation was made of the written records of 37 students before, and 58 students after, the introduction of the program using a Rubric score with four domains.", {"entities": []}], ["The intraobserver interclass correlation coefficient was 0.94 and the interobserver interclass correlation was 0.71(n=25).", {"entities": []}], ["The students\u2019 mean total Rubric score in spring 2012 (7.0) was significantly higher (p<0.001, 95% CI 1.34\u20133.20) than autumn 2011 (4.7).", {"entities": []}], ["Cohen's d was 1.1 (95% CI 0.6\u20131.7).", {"entities": []}], ["Single domains scores increased significantly for general assessment (1.30 versus 0.57) (p<0.002, 95% CI 0.45\u20131.18), recognition of principal symptoms (1.38 versus 0.81) (p<0.008, 95% CI 0.22\u20130.91), appropriate diagnosis (2.28 versus 1.78) (p<0.002, 95% CI 0.16\u20130.82) and consistency between observed symptoms and diagnosis (1.94 versus 1.57) (p=0.0482, 95% CI 0.00\u20130.79).", {"entities": []}], ["Students improved in evaluating pediatric patients presented as video cases after the introduction of the program.", {"entities": []}], ["The impact on real-life situations remains to be established.", {"entities": []}], ["Previous studies of the natural history of alpha-1-antitrypsin (AAT) deficiency are mostly based on highly selected patients.", {"entities": []}], ["The aim of this study was to analyse the mortality of PiZZ individuals.", {"entities": []}], ["Data from 1339 adult PiZZ individuals from the Swedish National AAT Deficiency Registry, followed from 1991 to 2008, were analysed.", {"entities": []}], ["Forty-three percent of these individuals were identified by respiratory symptoms (respiratory cases), 32% by liver diseases and other diseases (non-respiratory cases) and 25% by screening (screened cases).", {"entities": []}], ["Smoking status was divided into two groups: smokers 737 (55%) and 602 (45%) never-smokers.", {"entities": []}], ["During the follow-up 315 individuals (24%) died.", {"entities": []}], ["The standardised mortality rate (SMR) for respiratory cases was 4.70 (95% Confidence Interval (CI) 4.10-5.40), 3.0 (95%CI 2.35-3.70) for the non-respiratory cases and 2.30 (95% CI 1.46-3.46) for the screened cases.", {"entities": []}], ["The smokers had a higher mortality risk than never-smokers, with a SMR of 4.80 (95%CI 4.20-5.50) for the smokers and 2.80(95%CI 2.30-3.40) for the never-smokers.", {"entities": []}], ["The Rate Ratio (RR) was 1.70 (95% CI 1.35-2.20).", {"entities": []}], ["Also among the screened cases, the mortality risk for the smokers was significantly higher than in the general Swedish population (SMR 3.40 (95% CI 1.98-5.40).", {"entities": []}], ["Smokers with severe AAT deficiency, irrespective of mode of identification, have a significantly higher mortality risk than the general Swedish population.", {"entities": []}], ["The rates of muscle aches, sprains, and inflammation are significantly increased during pregnancy.", {"entities": []}], ["However, women are afraid to use systemic analgesics due to perceptions of fetal risks.", {"entities": []}], ["Thus, topical products are important alternatives to consider for those women.", {"entities": []}], ["Of interest, Professional Therapy MuscleCare (PTMC) has shown to be effective in alleviating the myofascial pain as reported in a randomized, placebo-controlled double-blinded comparative clinical study of five topical analgesics.", {"entities": []}], ["However, to date, there is no complete review or long-term safety studies on the safety of these products during pregnancy and lactation.", {"entities": []}], ["Thus, the aim of this article was to review toxicological, developmental, and reproductive effects associated with the use of PTMC products.", {"entities": []}], ["We performed a systematic review on safety of PTMC from all toxicological articles investigating the effects of PTMC\u2019s ingredients.", {"entities": []}], ["This search was conducted through medical and toxicological databases including, Web of Science, EMBASE, Medline, and Micromedix.", {"entities": []}], ["Both reported and theoretical adverse effects were extensively reviewed.", {"entities": []}], ["Of the 1500 publications reviewed, 100 papers were retrieved and included in the review.", {"entities": []}], ["Although some ingredients in PTMC products might cause adverse reproductive effects at high systemic doses, these doses are hundreds to thousands fold greater than those systemically available from topical use at the recommended maximum dose (i.e.", {"entities": []}], ["This study provides evidence that, when used as indicated, PTMC is apparently safe for pregnant women and their unborn babies as well as for breastfed infants.", {"entities": []}], ["Reports of increasing worldwide circulation of human enterovirus-68 (EV68) are well documented.", {"entities": []}], ["Despite health concerns posed by resurgence of these viruses, little is known about EV68 strains circulating in Kenya.", {"entities": []}], ["In this study, we characterized 13 EV68 strains isolated in Kenya between 2008 and 2011 based on the Hypervariable 3\u2032- end of the VP1 gene.", {"entities": []}], ["Viral RNA was extracted from the isolates and partial VP1 gene amplified by RT-PCR, followed by nucleotide sequencing.", {"entities": []}], ["Alignment of deduced amino acid sequences revealed substitutions in Kenyan EV68 isolates absent in the prototype reference strain (Fermon).", {"entities": []}], ["The majority of these changes were present in the BC and DE-loop regions, which are associated with viral antigenicity and virulence.", {"entities": []}], ["The Kenyan strains exhibited high sequence homology with respect to those from other countries.", {"entities": []}], ["Natural selection analysis based on the VP1 region showed that the Kenyan EV68 isolates were under purifying selection.", {"entities": []}], ["Phylogenetic analysis revealed that majority (84.6%) of the Kenyan strains belonged to clade A, while a minority belonged to clades B and C. Overall, our results illustrate that although EV68 strains isolated in Kenya were genetically and antigenically divergent from the prototype strain (Fermon), they were closely related to those circulating in other countries, suggesting worldwide transmissibility.", {"entities": []}], ["Further, the presence of shared mutations by Kenyan EV68 strains and those isolated in other countries, indicates evolution in the VP1 region may be contributing to increased worldwide detection of the viruses.", {"entities": []}], ["This is the first study to document circulation of EV68 in Kenya.", {"entities": []}], ["In patients with chronic disease, many health care professionals are involved during treatment and follow-up.", {"entities": []}], ["This leads to fragmentation that in turn may lead to suboptimal care.", {"entities": []}], ["Shared care is a means to improve the integration of care delivered by various providers, specifically primary care physicians (PCPs) and specialty care professionals, for patients with chronic disease.", {"entities": []}], ["The use of information technology (IT) in this field seems promising.", {"entities": []}], ["Our aim was to systematically review the literature regarding the effectiveness of IT-supported shared care interventions in chronic disease in terms of provider or professional, process, health or clinical and financial outcomes.", {"entities": []}], ["Additionally, our aim was to provide an inventory of the IT applications' characteristics that support such interventions.", {"entities": []}], ["PubMed, Scopus, and EMBASE were searched from 2006 to 2015 to identify relevant studies using search terms related to shared care, chronic disease, and IT.", {"entities": []}], ["Eligible studies were in the English language, and the randomized controlled trials (RCTs), controlled trials, or single group pre-post studies used reported on the effects of IT-supported shared care in patients with chronic disease and cancer.", {"entities": [[238, 244, "DISEASE"]]}], ["The interventions had to involve providers from both primary and specialty health care.", {"entities": []}], ["Intervention and IT characteristics and effectiveness\u2014in terms of provider or professional (proximal), process (intermediate), health or clinical and financial (distal) outcomes\u2014were extracted.", {"entities": []}], ["Risk of bias of (cluster) RCTs was assessed using the Cochrane tool.", {"entities": []}], ["The initial search yielded 4167 results.", {"entities": []}], ["Thirteen publications were used, including 11 (cluster) RCTs, a controlled trial, and a pre-post feasibility study.", {"entities": []}], ["Four main categories of IT applications were identified: (1) electronic decision support tools, (2) electronic platform with a call-center, (3) electronic health records, and (4) electronic communication applications.", {"entities": []}], ["Positive effects were found for decision support-based interventions on financial and health outcomes, such as physical activity.", {"entities": []}], ["Electronic health record use improved PCP visits and reduced rehospitalization.", {"entities": []}], ["Electronic platform use resulted in fewer readmissions and better clinical outcomes\u2014for example, in terms of body mass index (BMI) and dyspnea.", {"entities": []}], ["The use of electronic communication applications using text-based information transfer between professionals had a positive effect on the number of PCPs contacting hospitals, PCPs\u2019 satisfaction, and confidence.", {"entities": []}], ["IT-supported shared care can improve proximal outcomes, such as confidence and satisfaction of PCPs, especially in using electronic communication applications.", {"entities": []}], ["Positive effects on intermediate and distal outcomes were also reported but were mixed.", {"entities": []}], ["Surprisingly, few studies were found that substantiated these anticipated benefits.", {"entities": []}], ["Studies showed a large heterogeneity in the included populations, outcome measures, and IT applications used.", {"entities": []}], ["Therefore, a firm conclusion cannot be drawn.", {"entities": []}], ["As IT applications are developed and implemented rapidly, evidence is needed to test the specific added value of IT in shared care interventions.", {"entities": []}], ["This is expected to require innovative research methods.", {"entities": []}], ["Biomaterial implants are an established part of medical practice, encompassing a broad range of devices that widely differ in function and structural composition.", {"entities": []}], ["However, one common property amongst biomaterials is the induction of the foreign body response: an acute sterile inflammatory reaction which overlaps with tissue vascularisation and remodelling and ultimately fibrotic encapsulation of the biomaterial to prevent further interaction with host tissue.", {"entities": []}], ["Severity and clinical manifestation of the biomaterial-induced foreign body response are different for each biomaterial, with cases of incompatibility often associated with loss of function.", {"entities": []}], ["However, unravelling the mechanisms that progress to the formation of the fibrotic capsule highlights the tightly intertwined nature of immunological responses to a seemingly noncanonical \u201cantigen.\u201d In this review, we detail the pathways associated with the foreign body response and describe possible mechanisms of immune involvement that can be targeted.", {"entities": []}], ["We also discuss methods of modulating the immune response by altering the physiochemical surface properties of the biomaterial prior to implantation.", {"entities": []}], ["Developments in these areas are reliant on reproducible and effective animal models and may allow a \u201ccombined\u201d immunomodulatory approach of adapting surface properties of biomaterials, as well as treating key immune pathways to ultimately reduce the negative consequences of biomaterial implantation.", {"entities": []}], ["Cat allergen is widely distributed in homes and schools; allergic sensitization is common.", {"entities": []}], ["To develop a model of cat allergen nasal challenge to establish dose\u2013response and time\u2013course characteristics and investigate local and systemic biomarkers of allergic inflammation.", {"entities": []}], ["Nineteen cat\u2010allergic individuals underwent titrated nasal challenge, range 0.243 to 14.6\u00a0\u03bcg/ mL Fel d1, and matched diluent\u2010only provocation.", {"entities": []}], ["Clinical response to 8\u00a0h was assessed by symptom scores and peak nasal inspiratory flow (PNIF).", {"entities": []}], ["Nasal fluid was collected using polyurethane sponges and analysed by ImmunoCAP and multiplex assays.", {"entities": []}], ["Whole blood flow cytometry for basophil surface CD63, CD107a, and CD203c was carried out at baseline and 6\u00a0h post\u2010challenge.", {"entities": [[48, 52, "GENE"]]}], ["A dose\u2013response to allergen was seen in symptom scores and PNIF, maximal at 10\u00a0000 BU/ mL (4.87\u00a0\u03bcg/ mL Fel d1), P \u00a0<\u00a00.0001 vs. diluent.", {"entities": []}], ["Nasal fluid tryptase was elevated at 5\u00a0min after challenge ( P \u00a0<\u00a00.05 vs. diluent); eotaxin, IL\u20104, \u20105, \u20109, and \u201013 were increased at 8\u00a0h ( P \u00a0<\u00a00.05 to P \u00a0<\u00a00.0001 vs. diluent); TSLP was undetectable; IL\u201010, IL\u201017A, and IL\u201033 were unchanged compared to diluent challenge.", {"entities": [[179, 183, "GENE"]]}], ["Nasal fluid IL\u20105 and IL\u201013 correlated inversely with PNIF after challenge (IL\u20105, r \u00a0=\u00a0\u22120.79, P \u00a0<\u00a00.0001; IL\u201013, r \u00a0=\u00a0\u22120.60, P \u00a0=\u00a00.006).", {"entities": []}], ["Surface expression of CD63 and CD107a was greater at 6\u00a0h than at baseline, both in the presence (both P \u00a0<\u00a00.05) and absence (CD63, P \u00a0<\u00a00.01; CD107a, P \u00a0<\u00a00.05) of in vitro allergen stimulation; no changes were seen on diluent challenge day.", {"entities": [[22, 26, "GENE"], [126, 130, "GENE"], [22, 26, "GENE"], [126, 130, "GENE"]]}], ["Cat allergen nasal challenge produces local and systemic Th2\u2010driven inflammatory responses and has potential as a surrogate outcome measure in clinical trials.", {"entities": []}], ["To define a minimum Standard Set of outcome measures and case\u2010mix factors for monitoring, comparing, and improving health care for patients with clinically diagnosed hip or knee osteoarthritis (OA), with a focus on defining the outcomes that matter most to patients.", {"entities": [[178, 192, "DISEASE"]]}], ["An international working group of patients, arthroplasty register experts, orthopedic surgeons, primary care physicians, rheumatologists, and physiotherapists representing 10 countries was assembled to review existing literature and practices for assessing outcomes of pharmacologic and nonpharmacologic OA therapies, including surgery.", {"entities": []}], ["A series of 8 teleconferences, incorporating a modified Delphi process, were held to reach consensus.", {"entities": []}], ["The working group reached consensus on a concise set of outcome measures to evaluate patients\u2019 joint pain, physical functioning, health\u2010related quality of life, work status, mortality, reoperations, readmissions, and overall satisfaction with treatment result.", {"entities": []}], ["To support analysis of these outcome measures, pertinent baseline characteristics and risk factor metrics were defined.", {"entities": []}], ["Annual outcome measurement is recommended for all patients.", {"entities": []}], ["We have defined a Standard Set of outcome measures for monitoring the care of people with clinically diagnosed hip or knee OA that is appropriate for use across all treatment and care settings.", {"entities": []}], ["We believe this Standard Set provides meaningful, comparable, and easy to interpret measures ready to implement in clinics and/or registries globally.", {"entities": []}], ["We view this set as an initial step that, when combined with cost data, will facilitate value\u2010based health care improvements in the treatment of hip and knee OA.", {"entities": []}], ["Despite progressive health policy, disease burdens in South Africa remain patterned by deeply entrenched social inequalities.", {"entities": []}], ["Accounting for the relationships between context, health and risk can provide important information for equitable service delivery.", {"entities": []}], ["The aims of the research were to initiate a participatory research process with communities in a low income setting and produce evidence of practical relevance.", {"entities": []}], ["We initiated a participatory action research (PAR) process in the Agincourt health and socio\u2013demographic surveillance site (HDSS) in rural north\u2013east South Africa.", {"entities": []}], ["Three village\u2013based discussion groups were convened and consulted about conditions to examine, one of which was under\u20135 mortality.", {"entities": []}], ["A series of discussions followed in which routine HDSS data were presented and participants\u2019 subjective perspectives were elicited and systematized into collective forms of knowledge using ranking, diagramming and participatory photography.", {"entities": []}], ["The process concluded with a priority setting exercise.", {"entities": []}], ["Visual and narrative data were thematically analyzed to complement the participants\u2019 analysis.", {"entities": []}], ["A range of social and structural root causes of under\u20135 mortality were identified: poverty, unemployment, inadequate housing, unsafe environments and shortages of clean water.", {"entities": []}], ["Despite these constraints, single mothers were often viewed as negligent.", {"entities": []}], ["A series of mid\u2013level contributory factors in clinics were also identified: overcrowding, poor staffing, delays in treatment and shortages of medications.", {"entities": []}], ["In a similar sense, pronounced blame and negativity were directed toward clinic nurses in spite of the systems constraints identified.", {"entities": []}], ["Actions to address these issues were prioritized as: expanding clinics, improving accountability and responsiveness of health workers, improving employment, providing clean water, and expanding community engagement for health promotion.", {"entities": []}], ["We initiated a PAR process to gain local knowledge and prioritize actions.", {"entities": []}], ["The process was acceptable to those involved, and there was willingness and commitment to continue.", {"entities": []}], ["The study provided a basis from which to gain support to develop fuller forms of participatory research in this setting.", {"entities": []}], ["The next steps are to build deeper involvement of participants in the process, expand to include the perspectives of those most marginalized, and engage in the health system at different levels to move toward an ongoing process of action and learning from action.", {"entities": []}], ["We evaluated predictors of coronary heart disease (CHD) death and sudden cardiac death (SCD) in the Atherosclerosis Risk in Communities (ARIC) study.", {"entities": [[36, 49, "DISEASE"], [27, 49, "DISEASE"], [88, 91, "GENE"]]}], ["The study population included 13 621 men and women 45 to 65 years of age free from manifest cardiovascular disease at entry.", {"entities": []}], ["Hazard ratios from Cox regression with 95% confidence intervals were computed for 18 dichotomized repolarization\u2010related ECG variables.", {"entities": []}], ["The average follow\u2010up was 14 years.", {"entities": []}], ["Independent predictors of CHD death in men were TaVR\u2010 and rate\u2010adjusted QTend (QT ea ), with a 2\u2010fold increased risk for both, and spatial angles between mean QRS and T vectors and between Tpeak (T p ) and normal R reference vectors [\u03b8(R m |T m ) and \u03b8(T p |T ref ), respectively], with a >1.5\u2010fold increased risk for both.", {"entities": []}], ["In women, independent predictors of the risk of CHD death were \u03b8(R m |T m ), with a 2\u2010fold increased risk for \u03b8(R m |T m ), and \u03b8(T p |T ref ), with a 1.7\u2010fold increased risk.", {"entities": []}], ["Independent predictors of SCD in men were \u03b8(T p |T ref ) and QT ea , with a 2\u2010fold increased risk, and \u03b8(T init |T term ), with a 1.6\u2010fold increased risk.", {"entities": [[26, 29, "GENE"]]}], ["In women, \u03b8(T init |T term ) was an independent predictor of SCD, with a >3\u2010fold increased risk, and \u03b8(R m |T m ) and TV1 were >2\u2010fold for both.", {"entities": [[61, 64, "GENE"]]}], ["\u03b8(R m |T m ) and \u03b8(T p |T ref ), reflecting different aspects of ventricular repolarization, were independent predictors of CHD death and SCD, and TaVR and TV1 were also independent predictors.", {"entities": [[138, 141, "GENE"]]}], ["The risk levels for independent predictors for both CHD death and SCD were stronger in women than in men, and QT ea was a significant predictor in men but not in women.", {"entities": [[66, 69, "GENE"]]}], ["Chlorophenol compounds and their derivatives are ubiquitous contaminants in the environment.", {"entities": []}], ["These compounds are used as intermediates in manufacturing agricultural chemicals, pharmaceuticals, biocides, and dyes.", {"entities": []}], ["Chlorophenols gets into the environment from a variety of sources such as industrial waste, pesticides, and insecticides, or by degradation of complex chlorinated hydrocarbons.", {"entities": []}], ["Thermal and chemical degradation of chlorophenols leads to the formation of harmful substances which constitute public health problems.", {"entities": []}], ["These compounds may cause histopathological alterations, genotoxicity, mutagenicity, and carcinogenicity amongst other abnormalities in humans and animals.", {"entities": []}], ["Furthermore, the recalcitrant nature of chlorophenolic compounds to degradation constitutes an environmental nuisance, and a good understanding of the fate and transport of these compounds and their derivatives is needed for a clearer view of the associated risks and mechanisms of pathogenicity to humans and animals.", {"entities": []}], ["This review looks at chlorophenols and their derivatives, explores current research on their effects on public health, and proffers measures for mitigation.", {"entities": []}], ["Intramuscular injections of vitamin A decrease the risk of broncho-pulmonary dysplasia.", {"entities": []}], ["Admixture of vitamin A with surfactant as a lipophilic vehicle might be a less invasive modality.", {"entities": []}], ["Test physical properties of surfactant + vitamin A. Miscibility and surface activity were tested in surfactant supplemented with retinyl-acetate, -palmitate, 13-cis-, or all-trans-retinoic acid.", {"entities": []}], ["Retinol acetate (5000 IU/mL) demonstrated miscibility with surfactant when premixing with ethanol.", {"entities": []}], ["Its surface activity was 40% lower compared to surfactant alone.", {"entities": []}], ["These findings warrant preclinical studies to test whether administration of vitamin A in subjects requiring surfactant is associated with beneficial functional properties.", {"entities": []}], ["Preterm birth is associated with abnormal respiratory functions throughout life.", {"entities": []}], ["The mechanisms underlying these long-term consequences are still unclear.", {"entities": []}], ["Shortening of telomeres was associated with many conditions, such as chronic obstructive pulmonary disease.", {"entities": [[69, 106, "DISEASE"]]}], ["We aimed to search for an association between telomere length and lung function in adolescents born preterm.", {"entities": []}], ["Lung function and telomere length were measured in 236 adolescents born preterm and 38 born full-term from the longitudinal EPIPAGE cohort.", {"entities": []}], ["Associations between telomere length and spirometric indices were tested in univariate and multivariate models accounting for confounding factors in the study population.", {"entities": []}], ["Airflows were significantly lower in adolescents born preterm than controls; forced expiratory volume in one second was 12% lower in the extremely preterm born group than controls (p<0.001).", {"entities": []}], ["Lower birth weight, bronchopulmonary dysplasia and postnatal sepsis were significantly associated with lower airflow values.", {"entities": []}], ["Gender was the only factor that was significantly associated with telomere length.", {"entities": []}], ["Telomere length correlated with forced expiratory flow 25\u201375 in the extremely preterm adolescent group in univariate and multivariate analyses (p = 0.01 and p = 0.02, respectively).", {"entities": []}], ["We evidenced an association between telomere length and abnormal airflow in a population of adolescents born extremely preterm.", {"entities": []}], ["There was no evident association with perinatal events.", {"entities": []}], ["This suggests other involved factors, such as a continuing airway oxidative stress leading to persistent inflammation and altered lung function, ultimately increasing susceptibility to chronic obstructive pulmonary disease.", {"entities": [[185, 222, "DISEASE"]]}], ["Observation care is a core component of emergency care delivery, yet, the prevalence of emergency department (ED) observation units (OUs) and use of observation care after ED visits is unknown.", {"entities": []}], ["Our objective was to describe the 1) prevalence of OUs in United States (US) hospitals, 2) clinical conditions most frequently evaluated with observation, and 3) patient and hospital characteristics associated with use of observation.", {"entities": []}], ["Retrospective analysis of the proportion of hospitals with dedicated OUs and patient disposition after ED visit (discharge, inpatient admission or observation evaluation) using the National Hospital Ambulatory Medical Care Survey (NHAMCS) from 2001 to 2008.", {"entities": []}], ["NHAMCS is an annual, national probability sample of ED visits to US hospitals conducted by the Center for Disease Control and Prevention.", {"entities": []}], ["Logistic regression was used to assess hospital-level predictors of OU presence and polytomous logistic regression was used for patient-level predictors of visit disposition, each adjusted for multi-level sampling data.", {"entities": []}], ["OU analysis was limited to 2007\u20132008.", {"entities": []}], ["In 2007\u20132008, 34.1% of all EDs had a dedicated OU, of which 56.1% were under ED administrative control (EDOU).", {"entities": []}], ["Between 2001 and 2008, ED visits resulting in a disposition to observation increased from 642,000 (0.60% of ED visits) to 2,318,000 (1.87%, p<.05).", {"entities": []}], ["Chest pain was the most common reason for ED visit resulting in observation and the most common observation discharge diagnosis (19.1% and 17.1% of observation evaluations, respectively).", {"entities": []}], ["In hospital-level adjusted analysis, hospital ownership status (non-profit or government), non-teaching status, and longer ED length of visit (>3.6 h) were predictive of OU presence.", {"entities": []}], ["After patient-level adjustment, EDOU presence was associated with increased disposition to observation (OR 2.19).", {"entities": []}], ["One-third of US hospitals have dedicated OUs and observation care is increasingly used for a range of clinical conditions.", {"entities": []}], ["Further research is warranted to understand the quality, cost and efficiency of observation care.", {"entities": []}], ["Subcutaneous human IgG (SCIG) therapy in primary immunodeficiency (PID) offers sustained IgG levels throughout the dosing cycle and fewer adverse events (AEs) compared to intravenous immunoglobulin (IVIG).", {"entities": []}], ["A phase I study showed good local tolerability of IgPro20, a new 20% liquid SCIG stabilized with L-proline.", {"entities": []}], ["A prospective, open-label, multicenter, single-arm, phase III study evaluated the efficacy and safety of IgPro20 in patients with PID over 15\u00a0months.", {"entities": []}], ["Forty-nine patients (5\u201372\u00a0years) previously treated with IVIG received weekly subcutaneous infusions of IgPro20.", {"entities": []}], ["The mean serum IgG level was 12.5\u00a0g/L.", {"entities": []}], ["No serious bacterial infections were reported.", {"entities": []}], ["There were 96 nonserious infections (rate 2.76/patient per year).", {"entities": []}], ["The rate of days missed from work/school was 2.06/patient per year, and the rate of hospitalization was 0.2/patient per year.", {"entities": []}], ["Ninety-nine percent of AEs were mild or moderate.", {"entities": []}], ["No serious, IgPro20-related AEs were reported.", {"entities": []}], ["IgPro20 effectively protected patients with PID against infections and maintained serum IgG levels without causing unexpected AEs.", {"entities": []}], ["Following the 2009 H1N1 pandemic, there have been a large number of studies focusing on the epidemiology and outcomes of influenza A infection; however, there have been fewer studies focused on other respiratory viral infections.", {"entities": [[121, 130, "DISEASE"]]}], ["To define the epidemiology and outcomes of non-influenza respiratory viral infections in hospitalized adults.", {"entities": [[47, 56, "DISEASE"]]}], ["Data on all patients \u226518 years of age with a positive molecular respiratory viral assay who were hospitalized at a single tertiary healthcare system in Chicago, IL, from retrospectively collected and analyzed.", {"entities": []}], ["Over the study period, 503 of 46 024 (1\u00b71%) admitted patients had a positive RVP result.", {"entities": []}], ["Human rhinovirus was the most commonly detected virus followed by influenza A, human metapneumovirus, respiratory syncytial virus, and parainfluenza virus, adenovirus, and influenza B, respectively.", {"entities": [[66, 75, "DISEASE"], [172, 181, "DISEASE"]]}], ["Infection in immunocompromised patients was associated with a higher rate of progression to pneumonia and death.", {"entities": [[92, 101, "DISEASE"]]}], ["Non-influenza respiratory viral infections are commonly detected among adults admitted to the hospital and can cause serious illness.", {"entities": [[4, 13, "DISEASE"]]}], ["The data can inform the prioritization of research into novel antiviral therapies for these infections.", {"entities": []}], ["Epidemiologic research has shown increases in adverse cardiovascular and respiratory outcomes in relation to mass concentrations of particulate matter (PM) \u22642.5 or \u226410 \u03bcm in diameter (PM 2.5 , PM 10 , respectively).", {"entities": []}], ["In a companion article [Delfino RJ, Sioutas C, Malik S. 2005.", {"entities": []}], ["Environ Health Perspect 113(8):934\u2013946]), we discuss epidemiologic evidence pointing to underlying components linked to fossil fuel combustion.", {"entities": []}], ["The causal components driving the PM associations remain to be identified, but emerging evidence on particle size and chemistry has led to some clues.", {"entities": []}], ["There is sufficient reason to believe that ultrafine particles < 0.1 \u03bcm (UFPs) are important because when compared with larger particles, they have order of magnitudes higher particle number concentration and surface area, and larger concentrations of adsorbed or condensed toxic air pollutants (oxidant gases, organic compounds, transition metals) per unit mass.", {"entities": []}], ["This is supported by evidence of significantly higher in vitro redox activity by UFPs than by larger PM.", {"entities": []}], ["Although epidemiologic research is needed, exposure assessment issues for UFPs are complex and need to be considered before undertaking investigations of UFP health effects.", {"entities": []}], ["These issues include high spatial variability, indoor sources, variable infiltration of UFPs from a variety of outside sources, and meteorologic factors leading to high seasonal variability in concentration and composition, including volatility.", {"entities": []}], ["To address these issues, investigators need to develop as well as validate the analytic technologies required to characterize the physical/chemical nature of UFPs in various environments.", {"entities": []}], ["In the present review, we provide a detailed discussion of key characteristics of UFPs, their sources and formation mechanisms, and methodologic approaches to assessing population exposures.", {"entities": []}], ["High-quality epidemiologic research is essential in reducing chronic diseases.", {"entities": []}], ["We analyzed the quality of systematic reviews of observational nontherapeutic studies.", {"entities": []}], ["We searched several databases for systematic reviews of observational nontherapeutic studies that examined the prevalence of or risk factors for chronic diseases and were published in core clinical journals from 1966 through June 2008.", {"entities": []}], ["We analyzed the quality of such reviews by using prespecified criteria and internal quality evaluation of the included studies.", {"entities": []}], ["Of the 145 systematic reviews we found, fewer than half met each quality criterion; 49% reported study flow, 27% assessed gray literature, 2% abstracted sponsorship of individual studies, and none abstracted the disclosure of conflict of interest by the authors of individual studies.", {"entities": []}], ["Planned, formal internal quality evaluation of included studies was reported in 37% of systematic reviews.", {"entities": []}], ["The journal of publication, topic of review, sponsorship, and conflict of interest were not associated with better quality.", {"entities": []}], ["Odds of formal internal quality evaluation (odds ratio [OR], 1.10 per year; 95% confidence interval [CI], 1.02-1.19) and either planned, formal internal quality evaluation or abstraction of quality criteria of included studies (OR, 1.17 per year; 95% CI, 1.08-1.26) increased over time, without positive trends in other quality criteria from 1990 through June 2008.", {"entities": []}], ["Systematic reviews with internal quality evaluation did not meet other quality criteria more often than those that ignored the quality of included studies.", {"entities": []}], ["Collaborative efforts from investigators and journal editors are needed to improve the quality of systematic reviews.", {"entities": []}], ["This consensus statement was developed by Special Interest Group \u2013 Urticaria (IADVL).", {"entities": [[67, 76, "DISEASE"]]}], ["Urticaria, a heterogeneous group of diseases, often cannot be recognized by its morphology.", {"entities": [[0, 9, "DISEASE"]]}], ["Due to non-specific and non-affordable diagnosis, management of urticaria, especially chronic urticaria, is very challenging.", {"entities": [[64, 73, "DISEASE"], [94, 103, "DISEASE"]]}], ["This guideline includes definition, causes, classification and management of urticaria.", {"entities": [[77, 86, "DISEASE"]]}], ["Urticaria has a profound impact on the quality of life and causes immense distress to patients, necessitating effective treatment.", {"entities": [[0, 9, "DISEASE"]]}], ["One approach to manage urticaria is identification and elimination of the underlying cause(s) and/or eliciting trigger(s), while the second one is treatment aimed at providing symptomatic relief.", {"entities": [[23, 32, "DISEASE"]]}], ["This guideline recommends use of second-generation non-sedating H1 antihistamines as the first-line treatment.", {"entities": []}], ["The dose can be increased up to four times to meet the expected results.", {"entities": []}], ["In case patients still do not respond, appropriate treatment options can be selected depending on the cost.", {"entities": []}], ["Overlap syndrome of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) leads to increased morbidity and mortality.", {"entities": [[20, 57, "DISEASE"], [8, 16, "DISEASE"]]}], ["There have been no reports available on the overlap syndrome for Koreans.", {"entities": [[52, 60, "DISEASE"]]}], ["Our primary aim was to identify prevalence and predictors of the overlap syndrome in Koreans.", {"entities": [[73, 81, "DISEASE"]]}], ["This is a cross-sectional study with a community-based sample of 1298 participants (mean age, 59.7\u200a\u00b1\u200a6.7) from the cohort of Korean Genomic and Epidemiologic Study during 2013 to 2014.", {"entities": []}], ["OSA and COPD were assessed by apnea\u2013hypopnea index (AHI) and the ratio of forced expiratory volume in 1\u200as to forced vital capacity (FEV 1 /FVC\u200a<\u200a70%), respectively, based on polysomnography and spirometry measurements.", {"entities": [[132, 135, "GENE"]]}], ["Using logistic regression with adjustment for the confounders identified by univariate analysis, odds ratio (OR) was estimated with 95% confidence interval (CI) of COPD among those with OSA.", {"entities": []}], ["The prevalence rate of OSA was 45.8%, of which 32.8% were moderate-to-severe (AHI \u2265 15); 10.8% of those having OSA also had COPD, that is, the overlap syndrome.", {"entities": [[151, 159, "DISEASE"]]}], ["The prevalence of COPD remained the same as 10.8% regardless of the presence of OSA.", {"entities": []}], ["The mean ratio of FEV 1 /FVC for those with COPD was 0.77, regardless of OSA.", {"entities": [[18, 21, "GENE"]]}], ["The OR increased for age (OR, 1.1; 95% CI, 1.0\u20131.1) and smokers (OR, 3.6; 95% CI, 2.0\u20136.4), but decreased for body mass index (BMI) (OR, 0.84; 95% CI, 0.8\u20130.9) and overweight state (OR, 0.4; 95% CI, 0.2\u20130.7).", {"entities": []}], ["Risk factors of the overlap syndrome differed by OSA severity, that is, BMI in those with moderate-to-severe OSA, whereas sex (OR, 4.7; 95% CI, 2.1\u201310.6) and age (OR, 1.1; 95% CI, 1.0\u20131.1) in those with mild OSA.", {"entities": [[28, 36, "DISEASE"]]}], ["In a population study from Korea, 10.8% of OSA patients had an overlap syndrome with COPD.", {"entities": [[71, 79, "DISEASE"]]}], ["Although BMI is a well-known risk factor of OSA, it is likely that being overweight may be protective for moderate-to-severe OSA patients from the risk of COPD (i.e., overlap syndrome).", {"entities": [[175, 183, "DISEASE"]]}], ["Humans may be a reservoir for this pathogen and transmit it from person to person.", {"entities": []}], ["The reservoir and mode of transmission of Pneumocystis jirovecii remain uncertain.", {"entities": []}], ["We conducted a cross-sectional study of 126 San Francisco General Hospital staff in clinical (n = 103) and nonclinical (n = 23) occupations to assess whether occupational exposure was associated with immune responses to P. jirovecii .", {"entities": []}], ["We examined antibody levels by ELISA for 3 overlapping fragments that span the P. jirovecii major surface glycoprotein (Msg): MsgA, MsgB, and MsgC1.", {"entities": []}], ["Clinical occupation participants had higher geometric mean antibody levels to MsgC1 than did nonclinical occupation participants (21.1 vs. 8.2, p = 0.004); clinical occupation was an independent predictor of higher MsgC1 antibody levels (parameter estimate = 0.89, 95% confidence interval 0.29\u20131.48, p = 0.003).", {"entities": []}], ["In contrast, occupation was not significantly associated with antibody responses to either MsgA or MsgB.", {"entities": []}], ["Healthcare workers may have occupational exposure to P. jirovecii .", {"entities": []}], ["Humans may be a reservoir for P. jirovecii and may transmit it from person to person.", {"entities": []}], ["In recent years, gabapentin has gained popularity as an adjuvant therapy for the treatment of postoperative pain.", {"entities": []}], ["Numerous studies have shown a decrease in pain score, even with immediate postoperative activity, which is significant for early post-op ambulation and regaining functionality sooner.", {"entities": []}], ["However, studies have been in conclusive in patients undergoing lower extremity orthopedic surgery.", {"entities": []}], ["For this reason, we hoped to study the effect of gabapentin on postoperative pain in patients undergoing total knee arthroplasty, total hip arthroplasty, or a hip fracture repair.", {"entities": []}], ["This was done in the setting of ensuring adequate postoperative analgesia with regional blocks and opioid PCA, as is protocol at our institution.", {"entities": []}], ["Given the sedative effects of gabapentin and the potential for improving postoperative sleep patterns, we also studied the drug's effect on this aspect of our patient's postoperative course.", {"entities": []}], ["We utilized the Pittsburg Sleep Quality Index and Visual Analog Scale for pain to obtain a more objective standardized score amongst our study population.", {"entities": []}], ["Our results indicate that gabapentin does not offer any additional relief in pain or improve sleep habits in patients who have received either a femoral or lumbar plexus block for lower extremity orthopedic surgery.", {"entities": []}], ["This trial is registered with NCT01546857 .", {"entities": []}], ["Globally, pneumonia is the leading cause of death in young children and burden of disease is disproportionately high in South-East Asia Region of WHO.", {"entities": [[10, 19, "DISEASE"]]}], ["This review article presents the current status of pneumonia disease burden, risk factors and the ability of health infrastructure to deal with the situation.", {"entities": [[51, 60, "DISEASE"]]}], ["Literature survey was done for the last 20 years and data from country offices were also collected.", {"entities": []}], ["The estimated incidence of pneumonia in under five children is 0.36 episodes per child, per year.", {"entities": [[27, 36, "DISEASE"]]}], ["Risk factors are malnutrition (40% in India), Indoor air pollution, non-breast feeding, chronic obstructive pulmonary disease, etc.", {"entities": [[88, 125, "DISEASE"]]}], ["Strengthening of health care delivery system for early detection and treatment and as well as minimization of preventable risk factors can avert a large proportion of death due to pneumonia.", {"entities": [[180, 189, "DISEASE"]]}], ["PubMed is the main access to medical literature on the Internet.", {"entities": []}], ["In order to enhance the performance of its information retrieval tools, primarily non-indexed citations, the authors propose a method: expanding users' queries using Unified Medical Language System' (UMLS) synonyms i.e.", {"entities": []}], ["all the terms gathered under one unique Concept Unique Identifier.", {"entities": []}], ["This method was evaluated using queries constructed to emphasize the differences between this new method and the current PubMed automatic term mapping.", {"entities": []}], ["Four experts assessed citation relevance.", {"entities": []}], ["Using UMLS, we were able to retrieve new citations in 45.5% of queries, which implies a small increase in recall.", {"entities": []}], ["The new strategy led to a heterogeneous 23.7% mean increase in non-indexed citation retrieved.", {"entities": []}], ["Of these, 82% have been published less than 4 months earlier.", {"entities": []}], ["The overall mean precision was 48.4% but differed according to the evaluators, ranging from 36.7% to 88.1% (Inter rater agreement was poor: kappa = 0.34).", {"entities": []}], ["This study highlights the need for specific search tools for each type of user and use-cases.", {"entities": []}], ["The proposed strategy may be useful to retrieve recent scientific advancement.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) has a high prevalence rate in Germany and a further increase is expected within the next years.", {"entities": []}], ["Although risk factors on an individual level are widely understood, only little is known about the spatial heterogeneity and population-based risk factors of COPD.", {"entities": []}], ["Background knowledge about broader, population-based processes could help to plan the future provision of healthcare and prevention strategies more aligned to the expected demand.", {"entities": []}], ["The aim of this study is to analyze how the prevalence of COPD varies across northeastern Germany on the smallest spatial-scale possible and to identify the location-specific population-based risk factors using health insurance claims of the AOK Nordost.", {"entities": []}], ["To visualize the spatial distribution of COPD prevalence at the level of municipalities and urban districts, we used the conditional autoregressive Besag\u2013York\u2013Molli\u00e9 (BYM) model.", {"entities": []}], ["Geographically weighted regression modelling (GWR) was applied to analyze the location-specific ecological risk factors for COPD.", {"entities": []}], ["The sex- and age-adjusted prevalence of COPD was 6.5% in 2012 and varied widely across northeastern Germany.", {"entities": []}], ["Population-based risk factors consist of the proportions of insurants aged 65 and older, insurants with migration background, household size and area deprivation.", {"entities": []}], ["The results of the GWR model revealed that the population at risk for COPD varies considerably across northeastern Germany.", {"entities": []}], ["Area deprivation has a direct and an indirect influence on the prevalence of COPD.", {"entities": []}], ["Persons ageing in socially disadvantaged areas have a higher chance of developing COPD, even when they are not necessarily directly affected by deprivation on an individual level.", {"entities": []}], ["This underlines the importance of considering the impact of area deprivation on health for planning of healthcare.", {"entities": []}], ["Additionally, our results reveal that in some parts of the study area, insurants with migration background and persons living in multi-persons households are at elevated risk of COPD.", {"entities": []}], ["Forecasting higher than expected numbers of health events provides potentially valuable insights in its own right, and may contribute to health services management and syndromic surveillance.", {"entities": []}], ["This study investigates the use of quantile regression to predict higher than expected respiratory deaths.", {"entities": []}], ["Data taken from 70,830 deaths occurring in New York were used.", {"entities": []}], ["Temporal, weather and air quality measures were fitted using quantile regression at the 90th-percentile with half the data (in-sample).", {"entities": []}], ["Four QR models were fitted: an unconditional model predicting the 90th-percentile of deaths (Model 1), a seasonal / temporal (Model 2), a seasonal, temporal plus lags of weather and air quality (Model 3), and a seasonal, temporal model with 7-day moving averages of weather and air quality.", {"entities": []}], ["Models were cross-validated with the out of sample data.", {"entities": []}], ["Performance was measured as proportionate reduction in weighted sum of absolute deviations by a conditional, over unconditional models; i.e., the coefficient of determination (R1).", {"entities": []}], ["The coefficient of determination showed an improvement over the unconditional model between 0.16 and 0.19.", {"entities": []}], ["The greatest improvement in predictive and forecasting accuracy of daily mortality was associated with the inclusion of seasonal and temporal predictors (Model 2).", {"entities": []}], ["No gains were made in the predictive models with the addition of weather and air quality predictors (Models 3 and 4).", {"entities": []}], ["However, forecasting models that included weather and air quality predictors performed slightly better than the seasonal and temporal model alone (i.e., Model 3 > Model 4 > Model 2) This study provided a new approach to predict higher than expected numbers of respiratory related-deaths.", {"entities": []}], ["The approach, while promising, has limitations and should be treated at this stage as a proof of concept.", {"entities": []}], ["Tobacco smoking is the world\u2019s leading cause of premature death and disability.", {"entities": []}], ["Global targets to reduce premature deaths by 25% by 2025 will require a substantial increase in the number of smokers making a quit attempt, and a significant improvement in the success rates of those attempts in low, middle and high income countries.", {"entities": []}], ["In many countries the only place where the majority of smokers can access support to quit is primary care.", {"entities": []}], ["There is strong evidence of cost-effective interventions in primary care yet many opportunities to put these into practice are missed.", {"entities": []}], ["This paper revises the approach proposed by the International Primary Care Respiratory Group published in 2008 in this journal to reflect important new evidence and the global variation in primary-care experience and knowledge of smoking cessation.", {"entities": []}], ["Specific for primary care, that advocates for a holistic, bio-psycho-social approach to most problems, the starting point is to approach tobacco dependence as an eminently treatable condition.", {"entities": []}], ["We offer a hierarchy of interventions depending on time and available resources.", {"entities": []}], ["We present an equitable approach to behavioural and drug interventions.", {"entities": []}], ["This includes an update to the evidence on behaviour change, gender difference, comparative information on numbers needed to treat, drug safety and availability of drugs, including the relatively cheap drug cytisine, and a summary of new approaches such as harm reduction.", {"entities": []}], ["This paper also extends the guidance on special populations such as people with long-term conditions including tuberculosis, human immunodeficiency virus, cardiovascular disease and respiratory disease, pregnant women, children and adolescents, and people with serious mental illness.", {"entities": [[111, 123, "DISEASE"]]}], ["We use expert clinical opinion where the research evidence is insufficient or inconclusive.", {"entities": []}], ["The paper describes trends in the use of waterpipes and cannabis smoking and offers guidance to primary-care clinicians on what to do faced with uncertain evidence.", {"entities": []}], ["Throughout, it recognises that clinical decisions should be tailored to the individual\u2019s circumstances and attitudes and be influenced by the availability and affordability of drugs and specialist services.", {"entities": []}], ["Finally it argues that the role of the International Primary Care Respiratory Group is to improve the confidence as well as the competence of primary care and, therefore, makes recommendations about clinical education and evaluation.", {"entities": []}], ["We also advocate for an update to the WHO Model List of Essential Medicines to optimise each primary-care intervention.", {"entities": []}], ["This International Primary Care Respiratory Group statement has been endorsed by the Member Organisations of World Organization of Family Doctors Europe.", {"entities": []}], ["Background.", {"entities": []}], ["The goal of the study is to investigate the association of IL -4-590 and IL -13-1112 genetic polymorphisms with type 2 diabetes mellitus (T2DM) in Egyptian patients.", {"entities": [[119, 136, "DISEASE"], [112, 136, "DISEASE"]]}], ["Subjects and Methods.", {"entities": []}], ["The study included 135 cases with T2DM and 75 healthy unrelated age-matched controls from the same locality of Egypt.", {"entities": []}], ["DNA was extracted and processed by the ARMS-PCR technique for characterization of genetic variants of IL -4-590 C>T and IL -13-1112 C>T polymorphisms.", {"entities": []}], ["Egyptian cases with T2DM showed a lower frequency of the IL -4-590 CC homozygous genotype compared to controls (10.4% versus 43.48%) with a higher CT heterozygous genotype (85.2% versus 47.8%).", {"entities": []}], ["Similarly, cases showed a lower frequency of the IL -13-1112 CC genotype (20.7% versus 56.8%) with a higher frequency of the heterozygous IL -13-1112 CT genotype (76.3% versus 41.3%).", {"entities": []}], ["Both polymorphisms showed significantly positive associations with T2DM in the dominant, codominant, and overdominant models of inheritance.", {"entities": []}], ["On the other hand, comparing genotypes of subgroups related to gender, positive family history, and positive consanguinity showed a nonsignificant difference ( P > 0.05).", {"entities": []}], ["Conclusion.", {"entities": []}], ["Heterozygous genotypes ( IL -4-590 CT and IL -13-1112 CT ) could be considered as risk factors, while the homozygous wild types (-590 CC and -1112 CC ) might be considered protective to T2DM.", {"entities": []}], ["Approximately 20.8 million people in the United States, or 7% of the population, have diabetes mellitus.", {"entities": [[86, 103, "DISEASE"]]}], ["Treatment for this disease costs Americans more than $130 billion yearly,\u00a0and it is the sixth leading cause of death.", {"entities": []}], ["The prevalence of diabetes has grown substantially in recent decades and is expected to continue to rise.", {"entities": []}], ["The medically underserved and poor are at greater risk of developing diabetes and its complications than are other members of the U.S. population.", {"entities": []}], ["The Health Resources and Services Administration makes health care resources and services available to economically disadvantaged populations through the Health Disparities Collaborative (HDC), a consortium formed to pool resources and services from state- and community-level donors.", {"entities": [[188, 191, "GENE"]]}], ["Since 1999, many of the Centers for Disease Control and Prevention's Division of Diabetes Translation State Diabetes Prevention and Control Programs (DPCPs) have joined the HDC to leverage resources and services.", {"entities": [[173, 176, "GENE"]]}], ["The purpose of a 2004 evaluation was to examine the impact that DPCP involvement with the Collaborative had on aspects of diabetes care at Federally Qualified Health Centers (FQHCs).", {"entities": []}], ["An electronic survey was administered to DPCP coordinators.", {"entities": []}], ["They were asked about 1) their roles and experience as participants in the Collaborative; 2) the skills and expertise most useful in developing and maintaining an effective collaboration for improved health care for diabetes; 3) which DPCP contributions were viewed as being routine and which were perceived to be essential; 4) the effects of DPCP contributions on the use of the chronic care model under which FQHCs operate; and 5) which health systems improvements played the greatest role in enhancing components of the chronic care model.", {"entities": []}], ["Most respondents identified themselves as DPCP coordinators with 3 years of experience in that position.", {"entities": []}], ["Organizational skills, such as communication, leadership, conflict resolution, negotiation, and meeting management, were cited as necessary to develop and maintain collaborative partnerships.", {"entities": []}], ["DPCP contributions to FQHCs were perceived to be training, technical assistance with clinical care and patient education, financial resources, linkages to other diabetes partners, educational materials, and improved linkages with community resources.", {"entities": []}], ["DPCPs contribute resources, skills, knowledge, and varied perspectives to the Collaborative that FQHCs may not have otherwise.", {"entities": []}], ["Wang et al.", {"entities": []}], ["examine how influenza A virus causes GI symptoms.", {"entities": [[12, 21, "DISEASE"]]}], ["Intranasal infection in mice causes intestinal pathology via virally activated CD4 T cells in the lung up-regulating CCR9 and migrating to the intestine where they secrete IFN-\u03b3 that alters homeostasis of the microbiota.", {"entities": [[79, 82, "GENE"], [117, 121, "GENE"]]}], ["Subsequent induction of IL-15 aids differentiation into pathogenic Th17 cells in the gut.", {"entities": []}], ["Influenza in humans is often accompanied by gastroenteritis-like symptoms such as diarrhea, but the underlying mechanism is not yet understood.", {"entities": [[0, 9, "DISEASE"], [82, 90, "DISEASE"], [44, 59, "DISEASE"]]}], ["We explored the occurrence of gastroenteritis-like symptoms using a mouse model of respiratory influenza infection.", {"entities": [[95, 104, "DISEASE"], [30, 45, "DISEASE"]]}], ["We found that respiratory influenza infection caused intestinal injury when lung injury occurred, which was not due to direct intestinal viral infection.", {"entities": [[26, 35, "DISEASE"]]}], ["Influenza infection altered the intestinal microbiota composition, which was mediated by IFN-\u03b3 produced by lung-derived CCR9", {"entities": [[0, 9, "DISEASE"], [120, 124, "GENE"]]}], ["Acrolein (Acr) is a potent cytotoxic and DNA damaging agent which is ubiquitous in the environment and abundant in tobacco smoke.", {"entities": [[10, 13, "GENE"]]}], ["Acr is also an active cytotoxic metabolite of the anti-cancer drugs cyclophosphamide and ifosfamide.", {"entities": [[55, 61, "DISEASE"], [0, 3, "GENE"]]}], ["The mechanisms via which Acr exerts its anti-cancer activity and cytotoxicity are not clear.", {"entities": [[45, 51, "DISEASE"], [25, 28, "GENE"]]}], ["In this study, we found that Acr induces cytotoxicity and cell death in human cancer cells with different activities of p53.", {"entities": [[78, 84, "DISEASE"], [29, 32, "GENE"]]}], ["Acr preferentially binds nucleolar ribosomal DNA (rDNA) to form Acr-deoxyguanosine adducts, and induces oxidative damage to both rDNA and ribosomal RNA (rRNA).", {"entities": [[0, 3, "GENE"], [64, 67, "GENE"]]}], ["Acr triggers ribosomal stress responses, inhibits rRNA synthesis, reduces RNA polymerase I binding to the promoter of rRNA gene, disrupts nucleolar integrity, and impairs ribosome biogenesis and polysome formation.", {"entities": [[0, 3, "GENE"]]}], ["Acr causes an increase in MDM2 levels and phosphorylation of MDM2 in A549 and HeLa cells which are p53 active and p53 inactive, respectively.", {"entities": [[0, 3, "GENE"], [26, 30, "GENE"], [61, 65, "GENE"], [26, 30, "GENE"], [61, 65, "GENE"]]}], ["It enhances the binding of ribosomal protein RPL11 to MDM2 and reduces the binding of p53 and E2F-1 to MDM2 resulting in stabilization/activation of p53 in A549 cells and degradation of E2F-1 in A549 and HeLa cells.", {"entities": [[45, 50, "GENE"], [54, 58, "GENE"], [103, 107, "GENE"], [54, 58, "GENE"], [103, 107, "GENE"]]}], ["We propose that Acr induces ribosomal stress which leads to activation of MDM2 and RPL11-MDM2 binding, consequently, activates p53 and enhances E2F-1 degradation, and that taken together these two processes induce apoptosis and cell death.", {"entities": [[16, 19, "GENE"], [74, 78, "GENE"], [89, 93, "GENE"]]}], ["Indoor air quality has an effect on respiratory health.", {"entities": []}], ["Children are more vulnerable to a decreased indoor air quality as their lungs are still developing.", {"entities": []}], ["We measured levels of allergens and \u03b2-(1,3)-glucans in 19 school buildings and determined whether measured levels could be reproduced.", {"entities": []}], ["School levels were compared to those in 169 homes and the effect of building characteristics on both home and school exposure was explored.", {"entities": []}], ["Electrostatic Dust fall Collectors were placed in school buildings for 8 weeks and in homes for 2 weeks to collect settled airborne dust.", {"entities": []}], ["Cat, dog, and mouse allergen levels, domestic mite antigen levels and \u03b2-(1,3)-glucans were measured in the extracts from the collectors.", {"entities": []}], ["Results were corrected for sampling duration.", {"entities": []}], ["Using questionnaire data, relations between measured levels and building and classroom characteristics were explored.", {"entities": []}], ["In schools, exposure levels were highest in classrooms and were influenced by the socioeconomic status of the children, the season measurements were performed, moisture status of the building and pet ownership.", {"entities": []}], ["Repeated measurements in different seasons and over the years showed significantly different levels.", {"entities": []}], ["Home exposure was influenced by socioeconomic status, occupancy and pet ownership.", {"entities": []}], ["Domestic mite antigen was found in higher levels in extracts from homes compared to schools while pet allergen levels were 13 times higher in schools compared to homes without pets.", {"entities": []}], ["For mouse allergen overall levels of exposure were low but still two times higher in schools compared to homes.", {"entities": []}], ["Levels of \u03b2-(1,3)-glucans were also approximately two times higher in schools than in homes.", {"entities": []}], ["Exposure levels of several allergens and \u03b2-(1,3)-glucans in schools differ over time and are higher than in homes.", {"entities": []}], ["For children, exposure levels measured at school could contribute to their total exposure as especially animal allergen levels can be much higher in schools compared to homes.", {"entities": []}], ["T cells modulate the antiviral and inflammatory responses of airway epithelial cells to human rhinoviruses (HRV).", {"entities": []}], ["Differentiated primary human nasal epithelial cells (HNEC) grown on collagen-coated filters were exposed apically to HRV14 for 6 h, washed thoroughly and co-cultured with anti-CD3/CD28 activated T cells added in the basolateral compartment for 40 h. HRV14 did not induce IFN\u03b3, NOS2, CXCL8 and IL-6 in HNEC, but enhanced expression of the T cell attractant CXCL10.", {"entities": [[277, 281, "GENE"], [356, 362, "GENE"]]}], ["On the other hand, HNEC co-cultured with activated T cells produced CXCL10 at a level several orders of magnitude higher than that induced by HRV14.", {"entities": [[68, 74, "GENE"]]}], ["Albeit to a much lower degree, activated T cells also induced CXCL8, IL-6 and NOS2.", {"entities": [[78, 82, "GENE"]]}], ["Anti-IFN\u03b3 antibodies and TNF soluble receptor completely blocked CXCL10 upregulation.", {"entities": [[25, 28, "GENE"], [65, 71, "GENE"]]}], ["Furthermore, a significant correlation was observed between epithelial CXCL10 mRNA expression and the amounts of IFN\u03b3 and TNF secreted by T cells.", {"entities": [[71, 77, "GENE"], [122, 125, "GENE"]]}], ["Likewise, increasing numbers of T cells to a constant number of HNEC in co-cultures resulted in increasing epithelial CXCL10 production, attaining a plateau at high IFN\u03b3 and TNF levels.", {"entities": [[118, 124, "GENE"], [174, 177, "GENE"]]}], ["Hence, HNEC activation by T cells is induced mainly by IFN\u03b3 and/or TNF.", {"entities": [[67, 70, "GENE"]]}], ["Activated T cells also markedly inhibited viral replication in HNEC, partially through activation of the nitric oxide pathway.", {"entities": []}], ["Cross-talk between T cells and HNEC results in activation of the latter and increases their contribution to airway inflammation and virus clearance.", {"entities": []}], ["Eosinophilic myocarditis is a rare form of myocarditis.", {"entities": [[13, 24, "DISEASE"], [43, 54, "DISEASE"]]}], ["It is characterized pathologically by diffuse or focal myocardial inflammation with eosinophilic infiltration, often in association with peripheral blood eosinophilia.", {"entities": [[154, 166, "DISEASE"]]}], ["We report a case of eosinophilic myocarditis secondary to hypereosinophilic syndrome.", {"entities": [[33, 44, "DISEASE"], [76, 84, "DISEASE"]]}], ["A 74-year-old Caucasian woman with a history of asthma, paroxysmal atrial fibrillation, stroke and coronary artery disease presented to the emergency department of our hospital with chest pain.", {"entities": [[48, 54, "DISEASE"]]}], ["Evaluations revealed that she had peripheral blood eosinophilia and elevated cardiac enzymes.", {"entities": [[51, 63, "DISEASE"]]}], ["Electrocardiographic findings were nonspecific.", {"entities": []}], ["Her electrocardiographic finding and elevated cardiac enzymes pointed to a non-ST-elevated myocardial infarction.", {"entities": [[91, 112, "DISEASE"]]}], ["Echocardiogram showed a severe decrease in the left ventricular systolic function.", {"entities": []}], ["Coronary angiogram showed nonobstructive coronary artery disease.", {"entities": []}], ["She then underwent cardiac magnetic resonance imaging, which showed neither infiltrative myocardial diseases nor any evidence of infarction.", {"entities": []}], ["This was followed by an endomyocardial biopsy which was consistent with eosinophilic myocarditis.", {"entities": [[85, 96, "DISEASE"]]}], ["Hematologic workup regarding her eosinophilia was consistent with hypereosinophilic syndrome.", {"entities": [[84, 92, "DISEASE"], [33, 45, "DISEASE"]]}], ["After being started on steroid therapy, her peripheral eosinophilia resolved and her symptoms improved.", {"entities": [[55, 67, "DISEASE"]]}], ["Her left ventricular ejection fraction, however, did not improve.", {"entities": []}], ["Eosinophilic myocarditis can present like an acute myocardial infarction and should be considered in the differential diagnosis of acute coronary syndrome in patients with a history of allergy, asthma or acute reduction of the left ventricular function with or without peripheral eosinophilia.", {"entities": [[13, 24, "DISEASE"], [146, 154, "DISEASE"], [51, 72, "DISEASE"], [280, 292, "DISEASE"], [45, 72, "DISEASE"], [194, 200, "DISEASE"]]}], ["Despite the growing burden of NCDs in South Africa, very little is known about how people living in urban townships manage these illnesses.", {"entities": []}], ["In this article we expound upon the findings of a study showing that only one-third of women with an NCD participating in the Birth to Twenty (Bt20) cohort study of Soweto-Johannesburg, South Africa, had sought biomedical services in the previous six months.", {"entities": []}], ["We evaluated quantitative data from a cross sectional health access survey conducted with adult women (mean age\u2009=\u200944.8) and examined 25 in-depth narrative interviews with twelve women who self-reported at least one NCD from the larger study.", {"entities": []}], ["The qualitative findings highlight the potential role of negative experiences of healthcare services and biomedicine in delaying the seeking of healthcare.", {"entities": []}], ["Multivariate analysis of the quantitative findings found that the possession of medical aid (OR\u2009=\u20091.7, CI\u2009=\u20091.01-2.84) and the self-reported use of patient strategies in negotiating healthcare access (OR\u2009=\u20091.6, CI\u2009=\u20091.04-2.34) were positively associated with the utilization of healthcare services.", {"entities": []}], ["Belief in the superior efficacy of traditional healers over doctors was associated with delay of NCD treatment (OR\u2009=\u20092.4, CI\u2009=\u20091.14-4.18).", {"entities": []}], ["Our data suggest that low healthcare utilization is due in part to low rates of expectation for consistent and high-quality care and potential mistrust of the medical system.", {"entities": []}], ["We conclude that both demand-side and supply-side measures focusing on high trust management practices will prove essential in ensuring access to healthcare services.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-014-0528-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Vitamin C is an immune-relevant micronutrient, which is depleted in viral infections and this deficiency seems to play a critical role in the pathogenesis of herpes infections and in the development of postherpetic neuralgia.", {"entities": []}], ["The objective of this observational multicenter study was to evaluate the utilization, safety and efficacy of intravenously administrated vitamin C in patients with shingles.", {"entities": []}], ["Between April 2009 and December 2010 16 general practitioners recorded data of 67 participants with symptomatic herpes zoster who received vitamin C intravenously (Pascorbin Mean declines of pain scores (VAS), number of affected dermatomes and efflorescences, and the presence of hemorrhagic vesicles between the baseline and follow-up assessments at 2 and 12 weeks were statistically significant.", {"entities": [[112, 125, "DISEASE"]]}], ["Overall, 6.4% of the participants experienced post-herpetic neuralgia.", {"entities": []}], ["Common complaints such as general fatigue and impaired concentration also improved during the study.", {"entities": []}], ["The effects and the tolerability of the treatment were evaluated positively by the physicians.", {"entities": []}], ["The risk of developing PHN was reduced.", {"entities": []}], ["The data presented here provide evidence that concomitant use of intravenously administered ascorbic acid may have beneficial effects on herpes zoster-associated pain, dermatologic findings and accompanying common complaints.", {"entities": [[137, 150, "DISEASE"]]}], ["To confirm our findings, randomized, placebo-controlled clinical studies are necessary.", {"entities": []}], ["To explore the evidence translation process during a 1-week national guideline development workshop (\u201cChild Health Evidence Week\u201d) in Kenya.", {"entities": []}], ["Nonparticipant observational study of the discussions of a multidisciplinary guideline development panel in Kenya.", {"entities": []}], ["Discussions were aided by GRADE (Grading of Recommendations Assessment, Development, and Evaluation) grid.", {"entities": []}], ["Three key thematic categories emerged: 1) \u201creferral to other evidence to support or refute the proposed recommendations;\u201d 2)\u00a0\u201cassessment of the presented research evidence;\u201d and 3) \u201cassessment of the local applicability of evidence.\u201d The types of evidence cited included research evidence and anecdotal evidence based on clinician experiences.", {"entities": []}], ["Assessment of the research evidence revealed important challenges in the translation of evidence into recommendations, including absence of evidence, low quality or inconclusive evidence, inadequate reporting of key features of the management under consideration, and differences in panelists\u2019 interpretation of the research literature.", {"entities": []}], ["A broad range of factors with potential to affect local applicability of evidence were discussed.", {"entities": []}], ["The process of the \u201cChild Health Evidence Week\u201d combined with the GRADE grid may aid transparency in the deliberative process of guideline development, and provide a mechanism for comprehensive assessment, documentation, and reporting of multiple factors that influence the quality and applicability of guideline recommendations.", {"entities": []}], ["Neutrophils are the most important effector cells during the development of chronic obstructive pulmonary disease (COPD).", {"entities": [[76, 113, "DISEASE"]]}], ["Although neutrophil elastase is critical in cigarette smoke (CS)-induced lung parenchyma, the mechanism by which CS triggers elastase release from neutrophils remains unclear.", {"entities": [[61, 63, "GENE"], [113, 115, "GENE"], [61, 63, "GENE"], [113, 115, "GENE"]]}], ["Here we report that CS induction of autophagy in neutrophils by activating platelet- activating factor receptor (PAFR) promotes COPD progression in mouse.", {"entities": [[20, 22, "GENE"]]}], ["We found that the dead neutrophils were increased in bronchoalveolar lavage fluid from CS-exposed mice.", {"entities": []}], ["Blocking PAFR suppressed the CS-induced autophagy in neutrophils, protected neutrophils from death, and reduced elastase release.", {"entities": []}], ["Mechanistically, CS enhanced ROS production and High mobility group box 1 (HMGB1) expression through activation of PAFR.", {"entities": [[17, 19, "GENE"], [75, 80, "GENE"]]}], ["The elevated HMGB1 interacted with beclin1, which promoted the dissociation of Bcl-2 from beclin1 and the assembly of autophagy core complex.", {"entities": [[13, 18, "GENE"]]}], ["Moreover, the antagonism of PAFR by rupatadine, a prescription PAFR inhibitor, protected against the development of emphysema, and reduced the autophagic death of neutrophils after CS exposure.", {"entities": [[181, 183, "GENE"]]}], ["These results suggest that CS contributes to the pathogenesis of COPD partly by inducing a PAFR-dependent autophagic death of neutrophils.", {"entities": [[27, 29, "GENE"]]}], ["Therefore, PAFR may be a therapeutic target for COPD and inhibition of PAFR may provide potential therapeutic benefits in the treatment of patients with COPD.", {"entities": []}], ["Many in the welding industry suffer from bronchitis, lung function changes, metal fume fever, and diseases related to respiratory damage.", {"entities": [[41, 51, "DISEASE"]]}], ["These phenomena are associated with welding fumes; however, the mechanism behind these findings remains to be elucidated.", {"entities": []}], ["In this study, the lungs of cynomolgus monkeys were exposed to MMA-SS welding fumes for 229\u00a0days and allowed to recover for 153\u00a0days.", {"entities": []}], ["After the exposure and recovery period, gene expression profiles were investigated using the Affymetrix GeneChip P \u00a0<\u00a00.01) for the T1 (31.4\u00a0\u00b1\u00a02.8\u00a0mg/m CHI3L1 , RARRES1 , and CTSB were up-regulated and genes such as CYP26B1 , ID4 , and NRGN were down-regulated in both monkeys and rats following welding fume exposure.", {"entities": [[152, 158, "GENE"], [161, 168, "GENE"], [175, 179, "GENE"], [216, 223, "GENE"], [226, 229, "GENE"], [236, 240, "GENE"]]}], ["This is the first comprehensive gene expression profiling conducted for welding fume exposure in monkeys, and these expressed genes are expected to be useful in helping to understand transcriptional changes in monkey lungs after welding fume exposure.", {"entities": []}], ["The online version of this article (doi:10.1007/s00204-009-0486-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The vaccine efficacy reported following Mycobacterium bovis Bacillus Calmette Guerin (BCG) administration to UK adolescents is 77% and defining the cellular immune response in this group can inform us as to the nature of effective immunity against tuberculosis.", {"entities": [[248, 260, "DISEASE"]]}], ["The aim of this study was to identify which cytokines and lymphocyte populations characterise the peripheral blood cellular immune response following BCG vaccination.", {"entities": []}], ["Diluted blood from before and after vaccination was stimulated with Mycobacterium tuberculosis purified protein derivative for 6 days, after which soluble biomarkers in supernatants were assayed by multiplex bead array.", {"entities": [[82, 94, "DISEASE"]]}], ["Ten out of twenty biomarkers measured were significantly increased (p < 0.0025) 1 month after BCG vaccination when compared to paired samples (n = 12) taken prior to vaccination (IFN\u03b3, TNF\u03b1, IL-1\u03b1, IL-2, IL-6, IL-10, IL-17, GM-CSF, MIP1\u03b1, IP-10).", {"entities": []}], ["All of these remained detectable by multiplex bead array in samples taken 12 months after BCG vaccination of a partially overlapping adolescent group (n = 12).", {"entities": []}], ["Intracellular cytokine staining after 24 hour Mycobacterium tuberculosis purified protein derivative stimulation of PBMC samples from the 12 month group revealed that IFN\u03b3 expression was detectable in CD4 and CD8 T-cells and natural killer cells.", {"entities": [[60, 72, "DISEASE"], [201, 204, "GENE"]]}], ["Polyfunctional flow cytometry analysis demonstrated that cells expressing IFN\u03b3 alone formed the majority in each subpopulation of cells.", {"entities": []}], ["Only in CD4 T-cells and NK cells were there a notable proportion of responding cells of a different phenotype and these were single positive, TNF\u03b1 producers.", {"entities": [[8, 11, "GENE"]]}], ["No significant expression of the cytokines IL-2, IL-17 or IL-10 was seen in any population of cells.", {"entities": []}], ["The broad array of biomarker responses detected by multiplex bead array suggests that BCG vaccination is capable, in this setting, of inducing a complex immune phenotype.", {"entities": []}], ["Although polyfunctional T-cells have been proposed to play a role in protective immunity, they were not present in vaccinated adolescents who, based on earlier epidemiological studies, should have developed protection against pulmonary tuberculosis.", {"entities": [[236, 248, "DISEASE"], [226, 248, "DISEASE"]]}], ["This may be due to the later sampling time point available for testing or on the kinetics of the assays used.", {"entities": []}], ["Ritodrine, a tocolytic \u03b22-agonist, has been used extensively in Europe and Asia despite its safety concerns.", {"entities": []}], ["This study was designed to identify associations between \u03b22-adrenergic receptor ( ADRB2 ) polymorphisms and adverse drug events (ADEs) in patients with preterm labor treated with ritodrine.", {"entities": [[82, 87, "GENE"]]}], ["This follow-up study was prospectively conducted at Ewha Womans University Mokdong Hospital in Korea.", {"entities": []}], ["Five single nucleotide polymorphisms (SNPs) of the ADRB2 gene (rs1042713, rs1042714, rs1042717, rs1042718, and rs1042719) were analyzed in 186 pregnant women with preterm labor.", {"entities": [[51, 56, "GENE"]]}], ["Patients with the AA genotype of rs1042717 had significantly lower incidence of ADEs compared to those with the G allele ( p \u00a0=\u00a00.009).", {"entities": []}], ["In multivariate analysis, one of the predictors of ADEs was the maximum infusion rate of ritodrine (AOR 4.47, 95% CI 1.31\u201315.25).", {"entities": []}], ["Rs1042719 was also a significant factor for ritodrine-induced ADEs.", {"entities": []}], ["The CC genotype carriers had 78% decreased risk of ADEs compared to those with other genotypes.", {"entities": []}], ["This study demonstrates that ADEs induced by ritodrine are associated with ADRB2 gene polymorphisms, as well as the infusion rate of ritodrine in pregnant women with preterm labor.", {"entities": [[75, 80, "GENE"]]}], ["Casual contact was not associated with transmission, and serologic methods were more sensitive than real-time reverse transcription-PCR.", {"entities": []}], ["Risk factors for human-to-human transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) are largely unknown.", {"entities": [[72, 80, "DISEASE"]]}], ["After MERS-CoV infections occurred in an extended family in Saudi Arabia in 2014, relatives were tested by using real-time reverse transcription PCR (rRT-PCR) and serologic methods.", {"entities": []}], ["Among 79 relatives, 19 (24%) were MERS-CoV positive; 11 were hospitalized, and 2 died.", {"entities": []}], ["Eleven (58%) tested positive by rRT-PCR; 8 (42%) tested negative by rRT-PCR but positive by serology.", {"entities": []}], ["Compared with MERS-CoV\u2013negative adult relatives, MERS-CoV\u2013positive adult relatives were older and more likely to be male and to have chronic medical conditions.", {"entities": []}], ["Risk factors for household transmission included sleeping in an index patient\u2019s room and touching respiratory secretions from an index patient.", {"entities": []}], ["Casual contact and simple proximity were not associated with transmission.", {"entities": []}], ["Serology was more sensitive than standard rRT-PCR for identifying infected relatives, highlighting the value of including serology in future investigations.", {"entities": []}], ["We aimed to provide a summary of the existing published knowledge on the association between adverse birth outcomes and the development of wheezing during the first two years of life.", {"entities": []}], ["We carried out a systematic review of epidemiological studies within the MEDLINE database.", {"entities": []}], ["Epidemiological studies on human subjects, published in English, were included in the review.", {"entities": []}], ["A comprehensive literature search yielded 72 studies for further consideration.", {"entities": []}], ["Following the application of the eligibility criteria we identified nine studies.", {"entities": []}], ["A positive association and an excess risk of wheezing during the first two years of life were revealed for adverse birth outcomes.", {"entities": []}], ["Previous studies have suggested a potential risk to healthcare workers applying isocyanate-containing casts, but the authors reached their conclusions based on immunological or clinical pulmonology test results alone.", {"entities": []}], ["We designed a study to assess potential exposure to methylene diphenyl diisocyanate (MDI) among medical personnel applying orthopedic casts using two different application methods.", {"entities": []}], ["Air, dermal, surface, and glove permeation sampling methods were combined with urinary biomonitoring to assess the overall risk of occupational asthma to workers handling these materials.", {"entities": [[144, 150, "DISEASE"]]}], ["No MDI was detected in any of the personal and area air samples obtained.", {"entities": []}], ["No glove permeation of MDI was detected.", {"entities": []}], ["A small proportion of surface (3/45) and dermal wipe (1/60) samples were positive for MDI, but were all from inexperienced technicians.", {"entities": []}], ["Urinary metabolites of MDI [methylenedianiline (MDA)] were detected in three of six study participants prior to both a \u2018dry\u2019 and \u2018wet\u2019 application method, five of six after the dry method, and three of six after the wet method.", {"entities": []}], ["All MDA results were below levels noted in worker or general populations.", {"entities": []}], ["Our conclusion is that the risk of MDI exposure is small, but unquantifiable.", {"entities": []}], ["Because there is some potential risk of dermal exposure, medical personnel are instructed to wear a minimum of 5-mil-thick (5 mil = 0.005 inches) nitrile gloves and avoid contact to unprotected skin.", {"entities": []}], ["This could include gauntlets, long sleeves, and/or a laboratory coat.", {"entities": []}], ["The antioxidant activity of water, ethanol and methanol Hieracium pilosella L. extracts is reported.", {"entities": []}], ["The antioxidative activity was tested by spectrophotometrically measuring their ability to scavenge a stable DPPH O -glucoside and umbelliferone).", {"entities": []}], ["The antioxidant activity of the investigated extracts slightly differs depending on the solvent used.", {"entities": []}], ["The concentration of 0.30 mg/mL of water, ethanol and methanol extract is less effective in scavenging hydroxyl radicals (56.35, 58.73 and 54.35%, respectively) in comparison with the DPPH", {"entities": []}], ["Obesity has been identified as a risk factor for higher prevalence of asthma and asthma-related symptoms in children.", {"entities": [[0, 7, "DISEASE"], [70, 76, "DISEASE"], [81, 87, "DISEASE"]]}], ["The objective of this study was to evaluate the relationship between the prevalence of asthma symptoms and obesity among school-age children in the city of Ahvaz, Iran.", {"entities": [[107, 114, "DISEASE"], [87, 93, "DISEASE"]]}], ["A total of 903 children, 7 to 11 years of age, were enrolled in this study through cluster sampling.", {"entities": []}], ["The International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire was used to identify the children who were currently suffering from asthma.", {"entities": [[27, 33, "DISEASE"], [151, 157, "DISEASE"]]}], ["Height and weight were measured and body mass index (BMI) was calculated in kg/m The prevalence of wheeze ever, current wheezing, obesity, and overweight was 21.56%, 8.7%, 6.87%, and 9.5%, respectively.", {"entities": [[130, 137, "DISEASE"]]}], ["The current prevalence of wheezing among obese and overweight children was 68.75% and 37%, respectively, and there was a statistical association between obesity and the prevalence of current wheezing (p < 0.001), night cough (p < 0.001), and exercise-induced wheezing (p = 0.009), but obesity and overweight were not associated with eczema and allergic rhinoconjunctivitis, so it seems that the pathophysiology of asthma in obese and overweight children is not related to allergy.", {"entities": [[153, 160, "DISEASE"], [285, 292, "DISEASE"], [414, 420, "DISEASE"]]}], ["There is a strong association between asthma symptoms and both overweight and obesity in both sexes among school-age children.", {"entities": [[78, 85, "DISEASE"], [38, 44, "DISEASE"]]}], ["Characteristics of patients with community-acquired pneumonia (CAP) due to pandemic influenza A 2009 (H1N1) have been inadequately compared to CAP caused by other respiratory pathogens.", {"entities": [[84, 93, "DISEASE"], [52, 61, "DISEASE"]]}], ["The performance of prediction rules for CAP during an epidemic with a new infectious agent are unknown.", {"entities": []}], ["Prospective, population-based study from November 2008\u2013November 2009, in centers representing 70% of hospital beds in Iceland.", {"entities": []}], ["Patients admitted with CAP underwent evaluation and etiologic testing, including polymerase chain reaction (PCR) for influenza.", {"entities": [[117, 126, "DISEASE"]]}], ["Data on influenza-like illness in the community and overall hospital admissions were collected.", {"entities": [[8, 17, "DISEASE"]]}], ["Clinical and laboratory data, including pneumonia severity index (PSI) and CURB-65 of patients with CAP due to H1N1 were compared to those caused by other agents.", {"entities": [[40, 49, "DISEASE"]]}], ["Of 338 consecutive and eligible patients 313 (93%) were enrolled.", {"entities": []}], ["During the pandemic peak, influenza A 2009 (H1N1) patients constituted 38% of admissions due to CAP.", {"entities": [[26, 35, "DISEASE"]]}], ["These patients were younger, more dyspnoeic and more frequently reported hemoptysis.", {"entities": []}], ["They had significantly lower severity scores than other patients with CAP (1.23 vs. 1.61, P \u200a=\u200a.02 for CURB-65, 2.05 vs. 2.87 for PSI, P <.001) and were more likely to require intensive care admission (41% vs. 5%, P <.001) and receive mechanical ventilation (14% vs. 2%, P \u200a=\u200a.01).", {"entities": []}], ["Bacterial co-infection was detected in 23% of influenza A 2009 (H1N1) patients with CAP.", {"entities": [[46, 55, "DISEASE"]]}], ["Clinical characteristics of CAP caused by influenza A 2009 (H1N1) differ markedly from CAP caused by other etiologic agents.", {"entities": [[42, 51, "DISEASE"]]}], ["Commonly used CAP prediction rules often failed to predict admissions to intensive care or need for assisted ventilation in CAP caused by the influenza A 2009 (H1N1) virus, underscoring the importance of clinical acumen under these circumstances.", {"entities": [[142, 151, "DISEASE"]]}], ["The digitization of health-related information through electronic health records (EHR) and electronic healthcare reimbursement claims and the continued growth of self-reported health information through social media provides both tremendous opportunities and challenges in developing effective biosurveillance tools.", {"entities": []}], ["With novel emerging infectious diseases being reported across different parts of the world, there is a need to build systems that can track, monitor and report such events in a timely manner.", {"entities": []}], ["Further, it is also important to identify susceptible geographic regions and populations where emerging diseases may have a significant impact.", {"entities": []}], ["In this paper, we present an overview of Oak Ridge Biosurveillance Toolkit (ORBiT), which we have developed specifically to address data analytic challenges in the realm of public health surveillance.", {"entities": []}], ["In particular, ORBiT provides an extensible environment to pull together diverse, large-scale datasets and analyze them to identify spatial and temporal patterns for various biosurveillance-related tasks.", {"entities": []}], ["We demonstrate the utility of ORBiT in automatically extracting a small number of spatial and temporal patterns during the 2009-2010 pandemic H1N1 flu season using claims data.", {"entities": []}], ["These patterns provide quantitative insights into the dynamics of how the pandemic flu spread across different parts of the country.", {"entities": []}], ["We discovered that the claims data exhibits multi-scale patterns from which we could identify a small number of states in the United States (US) that act as \"bridge regions\" contributing to one or more specific influenza spread patterns.", {"entities": [[211, 220, "DISEASE"]]}], ["Similar to previous studies, the patterns show that the south-eastern regions of the US were widely affected by the H1N1 flu pandemic.", {"entities": []}], ["Several of these south-eastern states act as bridge regions, which connect the north-east and central US in terms of flu occurrences.", {"entities": []}], ["These quantitative insights show how the claims data combined with novel analytical techniques can provide important information to decision makers when an epidemic spreads throughout the country.", {"entities": []}], ["Taken together ORBiT provides a scalable and extensible platform for public health surveillance.", {"entities": []}], ["To investigate the association of concussion with cognitive ability (CA) and educational level (EL).", {"entities": []}], ["Epidemiological\u2014cross-linkage of national computer registers.", {"entities": []}], ["130\u2005420 young men appearing before the Danish draft board during the period 2006\u20132010.", {"entities": []}], ["CA test scores, EL and occurrence of concussion during the period 2004\u20132009, treated either in an A&E unit or upon admission to a hospital ward.", {"entities": []}], ["The 3067 men who had suffered a concussion had lower CAs (mean=96.5, SD=15, 95% CI 95.0 to 97.0) than the total cohort and they were lower for 1452 who were admitted to a hospital ward (mean CA=95.8, SD=15, 95% CI 95.1 to 96.6) than for 1615 who were treated only at an A&E unit (mean CA=97.1, SD=15, 95% CI 96.3 to 98.0).", {"entities": []}], ["Multiple logistic regressions revealed that the effects for EL were stronger than those for CA.", {"entities": []}], ["Among 127\u2005353 men not sustaining a concussion, 48% attended a \u2018gymnasium\u2019 (sixth-form college), among men treated for a concussion at an A&E unit, this falls to 36% and among men hospitalised for a concussion to 30%.", {"entities": []}], ["Transfer to a gymnasium, if it happens, almost invariably does so before the 18th birthday.", {"entities": []}], ["Among 701 men suffering a concussion and admitted to a hospital department after this date, only 26% (n=182) were previously transferred to a gymnasium.", {"entities": []}], ["Among the 804 men treated at an A&E unit after their 18th birthday, 33% (n=265) had done so.", {"entities": []}], ["These two percentages are significantly below the corresponding non-concussed population (48%).", {"entities": []}], ["Taken together, the results suggest that lower CA and, in particular, lower EL are risk factors for sustaining a concussion, the risk increasing with the severity of the injury.", {"entities": []}], ["The etiology of childhood obesity is multidimensional and includes individual, familial, organizational, and societal factors.", {"entities": [[26, 33, "DISEASE"]]}], ["Policymakers and researchers are promoting social\u2013ecological approaches to obesity prevention that encompass multiple community sectors.", {"entities": [[75, 82, "DISEASE"]]}], ["Programs that successfully engage low-income families in making healthy choices are greatly needed, yet little is known about the extent to which stakeholders understand the complexity of barriers encountered by families.", {"entities": []}], ["The objective of this study was to contextually frame barriers faced by low-income families reported by community stakeholders by using the Family Ecological Model (FEM).", {"entities": []}], ["From 2012 through 2013, we conducted semistructured interviews with 39 stakeholders from 2 communities in Massachusetts that were participating in a multisector intervention for childhood obesity prevention.", {"entities": [[188, 195, "DISEASE"]]}], ["Stakeholders represented schools; afterschool programs; health care; the Special Supplemental Nutrition Program for Women, Infants, and Children; and early care and education.", {"entities": []}], ["Interviews were audio-recorded, transcribed, coded, and summarized.", {"entities": []}], ["Stakeholder reports of the barriers experienced by low-income families had a strong degree of overlap with FEM and reflected awareness of the broader contextual factors (eg, availability of community resources, family culture, education) and social and emotional dynamics within families (eg, parent knowledge, social norms, distrust of health care providers, chronic life stressors) that could affect family adoption of healthy lifestyle behaviors.", {"entities": []}], ["Furthermore, results illustrated a level of consistency in stakeholder awareness across multiple community sectors.", {"entities": []}], ["The congruity of stakeholder perspectives with those of low-income parents as summarized in FEM and across community sectors illustrates potential for synergizing the efforts necessary for multisector, multilevel community interventions for the prevention of childhood obesity.", {"entities": [[269, 276, "DISEASE"]]}], ["To assess the effects of a home-based telehealth intervention on the use of secondary healthcare and mortality.", {"entities": []}], ["Observational study of a mainstream telehealth service, using person-level administrative data.", {"entities": []}], ["Time to event analysis (Cox regression) was performed comparing telehealth patients with controls who were matched using a machine-learning algorithm.", {"entities": []}], ["A predominantly rural region of England (North Yorkshire).", {"entities": []}], ["716 telehealth patients were recruited from community, general practice and specialist acute care, between June 2010 and March 2013.", {"entities": []}], ["Patients had chronic obstructive pulmonary disease, congestive heart failure or diabetes, and a history of associated inpatient admission.", {"entities": [[52, 76, "DISEASE"], [13, 50, "DISEASE"]]}], ["Patients were matched 1:1 to control patients, also selected from North Yorkshire, with respect to demographics, diagnoses of health conditions, previous hospital use and predictive risk score.", {"entities": []}], ["Telehealth involved the remote exchange of medical data between patients and healthcare professionals as part of the ongoing management of the patient's health condition.", {"entities": []}], ["Monitoring centre staff alerted healthcare professionals if the telemonitored data exceeded preset thresholds.", {"entities": []}], ["Control patients received usual care, without telehealth.", {"entities": []}], ["Time to the first emergency (unplanned) hospital admission or death.", {"entities": []}], ["Secondary metrics included time to death and time to first admission, outpatient attendance and emergency department visit.", {"entities": []}], ["Matched controls and telehealth patients were similar at baseline.", {"entities": []}], ["Following enrolment, telehealth patients were more likely than matched controls to experience emergency admission or death (adjusted HR 1.34, 95% CI 1.16 to 1.56, p<0.001).", {"entities": [[133, 135, "GENE"]]}], ["They were also more likely to have outpatient attendances (adjusted HR=1.25, 1.11 to 1.40, p<0.001), but mortality rates were similar between groups.", {"entities": []}], ["Sensitivity analyses showed that we were unlikely to have missed reductions in the likelihood of an emergency admission or death because of unobserved baseline differences between patient groups.", {"entities": []}], ["Telehealth was not associated with a reduction in secondary care utilisation.", {"entities": []}], ["Although increased synchrony of the neural activity in the basal ganglia may underlie the motor deficiencies exhibited in Parkinson's disease (PD), how this synchrony arises, propagates through the basal ganglia, and changes under dopamine replacement remains unknown.", {"entities": []}], ["Gap junctions could play a major role in modifying this synchrony, because they show functional plasticity under the influence of dopamine and after neural injury.", {"entities": []}], ["In this study, confocal imaging was used to detect connexin-36, the major neural gap junction protein, in postmortem tissues of PD patients and control subjects in the putamen, subthalamic nucleus (STN), and external and internal globus pallidus (GPe and GPi, respectively).", {"entities": [[255, 258, "GENE"]]}], ["Moreover, we quantified how gap junctions affect synchrony in an existing computational model of the basal ganglia.", {"entities": []}], ["We detected connexin-36 in the human putamen, GPe, and GPi, but not in the STN.", {"entities": [[55, 58, "GENE"]]}], ["Furthermore, we found that the number of connexin-36 spots in PD tissues increased by 50% in the putamen, 43% in the GPe, and 109% in the GPi compared with controls.", {"entities": [[138, 141, "GENE"]]}], ["In the computational model, gap junctions in the GPe and GPi strongly influenced synchrony.", {"entities": [[57, 60, "GENE"]]}], ["The basal ganglia became especially susceptible to synchronize with input from the cortex when gap junctions were numerous and high in conductance.", {"entities": []}], ["In conclusion, connexin-36 expression in the human GPe and GPi suggests that gap junctional coupling exists within these nuclei.", {"entities": [[59, 62, "GENE"]]}], ["In PD, neural injury and dopamine depletion could increase this coupling.", {"entities": []}], ["Therefore, we propose that gap junctions act as a powerful modulator of synchrony in the basal ganglia.", {"entities": []}], ["Cytokines play a critical role in the normal development and\t\t\t function of the immune system.", {"entities": []}], ["On the other hand, many rheumatologic diseases\t\t\t are characterized by poorly controlled responses to or dysregulated production\t\t\t of these mediators.", {"entities": []}], ["Over the past decade tremendous strides have been made in\t\t\t clarifying how cytokines transmit signals via pathways using the Janus kinase\t\t\t (Jak) protein tyrosine kinases and the Signal transducer and activator of\t\t\t transcription (Stat) proteins.", {"entities": []}], ["More recently, research has focused on several\t\t\t distinct proteins responsible for inhibiting these pathways.", {"entities": []}], ["It is hoped that\t\t\t further elucidation of cytokine signaling through these pathways will not only\t\t\t allow for a better comprehension of the etiopathogenesis of rheumatologic\t\t\t illnesses, but may also direct future treatment options.", {"entities": []}], ["In the US, the approved multiple sclerosis (MS) oral disease-modifying therapies (ODMTs) are fingolimod (FTY), teriflunomide (TFN), and dimethyl fumarate (DMF).", {"entities": [[24, 42, "DISEASE"]]}], ["FTY and TFN are recommended with once-daily doses with no up-titration, whereas DMF treatment is recommended twice-daily (BID) and is initiated with a 7-day starter dose of 120\u00a0mg BID before up-titration to the maintenance dose of 240\u00a0mg BID.", {"entities": []}], ["Limited information exists regarding real-world ODMT prescribing patterns to aid physician/patient decision-making.", {"entities": []}], ["Eligible patients for this retrospective medical record review were \u226518\u00a0years, had one visit related to ODMT initiation (index visit), and \u22651 visit within 12\u00a0months before and after the index visit.", {"entities": []}], ["Primary objectives were to assess post-index ODMT persistency (i.e., discontinuation), prescribing patterns (medication switching, dose up-titrations, dose reduction, re-starts, and add-ons) and medical resource utilization (office-visits, MRI procedures, and mobility indicators) at distinct time windows of 3, 6, 9, and 12\u00a0months.", {"entities": []}], ["Chi-square or Wilcoxon Rank Sum tests were used for 3-way ODMT group comparisons.", {"entities": []}], ["Medical records of 293 MS-diagnosed patients using ODMTs were abstracted from 19 US-based neurology clinics between December 31, 2010 and June 30, 2014 (FTY: 101; DMF: 133; TFN: 59).", {"entities": []}], ["Persistency rates among ODMT groups were similar.", {"entities": []}], ["MS-related medication switching, dose reduction, re-starts, and add-ons were infrequently observed and were similar across ODMT groups.", {"entities": []}], ["Of DMF patients with a confirmed starting dose of 120\u00a0mg BID with \u226512\u00a0months follow-up ( n \u2009=\u200926), the percentage who were prescribed dose up-titrations to the recommended maintenance DMF dose was 23.1\u00a0% at 1\u20133 months, 26.9\u00a0% at 4\u20136 months, 42.3\u00a0% at 7\u20139 months, and 0\u00a0% at 10\u201312 months.", {"entities": []}], ["There were no significant differences at any time window among the ODMT groups in the number of office visits or percent of patients receiving MRIs.", {"entities": []}], ["Mobility indicator patterns (proportion of patients with abnormal gait, wheelchair use, etc.)", {"entities": []}], ["were consistent over time.", {"entities": []}], ["There was no difference in persistency, prescribing patterns (medication switching, dose reduction, re-starts, and add-ons) or medical resource utilization (office-visits, MRI procedures, and mobility indicators) among the ODMTs.", {"entities": []}], ["However, in a small sub-group of patients, delays of up to 9\u00a0months in DMF dose-up titration to the recommended maintenance dose were observed.", {"entities": []}], ["The online version of this article (doi:10.1186/s12883-016-0698-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["It is well documented that exhaustive physical exercise leads to inflammation and skeletal muscle tissue damage.", {"entities": []}], ["With this in mind, melatonin has been acutely administered before physical exercise; nevertheless, the use of melatonin as an ergogenic agent to prevent tissue inflammation and damage remains uncertain.", {"entities": []}], ["We evaluated the effects of melatonin on swimming performance, muscle inflammation and damage and several physiological parameters after exhaustive exercise at anaerobic threshold intensity (iLAn) performed during light or dark circadian periods.", {"entities": []}], ["The iLAn was individually determined and two days later, the animals performed an exhaustive exercise bout at iLAn 30\u2009minutes after melatonin administration.", {"entities": []}], ["The exercise promoted muscle inflammation and damage, mainly during the dark period, and the exogenous melatonin promoted a high ergogenic effect.", {"entities": []}], ["The expressive ergogenic effect of melatonin leads to longer periods of muscle contraction, which superimposes a possible melatonin protective effect on the tissue damage and inflammation.", {"entities": []}], ["Persistent daytime hypersomnolence is associated with significant morbidity and mortality, but its prevalence in the population has been poorly documented.", {"entities": []}], ["This study sought to characterize the prevalence of persistent daytime hypersomnolence, difficulties initiating and maintaining sleep, unrefreshing sleep, snoring, and the presence of physician-diagnosed sleep disorders in metropolitan, urban, and rural US Georgia populations.", {"entities": []}], ["Between September 2004 and July 2005, a total of 6,530 randomly selected well and unwell adults, identified by screening interviews of 10,837 households (contacted by random digit dialing), completed a detailed phone interview.", {"entities": []}], ["Sixteen percent reported persistent problems staying awake during the day; 26% reported persistent problems falling asleep at night; 31% experienced problems sleeping through the night; 34% were bothered by unrefreshing sleep; and 33% reported that they snored.", {"entities": []}], ["In spite of the high occurrence of reported persistent sleep problems, only 10% of the survey participants reported having been diagnosed with a sleep disorder.", {"entities": [[145, 159, "DISEASE"]]}], ["These study findings highlight the need for increased public and clinician awareness with respect to proactively indentifying signs and symptoms of sleep disorders, a better understanding of their adverse impact upon morbidity and mortality, and their negative impact upon socioeconomic and academic potential.", {"entities": []}], ["T regulatory cell (Treg) plays a critical role in respiratory allergy and allergen-specific immunotherapy (SIT), and \u03b3\u03b4 T cells might participate in mediating Treg quantity and/or function in some immunological diseases.", {"entities": []}], ["To further characterize whether \u03b3\u03b4 T cells could influence Treg in allergic rhinitis (AR) and SIT, we investigated the expression pattern of Treg\u2019s Foxp3 gene and \u03b3\u03b4 T cell receptor (TCR) V\u03b3 subfamily genes in peripheral blood mononuclear cells (PBMCs) of AR patients before and after SIT.", {"entities": [[67, 84, "DISEASE"], [76, 84, "DISEASE"], [148, 153, "GENE"]]}], ["Eighteen AR patients undergoing effective SIT with house dust mite extract for one year were recruited.", {"entities": []}], ["Visual Analogue Scale (VAS) was applied to evaluate the severity.", {"entities": []}], ["Immunofluorescence quantification analysis was performed to determine the serum specific IgE (sIgE) content.", {"entities": []}], ["Real-time PCR was used to detect the expression levels of Foxp3 and TCR V\u03b3 subfamilies.", {"entities": [[58, 63, "GENE"]]}], ["Ten healthy volunteers were recruited as the controls.", {"entities": []}], ["Nasal uni-VAS score after SIT was significantly lower than that before SIT, while serum sIgE content was similar before and after SIT.", {"entities": []}], ["Expression levels of Foxp3 and TCR V\u03b3 subfamilies in AR patients before treatment were significantly lower than those in healthy subjects.", {"entities": [[21, 26, "GENE"]]}], ["Expression levels of V\u03b3I and II were similar before and after SIT, while expression levels of Foxp3 and V\u03b3III after SIT were significantly higher than those before.", {"entities": [[94, 99, "GENE"]]}], ["Before SIT, the significant positive correlation was observed between expression levels of Foxp3 and V\u03b3I, II, III, while negative correlation was observed between Foxp3, V\u03b3III and VAS.", {"entities": [[91, 96, "GENE"], [163, 168, "GENE"], [91, 96, "GENE"], [163, 168, "GENE"]]}], ["After SIT, the significant positive correlation between expression levels of Foxp3 and V\u03b3III and negative correlation between Foxp3, V\u03b3III and VAS were observed.", {"entities": [[77, 82, "GENE"], [126, 131, "GENE"], [77, 82, "GENE"], [126, 131, "GENE"]]}], ["Treg and V\u03b3 subfamily T cells were in a dynamic equilibrium in AR patients before and after effective immunotherapy for one year.", {"entities": []}], ["The early improvement of symptoms following immunotherapy might be independent of the serum sIgE content in AR patients, but associated with the reconstitution of T cell immunity.", {"entities": []}], ["Periostin, also called osteoblast-specific factor 2, is a secreted cell adhesion protein, which shares a homology with the insect cell adhesion molecule fasciclin I.", {"entities": []}], ["It has been shown to be an important regulator of bone and tooth formation and maintenance, and of cardiac development and healing.", {"entities": []}], ["Recent studies revealed that periostin plays an important role in tumor development and is upregulated in a wide variety of cancers such as colon, pancreatic, ovarian, breast, head and neck, thyroid, and gastric cancer as well as in neuroblastoma.", {"entities": [[233, 246, "DISEASE"], [212, 218, "DISEASE"]]}], ["Periostin binding to the integrins activates the Akt/PKB- and FAK-mediated signaling pathways which lead to increased cell survival, angiogenesis, invasion, metastasis, and importantly, epithelial-mesenchymal transition of carcinoma cells.", {"entities": [[223, 232, "DISEASE"]]}], ["In this review we summarize recent clinicopathological studies that have investigated periostin expression in lung, kidney, prostate, liver cancer, and malignant pleural mesothelioma and discuss the role of periostin isoforms in tumorigenesis and their potential as targets for stroma-targeted anticancer therapy.", {"entities": [[152, 182, "DISEASE"], [134, 146, "DISEASE"], [140, 146, "DISEASE"]]}], ["Improvements in ventilatory mechanics with tiotropium increases exercise tolerance during pulmonary rehabilitation.", {"entities": []}], ["We wondered whether tiotropium also increased physical activities outside of pulmonary rehabilitation.", {"entities": []}], ["COPD patients participating in 8 weeks of pulmonary rehabilitation were studied in a randomized, double-blind, placebo-controlled trial of tiotropium 18 \u03bcg daily (tiotropium = 47, placebo = 44).", {"entities": []}], ["Study drug was administered for 5 weeks prior to, 8 weeks during, and 12 weeks following pulmonary rehabilitation.", {"entities": []}], ["Patients completed a questionnaire documenting participation in pre-defined activities outside of pulmonary rehabilitation during the 2 weeks prior to each visit.", {"entities": []}], ["Patients who submitted an activity questionnaire at week 4 and on at least one subsequent visit were included in the analysis.", {"entities": []}], ["For each patient, the number of sessions was multiplied with the duration of each activity and then summed to give overall activity duration.", {"entities": []}], ["Patients (n = 46) had mean age of 67 years, mean baseline FEV 1 of 0.84 L (33% predicted).", {"entities": [[58, 61, "GENE"]]}], ["Mean (SE) increase in duration of activities (minutes during 2 weeks prior to each visit) from week 4 (prior to PR) to week 13 (end of PR) was 145 (84) minutes with tiotropium and 66 (96) minutes with placebo.", {"entities": []}], ["The increase from week 4 to week 25 (end of follow-up) was 262 (96) and 60 (93) minutes for the respective groups.", {"entities": []}], ["Increases in activity duration from week 4 to weeks 17, 21, and 25 were statistically significant with tiotropium.", {"entities": []}], ["No statistical differences over time were observed within the placebo-treated group and differences between groups were not significant.", {"entities": []}], ["Tiotropium appears to amplify the effectiveness of pulmonary rehabilitation as seen by increases in patient self-reported participation in physical activities.", {"entities": []}], ["Non-syndromic cleft lip with palate (NSCLP) is the most serious sub-phenotype of non-syndromic orofacial clefts (NSOFC), which are the most common craniofacial birth defects in humans.", {"entities": [[14, 23, "DISEASE"]]}], ["Here we conduct a GWAS of NSCLP with multiple independent replications, totalling 7,404 NSOFC cases and 16,059 controls from several ethnicities, to identify new NSCLP risk loci, and explore the genetic heterogeneity between sub-phenotypes of NSOFC.", {"entities": []}], ["We identify 41 SNPs within 26 loci that achieve genome-wide significance, 14 of which are novel ( RAD54B , TMEM19 , KRT18 , WNT9B , GSC / DICER1 , PTCH1 , RPS26 , OFCC1/TFAP2A , TAF1B , FGF10 , MSX1 , LINC00640 , FGFR1 and SPRY1 ).", {"entities": [[98, 104, "GENE"], [116, 121, "GENE"], [124, 129, "GENE"], [132, 135, "GENE"], [138, 144, "GENE"], [147, 152, "GENE"], [155, 160, "GENE"], [178, 183, "GENE"], [186, 191, "GENE"], [194, 198, "GENE"], [213, 218, "GENE"], [223, 228, "GENE"]]}], ["These 26 loci collectively account for 10.94% of the heritability for NSCLP in Chinese population.", {"entities": []}], ["We find evidence of genetic heterogeneity between the sub-phenotypes of NSOFC and among different populations.", {"entities": []}], ["This study substantially increases the number of genetic susceptibility loci for NSCLP and provides important insights into the genetic aetiology of this common craniofacial malformation.", {"entities": []}], ["Non-syndromic cleft lip with palate is a common birth defect of unknown aetiology.", {"entities": [[14, 23, "DISEASE"]]}], ["Here, the authors discover 14 new genes associated with this condition, and show genetic heterogeneity in this and other non-syndromic orofacial clefting disorders.", {"entities": []}], ["Patients suffering from major depressive disorder are more likely to suffer from alcohol use disorder.", {"entities": [[24, 49, "DISEASE"]]}], ["The data is inconclusive for the effectiveness of antidepressant treatment of patients suffering from both illnesses in regards to improving sobriety and reducing alcohol-related healthcare expenses such as hospitalizations.", {"entities": []}], ["The objective of this study is to determine if a new prescription of an antidepressant upon inpatient discharge is associated with a reduction in the number of future acute alcohol-related hospital readmissions to the same institution in patients suffering from major depressive disorder and alcohol-use disorder.", {"entities": [[262, 287, "DISEASE"]]}], ["A retrospective, medical record review study was conducted at a publicly-supported hospital in Sylmar, CA.", {"entities": []}], ["A query was performed for adult patients admitted between 1/1/2005\u201312/31/2013 who had ICD-9 codes for both alcohol-use disorder and depression.", {"entities": []}], ["Index admission was the first hospitalization in which the patient was currently consuming alcohol and had depression as identified by physician documentation as a problem.", {"entities": []}], ["Acute alcohol-related admissions were those for alcohol intoxication or withdrawal (indicating current alcohol use).", {"entities": []}], ["Patients were excluded if they were receiving an antidepressant on index admission, <18\u00a0years old, no patient data available, or not currently consuming alcohol; 139 patients met inclusion criteria.", {"entities": []}], ["Multivariate logistical regression analysis was performed on the primary predictive variable of discharge prescription of an antidepressant along with other independent variables for alcohol readmissions: homelessness, family history of alcohol use disorder, and smoking.", {"entities": []}], ["Discharging patients with a prescription of an antidepressant was not associated with a reduction in acute alcohol-related readmission.", {"entities": []}], ["There was no difference in acute alcohol-related readmissions between patients discharged with (44.6\u00a0%) versus without (47.0\u00a0%) a prescription for an antidepressant ( p \u2009=\u20090.863).", {"entities": []}], ["The median number of days between index admission and first readmission for those discharged on an antidepressant was 141\u00a0days while those who were not was 112\u00a0days ( p \u2009=\u20090.284).", {"entities": []}], ["Discharging patients suffering from both alcohol-use disorder and major depressive disorder with a prescription for an antidepressant is not associated with a reduction in future readmissions, nor significantly increase the number of days to readmission.", {"entities": [[66, 91, "DISEASE"]]}], ["The study does not support the concept of antidepressants in reducing acute alcohol-related readmissions.", {"entities": []}], ["T lymphocytes from the immune system are bone marrow-derived cells whose development and activities are carefully supervised by two sets of accessory cells.", {"entities": []}], ["In the thymus, the immature young T lymphocytes are engulfed by epithelial \u201cnurse cells\u201d and retained in vacuoles, where most of them (95%) are negatively selected and removed when they have an incomplete development or express high affinity autoreactive receptors.", {"entities": []}], ["The mature T lymphocytes that survive to this selection process leave the thymus and are controlled in the periphery by another subpopulation of accessory cells called \u201cregulatory cells,\u201d which reduce any excessive immune response and the risk of collateral injuries to healthy tissues.", {"entities": []}], ["By different times and procedures, nurse cells and regulatory cells control both the development and the functions of T lymphocyte subpopulations.", {"entities": []}], ["Disorders in the T lymphocytes development and migration have been observed in some parasitic diseases, which disrupt the thymic microenvironment of nurse cells.", {"entities": []}], ["In other cases, parasites stimulate rather than depress the functions of regulatory T cells decreasing T-mediated host damages.", {"entities": []}], ["This paper is a short review regarding some features of these accessory cells and their main interactions with T immature and mature lymphocytes.", {"entities": []}], ["The modulatory role that neurotransmitters and hormones play in these interactions is also revised.", {"entities": []}], ["The Education Th\u00e9rapeutique des patients Insuffisants Cardiaques (ETIC; Therapeutic Education for Patients with Cardiac Failure) trial aimed to determine whether a pragmatic education intervention in general practice could improve the quality of life of patients with chronic heart failure (CHF) compared with routine care.", {"entities": [[28, 31, "GENE"]]}], ["This cluster randomised controlled clinical trial included 241 patients with CHF attending 54 general practitioners (GPs) in France and involved 19\u00a0months of follow-up.", {"entities": []}], ["The GPs in the Intervention Group were trained during a 2-day interactive workshop to provide a patient education programme.", {"entities": []}], ["The mean age of the patients was 74\u00a0years (\u00b110.5), 62\u00a0% were men and their mean left-ventricular ejection fraction was 49.3\u00a0% (\u00b1 14.3).", {"entities": []}], ["At the end of the follow-up period, the mean Minnesota Living with Heart Failure Questionnaire scores in the Intervention and Control Groups were 33.4 (\u00b1 22.1) versus 27.2 (\u00b1 23.3; P \u2009=\u20090.74, intra-cluster coefficient [ICC]\u2009=\u20090.11).", {"entities": []}], ["At the end of the follow-up period, the 36-Item Short Form Health Survey (mental health and physical health) scores in the Intervention and Control Groups were 58 (\u00b1 22.1) versus 58.7 (\u00b1 23.9; P \u2009=\u20090.58, ICC\u2009=\u20090.01) and 52.8 (\u00b1 23.8) versus 51.6 (\u00b1 25.5; P \u2009=\u20090.57, ICC\u2009=\u20090.01), respectively.", {"entities": []}], ["Patient education delivered by GPs to elderly patients with stable heart failure in the ETIC programme did not achieve an improvement in their quality of life compared with routine care.", {"entities": []}], ["Further research on improving the quality of life and clinical outcomes of elderly patients with CHF in primary care is necessary.", {"entities": []}], ["The Education Th\u00e9rapeutique des patients Insuffisants Cardiaques ( ETIC; Therapeutic Education for Patients with Cardiac Failure) trial is a cluster randomised controlled trial registered with ClinicalTrials.gov (Registration Number: NCT01065142 ) and the French Drug Agency ( Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9 ; Registration Number: 2009-A01142-55).", {"entities": [[28, 31, "GENE"], [323, 326, "GENE"], [28, 31, "GENE"], [323, 326, "GENE"]]}], ["The online version of this article (doi:10.1186/s12875-016-0473-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Antioxidant proteins perform significant functions in maintaining oxidation/antioxidation balance and have potential therapies for some diseases.", {"entities": []}], ["Accurate identification of antioxidant proteins could contribute to revealing physiological processes of oxidation/antioxidation balance and developing novel antioxidation-based drugs.", {"entities": []}], ["In this study, an ensemble method is presented to predict antioxidant proteins with hybrid features, incorporating SSI (Secondary Structure Information), PSSM (Position Specific Scoring Matrix), RSA (Relative Solvent Accessibility), and CTD (Composition, Transition, Distribution).", {"entities": []}], ["The prediction results of the ensemble predictor are determined by an average of prediction results of multiple base classifiers.", {"entities": []}], ["Based on a classifier selection strategy, we obtain an optimal ensemble classifier composed of RF (Random Forest), SMO (Sequential Minimal Optimization), NNA (Nearest Neighbor Algorithm), and J48 with an accuracy of 0.925.", {"entities": [[115, 118, "GENE"]]}], ["A Relief combined with IFS (Incremental Feature Selection) method is adopted to obtain optimal features from hybrid features.", {"entities": []}], ["With the optimal features, the ensemble method achieves improved performance with a sensitivity of 0.95, a specificity of 0.93, an accuracy of 0.94, and an MCC (Matthew\u2019s Correlation Coefficient) of 0.880, far better than the existing method.", {"entities": [[156, 159, "GENE"]]}], ["To evaluate the prediction performance objectively, the proposed method is compared with existing methods on the same independent testing dataset.", {"entities": []}], ["Encouragingly, our method performs better than previous studies.", {"entities": []}], ["In addition, our method achieves more balanced performance with a sensitivity of 0.878 and a specificity of 0.860.", {"entities": []}], ["These results suggest that the proposed ensemble method can be a potential candidate for antioxidant protein prediction.", {"entities": []}], ["For public access, we develop a user-friendly web server for antioxidant protein identification that is freely accessible at http://antioxidant.weka.cc .", {"entities": []}], ["India is rapidly undergoing an epidemiological transition with a sudden change in the disease profile of its population.", {"entities": []}], ["It is important to understand the changing nature of the burden of disease across the states of India for adequate policy intervention.", {"entities": []}], ["We analyzed the trend and pattern of self-reported morbidity across states of India using three rounds of (52nd, 60th and 71st) National Sample Survey Organization (NSSO) data.", {"entities": []}], ["Descriptive analysis was carried out to understand the prevalence of self-reported morbidity variation over a period of two decades (1995-2014) and multivariate analysis was performed to identify the significant determinants of various types of self-reported morbidities.", {"entities": []}], ["The results indicated an increasing trend of infectious disease, Cardio Vascular Diseases (CVDs) and Non-Communicable Diseases (NCDs) over the last two decades (1995-2014).", {"entities": []}], ["CVDs increased by a whopping eight-fold and the NCDs increased by three times during this period.", {"entities": []}], ["A higher prevalence of self-reported morbidity was observed among the elderly and female, particularly in the urban locality.", {"entities": []}], ["The growing incidence of CVDs and NCDs, especially among the elderly were reported from Kerala, Tamil Nadu, Punjab and West Bengal.", {"entities": []}], ["The already constrained public health system in India is likely to face serious challenges with a double burden of communicable and non-communicable diseases.", {"entities": []}], ["An effective and responsive public health system needs to be in place to make health care services available for NCDs and CVDs at the primary level.", {"entities": []}], ["In order to ameliorate caregiving, the involvement of family will be critical.", {"entities": []}], ["Informing the people inculcate healthy habits may be an effective health promotion measure.", {"entities": []}], ["There is great interest in substituting animal work with in vitro experimentation in human health risk assessment; however, there are only few comparisons of in vitro and in vivo biological responses to engineered nanomaterials.", {"entities": []}], ["We used high-content genomics tools to compare in vivo pulmonary responses of multiwalled carbon nanotubes (MWCNT) to those in vitro in cultured lung epithelial cells (FE1) at the global transcriptomic level.", {"entities": []}], ["Primary size, surface area and other properties of MWCNT- XNRI -7 (Mitsui7) were characterized using DLS, SEM and TEM.", {"entities": []}], ["Mice were exposed via a single intratracheal instillation to 18, 54, or 162 \u03bcg of Mitsui7/mouse.", {"entities": []}], ["FE1 cells were incubated with 12.5, 25 and 100 \u03bcg/ml of Mitsui7.", {"entities": []}], ["Tissue and cell samples were collected at 24 hours post-exposure.", {"entities": []}], ["DNA microarrays were employed to establish mechanistic differences and similarities between the two models.", {"entities": []}], ["Microarray results were confirmed using gene-specific RT-qPCR.", {"entities": []}], ["Bronchoalveolar lavage (BAL) fluid was assessed for indications of inflammation in vivo .", {"entities": []}], ["A strong dose-dependent activation of acute phase and inflammation response was observed in mouse lungs reflective mainly of an inflammatory response as observed in BAL.", {"entities": []}], ["In vitro , a wide variety of core cellular functions were affected including transcription, cell cycle, and cellular growth and proliferation.", {"entities": []}], ["Oxidative stress, fibrosis and inflammation processes were altered in both models.", {"entities": []}], ["Although there were similarities observed between the two models at the pathway-level, the specific genes altered under these pathways were different, suggesting that the underlying mechanisms of responses are different in cells in culture and the lung tissue.", {"entities": []}], ["Our results suggest that careful consideration should be given in selecting relevant endpoints when substituting animal with in vitro testing.", {"entities": []}], ["Endo-derived nitric oxide (NO) is synthesized from L-arginine by endothelial nitric oxide synthase (NOS3).", {"entities": [[100, 104, "GENE"]]}], ["Since reduced NO synthesis in endothelial cells has been implicated in the development of coronary atherosclerosis, we investigated the association of NOS3 gene polymorphisms and coronary artery disease (CAD) in an Iranian population.", {"entities": [[99, 114, "DISEASE"], [151, 155, "GENE"]]}], ["We studied the NOS3 gene Glu298Asp polymorphism in 241 CAD patients with positive coronary angiograms (i.e., >50% stenosis affecting at least one coronary vessel) in Shahid Rajaee Heart Hospital and 261 control subjects without a history of symptomatic CAD.", {"entities": [[15, 19, "GENE"]]}], ["The NOS3 gene polymorphism was analyzed by polymerase chain reaction and restriction fragment length polymorphism.", {"entities": [[4, 8, "GENE"]]}], ["Lipid profile and other risk factors were also determined.", {"entities": []}], ["The genotype frequencies of Glu298Asp polymorphism for Glu/Glu, Glu/Asp, and Asp/Asp were 61.3%, 32.2%, and 6.5%, respectively, in control subjects, and 46.5%, 42.7%, and 10.8% in CAD patients, respectively.", {"entities": []}], ["The genotype frequencies differed significantly between the two groups ( P =.003).", {"entities": []}], ["The frequencies of the Asp alleles were 32.2% and 22.6% for CAD patients and control subjects, respectively; the difference between the two groups was statistically significant ( P =.001; odds ratio=1.6).", {"entities": []}], ["Plasma lipids, except HDL-C, were also significantly increased in the CAD groups.", {"entities": []}], ["These results suggest that CAD is associated with Glu298Asp polymorphism of the NOS3 gene in our population and that this polymorphism is an independent risk factor for CAD.", {"entities": [[80, 84, "GENE"]]}], [": To present the Programa Infantil de Preven\u00e7\u00e3o de Asma (PIPA, Program for the Prevention of Childhood Asthma) and the characteristics of the patients followed in this program.", {"entities": [[103, 109, "DISEASE"]]}], [": Implemented in the city of Uruguaiana, Brazil, PIPA has as its target population children and adolescents (< 18 years of age) with asthma or suspected asthma.", {"entities": [[133, 139, "DISEASE"], [153, 159, "DISEASE"]]}], ["Patients either enroll in PIPA spontaneously or are referred by pediatricians or primary care physicians.", {"entities": []}], ["In this retrospective study, we use a standardized protocol to assess PIPA patients.", {"entities": []}], [": By the end of the study period, 646 patients were being followed.", {"entities": []}], ["Of those, 298 (46.1%) were \u2264 3 years of age.", {"entities": []}], ["In this group of patients, recurrent wheezing was identified in 60.7%, and the first episode of wheezing occurred in the first six months of life in 86.0%.", {"entities": []}], ["Severe wheezing was identified in 29.5% and 45.4% in the children \u2264 3 and > 3 years of age, respectively.", {"entities": []}], ["Physician-diagnosed asthma was reported in 26.5% and 82.2%, respectively.", {"entities": [[20, 26, "DISEASE"]]}], ["In the sample as a whole, the prevalence of passive smoking was high (> 36%), occurring during pregnancy in > 15%; > 40% of the patients had been born by cesarean section; and 30% had a mother who had had < 8 years of schooling.", {"entities": []}], [": A prevention program for children with asthma is an effective strategy for controlling the disease.", {"entities": [[41, 47, "DISEASE"]]}], ["Knowledge of local epidemiological and environmental characteristics is essential to reducing the prevalence of the severe forms of asthma, to improving the use of health resources, and to preventing pulmonary changes that could lead to COPD in adulthood.", {"entities": [[132, 138, "DISEASE"]]}], [": Apresentar o Programa Infantil de Preven\u00e7\u00e3o de Asma (PIPA), assim como as caracter\u00edsticas dos pacientes nele acompanhados.", {"entities": []}], [": O PIPA, implantado em Uruguaiana (RS), tem como popula\u00e7\u00e3o alvo crian\u00e7as e adolescentes com asma ou suspeita de asma, menores de 18 anos, referidos por pediatras, m\u00e9dicos de aten\u00e7\u00e3o prim\u00e1ria ou por procura espont\u00e2nea.", {"entities": [[149, 152, "GENE"], [195, 198, "GENE"], [149, 152, "GENE"], [195, 198, "GENE"]]}], ["Neste estudo retrospectivo, os participantes foram avaliados segundo um protocolo padronizado de atendimento.", {"entities": []}], [": Ao final do per\u00edodo do estudo, estavam em seguimento 646 pacientes.", {"entities": []}], ["Desses, 298 (46,1%) tinham idade \u2264 3 anos.", {"entities": []}], ["Nesse grupo de pacientes, houve sibil\u00e2ncia recorrente em 60,7% e o primeiro epis\u00f3dio de sibil\u00e2ncia ocorreu nos primeiros seis meses de vida em 86,0%.", {"entities": []}], ["Sibil\u00e2ncia grave foi apontada em 29,5% e 45,4% nas crian\u00e7as com \u2264 3 anos e com > 3 anos, respectivamente.", {"entities": []}], ["Houve diagn\u00f3stico m\u00e9dico de asma em 26,5% e 82,2%, respectivamente.", {"entities": []}], ["Na amostra total, a preval\u00eancia de exposi\u00e7\u00e3o passiva ao fumo foi elevada (> 36%), ocorrendo durante a gesta\u00e7\u00e3o em > 15%; o n\u00famero de nascimentos por cesariana foi > 40%, e o n\u00edvel educacional materno foi inferior a 8 anos em 30%.", {"entities": [[145, 148, "GENE"]]}], [": Um programa de preven\u00e7\u00e3o para atendimento de crian\u00e7as com asma \u00e9 uma estrat\u00e9gia eficaz para o controle da doen\u00e7a.", {"entities": []}], ["O conhecimento das caracter\u00edsticas epidemiol\u00f3gicas e ambientais da popula\u00e7\u00e3o local \u00e9 primordial para que haja a redu\u00e7\u00e3o das formas graves da asma, melhor utiliza\u00e7\u00e3o dos recursos de sa\u00fade e poss\u00edvel preven\u00e7\u00e3o de altera\u00e7\u00f5es pulmonares que possam levar a DPOC no adulto.", {"entities": []}], ["Environmental tobacco smoke (ETS) exposure harms the respiratory health of children and is associated with an increased risk of asthma and sudden infant death syndrome (SIDS).", {"entities": [[159, 167, "DISEASE"], [139, 167, "DISEASE"], [128, 134, "DISEASE"]]}], ["The mechanisms by which ETS causes these effects are not understood.", {"entities": []}], ["We hypothesized that one mechanism is an upregulation of the lung C-fiber central nervous system (CNS) reflex responses, which would result in exaggerated reflex responses of apnea, bronchoconstriction, and mucous hypersecretion.", {"entities": []}], ["The purpose of this work is to highlight evidence obtained in an animal model of postnatal ETS exposure supporting the hypothesis and present data suggesting that actions of the neuropeptide substance P in the nucleus tractus solitarius (NTS) may contribute.", {"entities": [[238, 241, "GENE"]]}], ["Exposing young guinea pigs to sidestream smoke, the surrogate for ETS, for 5 weeks during the equivalent of human childhood, increased the excitability of afferent lung C fibers and NTS neurons in the CNS reflex pathway and prolonged the expiratory apnea.", {"entities": [[182, 185, "GENE"]]}], ["The findings suggest that an increased excitability of NTS neurons that can augment reflex output may contribute to respiratory symptoms in children exposed to ETS.", {"entities": [[55, 58, "GENE"]]}], ["Besides ETS exposure, substance P can also excite NTS neurons and augment lung C-fiber CNS reflex responses.", {"entities": [[50, 53, "GENE"]]}], ["Others have shown that substance P synthesis in lung C fibers is upregulated by another environmental stimulant, allergen.", {"entities": []}], ["Thus, an upregulation of the substance P system at NTS synapses could contribute to the increased NTS excitability and enhanced reflex responses to lung C-fiber stimulation, providing a potential mechanism to help explain the association of ETS exposure with respiratory symptoms and SIDS.", {"entities": [[51, 54, "GENE"], [98, 101, "GENE"], [51, 54, "GENE"], [98, 101, "GENE"]]}], ["Human skin harbors two major T cell compartments of equal size that are distinguished by expression of the chemokine receptor CCR8.", {"entities": [[126, 130, "GENE"]]}], ["In vitro studies have demonstrated that CCR8 expression is regulated by TCR engagement and the skin tissue microenvironment.", {"entities": [[40, 44, "GENE"]]}], ["To extend these observations, we examined the relationship between CCR8 TRB ) gene rearrangements showed that these CCR8-defined populations are clonotypically distinct, suggesting unique ontogenies in response to separate antigenic challenges and/or stimulatory conditions.", {"entities": [[67, 71, "GENE"], [116, 120, "GENE"]]}], ["Moreover, CCR8", {"entities": [[10, 14, "GENE"]]}], ["Considerable variation exists in the protocols used to induce hyperresponsiveness in murine models of allergic sensitisation.", {"entities": []}], ["We examined the effect of varying the number of antigen exposures at challenge on the development of methacholine responsiveness in systemically sensitised mice.", {"entities": []}], ["BALB/c mice were sensitised with ovalbumin (OVA), challenged with 1, 3 or 6 OVA aerosols.", {"entities": []}], ["Lung function was measured using low frequency forced oscillations and partitioned into components representing the airways (R aw ) and lung parenchyma (tissue damping (G) and tissue elastance (H)).", {"entities": []}], ["Responsiveness to inhaled methacholine (MCh), inflammatory cell profile and circulating IgE were assessed 24 and 48 hours after challenge.", {"entities": []}], ["The threshold dose of MCh required to elicit a detectable response (sensitivity) and response to 30 mg.mL Sensitivity ; All three OVA protocols resulted in an increased sensitivity to MCh in R aw but not in G or H. These responses where present at 24 and 48 hrs, except 1 OVA aerosol in which changes had resolved by 48 hrs.", {"entities": []}], ["Maximal response ; 1 OVA aerosol increased maximal responses in R aw , G and H at 24 hrs, which was gone by 48 hrs.", {"entities": []}], ["Three OVA aerosols increased responses in H at 48 hrs only.", {"entities": []}], ["Six OVA challenges caused increases in R aw , G and H at both 24 and 48 hrs.", {"entities": []}], ["Eosinophils increased with increasing antigen challenges.", {"entities": []}], ["IgE was elevated by OVA sensitisation but not boosted by OVA aerosol challenge.", {"entities": []}], ["The pattern of eosinophilia, IgE and MCh responsiveness in mice was determined by antigen dose at challenge.", {"entities": [[15, 27, "DISEASE"]]}], ["In this study, increased sensitivity to MCh was confined to the airways whereas increases in maximal responses occurred in both the airway and parenchymal compartments.", {"entities": []}], ["The presence of eosinophilia and IgE did not always coincide with increased responsiveness to inhaled MCh.", {"entities": [[16, 28, "DISEASE"]]}], ["These findings require further systematic study to determine whether different mechanisms underlie airway and parenchymal hyperresponsiveness post antigen challenge.", {"entities": []}], ["Characteristic patterns of variation over time, namely rhythms, represent a defining feature of complex systems, one that is synonymous with life.", {"entities": []}], ["Despite the intrinsic dynamic, interdependent and nonlinear relationships of their parts, complex biological systems exhibit robust systemic stability.", {"entities": []}], ["Applied to critical care, it is the systemic properties of the host response to a physiological insult that manifest as health or illness and determine outcome in our patients.", {"entities": []}], ["Variability analysis provides a novel technology with which to evaluate the overall properties of a complex system.", {"entities": []}], ["This review highlights the means by which we scientifically measure variation, including analyses of overall variation (time domain analysis, frequency distribution, spectral power), frequency contribution (spectral analysis), scale invariant (fractal) behaviour (detrended fluctuation and power law analysis) and regularity (approximate and multiscale entropy).", {"entities": []}], ["Each technique is presented with a definition, interpretation, clinical application, advantages, limitations and summary of its calculation.", {"entities": []}], ["The ubiquitous association between altered variability and illness is highlighted, followed by an analysis of how variability analysis may significantly improve prognostication of severity of illness and guide therapeutic intervention in critically ill patients.", {"entities": []}], ["Nebivolol is a highly selective \u03b2 1 -adrenergic receptor antagonist with a pharmacologic profile that differs from those of other drugs in its class.", {"entities": []}], ["In addition to cardioselectivity mediated via \u03b2 1 receptor blockade, nebivolol induces nitric oxide-mediated vasodilation by stimulating endothelial nitric oxide synthase via \u03b2 3 agonism.", {"entities": []}], ["This vasodilatory mechanism is distinct from those of other vasodilatory \u03b2-blockers (carvedilol, labetalol), which are mediated via \u03b1-adrenergic receptor blockade.", {"entities": []}], ["Nebivolol is approved for the treatment of hypertension in the US, and for hypertension and heart failure in Europe.", {"entities": [[43, 55, "DISEASE"], [75, 87, "DISEASE"]]}], ["While \u03b2-blockers are not recommended within the current US guidelines as first-line therapy for treatment of essential hypertension, nebivolol has shown comparable efficacy to currently recommended therapies in lowering peripheral blood pressure in adults with hypertension with a very low rate of side effects.", {"entities": [[119, 131, "DISEASE"], [261, 273, "DISEASE"], [109, 131, "DISEASE"]]}], ["Nebivolol also has beneficial effects on central blood pressure compared with other \u03b2-blockers.", {"entities": []}], ["Clinical data also suggest that nebivolol may be useful in patients who have experienced erectile dysfunction while on other \u03b2-blockers.", {"entities": []}], ["Here we review the pharmacological profile of nebivolol, the clinical evidence supporting its use in hypertension as monotherapy, add-on, and combination therapy, and the data demonstrating its positive effects on heart failure and endothelial dysfunction.", {"entities": [[101, 113, "DISEASE"]]}], ["Pneumonia remains the leading cause of death in children outside the neonatal period, despite advances in prevention and management.", {"entities": [[0, 9, "DISEASE"]]}], ["Over the last 20\u00a0years, there has been a substantial decrease in the incidence of childhood pneumonia and pneumonia-associated mortality.", {"entities": [[92, 101, "DISEASE"], [106, 115, "DISEASE"]]}], ["New conjugate vaccines against Haemophilus influenzae type b and Streptococcus pneumoniae have contributed to decreases in radiologic, clinical and complicated pneumonia cases and have reduced hospitalization and mortality.", {"entities": [[160, 169, "DISEASE"]]}], ["The importance of co-infections with multiple pathogens and the predominance of viral-associated disease are emerging.", {"entities": []}], ["Better access to effective preventative and management strategies is needed in low- and middle-income countries, while new strategies are needed to address the residual burden of disease once these have been implemented.", {"entities": []}], ["To characterize the relationship between endothelin-1 and fibrosis in epiretinal membranes in proliferative diabetic retinopathy and explore the role of endothelial-mesenchymal transition in these membranes.", {"entities": [[108, 128, "DISEASE"], [94, 128, "DISEASE"]]}], ["Membranes were obtained from eyes undergoing pars plana vitrectomy for complicated proliferative diabetic retinopathy or idiopathic epiretinal membrane.", {"entities": [[97, 117, "DISEASE"], [83, 117, "DISEASE"]]}], ["Through standard immunohistochemical techniques, we labeled membranes to explore the distribution of endothelin-1 and endothelin receptor B, comparing proliferative diabetic retinopathy and idiopathic epiretinal membranes.", {"entities": [[165, 185, "DISEASE"], [151, 185, "DISEASE"]]}], ["In addition, membranes were also labeled with markers for fibroblasts, endothelial, and glial cells and studied with confocal laser scanning microscopy.", {"entities": []}], ["The intensity of endothelin-1 labeling was quantified using standard image analysis software.", {"entities": []}], ["Fourteen membranes were included in the analysis, nine from eyes with proliferative diabetic retinopathy and five idiopathic membranes.", {"entities": [[84, 104, "DISEASE"], [70, 104, "DISEASE"]]}], ["Flatmount diabetic membranes showed co-localization of endothelin-1 with S100A4 and CD31.", {"entities": [[73, 79, "GENE"]]}], ["Immunohistochemistry and quantitative analysis of cross-sectional membranes showed significantly higher endothelin-1 labeling in proliferative diabetic retinopathy membranes compared to idiopathic membranes (p<0.05).", {"entities": [[143, 163, "DISEASE"], [129, 163, "DISEASE"]]}], ["Diabetic membranes showed more elements staining positive for S100A4 compared to idiopathic membranes.", {"entities": [[62, 68, "GENE"]]}], ["Epiretinal membrane formation in proliferative diabetic retinopathy involves higher tissue levels of endothelin-1 and fibroblastic activity.", {"entities": [[47, 67, "DISEASE"], [33, 67, "DISEASE"]]}], ["Furthermore, endothelin-1, endothelial and fibroblastic staining appear to be correlated, suggestive of endothelial-to-mesenchymal transition in proliferative diabetic retinopathy.", {"entities": [[159, 179, "DISEASE"], [145, 179, "DISEASE"]]}], ["We tested the hypothesis that cardiovascular responses to PM 2.5 exposure will be enhanced in hypertensive rats and linked to specific carbonaceous pollutants in an urban industrial setting.", {"entities": []}], ["Spontaneously hypertensive rats were exposed by inhalation to concentrated PM 2.5 in an industrial area of Dearborn, Michigan, for four consecutive summer days.", {"entities": []}], ["Blood pressure (BP), heart rate (HR) and HR variability (HRV) metrics (SDNN, RMSSD) were assessed by radiotelemetry and compared to 1\u00a0h- and 8\u00a0h-averaged fluctuations in PM 2.5 composition, with a focus on elemental and organic carbon (EC and OC, respectively), and temperature-resolved subfractions (EC1-EC5, PC (pyrolized carbon), and OC1-OC4), as well as other major and minor PM components.", {"entities": [[33, 35, "GENE"], [41, 43, "GENE"], [33, 35, "GENE"], [41, 43, "GENE"], [310, 312, "GENE"]]}], ["Mean HR and BP were increased, while HRV was decreased over 4\u00a0days of exposure.", {"entities": [[5, 7, "GENE"]]}], ["Using 1\u00a0h averages, EC (1\u00a0\u03bcg/m These findings are the first to describe associations between acute cardiovascular responses and thermally resolved carbon subfractions.", {"entities": []}], ["We report that cardiovascular responses to PM 2.5 carbonaceous materials appear to be driven by EC and its EC1 fraction.", {"entities": []}], ["For at least half a century, noninvasive techniques have been available to quantify skin barrier function, and these have shown that a number of human skin conditions and disorders are associated with defects in skin permeability.", {"entities": []}], ["In the last decade, several genes responsible for skin barrier defects observed in both monogenetic and complex, polygenic disorders have been elucidated and functionally characterized.", {"entities": []}], ["This has led to an explosion of work in the last six years that has identified pathways connecting epidermal barrier disruption and antigen uptake as well as the quality and/or magnitude of the antigen-specific adaptive immune response.", {"entities": []}], ["This review will introduce the notion that diseases arise from the dynamic crosstalk that occurs between the skin barrier and immune system using atopic dermatitis or eczema as the disease prototype.", {"entities": [[146, 163, "DISEASE"], [153, 163, "DISEASE"]]}], ["Nevertheless, the concepts put forth are highly relevant to a number of antigen-driven disorders for which skin barrier is at least transiently compromised such as psoriasis, allergic contact dermatitis and blistering disorders.", {"entities": [[184, 202, "DISEASE"], [164, 173, "DISEASE"], [175, 202, "DISEASE"], [192, 202, "DISEASE"]]}], ["Human metapneumovirus, which belongs to the Paramyxoviridae family and has been classified as a member of the Pneumovirus genus, is genetically and clinically similar to other family members such as human respiratory syncytial virus.", {"entities": []}], ["A total of 1146 nasopharyngeal aspirates from pediatric patients with moderate and severe acute lower respiratory tract infections, hospitalized at the Ricardo Gutierrez Childre\u0144s Hospital (Buenos Aires, Argentina), were tested by real time RT-PCR for human metapneumovirus.", {"entities": []}], ["Results showed that 168 (14.65%) were positive.", {"entities": []}], ["Thirty-six of these 168 samples were randomly selected to characterize positive cases molecularly.", {"entities": []}], ["The phylogenetic analysis of the sequences of the G and F genes showed that genotypes A2 and B2 cocirculated during 2009 and 2010 and that only genotype A2 circulated in 2011 in Argentina.", {"entities": []}], ["Genotype A2 prevailed during the study period, a fact supported by a higher effective population size (Ne\u03c4) and higher diversity as compared to that of genotype B2 (10.9% (SE 1.3%) vs. 1.7% (SE 0.4%), respectively).", {"entities": []}], ["The phylogeographic analysis of the G protein gene sequences showed that this virus has no geographical restrictions and can travel globally harbored in hosts.", {"entities": []}], ["The selection pressure analysis of the F protein showed that although this protein has regions with polymorphisms, it has vast structural and functional constraints.", {"entities": []}], ["In addition, the predicted B-linear epitopes and the sites recognized by previously described monoclonal antibodies were conserved in all Argentine sequences.", {"entities": []}], ["This points out this protein as a potential candidate to be the target of future humanized antibodies or vaccines.", {"entities": []}], ["Allergic asthma is a disease characterized by persistent allergen-driven airway inflammation, remodeling, and airway hyperresponsiveness.", {"entities": [[0, 15, "DISEASE"], [9, 15, "DISEASE"]]}], ["CD4 via modifying the natural course of allergy by interfering with the underlying immunological mechanisms.", {"entities": [[0, 3, "GENE"]]}], ["However, although SIT is effective in allergic rhinitis and insect venom allergy, in allergic asthma it seldom results in complete alleviation of the symptoms.", {"entities": [[38, 55, "DISEASE"], [85, 100, "DISEASE"], [47, 55, "DISEASE"], [94, 100, "DISEASE"]]}], ["Improvement of SIT is needed to enhance its efficacy in asthmatic patients.", {"entities": []}], ["Herein, the immunoregulatory mechanisms underlying the beneficial effects of SIT are discussed with the ultimate aim to improve its treatment efficacy.", {"entities": []}], ["Multiple sclerosis (MS) is an autoimmune neuro-inflammatory disease arising from complex interactions of genetic, epigenetic, and environmental factors.", {"entities": []}], ["Variations in genes of some microRNAs\u2014key post-transcriptional regulators of many genes\u2014can influence microRNAs expression/function and contribute to MS via expression changes of protein-coding target mRNA genes.", {"entities": []}], ["We performed an association study of polymorphous variants of MIR146A rs2910164, MIR196A2 rs11614913, MIR499A rs3746444 MIR223 rs1044165 and their combinations with MS risk and severity.", {"entities": []}], ["561 unrelated patients with bout-onset MS and 441 healthy volunteers were enrolled in the study.", {"entities": []}], ["We observed associations of MS risk with allele MIR223 *T and combination ( MIR223 *T + MIR146A *G/G) carriage in the entire groups and in women at Bonferroni-corrected significance level ( p corr < 0.05).", {"entities": []}], ["Besides, MIR146A *G/G association with MS was observed in women with nominal significance ( p f = 0.025).", {"entities": []}], ["No MS associations were found in men.", {"entities": []}], ["A more severe MS course (MSSS value > 3.5) was associated with the carriage of MIR499A *C/T and, less reliably, of MIR499A *C ( p corr = 0.006 and p corr = 0.024, respectively) and with the carriage of combinations ( MIR499A *C/T + MIR196A2 *C) and ( MIR499A *C + MIR196A2 *C) ( p corr = 0.00078 and p corr = 0.0059, respectively).", {"entities": []}], ["These associations also showed gender specificity, as they were not significant in men and substantially reinforced in women.", {"entities": []}], ["The strongest association with MS severity was observed in women for combination ( MIR499A *C/T + MIR196A2 *C): p corr = 4.43 \u00d7 10", {"entities": []}], ["Need for help is perceived as an important first step towards weight related health-care use among overweight and obese individuals and several studies have reported gender as an important predisposing characteristic of need for help.", {"entities": []}], ["Therefore, the goal of the current study is to gain insight into factors that might determine need for help for weight loss in men and women.", {"entities": []}], ["In the current study, data from the Dutch cross-sectional survey Health Monitor 2012 was used.", {"entities": []}], ["Overweight and obese men ( N \u2009=\u20092218) and women ( N \u2009=\u20092002) aged 19\u201364\u00a0years were selected for the current study.", {"entities": []}], ["Potential predictors of need for help were age, ethnicity, marital status, educational level, perceived health, weight status, comorbidities, physical activity level, and income.", {"entities": []}], ["Multiple logistic regression analyses were conducted separately among men and women to establish prediction models of need for help for weight loss.", {"entities": []}], ["The mean age of the adult women in this study population was 47.7\u00a0years and 68% was medium educated, whereas the mean age of men was 49.0\u00a0years and 63.0% was medium educated .", {"entities": []}], ["Of the respondents, 24.9% indicated they either felt a need for help for weight loss, 6.4% already received help and 68.7% felt no need for help.", {"entities": []}], ["Women were more likely to indicate a need for help than men (OR\u2009=\u20092.17).", {"entities": []}], ["Among both genders, need for help was significantly predicted by obesity (OR men \u2009=\u20093.80, OR women \u2009=\u20092.20) and \u201cpoor\u201d perceived health (ORmen\u2009=\u20092.14, OR women \u2009=\u20091.94).", {"entities": [[65, 72, "DISEASE"]]}], ["Besides, \u201cunmarried\u201d (OR men \u2009=\u20091.57) and suffering from comorbidities (OR men \u2009=\u20091.26) predicted need for help among men.", {"entities": []}], ["Whereas among women, need for help was predicted by younger age (i.e.", {"entities": []}], ["19\u201334\u00a0years (OR women \u2009=\u20092.07) and 35\u201349\u00a0years (OR women \u2009=\u20091.35)).", {"entities": []}], ["The current study revealed specific predictors of need for help for weight loss for men and women.", {"entities": []}], ["Among men, the strongest predictors were obesity and poor perceived health, whereas among women need for help was most strongly predicted by obesity and young age.", {"entities": [[41, 48, "DISEASE"], [141, 148, "DISEASE"]]}], ["Insight into these specific predictors enables health professionals to reach overweight individuals with a need for help for weight loss by connecting their need to available support.", {"entities": []}], ["To compare the effectiveness of cromolyn sodium (CS) (10 mg) and nedocromil sodium (NS) (4 mg) administered by a metered dose inhaler (MDI) with a spacer device in preventing exercise-induced asthma (EIA), eight asthmatic children with EIA were studied in a randomized double-blind, cross-over, placebo-controlled study, CS and NS provided significant, comparable protection from EIA and both were better than placebo.", {"entities": [[192, 198, "DISEASE"], [49, 51, "GENE"], [321, 323, "GENE"], [49, 51, "GENE"], [321, 323, "GENE"]]}], ["We conclude that CS and NS administered by a pressurized aerosol with a spacer device provide equal protection against EIA in children.", {"entities": [[17, 19, "GENE"]]}], ["Evidence from human and animal research indicates that choline metabolic pathways may be activated during a variety of diseases, including cancer.", {"entities": [[139, 145, "DISEASE"]]}], ["We report results of a case-control study of 2821 lung cancer cases and 2923 controls that assessed associations of choline and betaine dietary intakes with lung cancer.", {"entities": [[50, 61, "DISEASE"], [157, 168, "DISEASE"], [55, 61, "DISEASE"], [162, 168, "DISEASE"]]}], ["Using multivariable logistic regression analyses, we report a significant association between higher betaine intake and lower lung cancer risk that varied by smoking status.", {"entities": [[126, 137, "DISEASE"], [131, 137, "DISEASE"]]}], ["Specifically, no significant association was observed between betaine intake and lung cancer among never-smokers.", {"entities": [[81, 92, "DISEASE"], [86, 92, "DISEASE"]]}], ["However, higher betaine intake was significantly associated with reduced lung cancer risk among smokers, and the protective effect was more evident among current than former smokers: for former and current smokers, the ORs (95% CI) of lung cancer for individuals with highest as compared to lowest quartiles of intake were 0.70(0.55\u20130.88) and 0.51(0.39\u20130.66) respectively.", {"entities": [[73, 84, "DISEASE"], [235, 246, "DISEASE"], [78, 84, "DISEASE"], [240, 246, "DISEASE"]]}], ["Significant linear trend of higher betaine intake and lower lung cancer risk was observed among both former (p trend \u200a=\u200a0.002) and current (p trend <0.0001) smokers.", {"entities": [[60, 71, "DISEASE"], [65, 71, "DISEASE"]]}], ["A similar protective effect was also observed with choline intake both in overall analysis as well as among current smokers, with p-values for chi-square tests being 0.001 and 0.004 respectively, but the effect was less evident, as no linear trend was observed.", {"entities": []}], ["Our results suggest that choline and betaine intake, especially higher betaine intake, may be protective against lung cancer through mitigating the adverse effect of smoking.", {"entities": [[113, 124, "DISEASE"], [118, 124, "DISEASE"]]}], ["Familial cold autoinflammatory syndrome (FCAS) is an extremely rare autosomal dominant inherited disease.", {"entities": [[31, 39, "DISEASE"]]}], ["Although there are four genes that have been linked with FCAS, its molecular diagnosis has been challenging in a relatively large proportion of cases.", {"entities": []}], ["In this study, we aimed to investigate the genetic defect of a recruited FCAS family using exome sequencing followed by in-depth bioinformatics analysis.", {"entities": []}], ["As a result, a novel heterozygous stop-gain mutation (Trp408X) in NLRP12 was identified in autosomal dominant inherited FCAS with clinical features of recurrent fever and skin urticaria due to cold conditions.", {"entities": [[176, 185, "DISEASE"], [66, 72, "GENE"]]}], ["When combined with previous studies, all of the reported mutations were found to have occurred in a highly conserved region in the NACHT domain coding sequence in NLRP12 exon 3, suggesting that a screening strategy for FCAS should focus on this area of the gene.", {"entities": [[163, 169, "GENE"]]}], ["In conclusion, this study demonstrates the importance of exome sequencing for clinical diagnosis of genetic disorders and provides molecular insight into FCAS treatment and diagnosis.", {"entities": []}], ["This study aimed to investigate the association between ADAM metallopeptidase domain 33 (ADAM33) gene polymorphisms and the risk of childhood asthma.", {"entities": [[142, 148, "DISEASE"], [89, 95, "GENE"]]}], ["The relevant studies about the relationship between ADAM33 gene polymorphisms and childhood asthma were searched from electronic databases and the deadline of retrieval was May 2016.", {"entities": [[92, 98, "DISEASE"], [52, 58, "GENE"]]}], ["The single nucleotide polymorphisms (SNPs) of ADAM33 (rs511898, rs2280092, rs3918396, rs528557, rs2853209, rs44707, rs2280091 and rs2280089) were analyzed based on several models including the allele, codominant, recessive and dominant models.", {"entities": [[46, 52, "GENE"]]}], ["The results showed that the ADAM33 rs2280091 polymorphism in all four genetic models was associated with an increased risk of childhood asthma.", {"entities": [[136, 142, "DISEASE"], [28, 34, "GENE"]]}], ["Positive associations were also found between the polymorphisms rs2280090, rs2787094, rs44707 and rs528557 and childhood asthma in some genetic models.", {"entities": [[121, 127, "DISEASE"]]}], ["This meta-analysis suggested that ADAM33 polymorphisms rs2280091, rs2280090, rs2787094, rs44707 and rs528557 were significantly associated with a high risk of childhood asthma.", {"entities": [[169, 175, "DISEASE"], [34, 40, "GENE"]]}], ["Respiratory tract infections in children result in more primary care consultations than any other acute condition, and are the most common reason for prescribing antibiotics (which are largely unnecessary).", {"entities": []}], ["About a fifth of children consult again for the same illness episode.", {"entities": []}], ["Providing parents with written information on respiratory tract infections may result in a reduction in re-consultation rates and antibiotic prescribing for these illnesses.", {"entities": []}], ["Asking clinicians to provide and discuss the information during the consultation may enhance effectiveness.", {"entities": []}], ["This paper outlines the protocol for a study designed to evaluate the use of a booklet on respiratory tract infections in children within primary care consultations.", {"entities": []}], ["This will be a cluster randomised controlled trial.", {"entities": []}], ["General practices will be randomised to provide parents consulting because their child has an acute respiratory tract infection with either an interactive booklet, or usual care.", {"entities": []}], ["The booklet provides information on the expected duration of their child's illness, the likely benefits of various treatment options, signs and symptoms that should prompt re-consultation, and symptomatic treatment advice.", {"entities": []}], ["It has been designed for use within the consultation and aims to enhance communication through the use of specific prompts.", {"entities": []}], ["Clinicians randomised to using the interactive booklet will receive online training in its use.", {"entities": []}], ["Outcomes will be assessed via a telephone interview with the parent two weeks after first consulting.", {"entities": []}], ["The primary outcome will be the proportion of children who re-consult for the same illness episode.", {"entities": []}], ["Secondary outcomes include: antibiotic use, parental satisfaction and enablement, and illness costs.", {"entities": []}], ["Consultation rates for respiratory tract infections for the subsequent year will be assessed by a review of practice notes.", {"entities": []}], ["Previous studies in adults and children have shown that educational interventions can result in reductions in re-consultation rates and use of antibiotics for respiratory tract infections.", {"entities": []}], ["This will be the first study to determine whether providing parents with a booklet on respiratory tract infections in children, and discussing it with them during the consultation, reduces re-consultations and antibiotic use for the same illness without reducing satisfaction with care.", {"entities": []}], ["Current Controlled Trials ISRCTN46104365", {"entities": []}], ["Resveratrol (RSV) has been shown to effectively suppress chronic rhinosinusitis with nasal polyps in a mouse model; however, when locally administered to the sinonasal cavity, bolus RSV is limited by low drug bioavailability owing to its low aqueous solubility and relatively rapid clearance from the administration site.", {"entities": []}], ["To address this limitation, we propose mucoadhesive nanostructured microparticles (PLGA/PEG NM) as a potential carrier for the sinonasal delivery of RSV.", {"entities": []}], ["In this study, PLGA/PEG NM released RSV in a sustained manner.", {"entities": []}], ["Owing to the enlarged specific surface area of the nanostructures, PLGA/PEG NM had synergistically enhanced mucoadhesiveness and thus showed improved in vivo retention properties in the sinonasal cavity.", {"entities": []}], ["Therefore, when tested in a mouse nasal polyp model, PLGA/PEG NM mitigated polyp formation and restored epithelial integrity better than the control treatments.", {"entities": []}], ["The therapeutic effect was similar at half the dose of PLGA/PEG NM, suggesting improved local bioavailability of RSV in the sinonasal cavity.", {"entities": []}], ["Previous research has suggested an association between poor vision and decreased mobility, including restricted levels of physical activity and travel away from home.", {"entities": []}], ["We sought to determine the impact of age-related macular degeneration (AMD) on these measures of mobility.", {"entities": [[49, 69, "DISEASE"]]}], ["Fifty-seven AMD patients with bilateral, or severe unilateral, visual impairment were compared to 59 controls with normal vision.", {"entities": []}], ["All study subjects were between the ages of 60 and 80.", {"entities": []}], ["Subjects wore accelerometers and cellular network-based tracking devices over 7\u00a0days of normal activity.", {"entities": []}], ["Number of steps taken, time spent in moderate-to-vigorous physical activity (MVPA), number of excursions from home, and time spent away from home were the primary outcome measures.", {"entities": []}], ["In multivariate negative binomial regression models adjusted for age, gender, race, comorbidities, and education, AMD participants took fewer steps than controls (18% fewer steps per day, p\u2009=\u20090.01) and spent significantly less time in MVPA (35% fewer minutes, p\u2009<\u20090.001).", {"entities": []}], ["In multivariate logistic regression models adjusting for age, sex, race, cognition, comorbidities, and grip strength, AMD subjects showed an increased likelihood of not leaving their home on a given day (odds ratio\u2009=\u20091.36, p\u2009=\u20090.04), but did not show a significant difference in the magnitude of time spent away from home (9% fewer minutes, p\u2009=\u20090.11).", {"entities": []}], ["AMD patients with poorer vision engage in significantly less physical activity and take fewer excursions away from the home.", {"entities": []}], ["Further studies identifying the factors mediating the relationship between vision loss and mobility are needed to better understand how to improve mobility among AMD patients.", {"entities": []}], ["The main function of our immune system is to protect us from invading pathogens and microorganisms by destroying infected cells, while minimizing collateral damage to tissues.", {"entities": []}], ["In order to maintain this balance between immunity and tolerance, current understanding of the immune system attributes a major role to regulatory T cells (Tregs) in controlling both immunity and tolerance.", {"entities": []}], ["Various subsets of Tregs have been identified based on their expression of cell surface markers, production of cytokines, and mechanisms of action.", {"entities": []}], ["In brief, naturally occurring thymic-derived CD 4 + CD 25 + Tregs are characterized by constitutive expression of the transcription factor FOXP3, while antigen-induced or adaptive Tregs are mainly identified by expression of immunosuppressive cytokines (interleukin-10 (IL-10) and/or transforming growth factor- \u03b2 (TGF- \u03b2 )).", {"entities": [[139, 144, "GENE"]]}], ["While Tregs in normal conditions regulate ongoing immune responses and prevent autoimmunity, imbalanced function or number of these Tregs, either enhanced or decreased, might lead, respectively, to decreased immunity (e.g., with tumor development or infections) or autoimmunity (e.g., multiple sclerosis).", {"entities": [[285, 303, "DISEASE"]]}], ["This review will discuss recent research towards a better understanding of the biology of Tregs, their interaction with other immune effector cells, such as dendritic cells, and possible interventions in human disease.", {"entities": []}], ["Adenosine cardiovascular magnetic resonance (CMR) can accurately quantify myocardial perfusion reserve.", {"entities": []}], ["While regadenoson is increasingly employed due to ease of use, imaging protocols have not been standardized.", {"entities": []}], ["We sought to determine the optimal regadenoson CMR protocol for quantifying myocardial perfusion reserve index (MPRi) \u2013 more specifically, whether regadenoson stress imaging should be performed before or after rest imaging.", {"entities": []}], ["Twenty healthy subjects underwent CMR perfusion imaging during resting conditions, during regadenoson-induced hyperemia (0.4 mg), and after 15 min of recovery.", {"entities": []}], ["In 10/20 subjects, recovery was facilitated with aminophylline (125 mg).", {"entities": []}], ["Myocardial time-intensity curves were used to obtain left ventricular cavity-normalized myocardial up-slopes.", {"entities": []}], ["MPRi was calculated in two different ways: as the up-slope ratio of stress to rest (MPRi-rest), and the up-slope ratio of stress to recovery (MPRi-recov).", {"entities": []}], ["In all 20 subjects, MPRi-rest was 1.78 \u00b1 0.60.", {"entities": []}], ["Recovery up-slope did not return to resting levels, regardless of aminophylline use.", {"entities": []}], ["Among patients not receiving aminophylline, MPRi-recov was 36\u2009\u00b1\u200916% lower than MPRi-rest (1.13\u2009\u00b1\u20090.38 vs. 1.82\u2009\u00b1\u20090.73, P \u2009=\u20090.001).", {"entities": []}], ["In the 10 patients whose recovery was facilitated with aminophylline, MPRi-recov was 20\u2009\u00b1\u200924% lower than MPRi-rest (1.40\u2009\u00b1\u20090.35 vs. 1.73\u2009\u00b1\u20090.43, P \u2009=\u20090.04), indicating incomplete reversal.", {"entities": []}], ["In 3 subjects not receiving aminophylline and 4 subjects receiving aminophylline, up-slope at recovery was greater than at stress, suggesting delayed maximal hyperemia.", {"entities": []}], ["MPRi measurements from regadenoson CMR are underestimated if recovery perfusion is used as a substitute for resting perfusion, even when recovery is facilitated with aminophylline.", {"entities": []}], ["True resting images should be used to allow accurate MPRi quantification.", {"entities": []}], ["The delayed maximal hyperemia observed in some subjects deserves further study.", {"entities": []}], ["ClinicalTrials.gov NCT00871260", {"entities": []}], ["Borg developed scales for rating pain and perceived exertion in adults that have also been used in pediatric populations.", {"entities": []}], ["Models describing functional relationships between perceived exertion and work capacity have not been studied in children.", {"entities": []}], ["We compared different models and their fits to individual trajectories and assessed the variability in these trajectories.", {"entities": []}], ["Ratings of perceived exertion (RPE) were collected from 79 children.", {"entities": [[31, 34, "GENE"]]}], ["Progressive cycle ergonometric testing was performed to maximal work capacity with test duration ranging from 6\u2010 12 minutes.", {"entities": []}], ["Ratings were obtained during each 1\u2010minute increment.", {"entities": []}], ["Work was normalized to individual maximal work capacity (Wmax).", {"entities": []}], ["A delay was defined as the fraction of Wmax at which point an increase in ratings of leg fatigue occurred.", {"entities": []}], ["Such a delay term allows the characterization of trajectories for children whose ratings were initially constant with increasing work.", {"entities": []}], ["Two models were considered, a delay model and a power model that is commonly used to analyze Borg ratings.", {"entities": []}], ["Individual model fit was assessed with root mean squared error (RMSE).", {"entities": []}], ["Functional clustering algorithms were used to identify patterns.", {"entities": []}], ["Leg tiredness developed quickly for some children while for others there was a delay before an in\u2010 creased ratings of leg exertion occurred with increasing work.", {"entities": []}], ["Models for individual trajectories with the smallest RMSE included a delay and a quadratic term (quadratic\u2010delay model), or a power function and a delay term (power\u2010delay model) compared to a simple power function.", {"entities": []}], ["The median delay was 40% Wmax (interquartile range (IQR): 26\u201049%) in a quadratic\u2010delay model, while the median exponent was 1.03 (IQR: 0.83\u20101.78) in a power\u2010delay model.", {"entities": []}], ["Nine clusters were identified showing linear or quadratic patterns with or without a delay.", {"entities": []}], ["Cluster membership did not depend on age, gender or diagnosis.", {"entities": []}], ["Children and adolescents vary widely in their capacity to rate their perceptions and exhibit different functional relationships between ratings of perceived exertion and work capacity normalized across individuals.", {"entities": []}], ["Models including a delay term, a linear component, or a power function can describe these individual trajectories of perceived leg exertion during incremental exercise to voluntary exhaustion.", {"entities": []}], ["Ambient air particles in the ultrafine size range (diameter < 100 nm) may contribute to the health effects of particulate matter.", {"entities": []}], ["However, there are few data on ultrafine particle deposition during spontaneous breathing, and none in people with asthma.", {"entities": [[115, 121, "DISEASE"]]}], ["Sixteen subjects with mild to moderate asthma were exposed for 2 hr, by mouthpiece, to ultrafine carbon particles with a count median diameter (CMD) of 23 nm and a geometric standard deviation of 1.6.", {"entities": [[39, 45, "DISEASE"], [65, 67, "GENE"]]}], ["Deposition was measured during spontaneous breathing at rest (minute ventilation, 13.3 +/- 2.0 L/min) and exercise (minute ventilation, 41.9 +/- 9.0 L/min).", {"entities": []}], ["The mean +/- SD fractional deposition was 0.76 +/- 0.05 by particle number and 0.69 +/- 0.07 by particle mass concentration.", {"entities": []}], ["The number deposition fraction increased as particle size decreased, reaching 0.84 +/- 0.03 for the smallest particles (midpoint CMD = 8.7 nm).", {"entities": []}], ["No differences between sexes were observed.", {"entities": []}], ["The deposition fraction increased during exercise to 0.86 +/- 0.04 and 0.79 +/- 0.05 by particle number and mass concentration, respectively, and reached 0.93 +/- 0.02 for the smallest particles.", {"entities": []}], ["Experimental deposition data exceeded model predictions during exercise.", {"entities": []}], ["The deposition at rest was greater in these subjects with asthma than in previously studied healthy subjects (0.76 +/- 0.05 vs. 0.65 +/- 0.10, p < 0.001).", {"entities": [[58, 64, "DISEASE"]]}], ["The efficient respiratory deposition of ultrafine particles increases further in subjects with asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["Key words: air pollution, asthma, deposition, dosimetry, inhalation, ultrafine particles.", {"entities": [[26, 32, "DISEASE"]]}], ["Surveys are a common way to measure annoyance due to road traffic noise, but the method has some draw-backs.", {"entities": []}], ["Survey context, question wording and answer alternatives could affect participation and answers and could have implications when comparing studies and/or performing pooled analyses.", {"entities": []}], ["The aim of this study was to investigate the difference in annoyance reporting due to road traffic noise in two types of surveys of which one was introduced broadly and the other with the clearly stated aim of investigating noise and health.", {"entities": []}], ["Data was collected from two surveys carried out in the municipality of Malm\u00f6, southern Sweden in 2007 and 2008 (n = 2612 and n = 3810).", {"entities": []}], ["The first survey stated an aim of investigating residential environmental exposure, especially noise and health.", {"entities": []}], ["The second survey was a broad public health survey stating a broader aim.", {"entities": []}], ["The two surveys had comparable questions regarding noise annoyance, although one used a 5-point scale and the other a 4-point scale.", {"entities": []}], ["We used geographic information systems (GIS) to assess the average road and railway noise (L Aeq,24h ) at the participants' residential address.", {"entities": []}], ["Logistic regression was used to calculate odds ratios for annoyance in relation to noise exposure.", {"entities": []}], ["Annoyance at least once a week due to road traffic noise was significantly more prevalent in the survey investigating environment and health compared to the public health survey at levels > 45 dB(A), but not at lower exposure levels.", {"entities": []}], ["However no differences in annoyance were found when comparing the extreme alternatives \"never\" and \"every day\".", {"entities": []}], ["In the study investigating environment and health, \"Noise sensitive\" persons were more likely to readily respond to the survey and were more annoyed by road traffic noise compared to the other participants in that survey.", {"entities": []}], ["The differences in annoyance reporting between the two surveys were mainly due to different scales, suggesting that extreme alternatives are to prefer before dichotomization when comparing results between the two.", {"entities": []}], ["Although some findings suggested that noise-sensitive individuals were more likely to respond to the survey investigating noise and health, we could not find convincing evidence that contextual differences affected either answers or participation.", {"entities": []}], ["Cross linking of the IgE receptor (Fc\u03b5RI) on mast cells plays a critical role in IgE-dependent allergy including allergic rhinitis, asthma, anaphylaxis, and delayed type hypersensitivity reactions.", {"entities": [[113, 130, "DISEASE"], [122, 130, "DISEASE"], [132, 138, "DISEASE"]]}], ["The Ca in vivo in the context of the whole organism under normal and pathological conditions.", {"entities": []}], ["Studying bone marrow derived mast cells (BMMC) isolated from PI3KC2\u03b2 PI3KC2\u03b2 PI3KC2\u03b2", {"entities": []}], ["Here, we characterize a subset of ILC3s that express Neuropilin1 (NRP1) and are present in lymphoid tissues, but not in the peripheral blood or skin.", {"entities": [[66, 70, "GENE"]]}], ["NRP1 \u2022 NRP1 \u2022 NRP1 \u2022 NRP1 is a marker for human ILC3s with LTi phenotype and in\u00a0vitro LTi activity \u2022 NRP1 NRP1 NRP1 NRP1 is a marker for human ILC3s with LTi phenotype and in\u00a0vitro LTi activity NRP1 Shikhagaie et\u00a0al.", {"entities": [[0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"], [0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"], [0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"], [0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"], [0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"], [0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"], [0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"], [0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"], [0, 4, "GENE"], [7, 11, "GENE"], [14, 18, "GENE"], [21, 25, "GENE"], [101, 105, "GENE"], [106, 110, "GENE"], [111, 115, "GENE"], [116, 120, "GENE"], [194, 198, "GENE"]]}], ["find that NRP1 expressing human ILC3s are LTi-like cells, which are present in fetal tissues and adult lymphoid tissues, but not in peripheral blood or skin.", {"entities": [[10, 14, "GENE"]]}], ["\u03b2-Oxidation cycle reactions, which are key stages in the metabolism of fatty acids in eucaryotic cells and in processes with a significant role in the degradation of acids used by microbes as a carbon source, have also found application in biotransformations.", {"entities": []}], ["One of the major advantages of biotransformations based on the \u03b2-oxidation cycle is the possibility to transform a substrate in a series of reactions catalyzed by a number of enzymes.", {"entities": []}], ["It allows the use of sterols as a substrate base in the production of natural steroid compounds and their analogues.", {"entities": []}], ["This route also leads to biologically active compounds of therapeutic significance.", {"entities": []}], ["Transformations of natural substrates via \u03b2-oxidation are the core part of the synthetic routes of natural flavors used as food additives.", {"entities": []}], ["Stereoselectivity of the enzymes catalyzing the stages of dehydrogenation and addition of a water molecule to the double bond also finds application in the synthesis of chiral biologically active compounds, including medicines.", {"entities": []}], ["Recent advances in genetic, metabolic engineering, methods for the enhancement of bioprocess productivity and the selectivity of target reactions are also described.", {"entities": []}], ["Expiratory flow limitation (EFL) during tidal breathing is common in patients with severe COPD, and a major determinant of dynamic hyperinflation and exercise limitation.", {"entities": []}], ["EFL can be measured by the forced oscillation technique (FOT); however, the relevance to clinical parameters is not fully understood.", {"entities": []}], ["We hypothesized that emphysema extent and pulmonary function would contribute independently to the degree of EFL.", {"entities": []}], ["Broadband frequency FOT and pulmonary function tests were performed in 74 patients with COPD to derive respiratory system resistance (Rrs) and reactance (Xrs), and the EFL index as expressed by the differences between inspiratory and expiratory phases of Xrs at 5\u00a0Hz (\u0394X5).", {"entities": []}], ["Emphysema extent was measured by high-resolution computed tomography and scored.", {"entities": []}], ["On the basis of the median value of \u0394X5 (0.55 cmH 2 O/L/s), patients were classified into a high or low EFL index group.", {"entities": []}], ["In multivariate regression analyses, a high EFL index was independently predicted by emphysema score, peripheral airway obstruction (forced expiratory flow between 25% and 75% of forced vital capacity), hyperinflation (functional residual capacity), and airway caliber (whole-breath Rrs at 5\u00a0Hz).", {"entities": []}], ["EFL measured by FOT is a global measure of COPD that has separable etiologies and is useful for evaluating the disease condition.", {"entities": []}], ["Few studies have investigated the association of environmental chromium exposure and preterm birth in general population.", {"entities": []}], ["This study was designed to investigate whether maternal chromium exposure during pregnancy is associated with reduced gestational age or risk of preterm birth using the data from Healthy Baby Cohort study conducted in Hubei, China between 2012 and 2014 (n\u2009=\u20097290).", {"entities": []}], ["Chromium concentrations in maternal urine samples collected at delivery were measured with inductively coupled plasma mass spectrometry.", {"entities": []}], ["Tertiles of chromium concentrations was negatively associated with gestational age in multivariable linear regression analyses [\u03b2 (95% CI): low\u2009=\u2009reference; middle\u2009=\u2009\u22120.67 days (\u22121.14, \u22120.20); high\u2009=\u2009\u22122.30 days (\u22122.93, \u22121.67); p trend <0.01].", {"entities": []}], ["Logistic regression analyses also indicated that higher maternal chromium [adjusted odds ratio (OR) (95% CI): 1.55(0.99, 2.42) for the medium tertile; 1.89(1.13, 3.18) for the highest tertile; p trend <0.01] was associated with increased risk of preterm birth.", {"entities": []}], ["The associations appeared to be more pronounced in male infants (adjusted OR (95% CI): 2.54 (1.29, 4.95) for the medium tertile; 2.92 (1.37, 6.19) for the highest tertile; p trend <0.01).", {"entities": []}], ["Our findings suggest maternal exposure to higher chromium levels during pregnancy may potentially increase the risk of delivering preterm infants, particularly for male infants.", {"entities": []}], ["Several studies have shown that cocoa and cocoa-containing foods have the potential to lower blood pressure and improve endothelial function.", {"entities": []}], ["Most of the studies reporting the beneficial effects of dark chocolate on blood pressure have been short (\u2264 4\u00a0weeks).", {"entities": []}], ["The aim of the present 8-wks (weeks) study was to assess the effects of regular consumption of dark chocolate during a reduced snack consumption intervention on blood pressure and other cardiovascular risk factors in mildly hypertensive individuals.", {"entities": []}], ["This was a randomized, controlled, cross-over trial involving 22 adults (8 women, 14 men), aged 33\u201364 y, BMI 27.7\u2009\u00b1\u20093.7\u00a0kg/m Daily consumption of dark chocolate had no effects on 24\u00a0h blood pressure, resting blood pressure (mean\u2009\u00b1\u2009SD, pre 142\u2009\u00b1\u200911.5/89\u2009\u00b1\u20098.4\u00a0mmHg vs. post 142\u2009\u00b1\u200914.2/88\u2009\u00b1\u20099.4\u00a0mmHg in systolic and diastolic blood pressure, respectively) or arterial stiffness (mean\u2009\u00b1\u2009SD, pre 7.68\u2009\u00b1\u20090.88 vs. post 7.76\u2009\u00b1\u20090.89).", {"entities": []}], ["Weight was reduced by 1.0\u2009\u00b1\u20092.2\u00a0kg during the control (reduced snack only) period, but was unchanged while eating chocolate (p\u2009<\u20090.027 between the treatments).", {"entities": []}], ["The data collected in this study indicates that inclusion of dark chocolate daily in the diet had no significant effects on blood pressure or other cardiovascular risk factors during a reduced snack period.", {"entities": []}], ["ClinicalTrials.gov identifier NCT02130141", {"entities": []}], ["Airway mucus overproduction is one of the most common symptoms of asthma that causes severe clinical outcomes in patients.", {"entities": [[66, 72, "DISEASE"]]}], ["Despite the effectiveness of general asthma therapies, specific treatments that prevent mucus overproduction in asthma patients remain lacking.", {"entities": [[37, 43, "DISEASE"], [112, 118, "DISEASE"]]}], ["Recent studies have found that activation of GABA A receptors (GABA A R) is important for promoting mucus oversecretion in lung airway epithelia.", {"entities": []}], ["Here, we report that luteolin, a natural flavonoid compound, suppresses mucus overproduction by functionally inhibiting the GABAergic system.", {"entities": []}], ["This hypothesis was investigated by testing the effects of luteolin on goblet cell hyperplasia, excessive mucus secretion, and GABAergic transmission using histological and electrophysiological approaches.", {"entities": []}], ["Our results showed that 10\u2009mg/kg luteolin significantly decreased the number of goblet cells in the lung tissue and inhibited mucus overproduction in an in vivo asthma model induced by ovalbumin (OVA) in mice.", {"entities": [[161, 167, "DISEASE"]]}], ["Patch-clamp recordings showed that luteolin inhibited GABA A R-mediated currents in A549 cells.", {"entities": []}], ["Furthermore, the inhibitory effects of luteolin on OVA-induced goblet cell hyperplasia and mucus overproduction were occluded by the GABA A R antagonist picrotoxin.", {"entities": []}], ["In conclusion, our observations indicate that luteolin effectively attenuates mucus overproduction at least partially by inhibiting GABA A Rs, suggesting the potential for therapeutic administration of luteolin in the treatment of mucus overproduction in asthma patients.", {"entities": [[255, 261, "DISEASE"]]}], ["Diagnosis and treatment of chronic and recurrent sinusitis in children is of potential importance and many factors can havean influence on it.", {"entities": [[49, 58, "DISEASE"]]}], ["This study assessed the chronic and recurrent sinusitis and affecting factors, as well as the role of allergy in its course and treatment in children.", {"entities": [[46, 55, "DISEASE"]]}], ["A total of 106 children with the diagnosis of chronic or recurrent sinusitis, referred to specialty clinics of otolaryngology and allergy of Tabriz Children Educational-Medical centres since 2010 to 2012, were enrolled.", {"entities": [[67, 76, "DISEASE"]]}], ["The history and physicalexamination findings were recorded for all patients and allergy Prick test was done for all.", {"entities": []}], ["Response to treatment was evaluated during the follow-up visits.", {"entities": []}], ["The mean age of studied patients was 6.5 \u00b1 2.9 years.", {"entities": []}], ["Of all the patients, 54 (50.9%) were male and 52 (49.1%) were female.", {"entities": []}], ["Skin Prick test was positive in 69.8%.", {"entities": []}], ["Response to treatment was seen in 86.8% of the patients while 7.5% did not have any favourable outcome.", {"entities": []}], ["Anti-allergic treatment caused better outcomes in patients with positive Skin Prick test than those with negative results.", {"entities": []}], ["The prevalence of allergic disease in children with chronic or recurrent sinusitis is considerable and anti-allergic treatments can result infavourable therapeutic outcomes in children with sinusitis, especially with positive skin prick test results.", {"entities": [[73, 82, "DISEASE"], [190, 199, "DISEASE"]]}], ["Poor psychosocial workplace factors have been found to cause or exacerbate a variety of health problems, including pain.", {"entities": []}], ["However, little work has focused on how psychosocial workplace factors, such as health-related employer support, relate to future medical expenditures after controlling for health.", {"entities": []}], ["Health-related support has also not been well explored in previous literature as a psychosocial factor.", {"entities": []}], ["This study estimated the association of health-related employer support and pain with future medical expenditures, after including many additional controls.", {"entities": []}], ["This study used a restricted data set comprised of medical claims and survey data for one company in the U.S.", {"entities": []}], ["Participants were included in the sample if they had worked for their employer for at least 12\u00a0months prior to the survey and if they were continuously eligible for health insurance (N=1,570).", {"entities": []}], ["Future medical expenditures were measured using administrative claims data covering inpatient, outpatient, mental health and pharmaceutical insurance claims during a year.", {"entities": []}], ["Health-related employer support was measured using participants\u2019 answers about whether the employer would support their efforts to positively change their emotional or physical health.", {"entities": []}], ["Pain was measured as recurring pain from any condition over the previous year.", {"entities": []}], ["Having any physical health-related employer support was associated with a 0.06 increase in the probability of having future medical expenditures greater than zero, 95% CI [0.01, 0.11], but not with total expenditures.", {"entities": []}], ["Having pain was associated with a 0.06 increase, 95% CI [0.04, 0.09], in the probability of having future medical expenditures greater than zero and with $3,027 additional total expenditures, 95% CI [$1,077, $4,987].", {"entities": []}], ["After controlling for health and pain, psychosocial workplace factors were not robustly associated with future medical expenditures.", {"entities": []}], ["Pain was associated with increased medical expenditures for the self-insured employer in this study, adjusting for a variety of factors.", {"entities": []}], ["Breastfeeding benefits both infants and mothers.", {"entities": []}], ["Recent research shows long-term health and human capital benefits among individuals who were breastfed.", {"entities": []}], ["Epigenetic mechanisms have been suggested as potential mediators of the effects of early-life exposures on later health outcomes.", {"entities": []}], ["We reviewed the literature on the potential effects of breastfeeding on DNA methylation.", {"entities": []}], ["Studies reporting original results and evaluating DNA methylation differences according to breastfeeding/breast milk groups (e.g., ever vs. never comparisons, different categories of breastfeeding duration, etc) were eligible.", {"entities": []}], ["Six databases were searched simultaneously using Ovid, and the resulting studies were evaluated independently by two reviewers.", {"entities": []}], ["Seven eligible studies were identified.", {"entities": []}], ["Five were conducted in humans.", {"entities": []}], ["Studies were heterogeneous regarding sample selection, age, target methylation regions, methylation measurement and breastfeeding categorisation.", {"entities": []}], ["Collectively, the studies suggest that breastfeeding might be negatively associated with promoter methylation of LEP (which encodes an anorexigenic hormone), CDKN2A (involved in tumour suppression) and Slc2a4 genes (which encodes an insulin-related glucose transporter) and positively with promoter methylation of the Nyp (which encodes an orexigenic neuropeptide) gene, as well as influence global methylation patterns and modulate epigenetic effects of some genetic variants.", {"entities": [[113, 116, "GENE"], [158, 164, "GENE"], [202, 208, "GENE"]]}], ["The findings from our systematic review are far from conclusive due to the small number of studies and their inherent limitations.", {"entities": []}], ["Further studies are required to understand the actual potential role of epigenetics in the associations of breastfeeding with later health outcomes.", {"entities": []}], ["Suggestions for future investigations, focusing on epigenome-wide association studies, are provided.", {"entities": []}], ["Retroviruses have been linked to a variety of diseases such as neoplastic and immunodeficiency disorders and neurologic and respiratory diseases.", {"entities": []}], ["Recently, a novel infectious human retrovirus, the xenotropic murine leukemia virus-related virus (XMRV), has been identified in cohorts of patients with either a familial type of prostate cancer or chronic fatigue syndrome.", {"entities": [[199, 223, "DISEASE"], [215, 223, "DISEASE"], [69, 77, "DISEASE"], [189, 195, "DISEASE"], [180, 195, "DISEASE"]]}], ["The apparent unrelatedness of these diseases raised the question of the potential involvement of XMRV in other diseases.", {"entities": []}], ["Here, we investigated the presence of XMRV in a selection of pediatric idiopathic infectious diseases with symptoms that are suggestive of a retroviral infection, as well as in children with respiratory diseases and in adult patients with spondyloarthritis (SpA).", {"entities": []}], ["Using a XMRV env -nested PCR, we screened 72 DNA samples obtained from 62 children hospitalized in the Montpellier university hospital (France) for hematological, neurological or inflammatory pathologies, 80 DNA samples from nasopharyngeal aspirates from children with respiratory diseases and 19 DNA samples from SpA.", {"entities": []}], ["None of the samples tested was positive for XMRV or MLV-like env sequences, indicating that XMRV is not involved in these pathologies.", {"entities": []}], ["The parasitic worm\u2013derived immunomodulator ES\u201062 protects against disease in the mouse collagen\u2010induced arthritis (CIA) model of rheumatoid arthritis (RA) by suppressing pathogenic interleukin\u201017 (IL\u201017) responses.", {"entities": [[129, 149, "DISEASE"], [104, 113, "DISEASE"], [140, 149, "DISEASE"]]}], ["The Th17\u2010associated cytokine IL\u201022 also appears to have a pathogenic role in autoimmune arthritis, particularly in promoting proinflammatory responses by synovial fibroblasts and osteoclastogenesis.", {"entities": [[88, 97, "DISEASE"]]}], ["The present study was undertaken to investigate whether the protection against joint damage afforded by ES\u201062 also reflects suppression of IL\u201022.", {"entities": []}], ["The role(s) of IL\u201022 was assessed by investigating the effects of neutralizing anti\u2013IL\u201022 antibodies and recombinant IL\u201022 (rIL\u201022) on proinflammatory cytokine production, synovial fibroblast responses, and joint damage in mice with CIA in the presence or absence of ES\u201062.", {"entities": []}], ["Neutralization of IL\u201022 during the initiation phase abrogated CIA, while administration of rIL\u201022 enhanced synovial fibroblast responses and exacerbated joint pathology.", {"entities": []}], ["In contrast, after disease onset anti\u2013IL\u201022 did not suppress progression, whereas administration of rIL\u201022 promoted resolution of inflammation.", {"entities": []}], ["Consistent with these late antiinflammatory effects, the protection afforded by ES\u201062 was associated with elevated levels of IL\u201022 in the serum and joints that reflected a desensitization of the synovial fibroblast responses.", {"entities": []}], ["Moreover, neutralization of IL\u201022 during the late effector stage of disease prevented ES\u201062\u2013mediated desensitization of synovial fibroblast responses and protection against CIA.", {"entities": []}], ["IL\u201022 plays a dual role in CIA, being pathogenic during the initiation phase while acting to resolve inflammation and joint damage during established disease.", {"entities": []}], ["Harnessing of the tissue repair properties of IL\u201022 by ES\u201062 highlights the potential for joint\u2010targeted therapeutic modulation of synovial fibroblast responses and consequent protection against bone damage in RA.", {"entities": []}], ["Numerous studies, including those using animal models of myopia development and human clinical trials, have shown that the non-selective muscarinic antagonist atropine is effective in preventing the axial elongation that leads to myopia development.", {"entities": [[57, 63, "DISEASE"], [230, 236, "DISEASE"]]}], ["Among all of the muscarinic acetylcholine receptors (mAChRs), mAChR 1 (M1) was the most effective in preventing myopic eye change.", {"entities": []}], ["Our specific aim in this study was to examine the association between high myopia and polymorphisms within the muscarinic acetylcholine receptors 1 gene (CHRM1) .", {"entities": [[75, 81, "DISEASE"], [154, 159, "GENE"]]}], ["The participants comprised of a high myopia group (n=194; age range, 17\u201324 years) having a myopic spherical equivalent greater than 6.5 diopters (D) and a control group (n=109; age range, 17\u201325 years) having a myopic spherical equivalent less than 0.5 D. Genotyping was performed using an assay-on-demand allelic discrimination assay.", {"entities": [[37, 43, "DISEASE"]]}], ["Polymerase chain reaction (PCR) was performed using 96 well plates on a thermal cycler.", {"entities": []}], ["The polymorphisms detected were S1 ( CHRM1 rs11823728 ), S2 ( CHRM1 rs544978 ), S3 ( CHRM1 rs2186410 ), and S4 ( CHRM1 rs542269 ).", {"entities": [[37, 42, "GENE"], [62, 67, "GENE"], [85, 90, "GENE"], [113, 118, "GENE"], [37, 42, "GENE"], [62, 67, "GENE"], [85, 90, "GENE"], [113, 118, "GENE"], [37, 42, "GENE"], [62, 67, "GENE"], [85, 90, "GENE"], [113, 118, "GENE"], [37, 42, "GENE"], [62, 67, "GENE"], [85, 90, "GENE"], [113, 118, "GENE"]]}], ["There was a significant difference in the distribution of S2 and S4 between the high myopia and control groups (p=2.40\u00d710 CHRM1 as all being significant in the development of high myopia.", {"entities": [[85, 91, "DISEASE"], [180, 186, "DISEASE"], [122, 127, "GENE"]]}], ["Moreover, the distributions of haplotype 4 (Ht4; C/A/A/A) differed significantly between the two groups (p=3.4\u00d710 Our results suggest that the S2 and S4 polymorphisms of CHRM1 are associated with susceptibility for developing high myopia.", {"entities": [[231, 237, "DISEASE"], [170, 175, "GENE"]]}], ["S1, S2, and S4 CHRM1 had a co-operative association with high myopia.", {"entities": [[62, 68, "DISEASE"], [15, 20, "GENE"]]}], ["The scavenger receptor MARCO mediates macrophage recognition and clearance of pathogens and their polyanionic ligands.", {"entities": []}], ["However, recent studies demonstrate MARCO expression and function in dendritic cells, suggesting MARCO might serve to bridge innate and adaptive immunity.", {"entities": []}], ["To gain additional insight into the role of MARCO in dendritic cell activation and function, we profiled transcriptomes of mouse splenic dendritic cells obtained from MARCO deficient mice and their wild type counterparts under resting and activating conditions.", {"entities": []}], ["In silico analysis uncovered major alterations in gene expression in MARCO deficient dendritic cells resulting in dramatic alterations in key dendritic cell-specific pathways and functions.", {"entities": []}], ["Specifically, changes in CD209, FCGR4 and Complement factors can have major consequences on DC-mediated innate responses.", {"entities": [[25, 30, "GENE"]]}], ["Notably, these perturbations were magnified following activation with the TLR-4 agonist lipopolysaccharide.", {"entities": []}], ["To validate our in silico data, we challenged DC\u2018s with various agonists that recognize all mouse TLRs and assessed expression of a set of immune and inflammatory marker genes.", {"entities": []}], ["This approach identified a differential contribution of MARCO to TLR activation and validated a major role for MARCO in mounting an inflammatory response.", {"entities": []}], ["Together, our data demonstrate that MARCO differentially affects TLR-induced DC activation and suggest targeting of MARCO could lead to different outcomes that depend on the inflammatory context encountered by DC.", {"entities": []}], ["The possible pathogenic role and mechanism of Di-iso-nonyl phthalate (DINP) in allergic dermatitis is still controversial.", {"entities": [[88, 98, "DISEASE"]]}], ["This work has shown that oral exposure to DINP exacerbated allergic dermatitis tissue lesions in FITC-sensitized mice.", {"entities": [[68, 78, "DISEASE"]]}], ["The lesions was accompanied by an enhancement of TRPA1 expression and an increase in IgG1, IL-6 and IL-13 levels.", {"entities": [[49, 54, "GENE"]]}], ["This work also found that blocking TRPA1 by HC030031 effectively prevented the development of allergic dermatitis resulting from oral exposure to DINP and/or FITC-sensitized mice.", {"entities": [[103, 113, "DISEASE"], [35, 40, "GENE"]]}], ["This result is marked by the down regulation of IgG1 levels, a reduction in mast cell degranulation and a decrease in IL-6 and IL-13 levels.", {"entities": []}], ["We also showed that blocking NF-\u03baB inhibited TRPA1 expression, and that blocking TRPA1 had no significant effect on the activation of NF-\u03baB or TSLP expression.", {"entities": [[45, 50, "GENE"], [81, 86, "GENE"], [45, 50, "GENE"], [81, 86, "GENE"], [143, 147, "GENE"]]}], ["This study helps in understanding the role DINP exposure plays in the development of allergic dermatitis and provides new insight into the mechanisms behind the DINP-induced adjuvant effect.", {"entities": [[94, 104, "DISEASE"]]}], ["Previously, we demonstrated that OVA-loaded macrophages (OVA-M\u03c6) partially suppress OVA-induced airway manifestations of asthma in BALB/c mice.", {"entities": [[121, 127, "DISEASE"]]}], ["In vitro studies showed that OVA-M\u03c6 start to produce IL-10 upon interaction with allergen-specific T cells, which might mediate their immunosuppressive effects.", {"entities": []}], ["Herein, we examined whether IL-10 is essential for the immunosuppressive effects of OVA-M\u03c6 in vivo , and whether ex vivo stimulation of the IL-10 production by OVA-M\u03c6 could enhance these effects.", {"entities": []}], ["Peritoneal M\u03c6 were loaded with OVA and stimulated with LPS or immunostimulatory sequence oligodeoxynucleotide (ISS-ODN) in vitro .", {"entities": []}], ["The increase of IL-10 production was examined and, subsequently, ex vivo stimulated OVA-M\u03c6 were used to treat (i.v.)", {"entities": []}], ["OVA-sensitized mice.", {"entities": []}], ["To further explore whether M\u03c6-derived IL-10 mediates the immunosuppressive effects, M\u03c6 isolated from IL-10 We found that stimulation with LPS or ISS-ODN highly increased the IL-10 production by OVA-M\u03c6 (2.5-fold and 4.5-fold increase, respectively).", {"entities": []}], ["ISS-ODN stimulation of OVA-M\u03c6 significantly potentiated the suppressive effects on allergic airway inflammation.", {"entities": []}], ["Compared to sham-treatment, ISS-ODN-stimulated OVA-M\u03c6 suppressed the airway eosinophilia by 85% (vs. 30% by unstimulated OVA-M\u03c6), IL-5 levels in bronchoalveolar lavage fluid by 80% (vs. 50%) and serum OVA-specific IgE levels by 60% (vs. 30%).", {"entities": [[76, 88, "DISEASE"]]}], ["Importantly, IL-10 ex vivo , failed to suppress OVA-induced airway inflammation.", {"entities": []}], ["These results demonstrate that M\u03c6-derived IL-10 mediates anti-inflammatory responses in a mouse model of allergic asthma, which both can be potentiated by stimulation with ISS-ODN.", {"entities": [[105, 120, "DISEASE"], [114, 120, "DISEASE"]]}], ["The relation between B2 cells and commensal microbes during atherosclerosis remains largely unexplored.", {"entities": [[60, 75, "DISEASE"]]}], ["Here we show that under hyperlipidemic conditions intestinal microbiota resulted in recruitment and ectopic activation of B2 cells in perivascular adipose tissue, followed by an increase in circulating IgG, promoting disease development.", {"entities": []}], ["In contrast, disruption of the intestinal microbiota by a broad-spectrum antibiotic cocktail (AVNM) led to the attenuation of atherosclerosis by suppressing B2 cells, despite the persistence of serum lipid abnormalities.", {"entities": [[126, 141, "DISEASE"]]}], ["Furthermore, pharmacological depletion of B2 cells with an anti-B2-cell surface CD23 antibody also attenuated commensal microbe-induced atherosclerosis.", {"entities": [[136, 151, "DISEASE"]]}], ["Moreover, expression analysis of TLR-signaling-related genes in the activated B2 cell subsets, assessed using the Toll-Like Receptor Signaling Pathway RT2 Profiler PCR Array, confirmed activation of the B2-cell autoantibody-production axis, which was associated with an increased capacity of B2 cells to bind to intestinal microbiota.", {"entities": []}], ["Together, our findings reveal the critical role of commensal microbe-specific activation of B2 cells in the development of atherogenesis through lipid metabolism-independent mechanisms.", {"entities": []}], ["Under hyperlipidemic condition, signals driven by the intestinal microbiota via TLRs signaling pathway cause B2 cells in spleen to become functionally active and activated B cells then modify responses such as antigen presentation (upregulation of costimulatory molecules-MHC class II molecules) and antibody production (generation of active antibodies IgG and IgG3), thereby contributing to the development of atherosclerosis.", {"entities": [[411, 426, "DISEASE"]]}], ["On the other hand, intestinal microbiota also resulted in recruitment and ectopic activation of B2 cells via TLRs signaling pathway in perivascular adipose tissue (PVAT) at the same time, and, subsequently, an increase in circulating IgG, led to the enhanced disease development.", {"entities": []}], ["Image 1 \u2022 Commensal microbe-specific activation of B2 cell plays a pivotal role in atherosclerosis through lipid metabolism-independent mechanism.", {"entities": [[83, 98, "DISEASE"]]}], ["\u2022 B2-cell TLR signaling mediates microbiota-driven atherosclerosis.", {"entities": [[51, 66, "DISEASE"]]}], ["\u2022 An anti-B2-cell antibody (CD23) was effective for preventing commensal microbe-derived atherosclerosis.", {"entities": [[89, 104, "DISEASE"]]}], ["Commensal microbe-specific activation of B2 cell plays a pivotal role in atherosclerosis through lipid metabolism-independent mechanism.", {"entities": [[73, 88, "DISEASE"]]}], ["B2-cell TLR signaling mediates microbiota-driven atherosclerosis.", {"entities": [[49, 64, "DISEASE"]]}], ["An anti-B2-cell antibody (CD23) was effective for preventing commensal microbe-derived atherosclerosis.", {"entities": [[87, 102, "DISEASE"]]}], ["Atherosclerosis is among the leading causes of mortality and morbidity worldwide.", {"entities": [[0, 15, "DISEASE"]]}], ["Commensal microbe-derived atherosclerosis developing via metabolism-dependent mechanisms has received increasing attention.", {"entities": [[26, 41, "DISEASE"]]}], ["However, whether the effect of the intestinal microbiota on atherosclerosis is mediated by immune mechanisms remains unknown.", {"entities": [[60, 75, "DISEASE"]]}], ["The results of our study provide evidence for a pathway of immune activation in commensal microbe-derived atherosclerosis, which is driven by B2 cells that sense microbiota, and suggest that B2 cells may serve as a target for the development of therapeutic interventions.", {"entities": [[106, 121, "DISEASE"]]}], ["The transcriptional activity of the glucocorticoid receptor (GR) is co-determined by its ability to recruit a vast and varying number of cofactors.", {"entities": []}], ["We here identify Striatin-3 (STRN3) as a novel interaction partner of GR that interferes with GR\u2019s ligand-dependent transactivation capacity.", {"entities": [[29, 34, "GENE"]]}], ["Remarkably, STRN3 selectively affects only GR-dependent transactivation and leaves GR-dependent transrepression mechanisms unhampered.", {"entities": [[12, 17, "GENE"]]}], ["We found that STRN3 down-regulates GR transactivation by an additional recruitment of the catalytic subunit of protein phosphatase 2A (PPP2CA) to GR.", {"entities": [[14, 19, "GENE"], [135, 141, "GENE"]]}], ["We hypothesize the existence of a functional trimeric complex in the nucleus, able to dephosphorylate GR at serine 211, a known marker for GR transactivation in a target gene-dependent manner.", {"entities": []}], ["The presence of STRN3 appears an absolute prerequisite for PPP2CA to engage in a complex with GR.", {"entities": [[16, 21, "GENE"], [59, 65, "GENE"]]}], ["Herein, the C-terminal domain of GR is essential, reflecting ligand-dependency, yet other receptor parts are also needed to create additional contacts with STRN3.", {"entities": [[156, 161, "GENE"]]}], ["Drug side effects cause a significant clinical and economic burden.", {"entities": []}], ["However, mechanisms of drug action underlying side effect pathogenesis remain largely unknown.", {"entities": []}], ["Here, we integrate pharmacogenomic and clinical data with a human metabolic network and find that non-pharmacokinetic metabolic pathways dysregulated by drugs are linked to the development of side effects.", {"entities": []}], ["We show such dysregulated metabolic pathways contain genes with sequence variants affecting side effect incidence, play established roles in pathophysiology, have significantly altered activity in corresponding diseases, are susceptible to metabolic inhibitors and are effective targets for therapeutic nutrient supplementation.", {"entities": []}], ["Our results indicate that metabolic dysregulation represents a common mechanism underlying side effect pathogenesis that is distinct from the role of metabolism in drug clearance.", {"entities": []}], ["We suggest that elucidating the relationships between the cellular response to drugs, genetic variation of patients and cell metabolism may help managing side effects by personalizing drug prescriptions and nutritional intervention strategies.", {"entities": []}], ["Adverse drug reactions are an important clinical problem.", {"entities": []}], ["Here the authors combine information about drug-induced gene expression changes and genetic variability of patients with a genome-scale metabolic model to identify drug-induced changes in cellular metabolism that may be linked to drug side effects.", {"entities": []}], ["Celiprolol is a \u03b2-blocker with a unique pharmacologic profile: it is a \u03b21-andrenoceptor antagonist with partial \u03b22 agonist activity.", {"entities": []}], ["Given this combination of effects, celiprolol may be better described as a selective adrenoreceptor modulator.", {"entities": []}], ["It has antihypertensive and antianginal properties and is indicated for those uses in various countries around the world.", {"entities": []}], ["In the United States, however, the proposed indication for this drug will be for the treatment of vascular type Ehlers\u2013Danlos syndrome, a rare connective tissue disorder characterized by fragile arterial structure and an increased risk of life-threatening vascular complications.", {"entities": [[126, 134, "DISEASE"]]}], ["By reducing heart rate and pulsatile pressure, celiprolol may reduce the mechanical stress on collagen fibers within the arterial wall and be of benefit in patients with vascular type Ehlers\u2013Danlos syndrome.", {"entities": [[198, 206, "DISEASE"]]}], ["The largest investigation of celiprolol in vascular Ehlers\u2013Danlos syndrome was prematurely terminated due to significant benefit with celiprolol in reducing arterial events in patients with this condition.", {"entities": [[66, 74, "DISEASE"]]}], ["Celiprolol, therefore, represents a \u03b2-blocker that is unique from others in its class in both its pharmacology and clinical applications.", {"entities": []}], ["Background .", {"entities": []}], ["We assessed vitamin D intakes and serum 25(OH) vitamin D levels in pediatric asthma patients on moderate-to-high dose inhaled steroids and compared them to published findings of healthy children in our city.", {"entities": [[77, 83, "DISEASE"]]}], ["Parents and/or patients were interviewed to estimate the children's vitamin D intakes from foods and supplements (using an adapted validated food frequency questionnaire) and asthma duration and management.", {"entities": [[175, 181, "DISEASE"]]}], ["Vitamin D status: serum 25-hyroxy vitamin D (25(OH)D) was obtained from the medical records.", {"entities": []}], ["Vitamin D intakes from food and supplements of the asthma patients ( n = 20, 742 \u00b1 185\u2009IU/day) were significantly higher compared to healthy Canadian children ( n = 1442, 229 \u00b1 121\u2009IU/day).", {"entities": [[51, 57, "DISEASE"]]}], ["Despite higher vitamin D intakes, the children had nonsignificantly lower serum 25(OH) vitamin D levels compared to the comparison group.", {"entities": []}], ["Serum 25(OH)D levels increased by 3.6\u2009nmol/L with each 100\u2009IU of vitamin D intake (95% Confidence interval = 2.0\u20134.0, R p = 0.001).", {"entities": []}], ["Conclusion .", {"entities": []}], ["Since adequate vitamin D status in asthma patients is necessary to support bone mineral accretion, it is important to achieve adequate vitamin D status by checking serum 25(OH)D status and supplement accordingly.", {"entities": [[35, 41, "DISEASE"]]}], ["Considerable interest and controversy over a possible decline in semen quality during the 20th century raised concern that semen quality could have reached a critically low level where it might affect human reproduction.", {"entities": []}], ["The authors therefore initiated a study to assess reproductive health in men from the general population and to monitor changes in semen quality over time.", {"entities": []}], ["Cross-sectional study of men from the general Danish population.", {"entities": []}], ["Inclusion criteria were place of residence in the Copenhagen area, and both the man and his mother being born and raised in Denmark.", {"entities": []}], ["Men with severe or chronic diseases were not included.", {"entities": []}], ["Danish one-centre study.", {"entities": []}], ["4867 men, median age 19\u2005years, included from 1996 to 2010.", {"entities": []}], ["Semen volume, sperm concentration, total sperm count, sperm motility and sperm morphology.", {"entities": []}], ["Only 23% of participants had optimal sperm concentration and sperm morphology.", {"entities": []}], ["Comparing with historic data of men attending a Copenhagen infertility clinic in the 1940s and men who recently became fathers, these two groups had significantly better semen quality than our study group from the general population.", {"entities": [[59, 70, "DISEASE"]]}], ["Over the 15\u2005years, median sperm concentration increased from 43 to 48\u2005million/ml (p=0.02) and total sperm count from 132 to 151 million (p=0.001).", {"entities": []}], ["The median percentage of motile spermatozoa and abnormal spermatozoa were 68% and 93%, and did not change during the study period.", {"entities": []}], ["This large prospective study of semen quality among young men of the general population showed an increasing trend in sperm concentration and total sperm count.", {"entities": []}], ["However, only one in four men had optimal semen quality.", {"entities": []}], ["In addition, one in four will most likely face a prolonged waiting time to pregnancy if they in the future want to father a child and another 15% are at risk of the need of fertility treatment.", {"entities": []}], ["Thus, reduced semen quality seems so frequent that it may impair the fertility rates and further increase the demand for assisted reproduction.", {"entities": []}], ["A paper by Carlsen et al 20\u2005years ago ( BMJ 1992;305:609\u201313) raised controversy with evidence of a decline in semen quality, and several studies on semen quality in human populations have followed.", {"entities": []}], ["There has been a lack of larger, prospectively collected quality-controlled data on semen quality in the general population.", {"entities": []}], ["This study brings good and bad news.", {"entities": []}], ["Fifteen years monitoring of semen quality in men of the general population indicated a slight increase in both median sperm concentration and total sperm count.", {"entities": []}], ["However, still only a fraction of the men (23%) had optimal sperm concentration and sperm morphology, and the median percentage of abnormal spermatozoa was as high as 93% with no sign of improvement during the study period.", {"entities": []}], ["Approximately 15% of the men had a sperm concentration at a level that would indicate a high risk of needing future fertility treatment if they want to father a child, and another 27% of the men will be at risk of a prolonged waiting time to pregnancy.", {"entities": []}], ["Large prospective study of semen quality among men of the general population unselected with regard to fertility.", {"entities": []}], ["Standardised inclusion and investigation procedures.", {"entities": []}], ["Lack of historical, directly comparable data.", {"entities": []}], ["Personalized medicine has the potential to improve our ability to maintain health and treat disease, while ameliorating continuously rising healthcare costs.", {"entities": []}], ["Translation of basic research findings to clinical applications within regulatory compliance is required for personalized medicine to become the new foundation for practice of medicine.", {"entities": []}], ["Deploying even a few of the thousands of potential diagnostic biomarkers identified each year as part of personalized treatment workflows requires clinically efficient biosensor technologies to monitor multiple biomarkers in patients in real time.", {"entities": []}], ["This paper discusses a critical component of a regulatory system, a microcavity optical biosensor for label-free monitoring of biomolecular interactions at physiologically-relevant concentrations.", {"entities": []}], ["While most current biosensor research focuses on improving sensitivity, this paper emphasizes other characteristics a biosensor technology requires to be practical in a clinical setting, presenting robust microcavity biosensors which are easy to manufacture and integrate with microfluidics into flexible and redesignable platforms making the microcavity biosensors deployable for continuous monitoring of biomarkers in body fluids in the clinic, in dense 2D random arrays for high-throughput applications like drug-library screening in interactomics, and of the secretory behavior of single cells in the laboratory.", {"entities": []}], ["Whilst facing a worldwide fast increase of food and environmental allergies, the medical community is also confronted with another inhomogeneous group of environment-associated disabling conditions, including multiple chemical sensitivity (MCS), fibromyalgia, chronic fatigue syndrome, electric hypersensitivity, amalgam disease and others.", {"entities": [[260, 284, "DISEASE"], [276, 284, "DISEASE"], [209, 238, "DISEASE"], [246, 258, "DISEASE"]]}], ["These share the features of poly-symptomatic multi-organ cutaneous and systemic manifestations, with postulated inherited/acquired impaired metabolism of chemical/physical/nutritional xenobiotics, triggering adverse reactions at exposure levels far below toxicologically-relevant values, often in the absence of clear-cut allergologic and/or immunologic involvement.", {"entities": []}], ["Due to the lack of proven pathogenic mechanisms generating measurable disease biomarkers, these environmental hypersensitivities are generally ignored by sanitary and social systems, as psychogenic or \u201cmedically unexplained symptoms\u201d.", {"entities": []}], ["The uncontrolled application of diagnostic and treatment protocols not corresponding to acceptable levels of validation, safety, and clinical efficacy, to a steadily increasing number of patients demanding assistance, occurs in many countries in the absence of evidence-based guidelines.", {"entities": []}], ["Here we revise available information supporting the organic nature of these clinical conditions.", {"entities": []}], ["Following intense research on gene polymorphisms of phase I/II detoxification enzyme genes, so far statistically inconclusive, epigenetic and metabolic factors are under investigation, in particular free radical/antioxidant homeostasis disturbances.", {"entities": []}], ["The finding of relevant alterations of catalase, glutathione-transferase and peroxidase detoxifying activities significantly correlating with clinical manifestations of MCS, has recently registered some progress towards the identification of reliable biomarkers of disease onset, progression, and treatment outcomes.", {"entities": []}], ["Telomere length and mitochondrial DNA (mtDNA) content are markers of aging and aging-related diseases.", {"entities": []}], ["There is inconclusive evidence concerning the mechanistic effects of airborne particulate matter (PM) exposure on biomolecular markers of aging.", {"entities": []}], ["The present study examines the association between short- and long-term PM exposure with telomere length and mtDNA content in the elderly and investigates to what extent this association is mediated by expression of genes playing a role in the telomere\u2013mitochondrial axis of aging.", {"entities": []}], ["Among 166 nonsmoking elderly participants, we used qPCR to measure telomere length and mtDNA content in leukocytes and RNA from whole blood to measure expression of SIRT1, TP53, PPARGC1A, PPARGC1B, NRF1, and NFE2L2.", {"entities": [[165, 170, "GENE"], [172, 176, "GENE"], [178, 186, "GENE"], [188, 196, "GENE"], [198, 202, "GENE"], [208, 214, "GENE"]]}], ["Associations between PM exposure and markers of aging were estimated using multivariable linear regression models adjusted for sex, age, BMI, socioeconomic status, statin use, past smoking status, white blood cell count, and percentage of neutrophils.", {"entities": []}], ["Mediation analysis was performed to explore the role of age-related markers between the association of PM exposure and outcome.", {"entities": []}], ["Annual PM2.5 exposure was calculated for each participant\u2019s home address using a high-resolution spatial\u2013temporal interpolation model.", {"entities": []}], ["Annual PM2.5 concentrations ranged from 15 to 23 \u03bcg/m3.", {"entities": []}], ["A 5-\u03bcg/m3 increment in annual PM2.5 concentration was associated with a relative decrease of 16.8% (95% CI: \u201326.0%, \u20137.4%, p = 0.0005) in telomere length and a relative decrease of 25.7% (95% CI: \u201335.2%, \u201316.2%, p < 0.0001) in mtDNA content.", {"entities": []}], ["Assuming causality, results of the mediation analysis indicated that SIRT1 mediated 19.5% and 22.5% of the estimated effect of PM2.5 exposure on telomere length and mtDNA content, respectively.", {"entities": [[69, 74, "GENE"]]}], ["Our findings suggest that the estimated effects of PM2.5 exposure on the telomere\u2013mitochondrial axis of aging may play an important role in chronic health effects of PM2.5.", {"entities": []}], ["Pieters N, Janssen BG, Dewitte H, Cox B, Cuypers A, Lefebvre W, Smeets K, Vanpoucke C, Plusquin M, Nawrot TS.", {"entities": []}], ["Biomolecular markers within the core axis of aging and particulate air pollution exposure in the elderly: a cross-sectional study.", {"entities": []}], ["Environ Health Perspect 124:943\u2013950;\u2002http://dx.doi.org/10.1289/ehp.1509728", {"entities": []}], ["The association between single health behaviours and incidence of and premature mortality from major chronic diseases, including myocardial infarction, stroke, diabetes mellitus, and cancer, has been demonstrated thoroughly.", {"entities": [[129, 150, "DISEASE"], [183, 189, "DISEASE"], [160, 177, "DISEASE"]]}], ["However, the association of several healthy behaviours with Disability-Adjusted Life Years (DALYs), which is a measure for total health combining Years Lost due to Disability and the Years of Life Lost due to premature mortality, has not been studied yet.", {"entities": []}], ["A prospective cohort study was conducted among 33,066 healthy men and women aged 20 to 70\u00a0years recruited into the EPIC-NL study during 1993 to 1997.", {"entities": []}], ["Participants\u2019 smoking status, BMI, physical activity, and adherence to a Mediterranean-style diet (excluding alcohol) were investigated separately and combined into a simple health behaviour score ranging from 0 to 4.", {"entities": []}], ["Participants were followed until the end of 2007 for occurrence of and mortality from the most important chronic diseases.", {"entities": []}], ["The association between lifestyle (separate lifestyle factors and a simple health behaviour score) and DALYs were adjusted for relevant confounders.", {"entities": []}], ["After a median follow-up of 12.4\u00a0years, 6,647 disease incidences and 1,482 deaths were documented.", {"entities": []}], ["Non-smoking, low BMI (BMI <25), being physically active, and adherence to a Mediterranean diet were all associated with a significantly lower disease burden.", {"entities": []}], ["Persons adhering to all four healthy lifestyle characteristics lived a minimum of 2\u00a0years longer in good health (DALYs: \u22122.13; 95% CI: \u22122.65 to \u22121.62) than persons with none.", {"entities": []}], ["Due to our non-extinct cohort, the total number of DALYs, and consequently the estimates, is underestimated.", {"entities": []}], ["Therefore, true lifetime health benefits of a healthy lifestyle will be even larger.", {"entities": []}], ["Non-smoking, a low BMI, being physically active, and adherence to a Mediterranean diet were associated with a lower disease burden.", {"entities": []}], ["Each additional healthy lifestyle factor contributed to a longer life in good health.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-015-0287-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This article presents the current handling of disease related to moldy buildings in Finland as an example of an integrated health strategy.", {"entities": []}], ["It describes the role of the Finnish Health Protection Act for indoor environments and how cases of indoor air problems are dealt with by local, regional, and national authorities.", {"entities": []}], ["The persistence of cholesterol-engorged macrophages (foam cells) in the artery wall fuels the development of atherosclerosis.", {"entities": [[109, 124, "DISEASE"]]}], ["However, the mechanism that regulates the formation of macrophage foam cells and impedes their emigration out of inflamed plaques is still elusive.", {"entities": []}], ["Here, we report that adhesion receptor CD146 controls the formation of macrophage foam cells and their retention within the plaque during atherosclerosis exacerbation.", {"entities": [[138, 153, "DISEASE"]]}], ["CD146 is expressed on the macrophages in human and mouse atheroma and can be upregulated by oxidized low-density lipoprotein (oxLDL).", {"entities": []}], ["CD146 triggers macrophage activation by driving the internalization of scavenger receptor CD36 during lipid uptake.", {"entities": [[90, 94, "GENE"]]}], ["In response to oxLDL, macrophages show reduced migratory capacity toward chemokines CCL19 and CCL21; this capacity can be restored by blocking CD146.", {"entities": [[84, 89, "GENE"], [94, 99, "GENE"]]}], ["Genetic deletion of macrophagic CD146 or targeting of CD146 with an antibody result in much less complex plaques in high-fat diet-fed ApoE", {"entities": [[134, 138, "GENE"]]}], ["The identification of modifiable risk factors for glaucoma progression is needed.", {"entities": [[50, 58, "DISEASE"]]}], ["Our objective was to determine whether maladaptive coping styles are associated with recent glaucoma progression or worse visual field mean deviation.", {"entities": [[92, 100, "DISEASE"]]}], ["A hospital-based case\u2013control study was conducted in the Glaucoma Service of Maisonneuve-Rosemont Hospital in Montreal, Canada.", {"entities": [[57, 65, "DISEASE"]]}], ["Patients with primary open angle glaucoma or normal tension glaucoma with \u22654 years of follow-up and \u22655 Humphrey visual fields were included.", {"entities": [[14, 41, "DISEASE"], [33, 41, "DISEASE"], [60, 68, "DISEASE"]]}], ["Cases had recent visual field progression as defined according to the Early Manifest Glaucoma Trial pattern change probability maps.", {"entities": [[85, 93, "DISEASE"]]}], ["Controls had stable visual fields.", {"entities": []}], ["The Brief Cope questionnaire, a 28-item questionnaire about 14 different ways of coping with the stress of a chronic disease, was asked.", {"entities": []}], ["Questions were also asked about demographic and medical factors, and the medical chart was examined.", {"entities": []}], ["Outcomes included glaucoma progression (yes, no) and visual field mean deviation.", {"entities": [[18, 26, "DISEASE"]]}], ["Logistic and linear regressions were used.", {"entities": []}], ["A total of 180 patients were included (82 progressors and 98 nonprogressors).", {"entities": []}], ["Although none of the 14 coping scales were associated with glaucoma progression ( P \u200a>\u200a0.05), higher denial was correlated with worse visual field mean deviation ( r \u200a=\u200a\u22120.173, P \u200a=\u200a0.024).", {"entities": [[59, 67, "DISEASE"]]}], ["In a linear regression model including age, sex, education, depression, intraocular pressure, and family history of glaucoma, greater levels of denial (\u03b2\u200a=\u200a\u22121.37, 95% confidence interval [CI] \u22122.32, \u22120.41), Haitian ethnicity (\u03b2\u200a=\u200a\u22127.78, 95% CI \u221212.52, \u22123.04), and the number of glaucoma medications (\u03b2\u200a=\u200a\u22121.20, 95% CI \u22122.00, \u22120.38) were statistically significantly associated with visual field mean deviation.", {"entities": [[116, 124, "DISEASE"], [278, 286, "DISEASE"]]}], ["The maladaptive coping mechanism of denial was a risk factor for worse visual field mean deviation.", {"entities": []}], ["Further prospective research will be required to verify the pathways by which denial may exert an effect on glaucomatous visual field loss.", {"entities": []}], ["Curcumin is a lipophilic molecule with an active ingredient in the herbal remedy and dietary spice turmeric.", {"entities": []}], ["It is used by different folks for treatment of many diseases.", {"entities": []}], ["Recent studies have discussed poor bioavailability of curcumin because of poor absorption, rapid metabolism, and rapid systemic elimination.", {"entities": []}], ["Nanotechnology is an emerging field that is potentially changing the way we can treat diseases through drug delivery with curcumin.", {"entities": []}], ["The recent investigations established several approaches to improve the bioavailability, to increase the plasma concentration, and to enhance the cellular permeability processes of curcumin.", {"entities": []}], ["Several types of nanoparticles have been found to be suitable for the encapsulation or loading of curcumin to improve its therapeutic effects in different diseases.", {"entities": []}], ["Nanoparticles such as liposomes, polymeric nanoparticles, micelles, nanogels, niosomes, cyclodextrins, dendrimers, silvers, and solid lipids are emerging as one of the useful alternatives that have been shown to deliver therapeutic concentrations of curcumin.", {"entities": []}], ["This review shows that curcumin's therapeutic effects may increase to some extent in the presence of nanotechnology.", {"entities": []}], ["The presented board of evidence focuses on the valuable special effects of curcumin on different diseases and candidates it for future clinical studies in the realm of these diseases.", {"entities": []}], ["Both adolescent substance use and adolescent depression are major public health problems, and have the tendency to co-occur.", {"entities": []}], ["Thousands of articles on adolescent substance use or depression have been published.", {"entities": []}], ["It is labor intensive and time consuming to extract huge amounts of information from the cumulated collections.", {"entities": []}], ["Topic modeling offers a computational tool to find relevant topics by capturing meaningful structure among collections of documents.", {"entities": []}], ["In this study, a total of 17,723 abstracts from PubMed published from 2000 to 2014 on adolescent substance use and depression were downloaded as objects, and Latent Dirichlet allocation (LDA) was applied to perform text mining on the dataset.", {"entities": []}], ["Word clouds were used to visually display the content of topics and demonstrate the distribution of vocabularies over each topic.", {"entities": []}], ["The LDA topics recaptured the search keywords in PubMed, and further discovered relevant issues, such as intervention program, association links between adolescent substance use and adolescent depression, such as sexual experience and violence, and risk factors of adolescent substance use, such as family factors and peer networks.", {"entities": []}], ["Using trend analysis to explore the dynamics of proportion of topics, we found that brain research was assessed as a hot issue by the coefficient of the trend test.", {"entities": []}], ["Topic modeling has the ability to segregate a large collection of articles into distinct themes, and it could be used as a tool to understand the literature, not only by recapturing known facts but also by discovering other relevant topics.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-016-2932-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Prebiotics are food ingredients, usually non-digestible oligosaccharides, that are selectively fermented by populations of beneficial gut bacteria.", {"entities": []}], ["Endoxylanases, altering the naturally present cereal arabinoxylans, are commonly used in the bread industry to improve dough and bread characteristics.", {"entities": []}], ["Recently, an in situ method has been developed to produce arabinoxylan-oligosaccharides (AXOS) at high levels in breads through the use of a thermophilic endoxylanase.", {"entities": []}], ["AXOS have demonstrated potentially prebiotic properties in that they have been observed to lead to beneficial shifts in the microbiota in vitro and in murine, poultry and human studies.", {"entities": []}], ["A double-blind, placebo controlled human intervention study was undertaken with 40 healthy adult volunteers to assess the impact of consumption of breads with in situ produced AXOS (containing 2.2\u2009g AXOS) compared to non-endoxylanase treated breads.", {"entities": []}], ["Volatile fatty acid concentrations in faeces were assessed and fluorescence in situ hybridisation was used to assess changes in gut microbial groups.", {"entities": []}], ["Secretory immunoglobulin A (sIgA) levels in saliva were also measured.", {"entities": []}], ["Consumption of AXOS-enriched breads led to increased faecal butyrate and a trend for reduced iso-valerate and fatty acids associated with protein fermentation.", {"entities": []}], ["Faecal levels of bifidobacteria increased following initial control breads and remained elevated throughout the study.", {"entities": []}], ["Lactobacilli levels were elevated following both placebo and AXOS-breads.", {"entities": []}], ["No changes in salivary secretory IgA levels were observed during the study.", {"entities": []}], ["Furthermore, no adverse effects on gastrointestinal symptoms were reported during AXOS-bread intake.", {"entities": []}], ["AXOS-breads led to a potentially beneficial shift in fermentation end products and are well tolerated.", {"entities": []}], ["Cardiovascular disease is an important comorbidity in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[68, 105, "DISEASE"]]}], ["We aimed to systematically review the evidence for: (1) risk of myocardial infarction (MI) in people with COPD; (2) risk of MI associated with acute exacerbation of COPD (AECOPD); (3) risk of death after MI in people with COPD.", {"entities": [[64, 85, "DISEASE"]]}], ["Systematic review and meta-analysis.", {"entities": []}], ["MEDLINE, EMBASE and SCI were searched up to January 2015.", {"entities": []}], ["Two reviewers screened abstracts and full text records, extracted data and assessed studies for risk of bias.", {"entities": []}], ["We used the generic inverse variance method to pool effect estimates, where possible.", {"entities": []}], ["Evidence was synthesised in a narrative review where meta-analysis was not possible.", {"entities": []}], ["Searches yielded 8362 records, and 24 observational studies were included.", {"entities": []}], ["Meta-analysis showed increased risk of MI associated with COPD (HR 1.72, 95% CI 1.22 to 2.42) for cohort analyses, but not in case\u2013control studies: OR 1.18 (0.80 to 1.76).", {"entities": [[64, 66, "GENE"]]}], ["Both included studies that investigated the risk of MI associated with AECOPD found an increased risk of MI after AECOPD (incidence rate ratios, IRR 2.27, 1.10 to 4.70, and IRR 13.04, 1.71 to 99.7).", {"entities": []}], ["Meta-analysis showed weak evidence for increased risk of death for patients with COPD in hospital after MI (OR 1.13, 0.97 to 1.31).", {"entities": []}], ["However, meta-analysis showed an increased risk of death after MI for patients with COPD during follow-up (HR 1.26, 1.13 to 1.40).", {"entities": [[107, 109, "GENE"]]}], ["There is good evidence that COPD is associated with increased risk of MI; however, it is unclear to what extent this association is due to smoking status.", {"entities": []}], ["There is some evidence that the risk of MI is higher during AECOPD than stable periods.", {"entities": []}], ["There is poor evidence that COPD is associated with increased in hospital mortality after an MI, and good evidence that longer term mortality is higher for patients with COPD after an MI.", {"entities": []}], ["Cardiotoxicity of doxorubicin (DOX) remains an important health concern.", {"entities": []}], ["DOX cardiotoxicity is cumulative-dose-dependent and begins with the first dose of chemotherapy.", {"entities": []}], ["No biomarker for presymptomatic detection of DOX cardiotoxicity has been validated.", {"entities": []}], ["Our hypothesis is that peripheral blood cells (PBC) gene expression induced by the early doses of DOX-based chemotherapy could identify potential biomarkers for presymptomatic cardiotoxicity in cancer patients.", {"entities": [[194, 200, "DISEASE"]]}], ["PBC gene expression of 33 breast cancer patients was conducted before and after the first cycle of DOX-based chemotherapy.", {"entities": [[26, 39, "DISEASE"], [33, 39, "DISEASE"]]}], ["Cardiac function was evaluated before the start of chemotherapy and at its completion.", {"entities": []}], ["Differentially expressed genes (DEG) of patients who developed DOX-associated cardiotoxicity after the completion of chemotherapy were compared with DEG of patients who did not.", {"entities": []}], ["Ingenuity database was used for functional analysis of DEG.", {"entities": []}], ["Sixty-sevens DEG (P<0.05) were identified in PBC of patients with DOX-cardiotoxicity.", {"entities": []}], ["Most of DEG encode proteins secreted by activated neutrophils.", {"entities": []}], ["The functional analysis of the DEG showed enrichment for immune- and inflammatory response.", {"entities": []}], ["This is the first study to identify the PBC transcriptome signature associated with a single dose of DOX-based chemotherapy in cancer patients.", {"entities": [[127, 133, "DISEASE"]]}], ["We have shown that PBC transcriptome signature associated with one dose of DOX chemotherapy in breast cancer can predict later impairment of cardiac function.", {"entities": [[95, 108, "DISEASE"], [102, 108, "DISEASE"]]}], ["This finding may be of value in identifying patients at high or low risk for the development of DOX cardiotoxicity during the initial doses of chemotherapy and thus to avoid the accumulating toxic effects from the subsequent doses during treatment.", {"entities": []}], ["When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical interventions (NPIs) often are the most readily available interventions to help slow transmission of the virus in communities, which is especially important before a pandemic vaccine becomes widely available.", {"entities": [[13, 22, "DISEASE"]]}], ["NPIs, also known as community mitigation measures, are actions that persons and communities can take to help slow the spread of respiratory virus infections, including seasonal and pandemic influenza viruses.", {"entities": [[190, 199, "DISEASE"]]}], ["These guidelines replace the 2007 Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States \u2014 Early, Targeted, Layered Use of Nonpharmaceutical Interventions ( https://stacks.cdc.gov/view/cdc/11425 ).", {"entities": [[106, 115, "DISEASE"]]}], ["Several elements remain unchanged from the 2007 guidance, which described recommended NPIs and the supporting rationale and key concepts for the use of these interventions during influenza pandemics.", {"entities": [[179, 188, "DISEASE"]]}], ["NPIs can be phased in, or layered, on the basis of pandemic severity and local transmission patterns over time.", {"entities": []}], ["Categories of NPIs include personal protective measures for everyday use (e.g., voluntary home isolation of ill persons, respiratory etiquette, and hand hygiene); personal protective measures reserved for influenza pandemics (e.g., voluntary home quarantine of exposed household members and use of face masks in community settings when ill); community measures aimed at increasing social distancing (e.g., school closures and dismissals, social distancing in workplaces, and postponing or cancelling mass gatherings); and environmental measures (e.g., routine cleaning of frequently touched surfaces).", {"entities": [[205, 214, "DISEASE"]]}], ["Several new elements have been incorporated into the 2017 guidelines.", {"entities": []}], ["First, to support updated recommendations on the use of NPIs, the latest scientific evidence available since the influenza A (H1N1)pdm09 pandemic has been added.", {"entities": [[113, 122, "DISEASE"]]}], ["Second, a summary of lessons learned from the 2009 H1N1 pandemic response is presented to underscore the importance of broad and flexible prepandemic planning.", {"entities": []}], ["Third, a new section on community engagement has been included to highlight that the timely and effective use of NPIs depends on community acceptance and active participation.", {"entities": []}], ["Fourth, to provide new or updated pandemic assessment and planning tools, the novel influenza virus pandemic intervals tool, the Influenza Risk Assessment Tool, the Pandemic Severity Assessment Framework, and a set of prepandemic planning scenarios are described.", {"entities": [[84, 93, "DISEASE"], [129, 138, "DISEASE"]]}], ["Finally, to facilitate implementation of the updated guidelines and to assist states and localities with prepandemic planning and decision-making, this report links to six supplemental prepandemic NPI planning guides for different community settings that are available online ( https://www.cdc.gov/nonpharmaceutical-interventions ).", {"entities": []}], ["There is no study exploring the trend of utilization in traditional Chinese medicine (TCM) from 2000 to 2010.", {"entities": []}], ["The objective of this study was to investigate the trends of TCM utilization among 3 cross-sectional cohorts of 2000, 2005, and 2010.", {"entities": []}], ["This study was a cross-sectional analysis of TCM utilization over time.", {"entities": []}], ["We compared the mean TCM visits among 3 cohorts of 2000, 2005, and 2010.", {"entities": []}], ["We derived 3 randomly sampled cohorts of nearly 1 million representative beneficiaries in each of 2000, 2005, and 2010 from National Health Insurance Research Database for this research.", {"entities": []}], ["Multivariate logistic regression was performed to evaluate the relative relationship in categorical variables correlating to TCM users.", {"entities": []}], ["The percentage change (% change) in mean TCM visits between 2000 and 2005 (2010) was used to evaluate the trends of TCM utilization during the period.", {"entities": []}], ["The ratio of TCM users increased throughout cohorts.", {"entities": []}], ["The ratio of TCM users among women was more than that among men in all cohorts of 2000, 2005, and 2010 (adjusted odds ratio = 1.47; 1.52; 1.62).", {"entities": []}], ["The mean TCM visits increased from 2000 to 2010.", {"entities": []}], ["The percentage change in mean TCM visits among women was more than that among men.", {"entities": []}], ["The group aged less than 20 years had the least percentage change in mean TCM visits (18.8%); nevertheless, the group aged 20 to 34 years had the largest change (30.2%).", {"entities": []}], ["The high socioeconomic status group had the largest percentage change in mean visits to TCM, whereas the central region had the least percentage change.", {"entities": []}], ["Neoplasms had the greatest increase in percentage change in mean TCM visits among all disease categories; in contrast, diseases of the respiratory system had the greatest decrease.", {"entities": []}], ["Both the ratio of TCM users and mean TCM visits increased gradually from 2000 to 2005 and further to 2010.", {"entities": []}], ["Women used TCM more than men, and this is expected to continue in the future.", {"entities": []}], ["The high socioeconomic status group used TCM more and more over time.", {"entities": []}], ["The picture of TCM need among different types of cancer patients should be explored in further research because of the substantial increase in TCM utilization for the disease category of neoplasms.", {"entities": [[49, 55, "DISEASE"]]}], ["Proton pump inhibitor (PPI) therapy is commonly used outside of Food and Drug Administration indication for a broad range of conditions such as extra-esophageal reflux and PPI-responsive esophageal eosinophilia.", {"entities": [[198, 210, "DISEASE"]]}], ["While this may be appropriate in some scenarios, it has also resulted in widespread inappropriate PPI use.", {"entities": []}], ["At the same time, data suggesting adverse effects of long-term PPI therapy are multiplying, albeit mainly from low quality studies.", {"entities": []}], ["The systematic review by Scarpignato et al.", {"entities": []}], ["( BMC Med 14:179, 2016) addresses this dilemma with a comprehensive analysis of the risks and benefits of PPI use.", {"entities": []}], ["The authors concluded that, while PPIs are highly efficacious in erosive acid-peptic disorders, efficacy is not equaled in other conditions.", {"entities": []}], ["In some instances, they found no supportive evidence of benefit.", {"entities": []}], ["With respect to side effects, they indicated that the questionable harms associated with PPI therapy do not outweigh the benefits afforded by appropriate PPI use.", {"entities": []}], ["However, inappropriate PPI use results in increased healthcare costs and unnecessary exposure to potential adverse effects.", {"entities": []}], ["Ideally, PPI therapy should be personalized, based on indication, effectiveness, patient preference, and risk assessment.", {"entities": []}], ["Please see related article: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0718-z .", {"entities": []}], ["Service and stakeholder evaluation of an NHS-funded service providing out-ofhours (OOH) emergency repeat medications to patients self-presenting at community pharmacies.", {"entities": []}], ["Community pharmacies across the North East of England accredited to provide this service.", {"entities": []}], ["Patients self-presenting to community pharmacies during OOH periods with emergency repeat medication supply requests.", {"entities": []}], ["Community pharmacists assessed each request for clinical appropriateness and when suitable provide an emergency repeat medication supply, with additional pharmaceutical advice and services if required.", {"entities": []}], ["Number of emergency repeat medication supplies, time of request, reason for access, medication(s), pharmaceutical advice and services provided.", {"entities": []}], ["Secondary outcomes were community pharmacist and patient satisfaction.", {"entities": []}], ["A total of 2485 patients were managed across 227 community pharmacies (15 December 2014 to 7 April 2015).", {"entities": []}], ["Most patients presented on Saturdays, with increased activity over national holidays.", {"entities": []}], ["Older age was associated with increased service use.", {"entities": []}], ["Of the 3226 medications provided, 439 were classified as high risk.", {"entities": []}], ["Patients found this service easy to access and were willing to access the community pharmacy in the future for medication-related issues.", {"entities": []}], ["In the absence of this service, 50% of patients would have missed their medication(s) until they saw their doctor and a further 46% would have accessed an alternative service.", {"entities": []}], ["The cost of National Health Service (NHS) service(s) for patients who would have accessed an alternative OOH service was estimated as 37 times that of the community pharmacy service provided.", {"entities": [[37, 40, "GENE"]]}], ["Community pharmacists were happy to provide this service despite increased consultation times and workload.", {"entities": []}], ["Community pharmacists were able to manage patients\u2019 OOH requests for emergency repeat medication and patients were happy with the service provided.", {"entities": []}], ["Since the service cost was favourable when compared with alternative OOH services, it would be a viable option to reduce the workload on the wider NHS.", {"entities": [[147, 150, "GENE"]]}], ["Cigarette smoke-induced release of pro-inflammatory cytokines including interleukin-8 (IL-8) from inflammatory as well as structural cells in the airways, including airway smooth muscle (ASM) cells, may contribute to the development of chronic obstructive pulmonary disease (COPD).", {"entities": [[236, 273, "DISEASE"]]}], ["Despite the wide use of pharmacological treatment aimed at increasing intracellular levels of the endogenous suppressor cyclic AMP (cAMP), little is known about its exact mechanism of action.", {"entities": []}], ["We report here that next to the \u03b2 2 -agonist fenoterol, direct and specific activation of either exchange protein directly activated by cAMP (Epac) or protein kinase A (PKA) reduced cigarette smoke extract (CSE)-induced IL-8 mRNA expression and protein release by human ASM cells.", {"entities": []}], ["CSE-induced I\u03baB\u03b1-degradation and p65 nuclear translocation, processes that were primarily reversed by Epac activation.", {"entities": []}], ["Further, CSE increased extracellular signal-regulated kinase (ERK) phosphorylation, which was selectively reduced by PKA activation.", {"entities": []}], ["CSE decreased Epac1 expression, but did not affect Epac2 and PKA expression.", {"entities": []}], ["Importantly, Epac1 expression was also reduced in lung tissue from COPD patients.", {"entities": []}], ["In conclusion, Epac and PKA decrease CSE-induced IL-8 release by human ASM cells via inhibition of NF-\u03baB and ERK, respectively, pointing at these cAMP effectors as potential targets for anti-inflammatory therapy in COPD.", {"entities": []}], ["However, cigarette smoke exposure may reduce anti-inflammatory effects of cAMP elevating agents via down-regulation of Epac1.", {"entities": []}], ["Not all new drug products are truly new.", {"entities": []}], ["Some are the result of marginal innovation and incremental patenting of existing products, but in such a way that confers no major therapeutic improvement.", {"entities": []}], ["This phenomenon, pejoratively known as \u201cevergreening\u201d, can allow manufacturers to preserve market exclusivity, but without significantly bettering the standard of care.", {"entities": []}], ["Other studies speculate that evergreening is especially problematic for medicine/device combination products, because patents on the device component may outlast expired patents on the medicine component, and thereby keep competing, possibly less-expensive generic products off the market.", {"entities": []}], ["We focused on four common conditions that are often treated by medicine/device product combinations: asthma and chronic obstructive pulmonary disease (COPD), diabetes, and severe allergic reactions.", {"entities": [[112, 149, "DISEASE"], [101, 107, "DISEASE"]]}], ["The patent data for a sample of such products (n = 49) for treating these conditions was extracted from the United States Food and Drug Administration\u2019s Orange Book.", {"entities": []}], ["Additional patent-related data (abstracts, claims, etc) were retrieved using LexisNexis TotalPatent.", {"entities": []}], ["Comparisons were then made between each product\u2019s device patents and medicine patents.", {"entities": []}], ["Unexpired device patents exist for 90 percent of the 49 medicine/device product combinations studied, and were the only sort of unexpired patent for 14 products.", {"entities": []}], ["Overall, 55 percent of the 235 patents found by our study were device patents.", {"entities": []}], ["Comparing the last-to-expire device patent to that of the last-to-expire active ingredient patent, the median additional years of patent protection afforded by device patents was 4.7 years (range: 1.3\u201315.2 years).", {"entities": []}], ["Incremental, patentable innovation in devices to extend the overall patent protection of medicine/device product combinations is very common.", {"entities": []}], ["Whether this constitutes \u201cevergreening\u201d depends on whether these incremental innovations and the years of extra patent protection they confer are proportionately matched by therapeutic improvements in the standard of care, which is highly debatable.", {"entities": []}], ["Postoperative delirium is prevalent in older patients and associated with worse outcomes.", {"entities": []}], ["Recent data in animal studies demonstrate increases in inflammatory markers in plasma and cerebrospinal fluid (CSF) even after aseptic surgery, suggesting that inflammation of the central nervous system may be part of the pathogenesis of postoperative cognitive changes.", {"entities": []}], ["We investigated the hypothesis that neuroinflammation was an important cause for postoperative delirium and cognitive dysfunction after major non-cardiac surgery.", {"entities": []}], ["After Institutional Review Board approval and informed consent, we recruited patients undergoing major knee surgery who received spinal anesthesia and femoral nerve block with intravenous sedation.", {"entities": []}], ["All patients had an indwelling spinal catheter placed at the time of spinal anesthesia that was left in place for up to 24\u00a0h. Plasma and CSF samples were collected preoperatively and at 3, 6, and 18\u00a0h postoperatively.", {"entities": []}], ["Cytokine levels were measured using ELISA and Luminex.", {"entities": []}], ["Postoperative delirium was determined using the confusion assessment method, and cognitive dysfunction was measured using validated cognitive tests (word list, verbal fluency test, digit symbol test).", {"entities": []}], ["Ten patients with complete datasets were included.", {"entities": []}], ["One patient developed postoperative delirium, and six patients developed postoperative cognitive dysfunction.", {"entities": []}], ["Postoperatively, at different time points, statistically significant changes compared to baseline were present in IL-5, IL-6, I-8, IL-10, monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-1\u03b1, IL-6/IL-10, and receptor for advanced glycation end products in plasma and in IFN-\u03b3, IL-6, IL-8, IL-10, MCP-1, MIP-1\u03b1, MIP-1\u03b2, IL-8/IL-10, and TNF-\u03b1 in CSF.", {"entities": [[209, 212, "GENE"], [329, 332, "GENE"], [337, 340, "GENE"]]}], ["Substantial pro- and anti-inflammatory activity in the central neural system after surgery was found.", {"entities": []}], ["If confirmed by larger studies, persistent changes in cytokine levels may serve as biomarkers for novel clinical trials.", {"entities": []}], ["The online version of this article (doi:10.1186/s12974-016-0681-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study evaluates the relationship between obstructive sleep apnea (OSA) and asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["Literature search was carried out in several electronic databases and random effects meta-analyses were performed to obtain pooled estimates of the prevalence of OSA, OSA risk and sleep disordered breathing (SDB) in asthma patients and pooled odds ratios of the prevalence between asthma and non-asthma patients.", {"entities": [[216, 222, "DISEASE"], [281, 287, "DISEASE"], [296, 302, "DISEASE"]]}], ["In adult asthma patients, the prevalence [95% confidence interval] of OSA, OSA risk, and SDB was 49.50 [36.39, 62.60] %, 27.50 [19.31, 35.69] %, and 19.65 [14.84, 24.46] % respectively.", {"entities": [[9, 15, "DISEASE"]]}], ["The odds of having OSA, OS risk and SDB by the asthma patients were 2.64 [1.76, 3.52], 3.73 [2.90, 4.57] and 1.73 [1.11, 2.36] times higher (p\u2009<\u20090.00001 for all) in asthma than in non-asthma patients, respectively.", {"entities": [[47, 53, "DISEASE"], [165, 171, "DISEASE"], [184, 190, "DISEASE"]]}], ["Adult asthma patients with OSA had significantly higher BMI in comparison with asthma patients without OSA.", {"entities": [[6, 12, "DISEASE"], [79, 85, "DISEASE"]]}], ["This study reveals that the prevalence of OSA in asthma patients is considerably higher; even higher than OSA risk and SDB.", {"entities": [[49, 55, "DISEASE"]]}], ["Sleep studies should be performed in asthma patients with symptoms suggestive of OSA/OSA risk/SDB.", {"entities": [[37, 43, "DISEASE"]]}], ["Cordyceps sinensis is a medicinal mushroom used for centuries in Asian countries as a health supplement and tonic.", {"entities": []}], ["Hirsutella sinensis \u2014the anamorphic, mycelial form of C. sinensis \u2014possesses similar properties, and is increasingly used as a health supplement.", {"entities": []}], ["Recently, C. sinensis extracts were shown to inhibit the production of the pro-inflammatory cytokine IL-1\u03b2 in lipopolysaccharide-treated macrophages.", {"entities": []}], ["However, the molecular mechanism underlying this process has remained unclear.", {"entities": []}], ["In addition, whether H. sinensis mycelium (HSM) extracts also inhibit the production of IL-1\u03b2 has not been investigated.", {"entities": []}], ["In the present study, the HSM extract suppresses IL-1\u03b2 and IL-18 secretion, and ATP-induced activation of caspase-1.", {"entities": []}], ["Notably, we observed that HSM not only reduced expression of the inflammasome component NLRP1 and the P2X 7 R but also reduced the activation of caspase-4, and ATP-induced ROS production.", {"entities": [[88, 93, "GENE"]]}], ["These findings reveal that the HSM extract has anti-inflammatory properties attributed to its ability to inhibit both canonical and non-canonical inflammasomes.", {"entities": []}], ["Increases in ambient particulate matter of aerodynamic diameter of 2.5\u2009\u03bcm (PM 2.5 ) are associated with asthma morbidity and mortality.", {"entities": [[104, 110, "DISEASE"]]}], ["The overall objective of this study was to test the hypothesis that PM 2.5 derived from two distinct urban U.S. communities would induce variable responses to aggravate airway symptoms during experimental asthma.", {"entities": [[205, 211, "DISEASE"]]}], ["We used a mobile laboratory to conduct community-based inhalation exposures to laboratory rats with ovalbumin-induced allergic airways disease.", {"entities": []}], ["In Grand Rapids exposures were conducted within 60\u2009m of a major roadway, whereas the Detroit was located in an industrial area more than 400\u2009m from roadways.", {"entities": []}], ["Immediately after nasal allergen challenge, Brown Norway rats were exposed by whole body inhalation to either concentrated air particles (CAPs) or filtered air for 8 h (7:00\u2009AM - 3:00\u2009PM).", {"entities": [[138, 142, "GENE"]]}], ["Both ambient and concentrated PM 2.5 was assessed for mass, size fractionation, and major component analyses, and trace element content.", {"entities": []}], ["Sixteen hours after exposures, bronchoalveolar lavage fluid (BALF) and lung lobes were collected and evaluated for airway inflammatory and mucus responses.", {"entities": []}], ["Similar CAPs mass concentrations were generated in Detroit (542\u2009\u03bcg/m Despite inhalation exposure to the same mass concentration of urban PM 2.5 , disparate health effects can be elicited in the airways of sensitive populations such as asthmatics.", {"entities": [[8, 12, "GENE"]]}], ["Modulation of airway inflammatory and immune responses is therefore dependent on specific chemical components and size distributions of urban PM 2.5 .", {"entities": []}], ["Our results suggest that air quality standards based on particle speciation and sources may be more relevant than particle mass to protect human health from PM exposure.", {"entities": []}], ["The well-documented latitudinal clines of genes affecting human skin color presumably arise from the need for protection from intense ultraviolet radiation (UVR) vs. the need to use UVR for vitamin D synthesis.", {"entities": []}], ["Sampling 751 subjects from a broad range of latitudes and skin colors, we investigated possible multilocus correlated adaptation of skin color genes with the vitamin D receptor gene ( VDR ), using a vector correlation metric and network method called BlocBuster.", {"entities": [[184, 187, "GENE"]]}], ["We discovered two multilocus networks involving VDR promoter and skin color genes that display strong latitudinal clines as multilocus networks, even though many of their single gene components do not.", {"entities": [[48, 51, "GENE"]]}], ["Considered one by one, the VDR components of these networks show diverse patterns: no cline, a weak declining latitudinal cline outside of Africa, and a strong in- vs. out-of-Africa frequency pattern.", {"entities": [[27, 30, "GENE"]]}], ["We confirmed these results with independent data from HapMap.", {"entities": []}], ["Standard linkage disequilibrium analyses did not detect these networks.", {"entities": []}], ["We applied BlocBuster across the entire genome, showing that our networks are significant outliers for interchromosomal disequilibrium that overlap with environmental variation relevant to the genes\u2019 functions.", {"entities": []}], ["These results suggest that these multilocus correlations most likely arose from a combination of parallel selective responses to a common environmental variable and coadaptation, given the known Mendelian epistasis among VDR and the skin color genes.", {"entities": [[221, 224, "GENE"]]}], ["We used data from nationally representative surveys conducted in the United States, Canada and Malta between 2008 and 2009 to answer three questions: Does the public believe that climate change poses human health risks, and if so, are they seen as current or future risks?", {"entities": []}], ["Whose health does the public think will be harmed?", {"entities": []}], ["In what specific ways does the public believe climate change will harm human health?", {"entities": []}], ["When asked directly about the potential impacts of climate change on health and well-being, a majority of people in all three nations said that it poses significant risks; moreover, about one third of Americans, one half of Canadians, and two-thirds of Maltese said that people are already being harmed.", {"entities": []}], ["About a third or more of people in the United States and Canada saw themselves (United States, 32%; Canada, 67%), their family (United States, 35%; Canada, 46%), and people in their community (United States, 39%; Canada, 76%) as being vulnerable to at least moderate harm from climate change.", {"entities": []}], ["About one third of Maltese (31%) said they were most concerned about the risk to themselves and their families.", {"entities": []}], ["Many Canadians said that the elderly (45%) and children (33%) are at heightened risk of harm, while Americans were more likely to see people in developing countries as being at risk than people in their own nation.", {"entities": []}], ["When prompted, large numbers of Canadians and Maltese said that climate change can cause respiratory problems (78\u201391%), heat-related problems (75\u201384%), cancer (61\u201390%), and infectious diseases (49\u201362%).", {"entities": [[152, 158, "DISEASE"]]}], ["Canadians also named sunburn (79%) and injuries from extreme weather events (73%), and Maltese cited allergies (84%).", {"entities": []}], ["However, climate change appears to lack salience as a health issue in all three countries: relatively few people answered open-ended questions in a manner that indicated clear top-of-mind associations between climate change and human health risks.", {"entities": []}], ["We recommend mounting public health communication initiatives that increase the salience of the human health consequences associated with climate change.", {"entities": []}], ["Undernutrition during fetal and postnatal life is still a major problem in many low- and middle-income countries.", {"entities": []}], ["Even in high-income countries malnutrition may exist in cases of intrauterine growth retardation, as well as in chronic conditions such as anorexia nervosa and inflammatory bowel disease.", {"entities": [[160, 186, "DISEASE"]]}], ["Children adopted from developing countries are often chronically malnourished.", {"entities": []}], ["Nutritional rehabilitation, resulting in catch-up growth, is often complicated by influences originating in fetal life as well as during postnatal growth.", {"entities": []}], ["This may result in hormonal and metabolic changes as well as alterations in pubertal development.", {"entities": []}], ["The present review focuses on fetal, postnatal and fetal-postnatal undernutrition and subsequent catch-up growth as well as catch-up growth in relation to pubertal development.", {"entities": []}], ["Catch-up growth in children can be associated with early puberty following fetal or combined fetal-postnatal undernutrition.", {"entities": []}], ["However, early puberty does not seem to occur following catch-up growth after isolated postnatal undernutrition.", {"entities": []}], ["Gonadotropins have been reported to be elevated in prepubertal adopted girls as well as during catch-up growth in animals.", {"entities": []}], ["Even if other factors may contribute, linear catch-up growth seems to be associated with the timing of pubertal development.", {"entities": []}], ["The mechanisms behind this are still unknown.", {"entities": []}], ["Future research may elucidate how to carry out nutritional rehabilitation without risk for early pubertal development.", {"entities": []}], ["The epidemic of childhood allergic disorders has been associated to the decline of infectious disease.", {"entities": []}], ["However, exposure to many triggers (airborne viruses, tobacco smoke, pollution, indoor allergens, etc.)", {"entities": []}], ["contribute to the disease.", {"entities": []}], ["Breast feeding practices, nutrition, dietary and obesity also play a multifaceted role in shaping the observed worldwide trends of childhood allergies.", {"entities": [[49, 56, "DISEASE"]]}], ["Guidelines for treatment are available, but their implementation is suboptimal.", {"entities": []}], ["Then developed countries are slowing learning integrating the development of suitable guidelines with implementation plans.", {"entities": []}], ["Awareness, psychosocial and family factors strongly influence asthma and food allergy control.", {"entities": [[73, 85, "DISEASE"], [62, 68, "DISEASE"]]}], ["Moreover, monitoring tools are necessary to facilitate self-management.", {"entities": []}], ["By taking into consideration these and many other pragmatic aspects, national public health programs to control the allergic epidemic have been successful in reducing its impact and trace the need for future research in the area.", {"entities": []}], ["Adverse childhood experiences (e.g., physical, sexual and emotional abuse, neglect, exposure to domestic violence, parental discord, familial mental illness, incarceration and substance abuse) constitute a major public health problem in the United States.", {"entities": [[176, 191, "DISEASE"]]}], ["The Adverse Childhood Experiences (ACE) scale is a standardized measure that captures multiple developmental risk factors beyond sexual, physical and emotional abuse.", {"entities": []}], ["Lesbian, gay, and bisexual (i.e., sexual minority) individuals may experience disproportionately higher prevalence of adverse childhood experiences.", {"entities": []}], ["To examine, using the ACE scale, prevalence of childhood physical, emotional, and sexual abuse and childhood household dysfunction among sexual minority and heterosexual adults.", {"entities": []}], ["Analyses were conducted using a probability-based sample of data pooled from three U.S. states\u2019 Behavioral Risk Factor Surveillance System (BRFSS) surveys (Maine, Washington, Wisconsin) that administered the ACE scale and collected information on sexual identity (n\u200a=\u200a22,071).", {"entities": []}], ["Compared with heterosexual respondents, gay/lesbian and bisexual individuals experienced increased odds of six of eight and seven of eight adverse childhood experiences, respectively.", {"entities": []}], ["Sexual minority persons had higher rates of adverse childhood experiences (IRR\u200a=\u200a1.66 gay/lesbian; 1.58 bisexual) compared to their heterosexual peers.", {"entities": []}], ["Sexual minority individuals have increased exposure to multiple developmental risk factors beyond physical, sexual and emotional abuse.", {"entities": []}], ["We recommend the use of the Adverse Childhood Experiences scale in future research examining health disparities among this minority population.", {"entities": []}], ["Human infants are frequently hospitalized due to infection with the paramyxovirus respiratory syncytial virus (RSV).", {"entities": []}], ["However, very little is known about the neonatal response to paramyxoviral infection.", {"entities": []}], ["Here, a neonatal model of paramyxoviral infection is developed using the mouse pathogen Sendai virus (SeV).", {"entities": []}], ["Adult mice infected with SeV developed a predominantly neutrophilic inflammatory cell influx and a concomitant reduction in lung function, as determined by oxygen saturation.", {"entities": []}], ["In contrast, neonates with SeV had significantly reduced inflammation and normal lung function.", {"entities": []}], ["Surprisingly, infected neonates had similar viral loads as adult mice.", {"entities": []}], ["A reduced neutrophil influx in the neonates may be due in part to reduced expression of both CXCL2 and intracellular adhesion molecule-1 (ICAM-1).", {"entities": [[93, 98, "GENE"]]}], ["Expression of IFN-\u03b3 and TNF-\u03b1 increased in a dose-dependent manner in adult lungs, but neonates did not increase expression of either of these cytokines, even at the highest doses.", {"entities": []}], ["Importantly, the expression of the RIG-I-like receptors (RLRs) was delayed in the neonatal mice, which might have contributed to their reduced inflammation and differential cytokine expression.", {"entities": []}], ["Neonatal mice developed similar SeV titers and cleared the virus with similar efficiency despite developing a dramatically lower degree of pulmonary inflammation compared to adults.", {"entities": []}], ["This suggests that inflammation in the lung may not be required to control viral replication.", {"entities": []}], ["Future studies will be needed to determine any effect the reduced inflammation may have on the development of a protective memory response in neonates.", {"entities": []}], ["This study is a cross sectional analysis, aiming to evaluate if atopy is as a risk factor for exercise induced bronchoconstriction (EIB) among Tunisian athletes.", {"entities": []}], ["Atopy was defined by a skin prick test result and EIB was defined as a decrease of at least 15% in forced expiratory volume in one second (FEV1) after 8-min running at 80\u201385% HRmaxTheo.", {"entities": []}], ["The study population was composed of 326 athletes (age: 20.8 \u00b1 2.7 yrs \u2013 mean \u00b1 SD; 138 women and 188 men) of whom 107 were elite athletes.", {"entities": []}], ["Atopy was found in 26.9% (88/326) of the athletes.", {"entities": []}], ["Post exercise spirometry revealed the presence of EIB in 9.8% of the athletes including 13% of the elite athletes.", {"entities": []}], ["Frequency of atopy in athletes with EIB was significantly higher than in athletes without EIB [62.5% vs 23.1%, respectively].", {"entities": []}], ["This study showed that atopic Tunisian athletes presented a higher risk of developing exercise induced bronchoconstriction than non-atopic athletes.", {"entities": []}], ["Investigate the acute and short-term (i.e., 24\u00a0h) effects of traditional (TRAD), superset (SS), and tri-set (TRI) resistance training protocols on perceptions of intensity and physiological responses.", {"entities": []}], ["Fourteen male participants completed a familiarisation session and three resistance training protocols (i.e., TRAD, SS, and TRI) in a randomised-crossover design.", {"entities": []}], ["Rating of perceived exertion, lactate concentration ([Lac]), creatine kinase concentration ([CK]), countermovement jump (CMJ), testosterone, and cortisol concentrations was measured pre, immediately, and 24-h post the resistance training sessions with magnitude-based inferences assessing changes/differences within/between protocols.", {"entities": []}], ["TRI reported possible to almost certainly greater efficiency and rate of perceived exertion, although session perceived load was very likely lower.", {"entities": []}], ["SS and TRI had very likely to almost certainly greater lactate responses during the protocols, with changes in [CK] being very likely and likely increased at 24\u00a0h, respectively.", {"entities": []}], ["At 24-h post-training, CMJ variables in the TRAD protocol had returned to baseline; however, SS and TRI were still possibly to likely reduced.", {"entities": []}], ["Possible increases in testosterone immediately post SS and TRI protocols were reported, with SS showing possible increases at 24-h post-training.", {"entities": []}], ["TRAD and SS showed almost certain and likely decreases in cortisol immediately post, respectively, with TRAD reporting likely decreases at 24-h post-training.", {"entities": []}], ["SS and TRI can enhance training efficiency and reduce training time.", {"entities": []}], ["However, acute and short-term physiological responses differ between protocols.", {"entities": []}], ["Athletes can utilise SS and TRI resistance training, but may require additional recovery post-training to minimise effects of fatigue.", {"entities": []}], ["Anaphylaxis following laminaria insertion rarely occurs but may be a life-threatening condition.", {"entities": []}], ["Laminaria tents, prepared from natural sea kelp, are commonly used prior to elective termination of pregnancy to achieve cervical dilatation.", {"entities": []}], ["We report herein two cases of anaphylaxis caused by IgE-mediated hypersensitivity to laminaria.", {"entities": []}], ["Two women, each of whom had undergone at least one previous abortion where a laminaria had been utilized, developed anaphylactic reaction following laminaria insertion.", {"entities": []}], ["The reaction included urticaria, nausea, breathing difficulty, and hypotension.", {"entities": [[22, 31, "DISEASE"]]}], ["The patients subsequently underwent skin testing and measurement of serum specific IgE level to laminaria extract, and were shown to elicit positive responses to laminaria.", {"entities": []}], ["The implication and impact of laminaria allergy on gynecologic procedures are significant and this allergy should be included in the list of differential diagnoses for hypersensitive reaction in gynecologic procedures.", {"entities": []}], ["Bovine dialyzable leukocyte extract (bDLE) is derived from immune leukocytes obtained from bovine spleen.", {"entities": []}], ["DLE has demonstrated to reduce transcription of Human Immunodeficiency Virus Type 1 (HIV-1) and inactivate the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) signaling pathway.", {"entities": []}], ["Therefore, we decided to clarify the mode of antiviral action of bDLE on the inhibition of HIV-1 infection through a panel of antiviral assays.", {"entities": []}], ["The cytotoxicity, HIV-1 inhibition activity, residual infectivity of bDLE in HIV-1, time of addition experiments, fusion inhibition of bDLE for fusogenic cells and the duration of cell protection even after the removal of bDLE were all assessed in order to discover more about the mode of the antiviral action.", {"entities": []}], ["HIV-1 infectivity was inhibited by bDLE at doses that were not cytotoxic for HeLa-CD4-LTR-\u03b2-gal cells.", {"entities": []}], ["Pretreatment of HIV-1 with bDLE did not decrease the infectivity of these viral particles.", {"entities": []}], ["Cell-based fusion assays helped to determine if bDLE could inhibit fusion of Env cells against CD4 cells by membrane fusion and this cell-based fusion was inhibited only when CD4 cells were treated with bDLE.", {"entities": [[95, 98, "GENE"], [175, 178, "GENE"], [95, 98, "GENE"], [175, 178, "GENE"]]}], ["Infection was inhibited in 80% compared with the positive (without EDL) at all viral life cycle stages in the time of addition experiments when bDLE was added at different time points.", {"entities": []}], ["Finally, a cell-protection assay against HIV-1 infection by bDLE was performed after treating host cells with bDLE for 30 minutes and then removing them from treatment.", {"entities": []}], ["From 0 to 7 hours after the bDLE was completely removed from the extracellular compartment, HIV-1 was then added to the host cells.", {"entities": []}], ["The bDLE was found to protect the cells from HIV-1 infection, an effect that was retained for several hours.", {"entities": []}], ["bDLE acted as an antiviral compound and prevented host cell infection by HIV-1 at all viral life cycle stages.", {"entities": []}], ["These cell protection effects lingered for hours after the bDLE was removed.", {"entities": []}], ["Interestingly, bDLE inhibited fusion of fusogenic cells by acting only on CD4 cells.", {"entities": [[74, 77, "GENE"]]}], ["bDLE had no virucidal effect, but could retain its antiviral effect on target cells after it was removed from the extracellular compartment, protecting the cells from infection for hours.", {"entities": []}], ["bDLE, which has no reported side effects or toxicity in clinical trials, should therefore be further studied to determine its potential use as a therapeutic agent in HIV-1 infection therapy, in combination with known antiretrovirals.", {"entities": []}], ["Health Information Technology (HIT) is sometimes seen as a silver bullet for human resource, medical and economic challenges facing health systems.", {"entities": []}], ["The evidence supporting widespread use of HIT is, however, still patchy and inconsistent.", {"entities": []}], ["In this Perspective piece, we seek to interpret and draw key lessons from a selection of illustrative trials in developed countries with robust health-care settings in respiratory medicine that failed to demonstrate effectiveness, and offer suggestions to maximise the chances of success in subsequent HIT deployments.", {"entities": []}], ["Particularly low- and middle-income countries, with relatively weak health infrastructures and limited health care, propose considerable room for improvement.", {"entities": []}], ["Early experiences of studying HIT thus far in high-income country settings suggest that this process should preferably begin with trials of low-cost, well-established technologies in patient groups with a moderate burden of disease while carefully evaluating patient safety.", {"entities": []}], ["To identify markers for earlier diagnosis of severe pneumonia, we assess the correlation between serum cytokine profile of children with different pneumonia severity.", {"entities": [[52, 61, "DISEASE"], [147, 156, "DISEASE"]]}], ["In 25 hospitalized children, 7 with mild pneumonia and 18 with severe pneumonia, the serum concentration of 11 cytokines in three sampling times were dosed.", {"entities": [[41, 50, "DISEASE"], [70, 79, "DISEASE"]]}], ["Statistical analysis included parametric and non-parametric tests, Pearson correlation and ROC curve for cut-off definition of cytokines.", {"entities": []}], ["At admission, IL-6 serum levels were high in mild or severe pneumonia, and was associated to vomiting ( P \u2009=\u20090.019) in both groups; and also to dyspnea ( P \u2009=\u20090.012) and white blood cell count ( P \u2009=\u20090.045) in patients with severe pneumonia.", {"entities": [[60, 69, "DISEASE"], [231, 240, "DISEASE"]]}], ["IL-10 levels were also high in patients with pneumonia and were associated to lymphocytosis (P\u2009=\u20090.025).", {"entities": [[45, 54, "DISEASE"]]}], ["The ROC curve of the IL-6:IL-10 serum levels ratio discriminated severe pneumonia cases at admission, and persistence of infection in the third day of antibiotic therapy, with positive predictive values of 93% and 89%, respectively.", {"entities": [[72, 81, "DISEASE"]]}], ["The balance between IL-6 and IL-10 serum levels showed to be a more discriminative marker for severity definition and evaluation of recovery in patients with pneumonia.", {"entities": [[158, 167, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12890-016-0324-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Solitary caecal diverticulum is an uncommon entity and therefore difficult to diagnose except at surgery.", {"entities": []}], ["Caecal diverticulitis is an infrequent cause of acute abdomen and usually presents in a manner similar to acute appendicitis.", {"entities": [[7, 21, "DISEASE"], [112, 124, "DISEASE"]]}], ["It is extremely difficult to differentiate it preoperative from acute appendicitis and such distinction is usually made in the operating room.", {"entities": [[70, 82, "DISEASE"]]}], ["The optimal management of this clinical condition is still controversial, ranging from conservative treatment with antibiotics to aggressive surgical resections.", {"entities": []}], ["We report a case of a 61 year old Caucasian who presented with acute onset right iliac fossa pain indistinguishable from acute appendicitis.", {"entities": [[127, 139, "DISEASE"]]}], ["The true diagnosis of a perforated acute caecal diverticulitis with an abscess mass was only made at operation in the presence of a macroscopically normal appendix.", {"entities": [[48, 62, "DISEASE"]]}], ["We reviewed the literature to highlight the difficulty of a preoperative diagnosis and the need for a high index of suspicion especially in the older age group presenting in manner similar to acute appendicitis.", {"entities": [[198, 210, "DISEASE"]]}], ["Crispr/Cas9-mediated mutation of the transcription factor GRHL2 or either of its predicted downstream targets ZNF750 and SMAGP in primary human bronchial epithelial basal cells leads to defects in ciliogenesis and/or barrier function.", {"entities": [[58, 63, "GENE"], [110, 116, "GENE"], [121, 126, "GENE"]]}], ["Pseudostratified airway epithelium of the lung is composed of polarized ciliated and secretory cells maintained by basal stem/progenitor cells.", {"entities": []}], ["An important question is how lineage choice and differentiation are coordinated with apical\u2013basal polarity and epithelial morphogenesis.", {"entities": []}], ["Our previous studies indicated a key integrative role for the transcription factor Grainyhead-like 2 (Grhl2).", {"entities": [[102, 107, "GENE"]]}], ["In this study, we present further evidence for this model using conditional gene deletion during the regeneration of airway epithelium and clonal organoid culture.", {"entities": []}], ["We also use CRISPR/Cas9 genome editing in primary human basal cells differentiating into organoids and mucociliary epithelium in vitro.", {"entities": []}], ["Loss of Grhl2 inhibits organoid morphogenesis and the differentiation of ciliated cells and reduces the expression of both notch and ciliogenesis genes ( Mcidas , Rfx2 , and Myb ) with distinct Grhl2 regulatory sites.", {"entities": [[8, 13, "GENE"], [194, 199, "GENE"], [163, 167, "GENE"], [174, 177, "GENE"], [8, 13, "GENE"], [194, 199, "GENE"]]}], ["The genome editing of other putative target genes reveals roles for zinc finger transcription factor Znf750 and small membrane adhesion glycoprotein in promoting ciliogenesis and barrier function as part of a network of genes coordinately regulated by Grhl2.", {"entities": [[101, 107, "GENE"], [252, 257, "GENE"]]}], ["Vaccination against amyloid-\u03b2 protein (A\u03b242) induces high levels of antibody, making it a promising strategy for treating Alzheimer\u2019s disease (AD).", {"entities": []}], ["One drawback in the past was that clinical trial approval was withheld because of speculation that the A\u03b242 vaccine induces CD4 We aimed to demonstrate that coimmunization with A\u03b242 protein and expression plasmid can be beneficial in a mouse AD model and can prevent inflammation.", {"entities": [[124, 127, "GENE"]]}], ["We immunized the AD mice with the coimmunization vaccine and assessed behavior change and A\u03b242 deposition.", {"entities": []}], ["Furthermore, to determine the safety of the coimmunization vaccine, we used an induced A\u03b242-EAE model to mimic the meningoencephalitis that happened in the AN-1792 vaccine clinical phase II trial and tested whether the coimmunization vaccine could ameliorate T-cell-mediated brain inflammation.", {"entities": [[115, 134, "DISEASE"]]}], ["The coimmunization vaccination reduced A\u03b2 plaques and significantly ameliorated cognitive deficit while inhibiting T-cell-mediated brain inflammation and infiltration.", {"entities": []}], ["These studies demonstrate that the coimmunization strategy that we describe in this article can ameliorate AD pathology without notable adverse effects in mice.", {"entities": []}], ["A coimmunization strategy leading to the development of a safe immunotherapeutic/preventive protocol against AD in humans is warranted.", {"entities": []}], ["Most children with detectable peanut-specific IgE (P-sIgE) are not allergic to peanut.", {"entities": []}], ["We addressed 2 non\u2013mutually exclusive hypotheses for the discrepancy between allergy and sensitization: (1) differences in P-sIgE levels between children with peanut allergy (PA) and peanut-sensitized but tolerant (PS) children and (2) the presence of an IgE inhibitor, such as peanut-specific IgG 4 (P-sIgG 4 ), in PS patients.", {"entities": []}], ["Two hundred twenty-eight children (108 patients with PA, 77 PS patients, and 43 nonsensitized nonallergic subjects) were studied.", {"entities": []}], ["Levels of specific IgE and IgG 4 to peanut and its components were determined.", {"entities": []}], ["IgE-stripped basophils or a mast cell line were used in passive sensitization activation and inhibition assays.", {"entities": []}], ["Plasma of PS subjects and patients submitted to peanut oral immunotherapy (POIT) were depleted of IgG 4 and retested in inhibition assays.", {"entities": []}], ["Basophils and mast cells sensitized with plasma from patients with PA but not PS patients showed dose-dependent activation in response to peanut.", {"entities": []}], ["Levels of sIgE to peanut and its components could only partially explain differences in clinical reactivity between patients with PA and PS patients.", {"entities": []}], ["P-sIgG 4 levels ( P \u00a0= .023) and P-sIgG 4 /P-sIgE ( P \u00a0< .001), Ara h 1\u2013sIgG 4 /Ara h 1\u2013sIgE ( P \u00a0= .050), Ara h 2\u2013sIgG 4 /Ara h 2\u2013sIgE ( P \u00a0= .004), and Ara h 3\u2013sIgG 4 /Ara h 3\u2013sIgE ( P \u00a0= .016) ratios were greater in PS children compared with those in children with PA. Peanut-induced activation was inhibited in the presence of plasma from PS children with detectable P-sIgG 4 levels and POIT but not from nonsensitized nonallergic children.", {"entities": []}], ["Depletion of IgG 4 from plasma of children with PS (and POIT) sensitized to Ara h 1 to Ara h 3 partially restored peanut-induced mast cell activation ( P \u00a0= .007).", {"entities": []}], ["Differences in sIgE levels and allergen specificity could not justify the clinical phenotype in all children with PA and PS children.", {"entities": []}], ["Blocking IgG 4 antibodies provide an additional explanation for the absence of clinical reactivity in PS patients sensitized to major peanut allergens.", {"entities": []}], ["The most common cystic fibrosis (CF) manifestation is the progressive chronic obstructive pulmonary disease caused by deficiency, dysfunction, or absence of the CFTR (Cystic Fibrosis Transmembrane Regulator) protein on the apical surface of the cells in the respiratory tract.", {"entities": [[70, 107, "DISEASE"], [16, 31, "DISEASE"], [167, 182, "DISEASE"], [161, 165, "GENE"]]}], ["The use of bronchodilators (BD), and inhaled corticosteroids (IC) have been suggested for the management of airway inflammation in CF.", {"entities": []}], ["The effectiveness of BD and IC have been verified, proven in laboratory and in the clinical treatment for asthma patients.", {"entities": [[106, 112, "DISEASE"]]}], ["However, in CF, the effectiveness of these drugs is controversial.", {"entities": []}], ["The extent of asthma\u2019s response to BD depends on the presence of polymorphisms in the ADRB2 gene.", {"entities": [[14, 20, "DISEASE"], [86, 91, "GENE"]]}], ["In contrast, in CF, little is known about the response to the BD and the association of CF\u00b4s severity with the different polymorphisms in ADRB2 gene.", {"entities": [[138, 143, "GENE"]]}], ["In this context, our objective was to verify whether the Arg16Gly and Glu27Gln polymorphisms in ADRB2 gene are associated with severity and with the bronchodilator response in CF patients.", {"entities": [[96, 101, "GENE"]]}], ["Cross-sectional study of 122 CF patients subjected to analysis of mutations in the CFTR gene, polymorphisms in ADRB2 gene, along with clinical and laboratorial characteristics of severity.", {"entities": [[83, 87, "GENE"], [111, 116, "GENE"]]}], ["The Arg16Gly polymorphism in ADRB2 gene was associated with pancreatic insufficiency(p:0.009), Bhalla score(p:0.039), forced expiratory volume in the first second[FEV 1 (%)](p:0.003), forced expiratory flow between 25 and 75% of the forced vital capacity-FVC[FEF25-75(%)](p:0.008) and lower age at the first isolation of the Pseudomonas aeruginosa (p:0.012).", {"entities": [[29, 34, "GENE"], [163, 166, "GENE"]]}], ["The response to the BD spirometry was associated with clinical severity markers, FEV 1 (%)(p:0.011) and FEF25-75(%)(p:0.019), for the Arg16Gly polymorphism in the ADRB2 gene.", {"entities": [[81, 84, "GENE"], [163, 168, "GENE"]]}], ["The haplotype analysis showed association with the FEV 1 /FVC marker from the spirometry test, before and after using the BD, with higher values in the group with Gly/Gly and Glu/Glu, respectively, for the Arg16Gly and Gln27Glu polymorphisms.", {"entities": [[51, 54, "GENE"]]}], ["The analysis by MDR2.0 software, showed association with FEF25-75%; the response to Arg16Gly was respondent by 17.35% and Gln27Glu by 6.8% in variation found.", {"entities": []}], ["There was an association between the Arg16Gly and Gln27Glu polymorphisms in ADRB2 gene with CF\u00b4s severity and bronchodilator response.", {"entities": [[76, 81, "GENE"]]}], ["This protocol presents the rationale and design for a trial evaluating the efficacy of intranasal oxytocin in improving pain and function among women with chronic pelvic musculoskeletal pain.", {"entities": []}], ["Oxytocin is a neuropeptide traditionally recognised for involvement in labour, delivery and lactation.", {"entities": []}], ["Novel evidence suggests that oxytocin decreases pain sensitivity in humans.", {"entities": []}], ["While oxytocin administration has been reported to lower pain sensitivity among patients experiencing chronic back pain, headache, constipation and colon pain, no research has evaluated the association between intranasal oxytocin and chronic pelvic musculoskeletal pain.", {"entities": [[131, 143, "DISEASE"]]}], ["The association between oxytocin and pain may differ in women with chronic pelvic musculoskeletal pain relative to other chronic pain conditions because of the abundance of oxytocin receptors in the uterus.", {"entities": []}], ["This is a prospective, randomised, placebo-controlled, double-blind, within-participants crossover trial.", {"entities": []}], ["50 women with chronic pelvic musculoskeletal pain will be recruited through a local chronic pain centre and gynaecology clinics.", {"entities": []}], ["Women will complete baseline measures and be randomised to an experimental or control condition that involve 2\u2005weeks of self-administering twice-daily doses of 24\u2005IU intranasal oxytocin or placebo, respectively.", {"entities": []}], ["Women will then undergo a 2-week washout period before crossing over to receive the condition that they had not yet received.", {"entities": []}], ["The primary outcome will be pain and function measured using the Brief Pain Inventory-Short Form.", {"entities": []}], ["Secondary outcomes include emotional function, sleep disturbance and global impression of change.", {"entities": []}], ["This trial will provide data on the 14-day safety and side-effect profile of intranasal oxytocin self-administered as an adjuvant treatment for chronic pelvic musculoskeletal pain.", {"entities": []}], ["This trial was granted approval from Health Canada and the University of Calgary Conjoint Health Research Ethics Board, and is registered online at ClinicalTrials.gov (#NCT02888574).", {"entities": []}], ["Results will be disseminated to healthcare professionals through peer-reviewed publications and to the general public through press releases.", {"entities": []}], ["NCT02888574 ; Pre-results.", {"entities": []}], ["TRPC6, a member of the TRPC family, attracts much attention from the public because of its relationship with the disease.", {"entities": [[0, 5, "GENE"]]}], ["In both the brain and kidney, TRPC6 serves a variety of functions.", {"entities": [[30, 35, "GENE"]]}], ["The aim of the present study was to observe the expression and effects of TRPC6 in renal cortex and hippocampus during early\u00a0postnatal development of\u00a0the mouse.", {"entities": [[74, 79, "GENE"]]}], ["In the present study, immunohistochemistry and Western blotting were used to detect the expression of TRPC6 in the mouse kidney and hippocampus of postnatal day 1, 3, 5, 7, 14, 21, 28 and 49 (P1, P3, P5, P7, P14, P21, P28 and P49).", {"entities": [[102, 107, "GENE"], [208, 211, "GENE"]]}], ["Results showed that the expression of TRPC6 was increased in the mouse hippocampus, and there was a significant increase between P7 and P14 during the postnatal development.", {"entities": [[38, 43, "GENE"], [136, 139, "GENE"]]}], ["Meanwhile, the expression of TRPC6 was also detected in glomerulus and tubules, and a decreased expression was found during postnatal maturation of mouse renal cortex.", {"entities": [[29, 34, "GENE"]]}], ["From these in vivo experiments, we concluded that the expression of TRPC6 was active in the developing mouse kidney cortex, and followed a loss of expression with the development of kidney.", {"entities": [[68, 73, "GENE"]]}], ["Meanwhile, an increased expression was found in the hippocampus with the development.", {"entities": []}], ["Together, these data suggested that the developmental changes in TRPC6 expression might be required for proper postnatal kidney cortex development, and played a critical role in the hippocampus during development, which formed the basis for understanding the nephrogenesis and neurogenesis in mice and provided a practically useful knowledge to the clinical and related research.", {"entities": [[65, 70, "GENE"]]}], ["Patients with co-morbidity and multi-morbidity have worse outcomes and greater healthcare needs.", {"entities": []}], ["Co-morbid depression and other long-term conditions present health services with challenges in delivering effective care for patients.", {"entities": []}], ["We provide some recent evidence from the literature to support the need for collaborative care, illustrated by practical examples of how to deliver a collaborative/integrated care continuum by presenting data collected between 2011 and 2012 from a London Borough clinical improvement programme that compared co-morbid diagnosis of depression and other long-term conditions and Accident and Emergency use.", {"entities": []}], ["We have provided some practical steps for developing collaborative care within primary care and suggest that primary care family practices should adopt closer collaboration with other services in order to improve clinical outcomes and cost-effectiveness.", {"entities": []}], ["This study documents the use of medicinal plants from the Mustang district of the north-central part of Nepal.", {"entities": []}], ["Traditional botanical medicine is the primary mode of healthcare for most of the population of this district and traditional Tibetan doctors ( Amchi ) serve as the local medical experts.", {"entities": []}], ["Field research was conducted in 27 communities of the Mustang district in Nepal from 2005-2007.", {"entities": []}], ["We sampled 202 interviewees, using random and snowball sampling techniques.", {"entities": []}], ["After obtaining prior informed consent, we collected data through semi-structured interviews and participant-observation techniques.", {"entities": []}], ["Voucher specimens of all cited botanic species were deposited at TUCH in Nepal.", {"entities": []}], ["We recorded the traditional uses of 121 medicinal plant species, belonging to 49 vascular plant and 2 fungal families encompassing 92 genera.", {"entities": []}], ["These 121 species are employed to treat a total of 116 ailments.", {"entities": []}], ["We present data on 58 plant species previously unknown for their medicinal uses in the Mustang district.", {"entities": []}], ["Of the medicinal plants reported, the most common growth form was herbs (73%) followed by shrubs, trees, and climbers.", {"entities": []}], ["We document that several parts of individual plant species are used as medicine.", {"entities": []}], ["Plant parts were generally prepared using hot or cold water as the 'solvent', but occasionally remedies were prepared with milk, honey, jaggery, ghee and oil.", {"entities": []}], ["Amchis recommended different types of medicine including paste, powder, decoction, tablet, pills, infusion, and others through oral, topical, nasal and others routes of administration.", {"entities": []}], ["The traditional pharmacopoeia of the Mustang district incorporates a myriad of diverse botanical flora.", {"entities": []}], ["Traditional knowledge of the remedies is passed down through oral traditions and dedicated apprenticeships under the tutelage of senior Amchi .", {"entities": []}], ["Although medicinal plants still play a pivotal role in the primary healthcare of the local people of Mustang, efforts to ensure the conservation and sustainable use of medicinal species are necessary.", {"entities": []}], ["The reticulon protein Nogo-B is highly expressed in the lungs, and its loss augments lung inflammation in part as a result of decreased expression of the antiinflammatory protein PLUNC.", {"entities": [[179, 184, "GENE"]]}], ["Nogo-B is a member of the reticulon family of proteins (RTN-4B) that is highly expressed in lung tissue; however, its function remains unknown.", {"entities": []}], ["We show that mice with Th2-driven lung inflammation results in a loss of Nogo expression in airway epithelium and smooth muscle compared with nonallergic mice, a finding which is replicated in severe human asthma.", {"entities": [[206, 212, "DISEASE"]]}], ["Mice lacking Nogo-A/B (Nogo-KO) display an exaggerated asthma-like phenotype, and epithelial reconstitution of Nogo-B in transgenic mice blunts Th2-mediated lung inflammation.", {"entities": [[55, 61, "DISEASE"]]}], ["Microarray analysis of lungs from Nogo-KO mice reveals a marked reduction in palate lung and nasal clone (PLUNC) gene expression, and the levels of PLUNC are enhanced in epithelial Nogo-B transgenic mice.", {"entities": [[106, 111, "GENE"], [148, 153, "GENE"], [106, 111, "GENE"], [148, 153, "GENE"]]}], ["Finally, transgenic expression of PLUNC into Nogo-KO mice rescues the enhanced asthmatic-like responsiveness in these KO mice.", {"entities": [[34, 39, "GENE"]]}], ["These data identify Nogo-B as a novel protective gene expressed in lung epithelia, and its expression regulates the levels of the antibacterial antiinflammatory protein PLUNC.", {"entities": [[169, 174, "GENE"]]}], ["Botulinum neurotoxin is the therapy of choice for all forms of cervical dystonia (CD), but treatment regimens still vary considerably.", {"entities": [[72, 80, "DISEASE"]]}], ["The interpretation of treatment outcome is mainly based on the clinical experience and on the scientific value of the rating scales applied.", {"entities": []}], ["The aim of this review is to describe the historical development of rating scales for the assessment of CD and to provide an appraisal of their advantages and drawbacks.", {"entities": []}], ["The Tsui score and the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) have been widely employed in numerous clinical studies as specific instruments for CD.", {"entities": []}], ["The obvious advantage of the Tsui score is its simplicity so that it can be easily implemented in clinical routine.", {"entities": []}], ["The TWSTRS allows a more sophisticated assessment of functional features of CD, but only the Tsui score includes a rating for tremor.", {"entities": []}], ["Other benefits of the TWSTRS are the disability and pain subscales, but despite its value in clinical trials, it might be too complex for routine clinical practice.", {"entities": []}], ["None of the rating scales used at present has been rigorously tested for responsiveness to detect significant changes in clinical status after therapeutic interventions.", {"entities": []}], ["Moreover, clinical data support a new classification of CD leading to a differentiation between head and neck subtypes.", {"entities": []}], ["As the current rating scales are not able to cover all these aspects of the disorder, further research is needed to develop a valid and reliable instrument which considers the most current classification of CD.", {"entities": []}], ["Marc Baguelin and colleagues use virological, clinical, epidemiological, and behavioral data to estimate how policies for influenza vaccination programs may be optimized in England and Wales.", {"entities": [[122, 131, "DISEASE"]]}], ["Please see later in the article for the Editors' Summary Influenza vaccine policies that maximise health benefit through efficient use of limited resources are needed.", {"entities": [[57, 66, "DISEASE"]]}], ["Generally, influenza vaccination programmes have targeted individuals 65 y and over and those at risk, according to World Health Organization recommendations.", {"entities": [[11, 20, "DISEASE"]]}], ["We developed methods to synthesise the multiplicity of surveillance datasets in order to evaluate how changing target populations in the seasonal vaccination programme would affect infection rate and mortality.", {"entities": []}], ["Using a contemporary evidence-synthesis approach, we use virological, clinical, epidemiological, and behavioural data to develop an age- and risk-stratified transmission model that reproduces the strain-specific behaviour of influenza over 14 seasons in England and Wales, having accounted for the vaccination uptake over this period.", {"entities": [[225, 234, "DISEASE"]]}], ["We estimate the reduction in infections and deaths achieved by the historical programme compared with no vaccination, and the reduction had different policies been in place over the period.", {"entities": []}], ["We find that the current programme has averted 0.39 (95% credible interval 0.34\u20130.45) infections per dose of vaccine and 1.74 (1.16\u20133.02) deaths per 1,000 doses.", {"entities": []}], ["Targeting transmitters by extending the current programme to 5\u201316-y-old children would increase the efficiency of the total programme, resulting in an overall reduction of 0.70 (0.52\u20130.81) infections per dose and 1.95 (1.28\u20133.39) deaths per 1,000 doses.", {"entities": []}], ["In comparison, choosing the next group most at risk (50\u201364-y-olds) would prevent only 0.43 (0.35\u20130.52) infections per dose and 1.77 (1.15\u20133.14) deaths per 1,000 doses.", {"entities": []}], ["This study proposes a framework to integrate influenza surveillance data into transmission models.", {"entities": [[45, 54, "DISEASE"]]}], ["Application to data from England and Wales confirms the role of children as key infection spreaders.", {"entities": []}], ["The most efficient use of vaccine to reduce overall influenza morbidity and mortality is thus to target children in addition to older adults.", {"entities": [[52, 61, "DISEASE"]]}], ["Please see later in the article for the Editors' Summary Every winter, millions of people catch influenza, a viral infection of the airways.", {"entities": [[96, 105, "DISEASE"]]}], ["Most infected individuals recover quickly, but seasonal influenza outbreaks (epidemics) kill about half a million people annually.", {"entities": [[56, 65, "DISEASE"]]}], ["In countries with advanced health systems, these deaths occur mainly among elderly people and among individuals with long-term illnesses such as asthma and heart disease that increase the risk of complications occurring after influenza virus infection.", {"entities": [[226, 235, "DISEASE"], [156, 169, "DISEASE"], [145, 151, "DISEASE"]]}], ["Epidemics of influenza occur because small but frequent changes in the influenza virus mean that an immune response produced one year through infection provides only partial protection against influenza the following year.", {"entities": [[13, 22, "DISEASE"], [71, 80, "DISEASE"], [193, 202, "DISEASE"]]}], ["Annual immunization with a vaccine that contains killed influenza viruses of the major circulating strains can greatly reduce a person's risk of catching influenza by preparing the immune system to respond quickly when challenged by a live influenza virus.", {"entities": [[56, 65, "DISEASE"], [154, 163, "DISEASE"], [240, 249, "DISEASE"]]}], ["Consequently, many countries run seasonal influenza vaccination programs that, in line with World Health Organization recommendations, target individuals 65 years old and older and people in high-risk groups.", {"entities": [[42, 51, "DISEASE"]]}], ["Is this approach the best use of available resources?", {"entities": []}], ["Might, for example, vaccination of children\u2014the main transmitters of influenza\u2014provide more benefit to the whole population than vaccination of elderly people?", {"entities": [[69, 78, "DISEASE"]]}], ["Vaccination of children would not directly prevent as many influenza-related deaths as vaccination of elderly people, but it might indirectly prevent deaths in elderly adults by inducing herd immunity\u2014vaccination of a large part of a population can protect unvaccinated members of the population by reducing the chances of an infection spreading.", {"entities": [[59, 68, "DISEASE"]]}], ["Policy makers need to know whether a change to an influenza vaccination program is likely to provide additional population benefits before altering the program.", {"entities": [[50, 59, "DISEASE"]]}], ["In this evidence synthesis and modeling study, the researchers combine (synthesize) longitudinal influenza surveillance datasets (data collected over time) from England and Wales, develop a mathematical model for influenza transmission based on these data using a Bayesian statistical approach, and use the model to evaluate the impact on influenza infections and deaths of changes to the seasonal influenza vaccination program in England and Wales.", {"entities": [[97, 106, "DISEASE"], [213, 222, "DISEASE"], [339, 348, "DISEASE"], [398, 407, "DISEASE"]]}], ["The researchers developed an influenza transmission model using clinical data on influenza-like illness consultations collected in a primary care surveillance scheme for each week of 14 influenza seasons in England and Wales, virological information on respiratory viruses detected in a subset of patients presenting with clinically suspected influenza, and data on vaccination coverage in the whole population (epidemiological data).", {"entities": [[29, 38, "DISEASE"], [81, 90, "DISEASE"], [186, 195, "DISEASE"], [343, 352, "DISEASE"]]}], ["They also incorporated data on social contacts (behavioral data) and on immunity to influenza viruses in the population (seroepidemiological data) into their model.", {"entities": [[84, 93, "DISEASE"]]}], ["To estimate the impact of potential changes to the current vaccination strategy in England and Wales, the researchers used their model, which replicated the patterns of disease observed in the surveillance data, to run simulated epidemics for each influenza season and for three strains of influenza virus under various vaccination scenarios.", {"entities": [[248, 257, "DISEASE"], [290, 299, "DISEASE"]]}], ["Compared to no vaccination, the current program (vaccination of people 65 years old and older and people in high-risk groups) averted 0.39 infections per dose of vaccine and 1.74 deaths per 1,000 doses.", {"entities": []}], ["Notably, the model predicted that extension of the program to target 5\u201316-year-old children would increase the efficiency of the program and would avert 0.70 infections per dose and 1.95 deaths per 1,000 doses.", {"entities": []}], ["The finding that the transmission model developed by the researchers closely fit the available surveillance data suggests that the model should be able to predict what would have happened in England and Wales over the study period if an alternative vaccination regimen had been in place.", {"entities": []}], ["The accuracy of such predictions may be limited, however, because the vaccination model is based on a series of simplifying assumptions.", {"entities": []}], ["Importantly, given that influenza vaccination for children is being rolled out in England and Wales from September 2013, the model confirms that children are key spreaders of influenza and suggests that a vaccination program targeting children will reduce influenza infections and potentially influenza deaths in the whole population.", {"entities": [[24, 33, "DISEASE"], [175, 184, "DISEASE"], [256, 265, "DISEASE"], [293, 302, "DISEASE"]]}], ["More generally, the findings of this study support wider adoption of national vaccination strategies designed to block influenza transmission and to target those individuals most at risk from the complications of influenza infection.", {"entities": [[119, 128, "DISEASE"], [213, 222, "DISEASE"]]}], ["Please access these websites via the online version of this summary at http://dx.doi.org/10.1371.journal.pmed.1001527 .", {"entities": []}], ["The UK National Health Service Choices website provides information for patients about seasonal influenza and about vaccination ; Public Health England (formerly the Health Protection Agency) provides information on influenza surveillance in the UK , including information about the primary care surveillance database used in this study The World Health Organization provides information on seasonal influenza (in several languages) The European Influenzanet is a system to monitor the activity of influenza-like illness with the aid of volunteers via the Internet The US Centers for Disease Control and Prevention also provides information for patients and health professionals on all aspects of seasonal influenza , including information about vaccination and about the US influenza surveillance system ; its website contains a short video about personal experiences of influenza Flu.gov , a US government website, provides access to information on seasonal influenza and vaccination MedlinePlus has links to further information about influenza and about immunization (in English and Spanish)", {"entities": [[96, 105, "DISEASE"], [216, 225, "DISEASE"], [400, 409, "DISEASE"], [498, 507, "DISEASE"], [706, 715, "DISEASE"], [775, 784, "DISEASE"], [872, 881, "DISEASE"], [960, 969, "DISEASE"], [1037, 1046, "DISEASE"]]}], ["Globally the omega-3 (n-3) fatty acid supplement industry is expanding rapidly while consumers are becoming more aware of the health benefits of n-3 fatty acids.", {"entities": []}], ["Our group conducted a survey in 2009 on 45 commercially available fish oil supplements on the South African market.", {"entities": []}], ["The aim of the study was to determine the fatty acid composition and content of supplements for comparison with the claimed contents on the product label.", {"entities": []}], ["The survey was repeated in 2012 on 63 supplements.", {"entities": []}], ["Sixty-three commercially available n-3 fatty acid supplements were analysed using gas\u2013liquid chromatography to determine their fatty acid composition and content.", {"entities": []}], ["This analysis has shown an improvement in the accuracy of EPA content (44% in 2009) declared on supplement labels compared to the 2012 (52%) survey.", {"entities": []}], ["It was also evident that a higher percentage of supplements (13% in 2009 vs 35% in 2012) contained DHA levels higher than declared.", {"entities": []}], ["In 2009, 64% of supplements cost R2.01 to R5.00 or more to achieve a daily intake of 500 mg EPA + DHA, compared to 81% in 2012.", {"entities": []}], ["Forty-four per cent of supplements were found to be in the early stages of rancidity [conjugated diene (CD) levels] compared to 73% in 2009.", {"entities": []}], ["More than 80% of supplements had peroxide levels higher than the recommended content as specified by the Global Organisation for EPA and DHA Omega-3 (GOED).", {"entities": []}], ["The majority (81%; n = 51) of the supplements under study in 2012 had a 1.1\u20131.5:1 EPA-to-DHA ratio or less, compared to 56% in 2009.", {"entities": []}], ["Almost a third (32%) of the supplements in the 2012 survey contained ethyl esters (EE) or a combination of ethyl esters and triglycerides.", {"entities": []}], ["Although the results of the 2012 versus the 2009 analysis were encouraging in terms of the accuracy of EPA declared on the supplement labels, the high peroxide levels found in the supplement oils are of concern.", {"entities": []}], ["High peroxide levels are associated with potential health implications.", {"entities": []}], ["EE were present in some of the supplements, even though the safety of EE has not been confirmed in vulnerable groups such as pregnant women and children.", {"entities": []}], ["Cardiometabolic diseases (CMDs) are an important cause of mortality worldwide and the burden associated with them is increasing in Sub-Saharan Africa.", {"entities": []}], ["The tracking of mortality helps support evidence based health policy and priority setting.", {"entities": []}], ["Given the growing prevalence of non-communicable diseases in Zimbabwe, a study was designed to determine the mortality attributable to CMDs in Zimbabwe.", {"entities": []}], ["The study design was a retrospective cross-sectional analysis of national mortality from 1996 to 2007, collated by the Ministry of Health and Child Welfare in Zimbabwe.", {"entities": []}], ["We employed generalized additive models to flexibly estimate the trend of the CMD mortality and a logistic regression model was used to find significant factors (cause of death according to the death certificate) of the CMD mortality and predict CMD mortality to 2040.", {"entities": []}], ["CMDs accounted for 8.13\u00a0% (95\u00a0% CI: 8.08\u00a0% - 8.18\u00a0%) of all deaths during 1996 to 2007 ( p \u2009=\u20090.005).", {"entities": []}], ["During the study period CMD mortality rate increased by 29.4\u00a0% (95\u00a0% CI: 19.9\u00a0% - 41.1\u00a0%).", {"entities": []}], ["The association between gender and CMD mortality indicated female mortality was higher for diabetes ( p \u2009<\u20090.001), hypertensive disease ( p \u2009<\u20090.001), CVD ( p \u2009<\u20090.001) and pulmonary disease ( p \u2009<\u20090.001), while male mortality was higher for ischaemic ( p \u2009=\u20090.010) and urinary diseases ( p \u2009<\u20090.001).", {"entities": []}], ["There was no gender difference for endocrine disease ( p \u2009=\u20090.893).", {"entities": []}], ["Overall, females have 1.65\u00a0% higher mortality than males ( p \u2009<\u20090.001).", {"entities": []}], ["CMD mortality is predicted to increase from 9.6\u00a0% (95\u00a0% CI: 8.0\u00a0% - 11.1\u00a0%) in 2015 to 13.7\u00a0% (95\u00a0% CI: 10.2\u00a0% - 17.2\u00a0%) in 2040 for males, and from 11.6\u00a0% (95\u00a0% CI: 10.2\u00a0% - 12.9\u00a0%) in 2015 to 16.2\u00a0% (95\u00a0% CI: 13.1\u00a0% - 19.3\u00a0%) in 2040 in females.", {"entities": []}], ["The findings of this study indicate a growing prevalence of CMDs and related mortality in Zimbabwe.", {"entities": []}], ["Health policy decisions and cost-effective preventive strategies to reduce the burden of CMDs are urgently required.", {"entities": []}], ["Pulmonary complications are the most common cause of death and morbidity in systemic sclerosis (SSc).", {"entities": []}], ["The forced oscillation technique (FOT) offers a simple and detailed approach to investigate the mechanical properties of the respiratory system.", {"entities": []}], ["We hypothesized that SSc may introduce changes in the resistive and reactive properties of the respiratory system, and that FOT may help the diagnosis of these abnormalities.", {"entities": []}], ["We tested these hypotheses in controls (n\u200a=\u200a30) and patients with abnormalities classified using spirometry (n\u200a=\u200a52) and pulmonary volumes (n\u200a=\u200a29).", {"entities": []}], ["Resistive data were interpreted with the zero-intercept resistance (Ri) and the slope of the resistance (S) as a function of frequency.", {"entities": []}], ["Reactance changes were evaluated by the mean reactance between 4 and 32 Hz (Xm) and the dynamic compliance (Crs,dyn).", {"entities": []}], ["The mechanical load was evaluated using the absolute value of the impedance in 4 Hz (Z4Hz).", {"entities": []}], ["A compartmental model was used to obtain central (R) and peripheral (Rp) resistances, and alveolar compliance (C).", {"entities": []}], ["The clinical usefulness was evaluated by investigating the area under the receiver operating characteristic curve (AUC).", {"entities": []}], ["The presence of expiratory flow limitation (EFL) was also evaluated.", {"entities": []}], ["For the groups classified using spirometry, SSc resulted in increased values in Ri, R, Rp and Z4Hz (p<0.003) and reductions in Crs,dyn, C and Xm (p<0.004).", {"entities": []}], ["Z4Hz, C and Crs,dyn exhibited a high diagnostic accuracy (AUC>0.90).", {"entities": []}], ["In groups classified by pulmonary volume, SSc resulted in reductions in S, Xm, C and Crs,dyn (p<0.01).", {"entities": []}], ["Xm, C and Crs,dyn exhibited adequate diagnostic accuracy (AUC>0.80).", {"entities": []}], ["It was also observed that EFL is not common in patients with SSc.", {"entities": []}], ["This study provides evidence that the respiratory resistance and reactance are changed in SSc.", {"entities": []}], ["This analysis provides a useful description that is of particular significance for understanding respiratory pathophysiology and to ease the diagnosis of respiratory abnormalities in these patients.", {"entities": []}], ["The purpose of this study was to estimate the national prevalence of childhood asthma and other allergic diseases in Korea, and to determine potential risk factors for the diseases.", {"entities": [[79, 85, "DISEASE"]]}], ["Stratified random samples of 42,886 were selected from 34 elementary (6-12 yr olds) and 34 middle schools (12-15 yr olds) nationwide, and 38,955 were in the final analysis.", {"entities": []}], ["The Korean-translated modified version of the International Study of Asthma and Allergies in Childhood questionnaire was used in this cross-sectional survey.", {"entities": [[69, 75, "DISEASE"]]}], ["Twelve-month prevalences of the symptoms of asthma, rhinoconjunctivitis, and flexural eczema were 8.7%, 10.5%, 7.3% in 6-12 yr olds, and 8.2%, 10.0%, 3.9% in 12-15 yr olds, respectively.", {"entities": [[44, 50, "DISEASE"]]}], ["For allergic conjunctivitis, food allergy, and drug allergy, the prevalences in 6-12 yr olds were 11.2%, 6.5%, and 1.5%, respectively.", {"entities": [[4, 27, "DISEASE"], [29, 41, "DISEASE"], [13, 27, "DISEASE"]]}], ["Asthma and flexural eczema decreased significantly with age.", {"entities": [[0, 6, "DISEASE"]]}], ["Other significant risk factors were also noted.", {"entities": []}], ["For 6-12 yr-old asthma, adjusted odds ratio (aOR) of body mass index was 1.21 with 95% confidence interval (CI) 1.0-1.48, aOR of passive smoking was 1.37 with 95%CI 1.24-1.51, aOR of carpet use was 1.28 with 95%CI 1.10-1.49.", {"entities": [[16, 22, "DISEASE"]]}], ["For 6-12 yr-old eczema, aOR of affluence was 1.22 with 95%CI 1.07-1.39.", {"entities": []}], ["The control of obesity and passive smoking would be the most important preventive measures of allergic diseases.", {"entities": [[15, 22, "DISEASE"]]}], ["We used California's Pesticide Use Report (PUR) and land-use survey data to conduct a simulation study evaluating the potential consequences of misclassifying residential exposure from proximity to agricultural pesticide application in health effect studies.", {"entities": []}], ["We developed a geographic model linking the PUR with crop location data from land-use surveys to assess the impact of exposure misclassification from simpler exposure models based solely on PUR or land-use data.", {"entities": []}], ["We simulated the random selection of population controls recruited into a hypothetical case-control study within an agricultural region.", {"entities": []}], ["Using residential parcel data, we derived annual exposure prevalences, sensitivity, and specificity for five pesticides and relied on the PUR plus land-use model as the \"gold standard.\"", {"entities": []}], ["Based on these estimates, we calculated the attenuation of prespecified true odds ratios (ORs), assuming nondifferential exposure misclassification.", {"entities": []}], ["True ORs were severely attenuated a) when residential exposure status was based on a larger geographic area yielding higher sensitivity but low specificity for exposure, in contrast to relying on a smaller area and increasing specificity; b) for less frequently applied pesticides; and c) with increasing mobility of residents among the study population.", {"entities": []}], ["Considerable effect estimate attenuation also occurred when we used residential distance to crops as a proxy for pesticide exposure.", {"entities": []}], ["Finally, exposure classifications based on annual instead of seasonal summaries of PUR resulted in highly attenuated ORs, especially during seasons when applications of specific pesticides were unlikely to occur.", {"entities": []}], ["These results underscore the importance of increasing the spatiotemporal resolution of pesticide exposure models to minimize misclassification.", {"entities": []}], ["Indoor air pollution has been identified as a major risk factor for acute and chronic respiratory diseases throughout the world.", {"entities": []}], ["In the sovereign Navajo Nation, an American Indian reservation located in the Four Corners area of the USA, people burn coal in their homes for heat.", {"entities": []}], ["To explore whether/how indoor coal combustion might contribute to poor respiratory health of residents, this study examined respiratory health data, identified household risk factors such as fuel and stove type and use, analyzed samples of locally used coal, and measured and characterized fine particulate airborne matter inside selected homes.", {"entities": []}], ["In twenty-five percent of homes surveyed coal was burned in stoves not designed for that fuel, and indoor air quality was frequently found to be of a level to raise concerns.", {"entities": []}], ["The average winter 24-hour PM 2.5 concentration in 20 homes was 36.0\u2009 \u03bc g/m 2.5 has been quantified and characterized inside Navajo reservation residents' homes.", {"entities": []}], ["Unaccustomed exercise can result in delayed onset of muscle soreness (DOMS) which can affect athletic performance.", {"entities": []}], ["Although DOMS is a useful tool to identify muscle damage and remodelling, prolonged symptoms of DOMS may be associated with the over-training syndrome.", {"entities": [[142, 150, "DISEASE"]]}], ["In order to reduce the symptoms of DOMS numerous management strategies have been attempted with no significant effect on DOMS-associated cytokines surge.", {"entities": []}], ["The present study aimed to investigate the acute and chronic effects of a 2 \u00d7 180 mg per day dose of eicosapentaenoic acid (EPA) on interleukin-6 (IL-6) mediated inflammatory response and symptoms associated with DOMS.", {"entities": []}], ["Seventeen healthy non-smoking females (age 20.4 \u00b1 2.1 years, height 161.2 \u00b1 8.3 cm and mass 61.48 \u00b1 7.4 kg) were randomly assigned to either placebo (N = 10) or EPA (N = 7).", {"entities": []}], ["Serum IL-6, isometric and isokinetic (concentric and eccentric) strength, and rating of perceived exertion (RPE) were recorded on four occasions: i-prior to supplementation, ii-immediately after three weeks of supplementation (basal effects), iii-48 hours following a single bout of resistance exercise (acute training response effects), and iv-48 hours following the last of a series of three bouts of resistance exercise (chronic training response effects).", {"entities": [[108, 111, "GENE"]]}], ["There was only a group difference in the degree of change in circulating IL-6 levels.", {"entities": []}], ["In fact, relative to the first baseline, by the third bout of eccentric workout, the EPA group had 103 \u00b1 60% increment in IL-6 levels whereas the placebo group only had 80 \u00b1 26% incremented IL-6 levels (P = 0.020).", {"entities": []}], ["We also describe a stable multiple linear regression model which included measures of strength and not IL-6 as predictors of RPE scale.", {"entities": [[125, 128, "GENE"]]}], ["The present study suggests that in doubling the standard recommended dose of EPA, whilst this may still not be beneficial at ameliorating the symptoms of DOMS, it counter intuitively appears to enhance the cytokine response to exercise.", {"entities": []}], ["In a context where previous in vitro work has shown EPA to decrease the effects of inflammatory cytokines, it may in fact be that the doses required in vivo is much larger than current recommended amounts.", {"entities": []}], ["An attempt to dampen the exercise-induced cytokine flux in fact results in an over-compensatory response of this system.", {"entities": []}], ["Some members of Rhododendron genus are traditionally used as medicinal plants for arthritis, acute and chronic bronchitis, asthma, pain, inflammation, rheumatism, hypertension and metabolic diseases.", {"entities": [[163, 175, "DISEASE"], [82, 91, "DISEASE"], [123, 129, "DISEASE"], [111, 121, "DISEASE"]]}], ["To the best of our knowledge, there is no report on the protective effects of R. oldhamii leaf extract on non-alcoholic fatty liver disease (NAFLD) in vivo and in vitro .", {"entities": [[120, 139, "DISEASE"], [126, 139, "DISEASE"]]}], ["In this study, the effects of R. oldhamii leaf extract on inhibiting the free fatty acid (FFA)-induced accumulation of fat in HepG2 cells and on improving fatty liver syndrome in mice with high fat diet (HFD)-induced NAFLD were investigated.", {"entities": [[167, 175, "DISEASE"]]}], ["For the in vitro assay, HepG2 cells were treated with FFAs (oleate/palmitate = 2:1) with or without treatment with R. oldhamii leaf ethyl acetate (EtOAc) fraction to observe lipid accumulation using Nile red and oil red O stains.", {"entities": []}], ["For the in vivo assay, C57BL/6 mice were randomly assigned to three groups ( n = 5), including the normal diet group, the HFD group and the HFD+EtOAc group.", {"entities": []}], ["After 11 weeks, body weight, serum biochemical indices and the mRNA expressions of the liver tissue, as well as the outward appearance, weight and histopathological analysis of liver and adipose tissues were evaluated.", {"entities": []}], ["Among the fractions derived from R. oldhamii leaf, the EtOAc fraction exhibited a strong fat-accumulation inhibitory activity.", {"entities": []}], ["Following reverse-phase high-performance liquid chromatography (HPLC), four specific phytochemicals, including (2 R , 3 R )-astilbin (AS), hyposide (HY), guaijaverin (GU) and quercitrin (QU), were isolated and identified from the EtOAc fraction of R. oldhamii leaf extract.", {"entities": []}], ["Among them, AS and HY showed excellent fat-accumulation inhibitory activity.", {"entities": []}], ["Thus, the EtOAc fraction of R. oldhamii leaf and its derived phytochemicals have great potential in preventing FFA-induced fat accumulation.", {"entities": []}], ["In addition, the EtOAc fraction of R. oldhamii leaf significantly improved fatty liver syndrome and reduced total cholesterol (TC) and triglyceride (TG) in HFD-induced NAFLD mice at a dosage of 200 mg/kg BW.", {"entities": [[87, 95, "DISEASE"], [149, 151, "GENE"]]}], ["These results demonstrated that the methanolic extracts from R. oldhamii leaf have excellent inhibitory activities against fat accumulation and anti-NAFLD activities and thus have great potential as a natural health product.", {"entities": []}], ["Altered DNA methylation is common in cancer and often considered an early event in tumorigenesis.", {"entities": [[37, 43, "DISEASE"]]}], ["However, the sources of heterogeneity of DNA methylation among tumours remain poorly defined.", {"entities": []}], ["Here we capitalize on the availability of multi-platform data on thousands of human tumours to build integrative models of DNA methylation.", {"entities": []}], ["We quantify the contribution of clinical and molecular factors in explaining intertumoral variability in DNA methylation.", {"entities": []}], ["We show that the levels of a set of metabolic genes involved in the methionine cycle is predictive of several features of DNA methylation in tumours, including the methylation of cancer genes.", {"entities": [[179, 185, "DISEASE"]]}], ["Finally, we demonstrate that patients whose DNA methylation can be predicted from the methionine cycle exhibited improved survival over cases where this regulation is disrupted.", {"entities": []}], ["This study represents a comprehensive analysis of the determinants of methylation and demonstrates the surprisingly large interaction between metabolism and DNA methylation variation.", {"entities": []}], ["Together, our results quantify links between tumour metabolism and epigenetics and outline clinical implications.", {"entities": []}], ["Altered DNA methylation is a feature of cancer and between-patient variability is prevalent.", {"entities": [[40, 46, "DISEASE"]]}], ["Here, the authors integrate data on thousands of human tumours, and find that expression levels of methionine metabolism genes are predictive of methylation features, and that the breakdown of this relationship is a negative prognostic marker.", {"entities": []}], ["In the article a brief description of the biological basis of the regulation of human biological clocks was presented in order to introduce the role of circadian rhythms in physiology and specifically in the pharmacological translational tools based on the computational physiology models to motivate the need to provide models of circadian fluctuation in plasma cations.", {"entities": []}], ["The main aim of the study was to develop statistical models of the circadian rhythm of potassium, sodium, and calcium concentrations in plasma.", {"entities": []}], ["The developed ion models were further tested by assessing their influence on QT duration (cardiac endpoint) as simulated by the biophysically detailed models of human left ventricular cardiomyocyte.", {"entities": []}], ["The main results are model equations along with an electronic supplement to the article that contains a fully functional implementation of all models.", {"entities": []}], ["The 75% of older adults with multiple chronic conditions are at risk of therapeutic competition (i.e.", {"entities": []}], ["treatment for one condition may adversely affect a coexisting condition).", {"entities": []}], ["The objective was to determine the prevalence of potential therapeutic competition in community-living older adults.", {"entities": []}], ["Cross-sectional descriptive study of a representative sample of 5,815 community-living adults 65 and older in the U.S, enrolled 2007\u20132009.", {"entities": []}], ["The 14 most common chronic conditions treated with at least one medication were ascertained from Medicare claims.", {"entities": []}], ["Medication classes recommended in national disease guidelines for these conditions and used by \u22652% of participants were identified from in-person interviews conducted 2008\u20132010.", {"entities": []}], ["Criteria for potential therapeutic competition included: 1), well-acknowledged adverse medication effect; 2) mention in disease guidelines; or 3) report in a systematic review or two studies published since 2000.", {"entities": []}], ["Outcomes included prevalence of situations of potential therapeutic competition and frequency of use of the medication in individuals with and without the competing condition.", {"entities": []}], ["Of 27 medication classes, 15 (55.5%) recommended for one study condition may adversely affect other study conditions.", {"entities": []}], ["Among 91 possible pairs of study chronic conditions, 25 (27.5%) have at least one potential therapeutic competition.", {"entities": []}], ["Among participants, 1,313 (22.6%) received at least one medication that may worsen a coexisting condition; 753 (13%) had multiple pairs of such competing conditions.", {"entities": []}], ["For example, among 846 participants with hypertension and COPD, 16.2% used a nonselective beta-blocker.", {"entities": [[41, 53, "DISEASE"]]}], ["In only 6 of 37 cases (16.2%) of potential therapeutic competition were those with the competing condition less likely to receive the medication than those without the competing condition.", {"entities": []}], ["One fifth of older Americans receive medications that may adversely affect coexisting conditions.", {"entities": []}], ["Determining clinical outcomes in these situations is a research and clinical priority.", {"entities": []}], ["Effects on coexisting conditions should be considered when prescribing medications.", {"entities": []}], ["Inflammation-induced pulmonary fibrosis (PF) leads to irreversible loss of lung function and is a predictor of mortality in numerous lung diseases.", {"entities": [[21, 39, "DISEASE"]]}], ["Why some subjects with lung inflammation but not others develop PF is unclear.", {"entities": []}], ["In a mouse model of hypersensitivity pneumonitis that progresses to lung fibrosis upon repeated exposure to the ubiquitous microorganism Bacillus subtilis , \u03b3\u03b4 T cells expand in the lung and inhibit collagen deposition.", {"entities": []}], ["We show that a subset of these \u03b3\u03b4 cells represents the predominant source of the Th17 cytokine IL-22 in this model.", {"entities": []}], ["Preventing expression of IL-22, either by mutating the aryl hydrocarbon receptor (AhR) or inhibiting AhR signaling, accelerated lung fibrosis.", {"entities": [[82, 85, "GENE"], [101, 104, "GENE"], [82, 85, "GENE"], [101, 104, "GENE"]]}], ["Direct blockade of IL-22 also enhanced collagen deposition in the lung, whereas administration of recombinant IL-22 inhibited lung fibrosis.", {"entities": []}], ["Moreover, the presence of protective \u03b3\u03b4 T cells and IL-22 diminished recruitment of CD4", {"entities": [[84, 87, "GENE"]]}], ["Neurotrophins (NT) belongs to a family of growth factors which promotes neurons survival and differentiation.", {"entities": []}], ["Increasing evidence show that NT and their receptor are expressed in lung tissues suggesting a possible role in lung health and disease.", {"entities": []}], ["Here we investigated the expression and functional role of the TrkB/BDNF axis in idiopathic pulmonary fibrotic lung (myo)fibroblasts.", {"entities": []}], ["Lung fibroblast were isolated from IPF patients and characterized for the expression of mesenchymal markers in comparison to normal lung fibroblasts isolated from non-IPF controls.", {"entities": []}], ["BDNF treatment promoted mesenchymal differentiation and this effect was counteracted by the TrkB inhibitor K252a.", {"entities": [[0, 4, "GENE"]]}], ["In this regard, we showed that K252a treatment was able to control the expression of transcription factors involved in epithelial to mesenchymal transition (EMT).", {"entities": []}], ["Accordingly, K252a treatment reduced matrix metalloproteinase-9 enzyme activity and E-cadherin expression while increased cytoplasmic \u03b2-catenin expression.", {"entities": []}], ["Our results suggest that BDNF/TrkB axis plays a role in EMT promoting the acquisition of (myo)fibroblast cell phenotype in IPF.", {"entities": []}], ["Targeting BDNF/TrkB seems to represent a viable approach in order to prevent EMT dependent lung fibrosis.", {"entities": []}], ["Fibromyalgia (FM) is conceptualized as a central sensitization (CS) condition, that presents high serum brain-derived neurotrophic factor (BDNF) and neuroglia activation.", {"entities": [[64, 66, "GENE"], [139, 143, "GENE"]]}], ["Although the S100B protein regulates neuroglia functions, it has been traditionally used as a proxy of central nervous system damage.", {"entities": [[13, 18, "GENE"]]}], ["However, neither BDNF nor S100B association with the clinical picture of FM has been elucidated.", {"entities": [[17, 21, "GENE"], [26, 31, "GENE"]]}], ["To explore their association with the pressure-pain threshold (PPT) in FM, we performed a cross-sectional study, including 56 females with confirmed FM aged 18\u201365 years.", {"entities": []}], ["Linear regression models were used to adjust for potential confounding factors between serum BDNF, S100B and PPT.", {"entities": [[93, 97, "GENE"], [99, 104, "GENE"]]}], ["Serum BDNF and S100B were correlated (Spearman\u2019s Rho\u2009=\u20090.29).", {"entities": [[6, 10, "GENE"], [15, 20, "GENE"]]}], ["Serum BDNF ( log ) and S100B ( log ) were correlated with the PPT ( log ) (Partial \u03b7 P \u2009=\u20090.012 for the BDNF ( log ), and Partial \u03b7 P \u2009=\u20090.025 for the S100B ( log )).", {"entities": [[6, 10, "GENE"], [104, 108, "GENE"], [23, 28, "GENE"], [151, 156, "GENE"], [6, 10, "GENE"], [104, 108, "GENE"], [23, 28, "GENE"], [151, 156, "GENE"]]}], ["Serum BDNF ( log ) was inversely associated with PPT ( log ) (\u03b2\u2009=\u2009-1.01, SE\u2009=\u20090.41), age (\u03b2\u2009=\u2009-0.02, SE\u2009=\u20090.15) and obsessive compulsive disorder (\u03b2\u2009=\u2009-0.36, SE\u2009=\u20090.15), while serum S100B ( log ) was inversely associated with PPT ( log ) (\u03b2\u2009=\u2009-1.38, SE\u2009=\u20090.50), only.", {"entities": [[6, 10, "GENE"], [182, 187, "GENE"]]}], ["Both neuroglia key mediators in the CS process were inversely correlated with the PPT.", {"entities": [[36, 38, "GENE"]]}], ["Serum assessment of BDNF and S100B deserve further study to determine its potential as a proxy for the CS spectrum in FM.", {"entities": [[20, 24, "GENE"], [29, 34, "GENE"], [103, 105, "GENE"]]}], ["Locally harvested wild edible plants (WEPs) provide food as well as cash income for indigenous people and are of great importance in ensuring global food security.", {"entities": []}], ["Some also play a significant role in maintaining the productivity and stability of traditional agro-ecosystems.", {"entities": []}], ["Shangri-la region of Yunnan Province, SW China, is regarded as a biodiversity hotspot.", {"entities": []}], ["People living there have accumulated traditional knowledge about plants.", {"entities": []}], ["However, with economic development, WEPs are threatened and the associated traditional knowledge is in danger of being lost.", {"entities": []}], ["Therefore, ethnobotanical surveys were conducted throughout this area to investigate and document the wild edible plants traditionally used by local Tibetan people.", {"entities": []}], ["Twenty-nine villages were selected to carry out the field investigations.", {"entities": []}], ["Information was collected using direct observation, semi-structured interviews, individual discussions, key informant interviews, focus group discussions, questionnaires and participatory rural appraisal (PRA).", {"entities": []}], ["Information about 168 wild edible plant species in 116 genera of 62 families was recorded and specimens were collected.", {"entities": []}], ["Most species were edible greens (80 species) or fruits (78).", {"entities": []}], ["These WEPs are sources for local people, especially those living in remote rural areas, to obtain mineral elements and vitamins.", {"entities": []}], ["More than half of the species (70%) have multiple use(s) besides food value.", {"entities": []}], ["Some are crop wild relatives that could be used for crop improvement.", {"entities": []}], ["Several also have potential values for further commercial exploitation.", {"entities": []}], ["However, the utilization of WEPs and related knowledge are eroding rapidly, especially in the areas with convenient transportation and booming tourism.", {"entities": []}], ["Wild food plants species are abundant and diverse in Shangri-la region.", {"entities": []}], ["They provide food and nutrients to local people and could also be a source of cash income.", {"entities": []}], ["However, both WEPs and their associated indigenous knowledge are facing various threats.", {"entities": []}], ["Thus, conservation and sustainable utilization of these plants in this area are of the utmost importance.", {"entities": []}], ["Documentation of these species may provide basic information for conservation, possibly further exploitation, and will preserve local traditional knowledge.", {"entities": []}], ["Image-guided radiotherapy (IGRT) facilitates the delivery of a very precise radiation dose.", {"entities": []}], ["In this study we compare the toxicity and biochemical progression-free survival between patients treated with daily image-guided intensity-modulated radiotherapy (IG-IMRT) and 3D conformal radiotherapy (3DCRT) without daily image guidance for high risk prostate cancer (PCa).", {"entities": [[262, 268, "DISEASE"], [253, 268, "DISEASE"]]}], ["A total of 503 high risk PCa patients treated with radiotherapy (RT) and endocrine treatment between 2000 and 2010 were retrospectively reviewed.", {"entities": []}], ["115 patients were treated with 3DCRT, and 388 patients were treated with IG-IMRT.", {"entities": []}], ["3DCRT patients were treated to 76\u00a0Gy and without daily image guidance and with 1\u20132\u00a0cm PTV margins.", {"entities": []}], ["IG-IMRT patients were treated to 78\u00a0Gy based on daily image guidance of fiducial markers, and the PTV margins were 5\u20137\u00a0mm.", {"entities": []}], ["Furthermore, the dose-volume constraints to both the rectum and bladder were changed with the introduction of IG-IMRT.", {"entities": []}], ["The 2-year actuarial likelihood of developing grade\u2009>\u2009= 2 GI toxicity following RT was 57.3% in 3DCRT patients and 5.8% in IG-IMRT patients (p\u2009<\u20090.001).", {"entities": []}], ["For GU toxicity the numbers were 41.8% and 29.7%, respectively (p\u2009=\u20090.011).", {"entities": []}], ["On multivariate analysis, 3DCRT was associated with a significantly increased risk of developing grade\u2009>\u2009= 2 GI toxicity compared to IG-IMRT (p\u2009<\u20090.001, HR\u2009=\u200911.59 [CI: 6.67-20.14]).", {"entities": [[153, 155, "GENE"]]}], ["3DCRT was also associated with an increased risk of developing GU toxicity compared to IG-IMRT.", {"entities": []}], ["The 3-year actuarial biochemical progression-free survival probability was 86.0% for 3DCRT and 90.3% for IG-IMRT (p\u2009=\u20090.386).", {"entities": []}], ["On multivariate analysis there was no difference in biochemical progression-free survival between 3DCRT and IG-IMRT.", {"entities": []}], ["The difference in toxicity can be attributed to the combination of the IMRT technique with reduced dose to organs-at-risk, daily image guidance and margin reduction.", {"entities": []}], ["COPD-diagnosis is confirmed by post-bronchodilator (BD) spirometry.", {"entities": []}], ["However, epidemiological studies often rely on pre-BD spirometry, self-reports, or medical records.", {"entities": []}], ["This population-based study aims to determine COPD-prevalence based on four different operational definitions and their level of agreement, and to compare associations between COPD-definitions and risk factors.", {"entities": []}], ["COPD-prevalence in 1,793 adults from the general Dutch population (aged 18\u201370 years) was assessed based on self-reported data, Electronic Medical Records (EMR), and post-BD spirometry: using the FEV1/FVC below the lower limit of normal (LLN) and GOLD fixed cut-off (FEV1/FVC <0.70).", {"entities": []}], ["Using spirometry as a reference, sensitivity was calculated for self-reported and EMR-based COPD.", {"entities": []}], ["Associations between COPD and known risk factors were assessed with logistic regression.", {"entities": []}], ["Data were collected as part of the cross-sectional VGO study (Livestock Farming and Neighboring Residents\u2019 Health Study).", {"entities": []}], ["The highest prevalence was found based on spirometry (GOLD: 10.9%, LLN: 5.9%), followed by self-report (4.6%) and EMR (2.9%).", {"entities": []}], ["Self-reported or EMR-based COPD identified less than 30% of all COPD-cases based on spirometry.", {"entities": []}], ["The direction of association between known risk factors and COPD was similar across the four definitions, however, magnitude and significance varied.", {"entities": []}], ["Especially indicators of allergy were more strongly associated with self-reported COPD compared to the other definitions.", {"entities": []}], ["COPD-prevalence varied depending on the used definition.", {"entities": []}], ["A substantial number of subjects with spirometry-based COPD cannot be identified with questionnaires or medical records which can cause underestimation of COPD-prevalence.", {"entities": []}], ["The influence of the different COPD-definitions on associations with known risk factors was limited.", {"entities": []}], ["Unlike other essential organs, the heart does not undergo tissue repair following injury.", {"entities": []}], ["Human embryonic stem cells (hESCs) grow indefinitely in culture while maintaining the ability to differentiate into many tissues of the body.", {"entities": []}], ["As such, they provide a unique opportunity to explore the mechanisms that control human tissue development, as well as treat diseases characterized by tissue loss, including heart failure.", {"entities": []}], ["MicroRNAs are small, non-coding RNAs that are known to play critical roles in the regulation of gene expression.", {"entities": []}], ["We profiled the expression of microRNAs during hESC differentiation into myocardial precursors and cardiomyocytes (CMs), and determined clusters of human microRNAs that are specifically regulated during this process.", {"entities": []}], ["We determined that miR-125b overexpression results in upregulation of the early cardiac transcription factors, GATA4 and Nkx2-5, and accelerated progression of hESC-derived myocardial precursors to an embryonic CM phenotype.", {"entities": [[19, 27, "GENE"], [111, 116, "GENE"], [121, 127, "GENE"]]}], ["We used an in silico approach to identify Lin28 as a target of miR-125b, and validated this interaction using miR-125b knockdown.", {"entities": [[63, 71, "GENE"], [110, 118, "GENE"], [63, 71, "GENE"], [110, 118, "GENE"]]}], ["Anti-miR-125b inhibitor experiments also showed that miR-125b controls the expression of miRNA let-7d, likely through the negative regulatory effects of Lin28 on let-7.", {"entities": [[5, 13, "GENE"], [53, 61, "GENE"], [95, 101, "GENE"]]}], ["We then determined that miR-125b overexpression inhibits the expression of Nanog and Oct4 and promotes the onset of Brachyury expression, suggesting that miR-125b controls the early events of human CM differentiation by inhibiting hESC pluripotency and promoting mesodermal differentiation.", {"entities": [[24, 32, "GENE"], [154, 162, "GENE"], [75, 80, "GENE"], [24, 32, "GENE"], [154, 162, "GENE"]]}], ["These studies identified miR-125b as an important regulator of hESC differentiation in general, and the development of hESC-derived mesoderm and cardiac muscle in particular.", {"entities": [[25, 33, "GENE"]]}], ["Manipulation of miR-125b-mediated pathways may provide a novel approach to directing the differentiation of hESC-derived CMs for cell therapy applications.", {"entities": []}], ["Background Potentially inappropriate prescribing (PIP) [encompassing potentially inappropriate medicines (PIMs) and potential prescribing omissions (PPOs)], is prevalent amongst older adults in primary and secondary care.", {"entities": []}], ["However, PIP prevalence in intermediate care (IC) is unknown.", {"entities": []}], ["Objective To determine the prevalence of PIMs/PPOs and associated patient factors.", {"entities": []}], ["Setting Three IC facilities in Northern Ireland.", {"entities": []}], ["Method The Screening Tool of Older People\u2019s Prescriptions and the Screening Tool to Alert doctors to Right Treatment were used to identify PIP over 8\u00a0weeks.", {"entities": []}], ["Wilcoxon signed-rank tests were performed to compare the prevalence of PIMs/PPOs at admission and discharge.", {"entities": []}], ["Spearman\u2019s correlation coefficients were calculated to determine factors associated with PIMs/PPOs ( p \u00a0<\u00a00.05 considered significant).", {"entities": []}], ["Main outcome measure Prevalence of PIMs/PPOs.", {"entities": []}], ["Results 74 patients [mean age 83.5(\u00b17.4) years] were included.", {"entities": []}], ["Discharge medication data were available for 30 (40.5%) patients.", {"entities": []}], ["53 (71.6%) and 22 (73.3%) patients had \u22651 PIM at admission and discharge, respectively.", {"entities": []}], ["45 (60.8%) and 15 (50.0%) patients had \u22651 PPO at admission and discharge, respectively.", {"entities": []}], ["No significant difference was found in PIM/PPO prevalence at admission compared to discharge (Z\u00a0=\u00a0\u22120.36, p \u00a0=\u00a00.72; Z\u00a0=\u00a0\u22121.63, p \u00a0=\u00a00.10).", {"entities": []}], ["Increasing comorbidity and medication regimen complexity were associated with PIMs at admission (r\u00a0=\u00a00.265, p \u00a0=\u00a00.023; r\u00a0=\u00a00.338 p \u00a0=\u00a00.003).", {"entities": []}], ["The number of medicines was correlated with PIMs at admission (r\u00a0=\u00a00.391, p \u00a0=\u00a00.001) and discharge (r\u00a0=\u00a00.515, p \u00a0=\u00a00.004).", {"entities": []}], ["Conclusion Whilst IC represents an ideal setting in which to review prescribing, this study found PIP to be highly prevalent in older adults in IC, with no detectably significant change in prevalence between admission to and discharge from this setting.", {"entities": []}], ["Respiratory syncytial virus (RSV) infection in preterm and newborn infants can result in severe bronchiolitis and hospitalization.", {"entities": [[96, 109, "DISEASE"]]}], ["The lamb lung has several key features conducive to modeling RSV infection in human infants, including susceptibility to human strains of RSV such as the A2, Long, and Memphis Strain 37 (M37).", {"entities": []}], ["In this study, the kinetics of M37 infection was investigated in newborn lambs in order to better define clinical, viral, physiological, and immunological parameters as well as the pathology and lesions.", {"entities": []}], ["Newborn lambs were nebulized with M37 hRSV (6 mL of 1.27 x 10 Lambs had increased expiratory effort (forced expiration) at days 4, 6, and 8 post-inoculation.", {"entities": []}], ["Nasal wash lacked RSV titers at day 1, but titers were present at low levels at days 3 (peak), 4, and 8.", {"entities": []}], ["Viral titers in bronchoalveolar lavage fluid (BALF) reached a plateau at day 3 (4.6 Log 10 FFU/mL), which was maintained until day 6 (4.83 Log 10 FFU/mL), and were markedly reduced or absent at day 8.", {"entities": []}], ["Viral RNA levels (detected by RT-qPCR) in BALF were indistinguishable at days 3 (6.22 \u00b1 0.08 Log 10 M37 RNA copies/mL; mean \u00b1 se) and 4 (6.20 \u00b1 0.16 Log 10 M37 RNA copies/mL; mean \u00b1 se) and increased slightly on day 6 (7.15 \u00b1 0.2 Log 10 M37 RNA copies/mL; mean \u00b1 se).", {"entities": []}], ["Viral antigen in lung tissue as detected by immunohistochemistry was not seen at day 1, was present at days 3 and 4 before reaching a peak by day 6, and was markedly reduced by day 8.", {"entities": []}], ["Viral antigen was mainly present in airways (bronchi, bronchioles) at day 3 and was increasingly present in alveolar cells at days 4 and 6, with reduction at day 8.", {"entities": []}], ["Histopathologic lesions such as bronchitis/bronchiolitis, epithelial necrosis and hyperplasia, peribronchial lymphocyte infiltration, and syncytial cells, were consistent with those described previously for lambs and infants.", {"entities": [[43, 56, "DISEASE"], [32, 42, "DISEASE"]]}], ["This work demonstrates that M37 hRSV replication in the lower airways of newborn lambs is robust with peak replication on day 3 and sustained until day 6.", {"entities": []}], ["These findings, along with the similarities of lamb lung to those of infants in terms of alveolar development, airway branching and epithelium, susceptibility to human RSV strains, lesion characteristics (bronchiolitis), lung size, clinical parameters, and immunity, further establish the neonatal lamb as a model with key features that mimic RSV infection in infants.", {"entities": [[205, 218, "DISEASE"]]}], ["Men and women differ in the risk of cardiovascular disease, but the underlying mechanisms are not completely understood.", {"entities": []}], ["We examined possible sex\u2010related differences in supine and upright cardiovascular regulation.", {"entities": []}], ["Hemodynamics were recorded from 167 men and 167 women of matching age (\u224845\u00a0years) and body mass index (\u224826.5) during passive head\u2010up tilt.", {"entities": []}], ["None had diabetes mellitus or cardiovascular disease other than hypertension or used antihypertensive medication.", {"entities": [[64, 76, "DISEASE"], [9, 26, "DISEASE"]]}], ["Whole\u2010body impedance cardiography, tonometric radial blood pressure, and heart rate variability were analyzed.", {"entities": []}], ["Results were adjusted for height, smoking, alcohol intake, mean arterial pressure, plasma lipids, and glucose.", {"entities": []}], ["Supine hemodynamic differences were minor: Men had lower heart rate (\u22124%) and higher stroke index (+7.5%) than women ( P <0.05 for both).", {"entities": []}], ["Upright systemic vascular resistance was lower (\u221210%), but stroke index (+15%), cardiac index (+16%), and left cardiac work were clearly higher (+20%) in men than in women ( P <0.001 for all).", {"entities": []}], ["Corresponding results were observed in a subgroup of men and postmenopausal women (n=76, aged >55\u00a0years).", {"entities": []}], ["Heart rate variability analyses showed higher low:high frequency ratios in supine ( P <0.001) and upright ( P =0.003) positions in men.", {"entities": []}], ["The foremost difference in cardiovascular regulation between sexes was higher upright hemodynamic workload for the heart in men, a finding not explained by known cardiovascular risk factors or hormonal differences before menopause.", {"entities": []}], ["Heart rate variability analyses indicated higher sympathovagal balance in men regardless of body position.", {"entities": []}], ["The deviations in upright hemodynamics could play a role in the differences in cardiovascular risk between men and women.", {"entities": []}], ["URL: http://www.clinicaltrials.gov .", {"entities": []}], ["Unique identifier: NCT 01742702.", {"entities": []}], ["High-heeled shoes (high heels) are frequently worn by many women and form an important part of female gender identity.", {"entities": []}], ["Issues of explicit and implicit compulsion to wear high heels have been noted.", {"entities": []}], ["Previous studies and reviews have provided evidence that high heels are detrimental to health.", {"entities": []}], ["However, the evidence base remains fragmented and no review has covered both the epidemiological and biomechanical literature.", {"entities": []}], ["In addition, no review has considered the psychosexual benefits that offer essential context in understanding the public health challenge of high heels.", {"entities": []}], ["We searched seven major bibliographic databases up to November 2016, in addition to supplementary searches.", {"entities": []}], ["We initially identified all review articles of any design that assessed either the psychosexual benefits or negative musculoskeletal health effects of high heels, the latter looking at both the epidemiological and biomechanical perspectives.", {"entities": []}], ["We additionally considered additional primary studies on areas that had not been reviewed before or in which a marked lack of evidence had been noted.", {"entities": []}], ["Data were extracted onto standardised forms.", {"entities": []}], ["Proportionate second review was conducted.", {"entities": []}], ["A total of 506 unique records were identified, 27 full-text publications were screened and 20 publications (7 reviews and 13 additional studies) were included in our evidence synthesis.", {"entities": []}], ["The most up-to-date epidemiological review provides clear evidence of an association between high heel wear and hallux valgus, musculoskeletal pain and first-party injury.", {"entities": []}], ["The body of biomechanical reviews provides clear evidence of changes indicative of increased risk of these outcomes, as well as osteoarthritis, which is not yet evidenced by epidemiological studies.", {"entities": [[128, 142, "DISEASE"]]}], ["There were no reviews on psychosexual benefits, but all five identified original studies provided evidence of increased attractiveness and/or an impact on men\u2019s behaviour associated with high heel wear.", {"entities": []}], ["With regard to second-party injury, evidence is limited to one descriptive study and eight case reports.", {"entities": []}], ["Our evidence synthesis clearly shows that high heels bring psychosexual benefits to women but are detrimental to their health.", {"entities": []}], ["In light of this dilemma, it is important that women\u2019s freedom of choice is respected and that any remaining issues of explicit or implicit compulsion are addressed.", {"entities": []}], ["Commotio cordis is blunt, nonpenetrating trauma to the chest resulting in irregular heart rhythm and often leading to sudden death.", {"entities": []}], ["This article presents the epidemiology, variables leading to commotio cordis, theories on predisposing factors, diagnosis, treatment, treatment outcomes, and return-to-play recommendations.", {"entities": []}], ["A PubMed (MEDLINE) search for commotio cordis was conducted on July 1, 2008, and it yielded 106 results, of which 26 were used for this review, including experimental models, simulation studies, case analysis studies, case reports, general recommendation, review articles, and editorials.", {"entities": []}], ["There are more than 190 reported cases of commotio cordis in the United States.", {"entities": []}], ["Forty-seven percent of reported cases occurred during athletic participation.", {"entities": []}], ["Commotio cordis is the second-most common cause of sudden cardiac death in athletes.", {"entities": []}], ["Occurrence of commotio cordis is related to time of impact during the cardiac cycle, direct impact over the heart, the hardness and speed of the projectile, and the ineffectiveness of chest barriers.", {"entities": []}], ["As a result, the US Consumer Product Safety Commission recommends that softer \u201csafety\u201d baseballs be used for youth baseball.", {"entities": []}], ["Resuscitation using defibrillation was effective in only 15% of cases.", {"entities": []}], ["Resuscitation within 3 minutes resulted in a survival rate of 25% (17 of 68 cases).", {"entities": []}], ["Survival drops to 3% when resuscitation is delayed beyond 3 minutes.", {"entities": []}], ["Survival of commotio cordis has risen from 10% to 15% since 2001.", {"entities": []}], ["Reduced ventricular ejection fraction has been identified in some commotio cordis survivors.", {"entities": []}], ["Preventive measures, such as using soft \u201csafety\u201d balls and making automated external defibrillators available at sporting venues, can reduce commotio cordis morbidity and mortality.", {"entities": []}], ["Chest protector designs can be improved to enhance protection.", {"entities": []}], ["Return to play is best left to clinical judgment given that data are lacking with regard to susceptibility for reoccurrence.", {"entities": []}], ["Oxidant production from DUOX1 has been proposed to lead to neutrophil recruitment into the airways when lung homeostasis is compromised.", {"entities": [[24, 29, "GENE"]]}], ["The objective of this study was to determine whether DUOX-derived hydrogen peroxide is required for LPS-induced neutrophil recruitment, using a functional DUOX knock out mouse model.", {"entities": []}], ["We found that LPS induced profound neutrophilic lung inflammation in both Duoxa+/+ and Duoxa-/- mice between 3h and 24h.", {"entities": []}], ["Duoxa-/- mice had significantly higher neutrophil influx 24h after LPS instillation despite similar cytokine levels (KC, MIP-2, or TGF-\u03b1) between the two groups.", {"entities": []}], ["These findings suggest that LPS-TLR-4-induced KC or MIP-2 cytokine induction and subsequent neutrophil recruitment in the airway does not require DUOX-derived hydrogen peroxide from airway epithelium.", {"entities": []}], ["IgE antibody-mediated allergies affect more than 25% of the population worldwide.", {"entities": []}], ["To investigate therapeutic and preventive effects of passive immunization with allergen-specific IgG antibodies on allergy in mouse models we used clinically relevant pollen allergens.", {"entities": []}], ["In a treatment model, mice were sensitized to the major birch pollen allergen Bet v 1 and to the major grass pollen allergens, Phl p 1 and Phl p 5 and then received passive immunization with rabbit IgG antibodies specific for the sensitizing or an unrelated allergen.", {"entities": []}], ["In a prevention model, mice obtained passive immunization with allergen-specific rabbit IgG before sensitization.", {"entities": []}], ["Kinetics of the levels of administered IgG antibodies, effects of administered allergen-specific IgG on allergen-specific IgE reactivity, the development of IgE and IgG responses and on immediate allergic reactions were studied by ELISA, rat basophil leukaemia degranulation assays and skin testing, respectively.", {"entities": []}], ["Treated mice showed an approximately 80% reduction of allergen-specific IgE binding and basophil degranulation which was associated with the levels of administered allergen-specific IgG antibodies.", {"entities": []}], ["Preventive administration of allergen-specific IgG antibodies suppressed the development of allergen-specific IgE and IgG 1 antibody responses as well as allergen-induced basophil degranulation and skin reactivity.", {"entities": []}], ["Our results show that passive immunization with allergen-specific IgG antibodies is effective for treatment and prevention of allergy to clinically important pollen allergens in a mouse model and thus may pave the road for the clinical application of allergen-specific antibodies in humans.", {"entities": []}], ["Smoking is a leading cause of respiratory infections worldwide.", {"entities": []}], ["Tobacco particulate matter disrupts iron homeostasis in the lungs and increases the iron content in the airways of smokers.", {"entities": []}], ["The airway epithelia secrete lactoferrin to quench iron required for bacteria to proliferate and cause lung infections.", {"entities": []}], ["We hypothesized that smokers would have increased bacterial growth and biofilm formation via iron lactoferrin imbalance.", {"entities": []}], ["We collected bronchoalveolar lavage (BAL) samples from non-smokers and smokers.", {"entities": []}], ["We challenged these samples using a standard inoculum of Staphylococcus aureus and Pseudomonas aeruginosa and quantified bacterial growth and biofilm formation.", {"entities": []}], ["We measured both iron and lactoferrin in the samples.", {"entities": []}], ["We investigated the effect of supplementing non-smoker BAL with cigarette smoke extract (CSE) or ferric chloride and the effect of supplementing smoker BAL with lactoferrin on bacterial growth and biofilm formation.", {"entities": []}], ["BAL from smokers had increased bacterial growth and biofilm formation compared to non-smokers after both S. aureus and P. aeruginosa challenge.", {"entities": []}], ["In addition, we found that samples from smokers had a higher iron to lactoferrin ratio.", {"entities": []}], ["Supplementing the BAL of non-smokers with cigarette smoke extract and ferric chloride increased bacterial growth.", {"entities": []}], ["Conversely, supplementing the BAL of smokers with lactoferrin had a concentration-dependent decrease in bacterial growth and biofilm formation.", {"entities": []}], ["Cigarette smoking produces factors which increase bacterial growth and biofilm formation in the BAL.", {"entities": []}], ["We propose that smoking disrupts the iron-to-lactoferrin in the airways.", {"entities": []}], ["This finding offers a new avenue for potential therapeutic interventions to prevent respiratory infections in smokers.", {"entities": []}], ["The online version of this article (10.1186/s12931-018-0743-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Francisella tularensis (Ft) causes a frequently fatal, acute necrotic pneumonia in humans and animals.", {"entities": [[70, 79, "DISEASE"]]}], ["Following lethal Ft infection in mice, infiltration of the lungs by predominantly immature myeloid cells and subsequent myeloid cell death drive pathogenesis and host mortality.", {"entities": []}], ["However, following sub-lethal Ft challenge, more mature myeloid cells are elicited and are protective.", {"entities": []}], ["In addition, inflammasome-dependent IL-1\u03b2 and IL-18 are important for protection.", {"entities": []}], ["As Nlrp3 appears dispensable for resistance to infection with Francisella novicida , we considered its role during infection with the virulent Type A strain SchuS4 and the attenuated Type B live vaccine strain LVS.", {"entities": [[3, 8, "GENE"]]}], ["Here we show that both in vitro macrophage and in vivo IL-1\u03b2 and IL-18 responses to Ft LVS and SchuS4 involve both the Aim2 and Nlrp3 inflammasomes.", {"entities": [[119, 123, "GENE"], [128, 133, "GENE"]]}], ["However, following lethal infection with Francisella, IL-1r-, Caspase-1/11-, Asc- and Aim2-deficient mice exhibited increased susceptibility as expected, while Nlrp3-deficient mice were more resistant.", {"entities": []}], ["Despite reduced levels of IL-1\u03b2 and IL-18, in the absence of Nlrp3, Ft infected mice have dramatically reduced lung pathology, diminished recruitment and death of immature myeloid cells, and reduced bacterial burden in comparison to wildtype and inflammasome-deficient mice.", {"entities": [[61, 66, "GENE"]]}], ["Further, increased numbers of mature neutrophil appear in the lung early during lethal Ft infection in Nlrp3-deficient mice.", {"entities": []}], ["Finally, Ft infection induces myeloid and lung stromal cell death that in part requires Nlrp3, is necrotic/necroptotic in nature, and drives host mortality.", {"entities": [[88, 93, "GENE"]]}], ["Thus, Nlrp3 mediates an inflammasome-independent process that restricts the appearance of protective mature neutrophils and promotes lethal necrotic lung pathology.", {"entities": [[6, 11, "GENE"]]}], ["The Nlrp3 inflammasome is critical for various innate and adaptive immune responses through elaboration of IL-1\u03b2 and IL-18.", {"entities": [[4, 9, "GENE"]]}], ["In contrast to the anticipated minimal, or perhaps absent, role of Nlrp3 in the pathogenesis of pulmonary tularemia, we find that Nlrp3 is a host susceptibility factor.", {"entities": [[106, 115, "DISEASE"], [67, 72, "GENE"], [130, 135, "GENE"], [67, 72, "GENE"], [130, 135, "GENE"]]}], ["Likely through promoting necrotic/necroptotic cell death, Nlrp3 contributes to the immature myeloid response and necrotic pathology that characterize lethal infection with Francisella tularensis.", {"entities": [[58, 63, "GENE"]]}], ["Citrus red mite (CRM) is known as the most common sensitizing allergen in subjects with asthma and rhinitis working on citrus farms.", {"entities": [[99, 107, "DISEASE"], [88, 94, "DISEASE"]]}], ["The aim of this study is to evaluate the role of specific IgG1 (slgG1) and specific IgG4 (slgG4) to CRM in citrus farmers.", {"entities": []}], ["Questionnaire survey and skin prick test including CRM antigen was done by 136 workers.", {"entities": []}], ["Specific IgE (slgE), slgG1 and slgG4 to CRM were detected by enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["CRM-sensitive-asthma was diagnosed upon presence of asthmatic symptoms by questionnaire, airway hyperresponsiveness to methacholine and slgE to CRM.", {"entities": [[14, 20, "DISEASE"]]}], ["CRM-sensitive rhinitis was diagnosed upon presence of rhinitis symptoms and slgE to CRM.", {"entities": [[14, 22, "DISEASE"], [54, 62, "DISEASE"]]}], ["Eleven (8.1%) had CRM-sensitive asthma and 25 (18.4%) had CRM-sensitive rhinitis.", {"entities": [[72, 80, "DISEASE"], [32, 38, "DISEASE"]]}], ["Significant association was noted between presence of asthmatic symptoms and slgE or slgG4 (p<0.05, respectively), while no significant association was noted in slgG1 (p>0.05).", {"entities": []}], ["Significant association was noted in the prevalence between slgG4 and slgE (p<0.05), while no significant association was noted between slgG1 and slgG4 or slgE (p<0.05, respectively).", {"entities": []}], ["There was a significant correlation between slgE and slgG4 level (r=0.39, p<0.05).", {"entities": []}], ["These findings suggest that the presence of slgG1 to CRM is response to CRM exposure, and further studies will be needed to evaluate the role of slgG4.", {"entities": []}], ["Community acquired pneumonia (CAP) is a major cause of morbidity and mortality.", {"entities": [[19, 28, "DISEASE"]]}], ["While there is much data about risk factors for severe outcome in the general population, there is less focus on younger group of patients.", {"entities": []}], ["Therefore, we aimed to detect simple prognostic factors for severe morbidity and mortality in young patients with CAP.", {"entities": []}], ["Patients of 60 years old or younger, who were diagnosed with CAP (defined as pneumonia identified 48 hours or less from hospitalization) between March 1, 2005 and December 31, 2008 were retrospectively analyzed for risk factors for complicated hospitalization and 90-day mortality.", {"entities": [[77, 86, "DISEASE"]]}], ["The cohort included 637 patients.", {"entities": []}], ["90-day mortality rate was 6.6% and the median length of stay was 5 days.", {"entities": []}], ["In univariate analysis, male patients and those with co-morbid conditions tended to have complicated disease.", {"entities": []}], ["In multivariate analysis, variables associated with complicated hospitalization included post chest radiation state, prior neurologic damage, blood urea nitrogen (BUN) > 10.7 mmol/L and red cell distribution width (RDW) > 14.5%; whereas, variables associated with an increased risk of 90-day mortality included age \u2265 51 years, prior neurologic damage, immunosuppression, and the combination of abnormal white blood cells (WBC) and elevated RDW.", {"entities": []}], ["Complicated hospitalization and mortality rate were significantly higher among patients with increased RDW regardless of the white blood cell count.", {"entities": []}], ["Elevated RDW was associated with a significant increase in complicated hospitalization and 90-day mortality rates irrespective to hemoglobin levels.", {"entities": []}], ["In young patients with CAP, elevated RDW levels are associated with significantly higher rates of mortality and severe morbidity.", {"entities": []}], ["RDW as a prognostic marker was unrelated with hemoglobin levels.", {"entities": []}], ["ClinicalTrials.Gov NCT00845312", {"entities": []}], ["HVC1, a novel formation containing four herbs, was developed and its hypolipidemic effects in rats with high cholesterol diet (HCD)-induced hyperlipidemia were investigated.", {"entities": []}], ["The rats were given a HCD for 8 weeks.", {"entities": []}], ["The HVC1-treated groups were orally administered HVC1 at doses of 10, 50 or 250 mg/kg, respectively, and the simvastatin group was treated at a dose of 10 mg/kg.", {"entities": []}], ["The normal diet and HCD control groups were administered with physiological saline.", {"entities": []}], ["Oral administration of HVC1 (10, 50 or 250 mg/kg) significantly reduced the body weight of rats with hyperlipidemia and regulated the total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol levels in the serum.", {"entities": []}], ["In addition, tissue analysis revealed that lipid accumulation in the liver and aorta was reduced by HVC1 administration.", {"entities": []}], ["Furthermore, HVC1 significantly reduced the mRNA expression of peroxisome proliferator-activated receptor-\u03b3, 3-hydroxy-3-methylglutaryl-CoA reductase and low-density lipoprotein receptor, as well as the protein level of 5\u2032 adenosine monophosphate-activated protein kinase in the liver.", {"entities": []}], ["The results clearly demonstrate that HVC1 has a potent hypolipidemic effect, and suggest that HVC1 should be evaluated as a potential treatment for hyperlipidemia.", {"entities": []}], ["For specific immunotherapy to pollen allergy, a pre-seasonal start of treatment is recommended by international guidelines.", {"entities": []}], ["In a placebo-controlled clinical trial with adults, an intra-seasonal start of therapy with the SQ-standardised grass allergy immunotherapy tablet (AIT) was well-tolerated.", {"entities": []}], ["The objective of our study was to investigate the feasibility of an intra-seasonal start of grass AIT administered during routine treatment by practising allergists.", {"entities": []}], ["In a multicentre, prospective, open-label, uncontrolled, non-interventional observational study, data on routine treatment with grass AIT were recorded in patients who started administration of tablets within the 2010 grass pollen season in Germany.", {"entities": []}], ["Adverse events (AEs) were recorded by the physician at visits for the first administration in the clinic and at the end of the 1- to 3-month observation period.", {"entities": []}], ["AEs and daily administration of the tablet were recorded by the patients in diaries for the first 14 days.", {"entities": []}], ["Treatment satisfaction, global tolerability and perceived effect of treatment were assessed by the patient and physician at the end of the study.", {"entities": []}], ["A total of 662 patients were treated with 1 tablet daily by 286 physicians.", {"entities": []}], ["Grass AIT was started intra-seasonally in 620 patients and post-season in 42.", {"entities": []}], ["The average treatment period was 51.6 days.", {"entities": []}], ["AEs were recorded in 52.1\u00a0% of all patients and in 35.6\u00a0% at first administration, with throat irritation (21.3\u00a0%), paraesthesia oral (19.9\u00a0%), oral pruritus (14.0\u00a0%) and ear pruritus (10.3\u00a0%) being the most frequent AEs related to grass AIT.", {"entities": []}], ["The intensity of the AEs was assessed as mild or moderate in 42.1\u00a0% of patients and severe in 8.0\u00a0%; AEs related to grass AIT were classified as serious in two patients.", {"entities": []}], ["Grass AIT was discontinued due to AEs in 7.7\u00a0% of patients.", {"entities": []}], ["Diaries were evaluable for 77.0\u00a0% of patients; the average rate of patients with AEs decreased continuously from 44.7\u00a0% (day 1) to 26.9\u00a0% (day 14) and the average daily rate of patients who forgot to take their tablet was about 5\u00a0%.", {"entities": []}], ["Overall tolerability was assessed by 87.2\u00a0% of patients and 91.4\u00a0% physicians as \u201cvery good\u201d or \u201cgood\u201d and effectiveness of treatment was assessed as \u201cvery good\u201d or \u201cgood\u201d in 81.4\u00a0% of patients and 85.8\u00a0% of physicians.", {"entities": []}], ["More than 90\u00a0% of patients and physicians were satisfied with the treatment.", {"entities": []}], ["The tolerability data for an intra-seasonal start of grass AIT during routine treatment confirm the safety profile from the previous controlled trial.", {"entities": []}], ["Tolerability was assessed as good in combination with high satisfaction with the treatment and compliance.", {"entities": []}], ["Background: In the city of New Orleans, Louisiana, and surrounding parishes (NOLA), children with asthma were perilously impacted by Hurricane Katrina as a result of disrupted health care, high home mold and allergen levels, and high stress.", {"entities": [[98, 104, "DISEASE"]]}], ["Objectives: The Head-off Environmental Asthma in Louisiana (HEAL) study was conducted to examine relationships between the post-Katrina environment and childhood asthma in NOLA and assess a novel asthma counselor intervention that provided case management and guidance for reducing home mold and allergen levels.", {"entities": [[39, 45, "DISEASE"], [162, 168, "DISEASE"], [196, 202, "DISEASE"]]}], ["Methods: Children (4\u201312 years old) with moderate-to-severe asthma were recruited from NOLA schools.", {"entities": [[59, 65, "DISEASE"]]}], ["Over 1 year, they received two clinical evaluations, three home environmental evaluations, and the asthma intervention.", {"entities": [[99, 105, "DISEASE"]]}], ["Quarterly end points included symptom days, medication use, and unscheduled emergency department or clinic visits.", {"entities": []}], ["A community advisory group was assembled and informed HEAL at all phases.", {"entities": []}], ["Results: Of the children ( n = 182) enrolled in HEAL, 67% were African American, and 25% came from households with annual incomes < $15,000.", {"entities": []}], ["HEAL children were symptomatic, averaging 6.6 symptom days in the 2 weeks before baseline, and had frequent unscheduled visits to clinics or emergency departments (76% had at least one unscheduled visit in the preceding 3 months).", {"entities": []}], ["In this report, we describe study design and baseline characteristics of HEAL children.", {"entities": []}], ["Conclusions: Despite numerous challenges faced by investigators, study staff, and participants, including destroyed infrastructure, disrupted lives, and lost jobs, HEAL was successful in terms of recruitment and retention, the high quality of data collected that will provide insight into asthma-allergen relationships, and the asthma intervention.", {"entities": [[289, 295, "DISEASE"], [328, 334, "DISEASE"]]}], ["This success was attributable to using an adaptive approach and refining processes as needed.", {"entities": []}], ["\u201cPatient activation\u201d reflects involvement in managing ones health.", {"entities": []}], ["This cross-sectional study assessed the psychometric properties of the Hebrew translation (PAM-H) of the PAM-13.", {"entities": []}], ["A nationally representative sample of 203 Hebrew-speaking Israeli adults answered the PAM-H, PHQ-9 depression scale, SF-12, and Self-efficacy Scale via telephone.", {"entities": []}], ["Mean PAM-H scores were 70.7\u00b115.4.", {"entities": []}], ["Rasch analysis indicated that the PAM-H is a good measure of activation.", {"entities": []}], ["There were no differences in PAM-H scores based on gender, age or education.", {"entities": []}], ["Subjects with chronic disease scored lower than those without.", {"entities": []}], ["Scores correlated with the Self-efficacy Scale (0.47), Total SF-12 (0.39) and PHQ-9 (\u22120.35, P<0.0001), indicating concurrent validity.", {"entities": []}], ["Discriminant validity was reflected by a significant difference in the mean PAM-H score of those who scored below 10 (72.1\u00b114.8) on the PHQ-9 (not depressed) compared to those scoring \u226510 (i.e.", {"entities": []}], ["probable depression) (59.2\u00b115.8; t 3.75; P\u200a=\u200a0.001).", {"entities": []}], ["The PAM-H psychometric properties indicate its usefulness with the Hebrew-speaking Israeli population.", {"entities": []}], ["PAM-H can be useful for assessing programs aimed at effecting changes in patient compliance, health behaviors, etc.", {"entities": []}], ["Researchers in Israel should use a single translation of the PAM-13 so that findings can be compared, increasing understanding of patient activation.", {"entities": []}], ["Lucanthone and hycanthone are thioxanthenone DNA intercalators used in the 1980s as antitumor agents.", {"entities": []}], ["Lucanthone is in Phase I clinical trial, whereas hycanthone was pulled out of Phase II trials.", {"entities": []}], ["Their potential mechanism of action includes DNA intercalation, inhibition of nucleic acid biosyntheses, and inhibition of enzymes like topoisomerases and the dual function base excision repair enzyme apurinic endonuclease 1 (APE1).", {"entities": []}], ["Lucanthone inhibits the endonuclease activity of APE1, without affecting its redox activity.", {"entities": []}], ["Our goal was to decipher the precise mechanism of APE1 inhibition as a prerequisite towards development of improved therapeutics that can counteract higher APE1 activity often seen in tumors.", {"entities": []}], ["The IC 50 values for inhibition of APE1 incision of depurinated plasmid DNA by lucanthone and hycanthone were 5 \u00b5M and 80 nM, respectively.", {"entities": []}], ["The K D values (affinity constants) for APE1, as determined by BIACORE binding studies, were 89 nM for lucanthone/10 nM for hycanthone.", {"entities": []}], ["APE1 structures reveal a hydrophobic pocket where hydrophobic small molecules like thioxanthenones can bind, and our modeling studies confirmed such docking.", {"entities": []}], ["Circular dichroism spectra uncovered change in the helical structure of APE1 in the presence of lucanthone/hycanthone, and notably, this effect was decreased (Phe266Ala or Phe266Cys or Trp280Leu) or abolished (Phe266Ala/Trp280Ala) when hydrophobic site mutants were employed.", {"entities": []}], ["Reduced inhibition by lucanthone of the diminished endonuclease activity of hydrophobic mutant proteins (as compared to wild type APE1) supports that binding of lucanthone to the hydrophobic pocket dictates APE1 inhibition.", {"entities": []}], ["The DNA binding capacity of APE1 was marginally inhibited by lucanthone, and not at all by hycanthone, supporting our hypothesis that thioxanthenones inhibit APE1, predominantly, by direct interaction.", {"entities": []}], ["Finally, lucanthone-induced degradation was drastically reduced in the presence of short and long lived free radical scavengers, e.g., TRIS and DMSO, suggesting that the mechanism of APE1 breakdown may involve free radical-induced peptide bond cleavage.", {"entities": []}], ["Most common plant oils have little \u03b1-linolenic acid (C18:3 Paeonia L., including 10 tree peony and one herbaceous species, were explored using gas chromatograph\u2013mass spectrometer.", {"entities": []}], ["Results indicated that all Paeonia had a \u03c96/\u03c93 ratio less than 1.0, and high amounts of ALA (26.7\u201350%), oleic acid (C18:1 Vaginatae species, whereas OA was predominant in two subsection Delavayanae species.", {"entities": []}], ["LA was a subdominant oil component in P. ostii and P. obovata .", {"entities": []}], ["Moreover, the FA composition and distribution of embryo (22 FAs), endosperm (14 FAs) and seed coat (6 FAs) in P. ostii , P. rockii and P. ludlowii were first reported.", {"entities": [[60, 63, "GENE"], [80, 83, "GENE"], [102, 105, "GENE"], [60, 63, "GENE"], [80, 83, "GENE"], [102, 105, "GENE"], [60, 63, "GENE"], [80, 83, "GENE"], [102, 105, "GENE"]]}], ["Peony species, particularly P. decomposita and P. rockii , can be excellent plant resources for edible oil because they provide abundant ALA to balance the \u03c96/\u03c93 ratio.", {"entities": []}], ["The differences in the ALA, LA and OA content proportion also make the peony species a good system for detailed investigation of FA biosynthesis pathway and ALA accumulation.", {"entities": []}], ["The association between daily cardiovascular/respiratory mortality and air pollution in an urban district of Beijing was investigated over a 6-year period (January 2003 to December 2008).", {"entities": []}], ["The purpose of this study was to evaluate the relative importance of the major air pollutants [particulate matter (PM), SO 2 , NO 2 ] as predictors of daily cardiovascular/respiratory mortality.", {"entities": []}], ["The time-series studied comprises years with lower level interventions to control air pollution (2003\u20132006) and years with high level interventions in preparation for and during the Olympics/Paralympics (2007\u20132008).", {"entities": []}], ["Concentrations of PM 10 , SO 2 , and NO 2 , were measured daily during the study period.", {"entities": []}], ["A generalized additive model was used to evaluate daily numbers of cardiovascular/respiratory deaths in relation to each air pollutant, controlling for time trends and meteorological influences such as temperature and relative humidity.", {"entities": []}], ["The results show that the daily cardiovascular/respiratory death rates were significantly associated with the concentration air pollutants, especially deaths related to cardiovascular disease.", {"entities": []}], ["The current day effects of PM 10 and NO 2 were higher than that of single lags (distributed lags) and moving average lags for respiratory disease mortality.", {"entities": []}], ["The largest RR of SO 2 for respiratory disease mortality was in Lag02.", {"entities": []}], ["For cardiovascular disease mortality, the largest RR was in Lag01 for PM 10 , and in current day (Lag0) for SO 2 and NO 2 .", {"entities": []}], ["NO 2 was associated with the largest RRs for deaths from both cardiovascular disease and respiratory disease.", {"entities": []}], ["Background .", {"entities": []}], ["The CD14 gene has an important role in the detection of inflammatory provoking pathogens and in the ensuing signaling of the innate immune response.", {"entities": [[4, 8, "GENE"]]}], ["We assessed the role of CD14 C-159T, G-1359T in the expression of asthma, croup, and allergy in Canadian school children of ages 6 to 14 years.", {"entities": [[74, 79, "DISEASE"], [66, 72, "DISEASE"], [24, 28, "GENE"]]}], ["Children attending schools in a rural community participated in a cross-sectional survey of respiratory health.", {"entities": []}], ["Following consent, we conducted clinical assessments to collect buccal swabs for genotyping and perform skin prick testing (SPT) to determine atopic status.", {"entities": []}], ["Genotyping and SPT results were available for 533 and 499 children, respectively.", {"entities": []}], ["Separate multivariable analyses that included both polymorphisms were conducted for each phenotype.", {"entities": []}], ["The prevalence of asthma, allergy, and croup was 18.6%, 22.4%, and 6.6%, respectively.", {"entities": [[39, 44, "DISEASE"], [18, 24, "DISEASE"]]}], ["Children with the T/T variant of CD14 G-1359T were more likely to have physician diagnosed asthma (26.8%).", {"entities": [[91, 97, "DISEASE"], [33, 37, "GENE"]]}], ["Children with C/C variant of CD14 C-159T had a significantly lower prevalence of croup (2.6%).", {"entities": [[81, 86, "DISEASE"], [29, 33, "GENE"]]}], ["Haplotype analyses of the two CD14 polymorphisms showed that individuals with the T|T haplotype combination were significantly more likely to have asthma ( P = 0.014).", {"entities": [[147, 153, "DISEASE"], [30, 34, "GENE"]]}], ["Conclusions .", {"entities": []}], ["In this study, CD14 variants are important for the expression of croup and asthma but not atopy.", {"entities": [[65, 70, "DISEASE"], [75, 81, "DISEASE"], [15, 19, "GENE"]]}], ["Tobacco consumption is a major risk factor for morbidity and mortality.", {"entities": []}], ["The Saudi Ministry of Health started a national tobacco control program in 2002 with increased and intensified efforts after joining the World Health Organization Framework Convention for Tobacco Control in 2005.", {"entities": []}], ["In order to assess the status of tobacco consumption in the Kingdom of Saudi Arabia (KSA), we conducted a survey on 10735 individuals aged 15\u00a0years or older (5253 men and 5482 women) which was performed between April and June 2013.", {"entities": []}], ["The Saudi Health Interview Survey had a multistage sampling and was nationally representative.", {"entities": []}], ["Data were collected through face-to-face interviews.", {"entities": []}], ["The survey included questions on socio-demographic characteristics, tobacco consumption, diet, physical activity, health care utilization, different health-related behaviors, and self-reported chronic conditions.", {"entities": []}], ["Overall prevalence of current smoking was 12.2\u00a0% and males were more likely to smoke than females (21.5\u00a0% vs. 1.1\u00a0%).", {"entities": []}], ["Mean age of smoking initiation was 19.1\u00a0years (\u00b16.5\u00a0years) with 8.9\u00a0% of ever smokers starting before the age of 15\u00a0years.", {"entities": []}], ["Daily shisha smoking was reported by 4.3\u00a0% of the population (7.3\u00a0% of men and 1.3\u00a0% of women).", {"entities": []}], ["Around 1.4\u00a0% of population (2.6\u00a0% of men and 0.1\u00a0% of women) were daily smokers of cigarette/cigar and shisha.", {"entities": []}], ["Receiving advice for quitting smoking by health care professionals during the last 12\u00a0months was reported by 53.2\u00a0% (95\u00a0% confidence interval [CI]: 49.8\u201356.5) of ever smokers.", {"entities": []}], ["Among ever smokers, 51.3\u00a0% of individuals reportedly attempted to quit smoking during the last 12\u00a0months.", {"entities": []}], ["Of those, 25.3\u00a0% were successful by the time of the survey.", {"entities": []}], ["Around 23.3\u00a0% of the entire population, 32.3\u00a0% of men and 13.5\u00a0% of women, were exposed to secondhand smoke for at least one day during the past 7\u00a0days at home, work, or school.", {"entities": []}], ["Although the indicators of tobacco consumption in KSA are better than most of the countries of the Middle East region and high-income countries, there are many potential areas for improvement.", {"entities": []}], ["Our findings call for the development and implementation of programs to prevent smoking initiation and encourage quitting.", {"entities": []}], ["To achieve its health goals, KSA may consider increasing taxation on tobacco products as well as other measures.", {"entities": []}], ["This study aims to identify novel markers for gestational diabetes (GDM) in the biochemical profile of maternal urine using NMR metabolomics.", {"entities": [[46, 66, "DISEASE"]]}], ["It also catalogs the general effects of pregnancy and delivery on the urine profile.", {"entities": []}], ["Urine samples were collected at three time points (visit V1: gestational week 8\u201320; V2: week 28\u00b12; V3\u223610\u201316 weeks post partum) from participants in the STORK Groruddalen program, a prospective, multiethnic cohort study of 823 healthy, pregnant women in Oslo, Norway, and analyzed using", {"entities": []}], ["This study investigates whether indoor environmental quality (IEQ) influences allostatic load (AL) and whether AL can be a predictor for sick building syndrome (SBS).", {"entities": [[151, 159, "DISEASE"], [137, 159, "DISEASE"]]}], ["We also assessed and compared the associations between AL and SBS versus 8-hydroxydeoxyguanosine (8-OHdG) and SBS.", {"entities": []}], ["A total of 115 office workers from 21 offices completed self-reported SBS questionnaires, and provided 11 biomarkers for their AL.", {"entities": []}], ["Multiple linear regressions and logistic regression analysis were applied to examine the correlations between IEQ and AL or 8-OHdG and between AL or 8-OHdG and SBS, respectively.", {"entities": []}], ["Our data revealed that the neuroendocrine system was correlated with CO 2 , the difference between indoor and outdoor CO 2 levels (dCO 2 ), and the indoor-outdoor ratio of CO 2 (CO 2 I/O).", {"entities": []}], ["Metabolic system effects were associated with illumination.", {"entities": []}], ["The relationships between illumination, CO 2 , dCO 2 , CO 2 I/O and 8-OHdG were consistent with those and AL in specific systems.", {"entities": []}], ["Furthermore, we found that risks for SBS syndromes were related with neuroendocrine and metabolic system of the AL.", {"entities": []}], ["8-OHdG was associated with eye dryness or irritation, eye tiredness and vomiting.", {"entities": []}], ["We conclude that IEQ significantly influences AL and that AL can be a predictor for reporting SBS with information on system-specific effects.", {"entities": []}], ["Pulmonary acinus is the largest airway unit provided with alveoli where blood/gas exchange takes place.", {"entities": []}], ["Understanding the complete structure of acinus is necessary to measure the pathway of gas exchange and to simulate various mechanical phenomena in the lungs.", {"entities": []}], ["The usual manual segmentation of a complete acinus structure from their experimentally obtained images is difficult and extremely time-consuming, which hampers the statistical analysis.", {"entities": []}], ["In this study, we develop a semiautomatic segmentation algorithm for extracting the complete structure of acinus from synchrotron micro-CT images of the closed chest of mouse lungs.", {"entities": []}], ["The algorithm uses a combination of conventional binary image processing techniques based on the multiscale and hierarchical nature of lung structures.", {"entities": []}], ["Specifically, larger structures are removed, while smaller structures are isolated from the image by repeatedly applying erosion and dilation operators in order, adjusting the parameter referencing to previously obtained morphometric data.", {"entities": []}], ["A cluster of isolated acini belonging to the same terminal bronchiole is obtained without floating voxels.", {"entities": []}], ["The extracted acinar models above 98% agree well with those extracted manually.", {"entities": []}], ["The run time is drastically shortened compared with manual methods.", {"entities": []}], ["These findings suggest that our method may be useful for taking samples used in the statistical analysis of acinus.", {"entities": []}], ["We have previously explored a therapeutic strategy for specifically targeting the profibrotic activity of IL-13 during experimental pulmonary fibrosis using a fusion protein comprised of human IL-13 and a mutated form of Pseudomonas aeruginosa exotoxin A (IL13-PE) and observed that the intranasal delivery of IL13-PE reduced bleomycin-induced pulmonary fibrosis through its elimination of IL-13-responsive cells in the lung.", {"entities": [[132, 150, "DISEASE"], [344, 362, "DISEASE"]]}], ["The aim of the present study was to determine whether the presence of an immune response to P. aeruginosa and/or its exotoxin A (PE) would diminish the anti-fibrotic properties of IL13-PE.", {"entities": []}], ["Fourteen days after P. aeruginosa infection, C57BL/6 mice were injected with bleomycin via the intratracheal route.", {"entities": []}], ["Other groups of mice received 4 doses of saline or IL13-PE by either intranasal or intraperitoneal application, and were challenged i.t.", {"entities": []}], ["with bleomycin 28 days later.", {"entities": []}], ["At day 21 after bleomycin, all mice received either saline vehicle or IL13-PE by the intranasal route and histopatological analyses of whole lung samples were performed at day 28 after bleomycin.", {"entities": []}], ["Intrapulmonary P. aeruginosa infection promoted a neutralizing IgG2A and IgA antibody response in BALF and serum.", {"entities": []}], ["Surprisingly, histological analysis showed that a prior P. aeruginosa infection attenuated the development of bleomycin-induced pulmonary fibrosis, which was modestly further attenuated by the intranasal administration of IL13-PE.", {"entities": [[128, 146, "DISEASE"]]}], ["Although prior intranasal administration of IL13-PE failed to elicit an antibody response, the systemic administration of IL13-PE induced a strong neutralizing antibody response.", {"entities": []}], ["However, the prior systemic sensitization of mice with IL13-PE did not inhibit the anti-fibrotic effect of IL13-PE in fibrotic mice.", {"entities": []}], ["Thus, IL13-PE therapy in pulmonary fibrosis works regardless of the presence of a humoral immune response to Pseudomonas exotoxin A. Interestingly, a prior infection with P. aeruginosa markedly attenuated the pulmonary fibrotic response suggesting that the immune elicitation by this pathogen exerts anti-fibrotic effects.", {"entities": [[25, 43, "DISEASE"]]}], ["Abnormal Savda Munziq (ASMq), a traditional uyghur medicine, has shown anti-tumour properties in vitro .", {"entities": []}], ["This study attempts to confirm these effects in vivo and measure effects on the immune system.", {"entities": []}], ["Kunming mice transplanted with Sarcoma 180 cells were treated with ASMq (2\u20138\u2009g/kg/day) by intra-gastric administration compared to model and cyclophosphamide (20\u2009mg/kg/day).", {"entities": []}], ["After the 14th day post tumour implant, thymus, liver, spleen and tumours were removed, weighed, and processed for histopathological analysis.", {"entities": []}], ["Blood samples were also taken for haematological and biochemical analyses including TNF-\u03b1 , IL-1 \u03b2 and IL-2.", {"entities": []}], ["Splenic lymphocyte function was measured with MTT; lymphocyte subpopulations were measured by flow cytometry.", {"entities": []}], ["ASMq treated animals had reduced tumour volume compared to model and increased concentrations of TNF-\u03b1, IL-1\u03b2 and IL-2 compared to untreated and to cyclophosphamide-treated animals.", {"entities": []}], ["No histopathological alterations were observed.", {"entities": []}], ["The absence of viable S180 cells and the presence of necrotic cells and granulation tissue were observed in tumour tissue of treated animals.", {"entities": []}], ["The effect on T lymphocytes was unclear.", {"entities": []}], ["ASMq confirmed in vivo anti-tumour effects observed in vitro, which may be at least in part mediated by increased immune activity.", {"entities": []}], ["Stress during pregnancy is associated with metabolic dysfunction in the adult offspring in human and other animals.", {"entities": []}], ["However, little is known about the metabolic effects of pregnancy stress on the mothers and fetuses during pregnancy itself.", {"entities": []}], ["This study aimed to determine the consequences of the common experimental procedures of injection and single housing in pregnant rats on fetal and maternal hepatic glucogenic capacities.", {"entities": []}], ["On day (D) 20 of pregnancy, feto\u2010placental weights and the glycogen content and activities of phosphoenolpyruvate carboxykinase ( PEPCK ) and glucose\u20106\u2010phosphatase (G6Pase) of fetal and maternal liver were measured in rats pair or single housed from D1 with or without saline injection from D15 to D19.", {"entities": []}], ["Housing and saline injection both affected hepatic glucogenic capacity.", {"entities": []}], ["In maternal liver, saline injection but not housing reduced glycogen content and raised G6Pase activity, whereas housing but not treatment increased PEPCK activity.", {"entities": []}], ["In fetuses, housing and injection interacted in regulating PEPCK activity and reducing hepatic glycogen content and placental weight.", {"entities": []}], ["Body weight was decreased and hepatic G6Pase increased by injection but not housing in the fetuses.", {"entities": []}], ["Single\u2010housed dams ate less than those pair\u2010housed near term while saline injection elevated maternal plasma corticosterone concentrations.", {"entities": []}], ["Thus, single housing and saline injection are both stresses during rat pregnancy that alter feto\u2010placental weight and hepatic glucogenic capacity of the fetuses and dams near term.", {"entities": []}], ["Routine experimental procedures per se may, therefore, have consequences for offspring hepatic phenotype as well as modifying the outcomes of dietary and other environmental challenges during pregnancy.", {"entities": []}], ["IL-6 is a multifunctional pro-inflammatory cytokine and has been implicated in many gestational disorders including preterm birth.", {"entities": []}], ["Currently, there are no appropriate therapeutic interventions available to circumvent inflammatory-mediated gestational disorders.", {"entities": []}], ["Therefore, the goal of this study was to identify a safe and effective pharmacological compound to counterbalance inflammatory responses in the uterus.", {"entities": []}], ["Curcumin, a naturally-occuring polyphenolic compound, has been widely used in alternative medicine to treat inflammatory diseases.", {"entities": []}], ["However, the anti-inflammatory effect of curcumin has not been explored in uterine decidual cells, a major source of IL-6.", {"entities": []}], ["Therefore, we examined the effect of curcumin on IL-6 expression using two types of uterine decidual cells 1) HuF cells, primary human fibroblast cells obtained from the decidua parietalis; 2) UIII cells, a rodent non-transformed decidual cell line.", {"entities": []}], ["Curcumin treatment completely abrogated the expression of IL-1\u03b2-induced IL-6 in these cells.", {"entities": []}], ["Curcumin also strongly inhibited the expression of gp130, a critical molecule in IL-6 signaling, whereas expression of IL-6R and sIL-6R was not affected.", {"entities": []}], ["Curcumin also inhibited phosphorylation and nuclear localization of STAT3, a well-known downstream mediator of IL-6 signaling.", {"entities": [[68, 73, "GENE"]]}], ["Furthermore, curcumin attenuated IL-1\u03b2-induced IL-6 promoter reporter activity suggesting transcriptional regulation.", {"entities": []}], ["To further understand whether NF-\u04a1B is involved in this inhibition, we examined the effect of curcumin on the expression of p50 and p65 subunits of NF-\u04a1B in decidual cells.", {"entities": []}], ["Expression of IL-1\u03b2-induced p50 mRNA was repressed by curcumin while p65 mRNA was not affected.", {"entities": []}], ["However, curcumin treatment dramatically inhibited both p50 and p65 protein levels and prevented its nuclear localization.", {"entities": []}], ["This effect is at least partly mediated through the deactivation of IKK, since IL-1\u03b2-induced IKK\u03b1/\u03b2 phosphorylation is decreased upon curcumin treatment.", {"entities": []}], ["Our results not only revealed molecular mechanisms underlying curcumin action in uterine decidual cells but also suggest that this compound may have therapeutic potential for the prevention of inflammation-mediated preterm birth and other gestational disorders.", {"entities": []}], ["Early in life, patients with cystic fibrosis (CF) are infected with microorganisms including bacteria and fungi, particularly Pseudomonas aeruginosa and Aspergillus fumigatus .", {"entities": [[29, 44, "DISEASE"]]}], ["Since recent research has identified the anti-inflammatory properties of statins (besides their lipid-lowering effects), we investigated the effect of fluvastatin on the production of the potent neutrophil chemoattractant chemokine, IL-8, in whole blood from CF patients, stimulated by Pseudomonas aeruginosa (LPS) and Aspergillus fumigatus (AFA) antigens.", {"entities": []}], ["Whole blood from adult patients with CF and from healthy volunteers was collected at the Rennes University Hospital (France).", {"entities": []}], ["Blood was pretreated for 1 h with fluvastatin (0\u2013300 \u00b5M) and incubated for 24 h with LPS (10 \u00b5g/mL) and/or AFA (diluted 1/200).", {"entities": []}], ["IL-8 protein levels, quantified by ELISA, were increased in a concentration-dependent manner when cells were stimulated by LPS or AFA.", {"entities": []}], ["Fluvastatin strongly decreased the levels of IL-8, in a concentration-dependent manner, in whole blood from CF patients.", {"entities": []}], ["However, its inhibitory effect was decreased or absent in whole blood from healthy subjects.", {"entities": []}], ["Furthermore, the inhibition induced by fluvastatin in CF whole blood was reversed in the presence of intermediates within the cholesterol biosynthesis pathway, mevalonate, farnesyl pyprophosphate or geranylgeranyl pyrophosphate that activate small GTPases by isoprenylation.", {"entities": []}], ["For the first time, the inhibitory effects of fluvastatin on CF systemic inflammation may reveal the important therapeutic potential of statins in pathological conditions associated with the over-production of pro-inflammatory cytokines and chemokines as observed during the manifestation of CF.", {"entities": []}], ["The anti-inflammatory effect could be related to the modulation of the prenylation of signalling proteins.", {"entities": []}], ["Data from exposure of experimental animals and human subjects to sulfuric acid presents a consistent picture of its toxicology.", {"entities": []}], ["Effects on airway resistance in asthmatic subjects were well predicted by data obtained on guinea pigs.", {"entities": []}], ["Sulfuric acid increases the irritant response to ozone in both rats and man.", {"entities": []}], ["In donkeys, rabbits, and human subjects, sulfuric acid alters clearance of particles from the lung in a similar manner.", {"entities": []}], ["These changes resemble those produced by cigarette smoke and could well lead to chronic bronchitis.", {"entities": [[88, 98, "DISEASE"]]}], ["Data obtained on guinea pigs indicate that very small amounts of sulfuric acid on the surface of ultrafine metal oxide aerosols produce functional, morphological, and biochemical pulmonary effects.", {"entities": []}], ["Such particles are typical of those emitted from coal combustion and smelting operations.", {"entities": []}], ["Sulfate is an unsatisfactory surrogate in existing epidemiology studies.", {"entities": []}], ["Sulfuric acid measurement is a critical need in such studies.", {"entities": []}], ["Lysophosphatidic acid receptor 1 (LPA1) is a druggable target for treating pulmonary inflammatory diseases.", {"entities": []}], ["However, the molecular regulation of LPA1 stability, a factor that critically impacts its biological activity, remains largely unknown.", {"entities": []}], ["Here we identify two enzymes that regulate the balance of LPA1 ubiquitination and deubiquitination.", {"entities": []}], ["Ubiquitin E3 ligase Nedd4L targets LPA1 for its site specific ubiquitination and degradation in the lysosome.", {"entities": [[20, 26, "GENE"]]}], ["Nedd4L negatively regulates LPA-LPA1-mediated cytokine release.", {"entities": [[0, 6, "GENE"]]}], ["The stability of LPA1 is up-regulated by ubiquitin-specific protease 11 (USP11), which deubiquitinates LPA1 and enhances LPA1-mediated pro-inflammatory effects.", {"entities": [[73, 78, "GENE"]]}], ["LPA1 is associated with USP11 in quiescent cells, while LPA treatment triggers LPA1 dis-association with USP11 and in turn binding to Nedd4L.", {"entities": [[24, 29, "GENE"], [105, 110, "GENE"], [56, 59, "GENE"], [24, 29, "GENE"], [105, 110, "GENE"], [134, 140, "GENE"]]}], ["Knockdown or inhibition of USP11 reduces LPA1 stability, levels of LPA1, and LPA1-CD14 interaction complex; thereby diminishing both LPA- and LPS-induced inflammatory responses and lung injury in preclinical murine models.", {"entities": [[27, 32, "GENE"]]}], ["Thus, our findings identify an ubiquitin E3 ligase and a deubiquitinating enzyme responsible for regulation of LPA1 stability and biological activities.", {"entities": []}], ["This study provides potential targets for the development of anti-inflammatory molecules to lessen lung injury.", {"entities": []}], ["\u2022 Nedd4L ubiquitinates LPA1 and diminishes LPA1 signaling.", {"entities": [[2, 8, "GENE"]]}], ["\u2022 USP11 deubiquitinates and stabilizes LPA1, thus promotes LPA1- and LPS-mediated pro-inflammatory response.", {"entities": [[2, 7, "GENE"]]}], ["\u2022 Inhibition of USP11 reduces LPS-induced acute lung injury.", {"entities": [[16, 21, "GENE"]]}], ["Nedd4L ubiquitinates LPA1 and diminishes LPA1 signaling.", {"entities": [[0, 6, "GENE"]]}], ["USP11 deubiquitinates and stabilizes LPA1, thus promotes LPA1- and LPS-mediated pro-inflammatory response.", {"entities": [[0, 5, "GENE"]]}], ["Inhibition of USP11 reduces LPS-induced acute lung injury.", {"entities": [[14, 19, "GENE"]]}], ["Lysophosphatidic acid (LPA) and its receptor (LPA1) play a critical role in lung inflammation through triggering cytokine release and neutrophil influx to the lungs.", {"entities": [[23, 26, "GENE"]]}], ["Here, we show that LPA1 is ubiquitinated and degraded in the lysosome, and the process is mediated by the ubiquitin E3 ligase Nedd4L.", {"entities": [[126, 132, "GENE"]]}], ["Further, we reveal that a deubiquitination enzyme USP11 stabilizes LPA1 by targeting and deubiquitinating LPA1.", {"entities": [[50, 55, "GENE"]]}], ["To investigate whether destabilization of LPA1 diminishes lung injury, USP11 was inhibited or down-regulated prior to endotoxin challenge.", {"entities": [[71, 76, "GENE"]]}], ["Destabilization of LPA1 reduces cytokine release and lung inflammation in a preclinical murine model of lung injury.", {"entities": []}], ["Unhealthy lifestyles and depression are highly interrelated: depression might elicit and exacerbate unhealthy lifestyles and people with unhealthy lifestyles are more likely to become depressed over time.", {"entities": []}], ["However, few longitudinal evidence of these relationships has been collected in emerging countries.", {"entities": []}], ["The present study aims i) to analyse whether people with unhealthy lifestyles are more likely to develop depression, and ii) to examine whether depressed people with unhealthy lifestyles are more likely to remain depressed.", {"entities": []}], ["A total of 7908 participants from Ghana, India, Mexico and Russia were firstly evaluated in the World Health Organization\u2019s Study on Global AGEing and Adult Health (SAGE) Wave 0 (2002\u20132004) and re-evaluated in 2007\u20132010 (Wave 1).", {"entities": []}], ["Data on tobacco use, alcohol drinking and physical activity, were collected.", {"entities": []}], ["Logistic regressions models were employed to assess whether baseline unhealthy lifestyles were related to depression in Wave 1, among people without 12-month depression in Wave 0 and any previous lifetime diagnosis of depression, and to 12-month depression at both study waves (persistent depression).", {"entities": []}], ["Baseline daily and non-daily smoking was associated with depression in Wave 1.", {"entities": []}], ["Low physical activity and heavy alcohol drinking were associated with persistent depression.", {"entities": []}], ["Unhealthy lifestyles and depression are also positively related in emerging countries.", {"entities": []}], ["Smoking on a daily and non-daily basis was longitudinally related to depression.", {"entities": []}], ["Depressed people with low physical activity and with heavy drinking patterns were more likely to become depressed over time.", {"entities": []}], ["Several interpretations of these results are given.", {"entities": []}], ["Further studies should check whether a reduction of these unhealthy lifestyles leads to lower depression rates and/or to a better clinical prognosis of depressed people.", {"entities": []}], ["Patient safety issues in pre-hospital care are poorly investigated.", {"entities": []}], ["The aim of the planned study is to survey patient safety problems in pre-hospital care in Sweden.", {"entities": []}], ["The study is a retro-perspective structured medical record review based on the use of 11 screening criteria.", {"entities": []}], ["Two instruments for structured medical record review are used: a trigger tool instrument designed for pre-hospital care and a newly development instrument designed to compare the pre-hospital assessment with the final hospital assessment.", {"entities": []}], ["Three different ambulance organisations are participating in the study.", {"entities": []}], ["Every month, one rater in each organisation randomly collects 30 medical records for review.", {"entities": []}], ["With guidance from the review instrument, he/she independently reviews the record.", {"entities": []}], ["Every month, the review team meet for a discussion of problematic reviews.", {"entities": []}], ["The results will be analysed with descriptive statistics and logistic regression.", {"entities": []}], ["The findings will make an important contribution to knowledge about patient safety issues in pre-hospital care.", {"entities": []}], ["Background .", {"entities": []}], ["The Akaki River in Ethiopia has been found to contain elevated levels of several metals.", {"entities": []}], ["Our objectives were to characterize metals exposures of residents living near the Akaki River and to assess metal levels in their drinking water.", {"entities": []}], ["In 2011, we conducted a cross-sectional study of 101 households in Akaki-Kality subcity (near the Akaki River) and 50 households in Yeka subcity (distant to the Akaki River).", {"entities": []}], ["One willing adult in each household provided urine, blood, and drinking water sample.", {"entities": []}], ["Urinary molybdenum ( p < 0.001), tungsten ( p < 0.001), lead ( p < 0.001), uranium ( p < 0.001), and mercury ( p = 0.049) were higher in Akaki-Kality participants compared to Yeka participants.", {"entities": []}], ["Participants in both subcities had low urinary iodine; 45% met the World Health Organization (WHO) classification for being at risk of moderate iodine deficiency.", {"entities": []}], ["In Yeka, 47% of households exceeded the WHO aesthetic-based reference value for manganese; in Akaki-Kality, only 2% of households exceeded this value ( p < 0.001).", {"entities": []}], ["There was no correlation between metals levels in water samples and clinical specimens.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Most of the exposures found during this investigation seem unlikely to cause acute health effects based on known toxic thresholds.", {"entities": []}], ["However, toxicity data for many of these metals are very limited.", {"entities": []}], ["Little is understood about the long term, indirect health consequences of drought (a period of abnormally dry weather).", {"entities": []}], ["In particular, the implications of drought for mental health via pathways such as loss of livelihood, diminished social support, and rupture of place bonds have not been extensively studied, leaving a knowledge gap for practitioners and researchers alike.", {"entities": []}], ["A systematic review of literature was performed to examine the mental health effects of drought.", {"entities": []}], ["The systematic review results were synthesized to create a causal process diagram that illustrates the pathways linking drought effects to mental health outcomes.", {"entities": []}], ["Eighty-two articles using a variety of methods in different contexts were gathered from the systematic review.", {"entities": []}], ["The pathways in the causal process diagram with greatest support in the literature are those focusing on the economic and migratory effects of drought.", {"entities": []}], ["The diagram highlights the complexity of the relationships between drought and mental health, including the multiple ways that factors can interact and lead to various outcomes.", {"entities": []}], ["The systematic review and resulting causal process diagram can be used in both practice and theory, including prevention planning, public health programming, vulnerability and risk assessment, and research question guidance.", {"entities": []}], ["The use of a causal process diagram provides a much needed avenue for integrating the findings of diverse research to further the understanding of the mental health implications of drought.", {"entities": []}], ["Adult full-thickness cutaneous wound repair suffers from an imbalanced immune response, leading to nonfunctional reconstructed tissue and fibrosis.", {"entities": []}], ["Although various treatments have been reported, the immune-mediated tissue regeneration driven by biomaterial offers an attractive regenerative strategy for damaged tissue repair.", {"entities": []}], ["In this research, we investigated a specific bone marrow-derived mesenchymal stem cell (BMSC) sheet that was induced by the Traditional Chinese Medicine curcumin (CS-C) and its immunomodulatory effects on wound repair.", {"entities": []}], ["Comparisons were made with the BMSC sheet induced without curcumin (CS-N) and control (saline).", {"entities": []}], ["In vitro cultured BMSC sheets (CS-C) showed that curcumin promoted the proliferation of BMSCs and modified the features of produced extracellular matrix (ECM) secreted by BMSCs, especially the contents of ECM structural proteins such as fibronectin (FN) and collagen I and III, as well as the ratio of collagen III/I.", {"entities": []}], ["Two-photon fluorescence (TPF) and second-harmonic generation (SHG) imaging of mouse implantation revealed superior engraftment of BMSCs, maintained for 35 days in the CS-C group.", {"entities": []}], ["Most importantly, CS-C created a favorable immune microenvironment.", {"entities": []}], ["The chemokine stromal cell-derived factor 1 (SDF1) was abundantly produced by CS-C, thus facilitating a mass migration of leukocytes from which significantly increased expression of signature T H 1 cells (interferon gamma) and M1 macrophages (tumor necrosis factor alpha) genes were confirmed at 7 days post-operation.", {"entities": []}], ["The number of T H 1 cells and associated pro-inflammatory M1 macrophages subsequently decreased sharply after 14 days post-operation, suggesting a rapid type I immune regression.", {"entities": []}], ["Furthermore, the CS-C group showed an increased trend towards M2 macrophage polarization in the early phase.", {"entities": []}], ["CS-C led to an epidermal thickness and collagen deposition that was closer to that of normal skin.", {"entities": []}], ["Curcumin has a good regulatory effect on BMSCs and this promising CS-C biomaterial creates a pro-regenerative immune microenvironment for cutaneous wound healing.", {"entities": []}], ["Uterine stress is associated with an increased risk of later life metabolic diseases.", {"entities": []}], ["In this study, we investigated the effect of diesel exhaust (DE) exposure in utero on adult susceptibility to atherosclerosis in genetically hyperlipidemic mice.", {"entities": [[110, 125, "DISEASE"]]}], ["Pregnant apolipoprotein E-deficient mice received either DE exposure (~250\u2013300\u00a0\u03bcg/m 2.5 for 6\u00a0h/day, 5\u00a0days/week) or filtered air (FA) throughout gestation.", {"entities": []}], ["Treatment effects on litter size and gender distribution were recorded.", {"entities": []}], ["Plasma cholesterol and triglycerides were measured at 8, 12 and 16\u00a0weeks of age.", {"entities": []}], ["Urinary 8-isoprostane and liver 8-hydroxy-deoxyguanosine levels were measured at killing at 16\u00a0weeks of age.", {"entities": []}], ["Expression of the antioxidant genes heme oxygenase-1 and the glutamate-cysteine ligase modifier and catalytic subunits were measured in the lung, liver and aorta.", {"entities": []}], ["The average area and frequency of atherosclerotic lesions were measured in the aortic sinus and innominate arteries.", {"entities": []}], ["There were significantly smaller litters and higher postnatal mortality in the DE-exposed mice.", {"entities": []}], ["There were no significant differences in plasma lipids or lipoprotein profiles, expression of antioxidant genes or markers of oxidative stress between treatment groups.", {"entities": []}], ["There were also no significant differences in average atherosclerotic lesion area in the aortic sinus or innominate arteries of the DE and FA groups although there was a higher frequency of lesions in the DE-exposed group.", {"entities": []}], ["Our study indicates that in utero DE exposure does not influence later life lipoprotein metabolism, redox homeostasis or the risk of developing larger atherosclerotic lesions.", {"entities": []}], ["The use of complementary and alternative products including Biological Based Therapy (BBT) has increased among patients with various medical illnesses and conditions.", {"entities": []}], ["The studies assessing the prevalence of BBT use among patients with cardiovascular diseases are limited.", {"entities": []}], ["Therefore, an evaluation of BBT in this patient population would be beneficial.", {"entities": []}], ["This was a survey designed to determine the effects of demographics on the use of Biological Based Therapy (BBT) in patients with cardiovascular diseases.", {"entities": []}], ["The objective of this study was to determine the effect of the education level on the use of BBT in cardiovascular patients.", {"entities": []}], ["This survey also assessed the perceptions of users regarding the safety/efficacy of BBT, types of BBT used and potential BBT-drug interactions.", {"entities": []}], ["The survey instrument was designed to assess the findings.", {"entities": []}], ["Patients were interviewed from February 2001 to December 2002.", {"entities": []}], ["198 inpatients with cardiovascular diseases (94 BBT users and 104 non-users) in a university hospital were included in the study.", {"entities": []}], ["Users had a significantly higher level of education than non-users (college graduate: 28 [30%] versus 12 [12%], p = 0.003).", {"entities": []}], ["Top 10 BBT products used were vitamin E [41(43.6%)], vitamin C [30(31.9%)], multivitamins [24(25.5%)], calcium [19(20.2%)], vitamin B complex [17(18.1%)], fish oil [12(12.8%)], coenzyme Q10 [11(11.7%)], glucosamine [10(10.6%)], magnesium [8(8.5%)] and vitamin D [6(6.4%)].", {"entities": []}], ["Sixty percent of users' physicians knew of the BBT use.", {"entities": []}], ["Compared to non-users, users believed BBT to be safer (p < 0.001) and more effective (p < 0.001) than prescription drugs.", {"entities": []}], ["Forty-two potential drug-BBT interactions were identified.", {"entities": []}], ["Incidence of use of BBT in cardiovascular patients is high (47.5%), as is the risk of potential drug interaction.", {"entities": []}], ["Health care providers need to monitor BBT use in patients with cardiovascular diseases.", {"entities": []}], ["Healthy Outlook is a service delivered by the UK Met Office directly to patients with chronic obstructive pulmonary disease (COPD) that has been in place since 2006.", {"entities": [[86, 123, "DISEASE"]]}], ["Its objective is to reduce the severity and length of COPD exacerbations, hence improving the quality of life and life expectancy.", {"entities": []}], ["To assess the effect of the Healthy Outlook service on hospital admission rates of all general practitioners that have used the service.", {"entities": []}], ["Control practices were selected for each of the 661 participating practices.", {"entities": []}], ["The number of hospital admissions for each practice was extracted from the Hospital Episode Statistics database.", {"entities": []}], ["The differences in admission rates per practice between the first year of use of the Healthy Outlook service and the previous year were compared by paired t -test analyses.", {"entities": []}], ["For admissions with a primary diagnosis of COPD, the difference between participating and control practices was \u22120.8% (95% confidence interval (CI)=\u22121.8 to 0.2%; P =0.13).", {"entities": []}], ["For admissions with a primary or co-morbid diagnosis of COPD, the difference was \u22122.3% (95% CI=\u22124.2 to \u22120.4%; P =0.02).", {"entities": []}], ["Participation in the Healthy Outlook service reduces hospital admission rates for patients coded on discharge with COPD (including co-morbid).", {"entities": []}], ["Most healthcare spending in developing countries is private out-of-pocket.", {"entities": []}], ["One explanation for low penetration of health insurance is that poorer individuals doubt their ability to enforce insurance contracts.", {"entities": []}], ["Community-based health insurance schemes (CBHI) are a solution, but launching CBHI requires obtaining accurate local data on morbidity, healthcare utilization and other details to inform package design and pricing.", {"entities": []}], ["We developed the \u201cIllness Mapping\u201d method (IM) for data collection (faster and cheaper than household surveys).", {"entities": []}], ["IM is a modification of two non-interactive consensus group methods (Delphi and Nominal Group Technique) to operate as interactive methods.", {"entities": []}], ["We elicited estimates from \u201cExperts\u201d in the target community on morbidity and healthcare utilization.", {"entities": []}], ["Interaction between facilitator and experts became essential to bridge literacy constraints and to reach consensus.", {"entities": []}], ["The study was conducted in Gaya District, Bihar (India) during April-June 2010.", {"entities": []}], ["The intervention included the IM and a household survey (HHS).", {"entities": []}], ["IM included 18 women\u2019s and 17 men\u2019s groups.", {"entities": []}], ["The HHS was conducted in 50 villages with1,000 randomly selected households (6,656 individuals).", {"entities": []}], ["We found good agreement between the two methods on overall prevalence of illness (IM: 25.9% \u00b13.6; HHS: 31.4%) and on prevalence of acute (IM: 76.9%; HHS: 69.2%) and chronic illnesses (IM: 20.1%; HHS: 16.6%).", {"entities": []}], ["We also found good agreement on incidence of deliveries (IM: 3.9% \u00b10.4; HHS: 3.9%), and on hospital deliveries (IM: 61.0%.", {"entities": []}], ["\u00b1\u20095.4; HHS: 51.4%).", {"entities": []}], ["For hospitalizations, we obtained a lower estimate from the IM (1.1%) than from the HHS (2.6%).", {"entities": []}], ["The IM required less time and less person-power than a household survey, which translate into reduced costs.", {"entities": []}], ["We have shown that our Illness Mapping method can be carried out at lower financial and human cost for sourcing essential local data, at acceptably accurate levels.", {"entities": []}], ["In view of the good fit of results obtained, we assume that the method could work elsewhere as well.", {"entities": []}], ["Atopic allergy is effected by a number of environmental exposures, such as dry air and time spent outdoors, but there are few estimates of the prevalence in populations from sub-arctic areas.", {"entities": []}], ["To determine the prevalence and severity of symptoms of food, inhalation and skin-related allergens and coeliac disease (CD) in the sub-arctic region of Sweden.", {"entities": []}], ["To study the correlation between self-reported allergy and allergy test results.", {"entities": []}], ["To estimate the heritability of these estimates.", {"entities": []}], ["The study was conducted in Karesuando and Soppero in Northern Sweden as part of the Northern Sweden Population Health Study (n=1,068).", {"entities": []}], ["We used a questionnaire for self-reported allergy and CD status and measured inhalation-related allergens using Phadiatop, food-related allergens using the F\u00d75 assay and IgA and IgG antibodies against tissue transglutaminase (anti-tTG) to indicate prevalence of CD.", {"entities": []}], ["The prevalence of self-reported allergy was very high, with 42.3% reporting mild to severe allergy.", {"entities": []}], ["Inhalation-related allergy was reported in 26.7%, food-related allergy in 24.9% and skin-related allergy in 2.4% of the participants.", {"entities": []}], ["Of inhalation-related allergy, 11.0% reported reactions against fur and 14.6% against pollen/grass.", {"entities": []}], ["Among food-related reactions, 14.9% reported milk (protein and lactose) as the cause.", {"entities": []}], ["The IgE measurements showed that 18.4% had elevated values for inhalation allergens and 11.7% for food allergens.", {"entities": []}], ["Self-reported allergies and symptoms were positively correlated (p<0.01) with age- and sex-corrected inhalation allergens.", {"entities": []}], ["Allergy prevalence was inversely correlated with age and number of hours spent outdoors.", {"entities": []}], ["High levels of IgA and IgG anti-tTG antibodies, CD-related allergens, were found in 1.4 and 0.6% of participants, respectively.", {"entities": []}], ["All allergens were found to be significantly (p<3 e\u201310) heritable, with estimated heritabilities ranging from 0.34 (F\u00d75) to 0.65 (IgA).", {"entities": []}], ["Self-reported allergy correlated well with the antibody measurements.", {"entities": []}], ["The prevalence of allergy was highest in the young and those working inside.", {"entities": []}], ["Heritability of atopy and sensitization was high.", {"entities": []}], ["The prevalence of CD-related autoantibodies was high and did not coincide with the self-reported allergy.", {"entities": []}], ["To investigate the effects of hypoxic conditioned media from rat cerebral cortical cells on the proliferation and differentiation of neural stem cells (NSCs) in vitro , and to study the roles of PI3-K/Akt and JNK signal transduction pathways in these processes.", {"entities": []}], ["Cerebral cortical cells from neonatal Sprague\u2013Dawley rat were cultured under hypoxic and normoxic conditions; the supernatant was collected and named \u2018hypoxic conditioned medium\u2019 (HCM) and \u2018normoxic conditioned medium\u2019 (NCM), respectively.", {"entities": []}], ["We detected the protein levels (by ELISA) of VEGF and BDNF in the conditioned media and mRNA levels (by RT-PCR) in cerebral cortical cells.", {"entities": [[54, 58, "GENE"]]}], ["The proliferation (number and size of neurospheres) and differentiation (proportion of neurons and astrocytes over total cells) of NSCs was assessed.", {"entities": []}], ["LY294002 and SP600125, inhibitors of PI3-K/Akt and JNK, respectively, were applied, and the phosphorylation levels of PI3-K, Akt and JNK were measured by western blot.", {"entities": []}], ["The protein levels and mRNA expressions of VEGF and BDNF in 4% HCM and 1% HCM were both higher than that of those in NCM.", {"entities": [[52, 56, "GENE"]]}], ["The efficiency and speed of NSCs proliferation was enhanced in 4% HCM compared with 1% HCM.", {"entities": []}], ["The highest percentage of neurons and lowest percentage of astrocytes was found in 4% HCM.", {"entities": []}], ["However, the enhancement of NSCs proliferation and differentiation into neurons accelerated by 4% HCM was inhibited by LY294002 and SP600125, with LY294002 having a stronger inhibitory effect.", {"entities": []}], ["The increased phosphorylation levels of PI3-K, Akt and JNK in 4% HCM were blocked by LY294002 and SP600125.", {"entities": []}], ["4%HCM could promote NSCs proliferation and differentiation into high percentage of neurons, these processes may be mainly through PI3-K/Akt pathways.", {"entities": []}], ["Massive resources are expended every year on cross-cultural communication training for physicians.", {"entities": []}], ["Such training is a focus of continuing medical education nationwide and is part of the curriculum of virtually every medical school in America.", {"entities": []}], ["There is a pressing need for evidence regarding the effects on patients of cross-cultural communication training for physicians.", {"entities": []}], ["There is a need to understand the added benefit of such training compared to more general communication.", {"entities": []}], ["We know of no rigorous study that has assessed whether cross-cultural communication training for physicians results in better health outcomes for their patients.", {"entities": []}], ["The current study aims to answer this question by enhancing the Physician Asthma Care Education (PACE) program to cross cultural communication (PACE Plus), and comparing the effect of the enhanced program to PACE on the health outcomes of African American and Latino/Hispanic children with asthma.", {"entities": [[74, 80, "DISEASE"], [290, 296, "DISEASE"]]}], ["A three-arm randomized control trial is used to compare PACE Plus, PACE, and usual care.", {"entities": []}], ["Both PACE and PACE Plus are delivered in two, two-hour sessions over a period of two weeks to 5\u201310 primary care physicians who treat African American and Latino/Hispanic children with asthma.", {"entities": [[184, 190, "DISEASE"]]}], ["One hundred twelve physicians and 1060 of their pediatric patients were recruited who self-identify as African American or Latino/Hispanic and experience persistent asthma.", {"entities": [[165, 171, "DISEASE"]]}], ["Physicians were randomized into receiving either the PACE Plus or PACE intervention or into the control group.", {"entities": []}], ["The comparative effectiveness of PACE and PACE Plus on clinician\u2019s therapeutic and communication practices with the family/patient, children\u2019s urgent care use for asthma, asthma control, and quality of life, and parent/caretaker satisfaction with physician performance will be assessed.", {"entities": [[163, 169, "DISEASE"], [171, 177, "DISEASE"]]}], ["Data are collected via telephone survey and medical record review at baseline, 9\u00a0months following the intervention, and 21\u00a0months following the intervention.", {"entities": []}], ["This study aims to reduce disparities in asthma outcomes among African American and Latino/Hispanic children through cross-cultural communication training of their physicians and assessing the added value of this training compared to general communication.", {"entities": [[41, 47, "DISEASE"]]}], ["The results of this study will provide important information about the value of cross-cultural training in helping to address persistent racial disparities in outcomes.", {"entities": []}], ["ClinicalTrials.gov: NCT01251523 December 1, 2010", {"entities": []}], ["It has now become clear that gene-gene interactions and gene-environment interactions are ubiquitous and fundamental mechanisms for the development of complex diseases.", {"entities": []}], ["Though a considerable effort has been put into developing statistical models and algorithmic strategies for identifying such interactions, the accurate identification of those genetic interactions has been proven to be very challenging.", {"entities": []}], ["In this paper, we propose a new approach for identifying such gene-gene and gene-environment interactions underlying complex diseases.", {"entities": []}], ["This is a hybrid algorithm and it combines genetic algorithm (GA) and an ensemble of classifiers (called genetic ensemble).", {"entities": []}], ["Using this approach, the original problem of SNP interaction identification is converted into a data mining problem of combinatorial feature selection.", {"entities": []}], ["By collecting various single nucleotide polymorphisms (SNP) subsets as well as environmental factors generated in multiple GA runs, patterns of gene-gene and gene-environment interactions can be extracted using a simple combinatorial ranking method.", {"entities": []}], ["Also considered in this study is the idea of combining identification results obtained from multiple algorithms.", {"entities": []}], ["A novel formula based on pairwise double fault is designed to quantify the degree of complementarity.", {"entities": []}], ["Our simulation study demonstrates that the proposed genetic ensemble algorithm has comparable identification power to Multifactor Dimensionality Reduction (MDR) and is slightly better than Polymorphism Interaction Analysis (PIA), which are the two most popular methods for gene-gene interaction identification.", {"entities": []}], ["More importantly, the identification results generated by using our genetic ensemble algorithm are highly complementary to those obtained by PIA and MDR.", {"entities": []}], ["Experimental results from our simulation studies and real world data application also confirm the effectiveness of the proposed genetic ensemble algorithm, as well as the potential benefits of combining identification results from different algorithms.", {"entities": []}], ["Understanding how the mucosal immune system in the human female reproductive tract might prevent or facilitate HIV infection has important implications for the design of effective interventions.", {"entities": []}], ["We and others have established cohorts of highly-exposed, HIV-seronegative individuals, such as HIV-uninfected commercial sex workers, who have remained HIV-negative after more than 5 years of active prostitution.", {"entities": []}], ["Observations obtained in studies of such individuals, who represent a model of natural immunity to HIV, indicate that HIV resistance may be associated with the host's capacity to preserve systemic integrity by constraining immune activity and controlling inflammatory conditions at the mucosal point of entry.", {"entities": []}], ["This likely necessitates the orchestration of balanced, first-line and adaptive immune responses.", {"entities": []}], ["Traditional assessment of patients with obstructive lung diseases (asthma and chronic obstructive pulmonary disease; COPD) relies on physiological tests.", {"entities": [[78, 115, "DISEASE"], [67, 73, "DISEASE"]]}], ["The COPD and Asthma Rotterdam Integrated Care Approach (CORONA) study aims to develop a diagnostic pathway with a more comprehensive approach to the assessment of patients with asthma and COPD in secondary care.", {"entities": [[13, 19, "DISEASE"], [177, 183, "DISEASE"]]}], ["An eight-step method was used to develop and implement the pathway for patients with asthma or COPD referred to an outpatient hospital setting.", {"entities": [[85, 91, "DISEASE"]]}], ["The diagnostic pathway consists of an evidence-based set of measurements prioritized by a Delphi procedure.", {"entities": []}], ["The pathway incorporates three innovative diagnostics: the metronome-paced hyperventilation test to measure dynamic hyperinflation, an activity monitor to objectively evaluate physical activity in daily life, and the Nijmegen Clinical Screening Instrument as a comprehensive assessment tool to acquire detailed insight into symptoms, functional limitations, and quality of life.", {"entities": []}], ["An innovative diagnostic pathway was developed and implemented for patients with obstructive lung diseases referred to secondary care.", {"entities": []}], ["As this pathway aims to provide a comprehensive analysis of health status, it focuses on biomedical aspects and also reviews behavioral aspects that further elucidate the patient\u2019s health status.", {"entities": []}], ["The added value of the diagnostic pathway needs to be determined from both an organizational perspective and from the individual patient\u2019s viewpoint.", {"entities": []}], ["We aimed to investigate whether the newborns of mothers with maternal depression (MD) had lower vitamin D levels than newborns of non-MD (NMD) mothers and identify the potential mechanism underlying this association.", {"entities": []}], ["Maternal depressive symptoms in late pregnancy and concentrations of cord blood 25 hydroxyvitamin D (25(OH)D) were measured in 1491 mother-infant pairs.", {"entities": []}], ["Data on maternal sociodemographic characteristics, health status, lifestyle and birth outcomes were prospectively collected.", {"entities": []}], ["For infants born in winter-spring, the infants of MD mothers had significantly reduced concentrations of 25(OH) D (adjusted \u03b2\u2009=\u2009\u22123.51\u2009nmol/L; 95% CI: \u22126.19, \u22120.84; P \u2009=\u20090.010) and lower birth weight (3267\u2009\u00b1\u2009470\u2009g vs 3348\u2009\u00b1\u2009598\u2009g, F\u2009=\u20094.64, P \u2009=\u20090.031), compared with the infants of NMD mothers.", {"entities": []}], ["A significant, inverse linear relationship was noted between maternal depression scores and the concentration of 25(OH)D for infants born in winter-spring (adjusted \u03b2\u2009=\u2009\u22120.158; 95% CI: \u22120.259, \u22120.057).", {"entities": []}], ["The significant, inverse linear relationship between maternal depression scores and fetomaternal ratios of 25(OH) D was also observed among the infants born in winter-spring (adjusted \u03b2\u2009=\u2009\u22120.005; 95% CI: \u22120.008, \u22120.003).", {"entities": []}], ["MD appears to significantly attenuate the vitamin D concentrations and birth weight of infants born in winter-spring.", {"entities": []}], ["A decreased fetomaternal ratio of 25(OH)D might be involved in this biological pathway.", {"entities": []}], ["This study examined the impact of four variables pertaining to the use of e-cigarettes (e-cigs) on cravings for tobacco cigarettes and for e-cigs after an overnight abstinence period.", {"entities": []}], ["The four variables were the nicotine level, the sensorimotor component, the visual aspect, and the aroma of the e-cig.", {"entities": []}], ["In an experimental study, 81 participants without prior vaping experience first got acquainted with using e-cigs in a one-week tryout period, after which they participated in a lab session assessing the effect of five minutes of vaping following an abstinence period of 12 h. A mixed-effects model clearly showed the importance of nicotine in craving reduction.", {"entities": []}], ["However, also non-nicotine factors, in particular the sensorimotor component, were shown to contribute to craving reduction.", {"entities": []}], ["Handling cues interacted with the level (presence/absence) of nicotine: it was only when the standard hand-to-mouth action cues were omitted that the craving reducing effects of nicotine were observed.", {"entities": []}], ["Effects of aroma or visual cues were not observed, or weak and difficult to interpret, respectively.", {"entities": []}], ["Fractional exhaled nitric oxide (FENO) is nitric oxide (NO) in the lower airway measured by oral exhalation.", {"entities": []}], ["FENO can be a useful non-invasive marker for asthma.", {"entities": [[45, 51, "DISEASE"]]}], ["Paraquat-mediated lung injury can be reflective of an ROS-induced lung injury.", {"entities": []}], ["We aimed to verify if FENO is a clinical parameter of ROS formation and responsiveness to medical therapies in acute paraquat intoxication.", {"entities": []}], ["We recruited 12 patients admitted with acute paraquat poisoning.", {"entities": []}], ["A portable and noninvasive device called NIOX MINO\u2122 (Aerocrine AB, Solna, Sweden) was used to measure FENO.", {"entities": []}], ["Measurements were made at the time of hospital admission and at 24, 48, 72, 96, and 120 h after paraquat ingestion.", {"entities": []}], ["Six out of the total 12 recruited patients had general conditions (e.g.", {"entities": []}], ["oral pain) that made it difficult for them to exhale with adequate force.", {"entities": []}], ["Mean plasma paraquat level was 1.4\u00b12.5 \u03bcg/mL.", {"entities": []}], ["We found no direct correlation between the paraquat levels (both ingestion amount and plasma concentration) and FENO (initial, maximal, and minimal values).", {"entities": []}], ["All the measured FENO values were no greater than 20 ppb for the 2 patients who died.", {"entities": []}], ["FENO did not vary more than 20% from the baseline.", {"entities": []}], ["Compared to the above findings, FENO measurements were found to be greater than 20 ppb for the patients who survived.", {"entities": []}], ["FENO tends to reach its peak value at between 50 h and 80 h. FENO did not predict mortality, and there was no increase of FENO in patients with severe paraquat intoxication.", {"entities": []}], ["Although Integrated Environmental Health Monitoring (IEHM) is considered an essential tool to better understand complex environmental health issues, there is no consensus on how to develop such a programme.", {"entities": []}], ["We reviewed four existing frameworks and eight monitoring programmes in the area of environmental health.", {"entities": []}], ["We identified the DPSEEA (Driving Force-Pressure-State-Exposure-Effect-Action) framework as most suitable for developing an IEHM programme for environmental health impact assessment.", {"entities": []}], ["Our review showed that most of the existing monitoring programmes have been designed for specific purposes, resulting in narrow scope and limited number of parameters.", {"entities": []}], ["This therefore limits their relevance for studying complex environmental health topics.", {"entities": []}], ["Other challenges include limited spatial and temporal data availability, limited development of data sharing mechanisms, heterogeneous data quality, a lack of adequate methodologies to link disparate data sources, and low level of interdisciplinary cooperation.", {"entities": []}], ["To overcome some of these challenges, we propose a DPSEEA-based conceptual framework for an IEHM programme that would enable monitoring and measuring the impact of environmental changes on human health.", {"entities": []}], ["We define IEHM as \u2018a systemic process to measure, analyse and interpret the state and changes of natural-eco-anthropogenic systems and its related health impact over time at the same location with causative explanations across the various compartments of the cause-effect chain\u2019.", {"entities": []}], ["We develop a structural work process to integrate information that is based on existing environmental health monitoring programmes.", {"entities": []}], ["Such a framework allows the development of combined monitoring systems that exhibit a large degree of compatibility between countries and regions.", {"entities": []}], ["Activity monitoring of a person for a long-term would be helpful for controlling lifestyle associated diseases.", {"entities": []}], ["Such diseases are often linked with the way a person lives.", {"entities": []}], ["An unhealthy and irregular standard of living influences the risk of such diseases in the later part of one's life.", {"entities": []}], ["The symptoms and the initial signs of these diseases are common to the people with irregular lifestyle.", {"entities": []}], ["In this paper, we propose a novel healthcare framework to manage lifestyle diseases using long-term activity monitoring.", {"entities": []}], ["The framework recognizes the user's activities with the help of the sensed data in runtime and reports the irregular and unhealthy activity patterns to a doctor and a caregiver.", {"entities": []}], ["The proposed framework is a hierarchical structure that consists of three modules: activity recognition, activity pattern generation and lifestyle disease prediction.", {"entities": []}], ["We show that it is possible to assess the possibility of lifestyle diseases from the sensor data.", {"entities": []}], ["We also show the viability of the proposed framework.", {"entities": []}], ["Metalloenzyme arginase is a therapeutically relevant target associated with tumor growth.", {"entities": []}], ["To fight cancer immunosuppression, arginase activity can be modulated by small chemical inhibitors binding to its catalytic center.", {"entities": [[9, 15, "DISEASE"]]}], ["To better understand molecular mechanisms of arginase inhibition, a careful computer-aided mechanistic structural investigation of this enzyme was conducted.", {"entities": []}], ["Using molecular dynamics (MD) simulations in the microsecond range, key regions of the protein active site were identified and their flexibility was evaluated and compared.", {"entities": []}], ["A cavity opening phenomenon was observed, involving three loops directly interacting with all known ligands, while metal coordinating regions remained motionless.", {"entities": []}], ["A novel dynamic 3D pharmacophore analysis method termed dynophores has been developed that allows for the construction of a single 3D-model comprising all ligand-enzyme interactions occurring throughout a complete MD trajectory.", {"entities": []}], ["This new technique for the in silico study of intermolecular interactions allows for loop flexibility analysis coupled with movements and conformational changes of bound ligands.", {"entities": []}], ["Presented MD studies highlight the plasticity of the size of the arginase active site, leading to the hypothesis that larger ligands can enter the cavity of arginase.", {"entities": []}], ["Experimental testing of a targeted fragment library substituted by different aliphatic groups validates this hypothesis, paving the way for the design of arginase inhibitors with novel binding patterns.", {"entities": []}], ["A high prevalence of chronic fatigue has previously been reported following giardiasis after a large waterborne outbreak in Bergen, Norway in 2004.", {"entities": [[76, 86, "DISEASE"]]}], ["The aim of this study was to describe and evaluate differential diagnoses and natural course of fatigue five years after giardiasis among patients who reported chronic fatigue three years after the infection.", {"entities": [[121, 131, "DISEASE"]]}], ["Patients who three years after Giardia infection met Chalder\u2019s criteria for chronic fatigue (n=347) in a questionnaire study among all patients who had laboratory confirmed giardiasis during the Bergen outbreak (n=1252) were invited to participate in this study five years after the infection (n=253).", {"entities": [[173, 183, "DISEASE"]]}], ["Structured interviews and clinical examination were performed by specialists in psychiatry, neurology and internal medicine/infectious diseases.", {"entities": []}], ["Fukuda et al\u2019s 1994 criteria were used to diagnose chronic fatigue syndrome (CFS) and idiopathic chronic fatigue (ICF).", {"entities": [[51, 75, "DISEASE"], [67, 75, "DISEASE"]]}], ["Self-reported fatigue recorded with Chalder Fatigue Questionnaire three and five years after infection were compared.", {"entities": []}], ["53 patients were included.", {"entities": []}], ["CFS was diagnosed in 41.5% (22/53) and ICF in 13.2% (7/53).", {"entities": []}], ["Chronic fatigue caused by other aetiology was diagnosed in 24.5% (13/53); five of these patients had sleep apnoea/hypopnoea syndrome, six had depression and five anxiety disorder, and among these two had more than one diagnosis.", {"entities": [[162, 178, "DISEASE"], [124, 132, "DISEASE"]]}], ["Fatigue had resolved in 20.8% (11/53).", {"entities": []}], ["Self-reported fatigue score in the cohort was significantly reduced at five years compared to three years (p<0.001).", {"entities": []}], ["The study shows that Giardia duodenalis may induce CFS persisting as long as five years after the infection.", {"entities": []}], ["Obstructive sleep apnoea/hypopnoea syndrome, depression and anxiety were important differential diagnoses, or possibly comorbidities, to post-infectious fatigue in this study.", {"entities": [[35, 43, "DISEASE"]]}], ["Improvement of chronic fatigue in the period from three to five years after giardiasis was found.", {"entities": [[76, 86, "DISEASE"]]}], ["Neutrophils release free zinc to eliminate the phagocytosed bacterial pathogen Streptococcus pyogenes (Group A Streptococcus ; GAS).", {"entities": []}], ["In this study, we investigated the mechanisms underpinning zinc toxicity towards this human pathogen, responsible for diseases ranging from pharyngitis and impetigo, to severe invasive infections.", {"entities": [[156, 164, "DISEASE"], [140, 151, "DISEASE"]]}], ["Using the globally-disseminated M1T1 GAS strain, we demonstrate that zinc stress impairs glucose metabolism through the inhibition of the glycolytic enzymes phosphofructokinase and glyceraldehyde-3-phosphate dehydrogenase.", {"entities": []}], ["In the presence of zinc, a metabolic shift to the tagatose-6-phosphate pathway allows conversion of D-galactose to dihydroxyacetone phosphate and glyceraldehyde phosphate, partially bypassing impaired glycolytic enzymes to generate pyruvate.", {"entities": []}], ["Additionally, zinc inhibition of phosphoglucomutase results in decreased capsule biosynthesis.", {"entities": []}], ["These data indicate that zinc exerts it toxicity via mechanisms that inhibit both GAS central carbon metabolism and virulence pathways.", {"entities": []}], ["Resident intravascular NKT cells exacerbate airway hyperreactivity in mice dependent on dendritic cell co-presentation of glycolipid and peptide antigens.", {"entities": []}], ["Airborne exposure to microbial cell wall lipids such as lipopolysaccharide triggers innate immune responses that regulate susceptibility to allergic airway inflammation.", {"entities": []}], ["\u03b1-Glycosylceramides represent another widespread class of microbial lipids that directly stimulate innate-like, IL-4\u2013 and IL-13\u2013producing, CD1d-restricted NKT cells.", {"entities": []}], ["In this study, we demonstrate that NKT cells constitutively accumulate and reside in the microvasculature of the mouse lung.", {"entities": []}], ["After a single airborne exposure to lipid antigen, they promptly extravasate to orchestrate the formation of peribronchiolar and interstitial lymphohistiocytic granulomas containing numerous eosinophils.", {"entities": []}], ["Concomitant airborne exposure to ovalbumin (OVA) induces the priming of OVA-specific Th2 cells and IgE antibodies by the same dendritic cell coexpressing CD1d and MHC class II.", {"entities": [[154, 158, "GENE"]]}], ["Although NKT cell activation remains confined to the lipid-exposed lung and draining lymph nodes, Th2 cells recirculate and seed the lung of a parabiotic partner, conferring susceptibility to OVA challenge months after the initial exposure, in a manner independent of NKT cells and CD1d.", {"entities": [[282, 286, "GENE"]]}], ["Thus, transient recruitment and activation of lung-resident intravascular NKT cells can trigger long-term susceptibility to allergic airway inflammation.", {"entities": []}], ["Under Executive Order 12898, the U.S. Environmental Protection Agency (EPA) must perform environmental justice (EJ) reviews of its rules and regulations.", {"entities": []}], ["EJ analyses address the hypothesis that environmental disamenities are experienced disproportionately by poor and/or minority subgroups.", {"entities": []}], ["Such analyses typically use communities as the unit of analysis.", {"entities": []}], ["While community-based approaches make sense when considering where polluting sources locate, they are less appropriate for national air quality rules affecting many sources and pollutants that can travel thousands of miles.", {"entities": []}], ["We compare exposures and health risks of EJ-identified individuals rather than communities to analyze EPA\u2019s Heavy Duty Diesel (HDD) rule as an example national air quality rule.", {"entities": []}], ["Air pollutant exposures are estimated within grid cells by air quality models; all individuals in the same grid cell are assigned the same exposure.", {"entities": []}], ["Using an inequality index, we find that inequality within racial/ethnic subgroups far outweighs inequality between them.", {"entities": []}], ["We find, moreover, that the HDD rule leaves between-subgroup inequality essentially unchanged.", {"entities": []}], ["Changes in health risks depend also on subgroups\u2019 baseline incidence rates, which differ across subgroups.", {"entities": []}], ["Thus, health risk reductions may not follow the same pattern as reductions in exposure.", {"entities": []}], ["These results are likely representative of other national air quality rules as well.", {"entities": []}], ["Acne, the most common problem that presents to dermatologists, can persist beyond teen years.", {"entities": [[0, 4, "DISEASE"]]}], ["Although its physical and psychosocial impact is studied in teen years, it is poorly understood in the Indian adult population.", {"entities": []}], ["To study the physical and psychosocial impact of acne in adult females.", {"entities": [[49, 53, "DISEASE"]]}], ["This exploratory study was done in the university setting.", {"entities": []}], ["Eleven adult, unmarried females, between the age group of 18 and 25 years, having (mild-to-moderate), acne, for two consecutive years, were interviewed using a semi-structured clinical interview of the Skindex, a quality-of-life measure for patients with skin disease, developed by Chren et al ., along with some open-ended questions.", {"entities": [[102, 106, "DISEASE"], [255, 267, "DISEASE"]]}], ["Both qualitative and quantitative analysis was done to analyze the data.", {"entities": []}], ["The results indicated a higher level of emotional and social impairment, in terms of the feelings of physical discomfort, anger, and the intermingling impact of these, among the participants.", {"entities": []}], ["Acne is a common problem among adults and appears to have a considerable impact on the mental health, therefore, for the treatment to be successful, a sympathetic approach by doctors and significant others, with the basic psychosomatic treatment, are necessary.", {"entities": [[0, 4, "DISEASE"]]}], ["One of the major complaints most people face during aging is an impairment in cognitive functioning.", {"entities": []}], ["This has a negative impact on the quality of daily life and is even more prominent in patients suffering from neurodegenerative and psychiatric disorders including Alzheimer\u2019s disease, schizophrenia, and depression.", {"entities": [[185, 198, "DISEASE"]]}], ["So far, the majority of cognition enhancers are generally targeting one particular neurotransmitter system.", {"entities": []}], ["However, recently phosphodiesterases (PDEs) have gained increased attention as a potential new target for cognition enhancement.", {"entities": []}], ["Inhibition of PDEs increases the intracellular availability of the second messengers cGMP and/or cAMP.", {"entities": []}], ["The aim of this review was to provide an overview of the effects of phosphodiesterase inhibitors (PDE-Is) on cognition, the possible underlying mechanisms, and the relationship to current theories about memory formation.", {"entities": []}], ["Studies of the effects of inhibitors of different PDE families (2, 4, 5, 9, and 10) on cognition were reviewed.", {"entities": []}], ["In addition, studies related to PDE-Is and blood flow, emotional arousal, and long-term potentiation (LTP) were described.", {"entities": []}], ["PDE-Is have a positive effect on several aspects of cognition, including information processing, attention, memory, and executive functioning.", {"entities": []}], ["At present, these data are likely to be explained in terms of an LTP-related mechanism of action.", {"entities": []}], ["PDE-Is are a promising target for cognition enhancement; the most suitable candidates appear to be PDE2-Is or PDE9-Is.", {"entities": []}], ["The future for PDE-Is as cognition enhancers lies in the development of isoform-specific PDE-Is that have limited aversive side effects.", {"entities": []}], ["Reducing domestic carbon dioxide and other associated emissions can lead to short-term, localized health benefits.", {"entities": []}], ["Quantifying and incorporating these health co-benefits into the development of national climate change mitigation policies may facilitate the adoption of stronger policies.", {"entities": []}], ["There is, however, a dearth of research exploring the role of health co-benefits on the development of such policies.", {"entities": []}], ["To address this knowledge gap, research was conducted in Australia involving the analysis of several data sources, including interviews carried out with Australian federal government employees directly involved in the development of mitigation policies.", {"entities": []}], ["The resulting case study determined that, in Australia, health co-benefits play a minimal role in the development of climate change mitigation policies.", {"entities": []}], ["Several factors influence the extent to which health co-benefits inform the development of mitigation policies.", {"entities": []}], ["Understanding these factors may help to increase the political utility of future health co-benefits studies.", {"entities": []}], ["This study was carried out to determine heart rate (HR) values, including diurnal, seasonal, and sex patterns, in the African giant rat ( Cricetomys gambianus , Waterhouse).", {"entities": [[52, 54, "GENE"]]}], ["HR was measured using stethoscope in grip-restrained African giant rats of either sex (103 bucks and 98 does), live-trapped from a tropical Savannah, and caged individually in the laboratory during the harmattan (cold-dry), hot-dry, and rainy seasons over a 3-year period.", {"entities": [[0, 2, "GENE"]]}], ["The HR fluctuated between 90 and 210\u00a0beats per minute (bpm) throughout the study period.", {"entities": [[4, 6, "GENE"]]}], ["Diurnal changes in HR (mean\u00a0\u00b1\u00a0SEM) during the hot-dry and rainy seasons were nonsignificant ( P \u00a0>\u00a00.05), but the morning and afternoon values differed ( P\u00a0 < \u00a0 0.01) during the cold-dry season.", {"entities": [[19, 21, "GENE"]]}], ["The HR varied ( P\u00a0 < \u00a0 0.05) among seasons, with peak, nadir, and moderate values recorded during the cold-dry (165.8\u00a0\u00b1\u00a00.51\u00a0bpm), hot-dry (153.1\u00a0\u00b1\u00a00.74\u00a0bpm), and rainy (163.4\u00a0\u00b1\u00a00.70\u00a0bpm) seasons, respectively.", {"entities": [[4, 6, "GENE"]]}], ["Mean HR of bucks was lower than that of does during the cold-dry ( P\u00a0 < \u00a0 0.0001) and hot-dry ( P\u00a0 < \u00a0 0.01) seasons, but sex difference during the rainy season was insignificant ( P\u00a0 > \u00a0 0.05).", {"entities": [[5, 7, "GENE"]]}], ["Overall, mean HR was lower ( P\u00a0 < \u00a0 0.0001) in bucks (158.8\u00a0\u00b1\u00a00.53\u00a0bpm) than in does (164.8\u00a0\u00b1\u00a00.53\u00a0bpm).", {"entities": [[14, 16, "GENE"]]}], ["In conclusion, values of HR in African giant rats are shown for the first time.", {"entities": [[25, 27, "GENE"]]}], ["Season, sex, and daytime influenced the HR, and should be considered during clinical evaluations of the rats.", {"entities": [[40, 42, "GENE"]]}], ["Resistant hypertension is inadequately controlled blood pressure (BP) despite treatment with at least three BP-lowering drugs.", {"entities": [[10, 22, "DISEASE"]]}], ["A popular hypothesis is that resistant hypertension is due to excessive Na Placebo-controlled, random crossover study of fourth-line treatment when added to standard (A+C+D) triple drug therapy: ACE inhibitor or Angiotensin receptor blocker (A) +Calcium channel blocker (C)+Diuretic (D).", {"entities": [[39, 51, "DISEASE"]]}], ["Patients (aged 18\u201379\u2005years) with clinical systolic BP\u2265140\u2005mm\u2005Hg (135\u2005mm\u2005Hg in diabetics) and Home BP Monitoring (HBPM) systolic BP average \u2265130\u2005mm\u2005Hg on treatment for at least 3\u2005months with maximum tolerated doses of A+C+D are randomised to four consecutive randomly allocated 12-week treatment cycles with an \u03b1-blocker, \u03b2-blocker, spironolactone and placebo.", {"entities": []}], ["The hierarchical coprimary end point is the difference in HBPM average systolic BP between (in order) spironolactone and placebo, spironolactone and the average of the other two active drugs, spironolactone and each of the other two drugs.", {"entities": []}], ["A key secondary outcome is to determine whether plasma renin predicts the BP response to the different drugs.", {"entities": []}], ["A sample size of 346 (allowing 15% dropouts) will confer 90% power to detect a 3\u2005mm\u2005Hg HBPM average systolic BP difference between any two drugs.", {"entities": []}], ["The study can also detect a 6\u2005mm\u2005Hg difference in HBPM average systolic BP between each patient's best and second-best drug predicted by tertile of plasma renin.", {"entities": []}], ["The study was initiated in May 2009 and results are expected in 2015.", {"entities": []}], ["These will provide RCT evidence to support future guideline recommendations for optimal drug treatment of resistant hypertension.", {"entities": [[116, 128, "DISEASE"]]}], ["Clinicaltrials.gov NCT02369081, EUDract number: 2008-007149-30.", {"entities": []}], ["Please cite this paper as: Tavana et\u00a0al.", {"entities": []}], ["(2011) Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.", {"entities": [[7, 16, "DISEASE"], [56, 67, "DISEASE"], [46, 67, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses DOI: 10.1111/j.1750\u20102659.2011.00290.x.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Sarcoidosis is an inflammatory, granulomatous disorder of unknown etiology.", {"entities": [[12, 23, "DISEASE"]]}], ["The role of cellular and humoral immune systems in this disease is unclear, whereas dysregulation of the immune system is suggested.", {"entities": []}], ["Patients with sarcoidosis show diverse responses while exposed to various antigens.", {"entities": [[14, 25, "DISEASE"]]}], ["Although influenza vaccination is recommended in pulmonary sarcoidosis, its efficacy and safety has not been investigated.", {"entities": [[9, 18, "DISEASE"], [59, 70, "DISEASE"], [49, 70, "DISEASE"]]}], ["Objectives\u2002 To evaluate safety and immunogenicity of influenza vaccine in patients with sarcoidosis.", {"entities": [[53, 62, "DISEASE"], [88, 99, "DISEASE"]]}], ["Patients/Methods\u2002 Influenza vaccination was performed in 23 eligible patients with sarcoidosis (SP) and 26 healthy controls (HC).", {"entities": [[18, 27, "DISEASE"], [83, 94, "DISEASE"]]}], ["Antibody titers against H1N1, H3N2, and B influenza virus antigens were evaluated just before and 1\u2003month after vaccination.", {"entities": [[42, 51, "DISEASE"]]}], ["Patients were followed for 6\u2003months to assess vaccine safety.", {"entities": []}], ["Results\u2002 Serological response and magnitude of changes in antibody titers against influenza vaccine antigens were comparable between SPs and HCs.", {"entities": [[82, 91, "DISEASE"]]}], ["Women showed a better serological response against B antigen ( P \u2003=\u20030\u00b7034) than men.", {"entities": []}], ["Twenty\u2010four\u2010hour urine calcium was associated with antibody response against H1N1 [correlation coefficient (CC)\u2003=\u20030\u00b7477, P \u2003=\u20030\u00b7003] and H3N2 (CC\u2003=\u20030\u00b7352, P \u2003=\u20030\u00b7028) antigens.", {"entities": []}], ["Serum angiotensin\u2010converting enzyme correlated negatively with antibody response against B antigen (CC\u2003=\u2003\u22120\u00b7331, P \u2003=\u20030\u00b7040).", {"entities": []}], ["Higher residual volume was associated with fewer rises in antibody titer against H3N2 antigen (CC\u2003=\u2003\u22120\u00b7377, P \u2003=\u20030\u00b7035).", {"entities": []}], ["No major adverse events or disease flare\u2010up was observed during follow\u2010up.", {"entities": []}], ["Conclusions\u2002 In this study, influenza vaccination did not cause any major adverse event in SPs, and their serological response was equal to HCs.", {"entities": [[28, 37, "DISEASE"]]}], ["Studies with larger sample size and a broader selection of subjects could help validate the results of this study.", {"entities": []}], ["Pandemic A (H1N1) 2009 mortality rates varied widely from one country to another.", {"entities": []}], ["Our aim was to identify potential socioeconomic determinants of pandemic mortality and explain between-country variation.", {"entities": []}], ["Based on data from a total of 30 European countries, we applied random-effects Poisson regression models to study the relationship between pandemic mortality rates (May 2009 to May 2010) and a set of representative environmental, health care-associated, economic and demographic country-level parameters.", {"entities": []}], ["The study was completed by June 2010.", {"entities": []}], ["Most regression approaches indicated a consistent, statistically significant inverse association between pandemic influenza-related mortality and per capita government expenditure on health.", {"entities": [[114, 123, "DISEASE"]]}], ["The findings were similar in univariable [coefficient: \u20130.00028, 95% Confidence Interval (CI): \u20130.00046, \u20130.00010, p\u200a=\u200a0.002] and multivariable analyses (including all covariates, coefficient: \u20130.00107, 95% CI: \u20130.00196, \u20130.00018, p\u200a=\u200a0.018).", {"entities": []}], ["The estimate was barely insignificant when the multivariable model included only significant covariates from the univariate step (coefficient: \u20130.00046, 95% CI: \u20130.00095, 0.00003, p\u200a=\u200a0.063).", {"entities": []}], ["Our findings imply a significant inverse association between public spending on health and pandemic influenza mortality.", {"entities": [[100, 109, "DISEASE"]]}], ["In an attempt to interpret the estimated coefficient (\u20130.00028) for the per capita government expenditure on health, we observed that a rise of 100 international dollars was associated with a reduction in the pandemic influenza mortality rate by approximately 2.8%.", {"entities": [[218, 227, "DISEASE"]]}], ["However, further work needs to be done to unravel the mechanisms by which reduced government spending on health may have affected the 2009 pandemic influenza mortality.", {"entities": [[148, 157, "DISEASE"]]}], ["A continuous process of trauma centre evaluation is essential to ensure the development and progression of trauma care at regional, national and international levels.", {"entities": []}], ["Evaluation may be by comparison between pooled datasets or by direct benchmarking between centres.", {"entities": []}], ["This study attempts to benchmark mortality at two trauma centres standardising this for multiple case-mix factors, which includes the prevalence of individual background pre-existing diseases within the study population.", {"entities": []}], ["Trauma patients with an Injury Severity Score (ISS) >15 admitted to the two centres in 2001 and 2002 were included in the study with the exception of those who died in the emergency department.", {"entities": []}], ["Patient characteristics were analysed in terms of 18 case-mix factors including Glasgow Coma Scale on arrival, Injury Severity Score and the presence or absence of 9 co-morbidity types, and patient outcome was compared based on in-hospital mortality before and after standardisation.", {"entities": []}], ["Crude mortality was greater at UHNS (18.2 vs 14.5%) with a non-significant odds ratio of 1.31 prior to adjusting for case-mix (P = 0.171).", {"entities": []}], ["Adjustment for case mix using logistic regression analysis altered the odds ratio to 1.64, which was not significant (P = 0.069).", {"entities": []}], ["This study did not demonstrate any significant difference in the outcome of patients treated at either hospital during the study period.", {"entities": []}], ["More importantly it has raised several important methodological issues pertinent to researchers undertaking registry based benchmarking studies.", {"entities": []}], ["Data at the two registries was collected by personnel with differing backgrounds, in formats that were not completely compatible and was collected for patients that met different admissions criteria.", {"entities": []}], ["The inclusion of a meaningful analysis of pre-existing disease was limited by the availability of robust data and sample size.", {"entities": []}], ["We suggest greater communication between trauma research coordinators to ensure equivalent data collection and facilitate future benchmarking studies.", {"entities": []}], ["A vast diversity of microbes colonizes in the human gastrointestinal tract, referred to intestinal microbiota.", {"entities": []}], ["Microbiota and products thereof are indispensable for shaping the development and function of host innate immune system, thereby exerting multifaceted impacts in gut health.", {"entities": []}], ["This paper reviews the effects on immunity of gut microbe-derived nucleic acids, and gut microbial metabolites, as well as the involvement of commensals in the gut homeostasis.", {"entities": []}], ["We focus on the recent findings with an intention to illuminate the mechanisms by which the microbiota and products thereof are interacting with host immunity, as well as to scrutinize imbalanced gut microbiota (dysbiosis) which lead to autoimmune disorders including inflammatory bowel disease (IBD), Type 1 diabetes (T1D) and systemic immune syndromes such as rheumatoid arthritis (RA).", {"entities": [[268, 294, "DISEASE"], [362, 382, "DISEASE"], [373, 382, "DISEASE"]]}], ["In addition to their well-recognized benefits in the gut such as occupation of ecological niches and competition with pathogens, commensal bacteria have been shown to strengthen the gut barrier and to exert immunomodulatory actions within the gut and beyond.", {"entities": []}], ["It has been realized that impaired intestinal microbiota not only contribute to gut diseases but also are inextricably linked to metabolic disorders and even brain dysfunction.", {"entities": []}], ["A better understanding of the mutual interactions of the microbiota and host immune system, would shed light on our endeavors of disease prevention and broaden the path to our discovery of immune intervention targets for disease treatment.", {"entities": []}], ["Chlamydia spp .", {"entities": []}], ["are believed to use a conserved virulence factor called type III secretion (T3S) to facilitate the delivery of effector proteins from the bacterial pathogen to the host cell.", {"entities": []}], ["Important early effector proteins of the type III secretion system (T3SS) are a class of proteins called the translocators.", {"entities": []}], ["The translocator proteins insert into the host cell membrane to form a pore, allowing the injectisome to dock onto the host cell to facilitate translocation of effectors.", {"entities": []}], ["CopB is a predicted hydrophobic translocator protein within the chlamydial T3SS.", {"entities": []}], ["In this study, we identified a novel interaction between the hydrophobic translocator, CopB, and the putative filament protein, CdsF.", {"entities": []}], ["Furthermore, we identified a conserved PxLxxP motif in CopB (amino acid residues 166\u2013171), which is required for interaction with its cognate chaperone, LcrH_1.", {"entities": []}], ["Using a synthetic peptide derived from the chaperone binding motif of CopB, we were able to block the LcrH_1 interaction with either CopB or CopD; this CopB peptide was capable of inhibiting C. pneumoniae infection of HeLa cells at micromolar concentrations.", {"entities": []}], ["An antibody raised against the N-terminus of CopB was able to inhibit C. pneumoniae infection of HeLa cells.", {"entities": []}], ["The inhibition of the LcrH_1:CopB interaction with a cognate peptide and subsequent inhibition of host cell infection provides strong evidence that T3S is an essential virulence factor for chlamydial infection and pathogenesis.", {"entities": []}], ["Together, these results support that CopB plays the role of a hydrophobic translocator.", {"entities": []}], ["Allergic rhinoconjunctivitis is the most common atopic condition encountered in clinical practice.", {"entities": []}], ["Analysis of the pathogenesis of this condition permits identification of optimal therapeutic targets.", {"entities": []}], ["The increased knowledge of the underlying pathophysiology suggests that multiple inflammatory mediators are involved in the pathogenesis of the allergic reaction in the ocular and nasal mucosa.", {"entities": []}], ["However, despite the presence of a wide range of different mediators, it would appear that histamine plays a key role.", {"entities": []}], ["Experimental allergen challenge studies have demonstrated that histamine is the only mediator which produces the full spectrum of clinical manifestations of the acute allergic reaction when applied to the mucosal surface.", {"entities": []}], ["While both H 1 - and H 2 -receptors are present in the nasal and ocular mucosa, only H 1 -receptor antagonists are capable of inhibiting histamine-induced symptoms of allergic rhinoconjunctivitis.", {"entities": []}], ["Furthermore, although the exact role of histamine in the immediate and prolonged allergic reaction has not yet been fully elucidated, these findings do not exclude the possibility that histamine is involved in these processes.", {"entities": []}], ["The available evidence therefore supports current clinical practice for use of H 1 -receptor antagonist as a first-line therapy in patients with this atopic condition.", {"entities": []}], ["High-sensitivity C-reactive protein (hs-CRP) is a commonly used inflammatory marker.", {"entities": []}], ["The association between hs-CRP and cancer is less consistent than that between hs-CRP and cardiovascular diseases.", {"entities": [[35, 41, "DISEASE"]]}], ["This study explored the association between hs-CRP and cancer, using a large database of Korean health examination records.", {"entities": [[55, 61, "DISEASE"]]}], ["A total of 80 781 Koreans who visited the health promotion center of a general hospital were included.", {"entities": []}], ["There were 729 cases of cancer of any primary site during a 3-year period.", {"entities": [[24, 30, "DISEASE"]]}], ["Subjects with a known cancer or a condition capable of affecting hs-CRP were excluded.", {"entities": [[22, 28, "DISEASE"]]}], ["Serum hs-CRP was significantly higher in cancer cases (2.9 mg/L) than in non-cases (1.4 mg/L; P < 0.0001).", {"entities": [[41, 47, "DISEASE"]]}], ["With the lowest hs-CRP category (<1 mg/L) as reference, the crude odds ratios (ORs) for cancer were 1.36 (95% confidence interval [CI] = 1.16\u20131.62) for the second highest category (1\u20133 mg/L) and 2.49 (95% CI = 2.02\u20133.07) for the highest category (>3 mg/L), and the adjusted ORs for cancer were 1.16 (95% CI = 0.95\u20131.42) for the second highest category and 1.94 (95% CI = 1.51\u20132.51) for the highest category.", {"entities": [[88, 94, "DISEASE"], [282, 288, "DISEASE"]]}], ["After excluding cancer cases detected within 1 year after the check-up, the associations remained, although the reduced number of cancer cases ( n = 88) attenuated the significance of the associations.", {"entities": [[16, 22, "DISEASE"], [130, 136, "DISEASE"]]}], ["Serum hs-CRP was positively associated with the risk of cancer, although causality cannot be inferred in this cross-sectional study.", {"entities": [[56, 62, "DISEASE"]]}], ["The results support the hypothesis that chronic inflammation plays a role in cancer.", {"entities": [[77, 83, "DISEASE"]]}], ["Supplemental Digital Content is available in the text Positron emission tomography (PET) visualizes increased cellular [ Patients (n\u200a=\u200a109) with end-stage pulmonary disease being evaluated for lung transplant were included in this observational study.", {"entities": []}], ["Mean standardized uptake value (SUV mean ) of predefined regions of interest in lung parenchyma (LP), left (LV), and right ventricle (RV) of the heart, and SUV max in pulmonary artery (PA) were determined and normalized to liver uptake.", {"entities": [[160, 163, "GENE"]]}], ["These SUV ratios (SUVRs) were compared with results from right heart catheterization (mean pulmonary artery pressure [mPAP], pulmonary vascular resistance [PVR]), and serum N-terminal pro-brain natriuretic peptide.", {"entities": [[156, 159, "GENE"]]}], ["Group comparisons were performed and Pearson correlation coefficients ( r ) were calculated.", {"entities": []}], ["The [ P \u200a=\u200a0.013, P \u200a=\u200a0.006, P \u200a=\u200a0.049, P \u200a=\u200a0.002, P \u200a=\u200a0.68, respectively) and with PVR \u2265480\u200adyn\u00b7s/cm P \u200a<\u200a0.001, P \u200a=\u200a0.045, P \u200a<\u200a0.001, P \u200a<\u200a0.001, P \u200a=\u200a0.26, respectively).", {"entities": [[88, 91, "GENE"]]}], ["The [ r \u200a=\u200a0.55, r \u200a=\u200a0.42, respectively).", {"entities": []}], ["Pulmonary and cardiac [", {"entities": []}], ["To determine variation over time and between practices in recording of concerns related to abuse and neglect (maltreatment) in children's primary care records.", {"entities": []}], ["Retrospective cohort study using a United Kingdom representative primary care database.", {"entities": []}], ["448 General Practices.", {"entities": []}], ["In total 1,548, 972 children (<18 y) registered between 1995 and 2010.", {"entities": []}], ["Change in annual incidence of one or more maltreatment-related codes per child year of registration.", {"entities": []}], ["Variation between general practices measured as the proportion of registered children with one or more maltreatment-related codes during 3 years (2008\u20132010).", {"entities": []}], ["From 1995\u20132010, annual incidence rates of any coded maltreatment-related concerns rose by 10.8% each year (95% confidence interval 10.5, 11.2; adjusted for sex, age and deprivation).", {"entities": []}], ["In 2010 the rate was 9.5 per 1000 child years (95%CI: 9.3, 9.8), equivalent to a prevalence of 0.8% of all registered children in 2010.", {"entities": []}], ["Across all practices, the median prevalence of children with any maltreatment-related codes in three years (2008 to 2010) was 0.9% (range 0%\u201313.4%; 11 practices (2.5%) had zero children with relevant codes in the same period).", {"entities": []}], ["Once we accounted for sex, age, and deprivation, the prevalence for each practice was within two standard errors of the grand mean.", {"entities": []}], ["General Practitioners (GPs) are far from disengaged from safeguarding children; they are consistently and increasingly recording maltreatment concerns.", {"entities": []}], ["As these results are likely to underestimate the burden of maltreatment known to primary care, there is much scope for increasing recording in primary care records with implications for resources to respond to concerns about maltreatment.", {"entities": []}], ["Interventions and policies should build on this evidence that the average GP in the UK is engaged in child safeguarding activity.", {"entities": []}], ["Natural allergen sources can supply large quantities of authentic allergen mixtures for use as immunotherapeutics.", {"entities": []}], ["However, such extracts are complex, difficult to define, vary from batch to batch, which may lead to unpredictable efficacy and/or unacceptable levels of side effects.", {"entities": []}], ["The use of recombinant expression systems for allergen production can alleviate some of these issues.", {"entities": []}], ["Several allergens have been tested in high-level expression systems and in most cases show immunereactivity comparable to their natural counterparts.", {"entities": []}], ["The gram positive lactic acid bacterium Lactococcus lactis is an attractive microorganism for use in the production of protein therapeutics.", {"entities": []}], ["L. lactis is considered food grade, free of endotoxins, and is able to secrete the heterologous product together with few other native proteins.", {"entities": []}], ["Hypersensitivity to peanut represents a serious allergic problem.", {"entities": []}], ["Some of the major allergens in peanut have been described.", {"entities": []}], ["However, for therapeutic usage more information about the individual allergenic components is needed.", {"entities": []}], ["In this paper we report recombinant production of the Ara h 2 peanut allergen using L. lactis .", {"entities": []}], ["A synthetic ara h 2 gene was cloned into an L. lactis expression plasmid containing the P170 promoter and the SP310mut2 signal sequence.", {"entities": []}], ["Flask cultures grown overnight showed secretion of the 17 kDa Ara h 2 protein.", {"entities": []}], ["A batch fermentation resulted in 40 mg/L recombinant Ara h 2.", {"entities": []}], ["Purification of Ara h 2 from the culture supernatant was done by hydrophobic exclusion and size separation.", {"entities": []}], ["Mass spectrometry and N-terminal analysis showed a recombinant Ara h 2 of full length and correctly processed by the signal peptidase.", {"entities": []}], ["The immunological activity of recombinant Ara h 2 was analysed by ELISA using antibodies specific for native Ara h 2.", {"entities": []}], ["The recombinant Ara h 2 showed comparable immunereactivity to that of native Ara h 2.", {"entities": []}], ["Recombinant production of Ara h 2 using L. lactis can offer high yields of secreted, full length and immunologically active allergen.", {"entities": []}], ["The L. lactis expression system can support recombinant allergen material for immunotherapy and component resolved allergen diagnostics.", {"entities": []}], ["The IL4 -590 gene polymorphism has been shown to be associated with elevated levels of anti- Plasmodium falciparum IgG antibodies and parasite intensity in the malaria protected Fulani of West Africa.", {"entities": [[160, 167, "DISEASE"], [4, 7, "GENE"]]}], ["This study aimed to investigate the possible impact of IL4 -590C/T polymorphism on anti- P. falciparum IgG subclasses and IgE antibodies levels and the alteration of malaria severity in complicated and uncomplicated malaria patients with or without previous malaria experiences.", {"entities": [[166, 173, "DISEASE"], [216, 223, "DISEASE"], [258, 265, "DISEASE"], [55, 58, "GENE"]]}], ["Anti- P.falciparum IgG subclasses and IgE antibodies in plasma of complicated and uncomplicated malaria patients with or without previous malaria experiences were analysed using ELISA.", {"entities": [[96, 103, "DISEASE"], [138, 145, "DISEASE"]]}], ["IL4 -590 polymorphisms were genotyped using RFLP-PCR.", {"entities": [[0, 3, "GENE"]]}], ["Statistical analyses of the IgG subclass levels were done by Oneway ANOVA.", {"entities": []}], ["Genotype differences were tested by Chi-squared test.", {"entities": []}], ["The IL4 -590T allele was significantly associated with anti- P. falciparum IgG3 antibody levels in patients with complicated ( P = 0.031), but not with uncomplicated malaria ( P = 0.622).", {"entities": [[166, 173, "DISEASE"], [4, 7, "GENE"]]}], ["Complicated malaria patients with previous malaria experiences carrying IL4 -590TT genotype had significantly lower levels of anti- P. falciparum IgG3 ( P = 0.0156), while uncomplicated malaria patients with previous malaria experiences carrying the same genotype had significantly higher levels (P = 0.0206) compared to their IL4 -590 counterparts.", {"entities": [[12, 19, "DISEASE"], [43, 50, "DISEASE"], [186, 193, "DISEASE"], [217, 224, "DISEASE"], [72, 75, "GENE"], [327, 330, "GENE"], [72, 75, "GENE"], [327, 330, "GENE"]]}], ["The different anti- P. falciparum IgG1 and IgG3 levels among IL4 genotypes were observed.", {"entities": [[61, 64, "GENE"]]}], ["Complicated malaria patients with previous malaria experiences tended to have lower IgG3 levels in individuals carrying TT when compared to CT genotypes ( P = 0.075).", {"entities": [[12, 19, "DISEASE"], [43, 50, "DISEASE"]]}], ["In contrast, complicated malaria patients without previous malaria experiences carrying CC genotype had significantly higher anti- P. falciparum IgG1 than those carrying either CT or TT genotypes ( P = 0.004, P = 0.002, respectively).", {"entities": [[25, 32, "DISEASE"], [59, 66, "DISEASE"]]}], ["The results suggest that IL4 -590C or T alleles participated differently in the regulation of anti-malarial antibody isotype profiles in primary and secondary malaria infection and, therefore, could play an important role in alteration of malaria severity.", {"entities": [[159, 166, "DISEASE"], [239, 246, "DISEASE"], [25, 28, "GENE"]]}], ["Based on the first National Study of Coal Workers\u2019 Pneumoconiosis (CWP) and the U.S. Geological Survey database of coal quality, we show that the prevalence of CWP in seven coal mine regions correlates with levels of bioavailable iron (BAI) in the coals from that particular region (correlation coefficient r = 0.94, p < 0.0015).", {"entities": []}], ["CWP prevalence is also correlated with contents of pyritic sulfur ( r = 0.91, p < 0.0048) or total iron ( r = 0.85, p < 0.016) but not with coal rank ( r = 0.59, p < 0.16) or silica ( r = 0.28, p < 0.54).", {"entities": []}], ["BAI was calculated using our model, taking into account chemical interactions of pyrite, sulfuric acid, calcite, and total iron.", {"entities": []}], ["That is, iron present in coals can become bioavailable by pyrite oxidation, which produces ferrous sulfate and sulfuric acid.", {"entities": []}], ["Calcite is the major component in coals that neutralizes the available acid and inhibits iron\u2019s bioavailability.", {"entities": []}], ["Therefore, levels of BAI in the coals are determined by the available amounts of acid after neutralization of calcite and the amount of total iron in the coals.", {"entities": []}], ["Using the linear fit of CWP prevalence and the calculated BAI in the seven coal mine regions, we have derived and mapped the pneumoconiotic potencies of 7,000 coal samples.", {"entities": []}], ["Our studies indicate that levels of BAI in the coals may be used to predict coal\u2019s toxicity, even before large-scale mining.", {"entities": []}], ["A retrospective analysis of a cross-sectional, multicenter survey was conducted in United States (US) medical practices to evaluate the concordance between patients with COPD and their physicians on disease-specific characteristics.", {"entities": []}], ["Associations between patient and disease-related characteristics with monotherapy, dual therapy, or triple therapy prescribed as COPD maintenance regimens were also examined.", {"entities": []}], ["Eligible physicians completed patient record forms (PRFs) for up to 6 consecutive patients with COPD.", {"entities": []}], ["Patients for whom a PRF was completed were invited to complete a patient self-completion (PSC) survey consisting of questions similar to those on the PRF, as well as several validated measures to assess the impact of COPD on patients\u2019 lives.", {"entities": []}], ["A total of 469 patients completed a PSC that was matched with the PRF completed by their physician, forming the sample for the concordance analysis.", {"entities": []}], ["Moderate agreement (kappa (\u03ba) = 0.41\u20130.60) was observed for 79% of measures, with the lowest concordance rating corresponding to hemoptysis (\u03ba = 0.22).", {"entities": []}], ["There were few differences in demographic or clinical characteristics between patients prescribed monotherapy and dual therapy.", {"entities": []}], ["Triple therapy rather than monotherapy or dual therapy was more often prescribed for patients with greater frequency of symptoms, negative impact of COPD on daily life and interpersonal relationships, and respiratory impairment based on the most recent FEV1.", {"entities": []}], ["Diverse factors influence US physicians\u2019 perceptions of disease and treatment choices, including patient symptoms, quality of life, and disease impact.", {"entities": []}], ["Our results highlight that concordance between physicians and patients regarding symptoms and physical function may contribute to optimal management of COPD.", {"entities": []}], ["Preliminary data are given on the LD50 of PdCl2 following different routes of exposure and on the LD50 of PtCl4 following intravenous exposure.", {"entities": [[42, 47, "GENE"]]}], ["The retention, tissue distribution, and excretion of 103Pd and 191Pt in rats was determined following oral, intravenous, intratracheal, and inhalation exposure.", {"entities": []}], ["The highest retention for both 103Pd and 191Pt was obtained following intravenous dosing, and the lowest retention occurred after oral dosing.", {"entities": []}], ["Following a single oral dose, almost all of the 103Pd and 191Pt was excreted in the feces due to nonabsorption, whereas after intravenous dosing, similar quantities were excreted in both the urine and feces.", {"entities": []}], ["Tissues containing the highest concentrations of these metals were the kidney, spleen and liver.", {"entities": []}], ["Following intravenous dosing of pregnant rats, a small amount of 103Pd and 191Pt was found in the fetuses.", {"entities": []}], ["This study is a systematic evaluation of a novel tobacco product, electronic cigarettes (ECIGs) using a two-site, four-arm, 6-month, parallel-group randomized controlled trial (RCT) with a follow-up to 9\u00a0months.", {"entities": []}], ["Virginia Commonwealth University is the primary site and Penn State University is the secondary site.", {"entities": []}], ["This RCT design is important because it is informed by analytical work, clinical laboratory results, and qualitative/quantitative findings regarding the specific ECIG products used.", {"entities": []}], ["Participants ( N \u2009=\u2009520) will be randomized across sites and must be healthy smokers of >9 cigarettes for at least one year, who have not had a quit attempt in the prior month, are not planning to quit in the next 6\u00a0months, and are interested in reducing cigarette intake.", {"entities": []}], ["Participants will be randomized into one of four 24-week conditions: a cigarette substitute that does not produce an inhalable aerosol; or one of three ECIG conditions that differ by nicotine concentration 0, 8, or 36\u00a0mg/ml.", {"entities": []}], ["Blocked randomization will be accomplished with a 1:1:1:1 ratio of condition assignments at each site.", {"entities": []}], ["Specific aims are to: characterize ECIG influence on toxicants, biomarkers, health indicators, and disease risk; determine tobacco abstinence symptom and adverse event profile associated with real-world ECIG use; and examine the influence of ECIG use on conventional tobacco product use.", {"entities": []}], ["Liquid nicotine concentration-related differences on these study outcomes are predicted.", {"entities": []}], ["Participants and research staff in contact with participants will be blinded to the nicotine concentration in the ECIG conditions.", {"entities": []}], ["Results from this study will inform knowledge concerning ECIG use as well as demonstrate a model that may be applied to other novel tobacco products.", {"entities": []}], ["The model of using prior empirical testing of ECIG devices should be considered in other RCT evaluations.", {"entities": []}], ["TRN: NCT02342795 , registered December 16, 2014.", {"entities": []}], ["In 2004, as an extension of the Enhanced Primary Care (EPC) program, the Australian Government introduced a policy of providing Medicare rebates for allied health services provided to patients with chronic or complex health conditions.", {"entities": []}], ["The objective of this study was to evaluate the utilisation of podiatry services provided under this scheme between 2004 and 2008.", {"entities": []}], ["Data pertaining to the Medicare item 10962 for the calendar years 2004-2008 were extracted from the Australian Medicare Benefits Schedule (MBS) database and cross-tabulated by sex and age.", {"entities": []}], ["Descriptive analyses were undertaken to assess sex and age differences in the number of consultations provided and to assess for temporal trends over the five-year assessment period.", {"entities": []}], ["The total cost to Medicare over this period was also determined.", {"entities": []}], ["During the 2004-2008 period, a total of 1,338,044 EPC consultations were provided by podiatrists in Australia.", {"entities": []}], ["Females exhibited higher utilisation than males (63 versus 37%), and those aged over 65 years accounted for 75% of consultations.", {"entities": []}], ["There was a marked increase in the number of consultations provided from 2004 to 2008, and the total cost of providing EPC podiatry services during this period was $62.9 M. Podiatry services have been extensively utilised under the EPC program by primary care patients, particularly older women, and the number of services provided has increased dramatically between 2004 and 2008.", {"entities": []}], ["Further research is required to determine whether the EPC program enhances clinical outcomes compared to standard practice.", {"entities": []}], ["Background Depression is a particular problem in older people and it is important to know how it affects and is affected by smoking cessation.", {"entities": []}], ["Aims To identify reciprocal, longitudinal relationships between smoking cessation and depression among older smokers.", {"entities": []}], ["Method Across four waves, covering six years (2002\u20132008), changes in smoking status and depression, measured using the 8-item Centre for Epidemiologic Studies Depression Scale, were assessed among recent ex-smokers and smokers ( n = 2375) in the English Longitudinal Study of Ageing.", {"entities": []}], ["Results In latent growth curve analysis, smoking at baseline predicted depression caseness longitudinally and vice versa.", {"entities": []}], ["When both processes were modelled concurrently, depression predicted continued smoking longitudinally (B(\u03b2) = 0.21 (0.27); 95% CI = 0.08\u20130.35) but not the other way round.", {"entities": []}], ["This was the case irrespective of mental health history and adjusting for a range of covariates.", {"entities": []}], ["Conclusions In older smokers, depression appears to act as an important barrier to quitting, although quitting has no long-term impact on depression.", {"entities": []}], ["Fredberg takes a physical approach to model mechanical properties of cells and tissues.", {"entities": []}], ["Fredberg takes a physical approach to model mechanical properties of cells and tissues.", {"entities": []}], ["An association between eosinophilic esophagitis (EoE) and celiac disease (CD) has been suggested in the literature.", {"entities": [[36, 47, "DISEASE"], [58, 72, "DISEASE"], [23, 47, "DISEASE"]]}], ["Our aim was to confirm and quantify the association between these two diseases.", {"entities": []}], ["All patients in a large Canadian city diagnosed with EoE or CD over a five-year period were identified.", {"entities": []}], ["Standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) were calculated.", {"entities": []}], ["Over the five-year study EoE was diagnosed in 421 patients and CD was diagnosed in 763 patients.", {"entities": []}], ["The incidence of EoE ranged from 2.1 to 10.7 cases per 100,000 population.", {"entities": []}], ["The incidence of CD ranged from 10.4 to 15.7 cases per 100,000 population.", {"entities": []}], ["Among the EoE cohort, 83 (20%) cases of EoE and 245 (32%) cases of CD were diagnosed in pediatric patients.", {"entities": []}], ["The incidence of EoE in the pediatric subpopulation ranged from 3.7 to 6.9 cases per 100,000 population.", {"entities": []}], ["The incidence of CD in the pediatric subpopulation ranged from 9.5 to 22.7 cases per 100,000 population.", {"entities": []}], ["The concomitant diagnosis of both EoE and CD was made in three patients, all of whom were pediatric males.", {"entities": []}], ["The SIR for EoE in the CD cohort was 48.4 (95% CI\u2009=\u20099.73, 141.41) with a SIR for CD within the paediatric EoE cohort of 75.05 (95% CI\u2009=\u200915.08, 219.28).", {"entities": []}], ["This study confirms the association between EoE and CD.", {"entities": []}], ["However, this association may be limited to pediatrics where the risk of each condition is increased 50 to 75-fold in patients diagnosed with the alternative condition.", {"entities": []}], ["The concomitant diagnosis of these conditions should be considered in pediatric patients with upper gastrointestinal symptoms.", {"entities": []}], ["Clinical quality indicators are used to monitor the performance of healthcare services and should wherever possible be based on research evidence.", {"entities": []}], ["Little is known however about the extent to which indicators in common use are based on research.", {"entities": []}], ["The objective of this study is to measure the extent to which clinical quality indicators used in asthma management in children with outcome measurements can be linked to results in randomised controlled clinical trial (RCT) reports.", {"entities": [[98, 104, "DISEASE"]]}], ["This work is part of a broader research program to trial methods that improve the efficiency and accuracy of indicator development.", {"entities": []}], ["National-level indicators for asthma management in children were extracted from the National Quality Measures Clearinghouse database and the National Institute for Health and Care Excellence quality standards by two independent appraisers.", {"entities": [[30, 36, "DISEASE"]]}], ["Outcome measures were extracted from all published English language RCT reports for asthma management in children below the age of 12 published between 2005 and 2014.", {"entities": [[84, 90, "DISEASE"]]}], ["The two sets were then linked by manually mapping both to a common set of Unified Medical Language System (UMLS) concepts.", {"entities": []}], ["The analysis identified 39 indicators and 562 full text RCTs dealing with asthma management in children.", {"entities": [[74, 80, "DISEASE"]]}], ["About 95% (37/39) of the indicators could be linked to RCT outcome measures.", {"entities": []}], ["It is possible to identify relevant RCT reports for the majority of indicators used to assess the quality of asthma management in childhood.", {"entities": [[109, 115, "DISEASE"]]}], ["The methods reported here could be automated to more generally support assessment of candidate indicators against the research evidence.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-017-2324-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This work provides the first description of the bacterial population of the lung microbiota in mice.", {"entities": []}], ["The aim of this study was to examine the lung microbiome in mice, the most used animal model for inflammatory lung diseases such as COPD, cystic fibrosis and asthma.", {"entities": [[138, 153, "DISEASE"], [158, 164, "DISEASE"]]}], ["Bacterial communities from broncho-alveolar lavage fluids and lung tissue were compared to samples taken from fecal matter (caecum) and vaginal lavage fluid from female BALB/cJ mice.", {"entities": []}], ["Using a customized 16S rRNA sequencing protocol amplifying the V3-V4 region our study shows that the mice have a lung microbiome that cluster separately from mouse intestinal microbiome (caecum).", {"entities": []}], ["The mouse lung microbiome is dominated by Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes and Cyanobacteria overlapping the vaginal microbiome.", {"entities": []}], ["We also show that removal of host tissue or cells from lung fluid during the DNA extraction step has an impact on the resulting bacterial community profile.", {"entities": []}], ["Sample preparation needs to be considered when choosing an extraction method and interpreting data.", {"entities": []}], ["We have consistently amplified bacterial DNA from mouse lungs that is distinct from the intestinal microbiome in these mice.", {"entities": []}], ["The gut microbiome has been extensively studied for its links to development of disease.", {"entities": []}], ["Here we suggest that also the lung microbiome could be important in relation to inflammatory lung diseases.", {"entities": []}], ["Further research is needed to understand the contribution of the lung microbiome and the gut-lung axis to the development of lung diseases such as COPD and asthma.", {"entities": [[156, 162, "DISEASE"]]}], ["The northern part of India harbours a great diversity of medicinal plants due to its distinct geography and ecological marginal conditions.", {"entities": []}], ["The traditional medical systems of northern India are part of a time tested culture and honored still by people today.", {"entities": []}], ["These traditional systems have been curing complex disease for more than 3,000 years.", {"entities": []}], ["With rapidly growing demand for these medicinal plants, most of the plant populations have been depleted, indicating a lack of ecological knowledge among communities using the plants.", {"entities": []}], ["Thus, an attempt was made in this study to focus on the ecological status of ethnomedicinal plants, to determine their availability in the growing sites, and to inform the communities about the sustainable exploitation of medicinal plants in the wild.", {"entities": []}], ["The ecological information regarding ethnomedicinal plants was collected in three different climatic regions (tropical, sub-tropical and temperate) for species composition in different forest layers.", {"entities": []}], ["The ecological information was assessed using the quadrate sampling method.", {"entities": []}], ["A total of 25 quadrats, 10 \u00d7 10 m were laid out at random in order to sample trees and shrubs, and 40 quadrats of 1 \u00d7 1 m for herbaceous plants.", {"entities": []}], ["In each climatic region, three vegetation sites were selected for ecological information; the mean values of density, basal cover, and the importance value index from all sites of each region were used to interpret the final data.", {"entities": []}], ["Ethnomedicinal uses were collected from informants of adjacent villages.", {"entities": []}], ["About 10% of inhabitants (older, experienced men and women) were interviewed about their use of medicinal plants.", {"entities": []}], ["A consensus analysis of medicinal plant use between the different populations was conducted.", {"entities": []}], ["Across the different climatic regions a total of 57 species of plants were reported: 14 tree species, 10 shrub species, and 33 herb species.", {"entities": []}], ["In the tropical and sub-tropical regions, Acacia catechu was the dominant tree while Ougeinia oojeinensis in the tropical region and Terminalia belerica in the sub-tropical region were least dominant reported.", {"entities": []}], ["In the temperate region, Quercus leucotrichophora was the dominant tree and Pyrus pashia the least dominant tree.", {"entities": []}], ["A total of 10 shrubs were recorded in all three regions: Adhatoda vasica was common species in the tropical and sub-tropical regions however, Rhus parviflora was common species in the sub-tropical and temperate regions.", {"entities": []}], ["Among the 33 herbs, Sida cordifolia was dominant in the tropical and sub-tropical regions, while Barleria prionitis the least dominant in tropical and Phyllanthus amarus in the sub-tropical region.", {"entities": []}], ["In temperate region, Vernonia anthelmintica was dominant and Imperata cylindrica least dominant.", {"entities": []}], ["The consensus survey indicated that the inhabitants have a high level of agreement regarding the usages of single plant.", {"entities": []}], ["The index value was high (1.0) for warts, vomiting, carminative, pain, boils and antiseptic uses, and lowest index value (0.33) was found for bronchitis.", {"entities": [[142, 152, "DISEASE"]]}], ["The medicinal plants treated various ailments.", {"entities": []}], ["These included diarrhea, dysentery, bronchitis, menstrual disorders, gonorrhea, pulmonary affections, migraines, leprosy.", {"entities": [[113, 120, "DISEASE"], [15, 23, "DISEASE"], [25, 34, "DISEASE"], [69, 78, "DISEASE"], [36, 46, "DISEASE"]]}], ["The ecological studies showed that the tree density and total basal cover increased from the tropical region to sub-tropical and temperate regions.", {"entities": []}], ["The species composition changed with climatic conditions.", {"entities": []}], ["Among the localities used for data collection in each climatic region, many had very poor vegetation cover.", {"entities": []}], ["The herbaceous layer decreased with increasing altitude, which might be an indication that communities at higher elevations were harvesting more herbaceous medicinal plants, due to the lack of basic health care facilities.", {"entities": []}], ["Therefore, special attention needs to be given to the conservation of medicinal plants in order to ensure their long-term availability to the local inhabitants.", {"entities": []}], ["Data on the use of individual species of medicinal plants is needed to provide an in-depth assessment of the plants availability in order to design conservation strategies to protect individual species.", {"entities": []}], ["IL-33, a member of the IL-1 family of cytokines, provokes Th2-type inflammation accompanied by accumulation of eosinophils through IL-33R, which consists of ST2 and IL-1RAcP.", {"entities": []}], ["We previously demonstrated that macrophages produce IL-33 in response to LPS.", {"entities": []}], ["Some immune responses were shown to differ between ST2-deficient mice and soluble ST2-Fc fusion protein-treated mice.", {"entities": []}], ["Even in anti-ST2 antibody (Ab)-treated mice, the phenotypes differed between distinct Ab clones, because the characterization of such Abs (i.e., depletion, agonistic or blocking Abs) was unclear in some cases.", {"entities": []}], ["To elucidate the precise role of IL-33, we newly generated neutralizing monoclonal Abs for IL-33.", {"entities": []}], ["Exogenous IL-33 potentiated LPS-mediated cytokine production by macrophages.", {"entities": []}], ["That LPS-mediated cytokine production by macrophages was suppressed by inhibition of endogenous IL-33 by the anti-IL-33 neutralizing mAbs.", {"entities": []}], ["Our findings suggest that LPS-mediated macrophage activation is accelerated by macrophage-derived paracrine IL-33 stimulation.", {"entities": []}], ["A 20-year-old man presented to our outpatient clinic with hemoptysis, cough, and pleuritic chest pain.", {"entities": []}], ["His chest radiograph and pulmonary function tests (PFT) were normal.", {"entities": []}], ["A bronchoscopy showed a small yellowish patch with a regular surface.", {"entities": []}], ["A direct bronchoscopic biopsy was performed.", {"entities": []}], ["The pathologic findings showed a benign granular cell tumor.", {"entities": [[40, 59, "DISEASE"]]}], ["The respiratory symptoms resolved after biopsying the tumor.", {"entities": []}], ["On follow.up, there were no signs of recurrence of the granular cell tumor after a period of 24 months.", {"entities": [[55, 74, "DISEASE"]]}], ["Medial medullary infarction accounts for less than 1% of brain infarctions, and medial medullary infarctions is very rarely caused by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.", {"entities": [[188, 198, "DISEASE"]]}], ["We report the case of a 76-year-old man at low risk of arteriosclerosis who presented with disorders on the left side including gaze-evoked nystagmus, paralysis of the extremities, pyramidal signs, sensory disturbance, and dysesthesia.", {"entities": [[55, 71, "DISEASE"]]}], ["Brain magnetic resonance imaging also showed right medial medullary infarction.", {"entities": []}], ["Medial medullary infarction caused by ANCA-related vasculitis was diagnosed based on mild renal dysfunction and high levels of blood leukocytes, C-reactive protein (CRP), and myeloperoxidase (MPO)-ANCA.", {"entities": [[51, 61, "DISEASE"], [165, 168, "GENE"], [192, 195, "GENE"]]}], ["He underwent two 3-day courses of steroid pulse therapy involving daily 1000\u200amg doses of methylpredonine.", {"entities": []}], ["He then received 30\u200amg/day (0.5\u200amg/kg/day) of prednisolone (PSL) without other immunosuppressants.", {"entities": []}], ["Levels of MPO-ANCA and the inflammatory marker CRP decreased rapidly a month after admission.", {"entities": [[47, 50, "GENE"]]}], ["Once MPO-ANCA became undetectable, the PSL dose was carefully reduced to 10\u200amg/day.", {"entities": []}], ["To treat his paralysis, we provided rehabilitation with a Hybrid Assistive Limb five times starting at a month post-onset.", {"entities": []}], ["His Barthel index score rose from 45 to 70 points.", {"entities": []}], ["Medullary infarction is mostly caused by arteriosclerosis and vertebral arterial dissection.", {"entities": [[41, 57, "DISEASE"]]}], ["When systemic inflammatory findings are obtained, ANCA-associated vasculitis should be considered a potential cause, and steroid pulse therapy should be promptly administered.", {"entities": [[66, 76, "DISEASE"]]}], ["In order to identify challenges in pediatric pharmacoepidemiological safety studies, we assessed the characteristics of such (published) studies.", {"entities": []}], ["Relevant articles from inception to 2013 were retrieved from Embase and Medline.", {"entities": []}], ["We sequentially screened titles, abstracts and full texts with independent validation.", {"entities": []}], ["We systematically collected data regarding general information, study methods and results.", {"entities": []}], ["Out of 4825 unique articles, 268 full texts (5.6%) were retained; 147 (54.9%) pertained to drugs rather than vaccines.", {"entities": []}], ["Considering the 268 studies, 202 (75.4%) concerned children and adolescents (2 to 11\u2009years) and 14 (5.3%) included preterm newborns.", {"entities": []}], ["Most studies originated from North America (154 [57.5%]) or Europe (92 [34.3%]).", {"entities": []}], ["Only 47 studies (17.5%) were privately funded.", {"entities": []}], ["The majority (174 [64.9%]) were cohort studies.", {"entities": []}], ["Out of 268 studies, 196 (73.1%) collected data retrospectively; paper medical charts were the most common data source for the exposures (85 [31.7%]) and outcomes (122 [45.5%]).", {"entities": []}], ["Only 3 (2.0%) drug\u2010only studies investigated rarely used drugs.", {"entities": []}], ["Considering all 268 studies, only 27 (10.1%) reported sample size or power calculation.", {"entities": []}], ["Most (75 [51.0%]) drug\u2010only studies corrected confounding by multivariate modeling unlike stratification in 66 (55.9%) vaccine\u2010only studies.", {"entities": []}], ["Considering 75 child\u2010only studies without any statistically significant result, 41 (54.7%) did not discuss lack of power.", {"entities": []}], ["Although the field of pediatric pharmacoepidemiology is steadily developing evaluation seldom includes neonates, is mainly focused on few drug classes and safety outcomes and concerns mainly drug use in developed countries.", {"entities": []}], ["Small study size is a specific challenge in pediatrics.", {"entities": []}], ["Reporting should be improved.", {"entities": []}], ["\u00a9 2016 The Authors.", {"entities": []}], ["Pharmacoepidemiology and Drug Safety Published by John Wiley & Sons Ltd.", {"entities": []}], ["This study aims to evaluate the association between high sensitivity troponins (hsTn) and mitral annular plane systolic excursion (MAPSE) in patients undergoing cardiac magnetic resonance imaging (cMRI).", {"entities": []}], ["Patients undergoing cMRI were prospectively enrolled.", {"entities": []}], ["Patients with right ventricular dysfunction (<\u00a050%) were excluded.", {"entities": []}], ["Blood samples for measurements of hsTn and amino-terminal pro-brain natriuretic peptide (NT-proBNP) were collected at the time of cMRI.", {"entities": []}], ["84 patients were included.", {"entities": []}], ["Median left ventricular ejection fraction was 59% (IQR 51\u201364%).", {"entities": []}], ["HsTn were correlated inversely with MAPSE within multivariable linear regression models (hsTnI: Beta \u2212\u00a00.19; T \u2212\u00a01.96; p \u00a0=\u00a00.05; hsTnT: Beta \u2212\u00a00.26; T \u2212\u00a03.26; p \u00a0=\u00a00.002).", {"entities": []}], ["HsTn increased significantly according to decreasing stages of impaired MAPSE ( p \u00a0<\u00a00.003).", {"entities": []}], ["HsTn discriminated patients with impaired MAPSE\u00a0<\u00a011\u00a0mm (hsTnT: AUC\u00a0=\u00a00.67; p \u00a0=\u00a00.008; hsTnI: AUC\u00a0=\u00a00.64; p \u00a0=\u00a00.03) and\u00a0<\u00a08\u00a0mm (hsTnT: AUC\u00a0=\u00a00.79; p \u00a0=\u00a00.0001; hsTnI: AUC\u00a0=\u00a00.75; p \u00a0=\u00a00.001) and were still significantly associated in multivariable logistic regression models with impaired MAPSE\u00a0<\u00a011\u00a0mm (hsTnT: OR\u00a0=\u00a04.71; p \u00a0=\u00a00.002; hsTnI: OR\u00a0=\u00a04.22; p \u00a0=\u00a00.009).", {"entities": []}], ["This study demonstrates that hsTn are able to reflect MAPSE being assessed by cMRI.", {"entities": []}], ["The online version of this article (doi:10.1186/s40001-017-0281-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background: There are no reference guidelines for health care providers regarding appropriate use and interpretation of urine eosinophil protein X (u\u2010EPX) in clinical practice.", {"entities": []}], ["Currently, there are no clear\u2010cut clinical or laboratory parameters to diagnose asthma in young children.", {"entities": [[80, 86, "DISEASE"]]}], ["Objective: In this study, we (1) systematically reviewed and qualitatively appraised the epidemiological evidence to determine diagnostic u\u2010EPX cut points for pediatric asthma, and (2) performed a meta\u2010analysis to provide u\u2010EPX estimates for diagnosing pediatric asthma.", {"entities": [[169, 175, "DISEASE"], [263, 269, "DISEASE"]]}], ["Methods: Research articles in literature were identified from PubMed/Medline and Web of Science databases from 1966 to August 2015.", {"entities": []}], ["Children <18 years of age were included.", {"entities": []}], ["Both serum and urine EPX were included.", {"entities": [[21, 24, "GENE"]]}], ["Twenty\u2010seven studies met the inclusion criteria for the systematic review and nine studies for the meta\u2010analysis.", {"entities": []}], ["Details regarding EPX analyses, treatment efficacy, and outcomes were assessed.", {"entities": [[18, 21, "GENE"]]}], ["For meta\u2010analyses, effect estimates were abstracted using standardized means.", {"entities": []}], ["Results: Over 70% of studies found a significant relationship between u\u2010EPX and childhood asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["There was 1.94 times higher standardized means of u\u2010EPX among acute asthmatics compared to healthy controls (confidence interval [CI]: 1.67\u20132.22).", {"entities": []}], ["Similarly, the difference in standardized means between asymptomatic asthmatics and healthy controls was 1.58 times higher (CI: 1.27\u20131.88).", {"entities": []}], ["Conclusions and Clinical Relevance: Despite differences in sample sizes, EPX processing and measurement, and ages of children, a consistent trend of higher EPX levels with childhood asthma was revealed.", {"entities": [[182, 188, "DISEASE"], [73, 76, "GENE"], [156, 159, "GENE"], [73, 76, "GENE"], [156, 159, "GENE"]]}], ["Using various methods, we analyzed the cause of death among weaned pigs from a pig farm in Hebei Province, China.", {"entities": []}], ["All 300 piglets (100% fatality) were identified as moribund, with death occurring within 1\u00a0month from the onset of clinical signs.", {"entities": []}], ["A single case exhibited obvious hemorrhagic necrotic changes with massive lymphocytic infiltration in multiple organs, in particular the liver, lungs and intestines.", {"entities": []}], ["Dysplasia and lymphocyte deterioration were common in lymphatic organs.", {"entities": []}], ["No visible bacterial colonies from liver and spleen were observed in nutrient, MacConkey, and blood agar plates.", {"entities": []}], ["Using polymerase chain reaction techniques for this case, we attempted to detect a number of epidemic swine viruses in spleen and liver, including PRRSV, CSF, HEV, and PCV2.", {"entities": []}], ["We found that this sample was positive for the presence of HEV and PRRSV.", {"entities": []}], ["We have detected HEV and PRRSV co-infection in one piglet.", {"entities": []}], ["Severe pathologic changes were observed.", {"entities": []}], ["The high mortality of weaned pigs which showed the similar clinical syptom was possibly a result of HEV and PRRSV co-infection, which has rarely been reported previously.", {"entities": []}], ["We speculated that co-infection with PRRSV and HEV might lead to more serious problems.", {"entities": []}], ["Asthma is a chronic disease that is commonly suffered by children.", {"entities": [[0, 6, "DISEASE"]]}], ["Asthmatic children have a lower quality of life than other children.", {"entities": []}], ["Physicians and pediatricians recommend that parents record the frequency of attacks and their symptoms to help manage their children's asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["However, the lack of a convenient device for monitoring the asthmatic condition leads to the difficulties in managing it, especially when it is suffered by young children.", {"entities": []}], ["This work develops a wheeze detection system for use at home.", {"entities": []}], ["A small and soft stethoscope was used to collect the respiratory sound.", {"entities": []}], ["The wheeze detection algorithm was the Adaptive Respiratory Spectrum Correlation Coefficient (RSACC) algorithm, which has the advantages of high sensitivity/specificity and a low computational requirement.", {"entities": []}], ["Fifty-nine sound files from eight young children (one to seven years old) were collected in the emergency room and analyzed.", {"entities": []}], ["The results revealed that the system provided 88% sensitivity and 94% specificity in wheeze detection.", {"entities": []}], ["In conclusion, this small soft stethoscope can be easily used on young children.", {"entities": []}], ["A noisy environment does not affect the effectiveness of the system in detecting wheeze.", {"entities": []}], ["Hence, the system can be used at home by parents who wish to evaluate and manage the asthmatic condition of their children.", {"entities": []}], ["We describe six individuals with microdeletions and microduplications in the distal 22q11.2 region detected by microarray.", {"entities": []}], ["Five of the abnormalities have breakpoints in the low-copy repeats (LCR) in this region and one patient has an atypical rearrangement.", {"entities": []}], ["Two of the six patients with abnormalities in the region between LCR22 D\u2013E have hearing loss, which has previously been reported only once in association with these abnormalities.", {"entities": []}], ["We especially note the behavioral/neuropsychiatric problems, including the severity and early onset, in patients with distal 22q11.2 rearrangements.", {"entities": []}], ["Our patients add to the genotype\u2013phenotype correlations which are still being generated for these chromosomal anomalies.", {"entities": []}], ["Endotracheal intubation is one of the most invasive stimuli in anesthesia and it's often accompanied by a hemodynamic pressor response.", {"entities": []}], ["The purpose of this study was to investigate the efficacy of a single pre-induction 2 \u00b5g/kg bolus injection of fentanyl followed by two puffs of nitroglycerin sub lingual spray (400 \u00b5g /spray) with a thiopentone/suxamethonium sequence in the attenuation of the hemodynamic response to endotracheal intubation in normotensive patients.", {"entities": []}], ["The study consisted of 80 randomly selected ASA physical status I/II male/female adults who were aged between 18 through 60 years and scheduled for elective surgery.", {"entities": []}], ["Group I received a single 2 \u00b5g/kg IV bolus of fentanyl diluted to 5 ml with normal saline 5 min prior to laryngoscopy followed by two puffs of nitroglycerin sub lingual spray (400 \u00b5g/spray) 2 minutes prior to intubation (n=40).", {"entities": []}], ["Group II received a single 2 \u00b5g/kg IV bolus of fentanyl diluted to 5 ml with normal saline 5 min prior to laryngoscopy (n=40).", {"entities": []}], ["Heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure and rate pressure product were compared to basal values at pre-induction, induction, intubation and post-intubation as well as at time increments of 1, 3, 5, 7 and 10 min.", {"entities": []}], ["Fentanyl combined with nitroglycerin did not attenuate hemodynamic pressor responses more than fentanyl alone.", {"entities": []}], ["Increases of HR (7.9%), DBP (4.0%), MAP (3.6%) and RPP (6.0%) along with attenuation of SBP (2.7%) were observed in the fentanyl-nitroglycerin group as compared to the equivalent control measured values.", {"entities": [[13, 15, "GENE"], [24, 27, "GENE"]]}], ["A single pre-induction bolus injection of fentanyl followed by two puffs of nitroglycerin sub lingual spray in a thiopentone/suxamethonium anesthetic sequence neither successfully attenuates nor successfully suppresses the hemodynamic pressor response more effectively than fentanyl alone in normotensive patients resulting from endotracheal intubation.", {"entities": []}], ["Most patients with chronic obstructive pulmonary disease (COPD) receive inhaled long-acting bronchodilators and inhaled corticosteroids.", {"entities": [[19, 56, "DISEASE"]]}], ["Conventional meta-analyses established that these drugs reduce COPD exacerbations when separately compared with placebo.", {"entities": []}], ["However, there are relatively few head-to-head comparisons and conventional meta-analyses focus on single comparisons rather than on a simultaneous analysis of competing drug regimens that would allow rank ordering of their effectiveness.", {"entities": []}], ["Therefore we assessed, using a network meta-analytic technique, the relative effectiveness of the common inhaled drug regimes used to reduce exacerbations in patients with COPD.", {"entities": []}], ["We conducted a systematic review and searched existing systematic reviews and electronic databases for randomized trials of \u2265 4 weeks' duration that assessed the effectiveness of inhaled drug regimes on exacerbations in patients with stable COPD.", {"entities": []}], ["We extracted participants and intervention characteristics from included trials and assessed their methodological quality.", {"entities": []}], ["For each treatment group we registered the proportion of patients with \u2265 1 exacerbation during follow-up.", {"entities": []}], ["We used treatment-arm based logistic regression analysis to estimate the absolute and relative effects of inhaled drug treatments while preserving randomization within trials.", {"entities": []}], ["We identified 35 trials enrolling 26,786 patients with COPD of whom 27% had \u2265 1 exacerbation.", {"entities": []}], ["All regimes reduced exacerbations statistically significantly compared with placebo (odds ratios ranging from 0.71 (95% confidence interval [CI] 0.64 to 0.80) for long-acting anticholinergics to 0.78 (95% CI 0.70 to 0.86) for inhaled corticosteroids).", {"entities": []}], ["Compared with long-acting bronchodilators alone, combined treatment was not more effective (comparison with long-acting beta-agonists: odds ratio 0.93 [95% CI 0.84 to 1.04] and comparison with long-acting anticholinergics: odds ratio 1.02 [95% CI 0.90 to 1.16], respectively).", {"entities": []}], ["If FEV 1 was \u2264 40% predicted, long-acting anticholinergics, inhaled corticosteroids, and combination treatment reduced exacerbations significantly compared with long-acting beta-agonists alone, but not if FEV 1 was > 40% predicted.", {"entities": [[3, 6, "GENE"], [205, 208, "GENE"], [3, 6, "GENE"], [205, 208, "GENE"]]}], ["This effect modification was significant for inhaled corticosteroids ( P = 0.02 for interaction) and combination treatment ( P = 0.01) but not for long-acting anticholinergics ( P = 0.46).", {"entities": []}], ["A limitation of this analysis is its exclusive focus on exacerbations and lack of FEV 1 data for individual patients.", {"entities": [[82, 85, "GENE"]]}], ["We found no evidence that one single inhaled drug regimen is more effective than another in reducing exacerbations.", {"entities": []}], ["Inhaled corticosteroids when added to long-acting beta-agonists reduce exacerbations only in patients with COPD with FEV 1 \u2264 40%.", {"entities": [[117, 120, "GENE"]]}], ["To examine the association between socioeconomic status (SES) and delay to a pediatric rheumatology clinic, disease severity, and illness perception in patients with juvenile idiopathic arthritis in England.", {"entities": [[186, 195, "DISEASE"]]}], ["Using the Index of Multiple Deprivation, 923 consecutive children from the Childhood Arthritis Prospective Study were assigned to SES groups: high\u2010SES (19.1%), middle\u2010SES (44.5%), or low\u2010SES (36.4%).", {"entities": [[85, 94, "DISEASE"]]}], ["At baseline, disease activity was assessed, and the Childhood Health Assessment Questionnaire (C\u2010HAQ), the Illness Perception Questionnaire, and the Child Health Questionnaire, version Parent Form 50, were completed.", {"entities": []}], ["Linear median regression analyses or zero\u2010inflated negative binominal (ZINB) regression analyses were used.", {"entities": []}], ["Delay to first pediatric rheumatology consultation was the same between the 3 SES groups.", {"entities": []}], ["Although disease activity scores assessed by the pediatric rheumatologist did not differ between the 3 SES groups, persons in the low\u2010SES group recorded higher C\u2010HAQ scores compared to the high\u2010SES group (zero\u2010inflated part of ZINB odds ratio 0.28 [95% confidence interval (95% CI) 0.14, 0.55], count part of ZINB \u03b2 0.26 [95% CI 0.05, 0.48]).", {"entities": []}], ["Parents with low SES also reported more often that their children's school work or activities with friends had been limited.", {"entities": []}], ["Furthermore, the low\u2010SES group had a worse perception about the consequences of the disease and the effect of treatment than those in the high\u2010SES group.", {"entities": []}], ["Patients from a low\u2010SES background report more problems with daily activities and have a lower perception of the consequences of the disease than patients from a high\u2010SES background, warranting special attention from a multidisciplinary team.", {"entities": []}], ["The pandemic novel influenza A (H1N1) infection was considered widespread in Brazil on July 16, 2009.", {"entities": [[19, 28, "DISEASE"]]}], ["Since then, 46,810 cases of acute respiratory syndrome have been reported in Brazil, most of them concentrated in S\u00e3o Paulo.", {"entities": [[46, 54, "DISEASE"]]}], ["Through September 16, we have confirmed 9,249 cases of novel influenza A H1N1in Brazil, including 699 deaths.", {"entities": [[61, 70, "DISEASE"]]}], ["The mortality rate observed in Brazil is 0.47/100,000 inhabitants and varies according to region.", {"entities": []}], ["In this period, S\u00e3o Paulo registered 3733 cases (40.3% of the total) of novel influenza A (H1N1) infection and 327 deaths, reflecting a mortality rate of 0.79/100,000 inhabitants.", {"entities": [[78, 87, "DISEASE"]]}], ["The Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de S\u00e3o Paulo (HC) is a reference center for H1N1 cases in S\u00e3o Paulo.", {"entities": []}], ["During the winter of 2009, 472 patients in this hospital were diagnosed with H1N1 infection; of these, 210 were admitted, and 16 died.", {"entities": []}], ["To control this pandemic and to provide adequate care for these patients, the Hospital das Cl\u00ednicas implemented \u201cbundles\u201d including prevention strategies, an epidemiologic surveillance service, availability of fast diagnosis, antiviral treatment and training of staff.", {"entities": []}], ["The purpose of this manuscript is to describe the epidemiologic features of novel human influenza A (H1N1) infection in the Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de S\u00e3o Paulo during the winter period of the 2009 pandemic.", {"entities": [[88, 97, "DISEASE"]]}], ["Lung adenocarcinoma (LAC) is the leading cause of cancer-related death worldwide.", {"entities": [[5, 19, "DISEASE"], [50, 56, "DISEASE"]]}], ["Aberrant expression of genes expressed preferentially in the lung tumor vasculature may yield clues for prognosis and treatment.", {"entities": []}], ["Von Willebrand factor (vWF) is a large multifunctional glycoprotein with a well-known function in hemostasis.", {"entities": [[23, 26, "GENE"]]}], ["However, vWF has been reported to exert an anti-tumor effect, independent of its role in hemostasis.", {"entities": [[9, 12, "GENE"]]}], ["We investigated the expression of vWF in LAC through immunohistochemical staining of tumor tissue microarrays (TMAs).", {"entities": [[34, 37, "GENE"]]}], ["We found that vWF was overexpressed preferentially in the tumor vasculature of LAC compared with the adjacent tissue vasculature.", {"entities": [[14, 17, "GENE"]]}], ["Consistently, elevated vWF expression was found in endothelial cells (ECs) of fresh human LAC tissues and transplanted mouse LAC tissues.", {"entities": [[23, 26, "GENE"]]}], ["To understand the mechanism underlying vWF up-regulation in LAC vessels, we established a co-culture system.", {"entities": [[39, 42, "GENE"]]}], ["In this system, conditioned media (CM) collected from A549 cells increased vWF expression in human umbilical vein endothelial cells (HUVECs), suggesting enhanced expression is regulated by the LAC secretome.", {"entities": [[75, 78, "GENE"]]}], ["Subsequent studies revealed that the transcription factor GATA3, but not ERG, a known regulator of vWF transcription in vascular cells, mediated the vWF elevation.", {"entities": [[58, 63, "GENE"], [99, 102, "GENE"], [149, 152, "GENE"], [99, 102, "GENE"], [149, 152, "GENE"]]}], ["Chromatin immunoprecipitation (ChIP) assays validated that GATA3 binds directly to the +220 GATA binding motif on the human vWF promoter and A549 conditioned media significantly increases the binding of GATA3.", {"entities": [[59, 64, "GENE"], [203, 208, "GENE"], [124, 127, "GENE"], [59, 64, "GENE"], [203, 208, "GENE"]]}], ["Taken together, we demonstrate that vWF expression in ECs of LAC is elevated by the cancer cell-derived secretome through enhanced GATA3-mediated transcription.", {"entities": [[84, 90, "DISEASE"], [36, 39, "GENE"]]}], ["A reproducible method to inhibit allergic immune responses is accomplished with hi-dose Ag sensitization, via intraperitoneal (IP) injection.", {"entities": []}], ["However, the role of CD4+ CD25+ FoxP3+ T regulatory cells (Treg) in this process is unknown, as is whether such modulation extends to ocular allergy.", {"entities": []}], ["We therefore determined herein whether hi-dose sensitization modulates ocular allergy, and whether CD4+ CD25+ FoxP3+ Treg are involved.", {"entities": []}], ["C57BL/6 mice were IP sensitized via low-dose (100 \u00b5g) versus hi-dose (1000 \u00b5g) ovalbumin (OVA), in aluminum hydroxide (1 mg) and pertussis-toxin (300 ng).", {"entities": [[129, 138, "DISEASE"]]}], ["Other mice received anti-CD25 Ab (PC61) to ablate Treg during sensitization.", {"entities": []}], ["In another experiment, Treg from hi-dose sensitized mice were adoptively transferred into low-dose sensitized mice.", {"entities": []}], ["Once daily OVA challenges were administered.", {"entities": []}], ["Clinical signs, IgE, T cell cytokines, and eosinophils were assessed.", {"entities": []}], ["Data revealed that hi-dose, but not low-dose, sensitization led to allergy modulation, indicated by decreased clinical signs, serum IgE levels, Th2 recall responses, and eosinophil recruitment.", {"entities": []}], ["T cells from hi-dose sensitized mice showed a robust increase in TGF-b production, and Treg from these mice were able to efficiently suppress effector T cell proliferation in vitro.", {"entities": []}], ["In addition, in vivo Treg ablation in hi-dose sensitized mice revoked allergy modulation.", {"entities": []}], ["Lastly, Treg from hi-dose sensitized mice were able to adoptively transfer allergy modulation to their low-dose sensitized counterparts.", {"entities": []}], ["Collectively, these findings indicate that modulation to hi-dose sensitization, which is extended to ocular allergy, occurs in a Treg-dependent manner.", {"entities": []}], ["In addition, our data suggest that hi-dose sensitization may henceforth facilitate the further examination of CD4+ CD25+ FoxP3+ Treg in allergic disease.", {"entities": []}], ["Endocrine disrupting chemicals (EDCs) are environmental contaminants causing increasing concerns due to their toxicity, persistence and ubiquity.", {"entities": []}], ["In the present study, degradative capabilities of Trametes versicolor , Pleurotus ostreatus and Phanerochaete chrysosporium to act on five EDCs, which represent different classes of chemicals (phenols, parabens and phthalate) and were first applied as single compounds, were assessed.", {"entities": []}], ["versicolor was selected due to its efficiency against target EDCs and its potentialities were exploited against a mixture of EDCs in a cost-effective bioremediation process.", {"entities": []}], ["A fed-batch approach as well as a starvation strategy were applied in order to reduce the need for input of \u2018fresh\u2019 biomass, and avoid the requirement for external nutrients.", {"entities": []}], ["The fungus was successfully operated in two different bioreactors over one week.", {"entities": []}], ["Semi-batch cultures were carried out by daily adding a mixture of EDCs to the bioreactors in a total of five consecutive degradation cycles.", {"entities": []}], ["versicolor was able to efficiently remove all compounds during each cycle converting up to 21 mg L T .", {"entities": []}], ["versicolor to remove EDCs without any additional nutrients represents the main outcome of this study, which enables to forecast its application in a water treatment process.", {"entities": []}], ["For many years, pathogenetic concepts and the results of clinical trials supported the view that anti-IgE treatment is specifically effective in allergic asthma.", {"entities": [[145, 160, "DISEASE"], [154, 160, "DISEASE"]]}], ["However, there is now growing clinical and mechanistic evidence suggesting that treatment with the anti-IgE antibody omalizumab can be effective in patients with intrinsic asthma.", {"entities": [[162, 178, "DISEASE"], [172, 178, "DISEASE"]]}], ["Therefore, large and well-controlled clinical trials with anti-IgE are urgently warranted in patients with intrinsic asthma.", {"entities": [[107, 123, "DISEASE"], [117, 123, "DISEASE"]]}], ["In addition, there is a need to find new biomarkers which can identify patients with asthma who respond to anti-IgE treatment.", {"entities": [[85, 91, "DISEASE"]]}], ["Asthma is a complex pulmonary inflammatory disease characterized by the hyper-responsiveness, remodeling and inflammation of airways.", {"entities": [[0, 6, "DISEASE"]]}], ["Formaldehyde is a common indoor air pollutant that can cause asthma in people experiencing long-term exposure.", {"entities": [[61, 67, "DISEASE"]]}], ["The irritant effect and adjuvant effect are the two possible pathways of formaldehyde promoted asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["To explore the neural mechanisms and adjuvant effect of formaldehyde, 48 Balb/c mice in six experimental groups were exposed to (a) vehicle control; (b) ovalbumin; (c) formaldehyde (3.0 mg/m Formaldehyde might be a key risk factor for the rise in asthma cases.", {"entities": [[247, 253, "DISEASE"]]}], ["Transient receptor potential ion channels and neuropeptides have important roles in formaldehyde promoted-asthma.", {"entities": [[106, 112, "DISEASE"]]}], ["Airway smooth muscle cells (ASMC) play a key role in bronchial hyperresponsiveness (BHR).", {"entities": []}], ["A major component of the signaling cascade leading to ASMC contraction is calcium.", {"entities": []}], ["So far, agonist-induced Ca H 2-lymphocytes and display a broad spectrum of asthma-like histological and functional characteristics.", {"entities": [[75, 81, "DISEASE"]]}], ["In this study, we aimed at investigating whether Ca Lung slices of 100 to 200 \u03bcm thickness were obtained from T-bet KO- and wild-type mice.", {"entities": []}], ["Airway contraction in response to acetylcholine (ACH) was measured by video-microscopy and Ca Airways from T-bet KO-mice showed increased baseline airway tone (BAT) and BHR compared to wild-type mice.", {"entities": []}], ["This could be mimicked by incubation of lung slices from wild-type mice with IL-13.", {"entities": []}], ["The increased BAT was correlated with an increased incidence of spontaneous changes in intracellular Ca Altered Ca", {"entities": []}], ["To determine links between human rhinoviruses (HRV) and asthma, we used data from a case\u2013control study, March 2003\u2013February 2004, among children with asthma.", {"entities": [[56, 62, "DISEASE"], [150, 156, "DISEASE"]]}], ["Molecular characterization identified several likely new HRVs and showed that association with asthma exacerbations was largely driven by HRV-A and a phylogenetically distinct clade of 8 strains, genogroup C.", {"entities": [[95, 101, "DISEASE"]]}], ["Inefficient clearance of dead cells or debris by epithelial cells can lead to or exacerbate debilitating conditions such as retinitis pigmentosa, macular degeneration, chronic obstructive pulmonary disease and asthma.", {"entities": [[124, 133, "DISEASE"], [168, 205, "DISEASE"], [124, 144, "DISEASE"], [210, 216, "DISEASE"], [146, 166, "DISEASE"]]}], ["Despite the importance of engulfment by epithelial cells, little is known about the molecular changes that are required within these cells.", {"entities": []}], ["The misregulation of integrins has previously been associated with disease states, suggesting that a better understanding of the regulation of receptor trafficking could be key to treating diseases caused by defects in phagocytosis.", {"entities": []}], ["Here, we demonstrate that the integrin heterodimer \u03b1PS3/\u03b2PS becomes apically enriched and is required for engulfment by the epithelial follicle cells of the Drosophila ovary.", {"entities": []}], ["We found that integrin heterodimer localization and function is largely directed by the \u03b1-subunit.", {"entities": []}], ["Moreover, proper cell polarity promotes asymmetric integrin enrichment, suggesting that \u03b1PS3/\u03b2PS trafficking occurs in a polarized fashion.", {"entities": []}], ["We show that several genes previously known for their roles in trafficking and cell migration are also required for engulfment.", {"entities": []}], ["Moreover, as in mammals, the same \u03b1-integrin subunit is required by professional and non-professional phagocytes and migrating cells in Drosophila .", {"entities": []}], ["Our findings suggest that migrating and engulfing cells use common machinery, and demonstrate a crucial role for integrin function and polarized trafficking of integrin subunits during engulfment.", {"entities": []}], ["This study also establishes the epithelial follicle cells of the Drosophila ovary as a powerful model for understanding the molecular changes required for engulfment by a polarized epithelium.", {"entities": []}], ["Summary: Apical integrin localization, mediated by polarized and directed trafficking, is crucial for proper engulfment by epithelial cells.", {"entities": []}], ["\u2022 Exercise intolerance is a hallmark in COPD patients.", {"entities": []}], ["\u2022 Changes in HRV dynamics are early and sensitive indices of impaired health.", {"entities": []}], ["\u2022 6MWD provides relevant information about functional (in)capacity in COPD patients.", {"entities": []}], ["\u2022 A system with loss of complexity interferes with exercise performance.", {"entities": []}], ["\u2022 HRV modulation to submaximal exercise may reflect ventilatory and hemodynamic abnormalities.", {"entities": []}], ["Exercise intolerance is a hallmark in COPD patients.", {"entities": []}], ["Changes in HRV dynamics are early and sensitive indices of impaired health.", {"entities": []}], ["6MWD provides relevant information about functional (in)capacity in COPD patients.", {"entities": []}], ["A system with loss of complexity interferes with exercise performance.", {"entities": []}], ["HRV modulation to submaximal exercise may reflect ventilatory and hemodynamic abnormalities.", {"entities": []}], ["Poor exercise capacity is an important negative prognostic marker in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[83, 120, "DISEASE"]]}], ["Heart rate variability (HRV) responses can indicate alterations in cardiac autonomic control.", {"entities": []}], ["Nevertheless, it remains unclear whether these abnormalities are related to cardiorespiratory responses to exercise in these patients.", {"entities": []}], ["To evaluate whether HRV at rest and submaximal exercise are related to impaired cardiopulmonary responses to exercise in COPD patients.", {"entities": []}], ["Fifteen men (66.2\u00a0\u00b1\u00a08.7 years) with COPD (FEV 1 : 55.1\u00a0\u00b1\u00a019.2%) were assessed.", {"entities": [[42, 45, "GENE"]]}], ["The R-R interval (RRi) data collection was performed at rest (stand position) and during the six-minute walk test (6MWT).", {"entities": []}], ["All patients performed a symptom-limited cardiopulmonary exercise test on a cycle ergometer.", {"entities": []}], ["The HRV changes from rest to submaximal exercise (\u0394 rest-6MWT) were calculated.", {"entities": []}], ["We found significant correlations between low frequency (LF) and high frequency (HF) \u0394 rest-6MWT with \u0394 oxyhemoglobin saturation by pulse oximetry ( r \u00a0=\u00a0\u22120.64 and r \u00a0=\u00a00.65, respectively; p \u00a0<\u00a00.05), minute ventilation/carbon dioxide output relationship from beginning to peak exercise ( r \u00a0=\u00a0\u22120.52 and r \u00a0=\u00a00.53, p \u00a0<\u00a00.05), and exercise ventilatory power ( r \u00a0=\u00a00.52 and r \u00a0=\u00a0\u22120.53, p \u00a0<\u00a00.05).", {"entities": []}], ["Interestingly, there was a strong positive correlation ( r \u00a0=\u00a00.82, p \u00a0<\u00a00.05) between six-minute walk distance (6MWD) and \u0394 LF/HF from rest to exercise.", {"entities": []}], ["HRV analysis in the transition from rest to submaximal exercise is associated with exercise ventilatory and hemodynamic abnormalities in COPD patients.", {"entities": []}], ["Rehabilitative strategies to improve HRV responses may provide an important tool to clinical practice in these patients.", {"entities": []}], ["Fibrous dysplasia (FD) is a rare bone disorder in which normal bone is replaced by fibrous tissue resulting in pain, deformities, pathological fractures or asymptomatic disease.", {"entities": []}], ["Illness perceptions are patients\u2019 cognitions and emotions about their illness and its treatment, which may impact on Quality of Life (QoL).", {"entities": []}], ["Here, we explore illness perceptions in patients with FD compared to other disorders, identify factors associated with illness perceptions and evaluate their relationship with QoL.", {"entities": []}], ["Ninety-seven out of 138 eligible patients from the LUMC FD cohort completed the Illness Perception Questionnaire-Revised (IPQ-R) and the Short Form-36 (SF-36).", {"entities": []}], ["Age, Gender, Skeletal Burden Score (SBS), FGF-23 levels, type of FD and SF-36 scores were analysed for an association with illness perceptions.", {"entities": []}], ["We observed significant ( p \u00a0<\u00a00.01) differences in patients\u2019 illness perceptions between FD subtypes in the domains: identity, timeline acute/chronic and consequences.", {"entities": []}], ["Patients with craniofacial FD reported to perceive more consequences ( p \u00a0=\u00a00.022).", {"entities": []}], ["High SBS was associated with perceiving more negative consequences and attributing the cause of FD to psychological factors ( p \u00a0<\u00a00.01), and high FGF-23 levels with attributing more symptoms to the disease and perceiving more consequences ( p \u00a0<\u00a00.01).", {"entities": []}], ["The IPQ-R domain identity, timeline acute/chronic, timeline cyclical, consequences, emotional representations and treatment control were significantly associated with impairments in QoL.", {"entities": []}], ["Illness perceptions in patients with FD relate to QoL, differ from those in patients with other disorders, and are associated with disease severity.", {"entities": []}], ["Identifying and addressing maladaptive illness perceptions may improve quality of life in patients with FD.", {"entities": []}], ["The online version of this article (doi:10.1007/s00223-017-0329-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Activated CD8", {"entities": []}], ["Androgen receptor (AR) is a key transcription factor playing a critical role in prostate cancer (PCa) initiation and progression.", {"entities": [[89, 95, "DISEASE"], [80, 95, "DISEASE"]]}], ["However, the molecular mechanisms of AR action in prostate cancer are not very clear.", {"entities": [[59, 65, "DISEASE"], [50, 65, "DISEASE"]]}], ["CXCL13, known as B cell attracting chemokine1 (BCA-1), is a member of CXC chemokine family and relevant to cancer metastasis.", {"entities": [[107, 113, "DISEASE"], [0, 6, "GENE"]]}], ["This study shows that CXCL13 is an androgen-responsive gene and involved in AR-induced PCa cell migration and invasion.", {"entities": [[22, 28, "GENE"]]}], ["In clinical specimens, expression of CXCL13 in PCa tissues is markedly higher than that in adjacent normal tissues.", {"entities": [[37, 43, "GENE"]]}], ["In cultures, expression of CXCL13 is up-regulated by androgen-AR axis at both mRNA and protein levels.", {"entities": [[27, 33, "GENE"]]}], ["Furthermore, Chip-Seq assay identifies canonical androgen responsive elements (ARE) at CXCL13 enhancer and dual-luciferase reporter assays reveals that the ARE is highly responsive to androgen while mutations of the ARE abolish the reporter activity.", {"entities": [[87, 93, "GENE"]]}], ["Additional chromatin immunoprecipitation (ChIP) assays also identify that the ARE presents androgen responsiveness.", {"entities": []}], ["In addition, CXCL13 promotes G2/M phase transition by increasing Cyclin B1 levels in PCa cells.", {"entities": [[13, 19, "GENE"]]}], ["Functional studies demonstrate that reducing endogenous CXCL13 expression in LNCaP cells largely weakens androgen-AR axis induced cell migration and invasion.", {"entities": [[56, 62, "GENE"]]}], ["Taken together, our study implicates for the first time that CXCL13 is an AR target gene and involved in AR-mediated cell migration and invasion in primary PCa.", {"entities": [[61, 67, "GENE"]]}], ["Despite high rates of antenatal care and relatively good access to health facilities, maternal and neonatal mortality remain high in Bangladesh.", {"entities": []}], ["There is an immediate need for implementation of evidence-based, cost-effective interventions to improve maternal and neonatal health outcomes.", {"entities": []}], ["The aim of the study is to assess the effect of the intervention namely Group Prenatal Care (GPC) on utilization of standard number of antenatal care, post natal care including skilled birth attendance and institutional deliveries instead of usual care.", {"entities": []}], ["The study is quasi-experimental in design.", {"entities": []}], ["We aim to recruit 576 pregnant women (288 interventions and 288 comparisons) less than 20\u00a0weeks of gestational age.", {"entities": []}], ["The intervention will be delivered over around 6\u00a0months.", {"entities": []}], ["The outcome measure is the difference in maternal service coverage including ANC and PNC coverage, skilled birth attendance and institutional deliveries between the intervention and comparison group.", {"entities": []}], ["Findings from the research will contribute to improve maternal and newborn outcome in our existing health system.", {"entities": []}], ["Findings of the research can be used for planning a new strategy and improving the health outcome for Bangladeshi women.", {"entities": []}], ["Finally addressing the maternal health goal, this study is able to contribute to strengthening health system.", {"entities": []}], ["A family of five and pet dog who rented a water-damaged home and developed multiple health problems.", {"entities": []}], ["The home was analyzed for species of mold and bacteria.", {"entities": []}], ["The diagnostics included MRI for chronic sinusitis with ENT and sinus surgery, and neurological testing for neurocognitive deficits.", {"entities": [[41, 50, "DISEASE"]]}], ["Bulk samples from the home, tissue from the sinuses, urine, nasal secretions, placenta, umbilical cord, and breast milk were tested for the presence of trichothecenes, aflatoxins, and Ochratoxin A.", {"entities": []}], ["The family had the following diagnosed conditions: chronic sinusitis, neurological deficits, coughing with wheeze, nose bleeds, and fatigue among other symptoms.", {"entities": [[59, 68, "DISEASE"]]}], ["An infant was born with a total body flare, developed multiple Cafe-au-Lait pigmented skin spots and diagnoses with NF1 at age 2.", {"entities": [[116, 119, "GENE"]]}], ["The mycotoxins were detected in bulk samples, urine and nasal secretions, breast milk, placenta, and umbilical cord.", {"entities": []}], ["Pseudomonas aueroginosa, Acinetobacter, Penicillium, and Aspergillus fumigatus were cultured from nasal secretions (father and daughter).", {"entities": []}], ["RT-PCR revealed A. fumigatus DNA in sinus tissues of the daughter.", {"entities": []}], ["The dog had 72 skin lesions (sebaceous glands and lipomas) from which trichothecenes and ochratoxin A. were detected.", {"entities": []}], ["The health of the family is discussed in relation to the most recent published literature regarding microbial contamination and toxic by-products present in water-damaged buildings.", {"entities": []}], ["The study aims to test the differential effects of a web-based text and a web-based video-driven computer-tailored approach for lower socio-economic status (LSES) and higher socio-economic status (HSES) smokers which incorporate multiple computer-tailored feedback moments.", {"entities": []}], ["The two programs differ only in the mode of delivery (video- versus text-based messages).", {"entities": []}], ["The paper aims to describe the development and design of the two computer-tailored programs.", {"entities": []}], ["Respondents who smoked at the time of the study inclusion, who were motivated to quit within the following six months and who were aged 18 or older were included in the program.", {"entities": []}], ["The study is a randomized control trial with a 2 (video/text) * 2(LSES/HSES) design.", {"entities": []}], ["Respondents were assigned either to one of the intervention groups (text versus video tailored feedback) or to the control group (non-tailored generic advice).", {"entities": []}], ["In all three conditions participants were asked to fill in the baseline questionnaire based on the I-Change model.", {"entities": []}], ["The questionnaire assessed socio-demographics, attitude towards smoking, knowledge, self-efficacy, social influence, depression, level of addiction, action planning, goal actions, intention to quit smoking, seven-day point prevalence and continued abstinence.", {"entities": []}], ["Follow-up measurements were conducted at six and twelve months after baseline.", {"entities": []}], ["The present paper describes the development of the two computer-tailored smoking cessation programs, their components and the design of the study.", {"entities": []}], ["The study results reveal different working mechanisms of multiple tailored smoking cessation interventions and will help us to gain more insight into effective strategies to target different subgroups, especially smokers with a lower socio-economic status.", {"entities": []}], ["Dutch Trial Register NTR3102", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by airflow limitation that is not fully reversible.", {"entities": []}], ["Bronchodilator therapy is the cornerstone in COPD treatment.", {"entities": []}], ["Bronchodilation in COPD is mainly achieved via administration of long- and ultralong-acting \u03b2 2 -agonists and with long-acting muscarinic antagonists.", {"entities": []}], ["New combinations of bronchodilators with dual-acting muscarinic antagonist and \u03b2 2 -agonist properties have been licensed, and others are currently being developed with the aim of achieving once-daily dosing, and therefore may improve the likelihood of treatment compliance.", {"entities": []}], ["These combination bronchodilators include glycopyrronium bromide/indacaterol maleate, umeclidinium (UMEC) bromide/vilanterol trifenatate (VI), aclidinium bromide/formoterol and tiotropium bromide/olodaterol (Boehringer Ingelheim, Germany).", {"entities": []}], ["This review will focus mainly on studies and clinical trials involving the novel fixed-dose combination of UMEC/VI at doses of 125/25 \u03bcg and 62.5/25 \u03bcg in patients with COPD.", {"entities": []}], ["Data from large clinical trials involving more than 4,500 COPD patients indicate that UMEC/VI is an effective once-daily treatment in COPD with improved pulmonary function.", {"entities": []}], ["Future studies assessing the impact of this combination on exacerbations, delay in disease progression, and health status in patients with COPD are warranted.", {"entities": []}], ["Background and purpose Femoral neck fractures are considerably more common in patients on hemodialysis than in the general population.", {"entities": []}], ["We determined the outcome of bipolar hemiarthroplasty for hip fracture in patients with long-term hemodialysis and compared it with that of a matched-paired group of patients with intact renal function.", {"entities": []}], ["Methods We analyzed 26 bipolar hemiarthroplasties in 23 hemodialysed patients with a mean age of 56 (41\u201378) years who were followed for mean 3.6 (1\u20138) years.", {"entities": []}], ["These cases were matched for age, sex, and BMI with 26 patients with femoral neck fractures and normal renal function.", {"entities": []}], ["The mean follow-up time in the control group was 7 (5\u201310) years.", {"entities": []}], ["As primary surgery for their femoral neck fracture, all patients had a bipolar hemiarthroplasty with a 28-mm metal-polyethylene internal articulation and a cemented stem.", {"entities": []}], ["Results The mortality rate was 21% in the hemodialysed group and 4% in the control group (p = 0.005).", {"entities": []}], ["The bipolar head migrated in 1 patient in the hemodialysed group but in none of the patients in the case-matched group.", {"entities": []}], ["In the hemodialysed group, 8 stems migrated and 3 of these were revised, whereas in the control group 3 stems migrated and 2 were revised.", {"entities": []}], ["The stem migration in the hemodialysed group was not preceded by the development of osteolysis or radiolucent lines at the bone-cement interface.", {"entities": []}], ["The cumulative survival for prosthesis migration as endpoint was 44% at 5 years in the hemodialysed group and 96% in the control group (p = 0.03).", {"entities": []}], ["Interpretation The main mode of failure of cemented bipolar hemiarthroplasties in hemodialysed patients is stem migration, due to failure of the bone-cement interface.", {"entities": []}], ["Critical transition, a phenomenon that a system shifts suddenly from one state to another, occurs in many real-world complex networks.", {"entities": []}], ["We propose an analytical framework for exactly predicting the critical transition in a complex networked system subjected to noise effects.", {"entities": []}], ["Our prediction is based on the characteristic return time of a simple one-dimensional system derived from the original higher-dimensional system.", {"entities": []}], ["This characteristic time, which can be easily calculated using network data, allows us to systematically separate the respective roles of dynamics, noise and topology of the underlying networked system.", {"entities": []}], ["We find that the noise can either prevent or enhance critical transitions, playing a key role in compensating the network structural defect which suffers from either internal failures or environmental changes, or both.", {"entities": []}], ["Our analysis of realistic or artificial examples reveals that the characteristic return time is an effective indicator for forecasting the sudden deterioration of complex networks.", {"entities": []}], ["Quality of life (QoL), which can be examined using self-reports or parental reports, might help healthcare providers understand obese children\u2019s subjective well-being in several domains of life.", {"entities": []}], ["Community-based obese children report their QoL lower than their parents do.", {"entities": []}], ["However, the differences between child- and parent-reported QoL have neither been tested across gender and grade nor analyzed by item.", {"entities": []}], ["This study probed the relationship between obesity and QoL item scores in children, and compared child-reported with parent-reported QoL stratified by gender and grade.", {"entities": [[43, 50, "DISEASE"]]}], ["One hundred eighty-seven dyads of 8- to 12-year-old children (60 obese, 127 normal-weight) and their parents were recruited.", {"entities": []}], ["QoL was assessed using both child- and parent-reported Pediatric Quality of Life Inventory 4.0 (PedsQL) questionnaires.", {"entities": []}], ["Regression analyses showed specific difficulties with physical and emotional QoL in third- and fourth-grade obese boys (\u03b2 = 0.278-0.620), and specific problems with social functioning in fifth- and sixth-grade obese girls (\u03b2 = 0.337-0.411).", {"entities": []}], ["Moreover, parents seemed unaware of the specific difficulties that their children faced (\u03b2 = 0.274-0.435).", {"entities": []}], ["Obese children seemed to have their difficulties from third to fifth grade, respectively, and their parents seemed unaware of them.", {"entities": []}], ["Thus, parents need to be more aware of specific difficulties related to childhood obesity.", {"entities": [[82, 89, "DISEASE"]]}], ["To investigate the effect of cysteamine (CYS) on mixed peripheral blood mononuclear cells (PBMCs) - human corneal endothelial cell (HCEC) reaction (MLER).", {"entities": []}], ["PBMC stimulation assay was performed using cultured HCEC.", {"entities": []}], ["MLERs were treated with various concentrations of CYS (0\u201320 mM).", {"entities": []}], ["The proliferation rate and secretion profiles of transforming growth factor-\u03b21 (TGF-\u03b21) and interleukin-6 (IL-6) of PBMCs stimulated by cultured HCEC were determined using bromodeoxyuridine proliferation assay and enzyme-linked immunosorbent assay, respectively.", {"entities": []}], ["CYS suppressed PBMC proliferation in a dose-dependent manner (p<0.001).", {"entities": []}], ["The intracellular reactive oxygen species (ROS) levels decreased with an increase in CYS concentration (p<0.001).", {"entities": []}], ["The levels of TGF-\u03b21 and IL-6 decreased in a dose-dependent manner as well (p=0.011 and 0.003, respectively).", {"entities": []}], ["This study showed that CYS decreased PBMC proliferation, IL-6 and TGF-\u03b21 levels via ROS formation.", {"entities": []}], ["Our results suggest that CYS could suppress inflammation associated with PBMCs to corneal endothelial cells.", {"entities": []}], ["Previous work showed that weaning stress causes gut barrier dysfunction partly by triggering the release of corticotropin releasing factor (CRF) and thereby inducing the degranulation of intestinal mast cell (MC).", {"entities": []}], ["This study investigated the hypothesis that attenuating the weaning-induced activation of the CRF-MC axis via administration of a MC stabilizing agent (cromolyn) may improve gut permeability and piglet performance after weaning.", {"entities": []}], ["To test the hypothesis twenty piglets were weaned (20\u2009\u00b1\u20091.0 d of age; 6.4\u2009\u00b1\u20090.4\u00a0kg of BW) and injected intraperitoneally with saline (control, n \u2009=\u200910) or 20\u00a0mg/kg BW of sodium cromolyn (cromolyn, n \u2009=\u200910) at \u2013 0.5, 8 and 16\u00a0h relative to weaning.", {"entities": []}], ["Piglets were housed individually and fed ad libitum a pre-starter diet from one to 15 d post-weaning followed by a starter diet until the end of the study on d 36.", {"entities": []}], ["Cromolyn improved intestinal permeability as indicated by the reduced recovery of cobalt and mannitol in plasma samples.", {"entities": []}], ["Cromolyn treated pigs consumed more feed (369 vs. 313\u00a0g/d; P \u2009<\u20090.009), gained more BW (283 vs. 238\u00a0g/d; P \u2009<\u20090.006), and grew more efficiently (0.60 vs. 0.40; P \u2009<\u20090.042) than their control counterparts.", {"entities": []}], ["As a result, cromolyn treated pigs were 1.4\u00a0kg heavier than those in the control group by d 36 after weaning (16.5 vs. 17.9\u00a0kg; P \u2009<\u20090.002).", {"entities": []}], ["In agreement with our hypothesis, present data indicate that the cromolyn-mediated improvement of intestinal permeability is associated with enhanced pig performance after weaning.", {"entities": []}], ["Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder associated with allergic hypersensitivity to food.", {"entities": [[13, 24, "DISEASE"]]}], ["We interrogated >1.5 million genetic variants in European EoE cases and subsequently in a multi-site cohort with local and out-of-study control subjects.", {"entities": []}], ["In addition to replication of the 5q22 locus (meta-analysis p = 1.9\u00d710 CAPN14, p = 2.5\u00d710 CAPN14 was specifically expressed in the esophagus, dynamically upregulated as a function of disease activity and genetic haplotype and after exposure of epithelial cells to IL-13, and located in an epigenetic hotspot modified by IL-13.", {"entities": [[71, 77, "GENE"], [90, 96, "GENE"], [71, 77, "GENE"], [90, 96, "GENE"]]}], ["There was enriched esophageal expression for the genes neighboring the top 208 EoE sequence variants.", {"entities": []}], ["Multiple allergic sensitization loci were associated with EoE susceptibility (4.8\u00d710", {"entities": []}], ["To study the effect of dexmedetomidine priming on convulsion reaction induced by lidocaine.", {"entities": []}], ["The New Zealand white rabbits were applied for the mechanism study of dexmedetomidine priming for preventing convulsion reaction induced by lidocaine.", {"entities": []}], ["The influence of dexmedetomidine priming with different doses on the time for convulsion occurrence and the duration time of convulsion induced by lidocaine, as well as contents of excitatory amino acids (aspartate [Asp], glutamate [Glu]) and inhibitory amino acids (glycine [Gly], \u03b3-aminobutyric acid [GABA]) in the brain tissue were investigated.", {"entities": []}], ["With 3 and 5\u200a\u03bcg/kg dexmedetomidine priming, the occurrence times of convulsion were prolonged from 196 seconds to 349 and 414 seconds, respectively.", {"entities": []}], ["With dexmedetomidine priming, the contents of excitatory amino acids (Asp, Glu) were much reduced at occurrence time of convulsion comparing with that without dexmedetomidine priming, while content of inhibitory amino acids Gly was much enhanced.", {"entities": []}], ["The application of dexmedetomidine before local anesthetics can improve intoxication dose threshold of the lidocaine, delay occurrence of the convulsion, and helped for the recovery of convulsion induced by lidocaine.", {"entities": []}], ["The positive effect of dexmedetomidine on preventing convulsion would owe to not only the inhibition of excitatory amino acids (Asp, Glu), but also the promotion of inhibitory amino acids Gly secretion.", {"entities": []}], ["Exogenously administered glucocorticoids enhance eosinophil and neutrophil granulocyte production from murine bone-marrow.", {"entities": []}], ["A hematological response dependent on endogenous glucocorticoids underlies bone-marrow eosinophilia induced by trauma or allergic sensitization/challenge.", {"entities": [[87, 99, "DISEASE"]]}], ["We detected a defect in granulopoiesis in nonsensitized, perforin-deficient mice.", {"entities": []}], ["In steady-state conditions, perforin- (Pfp-) deficient mice showed significantly decreased bone-marrow and blood eosinophil and neutrophil counts, and colony formation in response to GM-CSF, relative to wild-type controls of comparable age and/or weight.", {"entities": []}], ["By contrast, peripheral blood or spleen total cell and lymphocyte numbers were not affected by perforin deficiency.", {"entities": []}], ["Dexamethasone enhanced colony formation by GM-CSF-stimulated progenitors from wild-type controls, but not Pfp mice.", {"entities": []}], ["Dexamethasone injection increased bone-marrow eosinophil and neutrophil counts in wild-type controls, but not Pfp mice.", {"entities": []}], ["Because perforin is expressed in effector lymphocytes, we examined whether this defect would be corrected by transferring wild-type lymphocytes into perforin-deficient recipients.", {"entities": []}], ["Short-term reconstitution of the response to dexamethasone was separately achieved for eosinophils and neutrophils by transfer of distinct populations of splenic lymphocytes from nonsensitized wild-type donors.", {"entities": []}], ["Transfer of the same amount of splenic lymphocytes from perforin-deficient donors was ineffective.", {"entities": []}], ["This demonstrates that the perforin-dependent, granulopoietic response to dexamethasone can be restored by transfer of innate lymphocyte subpopulations.", {"entities": []}], ["Many genetic variants have been associated with susceptibility to complex traits by genome wide association studies (GWAS), but for most, causal genes and mechanisms of action have yet to be elucidated.", {"entities": []}], ["Using bioinformatics, we identified index and proxy variants associated with autoimmune disease susceptibility, with the potential to affect splicing of candidate genes.", {"entities": []}], ["PCR and sequence analysis of whole blood RNA samples from population controls was then carried out for the 8 most promising variants to determine the effect of genetic variation on splicing of target genes.", {"entities": []}], ["We identified 31 splice site SNPs with the potential to affect splicing, and prioritised 8 to determine the effect of genotype on candidate gene splicing.", {"entities": []}], ["We identified that variants rs11078928 and rs2014886 were associated with altered splicing of the GSDMB and TSFM genes respectively.", {"entities": [[98, 103, "GENE"], [108, 112, "GENE"]]}], ["rs11078928, present in the asthma and autoimmune disease susceptibility locus on chromosome 17q12-21, was associated with the production of a novel \u0394 exon5-8 transcript of the GSDMB gene, and a separate decrease in the percentage of transcripts with inclusion of exon 6, whereas the multiple sclerosis susceptibility variant rs2014886, was associated with an alternative TFSM transcript encompassing a short cryptic exon within intron 2.", {"entities": [[283, 301, "DISEASE"], [27, 33, "DISEASE"], [176, 181, "GENE"]]}], ["Our findings demonstrate the utility of a bioinformatic approach in identification and prioritisation of genetic variants effecting splicing of their host genes, and suggest that rs11078928 and rs2014886 may affect the splicing of the GSDMB and TSFM genes respectively.", {"entities": [[235, 240, "GENE"], [245, 249, "GENE"]]}], ["Patients with chronic obstructive pulmonary disease (COPD) often experience depression and anxiety, but little information is available regarding Chinese patients with these conditions.", {"entities": [[14, 51, "DISEASE"]]}], ["The present study assessed depression and anxiety in Chinese patients with COPD.", {"entities": []}], ["A case\u2013controlled study was designed with 1100 patients with COPD enrolled in the case group and1100 residents without COPD and respiratory symptoms selected as the control group.", {"entities": []}], ["Anxiety and depression in both groups were evaluated using the Hospital Anxiety and Depression Scale (HADS).", {"entities": []}], ["The body mass index,degree of airflow obstruction, dyspnea, and exercise capacity (BODE ) index was used to assess COPD severity.", {"entities": []}], ["Binary logistic regression models were used to test the association between anxiety and depression.", {"entities": []}], ["The patients with COPD were more likely than controls to experience depression (cases, HADS 10.5 \u00b1 3.6, prevalence 35.7%; controls, HADS 8.7 \u00b1 2.7, prevalence 7.2%) and anxiety (cases, HADS 10.4 \u00b1 3.1, prevalence 18.3%; controls, HADS 8.6 \u00b1 2.1, prevalence 5.3%).", {"entities": []}], ["Subjects with anxious and depressive symptoms had poorer health outcomes including a higher BODE index, a shorter 6-minute-walk distance (6MWD), more dyspnea, and a higher St George\u2019s respiratory questionnaire (SGRQ) score.", {"entities": []}], ["The prevalence of anxious and depressive symptoms increased with increasing BODE scores.", {"entities": []}], ["On the basis of binary logistic regression, the BODE index was significantly correlated with anxiety (OR = 1.47, p < 0.001) and depression (OR = 1.51, p < 0.001).", {"entities": []}], ["Anxious and depressive symptoms were also associated with several factors including younger age, female sex, higher education level, lower household income and history of smoking.", {"entities": []}], ["This study confirmed the high prevalence of anxiety and depression in Chinese outpatients with COPD.", {"entities": []}], ["Patients with COPD who had anxiety and/or depression had a poorer health-related quality of life.", {"entities": []}], ["Chinese Clinical Trials Registration(ChiCTR-TRC-12001958)", {"entities": []}], ["The present work was aimed at optimizing a culture medium for biomass production and phenolic compounds by using Ganoderma lucidum .", {"entities": []}], ["The culture was optimized in two stages; a Plackett-Burman design was used in the first one for identifying key components in the medium and a central composite design was used in the second one for optimizing their concentration.", {"entities": []}], ["Both responses (biomass and phenolic compounds) were simultaneously optimized by the latter methodology regarding desirability, and the optimal concentrations obtained were 50.00 g/L sucrose, 13.29 g/L yeast extract and 2.99 g/L olive oil.", {"entities": []}], ["Maximum biomass production identified in these optimal conditions was 9.5 g/L and that for phenolic compounds was 0.0452 g/L, this being 100% better than that obtained in the media usually used in the laboratory.", {"entities": []}], ["Similar patterns regarding chemical characterization and biological activity towards Aspergillus sp., from both fruiting body and mycelium-derived secondary metabolites and extracts obtained in the proposed medium were observed.", {"entities": []}], ["It was shown that such statistical methodologies are useful for optimizing fermentation and, in the specific case of G. lucidum , optimizing processes for its production and its metabolites in submerged culture as an alternative to traditional culture.", {"entities": []}], ["Chronic pelvic pain (CPP) affects 24% of premenopausal women, accounts for 20%\u201330% of UK gynecology outpatient appointments, and has an annual pan-European economic cost of \u20ac3.8 billion.", {"entities": []}], ["Despite extensive investigation, often including laparoscopy, up to 55% of women do not receive a diagnosis and endure persistent symptoms.", {"entities": []}], ["In these patients, clinical management focuses on symptom control rather than treatment.", {"entities": []}], ["It is possible that pelvic vein incompetence (PVI) is a cause of CPP, although the quality of studies investigating an association is generally low.", {"entities": []}], ["PVI may develop during and after pregnancy, as uterine blood flow increases significantly, pushing venous valve leaflets apart, and enabling retrograde venous flow.", {"entities": []}], ["Analogies with varicose veins of the lower limb are helpful, and symptoms are similar.", {"entities": [[15, 29, "DISEASE"]]}], ["Women with symptomatic PVI report a dull pelvic ache that is worse on standing and sitting and persists throughout the day.", {"entities": []}], ["It can be relieved by lying down.", {"entities": []}], ["Early treatments for PVI included laparoscopic ligation; however, since the advent of endovascular occlusive techniques, treatments have lower risk and lower cost, and can be undertaken without sedation or anesthetic.", {"entities": []}], ["However, there have been no high-quality randomized controlled trials of interventions and, therefore, the evidence is limited to single-center case series.", {"entities": []}], ["The prevalence of asthma, measured either as the frequency of hospital admissions or number of deaths attributed to asthma, has increased over the last 15 to 20 years.", {"entities": [[18, 24, "DISEASE"], [116, 122, "DISEASE"]]}], ["Rapid increases in disease prevalence are more likely to be attributable to environmental than genetic factors.", {"entities": []}], ["Inferring from past associations between air pollution and asthma, it is feasible that changes in the ambient environment could contribute to this increase in morbidity and mortality.", {"entities": [[59, 65, "DISEASE"]]}], ["Scientific evaluation of the links between air pollution and the exacerbation of asthma is incomplete, however.", {"entities": [[81, 87, "DISEASE"]]}], ["Currently, criteria pollutants [SOx, NOx, O3, CO, Pb, particulate matter (PM10)] and other risk factors (exposure to environmental tobacco smoke, volatile organic compounds, etc.)", {"entities": []}], ["are constantly being evaluated as to their possible contributions to this situation.", {"entities": []}], ["Data from these studies suggest that increases in respiratory disease are associated with exposures to ambient concentrations of particulate and gaseous pollutants.", {"entities": []}], ["Similarly, exposure to environmental tobacco smoke, also a mixture of particulate and gaseous air toxics, has been associated with an increase in asthma among children.", {"entities": [[146, 152, "DISEASE"]]}], ["In addition, current associations of adverse health effects with existing pollution measurements are often noted at concentrations below those that produce effects in controlled animal and human exposures to each pollutant alone.", {"entities": []}], ["These findings imply that adverse responses are augmented when persons are exposed to irritant mixtures of particles and gases and that current measurements of air pollution are, in part, indirect in that the concentrations of criteria pollutants are acting as surrogates of our exposure to a complex mixture.", {"entities": []}], ["Other irritant air pollutants, including certain urban air toxics, are associated with asthma in occupational settings and may interact with criteria pollutants in ambient air to exacerbate asthma.", {"entities": [[87, 93, "DISEASE"], [190, 196, "DISEASE"]]}], ["An evaluation of dose-response information for urban air toxics and biological feasibility as possible contributors to asthma is therefore needed.", {"entities": [[119, 125, "DISEASE"]]}], ["However, this evaluation is compounded by a lack of information on the concentrations of these compounds in the ambient air and their effects on asthma morbidity and mortality.", {"entities": [[145, 151, "DISEASE"]]}], ["Through an initial review of the current toxicological literature, we propose a tentative list of 30 compounds that could have the highest impact on asthma and respiratory health.", {"entities": [[149, 155, "DISEASE"]]}], ["These compounds were selected based on their ability to induce or exacerbate asthma in occupational and nonoccupational settings, their allergic potential and ability to react with biological macromolecules, and lastly, their ability to irritate the respiratory passages.", {"entities": [[77, 83, "DISEASE"]]}], ["We recommend better documentation of exposure to these compounds through routine air sampling and evaluation of total exposure and further evaluation of biological mechanisms through laboratory and epidemiological studies directed specifically at the role these substances play in the induction and exacerbation of asthma.", {"entities": [[315, 321, "DISEASE"]]}], ["Despite optimal control of hyperglycaemia, hypertension, and dyslipidaemia, the number of patients with diabetic nephropathy (DN) continues to grow.", {"entities": [[43, 55, "DISEASE"]]}], ["Strategies to target various signaling pathways to prevent DN have been intensively investigated in animal models and many have been proved to be promising.", {"entities": []}], ["However, targeting these pathways once kidney disease is established, remain unsatisfactory.", {"entities": [[39, 53, "DISEASE"]]}], ["The clinical scenario is that patients with diabetes mellitus often present with established kidney damage and need effective treatments to repair and reverse the kidney damage.", {"entities": [[44, 61, "DISEASE"]]}], ["In this studies, eNOS-/- mice were administered with streptozotocin to induce diabetes.", {"entities": []}], ["At 24 weeks, at which time we have previously demonstrated albuminuria and pathological changes of diabetic nephropathy, mice were randomised to receive TRAM34 subcutaneously, a highly selective inhibitor of potassium channel KCa3.1 or DMSO (vehicle) for a further 14 weeks.", {"entities": []}], ["Albuminuria was assessed, inflammatory markers (CD68, F4/80) and extracellular matrix deposition (type I collagen and fibronectin) in the kidneys were examined.", {"entities": [[48, 52, "GENE"]]}], ["The results clearly demonstrate that TRAM34 reduced albuminuria, decreased inflammatory markers and reversed extracellular matrix deposition in kidneys via inhibition of the TGF-\u03b21 signaling pathway.", {"entities": []}], ["These results indicate that KCa3.1 blockade effectively reverses established diabetic nephropathy in this rodent model and provides a basis for progressing to human studies.", {"entities": []}], ["Although dendritic cells (DCs) are adept initiators of CD4 Schistosoma mansoni .", {"entities": [[55, 58, "GENE"]]}], ["DTx treatment significantly depleted CD11c", {"entities": []}], ["Cameroon is experiencing an increase in the burden of chronic non-communicable diseases (NCDs), which accounted for 43% of all deaths in 2002.", {"entities": []}], ["This article reviews the published literature to critically evaluate the evidence on the frequency, determinants and consequences of NCDs in Cameroon, and to identify research, intervention and policy gaps.", {"entities": []}], ["The rising trends in NCDs have been documented for hypertension and diabetes, with a 2-5 and a 10-fold increase in their respective prevalence between 1994 and 2003.", {"entities": [[51, 63, "DISEASE"]]}], ["Magnitudes are much higher in urban settings, where increasing prevalence of overweight/obesity (by 54-82%) was observed over the same period.", {"entities": [[88, 95, "DISEASE"]]}], ["These changes largely result from the adoption of unfavorable eating habits, physical inactivity, and a probable increasing tobacco use.", {"entities": []}], ["These behavioral changes are driven by the economic development and social mobility, which are part of the epidemiologic transition.", {"entities": []}], ["There is still a dearth of information on chronic respiratory diseases and cancers, as well as on all NDCs and related risk factors in children and adolescents.", {"entities": []}], ["More nationally representative data is needed to tract risk factors and consequences of NCDs.", {"entities": []}], ["These conditions are increasingly been recognized as a priority, mainly through locally generated evidence.", {"entities": []}], ["Thus, national-level prevention and control programs for chronic diseases (mainly diabetes and hypertension) have been established.", {"entities": [[95, 107, "DISEASE"]]}], ["However, the monitoring and evaluation of these programs is necessary.", {"entities": []}], ["Budgetary allocations data by the ministry of health would be helpful, to evaluate the investment in NCDs prevention and control.", {"entities": []}], ["Establishing more effective national-level tobacco control measures and food policies, as well as campaigns to promote healthy diets, physical activity and tobacco cessation would probably contribute to reducing the burden of NCDs.", {"entities": []}], ["Cigarette smoking contributes to the development of pulmonary hypertension (PH) complicated with chronic obstructive pulmonary disease (COPD), and the pulmonary vascular remodeling, the structural basis of PH, could be attributed to abnormal proliferation of pulmonary artery smooth muscle cells (PASMCs).In this study, morphometrical analysis showed that the pulmonary vessel wall thickness in smoker group and COPD group was significantly greater than in nonsmokers.", {"entities": [[62, 74, "DISEASE"], [97, 134, "DISEASE"], [52, 74, "DISEASE"]]}], ["In addition, we determined the expression patterns of connective tissue growth factor (CTGF) and cyclin D1 in PASMCs harvested from smokers with normal lung function or mild to moderate COPD, finding that the expression levels of CTGF and cyclin D1 were significantly increased in smoker group and COPD group.", {"entities": [[87, 91, "GENE"], [230, 234, "GENE"], [87, 91, "GENE"], [230, 234, "GENE"]]}], ["In vitro experiment showed that the expression of CTGF, cyclin D1 and E2F were signi\ufb01cantly increased in human PASMCs (HPASMCs) treated with 2% cigarette smoke extract (CSE), and two CTGF siRNAs with different mRNA hits successfully attenuated the upregulated cyclin D1 and E2F, and significantly restored the CSE-induced proliferation of HPASMCs by causing cell cycle arrest in G0.", {"entities": [[50, 54, "GENE"], [183, 187, "GENE"], [50, 54, "GENE"], [183, 187, "GENE"]]}], ["These \ufb01ndings suggest that CTGF may contribute to the pathogenesis of abnormal proliferation of HPASMCs by promoting the expression of its downstream effectors in smokers with or without COPD.", {"entities": [[27, 31, "GENE"]]}], ["Adverse health impacts of Asian dust storms (ADS) have been widely investigated and discussed in respiratory disease, but no study has examined the association between ADS events and their impact on eye diseases, especially in children.", {"entities": []}], ["The impact of ADS events on the incidence of children's conjunctivitis is examined by analyzing the data from children's clinic visits registered in the 41 districts of Taipei area in Taiwan during the period 2002\u20132007.", {"entities": [[56, 70, "DISEASE"]]}], ["The structural additive regression modeling approach was used to assess the association between ADS events and clinic visits for conjunctivitis in children with consideration of day-of-the-week effects, temperature, and air quality levels.", {"entities": [[129, 143, "DISEASE"]]}], ["This study identifies an acute increase in the relative rate for children's conjunctivitis clinic visits during ADS periods with 1.48% (95% CI\u200a=\u200a0.79, 2.17) for preschool children (aged <6 years old) and 9.48% (95% CI\u200a=\u200a9.03, 9.93) for schoolchildren (aged \u22656 years old), respectively.", {"entities": [[76, 90, "DISEASE"]]}], ["The relative rates during post-ADS periods were still statistically significant, but much lower than those during ADS periods.", {"entities": []}], ["The spatial analysis presents geographic heterogeneity of children's conjunctivitis clinic visits where higher relative rates were more likely observed in the most populated districts Compared to previous ADS studies related to respiratory diseases, our results reveals significantly acute impacts on children's conjunctivitis during ADS periods, and much influence on schoolchildren.", {"entities": [[69, 83, "DISEASE"], [312, 326, "DISEASE"]]}], ["Vulnerable areas were also identified in high density population.", {"entities": []}], ["Background: There is broad consensus regarding the health impact of tobacco use and secondhand smoke exposure, yet considerable ambiguity exists about the nature and consequences of thirdhand smoke (THS).", {"entities": []}], ["Objectives: We introduce definitions of THS and THS exposure and review recent findings about constituents, indoor sorption\u2013desorption dynamics, and transformations of THS; distribution and persistence of THS in residential settings; implications for pathways of exposure; potential clinical significance and health effects; and behavioral and policy issues that affect and are affected by THS.", {"entities": []}], ["Discussion: Physical and chemical transformations of tobacco smoke pollutants take place over time scales ranging from seconds to months and include the creation of secondary pollutants that in some cases are more toxic (e.g., tobacco-specific nitrosamines).", {"entities": []}], ["THS persists in real-world residential settings in the air, dust, and surfaces and is associated with elevated levels of nicotine on hands and cotinine in urine of nonsmokers residing in homes previously occupied by smokers.", {"entities": []}], ["Much still needs to be learned about the chemistry, exposure, toxicology, health risks, and policy implications of THS.", {"entities": []}], ["Conclusion: The existing evidence on THS provides strong support for pursuing a programmatic research agenda to close gaps in our current understanding of the chemistry, exposure, toxicology, and health effects of THS, as well as its behavioral, economic, and sociocultural considerations and consequences.", {"entities": []}], ["Such a research agenda is necessary to illuminate the role of THS in existing and future tobacco control efforts to decrease smoking initiation and smoking levels, to increase cessation attempts and sustained cessation, and to reduce the cumulative effects of tobacco use on morbidity and mortality.", {"entities": []}], ["Exclusive feeding of an iodine\u2010restricted diet has been proposed as a method for controlling clinical manifestations of hyperthyroidism in hyperthyroid cats.", {"entities": [[120, 135, "DISEASE"]]}], ["To determine the effect of feeding an iodine\u2010restricted diet on TT 4 concentrations and clinical signs in cats with spontaneous hyperthyroidism.", {"entities": [[128, 143, "DISEASE"]]}], ["Forty\u2010nine client\u2010owned cats with spontaneous hyperthyroidism.", {"entities": [[46, 61, "DISEASE"]]}], ["Retrospective case series.", {"entities": []}], ["Hyperthyroid cats were exclusively fed a commercially available iodine\u2010restricted diet.", {"entities": []}], ["Clinical response was assessed by change in weight and heart rate and serum TT 4, blood urea nitrogen (BUN), and creatinine concentrations at various times during dietary management (21\u201360\u00a0days, 60\u2013180\u00a0days).", {"entities": []}], ["Serum TT 4 normalized in 20/48 cats (42%) and 39/47 cats (83%) at 21\u201360\u00a0days and 61\u2013180\u00a0days, respectively.", {"entities": []}], ["Cats in which the TT 4 concentrations were still above reference range at 21\u201360\u00a0days had a significantly higher starting TT 4 than those that normalized their TT 4 levels during the same time period ( P \u00a0=\u00a0.038).", {"entities": []}], ["Body weight did not significantly increase ( P \u00a0=\u00a0.34) nor heart rate decrease ( P \u00a0=\u00a0.64) during the study.", {"entities": []}], ["There was a significant decrease in serum creatinine ( P \u00a0=\u00a0.028).", {"entities": []}], ["Cats in the low reference range for serum TT 4 concentrations did not have a significant increase in body weight ( P \u00a0=\u00a0.41) nor creatinine ( P \u00a0=\u00a0.54) when compared to those with high reference range.", {"entities": []}], ["Restricted\u2010iodine diets were effective at maintaining serum TT 4 concentrations within reference ranges for a majority of cats with spontaneous hyperthyroidism over 1\u00a0year, although not all clinical signs of hyperthyroidism improved.", {"entities": [[144, 159, "DISEASE"], [208, 223, "DISEASE"]]}], ["The fetal time period is a critical window of immune system development and resulting heightened susceptibility to the adverse effects of environmental exposures.", {"entities": []}], ["Epidemiologists and toxicologists have hypothesized that persistent organic pollutants, pesticides and metals have immunotoxic properties.", {"entities": []}], ["Immunotoxic effects may manifest as an altered immune system profile at birth.", {"entities": []}], ["Immunoglobulin E, thymic stromal lymphopoietin (TSLP), and interleukin-33 (IL-33) may be implicated in the etiology of childhood allergy and are detectable at birth.", {"entities": [[48, 52, "GENE"]]}], ["The objective of this study was to examine the potential relationship between maternal concentrations of metals, persistent organic pollutants, and pesticides and elevated umbilical cord blood concentrations of IgE, TSLP, and IL-33 in a Canadian birth cohort.", {"entities": [[216, 220, "GENE"]]}], ["This study utilized data collected in the Maternal-Infant Research on Environmental Chemicals (MIREC) Study, a trans-Canada cohort study of 2,001 pregnant women.", {"entities": []}], ["Of these women, 1258 had a singleton, term birth and cord blood sample.", {"entities": []}], ["Logistic regression was used to determine associations between log-transformed continuous variables and immune system biomarkers.", {"entities": []}], ["Inverse relationships were observed between lead, DDE, PCB-118, and a summary index of organophosphorous metabolites and jointly elevated concentrations of IL-33 and TSLP.", {"entities": [[166, 170, "GENE"]]}], ["None of the environmental contaminants were associated with increased odds of a high cord blood immune system biomarker concentration.", {"entities": []}], ["In this primarily urban Canadian population of pregnant women and their newborns, maternal blood or urine concentrations of persistent organic pollutants, pesticides, and metals were not associated with immunotoxic effects that manifest as increased odds of elevated concentrations of IgE, TSLP or IL-33.", {"entities": [[290, 294, "GENE"]]}], ["Disturbances in sodium concentration are common in the critically ill patient and associated with increased mortality.", {"entities": []}], ["The key principle in treatment and prevention is that plasma [Na", {"entities": []}], ["Ischemic colitis (IC) is a disease with high postoperative morbidity and mortality.", {"entities": []}], ["Knowledge of the risk factors for postoperative mortality could be helpful in clinical decision making and in optimizing postoperative treatment.", {"entities": []}], ["From a prospective database, we conducted a retrospective medical record review of 50 patients who underwent surgery for IC between 2003 and 2011 at our institution.", {"entities": []}], ["We analyzed the causes and potential risk factors for early mortality after surgery for IC.", {"entities": []}], ["The early postoperative mortality and morbidity rates were 30.0% (15/50) and 54% (27/50), respectively.", {"entities": []}], ["The two most common causes of death were multi-organ failure (66.7%, 10/15) and fulminant septic shock (20.0%, 3/15).", {"entities": []}], ["Univariate analysis showed that postoperative mortality was significantly associated with preoperative nephropathy, coronary artery disease, a previous history of cardiovascular surgery, an ASA score\u2009\u2265\u20094, surgical delay\u2009\u2265\u20093\u00a0days, preoperative hemodynamic instability, and use of pre- and intraoperative adrenergic vasopressors.", {"entities": []}], ["In the multivariate analysis, a previous history of cardiovascular surgery (odds ratio [OR], 8.2; 95% confidence interval [CI], 1.2\u201356.5) and surgical delay\u2009\u2265\u20093\u00a0days (OR, 5.7; 95% CI, 1.2\u201327.9) were identified as independent risk factors for postoperative mortality.", {"entities": []}], ["Because surgical delay is an avoidable determinant of early mortality, a high index of suspicion and early surgical intervention can increase survival.", {"entities": []}], ["A routine postoperative evaluation for IC may be helpful in patients with a previous history of cardiovascular surgery.", {"entities": []}], ["To examine local and systemic oxidative status of lung cancer (LC) and oxidant effects of radiotherapy (RT), this study evaluated antioxidants and markers of oxidative and nitrosative stress in bronchoalveolar lavage (BAL) fluid and in the blood of 36 LC patients and 36 non-cancer controls at baseline and during and after RT for LC.", {"entities": [[50, 61, "DISEASE"], [55, 61, "DISEASE"], [275, 281, "DISEASE"]]}], ["LC patients had higher baseline serum urate, plasma nitrite and lower serum oxidized proteins than controls ( p = 0.016, p < 0.001 and p = 0.027, respectively), but BAL fluid oxidative stress markers were similar.", {"entities": []}], ["RT tended to raise some antioxidants, however, significant increases were seen in serum urate, conjugated dienes and TBARS ( p = 0.044, p = 0.034 and p = 0.004, respectively) 3 months after RT.", {"entities": []}], ["High urate at baseline may compensate against the oxidative stress caused by LC.", {"entities": []}], ["RT shifts the oxidant/antioxidant balance towards lipid peroxidation, although the antioxidant defense mechanisms of the body appear to counteract the increased oxidative stress rather effectively.", {"entities": []}], ["Lymphocyte chemoattractant factor (LCF) is a tetrameric glycoprotein of 56,000 relative molecular mass produced by activated T lymphocytes.", {"entities": []}], ["LCF binds to CD4 and has previously been found to stimulate migration of CD4+ lymphocytes and monocytes.", {"entities": [[13, 16, "GENE"], [73, 76, "GENE"]]}], ["Because human eosinophils, like T cells and monocytes, express CD4, we examined functional responses of eosinophils to LCF.", {"entities": [[63, 66, "GENE"]]}], ["Recombinant LCF (rLCF) expressed in COS cells was purified on a CD4 affinity column.", {"entities": [[64, 67, "GENE"]]}], ["Migration of eosinophils was elicited by rLCF at low concentrations: the 50% effective dose (ED50) was 10(-12) to 10(-11) M, concentrations 100- to 1,000-fold lower than the ED50s for the recognized eosinophil chemoattractants C5a and platelet-activating factor.", {"entities": []}], ["Two other ligands which bound to CD4, human immunodeficiency virus-1 envelope glycoprotein gp120 and monoclonal antibody OKT4, also stimulated eosinophil migration.", {"entities": [[33, 36, "GENE"]]}], ["Monovalent OKT4 Fab competitively inhibited eosinophil responses to rLCF.", {"entities": []}], ["rLCF did not influence other functional responses of eosinophils tested, including degranulation, superoxide generation, leukotriene C4 production, in vitro survival, or surface expression of the adherence receptor CR3 (CD11b), human histocompatibility leukocyte antigen DR, or interleukin 2 receptor p55 (CD25).", {"entities": []}], ["We conclude that CD4 on eosinophils is capable of transducing a migratory stimulus and serves as a receptor for a chemoattractant lymphokine LCF.", {"entities": [[17, 20, "GENE"]]}], ["T cell-derived LCF may contribute to recruitment of eosinophils and CD4+ mononuclear cells concomitantly at inflammatory reactions.", {"entities": []}], ["The prevalence of obesity among U.S. preschoolers has doubled in recent decades.", {"entities": [[18, 25, "DISEASE"]]}], ["Childhood obesity increases the risk for adult obesity and is associated with negative health consequences.", {"entities": [[10, 17, "DISEASE"], [47, 54, "DISEASE"]]}], ["Trends in the state-specific prevalence of obesity among low-income U.S. preschool children have not been examined since 2008.", {"entities": [[43, 50, "DISEASE"]]}], ["State-specific obesity prevalence surveillance helps determine the need for and impact of state and local obesity prevention strategies.", {"entities": [[15, 22, "DISEASE"], [106, 113, "DISEASE"]]}], ["Measured weight and height data from approximately 11.6 million low-income children aged 2\u20134 years from 40 states, the District of Columbia, and two U.S. territories who participated in the Pediatric Nutrition Surveillance System during 2008\u20132011 were used to estimate state obesity prevalence.", {"entities": [[275, 282, "DISEASE"]]}], ["Obesity was defined as having an age- and sex-specific body mass index \u226595th percentile, according to the 2000 CDC growth charts.", {"entities": [[0, 7, "DISEASE"]]}], ["Logistic regression models adjusted for age, sex, and race/ethnicity were used to examine trends in the state-specific obesity prevalence.", {"entities": [[119, 126, "DISEASE"]]}], ["During 2008\u20132011, statistically significant downward trends in obesity prevalence were observed in 18 states and the U.S. Virgin Islands.", {"entities": [[63, 70, "DISEASE"]]}], ["Florida, Georgia, Missouri, New Jersey, South Dakota, and the U.S. Virgin Islands had the largest absolute decreases in obesity prevalence, each with a decrease of \u22651 percentage point.", {"entities": [[120, 127, "DISEASE"]]}], ["Twenty states and Puerto Rico experienced no significant change, and obesity prevalence increased significantly in three states.", {"entities": [[69, 76, "DISEASE"]]}], ["Small but significant declines in obesity among low-income preschoolers were observed in 19 of 43 states/territories examined.", {"entities": [[34, 41, "DISEASE"]]}], ["Continued prevention efforts are needed to sustain and expand the implementation and evaluation of population-level interventions to prevent childhood obesity.", {"entities": [[151, 158, "DISEASE"]]}], ["Many cystic fibrosis (CF) patients display airway hyperresponsiveness and have symptoms of asthma such as cough, wheezing and reversible airway obstruction.", {"entities": [[5, 20, "DISEASE"], [91, 97, "DISEASE"]]}], ["Chronic airway bacterial colonization, associated with neutrophilic inflammation and high levels of interleukin-8 (IL-8) is also a common occurrence in these patients.", {"entities": []}], ["The aim of this work was to determine the responsiveness of airway smooth muscle to IL-8 in CF patients compared to non-CF individuals.", {"entities": []}], ["Experiments were conducted on cultured ASM cells harvested from subjects with and without CF (control subjects).", {"entities": []}], ["Cells from the 2 i ), cell contraction, migration and proliferation.", {"entities": []}], ["The IL-8 receptors CXCR1 and CXCR2 were expressed in both non-CF and CF ASM cells to a comparable extent.", {"entities": [[19, 24, "GENE"], [29, 34, "GENE"]]}], ["IL-8 (100 nM) induced a peak Ca 20 ) in CF than in control cells.", {"entities": []}], ["In addition, MLC 20 expression was also increased in CF cells.", {"entities": []}], ["Exposure to IL-8 induced migration and proliferation of both groups of ASM cells but was not different between CF and non-CF cells.", {"entities": []}], ["ASM cells of CF patients are more contractile to IL-8 than non-CF ASM cells.", {"entities": []}], ["This enhanced contractility may be due to an increase in the amount of contractile protein MLC 20 .", {"entities": []}], ["Higher expression of MLC 20 by CF cells could contribute to airway hyperresponsiveness to IL-8 in CF patients.", {"entities": []}], ["The sector wide approach (SWAp) used in many developing countries is difficult to assess.", {"entities": []}], ["One way is to consider the essential health package (EHP) which is commonly the vehicle for a SWAp's policies and plans.", {"entities": []}], ["It is not possible to measure the impact of an EHP by measuring health outcomes in countries such as Malawi.", {"entities": []}], ["But it is possible to assess the choice of interventions and their delivery in terms of coverage.", {"entities": []}], ["This paper describes an attempt to assess the Malawi SWAp through its EHP using these available measures of technical efficiency.", {"entities": []}], ["A burden of disease model was used to identify the priority diseases and their estimated incidence.", {"entities": []}], ["Data from the health management information system (HMIS) were used to measure the coverage of these interventions.", {"entities": []}], ["A review of the cost-effectiveness of the chosen and potential interventions was undertaken to assess the appropriateness of each intervention used in the EHP.", {"entities": []}], ["Expenditure data were used to assess the level of funding of the EHP.", {"entities": []}], ["33 of the 55 EHP interventions were found to be potentially cost-effective (<$150/DALY), 12 were not so cost-effective (>$150/DALY) and cost-effective estimates were not available for ten.", {"entities": []}], ["15 potential interventions, which were cost-effective and tackling one of the top 20 ranked diseases, were identified.", {"entities": []}], ["Provision had increased in nearly all EHP services over the period of the SWAp.", {"entities": []}], ["The rates of out patient attendances and inpatient days per 1000 population had both increased from 929 attendances in 2002/3 to 1135 in 2007/08 and from 124 inpatient days in 2002/03 to 179 in 2007/08.", {"entities": []}], ["However, by 2007/08 the mean gap between what was required and what was provided was 0.68 of the estimated need.", {"entities": []}], ["Two services involving the treatment of malaria were overprovided, but the majority were underprovided, with some such as maternity care providing less than half of what was required.", {"entities": [[40, 47, "DISEASE"]]}], ["The EHP was under-funded throughout the period covering on average 57% of necessary costs.", {"entities": []}], ["By 2007/08 the funding paid by SWAp partners including the government of Malawi to fund the EHP was at US$13.5 per capita per annum, which was almost half of the revised EHP estimated required expenditure per capita per annum.", {"entities": []}], ["The SWAp had invested in some very cost-effective health interventions.", {"entities": []}], ["In terms of numbers of patients treated, the EHP had delivered two thirds of the services required.", {"entities": []}], ["This was despite serious under-funding of the EHP, an increase in the population and shortage of staff.", {"entities": []}], ["The identification of interventions of proven effectiveness and good value for money and earmarked funding through a SWAp process can produce measurable improvement in health service delivery at extremely low cost.", {"entities": []}], ["Pulmonary eosinophilia comprises a heterogeneous group of diseases that are defined by eosinophilia in pulmonary infiltrates or in tissue.", {"entities": [[10, 22, "DISEASE"], [87, 99, "DISEASE"]]}], ["Drugs can cause almost all histopathologic patterns of interstitial pneumonias, such as cellular and fibrotic nonspecific interstitial pneumonia, pulmonary infiltrates and eosinophilia, organizing pneumonia, lymphocytic interstitial pneumonia, desquamative interstitial pneumonia, a pulmonary granulomatosis-like reaction, and a usual interstitial pneumonia-like pattern.", {"entities": [[244, 279, "DISEASE"], [135, 144, "DISEASE"], [197, 206, "DISEASE"], [233, 242, "DISEASE"], [270, 279, "DISEASE"], [348, 357, "DISEASE"], [110, 144, "DISEASE"], [172, 184, "DISEASE"]]}], ["We present a very rare case of chronic eosinophilic pneumonia due to radiographic contrast infusion diagnosed with video-assisted thoracoscopy.", {"entities": [[31, 61, "DISEASE"], [52, 61, "DISEASE"], [39, 61, "DISEASE"]]}], ["The patient after 1 year is still under corticosteroid treatment with the disease stabilized.", {"entities": []}], ["Circular RNA (circRNA) is a large group of RNA family extensively existed in cells and tissues.", {"entities": []}], ["High-throughput sequencing provides a way to view circRNAs across different samples, especially in various diseases.", {"entities": []}], ["However, there is still no comprehensive database for exploring the cancer-specific circRNAs.", {"entities": [[68, 74, "DISEASE"]]}], ["We collected 228 total RNA or polyA(-) RNA-seq samples from both cancer and normal cell lines, and identified 272 152 cancer-specific circRNAs.", {"entities": [[65, 71, "DISEASE"], [118, 124, "DISEASE"]]}], ["A total of 950 962 circRNAs were identified in normal samples only, and 170 909 circRNAs were identified in both tumor and normal samples, which could be further used as non-tumor background.", {"entities": []}], ["We constructed a c ancer- s pecific c ircRNA d atabase (CSCD, http://gb.whu.edu.cn/CSCD ).", {"entities": []}], ["To understand the functional effects of circRNAs, we predicted the microRNA response element sites and RNA binding protein sites for each circRNA.", {"entities": []}], ["We further predicted potential open reading frames to highlight translatable circRNAs.", {"entities": []}], ["To understand the association between the linear splicing and the back-splicing, we also predicted the splicing events in linear transcripts of each circRNA.", {"entities": []}], ["As the first comprehensive cancer-specific circRNA database, we believe CSCD could significantly contribute to the research for the function and regulation of cancer-associated circRNAs.", {"entities": [[27, 33, "DISEASE"], [159, 165, "DISEASE"]]}], ["Elevated plasma B-type natriuretic peptide (BNP) levels and their association with heart failure have been reported in subjects with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).", {"entities": [[156, 193, "DISEASE"]]}], ["To examine and compare plasma BNP levels and diastolic and systolic dysfunction in subjects with AECOPD and stable chronic obstructive pulmonary disease (COPD).", {"entities": [[115, 152, "DISEASE"]]}], ["In all, 87 unselected consecutive hospitalizations due to AECOPD in 61 subjects and a total of 190 consecutive subjects with stable COPD were recruited.", {"entities": []}], ["Plasma BNP levels were compared cross-sectionally and longitudinally.", {"entities": []}], ["Transthoracic echocardiographic examinations were also performed in the hospitalized subjects.", {"entities": []}], ["In the hospitalized subjects, the median plasma BNP level (interquartile range) was 55.4 (26.9\u2013129.3) pg/mL and was higher than that of patients with stable COPD: 18.3 (10.0\u201345.3) for Global Initiative for Chronic Obstructive Lung Disease grade I; 25.8 (11.0\u201353.7) for grade II; 22.1 (9.1\u201352.6) for grade III; and 17.2 (9.6\u201322.9) pg/mL for grade I V, all P <0.001.", {"entities": []}], ["In 15 subjects studied prospectively, the median plasma BNP level was 19.4 (9.8\u201332.2) pg/mL before AECOPD, 72.7 (27.7\u2013146.3) pg/mL during AECOPD, and 14.6 (12.9\u201339.0) pg/mL after AECOPD ( P <0.0033 and P <0.0013, respectively).", {"entities": []}], ["Median plasma BNP levels during AECOPD were significantly higher in ten unsuccessfully discharged subjects 260.5 (59.4\u2013555.0) than in 48 successfully discharged subjects 48.5 (24.2\u2013104.0) pg/mL ( P =0.0066).", {"entities": []}], ["Only 5.6% of AECOPD subjects were associated with systolic dysfunction defined as a left ventricular ejection fraction (LVEF) <50%; a further 7.4% were considered to have impaired relaxation defined as an E/A wave velocity ratio <0.8 and a deceleration time of E >240 ms. BNP levels were weakly correlated with the E/peak early diastolic velocity of the mitral annulus (Ea) ratio (Spearman\u2019s rank correlation coefficient =0.353, P =0.018), but they were not correlated with the LVEF (Spearman\u2019s rank correlation coefficient =\u22120.221, P =0.108).", {"entities": []}], ["A modest elevation of plasma BNP is observed during AECOPD.", {"entities": []}], ["It appears that AECOPD may have an impact on plasma BNP levels that is not attributable to heart failure.", {"entities": []}], ["Clinical and experimental data suggest that the inflammatory response is impaired in diabetics and can be modulated by insulin.", {"entities": []}], ["The present study was undertaken to investigate the role of insulin on the early phase of allergic airway inflammation.", {"entities": []}], ["Diabetic male Wistar rats (alloxan, 42 mg/Kg, i.v., 10 days) and controls were sensitized by s.c. injection of ovalbumin (OA) in aluminium hydroxide 14 days before OA (1 mg/0.4 mL) or saline intratracheal challenge.", {"entities": []}], ["The following analyses were performed 6 hours thereafter: a) quantification of interleukin (IL)-1\u03b2, tumor necrosis factor (TNF)-\u03b1 and cytokine-induced neutrophil chemoattractant (CINC)-1 in the bronchoalveolar lavage fluid (BALF) by Enzyme-Linked Immunosorbent Assay, b) expression of E- and P- selectins on lung vessels by immunohistochemistry, and c) inflammatory cell infiltration into the airways and lung parenchyma.", {"entities": [[123, 126, "GENE"]]}], ["NPH insulin (4 IU, s.c.) was given i.v.", {"entities": []}], ["2 hours before antigen challenge.", {"entities": []}], ["Diabetic rats exhibited significant reduction in the BALF concentrations of IL-1\u03b2 (30%) and TNF-\u03b1 (45%), and in the lung expression of P-selectin (30%) compared to non-diabetic animals.", {"entities": []}], ["This was accompanied by reduced number of neutrophils into the airways and around bronchi and blood vessels.", {"entities": []}], ["There were no differences in the CINC-1 levels in BALF, and E-selectin expression.", {"entities": []}], ["Treatment of diabetic rats with NPH insulin, 2 hours before antigen challenge, restored the reduced levels of IL-1\u03b2, TNF-\u03b1 and P-selectin, and neutrophil migration.", {"entities": []}], ["Data presented suggest that insulin modulates the production/release of TNF-\u03b1 and IL-1\u03b2, the expression of P- and E-selectin, and the associated neutrophil migration into the lungs during the early phase of the allergic inflammatory reaction.", {"entities": []}], ["To examine the agreement between depression symptoms using an assessment tool (PHQ-9), and physician documentation of the same symptoms during a clinic visit, and then to examine how the presence of these symptoms affects depression diagnosis in primary care settings.", {"entities": []}], ["Interviewer administered surveys and medical record reviews.", {"entities": []}], ["A total of 304 participants were recruited from 2321 participants screened for depression at two large urban primary care community settings.", {"entities": []}], ["Of the 2321 participants screened for depression 304 were positive for depression and of these 75.3% (n = 229) were significantly depressed (PHQ-9 score \u2265 10).", {"entities": []}], ["Of these, 31.0% were diagnosed by a physician with a depressive disorder.", {"entities": []}], ["A total of 57.6% (n = 175) of study participants had both significant depression symptoms and functional impairment.", {"entities": []}], ["Of these 37.7% were diagnosed by physicians as depressed.", {"entities": []}], ["Cohen's Kappa analysis, used to determine the agreement between depression symptoms elicited using the PHQ-9 and physician documentation of these symptoms showed only slight agreement (0.001\u20130.101) for all depression symptoms using standard agreement rating scales.", {"entities": []}], ["Further analysis showed that only suicidal ideation and hypersomnia or insomnia were associated with an increased likelihood of physician depression diagnosis (OR 5.41 P sig < .01 and (OR 2.02 P sig < .05 respectively).", {"entities": []}], ["Other depression symptoms and chronic medical conditions had no affect on physician depression diagnosis.", {"entities": []}], ["Two-thirds of individuals with depression are undiagnosed in primary care settings.", {"entities": []}], ["While functional impairment increases the rate of physician diagnosis of depression, the agreement between a structured assessment and physician elicited and or documented symptoms during a clinical encounter is very low.", {"entities": []}], ["Suicidality, hypersomnia and insomnia are associated with an increase in the rate of depression diagnosis even when physician and self report of the symptom differ.", {"entities": []}], ["Interventions that emphasize the use of routine structured screening of primary care patients might also improve the rate of diagnosis of depression in these settings.", {"entities": []}], ["Further studies are needed to explore depression symptom assessment during physician patient encounter in primary care settings.", {"entities": []}], ["To study expression changes in inflammation-related genes in peripheral blood of patients with pneumoconiosis and to explore the possibility of these genes as pneumoconiosis biomarkers.", {"entities": [[95, 109, "DISEASE"], [159, 173, "DISEASE"]]}], ["Peripheral blood samples of patients with pneumoconiosis patients and controls were collected, and total RNA of the blood cells were extracted and reverse transcribed to cDNA.", {"entities": [[42, 56, "DISEASE"]]}], ["Screenings of deferentially expressed genes associated with inflammation between patients with pneumoconiosis and controls were performed using real-time quantitative PCR array and the expressions of the three most upregulated genes were confirmed by real-time PCR.", {"entities": [[95, 109, "DISEASE"]]}], ["The expression of 11 genes was significantly altered in patients with pneumoconiosis compared with those of the control.", {"entities": [[70, 84, "DISEASE"]]}], ["Among these 11 genes, 8 genes were upregulated and 3 were downregulated.", {"entities": []}], ["Preliminary results indicated that interleukin 6 (IL-6) mRNA expression in patients with pneumoconiosis was higher than that in controls (P=0.019).", {"entities": [[89, 103, "DISEASE"]]}], ["The level of IL6 mRNA expression in the patients was higher than that in non-smoking controls, but it was neither affected by type and stage of pneumoconiosis nor by time of contact with dust.", {"entities": [[144, 158, "DISEASE"], [13, 16, "GENE"]]}], ["IL6 was possibly involved in the development of pneumoconiosis.", {"entities": [[48, 62, "DISEASE"], [0, 3, "GENE"]]}], ["Understanding patients\u2019 views about medication is crucial to maximize adherence.", {"entities": []}], ["Thalassemia is a congenital blood disorder requiring chronic blood transfusions and daily iron chelation therapy.", {"entities": [[0, 11, "DISEASE"]]}], ["The Beliefs in Medicine Questionnaire (BMQ) was used to assess beliefs in chelation in thalassemia patients from North America and London in the Thalassemia Longitudinal Cohort (TLC) of the Thalassemia Clinical Research Network (TCRN).", {"entities": [[87, 98, "DISEASE"], [145, 156, "DISEASE"], [190, 201, "DISEASE"]]}], ["Chelation adherence was based on patient report of doses administered out of those prescribed in the last four weeks.", {"entities": []}], ["Of 371 patients (ages 5-58y, mean 24y), 93% were transfused and 92% receiving chelation (26% deferoxamine (DFO; a slow subcutaneous infusion via portable pump), 63% oral, 11% combination).", {"entities": []}], ["Patients expressed high \u201cnecessity\u201d for transfusion (96%), DFO chelation (92%) and oral chelation (89%), with lower \u201cconcern\u201d about treatment (48%, 39%, 19% respectively).", {"entities": []}], ["Concern about oral chelation was significantly lower than that of DFO (p<0.001).", {"entities": []}], ["Self-reported adherence to chelation was not associated with views about necessity or concerns, but negatively correlated with perceived sensitivity to DFO (Sensitive Soma scale; r=\u22120.23, p=0.01) and side effects of oral chelation (r=\u22120.14, p=0.04).", {"entities": []}], ["High ferritin iron levels, potentially indicating lower adherence, were found in 41% of patients reporting low necessity of oral chelation compared to 24% reporting high necessity (p=0.048).", {"entities": []}], ["Concerns about treatment were associated with lower quality of life and more symptoms of anxiety and depression.", {"entities": []}], ["Despite their requirement for multimodal therapy, thalassemia patients have positive views about medicine, more so than in other disease populations.", {"entities": [[50, 61, "DISEASE"]]}], ["Patients may benefit from education about the tolerability of chelation and strategies to effectively cope with side effects, both of which might be beneficial in lowering body iron burden.", {"entities": []}], ["NCT00661804", {"entities": []}], ["The prevalence of childhood overweight and obesity has become a public health problem worldwide.", {"entities": [[43, 50, "DISEASE"]]}], ["The objectives of the study were: 1) to establish the BMI prevalence in 12-year olds residing in Puerto Rico, and 2) to determine BMI differences by sex, public-private school type, and geographic regions.", {"entities": []}], ["Data was obtained from an island-wide probabilistic stratified sample of 1,582 twelve-year-olds (53% girls and 47% boys).", {"entities": []}], ["The BMI was determined using the National Health and Nutrition Examination Survey procedures.", {"entities": []}], ["Children were categorized as underweight, healthy weight, overweight or obese using the Center for Disease Control and Prevention\u2019s age and gender specific growth charts.", {"entities": []}], ["A logistic regression model was used to estimate BMI category prevalence.", {"entities": []}], ["Odds ratios were calculated using a multinomial regression.", {"entities": []}], ["In this study, 18.8% of the children were overweight and 24.3% were obese.", {"entities": []}], ["A higher prevalence of obesity was observed in boys as compared to girls, 28.2% vs. 20.2%, respectively.", {"entities": [[23, 30, "DISEASE"]]}], ["The estimated prevalence of overweight and obesity in children from public schools was lower than for those from private schools.", {"entities": [[43, 50, "DISEASE"]]}], ["After adjusting for type of school and region, boys had a significantly higher risk of being obese (64%) as compared to girls.", {"entities": []}], ["In public schools, boys had a lower prevalence of being overweight while girls had a higher prevalence compared to children attending private schools.", {"entities": []}], ["Girls attending private schools had a higher obesity prevalence (27.8%) compared to girls from public schools (19.8%).", {"entities": [[45, 52, "DISEASE"]]}], ["The prevalence of underweight (2.7%) is slightly lower than in the United States.", {"entities": []}], ["The prevalence of overweight and obesity of 12-year-olds residing in PR was 18.8% and 24.3%, respectively; higher than in the U.S. (by groups).", {"entities": [[33, 40, "DISEASE"]]}], ["Boys were at higher risk of obesity than girls.", {"entities": [[28, 35, "DISEASE"]]}], ["There is an urgent need to implement public health policies/programs to reduce the prevalence of overweight and obesity in children in PR.", {"entities": [[112, 119, "DISEASE"]]}], ["Studies have shown that chronic inflammation may play a vital role in the pathophysiology of both gastroesophageal reflux disease (GERD) and bipolar disorder.", {"entities": [[141, 157, "DISEASE"], [98, 129, "DISEASE"]]}], ["Among patients with GERD, the risk of bipolar disorder has not been well characterized.", {"entities": [[38, 54, "DISEASE"]]}], ["We explored the relationship between GERD and the subsequent development of bipolar disorder, and examined the risk factors for bipolar disorder in patients with GERD.", {"entities": [[76, 92, "DISEASE"], [128, 144, "DISEASE"]]}], ["We identified patients who were diagnosed with GERD in the Taiwan National Health Insurance Research Database.", {"entities": []}], ["A comparison cohort without GERD was matched according to age, sex, and comorbidities.", {"entities": []}], ["The occurrence of bipolar disorder was evaluated in both cohorts based on diagnosis and the prescription of medications.", {"entities": [[18, 34, "DISEASE"]]}], ["The GERD cohort consisted of 21,674 patients, and the comparison cohort consisted of 21,674 matched control patients without GERD.", {"entities": []}], ["The incidence of bipolar disorder (incidence rate ratio [IRR] 2.29, 95% confidence interval [CI] 1.58\u20133.36, P <.001) was higher among GERD patients than among comparison cohort.", {"entities": [[17, 33, "DISEASE"]]}], ["Multivariate, matched regression models showed that the female sex (hazard ratio [HR] 1.78, 95% CI 1.76\u20132.74, P \u200a=\u200a.008), being younger than 60 years old (HR 2.35, 95% CI 1.33\u20134.16, P \u200a=\u200a.003), and alcohol use disorder (HR 4.89, 95% CI 3.06\u20137.84, P \u200a=\u200a.004) were independent risk factors for the development of bipolar disorder among GERD patients.", {"entities": [[311, 327, "DISEASE"], [82, 84, "GENE"], [155, 157, "GENE"], [220, 222, "GENE"], [82, 84, "GENE"], [155, 157, "GENE"], [220, 222, "GENE"], [82, 84, "GENE"], [155, 157, "GENE"], [220, 222, "GENE"]]}], ["GERD may increase the risk of developing bipolar disorder.", {"entities": [[41, 57, "DISEASE"]]}], ["Based on our data, we suggest that attention should be focused on female patients younger than 60 years, and patients with alcohol use disorder, following a GERD diagnosis.", {"entities": []}], ["Juvenile Idiopathic Arthritis (JIA) affects children and adolescents with both short-term and long-term disability.", {"entities": []}], ["These children also report lower health-related quality of life (HRQOL) compared to their healthy peers.", {"entities": []}], ["However, there seems to be some discrepancies between self- and parent-reports, and gender differences need to be further studied.", {"entities": []}], ["This study aims to describe HRQOL in girls and boys with JIA, and to explore gender differences in self-reports compared to parent-reports of HRQOL in children with JIA.", {"entities": []}], ["Fifty-three children and adolescents with JIA (70% girls and 30% boys) with a median age of 14 years (8\u201318 years), and their parents, participated in this cross-sectional study in Sweden.", {"entities": []}], ["Data was systematically collected prior to ordinary visits at a Pediatric outpatient clinic, during a period of 16 months (2009\u20132010).", {"entities": []}], ["Disability was assessed with the Childhood Health Assessment Questionnaire (CHAQ), and disease activity by physicians\u2019 assessments and Erythrocyte Sedimentation Rate (ESR).", {"entities": []}], ["The Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL) was used to assess self- and parent-reports of HRQOL in the child.", {"entities": []}], ["In this sample of children with generally low disease activity and mild to moderate disability, more than half of the children experienced suboptimal HRQOL, equally in girls and boys.", {"entities": []}], ["Significant differences between self- and parent-reports of child HRQOL were most evident among girls, with lower parent-reports regarding the girl\u2019s physical- and psychosocial health as well as in the total HRQOL score.", {"entities": []}], ["Except for the social functioning subscale, where parents\u2019 reports were higher compared to their sons, there were no significant differences between boys- and parent-reports.", {"entities": []}], ["More than half of the girls and boys experienced suboptimal HRQOL in this sample, with no gender differences.", {"entities": []}], ["However, there were differences between self- and parent-reports of child HRQOL, with most significant differences found among the girls.", {"entities": []}], ["Thus, differences between self- and parent-reports of child HRQOL must be taken into account in clinical settings, especially among girls with JIA.", {"entities": []}], ["Polymorphic inversions are a source of genetic variability with a direct impact on recombination frequencies.", {"entities": []}], ["Given the difficulty of their experimental study, computational methods have been developed to infer their existence in a large number of individuals using genome-wide data of nucleotide variation.", {"entities": []}], ["Methods based on haplotype tagging of known inversions attempt to classify individuals as having a normal or inverted allele.", {"entities": []}], ["Other methods that measure differences between linkage disequilibrium attempt to identify regions with inversions but unable to classify subjects accurately, an essential requirement for association studies.", {"entities": []}], ["We present a novel method to both identify polymorphic inversions from genome-wide genotype data and classify individuals as containing a normal or inverted allele.", {"entities": []}], ["Our method, a generalization of a published method for haplotype data [ We demonstrate the accuracy of our method to detect inversions and classify individuals on principled-simulated genotypes, produced by the evolution of an inversion event within a coalescent model [", {"entities": []}], ["To describe noninvasive positive-pressure ventilation use in intensive care unit clinical practice, factors associated with NPPV failure and the associated prognosis.", {"entities": []}], ["A prospective cohort study.", {"entities": []}], ["Medical disorders (59%) and elective surgery (21%) were the main causes for admission to the intensive care unit.", {"entities": []}], ["The main indications for the initiation of noninvasive positive-pressure ventilation were the following: post-extubation, acute respiratory failure and use as an adjunctive technique to chest physiotherapy.", {"entities": [[128, 147, "DISEASE"]]}], ["The noninvasive positive-pressure ventilation failure group was older and had a higher Simplified Acute Physiology Score II score.", {"entities": []}], ["The noninvasive positive-pressure ventilation failure rate was 35%.", {"entities": []}], ["The main reasons for intubation were acute respiratory failure (55%) and a decreased level of consciousness (20%).", {"entities": [[43, 62, "DISEASE"]]}], ["The noninvasive positive-pressure ventilation failure group presented a shorter period of noninvasive positive-pressure ventilation use than the successful group [three (2-5) versus four (3-7) days]; they had lower levels of pH, HCO 3 and base excess, and the FiO 2 level was higher.", {"entities": []}], ["These patients also presented lower PaO2:FiO2 ratios; on the last day of support, the inspiratory positive airway pressure and expiratory positive airway pressure were higher.", {"entities": []}], ["The failure group also had a longer average duration of stay in the intensive care unit [17 (10-26) days vs. 8 (5-14) days], as well as a higher mortality rate (9 vs. 51%).", {"entities": []}], ["There was an association between failure and mortality, which had an odds ratio (95% CI) of 10.6 (5.93 \u2013 19.07).", {"entities": []}], ["The multiple logistic regression analysis using noninvasive positive pressure ventilation failure as a dependent variable found that treatment tended to fail in patients with a Simplified Acute Physiology Score II\u226534, an inspiratory positive airway pressure level\u226515 cmH2O and pH<7.40.", {"entities": []}], ["The indications for noninvasive positive-pressure ventilation were quite varied.", {"entities": []}], ["The failure group had a longer intensive care unit stay and higher mortality.", {"entities": []}], ["Simplified Acute Physiology Score II\u226534, pH<7.40 and higher inspiratory positive airway pressure levels were associated with failure.", {"entities": []}], ["Asthma affects at least 10% of Aboriginal children (aged 11 or younger) in Canada, making it the second most common chronic disease suffered by this demographic group; yet asthma support strategies specific to Aboriginal peoples have only begun to be identified.", {"entities": [[0, 6, "DISEASE"], [172, 178, "DISEASE"]]}], ["This research builds on earlier phases of a recent study focused on identifying the support needs and intervention preferences of Aboriginal children with asthma and their parents or caregivers.", {"entities": [[155, 161, "DISEASE"]]}], ["Here, we seek to identify the implications of our initial findings for asthma programs, policies, and practices in an Aboriginal context and to determine strategies for implementing prevention programs in Aboriginal communities.", {"entities": [[71, 77, "DISEASE"]]}], ["Five focus groups were conducted with 22 recruited community health care professionals and school personnel in 5 Mi\u2019kmaq communities in Unama\u2019ki (Cape Breton), Nova Scotia, Canada, through a community-based participatory research design.", {"entities": []}], ["Each focus group was first introduced to findings from a local \u201csocial support for asthma\u201d intervention, and then the groups explored issues associated with implementing social support from their respective professional positions.", {"entities": [[83, 89, "DISEASE"]]}], ["Thematic analysis revealed 3 key areas of opportunity and challenges for implementing asthma prevention and management initiatives in Mi\u2019kmaq communities in terms of 1) professional awareness, 2) local school issues, and 3) community health centers.", {"entities": [[86, 92, "DISEASE"]]}], ["Culturally relevant support initiatives are feasible and effective community-driven ways of improving asthma support in Mi\u2019kmaq communities; however, ongoing assistance from the local leadership (ie, chief and council), community health directors, and school administrators, in addition to partnerships with respiratory health service organizations, is needed.", {"entities": [[102, 108, "DISEASE"]]}], ["Objectives .", {"entities": []}], ["To investigate the potential association of tumor necrosis factor- \u03b1 T-857C polymorphism with susceptibility to the five common malignant tumors.", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["A comprehensive search of PubMed/Medline, Embase, and Web of Science databases was performed up to November 2015.", {"entities": []}], ["Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated to assess the strength of the association.", {"entities": []}], ["Subgroup analysis, heterogeneity analyses, and publication bias were also texted in the meta-analysis.", {"entities": []}], ["A total of twenty-two publications involving 5215 cases and 6755 controls were recruited.", {"entities": []}], ["Overall, the meta-analysis revealed an increased risk between the TNF- \u03b1 T-857C polymorphism and gastric cancer susceptibility in T versus C model, heterozygote genetic model, and dominant genetic model.", {"entities": [[105, 111, "DISEASE"]]}], ["An increased risk between the TNF- \u03b1 T-857C polymorphism and hepatocellular cancer susceptibility in homozygote genetic model and recessive genetic model was also found.", {"entities": [[76, 82, "DISEASE"]]}], ["No significant association was found between the TNF- \u03b1 T-857C polymorphism and colorectal cancer, cervical cancer, and prostate cancer.", {"entities": [[80, 97, "DISEASE"], [91, 97, "DISEASE"], [108, 114, "DISEASE"], [129, 135, "DISEASE"], [99, 114, "DISEASE"], [120, 135, "DISEASE"]]}], ["Conclusions .", {"entities": []}], ["Our meta-analyses suggest that TNF- \u03b1 T-857C polymorphism may be associated with increased risk of gastric cancer and hepatocellular cancer development.", {"entities": [[107, 113, "DISEASE"], [133, 139, "DISEASE"]]}], ["Therefore, the TNF- \u03b1 T-857C polymorphism could be considered as one possible risk factor of gastric cancer and hepatocellular cancer according to our study.", {"entities": [[101, 107, "DISEASE"], [127, 133, "DISEASE"]]}], ["Still picture transmission was performed using a telemedicine system in an Emergency Medical Service (EMS) during a prospective, controlled trial.", {"entities": []}], ["In this ancillary, retrospective study the quality and content of the transmitted pictures and the possible influences of this application on prehospital time requirements were investigated.", {"entities": []}], ["A digital camera was used with a telemedicine system enabling encrypted audio and data transmission between an ambulance and a remotely located physician.", {"entities": []}], ["By default, images were compressed (jpeg, 640 x 480 pixels).", {"entities": []}], ["On occasion, this compression was deactivated (3648 x 2736 pixels).", {"entities": []}], ["Two independent investigators assessed all transmitted pictures according to predefined criteria.", {"entities": []}], ["In cases of different ratings, a third investigator had final decision competence.", {"entities": []}], ["Patient characteristics and time intervals were extracted from the EMS protocol sheets and dispatch centre reports.", {"entities": []}], ["Overall 314 pictures (mean 2.77\u2009\u00b1\u20092.42 pictures/mission) were transmitted during 113 missions (group 1).", {"entities": []}], ["Pictures were not taken for 151 missions (group 2).", {"entities": []}], ["Regarding picture quality, the content of 240 (76.4%) pictures was clearly identifiable; 45 (14.3%) pictures were considered \u201climited quality\u201d and 29 (9.2%) pictures were deemed \u201cnot useful\u201d due to not/hardly identifiable content.", {"entities": []}], ["For pictures with file compression (n\u2009=\u200984 missions) and without (n\u2009=\u200917 missions), the content was clearly identifiable in 74% and 97% of the pictures, respectively (p\u2009=\u20090.003).", {"entities": []}], ["Medical reports (n\u2009=\u200998, 32.8%), medication lists (n\u2009=\u200949, 16.4%) and 12-lead ECGs (n\u2009=\u200928, 9.4%) were most frequently photographed.", {"entities": []}], ["The patient characteristics of group 1 vs. 2 were as follows: median age \u2013 72.5 vs. 56.5 years, p\u2009=\u20090.001; frequency of acute coronary syndrome \u2013 24/113 vs. 15/151, p\u2009=\u20090.014.", {"entities": [[135, 143, "DISEASE"]]}], ["The NACA scores and gender distribution were comparable.", {"entities": [[4, 8, "GENE"]]}], ["Median on-scene times were longer with picture transmission (26 vs. 22 min, p\u2009=\u20090.011), but ambulance arrival to hospital arrival intervals did not differ significantly (35 vs. 33 min, p\u2009=\u20090.054).", {"entities": []}], ["Picture transmission was used frequently and resulted in an acceptable picture quality, even with compressed files.", {"entities": []}], ["In most cases, previously existing \u201cpaper data\u201d was transmitted electronically.", {"entities": []}], ["This application may offer an alternative to other modes of ECG transmission.", {"entities": []}], ["Due to different patient characteristics no conclusions for a prolonged on-scene time can be drawn.", {"entities": []}], ["Mobile picture transmission holds important opportunities for clinical handover procedures and teleconsultation.", {"entities": []}], ["We conducted a study on building-related respiratory disease and associated social impact in an office building with water incursions in the northeastern United States.", {"entities": []}], ["An initial questionnaire had 67% participation (888/1,327).", {"entities": []}], ["Compared with the U.S. adult population, prevalence ratios were 2.2\u20132.5 for wheezing, lifetime asthma, and current asthma, 3.3 for adult-onset asthma, and 3.4 for symptoms improving away from work ( p < 0.05).", {"entities": [[95, 101, "DISEASE"], [115, 121, "DISEASE"], [143, 149, "DISEASE"]]}], ["Two-thirds (66/103) of the adult-onset asthma arose after occupancy, with an incidence rate of 1.9/1,000 person-years before building occupancy and 14.5/1,000 person-years after building occupancy.", {"entities": [[39, 45, "DISEASE"]]}], ["We conducted a second survey on 140 respiratory cases, 63 subjects with fewer symptoms, and 44 comparison subjects.", {"entities": []}], ["Health-related quality of life decreased with increasing severity of respiratory symptoms and in those with work-related symptoms.", {"entities": []}], ["Symptom status was not associated with job satisfaction or how often jobs required hard work.", {"entities": []}], ["Respiratory health problems accounted for one-third of sick leave, and respiratory cases with work-related symptoms had more respiratory sick days than those without work-related symptoms (9.4 vs. 2.4 days/year; p < 0.01).", {"entities": []}], ["Abnormal lung function and/or breathing medication use was found in 67% of respiratory cases, in 38% of participants with fewer symptoms, and in 11% of the comparison group ( p < 0.01), with similar results in never-smokers.", {"entities": []}], ["Postoccupancy-onset asthma was associated with less atopy than preoccupancy-onset asthma.", {"entities": [[20, 26, "DISEASE"], [82, 88, "DISEASE"]]}], ["Occupancy of the water-damaged building was associated with onset and exacerbation of respiratory conditions, confirmed by objective medical tests.", {"entities": []}], ["The morbidity and lost work time burdened both employees and employers.", {"entities": []}], ["Background: People with coronary disease have a higher risk of functional limitations than their same-age counterparts without disease.", {"entities": []}], ["This study examined prospectively the extent to which functioning and independent living among individuals with coronary disease in early old age are associated with lifestyle factors before and after disease onset.", {"entities": []}], ["Methods: Participants were 986 British civil servants (657 men and 329 women aged 35\u201355 years), who were free of coronary disease at study entry in 1985\u201388 but developed disease during 21 years follow-up (the Whitehall II study).", {"entities": []}], ["Lifestyle factors (obesity, smoking, alcohol, diet and physical activity) were measured at baseline and follow-up in 2007\u201309.", {"entities": [[19, 26, "DISEASE"]]}], ["Post-disease limitations to functioning were measured in 2006\u201309 at mean age is 68 years using activities of daily living scales.", {"entities": []}], ["Results: Low physical activity and being overweight [body mass index (BMI) \u226525] before and after disease onset were associated with having one or more limitations in activities of daily living among coronary patients [age-, sex- and socio-economic position adjusted odds ratios for pre-disease inactivity and obesity 1.53 [95% confidence interval (95% CI) 0.99\u20132.35] and 2.53 (95% CI 1.53\u20134.18), respectively].", {"entities": [[309, 316, "DISEASE"]]}], ["A decrease in physical activity [odds ratio (OR): 2.42, 95% CI 1.59\u20133.68] and an increase of >5 U in BMI (OR: 2.05, 95% CI 1.34\u20133.13) were also related to limitations in activities of daily living after disease onset.", {"entities": []}], ["These relationships were not accounted for by measured co-morbidities.", {"entities": []}], ["No robust associations were observed for smoking, alcohol use and diet.", {"entities": []}], ["Conclusion: Physical activity and weight control across the adult life course are associated with fewer limitations to functioning and independent living after the onset of coronary disease.", {"entities": []}], ["Pregnancy presents a unique situation for the management of asthma as it can alter the course of asthma severity and its treatment, which in turn can affect pregnancy outcomes.", {"entities": [[60, 66, "DISEASE"], [97, 103, "DISEASE"]]}], ["Despite awareness of the substantial adverse effects associated with asthma during pregnancy, little has been done to improve its management and reduce associated perinatal morbidity and mortality.", {"entities": [[69, 75, "DISEASE"]]}], ["The aim of this randomized controlled trial is to evaluate the clinical and cost effectiveness of an Antenatal Asthma Management Service.", {"entities": [[111, 117, "DISEASE"]]}], ["Design: Multicentre, randomized controlled trial.", {"entities": []}], ["Inclusion criteria: Women with physician diagnosed asthma, which is not currently in remission, who are less than 20 weeks gestation with a singleton pregnancy and do not have a chronic medical condition.", {"entities": [[51, 57, "DISEASE"]]}], ["Trial entry and randomization: Eligible women with asthma, stratified by treatment site, disease severity and parity, will be randomized into either the \u2018Standard Care Group\u2019 or the \u2018Intervention Group\u2019.", {"entities": [[51, 57, "DISEASE"]]}], ["Study groups: Both groups will be followed prospectively throughout pregnancy.", {"entities": []}], ["Women in the \u2018Standard Care Group\u2019 will receive routine obstetric care reflecting current clinical practice in Australian hospitals.", {"entities": []}], ["Women in the \u2018Intervention Group\u2019 will receive additional care through the nurse-led Antenatal Asthma Management Service, based in the antenatal outpatient clinic.", {"entities": [[95, 101, "DISEASE"]]}], ["Women will receive asthma education with a full assessment of their asthma at 18, 24, 30 and 36 weeks gestation.", {"entities": [[19, 25, "DISEASE"], [68, 74, "DISEASE"]]}], ["Each antenatal visit will include a 60 min session where asthma management skills are assessed including: medication adherence and knowledge, inhaler device technique, recognition of asthma deterioration and possession of a written asthma action plan.", {"entities": [[57, 63, "DISEASE"], [183, 189, "DISEASE"], [232, 238, "DISEASE"]]}], ["Furthermore, subjects will receive education about asthma control and management skills including trigger avoidance and smoking cessation counseling when appropriate.", {"entities": [[51, 57, "DISEASE"]]}], ["Primary study outcome: Asthma exacerbations during pregnancy.", {"entities": [[23, 29, "DISEASE"]]}], ["Sample size: A sample size of 378 women will be sufficient to show an absolute reduction in asthma exacerbations during pregnancy of 20% (alpha 0.05 two-tailed, 90% power, 5% loss to follow-up).", {"entities": [[92, 98, "DISEASE"]]}], ["The integration of an asthma education program within the antenatal clinic setting has the significant potential to improve the participation of pregnant women in the self-management of their asthma, reduce asthma exacerbations and improve perinatal health outcomes.", {"entities": [[22, 28, "DISEASE"], [192, 198, "DISEASE"], [207, 213, "DISEASE"]]}], ["ACTRN12613000244707", {"entities": []}], ["Specific treatment is not available for human botulism.", {"entities": [[46, 54, "DISEASE"]]}], ["Current remedial mainstay is the passive administration of polyclonal antibody to botulinum neurotoxin (BoNT) derived from heterologous species (immunized animal or mouse hybridoma) together with supportive and symptomatic management.", {"entities": []}], ["The antibody works extracellularly, probably by blocking the binding of receptor binding (R) domain to the neuronal receptors; thus inhibiting cellular entry of the holo-BoNT.", {"entities": []}], ["The antibody cannot neutralize the intracellular toxin.", {"entities": []}], ["Moreover, a conventional antibody with relatively large molecular size (150 kDa) is not accessible to the enzymatic groove and, thus, cannot directly inhibit the BoNT zinc metalloprotease activity .", {"entities": []}], ["Recently, a 15\u201320 kDa single domain antibody (V H H) that binds specifically to light chain of BoNT serotype A was produced from a humanized-camel VH/V H H phage display library.", {"entities": []}], ["The V H H has high sequence homology (>80%) to the human VH and could block the enzymatic activity of the BoNT.", {"entities": []}], ["Molecular docking revealed not only the interface binding between the V H H and the toxin but also an insertion of the V H H CDR3 into the toxin enzymatic pocket.", {"entities": []}], ["It is envisaged that, by molecular linking the V H H to a cell penetrating peptide (CPP), the CPP-V H H fusion protein would be able to traverse the hydrophobic cell membrane into the cytoplasm and inhibit the intracellular BoNT.", {"entities": []}], ["This presents a novel and safe immunotherapeutic strategy for botulism by using a cell penetrating, humanized-single domain antibody that inhibits the BoNT by means of a direct blockade of the groove of the menace enzyme.", {"entities": [[62, 70, "DISEASE"]]}], ["A key strategy in improving care for people with chronic obstructive pulmonary disease (COPD) is the provision of pulmonary rehabilitation programmes.", {"entities": [[49, 86, "DISEASE"]]}], ["Pulmonary rehabilitation programmes have been successful in improving patients' sense of dyspnoea and Health Related Quality of Life.", {"entities": []}], ["However, the effectiveness of structured education pulmonary rehabilitation programmes delivered at the level of the general practice on the health status of people with COPD remains uncertain and there is a need for a robust and fair assessment of this.", {"entities": []}], ["The PRINCE study will evaluate the effectiveness of a Structured Education Pulmonary Rehabilitation Programme (SEPRP), delivered at the level of the general practice, on the health status of people with COPD.", {"entities": []}], ["The PRINCE Trial is a two-armed, single blind cluster randomised trial conducted in the primary care setting in Ireland.", {"entities": []}], ["Randomisation to control and intervention is at the level of the General Practice.", {"entities": []}], ["Participants in the intervention arm will receive a SEPRP and those allocated to the control arm will receive usual care.", {"entities": []}], ["Delivery of the SEPRP will be by a practice nurse and physiotherapist in the General Practice (GP) site.", {"entities": []}], ["The primary outcome measure of the study will be health status as measured by the Chronic Respiratory Questionnaire (CRQ).", {"entities": []}], ["Blinded outcome assessment will be undertaken at baseline and at twelve-fourteen weeks after completion of the programme.", {"entities": []}], ["A comparison of outcomes between the intervention and control sites will be made to examine if differences exist and, if so, to what extent between control and experimental groups.", {"entities": []}], ["Sample size calculations estimate that 32 practices with a minimum of 10 participants per practice are required, in total, to be randomised to control and intervention arms for power of at least 80% with alpha levels of 0.05, to determine a clinically significant change of 0.5 units in the CRQ.", {"entities": []}], ["A cost effectiveness analysis will also be conducted.", {"entities": []}], ["The results of this trial are directly applicable to primary care settings in Ireland.", {"entities": []}], ["Should a SEPRP delivered by practice nurses and physiotherapists in primary care be found to be effective in improving patients' sense of dyspnoea and HRQoL, then the findings would be applicable to many thousands of individuals in Ireland and beyond.", {"entities": []}], ["ISRCTN: ISRCTN52403063", {"entities": []}], ["Patients with cirrhosis often have functional limitations, decreased muscle mass, and a high risk of falls.", {"entities": []}], ["These variables could improve with exercise.", {"entities": []}], ["The aim was to study the effects of moderate exercise on functional capacity, body composition and risk of falls in patients with cirrhosis.", {"entities": []}], ["Twenty-three cirrhotic patients were randomized to an exercise programme (n = 14) or to a relaxation programme (n = 9).", {"entities": []}], ["Both programmes consisted of a one-hour session 3 days a week for 12 weeks.", {"entities": []}], ["At the beginning and end of the study, we measured functional capacity using the cardiopulmonary exercise test, evaluated body composition using anthropometry and dual energy X-ray absorptiometry, and estimated risk of falls using the Timed Up&Go test.", {"entities": []}], ["In the exercise group, cardiopulmonary exercise test showed an increase in total effort time (p<0.001) and ventilatory anaerobic threshold time (p = 0.009).", {"entities": []}], ["Upper thigh circumference increased and mid-arm and mid-thigh skinfold thickness decreased.", {"entities": []}], ["Dual energy X-ray absorptiometry showed a decrease in fat body mass (-0.94 kg, 95%CI -0.48 to -1.41, p = 0.003) and an increase in lean body mass (1.05 kg, 95%CI 0.27 to 1.82, p = 0.01), lean appendicular mass (0.38 kg, 95%CI 0.06 to 0.69, p = 0.03) and lean leg mass (0.34 kg, 95%CI 0.10 to 0.57, p = 0.02).", {"entities": []}], ["The Timed Up&Go test decreased at the end of the study compared to baseline (p = 0.02).", {"entities": []}], ["No changes were observed in the relaxation group.", {"entities": []}], ["We conclude that a moderate exercise programme in patients with cirrhosis improves functional capacity, increases muscle mass, and decreases body fat and the Timed Up&Go time.", {"entities": []}], ["Trial Registration : ClinicalTrials.gov NCT01447537", {"entities": []}], ["Objective: To evaluate the initial management of pediatric parapneumonic effusion or pleural empyema (PPE/PE) with regard to length of hospital stay (LOS).", {"entities": [[85, 100, "DISEASE"]]}], ["Methods: Collection of pediatric PPE/PE cases using a nationwide surveillance system (ESPED) from 10/2010 to 06/2013, in all German pediatric hospitals.", {"entities": []}], ["Inclusion of PPE/PE patients <18 years of age requiring drainage or with a PPE/PE persistence >7 days.", {"entities": []}], ["Staging of PPE/PE based on reported pleural sonographic imaging.", {"entities": []}], ["Comparison of LOS after diagnosis between children treated with different forms of initial invasive procedures performed \u22643 days after PPE/PE diagnosis: pleural puncture, draining catheter, intrapleural fibrinolytic therapy, surgical procedures.", {"entities": []}], ["Results: Inclusion of 645 children (median age 5 years); median total LOS 17 days.", {"entities": []}], ["Initial therapy was non\u2010invasive in 282 (45%) cases and invasive in 347 (55%) cases (pleural puncture: 62 [10%], draining catheter: 153 [24%], intrapleural fibrinolytic therapy: 89 [14%], surgical procedures: 43 [7%]).", {"entities": []}], ["LOS after diagnosis did not differ between children initially treated with different invasive procedures.", {"entities": []}], ["Results remained unchanged when controlling for sonographic stage, preexisting diseases, and other potential confounders.", {"entities": []}], ["Repeated use of invasive procedures was observed more often after initial non\u2010invasive treatment or pleural puncture alone than after initial pleural drainage, intrapleural fibrinolytic therapy or surgery.", {"entities": []}], ["Conclusions: Initial treatment with intrapleural fibrinolytic therapy or surgical procedures did not result in shorter LOS than initial pleural puncture alone.", {"entities": []}], ["Larger prospective studies are required to investigate which children benefit significantly from more intensive forms of initial invasive treatment.", {"entities": []}], ["Pediatr Pulmonol.", {"entities": []}], ["2017;52:540\u2013547.", {"entities": []}], ["\u00a9 2016 The Authors.", {"entities": []}], ["Pediatric Pulmonology Published by Wiley Periodicals, Inc.", {"entities": []}], ["Interleukin-33 (IL-33) has been linked to chronic heart failure (CHF) in animal studies, but data on serum IL-33 levels in human CHF are not available.", {"entities": []}], ["We analyzed levels of IL-33 in serum, and investigated the possible role of IL-33 in oxidative stress.", {"entities": []}], ["A total of 191 subjects with advanced systolic CHF (CHF group), 175 patients with pre-existing cardiac diseases but no CHF (non-CHF group), and 177 healthy controls (HC group) were enrolled.", {"entities": []}], ["Serum levels of IL-33, soluble ST2 (sST2) and N-terminal-pro-brain natriuretic peptide (NT-proBNP), malondialdehyde (MDA) content, erythrocyte superoxide dismutase (eSOD) activity, as well as left ventricular ejection fraction (LVEF), were determined.", {"entities": []}], ["The exact form of IL-33 in serum was identified.", {"entities": []}], ["Effects of IL-33 and sST2 on MDA content and SOD activity in angiotensin (Ang II)-stimulated AC16 cells were assessed.", {"entities": [[74, 77, "GENE"]]}], ["Serum levels of IL-33 and sST2 were elevated in CHF patients, whereas IL-33/sST2 ratios were decreased.", {"entities": []}], ["In CHF patients, pre-existing cardiac diseases and medications used upon hospital admission did not affect IL-33 concentrations or the IL-33/sST2 ratio.", {"entities": []}], ["Full-length IL-33, which could not be detected in serum from HC and barely detected in non-CHF patients, was significantly up-regulated in CHF patients.", {"entities": []}], ["IL-33 levels were positively correlated with markers of CHF severity.", {"entities": []}], ["IL-33/sST2 ratios were slightly and negatively related to MDA concentrations.", {"entities": []}], ["IL-33 directly reduced MDA and enhanced SOD activity in Ang II-stimulated AC16 cells, which were greatly attenuated by sST2.", {"entities": [[56, 59, "GENE"]]}], ["Serum levels of IL-33, especially the full-length form, were elevated in CHF patients whereas IL-33 bioactivity was reduced.", {"entities": []}], ["In advanced CHF, IL-33 may exert anti-oxidation effects, which may be overwhelmed by concurrently elevated levels of sST2.", {"entities": []}], ["Injury to airway smooth muscle (ASM) cells hallmarks the pathological progression of asthma, a chronic inflammatory airway disease.", {"entities": [[85, 91, "DISEASE"]]}], ["MicroRNAs (miRNAs) play essential roles in the development of asthma as well as airway remodeling.", {"entities": [[62, 68, "DISEASE"]]}], ["Here we studied the involvement of miRNAs in the regulation of autophagic survival of ASM cells and airway disorder.", {"entities": []}], ["We analyzed autophagy-associated factors LC3 and Beclin-1 by RT-qPCR and protein blotting in purified airway smooth muscle cells from ovalbumin (OVA)-induced asthmatic mice.", {"entities": []}], ["The biological activity of miRNA targeting Beclin-1 was explored by bioinformatics method and confirmed in a dual luciferase reporter assay.", {"entities": []}], ["Loss of function experiment was performed via transplantation of miRNA in OVA-induced asthmatic mice.", {"entities": []}], ["We detected high autophagy levels in ASM cells, which appeared to result from augmentation of Beclin-1 protein, rather than Beclin-1 mRNA, suggesting presence of post-transcriptional control of Beclin-1.", {"entities": []}], ["Next, miR-384 was figured out to be a Belcin-1-targeting miRNA, which significantly decreased after OVA treatment.", {"entities": [[6, 13, "GENE"]]}], ["Mechanistically, binding of miR-384 to 3\u2019-UTR of Beclin-1 mRNA potently suppressed Beclin-1 protein translation in ASM cells, similar to previous finding in another cell type.", {"entities": [[28, 35, "GENE"]]}], ["In vivo, transplantation of miR-384 significantly attenuated Belcin-1 protein levels in ASM cells, resulting in reduced autophagy of ASM cells and attenuation of asthmatic features by OVA.", {"entities": [[28, 35, "GENE"]]}], ["Together, these data suggest that re-expression of miR-384 may reduce augmentation of Beclin-1-dependent autophagy of ASM cells, as a novel promising treatment for asthma.", {"entities": [[164, 170, "DISEASE"], [51, 58, "GENE"]]}], ["The aim of this study was to investigate the antimicrobial activity of different extracts and fractions obtained from Hymenaea stigonocarpa stem barks.", {"entities": []}], ["The cyclohexanic, ethyl acetate, ethanol, aqueous, and hydroalcoholic extracts were obtained by maceration.", {"entities": []}], ["The hydroalcoholic extract was partitioned, which resulted in the ethyl acetate and aqueous fractions.", {"entities": []}], ["All extracts and fractions were subjected to phytochemical screening and evaluation of total phenol and tannin contents.", {"entities": []}], ["An HPLC-DAD and ultrastructural alterations analysis were performed.", {"entities": []}], ["Terpenes and coumarins were detected in the cyclohexanic extract.", {"entities": []}], ["Flavonoids and condensed tannins were present in the other extracts and fractions.", {"entities": []}], ["The extracts with the highest contents of tannins, ethanol (EE), hydroalcoholic (HE), and aqueous fraction (AF) showed also the highest antimicrobial activity.", {"entities": []}], ["The MIC values ranged from 64 to 526\u2009 \u00b5 g/mL.", {"entities": []}], ["The chromatographic fingerprints suggest the presence of astilbin and other flavonoids in EE and HE.", {"entities": []}], ["Presence of the thick cell wall, undulating outer layer, abnormal septa, and leakage of the cytoplasmic contents and absence of cell wall and cell lyses were the main alterations observed on Staphylococcus aureus ATCC 33591 after treatment with the Hymenaea stigonocarpa hydroalcoholic extract.", {"entities": []}], ["The presence of phenolic compounds like flavonoids and tannins is possibly the reason for the antimicrobial activity.", {"entities": []}], ["A small proportion of patients use an excessively large amount of emergency care resources which often results in emergency department (ED) overcrowding, decreased quality of care and efficiency.", {"entities": []}], ["There is a need to better identify these patients in order to target those who will benefit most from interventions adapted to their specific needs.", {"entities": []}], ["We aimed to identify the predictive factors of short-term frequent use of ED (over a 1-year period) and chronic frequent use of ED (over a multiple-year period) and to highlight recurring characteristics in patients.", {"entities": []}], ["A scoping review was performed of all relevant articles found in Medline published between 1979 and 2015 (Ovid).", {"entities": []}], ["This scoping review included a total of 20 studies, of these, 16 articles focussed on frequent ED users and four others on chronic frequent ED users.", {"entities": []}], ["A majority of articles confirm that patients who frequently visit the ED are persons of low socioeconomic status.", {"entities": []}], ["Both frequent and chronic frequent ED users show high levels of health care use (other than the ED) and suffer from multiple physical and mental conditions.", {"entities": []}], ["This research highlights which individual factors predict frequent emergency department use.", {"entities": []}], ["Further research is needed to better characterize and understand chronic frequent users as well as the health issues and unmet medical needs that lead to chronic frequent ED use.", {"entities": []}], ["Asthma is major health burden throughout the world, and there are no therapies that have been shown to be able to prevent the development of disease.", {"entities": [[0, 6, "DISEASE"]]}], ["A severe respiratory paramyxoviral infection early in life has been demonstrated to greatly increase the risk of developing asthma.", {"entities": [[124, 130, "DISEASE"]]}], ["We have a mouse model of a severe respiratory paramyxoviral infection (Sendai virus, SeV) that mimics human disease, and requires early expression of the cytokine CCL28 to drive the development of post\u2010viral airway disease.", {"entities": [[163, 168, "GENE"]]}], ["The known receptors for CCL28 are CCR3 and CCR10.", {"entities": [[24, 29, "GENE"], [34, 38, "GENE"], [43, 48, "GENE"]]}], ["However, it is not known if blockade of these receptors will prevent the development of post\u2010viral airway disease.", {"entities": []}], ["The objective of this study was to determine if treatment with a protein epitope mimetic antagonist of CCR10, POL7085, will provide sufficient protection against the development of post\u2010viral airway disease.", {"entities": [[103, 108, "GENE"]]}], ["C57BL6 mice were inoculated with SeV or UV inactivated SeV.", {"entities": []}], ["From day 3\u201319 post inoculation (PI), mice were subcutaneously administered daily POL7085 or saline, or every other day anti\u2010CCL28 mAb.", {"entities": []}], ["On days 8, 10, and 12 PI bronchoalveolar cytokines, serum IgE, and lung cellular constituents were measured.", {"entities": []}], ["At day 21 PI airway hyper\u2010reactivity to methacholine and mucous cell metaplasia was measured.", {"entities": []}], ["Treatment with either anti\u2010CCL28 or POL7085 significantly reduced development of airway hyper\u2010reactivity and mucous cell metaplasia following SeV infection.", {"entities": []}], ["The prevention of post\u2010viral airway disease was associated with early reductions in innate immune cells, but did not appear to be due to a reduction in IL\u201013 or IgE.", {"entities": []}], ["Blockade of CCL28 or CCR10 during an acute severe respiratory paramyxoviral infection is sufficient to prevent the development of post\u2010viral airway disease.", {"entities": [[12, 17, "GENE"], [21, 26, "GENE"]]}], ["However, the mechanism of action is unclear and requires further exploration.", {"entities": []}], ["Thymic stromal lymphopoietin (TSLP) is an epithelial cytokine expressed at barrier surfaces of the skin, gut, nose, lung, and the maternal/fetal interphase.", {"entities": [[30, 34, "GENE"]]}], ["At these sites, it is important for the generation and maintenance of non-inflammatory, tissue-resident dendritic cell responses.", {"entities": []}], ["We show here that TSLP is also expressed in the central nervous system (CNS) where it is produced by choroid plexus epithelial cells and astrocytes in the spinal cord.", {"entities": [[18, 22, "GENE"]]}], ["Under conditions of low-grade myelin degeneration, the numbers of TSLP-expressing astrocytes increase, and microglia express transcripts for the functional TSLP receptor dimer indicating that these cells are targets for TSLP in the myelin-degenerative CNS.", {"entities": [[66, 70, "GENE"], [156, 160, "GENE"], [220, 224, "GENE"], [66, 70, "GENE"], [156, 160, "GENE"], [220, 224, "GENE"]]}], ["Cell count in induced sputum is a noninvasive biomarker to assess airway inflammation phenotypes.", {"entities": []}], ["Accordingly, sputum cell counts are extensively used in the treatment of asthma and COPD.", {"entities": [[73, 79, "DISEASE"]]}], ["Nevertheless, the clinical application of sputum cell counts in patients with asthma\u2013COPD overlap (ACO) remains elusive.", {"entities": [[78, 84, "DISEASE"]]}], ["The aim of this study was to investigate sputum cell counts in patients with ACO which are different from those in patients with asthma and COPD and also to examine the relationship between sputum cell counts in bronchial reversibility and bronchial hyperresponsiveness (BHR).", {"entities": [[129, 135, "DISEASE"]]}], ["A total of 374 patients participated in the study, including 142 patients with asthma, 160 patients with COPD and 72 patients with ACO.", {"entities": [[79, 85, "DISEASE"]]}], ["All patients underwent the following tests on the same day: pulmonary function test (PFT), BHR test or bronchodilator reversibility test and inducing sputum.", {"entities": []}], ["They were classified into the asthma group, COPD group or ACO group based on a clinical history, PFT values and BHR test or bronchodilator reversibility test.", {"entities": [[30, 36, "DISEASE"]]}], ["The three groups had different PFT values ( p <0.001) except for forced vital capacity (FVC) between the asthma and ACO groups ( p =0.378).", {"entities": [[105, 111, "DISEASE"]]}], ["The sputum levels of eosinophil% were decreased in patients with COPD when compared with those in patients with asthma and ACO ( p <0.001 and p <0.001, respectively).", {"entities": [[112, 118, "DISEASE"]]}], ["There was a difference in sputum neutrophil% and macrophage% counts among the three groups ( p <0.001 and p <0.001, respectively); there was no difference in sputum eosinophil% counts between patients with ACO and asthma ( p =0.668) and there was no difference in the percentage of induced sputum cells between the stage of airway obstruction and the stage of BHR.", {"entities": [[214, 220, "DISEASE"]]}], ["The clinical relevance of this study provides evidence that sputum cell counts as an inflammatory biomarker could carry some information to distinguish ACO, asthma and COPD, and these biomarkers need more studies to provide diagnostic value in the differentiation between ACO, asthma and COPD.", {"entities": [[157, 163, "DISEASE"], [277, 283, "DISEASE"]]}], ["Extracellular vesicles (EVs) have emerged as a ubiquitous mechanism for transferring information between cells and organisms across all three kingdoms of life.", {"entities": []}], ["In addition to their roles in normal physiology, vesicles also transport molecules from pathogens to hosts and can spread antigens as well as infectious agents.", {"entities": []}], ["Although initially described in the host\u2013pathogen context for their functions in immune surveillance, vesicles enable multiple modes of communication by, and between, parasites.", {"entities": []}], ["Here we review the literature demonstrating that EVs are secreted by intracellular and extracellular eukaryotic parasites, as well as their hosts, and detail the functional properties of these vesicles in maturation, pathogenicity and survival.", {"entities": []}], ["We further describe the prospects for targeting or exploiting these complexes in therapeutic and vaccine strategies.", {"entities": []}], ["EVs are secreted by most or all organisms and are emerging as a ubiquitous and functionally diverse type of host\u2013pathogen interaction.", {"entities": []}], ["EVs contain a diverse suite of molecules including proteins, lipids, and nucleic acids, some of which are known to have immunomodulatory properties.", {"entities": []}], ["Parasite-derived EVs can communicate information and transfer genetic material to host cells or other parasites.", {"entities": []}], ["Host-derived EVs can play a key role in host defense and are candidates for generating a vaccine against pathogenic infection.", {"entities": []}], ["Despite important implications for the budgets, statistical power and generalisability of research findings, detailed reports of recruitment and retention in randomised controlled trials (RCTs) are rare.", {"entities": []}], ["The NOURISH RCT evaluated a community-based intervention for first-time mothers that promoted protective infant feeding practices as a primary prevention strategy for childhood obesity.", {"entities": [[177, 184, "DISEASE"]]}], ["The aim of this paper is to provide a detailed description and evaluation of the recruitment and retention strategies used.", {"entities": []}], ["A two stage recruitment process designed to provide a consecutive sampling framework was used.", {"entities": []}], ["First- time mothers delivering healthy term infants were initially approached in postnatal wards of the major maternity services in two Australian cities for consent to later contact (Stage 1).", {"entities": []}], ["When infants were approximately four months old mothers were re-contacted by mail for enrolment (Stage 2), baseline measurements (Time 1) and subsequent random allocation to the intervention or control condition.", {"entities": []}], ["Outcomes were assessed at infant ages 14 months (Time 2) and 24 months (Time 3).", {"entities": []}], ["At Stage 1, 86% of eligible mothers were approached and of these women, 76% consented to later contact.", {"entities": []}], ["At Stage 2, 3% had become ineligible and 76% could be recontacted.", {"entities": []}], ["Of the latter, 44% consented to full enrolment and were allocated.", {"entities": []}], ["This represented 21% of mothers screened as eligible at Stage 1.", {"entities": []}], ["Retention at Time 3 was 78%.", {"entities": []}], ["Mothers who did not consent or discontinued the study were younger and less likely to have a university education.", {"entities": []}], ["The consent and retention rates of our sample of first time mothers are comparable with or better than other similar studies.", {"entities": []}], ["The recruitment strategy used allowed for detailed information from non-consenters to be collected; thus selection bias could be estimated.", {"entities": []}], ["Recommendations for future studies include being able to contact participants via mobile phone (particularly text messaging), offering home visits to reduce participant burden and considering the use of financial incentives to support participant retention.", {"entities": []}], ["Australian and New Zealand Clinical Trials Registry Number ACTRN12608000056392", {"entities": []}], ["This review focuses key advances in different pediatric fields that were published in Italian Journal of Pediatrics and in international journals in 2015.", {"entities": []}], ["Weaning studies continue to show promise for preventing food allergy.", {"entities": [[56, 68, "DISEASE"]]}], ["New diagnostic tools are available for identifying the allergic origin of allergic-like symptoms.", {"entities": []}], ["Advances have been reported in obesity, short stature and autoimmune endocrine disorders.", {"entities": [[31, 38, "DISEASE"]]}], ["New molecules are offered to reduce weight gain and insulin-resistance in obese children.", {"entities": []}], ["Regional investigations may provide suggestions for preventing short stature.", {"entities": []}], ["Epidemiological studies have evidenced the high incidence of Graves\u2019 disease and Hashimoto\u2019s thyroiditis in patients with Down syndrome.", {"entities": [[93, 104, "DISEASE"], [127, 135, "DISEASE"]]}], ["Documentation of novel risk factors for celiac disease are of use to develop strategies for prevention in the population at-risk.", {"entities": [[40, 54, "DISEASE"]]}], ["Diagnostic criteria for non-celiac gluten sensitivity have been reported.", {"entities": []}], ["Negative effect on nervous system development of the supernumerary X chromosome in Klinefelter syndrome has emerged.", {"entities": [[95, 103, "DISEASE"]]}], ["Improvements have been made in understanding rare diseases such as Rubinstein-Taybi syndrome.", {"entities": [[84, 92, "DISEASE"]]}], ["Eltrombopag is an effective therapy for immune trombocytopenia.", {"entities": []}], ["Children with sickle-cell anemia are at risk for nocturnal enuresis.", {"entities": [[26, 32, "DISEASE"]]}], ["Invasive diseases caused by Streptococcus pyogenes are still common despite of vaccination.", {"entities": []}], ["No difference in frequency of antibiotic prescriptions for acute otitis media between before the publication of the national guideline and after has been found.", {"entities": [[65, 77, "DISEASE"]]}], ["The importance of timing of iron administration in low birth weight infants, the effect of probiotics for preventing necrotising enterocolitis and perspectives for managing jaundice and cholestasis in neonates have been highlighted.", {"entities": [[186, 197, "DISEASE"]]}], ["New strategies have been developed to reduce the risk for relapse in nephrotic syndrome including prednisolone during upper respiratory infection.", {"entities": [[69, 87, "DISEASE"], [79, 87, "DISEASE"]]}], ["Insights into the pathophysiology of cerebral palsy, arterial ischemic stroke and acute encephalitis may drive advances in treatment.", {"entities": [[37, 51, "DISEASE"], [88, 100, "DISEASE"]]}], ["Recommendations on breastfeeding and complementary feeding have been updated.", {"entities": []}], ["Novel treatments for rhabdomyosarcoma should be considered for paediatric patients.", {"entities": [[21, 37, "DISEASE"]]}], ["Control of risk factors for bronchiolitis and administration of pavilizumab for preventing respiratory syncytial virus infection may reduce hospitalization.", {"entities": [[28, 41, "DISEASE"]]}], ["Identification of risk factors for hospitalization in children with wheezing can improve the management of this disease.", {"entities": []}], ["Deletions or mutations in genes encoding proteins for surfactant function may cause diffuse lung disease.", {"entities": [[92, 104, "DISEASE"]]}], ["Chronic rhinosinusitis (CRS) is a frequently occurring chronic respiratory disease.", {"entities": []}], ["There is evidence that effective treatment of CRS can improve patients\u2019 quality of life, but the data regarding the extent to which CRS impairs patients\u2019 quality of life (QoL) is sparse.", {"entities": []}], ["This study aimed to evaluate the effect of self-reported CRS on health-related QoL and to determine whether the influence was associated with gender, age and socio-economic status.", {"entities": []}], ["A four-stage random sampling method was used to select the participants from the general population in Guangzhou, China.", {"entities": []}], ["All participants were interviewed face-to-face at their homes using a standardized questionnaire.", {"entities": []}], ["The health-related QoL of each participant was assessed using the SF-36 Health Survey.", {"entities": []}], ["The scores of the SF-36 after adjusting for gender, age, socioeconomic conditions, smoking and some important comorbid conditions were compared between the CRS group and the non-CRS group using analysis of covariance.", {"entities": []}], ["A multiple linear regression model with interaction terms was established to determine whether CRS affected QoL to the same degree across the different subpopulations.", {"entities": []}], ["Among a total of 1,411 participants aged at least 15 years, 118 persons (8.4%) had self-reported CRS.", {"entities": []}], ["Subjects with CRS had an increased prevalence of allergic rhinitis, chronic obstructive pulmonary disease and gout than subjects without CRS.", {"entities": [[49, 66, "DISEASE"], [58, 66, "DISEASE"], [68, 105, "DISEASE"], [110, 114, "DISEASE"]]}], ["The CRS group had lower scores in all eight domains and the physical and mental component summary than those without CRS (P<0.05), and the greatest differences were in role emotional function (RE), general health (GH) and role physical function (RP).", {"entities": []}], ["The impairments of the CRS participants in RE and RP were greater among the females than the males.", {"entities": []}], ["Moreover, physical domains were affected to greater degrees among the elderly and those with high-level education.", {"entities": []}], ["In conclusion, CRS is a common chronic disorder.", {"entities": []}], ["Persons with self-reported CRS perceived themselves as having impaired QoL in both the physical and mental domains.", {"entities": []}], ["These findings shed new light on the health burden of CRS and should be taken into account by clinicians involved in the care of CRS patients.", {"entities": []}], ["The management of childhood asthma is often sub-optimal.", {"entities": [[28, 34, "DISEASE"]]}], ["Parents and other caregivers are primarily responsible for disease management and this responsibility includes communication with health professionals.", {"entities": []}], ["The aim of this multi-perspective qualitative study was to explore the views of children, parents and health professionals to gain insight into the approach to clinical care in the management of childhood asthma.", {"entities": [[205, 211, "DISEASE"]]}], ["Interviews were held with nine parent\u2013child (6\u20138 years) dyads, and 13 health professionals working in primary and secondary care.", {"entities": []}], ["Interviews were transcribed verbatim and analysed thematically.", {"entities": []}], ["Three key themes emerged that were common to all data sets; (1) Child and parent awareness of symptoms; (2) Management and child wellbeing; and (3) Professional communication education and consultation with families.", {"entities": []}], ["Although some children demonstrate good awareness of symptoms and appropriate use of medication, some parents expressed difficulty in identifying triggers and symptoms of asthma.", {"entities": [[171, 177, "DISEASE"]]}], ["Furthermore, parents lacked awareness regarding appropriate use of medication for preventing and managing symptoms of asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["Health professionals believed that communication and education was lacking.", {"entities": []}], ["Data from all participants suggested that consultations could be enhanced with greater emphasis on children\u2019s and parents\u2019 perceptions of asthma in the development of asthma management plans.", {"entities": [[138, 144, "DISEASE"], [167, 173, "DISEASE"]]}], ["Both parents\u2019 and children\u2019s perceptions and understanding of childhood asthma should be considered when developing asthma management plans.", {"entities": [[72, 78, "DISEASE"], [116, 122, "DISEASE"]]}], ["The management of asthma is challenging and can result in poor disease outcomes if care is not taken.", {"entities": [[18, 24, "DISEASE"]]}], ["An individual\u2019s perception of their (or their child\u2019s) asthma can also affect the efficacy of treatment.", {"entities": [[55, 61, "DISEASE"]]}], ["Aidan Searle at the Bristol Biomedical Research Centre, UK, and co-workers, interviewed nine parent-child groups and thirteen health professionals to determine their perceptions of childhood asthma management in primary care.", {"entities": [[191, 197, "DISEASE"]]}], ["While some children had a strong awareness of symptoms and appropriate medication use, some parents found it difficult to identify asthma triggers and symptoms.", {"entities": [[131, 137, "DISEASE"]]}], ["Parents also displayed a lack of understanding of management through medication.", {"entities": []}], ["Health professionals focused on the need for clearer information for families when guiding management of childhood asthma.", {"entities": [[115, 121, "DISEASE"]]}], ["The regulation of the inflammatory response is essential to maintaining homeostasis.", {"entities": []}], ["Several studies have investigated new drugs that may contribute to avoiding or minimizing excessive inflammatory process.", {"entities": []}], ["The aim of this study was to evaluate the effect of extracts of green algae Caulerpa mexicana on models inflammation.", {"entities": []}], ["In mice, the inflammatory peritonitis model is induced by zymosan.", {"entities": [[26, 37, "DISEASE"]]}], ["Previous treatment of mice with aqueous and methanolic extracts of C. mexicana was able to suppress the cell migration to the peritoneal cavity, in a time-dependent but not in a dose-dependent manner.", {"entities": []}], ["The treatment of mice with C. mexicana extracts also decreased the xylene-induced ear edema, exerting strong inhibitory leukocyte migration elicited by zymosan into the air pouch.", {"entities": []}], ["We concluded that administration of the extracts resulted in a reduction of cell migration to different sites as well as a decrease in edema formation induced by chemical irritants.", {"entities": []}], ["This study demonstrates for the first time the anti-inflammatory effect of aqueous and methanolic extracts from the green marine algae Caulerpa mexicana .", {"entities": []}], ["In severe burn injury the unique setting of a depleted, dysfunctional immune system along with a loss of barrier function commonly results in opportunistic infections that eventually proof fatal.", {"entities": []}], ["Unfortunately, the dynamic sequence of bacterial contamination, colonization and eventually septic invasion with bacteria such as Pseudomonas species is still poorly understood although a limiting factor in clinical decision making.", {"entities": []}], ["Increasing evidence supports the notion that inhibition of bacterial translocation into the wound site may be an effective alternative to prevent infection.", {"entities": []}], ["In this context we investigated the role of the mammalian Chitinase-3-Like-1 (CHI3L1) non-enyzmatic protein predominately expressed on epithelial as well as innate immune cells as a potential bacterial-translocation-mediating factor.", {"entities": [[78, 84, "GENE"]]}], ["We show a strong trend that a modulation of chitinase expression is likely to be effective in reducing mortality rates in a mouse model of burn injury with superinfection with the opportunistic PA14 Pseudomonas strain, thus demonstrating possible clinical leverage.", {"entities": []}], ["Autoimmunity may contribute to the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[51, 88, "DISEASE"]]}], ["Studies have identified disease-specific autoantibodies (DSAAbs) in COPD patients, but natural autoantibodies (NAAbs) may also play a role.", {"entities": []}], ["Previous studies have concentrated on circulating autoantibodies, but lung-associated autoantibodies may be most important.", {"entities": []}], ["Our aim was to investigate NAAbs and DSAAbs in the circulation and lungs of COPD smoking (CS) patients compared to smokers (S) without airway obstruction and subjects who have never smoked (NS).", {"entities": [[90, 92, "GENE"]]}], ["Immunoglobulin (Ig)G antibodies that bind to lung tissue components were significantly lower in the circulation of CS patients than NS (with intermediate levels in S), as detected by enzyme-linked immunosorbent assay (ELISA).", {"entities": [[115, 117, "GENE"]]}], ["The levels of antibodies to collagen-1 (the major lung collagen) detected by ELISA were also reduced significantly in CS patients\u2019 sera compared to NS.", {"entities": [[118, 120, "GENE"]]}], ["The detection of these antibodies in NS subjects indicates that they are NAAbs.", {"entities": []}], ["The occurrence of DSAAbs in some CS patients and S subjects was indicated by high levels of serum IgG antibodies to cytokeratin-18 and collagen-5; furthermore, antibodies to collagen-5 eluted from homogenized lung tissue exposed to low pH (0\u00b71\u2009M glycine, pH\u20092\u00b78) were raised significantly in CS compared to S and NS.", {"entities": [[33, 35, "GENE"], [292, 294, "GENE"], [33, 35, "GENE"], [292, 294, "GENE"]]}], ["Thus, this study supports a role in COPD for both NAAbs and DSAAbs.", {"entities": []}], ["Inhaled corticosteroids (ICS) are the cornerstone of asthma treatment in children.", {"entities": [[53, 59, "DISEASE"]]}], ["However, there is considerable inter-individual variation in glucocorticoid sensitivity, leading to over- as well as undertreatment.", {"entities": []}], ["A simple and fast test to predict glucocorticoid sensitivity would enable more tailored therapy in children with asthma.", {"entities": [[113, 119, "DISEASE"]]}], ["To study reproducibility and utility of an overnight 0.25\u00a0mg dexamethasone suppression test (DST) with salivary cortisol levels as marker for glucocorticoid sensitivity in asthmatic children.", {"entities": [[93, 96, "GENE"]]}], ["23 children with atopic asthma were recruited for two overnight 0.25\u00a0mg DST\u2019s, 1\u00a0month apart.", {"entities": [[24, 30, "DISEASE"], [72, 75, "GENE"]]}], ["Baseline cortisol levels correlated well between both tests.", {"entities": []}], ["However, cortisol levels, change in cortisol levels or fractional suppression of cortisol levels after dexamethasone did not correlate between the two tests.", {"entities": []}], ["Bland\u2013Altman plots showed that the difference in salivary cortisol levels between test 1 and 2 of an individual patient could go up to 12\u00a0nmol/l, which is a clinically relevant difference.", {"entities": []}], ["ICS dose did not correlate with baseline cortisol levels, height and BMI SDS.", {"entities": [[73, 76, "GENE"]]}], ["The low-dose salivary DST test in its current form is not suitable for use in clinical practice in children with asthma, due to low reproducibility.", {"entities": [[113, 119, "DISEASE"], [22, 25, "GENE"]]}], ["Therefore, studies using the 0.25\u00a0mg salivary DST should be interpreted cautiously.", {"entities": [[46, 49, "GENE"]]}], ["Hyperglycaemia increases glucose concentrations in airway surface liquid and increases the risk of pulmonary Pseudomonas aeruginosa infection.", {"entities": []}], ["We determined whether reduction of blood and airway glucose concentrations by the anti\u2010diabetic drug dapagliflozin could reduce P.\u00a0aeruginosa growth/survival in the lungs of diabetic mice.", {"entities": []}], ["The effect of dapagliflozin on blood and airway glucose concentration, the inflammatory response and infection were investigated in C57BL/6J (wild type, WT) or leptin receptor\u2010deficient (db/db) mice, treated orally with dapagliflozin prior to intranasal dosing with LPS or inoculation with P.\u00a0aeruginosa .", {"entities": []}], ["Pulmonary glucose transport and fluid absorption were investigated in Wistar rats using the perfused fluid\u2010filled lung technique.", {"entities": []}], ["Fasting blood, airway glucose and lactate concentrations were elevated in the db/db mouse lung.", {"entities": []}], ["LPS challenge increased inflammatory cells in bronchoalveolar lavage fluid from WT and db/db mice with and without dapagliflozin treatment.", {"entities": []}], ["P.\u00a0aeruginosa colony\u2010forming units (CFU) were increased in db/db lungs.", {"entities": []}], ["Pretreatment with dapagliflozin reduced blood and bronchoalveolar lavage glucose concentrations and P.\u00a0aeruginosa CFU in db/db mice towards those seen in WT.", {"entities": []}], ["Dapagliflozin had no adverse effects on the inflammatory response in the mouse or pulmonary glucose transport or fluid absorption in the rat lung.", {"entities": []}], ["Pharmacological lowering of blood glucose with dapagliflozin effectively reduced P.\u00a0aeruginosa infection in the lungs of diabetic mice and had no adverse pulmonary effects in the rat.", {"entities": []}], ["Dapagliflozin has potential to reduce the use, or augment the effect, of antimicrobials in the prevention or treatment of pulmonary infection.", {"entities": []}], ["A novel independent Th-cell subset, characterized by high expression of interleukin (IL)-9, has been recognized as the Th9 subset.", {"entities": []}], ["Although Th9 cells are important in many diseases, their contribution to allergic rhinitis (AR) remains unclear.", {"entities": [[73, 90, "DISEASE"], [82, 90, "DISEASE"]]}], ["We therefore first determined whether Th9 cells were present in a mouse model of AR.", {"entities": []}], ["We then investigated the their involvement in the distribution of CD4 Ifn-?", {"entities": [[66, 69, "GENE"]]}], ["mRNA/protein, T-bet mRNA), Th2 (Th2 cell percentage, Il-4 mRNA/protein, Gata3 mRNA), Th9 (Th9 cell percentages Il-9 mRNA/protein, PU.1 and Irf4 mRNA), Th17 (Th17 cell percentage, Il-17 mRNA/protein, Ror?t mRNA), and Treg (Treg cell percentage, Foxp3 mRNA) responses in the nasal mucosa.", {"entities": [[72, 77, "GENE"], [139, 143, "GENE"], [244, 249, "GENE"]]}], ["Treatment with anti-IL-9 Abs markedly reduced nasal rubbing, sneezing, eosinophil infiltration, and Th2, Th9, and Th17 responses, and increased the Treg response.", {"entities": []}], ["Our findings emphasize the importance of IL-9/Th9 in the pathogenesis of AR, and suggest that anti-IL-9 Ab treatment may be an effective therapeutic strategy for AR.", {"entities": []}], ["Patient safety experts have postulated that increasing patient participation in communications during patient handovers will improve the quality of patient transitions, and that this may reduce hospital readmissions.", {"entities": []}], ["Choosing strategies that enhance patient safety through improved handovers requires better understanding of patient experiences and preferences for participation.", {"entities": []}], ["The aim of this paper is to explore the patients\u2019 experiences and perspectives related to the handovers between their primary care providers and the inpatient hospital.", {"entities": []}], ["A qualitative secondary analysis was performed, based on individual and focus group patient interviews with 90 patients in five European countries.", {"entities": []}], ["The analysis revealed three themes: patient positioning in the handover process ; prerequisites for patient participation and patient preferences for the handover process.", {"entities": []}], ["Patients\u2019 participation ranged from being the key actor, to sharing the responsibility with healthcare professional(s), to being passive participants.", {"entities": []}], ["For active participation patients required both personal and social resources as well as prerequisites such as information and respect.", {"entities": []}], ["Some patients preferred to be the key actor in charge; others preferred their healthcare professionals to be the key actors in the handover.", {"entities": []}], ["Patients\u2019 participation is related to the healthcare system, the activity of healthcare professionals\u2019 and patients\u2019 capacity for participation.", {"entities": []}], ["Patients prefer a handover process where the responsibility is clear and unambiguous.", {"entities": []}], ["Healthcare organisations need a clear and well-considered system of responsibility for handover processes, that takes into account the individual patient's need of clarity, and support in relation to his/hers own recourses.", {"entities": []}], ["Recent studies have indicated that an imbalance of gut microbiota is associated with the development of type 1 diabetes mellitus (T1DM) and there is no literature regarding it in Chinese children yet.", {"entities": [[104, 128, "DISEASE"], [111, 128, "DISEASE"]]}], ["The aim of this study was to evaluate the alteration of gut microbiota between children with newly diagnosed T1DM and healthy controls and to determine if gut microbiota could partly explain the etiology of this disease.", {"entities": []}], ["A case-control study was carried out with 15 children with T1DM and 15 healthy children.", {"entities": []}], ["The fecal bacteria composition was investigated by high-throughput sequencing of the V3\u2013V4 region of the 16S rDNA gene and analyzed by the estimators of community richness (Chao) indexes.", {"entities": []}], ["There was a notable lower richness of fecal bacteria in T1DM group than controls (156.53 \u00b1 36.96 vs. 130.0 \u00b1 32.85, P = 0.047).", {"entities": []}], ["At the genus level, the composition of Blautia was increased in T1DM group than control group whereas the composition of Haemophilus , Lachnospira , Dialister , and Acidaminococcus was decreased.", {"entities": []}], ["In addition, we found that the percentage of Blautia was correlated positively with HbA1c (\u03c1 = 0.40, P = 0.031), the numbers of T1DM autoantibodies (\u03c1 = 0.42, P = 0.023), and the titers of tyrosine phosphatase autoantibodies (IA-2) (\u03c1 = 0.82, P = 0.000) in the study.", {"entities": []}], ["This study showed that gut microbiota was associated with the development of T1DM by affecting the autoimmunity, and the results suggested a potential therapy for T1DM via modulating the gut microbiota.", {"entities": []}], ["We evaluated 49 swine industry workers and 79 nonexposed controls for antibodies to swine influenza viruses.", {"entities": [[84, 99, "DISEASE"], [90, 99, "DISEASE"]]}], ["Multivariate modeling showed that workers who seldom used gloves (odds ratio [OR] 30.3) or who smoked (OR 18.7) most frequently had evidence of previous H1N1 swine virus.", {"entities": []}], ["These findings may be valuable in planning for pandemic influenza.", {"entities": [[56, 65, "DISEASE"]]}], ["The establishment of robust biosurveillance capabilities is an important component of the U.S. strategy for identifying disease outbreaks, environmental exposures and bioterrorism events.", {"entities": []}], ["Currently, U.S.", {"entities": []}], ["Departments of Defense (DoD) and Veterans Affairs (VA) perform biosurveillance independently.", {"entities": []}], ["This article describes a joint VA/DoD biosurveillance project at North Chicago-VA Medical Center (NC-VAMC).", {"entities": []}], ["The Naval Health Clinics-Great Lakes facility physically merged with NC-VAMC beginning in 2006 with the full merger completed in October 2010 at which time all DoD care and medical personnel had relocated to the expanded and remodeled NC-VAMC campus and the combined facility was renamed the Lovell Federal Health Care Center (FHCC).", {"entities": []}], ["The goal of this study was to evaluate disease surveillance using a biosurveillance application which combined data from both populations.", {"entities": []}], ["A retrospective analysis of NC-VAMC/Lovell FHCC and other Chicago-area VAMC data was performed using the ESSENCE biosurveillance system, including one infectious disease outbreak (Salmonella/Taste of Chicago-July 2007) and one weather event (Heat Wave-July 2006).", {"entities": []}], ["Influenza-like-illness (ILI) data from these same facilities was compared with CDC/Illinois Sentinel Provider and Cook County ESSENCE data for 2007-2008.", {"entities": []}], ["Following consolidation of VA and DoD facilities in North Chicago, median number of visits more than doubled, median patient age dropped and proportion of females rose significantly in comparison with the pre-merger NC-VAMC facility.", {"entities": []}], ["A high-level gastrointestinal alert was detected in July 2007, but only low-level alerts at other Chicago-area VAMCs.", {"entities": []}], ["Heat-injury alerts were triggered for the merged facility in June 2006, but not at the other facilities.", {"entities": []}], ["There was also limited evidence in these events that surveillance of the combined population provided utility above and beyond the VA-only and DoD-only components.", {"entities": []}], ["Recorded ILI activity for NC-VAMC/Lovell FHCC was more pronounced in the DoD component, likely due to pediatric data in this population.", {"entities": []}], ["NC-VAMC/Lovell FHCC had two weeks of ILI activity exceeding both the Illinois State and East North Central Regional baselines, whereas Hines VAMC had one and Jesse Brown VAMC had zero.", {"entities": []}], ["Biosurveillance in a joint VA/DoD facility showed potential utility as a tool to improve surveillance and situational awareness in an area with Veteran, active duty and beneficiary populations.", {"entities": []}], ["Based in part on the results of this pilot demonstration, both agencies have agreed to support the creation of a combined VA/DoD ESSENCE biosurveillance system which is now under development.", {"entities": []}], ["Medicines play an important role in healthcare, but prices can be a barrier to patient care.", {"entities": []}], ["Few studies have looked at the prices of essential medicines in low- and middle-income countries in terms of patient affordability.", {"entities": []}], ["To determine the prices, availability and affordability of medicines along the supply chain in Swaziland.", {"entities": []}], ["Private- and public-sector facilities in Manzini, Swaziland.", {"entities": []}], ["The standardised methodology designed by the World Health Organization and Health Action International was used to survey 16 chronic disease medicines.", {"entities": []}], ["Data were collected in one administrative area in 10 private retail pharmacies and 10 public health facilities.", {"entities": []}], ["Originator brand (OB) and lowest-priced generic equivalent (LPG) medicines were monitored and these prices were then compared with international reference prices (IRPs).", {"entities": []}], ["Affordability was calculated in terms of the daily wage of the lowest-paid unskilled government worker.", {"entities": []}], ["Mean availability was 68% in the public sector.", {"entities": []}], ["Private sector OB medicines were priced 32.4 times higher than IRPs, whilst LPGs were 7.32 times higher.", {"entities": []}], ["OBs cost 473% more than LPGs.", {"entities": []}], ["The total cumulative mark-ups for individual medicines range from 190.99% \u2013 440.27%.", {"entities": []}], ["The largest contributor to add-on cost was the retail mark-up (31% \u2013 53%).", {"entities": []}], ["Standard treatment with originator brands cost more than a day's wage.", {"entities": []}], ["Various policy measures such as introducing price capping at all levels of the medicine supply chain, may increase the availability, whilst at the same time reducing the prices of essential medicines for the low income population.", {"entities": []}], ["Pediatric obstructive sleep apnea (OSA) is associated with chronic systemic inflammation and with cognitive impairments.", {"entities": []}], ["This study aimed to investigate the status of proinflammatory cytokines, particularly interleukin 17 (IL-17) and interleukin 23 (IL-23) and cognition in pediatric OSA.", {"entities": []}], ["Controls and OSA children participated in the study.", {"entities": []}], ["Exclusion criteria were adenotonsillectomy, heart, neurological and severe psychiatric diseases, craniofacial syndromes, and obesity.", {"entities": [[125, 132, "DISEASE"]]}], ["Polysomnogram was followed by serum testing for inflammatory markers and neurocognitive tests such as continuous performance task (CPT) and Wisconsin card sorting test, questionnaires, analyses of plasma high-sensitivity C-reactive protein (HS-CRP), tumor necrosis factor alpha (TNF-\u03b1), interleukin 1 (IL-1), interleukin 6 (IL-6), IL-17, and IL-23.", {"entities": []}], ["Seventy-nine, 4 to 12-year-old subjects in 2 groups ended the study: 47 nonobese OSA children (mean age = 7.84\u200a\u00b1\u200a0.56 years, body mass index [BMI] = 16.95\u200a\u00b1\u200a0.47\u200akg/m P = 0.002, P = 0.024, and P = 0.047).", {"entities": []}], ["Regression test showed significant influence of HS-CRP, TNF-\u03b1, IL-6, IL-17, and specifically IL-23, with the continuous performance test and Wisconsin card sorting test.", {"entities": []}], ["OSA children have abnormal levels of IL-17, an interleukin related to T helper 17 cells, a T helper cell involved in development of autoimmunity and inflammation.", {"entities": []}], ["This high expression level may contribute to the complications of pediatric OSA; we also found a significant influence of inflammatory cytokines, particularly IL-23, on abnormal neurocognitive testing.", {"entities": []}], ["Diabetes mellitus is an increasingly common systemic disease.", {"entities": []}], ["Many diabetic patients seek cataract surgery for a better visual acuity.", {"entities": [[28, 36, "DISEASE"]]}], ["Unlike in the general population, the influence of cataract surgery on tear film function in diabetic patients remains elusive.", {"entities": [[51, 59, "DISEASE"]]}], ["The aim of this study was to evaluate the tear function in diabetic and nondiabetic patients following cataract surgery.", {"entities": [[103, 111, "DISEASE"]]}], ["In this prospective, interventional case series, 174 diabetic patients without dry eye syndrome (DES) and 474 age-matched nondiabetic patients as control who underwent phacoemulsification were enrolled at two different eye centers between January 2011 and January 2013.", {"entities": [[79, 95, "DISEASE"], [87, 95, "DISEASE"], [97, 100, "GENE"]]}], ["Patients were followed up at baseline and at 7 days, 1 month, and 3 months postoperatively.", {"entities": []}], ["Ocular symptom scores (Ocular Surface Disease Index, OSDI) and tear film function including tear film stability (tear film break-up time, TBUT), corneal epithelium integrity (corneal fluorescein staining, CFS), and tear secretion (Schirmer\u2019s I test, SIT) were evaluated.", {"entities": []}], ["In total, 83.9% of the diabetic patients (146 cases with 185 eyes) and 89.0% of the nondiabetic patients (422 cases with 463 eyes) completed all check-ups after the interventions ( P = 0.095).", {"entities": []}], ["The incidence of DES was 17.1% in the diabetic patients and 8.1% in the nondiabetic patients at 7 days after cataract surgery.", {"entities": [[109, 117, "DISEASE"], [17, 20, "GENE"]]}], ["In the diabetic patients, the incidence of DES remained 4.8% at 1 month postoperatively and decreased to zero at 3 months after surgery.", {"entities": [[43, 46, "GENE"]]}], ["No DES was diagnosed in nondiabetic patients at either the 1-month or 3-month follow-up.", {"entities": [[3, 6, "GENE"]]}], ["Compared with the baseline, the diabetic patients had worse symptom scores and lower TBUT values at 7 days and 1 month but not at 3 months postoperatively.", {"entities": []}], ["In the nondiabetic patients, symptom scores and TBUT values had returned to preoperative levels at 1-month check-up.", {"entities": []}], ["CFS scores and SIT values did not change significantly postoperatively in either group ( P = 0.916 and P = 0.964, respectively).", {"entities": []}], ["Diabetic patients undergoing cataract surgery are prone to DES.", {"entities": [[29, 37, "DISEASE"], [59, 62, "GENE"]]}], ["Ocular symptoms and tear film stability are transiently worsened in diabetic patients and are restored more slowly than those in nondiabetic patients.", {"entities": []}], ["Environmental irritants are important risk factors for skin diseases, but little is known about the influence of environmental factors on eczema incidence.", {"entities": []}], ["In this time-series study, our objective was to examine the associations of environmental factors with outpatient visits for eczema.", {"entities": []}], ["Daily outpatient visits between 2007 and 2011 (1826 days) were collected from Huashan Hospital in Shanghai, China.", {"entities": []}], ["We used an overdispersed generalized additive model to investigate the short-term association between environmental factors and outpatient visits for eczema.", {"entities": []}], ["Daily outpatient visits for eczema were significantly associated with air pollution and meteorological factors.", {"entities": []}], ["For example, a 10 \u03bcg/m 10 (particulate matter no greater than 10 microns), SO 2 , NO 2 was associated with 0.81% (95% confidence intervals (CI) 0.39%, 1.22%), 2.22% (95% CI: 1.27%, 3.16%) and 2.31% (95% CI: 1.17%, 3.45%) increase in outpatient visits for eczema, respectively.", {"entities": []}], ["A 10 \u00b0C elevation of temperature on lag 0 day were associated with 8.44% (95% CI: 4.66%, 12.22%) increase in eczema visits, whereas 10 unit decrease of 7-day average relative humidity were associated with 10.86% (95% CI: 8.83%, 12.89%) increase in eczema visits.", {"entities": []}], ["This study provided clear evidence of ambient air pollution, high temperature and low relative humidity on increasing the incidence of eczema in Shanghai, China.", {"entities": []}], ["More than 40% of allergic patients suffer from grass pollen allergy.", {"entities": []}], ["Phl p 1, the major timothy grass pollen allergen, belongs to the cross-reactive group 1 grass pollen allergens that are thought to initiate allergic sensitization to grass pollen.", {"entities": []}], ["Repeated allergen encounter boosts allergen-specific IgE production and enhances clinical sensitivity in patients.", {"entities": []}], ["To investigate immunological mechanisms underlying the boosting of allergen-specific secondary IgE Ab responses and the allergen epitopes involved, a murine model for Phl p 1 was established.", {"entities": []}], ["A B cell epitope\u2013derived peptide of Phl p 1 devoid of allergen-specific T cell epitopes, as recognized by BALB/c mice, was fused to an allergen-unrelated carrier in the form of a recombinant fusion protein and used for sensitization.", {"entities": []}], ["This fusion protein allowed the induction of allergen-specific IgE Ab responses without allergen-specific T cell help.", {"entities": []}], ["Allergen-specific Ab responses were subsequently boosted with molecules containing the B cell epitope\u2013derived peptide without carrier or linked to other allergen-unrelated carriers.", {"entities": []}], ["Oligomeric peptide bound to a carrier different from that which had been used for sensitization boosted allergen-specific secondary IgE responses without a detectable allergen-specific T cell response.", {"entities": []}], ["Our results indicate that allergen-specific secondary IgE Ab responses can be boosted by repetitive B cell epitopes without allergen-specific T cell help by cross-linking of the B cell epitope receptor.", {"entities": []}], ["This finding has important implications for the design of new allergy vaccines.", {"entities": []}], ["BACKGROUND: Hydrogen peroxide (H2O2) in exhaled air condensate is elevated in inflammatory disorders of the lower respiratory tract.", {"entities": []}], ["It is unknown whether viral colds contribute to exhaled H2O2.", {"entities": []}], ["AIM: To assess exhaled H2O2 during and after a common cold.", {"entities": [[47, 58, "DISEASE"]]}], ["METHODS: We examined H2O2 in the breath condensate of 20 normal subjects with acute symptoms of a common cold and after recovery 2 weeks later and, similarly, in 10 subjects without infection.", {"entities": [[98, 109, "DISEASE"]]}], ["H2O2 was measured with a fluorimetric assay.", {"entities": []}], ["RESULTS: At the time of infection exhaled H2O2 (median, ranges) was 0.20 microM (0.03-1.2 microM), and this decreased to 0.09 microM (< 0.01-0.40 microM) after recovery (p = 0.006).", {"entities": []}], ["There was no significant difference in lung function (forced vital capacity and forced expiratory volume in 1 sec) during and after colds.", {"entities": []}], ["In the controls, exhaled H2O2 did not change over a 2-week period.", {"entities": []}], ["CONCLUSIONS: H2O2 in exhaled air condensate is elevated during a common cold, and returns to normal within 2 weeks of recovery in healthy subjects.", {"entities": [[65, 76, "DISEASE"]]}], ["Hence, symptomatic upper respiratory tract infection may act as a confounder in studies of H2O2 as a marker of chronic lower airway inflammation.", {"entities": []}], ["Inflammatory bowel diseases (IBDs) are characterized by autoimmune and inflammation-related complications of the large intestine (ulcerative colitis) and additional parts of the digestive tract (Crohn's disease).", {"entities": [[130, 148, "DISEASE"]]}], ["Complications include pain, diarrhoea, chronic inflammation, and cancer.", {"entities": [[65, 71, "DISEASE"]]}], ["IBD prevalence has increased during the past decades, especially in Westernized countries, being as high as 1%.", {"entities": []}], ["As prognosis is poor and medication often ineffective or causing side effects, additional preventive/adjuvant strategies are sought.", {"entities": []}], ["A possible approach is via diets rich in protective constituents.", {"entities": []}], ["Polyphenols, the most abundant phytochemicals, have been associated with anti-inflammatory, antioxidant, immunomodulatory, and apoptotic properties.", {"entities": []}], ["Locally reducing oxidative stress, they can further act on cellular targets, altering gene expression related to inflammation, including NF- \u03ba B, Nrf-2, Jak/STAT, and MAPKs, suppressing downstream cytokine formation (e.g., IL-8, IL-1 \u03b2 , and TNF- \u03b1 ), and boosting the bodies' own antioxidant status (HO-1, SOD, and GPx).", {"entities": []}], ["Moreover, they may promote, as prebiotics, healthy microbiota (e.g., Bifidobacteria, Akkermansia ), short-chain fatty acid formation, and reduced gut permeability/improved tight junction stability.", {"entities": []}], ["However, potential adverse effects such as acting as prooxidants, or perturbations of efflux transporters and phase I/II metabolizing enzymes, with increased uptake of undesired xenobiotics, should also be considered.", {"entities": []}], ["In this review, we summarize current knowledge around preventive and arbitrary actions of polyphenols targeting IBD.", {"entities": []}], ["Climate change is a major public health threat that is exacerbated by food production.", {"entities": []}], ["Food items differ substantially in the amount of greenhouse gases their production generates and therefore individuals, if willing, can mitigate climate change through dietary choices.", {"entities": []}], ["We conducted a population-based cross-sectional study to assess if the understanding of climate change, concern over climate change or socio-economic characteristics are reflected in the frequencies of climate-friendly food choices.", {"entities": []}], ["The study population comprised 1623 young adults in Finland who returned a self-administered questionnaire (response rate 64.0%).", {"entities": []}], ["We constructed a Climate-Friendly Diet Score (CFDS) ranging theoretically from \u221214 to 14 based on the consumption of 14 food items.", {"entities": []}], ["A higher CFDS indicated a climate-friendlier diet.", {"entities": []}], ["Multivariate linear regression analyses on the determinants of CFDS revealed that medium concern raised CFDS on average by 0.51 points (95% confidence interval (CI) 0.03, 0.98) and high concern by 1.30 points (95% CI 0.80, 1.80) compared to low concern.", {"entities": []}], ["Understanding had no effect on CFDS on its own.", {"entities": []}], ["Female gender raised CFDS by 1.92 (95% CI 1.59, 2.25).", {"entities": []}], ["Unemployment decreased CFDS by 0.92 (95% CI \u22121.68, \u22120.15).", {"entities": []}], ["Separate analyses of genders revealed that high concern over climate change brought about a greater increase in CFDS in females than in males.", {"entities": []}], ["Good understanding of climate change was weakly connected to climate-friendly diet among females only.", {"entities": []}], ["Our results indicate that increasing awareness of climate change could lead to increased consumption of climate-friendly food, reduction in GHG emissions, and thus climate change mitigation.", {"entities": []}], ["We have recently reported that protein phosphate 2A (PP2A) inactivation resulted in increased phosphorylation of the mitogen-activated protein kinase (MAPK) c-Jun N-terminal kinase 1 (JNK1) and glucocorticoid receptors (GR) at Ser Corticosteroid sensitivity, GR nuclear translocation, phosphorylation levels of GR-Ser C )-Tyr C were evaluated in U937 cells and/or peripheral blood mononuclear cells (PBMCs).", {"entities": []}], ["Knock-down effects of MAPK-PTPs using siRNA were also evaluated.", {"entities": []}], ["Knock-down of PTP-RR, but not of PTP-N5 or PTP-N7 impaired corticosteroid sensitivity, induced GR-Ser C -Tyr We demonstrated that with corticosteroid insensitivity PTP-RR fails to reduce phosphorylation of JNK1 and GR-Ser The online version of this article (doi:10.1186/s12931-016-0349-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The class Dothideomycetes is one of the largest groups of fungi with a high level of ecological diversity including many plant pathogens infecting a broad range of hosts.", {"entities": []}], ["Here, we compare genome features of 18 members of this class, including 6 necrotrophs, 9 (hemi)biotrophs and 3 saprotrophs, to analyze genome structure, evolution, and the diverse strategies of pathogenesis.", {"entities": []}], ["The Dothideomycetes most likely evolved from a common ancestor more than 280 million years ago.", {"entities": []}], ["The 18 genome sequences differ dramatically in size due to variation in repetitive content, but show much less variation in number of (core) genes.", {"entities": []}], ["Gene order appears to have been rearranged mostly within chromosomal boundaries by multiple inversions, in extant genomes frequently demarcated by adjacent simple repeats.", {"entities": []}], ["Several Dothideomycetes contain one or more gene-poor, transposable element (TE)-rich putatively dispensable chromosomes of unknown function.", {"entities": []}], ["The 18 Dothideomycetes offer an extensive catalogue of genes involved in cellulose degradation, proteolysis, secondary metabolism, and cysteine-rich small secreted proteins.", {"entities": []}], ["Ancestors of the two major orders of plant pathogens in the Dothideomycetes , the Capnodiales and Pleosporales , may have had different modes of pathogenesis, with the former having fewer of these genes than the latter.", {"entities": []}], ["Many of these genes are enriched in proximity to transposable elements, suggesting faster evolution because of the effects of repeat induced point (RIP) mutations.", {"entities": []}], ["A syntenic block of genes, including oxidoreductases, is conserved in most Dothideomycetes and upregulated during infection in L. maculans , suggesting a possible function in response to oxidative stress.", {"entities": []}], ["Dothideomycetes is the largest and most ecologically diverse class of fungi that includes many plant pathogens with high economic impact.", {"entities": []}], ["Currently 18 genome sequences of Dothideomycetes are available, 14 of which are newly described in this paper and in several companion papers, allowing unprecedented resolution in comparative analyses.", {"entities": []}], ["These 18 organisms have diverse lifestyles and strategies of plant pathogenesis.", {"entities": []}], ["Three feed on dead organic matter only, six are necrotrophs (killing the host plant cells), one is a biotroph (forming an association with and thus feeding on the living cells of the host plant cells) and 8 are hemibiotrophs (having an initial biotrophic stage, and killing the host plant at a later stage).", {"entities": []}], ["These various lifestyles are also reflected in the gene sets present in each group.", {"entities": []}], ["For example, sets of genes involved in carbohydrate degradation and secondary metabolism are expanded in necrotrophs.", {"entities": []}], ["Many genes involved in pathogenesis are located near repetitive sequences, which are believed to speed up their evolution.", {"entities": []}], ["Blocks of genes with conserved gene order were identified.", {"entities": []}], ["In addition to this we deduce that the mechanism for mesosynteny, a type of genome evolution particular to Dothideomycetes , is by intra-chromosomal inversions.", {"entities": []}], ["Past civilisations saw excess body fat as a symbol of wealth and prosperity as the general population struggled with food shortages and famine.", {"entities": []}], ["Nowadays it is recognised that obesity is associated with co-morbidities such as cardiovascular disease and diabetes.", {"entities": [[31, 38, "DISEASE"]]}], ["Our views on the roll of adipose tissue have also changed, from being solely a passive energy store, to an important endocrine organ that modulates metabolism, immunity and satiety.", {"entities": []}], ["The relationship between increased visceral adiposity and obesity-related co-morbidities has lead to the recognition that variation in fat distribution contributes to ethnic differences in the prevalence of obesity-related diseases.", {"entities": [[58, 65, "DISEASE"], [207, 214, "DISEASE"]]}], ["Our current negative view of adipose tissue may change with the use of pluripotent adipose-derived stromal cells, which may lead to future autologous stem cell therapies for bone, muscle, cardiac and cartilage disorders.", {"entities": []}], ["Here, we briefly review the concepts that adipose tissue is an endocrine organ, that differences in body fat distribution underline the aetiology of obesity-related co-morbidities, and the use of adipose-derived stem cells for future therapies.", {"entities": [[149, 156, "DISEASE"]]}], ["We evaluated the utility and feasibility of customizing Asthma Control Test (ACT) items to generate a Korean Asthma Control Test (KACT) specific for Korean patients.", {"entities": [[56, 62, "DISEASE"], [109, 115, "DISEASE"]]}], ["We surveyed 392 asthma patients with 19 items, selected to reflect the Korean sociocultural context.", {"entities": [[16, 22, "DISEASE"]]}], ["Guideline ratings were integrated with the evaluations of specialists (i.e., using both guide base rating together with specialist's rating), and items with the greatest discriminating validity were identified.", {"entities": []}], ["Stepwise regression methods were used to select items.", {"entities": []}], ["KACT scale scores showed significant differences between the asthma control ratings generated by integrating ratings (r=0.77, P <0.001), by specialist's evaluations (r=0.54, P <0.001), or by FEV 1 percent predicted (r=0.39, P <0.001).", {"entities": [[61, 67, "DISEASE"], [191, 194, "GENE"]]}], ["Specialist's and guideline ratings detected 56% and 48.6% of patients with well-controlled asthma, respectively.", {"entities": [[91, 97, "DISEASE"]]}], ["However, the integrated ratings indicated that only 34.3% of the patients in the test sample were well controlled.", {"entities": []}], ["The overall agreement between KACT and the integrated rating ranged from 45% to 78%, depending on the cut-off points used.", {"entities": []}], ["It is possible to formulate a valid, useful country-specific diagnostic tool for the assessment of asthma patients based on the original ACT that reflect differences in sociocultural context.", {"entities": [[99, 105, "DISEASE"]]}], ["Our objectives were to determine the causes of acute respiratory failure (ARF) in elderly patients and to assess the accuracy of the initial diagnosis by the emergency physician, and that of the prognosis.", {"entities": [[53, 72, "DISEASE"]]}], ["In this prospective observational study, patients were included if they were admitted to our emergency department, aged 65 years or more with dyspnea, and fulfilled at least one of the following criteria of ARF: respiratory rate at least 25 minute 2 ) 70 mmHg or less, or peripheral oxygen saturation 92% or less in breathing room air; arterial partial pressure of CO 2 (PaCO 2 ) \u2265 45 mmHg, with pH \u2264 7.35.", {"entities": []}], ["The final diagnoses were determined by an expert panel from the completed medical chart.", {"entities": []}], ["A total of 514 patients (aged (mean \u00b1 standard deviation) 80 \u00b1 9 years) were included.", {"entities": []}], ["The main causes of ARF were cardiogenic pulmonary edema (43%), community-acquired pneumonia (35%), acute exacerbation of chronic respiratory disease (32%), pulmonary embolism (18%), and acute asthma (3%); 47% had more than two diagnoses.", {"entities": [[82, 91, "DISEASE"], [40, 55, "DISEASE"], [156, 174, "DISEASE"], [192, 198, "DISEASE"]]}], ["In-hospital mortality was 16%.", {"entities": []}], ["A missed diagnosis in the emergency department was noted in 101 (20%) patients.", {"entities": []}], ["The accuracy of the diagnosis of the emergency physician ranged from 0.76 for cardiogenic pulmonary edema to 0.96 for asthma.", {"entities": [[90, 105, "DISEASE"], [118, 124, "DISEASE"]]}], ["An inappropriate treatment occurred in 162 (32%) patients, and lead to a higher mortality (25% versus 11%; p < 0.001).", {"entities": []}], ["In a multivariate analysis, inappropriate initial treatment (odds ratio 2.83, p < 0.002), hypercapnia > 45 mmHg (odds ratio 2.79, p < 0.004), clearance of creatinine < 50 ml minute p < 0.013), elevated NT-pro-B-type natriuretic peptide or B-type natriuretic peptide (odds ratio 2.06, p < 0.046), and clinical signs of acute ventilatory failure (odds ratio 1.98, p < 0.047) were predictive of death.", {"entities": []}], ["Inappropriate initial treatment in the emergency room was associated with increased mortality in elderly patients with ARF.", {"entities": []}], ["Human respiratory syncytial virus (RSV) is a common and highly contagious viral agent responsible for acute lower respiratory infection in infants.", {"entities": []}], ["This pathology characterized by mucus hypersecretion and a disturbed T cell immune response is one of the major causes of infant hospitalization for severe bronchiolitis.", {"entities": [[156, 169, "DISEASE"]]}], ["Although different risk factors are associated with acute RSV bronchiolitis, the immunological factors contributing to the susceptibility of RSV infection in infants are not clearly elucidated.", {"entities": [[62, 75, "DISEASE"]]}], ["Epidemiological studies have established that the age at initial infection plays a central role in the severity of the disease.", {"entities": []}], ["Thus, neonatal susceptibility is intrinsically linked to the immunological characteristics of the young pulmonary mucosa.", {"entities": []}], ["Early life is a critical period for the lung development with the first expositions to external environmental stimuli and microbiota colonization.", {"entities": []}], ["Furthermore, neonates display a lung immune system that profoundly differs to those from adults, with the predominance of type 2 immune cells.", {"entities": []}], ["In this review, we discuss the latest information about the lung immune environment in the early period of life at a steady state and upon RSV infection and how we can modulate neonatal susceptibility to RSV infection.", {"entities": []}], ["Interleukin-8 (IL-8) is a potent chemo-attractant cytokine responsible for neutrophil infiltration in lungs with idiopathic pulmonary fibrosis (IPF).", {"entities": [[124, 142, "DISEASE"], [113, 142, "DISEASE"]]}], ["The IL-8 protein and mRNA expression are increased in the lung with IPF.", {"entities": []}], ["We evaluated the effect of single nucleotide polymorphisms (SNPs) of the IL-8 gene on the risk of IPF.", {"entities": []}], ["One promoter (rs4073T>A) and two intronic SNPs (rs2227307T>G and rs2227306C>T) of the IL-8 genes were genotyped in 237 subjects with IPF and 456 normal controls.", {"entities": []}], ["Logistic regression analysis was applied to evaluate the association of these SNPs with IPF.", {"entities": []}], ["IL-8 in BAL fluids was measured using a quantitative sandwich enzyme immunoassay, and promoter activity was assessed using the luciferase reporter assay.", {"entities": []}], ["The minor allele frequencies of rs4073T>A and rs2227307T>G were significantly lower in the 162 subjects with surgical biopsy-proven IPF and 75 subjects with clinical IPF compared with normal controls in the recessive model (OR = 0.46 and 0.48, p = 0.006 and 0.007, respectively).", {"entities": []}], ["The IL-8 protein concentration in BAL fluids significantly increased in 24 subjects with IPF compared with 14 controls ( p = 0.009).", {"entities": []}], ["Nine IPF subjects homozygous for the rs4073 T>A common allele exhibited higher levels of the IL-8 protein compared with six subjects homozygous for the minor allele ( p = 0.024).", {"entities": []}], ["The luciferase activity of the rs4073T>A common allele was significantly higher than that of the rs4073T>A minor allele ( p = 0.002).", {"entities": []}], ["The common allele of a promoter SNP, rs4073T>A, may increase susceptibility to the development of IPF via up-regulation of IL-8.", {"entities": []}], ["Menopausal hormone therapy (MHT) has been proven to have beneficial effects on several components of metabolic syndrome.", {"entities": [[111, 119, "DISEASE"]]}], ["However, the effects vary according to different regimens, dosages, and duration of MHT.", {"entities": []}], ["The aim of the study was to evaluate the effect of standard-dose 0.625 mg conjugated equine estrogen (CEE) and half-dose 0.3 mg CEE daily with different progestogens in a continuous sequential regimen on postmenopausal metabolic parameters in generally healthy postmenopausal women.", {"entities": []}], ["A prospective, open-label, randomized controlled clinical trial was conducted between February 2014 and December 2015.", {"entities": []}], ["Totally 123 Chinese postmenopausal women with climacteric symptoms were included in this study and were randomly assigned to three groups: Group A received CEE 0.3 mg/micronized progesterone (MP) 100 mg daily; Group B received CEE 0.625 mg/MP 100 mg daily; and Group C received CEE 0.625 mg/dydrogesterone 10 mg daily.", {"entities": []}], ["Drugs were given in a continuous sequential pattern.", {"entities": []}], ["The duration of treatment was 12 months.", {"entities": []}], ["Clinical, anthropometrical, and metabolic variables were measured.", {"entities": []}], ["Data were analyzed according to intention-to-treat analysis, using Student's t -test and analysis of variance.", {"entities": []}], ["A total of 107 participants completed the 12-month follow-up and were included in the data analysis.", {"entities": []}], ["At 12 months of treatment, high-density lipoprotein cholesterol and apolipoprotein A significantly increased, and low-density lipoprotein cholesterol, fasting glucose, and glycosylated hemoglobin significantly decreased in Groups B and C, compared with baseline (all P < 0.05).", {"entities": []}], ["Among the three groups, only Group C showed significantly increased triglycerides compared with baseline (1.61 \u00b1 0.80 mmol/L vs. 1.21 \u00b1 0.52 mmol/L, P = 0.026).", {"entities": []}], ["Each group showed a neutral effect on total cholesterol, lipoprotein A, apolipoprotein B, and fasting insulin levels.", {"entities": []}], ["No cardiovascular and venous thromboembolic events occurred in the three groups.", {"entities": []}], ["Among Chinese postmenopausal women, half-dose CEE was not sufficient to induce a favorable lipid and carbohydrate profile compared with standard-dose CEE.", {"entities": []}], ["Adding natural MP may counterbalance the TG-increasing effect of CEE.", {"entities": []}], ["ClinicalTrials.gov, NCT01698164; https://clinicaltrials.gov/ct2/show/NCT01698164?term=NCT01698164&rank=1 .", {"entities": []}], ["In April 2009, a novel influenza A H1N1 (nH1N1) virus emerged and spread rapidly worldwide.", {"entities": [[23, 32, "DISEASE"]]}], ["News of the pandemic led to a heightened awareness of the consequences of influenza and generally resulted in enhanced infection control practices and strengthened vaccination efforts for both healthcare workers and the general population.", {"entities": [[74, 83, "DISEASE"]]}], ["Seasonal influenza (SI) illness in the pediatric population has been previously shown to result in significant morbidity, mortality, and substantial hospital resource utilization.", {"entities": [[9, 18, "DISEASE"]]}], ["Although influenza pandemics have the possibility of resulting in considerable illness, we must not ignore the impact that we can experience annually with SI.", {"entities": [[9, 18, "DISEASE"]]}], ["We compared the outcomes of pediatric patients \u226418 years of age at a large urban hospital with laboratory confirmed influenza and an influenza-like illness (ILI) during the 2009 pandemic and two prior influenza seasons.", {"entities": [[116, 125, "DISEASE"], [133, 142, "DISEASE"], [201, 210, "DISEASE"]]}], ["The primary outcome measure was hospital length of stay (LOS).", {"entities": []}], ["All variables potentially associated with LOS based on univariable analysis, previous studies, or hypothesized relationships were included in the regression models to ensure adjustment for their effects.", {"entities": []}], ["There were 133 pediatric cases of nH1N1 admitted during 2009 and 133 cases of SI admitted during the prior 2 influenza seasons (2007-8 and 2008-9).", {"entities": [[109, 118, "DISEASE"]]}], ["Thirty-six percent of children with SI and 18% of children with nH1N1 had no preexisting medical conditions (p = 0.14).", {"entities": []}], ["Children admitted with SI had 1.73 times longer adjusted LOS than children admitted for nH1N1 (95% CI 1.35 - 2.13).", {"entities": []}], ["There was a trend towards more children with SI requiring mechanical ventilation compared with nH1N1 (16 vs.7, p = 0.08).", {"entities": []}], ["This study strengthens the growing body of evidence demonstrating that SI results in significant morbidity in the pediatric population.", {"entities": []}], ["Pandemic H1N1 received considerable attention with strong media messages urging people to undergo vaccination and encouraging improved infection control efforts.", {"entities": []}], ["We believe that this attention should become an annual effort for SI.", {"entities": []}], ["Strong unified messages from health care providers and the media encouraging influenza vaccination will likely prove very useful in averting some of the morbidity related to influenza for future epidemics.", {"entities": [[77, 86, "DISEASE"], [174, 183, "DISEASE"]]}], ["COPD is the third-largest killer in the world, and certainly takes a toll on the health care system.", {"entities": []}], ["Recurrent COPD exacerbations accelerate lung-function decline, worsen mortality, and consume over US$50 billion in health care spending annually.", {"entities": []}], ["This has led to a tide of payment reforms eliciting interest in strategies reducing preventable COPD exacerbations.", {"entities": []}], ["In this review, we analyze and discuss the evidence for COPD action plan-based self-management strategies.", {"entities": []}], ["Although action plans may provide stabilization of acute symptomatology, there are several limitations.", {"entities": []}], ["These include patient-centered attributes, such as comprehension and adherence, and nonadherence of health care providers to established guidelines.", {"entities": []}], ["While no single intervention can be expected independently to translate into improved outcomes, structured together within a comprehensive integrated disease-management program, they may provide a robust paradigm.", {"entities": []}], ["In the United States, non-alcoholic fatty liver disease (NAFLD) is the most common liver disease and associated with higher mortality according to data from earlier National Health and Nutrition Examination Survey (NHANES) 1988\u20131994.", {"entities": [[36, 55, "DISEASE"], [42, 55, "DISEASE"], [83, 96, "DISEASE"]]}], ["Our goal was to determine the NAFLD prevalence in the recent 1999\u20132012 NHANES, risk factors for advanced fibrosis (stage 3\u20134) and mortality.", {"entities": []}], ["NAFLD was defined as having a United States Fatty Liver Index (USFLI) > 30 in the absence of heavy alcohol use and other known liver diseases.", {"entities": []}], ["The probability of low/high risk of having advanced fibrosis was determined by the NAFLD Fibrosis Score (NFS).", {"entities": []}], ["In total, 6000 persons were included; of which, 30.0% had NAFLD and 10.3% of these had advanced fibrosis.", {"entities": []}], ["Five and eight-year overall mortality in NAFLD subjects with advanced fibrosis was significantly higher than subjects without NAFLD ((18% and 35% vs. 2.6% and 5.5%, respectively) but not NAFLD subjects without advanced fibrosis (1.1% and 2.8%, respectively).", {"entities": []}], ["NAFLD with advanced fibrosis (but not those without) is an independent predictor for mortality on multivariate analysis (HR = 3.13, 95% CI 1.93\u20135.08, p <0.001).", {"entities": [[121, 123, "GENE"]]}], ["In conclusion, in this most recent NHANES, NAFLD prevalence remains at 30% with 10.3% of these having advanced fibrosis.", {"entities": []}], ["NAFLD per se was not a risk factor for increased mortality, but NAFLD with advanced fibrosis was.", {"entities": []}], ["Mexican American ethnicity was a significant risk factor for NAFLD but not for advanced fibrosis or increased mortality.", {"entities": []}], ["Human and bovine respiratory syncytial viruses (HRSV/BRSV) are major causes of severe lower respiratory tract infections in children and calves, respectively.", {"entities": []}], ["Shared epidemiological, clinical, pathological and genetic characteristics of these viruses make comparative research highly relevant.", {"entities": []}], ["To characterise the host response against BRSV infection, bronchoalveolar lavage supernatant (BAL) from i) non-vaccinated, BRSV-infected ii) vaccinated, BRSV-infected and iii) non-infected calves was analysed by tandem mass spectrometry.", {"entities": []}], ["Proteins were semi-quantified and protein expression was validated by immunoblotting.", {"entities": []}], ["Correlations between selected proteins and pathology, clinical signs and virus shedding were investigated.", {"entities": []}], ["Calves with BRSV-induced disease had increased total protein concentrations and a decreased number of proteins identified in BAL.", {"entities": []}], ["The protein profile was characterised by neutrophil activation and a reduction in identified antioxidant enzymes.", {"entities": []}], ["The presence of neutrophils in alveolar septa, the expression level of neutrophil-related or antioxidant proteins and LZTFL1 correlated significantly with disease.", {"entities": [[118, 124, "GENE"]]}], ["Citrullinated histone 3, an indicator of extracellular traps (ETs), was only detected in non-vaccinated, BRSV-infected animals.", {"entities": []}], ["By bringing disequilibrium in the release and detoxification of reactive oxygen species, generating ETs and causing elastine degradation, exaggerated neutrophil responses might exacerbate RSV-induced disease.", {"entities": []}], ["Neutrophil-mitigating or antioxidant treatments should be further explored.", {"entities": []}], ["Smoking is a dominant risk factor for chronic obstructive pulmonary disease (COPD) and emphysema, but not every smoker develops emphysema.", {"entities": [[38, 75, "DISEASE"]]}], ["Immune responses in smokers vary.", {"entities": []}], ["Some autoantibodies have been shown to contribute to the development of emphysema in smokers.", {"entities": []}], ["\u03b2 2 -adrenergic receptors (\u03b2 2 -ARs) are important targets in COPD therapy.", {"entities": []}], ["\u03b2 2 -adrenergic receptor autoantibodies (\u03b2 2 -AAbs), which may directly affect \u03b2 2 -ARs, were shown to be increased in rats with passive-smoking-induced emphysema in our current preliminary studies.", {"entities": []}], ["Using cigarette-smoke exposure (CS-exposure) and active-immune (via injections of \u03b2 2 -AR second extracellular loop peptides) rat models, we found that CS-exposed rats showed higher serum \u03b2 2 -AAb levels than control rats before alveolar airspaces became enlarged.", {"entities": []}], ["Active-immune rats showed increased serum \u03b2 2 -AAb levels, and exhibited alveolar airspace destruction.", {"entities": []}], ["CS-exposed-active-immune treated rats showed more extensive alveolar airspace destruction than rats undergoing CS-exposure alone.", {"entities": []}], ["In our current clinical studies, we showed that plasma \u03b2 2 -AAb levels were positively correlated with the RV/TLC (residual volume/total lung capacity) ratio ( r \u2009=\u20090.455, p \u2009<\u20090.001) and RV%pred (residual volume/residual volume predicted percentage, r \u2009=\u20090.454, p \u2009<\u20090.001) in 50 smokers; smokers with higher plasma \u03b2 2 -AAb levels exhibited worse alveolar airspace destruction.", {"entities": []}], ["We suggest that increased circulating \u03b2 2 -AAbs are associated with smoking-related emphysema.", {"entities": []}], ["Informative genes from microarray data can be used to construct prediction model and investigate biological mechanisms.", {"entities": []}], ["Differentially expressed genes, the main targets of most gene selection methods, can be classified as single- and multiple-class specific signature genes.", {"entities": []}], ["Here, we present a novel gene selection algorithm based on a Group Marker Index (GMI), which is intuitive, of low-computational complexity, and efficient in identification of both types of genes.", {"entities": []}], ["Most gene selection methods identify only single-class specific signature genes and cannot identify multiple-class specific signature genes easily.", {"entities": []}], ["Our algorithm can detect de novo certain conditions of multiple-class specificity of a gene and makes use of a novel non-parametric indicator to assess the discrimination ability between classes.", {"entities": []}], ["Our method is effective even when the sample size is small as well as when the class sizes are significantly different.", {"entities": []}], ["To compare the effectiveness and robustness we formulate an intuitive template-based method and use four well-known datasets.", {"entities": []}], ["We demonstrate that our algorithm outperforms the template-based method in difficult cases with unbalanced distribution.", {"entities": []}], ["Moreover, the multiple-class specific genes are good biomarkers and play important roles in biological pathways.", {"entities": []}], ["Our literature survey supports that the proposed method identifies unique multiple-class specific marker genes (not reported earlier to be related to cancer) in the Central Nervous System data.", {"entities": [[150, 156, "DISEASE"]]}], ["It also discovers unique biomarkers indicating the intrinsic difference between subtypes of lung cancer.", {"entities": [[92, 103, "DISEASE"], [97, 103, "DISEASE"]]}], ["We also associate the pathway information with the multiple-class specific signature genes and cross-reference to published studies.", {"entities": []}], ["We find that the identified genes participate in the pathways directly involved in cancer development in leukemia data.", {"entities": [[105, 113, "DISEASE"], [83, 89, "DISEASE"]]}], ["Our method gives a promising way to find genes that can involve in pathways of multiple diseases and hence opens up the possibility of using an existing drug on other diseases as well as designing a single drug for multiple diseases.", {"entities": []}], ["Current data concerning maternal paracetamol intake during pregnancy, or intake during infancy and risk of wheezing or asthma in childhood is inconclusive based on epidemiological studies.", {"entities": [[119, 125, "DISEASE"]]}], ["We have investigated whether there is a causal link between maternal paracetamol intake during pregnancy and lactation and the development of house dust mite (HDM) induced allergic airways disease (AAD) in offspring using a neonatal mouse model.", {"entities": []}], ["Pregnant mice were administered paracetamol or saline by oral gavage from the day of mating throughout pregnancy and/or lactation.", {"entities": []}], ["Subsequently, their pups were exposed to intranasal HDM or saline from day 3 of life for up to 6\u2005weeks.", {"entities": []}], ["Assessments of airway hyper-responsiveness, inflammation and remodelling were made at weaning (3\u2005weeks) and 6\u2005weeks of age.", {"entities": []}], ["Maternal paracetamol exposure either during pregnancy and/or lactation did not affect development of AAD in offspring at weaning or at 6\u2005weeks.", {"entities": []}], ["There were no effects of maternal paracetamol at any time point on airway remodelling or IgE levels.", {"entities": []}], ["Maternal paracetamol did not enhance HDM induced AAD in offspring.", {"entities": []}], ["Our mechanistic data do not support the hypothesis that prenatal paracetamol exposure increases the risk of childhood asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["The use of complementary and alternative medicines (CAM) is growing in the general population.", {"entities": []}], ["Herbal medicines are used in all countries of the world and are included in the top CAM therapies used.", {"entities": []}], ["A multinational study on how women treat disease and pregnancy-related health ailments was conducted between October 2011 and February 2012 in Europe, North and South America and Australia.", {"entities": []}], ["In this study, the primary aim was to determine the prevalence of herbal medicine use in pregnancy and factors related to such use across participating countries and regions.", {"entities": []}], ["The secondary aim was to investigate who recommended the use of herbal medication in pregnancy.", {"entities": []}], ["There were 9,459 women from 23 countries participating in the study.", {"entities": []}], ["Of these, 28.9% reported the use of herbal medicines in pregnancy.", {"entities": []}], ["Most herbal medicines were used for pregnancy-related health ailments such as cold and nausea.", {"entities": []}], ["Ginger, cranberry, valerian and raspberry were the most commonly used herbs in pregnancy.", {"entities": []}], ["The highest reported rate of herbal use medicines was in Russia (69%).", {"entities": []}], ["Women from Eastern Europe (51.8%) and Australia (43.8%) were twice as likely to use an herbal medicine versus other regions.", {"entities": []}], ["Women using herbal medicines were characteristically having their first child, non-smokers, using folic acid and consuming some alcohol in pregnancy.", {"entities": []}], ["Also, women who were currently students and women with an education other than a high school degree were more likely to use herbal medicines than other women.", {"entities": []}], ["Although 1 out of 5 women stated that a physician had recommended the herbal use, most women used herbal medicine in pregnancy on their own initiative.", {"entities": []}], ["In this multinational study herbal medicine use in pregnancy was high although there were distinct differences in the herbs and users of herbal medicines across regions.", {"entities": []}], ["Most commonly the women self-medicated with herbal medicine to treat pregnancy-related health ailments.", {"entities": []}], ["More knowledge regarding the efficacy and safety of herbal medicines in pregnancy is warranted.", {"entities": []}], ["Our previous salivary study had demonstrated an apparent T helper 2 (Th2)-predominance in saliva of oral lichen planus (OLP) patients and suggested a potential of salivary interleukin-4 (IL-4) as a biomarker for monitoring disease severity.", {"entities": [[105, 118, "DISEASE"]]}], ["To further determine the consistency of Th1/Th2 bias of OLP, this study investigated the expression profile of interferon- \u03b3 (IFN-\u03b3) and IL-4 in serum and the relationship of the serum levels of these cytokines with their saliva partners.", {"entities": []}], ["Sixty ethnic Chinese patients with OLP (40 of the erythematous/ulcerative form and 20 of the reticular form) were recruited for this study, with 40 age\u2013sex-matched healthy volunteers as control group.", {"entities": []}], ["IFN-\u03b3 and IL-4 levels in serum and paired saliva samples were screened by enzyme-linked immunosorbent assay.", {"entities": []}], ["OLP patient showed a low-level IFN-\u03b3 but high-level IL-4 expression profile in both serum and saliva, with a lower IFN-\u03b3/IL-4 ratio.", {"entities": []}], ["Serum IL-4 level in the erythematous/ulcerative group was significantly higher than that in the reticular group.", {"entities": []}], ["Serum levels of IFN-\u03b3 and IL-4 were significantly and positively correlated with their saliva partners.", {"entities": []}], ["These results provided more evidence for Th2 cytokine-predominant immune imbalance in OLP, as well as the potential of IL-4 as the biomarker for monitoring severity of OLP.", {"entities": []}], ["The importance of arachidonic acid (ARA) among the elderly has recently gained increased attention.", {"entities": []}], ["The effects of ARA supplementation in the elderly are not fully understood, although ARA is considered to be associated with various diseases.", {"entities": []}], ["We investigate whether ARA supplementation to Japanese elderly subjects affects clinical parameters involved in cardiovascular, inflammatory, and allergic diseases.", {"entities": []}], ["We also examine the levels of ARA metabolites such as prostanoids during intervention.", {"entities": []}], ["We conducted a randomized, double-blind and placebo-controlled parallel group intervention trial.", {"entities": []}], ["ARA-enriched oil (240 or 720 mg ARA per day) or placebo was administered to Japanese healthy men and women aged 55-70 years for 4 weeks followed by a 4-week washout period.", {"entities": []}], ["The fatty acid contents of plasma phospholipids, clinical parameters, and ARA metabolites were determined at baseline, 2, 4, and 8 weeks.", {"entities": []}], ["The ARA content in plasma phospholipids in the ARA-administrated groups increased dose-dependently and was almost the same at 2 weeks and at 4 weeks.", {"entities": []}], ["The elevated ARA content decreased to nearly baseline during a 4-week washout period.", {"entities": []}], ["During the supplementation and washout periods, no changes were observed in eicosapentaenoic acid and docosahexaenoic acid contents.", {"entities": []}], ["There were no changes in clinical blood parameters related to cardiovascular, inflammatory and allergic diseases.", {"entities": []}], ["ARA supplementation did not alter the level of ARA metabolites such as urinary 11-dehydro thromboxane B 2 , 2,3-dinor-6-keto prostaglandin (PG) F 1\u03b1 and 9,15-dioxo-11\u03b1-hydroxy-13,14-dihydro-2,3,4,5-tetranor-prostan-1,20-dioic acid (tetranor-PGEM), and plasma PGE 2 and lipoxin A 4 .", {"entities": []}], ["ARA in plasma phospholipids was not correlated with ARA metabolite levels in the blood or urine.", {"entities": []}], ["These results indicate that ARA supplementation, even at a relatively high dose, does not increase ARA metabolites, and suggest that it does not induce cardiovascular, inflammatory or allergic diseases in Japanese elderly individuals.", {"entities": []}], ["Postpartum depression affects a huge number of women and has detrimental consequences.", {"entities": []}], ["Knowing the factors associated with postpartum depression during pregnancy can help its prevention.", {"entities": []}], ["Although there is evidence surrounding behavioral or psychological predictors of postpartum depression, there is a lack of evidence of biological forecasters.", {"entities": []}], ["The aim of this study was to analyze the sociodemographic, obstetric, and psychological variables along with hair cortisol levels during the first, second, and third trimesters of pregnancy that could predict postpartum depression symptoms.", {"entities": []}], ["A sample of 44 pregnant women was assessed during 3 trimesters of pregnancy and the postpartum period using psychological questionnaires and hair cortisol levels.", {"entities": []}], ["Participants were divided into 2 groups: a group with postpartum depression symptoms and a group with no postpartum depression symptoms.", {"entities": []}], ["Results showed significant positive differences between groups in the first trimester regarding the Somatization subscale of the SCL-90-R ( p < .05).", {"entities": []}], ["In the second trimester, significant differences were found in the Somatization, Depression, Anxiety, and GSI subscales ( p < .05).", {"entities": []}], ["In the third trimester significant differences between both groups were found regarding pregnancy-specific stress.", {"entities": []}], ["We found significant positive differences between groups regarding hair cortisol levels in the first and the third trimester.", {"entities": []}], ["Hair cortisol levels could predict 21.7% of the variance of postpartum depression symptoms.", {"entities": []}], ["In conclusion, our study provided evidence that psychopathological symptoms, pregnancy-specific stress, and hair cortisol levels can predict postpartum depression symptoms at different time-points during pregnancy.", {"entities": []}], ["These findings can be applied in future studies and improve maternal care in clinical settings.", {"entities": []}], ["Several measures of oral health-related quality of life have been developed for children.", {"entities": []}], ["The most frequently used are the Child Perceptions Questionnaire (CPQ), the Child Oral Impacts on Daily Performances (C-OIDP) and the Child Oral Health Impact Profile (COHIP).", {"entities": []}], ["The aim of this study was to assess the methodological quality of the development and testing of these three measures.", {"entities": []}], ["A systematic search strategy was used to identify eligible studies published up to December 2012, using both MEDLINE and Web of Science.", {"entities": []}], ["Titles and abstracts were read independently by two investigators and full papers retrieved where the inclusion criteria were met.", {"entities": []}], ["Data were extracted by two teams of two investigators using a piloted protocol.", {"entities": []}], ["The data were used to describe the development of the measures and their use against existing criteria.", {"entities": []}], ["The methodological quality and measurement properties of the measures were assessed using standards proposed by the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) group.", {"entities": []}], ["The search strategy yielded 653 papers, of which 417 were duplicates.", {"entities": []}], ["Following analysis of the abstracts, 119 papers met the inclusion criteria.", {"entities": []}], ["The majority of papers reported cross-sectional studies (n\u2009=\u2009117) with three of longitudinal design.", {"entities": []}], ["Fifteen studies which had used the original version of the measures in their original language were included in the COSMIN analysis.", {"entities": []}], ["The most frequently used measure was the CPQ.", {"entities": []}], ["Reliability and construct validity appear to be adequate for all three measures.", {"entities": []}], ["Children were not fully involved in item generation which may compromise their content validity.", {"entities": []}], ["Internal consistency was measured using classic test theory with no evidence of modern psychometric techniques being used to test unidimensionality of the measures included in the COSMIN analysis.", {"entities": []}], ["The three measures evaluated appear to be able to discriminate between groups.", {"entities": []}], ["CPQ has been most widely tested and several versions are available.", {"entities": []}], ["COHIP employed a rigorous development strategy but has been tested in fewer populations.", {"entities": []}], ["C-OIDP is shorter and has been used successfully in epidemiological studies.", {"entities": []}], ["Further testing using modern psychometric techniques such as item response theory is recommended.", {"entities": []}], ["Future developments should also focus on the development of measures which can evaluate longitudinal change.", {"entities": []}], ["Telomere length has been associated with risk of many cancers, but results are inconsistent.", {"entities": []}], ["Seven single nucleotide polymorphisms (SNPs) previously associated with mean leukocyte telomere length were either genotyped or well-imputed in 11108 case patients and 13933 control patients from Europe, Israel, the United States and Australia, four of the seven SNPs reached a P value under .05 (two-sided).", {"entities": []}], ["A genetic score that predicts telomere length, derived from these seven SNPs, is strongly associated ( P = 8.92x10", {"entities": []}], ["Using PCR\u2013denaturing gradient gel electrophoresis, we examined 49 fecal samples from healthy volunteers and 128 diarrhea specimens to assess the distribution of Epsilonproteobacteria that might be routinely overlooked.", {"entities": [[112, 120, "DISEASE"]]}], ["Our results suggest that certain taxa that are not routinely examined for could account for a proportion of diarrhea of previously unknown etiology.", {"entities": [[108, 116, "DISEASE"]]}], ["A hallmark of smooth muscle cells is their ability to adapt their functions to meet temporal and chronic fluctuations in their demands.", {"entities": []}], ["These functions include force development and growth.", {"entities": []}], ["Understanding the mechanisms underlying the functional plasticity of smooth muscles, the major constituent of organ walls, is fundamental to elucidating pathophysiological rationales of failures of organ functions.", {"entities": []}], ["Also, the knowledge is expected to facilitate devising innovative strategies that more precisely monitor and normalize organ functions by targeting individual smooth muscles.", {"entities": []}], ["Evidence has established a current paradigm that the myosin light chain phosphatase (MLCP) is a master regulator of smooth muscle responsiveness to stimuli.", {"entities": []}], ["Cellular MLCP activity is negatively and positively regulated in response to G-protein activation and cAMP/cGMP production, respectively, through the MYPT1 regulatory subunit and an endogenous inhibitor protein named CPI-17.", {"entities": []}], ["In this article we review the outcomes from two decade of research on the CPI-17 signaling and discuss emerging paradoxes in the view of signaling pathways regulating smooth muscle functions through MLCP.", {"entities": []}], ["Glucocorticoids have been known to be less effective for treating ankylosing spondylitis (AS) patients than for treating rheumatoid arthritis (RA) patients.", {"entities": [[77, 88, "DISEASE"], [121, 141, "DISEASE"], [132, 141, "DISEASE"], [66, 88, "DISEASE"]]}], ["To elucidate the mechanisms underlying this phenomenon, we evaluated whether the glucocorticoid receptor (GR)\u03b2 expression of the peripheral blood mononuclear cells (PBMCs) in patients with AS is increased compared with patients with RA.", {"entities": []}], ["PBMCs were isolated from the subjects of 3 study groups: the healthy controls (n=25), the RA patients (n=25), and the AS patients (n=25).", {"entities": []}], ["All the subjects had never taken corticosteroids and the patients with RA or AS were newly diagnosed.", {"entities": []}], ["The expression of GR\u03b2 messenger RNA (mRNA) was determined by reverse transcription of the total RNA, and this was followed by semi-quantitative polymerase chain reaction analysis (RT-PCR).", {"entities": []}], ["The level of GR\u03b1 mRNA expression was not different among three groups.", {"entities": []}], ["GR\u03b2 mRNA expression of the AS patients (2.02 [range: 0.99-7.21], median [25 The expression of GR\u03b2 mRNA, which is a dominant negative regulator for the glucocorticoid response, was increased in AS patients.", {"entities": []}], ["The results suggest that the increased expression of GR\u03b2 mRNA may be related to the ineffectiveness of glucocorticoids for the treatment of AS.", {"entities": []}], ["Moraxella catarrhalis causes approximately 10% of exacerbations in chronic obstructive pulmonary disease (COPD) and also colonizes the lower airway in stable patients.", {"entities": [[67, 104, "DISEASE"]]}], ["Little is known about the effects of colonization by M. catarrhalis on airway inflammation and protease-antiprotease balance, and how these changes compare to those seen during exacerbations.", {"entities": []}], ["Since COPD is a progressive inflammatory disease, elucidating the effects of bacterial colonization and exacerbation on airway inflammation is relevant to understanding disease progression in COPD.", {"entities": []}], ["Our aims were (1) Analyze changes in airway inflammation in colonization and exacerbation of COPD due to M. catarrhalis ; (2) Explore protease-antiprotease balance in colonization and exacerbation due to M. catarrhalis .", {"entities": []}], ["Our hypothesis were (1) Acquisition of a new strain of M. catarrhalis in COPD increases airway inflammation from baseline and alters the protease-antiprotease balance towards a more proteolytic environment; (2) These changes are greater during exacerbations associated with M. catarrhalis as compared to colonization.", {"entities": []}], ["Thirty-nine consecutive COPD patients with 76 acquisitions of a new strain of M. catarrhalis over a 6-year period were identified in a prospective study.", {"entities": []}], ["Seventy-six pre-acquisition sputum supernatant samples, obtained just before acquisition of M catarrhalis , and 76 acquisition samples (34 were associated with exacerbation, 42 with colonization) were analyzed for IL-8, TNF-\u03b1, Neutrophil Elastase (NE) and Secretory leukocyte protease inhibitor (SLPI).", {"entities": [[296, 300, "GENE"]]}], ["Changes were compared in paired samples from each patient.", {"entities": []}], ["IL-8, TNF-\u03b1 and NE were significantly elevated after acquisition of M. catarrhalis , compared to pre-acquisition samples (p =< 0.001 for all three).", {"entities": []}], ["These changes were present in colonization (p = 0.015 for IL-8; p =< 0.001 for TNF-\u03b1 and NE) as well as in exacerbation (p =< 0.001 for all three), compared to pre-acquisition levels.", {"entities": []}], ["SLPI was significantly lower after acquisition (p =< 0.001), in colonization (p =< 0.001) as well as in exacerbation (p = 0.004), compared to pre-acquisition levels.", {"entities": [[0, 4, "GENE"]]}], ["SLPI levels correlated negatively with NE levels (R Acquisition of M. catarrhalis in COPD causes increased airway inflammation and worsening protease-antiprotease imbalance during exacerbations and also in colonization, even in the absence of increased symptoms.", {"entities": [[0, 4, "GENE"]]}], ["These effects could contribute to progression of airway disease in COPD.", {"entities": []}], ["Multiple sclerosis is a human autoimmunological disease that causes neurodegeneration.", {"entities": []}], ["One of the potential ways to stop its development is induction of oral tolerance, whose effect lies in decreasing immune response to the fed antigen.", {"entities": []}], ["It was shown in animal models that administration of specific epitopes of the three main myelin proteins \u2013 myelin oligodendrocyte glycoprotein (MOG), myelin basic protein (MBP), and proteolipid protein (PLP) \u2013 results in induction of oral tolerance and suppression of disease symptoms.", {"entities": [[172, 175, "GENE"]]}], ["Use of bacterial cells to produce and deliver antigens to gut mucosa seems to be an attractive method for oral tolerance induction in treatment of diseases with autoimmune background.", {"entities": []}], ["Synthetic genes of MOG35-55, MBP85-97, and PLP139-151 myelin epitopes were generated and cloned in Lactococcus lactis under a CcpA-regulated promoter.", {"entities": []}], ["The tolerogenic effect of bacterial preparations was tested on experimental autoimmune encephalomyelitis, which is the animal model of MS. EAE was induced in rats by intradermal injection of guinea pig spinal cord homogenate into hind paws.", {"entities": [[87, 104, "DISEASE"]]}], ["Rats were administered preparations containing whole-cell lysates of L. lactis producing myelin antigens using different feeding schemes.", {"entities": []}], ["Our study demonstrates that 20-fold, but not 4-fold, intragastric administration of autoantigen-expressing L. lactis cells under specific conditions reduces the clinical symptoms of EAE in rats.", {"entities": []}], ["The present study evaluated the use of myelin antigens produced in L. lactis in inhibiting the onset of experimental autoimmune encephalomyelitis in rats.", {"entities": [[128, 145, "DISEASE"]]}], ["Obtained results indicate that application of such recombinant cells can be an attractive method of oral tolerance induction.", {"entities": []}], ["We tested whether NF \u2010 \u03ba B pathway is indispensable for the increase in expression of E3\u2010ligases and unloading\u2010induced muscle atrophy using IKK \u03b2 inhibitor IMD \u20100354.", {"entities": []}], ["Three groups of rats were used: nontreated control (C), 3\u00a0days of unloading/hindlimb suspension with ( HS + IMD ) or without ( HS ) IMD \u20100354.", {"entities": []}], ["Levels of I \u03ba B \u03b1 were higher in HS + IMD (1.16\u2010fold) and lower in HS (0.82\u2010fold) when compared with C group.", {"entities": []}], ["IMD \u20100354 treatment during unloading: had no effect on loss of muscle mass; increased mRNA levels of Mu RF 1 and MAF bx; increased level s of pF oxO3; and had no effect on levels of Bcl\u20103, p105, and p50 proteins.", {"entities": [[113, 116, "GENE"]]}], ["Our study for the first time showed that inhibiting IKK \u03b2 in\u00a0vivo during 3\u2010day unloading failed to diminish expression of ubiquitin ligases and prevent muscle atrophy.", {"entities": []}], ["Grass pollen is one of the most important sources of respiratory allergies worldwide.", {"entities": []}], ["This study describes the development of a grass pollen allergy vaccine based on recombinant hypoallergenic derivatives of the major timothy grass pollen allergens Phl p 1, Phl p 2, Phl p 5, and Phl p 6 by using a peptide-carrier approach.", {"entities": []}], ["Fusion proteins consisting of nonallergenic peptides from the 4 major timothy grass pollen allergens and the PreS protein from hepatitis B virus as a carrier were expressed in Escherichia coli and purified by means of chromatography.", {"entities": [[127, 136, "DISEASE"]]}], ["Recombinant PreS fusion proteins were tested for allergenic activity and T-cell activation by means of IgE serology, basophil activation testing, T-cell proliferation assays, and xMAP Luminex technology in patients with grass pollen allergy.", {"entities": []}], ["Rabbits were immunized with PreS fusion proteins to characterize their immunogenicity.", {"entities": []}], ["Ten hypoallergenic PreS fusion proteins were constructed, expressed, and purified.", {"entities": []}], ["According to immunogenicity and induction of allergen-specific blocking IgG antibodies, 4 hypoallergenic fusion proteins (BM321, BM322, BM325, and BM326) representing Phl p 1, Phl p 2, Phl p 5, and Phl p 6 were included as components in the vaccine termed BM32.", {"entities": []}], ["BM321, BM322, BM325, and BM326 showed almost completely abolished allergenic activity and induced significantly reduced T-cell proliferation and release of proinflammatory cytokines in patients' PBMCs compared with\u00a0grass pollen allergens.", {"entities": []}], ["On immunization, they induced allergen-specific IgG antibodies, which inhibited patients' IgE binding to all 4 major allergens of grass pollen, as well as allergen-induced basophil activation.", {"entities": []}], ["A recombinant hypoallergenic grass pollen allergy vaccine (BM32) consisting of 4 recombinant PreS-fused grass pollen allergen peptides was developed for safe immunotherapy of grass pollen allergy.", {"entities": []}], ["Given that the diagnosis of chronic obstructive pulmonary disease (COPD) relies on demonstrating airflow limitation by spirometry, which is known to be poorly sensitive to early disease, and to regional differences in emphysema, we sought to evaluate individual lobar contributions to global spirometric measures.", {"entities": [[28, 65, "DISEASE"]]}], ["Subjects with COPD were compared with smokers without airflow obstruction, and non-smokers.", {"entities": []}], ["Emphysema (% low attenuation area, LAA insp <\u2212950 HU, at end-inspiration) and gas trapping (%LAA exp <\u2212856 HU at end-expiration) on CT were quantified using density mask analyses for the whole lung and for individual lobes, and distribution across lobes and strength of correlation with spirometry were compared.", {"entities": []}], ["The right middle lobe had the highest %LAA insp <\u2212950 HU in smokers and controls, and the highest %LAA exp <\u2212856 HU in all three groups.", {"entities": []}], ["While RML contributed to emphysema and gas trapping disproportionately to its relatively small size, it also showed the least correlation with spirometry.", {"entities": []}], ["There was no change in correlation of whole lung CT metrics with spirometry when the middle lobe was excluded from analyses.", {"entities": []}], ["Similarly, RML had the highest %LAA exp <\u2212856 HU while having the least correlation with spirometry.", {"entities": []}], ["Because of the right middle lobe\u2019s disproportionate contribution to CT-based emphysema measurements, and low contribution to spirometry, longitudinal studies of emphysema progression may benefit from independent analysis of the middle lobe in whole lung quantitative CT assessments.", {"entities": []}], ["Our findings may also have implications for heterogeneity assessments and target lobe selection for lung volume reduction.", {"entities": []}], ["ClinicalTrials.gov NCT00608764", {"entities": []}], ["Aspirin-exacerbated respiratory disease (AERD) is one phenotype of asthma, often occurring in the form of a severe and sudden attack.", {"entities": [[67, 73, "DISEASE"]]}], ["Due to the time-consuming nature and difficulty of oral aspirin challenge (OAC) for AERD diagnosis, non-invasive biomarkers have been sought.", {"entities": []}], ["The aim of this study was to identify AERD-associated exonic SNPs and examine the diagnostic potential of a combination of these candidate SNPs to predict AERD.", {"entities": []}], ["DNA from 165 AERD patients, 397 subjects with aspirin-tolerant asthma (ATA), and 398 normal controls were subjected to an Exome BeadChip assay containing 240K SNPs.", {"entities": [[63, 69, "DISEASE"]]}], ["1,023 models (2 p -values in association with AERD.", {"entities": []}], ["The area under the curve (AUC) of the receiver operating characteristic (ROC) curves was calculated for each model.", {"entities": []}], ["SNP Function Portal and PolyPhen-2 were used to validate the functional significance of candidate SNPs.", {"entities": []}], ["An exonic SNP, exm537513 in HLA-DPB1, showed the lowest p-value ( p \u200a=\u200a3.40\u00d710 p -value of 7.94\u00d710 CHIA were predicted to be \u201cprobably damaging\u201d to the structure and function of the protein, with a high score of \u20181\u2019.", {"entities": [[28, 36, "GENE"]]}], ["A combination model of seven SNPs may provide a useful, non-invasive genetic marker combination for predicting AERD.", {"entities": []}], ["Primary intradural extramedullary hydatid cyst is a rare form of parasitic infection, causing focal neurological signs, commonly observed in sheep-raising areas of the world.", {"entities": []}], ["We report a rare case of intradural, extramedullary spinal cyst, which we had misdiagnosis in the first surgery, because of rarity of the case.", {"entities": []}], ["A 55-year-old man presented to our hospital in August 2008.", {"entities": []}], ["He was admitted to our clinic because of lumbar pain of increasing severity and progressive difficulty with walking and stiffness of both lower limbs, which had lasted for 1\u00a0month.", {"entities": []}], ["On the basis of imaging results, arachnoid cyst of the lumbar spine was diagnosed.", {"entities": []}], ["Due to rapid progression of the patient\u2019s symptoms toward spastic paraplegia, he underwent an emergency surgical decompression procedure.", {"entities": [[66, 76, "DISEASE"]]}], ["The patient underwent exploratory surgery using a posterior approach.", {"entities": []}], ["A L1\u2013L2 laminectomy was performed.", {"entities": []}], ["After opening the dura, an intradural extramedullary cystic mass was determined.", {"entities": []}], ["The surgical specimen measured 6\u00a0\u00d7\u00a02\u00a0cm and was described as a whitish, pearl-like, semitranslucent, cystic material, which was thought to be parasitic.", {"entities": []}], ["Surgery has to be followed by albendazole therapy.", {"entities": []}], ["Hypogonadotropic hypogonadism (HH) in men results in insufficient testicular function and deficiencies in testosterone and spermatogenesis.", {"entities": [[17, 29, "DISEASE"]]}], ["Combinations of human chorionic gonadotropin (hCG) and recombinant follicle-stimulating hormone (recFSH) have been successful in the treatment of HH.", {"entities": []}], ["Corifollitropin alfa is a long-acting FSH-analog with demonstrated action in women seeking infertility care.", {"entities": [[91, 102, "DISEASE"]]}], ["The aim of this study was to investigate the efficacy and safety of corifollitropin alfa combined with hCG to increase testicular volume and induce spermatogenesis in men with HH.", {"entities": []}], ["This was a Phase III, multi-center, open-label, single-arm trial of corifollitropin alfa in azoospermic men aged 18 to 50\u00a0years with HH.", {"entities": []}], ["After 16\u00a0weeks of pretreatment of 23 subjects with hCG alone, 18 subjects with normalized testosterone (T) levels who remained azoospermic entered the 52-week combined treatment phase with hCG twice-weekly and 150\u00a0\u03bcg corifollitropin alfa every other week.", {"entities": []}], ["The increase in testicular volume (primary efficacy endpoint) and induction of spermatogenesis resulting in a sperm count \u22651\u2009\u00d7\u200910 Mean (\u00b1SD) testicular volume increased from 8.6 (\u00b16.09) mL to 17.8 (\u00b18.93) mL (geometric mean fold increase, 2.30 [95% CI: 2.03, 2.62]); 14 (77.8%) subjects reached a sperm count \u22651\u2009\u00d7\u200910 Corifollitropin alfa 150\u00a0\u03bcg administrated every other week combined with twice-weekly hCG for 52\u00a0weeks increased testicular volume significantly, and induced spermatogenesis in >75% of men with HH who had remained azoospermic after hCG treatment alone.", {"entities": []}], ["ClinicalTrials.gov: NCT01709331 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12958-017-0232-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Considerable variety in how patients respond to treatments, driven by differences in their geno- and/ or phenotypes, calls for a more tailored approach.", {"entities": []}], ["This is already happening, and will accelerate with developments in personalized medicine.", {"entities": []}], ["However, its promise has not always translated into improvements in patient care due to the complexities involved.", {"entities": []}], ["There are also concerns that advice for tests has been reversed, current tests can be costly, there is fragmentation of funding of care, and companies may seek high prices for new targeted drugs.", {"entities": []}], ["There is a need to integrate current knowledge from a payer\u2019s perspective to provide future guidance.", {"entities": []}], ["Multiple findings including general considerations; influence of pharmacogenomics on response and toxicity of drug therapies; value of biomarker tests; limitations and costs of tests; and potentially high acquisition costs of new targeted therapies help to give guidance on potential ways forward for all stakeholder groups.", {"entities": []}], ["Overall, personalized medicine has the potential to revolutionize care.", {"entities": []}], ["However, current challenges and concerns need to be addressed to enhance its uptake and funding to benefit patients.", {"entities": []}], ["There is abundant research relevant to genetic and environmental influences on asthma and hayfever, but little is known about dietary risk factors in Australian adults.", {"entities": [[79, 85, "DISEASE"]]}], ["This study\u2019s purpose was to identify dietary factors associated with lifetime asthma (AS) and asthma or hayfever (AS/HF) diagnosis in Australian middle-aged and older adults.", {"entities": [[78, 84, "DISEASE"], [94, 100, "DISEASE"]]}], ["From The 45 and Up Study baseline self-report data, this study included 156,035 adult men and women.", {"entities": []}], ["Participants were sampled from the general population of New South Wales, Australia in 2006\u20132009.", {"entities": []}], ["About 12% of participants reported ever receiving an AS diagnosis (men 10%; women 14%) and 23% reported AS/HF diagnosis (men 19%; women 26%).", {"entities": []}], ["Following principle components factor analysis, dietary items loaded onto one of four factors for men (meats/cheese; fruits/vegetables; poultry/seafood; grains/alcohol) or five factors for women (meats; fruits/vegetables; poultry/seafood; cereal/alcohol; brown bread/cheese).", {"entities": []}], ["Logistic regression was used to analyze the associations between dietary factors and AS or AS/HF diagnosis.", {"entities": []}], ["For men, the meats/cheese factor was positively associated with AS (AOR = adjusted odds ratio for highest versus lowest quintile = 1.18, 95%CI = 1.08, 1.28; P trend = 0.001) and AS/HF (AOR for highest versus lowest quintile = 1.22, 95%CI = 1.14, 1.29; P trend < 0.001).", {"entities": []}], ["Poultry/seafood was also associated with AS/HF in men (AOR for highest versus lowest quintile = 1.11, 95%CI = 1.04, 1.17; P trend = 0.002).", {"entities": []}], ["For women, significant risk factors for AS/HF included meats (AOR for highest versus lowest quintile = 1.25, 95%CI = 1.19, 1.31; P trend = 0.001), poultry/seafood (AOR for highest versus lowest quintile = 1.06, 95%CI = 1.01, 1.12; P trend = 0.016), and fruits/vegetables (AOR for highest versus lowest quintile = 1.07, 95%CI = 1.02, 1.12; P trend = 0.011).", {"entities": []}], ["In contrast, the cheese/brown bread dietary factor was protective against AS in women (AOR for highest versus lowest quintile = 0.88, 95%CI = 0.82, 0.94; P trend < 0.001).", {"entities": []}], ["Generally, diets marked by greater intakes of meats, poultry, and seafood were associated with diagnosed AS and AS/HF.", {"entities": []}], ["Taken together, these findings suggest that adherence to a more meat-based diet may pose risk for AS and AS/HF in Australian adults.", {"entities": []}], ["Recent increases in obesity prevalence have led to research into the neighbourhood food environment.", {"entities": [[20, 27, "DISEASE"]]}], ["Research suggests that proximity and density of food outlets around the home is associated with childhood obesity prevalence, however, the evidence is inconclusive, and associations between food outlet locations and diet are less clear.", {"entities": [[106, 113, "DISEASE"]]}], ["The purpose of this study is to assess area level associations between sales of unhealthy foods in supermarkets and weight status of children.", {"entities": []}], ["This study examined the association between weight status in children (4\u20135 year olds and 10\u201311 year olds) measured in the National Child Measurement Programme over three time points (2008/9, 2009/10, 2010/11) and annual sales of unhealthy foods (2012/3), as identified from a large supermarket chain.", {"entities": []}], ["Geographical analysis was conducted to link store-based food sales for 537 stores with 6517 UK Census Areas.", {"entities": []}], ["Unadjusted associations were examined with error-bar plots and linear regression was used to examine the relationship between the prevalence of overweight and obesity and sales of unhealthy food, while controlling for covariates known to predict weight status in children.", {"entities": [[159, 166, "DISEASE"]]}], ["A statistically significant relationship was identified between the sales of unhealthy foods and the prevalence of overweight and obese children in both age groups ( p \u2009<\u20090.01).", {"entities": []}], ["Of the covariates, area deprivation was positively associated with weight status ( p < 0.001).", {"entities": []}], ["Non-white population (%) was negatively associated ( p \u2009<\u20090.001) with overweight and obesity among Reception children, but positively associated with the other weight statuses ( p < 0.001).", {"entities": [[85, 92, "DISEASE"]]}], ["A higher proportion of children in the same age group were associated with statistically significantly lower overweight and obesity prevalence in Reception ( p <0.01) but not Year 6 children.", {"entities": [[124, 131, "DISEASE"]]}], ["The study provides novel findings linking supermarket food sales with the weight status of children.", {"entities": []}], ["Food sales in geographically referenced supermarkets are a valuable source of data for research into the factors that influence the weight of the surrounding population.", {"entities": []}], ["Future research could identify factors that might modify food shopping in supermarkets and use of purchasing data could be an effective way to measure the impact of healthy eating campaigns on the weight status of children over time.", {"entities": []}], ["Crohn's disease (CD) is clinically expressed as a chronic affection of the gastrointestinal tract currently known to have a multifactorial etiology involving a complex pathophysiological host response modulated by genetic susceptibilities, demographic determinants and environmental factors.", {"entities": []}], ["With more than 20 cases per 100,000 person-years, the province of Quebec, Canada is among regions of the world with highest reported occurrence of CD in relation to other places where comparable estimates are available.", {"entities": []}], ["This ecological study was designed to provide a medium-scale spatial exploration of CD incidence after accounting for the influence of known population and regional determinants.", {"entities": []}], ["Health records of consulting patients in southern Quebec were compiled from 1995 to 2000 and used to estimate age and sex standardized rates per health area (n = 156).", {"entities": []}], ["Various statistical models taking into account the regional effect of Jewish ethnicity, aboriginal ancestry, material deprivation, prescription for oral contraceptives, reportable enteric infection incidence, smoking as well as latitude and longitude locations were fitted.", {"entities": []}], ["The final regression model presented a coefficient of determination of 22.8% and there was evidence of an eastern trend in the residual incidence (p = 0.018).", {"entities": []}], ["Overall, the smoothed residual incidence presented a heterogeneous spatial pattern with evidence of patches (multiple health areas) of high, low and contrasting values.", {"entities": []}], ["Health areas with most extreme incidence residuals where also distributed over the whole province including one area in the metropolitan area of Montreal and others in surrounding areas.", {"entities": []}], ["These findings suggest that known populational and regional factors derived through census information only explain a limited fraction of the geographical variation of CD incidence and lead to speculate that the effects of these factors may be incompletely captured (imperfect construction of proxy variables) or that other important factors remain unmeasured.", {"entities": []}], ["In this view, markers of genetic profiles of homogeneous sub-populations, and other factors linked to agroenvironmental microbial exposure should be further investigated.", {"entities": []}], ["Once accounting for known factors, it would also be worth comparing adjacent geographical areas demonstrating abrupt changes in residual incidence rates to further explore effect linked to regional factors from those resulting from various reporting systems.", {"entities": []}], ["Patient safety is a national and international priority with medication safety earmarked as both a prevalent and high-risk area of concern.", {"entities": []}], ["To date, medication safety research has focused overwhelmingly on institutional based care provided by paid healthcare professionals, which often has little applicability to the home care setting.", {"entities": []}], ["This critical gap in our current understanding of medication safety in the home care sector is particularly evident with the elderly who often manage more than one chronic illness and a complex palette of medications, along with other care needs.", {"entities": []}], ["This study addresses the medication management issues faced by seniors with chronic illnesses, their family, caregivers, and paid providers within Canadian publicly funded home care programs in Alberta (AB), Ontario (ON), Quebec (QC) and Nova Scotia (NS).", {"entities": []}], ["Informed by a socio-ecological perspective, this study utilized Interpretive Description (ID) methodology and participatory photographic methods to capture and analyze a range of visual and textual data.", {"entities": []}], ["Three successive phases of data collection and analysis were conducted in a concurrent, iterative fashion in eight urban and/or rural households in each province.", {"entities": []}], ["A total of 94 participants (i.e., seniors receiving home care services, their family/caregivers, and paid providers) were interviewed individually.", {"entities": []}], ["In addition, 69 providers took part in focus groups.", {"entities": []}], ["Analysis was iterative and concurrent with data collection in that each interview was compared with subsequent interviews for converging as well as diverging patterns.", {"entities": []}], ["Six patterns were identified that provide a rich portrayal of the complexity of medication management safety in home care: vulnerabilities that impact the safe management and storage of medication, sustaining adequate supports, degrees of shared accountability for care, systems of variable effectiveness, poly-literacy required to navigate the system, and systemic challenges to maintaining medication safety in the home.", {"entities": []}], ["There is a need for policy makers, health system leaders, care providers, researchers, and educators to work with home care clients and caregivers on three key messages for improvement: adapt care delivery models to the home care landscape; develop a palette of user-centered tools to support medication safety in the home; and strengthen health systems integration.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-1193-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The current generation of older adults reports a higher lifetime prevalence of prescription, over-the-counter, and recreational drug use.", {"entities": []}], ["The purpose of this analysis is to characterize the drug usage and determine the risk of motor vehicle collision associated with individual medications in a population of drivers\u00a0\u226565\u00a0years.", {"entities": []}], ["A case-crossover study was conducted at West Virginia University Healthcare\u2019s facilities using data obtained from the electronic health records (n\u00a0=\u00a0611) of drivers\u00a0\u226565\u00a0years admitted for medical treatment following a motor vehicle collision which occurred between Jan. 1, 2009 and June 30, 2014.", {"entities": []}], ["Patients\u2019 medication usage 14\u00a0days before collision were matched and compared to their medication usage during four control periods prior to collision.", {"entities": []}], ["Odds ratios were then calculated for the most prevalent individual medications and pharmaceutical sub-classes using conditional logistic regression.", {"entities": []}], ["Analgesic, cardiovascular and gastrointestinal medicines were common.", {"entities": []}], ["Few drivers tested positive for either licit or illicit drugs.", {"entities": []}], ["Of those testing positive for drugs, benzodiazepines and opiates were prevalent.", {"entities": []}], ["Drivers consuming Tramadol (adjusted OR 11.41; 95\u00a0% CI 1.27, 102.15) were at a significantly increased risk of motor vehicle collision.", {"entities": []}], ["Older adult drivers who have a prescription for this medication may need to be aware of the potential risk.", {"entities": []}], ["Further research is necessary in a larger, more nationally representative population.", {"entities": []}], ["A significant genetic component has been described for idiopathic pulmonary fibrosis (IPF).", {"entities": [[66, 84, "DISEASE"], [55, 84, "DISEASE"]]}], ["The R131H (rs1801274) polymorphism of the IgG receptor Fc\u03b3RIIa determines receptor affinity for IgG subclasses and is associated with several chronic inflammatory diseases.", {"entities": []}], ["We investigated whether this polymorphism is associated with IPF susceptibility or progression.", {"entities": []}], ["In a case-control study, we compared the distribution of Fc\u03b3RIIa R131H genotypes in 142 patients with IPF and in 218 controls using allele-specific PCR amplification.", {"entities": []}], ["No differences in the frequency of Fc\u03b3RIIa genotypes were evident between IPF patients and control subjects.", {"entities": []}], ["However, significantly impaired pulmonary function at diagnosis was observed in HH compared to RR homozygotes, with evidence of more severe restriction (reduced forced vital capacity (FVC)) and lower diffusing capacity for carbon monoxide (D L CO ).", {"entities": []}], ["Similarly, increased frequency of the H131 allele was observed in patients with severe disease (D L CO < 40% predicted) (0.53 vs. 0.38; p = 0.03).", {"entities": []}], ["Furthermore, the H131 allele was associated with progressive pulmonary fibrosis as determined by > 10% drop in FVC and/or > 15% fall in D L CO at 12 months after baseline (0.48 vs. 0.33; p = 0.023).", {"entities": [[61, 79, "DISEASE"]]}], ["These findings support an association between the Fc\u03b3RIIa R131H polymorphism and IPF severity and progression, supporting the involvement of immunological mechanisms in IPF pathogenesis.", {"entities": []}], ["Extranodal spread (ENS) in patients with head and neck squamous cell carcinoma (HNSCC) can greatly influence the prognostic outcomes.", {"entities": [[69, 78, "DISEASE"], [55, 78, "DISEASE"]]}], ["However, the relative risks of ENS in the primary (1st) and secondary (2nd) metastatic nodes (mets) are not well documented.", {"entities": []}], ["We retrospectively analyzed the hazard ratios (HRs) of ENS in the 1st and 2nd mets from 516 HNSCC patients who had undergone primary tumor excision.", {"entities": []}], ["The impact of clinically and/or histologically confirmed ENS-positive mets on prognosis in terms of cancer-specific survival was analyzed.", {"entities": [[100, 106, "DISEASE"]]}], ["Cox proportional hazard regression analysis indicated that ENS-positive 1st met (adjusted HR = 3.15; 95% CI, 1.40\u20137.56; p = 0.006) and ENS-positive 2nd met (adjusted HR = 4.03; 95% CI, 1.41\u201316.96; p = 0.007) significantly and independently predicted poor prognosis; however, other variables including primary site, met size or numbers, and met location in the contralateral side of the primary lesion, did not.", {"entities": [[90, 92, "GENE"], [166, 168, "GENE"], [90, 92, "GENE"], [166, 168, "GENE"]]}], ["Cumulative incidence function and Cox analyses indicated that differences in ENS profiles of 1st and 2nd mets stratified HNSCC patients with varying risks of poor outcome; HRs relative to patients with ENS-positive 1st met (-)/ENS-positive 2nd met (-) were 4.02 (95% CI, 1.78\u20138.24; p = 0.002), 8.29 (95% CI, 4.58\u201314.76; p <0.001), and 25.80 (95% CI, 10.15\u201357.69; p <0.001) for patients with ENS-positive 1st met (+)/ENS-positive 2nd met (-), ENS-positive 1st met (-)/ENS-positive 2nd met (+), and ENS-positive 1st met (+)/ENS-positive 2nd met (+) patients, respectively.", {"entities": []}], ["Kaplan-Meier analysis indicated that the 2nd met that appeared in the neck side with a history of 1st met and neck dissection had a higher risk of ENS than the 2nd met in the neck side without the history (p = 0.003).", {"entities": []}], ["These results suggested that ENS is a dominant prognostic predictor of HNSCC patients, with double-positive ENS in the 1st and 2nd mets predicting the most devastating outcome.", {"entities": []}], ["This study aimed to examine whether a mismatch between a woman\u2019s preferred and actual mode of delivery increases the risk of post-traumatic stress symptoms after childbirth.", {"entities": []}], ["The study sample consisted of 1,700 women scheduled to give birth between 2009 and 2010 at Akershus University Hospital, Norway.", {"entities": []}], ["Questionnaire data from pregnancy weeks 17 and 32 and from 8\u00a0weeks postpartum were used along with data obtained from hospital birth records.", {"entities": []}], ["Post-traumatic stress symptoms were measured with the Impact of Event Scale.", {"entities": []}], ["Based on the women\u2019s preferred and actual mode of delivery, four groups were established: Match 1 (no preference for cesarean section, no elective cesarean section, N\u2009=\u20091,493); Match 2 (preference for cesarean section, elective cesarean section, N\u2009=\u200953); Mismatch 1 (no preference for cesarean section, elective cesarean section, N\u2009=\u200942); and Mismatch 2 (preference for cesarean section, no elective cesarean section, N\u2009=\u2009112).", {"entities": []}], ["Analysis of variance (ANOVA) and analysis of covariance (ANCOVA) were conducted to examine whether the level of post-traumatic stress symptoms differed significantly among these four groups.", {"entities": []}], ["Examining differences for all four groups, ANOVA yielded significant overall group differences (F\u2009=\u200911.96, p\u2009<\u20090.001).", {"entities": []}], ["However, Bonferroni post-hoc tests found significantly higher levels of post-traumatic stress symptoms only in Mismatch 2 compared to Match 1.", {"entities": []}], ["This difference could be partly explained by a number of risk factors, particularly psychological risk factors such as fear of childbirth, depression, and anxiety.", {"entities": []}], ["The results suggest increased post-traumatic stress symptoms in women who preferred delivery by cesarean section but delivered vaginally compared to women who both preferred vaginal delivery and delivered vaginally.", {"entities": []}], ["In psychologically vulnerable women, such mismatch may threaten their physical integrity and, in turn, result in post-traumatic stress symptoms.", {"entities": []}], ["These women, who often fear childbirth, may prefer a cesarean section even though vaginal delivery is usually the best option in the absence of medical indications.", {"entities": []}], ["To avoid potential trauma, fear of childbirth and maternal requests for a cesarean section should be taken seriously and responded to adequately.", {"entities": []}], ["Initial studies suggested that polymorphisms in Tim1 and Tim3 contribute to the development of airway hyperreactivity (AHR) in an acute mouse model of asthma.", {"entities": [[151, 157, "DISEASE"], [119, 122, "GENE"]]}], ["This was also mirrored in human genetic studies where polymorphisms in Tim1 and Tim3 have been associated with atopic populations.", {"entities": []}], ["Further studies using anti-Tim1 or -Tim3 antibodies, or Tim fusion proteins, have also suggested that these molecules may function as regulators of type-1 and type-2 immunity.", {"entities": []}], ["However, their role in the development of AHR and airway inflammation remains unclear.", {"entities": [[42, 45, "GENE"]]}], ["Given the proposed roles for Tim1 and Tim3 in type-1 and type-2 responses, we sought to determine whether these molecules were important in regulating antigen-driven lung allergy and inflammation.", {"entities": []}], ["We used Tim1- and Tim3-deficient mice and determined how the development of allergic lung inflammation was affected.", {"entities": []}], ["AHR was induced normally in the absence of both Tim1 and Tim3, although Tim1-deficient mice did show a small but significant decrease in cell infiltration in the lung and blood eosinophilia.", {"entities": [[177, 189, "DISEASE"], [0, 3, "GENE"]]}], ["Although Tim3 was expressed on CD4 Thus, Tim1 and Tim3 are not essential for the induction of the type-2 response in lung allergy.", {"entities": [[31, 34, "GENE"]]}], ["This is contrary to what was proposed in a number of other studies using neutralizing and activating antibodies and questions the clinical relevance of Tim1 and Tim3 for novel allergy therapies.", {"entities": []}], ["Cite this as : J. L. Barlow, S. H. Wong, S. J. Ballantyne, H. E. Jolin and A. N. J. McKenzie, Clinical & Experimental Allergy , 2011 (41) 1012\u20131021.", {"entities": []}], ["Malaria remains one of the most important infectious diseases in the world, being a significant public health problem associated with poverty and it is one of the main obstacles to the economy of an endemic country.", {"entities": [[0, 7, "DISEASE"]]}], ["Among the several complications, the effects of malaria seem to target the skeletal muscle system, leading to symptoms, such as muscle aches, muscle contractures, muscle fatigue, muscle pain, and muscle weakness.", {"entities": [[48, 55, "DISEASE"]]}], ["Malaria cause also parasitic coronary artery occlusion.", {"entities": [[0, 7, "DISEASE"]]}], ["This article reviews the current knowledge regarding the effect of malaria disease and the anti-malarial drugs on skeletal and cardiac muscles.", {"entities": [[67, 74, "DISEASE"]]}], ["Research articles and case report publications that addressed aspects that are important for understanding the involvement of malaria parasites and anti-malarial therapies affecting skeletal and cardiac muscles were analysed and their findings summarized.", {"entities": [[126, 133, "DISEASE"]]}], ["Sequestration of red blood cells, increased levels of serum creatine kinase and reduced muscle content of essential contractile proteins are some of the potential biomarkers of the damage levels of skeletal and cardiac muscles.", {"entities": []}], ["These biomarkers might be useful for prevention of complications and determining the effectiveness of interventions designed to protect cardiac and skeletal muscles from malaria-induced damage.", {"entities": [[170, 177, "DISEASE"]]}], ["T helper 17 (Th17) cells can recruit neutrophils to inflammatory sites through production of IL-17, which induces chemokine release.", {"entities": []}], ["IL-23 is an important inducer of IL-17 and IL-22 production.", {"entities": []}], ["Our aim was to study the role of Th17 cells in cystic fibrosis (CF) lung disease by measuring IL-17 protein and mRNA levels and IL-22 and IL-23 mRNA in sputum of clinically stable CF patients and by comparing these levels with healthy controls.", {"entities": [[47, 62, "DISEASE"], [68, 80, "DISEASE"]]}], ["Sputum induction was performed in adult CF patients outside of an exacerbation and healthy control subjects.", {"entities": []}], ["IL-17A protein levels were measured in supernatants with cytometric bead array (CBA) and RNA was isolated and quantitative RT-PCR was performed for IL-17A, IL-22 and IL-23.", {"entities": []}], ["We found significantly higher levels of IL-17A protein and mRNA levels (both: p < 0.0001) and IL-23 mRNA levels (p < 0.0001) in the sputum of CF group as compared to controls.", {"entities": []}], ["We found very low levels of IL-22 mRNA in the CF group.", {"entities": []}], ["The levels of IL-17 and IL-23 mRNA were higher in patients chronically infected with Pseudomonas aeruginosa ( P. aeruginosa ) as compared to those who were not chronically infected with P. aeruginosa .", {"entities": []}], ["The presence of Staphylococcus aureus ( S. aureus ) on sputum did not affect the IL-17 or IL-23 levels.", {"entities": []}], ["There was no correlation between IL-17 or IL-23 levels and FEV 1 nor sputum neutrophilia.", {"entities": [[59, 62, "GENE"]]}], ["The elevated levels of IL-17 and IL-23 might indicate that Th17 cells are implicated in the persistent neutrophil infiltration in CF lung disease and chronic infection with P. aeruginosa .", {"entities": [[133, 145, "DISEASE"]]}], ["Selectin mediated tethering represents one of the earliest steps in T cell extravasation into lymph nodes via high endothelial venules and is dependent on the biosynthesis of sialyl Lewis X (sLe To understand how loss of selectin ligands (sLe Taken together, our results suggest that impaired T cell entry into lymph nodes via high endothelial venules due to genetic deficiency of selectin ligands results in the selective re-distribution and accumulation of T cells in non-lymphoid organs, and correlates with their increased frequency in the blood.", {"entities": []}], ["Re-distribution of T cells into organs could potentially play a role in the initiation of T cell mediated organ diseases.", {"entities": []}], ["Network analysis is a common approach for the study of genetic view of diseases and biological pathways.", {"entities": []}], ["Typically, when a set of genes are identified to be of interest in relation to a disease, say through a genome wide association study (GWAS) or a different gene expression study, these genes are typically analyzed in the context of their protein-protein interaction (PPI) networks.", {"entities": []}], ["Further analysis is carried out to compute the enrichment of known pathways and disease-associations in the network.", {"entities": []}], ["Having tools for such analysis at the fingertips of biologists without the requirement for computer programming or curation of data would accelerate the characterization of genes of interest.", {"entities": []}], ["Currently available tools do not integrate network and enrichment analysis and their visualizations, and most of them present results in formats not most conducive to human cognition.", {"entities": []}], ["We developed the tool Lens for Enrichment and Network Studies of human proteins (LENS) that performs network and pathway and diseases enrichment analyses on genes of interest to users.", {"entities": []}], ["The tool creates a visualization of the network, provides easy to read statistics on network connectivity, and displays Venn diagrams with statistical significance values of the network's association with drugs, diseases, pathways, and GWASs.", {"entities": []}], ["We used the tool to analyze gene sets related to craniofacial development, autism, and schizophrenia.", {"entities": [[87, 100, "DISEASE"]]}], ["LENS is a web-based tool that does not require and download or plugins to use.", {"entities": []}], ["The tool is free and does not require login for use, and is available at http://severus.dbmi.pitt.edu/LENS .", {"entities": []}], ["The epidermis is a dynamic tissue in which keratinocytes proliferate in the basal layer and undergo a tightly controlled differentiation while moving into the suprabasal layers.", {"entities": []}], ["The balance between keratinocyte proliferation, differentiation, and death is essential, and its perturbation can result in pathological changes.", {"entities": []}], ["Some common skin diseases, such as psoriasis, are characterized by hyperproliferation accompanied by inflammatory reactions, suggesting that molecules with topical anti-inflammatory and ROS scavenging abilities may be useful for their treatment.", {"entities": [[35, 44, "DISEASE"]]}], ["Here we investigate the potential of the flavone Luteolin-7-glucoside (LUT-7G) as a treatment for psoriasis.", {"entities": [[98, 107, "DISEASE"]]}], ["We show that LUT-7G leads to a modification of the cell cycle and the induction of keratinocyte differentiation, with modification of energy, fatty acid, and redox metabolism.", {"entities": []}], ["LUT-7G treatment also neutralizes the proliferative stimulus induced by the proinflammatory cytokines IL-22 and IL-6 in HEKn.", {"entities": []}], ["Moreover, in the Imiquimod (IMQ) mouse model of psoriasis, topical administration of LUT-7G leads to a marked reduction of acanthosis and re-expression of epidermal differentiation markers.", {"entities": [[48, 57, "DISEASE"]]}], ["Dissection of the IL-22 signalling pathway, activated by IMQ treatment, demonstrates that LUT-7G impairs the nuclear translocation of phosphorylated (activated) STAT3, blocking the IL-22 signalling cascade.", {"entities": [[161, 166, "GENE"]]}], ["Thus LUT-7G appears to be a promising compound for the treatment of hyperproliferative and inflammatory skin diseases, such as psoriasis.", {"entities": [[127, 136, "DISEASE"]]}], ["Combination therapy with two antimicrobial agents is superior to monotherapy in severe community-acquired pneumonia, and recent data suggest that addition of a macrolide as the second antibiotic might be superior to other combinations.", {"entities": [[106, 115, "DISEASE"]]}], ["This observation requires confirmation in a randomised control trial, but this group of antibiotics have pleiotropic effects that extend beyond bacterial killing.", {"entities": []}], ["Macrolides inhibit bacterial cell-to-cell communication or quorum sensing, which not only might be an important mechanism of action for these drugs in severe infections but may also provide a novel target for the development of new anti-infective drugs.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) mortality has been steadily increasing in Taiwan since 2009.", {"entities": []}], ["In order to understand where the hotspot areas are and what the local risk factors are, we integrated an ecological and a case-control study.", {"entities": []}], ["We used a two-stage approach to identify hotspots and explore the possible risk factors for developing COPD.", {"entities": []}], ["The first stage used the annual township COPD mortality from 2000 to 2012 and applied the retrospective space-time scan statistic to calculate the local relative risks in each township.", {"entities": []}], ["In the second stage, we conducted a case-control study, recruiting 200 patients from one local hospital within the one identified hotspot area located in southern Taiwan.", {"entities": []}], ["Logistic regression was applied for analyzing the personal risk factors of COPD.", {"entities": []}], ["The univariate analyses showed that higher percentages of aborigines, patients with tuberculosis (TB) history, and those with smoking history had COPD ( p < 0.05).", {"entities": [[84, 96, "DISEASE"]]}], ["After controlling for demographic variables, aboriginal status (adjusted odds ratios (AORs): 3.01, 95% CI: 1.52\u20135.93) and smoking history (AORs: 2.64, 95% CI: 1.46\u20134.76) were still the two significant risk factors.", {"entities": []}], ["This two-stage approach might be beneficial to examine and cross-validate the findings from an aggregate to an individual scale, and can be easily extended to other chronic diseases.", {"entities": []}], ["Homeless persons experience a high burden of health problems; yet, they face significant barriers in accessing health care.", {"entities": []}], ["Less is known about unmet needs for care among vulnerably housed persons who live in poor-quality or temporary housing and are at high risk of becoming homeless.", {"entities": []}], ["The objectives of this study were to examine the prevalence of and factors associated with unmet needs for health care in a population-based sample of homeless and vulnerably housed adults in three major cities within a universal health insurance system.", {"entities": []}], ["Participants were recruited at shelters, meal programs, community health centers, drop-in centers, rooming houses, and single room occupancy hotels in Vancouver, Toronto, and Ottawa, Canada, throughout 2009.", {"entities": []}], ["Baseline interviews elicited demographic characteristics, health status, and barriers to health care.", {"entities": []}], ["Logistic regression was used to identify factors associated with self-reported unmet needs for health care in the past 12\u00a0months.", {"entities": []}], ["Of the 1,181 participants included in the analysis, 445 (37%) reported unmet needs.", {"entities": []}], ["In adjusted analyses, factors associated with a greater odds of reporting unmet needs were having employment in the past 12\u00a0months (AOR\u2009=\u20091.40, 95% CI\u2009=\u20091.03\u20131.91) and having \u22653 chronic health conditions (AOR\u2009=\u20092.17, 95% CI\u2009=\u20091.24\u20133.79).", {"entities": []}], ["Having higher health-related quality of life (AOR\u2009=\u20090.21, 95% CI\u2009=\u20090.09\u20130.53), improved mental (AOR\u2009=\u20090.97, 95% CI\u2009=\u20090.96\u20130.98) or physical health (AOR\u2009=\u20090.98, 95% CI\u2009=\u20090.96\u20130.99), and having a primary care provider (AOR\u2009=\u20090.63, 95% CI\u2009=\u20090.46\u20130.85) decreased the odds of reporting unmet needs.", {"entities": []}], ["Homeless and vulnerably housed adults have a similar likelihood of experiencing unmet health care needs.", {"entities": []}], ["Strategies to improve access to primary care and reduce barriers to accessing care in these populations are needed.", {"entities": []}], ["The mechanisms by which viruses cause asthma exacerbations are not precisely known.", {"entities": [[38, 44, "DISEASE"]]}], ["Previously, we showed that, in ovalbumin (OVA)-sensitized and -challenged mice with allergic airway inflammation, rhinovirus (RV) infection increases type 2 cytokine production from alternatively-activated (M2) airway macrophages, enhancing eosinophilic inflammation and airways hyperresponsiveness.", {"entities": []}], ["In this paper, we tested the hypothesis that IL-4 signaling determines the state of macrophage activation and pattern of RV-induced exacerbation in mice with allergic airways disease.", {"entities": []}], ["Eight week-old wild type or IL-4 receptor knockout (IL-4R KO) mice were sensitized and challenged with OVA and inoculated with RV1B or sham HeLa cell lysate.", {"entities": []}], ["In contrast to OVA-treated wild-type mice with both neutrophilic and eosinophilic airway inflammation, OVA-treated IL-4R KO mice showed increased neutrophilic inflammation with few eosinophils in the airways.", {"entities": []}], ["Like wild-type mice, IL-4R KO mice showed OVA-induced airway hyperreactivity which was further exacerbated by RV.", {"entities": []}], ["There was a shift in lung cytokines from a type 2-predominant response to a type 1 response, including production of IL-12p40 and TNF-\u03b1.", {"entities": []}], ["IL-17A was also increased.", {"entities": []}], ["RV infection of OVA-treated IL-4R KO mice further increased neutrophilic inflammation.", {"entities": []}], ["Bronchoalveolar macrophages showed an M1 polarization pattern and ex vivo RV infection increased macrophage production of TNF-\u03b1, IFN-\u03b3 and IL-12p40.", {"entities": []}], ["Finally, lung cells from OVA-treated IL-4R KO mice showed reduced CD206+ CD301+ M2 macrophages, decreased IL-13 and increased TNF-\u03b1 and IL-17A production by F4/80+, CD11b+\u2009macrophages.", {"entities": []}], ["OVA-treated IL-4R KO mice show neutrophilic airway inflammation constituting a model of allergic, type 1 cytokine-driven neutrophilic asthma.", {"entities": [[134, 140, "DISEASE"]]}], ["In the absence of IL-4/IL-13 signaling, RV infection of OVA-treated mice increased type 1 cytokine and IL-17A production from conventionally-activated macrophages, augmenting neutrophilic rather than eosinophilic inflammation.", {"entities": []}], ["In mice with allergic airways inflammation, IL-4R signaling determines macrophage activation state and the response to subsequent RV infection.", {"entities": []}], ["The anti-inflammatory pharmacological effect of eight 2-phenylnaphthalenes ( PNAP - 1 \u2212 PNAP - 8 ) on lipopolysaccharide (LPS)-induced RAW 264.7 (a mouse cell line) was investigated.", {"entities": []}], ["Among them, 6,7-dihydroxy-2-(4\u2032-hydroxyphenyl)naphthalene ( PNAP - 6 ) and 2-(4\u2032-aminophenyl)-6,7-dimethoxynaphthalene ( PNAP - 8 ) exhibited the best anti-inflammatory activity in this study.", {"entities": []}], ["PNAP - 6 and PNAP - 8 not only significantly decreased the expression of inducible nitric oxide synthase and cyclooxygenase-II, but also inhibited the production of nitric oxide, interleukin-6, and tumor necrosis factor-\u03b1 in LPS stimulated cells.", {"entities": []}], ["Moreover, PNAP - 6 and PNAP - 8 inhibited nuclear factor (NF)-\u03baB activation by decreasing the degradation of I\u03baB and nuclear translocation of NF-\u03baB subunit (p65).", {"entities": []}], ["In addition, PNAP - 6 and PNAP - 8 also attenuated the phosphorylation of ERK, p38, and JNK.", {"entities": []}], ["These results suggest that PNAP - 6 and PNAP - 8 exert anti-inflammatory activities by down regulating NF-\u03baB activation and the mitogen-activated protein kinase signaling pathway in LPS-stimulated Raw 264.7 cells.", {"entities": []}], ["This is the first study demonstrating that PNAPs can inhibit LPS-induced pro-inflammatory mediators in macrophages cells.", {"entities": []}], ["We have utilized a range of manufactured or commercial nanoparticulate materials, including surrogate carbon nano-PM along with combustion-generated carbonaceous (soot) nano-PM characteristic of environmental nano-PM (both indoor and outdoor) to investigate and compare their cytotoxic response in vitro with an immortalized human epithelial (lung model) cell line (A549).", {"entities": []}], ["These have included nano-Ag, Al 2 O 3 , TiO 2 , Fe 2 O 3 , ZrO 2 , Si 3 N 4 , chrysotile asbestos, BC, 2 types of MWCNT-aggregate PM (MWCNT-R and MWCNT-N), and high-volume glass fiber collected soots: candle, wood, diesel (truck), tire, and 3-types of natural gas kitchen burner-generated soots: yellow (fuel-rich) flame, low-flow blue flame, and normal flow blue flame soot PM.", {"entities": []}], ["These carbonaceous nano-PM species can be found in either the indoor and outdoor environments or microenvironments.", {"entities": []}], ["Two-day and two-week in-vitro cultures of A549 showed cell death (or decreased cell viability) for all nanoparticulate materials, but especially significant for all but the TiO 2 and candle, wood, and diesel PM.", {"entities": []}], ["The natural gas kitchen burner combustion PM cell death response was characteristic of BC and MWCNT PM.", {"entities": []}], ["There was no correlation with total PAH content of the soot PM.", {"entities": []}], ["Cytokine release (IL-6, IL-8) was detected for the Ag, Fe 2 O 3 , asbestos, BC and the MWCNT PM.", {"entities": []}], ["Reactive oxygen species (ROS) production was also detected for Ag, Fe 2 O 3 , ZrO 2 , asbestos, BC, and the MWCNT aggregate PM, as well as the natural gas kitchen burner combustion PM.", {"entities": []}], ["TEM, FESEM, and optical microscopy examination of these nanomaterials illustrate the wide range in PM morphologies and crystallinities as well as cell morphologies.", {"entities": []}], ["Taken together, these results illustrate proinflammatory and related respiratory health issues in relation to environmental nanoparticulates.", {"entities": []}], ["Peripheral arterial disease (PAD) is a common disease associated with a considerably increased risk of future cardiovascular events and most of these patients will die from coronary artery disease (CAD).", {"entities": []}], ["Screening for silent CAD has become an option with recent non-invasive developments in CT (computed tomography)-angiography and MR (magnetic resonance) stress testing.", {"entities": []}], ["Screening in combination with more aggressive treatment may improve prognosis.", {"entities": []}], ["Therefore we propose to study whether a cardiac imaging algorithm, using non-invasive imaging techniques followed by treatment will reduce the risk of cardiovascular disease in PAD patients free from cardiac symptoms.", {"entities": []}], ["The GROUND study is designed as a prospective, multi-center, randomized clinical trial.", {"entities": []}], ["Patients with peripheral arterial disease, but without symptomatic cardiac disease will be asked to participate.", {"entities": []}], ["All patients receive a proper risk factor management before randomization.", {"entities": []}], ["Half of the recruited patients will enter the 'control group' and only undergo CT calcium scoring.", {"entities": []}], ["The other half of the recruited patients (index group) will undergo the non invasive cardiac imaging algorithm followed by evidence-based treatment.", {"entities": []}], ["First, patients are submitted to CT calcium scoring and CT angiography.", {"entities": []}], ["Patients with a left main (or equivalent) coronary artery stenosis of > 50% on CT will be referred to a cardiologist without further imaging.", {"entities": []}], ["All other patients in this group will undergo dobutamine stress magnetic resonance (DSMR) testing.", {"entities": []}], ["Patients with a DSMR positive for ischemia will also be referred to a cardiologist.", {"entities": [[34, 42, "DISEASE"]]}], ["These patients are candidates for conventional coronary angiography and cardiac interventions (coronary artery bypass grafting (CABG) or percutaneous cardiac interventions (PCI)), if indicated.", {"entities": []}], ["All participants of the trial will enter a 5 year follow up period for the occurrence of cardiovascular events.", {"entities": []}], ["Sequential interim analysis will take place.", {"entities": []}], ["Based on sample size calculations about 1200 patients are needed to detect a 24% reduction in primary outcome.", {"entities": []}], ["The GROUND study will provide insight into the question whether non-invasive cardiac imaging reduces the risk of cardiovascular events in patients with peripheral arterial disease, but without symptoms of coronary artery disease.", {"entities": []}], ["Clinicaltrials.gov NCT00189111", {"entities": []}], ["Although in developing countries the burden of morbidity and mortality due to infectious diseases has often overshadowed that due to chronic non-communicable diseases (NCDs), there is evidence now of a shift of attention to NCDs.", {"entities": []}], ["Decreasing the chronic NCD burden requires a two-pronged approach: implementation of the multisectoral policies aimed at decreasing population-level risks for NCDs, and effective and affordable delivery of primary care interventions for patients with chronic NCDs.", {"entities": []}], ["The primary care response to common NCDs is often unstructured and inadequate.", {"entities": []}], ["We therefore propose a programmatic, standardized approach to the delivery of primary care interventions for patients with NCDs, with a focus on hypertension, diabetes mellitus, chronic airflow obstruction, and obesity.", {"entities": [[145, 157, "DISEASE"], [211, 218, "DISEASE"], [159, 176, "DISEASE"]]}], ["The benefits of this approach will extend to patients with related conditions, e.g.", {"entities": []}], ["those with chronic kidney disease caused by hypertension or diabetes.", {"entities": [[44, 56, "DISEASE"], [19, 33, "DISEASE"]]}], ["This framework for a \"public health approach\" is informed by experience of scaling up interventions for chronic infectious diseases (tuberculosis and HIV).", {"entities": [[133, 145, "DISEASE"]]}], ["The lessons learned from progress in rolling out these interventions include the importance of gaining political commitment, developing a robust strategy, delivering standardised interventions, and ensuring rigorous monitoring and evaluation of progress towards defined targets.", {"entities": []}], ["The goal of the framework is to reduce the burden of morbidity, disability and premature mortality related to NCDs through a primary care strategy which has three elements: 1) identify and address modifiable risk factors, 2) screen for common NCDs and 3) and diagnose, treat and follow-up patients with common NCDs using standard protocols.", {"entities": []}], ["The proposed framework for NCDs borrows the same elements as those developed for tuberculosis control, comprising a goal, strategy and targets for NCD control, a package of interventions for quality care, key operations for national implementation of these interventions (political commitment, case-finding among people attending primary care services, standardised diagnostic and treatment protocols, regular drug supply, and systematic monitoring and evaluation), and indicators to measure progress towards increasing the impact of primary care interventions on chronic NCDs.", {"entities": [[81, 93, "DISEASE"]]}], ["The framework needs evaluation, then adaptation in different settings.", {"entities": []}], ["A framework for a programmatic \"public health approach\" has the potential to improve on the current unstructured approach to primary care of people with chronic NCDs.", {"entities": []}], ["Research to establish the cost, value and feasibility of implementing the framework will pave the way for international support to extend the benefit of this approach to the millions of people worldwide with chronic NCDs.", {"entities": []}], ["Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are overlapping manifestations on a spectrum of acute drug-induced conditions associated with severe blistering, skin peeling, and multi-organ damage.", {"entities": [[16, 24, "DISEASE"]]}], ["TEN is an eruption resembling severe scalding, with \u226530% skin detachment.", {"entities": []}], ["SJS is a mild form of TEN, characterized histologically by epidermal keratinocyte apoptosis with dermo-epidermal separation and extensive small blisters with <10% body surface skin detachment.", {"entities": []}], ["The syndrome can be induced by numerous medications and typically occurs 1\u20134 weeks after the initiation of therapy.", {"entities": [[4, 12, "DISEASE"]]}], ["Granulysin is found in the lesions of patients with SJS/TEN and plays a significant pathogenic role in the condition, but the overall mechanisms linking medications, granulysin, and disease manifestations remain obscure.", {"entities": []}], ["This paper reviews evidence suggesting that the different medications implicated in SJS/TEN have the common property of interacting and synergizing with endogenous retinoids (vitamin A and its congeners), in many instances causing the latter to accumulate in and damage the liver, the main storage organ for vitamin A.", {"entities": []}], ["It is hypothesized that liver damage leads to the spillage of toxic retinoid compounds into the circulation, resulting in an endogenous form of hypervitaminosis A and cytotoxicity with widespread apoptosis, mediated by granulysin and recognized as SJS/TEN.", {"entities": []}], ["Subject to testing, the model suggests that symptom worsening could be arrested at onset by lowering the concentration of circulating retinoids and/or granulysin via phlebotomy or plasmapheresis or by pharmacological measures to limit their expression.", {"entities": []}], ["Early diagnostic and prognostic stratification of patients with suspected infection is a difficult clinical challenge.", {"entities": []}], ["We studied plasma pentraxin 3 (PTX3) upon admission to the emergency department in patients with suspected infection.", {"entities": [[31, 35, "GENE"]]}], ["The study comprised 537 emergency room patients with suspected infection: 59 with no systemic inflammatory response syndrome (SIRS) and without bacterial infection (group 1), 67 with bacterial infection without SIRS (group 2), 54 with SIRS without bacterial infection (group 3), 308 with sepsis (SIRS and bacterial infection) without organ failure (group 4) and 49 with severe sepsis (group 5).", {"entities": [[116, 124, "DISEASE"]]}], ["Plasma PTX3 was measured on admission using a commercial solid-phase enzyme-linked immunosorbent assay (ELISA).", {"entities": [[7, 11, "GENE"]]}], ["The median PTX3 levels in groups 1\u20135 were 2.6 ng/ml, 4.4 ng/ml, 5.0 ng/ml, 6.1 ng/ml and 16.7 ng/ml, respectively (p<0.001).", {"entities": [[11, 15, "GENE"]]}], ["The median PTX3 concentration was higher in severe sepsis patients compared to others (16.7 vs. 4.9 ng/ml, p<0.001) and in non-survivors (day 28 case fatality) compared to survivors (14.1 vs. 5.1 ng/ml, p<0.001).", {"entities": [[11, 15, "GENE"]]}], ["A high PTX3 level predicted the need for ICU stay (p<0.001) and hypotension (p<0.001).", {"entities": [[7, 11, "GENE"]]}], ["AUC A high PTX3 level on hospital admission predicts severe sepsis and case fatality in patients with suspected infection.", {"entities": [[11, 15, "GENE"]]}], ["A recent study revealed that ES (embryonic stem) cell lines derived from the 129 murine strain carry an inactivating mutation within the caspase 11 gene ( Casp4 ) locus [Kayagaki, Warming, Lamkanfi, Vande Walle, Louie, Dong, Newton, Qu, Liu, Heldens, Zhang, Lee, Roose-Girma and Dixit (2011) Nature 479 , 117\u2013121].", {"entities": [[155, 160, "GENE"]]}], ["Thus, if 129 ES cells are used to target genes closely linked to caspase 11, the resulting mice might also carry the caspase 11 deficiency as a passenger mutation.", {"entities": []}], ["In the present study, we examined the genetic loci of mice targeted for the closely linked c-IAP (cellular inhibitor of apoptosis) genes, which were generated in 129 ES cells, and found that, despite extensive backcrossing into a C57BL/6 background, c-IAP1", {"entities": []}], ["Cecropia pachystachya is a species traditionally used in Brazil to treat inflammation.", {"entities": []}], ["This work aims to evaluate the topical anti-inflammatory and antioxidant activities of the methanolic extract of C. pachystachya (CPM) and to perform its chemical fingerprint by HPLC-DAD.", {"entities": [[130, 133, "GENE"]]}], ["The topical anti-inflammatory activity was evaluated using the mouse models of acute ear inflammation induced by croton oil, arachidonic acid, capsaicin, EPP, phenol, and chronic inflammation induced by multiple application of croton oil.", {"entities": []}], ["The in vitro antioxidant effect of CPM was investigated using DPPH, reducing power, \u03b2 -carotene bleaching, and TBARS assays.", {"entities": [[35, 38, "GENE"]]}], ["HPLC analysis was performed to quantify the antioxidant phenolics orientin, isoorientin, and chlorogenic acid previously identified in CPM.", {"entities": [[135, 138, "GENE"]]}], ["CPM exhibited significant anti-inflammatory effect in the acute models, in some cases comparable to the reference drugs.", {"entities": [[0, 3, "GENE"]]}], ["Histopathological analysis showed a moderate chronic skin anti-inflammatory effect with decrease in vasodilation, edema, cell infiltration, and epidermal hyperproliferation.", {"entities": []}], ["It also showed strong in vitro antioxidant activity.", {"entities": []}], ["The contents of orientin, isoorientin, and chlorogenic acid were 66.5\u2009\u00b1\u20091.8, 118.8\u2009\u00b1\u20090.7, and 5.4\u2009\u00b1\u20090.2\u2009\u00b5g/mg extract, respectively.", {"entities": []}], ["The topical anti-inflammatory activity of CPM could be based on its antioxidant properties, although other effects are probably involved, including COX inhibition and other mechanisms.", {"entities": [[42, 45, "GENE"]]}], ["Background : Evidence supports the use of pricing interventions in achieving healthier behaviour at population level.", {"entities": []}], ["The public acceptability of this strategy continues to be debated throughout Europe, Australasia and USA.", {"entities": []}], ["We examined public attitudes towards, and beliefs about the acceptability of pricing policies to change health-related behaviours in the UK.", {"entities": []}], ["The study explores what underlies ideas of acceptability, and in particular those values and beliefs that potentially compete with the evidence presented by policy-makers.", {"entities": []}], ["Methods : Twelve focus group discussions were held in the London area using a common protocol with visual and textual stimuli.", {"entities": []}], ["Over 300 000 words of verbatim transcript were inductively coded and analyzed, and themes extracted using a constant comparative method.", {"entities": []}], ["Results : Attitudes towards pricing policies to change three behaviours (smoking, and excessive consumption of alcohol and food) to improve health outcomes, were unfavourable and acceptability was low.", {"entities": []}], ["Three sets of beliefs appeared to underpin these attitudes: (i) pricing makes no difference to behaviour; (ii) government raises prices to generate income, not to achieve healthier behaviour and (iii) government is not trustworthy.", {"entities": []}], ["These beliefs were evident in discussions of all types of health-related behaviour.", {"entities": []}], ["Conclusions : The low acceptability of pricing interventions to achieve healthier behaviours in populations was linked among these responders to a set of beliefs indicating low trust in government.", {"entities": []}], ["Acceptability might be increased if evidence regarding effectiveness came from trusted sources seen as independent of government and was supported by public involvement and hypothecated taxation.", {"entities": []}], ["Previous studies have reported discrepancies in cause-specific mortality among groups of individuals with different socio-economic status.", {"entities": []}], ["However, most of the studies were limited by the specificity of the investigated populations and the broad definitions of the causes of death.", {"entities": []}], ["The aim of the present population-based study was to explore the dependence of disease specific mortalities on the socio-economic status in Sweden, a country with universal health care.", {"entities": []}], ["Another aim was to investigate possible gender differences.", {"entities": []}], ["Using the 2006 update of the Swedish Family-Cancer Database, we identified over 2 million individuals with socio-economic data recorded in the 1960 national census.", {"entities": [[44, 50, "DISEASE"]]}], ["The association between mortality and socio-economic status was investigated by Cox's proportional hazards models taking into account the age, time period and residential area in both men and women, and additionally parity and age at first birth in women.", {"entities": []}], ["We observed significant associations between socio-economic status and mortality due to cardiovascular diseases, respiratory diseases, to cancer and to endocrine, nutritional and metabolic diseases.", {"entities": [[138, 144, "DISEASE"]]}], ["The influence of socio-economic status on female breast cancer was markedly specific: women with a higher socio-economic status showed increased mortality due to breast cancer.", {"entities": [[42, 62, "DISEASE"], [49, 62, "DISEASE"], [162, 175, "DISEASE"], [56, 62, "DISEASE"], [169, 175, "DISEASE"]]}], ["Even in Sweden, a country where health care is universally provided, higher socio-economic status is associated with decreased overall and cause-specific mortalities.", {"entities": []}], ["Comparison of mortality among female and male socio-economic groups may provide valuable insights into the underlying causes of socio-economic inequalities in length of life.", {"entities": []}], ["For EPs-7630, a herbal drug preparation from Pelargonium sidoides roots, therapeutic effects in respiratory tract infections outside the strict indication for antibiotics have already been demonstrated in adults.", {"entities": []}], ["Now, a dose-finding study for EPs-7630 was performed in children and adolescents.", {"entities": []}], ["A total of 400 patients (aged 6\u201318 years) were randomized to receive either 30 mg, 60 mg or 90 mg EPs-7630 or placebo daily.", {"entities": []}], ["Primary outcome criterion was the change in the Bronchitis Severity Score (BSS) from day 0 to day 7.", {"entities": [[48, 58, "DISEASE"]]}], ["After 7 days of treatment, the change in the BSS total score was significantly better in the 60 mg and 90 mg groups compared with placebo that of the without relevant differences between these two dosages.", {"entities": []}], ["Especially \u2018coughing\u2019, \u2018sputum\u2019 and \u2018rales at auscultation\u2019 improved under EPs-7630.", {"entities": []}], ["Onset of effect was faster, time of bed rest shorter and treatment outcome and satisfaction with treatment were rated better.", {"entities": []}], ["Tolerability was comparable with placebo in all treatment groups.", {"entities": []}], ["EPs-7630 is effective in acute bronchitis outside the strict indication for antibiotics in 6\u201318 years old patients, with a dose of 60 mg or 90 mg daily offering the best benefit/risk ratio.", {"entities": [[31, 41, "DISEASE"]]}], ["EPs-7630 significantly reduces the severity of symptoms, leads to a more favourable course of the disease and a faster recovery from acute bronchitis compared with the placebo, and is well tolerated.", {"entities": [[139, 149, "DISEASE"]]}], ["This study reflects on the development and teaching of communication skills courses in additional national languages to health care staff within two primary health care facilities in Cape Town, South Africa.", {"entities": []}], ["These courses were aimed at addressing the language disparities that recent research has identified globally between patients and health care staff.", {"entities": []}], ["Communication skills courses were offered to staff at two Metropolitan District Health Services clinics to strengthen patient access to health care services.", {"entities": []}], ["This study reflects on the communicative proficiency in the additional languages that were offered to health care staff.", {"entities": []}], ["A mixed-method approach was utilised during this case study with quantitative data-gathering through surveys and qualitative analysis of assessment results.", {"entities": []}], ["The language profiles of the respective communities were assessed through data obtained from the South African National census, while staff language profiles were obtained at the health care centres.", {"entities": []}], ["Quantitative measuring, by means of a patient survey at the centres, occurred on a randomly chosen day to ascertain the language profile of the patient population.", {"entities": []}], ["Participating staff performed assessments at different phases of the training courses to determine their skill levels by the end of the course.", {"entities": []}], ["The performances of the participating staff during the Xhosa and Afrikaans language courses were assessed, and the development of the staff communicative competencies was measured.", {"entities": []}], ["Health care staff learning the additional languages could develop Basic or Intermediate Xhosa and Afrikaans that enables communication with patients.", {"entities": []}], ["In multilingual countries such as South Africa, language has been recognised as a health care barrier preventing patients from receiving quality care.", {"entities": []}], ["Equipping health care staff with communication skills in the additional languages, represents an attempt to bridge a vital barrier in the South African health care system.", {"entities": []}], ["The study proves that offering communication skills courses in additional languages, begins to equip health care staff to be multilingual, that allows patients to communicate about their illnesses within their mother tongues.", {"entities": []}], ["Despite their growing popularity, the potential respiratory toxicity of electronic cigarettes (e-cigarettes) remains largely unknown.", {"entities": []}], ["One potential aspect of e-cigarette toxicity is the effect of e-cigarette vapor on lung surfactant function.", {"entities": []}], ["Lung surfactant is a mixture of lipids and proteins that lines the alveolar region.", {"entities": []}], ["The surfactant layer reduces the surface tension of the alveolar fluid, thereby playing a crucial role in lung stability.", {"entities": []}], ["Due to their small size, particulates in e-cigarette vapor can penetrate the deep lungs and come into contact with the lung surfactant.", {"entities": []}], ["The current study sought to examine the potential adverse effects of e-cigarette vapor and conventional cigarette smoke on lung surfactant interfacial properties.", {"entities": []}], ["Infasurf E-cigarette vapor regardless of the dose and flavoring of the e-liquid did not affect surfactant interfacial properties.", {"entities": []}], ["In contrast, smoke from conventional cigarettes had a drastic, dose-dependent effect on Infasurf While both e-cigarette vapor and conventional cigarette smoke affect surfactant lateral structure, only cigarette smoke disrupts surfactant interfacial properties.", {"entities": []}], ["The surfactant inhibitory compound in conventional cigarettes is tar, which is a product of burning and is thus absent in e-cigarette vapor.", {"entities": []}], ["There is an increasing interest in cognitive and functional outcomes in the respective stages of Alzheimer\u2019s disease (AD) and in novel therapies particularly for the milder phases of AD.", {"entities": []}], ["Our aim was to describe and compare various aspects of disease progression in patients with mild versus moderate AD in routine clinical practice of cholinesterase inhibitor (ChEI) therapy.", {"entities": []}], ["This 3-year, prospective, observational, multicentre study included 1021 participants.", {"entities": []}], ["Of these, 734 had mild AD (Mini-Mental State Examination (MMSE) score, 20\u201326) and 287 had moderate AD (MMSE score, 10\u201319) at the start of ChEI treatment.", {"entities": []}], ["At baseline and every 6\u00a0months, patients were assessed using cognitive, global, instrumental and basic activities of daily living (ADL) scales.", {"entities": []}], ["Potential predictors of deterioration in moderate AD were analysed using mixed-effects models.", {"entities": []}], ["The change from baseline between participants with mild and moderate stages of AD after 3\u00a0years of ChEI therapy differed significantly on the Alzheimer\u2019s Disease Assessment Scale-cognitive subscale (ADAS-cog) and basic ADL, but not using the MMSE and instrumental ADL scales.", {"entities": []}], ["Protective independent factors for better cognitive long-term outcome in the group with moderate AD were older age, higher instrumental ADL ability, no antipsychotics, usage of non-steroidal anti-inflammatory drugs/acetylsalicylic acid, living with family member, lower education and a higher mean dose of ChEI.", {"entities": []}], ["Apolipoprotein E genotype did not influence the rates of disease progression or the longitudinal outcomes.", {"entities": []}], ["Prediction models were provided for moderate AD.", {"entities": []}], ["More sensitive cognitive measures, such as the ADAS-cog scale, are required to detect a possibly faster deterioration among the participants with moderate AD.", {"entities": []}], ["This study highlighted the clinical importance of instrumental ADL evaluations in patients at a mild stage of AD, and the importance of optimizing the ChEI dose even for individuals with moderate AD.", {"entities": []}], ["Solitary living was a risk factor for faster cognitive decline, and probably expanded the need for formal care in the group with moderate AD.", {"entities": []}], ["The patients with more advanced AD and presumably more pronounced neuroinflammation might have additional cognitive benefits from longer-term treatment with anti-inflammatory drugs.", {"entities": []}], ["Spatial control of G-protein-coupled receptor (GPCR) signaling, which is used by cells to translate complex information into distinct downstream responses, is achieved by using plasma membrane (PM) and endocytic-derived signaling pathways.", {"entities": []}], ["The roles of the endomembrane in regulating such pleiotropic signaling via multiple G-protein pathways remain unknown.", {"entities": []}], ["Here, we investigated the effects of disease-causing mutations of the adaptor protein-2 \u03c3 subunit (AP2\u03c3) on signaling by the class C GPCR calcium-sensing receptor (CaSR).", {"entities": [[164, 168, "GENE"]]}], ["These AP2\u03c3 mutations increase CaSR PM expression yet paradoxically reduce CaSR signaling.", {"entities": [[30, 34, "GENE"], [74, 78, "GENE"], [30, 34, "GENE"], [74, 78, "GENE"]]}], ["Hypercalcemia-associated AP2\u03c3 mutations reduced CaSR signaling via\u00a0G\u03b1 q/11 and G\u03b1 i/o pathways.", {"entities": [[0, 13, "DISEASE"], [48, 52, "GENE"]]}], ["The mutations also delayed CaSR internalization due to prolonged residency time of CaSR in\u00a0clathrin structures that\u00a0impaired or abolished endosomal signaling, which was predominantly mediated by G\u03b1 q/11 .", {"entities": [[27, 31, "GENE"], [83, 87, "GENE"], [27, 31, "GENE"], [83, 87, "GENE"]]}], ["Thus, compartmental bias for CaSR-mediated G\u03b1 q/11 endomembrane signaling provides a mechanistic basis for multidimensional GPCR signaling.", {"entities": []}], ["\u2022 Disease-causing AP2\u03c3 mutants impair G\u03b1 q/11 and G\u03b1 i/o signaling by CaSR, a class C GPCR \u2022 AP2\u03c3 mutants impair trafficking of the CaSR \u2022 The CaSR can signal by a sustained endosomal pathway \u2022 CaSR differentially uses G\u03b1 q/11 and G\u03b1 i/o for cell-surface and endosomal signaling Disease-causing AP2\u03c3 mutants impair G\u03b1 q/11 and G\u03b1 i/o signaling by CaSR, a class C GPCR AP2\u03c3 mutants impair trafficking of the CaSR The CaSR can signal by a sustained endosomal pathway CaSR differentially uses G\u03b1 q/11 and G\u03b1 i/o for cell-surface and endosomal signaling Gorvin et\u00a0al.", {"entities": [[70, 74, "GENE"], [132, 136, "GENE"], [143, 147, "GENE"], [194, 198, "GENE"], [347, 351, "GENE"], [407, 411, "GENE"], [416, 420, "GENE"], [465, 469, "GENE"], [70, 74, "GENE"], [132, 136, "GENE"], [143, 147, "GENE"], [194, 198, "GENE"], [347, 351, "GENE"], [407, 411, "GENE"], [416, 420, "GENE"], [465, 469, "GENE"], [70, 74, "GENE"], [132, 136, "GENE"], [143, 147, "GENE"], [194, 198, "GENE"], [347, 351, "GENE"], [407, 411, "GENE"], [416, 420, "GENE"], [465, 469, "GENE"], [70, 74, "GENE"], [132, 136, "GENE"], [143, 147, "GENE"], [194, 198, "GENE"], [347, 351, "GENE"], [407, 411, "GENE"], [416, 420, "GENE"], [465, 469, "GENE"], [70, 74, "GENE"], [132, 136, "GENE"], [143, 147, "GENE"], [194, 198, "GENE"], [347, 351, "GENE"], [407, 411, "GENE"], [416, 420, "GENE"], [465, 469, "GENE"], [70, 74, "GENE"], [132, 136, "GENE"], [143, 147, "GENE"], [194, 198, "GENE"], [347, 351, "GENE"], [407, 411, "GENE"], [416, 420, "GENE"], [465, 469, "GENE"], [70, 74, "GENE"], [132, 136, "GENE"], [143, 147, "GENE"], [194, 198, "GENE"], [347, 351, "GENE"], [407, 411, "GENE"], [416, 420, "GENE"], [465, 469, "GENE"], [70, 74, "GENE"], [132, 136, "GENE"], [143, 147, "GENE"], [194, 198, "GENE"], [347, 351, "GENE"], [407, 411, "GENE"], [416, 420, "GENE"], [465, 469, "GENE"]]}], ["show that the class C GPCR calcium-sensing receptor (CaSR) mediates signaling from plasma membranes using G\u03b1 q/11 and G\u03b1 i/o and from endosomes by using only G\u03b1 q/11 .", {"entities": [[53, 57, "GENE"]]}], ["Adaptor protein-2 \u03c3 subunit (AP2\u03c3) mutations impair CaSR internalization, leading to reduced sustained endosomal signaling and hypercalcemia in humans.", {"entities": [[127, 140, "DISEASE"], [52, 56, "GENE"]]}], ["The relationship between spirituality, religion and medicine has been recognized since antiquity.", {"entities": []}], ["Despite large differences in their history, society, economy and cultures human communities shared a common belief that spirituality and religion played an important role in the healing of diseases.", {"entities": []}], ["The study of religious remedies used by Italian folk medicine in order to treat diseases was based on a review of literature sources compiled between the late nineteenth century and the early to mid twentieth century.", {"entities": []}], ["This approach lead to the unearthing of heterogeneous healing methods that have been divided into different categories: Saints, Pilgrimages, Holy Water/Blessed Oil, Blessings, Religious Objects, Contact, Signs, Formulas and The Religious Calendar.", {"entities": []}], ["Some of these practices, partly still performed in Italy, are a part of the landscape of the official Catholic Church, others come out of a process of syncretism between the Catholic Religion, the magic world and pre-Christian rituals.", {"entities": []}], ["The vastus corpus of religious remedies, highlighted in the present work, shows the need for spirituality of the sick and represent a symbolic framework, that works as a filter, mediates, containing the pain that constantly fills everyone\u2019s lives in remote ages even in the third millennium.", {"entities": []}], ["All of this confirms how important the health-workers know and interpret these existential needs from anthropological and psychological points of view.", {"entities": []}], ["Observational studies suggest high prenatal vitamin D intake may be associated with reduced childhood wheezing.", {"entities": []}], ["We examined the effect of prenatal vitamin D on childhood wheezing in an interventional study.", {"entities": []}], ["We randomised 180 pregnant women at 27 weeks gestation to either no vitamin D, 800 IU ergocalciferol daily until delivery or single oral bolus of 200,000 IU cholecalciferol, in an ethnically stratified, randomised controlled trial.", {"entities": []}], ["Supplementation improved but did not optimise vitamin D status.", {"entities": []}], ["Researchers blind to allocation assessed offspring at 3 years.", {"entities": []}], ["Primary outcome was any history of wheeze assessed by validated questionnaire.", {"entities": []}], ["Secondary outcomes included atopy, respiratory infection, impulse oscillometry and exhaled nitric oxide.", {"entities": []}], ["Primary analyses used logistic and linear regression.", {"entities": []}], ["We evaluated 158 of 180 (88%) offspring at age 3 years for the primary outcome.", {"entities": []}], ["Atopy was assessed by skin test for 95 children (53%), serum IgE for 86 (48%), exhaled nitric oxide for 62 (34%) and impulse oscillometry of acceptable quality for 51 (28%).", {"entities": []}], ["We found no difference between supplemented and control groups in risk of wheeze [no vitamin D: 14/50 (28%); any vitamin D: 26/108 (24%) (risk ratio 0.86; 95% confidence interval 0.49, 1.50; P\u200a=\u200a0.69)].", {"entities": []}], ["There was no significant difference in atopy, eczema risk, lung function or exhaled nitric oxide between supplemented groups and controls.", {"entities": []}], ["Prenatal vitamin D supplementation in late pregnancy that had a modest effect on cord blood vitamin D level, was not associated with decreased wheezing in offspring at age three years.", {"entities": []}], ["Controlled-Trials.com ISRCTN68645785", {"entities": []}], ["Macrophages are involved in low-grade inflammation in diabetes, and play pathogenic roles in proliferative diabetic retinopathy (PDR) by producing proinflammatory cytokines.", {"entities": [[107, 127, "DISEASE"], [93, 127, "DISEASE"]]}], ["T cells as well as other cells are also activated by proinflammatory cytokines, and infiltration into the vitreous of patients with PDR has been shown.", {"entities": []}], ["In this study, we measured helper T (Th) cell-related cytokines in the vitreous of PDR patients to define the characteristics of Th-mediated immune responses associated with PDR.", {"entities": []}], ["The study group consisted of 25 type 2 diabetic patients (25 eyes) with PDR.", {"entities": []}], ["The control group consisted of 27 patients with epiretinal membrane (ERM), 26 patients with idiopathic macular hole (MH), and 26 patients with uveitis associated with sarcoidosis.", {"entities": [[167, 178, "DISEASE"], [143, 150, "DISEASE"]]}], ["Vitreous fluid was obtained at the beginning of vitrectomy, and centrifuging for cellular removals was not performed.", {"entities": []}], ["Serum was also collected from PDR patients.", {"entities": []}], ["IL-1\u03b2, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, IFN-\u03b3, soluble sCD40L, and TNF\u03b1 in the vitreous and serum samples were measured.", {"entities": []}], ["Both percent detectable and levels of IL-4, IL-6, IL-17A, IL-21, IL-22, and TNF\u03b1 in the vitreous were significantly higher than those in the serum in PDR patients.", {"entities": []}], ["Vitreous levels of these cytokines and IL-31 were significantly higher in PDR than in ERM or MH patients.", {"entities": []}], ["Vitreous levels of IL-4, IL-17A, IL-22, IL-31, and TNF\u03b1 in PDR patients were also significantly higher than those of sarcoidosis patients.", {"entities": [[117, 128, "DISEASE"]]}], ["In PDR patients, vitreous IL-17A level correlated significantly with vitreous levels of IL-22 and IL-31, and especially with IL-4 and TNF\u03b1.", {"entities": []}], ["Although it is unclear whether these cytokines play facilitative roles or inhibitory roles for the progression of PDR, the present study indicated that Th2- and Th17-related immune responses are involved in the pathogenesis of PDR.", {"entities": []}], ["To analyze the temporal evolution of the hospitalization of older adults due to ambulatory care sensitive conditions according to their structure, magnitude and causes.", {"entities": []}], ["Cross-sectional study based on data from the Hospital Information System of the Brazilian Unified Health System and from the Primary Care Information System, referring to people aged 60 to 74 years living in the state of Rio de Janeiro, Souhteastern Brazil.", {"entities": []}], ["The proportion and rate of hospitalizations due to ambulatory care sensitive conditions were calculated, both the global rate and, according to diagnoses, the most prevalent ones.", {"entities": []}], ["The coverage of the Family Health Strategy and the number of medical consultations attended by older adults in primary care were estimated.", {"entities": []}], ["To analyze the indicators\u2019 impact on hospitalizations, a linear correlation test was used.", {"entities": []}], ["We found an intense reduction in hospitalizations due to ambulatory care sensitive conditions for all causes and age groups.", {"entities": []}], ["Heart failure, cerebrovascular diseases and chronic obstructive pulmonary diseases concentrated 50.0% of the hospitalizations.", {"entities": []}], ["Adults older than 69 years had a higher risk of hospitalization due to one of these causes.", {"entities": []}], ["We observed a higher risk of hospitalization among men.", {"entities": []}], ["A negative correlation was found between the hospitalizations and the indicators of access to primary care.", {"entities": []}], ["Primary healthcare in the state of Rio de Janeiro has been significantly impacting the hospital morbidity of the older population.", {"entities": []}], ["Studies of hospitalizations due to ambulatory care sensitive conditions can aid the identification of the main causes that are sensitive to the intervention of the health services, in order to indicate which actions are more effective to reduce hospitalizations and to increase the population\u2019s quality of life.", {"entities": []}], ["Adherence is vital for an effective antiretroviral treatment.", {"entities": []}], ["This cross-sectional study explored social and psychosocial factors associated with adherence among adolescents with perinatal human immunodeficiency virus type 1 infection in Panama from a gender perspective.", {"entities": []}], ["A questionnaire developed for the study was applied to 38 adolescent patients (20 female, 18 male; median age, 14 years).", {"entities": []}], ["Thirty-two patients (86%; one missing response) still depended on an adult to remember taking their medication, among whom 28 relied on a female relative.", {"entities": []}], ["Although 18 (47%) patients reported to become ill no more than once a year, only 10 (26%) patients showed an undetectable viral load, and 4 (11%) patients showed no CD4 suppression.", {"entities": [[165, 168, "GENE"]]}], ["Seventeen (45%) patients recalled correctly their medication.", {"entities": []}], ["During the week prior to the interview, 26 patients (68%) reported that they had missed at least one dose.", {"entities": []}], ["When asked the reason for missing a dose, 23 out of 34 (68%; 4 missing responses) patients responded, \u201cI forgot\u201d.", {"entities": []}], ["Female patients gave more excuses for missing doses (mean\u2009\u00b1\u2009SD number of excuses per female, 2.4\u2009\u00b1\u20092; per male, 1.2\u2009\u00b1\u20091; p \u2009=\u2009.02), while more male than female patients described an action plan if they ran out of medication (13 vs. 8; p \u2009=\u2009.05).", {"entities": []}], ["Educational programs involving patients and also family members are warranted to improve adherence.", {"entities": []}], ["Regional networks have been recognized as an interesting model to support interdisciplinary and inter-organizational interactions that lead to meaningful care improvements.", {"entities": []}], ["Existing communities of practice within the a regional network, the Montreal Stroke Network (MSN) offers a compelling structure to better manage the exponential growth of knowledge and to support care providers to better manage the complex cases they must deal with in their practices.", {"entities": [[93, 96, "GENE"]]}], ["This research project proposes to examine internal and external factors that influence individual and organisational readiness to adopt national stroke best practices and to assess the impact of an e-collaborative platform in facilitating knowledge translation activities.", {"entities": []}], ["We will develop an e-collaborative platform that will include various social networking and collaborative tools.", {"entities": []}], ["We propose to create online brainstorming sessions ('jams') around each best practice recommendation.", {"entities": []}], ["Jam postings will be analysed to identify emergent themes.", {"entities": []}], ["Syntheses of these analyses will be provided to members to help them identify priority areas for practice change.", {"entities": []}], ["Discussions will be moderated by clinical leaders, whose role will be to accelerate crystallizing of ideas around 'how to' implement selected best practices.", {"entities": []}], ["All clinicians (~200) involved in stroke care among the MSN will be asked to participate.", {"entities": [[56, 59, "GENE"]]}], ["Activities during face-to-face meetings and on the e-collaborative platform will be documented.", {"entities": []}], ["Content analysis of all activities will be performed using an observation grid that will use as outcome indicators key elements of communities of practice and of the knowledge creation cycle developed by Nonaka.", {"entities": []}], ["Semi-structured interviews will be conducted among users of the e-collaborative platform to collect information on variables of the knowledge-to-action framework.", {"entities": []}], ["All participants will be asked to complete three questionnaires: the typology questionnaire, which classifies individuals into one of four mutually exclusive categories of information seeking; the e-health state of readiness, which covers ten domains of the readiness to change; and a community of practice evaluation survey.", {"entities": []}], ["This project is expected to enhance our understanding of collaborative work across disciplines and organisations in accelerating implementation of best practices along the continuum of care, and how e-technologies influence access, sharing, creation, and application of knowledge.", {"entities": []}], ["Albania is a country on the western part of the Balkan Peninsula.", {"entities": []}], ["The Mediterranean climate is favourable for the stable development of many arthropod species, which are incriminated as vectors for various agents.", {"entities": []}], ["Recently, several papers have reported on epidemiological aspects of parasitic diseases including vector-borne disease agents of dogs with zoonotic characteristics in Albania.", {"entities": []}], ["However, data on the epidemiology of feline parasitic and bacterial agents in Albania is scarce.", {"entities": []}], ["Serum and EDTA-blood samples collected from 146 domestic cats from Tirana during 2008 through 2010 were examined for exposure to Toxoplasma gondii , Neospora caninum , Leishmania infantum , and Anaplasma spp.", {"entities": []}], ["with IFAT, for infection with L. infantum , A. phagocytophilum, Bartonella spp.", {"entities": []}], ["and haemotropic mycoplasmas with conventional PCR and real-time PCR and for Dirofilaria immitis with antigen ELISA.", {"entities": []}], ["Additionally blood smear microscopy was carried out for detection of blood-borne pathogens.", {"entities": []}], ["Antibodies to T. gondii (titre \u22651:100) were demonstrated in 91 cats (62.3%).", {"entities": []}], ["Antibodies to N. caninum (titre \u22651:100), L. infantum (titre \u22651:64) and Anaplasma spp.", {"entities": []}], ["(titre \u22651:100) were found in the serum of 15 (10.3%), 1 (0.7%) or 3 (2.1%) cats, respectively.", {"entities": []}], ["DNA of haemotropic mycoplasmas was detected in the blood of 45 cats (30.8%), namely Candidatus Mycoplasma haemominutum (21.9%), Mycoplasma haemofelis (10.3%), and Candidatus Mycoplasma turicensis (5.5%), with ten cats harbouring co-infections of two mycoplasmas each; blood from one cat was PCR positive for Bartonella henselae .", {"entities": []}], ["No DNA of Leishmania spp.", {"entities": []}], ["and A. phagocytophilum or circulating D. immitis antigen was detected in any cat sample.", {"entities": []}], ["The overall prevalence of haemotropic mycoplasmas was significantly higher in male compared to female cats (40.6% vs. 24.1%, p\u2009=\u20090.0444); and age was associated positively with the prevalence of antibodies to T. gondii (p\u2009=\u20090.0008) and the percentage of haemotropic mycoplasma infection (p\u2009=\u20090.0454).", {"entities": []}], ["With the broad screening panel including direct and indirect methods applied in the present study, a wide spectrum of exposure to or infection with parasitic or bacterial agents was detected.", {"entities": []}], ["Impaired renal function is often neglected in COPD patients.", {"entities": []}], ["Considering that COPD patients usually have an ongoing prothrombotic state and systemic inflammation status, we investigated the association among them and explored the predictive value of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS-13), on concealed chronic renal failure (CRF) in COPD patients.", {"entities": []}], ["COPD patients were recruited from the First Affiliated Hospital of Sun Yat-Sen University between January 2015 and December 2016.", {"entities": []}], ["Control was selected from contemporaneous hospitalized patients without COPD and matched by age and gender at a ratio of 1:1.", {"entities": []}], ["Estimated glomerular filtration rate (eGFR) was calculated by using the Chronic Kidney Disease Epidemiology Collaboration formula, and all subjects were categorized as having normal renal function (eGFR \u226560 mL min In total, 106 COPD and 106 non-COPD patients were finally recruited, and the incidences of concealed CRF were 19.81% and 7.55%, respectively.", {"entities": [[38, 42, "GENE"], [198, 202, "GENE"], [38, 42, "GENE"], [198, 202, "GENE"]]}], ["ADAMTS-13 (odds ratio [OR] =0.858, 95% CI =0.795\u20130.926), D-dimer (OR =1.095, 95% CI =1.027\u20131.169), and C-reactive protein (OR =1.252, 95% CI =1.058\u20131.480) were significantly associated with concealed CRF.", {"entities": []}], ["Sensitivity and specificity at an ADAMTS-13 cutoff of 318.72 ng/mL were 100% and 81.2%, respectively.", {"entities": []}], ["The area under the ROC curve was 0.959.", {"entities": []}], ["Prothrombotic state and systemic inflammation status might contribute to explaining the high incidence of concealed CRF in COPD, and plasma ADAMTS-13 levels may serve as a strong predictor.", {"entities": []}], ["Bat-borne viruses can pose a serious threat to human health, with examples including Nipah virus (NiV) in Bangladesh and Malaysia, and Marburg virus (MARV) in Africa.", {"entities": []}], ["To date, significant human outbreaks of such viruses have not been reported in the European Union (EU).", {"entities": []}], ["However, EU countries have strong historical links with many of the countries where NiV and MARV are present and a corresponding high volume of commercial trade and human travel, which poses a potential risk of introduction of these viruses into the EU.", {"entities": []}], ["In assessing the risks of introduction of these bat-borne zoonotic viruses to the EU, it is important to consider the location and range of bat species known to be susceptible to infection, together with the virus prevalence, seasonality of viral pulses, duration of infection and titre of virus in different bat tissues.", {"entities": []}], ["In this paper, we review the current scientific knowledge of all these factors, in relation to the introduction of NiV and MARV into the EU.", {"entities": []}], ["The study of the seasonal variation of disease is receiving increasing attention from health researchers.", {"entities": []}], ["Available statistical tests for seasonality typically indicate the presence or absence of statistically significant seasonality but do not provide a meaningful measure of its strength.", {"entities": []}], ["We propose the coefficient of determination of the autoregressive regression model fitted to the data ( ) as a measure for quantifying the strength of the seasonality.", {"entities": []}], ["The performance of the proposed statistic is assessed through a simulation study and using two data sets known to demonstrate statistically significant seasonality: atrial fibrillation and asthma hospitalizations in Ontario, Canada.", {"entities": [[189, 195, "DISEASE"]]}], ["The simulation results showed the power of the in adequately quantifying the strength of the seasonality of the simulated observations for all models.", {"entities": []}], ["In the atrial fibrillation and asthma datasets, while the statistical tests such as Bartlett's Kolmogorov-Smirnov (BKS) and Fisher's Kappa support statistical evidence of seasonality for both, the quantifies the strength of that seasonality.", {"entities": [[31, 37, "DISEASE"]]}], ["Corroborating the visual evidence that asthma is more conspicuously seasonal than atrial fibrillation, the calculated for atrial fibrillation indicates a weak to moderate seasonality ( = 0.44, 0.28 and 0.45 for both genders, males and females respectively), whereas for asthma, it indicates a strong seasonality ( = 0.82, 0.78 and 0.82 for both genders, male and female respectively).", {"entities": [[39, 45, "DISEASE"], [270, 276, "DISEASE"]]}], ["For the purposes of health services research, evidence of the statistical presence of seasonality is insufficient to determine the etiologic, clinical and policy relevance of findings.", {"entities": []}], ["Measurement of the strength of the seasonal effect, as can be determined using the technique, is also important in order to provide a robust sense of seasonality.", {"entities": []}], ["Health related quality of life (HRQL) has been recognised as an important paediatric outcome measurement.", {"entities": []}], ["One of the more promising measures to emerge in recent years is the Pediatric Quality Of Life Inventory (PedsQL\u2122), developed in the US.", {"entities": []}], ["Advantages of the PedsQL\u2122 include brevity, availability of age appropriate versions and parallel forms for child and parent.", {"entities": []}], ["This study developed a UK-English version of PedsQL\u2122 generic module and assessed its performance in a group of UK children and their parents.", {"entities": []}], ["PedsQL\u2122 was translated to UK-English.", {"entities": []}], ["The psychometric properties of the UK version were then tested following administration to 1399 children and 970 of their parents.", {"entities": []}], ["The sample included healthy children, children diagnosed with asthma, diabetes or inflammatory bowel disease and children in remission from cancer.", {"entities": [[82, 108, "DISEASE"], [62, 68, "DISEASE"], [140, 146, "DISEASE"]]}], ["Psychometric properties were similar to those reported for the original PedsQL\u2122.", {"entities": []}], ["Internal reliability exceeded 0.70 for all proxy and self-report sub-scales.", {"entities": []}], ["Discriminant validity was established for proxy and self-report with higher HRQL being reported for healthy children than those with health problems.", {"entities": []}], ["Sex differences were noted on the emotional functioning subscale, with females reporting lower HRQL than males.", {"entities": []}], ["Proxy and self-report correlation was higher for children with health problems than for healthy children.", {"entities": []}], ["The UK-English version of PedsQL\u2122 performed as well as the original PedsQL\u2122 and is recommended for assessment of paediatric HRQL in the UK.", {"entities": []}], ["Epicutaneous sensitization with protein allergen that induces predominant Th2 responses is an important sensitization route in atopic dermatitis.", {"entities": [[127, 144, "DISEASE"], [134, 144, "DISEASE"]]}], ["Fungal components have been shown to modulate Th cell differentiation.", {"entities": []}], ["However, the effects of fungal components on epicutaneous sensitization are unclear.", {"entities": []}], ["In this study, we showed that co-administration of curdlan, a dectin-1 agonist, during epicutaneous ovalbumin sensitization of BALB/c mice decreased the IL-5 and IL-13 levels in supernatants of lymph node cell ovalbumin reactivation cultures.", {"entities": []}], ["Mechanistically, curdlan co-administration decreased IL-4 and IL-1\u03b2 expressions in draining lymph nodes.", {"entities": []}], ["Curdlan co-administration also lower the migration of langerin These results indicated that concurrent exposure to a dectin-1 agonist suppresses the epicutaneously induced Th2 response by modulating the cytokine expression profiles in draining LNs and the migration of epidermal Langerhans cells.", {"entities": []}], ["These results highlight the effects of fungal components on epicutaneous allergen sensitization in atopic diseases.", {"entities": []}], ["This study aimed to assess the efficacy and tolerability of atorvastatin in Tanner stage (TS) 1 patients ages 6 to 10\u00a0years and TS \u22652 patients ages 10 to <18\u00a0years with genetically confirmed heterozygous familial hypercholesterolemia (HeFH) and a low density lipoprotein cholesterol (LDL-C) level of 4\u00a0mmol/l (155\u00a0mg/dl) or higher.", {"entities": [[204, 233, "DISEASE"]]}], ["In this open-label, 8-week study, 15 TS 1 children were treated initially with atorvastatin 5\u00a0mg/day and 24 TS \u22652 children with 10\u00a0mg/day.", {"entities": []}], ["Doses were doubled at week 4 if the LDL-C target (<3.35\u00a0mmol/l [130\u00a0mg/dl]) was not achieved.", {"entities": []}], ["The efficacy variables were the percentage change from baseline in LDL-C, total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), very low density lipoprotein cholesterol (VLDL-C), and apolipoprotein (Apo) A-I and Apo B.", {"entities": [[113, 115, "GENE"]]}], ["Safety evaluations included clinical monitoring, subject-reported adverse events (AEs), vital signs, and clinical laboratory tests.", {"entities": []}], ["The mean values for LDL-C, TC, VLDL-C, and Apo B decreased by week 2 among all TS 1 and TS \u22652 patients, whereas TG, HDL-C, and Apo A-I varied considerably from week to week.", {"entities": [[112, 114, "GENE"]]}], ["After 8\u00a0weeks, the mean reduction in LDL-C was \u221240.7%\u00a0\u00b1\u00a08.4 for the TS 1 children and \u221239.7%\u00a0\u00b1\u00a010.3 for the TS \u22652 children.", {"entities": []}], ["For the TS 1 patients, the mean reductions were \u221234.1%\u00a0\u00b1\u00a06.9 for TC and \u22126.0%\u00a0\u00b1\u00a032.1 for TG.", {"entities": [[89, 91, "GENE"]]}], ["The corresponding changes for the TS \u22652 patients were \u221235.6%\u00a0\u00b1\u00a09.5 for TC and \u221221.1%\u00a0\u00b1\u00a029.7 for TG.", {"entities": [[96, 98, "GENE"]]}], ["Four patients experienced mild to moderate treatment-related AEs.", {"entities": []}], ["No serious AEs or discontinuations were reported.", {"entities": []}], ["Overall, no difference in safety or tolerability was observed between the younger and older cohorts.", {"entities": []}], ["Across the range of exposures after atorvastatin 5 to 10\u00a0mg (TS 1) or atorvastatin 10 to 20\u00a0mg (TS \u22652) doses for 8\u00a0weeks, clinically meaningful reductions in LDL-C, TC, VLDL-C, and Apo were observed with atorvastatin in pediatric patients who had HeFH.", {"entities": []}], ["Atorvastatin also was well tolerated in this population.", {"entities": []}], ["No formal definition for the \u201ccomplex elderly\u201d exists; moreover, these older patients with high levels of multi-morbidity are not readily identified as such at point of hospitalisation, thus missing a valuable opportunity to manage the older patient appropriately within the hospital setting.", {"entities": []}], ["To empirically identify the complex elderly patient based on degree of multi-morbidity.", {"entities": []}], ["Retrospective observational study using administrative data.", {"entities": []}], ["English hospitals during the financial year 2012\u201313.", {"entities": []}], ["All admitted patients aged 65 years and over.", {"entities": []}], ["By using exploratory analysis (correspondence analysis) we identify multi-morbidity groups based on 20 target conditions whose hospital prevalence was \u2265 1%.", {"entities": []}], ["We examined a total of 2788900 hospital admissions.", {"entities": []}], ["Multi-morbidity was highly prevalent, 62.8% had 2 or more of the targeted conditions while 4.7% had six or more.", {"entities": []}], ["Multi-morbidity increased with age from 56% (65-69yr age-groups) up to 67% (80-84yr age-group).", {"entities": []}], ["The average multi-morbidity was 3.2\u00b11.2 (SD).", {"entities": []}], ["Correspondence analysis revealed 3 distinct groups of older patients.", {"entities": []}], ["Group 1 (multi-morbidity \u22642), associated with cancer and/or metastasis; Group 2 (multi-morbidity of 3, 4 or 5), associated with chronic pulmonary disease, lung disease, rheumatism and osteoporosis; finally Group 3 with the highest level of multi-morbidity (\u22656) and associated with heart failure, cerebrovascular accident, diabetes, hypertension and myocardial infarction.", {"entities": [[332, 344, "DISEASE"], [349, 370, "DISEASE"], [184, 196, "DISEASE"], [155, 167, "DISEASE"], [46, 52, "DISEASE"], [296, 320, "DISEASE"]]}], ["By using widely available hospital administrative data, we propose patients in Groups 2 and 3 to be identified as the complex elderly .", {"entities": []}], ["Identification of multi-morbidity patterns can help to predict the needs of the older patient and improve resource provision.", {"entities": []}], ["This review article provides a historical perspective on the role of purinergic signalling in the regulation of various subsets of immune cells from early discoveries to current understanding.", {"entities": []}], ["It is now recognised that adenosine 5\u2032-triphosphate (ATP) and other nucleotides are released from cells following stress or injury.", {"entities": []}], ["They can act on virtually all subsets of immune cells through a spectrum of P2X ligand-gated ion channels and G protein-coupled P2Y receptors.", {"entities": []}], ["Furthermore, ATP is rapidly degraded into adenosine by ectonucleotidases such as CD39 and CD73, and adenosine exerts additional regulatory effects through its own receptors.", {"entities": []}], ["The resulting effect ranges from stimulation to tolerance depending on the amount and time courses of nucleotides released, and the balance between ATP and adenosine.", {"entities": []}], ["This review identifies the various receptors involved in the different subsets of immune cells and their effects on the function of these cells.", {"entities": []}], ["Patients with distributive shock who require high dose vasopressors have a high mortality.", {"entities": []}], ["Angiotensin II (ATII) may prove useful in patients who remain hypotensive despite catecholamine and vasopressin therapy.", {"entities": []}], ["The appropriate dose of parenteral angiotensin II for shock is unknown.", {"entities": []}], ["In total, 20 patients with distributive shock and a cardiovascular Sequential Organ Failure Assessment score of 4 were randomized to either ATII infusion (N =10) or placebo (N =10) plus standard of care.", {"entities": []}], ["ATII was started at a dose of 20\u00a0ng/kg/min, and titrated for a goal of maintaining a mean arterial pressure (MAP) of 65\u00a0mmHg.", {"entities": []}], ["The infusion (either ATII or placebo) was continued for 6\u00a0hours then titrated off.", {"entities": []}], ["The primary endpoint was the effect of ATII on the standing dose of norepinephrine required to maintain a MAP of 65\u00a0mmHg.", {"entities": []}], ["ATII resulted in marked reduction in norepinephrine dosing in all patients.", {"entities": []}], ["The mean hour 1 norepinephrine dose for the placebo cohort was 27.6\u2009\u00b1\u200929.3 mcg/min versus 7.4\u2009\u00b1\u200912.4 mcg/min for the ATII cohort ( P =0.06).", {"entities": []}], ["The most common adverse event attributable to ATII was hypertension, which occurred in 20% of patients receiving ATII.", {"entities": [[55, 67, "DISEASE"]]}], ["30-day mortality for the ATII cohort and the placebo cohort was similar (50% versus 60%, P =1.00).", {"entities": []}], ["Angiotensin II is an effective rescue vasopressor agent in patients with distributive shock requiring multiple vasopressors.", {"entities": []}], ["The initial dose range of ATII that appears to be appropriate for patients with distributive shock is 2 to 10\u00a0ng/kg/min.", {"entities": []}], ["Clinicaltrials.gov NCT01393782 .", {"entities": []}], ["Registered 12 July 2011.", {"entities": []}], ["Observational studies using case-control designs have showed an increased risk of pneumonia associated with inhaled corticosteroid (ICS)-containing medications in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[82, 91, "DISEASE"], [177, 214, "DISEASE"]]}], ["New-user observational cohort designs may minimize biases associated with previous case-control designs.", {"entities": []}], ["To estimate the association between ICS and pneumonia among new users of ICS relative to inhaled long-acting bronchodilator (LABD) monotherapy.", {"entities": [[44, 53, "DISEASE"]]}], ["Pneumonia events in COPD patients \u226545 years old were compared among new users of ICS medications (n\u200a=\u200a11,555; ICS, ICS/long-acting \u03b2 2 -agonist [LABA] combination) and inhaled LABD monotherapies (n\u200a=\u200a6,492; LABA, long-acting muscarinic antagonists) using Cox proportional hazards models, with propensity scores to adjust for confounding.", {"entities": [[0, 9, "DISEASE"]]}], ["Setting: United Kingdom electronic medical records with linked hospitalization and mortality data (2002\u20132010).", {"entities": []}], ["New users were censored at earliest of: pneumonia event, death, changing/discontinuing treatment, or end of follow-up.", {"entities": [[40, 49, "DISEASE"]]}], ["Outcomes: severe pneumonia (primary) and any pneumonia (secondary).", {"entities": [[17, 26, "DISEASE"], [45, 54, "DISEASE"]]}], ["Following adjustment, new use of ICS-containing medications was associated with an increased risk of pneumonia hospitalization (n\u200a=\u200a322 events; HR\u200a=\u200a1.55, 95% CI: 1.14, 2.10) and any pneumonia (n\u200a=\u200a702 events; HR\u200a=\u200a1.49, 95% CI: 1.22, 1.83).", {"entities": [[101, 110, "DISEASE"], [183, 192, "DISEASE"], [144, 146, "GENE"], [210, 212, "GENE"], [144, 146, "GENE"], [210, 212, "GENE"]]}], ["Crude incidence rates of any pneumonia were 48.7 and 30.9 per 1000 person years among the ICS-containing and LABD cohorts, respectively.", {"entities": [[29, 38, "DISEASE"]]}], ["Excess risk of pneumonia with ICS was reduced when requiring \u22651 month or \u2265 6 months of new use.", {"entities": [[15, 24, "DISEASE"]]}], ["There was an apparent dose-related effect, with greater risk at higher daily doses of ICS.", {"entities": []}], ["There was evidence of channeling bias, with more severe patients prescribed ICS, for which the analysis may not have completely adjusted.", {"entities": []}], ["The results of this new-user cohort study are consistent with published findings; ICS were associated with a 20\u201350% increased risk of pneumonia in COPD, which reduced with exposure time.", {"entities": [[134, 143, "DISEASE"]]}], ["This risk must be weighed against the benefits when prescribing ICS to patients with COPD.", {"entities": []}], ["Venoms secreted by the venom gland (VG) of parasitoid wasp help ensure successful parasitism by host immune suppression and developmental regulation.", {"entities": []}], ["Cotesia vestalis , a larval endoparasitoid, and Diadromus collaris , a pupal endoparasitoid, parasitize the diamondback moth (DBM), Plutella xylostella .", {"entities": []}], ["To explore and compare the venom components of two endoparasitoids, we sequenced transcriptomes of the VGs and wasp bodies without VGs (BWVGs) of the two endoparasitoids.", {"entities": []}], ["Statistically enriched GO terms and KEGG pathways of the two VGs compared to respective whole-body background were similar and reflected active protein biosynthesis activities in the two VGs.", {"entities": []}], ["1,595 VG specific genes of the D .", {"entities": []}], ["collaris VG and 1,461 VG specific genes of the C .", {"entities": []}], ["vestalis VG were identified by comparative transcript profiling.", {"entities": []}], ["A total of 444 and 513 genes encoding potential secretory proteins were identified and defined as putative venom genes in D .", {"entities": []}], ["collaris VG and C .", {"entities": []}], ["vestalis VG, respectively.", {"entities": []}], ["The putative venom genes of the two wasps showed no significant similarity or convergence.", {"entities": []}], ["More venom genes were predicted in D .", {"entities": []}], ["collaris VG than C .", {"entities": []}], ["vestalis VG, especially hydrolase-coding genes.", {"entities": []}], ["Differences in the types and quantities of putative venom genes shed light on different venom functions.", {"entities": []}], ["One of the most widely used self-reporting tools assessing diabetes self-management in English is the Summary of Diabetes Self-Care Activities (SDSCA) measure.", {"entities": []}], ["To date there is no psychometric validated instrument in German to assess self-management in patients with diabetes mellitus.", {"entities": [[107, 124, "DISEASE"]]}], ["Therefore, this study aimed to translate the SDSCA into German and examine its psychometric properties.", {"entities": []}], ["The English version of the SDSCA was translated into German following the guidelines for cultural adaptation.", {"entities": []}], ["The German version of the SDSCA (SDSCA-G) was administered to a random sample of 315 patients with diabetes mellitus type 2.", {"entities": [[99, 116, "DISEASE"]]}], ["Reliability was analyzed using Cronbach\u2019s alpha coefficient and item characteristics were assessed.", {"entities": []}], ["Exploratory and confirmatory factor analysis (EFA and CFA) were carried out to explore the construct validity.", {"entities": []}], ["A multivariable linear regression model was used to identify the influence of predictor variables on the SDSCA-G sum score.", {"entities": []}], ["The Cronbach\u2019s alpha for the SDSCA-G (all items) was \u03b1\u2009=\u20090.618 and an acceptable correlation between the SDSCA-G and Self-management Diabetes Mellitus-Questionnaire (SDQ) (\u03c1\u2009=\u20090.664) was identified.", {"entities": [[133, 150, "DISEASE"]]}], ["The EFA suggested a four factor construct as did the postulated model.", {"entities": []}], ["The CFA showed the goodness of fit of the SDSCA-G.", {"entities": []}], ["However, item 4 was found to be problematic regarding the analysis of psychometric properties.", {"entities": []}], ["The omission of item 4 yielded an increase in Cronbach\u2019s alpha (\u03b1\u2009=\u20090.631) and improvements of the factor structure and model fit.", {"entities": []}], ["No statistically significant influences of predictor variables on the SDSCA-G sum score were observed.", {"entities": []}], ["The revised German version of the SDSCA (SDSCA-G) is a reliable and valid tool assessing self-management in adults with type 2 diabetes in Germany.", {"entities": []}], ["The online version of this article (doi:10.1186/s12955-014-0185-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Since the early 1960s, a compelling body of evidence has accumulated to show that proteinases play critical roles in airspace enlargement in chronic obstructive pulmonary disease (COPD).", {"entities": [[141, 178, "DISEASE"]]}], ["However, until recently the causative enzymes and their exact roles in pathologic processes in COPD have not been clear.", {"entities": []}], ["Recent studies of gene-targeted mice in murine models of COPD have confirmed roles for proteinases not only in airspace enlargement, but also in airway pathologies in COPD.", {"entities": []}], ["These studies have also shed light on the specific proteinases involved in COPD pathogenesis, and the mechanisms by which these proteinases injure the lung.", {"entities": []}], ["They have also identified important interactions between different classes of proteinases, and between proteinases and other molecules that amplify lung inflammation and injury.", {"entities": []}], ["This review will discuss the biology of proteinases and the mechanisms by which they contribute to the pathogenesis of COPD.", {"entities": []}], ["In addition, I will discuss the potential of proteinase inhibitors and anti-inflammatory drugs as new treatment strategies for COPD patients.", {"entities": []}], ["Background: Government policy measures have a key role to play in the prevention and control of non-communicable diseases (NCDs).", {"entities": []}], ["The Caribbean, a middle-income region, has the highest per capita burden of NCDs in the Americas.", {"entities": []}], ["Our aim was to examine policy development and implementation between the years 2000 and 2013 on NCD prevention and control in Barbados, and to investigate factors promoting, and hindering, success.", {"entities": []}], ["Methods: A qualitative case study design was used involving a structured policy document review and semi-structured interviews with key informants, identified through stakeholder analysis and \u2018cascading.\u2019 Documents were abstracted into a standard form.", {"entities": []}], ["Interviews were recorded, transcribed verbatim and underwent framework analysis, guided by the multiple streams framework (MSF).", {"entities": []}], ["There were 25 key informants, from the Ministry of Health (MoH), other government Ministries, civil society organisations, and the private sector.", {"entities": []}], ["Results: A significant policy window opened between 2005 and 2007 in which new posts to address NCDs were created in the MoH, and a government supported multi-sectoral national NCD commission was established.", {"entities": []}], ["Factors contributing to this government commitment and funding included a high level of awareness, throughout society, of the NCD burden, including media coverage of local research findings; the availability of policy recommendations by international bodies that could be adopted locally, notably the framework convention on tobacco control (FCTC); and the activities of local highly respected policy entrepreneurs with access to senior politicians, who were able to bring together political concern for the problem with potential policy solutions.", {"entities": []}], ["However, factors were also identified that hindered multi-sectoral policy development in several areas, including around nutrition, physical activity, and alcohol.", {"entities": []}], ["These included a lack of consensus (valence) on the nature of the problem, often framed as being predominantly one of individuals needing to take responsibility for their health rather than requiring government-led environmental changes; lack of appropriate detailed policy guidance for local adaptation; conflicts with other political priorities, such as production and export of alcohol, and political reluctance to use legislative and fiscal measures.", {"entities": []}], ["Conclusion: The study\u2019s findings indicate mechanisms to promote and support NCD policy development in the Caribbean and similar settings.", {"entities": []}], ["Cyclooxygenase (COXs) and Lipoxygenase (LOXs) pathways are the two major enzymatic pathways in arachidonic acid (AA) metabolism.", {"entities": []}], ["The term eicosanoid is used to describe biologically active lipid mediators including prostaglandins, thromboxanes, leukotrienes and other oxygenated derivatives, which are produced primarily from AA.", {"entities": []}], ["Eicosanoids generated in a tissue specific manner play a key role in inflammation and cancer.", {"entities": [[86, 92, "DISEASE"]]}], ["As AA is the substrate common to variety of COXs and LOXs, inhibition of one pathway results in diversion of the substrate to other pathways, which often is responsible for undesirable side effects.", {"entities": []}], ["Hence there is need for development of not only isozyme specific inhibitors but also dual/multi enzyme inhibitors.", {"entities": []}], ["Understanding the interactions of AA and characterizing its binding sites in these enzymes therefore is crucial for developing enzyme specific and multi enzyme inhibitors for enhancing therapeutic efficacy and/or overcoming side effects.", {"entities": []}], ["AA binding sites in COXs and LOXs are identified and compared by the development of receptor based pharmacophore using MultiBind.", {"entities": []}], ["Physico chemical properties were compared to understand the details of the binding sites in all the enzymes and to elucidate important amino acids that can be targeted for drug design.", {"entities": []}], ["The alignment of AA binding sites in the seven enzymes COX-1, COX-2, 5-LOX, 12-LOX, 15-LOX and plant soybean LOX-1 and LOX-3 indicated a common pattern of five common interacting groups.", {"entities": []}], ["In the same way, comparison of AA binding sites was done pair wise and by multiple alignment in various combinations.", {"entities": []}], ["It has been identified that aliphatic and aromatic interactions are the most common in all the enzymes.", {"entities": []}], ["In addition interactions unique to each one of these enzymes were identified.", {"entities": []}], ["The complete analysis of AA binding sites in the seven enzymes was performed; 120 combinations for the seven enzymes were studied in detail.", {"entities": []}], ["All the seven enzymes are structurally quite different, yet they share AA as the common binding partner.", {"entities": []}], ["Comparisons in various combinations showed how they are similar and dissimilar with each other.", {"entities": []}], ["This information will be helpful in designing specific as well as common inhibitors.", {"entities": []}], ["The online version of this article (doi:10.1186/s13104-015-1101-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Health information technology, particularly electronic decision support systems, can reduce the existing gap between evidence-based knowledge and health care practice but professionals have to accept and use this information.", {"entities": []}], ["Evidence is scant on which features influence the use of computer-based clinical decision support (eCDS) in primary care and how different professional groups experience it.", {"entities": []}], ["Our aim was to describe specific reasons for using or not using eCDS among primary care professionals.", {"entities": []}], ["The setting was a Finnish primary health care organization with 48 professionals receiving patient-specific guidance at the point of care.", {"entities": []}], ["Multiple data (focus groups, questionnaire and spontaneous feedback) were analyzed using deductive content analysis and descriptive statistics.", {"entities": []}], ["The content of the guidance is a significant feature of the primary care professional\u2019s intention to use eCDS.", {"entities": []}], ["The decisive reason for using or not using the eCDS is its perceived usefulness.", {"entities": []}], ["Functional characteristics such as speed and ease of use are important but alone these are not enough.", {"entities": []}], ["Specific information technology, professional, patient and environment features can help or hinder the use.", {"entities": []}], ["Primary care professionals have to perceive eCDS guidance useful for their work before they use it.", {"entities": []}], ["Protein tyrosine phosphatase 1B (PTP1B) has anti-inflammatory potential but PTP1B responses are desensitized in the lung by prolonged cigarette smoke exposure.", {"entities": []}], ["Here we investigate whether PTP1B expression impacts lung disease severity during respiratory syncytial viral (RSV) exacerbations of chronic obstructive pulmonary disease (COPD).", {"entities": [[133, 170, "DISEASE"], [53, 65, "DISEASE"]]}], ["Ptp1b Ptp1b", {"entities": []}], ["Posttraumatic stress disorder (PTSD) is a severe problem among soldiers with combating experience difficult to treat.", {"entities": []}], ["The pathogenesis is still not fully understood at the psychological level.", {"entities": []}], ["Therefore, genetic research became a focus of interest.", {"entities": []}], ["The identification of single nucleotide polymorphisms (SNPs) may help to predict, which persons are at high risk to develop PTSD as a starting point to develop novel targeted drugs for treatment.", {"entities": []}], ["We conducted a systematic review on SNPs in genes related to PTSD pathology and development of targeted pharmacological treatment options based on PubMed database searches.", {"entities": []}], ["We focused on clinical trials with military personnel.", {"entities": []}], ["SNPs in 22 human genes have been linked to PTSD.", {"entities": []}], ["These genes encode proteins acting as neurotransmitters and receptors, downstream signal transducers and metabolizing enzymes.", {"entities": []}], ["Pharmacological inhibitors may serve as drug candidates for PTSD treatment, e.g.", {"entities": []}], ["\u03b22 adrenoreceptor antagonists, dopamine antagonists, partial dopamine D2 receptor agonists, dopamine \u03b2 hydroxylase inhibitors, fatty acid amid hydrolase antagonists, glucocorticoid receptor agonists, tropomyosin receptor kinase B agonists, selective serotonin reuptake inhibitors, catechol-O-methyltransferase inhibitors, gamma-amino butyric acid receptor agonists, glutamate receptor inhibitors, monoaminoxidase B inhibitors, N-methyl-d-aspartate receptor antagonists.", {"entities": []}], ["The combination of genetic and pharmacological research may lead to novel target-based drug developments with improved specificity and efficacy to treat PTSD.", {"entities": []}], ["Specific SNPs may be identified as reliable biomarkers to assess individual disease risk.", {"entities": []}], ["Focusing on soldiers suffering from PTSD will not only help to improve treatment options for this specific group, but for all PTSD patients and the general population.", {"entities": []}], ["Rheumatoid arthritis (RA) affects millions world-wide.", {"entities": [[11, 20, "DISEASE"]]}], ["While anti-TNF treatment is widely used to reduce disease progression, treatment fails in \u223cone-third of patients.", {"entities": []}], ["No biomarker currently exists that identifies non-responders before treatment.", {"entities": []}], ["A rigorous community-based assessment of the utility of SNP data for predicting anti-TNF treatment efficacy in RA patients was performed in the context of a DREAM Challenge ( http://www.synapse.org/RA_Challenge ).", {"entities": []}], ["An open challenge framework enabled the comparative evaluation of predictions developed by 73 research groups using the most comprehensive available data and covering a wide range of state-of-the-art modelling methodologies.", {"entities": []}], ["Despite a significant genetic heritability estimate of treatment non-response trait ( h P value=0.02), no significant genetic contribution to prediction accuracy is observed.", {"entities": []}], ["Results formally confirm the expectations of the rheumatology community that SNP information does not significantly improve predictive performance relative to standard clinical traits, thereby justifying a refocusing of future efforts on collection of other data.", {"entities": []}], ["Rheumatoid arthritis patients respond differently to anti-TNF treatment.", {"entities": [[11, 20, "DISEASE"]]}], ["Using community-based challenge, the authors show that currently available data does not reveal meaningful genetic predictors of response to anti-TNF therapy, thus confirming clinical observations.", {"entities": []}], ["Estimating patient risk of future emergency department (ED) revisits can guide the allocation of resources, e.g.", {"entities": []}], ["local primary care and/or specialty, to better manage ED high utilization patient populations and thereby improve patient life qualities.", {"entities": []}], ["We set to develop and validate a method to estimate patient ED revisit risk in the subsequent 6\u00a0months from an ED discharge date.", {"entities": []}], ["An ensemble decision-tree-based model with Electronic Medical Record (EMR) encounter data from HealthInfoNet (HIN), Maine\u2019s Health Information Exchange (HIE), was developed and validated, assessing patient risk for a subsequent 6\u00a0month return ED visit based on the ED encounter-associated demographic and EMR clinical history data.", {"entities": []}], ["A retrospective cohort of 293,461 ED encounters that occurred between January 1, 2012 and December 31, 2012, was assembled with the associated patients\u2019 1-year clinical histories before the ED discharge date, for model training and calibration purposes.", {"entities": []}], ["To validate, a prospective cohort of 193,886 ED encounters that occurred between January 1, 2013 and June 30, 2013 was constructed.", {"entities": []}], ["Statistical learning that was utilized to construct the prediction model identified 152 variables that included the following data domains: demographics groups (12), different encounter history (104), care facilities (12), primary and secondary diagnoses (10), primary and secondary procedures (2), chronic disease condition (1), laboratory test results (2), and outpatient prescription medications (9).", {"entities": []}], ["The c -statistics for the retrospective and prospective cohorts were 0.742 and 0.730 respectively.", {"entities": []}], ["Total medical expense and ED utilization by risk score 6\u00a0months after the discharge were analyzed.", {"entities": []}], ["Cluster analysis identified discrete subpopulations of high-risk patients with distinctive resource utilization patterns, suggesting the need for diversified care management strategies.", {"entities": []}], ["Integration of our method into the HIN secure statewide data system in real time prospectively validated its performance.", {"entities": []}], ["It promises to provide increased opportunity for high ED utilization identification, and optimized resource and population management.", {"entities": []}], ["The online version of this article (doi:10.1186/s12873-016-0074-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A multicenter, double-blind, randomized study was conducted to assess the effect of caffeine on regadenoson stress myocardial perfusion imaging (MPI).", {"entities": [[145, 148, "GENE"]]}], ["Subjects with a high likelihood of coronary artery disease underwent a rest single-photon emission computed tomography MPI on day 1 (MPI-1) and a stress MPI with regadenoson on day 3 (MPI-2).", {"entities": [[119, 122, "GENE"], [133, 136, "GENE"], [153, 156, "GENE"], [184, 187, "GENE"], [119, 122, "GENE"], [133, 136, "GENE"], [153, 156, "GENE"], [184, 187, "GENE"]]}], ["Individuals with \u22651 segment with a reversible defect received double-blind caffeine tablets (200 or 400\u00a0mg) or placebo 90\u00a0min before a repeat regadenoson stress MPI (MPI-3) on day 5.", {"entities": [[161, 164, "GENE"], [166, 169, "GENE"]]}], ["Overall, 207 subjects completed the study (caffeine 200\u00a0mg, n \u00a0=\u00a070; caffeine 400\u00a0mg, n \u00a0=\u00a071; placebo, n \u00a0=\u00a066).", {"entities": []}], ["The mean number of segments with reversible defects decreased from MPI-2 to MPI-3 in the caffeine 200 and 400\u00a0mg groups versus no significant change in the placebo group [mean\u00a0\u00b1\u00a0standard deviation: \u22120.61\u00a0\u00b1\u00a01.097, \u22120.62\u00a0\u00b1\u00a01.367, and 0.12\u00a0\u00b1\u00a00.981, respectively (overall treatment effect, P \u00a0<\u00a00.001)].", {"entities": []}], ["The majority of subjects who received caffeine shifted to a lower ischemia size category from MPI-2 to MPI-3, with no clear pattern observed in subjects who received placebo.", {"entities": [[66, 74, "DISEASE"]]}], ["For caffeine exposed patients with \u22653 segments with reversible defects at MPI-2, 21/23 had fewer detected at MPI-3.", {"entities": []}], ["Both the 200 and 400\u00a0mg doses of caffeine significantly reduced the number of segments with reversible defects detected by regadenoson stress MPI.", {"entities": [[142, 145, "GENE"]]}], ["TGF-\u03b2 is an important mediator of pulmonary allergic inflammation, and it has been recently reported to be a potential inhibitor of lung tumor progression.", {"entities": []}], ["The correlation between cancer and allergic inflammatory diseases remains controversial.", {"entities": [[24, 30, "DISEASE"]]}], ["Thus, the aim of the present study was to evaluate the effects of pulmonary allergic inflammation and in particular the role of TGF-\u03b2 on cancer progression.", {"entities": [[137, 143, "DISEASE"]]}], ["Cancer cells were implanted in a BALB/c mice model of allergic airway inflammation, and tumor growth was measured.", {"entities": [[0, 6, "DISEASE"]]}], ["Apoptosis was evaluated by TUNEL assay, and TGF-\u03b2 was measured by ELISA.", {"entities": []}], ["Expression of proliferating cell nuclear antigen, TGF-\u03b2, TGF-\u03b2 receptors I and II, phospho-Smad2 and phospho-Smad4 was evaluated by immunohistochemistry and quantified using digital pathology.", {"entities": []}], ["The effect of a TGF-\u03b2 activity inhibitor and recombinant TGF-\u03b2 on tumor growth was analyzed.", {"entities": []}], ["The effect of exogenous TGF-\u03b2 on cell proliferation and apoptosis was evaluated in vitro.", {"entities": []}], ["Mice with allergic airway inflammation exhibited decreased tumor volumes due to cell proliferation inhibition and increased apoptosis.", {"entities": []}], ["TGF-\u03b2 was increased in the sera and tumor tissues of allergic mice.", {"entities": []}], ["TGF-\u03b2 activity inhibition increased tumor progression in allergic mice by enhancing proliferation and decreasing apoptosis of tumor cells.", {"entities": []}], ["The administration of TGF-\u03b2 resulted in reduced tumor growth.", {"entities": []}], ["This study is the first to establish an inverse relationship between allergic airway inflammation and tumor progression.", {"entities": []}], ["This effect appears to be mediated by TGF-\u03b2, which is overexpressed in tumor cells during pulmonary allergic inflammation.", {"entities": []}], ["This study indicates that TGF-\u03b2 is a potential target for antitumor therapy.", {"entities": []}], ["The online version of this article (doi:10.1007/s00262-015-1722-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Positive activity behaviours (i.e.", {"entities": []}], ["higher physical activity [PA]/lower sedentary behaviour [SB]) are beneficial from infancy, yet evidence suggests that young children (0\u2010 to 6\u2010year\u2010olds) are relatively inactive.", {"entities": []}], ["To better understand the perceived influences on these behaviours and to aid intervention development, this paper systematically synthesizes the extensive qualitative literature regarding perceived barriers and facilitators to PA and SB in young children (0\u20136\u00a0years old).", {"entities": []}], ["A search of eight electronic databases (July 2016) identified 43 papers for inclusion.", {"entities": []}], ["Data extraction and evidence synthesis were conducted using thematic content analysis, underpinned by the socio\u2010ecological model (i.e.", {"entities": []}], ["individual, interpersonal, community, organizational and policy levels).", {"entities": []}], ["Parents, childcare providers and children perceived seven broad themes to be important for PA and SB, including the child; the home; out\u2010of\u2010home childcare; parent\u2013childcare provider interactions; environmental factors; safety; and weather.", {"entities": []}], ["Each theme mapped onto between one and five levels of the socio\u2010ecological model; barriers and facilitators at the interpersonal level (e.g.", {"entities": []}], ["parents, care providers and family) were most frequently cited, reflecting the important (perceived) role adults/peers play in shaping young children's behaviours.", {"entities": []}], ["We provide an overarching framework to explain PA and SB in early childhood.", {"entities": []}], ["We also highlight where gaps in the current literature exist (e.g.", {"entities": []}], ["from male carers; in developing countries; and barriers and facilitators in the environmental and policy domains) and where future quantitative work may focus to provide novel insights about children's activity behaviours (e.g.", {"entities": []}], ["safety and weather).", {"entities": []}], ["Several studies have reported age-associated changes in DNA methylation in the first few years of life and in adult populations, but the extent of such changes during childhood is less well studied.", {"entities": []}], ["The goals of this study were to investigate to what degree intra-individual changes in DNA methylation are associated with aging during childhood and dissect the methylation changes directly associated with aging from the effect mediated through variation in cell-type composition (CTC).", {"entities": []}], ["We performed reduced representation bisulfite sequencing (RRBS) in peripheral whole-blood samples collected at 2, 10, and 16\u00a0years of age.", {"entities": []}], ["We identified age-associated longitudinal changes in DNA methylation at 346 CpGs in 178 genes.", {"entities": []}], ["Analyses separating the effect mediated by CTC variability across age identified 26 CpGs located in 12 genes that associated directly with age.", {"entities": []}], ["Hence, the CTC changes across age appear to act as a mediator of the observed DNA methylation associated with age.", {"entities": []}], ["The results were replicated using EpiTYPER in a second sample set selected from the same cohort.", {"entities": []}], ["Gene ontology analyses revealed enrichment of transcriptional regulation and developmental processes.", {"entities": []}], ["Further, comparisons of the mean DNA methylation differences between the time points reveal greater differences between 2 to 10\u00a0years and 10 to 16\u00a0years, suggesting that the identified age-associated DNA methylation patterns manifests in early childhood.", {"entities": []}], ["This study reveals insights into the epigenetic dynamics associated with aging early in life.", {"entities": []}], ["Such information could ultimately provide clues and point towards molecular pathways that are susceptible to aging-related disease-associated epigenetic dysregulation.", {"entities": []}], ["The online version of this article (doi:10.1186/s13148-016-0277-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chronic rhinosinusitis with nasal polyps is a chronic disease frequently seen in otorhinolaryngological practice.", {"entities": []}], ["Along with its chronic disease burden it creates high societal costs.", {"entities": []}], ["Therapy consists of long-term use of medication and, if insufficient, endoscopic sinus surgery.", {"entities": []}], ["No consensus exists on the right timing and extent of disease that warrants surgery.", {"entities": []}], ["Furthermore, there is lack of clinical knowledge about the benefit of surgery over medication only.", {"entities": []}], ["The current trial evaluates the clinical effectiveness and cost-effectiveness of endoscopic sinus surgery in addition to drug treatment versus medication exclusively in the adult patient group with nasal polyps.", {"entities": []}], ["A prospective, multicentre, superiority, randomised controlled (PolypESS) trial in 238 patients aged 18 years or older selected for primary or revision endoscopic sinus surgery by the otorhinolaryngologist was designed.", {"entities": []}], ["Patients will be randomised to either endoscopic sinus surgery in addition to medication or medical therapy only.", {"entities": []}], ["Relevant data will be collected prior to randomisation, at baseline and 3, 6, 12, 18 and 24\u00a0months after start of treatment.", {"entities": []}], ["Complete follow-up will be 24\u00a0months.", {"entities": []}], ["Primary outcome is disease-specific Health-related Quality of Life quantified by the SNOT-22 after 12-month follow-up.", {"entities": []}], ["Secondary outcomes are generic Health-related Quality of Life, cost-effectiveness, objective signs of disease and adverse effects of treatment.", {"entities": []}], ["Subgroup analyses will be performed to verify whether treatment effects differ among patient phenotypes.", {"entities": []}], ["The PolypESS trial will investigate tailored care in adult patients with chronic rhinosinusitis with nasal polyps and will result in improved clinical pathways to help to determine in which circumstances to perform surgery.", {"entities": []}], ["Dutch Trial Register, NTR4978 .", {"entities": []}], ["Registered on 27 November 2014.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-016-1728-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Overweight and obesity is a growing problem in Ireland.", {"entities": [[15, 22, "DISEASE"]]}], ["Many parents are unaware when their child is overweight or obese.", {"entities": []}], ["Our objectives were to examine parents\u2019 perceptions of a healthy diet and their children\u2019s BMI; and to evaluate the food offered to children in our paediatric in-patient unit.", {"entities": []}], ["A retrospective questionnaire was distributed to 95 patients and their families admitted over one month.", {"entities": []}], ["Seventy-eight had BMI values calculated (42 males, 36 females).", {"entities": []}], ["Twenty-one children (26.9%) were overweight/obese: 14/21 parents (66.7%) thought their child had a normal weight.", {"entities": []}], ["Sixty percent of children served dinner in the hospital were given fried potatoes.", {"entities": []}], ["Four had fruit/vegetables.", {"entities": []}], ["Forty-six parents brought food into hospital, of these 14 brought purchased food.", {"entities": []}], ["This study highlights the problem of child obesity in Ireland and parental underestimation of this problem.", {"entities": [[43, 50, "DISEASE"]]}], ["The nutritional value of food served to children in hospital needs to be improved and hospital admissions used as opportunities to promote healthy eating habits.", {"entities": []}], ["Asthma is characterized by aberrant airways including epithelial thickening, goblet cell hyperplasia, and smooth muscle hypertrophy within the airway wall.", {"entities": [[0, 6, "DISEASE"]]}], ["The current study examined whether kaempferol inhibited mast cell degranulation and prostaglandin (PG) release leading to the development of aberrant airways, using an in vitro model of dinitrophenylated bovine serum albumin (DNP-BSA)-sensitized rat basophilic leukemia (RBL-2H3) mast cells and an in vivo model of BSA-challenged asthmatic mice.", {"entities": [[261, 269, "DISEASE"]]}], ["Nontoxic kaempferol at 10\u201320 \u03bcM suppressed \u03b2-hexosaminidase release and cyclooxygenase 2 (COX2)-mediated production of prostaglandin D2 (PGD2) and prostaglandin F2\u03b1 (PGF2\u03b1) in sensitized mast cells.", {"entities": []}], ["Oral administration of \u226420 mg/kg kaempferol blocked bovine serum albumin (BSA) inhalation-induced epithelial cell excrescence and smooth muscle hypertrophy by attenuating the induction of COX2 and the formation of PGD2 and PGF2\u03b1, together with reducing the anti-\u03b1-smooth muscle actin (\u03b1-SMA) expression in mouse airways.", {"entities": []}], ["Kaempferol deterred the antigen-induced mast cell activation of cytosolic phospholipase A2 (cPLA2) responsive to protein kinase C\u03bc (PKC\u03bc) and extracellular signal-regulated kinase (ERK).", {"entities": []}], ["Furthermore, the antigen-challenged activation of Syk-phospholipase C\u03b3 (PLC\u03b3) pathway was dampened in kaempferol-supplemented mast cells.", {"entities": []}], ["These results demonstrated that kaempferol inhibited airway wall thickening through disturbing Syk-PLC\u03b3 signaling and PKC\u03bc-ERK-cPLA2-COX2 signaling in antigen-exposed mast cells.", {"entities": []}], ["Thus, kaempferol may be a potent anti-allergic compound targeting allergic asthma typical of airway hyperplasia and hypertrophy.", {"entities": [[66, 81, "DISEASE"], [75, 81, "DISEASE"]]}], ["Aqueous extract of macerated Vochysia rufa stem bark has been commonly used in the treatment of diabetes.", {"entities": []}], ["Therefore, we evaluated the antihyperglycemic and antioxidant effects of an extract of V .", {"entities": []}], ["rufa on the pancreata of streptozotocin (STZ)-induced diabetic rats.", {"entities": []}], ["Animals received one of the following treatments daily by oral gavage: water (diabetic-control), V .", {"entities": []}], ["rufa extract (diabetic- V .", {"entities": []}], ["rufa ), or glibenclamide (diabetic-GBD).", {"entities": []}], ["Total antioxidant capacity; levels of thiobarbituric acid reactive substances, reduced glutathione, and sulfhydryls; and superoxide dismutase, catalase, and glutathione peroxidase (GPx) activities were measured in the pancreas.", {"entities": []}], ["Biochemical analysis of serum total cholesterol and fractions, triglycerides, creatinine, urea, acid uric, ALP, \u03b3-GT, AST, and ALT was performed, and pancreatic \u03b2-cells positive for insulin were evaluated by immunohistochemistry.", {"entities": []}], ["Rats treated with extract exhibited a decrease in fasting blood glucose compared with levels in diabetic control rats.", {"entities": []}], ["GPx activity and sulfhydryl levels were significantly lower in diabetic- V .", {"entities": []}], ["rufa rats compared with those of diabetic-control rats.", {"entities": []}], ["rufa extract acted to normalize the biochemical alterations found in diabetic rats (diabetic-controls), as demonstrated by increases in urea, HDL, ALP, AST, and ALT.", {"entities": []}], ["Reduction in blood glucose was independent of an increase in insulin.", {"entities": []}], ["rufa extract was found to be composed of free sugars (inositol, galactose, glucose, mannose, sucrose, arabinose, and ribose) as the main metabolites.", {"entities": []}], ["Thus, aqueous extract of the stem bark of V .", {"entities": []}], ["rufa is capable of reducing blood glucose, resulting in an antioxidant effect on the pancreatic tissue of STZ-diabetic rats.", {"entities": []}], ["Standardized Patients (SPs) are actors trained to portray health care patients during the training and assessment of health care providers.", {"entities": []}], ["This paper describes the methods and costs associated with using SPs to evaluate the skills of telephone counselors working on a clinical trial that evaluated a telephone smoking cessation program tailored for smokers using Department of Veterans Affairs mental health clinics.", {"entities": []}], ["Conducting the SP exercises required five main steps: (1) Write a SP case description detailing patient demographics, demeanor, clinical symptoms and history, and instructions on how to respond to counseling, (2) Identify, select and train actors to portray the SP cases; (3) Conduct audio-taped counseling encounters between the SPs and counselors, (4) Rate the counselors on their core counseling competencies, (5) Provide feedback to counselors.", {"entities": []}], ["The SPs and study supervisors reported that the checklist was easy to use when rating the counselors.", {"entities": []}], ["Counselors reported that the SP encounters were realistic and helpful for practicing their clinical work and for building self-efficacy for working with real patients.", {"entities": []}], ["The labor costs of developing two SP cases and training two SP actors was approximately $1,475.", {"entities": []}], ["The per-session labor cost of conducting a 1-hour counseling session between one SP and one counselor was approximately $314.", {"entities": []}], ["Using SPs to train telephone counselors working on a clinical trial was feasible and offered training benefits beyond those provided by didactic instruction and role plays.", {"entities": []}], ["Our research group is now routinely using SPs for the training of incoming telephone counselors.", {"entities": []}], ["Fungi have a potential of using both as nutritive and medicinal food stuff.", {"entities": []}], ["Because of containing several therapeutic agents, they are reported to be used for hundreds of years to treat several diseases caused by bacteria, fungi, viruses and parasites.", {"entities": []}], ["The aim of this study is to determine the in vitro antimicrobial activity of Xylaria hypoxylon , which were collected from Yomra, Trabzon, Turkey.", {"entities": []}], ["X. hypoxylon samples were air dried and extracted by using ethanol.", {"entities": []}], ["Antimicrobial activity of X. hypoxylon ethanol extracts were investigated against 21 bacterial and 2 fungal strains, namely, Bacillus subtilis DSMZ 1971, Bacillus subtilis ATCC 6633, Candida albicans ATCC 10231, Candida albicans DSMZ 1386, Enterobacter aerogenes ATCC 13048, Enterococcus durans, Enterococcus faecalis ATCC 29212, Enterococcus faecium, Escherichia coli ATCC 25922, Escherichia coli CFAI, Klebsiella pneumoniae, Listeria innocula, Listeria monocytogenes ATCC 7644, Pseudomonas aeruginosa DSMZ 50071, Pseudomonas fluorescence P1, Salmonella enteritidis ATCC 13075, Salmonella infantis, Salmonella kentucky, Salmonella typhimurium SL 1344, Staphylococcus aureus ATCC 25923, Staphylococcus carnosus MC1.B, Staphylococcus epidermidis DSMZ 20044 and Streptococcus agalactiae DSMZ 6784 by using the disk diffusion method.", {"entities": []}], ["It is observed that ethanol extracts of X. hypoxylon has antimicrobial activity against several Gram positive and Gram negative microorganisms tested.", {"entities": []}], ["As a result of the study, an antimicrobial activity of X. hypoxylon found against most of strains used in the study.", {"entities": []}], ["The results of our study clearly puts forward that X. hypoxylon could have a possible medicinal use.", {"entities": []}], ["Direct immunofluorescence assays (DFA) are a rapid and inexpensive method for the detection of respiratory viruses and may therefore be used for surveillance.", {"entities": []}], ["Few epidemiological studies have been published based solely on DFA and none included respiratory picornaviruses and human metapneumovirus (hMPV).", {"entities": []}], ["We wished to evaluate the use of DFA for epidemiological studies with a long-term observation of respiratory viruses that includes both respiratory picornaviruses and hMPV.", {"entities": []}], ["Since 1998 all children hospitalized with respiratory illness at the University Hospital Bern have been screened with DFA for common respiratory viruses including adenovirus, respiratory syncytial virus (RSV), influenza A and B, and parainfluenza virus 1-3.", {"entities": [[210, 219, "DISEASE"]]}], ["In 2006 assays for respiratory picornaviruses and hMPV were added.", {"entities": []}], ["Here we describe the epidemiological pattern for these respiratory viruses detected by DFA in 10'629 nasopharyngeal aspirates collected from 8'285 patients during a 12-year period (1998-2010).", {"entities": []}], ["Addition of assays for respiratory picornaviruses and hMPV raised the proportion of positive DFA results from 35% to 58% (p < 0.0001).", {"entities": []}], ["Respiratory picornaviruses were the most common viruses detected among patients \u22651 year old.", {"entities": []}], ["The seasonal patterns and age distribution for the studied viruses agreed well with those reported in the literature.", {"entities": []}], ["In 2010, an hMPV epidemic of unexpected size was observed.", {"entities": []}], ["DFA is a valid, rapid, flexible and inexpensive method.", {"entities": []}], ["The addition of assays for respiratory picornaviruses and hMPV broadens its range of viral detection.", {"entities": []}], ["DFA is, even in the \"PCR era\", a particularly adapted method for the long term surveillance of respiratory viruses in a pediatric population.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) and asthma are common chronic diseases that are frequently accompanied by depression and/or anxiety.", {"entities": [[49, 55, "DISEASE"]]}], ["However, symptoms of depression and anxiety are often not recognized and therefore not treated.", {"entities": []}], ["Currently, only a few studies have tested new clinical approaches that could improve the treatment of co-morbid depression and anxiety in these groups of patients.", {"entities": []}], ["The present randomized controlled study will be conducted within the framework of PoZoB (Praktijk Ondersteuning Zuid-Oost Brabant), a large primary care organization in the Netherlands.", {"entities": []}], ["Patients with asthma/COPD and co-morbid anxiety/depression will be included in order to test the effectiveness of a disease management approach to treat these co-morbid disorders.", {"entities": [[14, 20, "DISEASE"]]}], ["Important elements of this approach are: 1) systematic screening to improve detection of anxiety and depression 2) treatment in case of positive screening 3) monitoring of anxiety and depression 4) intensified treatment in case of non-remission (stepped care).", {"entities": []}], ["The present study is a large primary care study on the treatment of co-morbid depression and anxiety in patients with asthma and COPD.", {"entities": [[118, 124, "DISEASE"]]}], ["Strengths of this study are its randomized design, the focus on implementation in primary care and the fact that it applies the latest findings on the treatment of depression and anxiety.", {"entities": []}], ["First results are expected in 2012/2013.", {"entities": []}], ["Netherlands Trial Register (NTR): NTR2626", {"entities": []}], ["Non-nutritive sweeteners (NNS) are increasingly consumed by children and pregnant women around the world, yet their long-term health impact is unclear.", {"entities": []}], ["Here, we review an emerging body of evidence suggesting that early-life exposure to NNS may adversely affect body composition and cardio-metabolic health.", {"entities": []}], ["Some observational studies suggest that children consuming NNS are at increased risk for obesity-related outcomes; however, others find no association or provide evidence of confounding.", {"entities": [[89, 96, "DISEASE"]]}], ["Fewer studies have examined prenatal NNS exposure, with mixed results from different analytical approaches.", {"entities": []}], ["There is a paucity of RCTs evaluating NNS in children, yielding inconsistent results that can be difficult to interpret due to study design limitations (e.g., choice of comparator, multifaceted interventions).", {"entities": []}], ["The majority of this research has been conducted in high-income countries.", {"entities": []}], ["Some rodent studies demonstrate adverse metabolic effects from NNS, but most have used extreme doses that are not relevant to humans, and few have distinguished prenatal from postnatal exposure.", {"entities": []}], ["Most studies focus on synthetic NNS in beverages, with few examining plant-derived NNS or NNS in foods.", {"entities": []}], ["Overall, there is limited and inconsistent evidence regarding the impact of early-life NNS exposure on the developmental programming of obesity and cardio-metabolic health.", {"entities": [[136, 143, "DISEASE"]]}], ["Further research and mechanistic studies are needed to elucidate these effects and inform dietary recommendations for expectant mothers and children worldwide.", {"entities": []}], ["Most women who give birth for the first time experience some form of perineal trauma.", {"entities": []}], ["Second\u2010degree tears contribute to long\u2010term consequences for women and are a risk factor for occult anal sphincter injuries.", {"entities": []}], ["The objective of this study was to evaluate a multifaceted midwifery intervention designed to reduce second\u2010degree tears among primiparous women.", {"entities": []}], ["An experimental cohort study where a multifaceted intervention consisting of 1) spontaneous pushing, 2) all birth positions with flexibility in the sacro\u2010iliac joints, and 3) a two\u2010step head\u2010to\u2010body delivery was compared with standard care.", {"entities": []}], ["Crude and Adjusted OR (95% CI ) were calculated between the intervention and the standard care group, for the various explanatory variables.", {"entities": []}], ["A total of 597 primiparous women participated in the study, 296 in the intervention group and 301 in the standard care group.", {"entities": []}], ["The prevalence of second\u2010degree tears was lower in the intervention group: [Adj.", {"entities": []}], ["OR 0.53 (95% CI 0.33\u20130.84)].", {"entities": []}], ["A low prevalence of episiotomy was found in both groups (1.7 and 3.0%).", {"entities": []}], ["The prevalence of epidural analgesia was 61.1 percent.", {"entities": []}], ["Despite the high use of epidural analgesia, the midwives in the intervention group managed to use the intervention.", {"entities": []}], ["It is possible to reduce second\u2010degree tears among primiparous women with the use of a multifaceted midwifery intervention without increasing the prevalence of episiotomy.", {"entities": []}], ["Furthermore, the intervention is possible to employ in larger maternity wards with midwives caring for women with both low\u2010 and high\u2010risk pregnancies.", {"entities": []}], ["To investigate trends in the prevalence of allergic disease over a 9-year period.", {"entities": []}], ["Using National Health Insurance Service (NHIS) data, the annual number of patients with allergic disease was obtained for each regional subdivisions (small cities, counties, and districts) from 2003 to 2011.", {"entities": []}], ["Annual populations for each sub-region were obtained and used to calculate the standardized prevalence.", {"entities": []}], ["To compare prevalence within the study period, data was standardized spatially and temporally.", {"entities": []}], ["For standardization, demographic data was used to obtain the registered population and demographic structure for 2010, which was used to perform direct standardization of previous years.", {"entities": []}], ["In addition, a geographic information system (GIS) was used to visualize prevalence for individual sub-regions, and allergic diseases were categorized into five groups according to prevalence.", {"entities": []}], ["The nationwide outpatient prevalence of allergic rhinitis increased approximately 2.3-fold, from 1.27% in 2003 to 2.97% in 2013, while inpatient prevalence also increased approximately 2.4-fold,.", {"entities": [[40, 57, "DISEASE"], [49, 57, "DISEASE"]]}], ["The outpatient prevalence of asthma increased 1.2-fold, and inpatient prevalence increased 1.3-fold.", {"entities": [[29, 35, "DISEASE"]]}], ["The outpatient prevalence of atopic dermatitis decreased approximately 12%, and inpatient prevalence decreased 5%.", {"entities": [[29, 46, "DISEASE"], [36, 46, "DISEASE"]]}], ["There was a large difference between prevalence estimated from actual treatment data and prevalence based on patients\u2019 self-reported data, particularly for allergic rhinitis.", {"entities": [[156, 173, "DISEASE"], [165, 173, "DISEASE"]]}], ["Prevalence must continually be calculated and trends should be analyzed for the efficient management of allergic diseases.", {"entities": []}], ["To this end, prevalence studies using NHIS claims data may be useful.", {"entities": []}], ["The effects of natural adjuvants on lung inflammation and tracheal responsiveness were examined in sensitized guinea pigs.", {"entities": []}], ["The responses of guinea pig tracheal chains and the serum levels of interleukin-4 and interferon-gamma were examined in control pigs and three other groups of guinea pigs: the sensitized group and two other sensitized groups treated with either adjuvant G2 or adjuvant G2F (n\u200a=\u200a7 for each group).", {"entities": []}], ["Sensitization of the animals was achieved by injection and inhalation of ovalbumin.", {"entities": []}], ["The results showed that sensitized animals had increased tracheal responsiveness and increased serum levels of interleukin-4 and interferon-gamma compared to controls ( p <0.05 to p <0.001).", {"entities": []}], ["Treatments with either G2 or G2F prevented the increase in tracheal responsiveness and serum interleukin-4 ( p <0.01 to p <0.001).", {"entities": []}], ["However, the serum levels of interferon-gamma and the interleukin-4-to-interferon-gamma ratio was increased in the treated groups ( p <0.001 for all cases).", {"entities": []}], ["These results indicate important preventive effects of two natural adjuvants, particularly G2, on the changes in tracheal responsiveness, serum cytokines and the interleukin-4-to-interferon-gamma ratio (T helper 1/T helper 2 balance) in sensitized guinea pigs.", {"entities": []}], ["The Korean National Health Insurance, which provides universal coverage for the entire Korean population, is now facing financial instability.", {"entities": []}], ["Frequent emergency department (ED) users may represent a medically vulnerable population who could benefit from interventions that both improve care and lower costs.", {"entities": []}], ["To understand the nature of frequent ED users in Korea, we analyzed claims data from a population-based national representative sample.", {"entities": []}], ["We performed both bivariate and multivariable analyses to investigate the association between patient characteristics and frequent ED use (4+ ED visits in a year) using claims data of a 1% random sample of the Korean population, collected in 2009.", {"entities": []}], ["Among 156,246 total ED users, 4,835 (3.1%) were frequent ED users.", {"entities": []}], ["These patients accounted for 14% of 209,326 total ED visits and 17.2% of $76,253,784 total medical expenses generated from all ED visits in the 1% data sample.", {"entities": []}], ["Frequent ED users tended to be older, male, and of lower socio-economic status compared with occasional ED users (p < 0.001 for each).", {"entities": []}], ["Moreover, frequent ED users had longer stays in the hospital when admitted, higher probability of undergoing an operative procedure, and increased mortality.", {"entities": []}], ["Among 8,425 primary diagnoses, alcohol-related complaints and schizophrenia showed the strongest positive correlation with the number of ED visits.", {"entities": [[62, 75, "DISEASE"]]}], ["Among the frequent ED users, mortality and annual outpatient department visits were significantly lower in the alcohol-related patient subgroup compared with other frequent ED users; furthermore, the rate was even lower than that for non-frequent ED users.", {"entities": []}], ["Our findings suggest that expanding mental health and alcohol treatment programs may be a reasonable strategy to decrease the dependence of these patients on the ED.", {"entities": []}], ["Chili hotness is very much dependent on the concentration of capsaicin present in the chili fruit.", {"entities": []}], ["A new biosensor based on a horseradish peroxidase enzyme-capsaicin reaction mediated by ferrocene has been successfully developed for the amperometric determination of chili hotness.", {"entities": []}], ["The amperometric biosensor is fabricated based on a single-step immobilization of both ferrocene and horseradish peroxidase in a photocurable hydrogel membrane, poly(2-hydroxyethyl methacrylate).", {"entities": []}], ["With mediation by ferrocene, the biosensor could measure capsaicin concentrations at a potential 0.22 V ( vs .", {"entities": []}], ["Ag/AgCl), which prevented potential interference from other electroactive species in the sample.", {"entities": []}], ["Thus a good selectivity towards capsaicin was demonstrated.", {"entities": []}], ["The linear response range of the biosensor towards capsaicin was from 2.5\u201399.0 \u03bcM with detection limit of 1.94 \u03bcM.", {"entities": []}], ["A good relative standard deviation (RSD) for reproducibility of 6.4%\u20139.9% was obtained.", {"entities": []}], ["The capsaicin biosensor demonstrated long-term stability for up to seven months.", {"entities": []}], ["The performance of the biosensor has been validated using a standard method for the analysis of capsaicin based on HPLC.", {"entities": []}], ["A better understanding of how social medicine evolved, says Porter, could help to focus its role in responding to the health needs of a post-industrial, globalizing world.", {"entities": []}], ["There is a paucity of data on the pulmonary immune-compartment interferon gamma (IFN \u03b3 ) response to M. tuberculosis , particularly in settings of high tuberculosis (TB) prevalence and in HIV-coinfected individuals.", {"entities": [[104, 116, "DISEASE"], [152, 164, "DISEASE"]]}], ["This data is necessary to understand the diagnostic potential of commercially available interferon gamma release assays (IGRAs) in both the pulmonary immune-compartment and peripheral blood.", {"entities": []}], ["We used intracellular cytokine staining by flow cytometry to assess the IFN \u03b3 response to purified protein derivative (PPD) and early secretory antigen 6 (ESAT6) in induced sputa (ISp) and blood samples from HIV-infected, smear-negative, TB suspects.", {"entities": []}], ["We found that individuals with active TB disease produced significantly less IFN \u03b3 in response to PPD in their induced sputa samples than individuals with non-active TB (control group).", {"entities": []}], ["This difference was not reflected in the peripheral blood, even within the CD27\u2212 CD4+ memory T lymphocyte population.", {"entities": []}], ["These findings suggest that progression to active TB disease may be associated with the loss of IFN \u03b3 secretion at the site of primary infection.", {"entities": []}], ["Our findings highlight the importance of studying pulmonary immune-compartment M. tuberculosis specific responses to elucidate IFN \u03b3 secretion across the spectrum of TB disease.", {"entities": [[82, 94, "DISEASE"]]}], ["Finasteride is a competitive inhibitor of 5 alpha-reductase enzyme, and is used for treatment of benign prostatic hyperplasia and androgenetic alopecia.", {"entities": [[143, 151, "DISEASE"]]}], ["Animal studies have shown that finasteride might induce behavioral changes.", {"entities": []}], ["Additionally, some cases of finasteride-induced depression have been reported in humans.", {"entities": []}], ["The purpose of this study was to examine whether depressive symptoms or anxiety might be induced by finasteride administration.", {"entities": []}], ["One hundred and twenty eight men with androgenetic alopecia, who were prescribed finasteride (1 mg/day) were enrolled in this study.", {"entities": [[51, 59, "DISEASE"]]}], ["Information on depressed mood and anxiety was obtained by Beck Depression Inventory (BDI), and Hospital Anxiety and Depression Scale (HADS).", {"entities": []}], ["Participants completed BDI and HADS questionnaires before beginning the treatment and also two months after it.", {"entities": []}], ["Mean age of the subjects was 25.8(\u00b1 4.4) years.", {"entities": []}], ["At baseline, mean BDI and HADS depression scores were 12.11(\u00b1 7.50) and 4.04(\u00b1 2.51), respectively.", {"entities": []}], ["Finasteride treatment increased both BDI (p < 0.001) and HADS depression scores significantly (p = 0.005).", {"entities": []}], ["HADS anxiety scores were increased, but the difference was not significant (p = 0.061).", {"entities": []}], ["This preliminary study suggests that finasteride might induce depressive symptoms; therefore this medication should be prescribed cautiously for patients with high risk of depression.", {"entities": []}], ["It seems that further studies would be necessary to determine behavioral effects of this medication in higher doses and in more susceptible patients.", {"entities": []}], ["A 56-year-old female with adult-onset asthma was admitted to the cardiology service with intermittent left-sided chest pain and progressive dyspnoea.", {"entities": [[38, 44, "DISEASE"]]}], ["Twelve months prior to this admission, she had received a course of prednisolone for bilateral anterior uveitis.", {"entities": [[95, 111, "DISEASE"], [104, 111, "DISEASE"]]}], ["Physical examination was unremarkable with blood sampling revealing a marked eosinophilia (eosinophil count 17.3\u00d710 What is the most appropriate therapy?", {"entities": [[77, 89, "DISEASE"]]}], ["Beta-blockade and ACE inhibition Methylprednisolone Intravenous antibiotics Endocardiectomy Implantable cardioverter defibrillator (ICD) Beta-blockade and ACE inhibition Methylprednisolone Intravenous antibiotics Endocardiectomy Implantable cardioverter defibrillator (ICD)", {"entities": []}], ["Indicators of quality of care for children in hospitals in low-income countries have been proposed, but information on their perceived validity and acceptability is lacking.", {"entities": []}], ["Potential indicators representing structural and process aspects of care for six common conditions were selected from existing, largely qualitative WHO assessment tools and guidelines.", {"entities": []}], ["We employed the Delphi technique, which combines expert opinion and existing scientific information, to assess their perceived validity and acceptability.", {"entities": []}], ["Panels of experts, one representing an international panel and one a national (Kenyan) panel, were asked to rate the indicators over 3 rounds and 2 rounds respectively according to a variety of attributes.", {"entities": []}], ["Based on a pre-specified consensus criteria most of the indicators presented to the experts were accepted: 112/137(82%) and 94/133(71%) for the international and local panels respectively.", {"entities": []}], ["For the other indicators there was no consensus; none were rejected.", {"entities": []}], ["Most indicators were rated highly on link to outcomes, reliability, relevance, actionability and priority but rated more poorly on feasibility of data collection under routine conditions.", {"entities": []}], ["There was moderate to substantial agreement between the two panels of experts.", {"entities": []}], ["This Delphi study provided evidence for the perceived usefulness of most of a set of measures of quality of hospital care for children proposed for use in low-income countries.", {"entities": []}], ["However, both international and local experts expressed concerns that data for many process-based indicators may not currently be available.", {"entities": []}], ["The feasibility of widespread quality assessment and responsiveness of indicators to intervention should be examined as part of continued efforts to improve approaches to informative hospital quality assessment.", {"entities": []}], ["Physical activity plays an important role in the prevention and treatment of chronic musculoskeletal pain, but chronic pain may implicate a poor rehabilitation outcome.", {"entities": []}], ["The concept of physical activity on prescription (PAP) is a therapeutic option for various diseases, but there is a lack of knowledge about how patients with chronic musculoskeletal pain experience receiving the prescription.", {"entities": []}], ["The objective of this study was to describe the experiences of and thoughts about receiving a prescription for physical activity of people with chronic musculoskeletal pain.", {"entities": []}], ["Interviews analysed using qualitative content analysis with an inductive approach.", {"entities": []}], ["Three primary healthcare centres in a mixed rural and suburban area in the vicinity of a large city in western Sweden.", {"entities": []}], ["Fifteen individuals with chronic musculoskeletal pain.", {"entities": []}], ["Four categories were identified with the overarching theme \u201cPhysical activity in chronic pain requires extra support\u201d.", {"entities": []}], ["There were several barriers for increasing activity level and these patients suffered from the additional burden of pain.", {"entities": []}], ["The categories were: \u201cImportant to identify needs\u201d, \u201cBarriers and facilitators for physical activity\u201d, \u201cPerceptions of PAP vary\u201d and \u201cEffects found of receiving PAP\u201d.", {"entities": []}], ["Despite the many positive experiences of receiving PAP, patients described confusion about the role and execution of PAP.", {"entities": []}], ["Chronic pain is an additional barrier for increasing activity level, and it is crucial to consider these patients\u2019 circumstances.", {"entities": []}], ["This study suggests that patients with chronic musculoskeletal pain have a greater need for information and extra support to overcome existing barriers, before or when physical activity is prescribed.", {"entities": []}], ["Physical activity is important for prevention and treatment of chronic pain and has earlier been shown to be increased by \u201cphysical activity on prescription\u201d.", {"entities": []}], ["Patients with chronic musculoskeletal pain required the prescriber to listen and take the patients\u2019 circumstances, context, symptoms and current activity level into account to a greater extent.", {"entities": []}], ["Patients with chronic musculoskeletal pain experienced more obstacles to increase their physical activity and, therefore, had a greater need for individually tailored information and support when prescribed physical activity.", {"entities": []}], ["Patients with chronic musculoskeletal pain found it difficult to distinguish between physical activity on prescription and physiotherapy and perceived that also the physicians could not tell the difference.", {"entities": []}], ["Physical activity is important for prevention and treatment of chronic pain and has earlier been shown to be increased by \u201cphysical activity on prescription\u201d.", {"entities": []}], ["Patients with chronic musculoskeletal pain required the prescriber to listen and take the patients\u2019 circumstances, context, symptoms and current activity level into account to a greater extent.", {"entities": []}], ["Patients with chronic musculoskeletal pain experienced more obstacles to increase their physical activity and, therefore, had a greater need for individually tailored information and support when prescribed physical activity.", {"entities": []}], ["Patients with chronic musculoskeletal pain found it difficult to distinguish between physical activity on prescription and physiotherapy and perceived that also the physicians could not tell the difference.", {"entities": []}], ["Acute exacerbations of chronic obstructive pulmonary disease (COPD) represent a major burden for patients and health care systems.", {"entities": [[23, 60, "DISEASE"]]}], ["Respiratory rehabilitation may improve prognosis in these patients by addressing relevant risk factors for exacerbations such as low exercise capacity.", {"entities": []}], ["To study whether respiratory rehabilitation after acute exacerbation improves prognosis and health status compared to usual care, we quantified its effects using meta-analyses.", {"entities": []}], ["Systematic review of randomized controlled trials identified by searches in six electronic databases, contacts with experts, hand-searches of bibliographies of included studies and conference proceedings.", {"entities": []}], ["We included randomized trials comparing the effect of respiratory rehabilitation and usual care on hospital admissions, health-related quality of life (HRQL), exercise capacity and mortality in COPD patients after acute exacerbation.", {"entities": []}], ["Two reviewers independently selected relevant studies, extracted the data and evaluated the study quality.", {"entities": []}], ["We pooled the results using fixed effects models where statistically significant heterogeneity (p \u2264 0.1) was absent.", {"entities": []}], ["We identified six trials including 230 patients.", {"entities": []}], ["Respiratory rehabilitation reduced the risk for hospital admissions (pooled relative risk 0.26 [0.12\u20130.54]) and mortality (0.45 [0.22\u20130.91]).", {"entities": []}], ["Weighted mean differences on the Chronic Respiratory Questionnaire were 1.37 (95% CI 1.13\u20131.61) for the fatigue domain, 1.36 (0.94\u20131.77) for emotional function and 1.88 (1.67\u20132.09) for mastery.", {"entities": []}], ["Weighted mean differences for the St. Georges Respiratory Questionnaire total score, impacts and activities domains were -11.1 (95% CI -17.1 to -5.2), -17.1 (95% CI -23.6 to -10.7) and -9.9 (95% CI -18.0 to -1.7).", {"entities": []}], ["In all trials, rehabilitation improved exercise capacity (64\u2013215 meters in six-minute walk tests and weighted mean difference for shuttle walk test 81 meter, 95% CI 48\u2013115).", {"entities": []}], ["Evidence from six trials suggests that respiratory rehabilitation is effective in COPD patients after acute exacerbation.", {"entities": []}], ["Larger trials, however, are needed to further investigate the role of respiratory rehabilitation after acute exacerbation and its potential to reduce costs caused by COPD.", {"entities": []}], ["High levels of asthma prevalence and severity of respiratory symptoms have been found in the Caribbean but little is known about the impact of air pollution in these regions.", {"entities": [[15, 21, "DISEASE"]]}], ["This study aimed to describe air pollution and measure the associations with child lung function in Guadeloupe (French West Indies).", {"entities": []}], ["Data from 30 randomly chosen elementary schools (8\u201313 years old) were obtained using a standardized protocol adapted from the ISAAC2 study.", {"entities": []}], ["We considered two health outcomes: peak expiratory flow (PEF) before running and the variation in peak expiratory flow (\u0394PEF) after running.", {"entities": []}], ["The associations between pollutants and outcomes were investigated using several air pollution exposure models: i) medium-term exposure to close-proximity pollution both indoor and outdoor for ozone (O 3 ) and nitrogen dioxide (NO 2 ) and ii) short- and medium-term exposure to background pollution for O 3 , NO 2 , sulphur dioxide (SO 2 ) and small particulate matter (PM 10 ).", {"entities": []}], ["Of 1,463 children, 277 (16%) were found to have asthma.", {"entities": [[48, 54, "DISEASE"]]}], ["A 1-\u03bcg/m3 increase in medium-term exposure to outdoor close-proximity pollution by O 3 was associated with a PEF decrease (\u03b2\u2009=\u2009\u22120.32; 95% CI: \u22120.61;-0.03).", {"entities": []}], ["No association was found with NO 2 regarding close-proximity pollution.", {"entities": []}], ["The association between medium-term exposure to background pollution and PEF decrease was stronger in asthmatic children than in non-asthmatic children for O 3.", {"entities": []}], ["No reduction in PEF or \u0394PEF was shown with NO 2 , SO 2 and PM 10 pollutants but a significant association was found between PM 10 and PEF increase.", {"entities": []}], ["Our results suggest that O 3 could have an acute effect on child lung function in the Caribbean even at a low concentration (below the WHO guidelines).", {"entities": []}], ["Further research in the Caribbean is needed to confirm these findings.", {"entities": []}], ["The study aimed to identify the potential biomarkers in pulmonary tuberculosis (TB) and TB latent infection based on bioinformatics analysis.", {"entities": [[66, 78, "DISEASE"], [56, 78, "DISEASE"]]}], ["The microarray data of GSE57736 were downloaded from Gene Expression Omnibus database.", {"entities": []}], ["A total of 7 pulmonary TB and 8 latent infection samples were used to identify the differentially expressed genes (DEGs).", {"entities": []}], ["The protein-protein interaction (PPI) network was constructed by Cytoscape software.", {"entities": []}], ["Then network-based neighborhood scoring analysis was performed to identify the important genes.", {"entities": []}], ["Furthermore, the functional enrichment analysis, correlation analysis and logistic regression analysis for the identified important genes were performed.", {"entities": []}], ["A total of 1084 DEGs were identified, including 565 down- and 519 up-regulated genes.", {"entities": []}], ["The PPI network was constructed with 446 nodes and 768 edges.", {"entities": []}], ["Down-regulated genes RIC8 guanine nucleotide exchange factor A ( RIC8A ), basic leucine zipper transcription factor, ATF-like ( BATF ) and microtubule associated monooxygenase, calponin LIM domain containing 1 ( MICAL1 ) and up-regulated genes ATPase, Na+/K+ transporting, alpha 4 polypeptide ( ATP1A4 ), histone cluster 1, H3c ( HIST1H3C ), histone cluster 2, H3d ( HIST2H3D ), histone cluster 1, H3e ( HIST1H3E ) and tyrosine kinase 2 ( TYK2 ) were selected as important genes in network-based neighborhood scoring analysis.", {"entities": [[128, 132, "GENE"], [295, 301, "GENE"], [330, 338, "GENE"], [367, 375, "GENE"], [404, 412, "GENE"], [439, 443, "GENE"]]}], ["The functional enrichment analysis results showed that these important DEGs were mainly enriched in regulation of osteoblast differentiation and nucleoside triphosphate biosynthetic process.", {"entities": []}], ["The gene pairs RIC8A - ATP1A4 , HIST1H3C - HIST2H3D , HIST1H3E - BATF and MICAL1 - TYK2 were identified with high positive correlations.", {"entities": [[23, 29, "GENE"], [32, 40, "GENE"], [43, 51, "GENE"], [54, 62, "GENE"], [65, 69, "GENE"], [83, 87, "GENE"]]}], ["Besides, these genes were selected as significant feature genes in logistic regression analysis.", {"entities": []}], ["The genes such as RIC8A , ATP1A4 , HIST1H3C , HIST2H3D , HIST1H3E , BATF , MICAL1 and TYK2 may be potential biomarkers in pulmonary TB or TB latent infection.", {"entities": [[26, 32, "GENE"], [35, 43, "GENE"], [46, 54, "GENE"], [57, 65, "GENE"], [68, 72, "GENE"], [86, 90, "GENE"]]}], ["Primary windpipe tumour is extremely rare.", {"entities": []}], ["Squamous cell carcinoma is the most common malignant form, especially in smokers.", {"entities": [[14, 23, "DISEASE"]]}], ["The radiological appearance of these neoplasms can be classified as intra-luminal, wall-thickening, exophytic form; the majority of the lesions are obstructive in nature and then tend to extra-luminal invasion.", {"entities": []}], ["This tumour is usually diagnosed late on account of delayed specific symptoms: haemoptysis, dyspnoea, coughing, hoarseness, stridor.", {"entities": []}], ["Surgery, followed by adjuvant radiotherapy, is the treatment of choice; primary radiotherapy, in inoperable cases, can represent a curative management option.", {"entities": []}], ["A case of primary tracheal cancer is described and a review of the literature is presented.", {"entities": [[18, 33, "DISEASE"], [27, 33, "DISEASE"]]}], ["The vitamin D recommended doses during pregnancy differ between societies.", {"entities": []}], ["The WHO guidelines do not recommend routine prenatal supplementation, but they underscore the fact that women with the lowest levels may benefit most.", {"entities": []}], ["The effects of routine supplementation during pregnancy on maternal and neonatal clinical outcomes have not been investigated in the Middle East, where hypovitaminosis D is prevalent.", {"entities": []}], ["Our hypothesis is that in Middle Eastern pregnant women, a vitamin D dose of 3000\u2005IU/day is required to reach a desirable maternal 25-hydroxyvitamin D [25(OH)D] level, and to positively impact infant bone mineral content (BMC).", {"entities": []}], ["This is a multicentre blinded randomised controlled trial.", {"entities": []}], ["Pregnant women presenting to the Obstetrics and Gynaecology clinics will be approached.", {"entities": []}], ["Eligible women will be randomised to daily equivalent doses of cholecalciferol, 600\u2005IU or 3000\u2005IU, from 15 to 18\u2005weeks gestation until delivery.", {"entities": []}], ["Maternal 25(OH)D and chemistries will be assessed at study entry, during the third trimester and at delivery.", {"entities": []}], ["Neonatal anthropometric variables and 25(OH)D level will be measured at birth, and bone and fat mass assessment by dual-energy X-ray absorptiometry scan at 1\u2005month.", {"entities": []}], ["A sample size of 280 pregnant women is needed to demonstrate a statistically significant difference in the proportion of women reaching a 25(OH)D level \u226550\u2005nmol/L at delivery, and a difference in infant BMC of 6 (10)g, for a 90% power and a 2.5% level of significance.", {"entities": []}], ["The proportions of women achieving a target 25(OH)D level will be compared between the two arms, using \u03c7 The protocol has been approved by the Institutional Review Board at the American University of Beirut-Lebanon (IM.GEHF.22).", {"entities": []}], ["The trial results will be published in peer-reviewed medical journals and presented at scientific conferences.", {"entities": []}], ["NCT02434380.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease of the lungs that is currently the fourth leading cause of death worldwide.", {"entities": []}], ["Genetic factors account for only a small amount of COPD risk, but epigenetic mechanisms, including DNA methylation, have the potential to mediate the interactions between an individual\u2019s genetics and environmental exposure.", {"entities": []}], ["DNA methylation is highly cell type-specific, and individual cell type studies of DNA methylation in COPD are sparse.", {"entities": []}], ["Fibroblasts are present within the airway and parenchyma of the lung and contribute to the aberrant deposition of extracellular matrix in COPD.", {"entities": []}], ["No assessment or comparison of genome-wide DNA methylation profiles in the airway and parenchymal fibroblasts from individuals with and without COPD has been undertaken.", {"entities": []}], ["These data provide valuable insight into the molecular mechanisms contributing to COPD and the differing pathologies of small airways disease and emphysema in COPD.", {"entities": []}], ["Genome-wide DNA methylation was evaluated at over 485,000 CpG sites using the Illumina Infinium HumanMethylation450 BeadChip array in the airway (non-COPD n \u2009=\u20098, COPD n \u2009=\u20097) and parenchymal fibroblasts (non-COPD n \u2009=\u200917, COPD n \u2009=\u200929) isolated from individuals with and without COPD.", {"entities": []}], ["Targeted gene expression was assessed by qPCR in matched RNA samples.", {"entities": []}], ["Differentially methylated DNA regions were identified between cells isolated from individuals with and without COPD in both airway and parenchymal fibroblasts.", {"entities": []}], ["Only in parenchymal fibroblasts was differential DNA methylation associated with differential gene expression.", {"entities": []}], ["A second analysis of differential DNA methylation variability identified 359 individual differentially variable CpG sites in parenchymal fibroblasts.", {"entities": []}], ["No differentially variable CpG sites were identified in the airway fibroblasts.", {"entities": []}], ["Five differentially variable-methylated CpG sites, associated with three genes, were subsequently assessed for gene expression differences.", {"entities": []}], ["Two genes (OAT and GRIK2) displayed significantly increased gene expression in cells isolated from individuals with COPD.", {"entities": [[19, 24, "GENE"]]}], ["Differential and variable DNA methylation was associated with COPD status in the parenchymal fibroblasts but not airway fibroblasts.", {"entities": []}], ["Aberrant DNA methylation was associated with altered gene expression imparting biological function to DNA methylation changes.", {"entities": []}], ["Changes in DNA methylation are therefore implicated in the molecular mechanisms underlying COPD pathogenesis and may represent novel therapeutic targets.", {"entities": []}], ["The online version of this article (10.1186/s13148-018-0464-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Epidemiological and pedigree studies suggest that lung cancer results from the combined effects of age, smoking, impaired lung function and genetic factors.", {"entities": [[50, 61, "DISEASE"], [55, 61, "DISEASE"]]}], ["In a case control association study of healthy smokers and lung cancer cases, we identified genetic markers associated with either susceptibility or protection to lung cancer.", {"entities": [[59, 70, "DISEASE"], [163, 174, "DISEASE"], [64, 70, "DISEASE"], [168, 174, "DISEASE"]]}], ["We screened 157 candidate single nucleotide polymorphisms (SNP) in a discovery cohort of 439 subjects (200 controls and 239 lung cancer cases) and identified 30 SNPs associated with either the healthy smokers (protective) or lung cancer (susceptibility) phenotype.", {"entities": [[124, 135, "DISEASE"], [225, 236, "DISEASE"], [129, 135, "DISEASE"], [230, 236, "DISEASE"]]}], ["After genotyping this 30 SNP panel in a validation cohort of 491 subjects (248 controls and 207 lung cancers) and, using the same protective and susceptibility genotypes from our discovery cohort, a 20 SNP panel was selected based on replication of SNP associations in the validation cohort.", {"entities": []}], ["Following multivariate logistic regression analyses, including the selected SNPs from runs 1 and 2, we found age and family history of lung cancer to be significantly and independently associated with lung cancer.", {"entities": [[135, 146, "DISEASE"], [201, 212, "DISEASE"], [140, 146, "DISEASE"], [206, 212, "DISEASE"]]}], ["Numeric scores were assigned to both the SNP and demographic data, and combined to form a simple algorithm of risk.", {"entities": []}], ["Significant differences in the distribution of the lung cancer susceptibility score was found between normal controls and lung cancer cases, which remained after accounting for differences in lung function.", {"entities": [[51, 62, "DISEASE"], [122, 133, "DISEASE"], [56, 62, "DISEASE"], [127, 133, "DISEASE"]]}], ["Validation in other case-control and prospective cohorts are underway to further define the potential clinical utility of this model.", {"entities": []}], ["The diagnosis of chronic obstructive pulmonary disease (COPD) is usually made based on history and physical exam alone.", {"entities": [[17, 54, "DISEASE"]]}], ["Symptoms of dyspnea, cough, and wheeze are nonspecific and attributable to a variety of diseases.", {"entities": []}], ["Confirmatory testing to verify the airflow obstruction is available but rarely used, which may result in substantial misdiagnoses of COPD.", {"entities": []}], ["The aim of this study is to evaluate the use of confirmatory testing and assess the accuracy of the diagnosis.", {"entities": []}], ["From January 2011 through December 2013, 6,018 patients with COPD as a principal or leading diagnosis were admitted at a community teaching hospital.", {"entities": []}], ["Of those, only 504 (8.4%) patients had spirometry performed during hospitalization.", {"entities": []}], ["The studies were reviewed by two board-certified pulmonologists to verify presence of persistent airflow obstruction.", {"entities": []}], ["Charts of these patients were then examined to determine if the spirometry results had changed the diagnosis or the treatment plan for these patients.", {"entities": []}], ["Spirometry confirmed the diagnosis of COPD in 270 patients (69.2%) treated as COPD during their hospitalization.", {"entities": []}], ["Restrictive lung disease was found to be present in 104 patients (26.6%) and normal in 16 patients (4.2%).", {"entities": [[12, 24, "DISEASE"]]}], ["Factors predictive of airflow obstruction included smoking status and higher pack-year history.", {"entities": []}], ["Negative predictive factors included higher body mass index (BMI) and other medical comorbidities.", {"entities": []}], ["These patients were significantly more likely to be misdiagnosed and mistreated as COPD.", {"entities": []}], ["Up to a third of patients diagnosed and treated as COPD in the hospital may be inaccurately diagnosed as COPD based on confirmatory spirometry testing.", {"entities": []}], ["Factors contributing to the inaccuracy of diagnosis include less smoking history, high BMI, and associated comorbidities.", {"entities": []}], ["Angiolymphoid hyperplasia with eosinophilia (ALHE) is a vasocentric process characterized by infiltrates of lymphocytes and eosinophils, usually affecting the muscular arteries of the head and neck.", {"entities": [[31, 43, "DISEASE"]]}], ["Currently it is unclear whether it is a reactive or neoplastic process.", {"entities": []}], ["We present a 61-year-old African American male with a twenty year history of superficial skin patches involving the head and neck region.", {"entities": []}], ["An excisional biopsy of a right submental lymph node revealed an atypical T-cell lymphocytic process, diagnosed as peripheral T-cell lymphoma after immunophenotyping and molecular studies.", {"entities": [[133, 141, "DISEASE"]]}], ["Three months later the patient underwent a biopsy of a left temporal nodule that was diagnosed as ALHE.", {"entities": []}], ["Subsequently, at two year follow-up, the patient was diagnosed with Mycosis Fungoides.", {"entities": []}], ["Polymerase chain reaction for T cell receptor gamma showed the same T-cell receptor gene rearrangement in both the temporal mass and the right submental lymph node.", {"entities": []}], ["ALHE with molecular evidence of monoclonality is extremely unusual, as is the association with nodal peripheral T-cell nodal lymphoma.", {"entities": [[125, 133, "DISEASE"]]}], ["The findings of this case support our hypothesis that ALHE might be an early form of T-cell lymphoma.", {"entities": [[92, 100, "DISEASE"]]}], ["Compared with whites, sleep disturbance and sleep deprivation appear more prevalent in African Americans (AA).", {"entities": []}], ["Long-term sleep deprivation may increase the risk of obesity through multiple metabolic and endocrine alterations.", {"entities": [[53, 60, "DISEASE"]]}], ["Previous studies have reported contradictory results on the association between habitual sleep duration and obesity.", {"entities": [[108, 115, "DISEASE"]]}], ["Accordingly, we aimed to assess whether sleep quality and duration are inversely associated with body mass index (BMI) and obesity and test whether these associations are modified by psychosocial stress, known to influence sleep quality.", {"entities": [[123, 130, "DISEASE"]]}], ["A sample of 1,515 AA residents of metropolitan Atlanta, aged 30-65 years, was recruited by a random-digit-dialing method in 2007-08.", {"entities": []}], ["The outcome obesity was defined by BMI (kg/m The mean (standard deviation) age was 47.5 (17.0) years, and 1,096 (72%) were women.", {"entities": [[12, 19, "DISEASE"]]}], ["GSQ score categorized into tertiles was associated with BMI.", {"entities": []}], ["Among women, after multivariable adjustment that included age, gender, physical activity, smoking status, education, total family income, financial stress and history of hypertension, hypercholesterolemia, diabetes and myocardial infarction, obesity was associated with sleep quality as assessed by GSQ continuous score, [odds ratio, OR (95% C.I.", {"entities": [[170, 182, "DISEASE"], [242, 249, "DISEASE"], [219, 240, "DISEASE"]]}], ["): 1.08 (1.03 - 1.12)], and with a worse sleep disturbance subcomponent score [OR (95% C.I.", {"entities": []}], ["): 1.48 (1.16 - 1.89)].", {"entities": []}], ["Among all participants, stress modified the association between obesity and sleep quality; there was an increased likelihood of obesity in the medium stress category, OR (95% C.I.", {"entities": [[64, 71, "DISEASE"], [128, 135, "DISEASE"]]}], ["): 1.09 (1.02 - 1.17).", {"entities": []}], ["Sleep quality was associated with obesity in women.", {"entities": [[34, 41, "DISEASE"]]}], ["The association of sleep quality with obesity was modified by perceived stress.", {"entities": [[38, 45, "DISEASE"]]}], ["Our results indicate the need for simultaneous assessment of sleep and stress.", {"entities": []}], ["Supplementing pregnant and lactating mothers with small quantity lipid-based nutrient supplements (SQ-LNS) has resulted in improvements in birth outcomes in some low-income settings.", {"entities": []}], ["In order to be effective, SQ-LNS must be consumed regularly over sustained periods.", {"entities": []}], ["The objective was to assess and compare acceptability of and adherence to SQ-LNS consumption among pregnant and lactating women in Ghana and Malawi throughout 12\u00a0months of supplementation.", {"entities": []}], ["We enrolled women before 20 gestation weeks into randomized trials in Ghana ( n \u2009=\u20091320) and Malawi ( n \u2009=\u2009869).", {"entities": []}], ["In the SQ-LNS group participants received a 20\u00a0g sachet of supplement per day during pregnancy and the first 6\u00a0months of lactation.", {"entities": []}], ["In the control groups participants received multiple micronutrients (MMN) during pregnancy and lactation or iron and folic acid (IFA) during pregnancy and calcium during lactation.", {"entities": []}], ["We used questionnaires to collect data on self-reported adherence to daily use of supplements and conducted in-depth interviews with women in the SQ-LNS group to examine acceptability.", {"entities": []}], ["The mean self-reported adherence during the supplementation period was lower in Ghana (79.9\u00a0%) than in Malawi (91.7\u00a0%) for all supplements (difference 11.8\u00a0%, P \u2009<\u20090.001).", {"entities": []}], ["Over time, adherence increased in Malawi but decreased in Ghana.", {"entities": []}], ["In both countries, adherence in the SQ-LNS group was non-inferior to that in the control groups.", {"entities": []}], ["Participants typically reported consuming SQ-LNS as instructed but when interviewers queried about experiences, most of the women described incidents of non-adherence.", {"entities": []}], ["A usual reason for not consuming SQ-LNS was nausea and vomiting during pregnancy.", {"entities": []}], ["Especially in Malawi, women reported sharing SQ-LNS with families and friends.", {"entities": []}], ["Sustained use of SQ-LNS was attributed to expected health benefits and favorable sensory attributes.", {"entities": []}], ["Often women compared their pregnancy to previous ones, and were of the view that SQ-LNS made a positive difference.", {"entities": []}], ["Self-reported sustained adherence to consume SQ-LNS daily was high in both sites but lower in Ghana than in Malawi.", {"entities": []}], ["In Ghana, adherence decreased over time whereas in Malawi adherence increased.", {"entities": []}], ["Acceptability and adherence appeared interlinked, complex and context-related.", {"entities": []}], ["Sustained consumption of SQ-LNS may require tailoring interventions by context.", {"entities": []}], ["The Ghana trial was registered at clinicaltrials.gov as NCT00970866 , and the Malawi trial as NCT01239693 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-016-1039-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["UV light, especially UVB, is known as a trigger of allergic reaction, leading to mast cell degranulation and histamine release.", {"entities": []}], ["In this study, phlorotannin Fucofuroeckol-A (F-A) derived from brown algal Ecklonia stolonifera Okamura was evaluated for its protective capability against UVB-induced allergic reaction in RBL-2H3 mast cells.", {"entities": []}], ["It was revealed that F-A significantly suppress mast cell degranulation via decreasing histamine release as well as intracellular Ca E. stolonifera was suggested to be promising candidate for its protective capability against UVB-induced allergic reaction.", {"entities": []}], ["Neighbourhood environments have important implications for human health.", {"entities": []}], ["In this piece, we reflect on the environments and health literature and argue that precise use of language is critical for acknowledging the complex and multifaceted influence that neighbourhood environments may have on physical activity and physical activity-related outcomes.", {"entities": []}], ["Specifically, we argue that the term \u201cneighbourhood walkability\u201d, commonly used in the neighbourhoods and health literature, constrains recognition of the breadth of influence that neighbourhood environments might have on a variety of physical activity behaviours.", {"entities": []}], ["The term draws attention to a single type of physical activity and\u00a0implies that a universal association exists when in fact the literature is quite mixed.", {"entities": []}], ["To maintain neutrality in this area of research, we suggest that researchers adopt the term \u201cneighbourhood physical activity environments\u201d for collective measures of neighbourhood attributes that they wish to study in relation to physical activity behaviours or physical activity-related health outcomes.", {"entities": []}], ["Health-state utilities for prisoners have not been described.", {"entities": []}], ["We used data from a 1996 cross-sectional survey of Australian prisoners (n = 734).", {"entities": []}], ["Respondent-level SF-36 data was transformed into utility scores by both the SF-6D and Nichol's method.", {"entities": []}], ["Socio-demographic and clinical predictors of SF-6D utility were assessed in univariate analyses and a multivariate general linear model.", {"entities": []}], ["The overall mean SF-6D utility was 0.725 (SD 0.119).", {"entities": []}], ["When subdivided by various medical conditions, prisoner SF-6D utilities ranged from 0.620 for angina to 0.764 for those with none/mild depressive symptoms.", {"entities": []}], ["Utilities derived by the Nichol's method were higher than SF-6D scores, often by more than 0.1.", {"entities": []}], ["In multivariate analysis, significant independent predictors of worse utility included female gender, increasing age, increasing number of comorbidities and more severe depressive symptoms.", {"entities": []}], ["The utilities presented may prove useful for future economic and decision models evaluating prison-based health programs.", {"entities": []}], ["Polyvagal theory emphasizes that autonomic nervous system functioning plays a key role in social behavior and emotion.", {"entities": []}], ["The theory predicts that psychiatric disorders of social dysfunction are associated with reduced heart rate variability, an index of autonomic control, as well as social inhibition and avoidance.", {"entities": []}], ["The purpose of this study was to examine whether heart rate variability was reduced in treatment-seeking patients diagnosed with social anxiety disorder, a disorder characterized by social fear and avoidance.", {"entities": [[136, 152, "DISEASE"]]}], ["Social anxiety patients ( n \u200a=\u200a53) were recruited prior to receiving psychological therapy.", {"entities": []}], ["Healthy volunteers were recruited through the University of Sydney and the general community and were matched by gender and age ( n \u200a=\u200a53).", {"entities": []}], ["Heart rate variability was assessed during a five-minute recording at rest, with participants completing a range of self-report clinical symptom measures.", {"entities": []}], ["Compared to controls, participants with social anxiety exhibited significant reductions across a number of heart rate variability measures.", {"entities": []}], ["Reductions in heart rate variability were observed in females with social anxiety, compared to female controls, and in patients taking psychotropic medication compared to non-medicated patients.", {"entities": []}], ["Finally, within the clinical group, we observed significant associations between reduced heart rate variability and increased social interaction anxiety, psychological distress, and harmful alcohol use.", {"entities": []}], ["The results of this study confirm that social anxiety disorder is associated with reduced heart rate variability.", {"entities": [[46, 62, "DISEASE"]]}], ["Resting state heart rate variability may therefore be considered a marker for social approach-related motivation and capacity for social engagement.", {"entities": []}], ["Additionally, heart rate variability may provide a useful biomarker to explain underlying difficulties with social approach, impaired stress regulation, and behavioral inhibition, especially in disorders associated with significant impairments in these domains.", {"entities": []}], ["The adenosine A 2B receptor is the least well characterized of the four adenosine subtypes due to the lack of potent and selective agonists and antagonists.", {"entities": []}], ["Despite the widespread distribution of A 2B receptor mRNA, little information is available with regard to their function.", {"entities": []}], ["The characterization of A 2B receptors, through radioligand binding studies, has been performed, until now, by using low-affinity and non-selective antagonists like 1,3-dipropyl-8-cyclopentylxanthine ([ 2B receptors, [N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy]acetamide ([ 2B receptors.", {"entities": []}], ["The pharmacology of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl Mol.", {"entities": [[24, 39, "DISEASE"], [77, 81, "GENE"]]}], ["2005 , 54 , 1736 ).", {"entities": []}], ["For this purpose, we evaluated the ability of the previously and newly synthesized 4-imidazo[2,1- b ]thiazoles-1,4-dihydropyridines without vascular activity and inotropic and/or chronotropic cardiac effects ( J. Med.", {"entities": []}], ["2008 , 54 , 1592 ) to enhance the activity of \u0394F508-CFTR.", {"entities": []}], ["Our studies indicate compounds 17 , 18 , 20 , 21 , 38 , and 39 as 1,4-DHPs with an interesting profile of activity.", {"entities": []}], ["Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are pattern-recognition receptors similar to toll-like receptors (TLRs).", {"entities": []}], ["While TLRs are transmembrane receptors, NLRs are cytoplasmic receptors that play a crucial role in the innate immune response by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).", {"entities": []}], ["Based on their N-terminal domain, NLRs are divided into four subfamilies: NLRA, NLRB, NLRC, and NLRP.", {"entities": []}], ["NLRs can also be divided into four broad functional categories: inflammasome assembly, signaling transduction, transcription activation, and autophagy.", {"entities": []}], ["In addition to recognizing PAMPs and DAMPs, NLRs act as a key regulator of apoptosis and early development.", {"entities": []}], ["Therefore, there are significant associations between NLRs and various diseases related to infection and immunity.", {"entities": []}], ["NLR studies have recently begun to unveil the roles of NLRs in diseases such as gout, cryopyrin-associated periodic fever syndromes, and Crohn's disease.", {"entities": [[80, 84, "DISEASE"]]}], ["As these new associations between NRLs and diseases may improve our understanding of disease pathogenesis and lead to new approaches for the prevention and treatment of such diseases, NLRs are becoming increasingly relevant to clinicians.", {"entities": []}], ["In this review, we provide a concise overview of NLRs and their role in infection, immunity, and disease, particularly from clinical perspectives.", {"entities": []}], ["Despite a decrease in incidence, smoking remains the most serious public health problem worldwide.", {"entities": []}], ["Identification of the factors contributing to changes in willingness to quit smoking may aid the development of strategies that encourage smoking cessation.", {"entities": []}], ["Pooled cross-sectional data from 11,924 smokers from the Korean National Health and Nutrition Examination Survey II\u2013V were analyzed.", {"entities": []}], ["The stages of change in smoking cessation were categorized as pre-contemplation, contemplation, and preparation.", {"entities": []}], ["Baseline characteristics, socioeconomic factors, quality of life, psychological status, and smoking-related factors were compared between groups.", {"entities": []}], ["The smokers were grouped as follows: 32.4% pre-contemplation, 54.4% contemplation, and 13.1% preparation.", {"entities": []}], ["The proportion of smokers in the pre-contemplation group decreased (from 37.4% to 28.4%) from 2001 to 2012, while the proportion in the preparation group increased (from 6.4% to 18.1%).", {"entities": []}], ["Compared with the preparation group, after adjusting for confounding factors, the pre-contemplation group was older [\u226565 years-old; odds ratio (OR) = 1.40], more often single (OR = 1.38), less educated (elementary school or lower; OR = 1.93), less physically active in terms of walking (OR = 1.38) or performing strengthening exercises (OR = 1.61), smoked more heavily (\u226520 cigarettes per day; OR = 4.75), and had a lower prevalence of chronic disease (OR = 0.76).", {"entities": []}], ["Moreover, smokers who had never received education on smoking cessation were less willing to quit than those who had (OR = 0.44).", {"entities": []}], ["In Korean smokers, the stages of change for smoking cessation were associated with age, education, marital status, chronic diseases, physical activity, and participation in smoking cessation programs.", {"entities": []}], ["Neutrophil extracellular traps (NETs) consist of antimicrobial molecules embedded in a web of extracellular DNA.", {"entities": []}], ["Formation of NETs is considered to be a defense mechanism utilized by neutrophils to ensnare and kill invading pathogens, and has been recently termed NETosis.", {"entities": []}], ["Neutrophils can be stimulated to undergo NETosis ex vivo, and are predicted to contain high levels of serine proteases, such as neutrophil elastase (NE), cathepsin G (CG) and proteinase 3 (PR3).", {"entities": []}], ["Serine proteases are important effectors of neutrophil-mediated immunity, which function directly by degrading pathogenic virulent factors and indirectly via proteolytic activation or deactivation of cytokines, chemokines and receptors.", {"entities": []}], ["In this study, we utilized a diverse and unbiased peptide library to detect and profile protease activity associated with NETs induced by phorbol-12-myristate-13-acetate (PMA).", {"entities": []}], ["We obtained a \u201cproteolytic signature\u201d from NETs derived from healthy donor neutrophils and used proteomics to assist in the identification of the source of this proteolytic activity.", {"entities": []}], ["In addition, we profiled each neutrophil serine protease and included the newly identified enzyme, neutrophil serine protease 4 (NSP4).", {"entities": []}], ["Each enzyme had overlapping yet distinct endopeptidase activities and often cleaved at unique sites within the same peptide substrate.", {"entities": []}], ["The dominant proteolytic activity in NETs was attributed to NE; however, cleavage sites corresponding to CG and PR3 activity were evident.", {"entities": []}], ["When NE was immunodepleted, the remaining activity was attributed to CG and to a lesser extent PR3 and NSP4.", {"entities": []}], ["Our results suggest that blocking NE activity would abrogate the major protease activity associated with NETs.", {"entities": []}], ["In addition, the newly identified substrate specificity signatures will guide the design of more specific probes and inhibitors that target NET-associated proteases.", {"entities": []}], ["Experimental autoimmune encephalomyelitis (EAE) is an inflammatory, demyelinating disease of the CNS that mimics human multiple sclerosis (MS), and it is thought to be driven by Th1 and Th17 myelin-reactive cells.", {"entities": [[119, 137, "DISEASE"], [68, 89, "DISEASE"], [24, 41, "DISEASE"]]}], ["Although adaptive immunity is clearly pivotal in the pathogenesis of EAE, with an essential role of CD4 \u03b1 in pDCs, significantly reduced disease severity in EAE, relative to controls (12.63 \u00b1 1.86 versus 23.49 \u00b1 1.46, resp.", {"entities": [[100, 103, "GENE"]]}], ["; p = 0.001).", {"entities": []}], ["Treatment also delayed onset of neurological deficits and reduced spinal cord demyelination, while increasing the percentage of splenic regulatory (Foxp3 \u03b3 in the CNS.", {"entities": [[148, 153, "GENE"]]}], ["Mechanistic insight into those events showed that CpG-A promoted a regulatory phenotype in pDCs.", {"entities": []}], ["Moreover, adoptive transfer of pDCs isolated from CpG-A-treated mice inhibited CNS inflammation and induced disease remission in acute-phase EAE.", {"entities": []}], ["Our data thus identify a link between TLR9 activation by specific ligands and the induction of tolerance via innate immunity mechanisms.", {"entities": [[38, 42, "GENE"]]}], ["Association studies hold great promise for the elucidation of the genetic basis of diseases.", {"entities": []}], ["Studies based on functional single nucleotide polymorphisms (SNPs) or on linkage disequilibrium (LD) represent two main types of designs.", {"entities": []}], ["LD-based association studies can be comprehensive for common causative variants, but they perform poorly for rare alleles.", {"entities": []}], ["Conversely, functional SNP-based studies are efficient because they focus on the SNPs with the highest a priori chance of being associated.", {"entities": []}], ["Our poor ability to predict the functional effect of SNPs, however, hampers attempts to make these studies comprehensive.", {"entities": []}], ["Recent progress in comparative genomics, and evidence that functional elements tend to lie in conserved regions, promises to change the landscape, permitting functional SNP association studies to be carried out that comprehensively assess common and rare alleles.", {"entities": []}], ["SNP genotyping technologies are already sufficient for such studies, but studies will require continued genomic sequencing of multiple species, research on the functional role of conserved sequences and additional SNP discovery and validation efforts (including targeted SNP discovery to identify the rare alleles in functional regions).", {"entities": []}], ["With these resources, we expect that comprehensive functional SNP association studies will soon be possible.", {"entities": []}], ["Orai/CRACM1 ion channels provide the major Ca Ca 3.1 modulates Ca Activation of Fc\u03b5RI-dependent HLMC K Ca 3.1 currents was dependent on the presence of extracellular Ca Ca 3.1 opener 1-EBIO were also attenuated by GSK-7975A.", {"entities": []}], ["The Orai1 E106Q dominant-negative mutant ablated 1-EBIO and Fc\u03b5RI-dependent K Ca 3.1 currents in HLMCs.", {"entities": [[4, 9, "GENE"]]}], ["Orai1 but not Orai2 was shown to co-immunoprecipitate with K Ca 3.1 when overexpressed in HEK293 cells, and Orai1 and K Ca 3.1 were seen to co-localise in the HEK293 plasma membrane using confocal microscopy.", {"entities": [[0, 5, "GENE"], [108, 113, "GENE"], [14, 19, "GENE"], [0, 5, "GENE"], [108, 113, "GENE"]]}], ["K Ca 3.1 activation in HLMCs is highly dependent on Ca", {"entities": []}], ["Mechanisms by which regulatory T (T reg ) cells fail to control inflammation in asthma remain poorly understood.", {"entities": [[80, 86, "DISEASE"]]}], ["We show that a severe asthma-associated polymorphism in the interleukin-4 receptor alpha chain ( IL4RA R576) promotes conversion of induced T reg (iT reg ) cells towards a T helper 17 (T H 17) cell fate.", {"entities": [[22, 28, "DISEASE"]]}], ["This skewing is mediated by the recruitment by IL-4R\u03b1-R576 of the growth factor receptor-bound protein 2 (GRB2) adaptor protein, which drives IL-17 expression by activating a pathway involving extracellular signal-regulated kinase, IL-6 and STAT3.", {"entities": [[106, 110, "GENE"], [241, 246, "GENE"]]}], ["T reg cell-specific deletion of Il6ra or Rorc , but not Il4 or Il13 , prevented exacerbated airway inflammation in Il4ra mice.", {"entities": [[41, 45, "GENE"], [56, 59, "GENE"], [63, 67, "GENE"]]}], ["Furthermore, treatment of Il4ra reg cell reprogramming into T H 17-like cells and protected against severe airway inflammation.", {"entities": []}], ["These findings identify a novel mechanism for the development of mixed T H 2-T H 17 cell inflammation in genetically prone individuals, and point to interventions that stabilize iT reg cells as potentially effective therapeutic strategies.", {"entities": []}], ["Objective .", {"entities": []}], ["We aimed to identify key enablers of physician prescription of a long-term controller in patients with persistent asthma.", {"entities": [[114, 120, "DISEASE"]]}], ["We conducted a mailed survey of randomly selected Quebec physicians.", {"entities": []}], ["We sent a 102-item questionnaire, seeking reported management regarding one of 4 clinical vignettes of a poorly controlled adult or child and endorsement of enablers to prescribe long-term controllers.", {"entities": []}], ["With a 56% participation rate, 421 physicians participated.", {"entities": []}], ["Most (86%) would prescribe a long-term controller (predominantly inhaled corticosteroids, ICS) to the patient in their clinical vignette.", {"entities": []}], ["Determinants of intention were the recognition of persistent symptoms (OR 2.67), goal of achieving long-term control (OR 5.31), and high comfort level in initiating long-term ICS (OR 2.33).", {"entities": []}], ["Decision tools, pharmacy reports, reminders, and specific training were strongly endorsed by \u226560% physicians to support optimal management.", {"entities": []}], ["Physicians strongly endorsed asthma education, lung function testing, specialist opinion, accessible asthma clinic, and paramedical healthcare professionals to guide patients, as enablers to improve patient adherence to and physicians' comfort with long-term ICS.", {"entities": [[29, 35, "DISEASE"], [101, 107, "DISEASE"]]}], ["Interpretation .", {"entities": []}], ["Tools and training to improve physician knowledge, skills, and perception towards long-term ICS and resources that increase patient adherence and physician comfort to facilitate long-term ICS prescription should be considered as targets for implementation.", {"entities": []}], ["Electronic cigarettes (e-cigs) are used to help smoking cessation.", {"entities": []}], ["However, these devices contain harmful chemicals, and there are safety concerns.", {"entities": []}], ["We have investigated the effects of e-cigs on the inflammatory response and viability of COPD bronchial epithelial cells (BECs).", {"entities": []}], ["BECs from COPD patients and controls were exposed to e-cig vapor extract (ECVE) and the levels of interleukin (IL)-6, C-X-C motif ligand 8 (CXCL8), and lactate dehydrogenase release were measured.", {"entities": []}], ["We also examined the effect of ECVE pretreatment on polyinosinic:polycytidylic acid (poly I:C)-stimulated cytokine release from BECs.", {"entities": []}], ["Parallel experiments using Calu-3 cells were performed.", {"entities": []}], ["Comparisons were made with cigarette smoke extract (CSE).", {"entities": []}], ["ECVE and CSE caused an increase in the release of IL-6 and CXCL8 from Calu-3 cells.", {"entities": []}], ["ECVE only caused toxicity in BECs and Calu-3 cells.", {"entities": []}], ["Furthermore, ECVE and CSE dampened poly I:C-stimulated C-X-C motif ligand 10 release from both cell culture models, reaching statistical significance for CSE at an optical density of 0.3.", {"entities": []}], ["ECVE caused toxicity and reduced the antiviral response to poly I:C. This raises concerns over the safety of e-cig use.", {"entities": []}], ["Cell therapy using stem cells has produced therapeutic benefits in animal models of COPD.", {"entities": []}], ["Secretory mediators are proposed as one mechanism for stem cell effects because very few stem cells engraft after injection into recipient animals.", {"entities": []}], ["Recently, nanovesicles that overcome the disadvantages of natural exosomes have been generated artificially from cells.", {"entities": []}], ["We generated artificial nanovesicles from adipose-derived stem cells (ASCs) using sequential penetration through polycarbonate membranes.", {"entities": []}], ["ASC-derived artificial nanovesicles displayed a 100\u2009nm-sized spherical shape similar to ASC-derived natural exosomes and expressed both exosomal and stem cell markers.", {"entities": []}], ["The proliferation rate of lung epithelial cells was increased in cells treated with ASC-derived artificial nanovesicles compared with cells treated with ASC-derived natural exosomes.", {"entities": []}], ["The lower dose of ASC-derived artificial nanovesicles had similar regenerative capacity compared with a higher dose of ASCs and ASC-derived natural exosomes.", {"entities": []}], ["In addition, FGF2 levels in the lungs of mice treated with ASC-derived artificial nanovesicles were increased.", {"entities": [[13, 17, "GENE"]]}], ["The uptake of ASC-derived artificial nanovesicles was inhibited by heparin, which is a competitive inhibitor of heparan sulfate proteoglycan that is associated with FGF2 signaling.", {"entities": [[165, 169, "GENE"]]}], ["Taken together, the data indicate that lower doses of ASC-derived artificial nanovesicles may have beneficial effects similar to higher doses of ASCs or ASC-derived natural exosomes in an animal model with emphysema, suggesting that artificial nanovesicles may have economic advantages that warrant future clinical studies.", {"entities": []}], ["Inhaled mannitol is a new bronchial provocation test (BPT) developed to improve portability and standardisation of osmotic challenge testing.", {"entities": []}], ["Osmotic challenge tests have an advantage over the traditional methods of measuring airway hyperresponsiveness using methacholine as they demonstrate higher specificity to identify asthma and thus the need for treatment with inhaled corticosteroids (ICS).", {"entities": [[181, 187, "DISEASE"]]}], ["The safety and the efficacy of mannitol (M) as a BPT to measure airway hyperresponsiveness were compared to hypertonic (4.5%) saline (HS) in people both with and without signs and symptoms of asthma.", {"entities": [[192, 198, "DISEASE"]]}], ["A phase III, multi-centre, open label, operator-blinded, crossover design, randomised trial, with follow-up.", {"entities": []}], ["Asthmatics and non-asthmatics (6\u201383 yr) were recruited and 592 subjects completed the study.", {"entities": []}], ["Mannitol was delivered using a low resistance dry powder inhaler and HS was delivered using an ultrasonic nebuliser.", {"entities": []}], ["The FEV 1 was measured 60 seconds after each dose of mannitol (5,10,20,40,80,160,160,160 mg) and after each exposure to HS (0.5,1.0,2.0,4.0,8.0 minutes).", {"entities": [[4, 7, "GENE"]]}], ["A 15% fall in FEV 1 defined a positive test.", {"entities": [[14, 17, "GENE"]]}], ["Adverse events were monitored and diaries kept for 7 days following the tests.", {"entities": []}], ["Mean pre-test FEV1 (mean \u00b1 SD) was 95.5 \u00b1 14% predicted.", {"entities": []}], ["296 were positive to mannitol (M+) and 322 positive to HS (HS+).", {"entities": []}], ["A post study physician conducted clinical assessment identified 82.3% asthmatic (44% classified mild) and 17.7% non-asthmatic.", {"entities": []}], ["Of those M+, 70.1% were taking ICS and of those mannitol negative (M-), 81.1 % were taking ICS.", {"entities": []}], ["The % fall in FEV1 for mannitol in asthmatics was 21.0% \u00b1 5.7 and for the non-asthmatics, 5.5% \u00b1 4.8.", {"entities": []}], ["The median PD15 M was 148 mg and PD15 HS 6.2 ml.", {"entities": []}], ["The sensitivity of M to identify HS+ was 80.7% and the specificity 86.7%.", {"entities": []}], ["The sensitivity of M compared with the clinical assessment was 59.8% and specificity 95.2% and increased to 88.7% and 95.0% respectively when the M- subjects taking ICS were excluded.", {"entities": []}], ["Cough was common during testing.", {"entities": []}], ["There were no serious adverse events.", {"entities": []}], ["The diarised events were similar for mannitol and HS, the most common being headache (17.2%M, 19%HS), pharyngolaryngeal pain (5.1%M, 3%HS), nausea (4.3%M, 3%HS), and cough (2.2%M, 2.4%HS).", {"entities": []}], ["The efficacy and safety of mannitol was demonstrated in non-asthmatic and clinically diagnosed asthmatic adults and children.", {"entities": []}], ["Allergic contact hypersensitivity to metals is a delayed-type allergy.", {"entities": []}], ["Although various metals are known to produce an allergic reaction, nickel is the most frequent cause of metal allergy.", {"entities": []}], ["Researchers have attempted to elucidate the mechanisms of metal allergy using animal models and human patients.", {"entities": []}], ["Here, the immunological and molecular mechanisms of metal allergy are described based on the findings of previous studies, including those that were recently published.", {"entities": []}], ["In addition, the adsorption and excretion of various metals, in particular nickel, is discussed to further understand the pathogenesis of metal allergy.", {"entities": []}], ["To investigate the reasons that lead to postponement of cardiac operations, in order to elucidate the problem and help patients through modes of prevention.", {"entities": []}], ["We retrospectively included in the study all patients submitted to elective adult heart surgery in our department during the 4-year period 2007-2010 and noted all cases of postponement after official inclusion in the operating schedule.", {"entities": []}], ["94 out of a total of 575 patients (16.34%) scheduled for elective cardiac operation had their procedure postponed.", {"entities": []}], ["The reasons were mainly organisatory (in 49 cases, 52.12%), which in order of significance were: unavailability in operating rooms, shortage in matching erythrocyte units and shortage in anaesthetic/nursing staff.", {"entities": []}], ["The rest of the cases (45, 47.88%) were postponed due to medical reasons, which in order of significance were: febrile situations, including infections of the respiratory, gastrointestinal and urinary system, problems with the regulation of antiplatelet and antithrombotic drugs, neurological manifestations such as stroke and transient ischaemic attacks, exacerbation of asthma/chronic obstructive pulmonary disease, arrhythmias, renal problems and allergic reactions to drugs.", {"entities": [[379, 416, "DISEASE"], [372, 378, "DISEASE"]]}], ["Patients with advanced age and increased Euroscore values were most possible to have their heart operation postponed.", {"entities": []}], ["Heart operations are postponed due to organisatory as well as medical reasons, the latter mainly affecting older, morbid patients who therefore require advanced preoperative care.", {"entities": []}], ["Hypoxia is an important disease mechanism in prematurity, childhood asthma and obesity.", {"entities": [[79, 86, "DISEASE"], [68, 74, "DISEASE"]]}], ["In children, hypoxia results in chronic inflammation.", {"entities": []}], ["We investigated the effects of hypoxia (Hx) (12% O 2 ) during postnatal day 2 to 20 in rats.", {"entities": []}], ["Control groups were normoxic (Nc), and normoxic growth restricted (14 pup liters) (Gr).", {"entities": []}], ["Hypoxia decreased growth similar Gr.", {"entities": []}], ["Hx increased plasma TNF\u03b1 and IL-6 and decreased IGF-I and VEGF.", {"entities": []}], ["Hypoxia resulted in right ventricular (RV) hypertrophy but disproportionate decrements in limb skeletal muscle (SM) growth.", {"entities": []}], ["miR206 was depressed in the hypertrophied RV of Hx rats while increased in growth retarded SM.", {"entities": []}], ["Hx resulted in a decreased RV mRNA for myostatin but had no effect on SM myostatin.", {"entities": []}], ["The mRNA for hypoxia sensitive factors such as HIF\u03b1 was depressed in the RV of Hx rats suggesting negative feedback.", {"entities": []}], ["The results indicate that Hx induces a proinflammatory state that depresses growth regulating mechanisms and that tissues critical for survival, such as the heart, can escape from this general regulatory program to sustain life.", {"entities": []}], ["This study identifies accessible biomarkers for evaluating the impact of interventions designed to mitigate the long-term deleterious consequences of hypoxia that all too often occur in babies born prematurely.", {"entities": []}], ["Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine produced by the pituitary gland and multiple cell types, including macrophages (M\u00f8), dendritic cells (DC) and T-cells.", {"entities": [[40, 43, "GENE"]]}], ["Upon releases MIF modulates the expression of several inflammatory molecules, such as TNF-\u03b1, nitric oxide and cyclooxygenase 2 (COX-2).", {"entities": [[14, 17, "GENE"]]}], ["These important MIF characteristics have prompted investigators to study its role in parasite infections.", {"entities": [[16, 19, "GENE"]]}], ["Several reports have demonstrated that MIF plays either a protective or deleterious role in the immune response to different pathogens.", {"entities": [[39, 42, "GENE"]]}], ["Here, we review the role of MIF in the host defense response to some important protozoan infections.", {"entities": [[28, 31, "GENE"]]}], ["Breath acetone is a noninvasive biomarker of heart failure; however, its significance in heart failure patients with diabetes mellitus has yet to be clarified.", {"entities": [[117, 134, "DISEASE"]]}], ["The objective of this study is to investigate whether exhaled acetone concentration is a noninvasive biomarker in heart failure patients with diabetes mellitus.", {"entities": [[142, 159, "DISEASE"]]}], ["This study prospectively included 35 diabetic patients with stage C heart failure and 20 diabetic patients with or at risk of heart failure (stage A or B).", {"entities": []}], ["Exhaled breath was collected after an overnight fast.", {"entities": []}], ["The stage C group had significantly higher brain natriuretic peptide levels, larger left ventricular diameter, lower left ventricular ejection fraction, and more frequent use of \u03b2-blocker, compared with the stage A or B group.", {"entities": []}], ["The stage C group had higher exhaled acetone concentrations than the stage A or B group ( p \u2009=\u20090.013).", {"entities": []}], ["Exhaled acetone concentration was correlated with total ketone bodies ( r \u2009=\u20090.588, p \u2009<\u20090.001) and brain natriuretic peptide ( r \u2009=\u20090.415, p \u2009=\u20090.002).", {"entities": []}], ["Stage C heart failure patients with diabetes mellitus have elevated exhaled acetone concentrations.", {"entities": [[36, 53, "DISEASE"]]}], ["Exhaled acetone concentration could be a noninvasive biomarker in heart failure patients with diabetes mellitus.", {"entities": [[94, 111, "DISEASE"]]}], ["Eczema, synonymous with atopic eczema or atopic dermatitis, is a chronic skin disease that has a similar impact on health-related quality of life as other chronic diseases.", {"entities": [[41, 58, "DISEASE"], [73, 85, "DISEASE"], [48, 58, "DISEASE"]]}], ["The proposed research aims to provide a comprehensive systematic assessment of the economic evidence base available to inform economic modelling and decision making on interventions to prevent and treat eczema at any stage of the life course.", {"entities": []}], ["Whilst the Global Resource of Eczema Trials (GREAT) database collects together the effectiveness evidence for eczema, there is currently no such systematic resource on the economics of eczema.", {"entities": []}], ["It is important to gain an overview of the current state of the art of economic methods in the field of eczema in order to strengthen the economic evidence base further.", {"entities": []}], ["The proposed study is a systematic review of the economic evidence surrounding interventions for the prevention and treatment of eczema.", {"entities": []}], ["Relevant search terms will be used to search MEDLINE, EMBASE, Database of Abstracts of Reviews of Effects, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, National Health Service (NHS) Economic Evaluation Database, Health Technology Assessment, Cumulative Index to Nursing and Allied Health Literature, EconLit, Scopus, Cost-Effectiveness Analysis Registry and Web of Science in order to identify relevant evidence.", {"entities": [[221, 224, "GENE"]]}], ["To be eligible for inclusion studies will be primary empirical studies evaluating the cost, utility or full economic evaluation of interventions for preventing or treating eczema.", {"entities": []}], ["Two reviewers will independently assess studies for eligibility and perform data abstraction.", {"entities": []}], ["Evidence tables will be produced presenting details of study characteristics, costing methods, outcome methods and quality assessment.", {"entities": []}], ["The methodological quality of studies will be assessed using accepted checklists.", {"entities": []}], ["The systematic review is being undertaken to identify the type of economic evidence available, summarise the results of the available economic evidence and critically appraise the quality of economic evidence currently available to inform future economic modelling and resource allocation decisions about interventions to prevent or treat eczema.", {"entities": []}], ["We aim to use the review to offer guidance about how to gather economic evidence in studies of eczema and/or what further research is necessary in order to inform this.", {"entities": []}], ["PROSPERO CRD42015024633 The online version of this article (doi:10.1186/s13643-016-0262-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Irritable bowel syndrome (IBS) affects 10\u201315% of adults in the US, and is associated with significant impairment in health-related quality of life (HRQoL); however, information specific to the diarrhea subtype (IBS-D) is lacking.", {"entities": [[16, 24, "DISEASE"], [193, 201, "DISEASE"]]}], ["We assessed the impact of IBS-D on HRQoL, work productivity, and daily activities, and the associated indirect costs, among a sample of the US population.", {"entities": []}], ["Respondents (\u226518\u00a0years) from the 2012 US National Health and Wellness Survey who reported an IBS-D diagnosis by a physician or symptoms consistent with Rome II criteria for IBS-D were identified as having IBS-D. Controls included respondents without IBS-D or inflammatory bowel disease.", {"entities": [[259, 285, "DISEASE"]]}], ["HRQoL was assessed via the Short Form 36 Health Survey version 2 questionnaire and summarized into Mental and Physical Component Summary (MCS; PCS) scores and a Short Form-6 dimension (SF-6D) utility score.", {"entities": []}], ["Work and activity impairment were assessed via the Work Productivity and Activity Impairment Questionnaire: General Health version (WPAI:GH), which measures absenteeism, presenteeism, overall work productivity loss, and daily activity impairment.", {"entities": []}], ["Indirect costs were calculated using unit cost data from the Bureau of Labor Statistics and variables from the WPAI:GH.", {"entities": []}], ["Generalized linear models were used to examine differences in health outcomes between respondents with IBS-D and controls, controlling for demographic and health characteristics.", {"entities": []}], ["In total, 66,491 respondents (1102 IBS-D; 65,389 controls) were analyzed.", {"entities": []}], ["Mean age was 48.7\u00a0years; 50% were female.", {"entities": []}], ["Compared with controls, the IBS-D cohort reported significantly lower HRQoL (mean MCS: 45.16 vs. 49.48; p \u2009<\u20090.001; mean PCS: 47.29 vs. 50.67; p \u2009<\u20090.001; mean SF-6D: 0.677 vs. 0.741; p \u2009<\u20090.001) and greater absenteeism (5.1% vs. 2.9%; p \u2009=\u20090.004), presenteeism (17.9% vs. 11.3%; p \u2009<\u20090.001), overall work productivity loss (20.7% vs. 13.2%; p \u2009<\u20090.001), and activity impairment (29.6% vs. 18.9%; p \u2009<\u20090.001).", {"entities": []}], ["Respondents with IBS-D also incurred an estimated $2486 more in indirect costs ($7008 vs. $4522; p \u2009<\u20090.001).", {"entities": []}], ["Compared with controls, IBS-D is associated with significantly lower HRQoL, greater impairments in work and daily activities, and higher indirect costs, imposing a substantial burden on patients and employers.", {"entities": []}], ["These findings suggest a significant unmet need exists for effective IBS-D treatments.", {"entities": []}], ["Microalgae have been used for centuries to provide nourishment to humans and animals, only very recently they have become much more widely cultured and harvested at large industrial scale.", {"entities": []}], ["This paper reviews the potential health benefits and nutrition provided by microalgae whose benefits are contributing to expand their market.", {"entities": []}], ["We also point out several key challenges that remain to be addressed in this field.", {"entities": []}], ["Recently, CD4 In this report, we demonstrate that mRNA expression for the Th17 cell cytokine IL-17A, as well as Th17 cells, are present in human glioma.", {"entities": [[10, 13, "GENE"]]}], ["The mRNA expression for IL-17A in glioma was recapitulated in an immunocompetent mouse model of malignant glioma.", {"entities": [[96, 112, "DISEASE"]]}], ["Furthermore, the presence of Th17 cells was confirmed in both human and mouse glioma.", {"entities": []}], ["Interestingly, some Th17 cells present in mouse glioma co-expressed the Th1 and Th2 lineage markers, IFN-\u03b3 and IL-4, respectively, but predominantly co-expressed the Treg lineage marker FoxP3.", {"entities": [[186, 191, "GENE"]]}], ["These data confirm the presence of Th17 cells in glia-derived CNS tumors and provide the rationale for further investigation into the role of Th17 cells in malignant glioma.", {"entities": [[156, 172, "DISEASE"]]}], ["Despite rising international rates of obesity, men remain reluctant to participate in weight loss research.", {"entities": [[38, 45, "DISEASE"]]}], ["There is a lack of evidence to guide the development of effective weight loss interventions that engage men.", {"entities": []}], ["The objective of this study was to provide a comprehensive process evaluation of the SHED-IT (Self-Help, Exercise and Diet using Information Technology) weight loss program for men, as delivered in the SHED-IT community weight loss trial, and to identify key components associated with success.", {"entities": []}], ["In an assessor-blinded randomised controlled trial, 159 overweight and obese men (BMI 25.0-40.0\u00a0kg/m Both SHED-IT intervention groups demonstrated greater weight loss during the intervention compared to the control, with no difference between intervention groups.", {"entities": []}], ["Most men engaged with the SCT tasks although compliance declined over time and utilisation of social support networks and reward selection was poor.", {"entities": []}], ["In a multiple regression model, the number of goals set (\u03b2 [95% CI]\u2009=\u2009-0.3 [-0.6, -0.1], p\u2009=\u20090.01) and the number of weight records documented (\u03b2 [95% CI]\u2009=\u2009-0.2 [-0.4, -0.0], p\u2009=\u20090.03) independently predicted weight loss.", {"entities": []}], ["The process evaluation indicated that men found the programs to be supportive, enjoyable and beneficial.", {"entities": []}], ["This process evaluation provides valuable information to inform the development of obesity treatment strategies that engage men.", {"entities": [[83, 90, "DISEASE"]]}], ["Future studies with men should include a strong focus on self-monitoring and goal setting to enhance behaviour change and improve treatment effects.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry ACTRN12610000699066 .", {"entities": []}], ["Nexvax2\u00ae is a novel, peptide-based, epitope-specific immunotherapy intended to be administered by regular injections at dose levels that increase the threshold for clinical reactivity to natural exposure to gluten and ultimately restore tolerance to gluten in patients with celiac disease.", {"entities": [[274, 288, "DISEASE"]]}], ["Celiac disease patients administered fixed intradermal doses of Nexvax2 become unresponsive to the HLA-DQ2\u00b75-restricted gluten epitopes in Nexvax2, but gastrointestinal symptoms and cytokine release mimicking gluten exposure, that accompany the first dose, limit the maximum tolerated dose to 150\u00a0\u03bcg.", {"entities": [[0, 14, "DISEASE"]]}], ["Our aim was to test whether stepwise dose escalation attenuated the first dose effect of Nexvax2 in celiac disease patients.", {"entities": [[100, 114, "DISEASE"]]}], ["We conducted a randomized, double-blind, placebo-controlled trial at four community sites in Australia (3) and New Zealand (1) in HLA-DQ2\u00b75 genotype positive adults with celiac disease who were on a gluten-free diet.", {"entities": [[170, 184, "DISEASE"]]}], ["Participants were assigned to cohort 1 if they were HLA-DQ2\u00b75 homozygotes; other participants were assigned to cohort 2, or to cohort 3 subsequent to completion of cohort 2.", {"entities": []}], ["Manual central randomization without blocking was used to assign treatment for each cohort.", {"entities": []}], ["Initially, Nexvax2-treated participants in cohorts 1 and 2 received an intradermal dose of 30\u00a0\u03bcg (consisting of 10\u00a0\u03bcg of each constituent peptide), followed by 60\u00a0\u03bcg, 90\u00a0\u03bcg, 150\u00a0\u03bcg, and then eight doses of 300\u00a0\u03bcg over six weeks, but this was amended to include doses of 3\u00a0\u03bcg and 9\u00a0\u03bcg and extended over a total of seven weeks.", {"entities": []}], ["Nexvax2-treated participants in cohort 3 received doses of 3\u00a0\u03bcg, 9\u00a0\u03bcg, 30\u00a0\u03bcg, 60\u00a0\u03bcg, 90\u00a0\u03bcg, 150\u00a0\u03bcg, 300\u00a0\u03bcg, 450\u00a0\u03bcg, 600\u00a0\u03bcg, 750\u00a0\u03bcg, and then eight of 900\u00a0\u03bcg over nine weeks.", {"entities": []}], ["The dose interval was 3 or 4\u00a0days.", {"entities": []}], ["Participants, care providers, data managers, sponsor personnel, and study site personnel were blinded to treatment assignment.", {"entities": []}], ["The primary outcome was the number of adverse events and percentage of participants with adverse events during the treatment period.", {"entities": []}], ["This completed trial is registered with ClinicalTrials.gov , number NCT02528799 .", {"entities": []}], ["From the 73 participants who we screened from 19 August 2015 to 31 October 2016, 24 did not meet eligibility criteria, and 36 were ultimately randomized and received study drug.", {"entities": []}], ["For cohort 1, seven participants received Nexvax2 (two with the starting dose of 30\u00a0\u03bcg and then five at 3\u00a0\u03bcg) and three received placebo.", {"entities": []}], ["For cohort 2, 10 participants received Nexvax2 (four with starting dose of 30\u00a0\u03bcg and then six at 3\u00a0\u03bcg) and four received placebo.", {"entities": []}], ["For cohort 3, 10 participants received Nexvax2 and two received placebo.", {"entities": []}], ["All 36 participants were included in safety and immune analyses, and 33 participants completed treatment and follow-up; in cohort 3, 11 participants were assessed and included in pharmacokinetics and duodenal histology analyses.", {"entities": []}], ["Whereas the maximum dose of Nexvax2 had previously been limited by adverse events and cytokine release, no such effect was observed when dosing escalated from 3\u00a0\u03bcg up to 300\u00a0\u03bcg in HLA-DQ2\u00b75 homozygotes or to 900\u00a0\u03bcg in HLA-DQ2.5 non-homozygotes.", {"entities": []}], ["Adverse events with Nexvax2 treatment were less common in cohorts 1 and 2 with the starting dose of 3\u00a0\u03bcg (72 for 11 participants) than with the starting dose of 30\u00a0\u03bcg (91 for six participants).", {"entities": []}], ["Adverse events during the treatment period in placebo-treated participants (46 for nine participants) were similar to those in Nexvax2-treated participants when the starting dose was 3\u00a0\u03bcg in cohort 1 (16 for five participants), cohort 2 (56 for six participants), and cohort 3 (44 for 10 participants).", {"entities": []}], ["Two participants in cohort 2 and one in cohort 3 who received Nexvax2 starting at 3\u00a0\u03bcg did not report any adverse event, while the other 33 participants experienced at least one adverse event.", {"entities": []}], ["One participant, who was in cohort 1, withdrew from the study due to adverse events, which included abdominal pain graded moderate or severe and associated with nausea after receiving the starting dose of 30\u00a0\u03bcg and one 60\u00a0\u03bcg dose.", {"entities": []}], ["The most common treatment-emergent adverse events in the Nexvax2 participants were headache (52%), diarrhoea (48%), nausea (37%), abdominal pain (26%), and abdominal discomfort (19%).", {"entities": []}], ["Administration of Nexvax2 at dose levels from 150\u00a0\u03bcg to 900\u00a0\u03bcg preceded by dose escalation was not associated with elevations in plasma cytokines at 4\u00a0h. Nexvax2 treatment was associated with trends towards improved duodenal histology.", {"entities": []}], ["Plasma concentrations of Nexvax2 peptides were dose-dependent.", {"entities": []}], ["We show that antigenic peptides recognized by CD4-positive T cells in an autoimmune disease can be safely administered to patients at high maintenance dose levels without immune activation if preceded by gradual dose escalation.", {"entities": []}], ["These findings facilitate efficacy studies that test high-dose epitope-specific immunotherapy in celiac disease.", {"entities": [[97, 111, "DISEASE"]]}], ["\u2022 Maximum tolerated doses of peptide-based epitope-specific immunotherapy for celiac disease are increased by dose escalation.", {"entities": [[78, 92, "DISEASE"]]}], ["\u2022 Starting dose rather than maximum dose during up-dosing determine tolerability of Nexvax2 in celiac disease patients.", {"entities": [[95, 109, "DISEASE"]]}], ["\u2022 After up-dosing, systemic exposure to antigenic peptides in Nexvax2 is not associated with cytokine release or symptoms.", {"entities": []}], ["Maximum tolerated doses of peptide-based epitope-specific immunotherapy for celiac disease are increased by dose escalation.", {"entities": [[76, 90, "DISEASE"]]}], ["Starting dose rather than maximum dose during up-dosing determine tolerability of Nexvax2 in celiac disease patients.", {"entities": [[93, 107, "DISEASE"]]}], ["After up-dosing, systemic exposure to antigenic peptides in Nexvax2 is not associated with cytokine release or symptoms.", {"entities": []}], ["Many autoimmune diseases including celiac disease are linked to activation of CD4\u00a0+ T cells by peptides from disease-specific antigens.", {"entities": [[35, 49, "DISEASE"], [78, 81, "GENE"]]}], ["The antigenic peptides in celiac disease are well defined, which has enabled the design of a peptide-based therapeutic vaccine intended to induce immune unresponsiveness to dietary gluten.", {"entities": [[26, 40, "DISEASE"]]}], ["For this targeted immunotherapy, high doses are expected to be more effective, but phase 1 studies revealed the first dose of Nexvax2 caused immune activation.", {"entities": []}], ["We found escalating from low doses prevents symptoms and cytokine release with later \u201chigh\u201d doses even at levels that result in measurable plasma peptide concentrations.", {"entities": []}], ["Disclosing virulence factors from pathogens is required to better understand the pathogenic mechanisms involved in their interaction with the host.", {"entities": []}], ["In the case of Trypanosoma cruzi several molecules are associated with virulence.", {"entities": []}], ["Among them, the trans -sialidase (TS) has arisen as one of particular relevance due to its effect on the immune system and involvement in the interaction/invasion of the host cells.", {"entities": []}], ["The presence of conserved genes encoding for an inactive TS (iTS) isoform is puzzlingly restricted to the genome of parasites from the Discrete Typing Units TcII, TcV, and TcVI, which include highly virulent strains.", {"entities": []}], ["Previous in vitro results using recombinant iTS support that this isoform could play a different or complementary pathogenic role to that of the enzymatically active protein.", {"entities": []}], ["However, direct evidence involving iTS in in vivo pathogenesis and invasion is still lacking.", {"entities": []}], ["Here we faced this challenge by transfecting iTS-null parasites with a recombinant gene that allowed us to follow its expression and association with pathological events.", {"entities": []}], ["We found that iTS expression improves parasite invasion of host cells and increases their in vivo virulence for mice as shown by histopathologic findings in heart and skeletal muscle.", {"entities": []}], ["Background: Evidence suggests that higher multi-morbidity rates among people with low socioeconomic status produces and maintains poverty.", {"entities": []}], ["Our research explores the relationship between socioeconomic deprivation and multi-morbidity among Palestinian refugees in Lebanon, a marginalized and impoverished population.", {"entities": []}], ["Methods: A representative sample of Palestinian refugees in Lebanon was surveyed, interviewing 2501 respondents (97% response rate).", {"entities": []}], ["Multi-morbidity was measured by mental health, chronic and acute illnesses and disability.", {"entities": []}], ["Multinomial logistic regression models assessed the association between indicators of poverty and multi-morbidities.", {"entities": []}], ["Results: Findings showed that 14% of respondents never went to school, 41% of households reported water leakage and 10% suffered from severe food insecurity.", {"entities": []}], ["Participants with an elementary education or less and those completing intermediate school were more than twice as likely to report two health problems than those with secondary education or more (OR: 2.60, CI: 1.73\u20133.91; OR: 2.47, CI: 1.62\u20133.77, respectively).", {"entities": []}], ["Those living in households with water leakage were nearly twice as likely to have three or more health reports (OR = 1.88, CI = 1.45\u20132.44); this pattern was more pronounced for severely food insecure households (OR = 3.41, CI = 1.83\u20136.35).", {"entities": []}], ["Conclusion: We identified a positive gradient between socioeconomic status and multi-morbidity within a refugee population.", {"entities": []}], ["These findings reflect inequalities produced by the health and social systems in Lebanon, a problem expected to worsen following the massive influx of refugees from Syria.", {"entities": []}], ["Ending legal discrimination and funding infrastructural, housing and health service improvements may counteract the effects of deprivation.", {"entities": []}], ["Addressing this problem requires providing a decent livelihood for refugees in Lebanon.", {"entities": []}], ["Despite a large amount of in vitro data, the dynamics of airway smooth muscle (ASM) mass increase in the airways of patients with asthma is not well understood.", {"entities": [[130, 136, "DISEASE"]]}], ["Here, we present a novel mathematical model that describes qualitatively the growth dynamics of ASM cells over short and long terms in the normal and inflammatory environments typically observed in asthma.", {"entities": [[198, 204, "DISEASE"]]}], ["The degree of ASM accumulation can be explained by an increase in the rate at which ASM cells switch between non-proliferative and proliferative states, driven by episodic inflammatory events.", {"entities": []}], ["Our model explores the idea that remodelling due to ASM hyperplasia increases with the frequency and magnitude of these inflammatory events, relative to certain sensitivity thresholds.", {"entities": []}], ["It highlights the importance of inflammation resolution speed by showing that when resolution is slow, even a series of small exacerbation events can result in significant remodelling, which persists after the inflammatory episodes.", {"entities": []}], ["In addition, we demonstrate how the uncertainty in long-term outcome may be quantified and used to design an optimal low-risk individual anti-proliferative treatment strategy.", {"entities": []}], ["The model shows that the rate of clearance of ASM proliferation and recruitment factors after an acute inflammatory event is a potentially important, and hitherto unrecognised, target for anti-remodelling therapy in asthma.", {"entities": [[216, 222, "DISEASE"]]}], ["It also suggests new ways of quantifying inflammation severity that could improve prediction of the extent of ASM accumulation.", {"entities": []}], ["This ASM growth model should prove useful for designing new experiments or as a building block of more detailed multi-cellular tissue-level models.", {"entities": []}], ["Poor aerobic fitness is associated with worsening of asthma symptoms and fitness training may improve asthma control.", {"entities": [[53, 59, "DISEASE"], [102, 108, "DISEASE"]]}], ["The mechanism linking fitness with asthma is not known.", {"entities": [[35, 41, "DISEASE"]]}], ["We hypothesized that repeated bouts of exercise would lead to a downregulation of glucocorticoid receptor (GR) expression on circulating leukocytes reflecting a reduced responsiveness to stress.", {"entities": []}], ["In a prospective exercise training intervention of healthy and asthmatic adolescents, GR expression in leukocytes was measured using flow cytometry in response to a brief exercise challenge before and after the training intervention.", {"entities": []}], ["PBMC gene expression of GR, GR\u03b2, HSP70, and TGF\u03b21, 2 were determined using RT-PCR.", {"entities": []}], ["Peak V\u0307O 2 increased by 14.6 \u00b1 2.3% indicating an effective training (p<0.01).", {"entities": []}], ["There was a significant difference in GR expression among leukocyte subtypes, with highest expression in eosinophils.", {"entities": []}], ["Following the training intervention, there was a significant decrease in baseline GR expression (p<0.05) in leukocyte and monocyte subtypes in both healthy and asthmatic adolescents.", {"entities": []}], ["This is the first study in adolescents to show that exercise training reduces GR expression on circulating leukocytes.", {"entities": []}], ["We speculate that exercise training downregulates the stress response in general, manifested by decreased GR expression, and may explain why improving fitness improves asthma health.", {"entities": [[168, 174, "DISEASE"]]}], ["Tuberculosis (TB) contact tracing is a key strategy for containing TB and provides addition to the passive case finding approach.", {"entities": [[0, 12, "DISEASE"]]}], ["However, this practice has not been implemented in Tanzania, where there is unacceptably high treatment gap of 62.1% between cases estimated and cases detected.", {"entities": []}], ["Therefore calls for more aggressive case finding for TB to close this gap.", {"entities": []}], ["We aimed to determine the magnitude and predictors of bacteriologically-confirmed pulmonary TB among household contacts of bacteriologically-confirmed pulmonary TB index cases in the city of Mwanza, Tanzania.", {"entities": []}], ["This study was carried out from August to December 2016 in Mwanza city at the TB outpatient clinics of Tertiary Hospital of the Bugando Medical Centre, Sekou-Toure Regional Hospital, and Nyamagana District Hospital.", {"entities": []}], ["Bacteriologically-confirmed TB index cases diagnosed between May and July 2016 were identified from the laboratory registers book.", {"entities": []}], ["Contacts were traced by home visits by study TB nurses, and data were collected using a standardized TB screening questionnaire.", {"entities": []}], ["To detect the bacterioriologically-confirmed pulmonary TB, two sputum samples per household contact were collected under supervision for all household contacts following standard operating procedures.", {"entities": []}], ["Samples were transported to the Bugando Medical Centre TB laboratory for investigation for TB using fluorescent smear microscopy, GeneXpert MTB/RIF and L\u00f6wenstein\u2013Jensen (LJ) culture.", {"entities": []}], ["Logistic regression was used to determine predictors of bacteriologically-confirmed pulmonary TB among household contacts.", {"entities": []}], ["During the study period, 456 household contacts from 93\u00a0TB index cases were identified.", {"entities": []}], ["Among these 456 household contacts, 13 (2.9%) were GeneXpert MTB/RIF positive, 18 (3.9%) were MTB-culture positive and four (0.9%) were AFB-smear positive.", {"entities": []}], ["Overall, 29 (6.4%) of contacts had bacteriologically-confirmed pulmonary TB.", {"entities": []}], ["Predictors of bacteriologically-confirmed pulmonary TB among household contacts were7being married (Odds ratio [OR], 3.3; 95% confidence interval [CI], 1.4\u20138.0; p \u2009=\u20090.012) and consuming less than three meals a day (OR, 3.7; 95% CI, 1.6\u20138.7; p \u2009=\u20090.009).", {"entities": []}], ["Our data suggest that in Mwanza, Tanzania, seven in 100 contacts living in the same house with a TB patient develop bacteriologically-confirmed pulmonary TB.", {"entities": []}], ["These results therefore underscore the need to implement routine TB contact tracing to control tuberculosis in high TB burden countries such as Tanzania.", {"entities": [[95, 107, "DISEASE"]]}], ["To evaluate the ability of COPD patients to perform activities of daily living (ADL); to identify barriers that prevent these individuals from performing ADL; and to correlate those barriers with dyspnea severity, six-minute walk test (6MWT), and an ADL limitation score.", {"entities": []}], ["In COPD patients and healthy, age-matched controls, the number of steps, the distance walked, and walking time were recorded with a triaxial accelerometer, for seven consecutive days.", {"entities": []}], ["A questionnaire regarding perceived barriers and the London Chest Activity of Daily Living (LCADL) scale were used in order to identify the factors that prevent the performance of ADL.", {"entities": []}], ["The severity of dyspnea was assessed with two scales, whereas submaximal exercise capacity was determined on the basis of the 6MWT.", {"entities": []}], ["We evaluated 40 COPD patients and 40 controls.", {"entities": []}], ["In comparison with the control values, the mean walk time was significantly shorter for COPD patients (68.5 \u00b1 25.8 min/day vs. 105.2 \u00b1 49.4 min/day; p < 0.001), as was the distance walked (3.9 \u00b1 1.9 km/day vs. 6.4 \u00b1 3.2 km/day; p < 0.001).", {"entities": []}], ["The COPD patients also walked fewer steps/day.", {"entities": []}], ["The most common self-reported barriers to performing ADL were lack of infrastructure, social influences, and lack of willpower.", {"entities": []}], ["The 6MWT distance correlated with the results obtained with the accelerometer but not with the LCADL scale results.", {"entities": []}], ["Patients with COPD are less active than are healthy adults of a comparable age.", {"entities": []}], ["Physical inactivity and the barriers to performing ADL have immediate implications for clinical practice, calling for early intervention measures.", {"entities": []}], ["Children\u2019s exposure to secondhand smoke (SHS) at home has numerous adverse health effects.", {"entities": []}], ["This study evaluated the effects of a pediatric in-patient department-based pilot smoking cessation intervention for household members to reduce children\u2019s SHS exposure and encourage smoking cessation.", {"entities": []}], ["A pre-post test design study was designed to assess the effectiveness of a telephone counseling intervention on household members of hospitalized children in pediatric departments.", {"entities": []}], ["Data were collected with a standardized Chinese language questionnaire.", {"entities": []}], ["At the three-month follow-up survey, the proportions of household members who reported adopting complete smoking restriction at home (55%), did not smoke at home at all (37%), did not allow others to smoke in the car (70%), or did not allow others to smoke around the child (57%) were significantly higher than the self-reported responses at the baseline survey.", {"entities": []}], ["The proportions of household members who reported smoking at home (49%) and in the car (22%) were significantly lower than the baseline survey.", {"entities": []}], ["Overall, 7% of the participants had reported quitting smoking after three months.", {"entities": []}], ["Pediatric in-patient department-based telephone counseling for smoking cessation was found to be acceptable to Chinese parents.", {"entities": []}], ["The intervention encouraged few parents to quit smoking, but encouraged more parents to take measures to reduce children\u2019s SHS exposure.", {"entities": []}], ["Background: Diabetes induces lung dysfunction, leading to alteration in the pulmonary functions.", {"entities": []}], ["Our aim was to investigate whether the early stage of diabetes alters the epithelium-dependent bronchial responses and whether nitric oxide (NO), K ATP channels and cyclooxygenase (COX) pathways contribute in this effect.", {"entities": []}], ["Methods: Guinea pigs were treated with a single injection of streptozotocin (180\u2005mg/kg, ip) for induction of diabetes.", {"entities": []}], ["Airway conductivity was assessed by inhaled histamine, using a non-invasive body plethysmography.", {"entities": []}], ["The contractile responses of tracheal rings induced by acetylcholine (ACh) and relaxant responses of precontracted rings, induced by isoproterenol (IP) were compared in the presence and absence of the epithelium.", {"entities": []}], ["Effects of N ATP channel inhibitor) and indomethacin (a COX inhibitor) were also assessed in diabetic guinea pigs.", {"entities": []}], ["Results: Early stage diabetes did not alter the airway conductivity.", {"entities": []}], ["ACh-induced bronchoconstriction in epithelium intact tracheal rings was not affected by the onset of diabetes, however a reduction in the increased ACh responses due to epithelium removal, to L-NAME or to indomethacin was observed.", {"entities": []}], ["The relaxation response to IP was impaired in trachea from guinea pigs in which diabetes had just developed.", {"entities": []}], ["Early diabetes significantly reduced the IP response to glybenclamide and to indomethacin.", {"entities": []}], ["Conclusion: Our results demonstrate that the early stage of diabetes, modulate the bronchial reactivity to both ACh and IP by disrupting the NO, K ATP channels and COX pathways, without affecting the airway conductivity in guinea pigs.", {"entities": []}], ["Metal ion toxicity both locally and systemically following MoM hip replacements remains a concern.", {"entities": []}], ["Cobalt ions have been shown to induce secretion of proinflammatory chemokines locally; however, little is known about their effect systemically.", {"entities": []}], ["We investigated the in vitro effect of cobalt ions on a variety of cell lines by measuring production of the proinflammatory chemokines IL-8 and MCP-1.", {"entities": []}], ["Renal, gastrointestinal, and respiratory epithelium and also neutrophils and monocytes were exposed to cobalt ions at 4, 12, 24, and 48 hours.", {"entities": []}], ["We found that cobalt ions enhanced the secretion of IL-8 and MCP-1 in renal epithelial cells, gastric and colon epithelium, monocytes and neutrophils, and small airway epithelial cells but not in alveolar cells.", {"entities": []}], ["Secretion of IL-8 and MCP-1 was markedly elevated in renal epithelium, where a 16-fold and 7-fold increase occurred compared to controls.", {"entities": []}], ["There was a 6-fold and 4-fold increase in IL-8 and MCP-1 secretion in colon epithelium and a 4-fold and 3-fold increase in gastric epithelium.", {"entities": []}], ["Small airway epithelial cells showed a maximum increase in secretion of 8-fold (IL-8) and of 4-fold (MCP-1).", {"entities": []}], ["The increase in chemokine secretion observed in alveolar cells was moderate and did not reach statistical significance.", {"entities": []}], ["Monocytes and neutrophils showed a 2.5-fold and 2-fold increase in IL-8 secretion and a 6-fold and 4-fold increase in MCP-1 secretion at 48 and 24 hours, respectively.", {"entities": []}], ["These data demonstrate the potent bioactivity of cobalt ions in a variety of cell types and the potential to induce a proinflammatory response.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a rare lung disease of unknown origin leading rapidly to death.", {"entities": [[11, 29, "DISEASE"], [46, 58, "DISEASE"]]}], ["This paper addresses the issue of whether sputum induction is a suitable tool to study respiratory tract inflammation and potential biomarkers in IPF compared to COPD, a fibrosing airway wall disease.", {"entities": []}], ["In a cross-sectional analysis, 15 IPF patients, 32 COPD and 30 healthy subjects underwent sputum induction.", {"entities": []}], ["Total sputum cell counts and the amount of TGF- \u03b2, IGF-1, IGF-2, IGFBP-1, IGFBP-2, IGFBP-3, IL-8, IL-13, MMP-7, MMP-9, YKL-40, TNF-\u03b1 and KL-6 in sputum supernatant were analysed.", {"entities": []}], ["We also profiled gene expression of cells in the induced sputum for TGF-\u03b2, MMP-7, YKL-40, IGFBP-2, IL-6, IL-8 and TNF-\u03b1.", {"entities": []}], ["IPF patients, like COPD, had increased sputum absolute number of neutrophils, eosinophils, macrophages and epithelial cells compared to HS.", {"entities": []}], ["IPF sputum supernatants had increased concentrations of IGFBP-2, IL-8, TGF-\u03b2, MMP-7, MMP-9 and KL-6 (p<0.05, p<0.0001, p<0.05, p<0.05, p<0.0001, p<0.05 respectively) when compared to healthy subjects where COPD had higher IL-6 and TNF-\u03b1 levels than IPF (p<0.05 and p<0.05 respectively) and HS (p<0.0001 and p<0.001 respectively) and higher IL-8 and MMP-9 than HS (p<0.0001 and p<0.001 respectively).", {"entities": []}], ["Conversely to IL-6 and TNF-\u03b1, MMP-7 was increased in IPF compared to COPD (p<0.05).", {"entities": []}], ["The KL-6 and MMP-7 protein levels in sputum were inversely correlated with total lung capacity (TLC, % of predicted) in IPF patients (r = -0.73 and r = -0.53 respectively).", {"entities": []}], ["Sputum gene expression analysis identified a significant increase for IGFBP-2, IL-6, IL-8 and MMP-7 in IPF compared to HS (p<0.05, p<0.01, p<0.05 and p<0.0001 respectively) and for IGFBP-2, YKL-40, IL-6, IL-8 and MMP-7 compared to COPD (p<0.01, p<0.01, p<0.05, p<0.01 and p<0.0001 respectively).", {"entities": []}], ["Furthermore, gene expression of TGF-\u03b2 was increased in IPF compared to COPD (p<0.001) but not to HS.", {"entities": []}], ["Our data show clear increase in expression and production of IGFBP-2, IL-8 and MMP-7 in sputum from patients with IPF that may contribute to the disease.", {"entities": []}], ["Nonelderly patients may require hospitalization if their symptoms of influenza are severe.", {"entities": [[69, 78, "DISEASE"]]}], ["However, little evidence is available about the risk factors for hospitalization for influenza.", {"entities": [[85, 94, "DISEASE"]]}], ["We used a multicenter outpatient and inpatient database to obtain patients\u2019 characteristics and clinical procedures.", {"entities": []}], ["We identified patients aged <65\u00a0years with a confirmed diagnosis of influenza between October 2013 and December 2014.", {"entities": [[68, 77, "DISEASE"]]}], ["We used a Cox regression model to identify the risk factors for hospitalization, using a comparison group of individuals with a confirmed diagnosis of influenza but who were not hospitalized.", {"entities": [[151, 160, "DISEASE"]]}], ["Of 88,054 patients diagnosed with influenza, 276 (0.3\u00a0%) patients were hospitalized.", {"entities": [[34, 43, "DISEASE"]]}], ["With reference to patients aged 18\u201364 years, the hazard ratio (95\u00a0% confidence interval) for hospitalization in patients aged <2, 2\u20134, and 5\u201317 years was 12.25 (8.37\u201317.93), 4.56 (3.10\u20136.72) and 1.45 (1.03\u20132.05), respectively.", {"entities": []}], ["Anemia, chronic obstructive pulmonary disease, neurologic disease, and regular steroid use were significantly associated with hospitalization.", {"entities": [[8, 45, "DISEASE"]]}], ["Hazard ratios were adjusted for age, sex, comorbidities, respiratory co-infection, virus type, and influenza season.", {"entities": [[99, 108, "DISEASE"]]}], ["Our findings suggest that younger age and several comorbidities are associated with higher probability of hospitalization for influenza.", {"entities": [[126, 135, "DISEASE"]]}], ["It is known that suboptimal adherence rates may affect endocrine treatments for breast cancer, but little information has been reported whether any efforts to improve treatment adherence have been successful.", {"entities": [[80, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["We designed a randomized, controlled study to investigate the effect of oral or written patient information program on adherence and persistence when receiving an aromatase inhibitor (AI).", {"entities": []}], ["The study cohort included 181 female patients receiving an adjuvant AI treatment randomly assigned to one of three groups.", {"entities": []}], ["The first group received reminder letters and information booklets, the second group was reminded and informed through telephone calls and the control group received neither.", {"entities": []}], ["The primary endpoint was the rate at which patients were classified as adhering to treatment after twelve months.", {"entities": []}], ["Baseline results showed a well-balanced randomization with no significant differences between groups.", {"entities": []}], ["After 12\u00a0months, 48% (CI 35\u201362) of the control group, 62.7% (CI 49\u201375) in the telephone group and 64.7% (CI 51\u201377) in the letter group were adhering to therapy.", {"entities": []}], ["A post hoc pooled analysis with a one-way hypothesis for both interventions versus control indicated a significant difference between the groups favouring the intervention (p\u2009=\u20090.039).", {"entities": []}], ["The aim of this study was to investigate the efficacy of a simple and practical interventional program in enhancing adherence to breast cancer treatment.", {"entities": [[129, 142, "DISEASE"], [136, 142, "DISEASE"]]}], ["Patients receiving additional/supplemental information appeared to have an improved adherence rate even though the differences between groups were not statistically significant for the primary endpoint.", {"entities": []}], ["Statins are the first-line agents used to treat patients with high serum low-density lipoprotein cholesterol levels, thus reducing the risk of death from arterial sclerotic cardiovascular disease; however, little is known about the effects of non-statin pharmacological interventions on mortality as well as about the potential protective effects of statin use against cancer death.", {"entities": [[369, 375, "DISEASE"]]}], ["This work aimed to compare all-cause and cancer mortality among patients with hyperlipidaemia who did and did not receive statin treatment.", {"entities": [[41, 47, "DISEASE"]]}], ["Between 2003 and 2007 fiscal years, we recruited Japanese patients diagnosed with hyperlipidaemia from 66 hospitals.", {"entities": []}], ["Patients in our cohort were followed up for a maximum of 12 years to observe the causes of death.", {"entities": []}], ["Kaplan\u2013Meier estimates from the baseline were used to compare the mortality of patients based on the administered medicine.", {"entities": []}], ["All-cause mortality were compared among patients with/without administration of statins and other agents; any-organ and colorectal cancer mortality were compared between patients with/without administration of statins.", {"entities": [[120, 137, "DISEASE"], [131, 137, "DISEASE"]]}], ["Our cohort included 41,930 patients with mean ages of 64\u201366 years and mean body mass indices of 24\u201325\u00a0kg/m Mortality rate has been similar for patients treated with statin monotherapy and lifestyle modification.", {"entities": []}], ["Statin monotherapy could potentially reduce any-organ- and colorectal cancer-related mortality.", {"entities": [[59, 76, "DISEASE"], [70, 76, "DISEASE"]]}], ["\u2022 Statin-mediated reduction of low-density lipoprotein levels reduces mortality.", {"entities": []}], ["\u2022 Little is known on the effect of non-statin hyperlipidaemia medicines on mortality.", {"entities": []}], ["\u2022 Statin monotherapy is safe in terms of cancer mortality.", {"entities": [[41, 47, "DISEASE"]]}], ["\u2022 Statin use may reduce colorectal cancer-related mortality.", {"entities": [[24, 41, "DISEASE"], [35, 41, "DISEASE"]]}], ["\u2022 Resin monotherapy was associated with the lowest mortality.", {"entities": []}], ["Statin-mediated reduction of low-density lipoprotein levels reduces mortality.", {"entities": []}], ["Little is known on the effect of non-statin hyperlipidaemia medicines on mortality.", {"entities": []}], ["Statin monotherapy is safe in terms of cancer mortality.", {"entities": [[39, 45, "DISEASE"]]}], ["Statin use may reduce colorectal cancer-related mortality.", {"entities": [[22, 39, "DISEASE"], [33, 39, "DISEASE"]]}], ["Resin monotherapy was associated with the lowest mortality.", {"entities": []}], ["Pulmonary fibrosis is a progressive fibrotic lung disease of persisting lung injury and ineffective wound repair, with poor prognosis.", {"entities": [[0, 18, "DISEASE"], [45, 57, "DISEASE"]]}], ["Epithelial\u2013mesenchymal transition (EMT) of alveolar epithelia cells is an early event in the development of pulmonary fibrosis, and transforming growth factor \u03b2 (TGF-\u03b2) is an acknowledged inducer of EMT.", {"entities": [[108, 126, "DISEASE"]]}], ["Epidemiological studies demonstrated that serum levels of 25-hydroxy-vitamin D were associated with the presence of fibrosis diseases.", {"entities": []}], ["We investigated whether vitamin D attenuated TGF-\u03b2-induced pro-fibrotic effects through inhibiting EMT in human alveolar epithelia A549 cells.", {"entities": []}], ["A549 cells were cultured with TGF-\u03b2 alone or in combination with 1\u03b1,25-dihydroxyvitamin D3 (1\u03b1,25(OH) 2 D 3 ).", {"entities": []}], ["TGF-\u03b2 increased the expression of the mesenchymal markers (N-cadherin and Vimentin), and decreased the expression of epithelial markers (E-cadherin).", {"entities": []}], ["1\u03b1,25(OH) 2 D 3 attenuated these TGF-\u03b2-induced alterations.", {"entities": []}], ["Furthermore, the EMT-related transcription factors (Snail and \u03b2-catenin) and the extracellular matrix genes (Collagen I and fibronectin) were inhibited by 1\u03b1,25(OH) 2 D 3 , while the expression of vitamin D receptor (VDR) was elevated.", {"entities": [[217, 220, "GENE"]]}], ["In addition, 1\u03b1,25(OH) 2 D 3 alleviated the cell migration and the invasion abilities in TGF-\u03b2-stimulated A549 cells, determined by the scratch wound healing and transwell assays.", {"entities": []}], ["Our findings suggested that 1\u03b1,25(OH) 2 D 3 inhibited the pro-fibrotic phenotype of lung epithelial cells under TGF-\u03b2 stimulation and provided new clues in the clinical management of pulmonary fibrosis.", {"entities": [[183, 201, "DISEASE"]]}], ["The World Health Organization (WHO) recommends Artemisinin-based Combination Therapy (ACT) for treating uncomplicated Plasmodium falciparum malaria.", {"entities": [[140, 147, "DISEASE"]]}], ["This review aims to assist the decision-making of malaria control programmes by providing an overview of the relative effects of dihydroartemisinin-piperaquine (DHA-P) versus other recommended ACTs.", {"entities": [[50, 57, "DISEASE"]]}], ["To evaluate the effectiveness and safety of DHA-P compared to other ACTs for treating uncomplicated P. falciparum malaria in adults and children.", {"entities": [[114, 121, "DISEASE"]]}], ["We searched the Cochrane Infectious Diseases Group Specialized Register; the Cochrane Central Register of Controlled Trials (CENTRAL) published in The Cochrane Library ; MEDLINE; EMBASE; LILACS, and the metaRegister of Controlled Trials (mRCT) up to July 2013.", {"entities": []}], ["Randomized controlled trials comparing a three-day course of DHA-P to a three-day course of an alternative WHO recommended ACT in uncomplicated P. falciparum malaria.", {"entities": [[158, 165, "DISEASE"]]}], ["Two authors independently assessed trials for eligibility and risk of bias, and extracted data.", {"entities": []}], ["We analysed primary outcomes in line with the WHO 'Protocol for assessing and monitoring antimalarial drug efficacy\u2019 and compared drugs using risk ratios (RR) and 95% confidence intervals (CI).", {"entities": []}], ["Secondary outcomes were effects on gametocytes, haemoglobin, and adverse events.", {"entities": []}], ["We assessed the quality of evidence using the GRADE approach.", {"entities": []}], ["We included 27 trials, enrolling 16,382 adults and children, and conducted between 2002 and 2010.", {"entities": []}], ["Most trials excluded infants aged less than six months and pregnant women.", {"entities": []}], ["DHA-P versus artemether-lumefantrine In Africa, over 28 days follow-up, DHA-P is superior to artemether-lumefantrine at preventing further parasitaemia (PCR-unadjusted treatment failure: RR 0.34, 95% CI 0.30 to 0.39, nine trials, 6200 participants, high quality evidence ), and although PCR-adjusted treatment failure was below 5% for both ACTs, it was consistently lower with DHA-P (PCR-adjusted treatment failure: RR 0.42, 95% CI 0.29 to 0.62, nine trials, 5417 participants, high quality evidence ).", {"entities": []}], ["DHA-P has a longer prophylactic effect on new infections which may last for up to 63 days (PCR-unadjusted treatment failure: RR 0.71, 95% CI 0.65 to 0.78, two trials, 3200 participants, high quality evidence ).", {"entities": []}], ["In Asia and Oceania, no differences have been shown at day 28 (four trials, 1143 participants, moderate quality evidence ), or day 63 (one trial, 323 participants, low quality evidence ).", {"entities": []}], ["Compared to artemether-lumefantrine, no difference was seen in prolonged QTc ( low quality evidence ), and no cardiac arrhythmias were reported.", {"entities": []}], ["The frequency of other adverse events is probably similar with both combinations ( moderate quality evidence ).", {"entities": []}], ["DHA-P versus artesunate plus mefloquine In Asia, over 28 days follow-up, DHA-P is as effective as artesunate plus mefloquine at preventing further parasitaemia (PCR-unadjusted treatment failure: eight trials, 3487 participants, high quality evidence ).", {"entities": []}], ["Once adjusted by PCR to exclude new infections, treatment failure at day 28 was below 5% for both ACTs in all eight trials, but lower with DHA-P in two trials (PCR-adjusted treatment failure: RR 0.41 95% CI 0.21 to 0.80, eight trials, 3482 participants, high quality evidence ).", {"entities": []}], ["Both combinations contain partner drugs with very long half-lives and no consistent benefit in preventing new infections has been seen over 63 days follow-up (PCR-unadjusted treatment failure: five trials, 2715 participants, moderate quality evidence ).", {"entities": []}], ["In the only trial from South America, there were fewer recurrent parastaemias over 63 days with artesunate plus mefloquine (PCR-unadjusted treatment failure: RR 6.19, 95% CI 1.40 to 27.35, one trial, 445 participants, low quality evidence ), but no differences were seen once adjusted for new infections (PCR-adjusted treatment failure: one trial, 435 participants, low quality evidence ).", {"entities": []}], ["DHA-P is associated with less nausea, vomiting, dizziness, sleeplessness, and palpitations compared to artesunate plus mefloquine ( moderate quality evidence ).", {"entities": []}], ["DHA-P was associated with more frequent prolongation of the QTc interval ( low quality evidence ), but no cardiac arrhythmias were reported.", {"entities": []}], ["In Africa, dihydroartemisinin-piperaquine reduces overall treatment failure compared to artemether-lumefantrine, although both drugs have PCR-adjusted failure rates of less than 5%.", {"entities": []}], ["In Asia, dihydroartemisinin-piperaquine is as effective as artesunate plus mefloquine, and is better tolerated.", {"entities": []}], ["This review summarises trials evaluating the effects of dihydroartemisinin-piperaquine (DHA-P) compared to other artemisinin-based combination therapies recommended by the World Health Organization.", {"entities": []}], ["After searching for relevant trials up to July 2013, we included 27 randomized controlled trials, enrolling 16,382 adults and children and conducted between 2002 and 2010.", {"entities": []}], ["What is uncomplicated malaria and how might dihydroartemisinin-piperaquine work Uncomplicated malaria is the mild form of malaria which usually causes a fever, with or without headache, tiredness, muscle pains, abdominal pains, nausea, and vomiting.", {"entities": [[22, 29, "DISEASE"], [94, 101, "DISEASE"], [122, 129, "DISEASE"]]}], ["If left untreated, uncomplicated malaria can develop into severe malaria with kidney failure, breathing difficulties, fitting, unconsciousness, and eventually death.", {"entities": [[78, 92, "DISEASE"], [33, 40, "DISEASE"], [65, 72, "DISEASE"]]}], ["DHA-P is one of five artemisinin-based combination therapies the World Health Organization currently recommends to treat malaria.", {"entities": [[121, 128, "DISEASE"]]}], ["These combinations contain an artemisinin component (such as dihydroartemisinin) which works very quickly to clear the malaria parasite from the person's blood, and a longer acting drug (such as piperaquine) which clears the remaining parasites from the blood and may prevent new infections with malaria for several weeks.", {"entities": [[119, 126, "DISEASE"], [296, 303, "DISEASE"]]}], ["What the research says DHA-P versus artemether lumefantrine In studies of people living in Africa, both DHA-P and artemether-lumefantrine are very effective at treating malaria ( high quality evidence ).", {"entities": [[169, 176, "DISEASE"]]}], ["However, DHA-P cures slightly more patients than artemether-lumefantrine, and it also prevents further malaria infections for longer after treatment ( high quality evidence ).", {"entities": [[103, 110, "DISEASE"]]}], ["DHA-P and artemether-lumefantrine probably have similar side effects ( moderate quality evidence ).", {"entities": []}], ["DHA-P versus artesunate plus mefloquine In studies of people living in Asia, DHA-P is as effective as artesunate plus mefloquine at treating malaria ( moderate quality evidence ).", {"entities": [[141, 148, "DISEASE"]]}], ["Artesunate plus mefloquine probably causes more nausea, vomiting, dizziness, sleeplessness, and palpitations than DHA-P ( moderate quality evidence ).", {"entities": []}], ["Overall, in some people, DHA-P has been seen to cause short term changes in electrocardiographs tracing the conduction of the heart rhythm ( low quality evidence ), but these small changes on the electrocardiograph resolved within one week without serious consequences.", {"entities": []}], ["Occupational asthma (OA) is the leading occupational respiratory disease.", {"entities": [[13, 19, "DISEASE"]]}], ["Cases compensated as OA by the Korea Workers' Compensation and Welfare Service (COMWEL) (218 cases), cases reported by a surveillance system (286 cases), case reports by related scientific journals and cases confirmed by the Occupational Safety and Health Research Institute (OSHRI) over 15 yr from 1992 to 2006 were analyzed.", {"entities": []}], ["Annual mean incidence rate was 1.6 by compensation and 3.5 by surveillance system, respectively.", {"entities": []}], ["The trend appeared to increase according to the surveillance system.", {"entities": []}], ["Incidence was very low compared with other countries.", {"entities": []}], ["The most frequently reported causative agent was isocyanate followed by reactive dye in dyeing factories.", {"entities": []}], ["Other chemicals, metals and dust were also found as causative agents.", {"entities": []}], ["OA was underreported according to compensation and surveillance system data.", {"entities": []}], ["In conclusion, a more effective surveillance system is needed to evaluate OA causes and distribution, and to effectively prevent newly developing OA.", {"entities": []}], ["An adequate blood supply is essential for cancer cells to survive and grow; thus, the concept of inhibiting tumor angiogenesis has been applied to cancer therapy, and several drugs are already in clinical use.", {"entities": [[42, 48, "DISEASE"], [147, 153, "DISEASE"]]}], ["It has been shown that treatment with those anti-angiogenic drugs improved the response rate and prolonged the survival of patients with various types of cancer; however, it is also true that the effect was mostly limited.", {"entities": [[154, 160, "DISEASE"]]}], ["Currently, the disappointing clinical results are explained by the existence of intrinsic or acquired resistance to the therapy mediated by both tumor cells and stromal cells.", {"entities": []}], ["This article reviews the mechanisms of resistance mediated by stromal cells such as endothelial cells, pericytes, fibroblasts and myeloid cells, with an emphasis on fibrocytes, which were recently identified as the cell type responsible for regulating acquired resistance to anti-angiogenic therapy.", {"entities": []}], ["In addition, the other emerging role of fibrocytes as mediator-producing cells in tumor progression is discussed.", {"entities": []}], ["Regulatory T cells, which stimulate or inhibit the effector functions of distinct T cell subsets, are critical in the control of the immune response.", {"entities": []}], ["We investigated the effect of TGF-\u03b2 and IL-10 on T cell subsets according to the Th1/Th2 immune status.", {"entities": []}], ["Sixty-two patients with asthma and 38 patients with pulmonary tuberculosis were included.", {"entities": [[62, 74, "DISEASE"], [24, 30, "DISEASE"], [52, 74, "DISEASE"]]}], ["Allergy skin tests, tuberculin tests, and chest radiography were performed.", {"entities": []}], ["The levels of circulating IL-4, IFN-\u03b3, TGF-\u03b21, and IL-10 were measured using ELISA.", {"entities": []}], ["The level of TGF-\u03b21 was higher in patients with asthma than in those with tuberculosis, but the IL-10 levels were the same between the asthma and tuberculosis groups.", {"entities": [[74, 86, "DISEASE"], [146, 158, "DISEASE"], [48, 54, "DISEASE"], [135, 141, "DISEASE"]]}], ["Atopy was unrelated to the tuberculin response.", {"entities": []}], ["The IFN-\u03b3 level was correlated with the IL-10 level, and the level of IL-4 was unrelated to the IL-10 or TGF-\u03b21 level.", {"entities": []}], ["The level of IL-10 was higher in the negative tuberculin reactors than in the positive tuberculin reactors among patients with asthma, and TGF-\u03b21 was higher in the positive tuberculin reactors than in the negative tuberculin reactors among patients with tuberculosis.", {"entities": [[254, 266, "DISEASE"], [127, 133, "DISEASE"]]}], ["These results demonstrate that the regulatory effects of circulating TGF-\u03b2 and IL-10 on T cell cytokines may be different between Th2-type asthma and Th1 tuberculosis.", {"entities": [[154, 166, "DISEASE"], [139, 145, "DISEASE"]]}], ["Influenza virus infections have a significant impact on global human health.", {"entities": [[0, 9, "DISEASE"]]}], ["Individuals with suppressed immunity, or suffering from chronic inflammatory conditions such as COPD, are particularly susceptible to influenza.", {"entities": [[134, 143, "DISEASE"]]}], ["Here we show that suppressor of cytokine signaling (SOCS) five has a pivotal role in restricting influenza A virus in the airway epithelium, through the regulation of epidermal growth factor receptor (EGFR).", {"entities": [[97, 106, "DISEASE"], [201, 205, "GENE"]]}], ["Socs5 -deficient mice exhibit heightened disease severity, with increased viral titres and weight loss.", {"entities": [[0, 5, "GENE"]]}], ["Socs5 levels were differentially regulated in response to distinct influenza viruses (H1N1, H3N2, H5N1 and H11N9) and were reduced in primary epithelial cells from COPD patients, again correlating with increased susceptibility to influenza.", {"entities": [[67, 76, "DISEASE"], [230, 239, "DISEASE"], [0, 5, "GENE"]]}], ["Importantly, restoration of SOCS5 levels restricted influenza virus infection, suggesting that manipulating SOCS5 expression and/or SOCS5 targets might be a novel therapeutic approach to influenza.", {"entities": [[52, 61, "DISEASE"], [187, 196, "DISEASE"], [28, 33, "GENE"], [108, 113, "GENE"], [132, 137, "GENE"], [28, 33, "GENE"], [108, 113, "GENE"], [132, 137, "GENE"], [28, 33, "GENE"], [108, 113, "GENE"], [132, 137, "GENE"]]}], ["DOI: http://dx.doi.org/10.7554/eLife.20444.001 Influenza, commonly referred to as the flu, is a highly contagious disease caused by a virus.", {"entities": [[47, 56, "DISEASE"]]}], ["When an infected person coughs or sneezes, droplets containing the virus are released into the air.", {"entities": []}], ["Other individuals nearby may breathe in the virus, which then enters the cells lining the lungs and multiplies.", {"entities": []}], ["Some people are more susceptible to the influenza virus than others.", {"entities": [[40, 49, "DISEASE"]]}], ["In particular, individuals with chronic obstructive pulmonary disease (COPD) often suffer much worse flu symptoms and are more likely to be admitted to hospital.", {"entities": [[32, 69, "DISEASE"]]}], ["COPD results from smoke exposure, including cigarette smoke and, in developing countries, the smoke from cooking fires, but it is not clear why individuals with COPD are more susceptible to the influenza virus.", {"entities": [[194, 203, "DISEASE"]]}], ["The influenza virus gains entry to lung cells by manipulating receptors on the cell surface.", {"entities": [[4, 13, "DISEASE"]]}], ["A protein called SOCS5 is present inside these cells and has been suggested as a potential regulator of these receptors.", {"entities": [[17, 22, "GENE"]]}], ["Here, Kedzierski et al.", {"entities": []}], ["reveal that SOCS5 plays a critical role in protecting lung cells in mice and humans from the virus.", {"entities": [[12, 17, "GENE"]]}], ["The experiments show that mice lacking the gene that encodes SOCS5 were more susceptible to infection by the influenza virus, had more severe symptoms of disease and increased amounts of virus in their lungs.", {"entities": [[109, 118, "DISEASE"], [61, 66, "GENE"]]}], ["Further experiments in lung cells collected from human volunteers show that SOCS5 levels increased in both healthy smokers and non-smokers in response to influenza infection.", {"entities": [[154, 163, "DISEASE"], [76, 81, "GENE"]]}], ["Conversely, SOCS5 levels in lung cells of smokers with COPD remained low after infection.", {"entities": [[12, 17, "GENE"]]}], ["This suggests that SOCS5 might be an important factor in the susceptibility of these patients to influenza.", {"entities": [[97, 106, "DISEASE"], [19, 24, "GENE"]]}], ["The next is step is to understand exactly how SOCS5 works, which may make it possible to develop new treatments that boost SOCS5 activity in influenza patients.", {"entities": [[141, 150, "DISEASE"], [46, 51, "GENE"], [123, 128, "GENE"], [46, 51, "GENE"], [123, 128, "GENE"]]}], ["DOI: http://dx.doi.org/10.7554/eLife.20444.002", {"entities": []}], ["Emerging evidence from the virtual ward care model showed that multidisciplinary case management are inadequate to reduce readmissions or death for high risk patients.", {"entities": []}], ["There is consensus that interventions should encompass both pre-hospital discharge and post-discharge transitional care to be effective.", {"entities": []}], ["Integrated practice units (IPU) had been proposed as an approach of restructuring the organization and work processes of multidisciplinary teams to achieve value in healthcare.", {"entities": []}], ["Our primary objective is to evaluate if the novel application of the IPU concept to organize a modified virtual ward model incorporating pre-hospital discharge transitional care can reduce readmissions of patients at highest risk for readmission.", {"entities": []}], ["We conducted an open label, assessor blinded randomized controlled trial on patients with one or more unscheduled readmissions in the prior 90 days and LACE score \u2265 10.", {"entities": []}], ["840 patients were randomized in 1:1 ratio and blocks of 6 to the intervention program (n = 420) or control (n = 420).", {"entities": []}], ["Allocation concealment was effected via an off-site telephone service maintained by a hospital administrator.", {"entities": []}], ["Intervention patients received discharge planning, medication reconciliation, coaching on self-management of chronic diseases using standardized action plans and an individualized care plan complete with written discharge instructions, appointments schedule, medication changes and the contact information of the outpatient VW nurse before discharge.", {"entities": []}], ["At discharge, care is handed over to the outpatient VW team.", {"entities": []}], ["Patients were closely monitored in the VW for three months that included a telephone review within 72 hours of discharge, home assessment, regular telephone reviews to identify early complications and early review clinics for patients who destabilize.", {"entities": []}], ["The VW meet daily to discuss new patients and review care plans for patients.", {"entities": []}], ["Control patients received standard hospital care that included a standardized patient copy of the hospital discharge summary listing their medical diagnoses and medications; and follow up is arranged with a primary care provider or specialist as considered necessary.", {"entities": []}], ["The primary outcome was the unplanned readmission rate to any hospital within 30 days of discharge.", {"entities": []}], ["Secondary outcomes included the unplanned readmission rate, emergency department (ED) attendance rate to any hospital and the probability without readmission or death up to 180 days of discharge.", {"entities": []}], ["Length of stay and mortality rate at 90-day were compared between the two groups.", {"entities": []}], ["Outcome data were objectively retrieved from the hospital and National Electronic Health Records by a blinded outcome assessor.", {"entities": []}], ["All patients\u2019 outcomes were included in an intention-to-treat analysis.", {"entities": []}], ["The characteristics of both study groups were similar.", {"entities": []}], ["Patients in the intervention group had a significant reduction in the number of 30-day readmissions, IRR 0.67 (95% CI, 0.52 to 0.86, p = 0.001) and the number of 30-day emergency department attendances, IRR 0.60 (95% CI, 0.46 to 0.79, p<0.001) compared to those receiving standard hospital care.", {"entities": []}], ["The effectiveness was sustained at 90 and 180 days.", {"entities": []}], ["The intervention group utilized 1164 fewer hospital bed days at 90-day post discharge.", {"entities": []}], ["No adverse events were reported.", {"entities": []}], ["Applying the integrated practice unit concept to the virtual ward program resulted in reduced readmissions in patients who are at highest risk of readmission.", {"entities": []}], ["Pulmonary inflammation and bacterial colonization are central to the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[85, 122, "DISEASE"]]}], ["Defects in macrophage phagocytosis of both bacteria and apoptotic cells contribute to the COPD phenotype.", {"entities": []}], ["Small molecule inhibitors with anti-inflammatory activity against p38 mitogen activated protein kinases (MAPKs), phosphatidyl-inositol-3 kinase (PI3K) and Rho kinase (ROCK) are being investigated as novel therapeutics in COPD.", {"entities": []}], ["Concerns exist, however, about off-target effects.", {"entities": []}], ["We investigated the effect of p38 MAPK inhibitors (VX745 and SCIO469), specific inhibitors of PI3K \u03b1 (NVS-P13K-2), \u03b4 (NVS-P13K-3) or \u03b3 (NVS-P13K-5) and a ROCK inhibitor PF4950834 on macrophage phagocytosis, early intracellular killing of bacteria and efferocytosis of apoptotic neutrophils.", {"entities": []}], ["Alveolar macrophages (AM) obtained from broncho-alveolar lavage (BAL) or monocyte-derived macrophages (MDM) from COPD patients (GOLD stage II/III) enrolled from a well characterized clinical cohort (MRC COPD-MAP consortium) or from healthy ex-smoker controls were studied.", {"entities": []}], ["Both COPD AM and MDM exhibited lower levels of bacterial phagocytosis (using Streptococcus pneumoniae and non-typeable Haemophilus influenzae) and efferocytosis than healthy controls.", {"entities": []}], ["None of the inhibitors altered bacterial internalization or early intracellular bacterial killing in AM or MDM.", {"entities": []}], ["Conversely PF4950834, but not other inhibitors, enhanced efferocytosis in COPD AM and MDM.", {"entities": []}], ["These results suggest none of these inhibitors are likely to exacerbate phagocytosis-related defects in COPD, while confirming ROCK inhibitors can enhance efferocytosis in COPD.", {"entities": []}], ["Office exposures have been linked to symptoms of sick building syndrome, but their relation to the development of asthma has not been studied previously.", {"entities": [[63, 71, "DISEASE"], [49, 71, "DISEASE"], [114, 120, "DISEASE"]]}], ["These exposures have increasing importance because an increasing proportion of the workforce is working in office environments.", {"entities": []}], ["The aim of this study was to assess the relations of exposure to carbonless copy paper (CCP), paper dust, and fumes from photocopiers and printers to adult-onset asthma.", {"entities": [[162, 168, "DISEASE"]]}], ["We conducted a population-based incident case\u2013control study of adults 21\u201363 years of age living in the Pirkanmaa District in South Finland.", {"entities": []}], ["All new clinically diagnosed cases ( n = 521) of asthma were recruited during a 3-year study period.", {"entities": [[49, 55, "DISEASE"]]}], ["A random sample of the source population formed the controls ( n = 1,016).", {"entities": []}], ["This part focused on 133 cases and 316 controls who were office workers according to their current occupation classified by the 1988 International Standard Classification of Occupations.", {"entities": []}], ["All participants answered a questionnaire on health, smoking, occupation, and exposures at work and home.", {"entities": []}], ["Subjects with previous asthma were excluded.", {"entities": [[23, 29, "DISEASE"]]}], ["Exposures to paper dust [adjusted odds ratio (OR) = 1.97; 95% confidence interval (CI), 1.25\u20133.10] and CCP (OR = 1.66; 95% CI, 1.03\u20132.66) were related to significantly increased risk of adult-onset asthma.", {"entities": [[198, 204, "DISEASE"]]}], ["An exposure\u2013response relation was observed between exposure to paper dust and risk of asthma.", {"entities": [[86, 92, "DISEASE"]]}], ["This study provides new evidence that exposures to paper dust and CCP in office work are related to increased risk of adult-onset asthma.", {"entities": [[130, 136, "DISEASE"]]}], ["Reduction of these exposures could prevent asthma in office workers.", {"entities": [[43, 49, "DISEASE"]]}], ["Clinicians seeing asthma patients should be aware of this link to office exposures.", {"entities": [[18, 24, "DISEASE"]]}], ["Vitamin D is a potent secosteroid hormone that provides many skeletal and extraskeletal health benefits.", {"entities": []}], ["Musculoskeletal injury prevention and recovery are potentially affected by sufficient circulating levels of the storage form of vitamin D: 25-hydroxyvitamin D 3 , or 25(OH)D. Vitamin D deficiency can exist among young, active, and healthy people, which may put them at increased risk for injury and prolonged recovery.", {"entities": []}], ["PubMed was searched using vitamin D and skeletal muscle, vitamin D and athletic performance, and vitamin D review articles.", {"entities": []}], ["Studies from the 1930s to 2012 were used for the review.", {"entities": []}], ["There is strong correlation between vitamin D sufficiency and optimal muscle function.", {"entities": []}], ["Increasing levels of vitamin D reduce inflammation, pain, and myopathy while increasing muscle protein synthesis, ATP concentration, strength, jump height, jump velocity, jump power, exercise capacity, and physical performance.", {"entities": [[62, 70, "DISEASE"]]}], ["25(OH)D levels above 40 ng/mL are required for fracture prevention, including stress fractures.", {"entities": []}], ["Optimal musculoskeletal benefits occur at 25(OH)D levels above the current definition of sufficiency (> 30 ng/mL) with no reported sports health benefits above 50 ng/mL.", {"entities": []}], ["Vitamin D deficiency is common in athletes.", {"entities": []}], ["For athletes presenting with stress fractures, musculoskeletal pain, and frequent illness, one should have a heightened awareness of the additional likely diagnosis of vitamin D deficiency.", {"entities": []}], ["Correction of this deficiency is completed by standardized and supervised oral supplementation protocols producing significant musculoskeletal sports health benefits.", {"entities": []}], ["The association between body mass index (BMI) and mortality in patients suffering from chronic obstructive pulmonary disease (COPD) has been a subject of interest for decades.", {"entities": [[87, 124, "DISEASE"]]}], ["However, the evidence is inadequate to draw robust conclusions because some studies were generally small or with a short follow-up.", {"entities": []}], ["We carried out a search in MEDLINE, Cochrane Central Register of Controlled Trials, and EMBASE database for relevant studies.", {"entities": []}], ["Relative risks (RRs) with 95% confidence interval (CI) were calculated to assess the association between BMI and mortality in patients with COPD.", {"entities": []}], ["In addition, a baseline risk-adjusted analysis was performed to investigate the strength of this association.", {"entities": []}], ["22 studies comprising 21,150 participants were included in this analysis.", {"entities": []}], ["Compared with patients having a normal BMI, underweight individuals were associated with higher mortality (RR \u200a=\u200a1.34, 95% CI \u200a=\u200a1.01\u20131.78), whereas overweight (RR \u200a=\u200a0.47, 95% CI \u200a=\u200a0.33\u20130.68) and obese (RR \u200a=\u200a0.59, 95% CI \u200a=\u200a0.38\u20130.91) patients were associated with lower mortality.", {"entities": []}], ["We further performed a baseline risk-adjusted analysis and obtained statistically similar results.", {"entities": []}], ["Our study showed that for patients with COPD being overweight or obese had a protective effect against mortality.", {"entities": []}], ["However, the relationship between BMI and mortality in different classes of obesity needed further clarification in well-designed clinical studies.", {"entities": [[76, 83, "DISEASE"]]}], ["Aspergillus fumigatus is a ubiquitous airborne fungal pathogen that presents a life-threatening health risk to individuals with weakened immune systems.", {"entities": []}], ["A. fumigatus pathogenicity depends on its ability to acquire iron from the host and to resist host-generated oxidative stress.", {"entities": []}], ["Gaining a deeper understanding of the molecular mechanisms governing A. fumigatus iron acquisition and oxidative stress response may ultimately help to improve the diagnosis and treatment of invasive aspergillus infections.", {"entities": []}], ["This study follows a systems biology approach to investigate how adaptive behaviors emerge from molecular interactions underlying A. fumigatus iron regulation and oxidative stress response.", {"entities": []}], ["We construct a Boolean network model from known interactions and simulate how changes in environmental iron and superoxide levels affect network dynamics.", {"entities": []}], ["We propose rules for linking long term model behavior to qualitative estimates of cell growth and cell death.", {"entities": []}], ["These rules are used to predict phenotypes of gene deletion strains.", {"entities": []}], ["The model is validated on the basis of its ability to reproduce literature data not used in model generation.", {"entities": []}], ["The model reproduces gene expression patterns in experimental time course data when A. fumigatus is switched from a low iron to a high iron environment.", {"entities": []}], ["In addition, the model is able to accurately represent the phenotypes of many knockout strains under varying iron and superoxide conditions.", {"entities": []}], ["Model simulations support the hypothesis that intracellular iron regulates A. fumigatus transcription factors, SreA and HapX, by a post-translational, rather than transcriptional, mechanism.", {"entities": []}], ["Finally, the model predicts that blocking siderophore-mediated iron uptake reduces resistance to oxidative stress.", {"entities": []}], ["This indicates that combined targeting of siderophore-mediated iron uptake and the oxidative stress response network may act synergistically to increase fungal cell killing.", {"entities": []}], ["The online version of this article (doi:10.1186/s12918-015-0163-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Atopic asthma is a complex disease associated with IgE-mediated immune reactions.", {"entities": [[7, 13, "DISEASE"]]}], ["Numerous genome-wide studies identified more than 100 genes in 22 chromosomes associated with atopic asthma, and different genetic backgrounds in different environments could modulate susceptibility to atopic asthma.", {"entities": [[101, 107, "DISEASE"], [209, 215, "DISEASE"]]}], ["Current knowledge emphasizes the effect of tobacco smoke on the development of childhood asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["This suggests that asthma, although heritable, is significantly affected by gene-gene and gene-environment interactions.", {"entities": [[19, 25, "DISEASE"]]}], ["Evidence has recently shown that molecular mechanism of a complex disease may be limited to not only DNA sequence differences, but also gene-environmental interactions for epigenetic difference.", {"entities": []}], ["This paper reviews and summarizes how gene-gene and gene-environment interactions affect IgE production and the development of atopic asthma in prenatal and childhood stages.", {"entities": [[134, 140, "DISEASE"]]}], ["Based on the mechanisms responsible for perinatal gene-environment interactions on IgE production and development of asthma, we formulate several potential strategies to prevent the development of asthma in the perinatal stage.", {"entities": [[117, 123, "DISEASE"], [197, 203, "DISEASE"]]}], ["Explorations of how the complex microbial communities that inhabit different body sites might contribute to health and disease have prompted research on the ways the harmonious relationship between a host and its microbiota could be used to keep animals healthy in their production conditions.", {"entities": []}], ["In particular, there is a growing interest in the bacterial signatures that can be found in the milk of healthy or mastitic dairy cows.", {"entities": []}], ["The concept of sterility of the healthy mammary gland of dairy ruminants has been challenged by the results of studies using bacterial DNA-based methodology.", {"entities": []}], ["The newly obtained data have led to the concept of the intramammary microbiota composed of a complex community of diverse bacteria.", {"entities": []}], ["Accordingly, mammary gland infections are not mere infections by a bacterial pathogen, but the consequence of mammary dysbiosis.", {"entities": []}], ["This article develops the logical implications of this paradigm shift and shows how this concept is incompatible with current knowledge concerning the innate and adaptive immune system of the mammary gland of dairy ruminants.", {"entities": []}], ["It also highlights how the concept of mammary microbiota clashes with results of experimental infections induced under controlled conditions or large field experiments that demonstrated the efficacy of the current mastitis control measures.", {"entities": [[214, 222, "DISEASE"]]}], ["To evaluate the pneumonia specific case fatality rate over time following the implementation of a Child Lung Health Programme (CLHP) within the existing government health services in Malawi to improve delivery of pneumonia case management.", {"entities": [[16, 25, "DISEASE"], [213, 222, "DISEASE"]]}], ["A prospective, nationwide public health intervention was studied to evaluate the impact on pneumonia specific case fatality rate (CFR) in infants and young children (0 to 59 months of age) following the implementation of the CLHP.", {"entities": [[91, 100, "DISEASE"]]}], ["The implementation was step-wise from October 1 Following implementation, 47,228 children were admitted to hospital for severe/very severe pneumonia with an overall CFR of 9\u20228%.", {"entities": [[139, 148, "DISEASE"]]}], ["In both analyses, the highest CFR was in the children 2 to 11 months, and those with very severe pneumonia.", {"entities": [[97, 106, "DISEASE"]]}], ["The majority (64%) of cases, 2\u201359 months, had severe pneumonia.", {"entities": [[53, 62, "DISEASE"]]}], ["In this group there was a significant effect of the intervention Odds Ratio (OR) 0\u202270 (95%CI: 0\u202250\u20130\u202298); p\u200a=\u200a0\u2022036), while in the same age group children treated for very severe pneumonia there was no interventional benefit (OR 0\u202297 (95%CI: 0\u202272\u20131\u202230); p\u200a=\u200a0\u20228).", {"entities": [[179, 188, "DISEASE"]]}], ["No benefit was observed for neonates (OR 0\u202283 (95%CI: 0\u202256\u20131\u202222); p\u200a=\u200a0\u2022335).", {"entities": []}], ["The nationwide implementation of the CLHP significantly reduced CFR in Malawian infants and children (2\u201359 months) treated for severe pneumonia.", {"entities": [[134, 143, "DISEASE"]]}], ["Reasons for the lack of benefit for neonates, infants and children with very severe pneumonia requires further research.", {"entities": [[84, 93, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is characterized by reduced lung function associated with increased local and systemic inflammatory markers, such as TNF\u03b1 and IL-1\u03b2.", {"entities": []}], ["Glucocorticoids are used to treat this chronic disease, however their efficacy is low and new drugs are very much required.", {"entities": []}], ["17-oxo-DHA is a cyclooxygenase-2-dependent, electrophilic, \u03b1,\u03b2-unsaturated keto-derivative of docosahexaenoic acid with anti-inflammatory properties.", {"entities": []}], ["We evaluated the action of 17-oxo-DHA alone or in combination with the steroid fluticasone propionate (FP) in peripheral blood mononuclear cells (PBMCs) from COPD patients and healthy individuals exposed to lipopolysaccharide.", {"entities": []}], ["We show that PBMCs from COPD patients released higher levels of TNF\u03b1 and IL-1\u03b2 compared to controls.", {"entities": []}], ["17-oxo-DHA displayed strong anti-inflammatory effects.", {"entities": []}], ["The addition of 17-oxo-DHA in combination with FP showed enhanced anti-inflammatory effects through the modulation of transcriptional and post-transcriptional mechanisms.", {"entities": []}], ["17-oxo-DHA, but not FP, was able to suppress the release of mature IL-1\u03b2 through inhibition of the NLRP3 inflammasome.", {"entities": [[99, 104, "GENE"]]}], ["Furthermore, 17-oxo-DHA inhibited inflammasome-dependent degradation of the glucocorticoid receptor (GR).", {"entities": []}], ["Our findings suggest that 17-oxo-DHA in combination with FP or other steroids might achieve higher therapeutic efficacy than steroids alone.", {"entities": []}], ["Combined treatment might be particularly relevant in those conditions where increased inflammasome activation may lead to GR degradation and steroid-unresponsive inflammation.", {"entities": []}], ["Human endogenous retroviruses (HERVs) are ancient sequences integrated in the germ line cells and vertically transmitted through the offspring constituting about 8\u00a0% of our genome.", {"entities": []}], ["In time, HERVs accumulated mutations that compromised their coding capacity.", {"entities": []}], ["A prominent exception is HERV-W locus 7q21.2, producing a functional Env protein (Syncytin-1) coopted for placental syncytiotrophoblast formation.", {"entities": []}], ["While expression of HERV-W sequences has been investigated for their correlation to disease, an exhaustive description of the group composition and characteristics is still not available and current HERV-W group information derive from studies published a few years ago that, of course, used the rough assemblies of the human genome available at that time.", {"entities": []}], ["This hampers the comparison and correlation with current human genome assemblies.", {"entities": []}], ["In the present work we identified and described in detail the distribution and genetic composition of 213 HERV-W elements.", {"entities": []}], ["The bioinformatics analysis led to the characterization of several previously unreported features and provided a phylogenetic classification of two main subgroups with different age and structural characteristics.", {"entities": []}], ["New facts on HERV-W genomic context of insertion and co-localization with sequences putatively involved in disease development are also reported.", {"entities": []}], ["The present work is a detailed overview of the HERV-W contribution to the human genome and provides a robust genetic background useful to clarify HERV-W role in pathologies with poorly understood etiology, representing, to our knowledge, the most complete and exhaustive HERV-W dataset up to date.", {"entities": []}], ["The online version of this article (doi:10.1186/s12977-016-0301-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["DPOP is a measure of the strength of respiratory modulations present in the pulse oximetry photoplethysmogram (pleth) waveform.", {"entities": []}], ["It has been proposed as a non-invasive parameter for the prediction of the response to volume expansion in hypovolemic patients.", {"entities": []}], ["The effect of resistive breathing on the DPOP parameter was studied to determine whether it may have an adjunct use as a measure of respiratory effort.", {"entities": []}], ["Healthy volunteers were tasked to breathe at fixed respiratory rates over a range of airway resistances generated by a flow resistor inserted within a mouthpiece.", {"entities": []}], ["Changes in respiratory efforts, effected by the subjects and measured as airway pressures at the mouth, were compared to DPOP values derived from a finger pulse oximeter probe.", {"entities": []}], ["It was found that the increased effort to breathe manifests itself as an associated increase in DPOP.", {"entities": []}], ["Further, a relationship between DPOP and percent modulation of the pleth waveform was observed.", {"entities": []}], ["A version of the DPOP algorithm that corrects for low perfusion was implemented which resulted in an improved relationship between DPOP and PPV.", {"entities": []}], ["Although a limited cohort of seven volunteers was used, the results suggest that DPOP may be useful as a respiratory effort parameter, given that the fluid level of the patient is maintained at a constant level over the period of analysis.", {"entities": []}], ["We aimed to determine whether vitamin D exposure, as estimated by use of multivitamins, is positively or negatively associated with recurrent wheezing in infants born preterm.", {"entities": []}], ["This prospective cohort study enrolled 300 infants, born at 28 55.9% of black and 36.6% of non-black infants experienced recurrent wheezing.", {"entities": []}], ["Adjusted odds ratios for the association between multivitamin exposure at 3 months and recurrent wheezing were 2.15 (95% CI: 0.97, 4.75) for black and 0.43 (95% CI: 0.19, 0.96) for non-black infants with an interaction by race (p=0.003).", {"entities": []}], ["In lag-effect models, odds ratios were 2.69 (95% CI: 1.41, 5.14) for black and 0.50 (95% CI: 0.27, 0.92) for non-black infants.", {"entities": []}], ["Differences by race were seen in associations between multivitamins and wheezing; population heterogeneity should be considered when evaluating vitamin supplementation.", {"entities": []}], ["Arnebia benthamii is a major ingredient of the commercial drug available under the name Gaozaban, which has antibacterial, antifungal, anti-inflammatory, and wound-healing properties.", {"entities": []}], ["In the present study, in vitro antioxidant and anticancer activity of different extracts of Arnebia benthamii were investigated.", {"entities": []}], ["Antioxidant potential of plant extracts was evaluated by means of total phenolics, DPPH, reducing power, microsomal lipid peroxidation, and hydroxyl radical scavenging activity.", {"entities": []}], ["The highest phenolic content (TPC) of 780\u2009mg\u2009GAE/g was observed in ethyl acetate, while the lowest TPC of 462\u2009mg\u2009GAE/g was achieved in aqueous extract.", {"entities": []}], ["At concentration of 700\u2009\u00b5g/mL, DPPH radical scavenging activity was found to be highest in ethyl acetate extract (87.99%) and lowest in aqueous extract (73%).", {"entities": []}], ["The reducing power of extracts increased in a concentration dependent manner.", {"entities": []}], ["We also observed its inhibition on Fe in vitro .", {"entities": []}], ["In addition, Arnebia benthamii extracts exhibited antioxidant effects on Calf thymus DNA damage induced by Fenton reaction.", {"entities": []}], ["Cytotoxicity of the extracts (10\u2013100\u2009\u00b5g/mL) was tested on five human cancer cell lines (lung, prostate, leukemia, colon, and pancreatic cell lines) using the Sulphorhodamine B assay.", {"entities": [[104, 112, "DISEASE"], [69, 75, "DISEASE"]]}], ["Observational studies suggest that asthma control improves after adenotonsillectomy, but longitudinal studies that correlate the effect of the procedure on the levels of biomarkers associated with airway inflammation are limited.", {"entities": [[35, 41, "DISEASE"]]}], ["We conducted a longitudinal, observational study on pediatric patients, both with and without asthma, undergoing adenotonsillectomy.", {"entities": [[94, 100, "DISEASE"]]}], ["Asthma Control Test (ACT) scores and chitinase activity in the circulation were measured at time of surgery and at 6-month follow-up.", {"entities": [[0, 6, "DISEASE"]]}], ["66 children with asthma and 64 control subjects were enrolled.", {"entities": [[17, 23, "DISEASE"]]}], ["Mean ACT scores improved by 3 points (p< 0.001) after 6 months.", {"entities": []}], ["85% of children with poorly-controlled asthma demonstrated an increase in ACT score of at least 3 points or a decrease in Emergency Department/Urgent Care visits, oral corticosteroid courses, or rescue short acting bronchodilator usage.", {"entities": [[39, 45, "DISEASE"]]}], ["Chitinase activity decreased significantly in asthmatics who improved (p< 0.01).", {"entities": []}], ["Higher chitinase activity levels at baseline were associated with improved asthma control following surgery (p< 0.01).", {"entities": [[75, 81, "DISEASE"]]}], ["In children with high pre-operative circulating chitinase activity levels, asthma control and healthcare utilization were significantly improved after adenotonsillecotmy.", {"entities": [[75, 81, "DISEASE"]]}], ["Chitinase activity decreased after surgery in children with improved control.", {"entities": []}], ["This suggests that adenotonsillectomy modulates chitinase activity, affecting airway inflammation and improving airway disease.", {"entities": []}], ["Males and females responses to gestational overnutrition set the stage for subsequent sex-specific differences in adult onset non communicable diseases.", {"entities": [[43, 56, "DISEASE"]]}], ["Placenta, as a widely recognized programming agent, contibutes to the underlying processes.", {"entities": []}], ["According to our previous findings, a high-fat diet during gestation triggers sex-specific epigenetic alterations within CpG and throughout the genome, together with the deregulation of clusters of imprinted genes.", {"entities": []}], ["We further investigated the impact of diet and sex on placental histology, transcriptomic and epigenetic signatures in mice.", {"entities": []}], ["Both basal gene expression and response to maternal high-fat diet were sexually dimorphic in whole placentas.", {"entities": []}], ["Numerous genes showed sexually dimorphic expression, but only 11 genes regardless of the diet.", {"entities": []}], ["In line with the key role of genes belonging to the sex chromosomes, 3 of these genes were Y-specific and 3 were X-specific.", {"entities": []}], ["Amongst all the genes that were differentially expressed under a high-fat diet, only 16 genes were consistently affected in both males and females.", {"entities": []}], ["The differences were not only quantitative but remarkably qualitative.", {"entities": []}], ["The biological functions and networks of genes dysregulated differed markedly between the sexes.", {"entities": []}], ["Seven genes of the epigenetic machinery were dysregulated, due to effects of diet, sex or both, including the Y- and X-linked histone demethylase paralogues Kdm5c and Kdm5d, which could mark differently male and female epigenomes.", {"entities": [[157, 162, "GENE"], [167, 172, "GENE"]]}], ["The DNA methyltransferase cofactor Dnmt3l gene expression was affected, reminiscent of our previous observation of changes in global DNA methylation.", {"entities": [[35, 41, "GENE"]]}], ["Overall, this striking sexual dimorphism of programming trajectories impose a considerable revision of the current dietary interventions protocols.", {"entities": []}], ["In Western countries, hypertension and hypertension-related complication are more common in ethnic minority groups of African descent than in indigenous populations.", {"entities": [[22, 34, "DISEASE"], [39, 51, "DISEASE"]]}], ["Addressing ethnic minority patients\u2019 perceptions of hypertension and its treatment through the use of cultural appropriate hypertension education (CAHE) increases adherence to medication and lifestyle recommendations.", {"entities": [[52, 64, "DISEASE"], [123, 135, "DISEASE"]]}], ["Given these effects, it seems warranted to develop a training program on how to deliver this type of patient education for Primary Care Nurse Practitioners (PCNPs).", {"entities": []}], ["Development and evaluation of a training program for PCNPs aimed at providing culturally appropriate hypertension patient education.", {"entities": [[101, 113, "DISEASE"]]}], ["Prospective cohort study evaluating attitude and intended behavioral changes.", {"entities": []}], ["Both experienced PCNPs and PCNPs in training participated in this study.", {"entities": []}], ["The effects of the CAHE-training were measured by 3 different questionnaires on 1) the satisfaction with the training program, 2) the attitude towards culturally appropriate care, and 3) the commitment to change.", {"entities": []}], ["The CAHE-training program consists of 10 different components divided over two 4-hour sessions and was taught to 87 participating PCNPs.", {"entities": []}], ["The program utilizes constructivist-learning principles and educational evidence on adult learning.", {"entities": []}], ["The content of the program is based on the knowledge obtained from our previous studies on culturally appropriate care.", {"entities": []}], ["The mean satisfaction-score was 7.5 (1\u201310 scale), with the role-play exercise with patient-actors scoring highest (8.2).", {"entities": []}], ["We observed non-significant but positive changes in attitude.", {"entities": []}], ["PCNPs who reported on the implementation of their intended behavior change showed significant attitude changes after three months.", {"entities": []}], ["We demonstrated that our evidence based training program for PCNPs resulted in a positive learning experience with adequate intended behavioral changes in practice.", {"entities": []}], ["Unfortunately, response rates were too low to demonstrate persistent changes in attitude.", {"entities": []}], ["The first genome-wide association study for coronary artery disease (CAD) in the Han Chinese population, we reported recently, had identified rs6903956 in gene ADTRP on chromosome 6p24.1 as a novel susceptibility locus for CAD.", {"entities": []}], ["The risk allele of rs6903956 was associated with decreased mRNA expression of ADTRP .", {"entities": []}], ["To further study the correlation of ADTRP expression and CAD, in this study we evaluated the associations of eight common variants in the expression-regulating regions of ADTRP with CAD in the Southern Han Chinese population.", {"entities": []}], ["Rs169790 in 3\u2019UTR, rs2076189 in 5\u2019UTR, four SNPs (rs2076188, rs7753407, rs11966356 and rs1018383) in promoter, and two SNPs (rs3734273, rs80355771) in the last intron of ADTRP were genotyped in 1716 CAD patients and 1572 controls.", {"entities": []}], ["The correlations between these loci and total or early-onset CAD were investigated.", {"entities": []}], ["None of these loci was discovered to associate with total CAD ( P > 0.05).", {"entities": []}], ["However, with early-onset CAD, significant both allelic and genotypic associations of rs7753407, rs11966356 and rs1018383 were identified, after adjustment for risk factors of age, gender, hypertension, diabetes, lipid profiles and smoking (adjusted P < 0.05).", {"entities": [[189, 201, "DISEASE"]]}], ["A haplotype AGCG (constructed by rs2076188, rs7753407, rs11966356 and rs1018383) was identified to protect subjects from early-onset CAD (OR = 0.332, 95% CI = 0.105\u20130.879, adjusted P = 0.010).", {"entities": []}], ["Real-time quantitative reverse transcription polymerase chain reaction assay showed that the risk alleles of the associated loci were significantly associated with decreased expression of ADTRP mRNA.", {"entities": []}], ["Moreover, the average level of ADTRP mRNA expression in early-onset CAD cases was significantly lower than that in controls.", {"entities": []}], ["Our results provide new evidence supporting the association of ADTRP with the pathogenesis of early-onset CAD.", {"entities": []}], ["Exhaled breath is a body secretion, and the sampling process of this is simple and cost effective.", {"entities": []}], ["It can be non-invasively collected for diagnostic procedures.", {"entities": []}], ["Variations in the chemical composition of exhaled breath resulting from gaseous exchange in the extensive capillary network of the body are proposed to be associated with pathophysiological changes.", {"entities": []}], ["In light of the foreseeable potential of exhaled breath as a diagnostic specimen, we used gas chromatography and mass spectrometry (GC-MS) to study the chemical compounds present in exhaled breath samples from patients with Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and from healthy individuals as a control group.", {"entities": []}], ["In addition, we also designed and developed a chemical-based exhaled breath sensor system to examine the distribution pattern in the patient and control groups.", {"entities": []}], ["The results of our study showed that several chemical compounds, such as 1-phenantherol and ethyl 3-cyano-2,3-bis (2,5,-dimethyl-3-thienyl)-acrylate, had a higher percentage area in the AD group than in the PD and control groups.", {"entities": []}], ["These results may indicate an association of these chemical components in exhaled breath with the progression of disease.", {"entities": []}], ["In addition, in-house fabricated exhaled breath sensor systems, containing several types of gas sensors, showed significant differences in terms of the normalized response of the sensitivity characteristics between the patient and control groups.", {"entities": []}], ["A subsequent clustering analysis was able to distinguish between the AD patients, PD patients, and healthy individuals using principal component analysis, Sammon\u2019s mapping, and a combination of both methods, in particular when using the exhaled breath sensor array system A consisting of eight sensors.", {"entities": []}], ["With this in mind, the exhaled breath sensor system could provide alternative option for diagnosis and be applied as a useful, effective tool for the screening and diagnosis of AD in the near future.", {"entities": []}], ["The number of genome-wide association studies (GWAS) is growing rapidly leading to the discovery and replication of many new disease loci.", {"entities": []}], ["Combining results from multiple GWAS datasets may potentially strengthen previous conclusions and suggest new disease loci, pathways or pleiotropic genes.", {"entities": []}], ["However, no database or centralized resource currently exists that contains anywhere near the full scope of GWAS results.", {"entities": []}], ["We collected available results from 118 GWAS articles into a database of 56,411 significant SNP-phenotype associations and accompanying information, making this database freely available here.", {"entities": []}], ["In doing so, we met and describe here a number of challenges to creating an open access database of GWAS results.", {"entities": []}], ["Through preliminary analyses and characterization of available GWAS, we demonstrate the potential to gain new insights by querying a database across GWAS.", {"entities": []}], ["Using a genomic bin-based density analysis to search for highly associated regions of the genome, positive control loci (e.g., MHC loci) were detected with high sensitivity.", {"entities": []}], ["Likewise, an analysis of highly repeated SNPs across GWAS identified replicated loci (e.g., APOE , LPL ).", {"entities": [[92, 96, "GENE"], [99, 102, "GENE"]]}], ["At the same time we identified novel, highly suggestive loci for a variety of traits that did not meet genome-wide significant thresholds in prior analyses, in some cases with strong support from the primary medical genetics literature ( SLC16A7, CSMD1, OAS1 ), suggesting these genes merit further study.", {"entities": [[238, 245, "GENE"], [247, 252, "GENE"], [254, 258, "GENE"]]}], ["Additional adjustment for linkage disequilibrium within most regions with a high density of GWAS associations did not materially alter our findings.", {"entities": []}], ["Having a centralized database with standardized gene annotation also allowed us to examine the representation of functional gene categories (gene ontologies) containing one or more associations among top GWAS results.", {"entities": []}], ["Genes relating to cell adhesion functions were highly over-represented among significant associations (p < 4.6 \u00d7 10 We provide access to a full gene-annotated GWAS database which could be used for further querying, analyses or integration with other genomic information.", {"entities": []}], ["We make a number of general observations.", {"entities": []}], ["Of reported associated SNPs, 40% lie within the boundaries of a RefSeq gene and 68% are within 60 kb of one, indicating a bias toward gene-centricity in the findings.", {"entities": []}], ["We found considerable heterogeneity in information available from GWAS suggesting the wider community could benefit from standardization and centralization of results reporting.", {"entities": []}], ["Severe arthritis of the knee is a disabling condition, with over 50,000 knee replacements performed each year in the UK.", {"entities": [[7, 16, "DISEASE"]]}], ["Isolated patellofemoral joint arthritis occurs in over 10% of these patients with the treatment options being patellofemoral arthroplasty or total knee arthroplasty.", {"entities": [[30, 39, "DISEASE"]]}], ["Whilst many surgeons believe total knee arthroplasty is the 'gold standard' treatment for severe knee arthritis, patellofemoral arthroplasty has certain potential advantages.", {"entities": [[102, 111, "DISEASE"]]}], ["Primarily, because this operation allows the patient to keep the majority of their own knee joint; preserving bone-stock and the patients' own ligaments.", {"entities": []}], ["Patellofemoral arthroplasty has also been recognised as a less 'invasive' operation than primary total knee arthroplasty, facilitating a more rapid recovery.", {"entities": []}], ["There are currently no published results of randomised clinical trials comparing the two arthroplasty techniques.", {"entities": []}], ["The primary objective of the current study is to assess whether there is a difference in functional knee scores and quality of life outcome assessments at one year post-operation between patellofemoral arthroplasty and total knee arthroplasty.", {"entities": []}], ["The secondary objective is to assess the complication rates for both procedures.", {"entities": []}], ["Patients who are deemed suitable, by an Orthopaedic Consultant, for patellofemoral arthroplasty and medically fit for surgery are eligible to take part in this trial.", {"entities": []}], ["The consenting patients will be randomised in a 1:1 allocation to a total knee or patellofemoral arthroplasty.", {"entities": []}], ["The randomisation sequence will be computer generated and administered by a central independent randomisation service.", {"entities": []}], ["Following consent, all participants will have their knee function, quality of life and physical activity level assessed through questionnaires.", {"entities": []}], ["The assigned surgery will then be performed using the preferred technique and implant of the operating surgeon.", {"entities": []}], ["The first post-operative assessments will take place at six weeks, followed by further assessments at 3, 6 and 12 months.", {"entities": []}], ["At each assessment time point all complications will be recorded.", {"entities": []}], ["In addition, community and social care services usage will be collected using a patient questionnaire at 3, 6 & 12 months.", {"entities": []}], ["The patients will then be sent an annual postal questionnaire.", {"entities": []}], ["The questionnaire will ask about any problems, knee pain and function following their knee arthroplasty to monitor long-term function and failure rates.", {"entities": []}], ["This trial is expected to deliver results in early 2013.", {"entities": []}], ["ISRCTN: ISRCTN34863373 UKCRN portfolio ID 6847", {"entities": []}], ["Dietary factors have been indicated to influence the pathogenesis and nature course of inflammatory bowel diseases (IBD) with their wide variances.", {"entities": []}], ["The aim of the study was to assess the prevalence and clinical significance of 14 serum food specific immunoglobulin G (sIgG) antibodies in patients with IBD.", {"entities": []}], ["This retrospective study comprised a total of 112 patients with IBD, including 79 with Crohn's disease (CD) and 33 with ulcerative colitis (UC).", {"entities": [[120, 138, "DISEASE"]]}], ["Medical records, clinical data and laboratory results were collected for analysis.", {"entities": []}], ["Serum IgG antibodies against 14 unique food allergens were detected by semi-quantitative enzyme linked immunosorbent assay (ELISA).", {"entities": []}], ["Food sIgG antibodies were detected in 75.9% (60/79) of CD patients, 63.6% (21/33) of UC patients and 33.1% (88/266) of healthy controls (HC).", {"entities": []}], ["IBD patients showed the significantly higher antibodies prevalence than healthy controls (CD vs. HC, P \u200a=\u200a0.000; UC vs. HC, P \u200a=\u200a0.001).", {"entities": []}], ["However no marked difference was observed between CD and UC groups ( P \u200a=\u200a0.184).", {"entities": []}], ["More subjects were found with sensitivity to multiple antigens (\u22653) in IBD than in HC group (33.9% vs.0.8%, P \u200a=\u200a0.000).", {"entities": []}], ["Egg was the most prevalent food allergen.", {"entities": []}], ["There was a remarkable difference in the levels of general serum IgM ( P \u200a=\u200a0.045) and IgG ( P \u200a=\u200a0.041) between patients with positive and negative sIgG antibodies.", {"entities": []}], ["Patients with multiple positive allergens (\u22653) were especially found with significant higher total IgG levels compared with sIgG-negative patients ( P \u200a=\u200a0.003).", {"entities": []}], ["Age was suggested as a protective factor against the occurrence of sIgG antibodies ( P \u200a=\u200a0.002).", {"entities": []}], ["The study demonstrates a high prevalence of serum IgG antibodies to specific food allergens in patients with IBD.", {"entities": []}], ["sIgG antibodies may potentially indicate disease status in clinical and be utilized to guide diets for patients.", {"entities": []}], ["Innate T helper type 2 (Th2) immune responses mediated by interleukin (IL)-33, thymic stromal lymphopoietin (TSLP), and IL-25 have been shown to play an important role in pulmonary fibrosis of animal models; however, their clinical implications remain poorly understood.", {"entities": [[171, 189, "DISEASE"], [109, 113, "GENE"]]}], ["TSLP, IL-25, and IL-33 concentrations were measured in bronchoalveolar lavage fluids obtained from normal controls (NCs; n \u2009=\u200940) and from patients with idiopathic pulmonary fibrosis (IPF; n \u2009=\u2009100), non-specific interstitial pneumonia (NSIP; n \u2009=\u200922), hypersensitivity pneumonitis (HP; n \u2009=\u200920), and sarcoidosis ( n \u2009=\u200919).", {"entities": [[226, 235, "DISEASE"], [301, 312, "DISEASE"], [164, 182, "DISEASE"], [153, 182, "DISEASE"], [0, 4, "GENE"], [283, 285, "GENE"]]}], ["The TSLP and IL-33 levels were significantly higher in patients with IPF relative to the NCs ( p \u2009=\u20090.01 and p \u2009=\u20090.0001, respectively), NSIP ( p \u2009=\u20094.95E\u2009\u2212\u20097 and p \u2009=\u20090.0002, respectively), HP ( p \u2009=\u20090.00003 and p \u2009=\u20090.000005, respectively), and sarcoidosis groups ( p \u2009=\u20090.003 and p \u2009=\u20090.0001, respectively).", {"entities": [[247, 258, "DISEASE"], [4, 8, "GENE"], [191, 193, "GENE"]]}], ["However, the IL-25 levels were not significantly different between NC and IPF group ( p \u2009=\u20090.432).", {"entities": []}], ["Receiver operating characteristic curves of the TSLP and IL-33 levels revealed clear differences between the IPF and NC groups (AUC\u2009=\u20090.655 and 0.706, respectively), as well as between the IPF and the other lung disease groups (AUC\u2009=\u20090.786 and 0.781, respectively).", {"entities": [[207, 219, "DISEASE"], [48, 52, "GENE"]]}], ["Cut-off values of 3.52\u00a0pg/\u03bcg TSLP and 3.77\u00a0pg/\u03bcg IL-33 were shown to differentiate between the IPF and NC groups with 99.2 and 94.3% accuracy.", {"entities": [[29, 33, "GENE"]]}], ["Cut-off values of 4.66\u00a0pg/\u03bcg TSLP and 2.52\u00a0pg/\u03bcg IL-33 possessed 99.4 and 93.2% accuracy for differentiating among the IPF and other interstitial lung disease groups.", {"entities": [[133, 158, "DISEASE"], [146, 158, "DISEASE"], [29, 33, "GENE"]]}], ["Innate immune responses may be associated with the development of IPF.", {"entities": []}], ["Furthermore, the IL-33 and TSLP levels in BAL fluids may be useful for differentiating IPF from other chronic interstitial lung diseases.", {"entities": [[27, 31, "GENE"]]}], ["The online version of this article (doi:10.1186/s12890-017-0380-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objective To compare the effectiveness of an algorithm for diagnosis of active labour in primiparous women with standard care in terms of maternal and neonatal outcomes.", {"entities": []}], ["Design Cluster randomised trial.", {"entities": []}], ["Setting Maternity units in Scotland with at least 800 annual births.", {"entities": []}], ["Participants 4503 women giving birth for the first time, in 14 maternity units.", {"entities": []}], ["Seven experimental clusters collected data from a baseline sample of 1029 women and a post-implementation sample of 896 women.", {"entities": []}], ["The seven control clusters had a baseline sample of 1291 women and a post-implementation sample of 1287 women.", {"entities": []}], ["Intervention Use of an algorithm by midwives to assist their diagnosis of active labour, compared with standard care.", {"entities": []}], ["Main outcomes Primary outcome: use of oxytocin for augmentation of labour.", {"entities": []}], ["Secondary outcomes: medical interventions in labour, admission management, and birth outcome.", {"entities": []}], ["Results No significant difference was found between groups in percentage use of oxytocin for augmentation of labour (experimental minus control, difference=0.3, 95% confidence interval \u22129.2 to 9.8; P=0.9) or in the use of medical interventions in labour.", {"entities": []}], ["Women in the algorithm group were more likely to be discharged from the labour suite after their first labour assessment (difference=\u221219.2, \u221229.9 to \u22128.6; P=0.002) and to have more pre-labour admissions (0.29, 0.04 to 0.55; P=0.03).", {"entities": []}], ["Conclusions Use of an algorithm to assist midwives with the diagnosis of active labour in primiparous women did not result in a reduction in oxytocin use or in medical intervention in spontaneous labour.", {"entities": []}], ["Significantly more women in the experimental group were discharged home after their first labour ward assessment.", {"entities": []}], ["Trial registration Current Controlled Trials ISRCTN00522952.", {"entities": []}], ["Medicare Advantage: Issues, Insights, and Implications for the Future Paul Cotton, Joseph P. Newhouse, PhD, Kevin G. Volpp, MD, PhD, A.", {"entities": []}], ["Mark Fendrick, MD, Susan Lynne Oesterle, Pat Oungpasuk, Ruchi Aggarwal, Gail Wilensky, PhD, and Kathleen Sebelius D.B.", {"entities": []}], ["Nash, and A.Y.", {"entities": []}], ["Schwartz P. Cotton J.P. Newhouse K.G.", {"entities": []}], ["Volpp A.M. Fendrick, S.L.", {"entities": []}], ["Oesterle, P. Oungpasuk, and R. Aggarwal G. Wilensky and K. Sebelius", {"entities": []}], ["Obesity, overweight and autism spectrum disorder (ASD) remain serious public health problems.", {"entities": [[0, 7, "DISEASE"], [24, 48, "DISEASE"]]}], ["Although lots of studies have recently explored the association among obesity, overweight and ASD, the findings are inconsistent.", {"entities": [[70, 77, "DISEASE"]]}], ["Thus, we conducted a meta-analysis of epidemiological studies to examine the association among obesity, overweight and ASD.", {"entities": [[95, 102, "DISEASE"]]}], ["PubMed, Embase, and the Cochrane Library were used for literature searches to identify eligible studies published in English before November 15, 2016.", {"entities": []}], ["Relevant studies estimating the association among obesity, overweight and ASD were included.", {"entities": [[50, 57, "DISEASE"]]}], ["Fifteen studies encompassing 49,937,078 participants and 1,045,538 individuals with ASD were included in this study.", {"entities": []}], ["A random effects model was chosen to synthesize the effect sizes of individual studies.", {"entities": []}], ["The prevalence of obesity was significantly higher in individuals with ASD than in controls (OR\u2009=\u20091.84, 95% confidence interval [CI]: 1.37\u20132.48, P \u2009<\u20090.001).", {"entities": [[18, 25, "DISEASE"]]}], ["However, the prevalence of overweight in individuals with ASD was not significantly different from that in controls (OR\u2009=\u20091.07, 95% CI: 0.83\u20131.38, P \u2009=\u20090.62).", {"entities": []}], ["Both sensitivity analysis and publication bias testing revealed that the findings were robust.", {"entities": []}], ["The meta-analysis showed a significant association between obesity and ASD.", {"entities": [[59, 66, "DISEASE"]]}], ["However, no significant association was identified between overweight and ASD.", {"entities": []}], ["Traditional plant treatment for diabetes has shown a surging interest in the last few decades.", {"entities": []}], ["Therefore, the purpose of this study was to assess the hypoglycemic effect of the aqueous extract of C. papaya leaves in diabetic rats.", {"entities": []}], ["Several studies have reported that some parts of the C. papaya plant exert hypoglycemic effects in both animals and humans.", {"entities": []}], ["Diabetes was induced in rats by intraperitoneal administration of 60 mg/kg of streptozotocin (STZ).", {"entities": []}], ["The aqueous extract of C. papaya was administered in three different doses (0.75, 1.5 and 3 g/100 mL) as drinking water to both diabetic and non-diabetic animals during 4 weeks.", {"entities": []}], ["The aqueous extract of Carica papaya (0.75 g and 1.5 g/100 mL) significantly decreased blood glucose levels (p<0.05) in diabetic rats.", {"entities": []}], ["It also decreased cholesterol, triacylglycerol and amino-transferases blood levels.", {"entities": []}], ["Low plasma insulin levels did not change after treatment in diabetic rats, but they significantly increased in non-diabetic animals.", {"entities": []}], ["Pancreatic islet cells were normal in non-diabetic treated animals, whereas in diabetic treated rats, C. papaya could help islet regeneration manifested as preservation of cell size.", {"entities": []}], ["In the liver of diabetic treated rats, C. papaya prevented hepatocyte disruption, as well as accumulation of glycogen and lipids.", {"entities": []}], ["Finally, an antioxidant effect of C. papaya extract was also detected in diabetic rats.", {"entities": []}], ["This study showed that the aqueous extract of C. papaya exerted a hypoglycemic and antioxidant effect; it also improved the lipid profile in diabetic rats.", {"entities": []}], ["In addition, the leaf extract positively affected integrity and function of both liver and pancreas.", {"entities": []}], ["Avian pathogenic Escherichia coli (APEC) is a major cause of disease impacting animal health.", {"entities": []}], ["The bone marrow is the reservoir of immature immune cells; however, it has not been examined to date for gene expression related to developmental changes (cell differentiation, maturation, programming) after APEC infection.", {"entities": []}], ["Here, we study gene expression in the bone marrow between infected and non-infected animals, and between infected animals with mild (resistant) versus severe (susceptible) pathology, at two times post-infection.", {"entities": []}], ["We sequenced 24 bone marrow RNA libraries generated from the six different treatment groups with four replicates each, and obtained an average of 22 million single-end, 100-bp reads per library.", {"entities": []}], ["Genes were detected as differentially expressed (DE) between APEC treatments (mild pathology, severe pathology, and mock-challenged) at a given time point, or DE between 1 and 5\u00a0days post-infection (dpi) within the same treatment group.", {"entities": []}], ["Results demonstrate that many immune cells, genes and related pathways are key contributors to the different responses to APEC infection between susceptible and resistant birds and between susceptible and non-challenged birds, at both times post-infection.", {"entities": []}], ["In susceptible birds, lymphocyte differentiation, proliferation, and maturation were greatly impaired, while the innate and adaptive immune responses, including dendritic cells, monocytes and killer cell activity, TLR- and NOD-like receptor signaling, as well as T helper cells and many cytokine activities, were markedly enhanced.", {"entities": []}], ["The resistant birds\u2019 immune system, however, was similar to that of non-challenged birds.", {"entities": []}], ["The DE genes in the immune cells and identified signaling models are representative of activation and resolution of infection in susceptible birds at both post-infection days.", {"entities": []}], ["These novel results characterizing transcriptomic response to APEC infection reveal that there is combinatorial activity of multiple genes controlling myeloid cells, and B and T cell lymphopoiesis, as well as immune responses occurring in the bone marrow in these early stages of response to infection.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-015-1850-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The significance of cytokine production by CD4 \u03b3 mRNA expression within 24 h of reencountering alloantigen in vivo.", {"entities": [[43, 46, "GENE"]]}], ["This expression kinetic was highly antigen-specific and was of functional significance.", {"entities": []}], ["Neutralizing IFN- \u03b3 at the time of cotransfer of alloantigen reactive T reg cells, together with CD45RB Rag \u03b3 \u2013deficient mice.", {"entities": []}], ["These data support a unique role for IFN- \u03b3 in the functional activity of alloantigen-reactive T reg cells during the development of operational tolerance to donor alloantigens in vivo.", {"entities": []}], ["To explore the prevalence rates and predictors of somatic symptoms among child and adolescent survivors with probable posttraumatic stress disorder (PTSD) after an earthquake.", {"entities": []}], ["A total of 3053 students from 21 primary and secondary schools in Baoxing County were administered the Patient Health Questionnaire-13 (PHQ-13), a short version of PHQ-15 without the two items about sexuality and menstruation, the Children's Revised Impact of Event Scale (CRIES), and the self-made Earthquake-Related Experience Questionnaire 3 months after the Lushan earthquake.", {"entities": []}], ["Among child and adolescent survivors, the prevalence rates of all somatic symptoms were higher in the probable PTSD group compared with the controls.", {"entities": []}], ["The most frequent somatic symptoms were trouble sleeping (83.2%), feeling tired or having low energy (74.4%), stomach pain (63.2%), dizziness (58.1%), and headache (57.7%) in the probable PTSD group.", {"entities": []}], ["Older age, having lost family members, having witnessed someone get seriously injured, and having witnessed someone get buried were predictors for somatic symptoms among child and adolescent survivors with probable PTSD.", {"entities": []}], ["Somatic symptoms among child and adolescent earthquake survivors with probable PTSD in schools were common, and predictors of these somatic symptoms were identified.", {"entities": []}], ["These findings may help those providing psychological health programs to find the child and adolescent students with probable PTSD who are at high risk of somatic symptoms in schools after an earthquake in China.", {"entities": []}], ["Several small studies found night-time awakenings due to COPD symptoms were associated with decreased health status.", {"entities": []}], ["In this study, night-time awakenings in patients with COPD were examined and effects of tiotropium therapy evaluated.", {"entities": []}], ["This study was a post hoc, exploratory, pooled analysis of twin, multicenter, double-blind, randomized, placebo-controlled, parallel-group trials.", {"entities": []}], ["Patients with stable moderate-to-severe COPD were randomized to tiotropium HandiHaler\u00ae ( n \u2009=\u2009550) or placebo ( n \u2009=\u2009371) and followed for 13\u00a0weeks.", {"entities": []}], ["During a 2-week, pre-treatment baseline period and for 13\u00a0weeks on treatment, self-reported night-time awakenings due to COPD symptoms, rescue medication (albuterol) use, and morning and evening peak expiratory flow rate (PEFR) were recorded daily.", {"entities": []}], ["Nightly, COPD-related awakenings were scored: 0\u2009=\u2009no awakenings; 1\u2009=\u20091 awakening; 2\u2009=\u20092\u20133 awakenings; or 3\u2009=\u2009awake most of the night.", {"entities": []}], ["Health-related quality-of-life (HRQoL) and energy\u2013fatigue questionnaires were completed at baseline and during treatment.", {"entities": []}], ["Patients were aged 65.2\u2009\u00b1\u20098.7\u00a0years (mean\u2009\u00b1\u2009SD), with a mean pre-bronchodilator FEV 1 of 36.1\u2009\u00b1\u200913.5\u00a0% predicted normal at baseline.", {"entities": [[80, 83, "GENE"]]}], ["Data for night-time awakenings and albuterol use were available for 543 (99\u00a0%) patients on tiotropium and 352 (95\u00a0%) on placebo.", {"entities": []}], ["At baseline, 280 (51.5\u00a0%) patients on tiotropium and 179 (50.1\u00a0%) on placebo reported \u22651 COPD-related night-time awakening per week.", {"entities": []}], ["Over the 13-weeks\u2019 treatment, tiotropium was associated with fewer night-time awakenings, with mean\u2009\u00b1\u2009SE overall awakening scores per week of 0.356\u2009\u00b1\u20090.006 compared with 0.421\u2009\u00b1\u20090.007 for placebo ( p \u2009<\u20090.001); means were significantly lower for tiotropium versus placebo in patients with baseline awakenings ( p \u2009<\u20090.001), but not for those without baseline awakenings.", {"entities": []}], ["COPD-related night-time awakenings were associated with increased nocturnal rescue medication use and lower HRQoL ratings in both treatment arms.", {"entities": []}], ["Following start of treatment, tiotropium decreased patients\u2019 use of rescue medication compared with placebo, and morning and evening adjusted means for PEFR were higher for tiotropium compared with placebo.", {"entities": []}], ["Tiotropium is associated with decreased COPD-related night-time awakenings.", {"entities": []}], ["Night-time awakenings are associated with increased nocturnal rescue medication use and may be a surrogate marker of symptom control in patients with COPD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0340-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Allergic bronchopulmonary aspergillosis (ABPA) is a Th2 hypersensitivity lung disease in response to Aspergillus fumigatus that affects asthmatic and cystic fibrosis (CF) patients.", {"entities": [[26, 39, "DISEASE"], [150, 165, "DISEASE"], [73, 85, "DISEASE"]]}], ["Sensitization to A. fumigatus is common in both atopic asthmatic and CF patients, yet only 1-2% of asthmatic and 7\u20139% of CF patients develop ABPA.", {"entities": []}], ["ABPA is characterized by wheezing and pulmonary infiltrates which may lead to pulmonary fibrosis and/or bronchiectasis.", {"entities": [[104, 118, "DISEASE"], [78, 96, "DISEASE"]]}], ["The inflammatory response is characterized by Th2 responses to Aspergillus allergens, increased serum IgE and eosinophilia.", {"entities": [[110, 122, "DISEASE"]]}], ["A number of genetic risks have recently been identified in the development of ABPA.", {"entities": []}], ["These include HLA-DR and HLA-DQ, IL-4 receptor alpha chain ( IL-4RA ) polymorphisms, IL-10-1082GA promoter polymorphisms, surfactant protein A2 (SP-A2) polymorphisms, and cystic fibrosis transmembrane conductance regulator gene ( CFTR ) mutations.", {"entities": [[171, 186, "DISEASE"], [230, 234, "GENE"]]}], ["The studies indicate that ABPA patients are genetically at risk to develop skewed and heightened Th2 responses to A. fumigatus antigens.", {"entities": []}], ["These genetic risk studies and their consequences of elevated biologic markers may aid in identifying asthmatic and CF patients who are at risk to the development of ABPA.", {"entities": []}], ["Furthermore, these studies suggest that immune modulation with medications such as anti-IgE, anti-IL-4 and/or IL-13 monoclonal antibodies may be helpful in the treatment of ABPA.", {"entities": []}], ["CD4+ and CD8+ alpha/beta+ T cells of the T helper cell (Th)2 phenotype produce the cytokines IL-4, IL-5, and IL-13 that promote IgE production and eosinophilic inflammation.", {"entities": []}], ["IL-4 may play an important role in mediating the differentiation of antigenically naive alpha/beta+ T cells into Th2 cells.", {"entities": []}], ["Murine NK1.1+ (CD4+ or CD4-CD8-) alpha/beta+ T cells comprise a beta 2-microglobulin (beta 2m)-dependent cell population that rapidly produces IL-4 after cell activation in vitro and in vivo and has been proposed as a source of IL-4 for Th2 cell differentiation.", {"entities": []}], ["alpha/beta+ CD8+ T cells, most of which require beta 2m for their development, have also been proposed as positive regulators of allergen-induced Th2 responses.", {"entities": []}], ["We tested whether beta 2m- dependent T cells were essential for Th2 cell-mediated allergic reactions by treating wild-type, beta 2m-deficient (beta 2m -/-), and IL-4-deficient (IL-4 -/-) mice of the C57BL/6 genetic background with ovalbumin (OVA), using a protocol that induces robust allergic pulmonary disease in wild-type mice.", {"entities": []}], ["OVA-treated beta 2m -/- mice had circulating levels of total and OVA-specific IgE, pulmonary eosinophilia, and expression of IL-4, IL-5, and IL-13 mRNA in bronchial lymph node tissue similar to that of OVA-treated wild-type mice.", {"entities": [[93, 105, "DISEASE"], [83, 105, "DISEASE"]]}], ["In contrast, these responses in OVA-treated IL-4 -/- mice were all either undetectable or markedly reduced compared with wild-type mice, confirming that IL-4 was required in this allergic model.", {"entities": []}], ["These results indicate that the NK1.1+ alpha/beta+ T cell population, as well as other beta 2m-dependent populations, such as most peripheral alpha/beta+ CD8+ T cells, are dispensable for the Th2 pulmonary response to protein allergens.", {"entities": []}], ["Nowadays breast cancer is the most important factor concerning the women\u2019s health which can affect the quality of life (QOL).", {"entities": [[9, 22, "DISEASE"], [16, 22, "DISEASE"]]}], ["This study was performed with aim to investigate the QOL and the related factors in Iranian women diagnosed with breast cancer in 2014-2015.", {"entities": [[113, 126, "DISEASE"], [120, 126, "DISEASE"]]}], ["This cross-sectional study was performed on 94 women with breast cancer who were selected by convenience sampling in Mashhad, Iran from 2014-2015.", {"entities": [[58, 71, "DISEASE"], [65, 71, "DISEASE"]]}], ["The data were collected through Demographic and Clinical Questionnaire and EORTC QLQ-C30.V3 Standard Questionnaire.", {"entities": []}], ["Data was analyzed by SPSS software (version 18) and also descriptive statistics and linear regression analysis.", {"entities": []}], ["P<0.05 was considered statistically significant.", {"entities": []}], ["The mean of total score for the quality of life was 71.45\u00b1 22.28.", {"entities": []}], ["In the area of the symptoms of disease, the highest score belonged to insomnia (22.73\u00b1 14.89) and fatigue (19.81\u00b1 14.42).", {"entities": []}], ["In the functional area, physical and emotional scales accounted for the highest (91.35\u00b19.67) and lowest (78.55\u00b12.84) scores, respectively.", {"entities": []}], ["The results of multiple regression analysis showed that the variables of age, social status, radiotherapy, and hormone therapy are effective factors in the QOL.", {"entities": []}], ["Breast cancer can affect the women\u2019s QOL.", {"entities": [[0, 13, "DISEASE"], [7, 13, "DISEASE"]]}], ["Therefore, efforts to promote the QOL in breast cancer patients is considered as one of the most important topics in women\u2019s health care.", {"entities": [[41, 54, "DISEASE"], [48, 54, "DISEASE"]]}], ["This requires more attention to identify various aspects of life and find effective ways to promote and improve the QOL in these patients.", {"entities": []}], ["Transcranial Magnetic Stimulation in de novo patients with Celiac Disease previously revealed an imbalance in the excitability of cortical facilitatory and inhibitory circuits.", {"entities": [[59, 73, "DISEASE"]]}], ["After a median period of 16 months of gluten-free diet, a global increase of cortical excitability was reported, suggesting a glutamate-mediated compensation for disease progression.", {"entities": []}], ["We have now evaluated cross-sectionally the changes of cortical excitability to TMS after a much longer gluten-free diet.", {"entities": []}], ["Twenty patients on adequate gluten-free diet for a mean period of 8.35 years were enrolled and compared with 20 de novo patients and 20 healthy controls.", {"entities": []}], ["Transcranial Magnetic Stimulation measures, recorded from the first dorsal interosseous muscle of the dominant hand, consisted of: resting motor threshold, cortical silent period, motor evoked potentials, central motor conduction time, mean short-latency intracortical inhibition and intracortical facilitation.", {"entities": []}], ["The cortical silent period was shorter in de novo patients, whereas in gluten-free diet participants it was similar to controls.", {"entities": []}], ["The amplitude of motor responses was significantly smaller in all patients than in controls, regardless of the dietary regimen.", {"entities": []}], ["Notwithstanding the diet, all patients exhibited a statistically significant decrease of mean short-latency intracortical inhibition and enhancement of intracortical facilitation with respect to controls; more intracortical facilitation in gluten-restricted compared to non-restricted patients was also observed.", {"entities": []}], ["Neurological examination and celiac disease-related antibodies were negative.", {"entities": [[29, 43, "DISEASE"]]}], ["In this new investigation, the length of dietary regimen was able to modulate the electrocortical changes in celiac disease.", {"entities": [[109, 123, "DISEASE"]]}], ["Nevertheless, an intracortical synaptic dysfunction, mostly involving excitatory and inhibitory interneurons within the motor cortex, may persist.", {"entities": []}], ["The clinical significance of subtle neurophysiological changes in celiac disease needs to be further investigated.", {"entities": [[66, 80, "DISEASE"]]}], ["Hypouricemia was reported as a risk factor for exercise-induced acute renal injury (EIAKI) and urinary stones.", {"entities": []}], ["However, the prevalence of kidney diseases among hypouricemic subjects has not been evaluated.", {"entities": []}], ["This study was conducted to clarify the prevalence of hypouricemia and the association of hypouricemia with kidney diseases by using a large-scale Japanese population data.", {"entities": []}], ["This study is a retrospective cross-sectional study at the Center for Preventive Medicine, St. Luke\u2019s International Hospital, Tokyo, Japan, and Sanin Rousai Hospital, Yonago, Japan.", {"entities": []}], ["We analyzed the medical records of 90,143 Japanese subjects at the center in St. Luke\u2019s International Hospital, Tokyo, and 4,837 subjects in Sanin Rousai Hospital, Yonago, who underwent annual regular health check-up between January 2004 and June 2010.", {"entities": []}], ["We defined hypouricemia as serum uric acid level of \u22642.0 mg/dL.", {"entities": []}], ["We checked the medical history of all the study subjects and compared the rates of complications including urinary stones and kidney diseases among those with or without hypouricemia.", {"entities": []}], ["The prevalence of hypouricemia was 0.19% in St. Luke\u2019s International Hospital, Tokyo, and 0.58% in Sanin Rousai Hospital, Yonago.", {"entities": []}], ["The prevalence of hypouricemia in women was larger than that in men both in Tokyo (0.31% vs 0.068%, p<0.001) and in Yonago (1.237% vs 0.318%, p<0.001).", {"entities": []}], ["Among 172 hypouricemic subjects (30 men), the rates of previous urinary stones and kidney diseases (including nephritis/nephrosis) were 1.2% (3.3% men, 0.7% women) and 2.3% (10% men, 0.7% women), respectively.", {"entities": [[110, 119, "DISEASE"], [120, 129, "DISEASE"]]}], ["Hypouricemic men had a 9-fold higher rate of previously having kidney diseases compared to non-hypouricemic men (p<0.001).", {"entities": []}], ["However, the rates of other diseases including urinary stones were not significantly different between the two groups.", {"entities": []}], ["Hypouricemia was associated with a history of kidney disease especially in men.", {"entities": [[46, 60, "DISEASE"]]}], ["All implant compounds undergo an electrochemical process when in contact with biological fluids, as well as mechanical corrosion due to abrasive wear, with production of metal debris that may inhibit repair processes.", {"entities": []}], ["None of the commonly-used methods can diagnose implant allergies when used singly, therefore a panel of tests should be performed on allergic patients as pre-operative screening, or when a postoperative metal sensitisation is suspected.", {"entities": []}], ["We analysed patients with painful prostheses and subjects prone to allergies using the Patch Test in comparison with the Lymphocyte Transformation Test.", {"entities": []}], ["Cytokine production was evaluated to identify prognostic markers for early diagnosis of aseptic loosening.", {"entities": []}], ["Metal debris endocytosis and cytoskeletal rearrangement was visualised by confocal microscopy.", {"entities": []}], ["Our results demonstrate that the Lymphocyte Transformation Test can identify patients who have a predisposition to develop allergic reactions and can confirm the diagnosis of hypersensitivity in patients with painful prostheses.", {"entities": []}], ["The prevalence of a Th2-cytokine pattern may be used to identify predisposition to the development of allergic diseases, while the selective presence of osteoclastogenic cytokines may be used as predictor of a negative outcome in patients with painful prosthesis.", {"entities": []}], ["The hypothesis of the prognostic value of these cytokines as early markers of aseptic loosening is attractive, but its confirmation would require extensive testing.", {"entities": []}], ["The Lymphocyte Transformation Test is the most suitable method for testing systemic allergies.", {"entities": []}], ["We suggest that the combined use of the Patch Test and the Lymphocyte Transformation Test, associated with cytokine detection in selected patients, could provide a useful tool for preventive evaluation of immune reactivity in patients undergoing primary joint replacement surgery, and for clinical monitoring of the possible onset of a metal sensitization in patients with implanted devices.", {"entities": []}], ["The unique properties of microporous zeolites, including ion-exchange properties, adsorption, molecular sieving, catalysis, conductivity have been exploited in improving the performance of gas sensors.", {"entities": []}], ["Zeolites have been employed as physical and chemical filters to improve the sensitivity and selectivity of gas sensors.", {"entities": []}], ["In addition, direct interaction of gas molecules with the extraframework cations in the nanoconfined space of zeolites has been explored as a basis for developing new impedance-type gas/vapor sensors.", {"entities": []}], ["In this review, we summarize how these properties of zeolites have been used to develop new sensing paradigms.", {"entities": []}], ["There is a considerable breadth of transduction processes that have been used for zeolite incorporated sensors, including frequency measurements, optical and the entire gamut of electrochemical measurements.", {"entities": []}], ["It is clear from the published literature that zeolites provide a route to enhance sensor performance, and it is expected that commercial manifestation of some of the approaches discussed here will take place.", {"entities": []}], ["The future of zeolite-based sensors will continue to exploit its unique properties and use of other microporous frameworks, including metal organic frameworks.", {"entities": []}], ["Zeolite composites with electronic materials, including metals will lead to new paradigms in sensing.", {"entities": []}], ["Use of nano-sized zeolite crystals and zeolite membranes will enhance sensor properties and make possible new routes of miniaturized sensors.", {"entities": []}], ["Monocyte chemoattractant protein-1 (MCP-1) levels are increased in scalp lesions of patients with alopecia areata (AA), suggesting a role in the development of AA.", {"entities": [[98, 113, "DISEASE"], [98, 106, "DISEASE"]]}], ["Recently, a biallelic A/G polymorphism in the MCP-1 promoter at position -2518 has been found, influencing the level of MCP-1 expression in response to an inflammatory stimulus.", {"entities": []}], ["We investigated whether the presence of these polymorphisms were associated with AA in Korean population.", {"entities": []}], ["145 Korean patients with AA, 246 healthy subjects without clinical evidence of AA were screened for genotype with a PCR-based assay.", {"entities": []}], ["In the AA patients the frequency of the A and G alleles was 40.3 and 59.7%, respectively and the distribution of the A/A, A/G and G/G genotypes was 19.3, 42.1 and 38.6%, respectively.", {"entities": []}], ["Amongst the controls the frequency of the A and G alleles was 39.8 and 60.2%, and the distribution of the A/A, A/G, G/G genotypes in the same group was 17.5, 44.7 and 37.8%, respectively.", {"entities": []}], ["There was no significant difference in the allele frequencies and genotype distributions between the patients and the controls ( p =0.889, p =0.848, respectively).", {"entities": []}], ["Our data indicates that no association exists between the -2518A/G polymorphism of the MCP-1 gene and susceptibility to alopecia areata.", {"entities": [[120, 135, "DISEASE"], [120, 128, "DISEASE"]]}], ["A hydrogen peroxide (H 2 O 2 )-activated cell-penetrating peptide was developed through incorporation of a boronic acid-containing cleavable linker between polycationic cell-penetrating peptide and polyanionic fragments.", {"entities": []}], ["Fluorescence labeling of the two ends of the molecule enabled monitoring its reaction with H 2 O 2 through release of the highly adhesive cell-penetrating peptide and disruption of fluorescence resonance energy transfer.", {"entities": []}], ["The H 2 O 2 sensor selectively reacts with endogenous H 2 O 2 in cell culture to monitor the oxidative burst of promyelocytes and in vivo to image lung inflammation.", {"entities": []}], ["Targeting H 2 O 2 has potential applications in imaging and therapy of diseases related to oxidative stress.", {"entities": []}], ["Pleural effusions have a major impact on the cardiorespiratory system.", {"entities": []}], ["This article reviews the pathophysiological effects of pleural effusions and pleural drainage, their relationship with breathlessness, and highlights key knowledge gaps.", {"entities": []}], ["The basis for breathlessness in pleural effusions and relief following thoracentesis is not well understood.", {"entities": []}], ["Many existing studies on the pathophysiology of breathlessness in pleural effusions are limited by small sample sizes, heterogeneous design and a lack of direct measurements of respiratory muscle function.", {"entities": []}], ["Gas exchange worsens with pleural effusions and improves after thoracentesis.", {"entities": []}], ["Improvements in ventilatory capacity and lung volumes following pleural drainage are small, and correlate poorly with the volume of fluid drained and the severity of breathlessness.", {"entities": []}], ["Rather than lung compression, expansion of the chest wall, including displacement of the diaphragm, appears to be the principle mechanism by which the effusion is accommodated.", {"entities": []}], ["Deflation of the thoracic cage and restoration of diaphragmatic function after thoracentesis may improve diaphragm effectiveness and efficiency, and this may be an important mechanism by which breathlessness improves.", {"entities": []}], ["Effusions do not usually lead to major hemodynamic changes, but large effusions may cause cardiac tamponade and ventricular diastolic collapse.", {"entities": [[90, 107, "DISEASE"]]}], ["Patients with effusions can have impaired exercise capacity and poor sleep quality and efficiency.", {"entities": []}], ["Pleural effusions are associated with abnormalities in gas exchange, respiratory mechanics, respiratory muscle function and hemodynamics, but the association between these abnormalities and breathlessness remains unclear.", {"entities": []}], ["Prospective studies should aim to identify the key mechanisms of effusion-related breathlessness and predictors of improvement following pleural drainage.", {"entities": []}], ["Carissa opaca Stapf ex Hanes fruits is traditionally used in the treatment of asthma, hepatitis and microbial infections.", {"entities": [[86, 95, "DISEASE"], [78, 84, "DISEASE"]]}], ["The present study was arranged to investigate the antimicrobial, cytotoxic and antitumor activity of various fractions of C. opaca extract and its bioactive metabolites responsible for that activity.", {"entities": []}], ["To characterize various fractions of C.opaca antibacterial, antifungal, cytotoxic and antitumor assays are used.", {"entities": []}], ["Eight strains of bacteria including Bacillus subtilis , Enterobactor aerogenes , Escherichia coli , Klebsiella pneumoniae , Micrococcus luteus , Pseudomonas aeroginosa , Salmonella typhy , and Staphylococcus aureus and four strains of fungal viz: Aspergillus flavus , Aspergillus fumigatus, Aspergillus niger a nd Fusarium solani are used.", {"entities": []}], ["Brine shrimps and potato dics are used for anticancer and antitumor potency of extract.", {"entities": []}], ["High performance liquid chromatography (HPLC) is utilized for determination of bioactive metabolites responsible for the activity.", {"entities": []}], ["HPLC chromatogram revealed the presence of orientin, isoquercetin, myricetin and apigenin.", {"entities": []}], ["Various fractions of C. oapca showed significant antibacterial, antitumor and anticancer activity.", {"entities": []}], ["In case of C. opaca fruit inhibition growth of Aspergillus niger was ranged between 23.2\u2009\u00b1\u20091.36% to 43.3\u2009\u00b1\u20092.39%, Aspergillus flavus ranged between 27.6\u2009\u00b1\u20091.39% to 65.6\u2009\u00b1\u20093.44%, Aspergillus fumigatus ranged between 13.2\u2009\u00b1\u20091.00% to 52.4\u2009\u00b1\u20091.54% and Fusarium solani ranged between 10.5\u2009\u00b1\u20091.02% to 14.6\u2009\u00b1\u20091.74%.", {"entities": []}], ["It can be concluded that, various fractions of C.opaca are accessible source of ethno pharmacy as they are consumed in different areas of Pakistan with ultimate health compensations.", {"entities": []}], ["Asthma is a common chronic disease of childhood that is associated with significant morbidity and mortality.", {"entities": [[0, 6, "DISEASE"]]}], ["We aimed to estimate the prevalence of asthma among secondary school pupils in urban and rural areas of coast districts of Tanzania.", {"entities": [[39, 45, "DISEASE"]]}], ["The study also aimed to describe pupils\u2019 perception towards asthma, and to assess their knowledge on symptoms, triggers, and treatment of asthma.", {"entities": [[60, 66, "DISEASE"], [138, 144, "DISEASE"]]}], ["A total of 610 pupils from Ilala district and 619 pupils from Bagamoyo district formed the urban and rural groups, respectively.", {"entities": []}], ["Using a modified International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire, a history of \u201cdiagnosed\u201d asthma or the presence of a wheeze in the previous 12\u00a0months was obtained from all the studied pupils, along with documentation of their perceptions regarding asthma.", {"entities": [[40, 46, "DISEASE"], [122, 128, "DISEASE"], [281, 287, "DISEASE"]]}], ["Pupils without asthma or wheeze in the prior 12\u00a0months were subsequently selected and underwent a free running exercise testing.", {"entities": [[15, 21, "DISEASE"]]}], ["A\u2009\u2265\u200920% decrease in the post-exercise Peak Expiratory Flow Rate (PEFR) values was the criterion for diagnosing exercise-induced asthma.", {"entities": [[128, 134, "DISEASE"]]}], ["The mean age of participants was 16.8 (\u00b11.8) years.", {"entities": []}], ["The prevalence of wheeze in the past 12\u00a0months was 12.1% in Bagamoyo district and 23.1% in Ilala district (p\u2009<\u20090.001).", {"entities": []}], ["Self-reported asthma was found in 17.6% and 6.4% of pupils in Ilala and Bagamoyo districts, respectively (p\u2009<\u20090.001).", {"entities": [[14, 20, "DISEASE"]]}], ["The prevalence of exercise-induced asthma was 2.4% in Bagamoyo, and 26.3% in Ilala (P\u2009<\u20090.002).", {"entities": [[35, 41, "DISEASE"]]}], ["In both districts, most information on asthma came from parents, and there was variation in symptoms and triggers of asthma reported by the pupils.", {"entities": [[39, 45, "DISEASE"], [117, 123, "DISEASE"]]}], ["Non-asthmatic pupils feared sleeping, playing, and eating with their asthmatic peers.", {"entities": []}], ["The prevalence rates of self-reported asthma, wheezing in the past 12\u00a0months, and exercise-induced asthma were significantly higher among urban than rural pupils.", {"entities": [[38, 44, "DISEASE"], [99, 105, "DISEASE"]]}], ["Although bronchial asthma is a common disease, pupils\u2019 perceptions about asthma were associated with fear of contact with their asthmatic peers in both rural and urban schools.", {"entities": [[19, 25, "DISEASE"], [73, 79, "DISEASE"]]}], ["The aim of this study was to assess the cost-utility of palivizumab versus no prophylaxis in the prevention of respiratory syncytial virus infection among high-risk preterm infants.", {"entities": []}], ["We used and adapted a pre-existent model in which two cohorts of patients received palivizumab or no prophylaxis.", {"entities": []}], ["The patients were followed for their expected lifetimes.", {"entities": []}], ["The economic evaluation was conducted from the perspective of the Italian National Health Service.", {"entities": []}], ["We considered Life-Years Gained (LYGs), Quality-Adjusted Life-Years (QALYs) and direct medical costs (pharmacological treatment, hospitalization, recurrences for wheezing, etc.).", {"entities": []}], ["LYGs and QALYs were based on the results of a double blind cohort study with prospective follow-up and direct medical costs were based on Italian treatment patterns.", {"entities": []}], ["Benefits and costs were discounted at 3%.", {"entities": []}], ["Costs were assessed in 2007 Euros.", {"entities": []}], ["Sensitivity and threshold analysis on key clinical and economic parameters were performed.", {"entities": []}], ["For the two cohorts, the expected life-years (per patient) with palivizumab versus no prophylaxis were 29.842 and 29.754 years, respectively.", {"entities": []}], ["Quality-adjusted life years (per patient) with palivizumab were 29.202, and for no prophylaxis were 29.043.", {"entities": []}], ["The expected cost (per patient) was \u20ac 6,244.20 with palivizumab and \u20ac 4,867.70 with no prophylaxis.", {"entities": []}], ["We calculated for palivizumab versus no prophylaxis the incremental cost per LYG and per QALY gained.", {"entities": []}], ["It was \u20ac 15,568.65 and \u20ac 8,676.74, respectively.", {"entities": []}], ["This study suggests that, compared with no prophylaxis, palivizumab is cost-effective in the prevention of respiratory syncytial virus infection among high risk preterm infants.", {"entities": []}], ["Pulmonary rehabilitation (PR) is recognized as an evidence-based treatment in improving dyspnea and quality of life in patients with COPD.", {"entities": []}], ["We evaluated the number needed to treat (NNT) to achieve an increase in physical capacity, as defined by a significant improvement in the six-minute walk test (6MWT) in patients with COPD undergoing PR.", {"entities": [[41, 44, "GENE"]]}], ["The study enrolled 284 patients aged 41 to 86 years (mean age 69.4 years) divided into two groups: a study group (222 patients) undergoing a PR program, and a control group (62 patients) treated only with drugs.", {"entities": []}], ["The study group included patients with COPD divided in four subgroups according to GOLD stages.", {"entities": []}], ["In the study group, 142 out of 222 patients (64%) had an increase of at least 54 m in the 6MWT following PR versus 8 out of 62 patients (13%) in the control group after the same time interval.", {"entities": []}], ["The NNT in the overall study group was 2; the same NNT was obtained in GOLD stages 2, 3, and 4, but was 8 in stage 1.", {"entities": [[4, 7, "GENE"], [51, 54, "GENE"], [4, 7, "GENE"], [51, 54, "GENE"]]}], ["PR is highly effective in improving the exercise capacity of patients with COPD, as demonstrated by a valuable NNT, with better results in patients with a more severe disease.", {"entities": [[111, 114, "GENE"]]}], ["Chitinase is an important enzyme responsible for chitin metabolism in a wide range of organisms including bacteria, yeasts and other fungi, nematodes and arthropods.", {"entities": []}], ["However, current knowledge on chitinolytic enzymes, especially their structures, functions and regulation is very limited.", {"entities": []}], ["In this study we have identified 20 chitinase and chitinase-like genes in the African malaria mosquito, Anopheles gambiae , through genome-wide searching and transcript profiling.", {"entities": [[86, 93, "DISEASE"]]}], ["We assigned these genes into eight different chitinase groupings (groups I\u2013VIII).", {"entities": []}], ["Domain analysis of their predicted proteins showed that all contained at least one catalytic domain.", {"entities": []}], ["However, only seven (AgCht4, AgCht5-1, AgCht6, AgCht7, AgCht8, AgCht10 and AgCht23) displayed one or more chitin-binding domains.", {"entities": []}], ["Analyses of stage- and tissue-specific gene expression revealed that most of these genes were expressed in larval stages.", {"entities": []}], ["However, AgCht8 was mainly expressed in the pupal and adult stages.", {"entities": []}], ["AgCht2 and AgCht12 were specifically expressed in the foregut, whereas AgCht13 was only expressed in the midgut.", {"entities": []}], ["The high diversity and complexity of An.", {"entities": []}], ["gambiae chitinase and chitinase-like genes suggest their diverse functions during different developmental stages and in different tissues of the insect.", {"entities": []}], ["A comparative genomic analysis of these genes along with those present in Drosophila melanogaster , Tribolium castaneum and several other insect species led to a uniform classification and nomenclature of these genes.", {"entities": []}], ["Our investigation also provided important information for conducting future studies on the functions of chitinase and chitinase-like genes in this important malaria vector and other species of arthropods.", {"entities": [[157, 164, "DISEASE"]]}], ["Thirdhand smoke (THS) is a new term for the toxins in cigarette smoke that linger in the environment long after the cigarettes are extinguished.", {"entities": []}], ["The effects of THS exposure on male reproduction have not yet been studied.", {"entities": []}], ["In this study, metabolic changes in male germ cell lines (GC-2 and TM-4) were analyzed after THS treatment for 24\u2009h. THS-loaded chromatography paper samples were generated in a laboratory chamber system and extracted in DMEM.", {"entities": []}], ["At a paper: DMEM ratio of 50\u2009\u03bcg/ml, cell viability in both cell lines was normal, as measured by the MTT assay and markers of cytotoxicity, cell cycle, apoptosis and ROS production were normal as measured by quantitative immunofluorescence.", {"entities": []}], ["Metabolomic analysis was performed on methanol extracts of GC-2 and TM-4 cells.", {"entities": []}], ["Glutathione metabolism in GC-2 cells, and nucleic acid and ammonia metabolism in TM-4 cells, was changed significantly by THS treatment.", {"entities": []}], ["RT-PCR analyses of mRNA for enzyme genes Gss and Ggt in GC-2 cells, and TK, SMS and Glna in TM-4 cells reinforced these findings, showing changes in the levels of enzymes involved in the relevant pathways.", {"entities": [[41, 44, "GENE"], [76, 79, "GENE"]]}], ["In conclusion, exposure to THS at very low concentrations caused distinct metabolic changes in two different types of male reproductive cell lines.", {"entities": []}], ["It has previously been shown that low back pain (LBP) often presents already in the teenage years and that previous LBP predicts future LBP.", {"entities": [[49, 52, "GENE"], [116, 119, "GENE"], [136, 139, "GENE"], [49, 52, "GENE"], [116, 119, "GENE"], [136, 139, "GENE"], [49, 52, "GENE"], [116, 119, "GENE"], [136, 139, "GENE"]]}], ["It is also well documented that there is a large degree of comorbidity associated with LBP, both in adolescents and adults.", {"entities": [[87, 90, "GENE"]]}], ["The objective of this study is to gain a deeper insight into the etiology of low back pain and to possibly develop a tool for early identification of high-risk groups.", {"entities": []}], ["This is done by investigating whether different types of morbidity in adolescence are associated with LBP in adulthood.", {"entities": [[102, 105, "GENE"]]}], ["Almost 10,000 Danish twins born between 1972 and 1982 were surveyed by means of postal questionnaires in 1994 and again in 2002.", {"entities": []}], ["The questionnaires dealt with various aspects of general health, including the prevalence of LBP, classified according to number of days affected during the previous year (0, 1\u20137, 8\u201330, >30).", {"entities": [[93, 96, "GENE"]]}], ["The predictor variables used in this study were LBP, headache, asthma and atopic disease at baseline; the outcome variable was persistent LBP (>30 days during the past year) at follow-up.", {"entities": [[63, 69, "DISEASE"], [48, 51, "GENE"], [138, 141, "GENE"], [48, 51, "GENE"], [138, 141, "GENE"]]}], ["Associations between morbidity in 1994 and LBP in 2002 were investigated.", {"entities": [[43, 46, "GENE"]]}], ["LBP, headache and asthma in adolescence were positively associated with future LBP.", {"entities": [[18, 24, "DISEASE"], [0, 3, "GENE"], [79, 82, "GENE"], [0, 3, "GENE"], [79, 82, "GENE"]]}], ["There was no association between atopic disease and future LBP.", {"entities": [[59, 62, "GENE"]]}], ["Individuals with persistent LBP at baseline had an odds ratio of 3.5 (2.8\u20134.5) for future LBP, while the odds ratio for those with persistent LBP, persistent headache and asthma was 4.5 (2.5\u20138.1).", {"entities": [[171, 177, "DISEASE"], [28, 31, "GENE"], [90, 93, "GENE"], [142, 145, "GENE"], [28, 31, "GENE"], [90, 93, "GENE"], [142, 145, "GENE"], [28, 31, "GENE"], [90, 93, "GENE"], [142, 145, "GENE"]]}], ["There was a large degree of clustering of these disorders, but atopic disease was not part of this pattern.", {"entities": []}], ["Young people from 12 to 22 years of age with persistent LBP during the previous year have an odds ratio of 3.5 persistent LBP eight years later.", {"entities": [[56, 59, "GENE"], [122, 125, "GENE"], [56, 59, "GENE"], [122, 125, "GENE"]]}], ["Both headache and asthma are also positively associated with future LBP and there is a large clustering of LBP, headache and asthma in adolescence.", {"entities": [[18, 24, "DISEASE"], [125, 131, "DISEASE"], [68, 71, "GENE"], [107, 110, "GENE"], [68, 71, "GENE"], [107, 110, "GENE"]]}], ["Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and programme decision making.", {"entities": []}], ["Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures to monitor such changes in population health: disability-adjusted life-years (DALYs) and healthy life expectancy (HALE).", {"entities": []}], ["We used these measures to track trends and benchmark progress compared with expected trends on the basis of the Socio-demographic Index (SDI).", {"entities": []}], ["We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 for all-cause mortality, cause-specific mortality, and non-fatal disease burden to derive HALE and DALYs by sex for 195 countries and territories from 1990 to 2016.", {"entities": []}], ["We calculated DALYs by summing years of life lost and years of life lived with disability for each location, age group, sex, and year.", {"entities": []}], ["We estimated HALE using age-specific death rates and years of life lived with disability per capita.", {"entities": []}], ["We explored how DALYs and HALE differed from expected trends when compared with the SDI: the geometric mean of income per person, educational attainment in the population older than age 15 years, and total fertility rate.", {"entities": []}], ["The highest globally observed HALE at birth for both women and men was in Singapore, at 75\u00b72 years (95% uncertainty interval 71\u00b79\u201378\u00b76) for females and 72\u00b70 years (68\u00b78\u201375\u00b71) for males.", {"entities": []}], ["The lowest for females was in the Central African Republic (45\u00b76 years [42\u00b70\u201349\u00b75]) and for males was in Lesotho (41\u00b75 years [39\u00b70\u201344\u00b70]).", {"entities": []}], ["From 1990 to 2016, global HALE increased by an average of 6\u00b724 years (5\u00b797\u20136\u00b748) for both sexes combined.", {"entities": []}], ["Global HALE increased by 6\u00b704 years (5\u00b774\u20136\u00b727) for males and 6\u00b749 years (6\u00b708\u20136\u00b777) for females, whereas HALE at age 65 years increased by 1\u00b778 years (1\u00b761\u20131\u00b793) for males and 1\u00b796 years (1\u00b769\u20132\u00b713) for females.", {"entities": []}], ["Total global DALYs remained largely unchanged from 1990 to 2016 (\u20132\u00b73% [\u20135\u00b79 to 0\u00b79]), with decreases in communicable, maternal, neonatal, and nutritional (CMNN) disease DALYs offset by increased DALYs due to non-communicable diseases (NCDs).", {"entities": []}], ["The exemplars, calculated as the five lowest ratios of observed to expected age-standardised DALY rates in 2016, were Nicaragua, Costa Rica, the Maldives, Peru, and Israel.", {"entities": []}], ["The leading three causes of DALYs globally were ischaemic heart disease, cerebrovascular disease, and lower respiratory infections, comprising 16\u00b71% of all DALYs.", {"entities": [[73, 96, "DISEASE"], [58, 71, "DISEASE"]]}], ["Total DALYs and age-standardised DALY rates due to most CMNN causes decreased from 1990 to 2016.", {"entities": []}], ["Conversely, the total DALY burden rose for most NCDs; however, age-standardised DALY rates due to NCDs declined globally.", {"entities": []}], ["At a global level, DALYs and HALE continue to show improvements.", {"entities": []}], ["At the same time, we observe that many populations are facing growing functional health loss.", {"entities": []}], ["Rising SDI was associated with increases in cumulative years of life lived with disability and decreases in CMNN DALYs offset by increased NCD DALYs.", {"entities": []}], ["Relative compression of morbidity highlights the importance of continued health interventions, which has changed in most locations in pace with the gross domestic product per person, education, and family planning.", {"entities": []}], ["The analysis of DALYs and HALE and their relationship to SDI represents a robust framework with which to benchmark location-specific health performance.", {"entities": []}], ["Country-specific drivers of disease burden, particularly for causes with higher-than-expected DALYs, should inform health policies, health system improvement initiatives, targeted prevention efforts, and development assistance for health, including financial and research investments for all countries, regardless of their level of sociodemographic development.", {"entities": []}], ["The presence of countries that substantially outperform others suggests the need for increased scrutiny for proven examples of best practices, which can help to extend gains, whereas the presence of underperforming countries suggests the need for devotion of extra attention to health systems that need more robust support.", {"entities": []}], ["Bill & Melinda Gates Foundation.", {"entities": []}], ["To examine patient knowledge and factors influencing knowledge about pregnancy in British women with inflammatory bowel disease (IBD).", {"entities": [[101, 127, "DISEASE"]]}], ["This is a post hoc analysis of a study of female members of Crohn\u2019s and Colitis United Kingdom, aged 18-45 years who were sent an online questionnaire recording patient demographics, education, employment, marital status, and disease characteristics.", {"entities": []}], ["Disease related pregnancy knowledge was recorded using Crohn\u2019s and colitis pregnancy knowledge score (CCPKnow).", {"entities": []}], ["Of 1324 responders, 776 (59%) suffered from Crohn\u2019s disease, 496 (38%) from ulcerative colitis and 52 (4%) from IBD-uncategorised.", {"entities": [[76, 94, "DISEASE"]]}], ["CCPKnow scores were poor (0-7) in 50.8%, adequate (8-10) in 23.6%, good (11-13) in 17.7% and very good (\u2265 14) in 7.8%.", {"entities": []}], ["Multiple linear regression analysis revealed that higher CCPKnow scores were independently associated with higher educational achievement ( P < 0.001), younger age at diagnosis ( P = 0.003) and having consulted a health care professional about pregnancy and IBD ( P = 0.001).", {"entities": []}], ["Knowledge was poor in 50%.", {"entities": []}], ["Speaking with health-care professionals was a modifiable factor associated with better knowledge.", {"entities": []}], ["This illustrates the importance of disease related pregnancy education", {"entities": []}], ["AIM: To determine induced sputum cell counts and interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-alpha) and leukotriene B4 (LTB4) levels as markers of neutrophilic inflammation in moderate persistent asthma, and to evaluate the response to inhaled steroid therapy.", {"entities": [[207, 213, "DISEASE"]]}], ["METHODS: Forty-five moderate asthmatic patients and 10 non-smoker controls were included in this study.", {"entities": []}], ["All patients received inhaled corticosteroid (800 microg of budesonide) for 12 weeks.", {"entities": []}], ["Before and after treatment pulmonary function tests were performed, and symptom scores were determined.", {"entities": []}], ["Blood was drawn for analysis of serum inflammatory markers, and sputum was induced.", {"entities": []}], ["RESULTS: Induced sputum cell counts and inflammatory markers were significantly higher in patients with asthma than in the control group.", {"entities": [[104, 110, "DISEASE"]]}], ["The induced sputum eosinophil counts of 12 patients (26%) were found to be less than 5%, the non-eosinophilic group, and sputum neutrophil counts, IL-8 and TNF-alpha levels were significantly higher than the eosinophilic group (neutrophil, 50+/-14% versus 19+/-10%, p<0.01).", {"entities": []}], ["In both groups, there was a significant decrease in sputum total cell counts and serum and sputum IL-8, TNF-alpha and LTB4 levels after the treatment.", {"entities": []}], ["There was no change in sputum neutrophil counts.", {"entities": []}], ["Although the sputum eosinophil count decreased only in the eosinophilic subjects, there was no significant difference in inflammatory markers between the groups.", {"entities": []}], ["The symptom scores were significantly improved after treatment, while the improvement did not reach statistical significance on pulmonary function test parameters.", {"entities": []}], ["CONCLUSION: Notably, in chronic asthma there is a subgroup of patients whose predominant inflammatory cells are not eosinophils.", {"entities": [[32, 38, "DISEASE"]]}], ["Sputum neutrophil counts and neutrophilic inflammatory markers are significantly higher in these patients.", {"entities": []}], ["In the non-eosinophilic group, inhaled steroid caused an important decrease in inflammatory markers; however, there was no change in the sputum eosinophil and neutrophil counts.", {"entities": []}], ["While the immunogenicity and effectiveness of seasonal influenza vaccines among subjects with severe motor and intellectual disability (SMID) are known to be diminished, the efficacy of the A/H1N1pdm vaccine has not been evaluated.", {"entities": [[55, 64, "DISEASE"], [111, 134, "DISEASE"]]}], ["We prospectively evaluated 103 subjects with SMID (mean age, 41.7 years) who received trivalent inactivated influenza vaccine during the 2010/11 influenza season.", {"entities": [[108, 117, "DISEASE"], [145, 154, "DISEASE"]]}], ["The hemagglutination inhibition (HI) antibody titer was measured in serum samples collected pre-vaccination (S0), post-vaccination (S1), and end-of-season (S2) to evaluate subjects\u2019 immunogenicity capacity.", {"entities": []}], ["Vaccine efficacy was assessed based on antibody efficacy and achievement proportion.", {"entities": []}], ["The proportions of seroprotection and seroconversion, and the geometric mean titer (GMT) ratio (GMT at S1/GMT at S0) for A/H1N1pdm were 46.0%, 16.0%, and 1.8, respectively\u2014values which did not meet the European Medicines Evaluation Agency criteria.", {"entities": []}], ["The achievement proportion was 26%.", {"entities": []}], ["During follow-up, 11 of 43 subjects with acute respiratory illness were diagnosed with type A influenza according to a rapid influenza diagnostic test (RIDT), and A/H1N1pdm strains were isolated from the throat swabs of 5 of those 11 subjects.", {"entities": [[94, 103, "DISEASE"], [125, 134, "DISEASE"]]}], ["When either or both RIDT-diagnosed influenza or serologically diagnosed influenza (HI titer at S2/HI titer at S1 \u22652) were defined as probable influenza, subjects with A/H1N1pdm seroprotection were found to have a lower incidence of probable influenza (odds ratio, 0.31; antibody efficacy, 69%; vaccine efficacy, 18%).", {"entities": [[35, 44, "DISEASE"], [72, 81, "DISEASE"], [142, 151, "DISEASE"], [241, 250, "DISEASE"]]}], ["In the present seasonal assessment, antibody efficacy was moderate against A/H1N1pdm among SMID subjects, but vaccine efficacy was low due to the reduced immunogenicity of SMID subjects.", {"entities": []}], ["HLA-G is a HLA-class Ib molecule with potent immunomodulatory activities, which is expressed in physiological conditions, where modulation of the immune response is required to avoid allograft recognition (i.e., maternal-fetal interface or transplanted patients).", {"entities": [[0, 5, "GENE"]]}], ["However, HLA-G can be expressed de novo at high levels in several pathological conditions, including solid and hematological tumors and during microbial or viral infections, leading to the impairment of the immune response against tumor cells or pathogens, respectively.", {"entities": [[9, 14, "GENE"]]}], ["On the other hand, the loss of HLA-G mediated control of the immune responses may lead to the onset of autoimmune/inflammatory diseases, caused by an uncontrolled activation of the immune effector cells.", {"entities": [[31, 36, "GENE"]]}], ["Here, we have reviewed novel findings on HLA-G functions in different physiological and pathological settings, which have been published in the last two years.", {"entities": [[41, 46, "GENE"]]}], ["These studies further confirmed the important role of this molecule in the modulation of the immune system.", {"entities": []}], ["The approved analgesic and anti-inflammatory drugs ibuprofen and indometacin block the small GTPase RhoA, a key enzyme that impedes axonal sprouting after axonal damage.", {"entities": [[100, 104, "GENE"]]}], ["Inhibition of the Rho pathway in a central nervous system-effective manner requires higher dosages compared with orthodox cyclooxygenase-blocking effects.", {"entities": []}], ["Preclinical studies on spinal cord injury (SCI) imply improved motor recovery after ibuprofen/indometacin-mediated Rho inhibition.", {"entities": []}], ["This has been reassessed by a meta-analysis of the underlying experimental evidence, which indicates an overall effect size of 20.2% regarding motor outcome achieved after ibuprofen/indometacin treatment compared with vehicle controls.", {"entities": []}], ["In addition, ibuprofen/indometacin may also limit sickness behaviour, non-neurogenic systemic inflammatory response syndrome (SIRS), neuropathic pain and heterotopic ossifications after SCI.", {"entities": [[116, 124, "DISEASE"]]}], ["Consequently, \u2018small molecule\u2019-mediated Rho inhibition after acute SCI warrants clinical investigation.", {"entities": []}], ["Protocol of an investigator-initiated clinical open-label pilot trial on high-dose ibuprofen treatment after acute traumatic, motor-complete SCI.", {"entities": []}], ["A sample of n=12 patients will be enrolled in two cohorts treated with 2400\u2005mg/day ibuprofen for 4 or 12\u2005weeks, respectively.", {"entities": []}], ["The primary safety end point is an occurrence of serious adverse events, primarily gastroduodenal bleedings.", {"entities": []}], ["Secondary end points are pharmacokinetics, feasibility and preliminary effects on neurological recovery, neuropathic pain and heterotopic ossifications.", {"entities": []}], ["The primary safety analysis is based on the incidence of severe gastrointestinal bleedings.", {"entities": []}], ["Additional analyses will be mainly descriptive and casuistic.", {"entities": []}], ["The clinical trial protocol was approved by the responsible German state Ethics Board, and the Federal Institute for Drugs and Medical Devices.", {"entities": []}], ["The study complies with the Declaration of Helsinki, the principles of Good Clinical Practice and all further applicable regulations.", {"entities": []}], ["This safety and pharmacokinetics trial informs the planning of a subsequent randomised controlled trial.", {"entities": []}], ["Regardless of the result of the primary and secondary outcome assessments, the clinical trial will be reported as a publication in a peer-reviewed journal.", {"entities": []}], ["NCT02096913; Pre-results.", {"entities": []}], ["G protein-coupled receptor kinases (GRKs) play pivotal roles in desensitizing GPCR signaling but little is known about how GRKs recognize and phosphorylate GPCRs due to the technical difficulties in detecting the highly dynamic GPCR/GRK interaction.", {"entities": []}], ["By combining a genetic approach with multiple biochemical assays, we identified the key determinants for the assembly of the prototypical GPCR rhodopsin with its kinase GRK1.", {"entities": [[169, 173, "GENE"]]}], ["Our work reveals that the regulatory G-protein signaling homology (RH) domain of GRKs is the primary binding site to GPCRs and an active conformation of the GRK1 kinase domain is required for efficient interaction with rhodopsin.", {"entities": [[157, 161, "GENE"]]}], ["In addition, we provide a mechanistic solution for the longstanding puzzle about the gain-of-function Q41L mutation in GRK5.", {"entities": [[119, 123, "GENE"]]}], ["This mutation is in the RH domain and increases the capacity of the GRK mutant to interact with and to desensitize GPCRs.", {"entities": []}], ["Finally we present the principal architecture of a rhodopsin/GRK complex through negative stain electron microscopy reconstruction.", {"entities": []}], ["Together, these data define the key components for the rhodopsin/GRK1 interaction and provide a framework for understanding GRK-mediated desensitization of GPCRs.", {"entities": []}], ["Current therapeutic antibodies such as Trastuzumab, are typically of the blood circulatory IgG1 class (C\u03ba/ CH\u03b31).", {"entities": []}], ["Due to the binding to Her2 also present on normal cell surfaces, side effects such as cardiac failure can sometimes be associated with such targeted therapy.", {"entities": []}], ["Using antibody isotype swapping, it may be possible to reduce systemic circulation through increased tissue localization, thereby minimising unwanted side effects.", {"entities": []}], ["However, the effects of such modifications have yet to be fully characterized, particularly with regards to their biophysical properties in antigen binding.", {"entities": []}], ["To do this, we produced all light and heavy chain human isotypes/subtypes recombinant versions of Trastuzumab and Pertuzumab, and studied them with respect to recombinant production and Her2 binding.", {"entities": []}], ["Our findings show that while the light chain constant region changes have no major effects on production or Her2 binding, some heavy chain isotypes, in particularly, IgM and IgD isotypes, can modulate antigen binding.", {"entities": []}], ["This study thus provides the groundwork for such isotype modifications to be performed in the future to yield therapeutics of higher efficacy and efficiency.", {"entities": []}], ["The value of combination therapy with inhaled corticosteroids and long-acting \u03b2-agonists (ICS/LABA) is well recognized in the management of asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[151, 188, "DISEASE"], [140, 146, "DISEASE"]]}], ["Despite differences in the pharmacological properties between two well-established ICS/LABA products (budesonide/formoterol and fluticasone/salmeterol), data from randomized clinical trials (RCTs) and meta-analyses suggest that these two products perform similarly under RCT conditions.", {"entities": []}], ["In contrast, a few recently reported real-world comparative effectiveness studies have suggested that there are substantial differences between ICS/LABA combination treatments in terms of clinical and healthcare outcomes in patients with asthma or COPD.", {"entities": [[238, 244, "DISEASE"]]}], ["The purpose of this article is to provide a brief review of the benefits, as well as the limitations, of comparative effectiveness research (CER) in the therapeutic area of asthma and COPD.", {"entities": [[173, 179, "DISEASE"]]}], ["We conducted a structured literature review of the current CER studies on ICS/LABA combinations in asthma and COPD.", {"entities": [[99, 105, "DISEASE"]]}], ["These articles were then used to illustrate the unique challenges of CER studies, providing a summary of study results and limitations.", {"entities": []}], ["We focus particularly on difficult biases and confounding factors that may be introduced before, during, and after the initiation of therapy.", {"entities": []}], ["Beyond being a review of these two ICS/LABA combination treatments, this article is intended to help those who wish to assess the quality of CER published projects in asthma and COPD, or guide investigators who wish to design new CER studies for chronic respiratory disease treatments.", {"entities": [[167, 173, "DISEASE"]]}], ["Chronic rhinosinusitis with nasal polyps (CRSwNP) in Caucasians is a chronic Th2 inflammatory disease of the nasal and paranasal mucosa and the recruitment of leukocytes to the site of inflammation is poorly understood.", {"entities": []}], ["We studied mRNA and protein expression profiles of adhesion molecules in nasal polyp and associated inferior turbinate tissues using molecular, biochemical, and immunohistological methods.", {"entities": []}], ["Analysis showed a strongly decreased E-selectin expression in nasal polyps with a significant difference between eosinophil and neutrophil counts in nasal polyps and balanced counts in inferior turbinates.", {"entities": []}], ["E-selectin expression is known to be downregulated in a Th2 milieu and has an essential role in immunosurveillance by locally activating neutrophil arrest and migratory function.", {"entities": []}], ["A downregulation of E-selectin may come along with an immune imbalance in Caucasian nasal polyps due to a significant inhibition of neutrophil recruitment.", {"entities": []}], ["Therefore, we suggest that an upregulation of E-selectin and the associated influx of neutrophils may play a significant role in the resolution of inflammation as well as for the pathophysiology of nasal polyps of Caucasian chronic rhinosinusitis patients.", {"entities": []}], ["To date, health effects of exposure to the September 11, 2001 disaster in New York City have been studied in specific groups, but no studies have estimated its impact across the different exposed populations.", {"entities": []}], ["This report provides an overview of the World Trade Center Health Registry (WTCHR) enrollees, their exposures, and their respiratory and mental health outcomes 2\u20133\u00a0years post-9/11.", {"entities": []}], ["Results are extrapolated to the estimated universe of people eligible to enroll in the WTCHR to determine magnitude of impact.", {"entities": []}], ["Building occupants, persons on the street or in transit in lower Manhattan on 9/11, local residents, rescue and recovery workers/volunteers, and area school children and staff were interviewed and enrolled in the WTCHR between September 2003 and November 2004.", {"entities": []}], ["A total of 71,437 people enrolled in the WTCHR, for 17.4% coverage of the estimated eligible exposed population (nearly 410,000); 30% were recruited from lists, and 70% were self-identified.", {"entities": []}], ["Many reported being in the dust cloud from the collapsing WTC Towers (51%), witnessing traumatic events (70%), or sustaining an injury (13%).", {"entities": []}], ["After 9/11, 67% of adult enrollees reported new or worsening respiratory symptoms, 3% reported newly diagnosed asthma, 16% screened positive for probable posttraumatic stress disorder (PTSD), and 8% for serious psychological distress (SPD).", {"entities": [[111, 117, "DISEASE"]]}], ["Newly diagnosed asthma was most common among rescue and recovery workers who worked on the debris pile (4.1%).", {"entities": [[16, 22, "DISEASE"]]}], ["PTSD was higher among those who reported Hispanic ethnicity (30%), household income <$25,000 (31%), or being injured (35%).", {"entities": []}], ["Using previously published estimates of the total number of exposed people per WTCHR eligibility criteria, we estimate between 3,800 and 12,600 adults experienced newly diagnosed asthma and 34,600\u201370,200 adults experienced PTSD following the attacks, suggesting extensive adverse health impacts beyond the immediate deaths and injuries from the acute event.", {"entities": [[179, 185, "DISEASE"]]}], ["Pneumonia plays an important role in children\u2019s morbidity and mortality.", {"entities": [[0, 9, "DISEASE"]]}], ["In Brazil, epidemiological and social changes occurred concomitantly with the universal introduction of the 10-valent pneumococcal conjugate vaccine.", {"entities": []}], ["This study identified risk factors for pneumonia following the implementation of a pneumococcal vaccination program.", {"entities": [[39, 48, "DISEASE"]]}], ["A hospital-based, case-control study involving incident cases of pneumonia in children aged 1\u201359\u00a0months was conducted between October 2010 and September 2013 at a tertiary hospital in northeastern Brazil.", {"entities": [[65, 74, "DISEASE"]]}], ["The diagnosis of pneumonia was based on the World Health Organization (WHO) criteria.", {"entities": [[17, 26, "DISEASE"]]}], ["The control group consisted of children admitted to the day-hospital ward for elective surgery.", {"entities": []}], ["Children with comorbidities were excluded.", {"entities": []}], ["The risk factors for pneumonia that were investigated were among those classified by the WHO as definite, likely and possible.", {"entities": [[21, 30, "DISEASE"]]}], ["A multivariate analysis was performed including variables that were significant at p \u2009\u2264\u20090.25 in the bivariate analysis.", {"entities": []}], ["The study evaluated 407 children in the case group and 407 children in the control group.", {"entities": []}], ["Household crowding (OR\u2009=\u20092.15; 95\u00a0% CI, 1,46\u20133,18) and not having been vaccinated against the influenza virus (OR\u2009=\u20093.59; 95\u00a0% CI, 2,62\u20134.91) were the only factors found to increase the likelihood of pneumonia.", {"entities": [[94, 103, "DISEASE"], [200, 209, "DISEASE"]]}], ["Male gender constituted a protective factor (OR\u2009=\u20090.53; 95\u00a0% CI, 0,39\u20130,72).", {"entities": []}], ["Changes on risk factors for pneumonia were most likely associated with the expansion of the vaccination program and social improvements; however, these improvements were insufficient to overcome inequalities, given that household crowding remained a significant risk factor.", {"entities": [[28, 37, "DISEASE"]]}], ["The protection provided by the influenza vaccine must be evaluated new etiological studies.", {"entities": [[31, 40, "DISEASE"]]}], ["Furthermore, additional risk factors should be investigated.", {"entities": []}], ["Human rhinovirus (HRV) infections target airway epithelium and are the leading cause of acute exacerbations of COPD.", {"entities": []}], ["Cigarette smoke (CS) increases the severity of viral infections, but there is no effective therapy for HRV infection.", {"entities": [[17, 19, "GENE"]]}], ["We determined whether \u03b11-antitrypsin (A1AT) reduces HRV-16 infection in CS-exposed primary human airway epithelial cells.", {"entities": []}], ["Brushed bronchial epithelial cells from normal subjects and patients diagnosed with COPD were cultured at air\u2013liquid interface to induce mucociliary differentiation.", {"entities": []}], ["These cells were treated with A1AT or bovine serum albumin for 2 hours and then exposed to air or whole cigarette smoke (WCS) with or without HRV-16 (5\u00d710 50 ]/transwell) infection for 24 hours.", {"entities": []}], ["WCS exposure significantly increased viral load by an average of fivefold and decreased the expression of antiviral genes interferon-\u03bb1, OAS1 , and MX1 .", {"entities": [[137, 141, "GENE"], [148, 151, "GENE"]]}], ["When A1AT was added to WCS-exposed cells, viral load significantly decreased by an average of 29-fold.", {"entities": []}], ["HRV-16 infection significantly increased HRV-16 receptor intercellular adhesion molecule-1 messenger RNA expression in air-exposed cells, which was decreased by A1AT.", {"entities": []}], ["A1AT-mediated reduction of viral load was not accompanied by increased epithelial antiviral gene expression or by inhibiting the activity of 3C protease involved in viral replication or maturation.", {"entities": []}], ["Our findings demonstrate that A1AT treatment prevents a WCS-induced increase in viral load and for the first time suggest a therapeutic effect of A1AT on HRV infection.", {"entities": []}], ["Air pollution is known to be a leading cause of respiratory symptoms.", {"entities": []}], ["Many cross-sectional studies reported that air pollution caused respiratory disease in Japanese individuals in the 1960s.", {"entities": []}], ["Japan has laws regulating air pollution levels and providing compensation for victims of pollution-related respiratory disease.", {"entities": []}], ["However, long-term changes in respiratory function and symptoms in individuals who were exposed to air pollution in the 1960s have not been well studied.", {"entities": []}], ["This study aimed to investigate longitudinal respiratory function and symptoms in older, non-smoking, long-term officially-acknowledged victims of pollution-related illness.", {"entities": []}], ["The study included 563 officially-acknowledged victims of pollution-related illness living in Kurashiki, Okayama who were aged \u2265 65\u00a0years in 2009.", {"entities": []}], ["Data were retrospectively collected from yearly respiratory symptom questionnaires and spirometry examinations conducted from 2000 to 2009.", {"entities": []}], ["Respiratory function declined significantly from 2000 to 2009 ( p < 0.01), but the mean annual changes were relatively small.", {"entities": []}], ["The change in mean vital capacity was \u221240.5\u00a0ml/year in males and \u221232.7\u00a0ml/year in females, and the change in mean forced expiratory volume in 1\u00a0second was \u221227.6\u00a0ml/year in males and \u221223.9\u00a0ml/year in females.", {"entities": []}], ["Dyspnea was the only symptom that worsened significantly from 2000 to 2009 in both sexes (males: p < 0.05, females: p < 0.01).", {"entities": []}], ["Our results suggest that the high concentrations of air pollutants around 1970 resulted in a decrease in respiratory function and an increase in respiratory symptoms in the study population.", {"entities": []}], ["From 2000 to 2009, the mean annual changes in respiratory function were within the normal range, even though the severity of dyspnea worsened.", {"entities": []}], ["The changes in respiratory function and symptoms over the study period were probably due to aging.", {"entities": []}], ["The laws governing air pollution levels and providing compensation for officially-acknowledged victims of pollution-related illness in Japan may be effective for respiratory disease cause by pollution.", {"entities": []}], ["Background: The long-term health effects of coarse particular matter (PM 10\u20132.5 ) are challenging to assess because of a limited understanding of the spatial variation in PM 10\u20132.5 mass and its chemical components.", {"entities": []}], ["Objectives: We conducted a spatially intensive field study and developed spatial prediction models for PM 10\u20132.5 mass and four selected species (copper, zinc, phosphorus, and silicon) in three American cities.", {"entities": []}], ["Methods: PM 10\u20132.5 snapshot campaigns were conducted in Chicago, Illinois; St. Paul, Minnesota; and Winston-Salem, North Carolina, in 2009 for the Multi-Ethnic Study of Atherosclerosis and Coarse Airborne Particulate Matter (MESA Coarse).", {"entities": []}], ["In each city, samples were collected simultaneously outside the homes of approximately 40 participants over 2 weeks in the winter and/or summer.", {"entities": []}], ["City-specific and combined prediction models were developed using land use regression (LUR) and universal kriging (UK).", {"entities": []}], ["Model performance was evaluated by cross-validation (CV).", {"entities": []}], ["Results: PM 10\u20132.5 mass and species varied within and between cities in a manner that was predictable by geographic covariates.", {"entities": []}], ["City-specific LUR models generally performed well for total mass (CV R R R R R Conclusions: Characterization of fine-scale spatial variability of these often heterogeneous pollutants using geographic covariates should reduce exposure misclassification and increase the power of epidemiological studies investigating the long-term health impacts of PM 10\u20132.5 .", {"entities": []}], ["Citation: Zhang K, Larson TV, Gassett A, Szpiro AA, Daviglus M, Burke GL, Kaufman JD, Adar SD.", {"entities": [[86, 90, "GENE"]]}], ["Characterizing spatial patterns of airborne coarse particulate (PM 10\u20132.5 ) mass and chemical components in three cities: the Multi-Ethnic Study of Atherosclerosis.", {"entities": []}], ["Environ Health Perspect 122:823\u2013830;\u2002 http://dx.doi.org/10.1289/ehp.1307287", {"entities": []}], ["For more accurate estimation of the global burden of pregnancy associated disease, clarity is needed on definition and assessment of non-severe maternal morbidity.", {"entities": []}], ["Our study aimed to define maternal morbidity with clear criteria for identification at primary care level and estimate the distribution of and evaluate associations between physical (infective and non-infective) and psychological morbidities in two different low-income countries.", {"entities": []}], ["Cross sectional study with assessment of morbidity in early pregnancy (34%), late pregnancy (35%) and the postnatal period (31%) among 3459 women from two rural communities in Pakistan (1727) and Malawi (1732).", {"entities": []}], ["Trained health care providers at primary care level used semi-structured questionnaires documenting signs and symptoms, clinical examination and laboratory tests which were bundled to reflect infectious, non-infectious and psychological morbidity.", {"entities": []}], ["One in 10 women in Malawi and 1 in 5 in Pakistan reported a previous pregnancy complication with 1 in 10 overall reporting a previous neonatal death or stillbirth.", {"entities": []}], ["In the index pregnancy, 50.1% of women in Malawi and 53% in Pakistan were assessed to have at least one morbidity (infective or non-infective).", {"entities": []}], ["Both infective (Pakistan) and non-infective morbidity (Pakistan and Malawi) was lower in the postnatal period than during pregnancy.", {"entities": []}], ["Multiple morbidities were uncommon (<10%).", {"entities": []}], ["There were marked differences in psychological morbidity: 26.9% of women in Pakistan 2.6% in Malawi had an Edinburgh Postnatal Depression Score (EPDS) > 9.", {"entities": []}], ["Complications during a previous pregnancy, infective morbidity (p <0.001), intra or postpartum haemorrhage (p <0.02) were associated with psychological morbidity in both settings.", {"entities": []}], ["Our findings highlight the need to strengthen the availability and quality of antenatal and postnatal care packages.", {"entities": []}], ["We propose to adapt and improve the framework and criteria used in this study, ensuring a basic set of diagnostic tests is available, to ensure more robust assessment of non-severe maternal morbidity.", {"entities": []}], ["Introduction As concerns grow that a thinning labor force due to retirement will lead to worker shortages, it becomes critical to support positive employment outcomes of groups who have been underutilized, specifically older workers and workers with disabilities.", {"entities": []}], ["Better understanding perceived age and disability discrimination and their intersection can help rehabilitation specialists and employers address challenges expected as a result of the evolving workforce.", {"entities": []}], ["Methods Using U.S.", {"entities": []}], ["Equal Employment Opportunity Commission Integrated Mission System data, we investigate the nature of employment discrimination charges that cite the Americans with Disabilities Act or Age Discrimination in Employment Act individually or jointly.", {"entities": []}], ["We focus on trends in joint filings over time and across categories of age, types of disabilities, and alleged discriminatory behavior.", {"entities": []}], ["Results We find that employment discrimination claims that originate from older or disabled workers are concentrated within a subset of issues that include reasonable accommodation, retaliation, and termination.", {"entities": []}], ["Age-related disabilities are more frequently referenced in joint cases than in the overall pool of ADA filings, while the psychiatric disorders are less often referenced in joint cases.", {"entities": [[99, 102, "GENE"]]}], ["When examining charges made by those protected under both the ADA and ADEA, results from a logit model indicate that in comparison to charges filed under the ADA alone, jointly-filed ADA/ADEA charges are more likely to be filed by older individuals, by those who perceive discrimination in hiring and termination, and to originate from within the smallest firms.", {"entities": [[62, 65, "GENE"], [158, 161, "GENE"], [183, 186, "GENE"], [62, 65, "GENE"], [158, 161, "GENE"], [183, 186, "GENE"]]}], ["Conclusion In light of these findings, rehabilitation and workplace practices to maximize the hiring and retention of older workers and those with disabilities are discussed.", {"entities": []}], ["The allergenicity of Ricinus communis L. (castor bean, Euphorbiaceae) is associated with components of its seeds and pollen.", {"entities": []}], ["Castor bean allergy has been described not only in laboratory workers, but also in personnel working in oil processing mills, fertilizer retail, the upholstery industry and other industrial fields.", {"entities": []}], ["In the present study, we describe the critical amino acids in the IgE-binding epitopes in Ric c 1 and Ric c 3, two major allergens of R. communis .", {"entities": []}], ["In addition, we also investigate the cross-reactivity between castor bean and some air and food allergen extracts commonly used in allergy diagnosis.", {"entities": []}], ["The IgE reactivity of human sera from atopic patients was screened by immune-dot blot against castor bean allergens.", {"entities": []}], ["Allergenic activity was evaluated in vitro using a rat mast cell activation assay and by ELISA.", {"entities": []}], ["Cross-reactivity was observed between castor bean allergens and extracts from shrimp, fish, gluten, wheat, soybean, peanut, corn, house dust, tobacco and airborne fungal allergens.", {"entities": []}], ["We observed that treatment of rat and human sera (from atopic patients) with glutamic acid reduced the IgE-epitope interaction.", {"entities": []}], ["The identification of glutamic acid residues with critical roles in IgE-binding to Ric c 3 and Ric c 1 support the potential use of free amino acids in allergy treatment.", {"entities": []}], ["Fruits rich in polyphenols, such as pomegranates, have been shown to have health benefits relating to their antioxidant and anti-inflammatory properties.", {"entities": []}], ["Using data obtained from PubMed and Scopus, this article provides a brief overview of the therapeutic effects of pomegranate on chronic inflammatory diseases (CID) such as inflammatory bowel disease (IBD), rheumatoid arthritis (RA), metabolic and cardiovascular disorders, and other inflammatory-associated conditions, with an emphasis on fruit-derived juices.", {"entities": [[172, 198, "DISEASE"], [206, 226, "DISEASE"], [217, 226, "DISEASE"]]}], ["Most studies regarding the effects of pomegranate juice have focused on its ability to treat prostate cancer, diabetes, and atherosclerosis.", {"entities": [[124, 139, "DISEASE"], [102, 108, "DISEASE"], [93, 108, "DISEASE"]]}], ["However, pomegranate juice has shown therapeutic potential for many other illnesses.", {"entities": []}], ["For instance, a small number of human clinical trials have highlighted the positive effects of pomegranate juice and extract consumption on cardiovascular health.", {"entities": []}], ["The beneficial effects of pomegranate components have also been observed in animal models for respiratory diseases, RA, neurodegenerative disease, and hyperlipidaemia.", {"entities": [[120, 145, "DISEASE"]]}], ["Furthermore, there exists strong evidence from rodent models suggesting that pomegranate juice can be used to effectively treat IBD, and as an anti-inflammatory agent to treat CID.", {"entities": []}], ["The effects of pomegranate intake should be further investigated by conducting larger and more well-defined human trials.", {"entities": []}], ["Although cystic fibrosis (CF) is an irreversible genetic disease, advances in treatment have increased the life expectancy of CF patients.", {"entities": [[9, 24, "DISEASE"], [49, 64, "DISEASE"]]}], ["Upper airway involvement, which is mainly due to pathological changes in the paranasal sinuses, is prevalent in CF patients, although many are only mildly symptomatic (with few symptoms).", {"entities": []}], ["The objective of this literature review was to discuss the pathophysiology and current therapeutic management of chronic rhinosinusitis (CRS) in CF patients.", {"entities": []}], ["The review was based on current evidence, which was classified in accordance with the Oxford Centre for Evidence-Based Medicine criteria.", {"entities": []}], ["When symptomatic, CRS with nasal polyps can affect quality of life and can lead to pulmonary exacerbations, given that the paranasal sinuses can be colonized with pathogenic bacteria, especially Pseudomonas aeruginosa .", {"entities": []}], ["Infection with P. aeruginosa plays a crucial role in morbidity and mortality after lung transplantation in CF patients.", {"entities": []}], ["Although clinical treatment of the upper airways is recommended as initial management, this recommendation is often extrapolated from studies of CRS in the general population.", {"entities": []}], ["When sinonasal disease is refractory to noninvasive therapy, surgery is indicated.", {"entities": []}], ["Further studies are needed in order to gain a better understanding of upper airway involvement and improve the management of CRS in CF patients, with the objective of preserving lung function and avoiding unnecessary invasive procedures.", {"entities": []}], ["Genetic susceptibility to complex diseases has been intensively studied during the last decade, yet only signals with small effect have been found leaving open the possibility that subgroups within complex traits show stronger association signals.", {"entities": []}], ["In rheumatoid arthritis (RA), autoantibody production serves as a helpful discriminator in genetic studies and today anti-citrullinated cyclic peptide (anti-CCP) antibody positivity is employed for diagnosis of disease.", {"entities": [[3, 23, "DISEASE"], [14, 23, "DISEASE"]]}], ["The HLA-DRB1 locus is known as the most important genetic contributor for the risk of RA, but is not sufficient to drive autoimmunity and additional genetic and environmental factors are involved.", {"entities": [[4, 12, "GENE"]]}], ["Hence, we addressed the association of previously discovered RA loci with disease-specific autoantibody responses in RA patients stratified by HLA-DRB1*04 .", {"entities": []}], ["We investigated 2178 patients from three RA cohorts from Sweden and Spain for 41 genetic variants and four autoantibodies, including the generic anti-CCP as well as specific responses towards citrullinated peptides from vimentin, alpha-enolase and type II collagen.", {"entities": []}], ["Our data demonstrated different genetic associations of autoantibody-positive disease subgroups in relation to the presence of DRB1*04 .", {"entities": []}], ["Two specific subgroups of autoantibody-positive RA were identified.", {"entities": []}], ["The SNP in PTPN22 was associated with presence of anti-citrullinated enolase peptide antibodies in carriers of HLA-DRB1*04 (Cochran-Mantel-Haenszel test P \u2009=\u20090.0001, P corrected <0.05), whereas SNPs in CDK6 and PADI4 were associated with anti-CCP status in DRB1*04 negative patients (Cochran-Mantel-Haenszel test P \u2009=\u20090.0004, P corrected <0.05 for both markers).", {"entities": [[11, 17, "GENE"], [202, 206, "GENE"], [211, 216, "GENE"]]}], ["Additionally we see allelic correlation with autoantibody titers for PTPN22 SNP rs2476601 and anti-citrullinated enolase peptide antibodies in carriers of HLA-DRB1*04 (Mann Whitney test P \u2009=\u20090.02) and between CDK6 SNP rs42041 and anti-CCP in non-carriers of HLA-DRB1*04 (Mann Whitney test P \u2009=\u20090.02).", {"entities": [[69, 75, "GENE"], [209, 213, "GENE"]]}], ["These data point to alternative pathways for disease development in clinically similar RA subgroups and suggest an approach for study of genetic complexity of disease with strong contribution of HLA.", {"entities": [[195, 198, "GENE"]]}], ["The online version of this article (doi:10.1186/s13075-014-0414-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To establish recurrence patterns among locally advanced head and neck non-nasopharyngeal squamous cell carcinoma (HNSCC) patients treated with radical (chemo-) radiotherapy and to correlate the sites of loco-regional recurrence with radiotherapy doses and target volumes 151 locally advanced HNSCC patients were treated between 2004-2005 using radical three-dimensional conformal radiotherapy.", {"entities": [[103, 112, "DISEASE"], [89, 112, "DISEASE"]]}], ["Patients with prior surgery to the primary tumour site were excluded.", {"entities": []}], ["The sites of locoregional relapses were correlated with radiotherapy plans by the radiologist and a planning dosimetrist.", {"entities": []}], ["Median age was 59 years (range:34-89).", {"entities": []}], ["35 patients had stage III disease, 116 patients had stage IV A/B.", {"entities": []}], ["36 patients were treated with radiotherapy alone, 42 with induction chemotherapy, 63 with induction and concomitant chemoradiotherapy and 10 concomitant chemoradiotherapy.", {"entities": []}], ["Median follow-up was 38 months (range 3-62).", {"entities": []}], ["3-year cause specific survival was 66.8%.", {"entities": []}], ["125 of 151 (82.8%) achieved a complete response to treatment.", {"entities": []}], ["Amongst these 125 there were 20 local-regional recurrence, comprising 8 local, 5 regional and 7 simultaneous local and regional; synchronous distant metastases occurred in 7 of the 20.", {"entities": []}], ["9 patients developed distant metastases in the absence of locoregional failure.", {"entities": []}], ["For the 14 local recurrences with planning data available, 12 were in-field, 1 was marginal, and 1 was out-of-field.", {"entities": []}], ["Of the 11 regional failures with planning data available, 7 were in-field, 1 was marginal and 3 were out-of-field recurrences.", {"entities": []}], ["The majority of failures following non-surgical treatment for locally advanced HNSCC were loco-regional, within the radiotherapy target volume.", {"entities": []}], ["Improving locoregional control remains a high priority.", {"entities": []}], ["To identify patterns of stability and change in co-occurrence in children between 5\u201311 years, and to assess if they vary by socio-demographic factors.", {"entities": []}], ["Data from 9548 singleton children from the UK Millennium Cohort Study (MCS) were assessed for co-occurrence of five common adverse conditions: wheeze; longstanding illness; unfavorable weight; injury; and socio-emotional difficulties.", {"entities": []}], ["We summed adverse conditions (0\u20135) for each child at ages 5, 7, and 11 and identified co-occurrence (\u22652 conditions).", {"entities": []}], ["Using multinomial regression, we explored associations between co-occurrence trajectories and child\u2019s sex and ethnicity, maternal education, and income quintile.", {"entities": []}], ["45.6% of children experienced co-occurrence between 5\u201311 years (7% experienced constant co-occurrence).", {"entities": []}], ["More children moved into co-occurrence than moved out (16.9 vs. 11.9%).", {"entities": []}], ["Mutually-adjusted relative risk ratios (aRRR) showed a gradient by maternal education: compared to children with no co-occurrence whose mothers had a higher/degree, children whose mothers had no qualifications were more likely to move into (aRRR = 1.32(95%CI:1.02,1.70)), out of (1.74(1.34,2.26)), have fluctuating (1.52(1.09,2.10)) or constant co-occurrence (2.58(1.76,3.80)).", {"entities": []}], ["The same gradient (high vs. low) was evident for income quintiles.", {"entities": []}], ["Girls were less likely to experience co-occurrence.", {"entities": []}], ["Co-occurrence of adverse conditions is common during childhood, and trajectories are socially patterned.", {"entities": []}], ["Child-focused care for lower-income children and boys early in life may prevent and reduce co-occurrence in later childhood.", {"entities": []}], ["Placental hypoxia is a result of abnormal and shallow trophoblast invasion and involved in the pathophysiology of preeclampsia.", {"entities": []}], ["Hypoxia increases extracellular adenosine levels and plays an important role in the regulation of angiogenesis, proliferation, vascular tone, endothelial permeability and inflammation.", {"entities": []}], ["It was shown that adenosine concentrations are higher in preeclamptic patients.", {"entities": []}], ["We tested the hypothesis that hypoxia and A 2B adenosine receptor activation influence cyclic adenosine monophosphate (cAMP) production, proliferation, invasion and cAMP-PKA-CREB signaling in trophoblast cells (HTR-8/SVneo).", {"entities": []}], ["HTR-8/SVneo and human uterine microvascular endothelial cells (HUtMVEC) were used as model for experiments.", {"entities": []}], ["We employed a cAMP assay, invasion assay, proliferation, RT-PCR and Western Blot.", {"entities": []}], ["Statistical analyses were performed with ANOVA, Kruskal-Wallis-, Wilcoxon signed rank- or Mann\u2013Whitney Test, as appropriate.", {"entities": []}], ["Hypoxia (2% O 2 ) in comparison to normoxia (21% O 2 ) led to increased A 2B mRNA levels (1.21 \u00b1 0.06 fold, 1 h 2% O 2 ; 1.66 \u00b1 0.2 fold, 4 h 2% O 2 and 1.2 \u00b1 0.04 fold, 24 h 2% O 2 ).", {"entities": []}], ["A 2B adenosine receptor activation (NECA) stimulated trophoblast proliferation at 2% O 2 (1.27 \u00b1 0.06 fold) and 8% O 2 (1.17 \u00b1 0.07 fold) after 24 h and at 2% O 2 (1.22 \u00b1 0.05 fold), 8% O 2 (1.23 \u00b1 0.09 fold) and 21% O 2 (1.15 \u00b1 0.04 fold) after 48 h of incubation.", {"entities": []}], ["Trophoblast invasion into an endothelial monolayer was significantly expanded by activation of the receptor (NECA) at 8% O 2 (1.20 \u00b1 0.07 fold) and 21% O 2 (1.22 \u00b1 0.006 fold).", {"entities": []}], ["A 2B adenosine receptor stimulation (NECA) additionally led to increased CREB phosphorylation in trophoblast cells at 2% O 2 (2.13 \u00b1 0.45 fold), 8% O 2 (1.55 \u00b1 0.13 fold) and 21% O 2 (1.71 \u00b1 0.34 fold).", {"entities": []}], ["Blocking of CREB signaling resulted in reduced proliferation and CREB phosphorylation.", {"entities": []}], ["These data expand the recent knowledge regarding the role of adenosine receptor A 2B in human placental development, and may provide insight in mechanisms associated with pregnancy complications linked to impaired trophoblast invasion such as preeclampsia.", {"entities": []}], ["TQ has been used as treatment and preventive agent for many diseases over the years.", {"entities": []}], ["The goal of this study was to investigate the effects of TQ supplement on fractions of serum proteins.", {"entities": []}], ["Fourteen male Wistar-Albino rats (200-250 g weight) were used as material for two groups; (control (C) and thymoquinone (TQ) respectively.", {"entities": []}], ["Each group contained seven rats.", {"entities": []}], ["The control group had only corn oil, while the TQ group was dissolved in corn oil.", {"entities": []}], ["30 mg/kg/day were given by oral gavage for four weeks.", {"entities": []}], ["The serum protein fractions were identified using cellulose acetate technique.", {"entities": []}], ["The total protein level and albumin, \u03b1-1, \u03b1-2 fractions and A/G ratio have showed no difference between groups (p>0.05).", {"entities": []}], ["\u03b2-globulin fractions of TQ group were higher than control\u2019s (p<0.05).", {"entities": []}], ["In addition, it was observed that the \u03b3-globulin levels of TQ group were lower than that of the control group\u2019s (p<0.05).", {"entities": []}], ["From the results, it was observed that the changes of these fractions may have originated from elevation or decline synthesis, or activities of containing proteins.", {"entities": []}], ["Carotenoid dietary intake and their endogenous levels have been associated with a decreased risk of several chronic diseases.", {"entities": []}], ["There are indications that carotenoid bioavailability depends, in addition to the food matrix, on host factors.", {"entities": []}], ["These include diseases (e.g.", {"entities": []}], ["colitis), life\u2010style habits (e.g.", {"entities": []}], ["smoking), gender and age, as well as genetic variations including single nucleotide polymorphisms that govern carotenoid metabolism.", {"entities": []}], ["These are expected to explain interindividual differences that contribute to carotenoid uptake, distribution, metabolism and excretion, and therefore possibly also their association with disease risk.", {"entities": []}], ["For instance, digestion enzymes fostering micellization (PNLIP, CES), expression of uptake/efflux transporters (SR\u2010BI, CD36, NPC1L1), cleavage enzymes (BCO1/2), intracellular transporters (FABP2), secretion into chylomicrons (APOB, MTTP), carotenoid metabolism in the blood and liver (LPL, APO C/E, LDLR), and distribution to target tissues such as adipose tissue or macula (GSTP1, StARD3) depend on the activity of these proteins.", {"entities": [[57, 62, "GENE"], [119, 123, "GENE"], [125, 131, "GENE"], [189, 194, "GENE"], [226, 230, "GENE"], [232, 236, "GENE"], [285, 288, "GENE"], [299, 303, "GENE"], [375, 380, "GENE"], [382, 388, "GENE"]]}], ["In addition, human microbiota, e.g.", {"entities": []}], ["via altering bile\u2010acid concentrations, may play a role in carotenoid bioavailability.", {"entities": []}], ["In order to comprehend individual, variable responses to these compounds, an improved knowledge on intra\u2010/interindividual factors determining carotenoid bioavailability, including tissue distribution, is required.", {"entities": []}], ["Here, we highlight the current knowledge on factors that may explain such intra\u2010/interindividual differences.", {"entities": []}], ["Alzheimer's disease (AD) is the most common form of dementia affecting millions of people worldwide and will continue to affect millions more with population aging on the rise.", {"entities": [[52, 60, "DISEASE"]]}], ["AD causality is multifactorial.", {"entities": []}], ["Known causal factors include genetic predisposition, age, and sex.", {"entities": []}], ["Environmental toxins such as air pollution (AP) have also been implicated in AD causation.", {"entities": []}], ["Exposure to AP can lead to chronic oxidative stress (OS), which is involved in the pathogenesis of AD.", {"entities": []}], ["Whereas AP plays a role in AD pathology, the epidemiological evidence for this association is limited.", {"entities": []}], ["Given the significant prevalence of AP exposure combined with increased population aging, epidemiological evidence for this link is important to consider.", {"entities": []}], ["In this paper, we examine the existing evidence supporting the relationship between AP, OS, and AD and provide recommendations for future research on the population level, which will provide evidence in support of public health interventions.", {"entities": []}], ["Glucocorticoids are effective for treating several respiratory diseases.", {"entities": []}], ["However, they can cause hyperglycemia.", {"entities": [[24, 37, "DISEASE"]]}], ["This study determined the incidence and risk factors of steroidinduced diabetes mellitus (S-DM) in patients treated with glucocorticoid for respiratory diseases.", {"entities": [[71, 88, "DISEASE"]]}], ["A retrospective study examined patients with respiratory diseases treated with a prednisolone-equivalent glucocorticoid dose exceeding 20 mg/day for at least 4 weeks between January 2003 and December 2008.", {"entities": []}], ["Patients whose initial random glucose level exceeded 200 mg/dL or who had pre-existing diabetes were excluded.", {"entities": []}], ["S-DM was defined as a fasting glucose concentration exceeding 126 mg/dL or a random glucose concentration exceeding 200 mg/dL at least twice after beginning steroid treatment.", {"entities": []}], ["A total of 231 patients with respiratory diseases met the inclusion criteria.", {"entities": []}], ["Their median age was 55 yr, and 139 were female.", {"entities": []}], ["The median cumulative prednisolone-equivalent glucocorticoid dose was 4,965 mg, and the median duration of steroid treatment was 193 days.", {"entities": []}], ["S-DM was diagnosed in 34 (14.7%) of 231 patients.", {"entities": []}], ["Multivariate logistic regression identified older age (odds ratio 1.05, 95% confidence interval 1.02-1.09) as a risk factor for S-DM.", {"entities": []}], ["S-DM is frequent among patients with respiratory diseases treated with glucocorticoid.", {"entities": []}], ["Clinicians should be aware of the possibility of S-DM, especially among elderly patients.", {"entities": []}], ["Despite numerous studies, there has been little progress in the use of biomarkers for predicting treatment response in patients with tuberculosis (TB).", {"entities": [[133, 145, "DISEASE"]]}], ["Patients with culture-confirmed pulmonary TB between 2010 and 2014 were prospectively recruited.", {"entities": []}], ["Blood samples were taken upon diagnosis and 2 months after the start of standard anti-TB treatment.", {"entities": []}], ["A pilot study utilizing measurement of TB-antigen-stimulated cytokines was conducted to select potential biomarkers for further testing.", {"entities": []}], ["Outcome was defined as persistent culture positivity at 2 months into treatment.", {"entities": []}], ["Of 167 enrolled patients, 26 had persistent culture positivity.", {"entities": []}], ["RANTES, IL-22, MMP-8, IL-18, MIG, and Granzyme A were selected as potential biomarkers.", {"entities": []}], ["For predicting persistent culture positivity, receiver-operating characteristics (ROC) analysis showed that initial RANTES (AUC: 0.725 [0.624\u20130.827]) and 2-month MMP-8 (AUC: 0.632 [0.512\u20130.713]) had good discriminative ability.", {"entities": []}], ["Using a logistic regression model, low initial RANTES level (<440\u200apg/mL), initial smear positivity, and high 2-month MMP-8 level (>3000\u200apg/mL) were associated with persistent culture positivity.", {"entities": []}], ["Low initial RANTES level and initial smear positivity had a positive predictive value of 60% (12/20) for persistent culture positivity, compared with 4% (3/75) among patients with high RANTES level and smear negativity upon diagnosis.", {"entities": []}], ["In the 72 patients with either low RANTES/smear negativity or high RANTES/smear positivity upon diagnosis, the 2-month MMP-8 level had a positive and negative predictive value of 24 and 94%, respectively, for 2-month culture status.", {"entities": []}], ["Aside from an initial sputum smear status, serum RANTES level at diagnosis and MMP-8 level at 2 months of treatment may be used to stratify risk for culture persistence.", {"entities": []}], ["Obstructive Sleep Apnea (OSA) is associated with many cardiovascular and psychiatric diseases.", {"entities": []}], ["Day-time sleepiness is a common consequence of sleep apnea and correlates with road-traffic accidents (RTA).", {"entities": []}], ["Pakistan has a high prevalence of factors which predispose an individual to OSA and death from RTAs are a huge burden.", {"entities": []}], ["However there is a dearth of prevalence studies in this regard.", {"entities": []}], ["We aim to understand local relevance of the disease and estimate the prevalence of individuals high-risk for OSA.", {"entities": []}], ["This cross-sectional survey was conducted among 450 individuals at Aga Khan University Hospital (AKUH), which is a tertiary care teaching hospital in Pakistan.", {"entities": []}], ["We used the BQ as our measurement tool.", {"entities": []}], ["Based on the responses, participants were grouped into high or low-risk for OSA.", {"entities": []}], ["Our study sample size was 418 with 63.2% males.", {"entities": []}], ["Mean age of our study population was 30.4 SD +/- 12.3 years; and mean BMI was 23.2 SD +/- 5 kg/m2.", {"entities": []}], ["Out of the total sample size 24.9% reported snoring and there were twice as many males who snored as compared to females.", {"entities": []}], ["Forty-five individuals reported that they had nodded off to sleep while driving at least once in their lifetime.", {"entities": []}], ["On the other hand, the highest proportion of high risk individuals 47.6% was found in the age group 60 or above.", {"entities": []}], ["The overall prevalence of individuals who were high risk for sleep apnea was 10%.", {"entities": []}], ["A significant proportion of the population is at high-risk for OSA.", {"entities": []}], ["Our study shows that despite low BMI and favorable craniofacial anatomy sleep apnea is still a locally relevant disease.", {"entities": []}], ["Given the local relevance of OSAS, it is important to increase awareness among general population but more importantly among physicians of the developing countries, like Pakistan, about common clinical features and pertinent risk factors and complications of OSAS.", {"entities": []}], ["There is an ongoing debate on whether patients with chronic obstructive pulmonary disease (COPD) seen in real-life clinical settings are represented in randomized controlled trials (RCTs) of COPD.", {"entities": [[52, 89, "DISEASE"]]}], ["It is thought that the stringent inclusion and exclusion criteria of RCTs may prevent the participation of patients with specific characteristics or risk factors.", {"entities": []}], ["We surveyed a database of patients recruited into 35 placebo-controlled tiotropium RCTs and also conducted a systematic literature review of large-scale observational studies conducted in patients with a documented diagnosis of COPD between 1990 and 2013.", {"entities": []}], ["Patient demographics and comorbidities with a high prevalence in patients with COPD were compared between the two patient populations at baseline.", {"entities": []}], ["Using the Medical Dictionary for Regulatory Activities (MedDRA; v 14.0), patient comorbidities in the pooled tiotropium RCTs were classified according to system organ class, pharmacovigilance (PV) endpoints, and Standardised MedDRA Queries to enable comparison with the observational studies.", {"entities": []}], ["We identified 24,555 patients in the pooled tiotropium RCTs and 61,361 patients among the 13 observational studies that met our search criteria.", {"entities": []}], ["The Global initiative for chronic Obstructive Lung Disease (GOLD) staging of patients in the RCTs differed from that in observational studies: the proportion of patients with GOLD stages I+II disease ranged from 40.0% to 51.5% in the RCTs but 24.5% to 44.1% in the observational studies; for GOLD stage III or IV disease these ranges were 7.2%\u201345.8% (RCTs) and 13.7\u201342.1% (observational studies).", {"entities": []}], ["The comorbidities with the highest prevalence reported in the RCTs and observational studies were: hypertension (39.4%\u201340.0% vs 40.1%\u201360.6%), other ischemic heart disease (12.3%\u201314.2% vs 12.5%\u201341.0%), diabetes (10.3%\u201310.9% vs 4.0%\u201338.9%), depression (8.5%\u20139.5% vs 17.0%\u201320.6%), and cardiac arrhythmia (7.8%\u201311.4% vs 11.3%\u201315.8%).", {"entities": [[99, 111, "DISEASE"], [148, 170, "DISEASE"], [157, 170, "DISEASE"]]}], ["The clinical profile of COPD patients treated in the tiotropium trial program appears to be largely in the range of clinical characteristics, including cardiovascular comorbidities, reported for \u201creal-life patients.\u201d The tiotropium RCTs tended to include patients with more severe disease than the observational studies.", {"entities": []}], ["Adults with multiple (\u22652) chronic conditions (MCCs) account for a large portion of US health care costs.", {"entities": []}], ["Despite the increase in MCC rates with age, most people with MCCs are working age.", {"entities": [[24, 27, "GENE"]]}], ["The study objective was to compare adults with MCCs who were younger than 65 years with those aged 65 years or older on selected measures to better understand the differences between groups and inform interventions that could lower health care costs.", {"entities": []}], ["Data from respondents to the 2015 Behavioral Risk Factor Surveillance System data (N = 201,711) were used to compare adults aged 65 or older with MCCs with those younger than 65 with MCCs in unadjusted and adjusted analyses on chronic conditions, quality of life measures, disability status, access to health care, and modifiable risk factors.", {"entities": []}], ["MCCs were based on up to 12 chronic conditions (heart disease, stroke, asthma, arthritis, chronic obstructive pulmonary disease, high cholesterol, cognitive impairment, diabetes, depression, chronic kidney disease, cancer other than skin, and hypertension).", {"entities": [[243, 255, "DISEASE"], [199, 213, "DISEASE"], [48, 61, "DISEASE"], [90, 127, "DISEASE"], [79, 88, "DISEASE"], [71, 77, "DISEASE"], [215, 221, "DISEASE"]]}], ["Consistent with 80% of all adults being younger than 65, more than 60% of adults with MCCs were younger than 65 years.", {"entities": []}], ["Compared with adults aged 65 or older with MCCs, those younger than 65 were more likely to report asthma, cognitive impairment, depression, smoking, obesity, poorer access to health care, disability, and worse quality of life in both unadjusted and adjusted analysis.", {"entities": [[149, 156, "DISEASE"], [98, 104, "DISEASE"]]}], ["To decrease the burden of chronic diseases, adults younger than 65 with MCCs should get the treatment they need to reduce the chance of developing more chronic conditions as they age.", {"entities": []}], ["The ultimate goal is to improve health status and reduce health care costs for everyone with MCCs.", {"entities": []}], ["Gene single nucleotide polymorphisms (SNPs) have been extensively studied in association with development and prognosis of various malignancies.", {"entities": []}], ["However, the potential role of genetic polymorphisms of cancer stem cell (CSC) marker genes with respect to cancer risk has not been examined.", {"entities": [[56, 62, "DISEASE"], [108, 114, "DISEASE"]]}], ["We conducted a case-control study involving a total of 1000 subjects (500 lung cancer patients and 500 age-matched cancer-free controls) from northeastern China.", {"entities": [[74, 85, "DISEASE"], [79, 85, "DISEASE"], [115, 121, "DISEASE"]]}], ["Lung cancer risk was analyzed in a logistic regression model in association with genotypes of four lung CSC marker genes (CD133, ALDH1, Musashi-1 , and EpCAM).", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [152, 157, "GENE"]]}], ["Using univariate analysis, the Musashi-1 rs2522137 GG genotype was found to be associated with a higher incidence of lung cancer compared with the TT genotype.", {"entities": [[117, 128, "DISEASE"], [122, 128, "DISEASE"]]}], ["No significant associations were observed for gene variants of CD133, ALDH1, or EpCAM.", {"entities": [[80, 85, "GENE"]]}], ["In multivariate analysis, Musashi-1 rs2522137 was still significantly associated with lung cancer when environmental and lifestyle factors were incorporated in the model, including lower BMI; family history of cancer; prior diagnosis of chronic obstructive pulmonary disease, pneumonia, or pulmonary tuberculosis; occupational exposure to pesticide; occupational exposure to gasoline or diesel fuel; heavier smoking; and exposure to heavy cooking emissions.", {"entities": [[86, 97, "DISEASE"], [276, 285, "DISEASE"], [237, 274, "DISEASE"], [300, 312, "DISEASE"], [290, 312, "DISEASE"], [91, 97, "DISEASE"], [210, 216, "DISEASE"]]}], ["The value of the area under the receiver-operating characteristic (ROC) curve (AUC) was 0.7686.", {"entities": []}], ["To our knowledge, this is the first report to show an association between a Musashi-1 genotype and lung cancer risk.", {"entities": [[99, 110, "DISEASE"], [104, 110, "DISEASE"]]}], ["Further, the prediction model in this study may be useful in determining individuals with high risk of lung cancer.", {"entities": [[103, 114, "DISEASE"], [108, 114, "DISEASE"]]}], ["In January 2015, British Columbia, Canada, reported avian influenza A(H7N9) virus infection in 2 travelers returning from China who sought outpatient care for typical influenza-like illness.", {"entities": [[58, 67, "DISEASE"], [167, 176, "DISEASE"], [52, 67, "DISEASE"]]}], ["There was no further spread, but serosurvey findings showed broad population susceptibility to H7N9 virus.", {"entities": []}], ["Travel history and timely notification are critical to emerging pathogen detection and response.", {"entities": []}], ["Studies reveal that lifestyles such as physical activity patterns, obesity, nutrition, and smoking, are factors that affect laboratory test results and pregnancy outcomes induced by assisted fertility techniques in infertile couples.", {"entities": [[67, 74, "DISEASE"]]}], ["The present study is a narrative review of studies in this area.", {"entities": []}], ["In this study, researchers conducted their computer search in public databases Google Scholar general search engine, and then more specific: Science Direct, ProQuest, SID, Magiran, Irandoc, Pubmed, Scopus, cochrane library, and Psych info; Cumulative Index to Nursing and Allied Health Literature (CINAHL), using Medical Subject Headings (MeSH) keywords: infertility (sterility, infertility), lifestyle (life behavior, lifestyle), Assisted Reproductive Techniques (ART), antioxidant and infertility, social health, spiritual health, mental health, Alcohol and drug abuse, preventive factors, and instruments., and selected relevant articles to the study subject from 2004 to 2013.", {"entities": [[355, 366, "DISEASE"], [379, 390, "DISEASE"], [487, 498, "DISEASE"]]}], ["Firstly, a list of 150 papers generated from the initial search.", {"entities": []}], ["Then reviewers studied titles and abstracts.", {"entities": []}], ["Secondly, 111 papers were included.", {"entities": []}], ["Finally, quality assessment of full text studies was performed by two independent reviewers.", {"entities": []}], ["Researchers reviewed summary of all articles sought, ultimately used data from 62 full articles to compile this review paper.", {"entities": []}], ["Review of literature led to arrangement of 9 general categories of ART results\u2019 relationship with weight watch and diet, exercise and physical activity, psychological health, avoiding medications, alcohol and drugs, preventing diseases, environmental health, spiritual health, social health, and physical health.", {"entities": []}], ["The following was obtained from review of studies: since lifestyle is among important, changeable, and influential factors in fertility, success of these methods can be greatly helped through assessment of lifestyle patterns of infertile couples, and design and implementation of healthy lifestyle counseling programs, before and during implementing assisted fertility techniques.", {"entities": []}], ["Methyl mercury is a developmental neurotoxicant.", {"entities": []}], ["Exposure results principally from consumption by pregnant women of seafood contaminated by mercury from anthropogenic (70%) and natural (30%) sources.", {"entities": []}], ["Throughout the 1990s, the U.S. Environmental Protection Agency (EPA) made steady progress in reducing mercury emissions from anthropogenic sources, especially from power plants, which account for 41% of anthropogenic emissions.", {"entities": []}], ["However, the U.S. EPA recently proposed to slow this progress, citing high costs of pollution abatement.", {"entities": []}], ["To put into perspective the costs of controlling emissions from American power plants, we have estimated the economic costs of methyl mercury toxicity attributable to mercury from these plants.", {"entities": []}], ["We used an environmentally attributable fraction model and limited our analysis to the neurodevelopmental impacts\u2014specifically loss of intelligence.", {"entities": []}], ["Using national blood mercury prevalence data from the Centers for Disease Control and Prevention, we found that between 316,588 and 637,233 children each year have cord blood mercury levels > 5.8 \u03bcg/L, a level associated with loss of IQ.", {"entities": []}], ["The resulting loss of intelligence causes diminished economic productivity that persists over the entire lifetime of these children.", {"entities": []}], ["This lost productivity is the major cost of methyl mercury toxicity, and it amounts to $8.7 billion annually (range, $2.2\u201343.8 billion; all costs are in 2000 US$).", {"entities": []}], ["Of this total, $1.3 billion (range, $0.1\u20136.5 billion) each year is attributable to mercury emissions from American power plants.", {"entities": []}], ["This significant toll threatens the economic health and security of the United States and should be considered in the debate on mercury pollution controls.", {"entities": []}], ["The pathophysiology of essential tremor, especially at the cellular level, is poorly understood.", {"entities": [[23, 39, "DISEASE"]]}], ["Although no drug has been specifically designed to treat essential tremor, several medications improve tremor, and others worsen it.", {"entities": [[57, 73, "DISEASE"]]}], ["Studying the mechanism of actions of these medications can help our understanding of tremor pathophysiology and contribute to future rational drug design.", {"entities": []}], ["We reviewed literature, concentrating on mechanisms of action, of various medications that mitigate tremor.", {"entities": []}], ["Many medications have multiple mechanisms of actions, making simple correlations difficult.", {"entities": []}], ["Medications that increase the duration of opening of gamma-aminobutyric acid (GABA)-A receptors are most consistently associated with tremor improvement.", {"entities": []}], ["Interestingly, drugs that increase GABA availability have not been associated with improved tremor.", {"entities": []}], ["Other mechanisms possibly associated with tremor improvement include antagonism of alpha-2 delta subunits associated with calcium channels, inhibition of carbonic anhydrase, and inhibition of the synaptic vesicle protein 2A.", {"entities": []}], ["Drugs that block voltage-gaited sodium channels do not affect tremor.", {"entities": []}], ["The ideal beta-adrenergic blocker requires B2 affinity (non-cardiac selective), has no sympathomimetic properties, does not require membrane stabilization properties, and may benefit from good central nervous system penetration.", {"entities": []}], ["To date, serendipitous observations have provided most of our understanding of tremor cellular physiology.", {"entities": []}], ["Based on similarities to currently effective drugs or rational approximations and inferences, several currently available agents should be considered for tremor trials.", {"entities": []}], ["Prevalence estimates of multimorbidity vary widely due to inconsistent definitions and measurement methods.", {"entities": []}], ["This study examines the independent effects on prevalence estimates of how \u2018disease entity\u2019 is defined\u2014as a single chronic condition or chapters/domains in the International Classification of Primary Care (V.2; ICPC-2), International Classification of Disease (10th revision; ICD-10) or the Cumulative Illness Rating Scale (CIRS), the number of disease entities required for multimorbidity, and the number of chronic conditions studied.", {"entities": []}], ["National prospective cross-sectional study.", {"entities": []}], ["Australian general practice.", {"entities": []}], ["8707 random consenting deidentified patient encounters with 290 randomly selected general practitioners.", {"entities": []}], ["Prevalence estimates of multimorbidity using different definitions.", {"entities": []}], ["Data classified to ICPC-2 chapters, ICD-10 chapters or CIRS domains produce similar multimorbidity prevalence estimates.", {"entities": []}], ["When multimorbidity was defined as two or more (2+) disease entities: counting individual chronic conditions and groups of chronic conditions produced similar estimates; the 12 most prevalent chronic conditions identified about 80% of those identified using all chronic conditions.", {"entities": []}], ["When multimorbidity was defined as 3+ disease entities: counting individual chronic conditions produced significantly higher estimates than counting groups of chronic conditions; the 12 most prevalent chronic conditions identified only two-thirds of patients identified using all chronic conditions.", {"entities": []}], ["Multimorbidity defined as 2+ disease entities can be measured using different definitions of disease entity with as few as 12 prevalent chronic conditions, but lacks specificity to be useful, especially in older people.", {"entities": []}], ["Multimorbidity, defined as 3+, requires more measurement conformity and inclusion of all chronic conditions, but provides greater specificity than the 2+ definition.", {"entities": []}], ["The proposed concept of \u201ccomplex multimorbidity\u201d, the co-occurrence of three or more chronic conditions affecting three or more different body systems within one person without defining an index chronic condition, may be useful in identifying high-need individuals.", {"entities": []}], ["CC chemokine ligand 2 (CCL2) is the most potent monocyte chemoattractant and inter-individual differences in its expression level have been associated with genetic variants mapping to the cis-regulatory regions of the gene.", {"entities": [[23, 27, "GENE"]]}], ["An A to G polymorphism in the CCL2 enhancer region at position \u20132578 (rs1024611; A>G), was found in most studies to be associated with higher serum CCL2 levels and increased susceptibility to a variety of diseases such as HIV-1 associated neurological disorders, tuberculosis, and atherosclerosis.", {"entities": [[281, 296, "DISEASE"], [263, 275, "DISEASE"], [30, 34, "GENE"], [148, 152, "GENE"], [30, 34, "GENE"], [148, 152, "GENE"]]}], ["However, the precise mechanism by which rs1024611influences CCL2 expression is not known.", {"entities": [[60, 64, "GENE"]]}], ["To address this knowledge gap, we tested the hypothesis that rs1024611G polymorphism is associated with allelic expression imbalance (AEI) of CCL2 .", {"entities": [[142, 146, "GENE"]]}], ["We used haplotype analysis and identified a transcribed SNP in the 3\u2032UTR (rs13900; C>T) can serve as a proxy for the rs1024611 and demonstrated that the rs1024611G allele displayed a perfect linkage disequilibrium with rs13900T allele.", {"entities": []}], ["Allele-specific transcript quantification in lipopolysaccharide treated PBMCs obtained from heterozygous donors showed that rs13900T allele were expressed at higher levels when compared to rs13900C allele in all the donors examined suggesting that CCL2 is subjected to AEI and that that the allele containing rs1024611G is preferentially transcribed.", {"entities": [[248, 252, "GENE"]]}], ["We also found that AEI of CCL2 is a stable trait and could be detected in newly synthesized RNA.", {"entities": [[26, 30, "GENE"]]}], ["In contrast to these in vivo findings, in vitro assays with haplotype-specific reporter constructs indicated that the haplotype bearing rs1024611G had a lower or similar transcriptional activity when compared to the haplotype containing rs1024611A.", {"entities": []}], ["This discordance between the in vivo and in vitro expression studies suggests that the CCL2 regulatory region polymorphisms may be functioning in a complex and context-dependent manner.", {"entities": [[87, 91, "GENE"]]}], ["In summary, our studies provide strong functional evidence and a rational explanation for the phenotypic effects of the CCL2 rs1024611G allele.", {"entities": [[120, 124, "GENE"]]}], ["New theoretical and conceptual frameworks are required for evolutionary biology to capitalize on the wealth of data now becoming available from the study of genomes, phenotypes, and organisms - including humans - in their natural environments.", {"entities": []}], ["People living in rural Australia are more likely to die in hospital following an acute myocardial infarction than those living in major cities.", {"entities": [[87, 108, "DISEASE"], [81, 108, "DISEASE"]]}], ["While several factors, including time taken to access hospital care, contribute to this risk, it is also partially attributable to the lower uptake of evidence-based guidelines for the administration of thrombolytic drugs in rural emergency departments where up to one-third of eligible patients do not receive this life-saving intervention.", {"entities": []}], ["Clinical pathways have the potential to link evidence to practice by integrating guidelines into local systems, but their impact has been hampered by variable implementation strategies and sub-optimal research designs.", {"entities": []}], ["The purpose of this study is to determine the impact of a five-step clinical pathways implementation process on the timely and efficient administration of thrombolytic drugs for acute myocardial infarctions managed in rural Australian emergency departments.", {"entities": []}], ["The design is a two-arm, cluster-randomised trial with rural hospital emergency departments that treat and do not routinely transfer acute myocardial infarction patients.", {"entities": [[139, 160, "DISEASE"], [133, 160, "DISEASE"]]}], ["Six rural hospitals in the state of Victoria will participate, with three in the intervention group and three in the control group.", {"entities": []}], ["Intervention hospitals will participate in a five-step clinical pathway implementation process: engagement of clinicians, pathway development according to local resources and systems, reminders, education, and audit and feedback.", {"entities": []}], ["Hospitals in the control group will each receive a hard copy of Australian national guidelines for chest pain and acute myocardial infarction management.", {"entities": [[120, 141, "DISEASE"], [114, 141, "DISEASE"]]}], ["Each group will include 90 cases to give a power of 80% at 5% significance level for the two primary outcome measures: proportion of those eligible for thrombolysis receiving the drug and time to delivery of thrombolytic drug.", {"entities": []}], ["Improved compliance with thrombolytic guidelines via clinical pathways will increase acute myocardial infarction survival rates in rural hospitals and thereby help to reduce rural-urban mortality inequalities.", {"entities": [[91, 112, "DISEASE"], [85, 112, "DISEASE"]]}], ["Such knowledge translation has the potential to be adapted for a range of clinical problems in a wide array of settings.", {"entities": []}], ["Australia New Zealand Clinical Trials Registry code ACTRN12608000209392.", {"entities": []}], ["The evaluation of the impact of probiotics on host health could help to understand how they can be used in the prevention of diseases.", {"entities": []}], ["On the basis of our previous studies and in vitro assays on PBMC and Caco-2 ccl20:luc reporter system presented in this work, the strain Lactobacillus kefiri CIDCA 8348 was selected and administrated to healthy Swiss mice daily for 21 days.", {"entities": [[76, 81, "GENE"]]}], ["The probiotic treatment increased IgA in feces and reduced expression of proinflammatory mediators in Peyer Patches and mesenteric lymph nodes, where it also increased IL-10.", {"entities": []}], ["In ileum IL-10, CXCL-1 and mucin 6 genes were upregulated; meanwhile in colon mucin 4 was induced whereas IFN- \u03b3 , GM-CSF, and IL-1 \u03b2 genes were downregulated.", {"entities": []}], ["Moreover, ileum and colon explants showed the anti-inflammatory effect of L. kefiri since the LPS-induced increment of IL-6 and GM-CSF levels in control mice was significantly attenuated in L. kefiri treated mice.", {"entities": []}], ["Regarding fecal microbiota, DGGE profiles allowed differentiation of experimental groups in two separated clusters.", {"entities": []}], ["Quantitative PCR analysis of different bacterial groups revealed only significant changes in Lactobacillus population.", {"entities": []}], ["In conclusion, L. kefiri is a good candidate to be used in gut inflammatory disorders.", {"entities": []}], ["The World Health Organization ( WHO ) is in the process of updating antenatal care ( ANC ) guidelines.", {"entities": []}], ["To map the existing clinical practice guidelines related to routine ANC for healthy women and to summarise all practices considered during routine ANC .", {"entities": []}], ["A systematic search in four databases for all clinical practice guidelines published after January 2000.", {"entities": []}], ["Two researchers independently assessed the list of potentially eligible publications.", {"entities": []}], ["Information on scope of the guideline, type of practice, associated gestational age, recommendation type and the source of evidence were mapped.", {"entities": []}], ["Of 1866 references, we identified 85 guidelines focusing on the ANC period: 15 pertaining to routine ANC and 70 pertaining to specific situations.", {"entities": []}], ["A total of 135 interventions from routine ANC guidelines were extracted, and categorised as clinical interventions ( n = 80), screening/diagnostic procedures ( n = 47) and health systems related ( n = 8).", {"entities": []}], ["Screening interventions, (syphilis, anaemia) were the most common practices.", {"entities": [[26, 34, "DISEASE"]]}], ["Within the 70 specific situation guidelines, 102 recommendations were identified.", {"entities": []}], ["Overall, for 33 (out of 171) interventions there were conflicting recommendations provided by the different guidelines.", {"entities": []}], ["Mapping the current guidelines including practices related to routine ANC informed the scoping phase for the WHO guideline for ANC .", {"entities": []}], ["Our analysis indicates that guideline development processes may lead to different recommendations, due to context, evidence base or assessment of evidence.", {"entities": []}], ["It would be useful for guideline developers to map and refer to other similar guidelines and, where relevant, explore the discrepancies in recommendations and others.", {"entities": []}], ["We identified existing ANC guidelines and mapped scope, practices, recommendations and source of evidence.", {"entities": []}], ["We identified existing ANC guidelines and mapped scope, practices, recommendations and source of evidence.", {"entities": []}], ["Diabetes is affecting the life of millions of people.", {"entities": []}], ["A large proportion of diabetic patients suffer from severe complications such as neuropathic pain, and current treatments for these complications have deleterious side effects.", {"entities": []}], ["Thus, alternate therapeutic strategies are needed.", {"entities": []}], ["Recently, the elevation of epoxy-fatty acids through inhibition of soluble epoxide hydrolase (sEH) was shown to reduce diabetic neuropathic pain in rodents.", {"entities": []}], ["In this report, we describe a series of newly synthesized sEH inhibitors with at least 5-fold higher potency and doubled residence time inside both the human and rodent sEH enzyme than previously reported inhibitors.", {"entities": []}], ["These inhibitors also have better physical properties and optimized pharmacokinetic profiles.", {"entities": []}], ["The optimized inhibitor selected from this new series displayed improved efficacy of almost 10-fold in relieving pain perception in diabetic neuropathic rats as compared to the approved drug, gabapentin, and previously published sEH inhibitors.", {"entities": []}], ["Therefore, these new sEH inhibitors could be an attractive alternative to treat diabetic neuropathy in humans.", {"entities": [[80, 99, "DISEASE"], [89, 99, "DISEASE"]]}], ["Itch, the unpleasant sensation that evokes a desire to scratch, accompanies numerous skin and nervous system disorders.", {"entities": []}], ["In many cases, pathological itch is insensitive to antihistamine treatment.", {"entities": []}], ["Recent studies have identified members of the Mas-related GPCR (Mrgpr) family that are activated by mast cell mediators and promote histamine-independent itch.", {"entities": []}], ["MrgprA3 and MrgprC11 act as receptors for the pruritogens chloroquine and BAM8\u201322, respectively.", {"entities": []}], ["However, the signaling pathways and transduction channels activated downstream of these pruritogens are largely unknown.", {"entities": []}], ["We found that TRPA1 is the downstream target of both MrgprA3 and MrgprC11, in cultured sensory neurons and heterologous cells.", {"entities": [[14, 19, "GENE"]]}], ["TRPA1 is required for Mrgpr-mediated signaling, as sensory neurons from TRPA1-deficient mice exhibited profoundly diminished responses to chloroquine and BAM8\u201322.", {"entities": [[0, 5, "GENE"], [72, 77, "GENE"]]}], ["Likewise, TRPA1-deficient mice displayed little to no scratching in response to these pruritogens.", {"entities": []}], ["Our findings demonstrate that TRPA1 is an essential component of the signaling pathways that promote histamine-independent itch.", {"entities": [[30, 35, "GENE"]]}], ["Recent epidemiological evidence has linked hypoxia with the development of Alzheimer disease (AD).", {"entities": []}], ["A number of in vitro and in vivo studies have reported that hypoxia can induce amyloid-\u03b2 peptide accumulation through various molecular mechanisms including the up-regulation of the amyloid-\u03b2 precursor protein, the \u03b2-secretase Bace1, or the \u03b3\u03b3-secretase complex components, as well as the down-regulation of A\u03b2-degrading enzymes.", {"entities": [[227, 232, "GENE"]]}], ["To investigate the effects of acute and chronic sustained hypoxia in A\u03b2 generation in vivo .", {"entities": []}], ["2\u20133 month-old C57/Bl6J wild-type mice were exposed to either normoxia (21% O 2 ) or hypoxia (9% O 2 ) for either 4 to 72 h (acute) or 21\u201330 days (chronic sustained) in a hermetic chamber.", {"entities": []}], ["Brain mRNA levels of A\u03b2-related genes were measured by quantitative real-time PCR, whereas levels of Bace1 protein, full length A\u03b2PP, and its C-terminal fragments (C99/C88 ratio) were measured by Western blot.", {"entities": [[101, 106, "GENE"]]}], ["In addition, 8 and 14-month-old APP/PS1 transgenic mice were subjected to 9% O 2 for 21 days and levels of A\u03b2 40 , A\u03b2 42 , full length A\u03b2PP, and soluble A\u03b2PP\u03b1 (sA\u03b2PP\u03b1) were measured by ELISA or WB.", {"entities": []}], ["Hypoxia (either acute or chronic sustained) did not impact the transcription of any of the A\u03b2-related genes in young wild-type mice.", {"entities": []}], ["A significant reduction of Bace1 protein level was noted with acute hypoxia for 16 h but did not correlate with an increased level of full length A\u03b2PP or a decreased C99/C83 ratio.", {"entities": [[27, 32, "GENE"]]}], ["Chronic sustained hypoxia did not significantly alter the levels of Bace1, full length A\u03b2PP or the C99/C83 ratio.", {"entities": [[68, 73, "GENE"]]}], ["Last, chronic sustained hypoxia did not significantly change the levels of A\u03b2 40 , A\u03b2 42 , full length A\u03b2PP, or sA\u03b2PP\u03b1 in either young or aged APP/PS1 mice.", {"entities": []}], ["Our results argue against a hypoxia-induced shift of A\u03b2PP proteolysis from the non-amyloidogenic to the amyloidogenic pathways.", {"entities": []}], ["We discuss the possible methodological caveats of previous in vivo studies.", {"entities": []}], ["Fibronectin glomerulopathy is a rare, inherited, autosomal dominant, glomerular disease characterized by proteinuria, microscopic hematuria, hypertension, massive glomerular deposits of fibronectin, and slow progression to end-stage renal failure.", {"entities": [[141, 153, "DISEASE"], [105, 116, "DISEASE"]]}], ["Because the incident of fibronectin glomerulopathy is extremely low, the pathophysiology, genetic abnormalities, epidemiology, and mechanisms remain to be elucidated.", {"entities": []}], ["We report a 21-year-old woman with fibronectin glomerulopathy, who had been diagnosed with persistent cloaca and congenital esophageal atresia at birth.", {"entities": [[124, 142, "DISEASE"]]}], ["She developed proteinuria and hematuria 7\u00a0months before admission.", {"entities": [[14, 25, "DISEASE"]]}], ["Urinary protein and serum creatinine levels were 3.38\u00a0g/gCr and 0.73\u00a0mg/dL.", {"entities": []}], ["Renal biopsy showed severe mesangial widening due to massive deposits, which was positive periodic acid-Schiff and negative methenamine silver.", {"entities": []}], ["Immunostaining was negative for immunoglobulin but positive for fibronectin.", {"entities": []}], ["Electron microscopy showed diffuse mesangial granular deposits.", {"entities": []}], ["Thus she was diagnosed with fibronectin glomerulopathy, despite a negative family history of kidney disease and lack of any known missense mutations of fibronectin 1 gene.", {"entities": [[93, 107, "DISEASE"]]}], ["We report a patient who developed fibronectin glomerulopathy during the clinical course of extremely rare congenital malformations, including persistent cloaca and congenital esophageal atresia.", {"entities": [[175, 193, "DISEASE"]]}], ["We describe a case of this condition in detail and summarize the 75 case reports of fibronectin glomerulopathy.", {"entities": []}], ["IL-17 is a cytokine mainly from IL-17-producing T cells, which are one of subsets of CD4+ T cells and play a role in adaptive immune system.", {"entities": []}], ["Recent studies have demonstrated that IL-17A can act rapidly as an innate immune responder during infection before the onset of its classic adaptive immune response.", {"entities": []}], ["This role of IL-17A in innate immune response is implicated in lipopolysaccharide (LPS)-induced lung inflammation.", {"entities": []}], ["Very recently, we have reported that endoplasmic reticulum (ER) stress is involved in LPS-induced lung inflammation in vivo and in vitro.", {"entities": []}], ["This study aimed to elucidate the role of IL-17A in LPS-induced lung injury, focusing on the link with ER stress.", {"entities": []}], ["We treated a murine model of LPS-induced lung injury with IL-17A neutralizing antibody and 4-phenylbutyrate (4-PBA), a representative ER stress inhibitor.", {"entities": []}], ["In addition, we evaluated the effects of IL-17A on ER stress in LPS-stimulated bronchial epithelial cells.", {"entities": []}], ["Our results showed that inhibition of IL-17A decreased LPS-induced pulmonary neutrophilia, vascular leakage, nuclear translocation of nuclear factor-\u03baB (NF-\u03baB), infiltration of dendritic cells, increased expression of Toll-like receptor 4 (TLR4), activation of NLRP3 inflammasome, and increased ER stress in the lung.", {"entities": [[240, 244, "GENE"], [261, 266, "GENE"]]}], ["4-PBA or TAK-242, a TLR4 inhibitor attenuated expression of IL-17A thereby improving LPS-induced lung inflammation.", {"entities": [[20, 24, "GENE"]]}], ["Intriguingly, we observed that stimulation with LPS increased expression of IL-17A in airway epithelial cells and co-stimulation with IL-17A further increased ER stress and NF-\u03baB activation.", {"entities": []}], ["This study indicates that the interrelationship between IL-17A and ER stress plays an important role in LPS-induced injury showing a positive feedback in airway epithelial cells and suggests that targeting their interaction can be a potential therapeutic approach to overcome one of severe refractory pulmonary disorders.", {"entities": []}], ["Senior high-cost users (HCUs) are estimated to represent 60% of all HCUs in Ontario, Canada\u2019s most populous province.", {"entities": []}], ["To improve our understanding of individual and health system characteristics related to senior HCUs, we will examine incident senior HCUs to determine their incremental healthcare utilisation and costs, characteristics of index hospitalisation episodes, mortality and their regional variation across Ontario.", {"entities": []}], ["A retrospective, population-based cohort study using administrative healthcare records will be used.", {"entities": []}], ["Incident senior HCUs will be defined as Ontarians aged \u226566 years who were in the top 5% of healthcare cost users during fiscal year 2013 but not during fiscal year 2012.", {"entities": []}], ["Each HCU will be matched to three non-HCUs by age, sex and health planning region.", {"entities": []}], ["Incremental healthcare use and costs will be determined using the method of recycled predictions.", {"entities": []}], ["We will apply multivariable logistic regression to determine patient and health service factors associated with index hospitalisation and inhospital mortality during the incident year.", {"entities": []}], ["The most common causes of admission will be identified and contrasted with the most expensive hospitalised conditions.", {"entities": []}], ["We will also calculate the ratio of inpatient costs incurred through admissions of ambulatory care sensitive conditions to the total inpatient expenditures.", {"entities": []}], ["The magnitude of variation in costs and health service utilisation will be established by calculating the extremal quotient, the coefficient of variation and the Gini mean difference for estimates obtained through multilevel regression analyses.", {"entities": []}], ["This study has been approved by Hamilton Integrated Research Ethics Board (ID#1715-C).", {"entities": []}], ["The results of the study will be distributed through peer-reviewed journals.", {"entities": []}], ["They also will be disseminated at research events in academic settings, national and international conferences as well as with presentations to provincial health authorities.", {"entities": []}], ["Epilepsy is the world\u2019s most common neurological disorder, affecting approximately 50 million people worldwide and contributed to different psychiatric illness.", {"entities": []}], ["Depression is one of the most frequent co morbid psychiatric disorders that affects the life of the patients\u2019.", {"entities": []}], ["This study aimed to assess the prevalence of depression and associated factors among epileptic patients attending the outpatient department of the University of Gondar Hospital, Northwest Ethiopia, 2014.", {"entities": []}], ["Institution based quantitative cross\u2014sectional study was conducted among 405 individual with epilepsy.", {"entities": []}], ["The participants were selected using systematic random sampling technique.", {"entities": []}], ["Semistructured questionnaires were used to obtain socio-demographic and clinical data.", {"entities": []}], ["Depression was measured using Beck\u2019s Depression Inventory Binary logistic regression used for analysis.", {"entities": []}], ["The estimated, prevalence of depression was found to be 45.2\u00a0%.", {"entities": []}], ["Out of these (29.6\u00a0%) were classified as mild, (14.8\u00a0%) as moderate and (0.8\u00a0%) were severely depressed.", {"entities": []}], ["A lower educational status was associated with an increased prevalence of depression and the adjusted odds ratio (AOR) for the illiterate [can\u2019t read and write] was 8.32 [95\u00a0% Confidence Interval (CI): 4.83, 14.29].", {"entities": []}], ["Perceived stress (AOR\u00a0=\u00a06.21, CI 3.69, 10.44), onset of illness <6\u00a0years (AOR\u00a0=\u00a05.29, CI 4.09, 15.89), seizure frequency of [1\u201311\u00a0per year (AOR\u00a0=\u00a01.34, CI 1.41, 4.36), \u22651\u00a0per month (AOR\u00a0=\u00a07.83, CI 3.52, 17.40)], poly-pharmacy (AOR\u00a0=\u00a07.63, CI 2.74, 21.26)] and difficulties of adherence to antiepileptic drugs (AOR\u00a0=\u00a04.80, CI 2.57, 8.96) were also found to be independently associated with depression.", {"entities": []}], ["Overall, the prevalence of depression was found to be high.", {"entities": []}], ["Lower educational status, early onset of illness, seizure frequency, poly-pharmacy and difficulties of adherence to anti-epileptic drugs (AEDs) were factors statistically associated with depression.", {"entities": []}], ["Strengthening the educational status of the patients on the effect of early onset of the illness, frequent seizure occurrence and difficulty of adherence to AEDs as a contributing factors for other co-morbid psychiatric disorder are suggested in the clinical care setting.", {"entities": []}], ["Lattice degeneration of the retina is a vitreoretinal disorder characterized by a visible fundus lesion predisposing the patient to retinal tears and detachment.", {"entities": []}], ["The etiology of this degeneration is still uncertain, but it is likely that both genetic and environmental factors play important roles in its development.", {"entities": []}], ["To identify genetic susceptibility regions for lattice degeneration of the retina, we performed a genome-wide association study (GWAS) using a dense panel of 23,465 microsatellite markers covering the entire human genome.", {"entities": []}], ["This GWAS in a Japanese cohort (294 patients with lattice degeneration and 294 controls) led to the identification of one microsatellite locus, D2S0276i, in the collagen type IV alpha 4 ( COL4A4 ) gene on chromosome 2q36.3.", {"entities": [[188, 194, "GENE"]]}], ["To validate the significance of this observation, we evaluated the D2S0276i region in the GWAS cohort and in an independent Japanese cohort (280 patients and 314 controls) using D2S0276i and 47 single nucleotide polymorphisms covering the region.", {"entities": []}], ["The strong associations were observed in D2S0276i and rs7558081 in the COL4A4 gene ( P c\u200a=\u200a5.8\u00d710 P c\u200a=\u200a1.0\u00d710 COL4A4 gene may contribute to the development of lattice degeneration of the retina.", {"entities": [[71, 77, "GENE"], [111, 117, "GENE"], [71, 77, "GENE"], [111, 117, "GENE"]]}], ["Although depression and anxiety represent significant yet treatable comorbidities in patients with idiopathic pulmonary fibrosis (IPF), their impact on the clinical course and prognosis of IPF remain unclear.", {"entities": [[110, 128, "DISEASE"], [99, 128, "DISEASE"]]}], ["We investigated the prevalence and clinical significance of depression and anxiety in patients with IPF.", {"entities": []}], ["The present study included a prospective cohort comprising 112 Korean patients with IPF who had completed the Hospital Anxiety and Depression Scale (HADS) questionnaire.", {"entities": []}], ["Symptoms of depression and anxiety were present in 25.9% and 21.4% of patients with IPF, respectively (HADS scores \u22658).", {"entities": []}], ["No significant differences in demographic data, age, sex, smoking status, Modified Medical Research Council Dyspnea Scale (MMRC) scores, pulmonary function tests, or Gender-Age-Physiology Index for IPF were observed between patients with depression or anxiety and those without.", {"entities": []}], ["However, in patients with anxiety, St. George's Respiratory Questionnaire (SGRQ) scores were significantly higher than those of patients without anxiety (40.5 versus 23.5; p = 0.003).", {"entities": []}], ["The survival rate and total number of hospital admissions did not significantly differ between patients with depression/anxiety and those without.", {"entities": []}], ["Our findings indicate that depression and anxiety are relatively common in patients with IPF.", {"entities": []}], ["Although no significant differences were noted with regard to survival rate and hospitalization, the present study suggests that depression and anxiety significantly influence quality of life in patients with IPF.", {"entities": []}], ["Various statistical approaches can be applied to integrate traditional and omics biomarkers, allowing the discovery of prognostic markers to classify subjects into poor and good prognosis groups in terms of responses to nutritional interventions.", {"entities": []}], ["Here, we performed a prototype study to identify metabolites that predict responses to an intervention against oxidative stress and inflammation, using a data set from a randomized controlled trial evaluating Korean black raspberry (KBR) in sedentary overweight/obese subjects.", {"entities": []}], ["First, a linear mixed-effects model analysis with multiple testing correction showed that four-week consumption of KBR significantly changed oxidized glutathione (GSSG, q = 0.027) level, the ratio of reduced glutathione (GSH) to GSSG ( q = 0.039) in erythrocytes, malondialdehyde (MDA, q = 0.006) and interleukin-6 ( q = 0.006) levels in plasma, and seventeen NMR metabolites in urine compared with those in the placebo group.", {"entities": []}], ["A subsequent generalized linear mixed model analysis showed linear correlations between baseline urinary glycine and N-phenylacetylglycine (PAG) and changes in the GSH:GSSG ratio ( p = 0.008 and 0.004) as well as between baseline urinary adenine and changes in MDA ( p = 0.018).", {"entities": []}], ["Then, receiver operating characteristic analysis revealed that a two-metabolite set (glycine and PAG) had the strongest prognostic relevance for future interventions against oxidative stress (the area under the curve (AUC) = 0.778).", {"entities": []}], ["Leave-one-out cross-validation confirmed the accuracy of prediction (AUC = 0.683).", {"entities": []}], ["The current findings suggest that a higher level of this two-metabolite set at baseline is useful for predicting responders to dietary interventions in subjects with oxidative stress and inflammation, contributing to the emergence of personalized nutrition.", {"entities": []}], ["The combination of asthma and chronic obstructive pulmonary disease (COPD), or ACOS is a recently defined syndrome.", {"entities": [[30, 67, "DISEASE"], [106, 114, "DISEASE"], [19, 25, "DISEASE"]]}], ["The epidemiology of the condition is poorly described and previous research has suggested ACOS is associated with worse outcomes than either condition alone.", {"entities": []}], ["We therefore decided to complete a systematic review of the published literature.", {"entities": []}], ["This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta- Analyses guidelines.", {"entities": []}], ["A structured search was performed in the PubMed, Embase, and Medline databases up to Feb 2015 to identify studies reporting incidence, prevalence, health care utilization, morbidity, or mortality in COPD and asthma.", {"entities": [[208, 214, "DISEASE"]]}], ["A total of 19 studies were included in the present study.", {"entities": []}], ["The pooled prevalence of overlap among COPD was 27% (95% CI: 0.16\u20130.38, p<0.0001) and 28% (95% CI: 0.09\u20130.47, p = 0.0032) in the population and hospital-based studies, respectively.", {"entities": []}], ["We found no significant difference between ACOS and COPD in terms of gender, smoking status, lung function and 6mWD.", {"entities": []}], ["However, in comparison to subject with only COPD, ACOS subjects were significantly younger, had higher BMI, healthcare utilization, and lower HRQoL.", {"entities": []}], ["ACOS is a common condition that exists in a substantial proportion of subjects with COPD.", {"entities": []}], ["ACOS represents a distinct clinical phenotype with more frequent exacerbations, hospitalization, worse health-related quality of life, and higher healthcare costs than either disease alone.", {"entities": []}], ["There is a critical need to better define the management and treatment of this syndrome.", {"entities": [[79, 87, "DISEASE"]]}], ["Background: Evidence suggests that increased ambient air pollution concentrations are associated with health effects, although relatively few studies have specifically examined infants.", {"entities": []}], ["Objective: We examined associations of daily ambient air pollution concentrations with central apnea (prolonged pauses in breathing) and bradycardia (low heart rate) events among infants prescribed home cardiorespiratory monitors.", {"entities": []}], ["Methods: The home monitors record the electrocardiogram, heart rate, and respiratory effort for detected apnea and bradycardia events in high-risk infants [primarily premature and low birth weight (LBW) infants].", {"entities": []}], ["From August 1998 through December 2002, 4,277 infants had 8,960 apnea event-days and 29,450 bradycardia event-days in > 179,000 days of follow-up.", {"entities": []}], ["We assessed the occurrence of apnea and bradycardia events in relation to speciated particulate matter and gaseous air pollution levels using a 2-day average of air pollution (same day and previous day), adjusting for temporal trends, temperature, and infant age.", {"entities": []}], ["Results: We observed associations between bradycardia and 8-hr maximum ozone [odds ratio (OR) = 1.049 per 25-ppb increase; 95% confidence interval (CI), 1.021\u20131.078] and 1-hr maximum nitrogen dioxide (OR =1.025 per 20-ppb increase; 95% CI, 1.000\u20131.050).", {"entities": []}], ["The association with ozone was robust to different methods of control for time trend and specified correlation structure.", {"entities": []}], ["In secondary analyses, associations of apnea and bradycardia with pollution were generally stronger in infants who were full term and of normal birth weight than in infants who were both premature and LBW.", {"entities": []}], ["Conclusions: These results suggest that higher air pollution concentrations may increase the occurrence of apnea and bradycardia in high-risk infants.", {"entities": []}], ["Severe human respiratory syncytial virus (hRSV) bronchiolitis in previously well infants may be due to differences in the innate immune response to hRSV infection.", {"entities": [[48, 61, "DISEASE"]]}], ["Aim: to determine if factors mediating proposed mechanisms for severe bronchiolitis differ with severity of disease.", {"entities": [[70, 83, "DISEASE"]]}], ["197 infants admitted to hospital with hRSV bronchiolitis were recruited and grouped according to no oxygen requirement (n\u200a=\u200a27), oxygen dependence (n\u200a=\u200a114) or mechanical ventilation (n\u200a=\u200a56).", {"entities": [[43, 56, "DISEASE"]]}], ["We collected clinical data, nasopharyngeal aspirate (NPA) and if ventilated bronchoalveolar lavage (BAL).", {"entities": []}], ["Interferon-gamma (IFN-\u03b3), substance P (SP), interleukin 9 (IL-9), urea and hRSV load, were measured in cell free supernatant from NPA and BAL.", {"entities": []}], ["Multivariate analysis compared independent effects of clinical, virological and immunological variables upon disease severity.", {"entities": []}], ["IFN-\u03b3 and SP concentrations were lower in NPA from infants who required oxygen or mechanical ventilation.", {"entities": []}], ["Viral load and IL-9 concentrations were high but did not vary with severity of disease.", {"entities": []}], ["Independent predictors of severe disease (in diminishing size of effect) were low weight on admission, low gestation at birth, low NPA IFN-\u03b3 and NPA SP.", {"entities": []}], ["Nasal airway sampling appears to be a useful surrogate for distal airway sampling since concentrations of IFN-\u03b3, SP, IL-9 and viral load in NPA correlate with the same in BAL.", {"entities": []}], ["Our data support two proposed mechanisms for severe hRSV disease; reduced local IFN-\u03b3 response and SP mediated inflammation.", {"entities": []}], ["We found large amounts of hRSV and IL-9 in airways secretions from the upper and lower respiratory tract but could not associate these with disease severity.", {"entities": []}], ["Adipose tissue secrets adipokines and fatty acids, which may contribute to obesity-associated vascular dysfunction and cardiovascular risk.", {"entities": [[75, 82, "DISEASE"]]}], ["This study investigated which factors are responsible for the synergistic effect of adipokine and oleic acid- (OA-) induced proliferation of human vascular smooth muscle cells (VSMC).", {"entities": []}], ["Adipocyte-conditioned medium (CM) from human adipocytes induces proliferation of VSMC in correlation to its vascular endothelial growth factor (VEGF) content.", {"entities": []}], ["CM increases VEGF-receptor (VEGF-R) 1 and 2 expression and VEGF secretion of VSMC, while OA only stimulates VEGF secretion.", {"entities": []}], ["VEGF neutralization abrogates CM- and OA-induced proliferation and considerably reduces proliferation induced by CM and OA in combination.", {"entities": []}], ["VEGF release is higher from visceral adipose tissue (VAT) of obese subjects compared to subcutaneous adipose tissue (SAT) and VAT from lean controls.", {"entities": []}], ["Furthermore, VEGF release from VAT correlates with its proliferative effect.", {"entities": []}], ["Perivascular adipose tissue (PAT) from type 2 diabetic patients releases significantly higher amounts of VEGF and induces stronger proliferation of VSMC as compared to SAT and SAT/PAT of nondiabetics.", {"entities": []}], ["In conclusion, VEGF is mediating CM-induced proliferation of VSMC.", {"entities": []}], ["As this adipokine is released in high amounts from VAT of obese patients and PAT of diabetic patients, VEGF might link adipose tissue inflammation to increased VSMC proliferation.", {"entities": []}], ["Treatment response to systemic corticosteroid in asthmatic children is heterogeneous and may be mediated by epigenetic mechanism(s).", {"entities": []}], ["We aim to identify DNA methylation (DNAm) changes responsive to steroid, and DNAm biomarkers that distinguish treatment response.", {"entities": []}], ["We followed 33 children (ages 5\u201318) presenting to the Emergency Department (ED) for asthma exacerbation.", {"entities": [[84, 90, "DISEASE"]]}], ["Based on whether they met discharge criteria in \u226424 hours, participants were grouped into good and poor responders to steroid treatment.", {"entities": []}], ["Nasal samples were collected upon presentation to the ED (T 0 ) and 18\u201324 hours later (T 1 ).", {"entities": []}], ["Genome-wide DNAm was measured for both time points in 20 subjects, and compared between T 0 and T 1 in good and poor responders respectively.", {"entities": []}], ["DNAm at T 1 was also compared between two responder groups.", {"entities": []}], ["DNAm of selected CpGs was verified in the complete cohort, and expression of associated genes was examined.", {"entities": []}], ["Interactions between DNAm, common single nucleotide polymorphism (SNP) located at the CpG sites and treatment responses were assessed.", {"entities": []}], ["Three CpGs located in the OTX2 promoter showed responder-specific DNAm changes from T 0 to T 1 , in which DNAm decreased in good but not in poor responders.", {"entities": [[26, 30, "GENE"]]}], ["Good and poor responders showed differential DNAm at T 1 in 127 CpGs without and 182 CpGs with common SNP co-localization.", {"entities": []}], ["Negative correlations between DNAm and gene expression were observed at CpGs located within the LDHC promoter, suggesting an impact of DNAm on gene regulation.", {"entities": [[96, 100, "GENE"]]}], ["Interactions between SNPs, DNAm and treatment response were detected.", {"entities": []}], ["Acute systemic steroid treatment modifies nasal DNAm in good responders.", {"entities": []}], ["Nasal DNAm, dependent or independent of SNPs, can differentiate response to treatment in acute asthmatic children.", {"entities": []}], ["The widespread use of genetically altered mouse models of experimental asthma has stimulated the development of lung function techniques in vivo to characterize the functional results of genetic manipulations.", {"entities": [[71, 77, "DISEASE"]]}], ["Here, we describe various classical and recent methods of measuring airway responsiveness in vivo including both invasive methodologies in anesthetized, intubated mice (repetitive/non-repetitive assessment of pulmonary resistance (R L ) and dynamic compliance (C dyn ); measurement of low-frequency forced oscillations (LFOT)) and noninvasive technologies in conscious animals (head-out body plethysmography; barometric whole-body plethysmography).", {"entities": []}], ["Outlined are the technical principles, validation and applications as well as the strengths and weaknesses of each methodology.", {"entities": []}], ["Reviewed is the current set of invasive and noninvasive methods of measuring murine pulmonary function, with particular emphasis on practical considerations that should be considered when applying them for phenotyping in the laboratory mouse.", {"entities": []}], ["Somatic mutations contribute to tumorigenesis.", {"entities": []}], ["Although these mutations occur in all proliferating cells, their accumulation under non-malignant conditions, such as in autoimmune disorders, has not been investigated.", {"entities": []}], ["Here, we show that patients with newly diagnosed rheumatoid arthritis have expanded CD8+ T-cell clones; in 20% (5/25) of patients CD8+ T cells, but not CD4+ T cells, harbour somatic mutations.", {"entities": [[49, 69, "DISEASE"], [60, 69, "DISEASE"]]}], ["In healthy controls ( n =20), only one mutation is identified in the CD8+ T-cell pool.", {"entities": []}], ["Mutations exist exclusively in the expanded CD8+ effector-memory subset, persist during follow-up, and are predicted to change protein functions.", {"entities": []}], ["Some of the mutated genes ( SLAMF6, IRF1 ) have previously been associated with autoimmunity.", {"entities": [[28, 34, "GENE"], [36, 40, "GENE"]]}], ["RNA sequencing of mutation-harbouring cells shows signatures corresponding to cell proliferation.", {"entities": []}], ["Our data provide evidence of accumulation of somatic mutations in expanded CD8+ T cells, which may have pathogenic significance for RA and other autoimmune diseases.", {"entities": []}], ["Accumulation of somatic mutations in lymphocytes is a feature of some cancers.", {"entities": []}], ["Here the authors show that patients with recent onset of rheumatoid arthritis also accumulate mutations in their expanded CD8+ effector memory T cell pool independent of cancer association.", {"entities": [[57, 77, "DISEASE"], [68, 77, "DISEASE"], [170, 176, "DISEASE"]]}], ["Traditional Indian and Australian medicinal plant extracts were investigated to determine their therapeutic potential to inhibit key enzymes in carbohydrate metabolism, which has relevance to the management of hyperglycemia and type 2 diabetes.", {"entities": [[210, 223, "DISEASE"]]}], ["The antioxidant activities were also assessed.", {"entities": []}], ["The evaluation of enzyme inhibitory activity of seven Australian aboriginal medicinal plants and five Indian Ayurvedic plants was carried out against \u03b1-amylase and \u03b1-glucosidase.", {"entities": []}], ["Antioxidant activity was determined by measuring (i) the scavenging effect of plant extracts against 2, 2-diphenyl-1-picryl hydrazyl (DPPH) and 2, 2\u2032-azinobis-3-ethylbenzothiazoline-6-sulfonate (ABTS) and (ii) ferric reducing power.", {"entities": []}], ["Total phenolic and total flavonoid contents were also determined.", {"entities": []}], ["Of the twelve plant extracts evaluated, the highest inhibitory activity against both \u03b1-amylase and \u03b1-glucosidase enzymes was exerted by Santalum spicatum and Pterocarpus marsupium with IC 50 values of 5.43\u2009\u03bcg/ml and 0.9\u2009\u03bcg/ml, respectively, and 5.16\u2009\u03bcg/ml and 1.06\u2009\u03bcg/ml, respectively.", {"entities": []}], ["However, the extracts of Acacia ligulata (IC 50 \u2009=\u20091.01\u2009\u03bcg/ml), Beyeria leshnaultii (0.39\u2009\u03bcg/ml), Mucuna pruriens (0.8\u2009\u03bcg/ml) and Boerhaavia diffusa (1.72\u2009\u03bcg/ml) exhibited considerable activity against \u03b1-glucosidase enzyme only.", {"entities": []}], ["The free radical scavenging activity was found to be prominent in extracts of Acacia kempeana , Acacia ligulata followed by Euphorbia drummondii against both DPPH and ABTS.", {"entities": []}], ["The reducing power was more pronounced in Euphorbia drummondii and Pterocarpus marsupium extracts.", {"entities": []}], ["The phenolic and flavonoid contents ranged from 0.42 to 30.27\u2009\u03bcg/mg equivalent of gallic acid and 0.51 to 32.94\u2009\u03bcg/mg equivalent of quercetin, respectively, in all plant extracts.", {"entities": []}], ["Pearson\u2019s correlation coefficient between total flavonoids and total phenolics was 0.796.", {"entities": []}], ["The results obtained in this study showed that most of the plant extracts have good potential for the management of hyperglycemia, diabetes and the related condition of oxidative stress.", {"entities": [[116, 129, "DISEASE"]]}], ["There is an ongoing demand for easily accessible biomarkers related to pathophysiological processes in chronic obstructive pulmonary disease (COPD).", {"entities": [[103, 140, "DISEASE"]]}], ["Short-term intense exercise is known to increase the peripheral blood levels of cytokines.", {"entities": []}], ["Therefore, we tested the potential and the repeatability of an exercise challenge to amplify seven serum biomarkers (interleukin 6 [IL6], C-reactive protein [CRP], myeloperoxidase [MPO], leukotriene B4, soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1, and von Willebrand factor [VWF]) in smokers with and without COPD.", {"entities": [[132, 135, "GENE"], [158, 161, "GENE"], [181, 184, "GENE"], [316, 319, "GENE"]]}], ["Twenty-three smokers with moderate COPD (GOLD 2) and 23 sex- and age-matched healthy smokers underwent up to 30-minute submaximal, constant-load exercise (75% of maximum work load) on two occasions separated by 4 weeks (second challenge n=19/20).", {"entities": []}], ["Serum samples were obtained before, 5 minutes after the start, at the end of exercise (maximum 30 minutes or until exhaustion), and after additional 20 minutes of rest.", {"entities": []}], ["The median (interquartile range) exercise time until exhaustion in the two challenges was 10.0 (4.0) minutes and 10.0 (8.0) minutes in smokers with COPD and 22.0 (16.0) minutes and 26.5 (14.5) minutes in healthy smokers.", {"entities": []}], ["The exercise challenge significantly increased the serum concentrations of IL6 and VWF, but decreased the concentrations of MPO.", {"entities": [[75, 78, "GENE"], [83, 86, "GENE"], [124, 127, "GENE"]]}], ["Healthy smokers showed a significantly greater increase (at the end of exercise compared to before exercise) in IL6 ( P =0.01) and a larger decline ( P =0.03) in MPO.", {"entities": [[112, 115, "GENE"], [162, 165, "GENE"]]}], ["The overall profile of the serum markers during the exercise challenge was shown to be repeatable in the second challenge.", {"entities": []}], ["In summary, intense load exercise is capable of changing the concentration of inflammatory and endothelial function markers.", {"entities": []}], ["Especially, the decline in the level of MPO, a marker closely related to cardiovascular risk, appears to be of clinical interest, as the exercise-induced decline might be related to the beneficial effects of physical activity in general.", {"entities": [[40, 43, "GENE"]]}], ["Water-soluble form of fullerene C 60 is a promising tool for the control of ROS-dependent inflammation including allergic diseases.", {"entities": []}], ["Anti-inflammatory effects of C 60 (nC 60 ) aqueous dispersion were evaluated in the mouse models of atopic dermatitis using subcutaneous (SC) and epicutaneous (EC) applications during 50\u00a0days period.", {"entities": [[100, 117, "DISEASE"], [107, 117, "DISEASE"]]}], ["A highly stable nC 60 was prepared by exhaustive dialysis of water-organic C 60 solution against water, where the size and \u03b6-potential of fullerene nanoparticles are about 100\u00a0nm and \u221230\u00a0mV, respectively.", {"entities": []}], ["To induce skin inflammation, female BALB/c mice were EC sensitized with ovalbumin three times during one-weekly exposures.", {"entities": []}], ["The nC 60 solution was administrated in mice subcutaneously (SC) (0.1\u00a0mg/kg) and epicutaneously (EC) (1\u00a0mg/kg).", {"entities": []}], ["Significant suppression of IgE and Th2 cytokines production and a concomitant rise in concentrations of Th1 cytokines were observed in nC 60 -treated groups.", {"entities": []}], ["In addition, a significant increase in the levels of Foxp3 We suppose that nC60 treatment shifts immune response from Th2 to Th1 and restores to some extent the function of the skin barrier.", {"entities": [[53, 58, "GENE"]]}], ["This approach can be a good alternative to the treatment of allergic and other inflammatory diseases.", {"entities": []}], ["The purpose of this study is to identify factors affecting CSHCN's receiving needed specialty care among different socioeconomic levels.", {"entities": []}], ["Previous literature has shown that Socioeconomic Status (SES) is a significant factor in CHSHCN receiving access to healthcare.", {"entities": []}], ["Other literature has shown that factors of insurance, family size, race/ethnicity and sex also have effects on these children's receipt of care.", {"entities": []}], ["However, this literature does not address whether other factors such as maternal education, geographic location, age, insurance type, severity of condition, or race/ethnicity have different effects on receiving needed specialty care for children in each SES level.", {"entities": []}], ["Data were obtained from the National Survey of Children with Special Health Care Needs, 2000\u20132002.", {"entities": []}], ["The study analyzed the survey which studies whether CHSCN who needed specialty care received it.", {"entities": []}], ["The analysis included demographic characteristics, geographical location of household, severity of condition, and social factors.", {"entities": []}], ["Multiple logistic regression models were constructed for SES levels defined by federal poverty level: < 199%; 200\u2013299%; \u2265 300%.", {"entities": []}], ["For the poorest children (,199% FPL) being uninsured had a strong negative effect on receiving all needed specialty care.", {"entities": []}], ["Being Hispanic was a protective factor.", {"entities": []}], ["Having more than one adult in the household had a positive impact on receipt of needed specialty care but a larger number of children in the family had a negative impact.", {"entities": []}], ["For the middle income group of children (200\u2013299% of FPL severity of condition had a strong negative association with receipt of needed specialty care.", {"entities": []}], ["Children in highest income group (> 300% FPL) were positively impacted by living in the Midwest and were negatively impacted by the mother having only some college compared to a four-year degree.", {"entities": []}], ["Factors affecting CSHCN receiving all needed specialty care differed among socioeconomic groups.", {"entities": []}], ["These differences should be addressed in policy and practice.", {"entities": []}], ["Future research should explore the CSHCN population by income groups to better serve this population", {"entities": []}], ["Next-generation sequencing is revolutionizing the molecular taxonomy of human disease.", {"entities": []}], ["Recent studies of patients with unexplained autoinflammatory disorders reveal germline genetic mutations that target important regulators of innate immunity.", {"entities": []}], ["Whole-exome analyses of previously undiagnosed patients have catalyzed the recognition of two new disease genes.", {"entities": []}], ["First, a phenotypic spectrum, including livedo racemosa, fever with early-onset stroke, polyarteritis nodosa, and Sneddon syndrome, is caused by loss-of-function mutations in cat eye syndrome chromosome region, candidate 1 ( CECR1 ), encoding adenosine deaminase 2.", {"entities": [[122, 130, "DISEASE"], [183, 191, "DISEASE"], [88, 108, "DISEASE"], [225, 230, "GENE"]]}], ["Adenosine deaminase 2 is a secreted protein expressed primarily in myeloid cells, and a regulator of macrophage differentiation and endothelial development.", {"entities": []}], ["Disease-associated mutations impair anti-inflammatory M2 macrophage differentiation.", {"entities": []}], ["Second, patients presenting with cold-induced urticaria, granulomatous rash, autoantibodies, and common variable immunodeficiency, or with blistering skin lesions, bronchiolitis, enterocolitis, ocular inflammation, and mild immunodeficiency harbor distinct mutations in phospholipase C\u03b3 2 , encoding a signaling molecule expressed in natural killer cells, mast cells, and B lymphocytes.", {"entities": [[46, 55, "DISEASE"], [97, 129, "DISEASE"], [164, 177, "DISEASE"]]}], ["These mutations inhibit the function of a phospholipase C\u03b3 2 autoinhibitory domain, causing increased or constitutive signaling.", {"entities": []}], ["These findings underscore the power of next-generation sequencing, demonstrating how the primary deficiency of key molecular regulators or even regulatory motifs may lead to autoinflammation, and suggesting a possible role for cat eye syndrome chromosome region, candidate 1 and phospholipase C\u03b3 2 in common diseases.", {"entities": [[235, 243, "DISEASE"]]}], ["Medicinal plants are used by 80% of people from developing countries to fulfill their primary health needs, occupying a key position on plant research and medicine.", {"entities": []}], ["Taking into account that, besides their pharmaceutical importance, these plants contribute greatly to ecosystems' stability, a continuous documentation and preservation of traditional knowledge is a priority.", {"entities": []}], ["The objective of this study was to organize a database of medicinal plants including their applications and associated procedures in Canhane village, district of Massingir, province of Gaza, Mozambique.", {"entities": []}], ["In order to gather information about indigenous medicinal plants and to maximize the collection of local knowledge, eleven informants were selected taking into account the dimension of the site and the fact that the vegetation presents a great homogeneity.", {"entities": []}], ["The data were collected through intensive structured and semi-structured interviews performed during field research.", {"entities": []}], ["Taxonomical identification of plant species was based on field observations and herbarium collections.", {"entities": []}], ["A total of 53 plant species have been reported, which were used to treat 50 different human health problems.", {"entities": []}], ["More than half of the species were used for stomach and intestine related disturbances (including major diseases such as diarrhea and dysentery).", {"entities": [[121, 129, "DISEASE"], [134, 143, "DISEASE"]]}], ["Additionally, four species with therapeutic applications were reported for the first time, whose potential can further be exploited.", {"entities": []}], ["The great majority of the identified species was also associated with beliefs and myths and/or used as food.", {"entities": []}], ["In general, the community was conscientious and motivated about conservational issues and has adopted measures for the rational use of medicinal plants.", {"entities": []}], ["The ethnomedicinal use of plant species was documented in the Canhane village.", {"entities": []}], ["The local community had a rich ethnobotanical knowledge and adopted sound management conservation practices.", {"entities": []}], ["The data compiled in this study show the social importance of the surveyed plants being a contribution to the documentation of PGR at the national and regional level.", {"entities": [[127, 130, "GENE"]]}], ["Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the world.", {"entities": []}], ["Present therapies for COPD have limited effect on reducing the progression of COPD and suppressing the inflammatory response in the lung.", {"entities": []}], ["Bulbs of Fritillaria cirrhosa D. Don (BFC) have been used in many Asian countries for a long time to treat pulmonary diseases, such as cough, expectoration, and asthma.", {"entities": [[161, 167, "DISEASE"]]}], ["Steroidal alkaloids are the major biological active constituents in BFC, whereby imperialine is one of the important steroidal alkaloids.", {"entities": []}], ["So far, there are no studies reporting the effect of imperialine on COPD.", {"entities": []}], ["In this study, we investigated the effect of imperialine on pulmonary function and structure and inflammation in a COPD-like rat model which was induced by the combination of exposure to CS and intratracheal administration of LPS.", {"entities": [[187, 189, "GENE"]]}], ["Our data show that imperialine mitigates pulmonary functional and structural impairment and suppressed inflammatory response in a COPD-like rat model by mediating expression of related cytokines in lung tissues of the COPD-like rats, such as IL-1 \u03b2 , IL-6, IL-8, TNF- \u03b1 , NF- \u03ba B, TGF- \u03b2 1, MMP-9, and TIMP-1.", {"entities": []}], ["Monozygotic and dizygotic twin studies investigating the relative roles of host genetics and environmental factors in shaping gut microbiota composition have produced conflicting results.", {"entities": []}], ["In this study, we investigated the gut microbiota composition of a healthy dichorionic triplet set.", {"entities": []}], ["The dichorionic triplet set contained a pair of monozygotic twins and a fraternal sibling, with similar pre- and post-natal environmental conditions including feeding regime.", {"entities": []}], ["V4 16S rRNA and rpoB amplicon pyrosequencing was employed to investigate microbiota composition, and the species and strain diversity of the culturable bifidobacterial population was also examined.", {"entities": []}], ["At month 1, the monozygotic pair shared a similar microbiota distinct to the fraternal sibling.", {"entities": []}], ["By month 12 however, the profile was more uniform between the three infants.", {"entities": []}], ["Principal coordinate analysis (PCoA) of the microbiota composition revealed strong clustering of the monozygotic pair at month 1 and a separation of the fraternal infant.", {"entities": []}], ["At months 2 and 3 the phylogenetic distance between the monozygotic pair and the fraternal sibling has greatly reduced and by month 12 the monozygotic pair no longer clustered separately from the fraternal infant.", {"entities": []}], ["Pulse field gel electrophoresis (PFGE) analysis of the bifidobacterial population revealed a lack of strain diversity, with identical strains identified in all three infants at month 1 and 12.", {"entities": []}], ["The microbiota of two antibiotic-treated dichorionic triplet sets was also investigated.", {"entities": []}], ["Not surprisingly, in both triplet sets early life antibiotic administration appeared to be a major determinant of microbiota composition at month 1, irrespective of zygosity.", {"entities": []}], ["By month 12, early antibiotic administration appeared to no longer exert such a strong influence on gut microbiota composition.", {"entities": []}], ["We hypothesize that initially host genetics play a significant role in the composition of an individual\u2019s gut microbiota, unless an antibiotic intervention is given, but by month 12 environmental factors are the major determinant.", {"entities": []}], ["We previously showed that intra-amniotic lipopolysaccharide (LPS) amplifies alveolar hypoplasia induced by postnatal hyperoxia.", {"entities": []}], ["We determined whether the priming effect of intra-amniotic LPS amplifies hyperoxia-induced airway hyperreactivity (AHR).", {"entities": [[115, 118, "GENE"]]}], ["LPS or normal saline was injected into the amniotic cavities of pregnant rats at the 20th day of gestation.", {"entities": []}], ["After birth, rat pups were exposed to 60% O 2 or air for 14 d. On postnatal day 14, rat pups underwent forced oscillometry, which included a challenge with nebulized methacholine, and the lungs were harvested for morphological studies.", {"entities": []}], ["Hyperoxia significantly increased airway reactivity and decreased compliance.", {"entities": []}], ["Intra-amniotic LPS further increased hyperoxia-induced AHR but did not further impair respiratory system compliance.", {"entities": [[55, 58, "GENE"]]}], ["Hyperoxia-induced changes in lung parenchymal and small airway morphology were not further altered by intra-amniotic LPS.", {"entities": []}], ["However, combined exposure to intra-amniotic LPS and hyperoxia increased the proportion of degranulating mast cells in the hilar airways.", {"entities": []}], ["Intra-amniotic LPS amplified postnatal hyperoxia-induced AHR.", {"entities": [[57, 60, "GENE"]]}], ["This was associated with increased airway mast cell degranulation, which has previously been linked with hyperoxia-induced AHR.", {"entities": [[123, 126, "GENE"]]}], ["There were no morphologic changes of parenchyma or airways that would account for the LPS augmentation of hyperoxia-induced AHR.", {"entities": [[124, 127, "GENE"]]}], ["The immune system evolved to efficiently eradicate invading bacteria and terminate inflammation through balancing inflammatory and regulatory T-cell responses.", {"entities": []}], ["In autoimmune arthritis, pathogenic T H 17 cells induce bone destruction and autoimmune inflammation.", {"entities": [[14, 23, "DISEASE"]]}], ["However, whether a beneficial function of T-cell-induced bone damage exists is unclear.", {"entities": []}], ["Here, we show that bone-damaging T cells have a critical function in the eradication of bacteria in a mouse model of periodontitis, which is the most common infectious disease.", {"entities": [[117, 130, "DISEASE"]]}], ["Bacterial invasion leads to the generation of specialized T H 17 cells that protect against bacteria by evoking mucosal immune responses as well as inducing bone damage, the latter of which also inhibits infection by removing the tooth.", {"entities": []}], ["Thus, bone-damaging T cells, which may have developed to stop local infection by inducing tooth loss, function as a double-edged sword by protecting against pathogens while also inducing skeletal tissue degradation.", {"entities": []}], ["IL-17-producing T cells are protective against infection, but the authors of this article previously showed that these cells also contribute to inflammatory bone destruction.", {"entities": []}], ["Here they show in the context of periodontitis that microbiota-driven Th17-mediated bone destruction may actually be a physiological rather than a\u00a0pathological process, as associated tooth loss prevents dissemination of oral bacteria.", {"entities": [[33, 46, "DISEASE"]]}], ["Among patients who are discharged from the Emergency Department (ED), about 3% return within 30 days.", {"entities": []}], ["Revisits can be related to the nature of the disease, medical errors, and/or inadequate diagnoses and treatment during their initial ED visit.", {"entities": []}], ["Identification of high-risk patient population can help device new strategies for improved ED care with reduced ED utilization.", {"entities": []}], ["A decision tree based model with discriminant Electronic Medical Record (EMR) features was developed and validated, estimating patient ED 30 day revisit risk.", {"entities": []}], ["A retrospective cohort of 293,461 ED encounters from HealthInfoNet (HIN), Maine's Health Information Exchange (HIE), between January 1, 2012 and December 31, 2012, was assembled with the associated patients' demographic information and one-year clinical histories before the discharge date as the inputs.", {"entities": []}], ["To validate, a prospective cohort of 193,886 encounters between January 1, 2013 and June 30, 2013 was constructed.", {"entities": []}], ["The c -statistics for the retrospective and prospective predictions were 0.710 and 0.704 respectively.", {"entities": []}], ["Clinical resource utilization, including ED use, was analyzed as a function of the ED risk score.", {"entities": []}], ["Cluster analysis of high-risk patients identified discrete sub-populations with distinctive demographic, clinical and resource utilization patterns.", {"entities": []}], ["Our ED 30-day revisit model was prospectively validated on the Maine State HIN secure statewide data system.", {"entities": []}], ["Future integration of our ED predictive analytics into the ED care work flow may lead to increased opportunities for targeted care intervention to reduce ED resource burden and overall healthcare expense, and improve outcomes.", {"entities": []}], ["Accurate and timely medication information at the point of discharge is essential for continuity of care.", {"entities": []}], ["There are scarce data on the clinical significance if poor quality medicines information is passed to the next episode of care.", {"entities": []}], ["This study aimed to compare the number and clinical significance of medication errors and omission in discharge medicines information, and the timeliness of delivery of this information to community-based health practitioners, between the existing Hospital Discharge Summary (HDS) and a pharmacist prepared Medicines Information Transfer Fax (MITF).", {"entities": [[343, 347, "GENE"]]}], ["The study used a sample of 80 hospital patients who were at high risk of medication misadventure, and who had a MITF completed in the study period June \u2013 October 2009 at a tertiary referral hospital.", {"entities": [[112, 116, "GENE"]]}], ["The medicines information in participating patients\u2019 MITFs was validated against their Discharge Prescriptions (DP).", {"entities": []}], ["Medicines information in each patient\u2019s HDS was then compared with their validated MITF.", {"entities": [[83, 87, "GENE"]]}], ["An expert clinical panel reviewed identified medication errors and omissions to determine their clinical significance.", {"entities": []}], ["The time between patient discharge and the dispatching of the MITF and the HDS to each patient\u2019s community-based practitioners was calculated from hospital records.", {"entities": [[62, 66, "GENE"]]}], ["DPs for 77 of the 80 patients were available for comparison with their MITFs.", {"entities": []}], ["Medicines information in 71 (92%) of the MITFs matched that of the DP.", {"entities": []}], ["Comparison of the HDS against the MITF revealed that no HDS was prepared for 16 (21%) patients.", {"entities": [[34, 38, "GENE"]]}], ["Of the remaining 61 patients; 33 (54%), had required medications omitted and 38 (62%) had medication errors in their HDS.", {"entities": []}], ["The Clinical Panel rated the significance of errors or omissions for 70 patients (16 with no HDS prepared and 54 who\u2019s HDS was inconsistent with the validated MITF).", {"entities": [[159, 163, "GENE"]]}], ["In 17 patients the error or omission was rated as insignificant to minor; 23 minor to moderate; 24 moderate to major and 6 major to catastrophic.", {"entities": []}], ["28 (35%) patients had their HDS dispatched to their community-based practitioners within 48 hours post discharge compared to 80 (100%) of MITFs.", {"entities": []}], ["The MITF is an effective approach for the timely delivery of accurate discharge medicines information to community-based practitioners responsible for the patient\u2019s ongoing care.", {"entities": [[4, 8, "GENE"]]}], ["Increased accumulation of macrophages in adipose tissue in obesity is linked to low-grade chronic inflammation, and associated with features of metabolic syndrome.", {"entities": [[59, 66, "DISEASE"], [154, 162, "DISEASE"]]}], ["Vitamin D 3 may have immunoregulatory effects and reduce adipose tissue inflammation, although the molecular mechanisms remain to be established.", {"entities": []}], ["This study investigated the effects of vitamin D 3 on macrophage-elicited inflammatory responses in cultured human adipocytes, particularly the signalling pathways involved.", {"entities": []}], ["Macrophage-conditioned (MC) medium (25% with adipocyte maintenance media) markedly inhibited protein expression of the nuclear factor-\u03baB (NF\u03baB) subunit inhibitor \u03baB\u03b1 (I\u03baB\u03b1) (71%, P <0.001) and increased NF\u03baB p65 (1.5-fold, P \u200a=\u200a0.026) compared with controls.", {"entities": []}], ["Treatment with 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) abolished macrophage-induced activation of NF\u03baB signalling by increasing I\u03baB\u03b1 expression (2.7-fold, P \u200a=\u200a0.005) and reducing NF\u03baB p65 phosphorylation (68%; P <0.001).", {"entities": []}], ["The mitogen-activated protein kinase (MAPK) signalling was activated by MC medium, which was also blunted by 1,25(OH) 2 D 3 with a downregulation of phosphorylated p38 MAPK (32%, P \u200a=\u200a0.005) and phosphorylated Erk1/2 (49%, P \u200a=\u200a0.001).", {"entities": []}], ["Furthermore, MC medium (12.5% or 25%) dose-dependently upregulated secretion of key proinflammatory chemokines/cytokines (22-368-fold; all P <0.001) and this was significantly decreased by 1,25(OH) 2 D 3 : IL-8 (61% and 31%, P <0.001), MCP-1 (37%, P <0.001 and 36%, P \u200a=\u200a0.002), RANTES (78% and 62%, P <0.001) and IL-6 (29%, P <0.001 and 34%, P \u200a=\u200a0.019).", {"entities": []}], ["Monocyte migration-elicited by adipocytes treated with 1,25(OH) 2 D 3 was also reduced (up to 25%, P <0.001).", {"entities": []}], ["In conclusion, vitamin D 3 could be anti-inflammatory in adipose tissue, decreasing macrophage-induced release of chemokines and cytokines by adipocytes and the chemotaxis of monocytes.", {"entities": []}], ["Our data suggests these effects are mediated by inhibition of the NF\u03baB and MAPK signalling pathways.", {"entities": []}], ["Integration of data from genome\u2010wide single nucleotide polymorphism (SNP) association studies of different traits should allow researchers to disentangle the genetics of potentially related traits within individually associated regions.", {"entities": []}], ["Formal statistical colocalisation testing of individual regions requires selection of a set of SNPs summarising the association in a region.", {"entities": []}], ["We show that the SNP selection method greatly affects type 1 error rates, with published studies having used methods expected to result in substantially inflated type 1 error rates.", {"entities": []}], ["We show that either avoiding variable selection and instead testing the most informative principal components or integrating over variable selection using Bayesian model averaging can help control type 1 error rates.", {"entities": []}], ["Application to data from Graves' disease and Hashimoto's thyroiditis reveals a common genetic signature across seven regions shared between the diseases, and indicates that in five of six regions associated with Graves' disease and not Hashimoto's thyroiditis, this more likely reflects genuine absence of association with the latter rather than lack of power.", {"entities": [[57, 68, "DISEASE"], [248, 259, "DISEASE"]]}], ["Our examination, by simulation, of the performance of colocalisation tests and associated software will foster more widespread adoption of formal colocalisation testing.", {"entities": []}], ["Given the increasing availability of large expression and genetic association datasets from disease\u2010relevant tissue and purified cell populations, coupled with identification of regulatory sequences by projects such as ENCODE, colocalisation analysis has the potential to reveal both shared genetic signatures of related traits and causal disease genes and tissues.", {"entities": []}], ["Suppression of Tumorigenicity 2 (ST2), a member of the interleukin-1 receptor (IL-1R) family, activates type 2 immune responses to pathogens and tissue damage via binding to IL-33.", {"entities": []}], ["Dysregulated responses contribute to asthma, graft-versus-host and autoinflammatory diseases and disorders.", {"entities": [[37, 43, "DISEASE"]]}], ["To study ST2 structure for inhibitor development, we performed the principal component (PC) analysis on the crystal structures of IL1-1R1, IL1-1R2, ST2 and the refined ST2 ectodomain (ST2", {"entities": [[88, 90, "GENE"]]}], ["Approximately 80% of patients complain of various symptoms immediately after laparoscopic Nissen fundoplication.", {"entities": []}], ["These symptoms typically are treated medically without an extensive evaluation to identify the cause.", {"entities": []}], ["We reviewed our experience of laparoscopic Nissen fundoplication to determine the course of postoperative symptomatology in our patient population, and present a rational approach to this problem.", {"entities": []}], ["Over a 10-year period, 628 patients underwent primary laparoscopic Nissen fundoplication for gastroesophageal reflux disease; patients were evaluated with a standard set of questions for postoperative gastrointestinal complaints.", {"entities": [[93, 124, "DISEASE"]]}], ["Three- and 6-month follow-up data were compared by using the chi square test.", {"entities": []}], ["One-year follow-up data were available for 615 patients (98%).", {"entities": []}], ["All of these patients had symptoms during the first 3 postoperative months.", {"entities": []}], ["Early satiety (88%), bloating/flatulence (64%), and dysphagia (34%) were the most common; however, 94% of patients had resolution of their symptoms by the 1-year follow-up visit, and most had resolved after 3 months.", {"entities": []}], ["Patients with persistent reflux or dysphagia after 3 months typically had an anatomic failure of the operation.", {"entities": []}], ["Most patients who have undergone laparoscopic Nissen fundoplication for gastroesophageal re-flux disease will have gastrointestinal complaints during the initial 3 postoperative months.", {"entities": []}], ["Nearly all of these patients will have resolved their symptomatology after 3 months.", {"entities": []}], ["Those with persistent symptoms after 3 months warrant evaluation for operative failure.", {"entities": []}], ["5-lipoxygenase (5-LO) is a key enzyme in the synthesis of leukotrienes and 5-Oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid (oxoETE).", {"entities": []}], ["These inflammatory signaling molecules play a role in the pathology of asthma and so 5-LO inhibition is a promising target for asthma therapy.", {"entities": [[71, 77, "DISEASE"], [127, 133, "DISEASE"]]}], ["The 5-LO redox inhibitor zileuton (Zyflo IR/CR\u00ae) is currently marketed for the treatment of asthma in adults and children, but widespread use of zileuton is limited by its efficacy/safety profile, potentially related to its redox characteristics.", {"entities": [[92, 98, "DISEASE"]]}], ["Thus, a quantitative, mechanistic description of its functioning may be useful for development of improved anti-inflammatory targeting this mechanism.", {"entities": []}], ["A mathematical model describing the operation of 5-LO, phospholipase A2, glutathione peroxidase and 5-hydroxyeicosanoid dehydrogenase was developed.", {"entities": []}], ["The catalytic cycles of the enzymes were reconstructed and kinetic parameters estimated on the basis of available experimental data.", {"entities": []}], ["The final model describes each stage of cys-leukotriene biosynthesis and the reactions involved in oxoETE production.", {"entities": []}], ["Regulation of these processes by substrates (phospholipid concentration) and intracellular redox state (concentrations of reduced glutathione, glutathione (GSH), and lipid peroxide) were taken into account.", {"entities": []}], ["The model enabled us to reveal differences between redox and non-redox 5-LO inhibitors under conditions of oxidative stress.", {"entities": []}], ["Despite both redox and non-redox inhibitors suppressing leukotriene A4 (LTA4) synthesis, redox inhibitors are predicted to increase oxoETE production, thus compromising efficacy.", {"entities": []}], ["This phenomena can be explained in terms of the pseudo-peroxidase activity of 5-LO and the ability of lipid peroxides to transform 5-LO into its active form even in the presence of redox inhibitors.", {"entities": []}], ["The mathematical model developed described quantitatively different mechanisms of 5-LO inhibition and simulations revealed differences between the potential therapeutic outcomes for these mechanisms.", {"entities": []}], ["Complex interactions between a series of environmental factors and genes result in progression to clinical type 1 diabetes in genetically susceptible individuals.", {"entities": []}], ["Despite several decades of research in the area, these interactions remain poorly understood.", {"entities": []}], ["Several studies have yielded associations of certain foods, infections, and immunizations with the onset and progression of diabetes autoimmunity, but most findings are still inconclusive.", {"entities": []}], ["Environmental triggers are difficult to identify mainly due to (i) large number and complex nature of environmental exposures, including bacteria, viruses, dietary factors, and environmental pollutants, (ii) reliance on low throughput technology, (iii) less efforts in quantifying host response, (iv) long silent period between the exposure and clinical onset of T1D which may lead to loss of the exposure fingerprints, and (v) limited sample sets.", {"entities": []}], ["Recent development in multiplex technologies has enabled systematic evaluation of different classes of molecules or macroparticles in a high throughput manner.", {"entities": []}], ["However, the use of multiplex assays in type 1 diabetes research is limited to cytokine assays.", {"entities": []}], ["In this review, we will discuss the potential use of multiplex high throughput technologies in identification of environmental triggers and host response in type 1 diabetes.", {"entities": []}], ["Brain tumor etiology is poorly understood.", {"entities": []}], ["Based on their ability to pass through the blood\u2013brain barrier, it has been hypothesized that exposure to metals may increase the risk of brain cancer.", {"entities": [[138, 150, "DISEASE"], [144, 150, "DISEASE"]]}], ["Results from the few epidemiological studies on this issue are limited and inconsistent.", {"entities": []}], ["We investigated the relationship between glioma risk and occupational exposure to five metals - lead, cadmium, nickel, chromium and iron- as well as to welding fumes, using data from the seven-country INTEROCC study.", {"entities": []}], ["A total of 1800 incident glioma cases and 5160 controls aged 30\u201369\u00a0years were included in the analysis.", {"entities": []}], ["Lifetime occupational exposure to the agents was assessed using the INTEROCC JEM, a modified version of the Finnish job exposure matrix FINJEM.", {"entities": []}], ["In general, cases had a slightly higher prevalence of exposure to the various metals and welding fumes than did controls, with the prevalence among ever exposed ranging between 1.7 and 2.2% for cadmium to 10.2 and 13.6% for iron among controls and cases, respectively.", {"entities": []}], ["However, in multivariable logistic regression analyses, there was no association between ever exposure to any of the agents and risk of glioma with odds ratios (95% confidence intervals) ranging from 0.8 (0.7\u20131.0) for lead to 1.1 (0.7\u20131.6) for cadmium.", {"entities": []}], ["Results were consistent across models considering cumulative exposure or duration, as well as in all sensitivity analyses conducted.", {"entities": []}], ["Findings from this large-scale international study provide no evidence for an association between occupational exposure to any of the metals under scrutiny or welding fumes, and risk of glioma.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-017-0300-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["As previous asthma mortality studies were undertaken between 1986 and 1997, and treatments have evolved since that time, in order to direct future asthma interventions, we investigated the reasons for asthma deaths between 2005 and 2009.", {"entities": [[12, 18, "DISEASE"], [147, 153, "DISEASE"], [201, 207, "DISEASE"]]}], ["We undertook a case series analysis by searching the National Coroners\u2019 Information System using the most recent International Classification of Diseases-10 codes J45 and J46 and the keyword \u2018asthma\u2019 as the underlying cause of death.", {"entities": [[192, 198, "DISEASE"]]}], ["Records for 283 cases aged 70\u2005years and under were retrieved from each Australian state and territory.", {"entities": []}], ["Coroner's findings, autopsy, toxicology and police reports were reviewed to determine: if the team agreed the death was due to asthma and whether the death was preventable or modifiable factors existed?", {"entities": [[127, 133, "DISEASE"]]}], ["Owing to the likelihood of comorbidities or alternative diagnoses contributing to deaths in those over 70\u2005years of age, this group was excluded.", {"entities": []}], ["Examination of available data in those aged under 70\u2005years identified risk factors associated with asthma death.", {"entities": [[99, 105, "DISEASE"]]}], ["These included physical barriers (rural and remote location, institutionalised care), psychosocial issues (social disengagement, mental illness, living alone, being unemployed), smoking, drug and alcohol dependence, allergies, respiratory tract infections, inadequate treatment and delay in seeking help.", {"entities": [[196, 214, "DISEASE"]]}], ["Our study provides a current assessment of death from asthma across Australia.", {"entities": [[54, 60, "DISEASE"]]}], ["Further reductions in the rate of asthma deaths will require interventions targeted at the personal, practice and policy levels.", {"entities": [[34, 40, "DISEASE"]]}], ["Asthma-related health literacy needs to be improved especially among those with episodic asthma.", {"entities": [[0, 6, "DISEASE"], [89, 95, "DISEASE"]]}], ["Reforms are also needed to address inequity in healthcare delivery to \u2018reach the unreached\u2019.", {"entities": []}], ["Our study points to the dangers associated with smoking, drug and alcohol use and the consequences of delay in seeking care among those with asthma.", {"entities": [[141, 147, "DISEASE"]]}], ["The Schedule of Fatigue and Anergy/General Physician (SOFA/GP) was developed to screen for prolonged fatigue in the primary care setting.", {"entities": []}], ["We aimed to evaluate the reliability and validity of the Korean version of the SOFA/GP (SOFA/GP-K), which is adapted from the original English version.", {"entities": []}], ["We performed translation and back translation, and after conducting a pilot study, we tested the final version of the questionnaire for its reliability and validity in a Korean primary care setting.", {"entities": []}], ["Two hundred participants that visited a health examination center in a university hospital completed the survey between September and November 2012.", {"entities": []}], ["A second survey was performed within 2 weeks of the primary survey to test for reliability.", {"entities": []}], ["We evaluated concurrent validity between the SOFA/GP-K score, the Fatigue Severity Scale (FSS), and Brief Fatigue Index (BFI) scores.", {"entities": []}], ["The Spearman correlation coefficient between SOFA/GP-K and FSS was 0.71 and 0.61 between SOFA/GP-K and BFI.", {"entities": []}], ["Internal consistency of SOFA/GP-K was observed (Cronbach's alpha = 0.82) and construct validity was confirmed by factor analysis.", {"entities": []}], ["The Kappa scores for test-retest reliability for each survey item were between 0.28 and 0.64.", {"entities": []}], ["The SOFA/GP-K is a valid and reliable questionnaire for screening fatigue in a primary care setting.", {"entities": []}], ["Regulation of an immune response requires complex crosstalk between cells of the innate and adaptive immune systems, via both cell\u2013cell contact and secretion of cytokines.", {"entities": []}], ["An important cytokine with a broad regulatory role in the immune system is transforming growth factor-\u03b2 (TGF-\u03b2).", {"entities": []}], ["TGF-\u03b2 is produced by and has effects on many different cells of the immune system, and plays fundamental roles in the regulation of immune responses during homeostasis, infection and disease.", {"entities": []}], ["Although many cells can produce TGF\u03b2, it is always produced as an inactive complex that must be activated to bind to the TGF\u03b2 receptor complex and promote downstream signalling.", {"entities": []}], ["Thus, regulation of TGF\u03b2 activation is a crucial step in controlling TGF\u03b2 function.", {"entities": []}], ["This review will discuss how TGF\u03b2 controls diverse immune responses and how TGF\u03b2 function is regulated, with a focus on recent work highlighting a critical role for the integrin \u03b1v\u03b28 expressed by dendritic cells in activating TGF\u03b2.", {"entities": []}], ["Art v 1, Amb a 4, and Par h 1 are allergenic defensin\u2010polyproline\u2013linked proteins present in mugwort, ragweed, and feverfew pollen, respectively.", {"entities": []}], ["We aimed to investigate the physicochemical and immunological features underlying the different allergenic capacities of those allergens.", {"entities": []}], ["Recombinant defensin\u2010polyproline\u2013linked proteins were expressed in E.\u00a0coli and physicochemically characterized in detail regarding identity, secondary structure, and aggregation status.", {"entities": []}], ["Allergenic activity was assessed by mediator releases assay, serum IgE reactivity, and IgE inhibition ELISA using sera of patients from Austria, Canada, and Korea.", {"entities": []}], ["Endolysosomal protein degradation and T\u2010cell cross\u2010reactivity were studied in\u00a0vitro.", {"entities": []}], ["Despite variations in the proline\u2010rich region, similar secondary structure elements were observed in the defensin\u2010like domains.", {"entities": []}], ["Seventy\u2010four percent and 52% of the Austrian and Canadian patients reacted to all three allergens, while Korean patients were almost exclusively sensitized to Art v 1.", {"entities": []}], ["This was reflected by IgE inhibition assays demonstrating high cross\u2010reactivity for Austrian, medium for Canadian, and low for Korean sera.", {"entities": []}], ["In a subgroup of patients, IgE reactivity toward structurally altered Amb a 4 and Par h 1 was not changed suggesting involvement of linear epitopes.", {"entities": []}], ["Immunologically relevant endolysosomal stability of the defensin\u2010like domain was limited to Art v 1 and no T\u2010cell cross\u2010reactivity with Art v 1 25\u201036 was observed.", {"entities": []}], ["Despite structural similarity, different IgE\u2010binding profiles and proteolytic processing impacted the allergenic capacity of defensin\u2010polyproline\u2013linked molecules.", {"entities": []}], ["Based on the fact that Amb a 4 demonstrated distinct IgE\u2010binding epitopes, we suggest inclusion in molecule\u2010based allergy diagnosis.", {"entities": []}], ["Omalizumab is a humanized monoclonal antibody that binds to the high-affinity type-I IgE Fc receptors on mast cells (MCs) and basophils, inhibiting the IgE immune pathway.", {"entities": []}], ["Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder, and dysregulation of the immune system likely contributes to its etiology and/or symptomatology.", {"entities": [[16, 24, "DISEASE"]]}], ["Colonic biopsies from patients with IBS demonstrate considerable increase in the number of degranulating MCs releasing histamine in proximity to nerves, and this event may underlie the common IBS symptom of abdominal pain.", {"entities": []}], ["Pharmacologic control of MC activation and mediator release is a current area of active interest in the field of IBS research.", {"entities": []}], ["Recently, we and Pearson et al described 2 cases of patients with IBS with diarrhea (IBS-D) showing positive clinical response to omalizumab.", {"entities": [[75, 83, "DISEASE"]]}], ["In both cases, the female patients had severe, long-lasting IBS-D and achieved an almost complete resolution of IBS symptoms.", {"entities": []}], ["Both patients were also able to discontinue all IBS medications after commencing the anti-IgE therapy.", {"entities": []}], ["For both patients, the omalizumab treatment showed a relatively rapid onset of action, resembling the efficacy observed in and previously reported for patients with chronic spontaneous urticaria.", {"entities": [[185, 194, "DISEASE"]]}], ["In this Editorial, we discuss the possible biological mechanisms that may underlie the clinical efficacy of omalizumab in IBS.", {"entities": []}], ["We suggest that there is a need for a well-designed prospective study to investigate the therapeutic effects of anti-IgE in IBS.", {"entities": []}], ["It is suspected that bone marrow (BM) microenvironmental factors may influence the evolution of chronic myeloid leukaemia (CML).", {"entities": []}], ["In this study, we postulated that adipocytes and lipids could be involved in the progression of CML.", {"entities": []}], ["To test this hypothesis, adipocytes were co-cultured with two BCR-ABL positive cell lines (PCMDS and K562).", {"entities": []}], ["T cell (Jurkat) and stroma cell (HS-5) lines were used as controls.", {"entities": []}], ["In the second set of experiments, leukemic cell lines were treated with stearic, oleic, linoleic or \u03b1-linolenic acids in presence or absence of leptin.", {"entities": []}], ["Survival, proliferation, leptin production, OB-R isoforms (OB-Ra and OB-Rb), phosphoinositide 3-kinase (PI3k) and BCL-2 expression have been tested after 24h, 48h and 72h of treatment.", {"entities": []}], ["Our results showed that adipocytes induced a decrease of CML proliferation and an increase in lipid accumulation in leukemic cells.", {"entities": []}], ["In addition, CML cell lines induced adipocytes cell death.", {"entities": []}], ["Chromatography analysis showed that BM microenvironment cells were full of saturated (SFA) and monounsaturated (MUFA) fatty acids, fatty acids that protect tumor cells against external agents.", {"entities": []}], ["Stearic acid increased Bcl-2 expression in PCMDS, whereas oleic and linoleic acids had no effects.", {"entities": []}], ["In contrast, \u03b1-linolenic acid decreased the proliferation and the survival of CML cell lines as well as BCL-2 and OB-R expression.", {"entities": []}], ["The effect of \u03b1-linolenic acids seemed to be due to PI3K pathway and Bcl-2 inhibition.", {"entities": []}], ["Leptin production was detected in the co-culture medium.", {"entities": []}], ["In the presence of leptin, the effect of \u03b1-linolenic acid on proliferation, survival, OB-R and BCl-2 expression was reduced.", {"entities": []}], ["Self-medication is a universal challenge that requires attention because of the potential threat not only to the pregnant women but also to unborn child.", {"entities": []}], ["Data on self-medication practice and predictors among pregnant women is lacking in Tanzania.", {"entities": []}], ["Information on the effects of this practice to the pregnant woman and the foetus globally is also scanty.", {"entities": []}], ["This was a cross sectional study which was conducted using face to face interview with 372 pregnant women at Makongoro health centre.", {"entities": []}], ["Semi-structured questionnaires were used.", {"entities": []}], ["Data were analysed using STATA 13 (Statistical Corporation, College Station, Texas, US).", {"entities": []}], ["A total of 372 pregnant women participated in the study.", {"entities": []}], ["The prevalence of self-medication among pregnant women was 172 (46.24%).", {"entities": []}], ["There was a significant statistical association between self-medication and occupation ( P value =0.01), gestation age ( P \u2009<\u20090.01) and education ( P \u2009<\u20090.01).", {"entities": []}], ["Age, marital status and gravidity were not associated with self-medication ( P \u2009=\u20090.809, P \u2009=\u20090.243 and P \u2009=\u20090.922) respectively.", {"entities": []}], ["When bivariate logistic regression was performed, occupation and education were the only determining factors for self-medication.", {"entities": []}], ["Pregnant women who were unemployed, doing business and house wife were most likely to practice self-medication than employed pregnant women ( P \u2009=\u20090.03; OR\u2009=\u20092.33; 95% CI, 1.06\u20135.31, P \u2009=\u20090.01; OR\u2009=\u20092.31; CI 1.21\u20134.41, P \u2009=\u2009<0.01, OR\u2009=\u20092.73, 95% CI 0.52\u20132.43) respectively.", {"entities": []}], ["Pregnant women with no formal education, incomplete primary education, primary education and secondary education were most likely to practice self-medication than pregnant women with college or university education ( P \u2009<\u20090.01, OR\u2009=\u20096.37 95% CI 2.37\u201319.03, P \u2009<\u20090.01, OR\u2009=\u20096.58, 95% CI 2.36\u201318.25, P \u2009<\u20090.01, OR\u2009=\u20093.78, 95% CI 1.89\u20137.56, P \u2009<\u20090.01, OR\u2009=\u20092.59 95% CI\u2009=\u20091.30\u20135.17).", {"entities": []}], ["The leading illness/symptoms which led to self-medication among pregnant women attending clinic were malaria 56 (32.56%, morning sickness 44 (25.55%) and headache 33(19.19%).", {"entities": [[101, 108, "DISEASE"]]}], ["Drugs commonly used in self-medication among pregnant women were ant malarial 42 (24.42%), antiemetics 59 (34.30%) and analgesics 33 (19.19%).", {"entities": []}], ["Prevalence of self-medication among pregnant women is high in Tanzania.", {"entities": []}], ["This is a threat to the safety of the developing foetus and the pregnant woman.", {"entities": []}], ["Therefore there is a need of interventions to minimize the practice among pregnant women.", {"entities": []}], ["The online version of this article (10.1186/s12884-017-1642-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The duration of influenza virus shedding in HIV-infected adults is unknown and could affect quarantine and treatment recommendations.", {"entities": [[16, 25, "DISEASE"]]}], ["Participants were monitored for influenza-like illness (ILI), defined as fever and cough or sore throat, using weekly telephone audio computer-assisted self-interviews.", {"entities": [[32, 41, "DISEASE"]]}], ["Those with ILI were further evaluated at three HIV specialty clinics.", {"entities": []}], ["For those with influenza, we collected nasopharyngeal washes every 3 days after the date of confirmed influenza infection for 21\u201328 days; specimens underwent reverse transcriptase - polymerase chain reaction (RT-PCR) and viral culture.", {"entities": [[15, 24, "DISEASE"], [102, 111, "DISEASE"]]}], ["Duration of influenza virus shedding was the interval from the date of onset (day 0) of ILI to the date of last culture-positive specimen.", {"entities": [[12, 21, "DISEASE"]]}], ["Characteristics were compared between patients with and without influenza using Fisher's exact test.", {"entities": [[64, 73, "DISEASE"]]}], ["We used the Wilcoxon rank-sum test to examine factors that may have affected influenza virus shedding.", {"entities": [[77, 86, "DISEASE"]]}], ["From October 2010 to April 2011, we enrolled 961 participants in syndromic surveillance and diagnosed 20 patients with influenza whose characteristics were as follows: median age 48 years (interquartile range [IQR]: 43\u201353), 60% male, 50% non-Hispanic black, 95% had been prescribed combination highly active antiretroviral therapy (cART), 85% were virologically suppressed (HIV RNA <400 copies/ml), median CD4 cell count 317 cells/mm p \u2009=\u2009.448), HIV viral suppression (2 vs. 6, p \u2009=\u2009.053), and oseltamivir use (5 vs. 0, p \u2009=\u2009.083).", {"entities": [[119, 128, "DISEASE"], [406, 409, "GENE"]]}], ["HIV-infected persons on cART in our study shed influenza virus for a similar duration as that reported for HIV-uninfected persons.", {"entities": [[47, 56, "DISEASE"]]}], ["It is generally accepted that emphysematous lungs are characterized by an increase in the numbers of neutrophils, macrophages, and CD8 We assessed parameters of systemic inflammation in normal individuals (smokers or non-smokers) and in emphysematous subjects with an active smoking history by measuring serum interleukine-6, C-reactive protein, and tumor necrosis factor.", {"entities": []}], ["Expression of perforin, granzyme B, and FasL protein by CD8 Emphysematous smokers had higher levels of serum interleukine-6 than normal subjects.", {"entities": []}], ["Even with the presence of systemic inflammation in emphysematous smokers, the percentage of peripheral CD8 Despite evidence of systemic inflammation, peripheral T lymphocytes of emphysematous smokers did not show higher levels of cytotoxic markers, suggesting that increase of activated T lymphocytes in the emphysematous lung may be due to either activation in the lung or specific peripheral recruitment.", {"entities": []}], ["Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established.", {"entities": [[156, 181, "DISEASE"]]}], ["Here we tested the role of DMN functional connectivity as a general and differential biomarker for predicting treatment outcomes in a large, unmedicated adult sample with MDD.", {"entities": []}], ["Seventy-five MDD outpatients completed fMRI scans before and 8 weeks after randomization to escitalopram, sertraline, or venlafaxine-XR.", {"entities": []}], ["A whole-brain voxel-wise t -test identified profiles of pretreatment intrinsic functional connectivity that distinguished patients who were subsequently classified as remitters or non-remitters at follow-up.", {"entities": []}], ["Connectivity was seeded in the PCC, an important node of the DMN.", {"entities": []}], ["We further characterized differences between remitters, non-remitters, and 31 healthy controls and characterized changes pretreatment to posttreatment.", {"entities": []}], ["Remitters were distinguished from non-remitters by relatively intact connectivity between the PCC and ACC/mPFC, not distinguishable from healthy controls, while non-remitters showed relative hypo-connectivity.", {"entities": []}], ["In validation analyses, we demonstrate that PCC\u2013ACC/mPFC connectivity predicts remission status with >80% cross-validated accuracy.", {"entities": []}], ["In analyses testing whether intrinsic connectivity differentially relates to outcomes for a specific type of antidepressant, interaction models did not survive the corrected threshold.", {"entities": []}], ["Our findings demonstrate that the overall capacity to remit on commonly used antidepressants may depend on intact organization of intrinsic functional connectivity between PCC and ACC/mPFC prior to treatment.", {"entities": []}], ["The findings highlight the potential utility of functional scans for advancing a more precise approach to tailoring antidepressant treatment choices.", {"entities": []}], ["Acute respiratory disorders may lead to sustained alveolar hypoxia with hypercapnia resulting in impaired pulmonary gas exchange.", {"entities": []}], ["Hypoxic pulmonary vasoconstriction (HPV) optimizes gas exchange during local acute (0-30 min), as well as sustained (> 30 min) hypoxia by matching blood perfusion to alveolar ventilation.", {"entities": []}], ["Hypercapnia with acidosis improves pulmonary gas exchange in repetitive conditions of acute hypoxia by potentiating HPV and preventing pulmonary endothelial dysfunction.", {"entities": []}], ["This study investigated, if the beneficial effects of hypercapnia with acidosis are preserved during sustained hypoxia as it occurs, e.g in permissive hypercapnic ventilation in intensive care units.", {"entities": []}], ["Furthermore, the effects of NO synthase inhibitors under such conditions were examined.", {"entities": []}], ["We employed isolated perfused and ventilated rabbit lungs to determine the influence of hypercapnia with or without acidosis (pH corrected with sodium bicarbonate), and inhibitors of endothelial as well as inducible NO synthase on acute or sustained HPV (180 min) and endothelial permeability.", {"entities": []}], ["In hypercapnic acidosis, HPV was intensified in sustained hypoxia, in contrast to hypercapnia without acidosis when HPV was amplified during both phases.", {"entities": []}], ["This increase disappeared after administration of 1400 W. Hypercapnia with and without acidosis increased HPV during conditions of sustained hypoxia.", {"entities": []}], ["The increase of sustained HPV and endothelial permeability in hypoxic hypercapnia without acidosis was iNOS dependent.", {"entities": []}], ["Wood smoke exposure is a risk factor for COPD.", {"entities": []}], ["For a given degree of airway obstruction, the reduction in DLCO is smaller in individuals with wood smoke-related COPD than in those with smoking-related COPD, suggesting that there is less emphysema in the former.", {"entities": []}], ["The objective of this study was to compare HRCT findings between women with wood smoke-related COPD and women with smoking-related COPD.", {"entities": []}], ["Twenty-two women with severe COPD (FEV 1 /FVC ratio < 70% and FEV 1 < 50%) were divided into two groups: those with wood smoke-related COPD (n = 12) and those with smoking-related COPD (n = 10).", {"entities": [[35, 38, "GENE"], [62, 65, "GENE"], [35, 38, "GENE"], [62, 65, "GENE"]]}], ["The two groups were compared regarding emphysema scores and airway involvement (as determined by HRCT); and functional abnormalities-spirometry results, DLCO, alveolar volume (VA), the DLCO/VA ratio, lung volumes, and specific airway resistance (sRaw).", {"entities": []}], ["There were no significant differences between the two groups in terms of FEV 1 , sRaw, or lung hyperinflation.", {"entities": [[73, 76, "GENE"]]}], ["Decreases in DLCO and in the DLCO/VA ratio were greater in the smoking-related COPD group subjects, who also had higher emphysema scores, in comparison with the wood smoke-related COPD group subjects.", {"entities": []}], ["In the wood smoke-related COPD group, HRCT scans showed no significant emphysema, the main findings being peribronchial thickening, bronchial dilation, and subsegmental atelectasis.", {"entities": []}], ["Female patients with severe wood smoke-related COPD do not appear to develop emphysema, although they do show severe airway involvement.", {"entities": []}], ["The reduction in DLCO and VA, with a normal DLCO/VA ratio, is probably due to severe bronchial obstruction and incomplete mixing of inspired gas during the determination of single-breath DLCO.", {"entities": []}], ["Underdiagnosis of chronic obstructive pulmonary disease (COPD) in primary care can be improved by a more efficient screening strategy.", {"entities": [[18, 55, "DISEASE"]]}], ["To evaluate a three-step method of screening for COPD consisting of an initial short questionnaire followed by measurement of forced expiratory volume in 1s/forced expiratory volume in 6s (FEV 1 /FEV 6 ) using an inexpensive pocket spirometer in those with high risk, and diagnostic quality spirometry in those with a low FEV 1 /FEV 6 .", {"entities": [[189, 192, "GENE"], [196, 199, "GENE"], [322, 325, "GENE"], [329, 332, "GENE"], [189, 192, "GENE"], [196, 199, "GENE"], [322, 325, "GENE"], [329, 332, "GENE"]]}], ["We analysed two related Mexico City cross-sectional samples.", {"entities": []}], ["The 2003 Mexico City PLATINO survey ( n =542) was used to develop a short questionnaire to determine the risk of COPD and a 2010 survey ( n =737) additionally used a pocket spirometer.", {"entities": []}], ["The discriminatory power of the two instruments was assessed with receiver operator characteristic (ROC) curves using three COPD definitions.", {"entities": []}], ["The developed COPD scale included two variables from a simple questionnaire and, in ROC analysis, an area under the curve (AUC) between 0.64 and 0.77 was found to detect COPD.", {"entities": []}], ["The pocket spirometer had an AUC between 0.85 and 0.88 to detect COPD.", {"entities": []}], ["Using the COPD scale as a first screening step excluded 35\u201348% of the total population from further testing at the cost of not detecting 8\u201318% of those with COPD.", {"entities": []}], ["Using the pocket spirometer and sending those with a FEV 1 /FEV 6 <0.80 for diagnostic quality spirometry is very efficient, and substantially improved the positive predictive value at the cost of not detecting one-third of COPD cases.", {"entities": [[53, 56, "GENE"], [60, 63, "GENE"]]}], ["A three-step screening strategy for COPD substantially reduces the need for spirometry testing when only a COPD scale is used for screening.", {"entities": []}], ["Occupational asthma and chronic obstructive pulmonary disease (COPD) are associated with the airway inflammatory process.", {"entities": [[24, 61, "DISEASE"], [13, 19, "DISEASE"]]}], ["The aim of this study was to compare the sputum and serum markers of inflammation in patients with occupational asthma and COPD.", {"entities": [[112, 118, "DISEASE"]]}], ["The study group included 20 patients with stable COPD, 24 patients with asthma, and 22 healthy subjects.", {"entities": [[72, 78, "DISEASE"]]}], ["Interleukin (IL)-6, IL-1\u03b2, tumor necrosis factor (TNF)-\u03b1, matrix metalloproteinase (MMP)-9 levels in serum and induced sputum as well as fibrinogen and CRP in serum were determined in all the subjects.", {"entities": [[50, 53, "GENE"], [152, 155, "GENE"]]}], ["Higher concentrations of IL-1\u03b2, IL-6, TNF-\u03b1, and MMP-9 in induced sputum and an increased concentration of acute-phase proteins in serum were observed in COPD patients compared with healthy subjects.", {"entities": []}], ["Higher concentrations of IL-1\u03b2 and MMP-9 in induced sputum and a higher concentration of C-reactive protein (CRP) were detected in COPD patients than in asthmatic subjects.", {"entities": [[109, 112, "GENE"]]}], ["Never smokers with COPD had significantly higher levels of IL-1\u03b2 and MMP-9 in induced sputum than never smoker controls.", {"entities": []}], ["There was no significant difference between the serum and sputum levels of cytokines and MMP-9 of never smokers and smokers with COPD.", {"entities": []}], ["Higher concentrations of IL-1\u03b2 and MMP-9 in induced sputum and a higher concentration of CRP in serum allow distinguishing between biomarker profiles of COPD patients and asthmatic patients.", {"entities": [[89, 92, "GENE"]]}], ["Occupational exposure induces a systemic proinflammatory state with increased levels of acute-phase proteins in stable COPD patients.", {"entities": []}], ["MMP-9 and IL-1\u03b2 concentrations are increased in induced sputum of never smokers with COPD, which is associated with occupational exposure.", {"entities": []}], ["Benefits of online learning in the health sector have been demonstrated in previous studies.", {"entities": []}], ["We examined the potential benefits of a joint web-based curriculum on atopic eczema for health personnel.", {"entities": []}], ["Enrolled doctors and nurses had access to the curriculum for 8 weeks.", {"entities": []}], ["After the course learners completed a questionnaire.", {"entities": []}], ["Two dermatologists rated the quality of the submitted homework assignments.", {"entities": []}], ["Based on data from the project's budget and the Norwegian Medical Association, we estimated the saved travel expenses.", {"entities": []}], ["Eighty-eight learners (46 doctors) registered for the course.", {"entities": []}], ["We received 55 questionnaires (response rate 63%).", {"entities": []}], ["Twenty-seven learners (31%; 16 doctors, 11 nurses; \u03c7 Doctors and nurses were equally satisfied with a joint web-based course on atopic eczema.", {"entities": []}], ["The use of an online discussion forum was limited but similar between doctors and nurses.", {"entities": []}], ["There were no significant differences in the quality of submitted homework assignments.", {"entities": []}], ["The cost of developing the course was 716 841 NOK and the first 86 learners saved 455 198 NOK in travel expenses.", {"entities": []}], ["The Council of the European Union (EU) has recommended that action should be taken to increase influenza vaccination in the elderly population.", {"entities": [[95, 104, "DISEASE"]]}], ["The aims were to systematically review and critically appraise economic evaluations for influenza vaccination in the elderly population in the EU.", {"entities": [[88, 97, "DISEASE"]]}], ["Electronic searches of the NHS Economic Evaluation, Health Technology Assessment, MEDLINE and Embase databases were run to identify full economic evaluations.", {"entities": [[27, 30, "GENE"]]}], ["Two levels of screening were used, with explicit inclusion criteria applied by two independent reviewers at each stage.", {"entities": []}], ["Prespecified data extraction and critical appraisal were performed on identified studies.", {"entities": []}], ["Results were summarised qualitatively.", {"entities": []}], ["Of the 326 search results, screening identified eight relevant studies.", {"entities": []}], ["Results varied widely, with the incremental cost-effectiveness ratio ranging from being both more effective and cheaper than no intervention to costing \u20ac4\u200959\u2009350 per life-year gained.", {"entities": []}], ["Cost-effectiveness was most sensitive to variations in influenza strain, vaccination type and strategy, population and modelling characteristics.", {"entities": [[55, 64, "DISEASE"]]}], ["Most studies suggest that vaccination is cost-effective (seven of eight studies identified at least one cost-effective scenario).", {"entities": []}], ["All but one study used economic models to synthesise data from different sources.", {"entities": []}], ["The results are uncertain due to the methods used and the relevance and robustness of the data used.", {"entities": []}], ["Sensitivity analysis to explore these aspects was limited.", {"entities": []}], ["Integrated, controlled prospective clinical and economic evaluations and surveillance data are needed to improve the evidence base.", {"entities": []}], ["This would allow more advanced modelling techniques to characterise the epidemiology of influenza more accurately and improve the robustness of cost-effectiveness estimates.", {"entities": [[88, 97, "DISEASE"]]}], ["Mobile phones have become nearly ubiquitous, offering a promising means to deliver health interventions.", {"entities": []}], ["However, little is known about smartphone applications (apps) for cancer.", {"entities": [[66, 72, "DISEASE"]]}], ["The purpose of this study was to characterize the purpose and content of cancer-focused smartphone apps available for use by the general public and the evidence on their utility or effectiveness.", {"entities": [[73, 79, "DISEASE"]]}], ["We conducted a systematic review of the official application stores for the four major smartphone platforms: iPhone, Android, Nokia, and BlackBerry.", {"entities": []}], ["Apps were included in the review if they were focused on cancer and available for use by the general public.", {"entities": [[57, 63, "DISEASE"]]}], ["This was complemented by a systematic review of literature from MEDLINE, Embase, and the Cochrane Library to identify evaluations of cancer-related smartphone apps.", {"entities": [[133, 139, "DISEASE"]]}], ["A total of 295 apps from the smartphone app stores met the inclusion criteria.", {"entities": [[40, 43, "GENE"]]}], ["The majority of apps targeted breast cancer (46.8%, 138/295) or cancer in general (28.5%, 84/295).", {"entities": [[30, 43, "DISEASE"], [37, 43, "DISEASE"], [64, 70, "DISEASE"]]}], ["The reported app purpose was predominantly to raise awareness about cancer (32.2%, 95/295) or to provide educational information about cancer (26.4%, 78/295), followed by apps to support fundraising efforts (12.9%, 38/295), assist in early detection (11.5%, 34/295), promote a charitable organization (10.2%, 30/295), support disease management (3.7%, 11/295), cancer prevention (2.0%, 6/295), or social support (1.0%, 3/295).", {"entities": [[68, 74, "DISEASE"], [135, 141, "DISEASE"], [361, 367, "DISEASE"], [13, 16, "GENE"]]}], ["The majority of the apps did not describe their organizational affiliation (64.1%, 189/295).", {"entities": []}], ["Apps affiliated with non-profit organizations were more likely to be free of cost (\u03c7 1 =16.3, P <.001) and have a fundraising or awareness purpose (\u03c7 2 =13.3, P =.001).", {"entities": []}], ["The review of the health literature yielded 594 articles, none of which reported an evaluation of a cancer-focused smartphone application.", {"entities": [[100, 106, "DISEASE"]]}], ["There are hundreds of cancer-focused apps with the potential to enhance efforts to promote behavior change, to monitor a host of symptoms and physiological indicators of disease, and to provide real-time supportive interventions, conveniently and at low cost.", {"entities": [[22, 28, "DISEASE"]]}], ["However, there is a lack of evidence on their utility, effectiveness, and safety.", {"entities": []}], ["Future efforts should focus on improving and consolidating the evidence base into a whitelist for public consumption.", {"entities": []}], ["Recurrent acute otitis media (rAOM, recurrent ear infection) is a common childhood disease caused by bacteria termed otopathogens, for which current treatments have limited effectiveness.", {"entities": [[16, 28, "DISEASE"]]}], ["Generic probiotic therapies have shown promise, but seem to lack specificity.", {"entities": []}], ["We hypothesised that healthy children with no history of AOM carry protective commensal bacteria that could be translated into a specific probiotic therapy to break the cycle of re-infection.", {"entities": []}], ["We characterised the nasopharyngeal microbiome of these children (controls) in comparison to children with rAOM (cases) to identify potentially protective bacteria.", {"entities": []}], ["As some children with rAOM do not appear to carry any of the known otopathogens, we also hypothesised that characterisation of the middle ear microbiome could identify novel otopathogens, which may also guide the development of more effective therapies.", {"entities": []}], ["Middle ear fluids, middle ear rinses and ear canal swabs from the cases and nasopharyngeal swabs from both groups underwent 16S rRNA gene sequencing.", {"entities": []}], ["The nasopharyngeal microbiomes of cases and controls were distinct.", {"entities": []}], ["We observed a significantly higher abundance of Corynebacterium and Dolosigranulum in the nasopharynx of controls.", {"entities": []}], ["Alloiococcus, Staphylococcus and Turicella were abundant in the middle ear and ear canal of cases, but were uncommon in the nasopharynx of both groups.", {"entities": []}], ["Gemella and Neisseria were characteristic of the case nasopharynx, but were not prevalent in the middle ear.", {"entities": []}], ["Corynebacterium and Dolosigranulum are characteristic of a healthy nasopharyngeal microbiome.", {"entities": []}], ["Alloiococcus, Staphylococcus and Turicella are possible novel otopathogens, though their rarity in the nasopharynx and prevalence in the ear canal means that their role as normal aural flora cannot be ruled out.", {"entities": []}], ["Gemella and Neisseria are unlikely to be novel otopathogens as they do not appear to colonise the middle ear in children with rAOM.", {"entities": []}], ["The online version of this article (10.1186/s12866-018-1154-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["It would be of considerable interest to clinicians if the burden of chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA) in India were known.", {"entities": [[86, 99, "DISEASE"], [136, 149, "DISEASE"], [110, 149, "DISEASE"]]}], ["Herein, we estimate the burden of CPA following pulmonary tuberculosis (PTB), and ABPA (and severe asthma with fungal sensitization [SAFS]) complicating asthma.", {"entities": [[58, 70, "DISEASE"], [99, 105, "DISEASE"], [153, 159, "DISEASE"], [48, 70, "DISEASE"]]}], ["We used the population estimates for India from the 2011 census data.", {"entities": []}], ["The burden of asthma was estimated using three different methods (Global Initiative against Asthma [GINA] report statement, World Health Survey [WHS] estimates, Indian study on the epidemiology of asthma and chronic bronchitis [INSEARCH]).", {"entities": [[14, 20, "DISEASE"], [92, 98, "DISEASE"], [197, 203, "DISEASE"], [216, 226, "DISEASE"]]}], ["Global and India-specific figures were used for calculating the prevalence of ABPA and SAFS.", {"entities": []}], ["The World Health Organization estimates were used for calculating PTB rates while the frequency of CPA was assessed from a previously published scoping review.", {"entities": []}], ["Sensitivity analysis was performed to determine the burden in various scenarios.", {"entities": []}], ["The total Indian population in 2011 was 1.2 billion.", {"entities": []}], ["The asthma prevalence in adults was estimated at about 27.6 (range, 17\u201330) million.", {"entities": [[4, 10, "DISEASE"]]}], ["The burden of ABPA ranged from 0.12\u20136.09 million with different assumptions (best estimate, 1.38 [range, 0.86\u20131.52] million).", {"entities": []}], ["The prevalence of SAFS was approximated at about 0.52\u20131.21 million (best estimate, 0.96 [range, 0.6\u20131.06] million).", {"entities": []}], ["The incident TB cases were about 2.1 million while the annual incidence of CPA varied 27,000-0.17 million cases, with different estimates.", {"entities": []}], ["If the mortality of CPA is estimated as 15% annually, the 5-year prevalence of CPA was placed at 290,147 cases with 5-year prevalence rate being 24 per 100,000.", {"entities": []}], ["There is a significant burden of ABPA, SAFS and CPA in India.", {"entities": []}], ["Prospective community-based studies are required to accurately determine the prevalence of these disorders.", {"entities": []}], ["Fifty percent of variability in HIV-1 susceptibility is attributable to host genetics.", {"entities": []}], ["Thus identifying genetic associations is essential to understanding pathogenesis of HIV-1 and important for targeting drug development.", {"entities": []}], ["To date, however, CCR5 remains the only gene conclusively associated with HIV acquisition.", {"entities": [[18, 22, "GENE"]]}], ["To identify novel host genetic determinants of HIV-1 acquisition, we conducted a genome-wide association study among a high-risk sample of 3,136 injection drug users (IDUs) from the Urban Health Study (UHS).", {"entities": []}], ["In addition to being IDUs, HIV- controls were frequency-matched to cases on environmental exposures to enhance detection of genetic effects.", {"entities": []}], ["We tested independent replication in the Women\u2019s Interagency HIV Study (N=2,533).", {"entities": []}], ["We also examined publicly available gene expression data to link SNPs associated with HIV acquisition to known mechanisms affecting HIV replication/infectivity.", {"entities": []}], ["Analysis of the UHS nominated eight genetic regions for replication testing.", {"entities": []}], ["SNP rs4878712 in FRMPD1 met multiple testing correction for independent replication (P=1.38x10 FBXO10 (r=-0.49, P=6.9x10 FBXO10 is a component of the Skp1-Cul1-F-box protein E3 ubiquitin ligase complex that targets Bcl-2 protein for degradation; (3) lower FBXO10 expression was associated with higher BCL2 expression (r=-0.49, P=8x10 in vitro studies.", {"entities": [[17, 23, "GENE"], [95, 101, "GENE"], [121, 127, "GENE"], [256, 262, "GENE"], [95, 101, "GENE"], [121, 127, "GENE"], [256, 262, "GENE"], [95, 101, "GENE"], [121, 127, "GENE"], [256, 262, "GENE"], [301, 305, "GENE"]]}], ["These results suggest new potential biological pathways by which host genetics affect susceptibility to HIV upon exposure for follow-up in subsequent studies.", {"entities": []}], ["We have identified a novel mAb, SG31, which recognizes the mouse integrin \u03b14 subunit.", {"entities": []}], ["Unlike the epitopes recognized by other anti-\u03b14 antibodies, the SG31 epitope is expressed on subpopulations of thymocytes and peripheral T cells.", {"entities": []}], ["After manganese ion, but not phorbol myristic acetate activation, the epitope is induced and expressed on the majority of peripheral T cells.", {"entities": []}], ["These data suggest that the SG31 epitope is an activation epitope and that manganese ions activate \u03b14 integrins by inducing a conformational change.", {"entities": []}], ["Comparative flow cytometric analyses showed that the SG31 epitope as well as the epitope detected by other anti-\u03b14 antibodies is expressed on all B lineage cells.", {"entities": []}], ["In the T lineage, expression of the \u03b14 integrins is down-regulated during thymocyte development.", {"entities": []}], ["Although mature thymocytes still express the \u03b14 integrins, they lose almost entirely the activation epitope recognized by SG31.", {"entities": []}], ["In contrast, the most immature thymocytes express high levels of this epitope.", {"entities": []}], ["In the periphery, SG31 epitope is expressed mostly by activated T cells, in contrast to the overall population of T cells that express the \u03b14 integrins at homogenous levels.", {"entities": []}], ["These results suggest that the activation of the \u03b14 integrins is parallel to that of T cells.", {"entities": []}], ["Text messaging (short message service, SMS) is a widely accessible and potentially cost-effective medium for encouraging behavior change.", {"entities": [[39, 42, "GENE"]]}], ["Few studies have examined text messaging interventions to influence child health behaviors or explored parental perceptions of mobile technologies to support behavior change among children.", {"entities": []}], ["Our aim was to examine parental acceptability and preferences for text messaging to support pediatric obesity-related behavior change.", {"entities": [[102, 109, "DISEASE"]]}], ["We conducted focus groups and follow-up interviews with parents of overweight and obese children, aged 6-12 years, seen for \u201cwell-child\u201d care in eastern Massachusetts.", {"entities": []}], ["A professional moderator used a semistructured discussion guide and sample text messages to catalyze group discussions.", {"entities": []}], ["Seven participants then received 3 weeks of text messages before a follow-up one-on-one telephone interview.", {"entities": []}], ["All focus groups and interviews were recorded and transcribed verbatim.", {"entities": []}], ["Using a framework analysis approach, we systematically coded and analyzed group and interview data to identify salient and convergent themes.", {"entities": []}], ["We reached thematic saturation after five focus groups and seven follow-up interviews with a total of 31 parents of diverse race/ethnicity and education levels.", {"entities": []}], ["Parents were generally enthusiastic about receiving text messages to support healthy behaviors for their children and preferred them to paper or email communication because they are brief and difficult to ignore.", {"entities": []}], ["Participants anticipated high responsiveness to messaging endorsed by their child\u2019s doctor and indicated they would appreciate messages 2-3 times/week or more as long as content remains relevant.", {"entities": []}], ["Suggestions for maintaining message relevance included providing specific strategies for implementation and personalizing information.", {"entities": []}], ["Most felt the negative features of text messaging (eg, limited message size) could be overcome by providing links within messages to other media including email or websites.", {"entities": []}], ["Text messaging is a promising medium for supporting pediatric obesity-related behavior change.", {"entities": [[62, 69, "DISEASE"]]}], ["Parent perspectives could assist in the design of text-based interventions.", {"entities": []}], ["Clinicaltrials.gov NCT01565161; http://clinicaltrials.gov/show/NCT01565161 (Archived by WebCite at http://www.webcitation.org/6LSaqFyPP).", {"entities": []}], ["We recently advocated in favour of naming a novel H2- haplotype consisting of K H2- haplotype in AD development was investigated in H2 h2 h2 h2 h2 h2 h2 h2", {"entities": []}], ["After Peripheral nerve injuries (PNI), many complicated pathophysiologic processes will happen.", {"entities": []}], ["A global view of functional changes following PNI is essential for the looking for the adequate therapeutic approaches.", {"entities": []}], ["In this study, we performed an in-depth analysis on the temporal expression profiles after sciatic nerve injury by bioinformatic methods, including (1) cluster analysis of the samples; (2) identification of gene co-expression modules(CEMs) correlated with the time points; (3) analysis of differentially expressed genes at each time point (DEGs-ET); (4) analysis of differentially expressed genes varying over time (DEGs-OT); (5) creating Pairwise Correlation Plot for the samples; (6) Time Series Regression Analysis; (7) Determining the pathway, GO (gene ontology) and drug by enrichment analysis.", {"entities": []}], ["We found that at a 3\u2009h \u201cwindow period\u201d some specific gene expression may exist after PNI, and responses to lipopolysaccharide (LPS) and TNF signaling pathway may play important roles, suggesting that the inflammatory microenvironment exists after PNI.", {"entities": [[136, 139, "GENE"]]}], ["We also found that troglitazone was closely associated with the change of gene expression after PNI.", {"entities": []}], ["Therefore, the further evaluation of the precise mechanism of troglitazone on PNI is needed and it may contribute to the development of new drugs for patients with PNI.", {"entities": []}], ["The National Health and Nutrition Examination Survey (NHANES) is one example of cross-sectional datasets that have been used to draw causal inferences regarding environmental chemical exposures and adverse health outcomes.", {"entities": []}], ["Our objectives were to analyze four NHANES datasets using consistent a priori selected methods to address the following questions: Is there a consistent association between urinary bisphenol A (BPA) measures and diabetes, coronary heart disease (CHD), and/or heart attack across surveys?", {"entities": [[231, 244, "DISEASE"], [222, 244, "DISEASE"]]}], ["Is NHANES an appropriate dataset for investigating associations between chemicals with short physiologic half-lives such as BPA and chronic diseases with multi-factorial etiologies?", {"entities": []}], ["Data on urinary BPA and health outcomes from 2003\u20132004, 2005\u20132006, 2007\u20132008, and 2009\u20132010 were available.", {"entities": []}], ["Regression models were adjusted for creatinine, age, gender, race/ethnicity, education, income, smoking, heavy drinking, BMI, waist circumference, calorie intake, family history of heart attack, hypertension, sedentary time, and total cholesterol.", {"entities": [[195, 207, "DISEASE"]]}], ["Urinary BPA was not significantly associated with adverse health outcomes for any of the NHANES surveys, with ORs (95% CIs) ranging from 0.996 (0.951\u20131.04) to 1.03 (0.978\u20131.09) for CHD, 0.987 (0.941\u20131.04) to 1.04 (0.996\u20131.09) for heart attack, and 0.957 (0.899\u20131.02) to 1.01 (0.980\u20131.05) for diabetes.", {"entities": []}], ["Using scientifically and clinically supportable exclusion criteria and outcome definitions, we consistently found no associations between urinary BPA and heart disease or diabetes.", {"entities": [[154, 167, "DISEASE"]]}], ["These results do not support associations and causal inferences reported in previous studies that used different criteria and definitions.", {"entities": []}], ["We are not drawing conclusions regarding whether BPA is a risk factor for these diseases.", {"entities": []}], ["We are stating the opposite\u2013that using cross-sectional datasets like NHANES to draw such conclusions about short-lived environmental chemicals and chronic complex diseases is inappropriate.", {"entities": []}], ["We need to expend resources on appropriately designed epidemiologic studies and toxicological explorations to understand whether these types of chemicals play a causal role in chronic diseases.", {"entities": []}], ["Small airway fibrosis is the main contributor in airflow obstruction in chronic obstructive pulmonary disease.", {"entities": [[72, 109, "DISEASE"]]}], ["Epithelial mesenchymal transition (EMT) has been implicated in this process, and in large airways, is associated with angiogenesis, ie, Type-3, which is classically promalignant.", {"entities": []}], ["In this study we have investigated whether EMT biomarkers are expressed in small airways compared to large airways in subjects with chronic airflow limitation (CAL) and what type of EMT is present on the basis of vascularity.", {"entities": []}], ["We evaluated epithelial activation, reticular basement membrane fragmentation (core structural EMT marker) and EMT-related mesenchymal biomarkers in small and large airways from resected lung tissue from 18 lung cancer patients with CAL and 9 normal controls.", {"entities": [[207, 218, "DISEASE"], [212, 218, "DISEASE"]]}], ["Tissues were immunostained for epidermal growth factor receptor (EGFR; epithelial activation marker), vimentin (mesenchymal marker), and S100A4 (fibroblast epitope).", {"entities": [[65, 69, "GENE"], [137, 143, "GENE"]]}], ["Type-IV collagen was stained to demonstrate vessels.", {"entities": []}], ["There was increased expression of EMT-related markers in CAL small airways compared to controls: EGFR ( P <0.001), vimentin ( P <0.001), S100A4 ( P <0.001), and fragmentation ( P <0.001), but this was less than that in large airways.", {"entities": [[97, 101, "GENE"], [137, 143, "GENE"]]}], ["Notably, there was no hypervascularity in small airway reticular basement membrane as in large airways.", {"entities": []}], ["Epithelial activation and S100A4 expression were related to airflow obstruction.", {"entities": [[26, 32, "GENE"]]}], ["EMT is active in small airways, but less so than in large airways in CAL, and may be relevant to the key pathologies of chronic obstructive pulmonary disease, small airway fibrosis, and airway cancers.", {"entities": [[120, 157, "DISEASE"]]}], ["Many candidate genes have been studied for asthma, but replication has varied.", {"entities": [[43, 49, "DISEASE"]]}], ["Novel candidate genes have been identified for various complex diseases using genome-wide association studies (GWASs).", {"entities": []}], ["We conducted a GWAS in 492 Mexican children with asthma, predominantly atopic by skin prick test, and their parents using the Illumina HumanHap 550 K BeadChip to identify novel genetic variation for childhood asthma.", {"entities": [[49, 55, "DISEASE"], [209, 215, "DISEASE"]]}], ["The 520,767 autosomal single nucleotide polymorphisms (SNPs) passing quality control were tested for association with childhood asthma using log-linear regression with a log-additive risk model.", {"entities": [[128, 134, "DISEASE"]]}], ["Eleven of the most significantly associated GWAS SNPs were tested for replication in an independent study of 177 Mexican case\u2013parent trios with childhood-onset asthma and atopy using log-linear analysis.", {"entities": [[160, 166, "DISEASE"]]}], ["The chromosome 9q21.31 SNP rs2378383 (p\u200a=\u200a7.10\u00d710 transducin-like enhancer of split 4 (TLE4) , gave a p-value of 0.03 and the same direction and magnitude of association in the replication study (combined p\u200a=\u200a6.79\u00d710 Asthma is a leading chronic childhood disease with a presumed strong genetic component, but no genes have been definitely shown to influence asthma development.", {"entities": [[217, 223, "DISEASE"], [358, 364, "DISEASE"], [87, 91, "GENE"]]}], ["Few genetic studies of asthma have included Hispanic populations.", {"entities": [[23, 29, "DISEASE"]]}], ["Here, we conducted a genome-wide association study of asthma in 492 Mexican children with asthma, predominantly atopic by skin prick test, and their parents to identify novel genetic variation for childhood asthma.", {"entities": [[54, 60, "DISEASE"], [90, 96, "DISEASE"], [207, 213, "DISEASE"]]}], ["We implicated several polymorphisms in or near TLE4 on chromosome 9q21.31 (a novel candidate region for childhood asthma) and replicated one polymorphism in an independent study of childhood-onset asthmatics with atopy and their parents of Mexican ethnicity.", {"entities": [[114, 120, "DISEASE"], [47, 51, "GENE"]]}], ["Hispanics have differing proportions of Native American, European, and African ancestries, and we found less Native American ancestry than expected at chromosome 9q21.31.", {"entities": []}], ["This suggests that chromosome 9q21.31 may underlie ethnic differences in childhood asthma and that future replication would be most effective in populations with Native American ancestry.", {"entities": [[83, 89, "DISEASE"]]}], ["Analysis of publicly available genome-wide expression data revealed that association signals in genes expressed in the lung differed most significantly from genes not expressed in the lung when compared to 50 other tissues, supporting the biological plausibility of the overall GWAS findings and the multigenic etiology of asthma.", {"entities": [[323, 329, "DISEASE"]]}], ["The characteristics of Mycoplasma pneumonia ( M. pneumoniae )-associated bronchiolitis obliterans (BO) are not well known.", {"entities": [[34, 43, "DISEASE"], [73, 97, "DISEASE"], [73, 86, "DISEASE"]]}], ["We retrospectively reviewed 17 patients with M. pneumoniae \u2013associated BO.", {"entities": []}], ["All patients had M. pneumoniae \u2013associated acute bronchiolitis prior to the development of BO.", {"entities": [[49, 62, "DISEASE"]]}], ["In the acute bronchiolitis stage, all patients had fever and cough; six patients also had wheezing and dyspnoea.", {"entities": [[13, 26, "DISEASE"]]}], ["BO was diagnosed approximately 1.5\u20138 months later based on clinical manifestations and chest high-resolution computed tomography (HRCT) findings.", {"entities": []}], ["All patients presented with wheezing and/or dyspnoea at the time of diagnosis of BO.", {"entities": []}], ["HRCT findings included mosaic attenuation, pronounced air trapping, central bronchiectasis and emphysema, according to disease severity.", {"entities": [[76, 90, "DISEASE"]]}], ["Lung function tests revealed mild to severe airway obstruction.", {"entities": []}], ["Fourteen of 17 patients had a greater than 12% increase in forced expiratory volume in 1\u2009second values after taking salbutamol.", {"entities": []}], ["All patients had positive allergy test results and family or personal history of atopic disease.", {"entities": []}], ["Four patients had a history of asthma before M. pneumonia bronchiolitis.", {"entities": [[48, 57, "DISEASE"], [31, 37, "DISEASE"], [58, 71, "DISEASE"]]}], ["Asthma was diagnosed before, at the time of or after the diagnosis of BO in 11 cases.", {"entities": [[0, 6, "DISEASE"]]}], ["M. pneumoniae \u2013associated BO may therefore develop following M. pneumonia bronchiolitis and overlap with asthma.", {"entities": [[64, 73, "DISEASE"], [105, 111, "DISEASE"], [74, 87, "DISEASE"]]}], ["This study aimed to examine the association between different inflammatory markers and specific clinical endpoints in patients with febrile neutropenia.", {"entities": [[140, 151, "DISEASE"]]}], ["We prospectively evaluated the expression of procalcitonin (PCT), interleukin 8 (IL-8), induced protein-10, tumor necrosis factor alpha (TNF-\u03b1), two soluble TNF-\u03b1 receptors (sTNF-R I and sTNF-R II), monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1 alpha, and eotaxin in 37 episodes of febrile neutropenia occurring in 31 hospitalized adult onco-hematologic patients.", {"entities": [[318, 329, "DISEASE"]]}], ["Peripheral blood samples were collected in the morning at inclusion (day of fever onset) and on days 1, 3, and 7 after the onset of fever.", {"entities": []}], ["Approximately 2\u20133 ml of plasma was obtained from each blood sample and stored at -80\u00b0C.", {"entities": []}], ["The sTNF-R II level at inclusion (day 1), the PCT level on the day of fever onset, and the change (day 3 - day 1) in the IL-8 and eotaxin levels were significantly higher in patients who died during the 28-day follow-up.", {"entities": []}], ["A requirement for early adjustment of antimicrobial treatment was associated with higher day 3 levels of IL-8, sTNF-R II, PCT, and MCP-1.", {"entities": []}], ["Procalcitonin, sTNF-R II, IL-8, MCP-1, and eotaxin could potentially be used to assess the risk of death and the requirement for early adjustment of antimicrobial treatment in febrile, neutropenic onco-hematologic patients.", {"entities": []}], ["The levels of the other markers showed no association with any of the evaluated endpoints.", {"entities": []}], ["Asthma patients are enrolled in multimodal pulmonary rehabilitation (PR) programs.", {"entities": [[0, 6, "DISEASE"]]}], ["However, available data for the effectiveness of PR in asthma are sparse.", {"entities": [[55, 61, "DISEASE"]]}], ["Therefore, the primary aim of this randomized control trial (RCT) is to evaluate short-term (end of rehabilitation) and intermediate-term effectiveness (3 months after rehabilitation) of PR for patients with asthma regarding asthma control (primary outcome) and other outcomes.", {"entities": [[208, 214, "DISEASE"], [225, 231, "DISEASE"]]}], ["Secondly, moderator effects of gender, age, baseline asthma control, quality of life, and anxiety will be examined.", {"entities": [[53, 59, "DISEASE"]]}], ["Thirdly, a longitudinal follow-up study will explore the course of the outcomes over one year and the annual costs.", {"entities": []}], ["The EPRA study is a single-center randomized controlled waiting-list trial in the Bad Reichenhall Clinic.", {"entities": []}], ["Inclusion criteria include a referral diagnosis for uncontrolled asthma, no cognitive impairment and no very severe co-morbidities that indicate significantly greater illness morbidity than asthma alone.", {"entities": [[65, 71, "DISEASE"], [190, 196, "DISEASE"]]}], ["In the intervention group (IG), participants will start PR within 4 weeks after randomization; participants of the control group (CG) will start PR 20 weeks after randomization.", {"entities": []}], ["Data will be assessed at randomization (T0), after 4 weeks (T1; IG: begin of PR), 7 weeks (T2; IG: end of PR), and 20 weeks (T3, CG: begin of PR).", {"entities": []}], ["The primary outcome is asthma control at T2/T3.", {"entities": [[23, 29, "DISEASE"]]}], ["Secondary outcomes are health-related quality of life, functional exercise capacity, dyspnea, anxiety, depression, subjective self-management skills, illness perceptions, sick leave and subjective work ability.", {"entities": []}], ["Outcomes will be analyzed with analysis of covariance, including baseline values of the respective outcomes as covariates.", {"entities": []}], ["Healthcare costs will be analyzed with a gamma model with a log-link.", {"entities": []}], ["A longitudinal follow-up study will generate additional data at 3/6/9/12 months after PR for both IG and CG.", {"entities": []}], ["Latent change models will be used to analyze the course of the primary and secondary outcomes.", {"entities": []}], ["Annual cost differences before and after rehabilitation will be compared by paired t-test.", {"entities": []}], ["This RCT will determine the effectiveness of a complex inpatient PR for asthma patients concerning asthma control.", {"entities": [[72, 78, "DISEASE"], [99, 105, "DISEASE"]]}], ["Furthermore, important medical and economic information regarding the effectiveness of PR as part of the long-term management of patients with uncontrolled asthma will be generated.", {"entities": [[156, 162, "DISEASE"]]}], ["German Clinical Trials Register ( DRKS00007740 , May 15, 2015).", {"entities": []}], ["Protocol version: 1.0 (December, 23, 2016).", {"entities": []}], ["The objective was to determine the relative association of social class and neighbourhood deprivation with primary care consultation for eight morbidities.", {"entities": []}], ["In 18 047 survey responders aged \u226550 years, living in more deprived neighbourhoods was independently associated with new consultation for chronic obstructive pulmonary disease, ischaemic heart disease, diabetes, asthma and depression.", {"entities": [[187, 200, "DISEASE"], [138, 175, "DISEASE"], [212, 218, "DISEASE"]]}], ["Lower social class was associated with diabetes and chronic obstructive pulmonary disease.", {"entities": [[52, 89, "DISEASE"]]}], ["No such associations were found with otitis media, osteoarthritis or upper respiratory tract infection.", {"entities": [[37, 49, "DISEASE"], [51, 65, "DISEASE"]]}], ["These findings suggest a role of social environment in certain morbidities and indicate the importance of identifying and acting on neighbourhood deprivation to reduce health inequalities.", {"entities": []}], ["A growing number of studies implicate the microbiome in the pathogenesis of intestinal inflammation.", {"entities": []}], ["Previous work has shown that adults with esophagitis related to gastroesophageal reflux disease have altered esophageal microbiota compared to those who do not have esophagitis.", {"entities": [[41, 52, "DISEASE"], [165, 176, "DISEASE"], [64, 95, "DISEASE"]]}], ["In these studies, sampling of the esophageal microbiome was accomplished by isolating DNA from esophageal biopsies obtained at the time of upper endoscopy.", {"entities": []}], ["The aim of the current study was to identify the esophageal microbiome in pediatric individuals with normal esophageal mucosa using a minimally invasive, capsule-based string technology, the Enterotest\u2122.", {"entities": []}], ["We used the proximal segment of the Enterotest string to sample the esophagus, and term this the \u201cEsophageal String Test\u201d (EST).", {"entities": []}], ["We hypothesized that the less invasive EST would capture mucosal adherent bacteria present in the esophagus in a similar fashion as mucosal biopsy.", {"entities": []}], ["EST samples and mucosal biopsies were collected from children with no esophageal inflammation (n\u200a=\u200a15) and their microbiome composition determined by 16S rRNA gene sequencing.", {"entities": []}], ["Microbiota from esophageal biopsies and ESTs produced nearly identical profiles of bacterial genera and were different from the bacterial contents of samples collected from the nasal and oral cavity.", {"entities": []}], ["We conclude that the minimally invasive EST can serve as a useful device for study of the esophageal microbiome.", {"entities": []}], ["Carbon nanotubes (CNT) represent a great promise for technological and industrial development but serious concerns on their health effects have also emerged.", {"entities": []}], ["Rod-shaped CNT are, in fact, able to induce asbestos-like pathogenicity in mice including granuloma formation in abdominal cavity and sub-pleural fibrosis.", {"entities": []}], ["Exposure to CNT, especially in the occupational context, happens mainly by inhalation.", {"entities": []}], ["However, little is known about the possible effects of CNT on pulmonary allergic diseases, such as asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["We exposed mice by inhalation to two types of multi-walled CNT, rigid rod-like and flexible tangled CNT, for four hours a day once or on four consecutive days.", {"entities": []}], ["Early events were monitored immediately and 24\u00a0hours after the single inhalation exposure and the four day exposure mimicked an occupational work week.", {"entities": []}], ["Mast cell deficient mice were used to evaluate the role of mast cells in the occurring inflammation.", {"entities": []}], ["Here we show that even a short-term inhalation of the rod-like CNT induces novel innate immunity-mediated allergic-like airway inflammation in healthy mice.", {"entities": []}], ["Marked eosinophilia was accompanied by mucus hypersecretion, AHR and the expression of Th2-type cytokines.", {"entities": [[7, 19, "DISEASE"], [61, 64, "GENE"]]}], ["Exploration of the early events by transcriptomics analysis reveals that a single 4-h exposure to rod-shaped CNT, but not to tangled CNT, causes a radical up-regulation of genes involved in innate immunity and cytokine/chemokine pathways.", {"entities": []}], ["Mast cells were found to partially regulate the inflammation caused by rod-like CNT, but also alveaolar macrophages play an important role in the early stages.", {"entities": []}], ["These observations emphasize the diverse abilities of CNT to impact the immune system, and they should be taken into account for hazard assessment.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-014-0048-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Curcumin and capsaicin are dietary xenobiotics with well-documented anti-inflammatory properties.", {"entities": []}], ["Previously, the beneficial effect of these spice principles in lowering chronic inflammation was demonstrated using a rat experimental model for arthritis.", {"entities": [[145, 154, "DISEASE"]]}], ["The extent of lowering of arthritic index by the spice principles was associated with a significant shift in macrophage function favoring the reduction of pro-inflammatory molecules such as reactive oxygen species and production and release of anti-inflammatory metabolites of arachidonic acid.", {"entities": []}], ["Beyond the cellular effects on macrophage function, oral administration of curcumin and capsaicin caused alterations in serum protein profiles of rats injected with adjuvant to develop arthritis.", {"entities": [[185, 194, "DISEASE"]]}], ["Specifically, a 72 kDa acidic glycoprotein, GpA72, which was elevated in pre-arthritic rats, was significantly lowered by feeding either curcumin or capsaicin to the rats.", {"entities": []}], ["Employing the tandem mass spectrometric approach for direct sequencing of peptides, here we report the identification of GpA72 as T-kininogen I also known as Thiostatin.", {"entities": []}], ["Since T-kininogen I is an early acute-phase protein, we additionally tested the efficiency of curcumin and capsaicin to mediate the inflammatory response in an acute phase model.", {"entities": []}], ["The results demonstrate that curcumin and capsaicin lower the acute-phase inflammatory response, the molecular mechanism for which is, in part, mediated by pathways associated with the lowering of T-kininogen I.", {"entities": []}], ["IL-18 has been found to be associated with eczema.", {"entities": []}], ["However, little is known of the role of IL-18 binding protein (BP) and IL-18 receptor (R) in eczema.", {"entities": []}], ["We therefore investigated the expression of IL-18, IL-18BP, and IL-18R on mast cells by using flow cytometry analysis and mouse eczema model.", {"entities": []}], ["The results showed that plasma free IL-18 and free IL-18BP levels in eczema patients were higher than those in healthy controls.", {"entities": []}], ["IL-18 provoked up to 3.1-fold increase in skin mast cells.", {"entities": []}], ["IL-18 induced also an increase in IL-18BP+ mast cells, but a reduction of IL-18R+ mast cells in mouse eczema skin.", {"entities": []}], ["It was found that house dust mite allergen Der p1 and egg allergen OVA induced upregulation of the expression of IL-18, IL-18BP, and IL-18R mRNAs in HMC-1 cells following 2 and 16 h incubation.", {"entities": []}], ["In conclusion, correlation of IL-18 and IL-18BP in eczema plasma suggests an important balance between IL-18 and IL-18BP in eczema.", {"entities": []}], ["The decrease in molar concentration ratio of plasma IL-18BP/IL-18 and allergen-induced upregulated expression of IL-18 and IL-18R in skin mast cells of the patients with eczema suggests that anti-IL-18 including IL-18BP therapy may be useful for the treatment of eczema.", {"entities": []}], ["Ulcerative colitis is a common inflammatory bowel disorder associated with considerable morbidity.", {"entities": [[0, 18, "DISEASE"]]}], ["Its incidence is increasing worldwide.", {"entities": []}], ["While familial aggregation of ulcerative colitis is a common phenomenon, genome-wide association studies, identifying a plethora of associated genes, have failed to reveal a unifying causative pathway.", {"entities": [[30, 48, "DISEASE"]]}], ["The well-documented impact of a number of environmental factors on disease occurrence and natural history suggests a major role for epigenetic events.", {"entities": []}], ["The epigenome-wide association study discussed in this highlight has revealed novel loci linked to colitis and has provided unique insights into the pathophysiology of this disorder information that could translate into new therapeutic approaches.", {"entities": []}], ["1) To estimate the annual cost of patients with stable chronic obstructive pulmonary disease (COPD) followed in primary care in Spain; 2) To analyze the possible cost predictor variables.", {"entities": [[55, 92, "DISEASE"]]}], ["A multicenter, epidemiological, observational, descriptive study.", {"entities": []}], ["Sociodemographic data, severity of disease, associated comorbidity, treatment followed by patients, quality of life (SF-12 questionnaire), health care resource utilization in the previous 12 months and duration of working disability due to COPD were collected.", {"entities": []}], ["A total of 10,711 patients (75.6% men; 24.4% women) with a mean age of 67.1 \u00b1 9.66 years were evaluated.", {"entities": []}], ["The mean forced expiratory volume in one second (FEV 1 ) value was 57.4 \u00b1 13.4%.", {"entities": [[49, 52, "GENE"]]}], ["The total cost per patient per year was \u20ac1,922.60 \u00b1 2,306.44.", {"entities": []}], ["The largest component of this cost was hospitalization (\u20ac788.72 \u00b1 1,766.65), followed by cost of drugs (\u20ac492.87 \u00b1 412.15) and visits to emergency rooms (\u20ac134.32 \u00b1 195.44).", {"entities": []}], ["Linear regression analysis found associated heart disease, FEV 1 , physical component of quality of life, number of medical visits (primary care physician, pneumologist and emergency room), hospital admissions (frequency and duration of stay) and duration of working disability to be significant predictors of the total annual cost.", {"entities": [[44, 57, "DISEASE"], [59, 62, "GENE"]]}], ["The total annual cost of a COPD patient followed in primary care in Spain was considered high in this study.", {"entities": []}], ["The presence of associated heart disease, severity of airflow obstruction, physical component of quality of life, health care resource utilization and duration of work disability were found to be predictor of cost.", {"entities": [[27, 40, "DISEASE"]]}], ["Despite major advances in research on acute stroke care interventions, relatively few stroke patients benefit from evidence-based care due to multiple barriers.", {"entities": []}], ["Yet current evidence of such barriers is predominantly from high-income countries.", {"entities": []}], ["This study seeks to understand stroke care professionals\u2019 views on the barriers which hinder the provision of optimal acute stroke care in Ghanaian hospital settings.", {"entities": []}], ["A qualitative approach using semistructured interviews.", {"entities": []}], ["Both thematic and grounded theory approaches were used to analyse and interpret the data through a synthesis of preidentified and emergent themes.", {"entities": []}], ["A multisite study, conducted in six major referral acute hospital settings (three teaching and three non-teaching regional hospitals) in Ghana.", {"entities": []}], ["A total of 40 participants comprising neurologists, emergency physician specialists, non-specialist medical doctors, nurses, physiotherapists, clinical psychologists and a dietitian.", {"entities": []}], ["Four key barriers and 12 subthemes of barriers were identified.", {"entities": []}], ["These include barriers at the patient (financial constraints, delays, sociocultural or religious practices, discharge against medical advice, denial of stroke), health system (inadequate medical facilities, lack of stroke care protocol, limited staff numbers, inadequate staff development opportunities), health professionals (poor collaboration, limited knowledge of stroke care interventions) and broader national health policy (lack of political will) levels.", {"entities": []}], ["Perceived barriers varied across health professional disciplines and hospitals.", {"entities": []}], ["Barriers from low/middle-income countries differ substantially from those in high-income countries.", {"entities": []}], ["For evidence-based acute stroke care in low/middle-income countries such as Ghana, health policy-makers and hospital managers need to consider the contrasts and uniqueness in these barriers in designing quality improvement interventions to optimise patient outcomes.", {"entities": []}], ["Background: Nitrogen dioxide (NO 2 ), a ubiquitous atmospheric pollutant, may enhance the asthmatic response to allergens through eosinophilic activation in the airways.", {"entities": []}], ["However, the effect of NO 2 on inflammation without allergen exposure is poorly studied.", {"entities": []}], ["Objectives: We investigated whether repeated peaks of NO 2 , at various realistic concentrations, induce changes in airway inflammation in asthmatics.", {"entities": []}], ["Methods: Nineteen nonsmokers with asthma were exposed at rest in a double-blind, crossover study, in randomized order, to 200 ppb NO 2 , 600 ppb NO 2 , or clean air once for 30 min on day 1 and twice for 30 min on day 2.", {"entities": [[34, 40, "DISEASE"]]}], ["The three series of exposures were separated by 2 weeks.", {"entities": []}], ["The inflammatory response in sputum was measured 6 hr (day 1), 32 hr (day 2), and 48 hr (day 3) after the first exposure, and compared with baseline values measured twice 10\u201330 days before the first exposure.", {"entities": [[51, 53, "GENE"], [66, 68, "GENE"], [85, 87, "GENE"], [51, 53, "GENE"], [66, 68, "GENE"], [85, 87, "GENE"], [51, 53, "GENE"], [66, 68, "GENE"], [85, 87, "GENE"]]}], ["Results: Compared with baseline measurements, the percentage of eosinophils in sputum increased by 57% after exposure to 600 ppb NO 2 ( p = 0.003) but did not change significantly after exposure to 200 ppb.", {"entities": []}], ["The slope of the association between the percentage of eosinophils and NO 2 exposure level was significant ( p = 0.04).", {"entities": []}], ["Eosinophil cationic protein in sputum was highly correlated with eosinophil count and increased significantly after exposure to 600 ppb NO 2 ( p = 0.001).", {"entities": []}], ["Lung function, which was assessed daily, was not affected by NO 2 exposure.", {"entities": []}], ["Conclusions: We observed that repeated peak exposures of NO 2 performed without allergen exposure were associated with airway eosinophilic inflammation in asthmatics in a dose-related manner.", {"entities": []}], ["Citation: Ezratty V, Guillossou G, Neukirch C, Dehoux M, Koscielny S, Bonay M, Cabanes PA, Samet JM, Mure P, Ropert L, Tokarek S, Lambrozo J, Aubier M. 2014.", {"entities": []}], ["Repeated nitrogen dioxide exposures and eosinophilic airway inflammation in asthmatics: a randomized crossover study.", {"entities": []}], ["Environ Health Perspect 122:850\u2013855;\u2002 http://dx.doi.org/10.1289/ehp.1307240", {"entities": []}], ["By analyzing the conservation of human proteins across 87 species, we sorted proteins into clusters of coevolution.", {"entities": []}], ["Some clusters are enriched for genes assigned to particular human diseases or molecular pathways; the other genes in the same cluster may function in related pathways and diseases.", {"entities": []}], ["Many genes that were thought to map to different diseases are actually coevolved together and mapped into the same phylogenetic clusters.", {"entities": []}], ["Many molecular pathways map to the same phylogenetic clusters as genes associated with specific human diseases.", {"entities": []}], ["Focusing on proteins coevolved with the microphthalmia-associated transcription factor (MITF), we identified the Notch pathway suppressor of hairless (RBP-Jk/SuH) transcription factor, and showed that RBP-Jk functions as an MITF cofactor.", {"entities": [[40, 54, "DISEASE"], [88, 92, "GENE"], [224, 228, "GENE"], [88, 92, "GENE"], [224, 228, "GENE"]]}], ["Our analysis thus establishes a connectivity between different diseases and pathways, linking diseases phenotypes and functional gene groups.", {"entities": []}], ["Many genes that were thought to map to different diseases are actually coevolved together and mapped into the same phylogenetic clusters.", {"entities": []}], ["Many molecular pathways map to the same phylogenetic clusters as genes associated with specific human diseases.", {"entities": []}], ["Focusing on proteins coevolved with the microphthalmia-associated transcription factor (MITF), we identified the Notch pathway suppressor of hairless (RBP-Jk/SuH) transcription factor, and showed that RBP-Jk functions as an MITF cofactor.", {"entities": [[40, 54, "DISEASE"], [88, 92, "GENE"], [224, 228, "GENE"], [88, 92, "GENE"], [224, 228, "GENE"]]}], ["Our analysis thus establishes a connectivity between different diseases and pathways, linking diseases phenotypes and functional gene groups.", {"entities": []}], ["Genes with common profiles of the presence and absence in disparate genomes tend to function in the same pathway.", {"entities": []}], ["By mapping all human genes into about 1000 clusters of genes with similar patterns of conservation across eukaryotic phylogeny, we determined that sets of genes associated with particular diseases have similar phylogenetic profiles.", {"entities": []}], ["By focusing on those human phylogenetic gene clusters that significantly overlap some of the thousands of human gene sets defined by their coexpression or annotation to pathways or other molecular attributes, we reveal the evolutionary map that connects molecular pathways and human diseases.", {"entities": []}], ["The other genes in the phylogenetic clusters enriched for particular known disease genes or molecular pathways identify candidate genes for roles in those same disorders and pathways.", {"entities": []}], ["Focusing on proteins coevolved with the microphthalmia-associated transcription factor (MITF), we identified the Notch pathway suppressor of hairless (RBP-Jk/SuH) transcription factor, and showed that RBP-Jk functions as an MITF cofactor.", {"entities": [[40, 54, "DISEASE"], [88, 92, "GENE"], [224, 228, "GENE"], [88, 92, "GENE"], [224, 228, "GENE"]]}], ["Fractional exhaled nitric oxide (FeNO) is a useful tool to diagnose and monitor eosinophilic bronchial inflammation in asthmatic children and adults.", {"entities": []}], ["In children younger than 2 years of age FeNO has been successfully measured both with the tidal breathing and with the single breath techniques.", {"entities": []}], ["However, there are a number of methodological issues that need to be addressed in order to increase the reproducibility of the FeNO measurements within and between infants.", {"entities": []}], ["Indeed, a standardized method to measure FeNO in the first 2 years of life would be extremely useful in order to meaningfully interpret FeNO values in this age group.", {"entities": []}], ["Several factors related to the measurement conditions have been found to influence FeNO, such as expiratory flow, ambient NO and nasal contamination.", {"entities": []}], ["Furthermore, the exposure to pre- and postnatal risk factors for respiratory morbidity has been shown to influence FeNO values.", {"entities": []}], ["Therefore, these factors should always be assessed and their association with FeNO values in the specific study population should be evaluated and, eventually, controlled for.", {"entities": []}], ["There is evidence consistently suggesting that FeNO is increased in infants with family history of atopy/atopic diseases and in infants with recurrent wheezing.", {"entities": []}], ["These findings could support the hypothesis that eosinophilic bronchial inflammation is present at an early stage in those infants at increased risk of developing persistent respiratory symptoms and asthma.", {"entities": [[199, 205, "DISEASE"]]}], ["Furthermore, it has been shown that FeNO measurements could represent a useful tool to assess bronchial inflammation in other airways diseases, such as primary ciliary dyskinesia, bronchopulmonary dysplasia and cystic fibrosis.", {"entities": [[152, 178, "DISEASE"], [211, 226, "DISEASE"]]}], ["Further studies are needed in order to improve the reproducibility of the measurements, and large prospective studies are warranted in order to evaluate whether FeNO values measured in the first years of life can predict the future development of asthma or other respiratory diseases.", {"entities": [[247, 253, "DISEASE"]]}], ["Zebrafish embryo is emerging as an important tool for behavior analysis as well as toxicity testing.", {"entities": []}], ["In this study, we compared the effect of nine different methylxanthine drugs using zebrafish embryo as a model.", {"entities": []}], ["We performed behavioral analysis, biochemical assay and Fish Embryo Toxicity (FET) test in zebrafish embryos after treatment with methylxanthines.", {"entities": []}], ["Each drug appeared to behave in different ways and showed a distinct pattern of results.", {"entities": []}], ["Embryos treated with seven out of nine methylxanthines exhibited epileptic-like pattern of movements, the severity of which varied with drugs and doses used.", {"entities": []}], ["Cyclic AMP measurement showed that, despite of a significant increase in cAMP with some compounds, it was unrelated to the observed movement behavior changes.", {"entities": []}], ["FET test showed a different pattern of toxicity with different methylxanthines.", {"entities": []}], ["Each drug could be distinguished from the other based on its effect on mortality, morphological defects and teratogenic effects.", {"entities": []}], ["In addition, there was a strong positive correlation between the toxic doses (TC 50 ) calculated in zebrafish embryos and lethal doses (LD 50 ) in rodents obtained from TOXNET database.", {"entities": []}], ["Taken together, all these findings elucidate the potentiality of zebrafish embryos as an in vivo model for behavioral and toxicity testing of methylxanthines and other related compounds.", {"entities": []}], ["Exposure to environmental endocrine-disrupting chemicals (EDCs) is often associated with dysregulated immune homeostasis, but the mechanisms of action remain unclear.", {"entities": []}], ["The aim of this study was to test a hypothesis that EDCs regulate the functions of human dendritic cells, a front-line, immunoregulatory cell type in contact with the environment.", {"entities": []}], ["We investigated circulating myeloid dendritic cells (mDCs) from five subjects and measured their responses, with or without coculture with autologous T cells, to two common EDCs, nonylphenol (NP) and 4-octylphenol (4-OP).", {"entities": []}], ["EDC-associated cytokine responses, signaling events, and histone modifications were examined using ELISA, Western blotting, and chromatin immunoprecipitation (ChIP) assays, respectively.", {"entities": []}], ["In all cases, mDCs treated with NP or 4-OP demonstrated increased expression of tumor necrosis factor-\u03b1 (TNF-\u03b1) but decreased baseline and lipopolysaccharide (LPS)-induced (interleukin) (IL)-10 production; the increase in TNF-\u03b1 was partially reversible by an estrogen receptor (ER) antagonist.", {"entities": []}], ["Activation of the MKK3/6-p38 signaling pathway marked the effect of NP on TNF-\u03b1 expression, concomitant with enhanced levels of methyltranferase complex [mixed-lineage leukemia (MLL) and tryptophan-aspartic acid repeat domain 5 (WDR5)] in the nucleus and of trimethylated H3K4, acetylated H3, and H4 at the TNFA gene locus.", {"entities": [[168, 176, "DISEASE"], [178, 181, "GENE"], [229, 233, "GENE"]]}], ["Further, up-regulated TNF-\u03b1 expression was significantly suppressed in NP-treated mDCs by a histone acetyltransferase inhibitor.", {"entities": []}], ["In the presence of NP-treated mDCs, T cells showed increased levels of IL-13 but decreased expression of interferon-\u03b3.", {"entities": []}], ["These results suggest that NP and 4-OP may have functional effects on the response of mDCs via, in part, the ER, MKK3/6-p38 MAPK signaling pathway, and histone modifications, with subsequent influence on the T-cell cytokine responses.", {"entities": []}], ["Social vulnerability is known to be related to ill health.", {"entities": []}], ["When a pregnant woman is socially vulnerable, the ill health does not only affect herself, but also the health and development of her (unborn) child.", {"entities": []}], ["To optimise care for highly vulnerable pregnant women, in Rotterdam, a holistic programme was developed in close collaboration between the university hospital, the local government and a non-profit organisation.", {"entities": []}], ["This programme aims to organise social and medical care from pregnancy until the second birthday of the child, while targeting adult and child issues simultaneously.", {"entities": []}], ["In 2014, a pilot in the municipality of Rotterdam demonstrated the significance of this holistic approach for highly vulnerable pregnant women.", {"entities": []}], ["In the \u2018Mothers of Rotterdam\u2019 study, we aim to prospectively evaluate the effectiveness of the holistic approach, referred to as targeted social care.", {"entities": []}], ["The Mothers of Rotterdam study is a pragmatic prospective cohort study planning to include 1200 highly vulnerable pregnant women for the comparison between targeted social care and care as usual.", {"entities": []}], ["Effectiveness will be compared on the following outcomes: (1) child development (does the child show adaptive development at year 1?)", {"entities": []}], ["and (2) maternal mental health (is maternal distress reduced at the end of the social care programme?).", {"entities": []}], ["Propensity scores will be used to correct for baseline differences between both social care programmes.", {"entities": []}], ["The prospective cohort study was approved by the Erasmus Medical Centre Ethics Committee (ref.", {"entities": []}], ["MEC-2016\u2013012) and the first results of the study are expected to be available in the second half of 2019 through publication in peer-reviewed international journals.", {"entities": []}], ["NTR6271; Pre-results.", {"entities": []}], ["In contrast to other organs, the lung completes a significant portion of its development after term birth.", {"entities": []}], ["During this stage of alveolarization, division of the alveolar ducts into alveolar sacs by secondary septation, and expansion of the pulmonary vasculature by means of angiogenesis markedly increase the gas exchange surface area of the lung.", {"entities": [[83, 87, "GENE"]]}], ["However, postnatal completion of growth renders the lung highly susceptible to environmental insults such as inflammation that disrupt this developmental program.", {"entities": []}], ["This is particularly evident in the setting of preterm birth, where impairment of alveolarization causes bronchopulmonary dysplasia, a chronic lung disease associated with significant morbidity.", {"entities": [[143, 155, "DISEASE"]]}], ["The nuclear factor \u03ba-B (NF\u03baB) family of transcription factors are ubiquitously expressed, and function to regulate diverse cellular processes including proliferation, survival, and immunity.", {"entities": []}], ["Extensive evidence suggests that activation of NF\u03baB is important in the regulation of inflammation and in the control of angiogenesis.", {"entities": []}], ["Therefore, NF\u03baB-mediated downstream effects likely influence the lung response to injury and may also mediate normal alveolar development.", {"entities": []}], ["This review summarizes the main biologic functions of NF\u03baB, and highlights the regulatory mechanisms that allow for diversity and specificity in downstream gene activation.", {"entities": []}], ["This is followed by a description of the pro and anti-inflammatory functions of NF\u03baB in the lung, and of NF\u03baB-mediated angiogenic effects.", {"entities": []}], ["Finally, this review summarizes the clinical and experimental data that support a role for NF\u03baB in mediating postnatal angiogenesis and alveolarization, and discusses the challenges that remain in developing therapies that can selectively block the detrimental functions of NF\u03baB yet preserve the beneficial effects.", {"entities": []}], ["Birth Defects Research (Part A) 100:202\u2013216, 2014 .", {"entities": []}], ["\u00a9 2014 Wiley Periodicals, Inc.", {"entities": []}], ["The regional deposition of a monodisperse 10-micron mass median aerodynamic diameter fog was studied in four healthy adult male nonsmokers.", {"entities": []}], ["The fog was radiolabeled with technetium-99m sulfur colloid to enable detection by an Anger camera of deposited activity in the following regions of the respiratory tract: oropharynx, larynx, trachea, and intrapulmonary airways.", {"entities": []}], ["Intrapulmonary deposition was further analyzed by computer with inner, intermediate, and outer zones, and within apical, intermediate and basal zones of the right lung.", {"entities": []}], ["The radiolabeled aerosol was inhaled by mouth through a face-mask with the nasal airway occluded.", {"entities": []}], ["Respiratory frequency, tidal volume, and jaw position were controlled and were commensurate with the oral component of oronasal breathing during moderate exercise.", {"entities": []}], ["Deposition in the larynx, trachea, and intrapulmonary airways was a function of the scrubbing efficiency of the oropharynx, which differed substantially among subjects, and ranged from 72 to 99%.", {"entities": []}], ["The density of the aerosol deposit in the larynx probably exceeded that of any of the subdivisions of the tracheobronchial tree and lung.", {"entities": []}], ["Within the lung, deposition favored the inner zone (assumed to contain the larger airways) over the outer zone (assumed to be dominated by smaller airways and alveoli).", {"entities": []}], ["Intrapulmonary aerosol distribution in an elderly subject with borderline evidence of airway obstruction differed from that observed in younger subjects.", {"entities": []}], ["The possible consequences of altered lung elastic recoil, as may occur with aging, for regional dosimetry is discussed.", {"entities": []}], ["In support of science and society, the USA National Phenology Network (USA-NPN) maintains a rapidly growing, continental-scale, species-rich dataset of plant and animal phenology observations that with over 10 million records is the largest such database in the United States.", {"entities": []}], ["The aim of this study was to explore the potential that exists in the broad and rich volunteer-collected dataset maintained by the USA-NPN for constructing models predicting the timing of phenological transition across species\u2019 ranges within the continental United States.", {"entities": []}], ["Contributed voluntarily by professional and citizen scientists, these opportunistically collected observations are characterized by spatial clustering, inconsistent spatial and temporal sampling, and short temporal depth (2009-present).", {"entities": []}], ["Whether data exhibiting such limitations can be used to develop predictive models appropriate for use across large geographic regions has not yet been explored.", {"entities": []}], ["We constructed predictive models for phenophases that are the most abundant in the database and also relevant to management applications for all species with available data, regardless of plant growth habit, location, geographic extent, or temporal depth of the observations.", {"entities": []}], ["We implemented a very basic model formulation\u2014thermal time models with a fixed start date.", {"entities": []}], ["Sufficient data were available to construct 107 individual species \u00d7 phenophase models.", {"entities": []}], ["Remarkably, given the limited temporal depth of this dataset and the simple modeling approach used, fifteen of these models (14%) met our criteria for model fit and error.", {"entities": []}], ["The majority of these models represented the \u201cbreaking leaf buds\u201d and \u201cleaves\u201d phenophases and represented shrub or tree growth forms.", {"entities": []}], ["Accumulated growing degree day (GDD) thresholds that emerged ranged from 454 GDDs ( Amelanchier canadensis -breaking leaf buds) to 1,300 GDDs ( Prunus serotina -open flowers).", {"entities": []}], ["Such candidate thermal time thresholds can be used to produce real-time and short-term forecast maps of the timing of these phenophase transition.", {"entities": []}], ["In addition, many of the candidate models that emerged were suitable for use across the majority of the species\u2019 geographic ranges.", {"entities": []}], ["Real-time and forecast maps of phenophase transitions could support a wide range of natural resource management applications, including invasive plant management, issuing asthma and allergy alerts, and anticipating frost damage for crops in vulnerable states.", {"entities": [[171, 177, "DISEASE"]]}], ["Our finding that several viable thermal time threshold models that work across the majority of the species ranges could be constructed from the USA-NPN database provides clear evidence that great potential exists this dataset to develop more enhanced predictive models for additional species and phenophases.", {"entities": []}], ["Further, the candidate models that emerged have immediate utility for supporting a wide range of management applications.", {"entities": []}], ["Tumor Necrosis Factor alpha (TNF\u03b1) is a pleiotropic cytokine extensively studied for its role in the pathogenesis of a variety of disease conditions, including in inflammatory diseases.", {"entities": []}], ["We have recently shown that, in vitro , that TNF\u03b1 utilizes PLD1 to mediate the activation of NF\u03baB and ERK1/2 in human monocytes.", {"entities": [[59, 63, "GENE"]]}], ["The aim of this study was to investigate the role(s) played by phospholipase D1 (PLD1) in TNF\u03b1-mediated inflammatory responses in vivo .", {"entities": [[81, 85, "GENE"]]}], ["Studies were performed in vivo using a mouse model of TNF\u03b1-induced peritonitis.", {"entities": [[67, 78, "DISEASE"]]}], ["The role of PLD1 was investigated by functional genomics, utilizing a specific siRNA to silence the expression of PLD1 .", {"entities": [[12, 16, "GENE"], [114, 118, "GENE"], [12, 16, "GENE"], [114, 118, "GENE"]]}], ["Administration of the siRNA against PLD1 significantly reduced PLD1 levels in vivo .", {"entities": [[36, 40, "GENE"], [63, 67, "GENE"], [36, 40, "GENE"], [63, 67, "GENE"]]}], ["TNF\u03b1 triggers a rapid pyrogenic response, but the in vivo silencing of PLD1 protects mice from the TNF\u03b1-induced rise in temperature.", {"entities": [[71, 75, "GENE"]]}], ["Similarly TNF\u03b1 caused an increase in the serum levels of IL-6, MIP-1\u03b1 and MIP-1\u03b2: this increase in cytokine/chemokine levels was inhibited in mice where PLD1 had been silenced.", {"entities": [[153, 157, "GENE"]]}], ["We then induced acute peritonitis with TNF\u03b1.", {"entities": [[22, 33, "DISEASE"]]}], ["Intraperitoneal injection of TNF\u03b1 triggered a rapid increase in vascular permeability, and the influx of neutrophils and monocytes into the peritoneal cavity.", {"entities": []}], ["By contrast, in mice where PLD1 had been silenced, the TNF\u03b1-triggered increase in vascular permeability and phagocyte influx was substantially reduced.", {"entities": [[27, 31, "GENE"]]}], ["Furthermore, we also show that the TNF\u03b1-mediated upregulation of the cell adhesion molecules VCAM and ICAM1, in the vascular endothelium, were dependent on PLD1.", {"entities": [[102, 107, "GENE"], [156, 160, "GENE"]]}], ["These novel data demonstrate a critical role for PLD1 in TNF\u03b1-induced inflammation in vivo and warrant further investigation.", {"entities": [[49, 53, "GENE"]]}], ["Indeed, our results suggest PLD1 as a novel target for treating inflammatory diseases, where TNF\u03b1 play key roles: these include diseases ranging from sepsis to respiratory and autoimmune diseases; all diseases with considerable unmet medical need.", {"entities": [[28, 32, "GENE"]]}], ["Whether the association of alcohol consumption and cardiovascular disease is the product of confounding and the degree to which this concern applies to other behaviors are unclear.", {"entities": []}], ["Using the 2003 Behavioral Risk Factor Surveillance System, a population-based telephone survey of adults in the US, we compared chronic disease risk factors between 123,359 abstainers and 126,674 moderate drinkers, defined as intake of \u2264 2 drinks per day among men and \u2264 1 drink per day among women, using age- and sex- and multivariable-adjusted models.", {"entities": []}], ["We also compared sedentary and active individuals, defined as moderate physical activity \u2265 30 minutes per day for \u2265 5 days per week, or vigorous activity for \u2265 20 minutes per day on \u2265 3 days.", {"entities": []}], ["Chronic disease risk factors and features of unhealthy lifestyle were generally more prevalent among abstainers than drinkers in age- and sex-adjusted analyses, but these differences were generally attenuated or eliminated by additional adjustment for race and education.", {"entities": []}], ["For low fruit and vegetable intake, divorced marital status, and absence of a personal physician, adjustment for race and education reversed initially positive age- and sex-adjusted associations with abstention.", {"entities": []}], ["Comparison of sedentary and active individuals produced similar findings, with generally lower levels of risk factors among more physical active individuals.", {"entities": []}], ["The differences between abstainers and drinkers are attenuated after adjustment for limited sociodemographic features, and sedentary and active individuals share a similar pattern.", {"entities": []}], ["Although observational studies of both factors may be susceptible to uncontrolled confounding, our results provide no evidence that moderate drinking is unique in this regard.", {"entities": []}], ["Ultimately, randomized trials of all such lifestyle factors will be needed to answer these questions definitively.", {"entities": []}], ["Mycoplasma pneumoniae and Chlamydia pneumoniae have been suggested to take part in the acute exacerbation of bronchial asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[130, 167, "DISEASE"], [119, 125, "DISEASE"]]}], ["Several studies have questioned whether they may play pathogenic roles in connection with bronchial asthma and COPD.", {"entities": [[100, 106, "DISEASE"]]}], ["This study was designed to evaluate the seroprevalences of M. pneumoniae and C. pneumoniae in stable asthma and COPD patients, and to compare with control patients.", {"entities": [[101, 107, "DISEASE"]]}], ["The medical records of one hundred forty patients who underwent M. pneumoniae and C. pneumoniae serology were retrospectively reviewed.", {"entities": []}], ["Seroprevalences of M. pneumoniae and C. pneumoniae in the asthma group (11.1% and 8.3%, respectively) were higher than in the control group (4.4% and 2.2%, respectively) without statistical significance.", {"entities": [[58, 64, "DISEASE"]]}], ["The seroprevalence of M. pneumoniae in the COPD group (16.9%) was significantly higher than in the control group, and the seroprevalence of C. pneumoniae in the COPD group (3.4%) was higher than in the control group without statistical significance.", {"entities": []}], ["This study raises important questions about the relation of M. pneumoniae and C. pneumoniae infection with stable asthma or COPD.", {"entities": [[114, 120, "DISEASE"]]}], ["Respiratory disease accounts for three of the ten leading causes of death worldwide.", {"entities": []}], ["Many of these diseases can be treated and diagnosed using a nebulizer.", {"entities": []}], ["Nebulizers can also be used to safely and efficiently deliver vaccines.", {"entities": []}], ["Unfortunately, commercially available nebulizers are not designed for use in regions of the world where lung disease is most prevalent: they are electricity-dependent, cost-prohibitive, and not built to be reliable in harsh operating conditions or under frequent use.", {"entities": [[104, 116, "DISEASE"]]}], ["To overcome these limitations, the Human Powered Nebulizer compressor (HPN) was developed.", {"entities": [[71, 74, "GENE"]]}], ["The HPN does not require electricity; instead airflow is generated manually through a hand-crank or bicycle-style pedal system.", {"entities": [[4, 7, "GENE"]]}], ["A health care worker or other trained individual operates the device while the patient receives treatment.", {"entities": []}], ["This study demonstrates functional specifications of the HPN in comparison with a standard commercially available electric jet nebulizer compressor, the DeVilbiss Pulmo-Aide 5650D (Pulmo-Aide).", {"entities": [[57, 60, "GENE"]]}], ["Pressure and flow characteristics were measured with a rotameter and pressure transducer, respectively.", {"entities": []}], ["Volume nebulized by each compressor was determined by mass, and particle size distribution was determined via laser diffraction.", {"entities": []}], ["The Hudson RCI Micro Mist nebulizer mouthpiece was used with both compressors.", {"entities": []}], ["The pressure and flow generated by the HPN and Pulmo-Aide were: 15.17\u00a0psi and 10.5\u00a0L/min; and 14.65\u00a0psi and 11.2\u00a0L/min, respectively.", {"entities": [[39, 42, "GENE"]]}], ["The volume of liquid delivered by each was equivalent, 1.097\u2009\u00b1\u20090.107\u00a0mL (mean\u2009\u00b1\u2009s.e.m., n\u2009=\u200913) for the HPN and 1.092\u2009\u00b1\u20090.116\u00a0mL for the Pulmo-Aide.", {"entities": [[104, 107, "GENE"]]}], ["The average particle size was also equivalent, 5.38\u2009\u00b1\u20090.040 micrometers (mean\u2009\u00b1\u2009s.e.m., n\u2009=\u20097) and 5.40\u2009\u00b1\u20090.025 micrometers, respectively.", {"entities": []}], ["Based on these characteristics, the HPN\u2019s performance is equivalent to a popular commercially available electric nebulizer compressor.", {"entities": [[36, 39, "GENE"]]}], ["The findings presented in this paper, combined with the results of two published clinical studies, suggest that the HPN could serve as an important diagnostic and therapeutic tool in the fight against global respiratory health challenges including: tuberculosis, chronic obstructive pulmonary disease, asthma, and lower respiratory infections.", {"entities": [[263, 300, "DISEASE"], [249, 261, "DISEASE"], [302, 308, "DISEASE"], [116, 119, "GENE"]]}], ["Ankylosing spondylitis (AS) is a chronic rheumatic and autoimmune disease.", {"entities": [[11, 22, "DISEASE"]]}], ["Little is known about the potential role of DNA methylation in the pathogenesis of AS.", {"entities": []}], ["This study was undertaken to explore the potential role of DNA methylation in the genetic mechanism of AS.", {"entities": []}], ["In this study, we compared the genome-wide DNA methylation profiles of peripheral blood mononuclear cells (PBMCs) between five AS patients and five healthy subjects, using the Illumina Infinium HumanMethylation450 BeadChip.", {"entities": []}], ["Quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) was performed to validate the relevance of the identified differentially methylated genes for AS, using another independent sample of five AS patients and five healthy subjects.", {"entities": []}], ["Compared with healthy controls, we detected 1915 differentially methylated CpG sites mapped to 1214 genes.", {"entities": []}], ["The HLA-DQB1 gene achieved the most significant signal (cg14323910, adjusted P \u2009=\u20091.84\u2009\u00d7\u200910 \u03b2 difference\u2009=\u20090.5634) for AS.", {"entities": [[4, 12, "GENE"]]}], ["Additionally, the CpG site cg04777551 of HLA-DQB1 presented a suggestive association with AS (adjusted P \u2009=\u20091.46\u2009\u00d7\u200910 \u03b2 difference\u2009=\u20090.3594).", {"entities": [[41, 49, "GENE"]]}], ["qRT-PCR observed that the mRNA expression level of HLA-DQB1 in AS PBMCs was significantly lower than that in healthy control PBMCs (ratio\u2009=\u20090.48\u2009\u00b1\u20090.10, P \u2009<\u20090.001).", {"entities": [[51, 59, "GENE"]]}], ["Gene Ontology (GO) and KEGG pathway enrichment analysis of differentially methylated genes identified four GO terms and 10 pathways for AS, functionally related to antigen dynamics and function.", {"entities": []}], ["Our results demonstrated the altered DNA methylation profile of AS and implicated HLA-DQB1 in the development of AS.", {"entities": [[82, 90, "GENE"]]}], ["The online version of this article (doi:10.1186/s13075-017-1382-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Ethnic origin, genetics, gender and environmental factors have been shown to influence some immunologic indices, so that development of reference values for populations of different backgrounds may be necessary.", {"entities": []}], ["We have determined the distribution of lymphocyte subsets in healthy Brazilian individuals from birth to adulthood.", {"entities": []}], ["Lymphocyte subsets were determined using four-colour cytometry in a cross-sectional study of 463 human immunodeficiency virus-unexposed children and adults from birth through 49 years of age.", {"entities": []}], ["Lymphocyte subsets varied according to age, as previously observed in other studies.", {"entities": []}], ["However, total CD4", {"entities": [[15, 18, "GENE"]]}], ["Previous studies have described the antispasmodic effect of mangiferin, a natural glucoside xanthone (2-C-\u03b2-Dgluco-pyranosyl-1,3,6,7-tetrahydroxyxanthone) that is present in mango trees and other plants, but its mechanism of action remains unknown.", {"entities": []}], ["The aim of this study was to examine the potential contribution of the nitric oxide-cyclic GMP pathway to the antispasmodic effect of mangiferin on isolated tracheal rings preparations.", {"entities": []}], ["The functional effect of mangiferin on allergic and non-allergic contraction of guinea pig tracheal rings was assessed in conventional organ baths.", {"entities": []}], ["Cultured tracheal rings were exposed to mangiferin or vehicle, and nitric oxide synthase (NOS) 3 and cyclic GMP (cGMP) levels were quantified using western blotting and enzyme immunoassays, respectively.", {"entities": []}], ["Mangiferin (0.1\u201310 \u00b5M) inhibited tracheal contractions induced by distinct stimuli, such as allergen, histamine, 5-hydroxytryptamine or carbachol, in a concentration-dependent manner.", {"entities": []}], ["Mangiferin also caused marked relaxation of tracheal rings that were precontracted by carbachol, suggesting that it has both anti-contraction and relaxant properties that are prevented by removing the epithelium.", {"entities": []}], ["The effect of mangiferin was inhibited by the nitric oxide synthase inhibitor, N\u03c9-nitro-L-arginine methyl ester (L-NAME) (100 \u00b5M), and the soluble guanylate cyclase inhibitor, 1H-", {"entities": []}], ["Inappropriate prescribing in primary care was implicated in nearly half of asthma deaths reviewed in the UK\u2019s recent National Review of Asthma Deaths.", {"entities": [[75, 81, "DISEASE"], [136, 142, "DISEASE"]]}], ["Using anonymised EMIS-Web data for 139 ethnically diverse general practices (total population 942,511) extracted from the North and East London Commissioning Support Unit, which holds hospital Secondary Uses Services (SUS)\u2013linked data, we examined the prevalence of over-prescribing of short-acting \u03b2 2 -agonist inhalers (SABA), under-prescribing of inhaled corticosteroid (ICS) inhalers and solo prescribing of long-acting \u03b2 2 -agonists (LABA) to assess the risk of hospitalisation for people with asthma for 1 year ending August 2015.", {"entities": [[499, 505, "DISEASE"]]}], ["In a total asthma population of 35,864, multivariate analyses in adults showed that the risk of admission increased with greater prescription of SABA inhalers above a baseline of 1\u20133 (4\u201312 SABA: odds ratio (OR) 1.71; 95% confidence interval (CI) 1.20\u20132.46, \u2a7e13 SABA: OR 3.22; 95% CI 2.04\u20135.07) with increasing British Thoracic Society step (Step 3: OR 2.90; 95% CI 1.79\u20134.69, Step 4/5: OR 9.42; 95% CI 5.27\u201316.84), and among Black (OR 2.30; 95% CI 1.64\u20133.23) and south Asian adult populations (OR 1.83; 95% CI 1.36\u20132.47).", {"entities": [[11, 17, "DISEASE"]]}], ["Results in children were similar, but risk of hospitalisation was not related to ethnic group.", {"entities": []}], ["There is a progressive risk of hospital admission associated with the prescription of more than three SABA inhalers a year.", {"entities": []}], ["Adults (but not children) from Black and South Asian groups are at an increased risk of admission.", {"entities": []}], ["Further work is needed to target care for these at-risk groups.", {"entities": []}], ["Cardiac inflammation has been suggested to be regulated by the sympathetic nervous system (SNS).", {"entities": []}], ["However, due to the lack of methodology to surgically eliminate the myocardial SNS in mice, neuronal control of cardiac inflammation remains ill-defined.", {"entities": []}], ["Here, we report a procedure for local cardiac sympathetic denervation in mice and tested its effect in a mouse model of heart failure post-myocardial infarction.", {"entities": [[139, 160, "DISEASE"]]}], ["Upon preparation of the carotid bifurcation, the right and the left superior cervical ganglia were localized and their pre- and postganglionic branches dissected before removal of the ganglion.", {"entities": []}], ["Ganglionectomy led to an almost entire loss of myocardial sympathetic innervation in the left ventricular anterior wall.", {"entities": []}], ["When applied at the time of myocardial infarction (MI), cardiac sympathetic denervation did not affect acute myocardial damage and infarct size.", {"entities": [[28, 49, "DISEASE"]]}], ["In contrast, cardiac sympathetic denervation significantly attenuated chronic consequences of MI, including myocardial inflammation, myocyte hypertrophy, and overall cardiac dysfunction.", {"entities": []}], ["These data suggest a critical role for local sympathetic control of cardiac inflammation.", {"entities": []}], ["Our model of myocardial sympathetic denervation in mice should prove useful to further dissect the molecular mechanisms underlying cardiac neural control.", {"entities": []}], ["The 'hygiene hypothesis' suggests that early exposure to microbes can be protective against atopic disease.", {"entities": []}], ["The intestinal microbial flora could operate as an important postnatal regulator of the Th1/Th2 balance.", {"entities": []}], ["The aim of the study was to investigate the association between early intestinal colonisation and the development of asthma in the first 3 years of life.", {"entities": [[117, 123, "DISEASE"]]}], ["In a prospective birth cohort, 117 children were classified according to the Asthma Predictive Index.", {"entities": [[77, 83, "DISEASE"]]}], ["A positive index included wheezing during the first three years of life combined with eczema in the child in the first years of life or with a parental history of asthma.", {"entities": [[163, 169, "DISEASE"]]}], ["A faecal sample was taken at the age of 3 weeks and cultured on selective media.", {"entities": []}], ["Asthma Predictive Index was positive in 26/117 (22%) of the children.", {"entities": [[0, 6, "DISEASE"]]}], ["The prevalence of colonisation with Bacteroides fragilis was higher at 3 weeks in index+ compared to index- children (64% vs. 34% p < 0,05).", {"entities": []}], ["Bacteroides fragilis and Total Anaerobes counts at 3 weeks were significantly higher in children with a positive index as compared with those without.", {"entities": []}], ["After adjusting for confounders a positive association was found between Bacteroides fragilis colonisation and Asthma Predictive Index (odds ratio: 4,4; confidence interval: 1,7 \u2013 11,8).", {"entities": [[111, 117, "DISEASE"]]}], ["Bacteroides fragilis colonisation at age 3 weeks is an early indicator of possible asthma later in life.", {"entities": [[83, 89, "DISEASE"]]}], ["This study could provide the means for more accurate targeting of treatment and prevention and thus more effective and better controlled modulation of the microbial milieu.", {"entities": []}], ["To assess the costs of the health effects of cigarette smoking and secondhand smoke (SHS) exposure to society.", {"entities": []}], ["Prevalence-based, disease-specific cost-of-illness study.", {"entities": []}], ["We used an epidemiological population-attributable risk method to determine the costs that can be attributed to smoking and SHS exposure.", {"entities": []}], ["All adult population aged 35 and older.", {"entities": []}], ["Direct costs of healthcare expenditures spent for treating tobacco-related diseases, indirect mortality costs measured by the value of lost productivity due to tobacco-related premature deaths and indirect morbidity costs measured by the value of time lost from work due to tobacco-related illness.", {"entities": []}], ["In 2010, direct costs of smoking and SHS exposure amounted to US$828 million, accounting for 3.4% of Taiwan's total personal healthcare expenditures.", {"entities": []}], ["Smoking and SHS exposure also contributed to 15\u2005555 premature deaths\u2014corresponding to a loss of 284\u2005765\u2005years of life and US$820 million in productivity\u2014and US$22 million in indirect morbidity costs.", {"entities": []}], ["These direct and indirect costs totalled US$1670 million, representing 0.4% of Taiwan's gross domestic product and averaging about US$720/adult smoker.", {"entities": []}], ["The share of the total costs was greater from active smoking (92%) than SHS exposure (8%), and greater for men (92%) than women (8%).", {"entities": []}], ["Smoking and SHS exposure impose a huge financial loss in Taiwan.", {"entities": []}], ["Sustained tobacco control efforts to encourage people to quit smoking, prevent smoking uptake by children and young adults and protect all people from SHS exposure are needed.", {"entities": []}], ["Medical professionals from Korea and Laos have been working together to develop a continuing professional development training program covering the major clinical fields of primary care.", {"entities": []}], ["This study aimed to evaluate the effectiveness of the program from 2013 to 2014 using the Kirkpatrick model.", {"entities": []}], ["A questionnaire was used to evaluate the reaction of the trainees, and the trainers assessed the level of trainees\u2019 performance at the beginning and the end of each clinical section.", {"entities": []}], ["The transfer (behavioral change) of the trainees was evaluated through the review of medical records written by the trainees before and after the training program.", {"entities": []}], ["The trainees were satisfied with the training program, for which the average score was 4.48 out of 5.0.", {"entities": []}], ["The average score of the trainees\u2019 performance at the beginning was 2.39 out of 5.0, and rose to 3.88 at the end of each section.", {"entities": []}], ["The average score of the medical records written before the training was 2.92 out of 5.0, and it rose to 3.34 after the training.", {"entities": []}], ["The number of patient visits to the district hospitals increased.", {"entities": []}], ["The continuing professional development training program, which was planned and implemented with the full engagement and responsibility of Lao health professionals, proved to be effective.", {"entities": []}], ["Bicycle commuting in an urban environment of high air pollution is known to be a potential health risk, especially for susceptible individuals.", {"entities": []}], ["While risk management strategies aimed to reduce exposure to motorised traffic emissions have been suggested, only limited studies have assessed the utility of such strategies in real-world circumstances.", {"entities": []}], ["The potential to lower exposure to ultrafine particles (UFP; < 0.1\u00a0\u03bcm) during bicycle commuting by reducing proximity to motorised traffic was investigated with real-time air pollution and intermittent acute inflammatory measurements in healthy individuals using their typical higher proximity, and an alternative lower proximity, bicycle commute route.", {"entities": []}], ["Thirty-five healthy adults (mean \u00b1 SD: age = 39 \u00b1 11\u00a0yr; 29% female) completed two return trips, one each in the condition of their typical route (HIGH) and a pre-determined alternative route of lower proximity to motorised traffic (LOW); proximity being determined by the proportion of on-road cycle paths.", {"entities": []}], ["Particle number concentration (PNC) and diameter (PD) were monitored in-commute in real-time.", {"entities": []}], ["Acute inflammatory indices of respiratory symptoms (as a scalar of frequency from very low to very high / 1 to 5), lung function and spontaneous sputum (for inflammatory cell analyses) were collected immediately pre-commute, and immediately and three hours post-commute.", {"entities": []}], ["In the condition of LOW, compared to in the condition of HIGH, there was a significant decrease in mean PNC (1.91 x e Exposure to PNC and offensive odour, and nasopharyngeal irritation, can be significantly lowered when utilising a route of lower proximity to motorised traffic whilst bicycle commuting, without significantly affecting commute distance or duration.", {"entities": []}], ["This may bring health benefits for both healthy and susceptible individuals.", {"entities": []}], ["The aim of this study was to examine the acceptability of point of care computerized prompts to improve health services delivery among a sample of primary care patients.", {"entities": []}], ["Primary data collection.", {"entities": []}], ["Cross-sectional survey.", {"entities": []}], ["Patients were surveyed after their visit with a primary care provider.", {"entities": []}], ["Data were obtained from patients of ten community-based primary care practices in the spring of 2001.", {"entities": []}], ["Almost all patients reported that they would support using a computer before each visit to prompt their doctor to: \"do health screening tests\" (92%), \"counsel about health behaviors (like diet and exercise)\" (92%) and \"change treatments for health conditions\" (86%).", {"entities": []}], ["In multivariate testing, the only variable that was associated with acceptability of the point of care computerized prompts was patient's confidence in their ability to answer questions about their health using a computer (beta = 0.39, p = .001).", {"entities": []}], ["Concerns about data security were expressed by 36.3% of subjects, but were not related to acceptability of the prompts.", {"entities": []}], ["Support for using computers to generate point of care prompts to improve quality-oriented processes of care was high in our sample, but may be contingent on patients feeling familiar with their personal medical history.", {"entities": []}], ["Floor dust is commonly used for microbial determinations in epidemiological studies to estimate early-life indoor microbial exposures.", {"entities": []}], ["Resuspension of floor dust and its impact on infant microbial exposure is, however, little explored.", {"entities": []}], ["The aim of our study was to investigate how floor dust resuspension induced by an infant\u2019s crawling motion and an adult walking affects infant inhalation exposure to microbes.", {"entities": []}], ["We conducted controlled chamber experiments with a simplified mechanical crawling infant robot and an adult volunteer walking over carpeted flooring.", {"entities": []}], ["We applied bacterial 16S rRNA gene sequencing and quantitative PCR to monitor the infant breathing zone microbial content and compared that to the adult breathing zone and the carpet dust as the source.", {"entities": []}], ["During crawling, fungal and bacterial levels were, on average, 8- to 21-fold higher in the infant breathing zone compared to measurements from the adult breathing zone.", {"entities": []}], ["During walking experiments, the increase in microbial levels in the infant breathing zone was far less pronounced.", {"entities": []}], ["The correlation in rank orders of microbial levels in the carpet dust and the corresponding infant breathing zone sample varied between different microbial groups but was mostly moderate.", {"entities": []}], ["The relative abundance of bacterial taxa was characteristically distinct in carpet dust and infant and adult breathing zones during the infant crawling experiments.", {"entities": []}], ["Bacterial diversity in carpet dust and the infant breathing zone did not correlate significantly.", {"entities": []}], ["The microbiota in the infant breathing zone differ in absolute quantitative and compositional terms from that of the adult breathing zone and of floor dust.", {"entities": []}], ["Crawling induces resuspension of floor dust from carpeted flooring, creating a concentrated and localized cloud of microbial content around the infant.", {"entities": []}], ["Thus, the microbial exposure of infants following dust resuspension is difficult to predict based on common house dust or bulk air measurements.", {"entities": []}], ["Improved approaches for the assessment of infant microbial exposure, such as sampling at the infant breathing zone level, are needed.", {"entities": []}], ["The online version of this article (10.1186/s40168-018-0405-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Diesel exhaust particles (DEPs) are deposited into the respiratory tract and are thought to be a risk factor for the development of diseases of the respiratory system.", {"entities": []}], ["In healthy individuals, the timing and mechanisms of respiratory tract injuries caused by chronic exposure to air pollution remain to be clarified.", {"entities": []}], ["We evaluated the effects of chronic exposure to DEP at doses below those found in a typical bus corridor in Sao Paulo (150 \u03bcg/m DEP decreased IFN-\u03b3 levels in BAL (p = 0.03), but did not significantly alter IL-4, IL-10 and IL-13 levels.", {"entities": []}], ["MAC2+ macrophage, CD4+ T cell and CD20+ B cell numbers were not altered; however, numbers of CD3+ T cells (p \u2264 0.001) and CD8+ T cells (p \u2264 0.001) increased in the parenchyma.", {"entities": []}], ["Although IL-13 (p = 0.008) expression decreased in the bronchiolar epithelium, Muc5ac gene expression was not altered in the lung of DEP-exposed animals.", {"entities": []}], ["Although respiratory mechanics, elastic and collagen density were not modified, the mean linear intercept (Lm) was increased in the DEP-exposed animals (p \u2264 0.001), and the index D2 was statistically different (p = 0.038) from the control animals.", {"entities": []}], ["Our data suggest that nasal instillation of low doses of DEP over a period of 90\u00a0days results in alveolar enlargement in the pulmonary parenchyma of healthy mice.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0172-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Dissociating glucocorticoid receptor (GR) ligands hold great promise for treating inflammatory disorders since it is assumed that they exert beneficial activities mediated by transrepression but avoid adverse effects of GR action requiring transactivation.", {"entities": []}], ["Here we challenged this paradigm by investigating 2-(4-acetoxyphenyl)-2-chloro- N -methyl-ethylammonium chloride (CpdA), a dissociating non-steroidal GR ligand, in the context of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS).", {"entities": [[247, 265, "DISEASE"], [203, 220, "DISEASE"]]}], ["CpdA inhibited pro-inflammatory mediators in myelin-specific T cells and fibroblasts in a GR-dependent manner while gene activation was abolished.", {"entities": []}], ["However, it also induced massive apoptosis in various cell types even in the absence of the GR by engaging a Bcl-2- and caspase-dependent pathway.", {"entities": []}], ["Administration of high-dose CpdA to mice was lethal while treatment of EAE with low to intermediate amounts of CpdA dissolved in water significantly ameliorated the disease.", {"entities": []}], ["The beneficial effect of CpdA required expression of the GR in T cells and was achieved by down regulating LFA-1 and CD44 on peripheral Th cells and by repressing IL-17 production.", {"entities": [[117, 121, "GENE"]]}], ["CpdA has significant therapeutic potential although adverse effects severely compromise its application in vivo .", {"entities": []}], ["Hence, non-steroidal GR ligands require careful analysis prior to their translation into new therapeutic concepts.", {"entities": []}], ["Exposure to ambient ozone (O 3 ) increases the susceptivity to allergens and triggers exacerbations in patients with asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["However, the detailed mechanisms of action for O 3 to trigger asthma exacerbations are still unclear.", {"entities": [[62, 68, "DISEASE"]]}], ["An ovalbumin (OVA)-established asthmatic mouse model was selected to expose to filtered air (OVA-model) or 1.0\u00a0ppm O 3 (OVA-O 3 model) during the process of OVA challenge.", {"entities": []}], ["Next, the possible involvements of p38 MAPK and oxidative stress in the ozone actions on the asthma exacerbations were investigated on the mice of OVA-O 3 model by treating them with SB239063 (a p38 MAPK inhibitor), and/or the \u03b1-tocopherol (antioxidant).", {"entities": [[93, 99, "DISEASE"]]}], ["Biological measurements were conducted including airway hyperresponsiveness (AHR), airway resistance (Raw), lung compliance (CL), inflammation in the airway lumen and lung parenchyma, the phosphorylation of p38 MAPK and heat shock protein (HSP) 27 in the tracheal tissues, and the malondialdehyde (MDA) content and the glutathione peroxidase (GSH-Px) activity in lung tissues.", {"entities": [[77, 80, "GENE"]]}], ["In OVA-allergic mice, O3 exposure deteriorated airway hyperresponsiveness (AHR), airway resistance (Raw), lung compliance (CL) and pulmonary inflammation, accompanied by the increased oxidative stress in lung tissues and promoted p38 MAPK and HSP27 phosphorylation in tracheal tissues.", {"entities": [[75, 78, "GENE"]]}], ["Administration of SB239063 (a p38 MAPK inhibitor) on OVA-O3 model exclusively mitigated the Raw, the CL, and the BAL IL-13 content, while \u03b1-tocopherol (antioxidant) differentially reduced the BAL number of eosinophils and macrophages, the content of BAL hyaluronan, the peribronchial inflammation, as well as the mRNA expression of TNF-\u03b1 and IL-5 in the lung tissues of OVA-O3 model.", {"entities": []}], ["Administration of these two chemical inhibitors similarly inhibited the AHR, the BAL IFN-\u03b3 and IL-6 production, the perivascular lung inflammation and the lung IL-17 mRNA expression of OVA-O3 model.", {"entities": [[72, 75, "GENE"]]}], ["Interestingly, the combined treatment of both compounds together synergistically inhibited neutrophil counts in the BALF and CXCL-1 gene expression in the lung.", {"entities": []}], ["O 3 exposure during the OVA challenge process promoted exacerbation in asthma.", {"entities": [[71, 77, "DISEASE"]]}], ["Both p38 MAPK and oxidative stress were found to play a critical role in this process and simultaneous inhibition of these two pathways significantly reduced the O 3 -elicited detrimental effects on the asthma exacerbation.", {"entities": [[203, 209, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a global health challenge and a major cause of mortality worldwide.", {"entities": []}], ["Bronchodilators, particularly long-acting \u03b2 2 -agonists and long-acting antimuscarinic agents, used singly or in combination, aim to improve lung function, reduce symptoms, prevent exacerbations, and enhance quality of life of COPD patients.", {"entities": []}], ["Indacaterol is a novel, inhaled, long-acting \u03b2 2 -agonist, with rapid onset of action and once-daily dosing providing 24-hour bronchodilation.", {"entities": []}], ["Currently, the recommended dose differs between Europe (150 \u03bcg; maximum 300 \u03bcg) and USA (75 \u03bcg), the latter is lower than that assessed in the majority of the conducted studies.", {"entities": []}], ["This review summarises published evidence regarding the efficacy, tolerability, and safety of indacaterol at a dose of 75 \u03bcg.", {"entities": []}], ["Indacaterol 75 \u03bcg was found to be superior than placebo regarding lung function, dyspnea, health status, use of rescue medication, and rate of exacerbations.", {"entities": []}], ["Furthermore, indacaterol 75 \u03bcg was well tolerated, while the most frequent adverse effect was deterioration of COPD occurring at a frequency similar to placebo, without major cardiovascular adverse effects.", {"entities": []}], ["In conclusion, indacaterol 75 \u03bcg, administered once daily, is efficacious and has an excellent tolerability and safety profile, and is therefore a valid alternative in the treatment of COPD patients.", {"entities": []}], ["Supplemental Digital Content is available in the text The early detection and diagnosis of chronic obstructive pulmonary disease (COPD) is critical to providing appropriate and timely treatment.", {"entities": [[91, 128, "DISEASE"]]}], ["We explored a new active case-finding strategy for COPD using handheld spirometry.", {"entities": []}], ["We recruited subjects over 40 years of age with a smoking history of more than 10 pack-years who visited a primary clinic complaining of respiratory symptoms.", {"entities": []}], ["A total of 190 of subjects were enrolled.", {"entities": []}], ["Medical information was obtained from historical records and physical examination by general practitioners.", {"entities": []}], ["All subjects had their pulmonary function evaluated using handheld spirometry with a COPD-6 device.", {"entities": []}], ["Because forced expiratory volume in 6\u200aseconds (FEV 6 ) has been suggested as an alternative to FVC, we measured forced expiratory volume in 1\u200asecond (FEV 1 )/FEV 6 for diagnosis of airflow limitation.", {"entities": [[47, 50, "GENE"], [150, 153, "GENE"], [158, 161, "GENE"], [47, 50, "GENE"], [150, 153, "GENE"], [158, 161, "GENE"]]}], ["All subjects were then referred to tertiary referral hospitals to complete a \u201cCould it be COPD?\u201d questionnaire, handheld spiromtery, and conventional spirometry.", {"entities": []}], ["The results of each instrument were compared to evaluate the efficacy of both handheld spirometry and the questionnaire.", {"entities": []}], ["COPD was newly diagnosed in 45 (23.7%) patients.", {"entities": []}], ["According to our receiver-operating characteristic (ROC) curve analysis, sensitivity and specificity were maximal when the FEV 1 /FEV 6 ratio was less than 77%.", {"entities": [[123, 126, "GENE"], [130, 133, "GENE"]]}], ["The area under the ROC curve was 0.759.", {"entities": []}], ["The sensitivity, specificity, positive predictive value, and negative predictive value were 72.7%, 77.1%, 50%, and 90%, respectively.", {"entities": []}], ["The area under the ROC curve of respiratory symptoms listed on the questionnaire ranged from 0.5 to 0.65, which indicates that there is almost no difference compared with the results of handheld spirometry.", {"entities": []}], ["The present study demonstrated the efficacy of handheld spirometry as an active case-finding tool for COPD in a primary clinical setting.", {"entities": []}], ["This study suggested that physicians should recommend handheld spirometry for people over the age of 40, who have a smoking history of more than 10 pack-years, regardless of respiratory symptoms.", {"entities": []}], ["Furthermore, people who have abnormal results, determined using the FEV 1 /FEV 6 \u22640.77 cut-off, should be referred for further conventional spirometry to confirm the diagnosis of COPD.", {"entities": [[68, 71, "GENE"], [75, 78, "GENE"]]}], ["However, further studies within the general population are necessary to establish efficacy in the public.", {"entities": []}], ["There is a need for short, specific instruments that assess quality of life (QOL) adequately in the older adult population.", {"entities": []}], ["The aims of the present study were to obtain evidence on the validity of the inferences that could be drawn from an instrument to measure QOL in the aging population (people 50+ years old), and to test its psychometric properties.", {"entities": []}], ["The instrument, WHOQOL-AGE, comprised 13 positive items, assessed on a five-point rating scale, and was administered to nationally representative samples (n\u2009=\u20099987) from Finland, Poland, and Spain.", {"entities": []}], ["Cronbach\u2019s alpha was employed to assess internal consistency reliability, whereas the validity of the questionnaire was assessed by means of factor analysis, graded response model, Pearson\u2019s correlation coefficient and unpaired t -test.", {"entities": []}], ["Normative values were calculated across countries and for different age groups.", {"entities": []}], ["The satisfactory goodness-of-fit indices confirmed that the factorial structure of WHOQOL-AGE comprises two first-order factors.", {"entities": []}], ["Cronbach\u2019s alpha was 0.88 for factor 1, and 0.84 for factor 2.", {"entities": []}], ["Evidence supporting a global score was found with a second-order factor model, according to the goodness-of-fit indices: CFI\u2009=\u20090.93, TLI\u2009=\u20090.91, RMSEA\u2009=\u20090.073.", {"entities": [[121, 124, "GENE"]]}], ["Convergent validity was estimated at r \u2009=\u20090.75 and adequate discriminant validity was also found.", {"entities": []}], ["Significant differences were found between healthy individuals (74.19\u2009\u00b1\u200913.21) and individuals with at least one chronic condition (64.29\u2009\u00b1\u200916.29), supporting adequate known-groups validity.", {"entities": []}], ["WHOQOL-AGE has shown good psychometric properties in Finland, Poland, and Spain.", {"entities": []}], ["Therefore, considerable support is provided to using the WHOQOL-AGE to measure QOL in older adults in these countries, and to compare the QOL of older and younger adults.", {"entities": []}], ["Cause-specific mortality statistics remain scarce for the majority of low-income countries, where the highest disease burdens are experienced.", {"entities": []}], ["Neither facility-based information systems nor vital registration provide adequate or representative data.", {"entities": []}], ["The expansion of sample vital registration with verbal autopsy procedures represents the most promising interim solution for this problem.", {"entities": []}], ["The development and validation of core verbal autopsy forms and suitable coding and tabulation procedures are an essential first step to extending the benefits of this method.", {"entities": []}], ["Core forms for peri- and neonatal, child, and adult deaths were developed and revised over 12 y through a project of the Tanzanian Ministry of Health and were applied to over 50,000 deaths.", {"entities": []}], ["The contents of the core forms draw upon and are generally comparable with previously proposed verbal autopsy procedures.", {"entities": []}], ["The core forms and coding procedures based on the International Statistical Classification of Diseases (ICD) were further adapted for use in China.", {"entities": []}], ["These forms, the ICD tabulation list, the summary validation protocol, and the summary validation results from Tanzania and China are presented here.", {"entities": []}], ["The procedures are capable of providing reasonable mortality estimates as adjudged against stated performance criteria for several common causes of death in two countries with radically different cause structures of mortality.", {"entities": []}], ["However, the specific causes for which the procedures perform well varied between the two settings because of differences in the underlying prevalence of the main causes of death.", {"entities": []}], ["These differences serve to emphasize the need to undertake validation studies of verbal autopsy procedures when they are applied in new epidemiological settings.", {"entities": []}], ["A procedure for recording verbal autopsy information was tested in two countries and found to be capable of providing reasonable mortality data.", {"entities": []}], ["The need to undertake validation studies was also demonstrated.", {"entities": []}], ["People living in developed countries take it for granted that when a loved one dies an accurate cause-of-death certificate will be issued.", {"entities": []}], ["But for two-thirds of the deaths that occur worldwide, there are no certificates.", {"entities": []}], ["Detailed information about what people die from is unavailable for more than 50% of countries, many of which have high death rates.", {"entities": []}], ["This information is badly needed for public-health planning, for using scarce health resources wisely, and for monitoring the effect of new health initiatives.", {"entities": []}], ["One way to improve knowledge about what people die from is a procedure called verbal autopsy (VA).", {"entities": []}], ["Relatives or caregivers are interviewed about the symptoms experienced by the deceased before their death and the circumstances surrounding their death by trained personnel who use a standard form.", {"entities": []}], ["Doctors then review the completed VA forms and assign a specific cause of death from a short version of the International Classifications of Diseases, or ICD, an internationally agreed on list of codes for hundreds of diseases.", {"entities": []}], ["VA procedures are being developed in many countries, but each step in a VA can be affected by factors that vary from place to place, such as how long after the death the interview is done, the training that interviewers receive, how the questions are worded, and the locally common diseases, which tend to be recognized better than rare diseases.", {"entities": []}], ["To ensure that the data collected are accurate and comparable between countries and also over time, VA procedures need to be standardized.", {"entities": []}], ["In this study, the researchers describe their efforts to achieve this through the development and validation of core VA procedures.", {"entities": []}], ["In 2001, the researchers refined the VA forms that were being used in Tanzania for deaths occurring around the time of birth and for deaths occurring in childhood and adulthood.", {"entities": []}], ["They then translated the forms for use in China, adapting them slightly to allow for cultural differences in how symptoms are described.", {"entities": []}], ["They also drew up a short list of ICD codes to use in tabulating and validating important causes of death.", {"entities": []}], ["Then, for four years, they collected VA and medical record information for the same deceased individuals and measured how well the VA procedure agreed with the medical record information in both countries.", {"entities": []}], ["They found that the procedure could be transferred between China and Tanzania but that it performed rather differently for different causes of death in the two countries.", {"entities": []}], ["So, in both countries, the procedure accurately recorded tuberculosis, cerebrovascular diseases such as strokes, and transport accidents as causes of death.", {"entities": [[57, 69, "DISEASE"]]}], ["But some other causes of death were accurately recorded in one country only\u2014generally the common diseases in that country\u2014and many causes of death were inaccurately reported in both countries.", {"entities": []}], ["The researchers use their experience of developing VAs for use in Tanzania and China and the results of this study to make several recommendations about how to develop standardized VA procedures that will yield accurate cause of death.", {"entities": []}], ["For example, they suggest that the VA form should contain a detailed core symptom duration checklist and only a short space for a narrative history (an open-ended description of the last illness provided by the relative or caregiver) because long narrative histories are hard to standardize.", {"entities": []}], ["They discuss the need to adapt core VA forms when moving between countries to allow for linguistic differences and colloquial expression and also the need to consider cultural differences between countries\u2014for example, how soon after bereavement a VA interview can occur.", {"entities": []}], ["Most importantly, they strongly recommend that validation studies like theirs should be routinely done when VA procedures are applied in new countries or if the major cause of death in a country changes because of a new epidemic or health initiative.", {"entities": []}], ["Provided this is done, write the researchers, although VA procedures can never be as accurate as proper medical certification at the time of death, they should provide important information about the causes of death for the many countries where this information would otherwise be completely missing.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0030268 .", {"entities": []}], ["\u2022\u2009World Health Organization information on mortality and on the International Classification of Diseases \u2022\u2009The United Nations' World Mortality Report 2005 \u2022\u2009Information on the Tanzania Ministry of Health Adult Morbidity and Mortality Project , which used the VA procedures on which this study was based \u2022\u2009A description of a standard VA method for investigating deaths in infants and children from the World Health Organization \u2022\u2009The INDEPTH Network , an organization collecting health statistics from developing countries that provides standardized VA forms \u2022\u2009 MEASURE Evaluation , a USAID-funded project that, in collaboration with the US Census Bureau and the University of Queensland (Australia), supports countries to implement core VA procedures and sample/sentinel vital registration methods \u2022\u2009The Health Metrics Network , a global collaboration focused on strengthening country health information systems to generate sound data for decision-making at country and global levels, is committed to improving sources of vital statistics and cause-of-death data", {"entities": []}], ["Hypoxia is a common phenomenon in prostate cancer, which leads to cell proliferation and tumor growth.", {"entities": [[43, 49, "DISEASE"], [34, 49, "DISEASE"]]}], ["Fractalkine (FKN) is a membrane-bound chemokine, which is implicated in the progression of human prostate cancer and skeletal metastasis.", {"entities": [[106, 112, "DISEASE"], [97, 112, "DISEASE"]]}], ["However, the association between FKN and hypoxia-induced prostate cancer cell proliferation remains to be elucidated.", {"entities": [[66, 72, "DISEASE"], [57, 72, "DISEASE"]]}], ["The present study demonstrated that hypoxia induced the expression and secretion of FKN in the DU145 prostate cancer cell line.", {"entities": [[110, 116, "DISEASE"], [101, 116, "DISEASE"]]}], ["Furthermore, inhibiting the activity of FKN with the anti-FKN FKN-specific antibody markedly inhibited hypoxia-induced DU145 cell proliferation.", {"entities": []}], ["Under normoxic conditions, DU145 cell proliferation markedly increased following exogenous administration of human recombinant FKN protein, and the increase was significantly alleviated by anti-FKN, indicating the importance of FKN in DU145 cell proliferation.", {"entities": []}], ["In addition, subsequent determination of cell cycle distribution and expression levels of two core cell cycle regulators, cyclin E and cyclin-dependent kinase (CDK)2, suggested that FKN promoted the G 1 /S phase transition by upregulating the expression levels of cyclin E and CDK2.", {"entities": [[277, 281, "GENE"]]}], ["The results of the present study demonstrated that hypoxia led to the upregulation of the secretion and expression of FKN, which enhanced cell proliferation by promoting cell cycle progression in the prostate cancer cells.", {"entities": [[209, 215, "DISEASE"], [200, 215, "DISEASE"]]}], ["These findings provide evidence of a novel function for FKN, and suggest that FKN may serve as a potential target for treating androgen-independent prostate cancer.", {"entities": [[157, 163, "DISEASE"], [148, 163, "DISEASE"]]}], ["Pneumococcal disease (including community-acquired pneumonia and invasive pneumococcal disease) poses a burden to the community all year round, especially in those with chronic underlying conditions.", {"entities": [[51, 60, "DISEASE"]]}], ["Individuals with COPD, asthma or who smoke, and those with chronic heart disease or diabetes mellitus have been shown to be at increased risk of pneumococcal disease compared with those without these risk factors.", {"entities": [[67, 80, "DISEASE"], [23, 29, "DISEASE"], [84, 101, "DISEASE"]]}], ["These conditions, and smoking, can also adversely affect patient outcomes, including short-term and long-term mortality rates, following pneumonia.", {"entities": [[137, 146, "DISEASE"]]}], ["Community-acquired pneumonia, and in particular pneumococcal pneumonia, is associated with a significant economic burden, especially in those who are hospitalised, and also has an impact on a patient's quality of life.", {"entities": [[19, 28, "DISEASE"], [61, 70, "DISEASE"]]}], ["Therefore, physicians should target individuals with COPD, asthma, heart disease or diabetes mellitus, and those who smoke, for pneumococcal vaccination at the earliest opportunity at any time of the year.", {"entities": [[67, 80, "DISEASE"], [59, 65, "DISEASE"], [84, 101, "DISEASE"]]}], ["Many smokers find currently available nicotine replacement therapies unsatisfactory.", {"entities": []}], ["The pharmacokinetics of nicotine delivered via a novel inhaler device, and its effect on craving satiation and smoking urges, were compared with the Nicorette\u00ae Inhalator (10mg).", {"entities": []}], ["Results are reported for Parts B ( N = 24) and D ( N = 24) of a 4-part Phase I study.", {"entities": []}], ["Participants (18\u201355 years, \u226510 cigarettes/day within 1hr of waking, expired carbon monoxide >10 ppm on screening) received single doses of nicotine on consecutive days (0.45 and 0.67mg [Part B] and 0.45mg [Part D] via the novel device; 10mg via Nicorette\u00ae [Parts B and D]).", {"entities": []}], ["Venous pharmacokinetics, craving, and tolerability were assessed.", {"entities": []}], ["In Part B, the novel device 0.45 and 0.67mg produced significantly lower C max , AUC last , and AUC all than Nicorette\u00ae (all p \u2264 .05), higher AUC 0\u201310 and significantly shorter T max (18.7 and 19.2min vs. 38.0min, respectively, p \u2264 .05).", {"entities": [[75, 78, "GENE"], [179, 182, "GENE"], [75, 78, "GENE"], [179, 182, "GENE"]]}], ["Craving score AUC was lower for the novel device 0.45mg than for Nicorette\u00ae in Part B (1356.3 vs. 1566.3, p = .029) and approached statistical significance in Part D (1208.5 vs. 1402.3 [ p = .059]).", {"entities": []}], ["Mean craving scores were lower for the novel device 0.45mg than Nicorette\u00ae at 7/8 postdose timepoints in Part B ( p \u2264 .05 at 180 and 240min) and at all timepoints in Part D ( p \u2264 .05 at 2, 4, and 10min).", {"entities": []}], ["The novel device was at least as effective as the Nicorette\u00ae Inhalator (10mg) in relieving craving and smoking urges and was statistically superior at certain timepoints and in an overall craving AUC analysis, despite lower total nicotine exposure.", {"entities": []}], ["Influenza vaccine effectiveness (VE) is influenced by the antigenic similarity between vaccine- and circulating strains.", {"entities": [[0, 9, "DISEASE"]]}], ["This paper presents data obtained by the Austrian sentinel surveillance system on the evolution of influenza viruses during the season 2014/15 and its impact on influenza vaccine effectiveness in primary care in Austria as estimated by a test-negative case control design.", {"entities": [[99, 108, "DISEASE"], [161, 170, "DISEASE"]]}], ["VE estimates were performed for each influenza virus type/subtype, stratified by underlying diseases and adjusted for age, sex and calendar week of infection.", {"entities": [[37, 46, "DISEASE"]]}], ["Detailed genetic and antigenic analyses showed that circulating A(H3N2) viruses were genetically distinct from the 2014/15 A(H3N2) vaccine component indicating a profound vaccine mismatch.", {"entities": []}], ["The Influenza A(H1N1)pdm09 viruses were antigenically conserved and matched the respective vaccine component.", {"entities": [[4, 13, "DISEASE"]]}], ["Influenza B viruses were lineage-matched B/Yamagata viruses with a clade-level variation.", {"entities": [[0, 9, "DISEASE"]]}], ["Consistent with substantial vaccine mismatch for the A(H3N2) viruses a crude overall VE of only 47% was estimated, whereas the VE estimates for A(H1N1)pdm09 were 84% and for influenza B viruses 70%.", {"entities": [[174, 183, "DISEASE"]]}], ["Increased VE estimates were obtained after stratification by underlying diseases and adjustment for the covariates sex and age, whereby the adjustment for the calendar week of infection was the covariate exerting the highest influence on adjusted VE estimates.", {"entities": []}], ["In summary, VE data obtained in this study underscore the importance to perform VE estimates in the context of detailed characterization of the contributing viruses and also demonstrate that the calendar week of influenza virus infection is the most important confounder of VE estimates.", {"entities": [[212, 221, "DISEASE"]]}], ["We investigated whether a relationship between small airways dysfunction and bronchodilator responsiveness exists in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[131, 168, "DISEASE"]]}], ["We studied 100 (20 female; mean age: 68\u00b110 years) patients with COPD (forced expiratory volume in 1 second [FEV 1 ]: 55% pred \u00b121%; FEV 1 /forced vital capacity [FVC]: 53%\u00b110%) by impulse oscillometry system.", {"entities": [[108, 111, "GENE"], [132, 135, "GENE"], [108, 111, "GENE"], [132, 135, "GENE"]]}], ["Resistance at 5 Hz and 20 Hz (R5 and R20, in kPa\u00b7s\u00b7L 1 (flow responders, FRs) and FVC (volume responders, VRs).", {"entities": []}], ["Eighty out of 100 participants had R5 \u2013 R20 >0.03 kPa\u00b7s\u00b7L 1 , FVC, FEV 1 /FVC, and X5, along with higher values of residual volume/total lung capacity and R5 ( P <0.05 for all comparisons).", {"entities": [[67, 70, "GENE"]]}], ["Compared to the 69 nonresponders and the 8 FRs, the 16 VRs had significantly higher R5 and R5 \u2013 R20 values ( P <0.05), lower X5 values ( P <0.05), and greater airflow obstruction and lung hyperinflation.", {"entities": []}], ["This study shows that peripheral airway resistance is increased in the vast majority of patients with COPD, who showed worse respiratory reactance, worse spirometry results, more severe lung hyperinflation, and poorer health status.", {"entities": []}], ["Small airway dysfunction was also associated with the bronchodilator responsiveness in terms of FVC, but not in terms of FEV 1 .", {"entities": [[121, 124, "GENE"]]}], ["To investigate the association between inhaled corticosteroid (ICS) exposure patterns and the risk of pneumonia in chronic obstructive pulmonary disease (COPD) patients, we performed a nested case-control study.", {"entities": [[102, 111, "DISEASE"], [115, 152, "DISEASE"]]}], ["Between 1998 and 2010, 51,739 patients, including 19,838 cases of pneumonia, were matched to 74,849 control subjects selected from a cohort of COPD patients using ICSs via risk-set sampling of the database constructed by the National Health Research Institutes of Taiwan.", {"entities": [[66, 75, "DISEASE"]]}], ["After adjusting for covariates, the current use of ICSs was associated with a 25% increase in the risk of pneumonia (odds ratio [OR] =1.25, 95% confidence interval [CI] =1.20\u20131.30), and there was an increase in the OR with increase in the average daily dosage.", {"entities": [[106, 115, "DISEASE"]]}], ["Additionally, users of fluticasone/salmeterol, fluticasone, and either fluticasone/salmeterol or fluticasone were more likely to be at a higher risk of pneumonia (OR =1.35, 95% CI =1.28\u20131.41; OR =1.22, 95% CI =1.10\u20131.35; and OR =1.33, 95% CI =1.27\u20131.39, respectively).", {"entities": [[152, 161, "DISEASE"]]}], ["In contrast, there were no statistically significant associations between the risk of pneumonia and the use of budesonide/formoterol, budesonide, or either budesonide/formoterol or budesonide.", {"entities": [[86, 95, "DISEASE"]]}], ["In conclusion, ICSs are significantly associated with an increased risk of pneumonia in COPD patients.", {"entities": [[75, 84, "DISEASE"]]}], ["The effect is prominent for fluticasone-containing ICSs but not for budesonide-containing ICSs.", {"entities": []}], ["Non-small-cell lung cancer (NSCLC) accounts for the most cases in clinical lung cancer patients.", {"entities": [[15, 26, "DISEASE"], [75, 86, "DISEASE"], [20, 26, "DISEASE"], [80, 86, "DISEASE"]]}], ["Patients with NSCLC are often diagnosed in advanced stage and frequently infected with gram-negative bacteria.", {"entities": []}], ["Pulmonary infection with gram-negative bacteria is the most frequent postoperative complication in NSCLC patients.", {"entities": []}], ["While accumulating evidence indicate an involvement of gram-negative bacteria in NSCLC progression, the underlying mechanisms remain largely unknown.", {"entities": []}], ["Herein, we explored the effect of gram-negative bacteria on tumor progression using tumor cells from NSCLC patients.", {"entities": []}], ["We observed that infection with gram-negative bacteria predicted advanced stages and decreased time interval to recurrence of NSCLC patients.", {"entities": []}], ["Incubation of NSCLC cells with gram-negative bacteria promoted their growth and metastasis.", {"entities": []}], ["Mechanistically, gram-negative bacteria activated Toll-like receptor 4 (TLR4) signaling in NSCLC cells, leading to increased mRNA and protein expression of interleukin 33 (IL-33) through MyD88-dependent pathway.", {"entities": [[72, 76, "GENE"]]}], ["Knockdown of IL-33 abrogated the contribution of gram-negative bacteria to NSCLC progression by regulating cancer metabolic activities and stem cell properties.", {"entities": [[107, 113, "DISEASE"]]}], ["In NSCLC patients, higher TLR4 expression was associated with increased IL-33 expression, Ki-67 proliferation index and CD133 expression in those with gram-negative bacterial infection.", {"entities": [[26, 30, "GENE"]]}], ["These findings shed new light on the molecular mechanisms underlie gram-negative bacteria mediated tumor progression and provide clues for innovative therapeutic explorations for NSCLC patients.", {"entities": []}], ["Houttuynia cordata Thunb (HCT) is widely used in oriental medicine as a remedy for inflammation.", {"entities": []}], ["However, at present there is no explanation for the mechanism by which HCT affects the production of inflammatory cytokines.", {"entities": []}], ["The current study aimed to determine the effect of an essence extracted from HCT on mast cell-mediated inflammatory responses.", {"entities": []}], ["Inflammatory cytokine production induced by phorbol myristate acetate (PMA) plus a calcium ionophore, A23187, was measured in the human mast cell line, HMC-1, incubated with various concentrations of HCT.", {"entities": []}], ["TNF-\u03b1, IL-6 and IL-8 secreted protein levels were measured using an ELISA assay.", {"entities": []}], ["TNF-\u03b1, IL-6 and IL-8 mRNA levels were measured using RT-PCR analysis.", {"entities": []}], ["Nuclear and cytoplasmic proteins were examined by western blot analysis.", {"entities": []}], ["The NF-\u03baB promoter activity was examined by luciferase assay.", {"entities": []}], ["It was observed that HCT inhibited PMA plus A23187-induced TNF-\u03b1 and IL-6 secretion and reduced the mRNA levels of TNF-\u03b1, IL-6 and IL-8.", {"entities": []}], ["It was also noted that HCT suppressed the induction of NF-\u03baB activity, inhibited nuclear translocation of NF-\u03baB and blocked the phosphorylation of I\u03baB\u03b1 in stimulated HMC-1 cells.", {"entities": []}], ["It was concluded that HCT is an inhibitor of NF-\u03baB and cytokines blocking mast cell-mediated inflammatory responses.", {"entities": []}], ["These results indicate that HCT may be used for the treatment of mast cell-derived allergic inflammatory diseases.", {"entities": []}], ["Main indoor allergens for humans are from house dust mites.", {"entities": []}], ["There are more than 30 allergens in Dermatophagoides farinae but only fourteen allergens have been identified from this mite including Der f 1\u20133, 6, 7, 10, 11, 13\u201318, and 22.", {"entities": []}], ["A native allergen protein (Der f 24, 90 kDa) was purified from D. farinae by gel filtration and anionic exchange liquid chromatography combined with IgE immunodetection.", {"entities": []}], ["Its primary structure was determined by Edman degradation, mass spectrometry analysis and cDNA cloning.", {"entities": []}], ["Enzyme-linked immunosorbent assay inhibition tests (ELISA-IT), immunoblots, basophil activation test (BAT) and skin prick test (SPT) were performed to evaluate the allergenicity.", {"entities": []}], ["It was identified as an alpha (\u03b1)-actinin containing a CaM-like domain with EF-hand motifs.", {"entities": []}], ["Der f 24 reacted to sera from 85.4% (35/41) of patients on western blot analysis.", {"entities": []}], ["It reduced \u223c20% sera IgE reactivity to D. farinae extracts on a competitive ELISA.", {"entities": []}], ["Eighty percent (8/10) of patients with D. farinae allergy showed positive reactions to Der f 24 in skin prick test.", {"entities": []}], ["The expression of CD63 on basophils from patients was up-regulated by Der f 24 by \u223c5.4-fold.", {"entities": [[18, 22, "GENE"]]}], ["Alpha-actinin was identified as a new type of house dust mite allergen.", {"entities": []}], ["To the best of our knowledge, this is the first report of \u03b1-actinin as an allergen.", {"entities": []}], ["Cysteine proteinase cathepsin S (Cat S) is expressed mainly in lymphatic tissues and has been characterised as a key enzyme in major histocompatibility complex class II (MHC-II) mediated antigen presentation.", {"entities": []}], ["Cat S has been measured in tissue cytosols of lung parenchyma, lung tumours and lymph nodes and in sera of patients with lung tumours and of healthy controls, by specific enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["A difference in Cat S level was found between tumour and adjacent control tissue cytosols of 60 lung cancer patients (median 4.3 vs. 2.8\u2008ng\u2008mg P < 0.001).", {"entities": [[96, 107, "DISEASE"], [101, 107, "DISEASE"]]}], ["Additionally, significantly higher levels were found in non-infiltrated than in infiltrated lymph nodes (median 16.6 vs 7.5\u2008ng\u2008mg P = 0.025 \u2013 tumours; P = 0.02 \u2013 parenchyma).", {"entities": []}], ["Immunohistochemical analysis (IHA) of lung parenchyma revealed a staining reaction in alveolar type II cells, macrophages and bronchial epithelial cells.", {"entities": []}], ["In regional lymph node tissue, strong staining of Cat S was found in lymphocytes and histiocytes.", {"entities": []}], ["Nevertheless, Cat S was detected also in tumour cells, independently of their origin.", {"entities": []}], ["Our results provide evidence that Cat S may be involved in malignant progression.", {"entities": []}], ["Its role, however, differs from that of the related Cats B and L and could be associated with the immune response rather than with remodelling of extracellular matrix.", {"entities": []}], ["\u00a9 2001 Cancer Research Campaign \u2002\u2002http://www.bjcancer.com", {"entities": [[7, 13, "DISEASE"]]}], ["Internationally, medical schools have long used a variety of approaches to develop hybrid Problem based learning (PBL) curricula.", {"entities": []}], ["However, Team-based learning (TBL), has gained recent popularity in medical education.", {"entities": []}], ["TBL maintains the advantages of small group teaching and learning, but in contrast to Problem-based learning (PBL), does not require large numbers of tutors.", {"entities": []}], ["In 2016, TBL was introduced to Year 1 of the Sydney Medical Program (SMP).This study sought to compare students\u2019 perceptions of using TBL in place of PBL.", {"entities": []}], ["Year 1 students ( n \u2009=\u2009169) completed three PBL and three TBL sessions during one of the following teaching blocks: Musculoskeletal ( n \u2009=\u200956), Respiratory ( n \u2009=\u200959) or Cardiovascular ( n \u2009=\u200954).", {"entities": []}], ["Student feedback following completion of each block of teaching was collected by questionnaire, using closed and open ended items.", {"entities": []}], ["Data were analysed using descriptive statistics and thematic analysis.", {"entities": []}], ["In total, 144/169 (85%) of participants completed a questionnaire regarding PBL, and 152/169 (90%) completed a similar questionnaire regarding TBL.", {"entities": []}], ["The students found positive aspects of their TBL experience to include the smaller group size, the use of readiness assurance tests, immediate feedback from senior clinicians, and time efficiency.", {"entities": []}], ["In PBL, students reported that variable expertise of tutors; limited direction; and large group size hindered their learning.", {"entities": []}], ["Overwhelmingly, students preferred TBL over PBL, as the optimal teaching strategy.", {"entities": []}], ["Students found the structure and format of the TBL sessions more conducive to learning, engagement and participation than PBL sessions.", {"entities": []}], ["Although the use of TBL required an instructional approach, needing direction from the tutor, it remained student-centred, generating a range of positive outcomes.", {"entities": []}], ["Study results provide confidence to change from PBL to TBL within Year 1 and Year 2 of the SMP in 2017.", {"entities": []}], ["Hereditary angioedema is a serious medical condition caused by a rare autosomal dominant genetic disorder and it is associated with deficient production or dysfunction of the C1 esterase inhibitor.", {"entities": [[0, 21, "DISEASE"], [11, 21, "DISEASE"], [89, 105, "DISEASE"]]}], ["In most cases, affected patients experience unexpected and recurrent crises of subcutaneous, gastrointestinal and laryngeal edema.", {"entities": []}], ["The unpredictability, intensity and other factors associated with the disease impact the quality of life of hereditary angioedema patients.", {"entities": [[108, 129, "DISEASE"], [119, 129, "DISEASE"]]}], ["We evaluated the quality of life in Brazilian hereditary angioedema patients.", {"entities": [[46, 67, "DISEASE"], [57, 67, "DISEASE"]]}], ["Patients older than 15 years with any severity of hereditary angioedema and laboratory confirmation of C1 inhibitor deficiency were included.", {"entities": [[50, 71, "DISEASE"], [61, 71, "DISEASE"]]}], ["Two questionnaires were used: a clinical questionnaire and the SF-36 (a generic questionnaire).", {"entities": []}], ["This protocol was approved by the Ethics Committee of Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de S\u00e3o Paulo.", {"entities": []}], ["The SF-36 showed that 90.4% (mean) of all the patients had a score below 70 and 9.6% had scores equal to or higher than 70.", {"entities": []}], ["The scores of the eight dimensions ranged from 51.03 to 75.95; vitality and social aspects were more affected than other arenas.", {"entities": []}], ["The internal consistency of the evaluation was demonstrated by a Cronbach's alpha value above 0.7 in seven of the eight domains.", {"entities": []}], ["In this study, Brazilian patients demonstrated an impaired quality of life, as measured by the SF-36.", {"entities": []}], ["The most affected domains were those related to vitality and social characteristics.", {"entities": []}], ["The generic SF-36 questionnaire was relevant to the evaluation of quality of life; however, there is a need for more specific instruments for better evaluation.", {"entities": []}], ["An ethnomedicinal study was conducted to document medicinal plants used in the treatment of ailments in villages surrounding Kimboza forest reserve, a low land catchment forest with high number of endemic plant species.", {"entities": []}], ["Ethnobotanical interviews on medicinal plants used to treat common illnesses were conducted with the traditional medical practitioners using open-ended semi -structured questionnaires.", {"entities": []}], ["Diseases treated, methods of preparation, use and habitat of medicinal plants were recorded.", {"entities": []}], ["A total of 82 medicinal plant species belonging to 29 families were recorded during the study.", {"entities": []}], ["The most commonly used plant families recorded were Fabaceae (29%), Euphorbiaceae (20%), Asteraceae and Moraceae (17% each) and Rubiaceae (15%) in that order.", {"entities": []}], ["The most frequently utilized medicinal plant parts were leaves (41.3%), followed by roots (29.0%), bark (21.7%), seeds (5.31%), and fruits (2.6%).", {"entities": []}], ["The study revealed that stomach ache was the condition treated with the highest percentage of medicinal plant species (15%), followed by hernia (13%), diarrhea (12), fever and wound (11% each), and coughs (10%).", {"entities": [[151, 159, "DISEASE"]]}], ["Majority of medicinal plant species (65.9%) were collected from the wild compared to only 26.7% from cultivated land.", {"entities": []}], ["A rich diversity of medicinal plant species are used for treating different diseases in villages around Kimboza forest reserve, with the wild habitat being the most important reservoir for the majority of the plants.", {"entities": []}], ["Awareness programmes on sustainable utilization and active involvement of community in conservation programmes are needed.", {"entities": []}], ["The high prevalence of both obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) in Western societies is well documented.", {"entities": [[62, 99, "DISEASE"]]}], ["However, OSA frequently remains unrecognized and untreated among patients with COPD.", {"entities": []}], ["Patients with both conditions have a greater risk for fatal and nonfatal cardiovascular events compared with patients with COPD or OSA alone.", {"entities": []}], ["Efficacious treatment with continuous positive airway pressure reduces the risk of cardiovascular complications in patients with OSA.", {"entities": []}], ["The aim of the present review is to discuss the diagnostic approach to patients with both conditions and to delineate the benefits of timely recognition and treatment of OSA in patients with COPD.", {"entities": []}], ["The fatality rate of invasive aspergillosis (IA) is still very high, especially in prolonged and untreated pulmonary cases.", {"entities": [[30, 43, "DISEASE"], [21, 43, "DISEASE"]]}], ["Aspergillus fumigatus is the main causative agent of IA and investigation of its metabolites could provide valuable insight into virulence factor(s) associated with this organism.", {"entities": []}], ["We evaluated the A. fumigatus culture filtrate (CF) products generated during short- and long-term aerated and non-aerated conditions and tested for (i) inhibition of cysteine or serine proteases and (ii) cytotoxicity.", {"entities": []}], ["In addition, the mathematical model was determined using response surface methodology (RSM) to estimate the influence of different fermentation conditions on A. fumigatus CF characteristics, predict enzyme inhibition and make possible correlations with in vivo conditions.", {"entities": []}], ["Biosynthesis of A. fumigatus low molecular weight proteinaceous products (from 6.4 to 15.4 kDa) was observed after 6 days of growth under aerated and alkaline conditions.", {"entities": []}], ["Also, only these CFs showed significant reduction in cell lines survival (Caco-2 and WISH 35.6% and 54.6%, respectively).", {"entities": []}], ["Obtained results provide solid starting point for further studies that would include: (i) detailed chemical characterization of A. fumigatus CF, (ii) activity relationships and in vivo correlation with pathogenicity of prolonged pulmonary IA and (iii) possible use of biomolecules as diagnostic or therapeutic markers.", {"entities": []}], ["Brevetoxins are potent neurotoxins produced by the marine dinoflagellate Karenia brevis .", {"entities": []}], ["Exposure to brevetoxins may occur during a K. brevis red tide when the compounds become aerosolized by wind and surf.", {"entities": []}], ["This study assessed possible adverse health effects associated with inhalation exposure to brevetoxin 3, one of the major brevetoxins produced by K. brevis and present in aerosols collected along beaches affected by red tide.", {"entities": []}], ["Male F344 rats were exposed to brevetoxin 3 at 0, 37, and 237 \u03bcg/m", {"entities": []}], ["This study aimed to investigate the role of social factors, especially social support for sleep, among victims living at home around 1\u20132 years after the Great East Japan Earthquake and tsunami.", {"entities": []}], ["A cross-sectional household survey was conducted between May and December 2012 (14\u201321 months after the disaster) in the Ishinomaki area, Japan.", {"entities": []}], ["Univariate and multivariate logistic regression models were used to examine the association between social factors, including social support, and prolonged sleep difficulties (persisting over 1 month).", {"entities": []}], ["Social support was divided into three functions: emotional, informational, and instrumental support.", {"entities": []}], ["Data were obtained on 2,593 individuals who were living at home after the disaster.", {"entities": []}], ["The prevalence of prolonged sleep difficulties was 6.9% (5.8% male, 7.7% female).", {"entities": []}], ["This study showed that lack of social support has a stronger association with prolonged sleep difficulties than non-modifiable or hardly modifiable consequences caused directly by the disaster, i.e., severity of home damage, change in family structure and income.", {"entities": []}], ["Among the three dimensions of social support, lack of emotional support showed the strongest association with prolonged sleep difficulties.", {"entities": []}], ["Social support, especially emotional support, may positively affect sleep among victims living at home around 1\u20132 years after a disaster.", {"entities": []}], ["Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and there is no approved pharmacotherapy.", {"entities": [[13, 32, "DISEASE"], [19, 32, "DISEASE"], [63, 76, "DISEASE"]]}], ["The efficacy of vitamin E and pioglitazone has been established in nonalcoholic steatohepatitis (NASH), a progressive form of NAFLD.", {"entities": []}], ["GLP-1RA and SGLT2 inhibitors, which are currently approved for use in diabetes, have shown early efficacy in NASH, and also have beneficial cardiovascular or renal effects.", {"entities": []}], ["Innovative NASH therapies include four main pathways.", {"entities": []}], ["The first approach is targeting hepatic fat accumulation.", {"entities": []}], ["Medications in this approach include modulation of peroxisome proliferator-activator receptors (e.g., pemafibrate, elafibranor), medications targeting farnesoid X receptor axis [obeticholic acid; OCA)], inhibitors of de novo lipogenesis (aramchol, ACC inhibitor), and fibroblast growth factor-21 analogues.", {"entities": []}], ["A second target is oxidative stress, inflammation, and apoptosis.", {"entities": []}], ["This class of drug includes apoptosis signaling kinase 1 (ASK1) inhibitor and emricasan (an irreversible caspase inhibitor).", {"entities": []}], ["A third target is intestinal microbiomes and metabolic endotoxemia.", {"entities": []}], ["Several agents are in ongoing trials, including IMMe124, TLR4 antagonist, and solithromycin (macrolide antibiotics).", {"entities": [[57, 61, "GENE"]]}], ["The final target is hepatic fibrosis, which is strongly associated with all-cause or liver-related mortality in NASH.", {"entities": []}], ["Antifibrotic agents are a cysteine\u2013cysteine motif chemokine receptor-2/5 antagonist (cenicriviroc; CVC) and galectin 3 antagonist.", {"entities": []}], ["Among a variety of medications in development, four agents such as OCA, elafibranor, ASK1 inhibitor, and CVC are currently being evaluated in an international phase 3 trial for the treatment of NASH.", {"entities": []}], ["Within the next few years, the availability of therapeutic options for NASH will hopefully curb the rising trend of NASH-related diseases.", {"entities": []}], ["Omics approaches are high-throughput unbiased technologies that provide snapshots of various aspects of biological systems and include: 1) genomics, the measure of DNA variation; 2) transcriptomics, the measure of RNA expression; 3) epigenomics, the measure of DNA alterations not involving sequence variation that influence RNA expression; 4) proteomics, the measure of protein expression or its chemical modifications; and 5) metabolomics, the measure of metabolite levels.", {"entities": []}], ["Our understanding of pulmonary diseases has increased as a result of applying these omics approaches to characterize patients, uncover mechanisms underlying drug responsiveness, and identify effects of environmental exposures and interventions.", {"entities": []}], ["As more tissue- and cell-specific omics data is analyzed and integrated for diverse patients under various conditions, there will be increased identification of key mechanisms that underlie pulmonary biological processes, disease endotypes, and novel therapeutics that are efficacious in select individuals.", {"entities": []}], ["We provide a synopsis of how omics approaches have advanced our understanding of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), idiopathic pulmonary fibrosis (IPF), and pulmonary arterial hypertension (PAH), and we highlight ongoing work that will facilitate pulmonary disease precision medicine.", {"entities": [[239, 251, "DISEASE"], [89, 126, "DISEASE"], [162, 170, "DISEASE"], [190, 208, "DISEASE"], [81, 87, "DISEASE"], [179, 208, "DISEASE"]]}], ["Underweight defined as body mass index (BMI) < 18.5 is associated with negative health and quality of life outcomes including mortality.", {"entities": []}], ["Yet, little is known about the socioeconomic differentials in underweight and its association with health and well-being among older adults in India.", {"entities": []}], ["This study examined the socioeconomic differentials in underweight among respondents aged \u226550 in India.", {"entities": []}], ["Consequently, three outcomes of the association of underweight were studied.", {"entities": []}], ["These are poor self-rated health, cognition and quality of life.", {"entities": []}], ["Cross-sectional data on 6,372 older adults derived from the first wave of the WHO\u2019s Study on global AGEing and adult health (SAGE), a nationally representative survey conducted in six states of India during 2007\u20138, were used.", {"entities": []}], ["Bivariate and multivariate regression analyses were applied to fulfil the objectives.", {"entities": []}], ["The overall prevalence of underweight was 38 percent in the study population.", {"entities": []}], ["Further, socioeconomic status showed a significant and negative association with underweight.", {"entities": []}], ["The association of underweight with poor self-rated health (OR = 1.60; p < .001), cognition (\u03b2 = \u20130.95; p < .001) and quality of life (\u03b2 = \u20131.90; p < .001) were remained statistically significant after adjusting for age, sex, place of residence, marital status, years of schooling, wealth quintile, sleep problems, chronic diseases, low back pain and state/province.", {"entities": []}], ["The results indicated significant socioeconomic differentials in underweight and its association with poor self-rated health, cognition and quality of life outcomes.", {"entities": []}], ["Interventions focussing on underweight older adults are important to enhance the overall wellbeing of the growing older population in India.", {"entities": []}], ["Ketogenic diets are high fat and low carbohydrate or very low carbohydrate diets, which render high production of ketones upon consumption known as nutritional ketosis (NK).", {"entities": []}], ["Ketosis is also produced during fasting periods, which is known as fasting ketosis (FK).", {"entities": []}], ["Recently, the combinations of NK and FK, as well as NK alone, have been used as resources for weight loss management and treatment of epilepsy.", {"entities": []}], ["A crossover study design was applied to 11 healthy individuals, who maintained moderately sedentary lifestyle, and consumed three types of diet randomly assigned over a three-week period.", {"entities": []}], ["All participants completed the diets in a randomized and counterbalanced fashion.", {"entities": []}], ["Each weekly diet protocol included three phases: Phase 1 - A mixed diet with ratio of fat: (carbohydrate\u2009+\u2009protein) by mass of 0.18 or the equivalence of 29% energy from fat from Day 1 to Day 5.", {"entities": []}], ["Phase 2- A mixed or a high-fat diet with ratio of fat: (carbohydrate\u2009+\u2009protein) by mass of approximately 0.18, 1.63, or 3.80 on Day 6 or the equivalence of 29%, 79%, or 90% energy from fat, respectively.", {"entities": []}], ["Phase 3 - A fasting diet with no calorie intake on Day 7.", {"entities": []}], ["Caloric intake from diets on Day 1 to Day 6 was equal to each individual\u2019s energy expenditure.", {"entities": []}], ["On Day 7, ketone buildup from FK was measured.", {"entities": []}], ["A statistically significant effect of Phase 2 (Day 6) diet was found on FK of Day 7, as indicated by repeated analysis of variance (ANOVA), F(2,20)\u2009=\u20096.73, p\u2009<\u20090.0058.", {"entities": []}], ["Using a Fisher LDS pair-wise comparison, higher significant levels of acetone buildup were found for diets with 79% fat content and 90% fat content vs. 29% fat content (with p\u2009=\u20090.00159**, and 0.04435**, respectively), with no significant difference between diets with 79% fat content and 90% fat content.", {"entities": []}], ["In addition, independent of the diet, a significantly higher ketone buildup capability of subjects with higher resting energy expenditure (R The online version of this article (doi:10.1186/s12937-015-0028-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Swedish government has increasingly begun to rely on so called informative governance when regulating healthcare.", {"entities": []}], ["The question this article sets out to answer is: considered to be \u201cthe backbone\u201d of the Swedish state\u2019s strategy for informative governance in healthcare, what kind of regulatory arrangement is the evidence-based National Guidelines?", {"entities": []}], ["Together with national medical registries and an extensive system of quality and efficiency indicators, the National Guidelines constitutes Sweden\u2019s quality management system.", {"entities": []}], ["A framework for evaluating and comparing regulatory arrangements was used.", {"entities": []}], ["It asks for instance: what is the purpose of the regulation and are regulation methods oriented towards deterrence or compliance?", {"entities": []}], ["The Swedish National Guidelines is a regulatory arrangement intended to govern the prioritizations of all decision makers \u2013 politicians and administrators in the self-governing county councils as well as healthcare professionals \u2013 through a compliance model backed up by top-down benchmarking and built-in mechanisms for monitoring.", {"entities": []}], ["It is thus an instrument for the central state to steer local political authorities.", {"entities": []}], ["The purpose is to achieve equitable and cost-effective healthcare.", {"entities": []}], ["This article suggests that the use of evidence-based guidelines in Swedish healthcare should be seen in the light of Sweden\u2019s constitutional setting, with several autonomous levels of political authority negotiating the scope for their decision-making power.", {"entities": []}], ["As decision-making capacity is relocated to the central government \u2013 from the democratically elected county councils responsible for financing and provision of healthcare \u2013 the Swedish National Guidelines is part of an ongoing process of healthcare recentralization in Sweden, reducing the scope for local decision-making.", {"entities": []}], ["This represents a new aspect of evidence-based medicine (EBM) and clinical practice guidelines (CPGs).", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-014-0509-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Suboptimal treatment adherence remains a barrier to the control of many infectious diseases, including tuberculosis and HIV/AIDS, which contribute significantly to the global disease burden.", {"entities": [[103, 115, "DISEASE"]]}], ["However, few of the many interventions developed to address this issue explicitly draw on theories of health behaviour.", {"entities": []}], ["Such theories could contribute to the design of more effective interventions to promote treatment adherence and to improving assessments of the transferability of these interventions across different health issues and settings.", {"entities": []}], ["This paper reviews behaviour change theories applicable to long-term treatment adherence; assesses the evidence for their effectiveness in predicting behaviour change; and examines the implications of these findings for developing strategies to improve TB and HIV/AIDS medication adherence.", {"entities": []}], ["We searched a number of electronic databases for theories of behaviour change.", {"entities": []}], ["Eleven theories were examined.", {"entities": []}], ["Little empirical evidence was located on the effectiveness of these theories in promoting adherence.", {"entities": []}], ["However, several models have the potential to both improve understanding of adherence behaviours and contribute to the design of more effective interventions to promote adherence to TB and HIV/AIDS medication.", {"entities": []}], ["Further research and analysis is needed urgently to determine which models might best improve adherence to long-term treatment regimens.", {"entities": []}], ["Chitin is an important cell wall component of Aspergillus fumigatus conidia, of which hundreds are inhaled on a daily basis.", {"entities": []}], ["Previous studies have shown that chitin has both anti- and proinflammatory properties; however the exact mechanisms determining the inflammatory signature of chitin are poorly understood, especially in human immune cells.", {"entities": []}], ["Human peripheral blood mononuclear cells were isolated from healthy volunteers and stimulated with chitin from Aspergillus fumigatus .", {"entities": []}], ["Transcription and production of the proinflammatory cytokine interleukin-1\u03b2 (IL-1\u03b2) and the anti-inflammatory cytokine IL-1 receptor antagonist (IL-1Ra) were measured from the cell culture supernatant by quantitative PCR (qPCR) or enzyme-linked immunosorbent assay (ELISA), respectively.", {"entities": []}], ["Chitin induced an anti-inflammatory signature characterized by the production of IL-1Ra in the presence of human serum, which was abrogated in immunoglobulin-depleted serum.", {"entities": []}], ["Fc-\u03b3-receptor-dependent recognition and phagocytosis of IgG-opsonized chitin was identified as a novel IL-1Ra-inducing mechanism by chitin.", {"entities": []}], ["IL-1Ra production induced by chitin was dependent on Syk kinase and phosphatidylinositol 3-kinase (PI3K) activation.", {"entities": [[53, 56, "GENE"]]}], ["In contrast, costimulation of chitin with the pattern recognition receptor (PRR) ligands lipopolysaccharide, Pam3Cys, or muramyl dipeptide, but not \u03b2-glucan, had synergistic effects on the induction of proinflammatory cytokines by human peripheral blood mononuclear cells (PBMCs).", {"entities": []}], ["In conclusion, chitin can have both pro- and anti-inflammatory properties, depending on the presence of pathogen-associated molecular patterns and immunoglobulins, thus explaining the various inflammatory signatures reported for chitin.", {"entities": []}], ["Invasive aspergillosis and allergic aspergillosis are increasing health care problems.", {"entities": [[9, 22, "DISEASE"], [36, 49, "DISEASE"]]}], ["Patients get infected by inhalation of the airborne spores of Aspergillus fumigatus .", {"entities": []}], ["A profound knowledge of how Aspergillus and its cell wall components are recognized by the host cell and which type of immune response it induces is necessary to develop target-specific treatment options with less severe side effects than the treatment options to date.", {"entities": []}], ["There is controversy in the literature about the receptor for chitin in human cells.", {"entities": []}], ["We identified the Fc-\u03b3 receptor and Syk/PI3K pathway via which chitin can induce anti-inflammatory immune responses by inducing IL-1 receptor antagonist in the presence of human immunoglobulins but also proinflammatory responses in the presence of bacterial components.", {"entities": []}], ["This explains why Aspergillus does not induce strong inflammation just by inhalation and rather fulfills an immune-dampening function.", {"entities": []}], ["While in a lung coinfected with bacteria, Aspergillus augments immune responses by shifting toward a proinflammatory reaction.", {"entities": []}], ["Chitinases are enzymes that hydrolyze chitin, a polymer of \u03b2-1, 4-linked N -acetyl-D-glucosamine (GlcNAc).", {"entities": []}], ["Chitin has long been considered as a source of dietary fiber that is not digested in the mammalian digestive system.", {"entities": []}], ["Here, we provide evidence that acidic mammalian chitinase (AMCase) can function as a major digestive enzyme that constitutively degrades chitin substrates and produces (GlcNAc) 2 fragments in the mouse gastrointestinal environment.", {"entities": []}], ["AMCase was resistant to endogenous pepsin C digestion and remained active in the mouse stomach extract at pH 2.0.", {"entities": []}], ["The AMCase mRNA levels were much higher than those of four major gastric proteins and two housekeeping genes and comparable to the level of pepsinogen C in the mouse stomach tissues.", {"entities": []}], ["Furthermore, AMCase was expressed in the gastric pepsinogen-synthesizing chief cells.", {"entities": []}], ["The enzyme was also stable and active in the presence of trypsin and chymotrypsin at pH 7.6, where pepsin C was completely degraded.", {"entities": []}], ["Mouse AMCase degraded polymeric colloidal and crystalline chitin substrates in the gastrointestinal environments in presence of the proteolytic enzymes.", {"entities": []}], ["Thus, AMCase can function as a protease-resistant major glycosidase under the conditions of stomach and intestine and degrade chitin substrates to produce (GlcNAc) 2 , a source of carbon, nitrogen and energy.", {"entities": []}], ["The burden of chronic obstructive pulmonary disease (COPD) is expected to increase in the coming decades.", {"entities": [[14, 51, "DISEASE"]]}], ["In Ulaanbaatar, Mongolia, air pollution, which has been suggested to correlate with COPD, is a growing concern.", {"entities": []}], ["However, the COPD prevalence in Ulaanbaatar is currently unknown.", {"entities": []}], ["This study aims to estimate the prevalence of airflow limitation and investigate the association between airflow limitation and putative risk factors in the Mongolian population.", {"entities": []}], ["Five cross-sectional studies were carried out in Ulaanbaatar.", {"entities": []}], ["Administration of a self-completed questionnaire, body measurements, and medical examination including spirometry were performed in 746 subjects aged 40 to 79 years living in Ulaanbaatar.", {"entities": []}], ["The age- and sex-standardized prevalence of airflow limitation in Ulaanbaatar varied widely from 4.0 to 10.9% depending on the criteria for asthma.", {"entities": [[140, 146, "DISEASE"]]}], ["Age, body mass index (BMI), and smoking habit were independent predictors for airflow limitation while residential area and household fuel type were not significant.", {"entities": []}], ["In conclusion, prevalence of putative COPD was 10.0% when subjects with physician-diagnosed asthma were excluded from COPD.", {"entities": [[92, 98, "DISEASE"]]}], ["Older age, lower BMI, and current smoking status were putative risk factors for airflow limitation.", {"entities": []}], ["This prevalence was consistent with reports from Asian countries.", {"entities": []}], ["To validate the prevalence rate of symptoms of asthma produced by the phase I ISAAC (International Study of Asthma and Allergies in Childhood) study, hypertonic saline challenge test was carried out during the phase II study at a year after the phase I study.", {"entities": [[47, 53, "DISEASE"], [108, 114, "DISEASE"]]}], ["For the phase II study, six middle schools from three cities in the phase I study were selected.", {"entities": []}], ["Finally, 499 children who responded to both studies were analyzed.", {"entities": []}], ["All subjects were asked to complete the written questionnaire (WQ) first, followed by a video questionnaire (AVQ 3.0) during the phase I study.", {"entities": []}], ["Of the 499 children, only 19 (3.8%) were positive to the hypertonic saline bronchial challenge test.", {"entities": []}], ["The degree of agreement between responses to the two corresponding questions \"wheezing at rest\" and \"nocturnal wheeze\" in the AVQ 3.0 and WQ were moderate and weak with a Kappa indices of 0.45 and 0.23, respectively.", {"entities": []}], ["The question on \"severe wheeze\" in the AVQ 3.0 had the highest Youden's index among the five questions related to asthma symptoms in the previous 12 months, but its specificity was low whereas its sensitivity was 1.0.", {"entities": [[114, 120, "DISEASE"]]}], ["There was no consistency of priority between the two questionnaires in predicting bronchial hyperreactivity in a group of Korean schoolchildren.", {"entities": []}], ["Therefore we need to develop more appropriate WQ or AVQ to compare the prevalences of asthma to other countries.", {"entities": [[86, 92, "DISEASE"]]}], ["Health professionals, policy-makers and researchers need to be able to explore potential associations between prevalence rates and quality of care with a range of possible determinants including socio-economic deprivation and morbidity levels to determine the impact of commissioning and service delivery.", {"entities": []}], ["In the UK, data in England are only available nationally at practice postcode level.", {"entities": []}], ["In Scotland, such data are available based on an aggregate of the practices population's postcodes.", {"entities": []}], ["The use of data assigned to the practice postcode may underestimate the association between ill health and income deprivation.", {"entities": []}], ["Here, we report on the impact of using data assigned to the practice population by comparing analyses using English and Scottish data.", {"entities": []}], ["Income deprivation based on data assigned to the practice postcode under-estimated deprivation compared to using income deprivation data assigned to the practice population for the five least deprived deciles, and over-estimated deprivation for the five most deprived deciles.", {"entities": []}], ["The biggest differences were found for the most deprived decile.", {"entities": []}], ["A similar trend was found for limiting long-term illness (LLTI).", {"entities": []}], ["Differences between the QOF prevalence rates of the least and most deprived deciles using practice postcode data were similar (0.2% points or less) in England and Scotland for 8 out of 10 clinical domains.", {"entities": []}], ["Using practice population assigned deprivation, differences in the prevalence rate between the least and most deprived deciles increase for all clinical domains.", {"entities": []}], ["A similar trend was again found for LLTI.", {"entities": []}], ["Using practice population assigned deprivation, differences for population achievement increase for all CHD quality indicators with the exception of beta-blockers (CHD10).", {"entities": []}], ["With practice postcode assigned deprivation, significant differences between the least and most deprived deciles were found for 2 out 8 indicators, compared to 5 using practice population assigned deprivation.", {"entities": []}], ["For LLTI differences between the lowest and most deprived deciles increased for all indicators when ill health assigned to the practice population was used.", {"entities": []}], ["We have found, through comparing deprivation and ill health data assigned to either the practice postcode or the practice population postcode in Scotland, that analyses based on practice postcode assigned data under-estimated the relationship between deprivation and ill health for both prevalence and quality care.", {"entities": []}], ["Given the importance of understanding the effect of deprivation and ill health on a range of determinants related to health care, policy makers should ensure that practice population data are available and used at national level in England and elsewhere where possible.", {"entities": []}], ["Mesenchymal stem cells (MSCs) reside in almost all of the body tissues, where they undergo self-renewal and multi-lineage differentiation.", {"entities": []}], ["MSCs derived from different tissues share many similarities but also show some differences in term of biological properties.", {"entities": []}], ["We aim to search for significant differences among various sources of MSCs and to explore their implications in physiopathology and clinical translation.", {"entities": []}], ["We compared the phenotype and biological properties among different MSCs isolated from human term placental chorionic villi (CV), umbilical cord (UC), adult bone marrow (BM) and adipose (AD).", {"entities": []}], ["We found that CD106 (VCAM-1) was expressed highest on the CV-MSCs, moderately on BM-MSCs, lightly on UC-MSCs and absent on AD-MSCs.", {"entities": []}], ["CV-MSCs also showed unique immune-associated gene expression and immunomodulation.", {"entities": []}], ["We thus separated CD106", {"entities": []}], ["Smoking is harmful to the health of adolescents because their bodies are still growing.", {"entities": []}], ["The aim of this study was to analyze the association between the smoking status of Korean adolescents\u2019 parents and friends and their own smoking behavior.", {"entities": []}], ["The study assessed a nationwide sample of 72,060 middle and high students from the 10th Korea Youth Risk Behavior Web-based Survey (2014).", {"entities": []}], ["Descriptive analysis, chi-square tests, and multiple logistic regression analysis were used to probe the association between family and friend smoking status and adolescent smoking behavior.", {"entities": []}], ["The current cigarette smoking rates were 13.3% of boys and 4.1% of girls.", {"entities": []}], ["The corresponding rates for electronic cigarette smoking were 4.1% and 1.5%, respectively.", {"entities": []}], ["Higher exposure to secondhand smoke, smoking by any family member, more friends smoking, and witnessed smoking at school were associated with current smoking and electronic smoking.", {"entities": []}], ["The smoking status of family and friends was significantly related to adolescent smoking behavior.", {"entities": []}], ["These results should be considered in designing programs to control adolescent smoking.", {"entities": []}], ["Periodontal disease (periodontitis) is a chronic inflammatory condition initiated by microbial infection that leads to gingival tissue destruction and alveolar bone resorption.", {"entities": [[21, 34, "DISEASE"], [0, 19, "DISEASE"]]}], ["The periodontal tissue\u2019s response to dental plaque is characterized by the accumulation of polymorphonuclear leukocytes, macrophages, and lymphocytes, all of which release inflammatory mediators and cytokines to orchestrate the immunopathogenesis of periodontal disease.", {"entities": [[250, 269, "DISEASE"]]}], ["Ubiquitination is achieved by a mechanism that involves a number of factors, including an ubiquitin-activating enzyme, ubiquitin-conjugating enzyme, and ubiquitin\u2013protein ligase.", {"entities": []}], ["Ubiquitination is a post-translational modification restricted to eukaryotes that are involved in essential host processes.", {"entities": []}], ["The ubiquitin system has been implicated in the immune response, development, and programmed cell death.", {"entities": []}], ["Increasing numbers of recent reports have provided evidence that many approaches are delivering promising reports for discovering the relationship between ubiquitination and periodontal disease.", {"entities": [[174, 193, "DISEASE"]]}], ["The scope of this review was to investigate recent progress in the discovery of ubiquitinated protein in diseased periodontium and to discuss the ubiquitination process in periodontal diseases.", {"entities": []}], ["The cornified envelope is assembled from transglutaminase cross-linked proteins and lipids in the outermost epidermal layers and is essential for skin barrier function.", {"entities": []}], ["Involucrin, envoplakin, and periplakin form the protein scaffold on which the envelope assembles.", {"entities": []}], ["To examine their combined function, we generated mice deficient in all three genes.", {"entities": []}], ["The triple knockouts have delayed embryonic barrier formation and postnatal hyperkeratosis (abnormal accumulation of cornified cells) resulting from impaired desquamation.", {"entities": []}], ["Cornified envelopes form but are ultrastructurally abnormal, with reduced lipid content and decreased mechanical integrity.", {"entities": []}], ["Expression of proteases is reduced and the protease inhibitor, serpina1b, is highly upregulated, resulting in defective filaggrin processing and delayed degradation of desmoglein 1 and corneodesmosin.", {"entities": []}], ["There is infiltration of CD4", {"entities": [[25, 28, "GENE"]]}], ["Plastic bronchitis is an uncommon disorder characterized by the formation of bronchial casts.", {"entities": [[8, 18, "DISEASE"]]}], ["It is associated with congenital heart disease or pulmonary disease.", {"entities": [[33, 46, "DISEASE"]]}], ["In children with underlying conditions such as allergy or asthma, influenza can cause severe plastic bronchitis resulting in respiratory failure.", {"entities": [[125, 144, "DISEASE"], [66, 75, "DISEASE"], [58, 64, "DISEASE"], [101, 111, "DISEASE"]]}], ["A review of the literature showed nine cases of plastic bronchitis with H1N1 including this case.", {"entities": [[56, 66, "DISEASE"]]}], ["We report a case of a child with recurrent plastic bronchitis with eosinophilic cast associated with influenza B infection, who had recovered from plastic bronchitis associated with an influenza A (H1N1) virus infection 5 months previously.", {"entities": [[101, 110, "DISEASE"], [185, 194, "DISEASE"], [51, 61, "DISEASE"], [155, 165, "DISEASE"]]}], ["To the best of our knowledge, this is the first case of recurrent plastic bronchitis related to influenza viral infection.", {"entities": [[96, 105, "DISEASE"], [74, 84, "DISEASE"]]}], ["If patients with influenza virus infection manifest acute respiratory distress with total lung atelectasis, clinicians should consider plastic bronchitis and early bronchoscopy should be intervened.", {"entities": [[17, 26, "DISEASE"], [143, 153, "DISEASE"]]}], ["In addition, management for underlying disease may prevent from recurrence of plastic bronchitis.", {"entities": [[86, 96, "DISEASE"]]}], ["Activation Induced Deaminase (AID) triggers the antigen-driven antibody diversification processes through its ability to edit DNA.", {"entities": []}], ["AID dependent DNA damage is also the cause of genetic alterations often found in mature B cell tumors.", {"entities": []}], ["A number of splice variants of AID have been identified, for which a role in the modulation of its activity has been hypothesized.", {"entities": []}], ["We have thus tested two of these splice variants, which we find catalytically inactive, for their ability to modulate the activity of endogenous AID in CH12F3 cells, a murine lymphoma cell line in which Class Switch Recombination (CSR) can be induced.", {"entities": [[175, 183, "DISEASE"]]}], ["In contrast to full-length AID, neither these splice variants or a catalytically impaired AID mutant affect the efficiency of Class Switch Recombination.", {"entities": []}], ["Thus, while a role for these splice variants at the RNA level remains possible, it is unlikely that they exert any regulatory effect on the function of AID.", {"entities": []}], ["Kawasaki disease (KD) is known to be associated with T help (Th) 2 reaction and subsequently allergic diseases.", {"entities": []}], ["Interleukin-31 (IL-31) has also been reported to be involved in Th2 mediated diseases such as allergic diseases.", {"entities": []}], ["However, the role of IL-31 in KD has not been previously reported.", {"entities": []}], ["The aim of this study is to investigate whether IL-31 is associated with KD and its clinical outcome.", {"entities": []}], ["A total of 78 KD patients who met the criteria of KD were enrolled in this study as well as 20 age-matched controls.", {"entities": []}], ["Plasma samples were conducted to measure IL-31 before intravenous immunoglobulin (IVIG) treatment (KD1), within 3 days after IVIG treatment (KD2) and at least 3 weeks after IVIG treatment (KD3) by utilizing enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["Our findings showed that IL-31 expression was higher in KD patients after IVIG treatment significantly (KD2>KD1: 1265.0\u00b1199.3 vs. 840.2\u00b1152.5 pg/ml, p<0.0001).", {"entities": []}], ["Further analysis revealed that IL-31 level was significantly higher in KD patients with coronary artery lesion (CAL) (656.6\u00b1139.5 vs. 1373.0\u00b1422.0 pg/ml, p\u200a=\u200a0.04) before IVIG treatment (KD1).", {"entities": []}], ["There were no significant differences between the IVIG resistance and IVIG responsiveness groups.", {"entities": []}], ["IL-31 was increased after IVIG treatment in patients with KD and was significantly associated with CAL formation.", {"entities": []}], ["The results from this study may help to identify a novel risk factor for predicting KD and CAL formation.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) experience symptoms that vary over the day.", {"entities": [[14, 51, "DISEASE"]]}], ["Symptoms at the start of the day might influence physical activity during the rest of the day.", {"entities": []}], ["Therefore, physical activity during the course of the day was studied in patients with low and high morning symptom scores.", {"entities": []}], ["This cross-sectional observational study included patients with moderate to very severe COPD.", {"entities": []}], ["Morning symptoms were evaluated with the PRO-morning COPD Symptoms Questionnaire (range 0\u201360); the median score was used to create two groups (low and high morning symptom scores).", {"entities": []}], ["Physical activity was examined with an accelerometer.", {"entities": []}], ["Activity parameters during the night, morning, afternoon and evening were compared between patients with low and high morning symptom scores using independent t-tests or Mann-Whitney U tests.", {"entities": []}], ["Seventy nine patients were included.", {"entities": []}], ["Patients were aged (mean\u2009\u00b1\u2009SD) 65.6\u2009\u00b1\u20098.8\u00a0years with a mean forced expiratory volume in 1\u00a0s of 55\u2009\u00b1\u200917%predicted.", {"entities": []}], ["Patients with low morning symptom scores (score\u2009<\u200917.0) took more steps in the afternoon ( p \u2009=\u20090.015) and morning ( p \u2009=\u20090.030).", {"entities": []}], ["There were no significant differences during the evening and night.", {"entities": []}], ["Patients with high morning symptom scores took significantly fewer steps in the morning and afternoon than those with low morning symptom scores.", {"entities": []}], ["Prospective studies are needed to prove causality between morning symptoms and physical activity during different parts of the day.", {"entities": []}], ["The online version of this article (10.1186/s12931-018-0749-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aims of this study are the following: to describe the female population of reproductive age having bariatric surgery in the UK, to assess the age and ethnicity of women accessing surgery, and to assess the effect of bariatric surgery on factors that underlie fertility and pregnancy outcomes.", {"entities": []}], ["Demographic details, comorbidities, and operative type of women aged 18\u201345\u00a0years were extracted from the National Bariatric Surgery Registry (NBSR).", {"entities": []}], ["A comparison was made with non-operative cases (aged 18\u201345 and BMI \u226540\u00a0kg/m Data were extracted on 15,222 women from NBSR and 1073 from HSE.", {"entities": []}], ["Women aged 18\u201345 comprised 53\u00a0% of operations.", {"entities": []}], ["Non-Caucasians were under-represented in NBSR compared to HSE (10 vs 16\u00a0% respectively, p \u2009<\u20090.0001).", {"entities": []}], ["The NBSR group was older than the HSE group\u2014median 38 (IQR 32\u201342) vs 36 (IQR 30\u201341) years (Wilcoxon test p \u2009<\u20090.0001).", {"entities": []}], ["Almost one third of women in NBSR had menstrual dysfunction at baseline (33.0\u00a0%).", {"entities": []}], ["BMI fell in the first year postoperatively from 48.2\u2009\u00b1\u20098.3 to 37.4\u2009\u00b1\u20097.5\u00a0kg/m t test, p \u2009<\u20090.001).", {"entities": []}], ["From NBSR, in the postoperative period, the prevalence of type 2 diabetes fell by 54\u00a0%, polycystic ovarian syndrome by 15\u00a0%, and any menstrual dysfunction by 12\u00a0%.", {"entities": [[107, 115, "DISEASE"]]}], ["Over half of all bariatric procedures are carried out on women of reproductive age.", {"entities": []}], ["More work is required to provide prompt and equal access across ethnic groups.", {"entities": []}], ["At least one in three women suffers from menstrual dysfunction at baseline.", {"entities": []}], ["Bariatric surgery improves factors that underlie fertility and pregnancy outcomes.", {"entities": []}], ["A prospective study is required to verify these effects.", {"entities": []}], ["Asthma is a major public health problem with a huge social and economic burden affecting 300 million people worldwide.", {"entities": [[0, 6, "DISEASE"]]}], ["Viral respiratory infections are the major cause of acute asthma exacerbations and may contribute to asthma inception in high risk young children with susceptible genetic background.", {"entities": [[58, 64, "DISEASE"], [101, 107, "DISEASE"]]}], ["Acute exacerbations are associated with decreased lung growth or accelerated loss of lung function and, as such, add substantially to both the cost and morbidity associated with asthma.", {"entities": [[178, 184, "DISEASE"]]}], ["While the importance of preventing viral infection is well established, preventive strategies have not been well explored.", {"entities": []}], ["Good personal hygiene, hand-washing and avoidance of cigarette smoke are likely to reduce respiratory viral infections.", {"entities": []}], ["Eating a healthy balanced diet, active probiotic supplements and bacterial-derived products, such as OM-85, may reduce recurrent infections in susceptible children.", {"entities": []}], ["There are no practical anti-viral therapies currently available that are suitable for widespread use.", {"entities": []}], ["Hand hygiene is the best measure to prevent the common cold.", {"entities": [[48, 59, "DISEASE"]]}], ["A healthy balanced diet, active probiotic supplements and immunostimulant OM-85 may reduce recurrent infections in asthmatic children.", {"entities": []}], ["To examine the long-term development of physical and mental health following exposure to a volcanic eruption.", {"entities": []}], ["Population-based prospective cohort study.", {"entities": []}], ["In spring 2010, the Icelandic volcano Eyjafjallaj\u00f6kull erupted.", {"entities": []}], ["Data were collected at 2 time points: in 2010 and 2013.", {"entities": []}], ["Adult residents in areas close to the Eyjafjallaj\u00f6kull volcano (N=1096), divided according to exposure levels, and a non-exposed sample (n=475), with 80% participation rate in 2013.", {"entities": []}], ["Physical symptoms in the previous year (chronic) and previous month (recent), and psychological distress (General Health Questionnaire-12-item version, GHQ-12), perceived stress (Perceived Stress Scale, PSS-4) and post traumatic stress disorder (PTSD) symptoms (Primary Care PTSD, PC-PTSD).", {"entities": []}], ["In the exposed group, certain symptoms were higher in 2013 than in 2010, for example, morning phlegm during winter (OR 2.14; 95% CI 1.49 to 3.06), skin rash/eczema (OR 2.86; 95% CI 1.76 to 4.65), back pain (OR 1.45; 95% CI 1.03 to 2.05) and insomnia (OR 1.53; 95% CI 1.01 to 2.30), in addition to a higher prevalence of regular use of certain medications (eg, for asthma (OR 2.80; 95% CI 1.01 to 7.77)).", {"entities": [[364, 370, "DISEASE"]]}], ["PTSD symptoms decreased between 2010 and 2013 (OR 0.33; 95% CI 0.17 to 0.61), while the prevalence of psychological distress and perceived stress remained similar.", {"entities": []}], ["In 2013, the exposed group showed a higher prevalence of various respiratory symptoms than did the non-exposed group, such as wheezing without a cold (high exposure OR 2.35; 95% CI 1.27 to 4.47) and phlegm (high exposure OR 2.81; 95% CI 1.48 to 5.55), some symptoms reflecting the degree of exposure (eg, nocturnal chest tightness (medium exposed OR 3.09; 95% CI 1.21 to 10.46; high exposed OR 3.42; 95% CI 1.30 to 11.79)).", {"entities": []}], ["The findings indicate that people exposed to a volcanic eruption, especially those most exposed, exhibit increased risk of certain symptoms 3\u20134\u2005years after the eruption.", {"entities": []}], ["Pattern recognition receptors (PRRs) such as Toll-like receptors are aberrantly expressed of peripheral blood mononuclear cells (PBMCs) in systemic lupus erythematosus (SLE) patients, for playing immunopathological roles.", {"entities": [[148, 167, "DISEASE"], [139, 167, "DISEASE"]]}], ["We investigated the expression and function of the PRR nucleotide-binding oligomerization domain (NOD2) in SLE.", {"entities": [[98, 102, "GENE"]]}], ["NOD2 expression in T, B lymphocytes, monocytes, myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs) was assessed in SLE patients and healthy controls (HCs) using flow cytometric analysis.", {"entities": [[0, 4, "GENE"]]}], ["Ex vivo production of cytokines from PBMCs upon NOD2 agonist muramyl dipeptide (MDP) stimulation was assessed using Cytometric Bead Array.", {"entities": [[48, 52, "GENE"]]}], ["Over-expression of NOD2 in monocytes was observed in immunosuppressant na\u00efve SLE patients, and was positively associated with longer disease duration.", {"entities": [[19, 23, "GENE"]]}], ["Immunosuppressive therapy was an independent explanatory variable for downregulating NOD2 expression in CD8+ T, monocytes, mDCs and pDCs.", {"entities": [[85, 89, "GENE"]]}], ["Ex vivo basal productions of cytokines (IL-6, IL-8 and IL-10) were significantly increased in immunosuppressant na\u00efve patients and patients with active disease despite immunosuppressants compared with HCs.", {"entities": []}], ["Upon MDP stimulaiton, relative induction (%) of cytokines (IL-1\u03b2) from PBMC was significantly increased in immunosuppressant na\u00efve patients with inactive disease, and patients with active disease despite immunosuppressant treatment compared with HCs.", {"entities": []}], ["Immunosuppressant usage was associated with a decreased basal production and MDP induced relative induction (%) of IL-10 in patients with inactive disease compared with immunosuppressant na\u00efve patients and HCs.", {"entities": []}], ["Bacterial exposure may increase the NOD2 expression in monocytes in immunosuppressant na\u00efve SLE patients which can subsequently lead to aberrant activation of PBMCs to produce proinflammatory cytokines, implicating the innate immune response for extracellular pathogens in the immunopathological mechanisms in SLE.", {"entities": [[36, 40, "GENE"]]}], ["Immunosuppressant therapy may downregulate NOD2 expression in CD8+ T lymphocytes, monocytes, and DCs in SLE patients which subsequently IL-10 reduction, contributing towards the regulation of immunopathological mechanisms of SLE, at the expense of increasing risk of bacterial infection.", {"entities": [[43, 47, "GENE"]]}], ["Medical education is increasingly being conducted in community-based teaching sites at diverse locations, making it difficult to provide a consistent curriculum.", {"entities": []}], ["We conducted a randomized trial to assess whether students who viewed digital lectures would perform as well on a measure of cognitive knowledge as students who viewed live lectures.", {"entities": []}], ["Students' perceptions of the digital lecture format and their opinion as whether a digital lecture format could serve as an adequate replacement for live lectures was also assessed.", {"entities": []}], ["Students were randomized to either attend a lecture series at our main campus or view digital versions of the same lectures at community-based teaching sites.", {"entities": []}], ["Both groups completed the same examination based on the lectures, and the group viewing the digital lectures completed a feedback form on the digital format.", {"entities": []}], ["There were no differences in performance as measured by means or average rank.", {"entities": []}], ["Despite technical problems, the students who viewed the digital lectures overwhelmingly felt the digital lectures could replace live lectures.", {"entities": []}], ["This study provides preliminary evidence digital lectures can be a viable alternative to live lectures as a means of delivering didactic presentations in a community-based setting.", {"entities": []}], ["Bioinformatics tools available for metagenomic sequencing analysis are principally devoted to the identification of microorganisms populating an ecological niche, but they usually do not consider viruses.", {"entities": []}], ["Only some software have been designed to profile the viral sequences, however they are not efficient in the characterization of viruses in the context of complex communities, like the intestinal microbiota, containing bacteria, archeabacteria, eukaryotic microorganisms and viruses.", {"entities": []}], ["In any case, a comprehensive description of the host-microbiota interactions can not ignore the profile of eukaryotic viruses within the virome, as viruses are definitely critical for the regulation of the host immunophenotype.", {"entities": []}], ["ViromeScan is an innovative metagenomic analysis tool that characterizes the taxonomy of the virome directly from raw data of next-generation sequencing.", {"entities": []}], ["The tool uses hierarchical databases for eukaryotic viruses to unambiguously assign reads to viral species more accurately and >1000 fold faster than other existing approaches.", {"entities": []}], ["We validated ViromeScan on synthetic microbial communities and applied it on metagenomic samples of the Human Microbiome Project, providing a sensitive eukaryotic virome profiling of different human body sites.", {"entities": []}], ["ViromeScan allows the user to explore and taxonomically characterize the virome from metagenomic reads, efficiently denoising samples from reads of other microorganisms.", {"entities": []}], ["This implies that users can fully characterize the microbiome, including bacteria and viruses, by shotgun metagenomic sequencing followed by different bioinformatic pipelines.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-016-2446-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Significant health disparities exist between limited English proficient and English-proficient patients.", {"entities": []}], ["Little is known about the impact of language services on chronic disease outcomes such as for diabetes.", {"entities": []}], ["To determine whether the amount and type of language services received during primary care visits had an impact on diabetes-related outcomes (hospitalization, emergency room utilization, glycemic control) in limited English proficient patients, a retrospective cohort design was utilized.", {"entities": []}], ["Hospital and medical record data was examined for 1425 limited English proficient patients in the Cambridge Health Alliance diabetes registry.", {"entities": []}], ["We categorized patients receiving usual care into 7 groups based on the amount and combination of language services (language concordant providers, formal interpretation and nothing) received at primary care visits during a 9 month period.", {"entities": []}], ["Bivariate analyses and multiple logistic regression were used to determine relationships between language service categories and outcomes in the subsequent 6 months.", {"entities": []}], ["Thirty-one percent of patients (445) had no documentation of interpreter use or seeing a language concordant provider in any visits.", {"entities": []}], ["Patients who received 100% of their primary care visits with language concordant providers were least likely to have diabetes-related emergency department visits compared to other groups (p<0001) in the following 6 months.", {"entities": []}], ["Patients with higher numbers of co-morbidities were more likely to receive formal interpretation.", {"entities": []}], ["Language concordant providers may help reduce health care utilization for limited English proficient patients with diabetes.", {"entities": []}], ["However, given the lack of such providers in sufficient numbers to meet patients' communication needs, strategies are needed to both increase their numbers and ensure that the highest risk patients receive the most appropriate language services.", {"entities": []}], ["In addition, systems serving diverse populations must clarify why some limited English proficient patients do not receive language services at some or all of their visits and whether this has an impact on quality of care.", {"entities": []}], ["Previous studies have suggested that children of mothers who experience depression during the perinatal period may have more infections, but such studies are few in number and none have been carried out in the United Kingdom (UK) population.", {"entities": []}], ["The aim of this study was to investigate the association between perinatal depression in mothers and the risk of childhood infections in offspring in the UK general population.", {"entities": []}], ["We used data from The Health Improvement Network (THIN), a large database of electronic primary care medical records to conduct a cohort study among all first-born singleton children born and enrolled in THIN between 1988 and 2004.", {"entities": []}], ["We used Poisson regression to compare the incidence of gastrointestinal infections and lower respiratory tract infections reported between birth and age 4 years among children of mothers with a record of perinatal depression with those born to mothers with no such history.", {"entities": []}], ["Children of mothers with perinatal depression had a 40% increased risk of gastrointestinal infections and a 27% increased risk of lower respiratory tract infections compared with children of mothers without perinatal depression (incidence rate ratios = 1.40 and 1.27; 95% confidence intervals 1.37-1.42 and 1.22-1.32, respectively).", {"entities": []}], ["On restricting to antibiotic-treated infections there was a slight increase in the magnitude of association with gastrointestinal infections but a decrease in that with lower respiratory tract infections (incidence rate ratios = 1.47 and 1.19; 95% confidence intervals 1.34-1.61 and 1.11-1.27, respectively).", {"entities": []}], ["Maternal perinatal depression is associated with increased rates of childhood gastrointestinal infections, particularly more severe infections, and lower respiratory tract infections in the UK.", {"entities": []}], ["Preventing maternal perinatal depression may avoid substantial morbidity among offspring, although further work is also needed to investigate the detailed reasons for these findings.", {"entities": []}], ["To evaluate bronchial challenges using three different stimuli as screening tools for bronchial hyper-responsiveness in sulfur mustard gas-induced asthma.", {"entities": [[147, 153, "DISEASE"]]}], ["Randomized, cross-over clinical study.", {"entities": []}], ["University hospital.", {"entities": []}], ["Eighteen veterans with mustard gas-induced asthma and 18 normal veterans as the control group.", {"entities": [[43, 49, "DISEASE"]]}], ["Pulmonary function tests and inhalation challenges with ultrasonically nebulized distilled water (UNDW), methacholine, and ultrasonically nebulized cold water (UNDCW) were performed on all patients and subjects.", {"entities": []}], ["Six mustard gas-induced asthmatic veterans did not respond to a 20% in FEV 1 after distilled water (13.3%), and two of them (11.11%) did not respond with distilled cold water; all responded with methacholine.", {"entities": [[71, 74, "GENE"]]}], ["Only one healthy subject developed a PC20 FEV 1 after methacholine but did not with both distilled water and distilled cold water challenges.", {"entities": [[42, 45, "GENE"]]}], ["The asthmatic patients were sensitive to distilled water with a median PD20 of 7.24 \u00b1 3.83 ml (range 2.54 ml to 15.83 ml), and sensitive to cold water with a median PD20 of 6.42 \u00b1 6.24 ml (range 1.92 ml to 25.15 ml).", {"entities": []}], ["The median PC20 methacholine was 1.90 \u00b1 1.88 mg/ml (range 0.14 mg/ml to 6.20 mg/ml).", {"entities": []}], ["In patients with a positive response to the distilled water challenge test, no significant correlation was found between PC20 of methacholine and PD20 of distilled water (Rho = \u22120.34, p = 0.25), whereas in patients whose responses to distilled cold water (DCW) were positive, PD20 of distilled cold water (DCW) correlated well with PC20 of methacholine (Rho = \u22120.69, p = 0.006).", {"entities": []}], ["Overall, the methacholine challenge test is the best method to distinguish these asthmatic patients from normal subjects in this study.", {"entities": []}], ["When compared to the methacholine challenge, although the airway response to ultrasonically nebulized distilled cold water test was somewhat less sensitive, it may be used as a simple, fast, inexpensive, and relatively reliable method to predict the absence of asthma in sulfur mustard gas-induced asthma.", {"entities": [[261, 267, "DISEASE"], [298, 304, "DISEASE"]]}], ["Phaxan\u2122 (PHAX, Chemic Labs, Canton, MA) is an aqueous solution of 10 mg/mL alphaxalone and 13% 7-sulfobutylether \u03b2-cyclodextrin (betadex).", {"entities": [[9, 13, "GENE"]]}], ["In preclinical studies, PHAX is a fast onset\u2013offset IV anesthetic like propofol, but causes less cardiovascular depression.", {"entities": [[24, 28, "GENE"]]}], ["This first-in-man study was designed to find the anesthetic dose of PHAX and to compare it with an equivalent dose of propofol for safety, efficacy, and quality of recovery from anesthesia and sedation.", {"entities": [[68, 72, "GENE"]]}], ["The study adhered to compliance with Good Clinical Practices regulations (clinical trials registry number, ACTRN12611000343909).", {"entities": []}], ["This randomized, double-blind study compared PHAX and propofol using a Bayesian algorithm to determine dose equivalence for effects on the bispectral index (BIS).", {"entities": [[45, 49, "GENE"]]}], ["Male volunteers, ASA physical status I, gave written informed consent ( n = 12 per group; PHAX or propofol).", {"entities": [[90, 94, "GENE"]]}], ["Parameters assessed for 80 minutes after drug injection (single bolus dose) were pain on injection, involuntary movement, BIS, blood pressure, need for airway support, and, as measures of recovery from sedation, the Richmond Agitation and Sedation Scale and the Digit Symbol Substitution Test.", {"entities": []}], ["Arterial blood was withdrawn for biochemistry, hematology, and complement levels.", {"entities": []}], ["No subject complained of pain on injection with PHAX, whereas 8 of the 12 subjects given propofol did.", {"entities": [[48, 52, "GENE"]]}], ["Nine PHAX and 8 propofol subjects reached BIS values of \u226450: median (interquartile range [IQR]) mg/kg dose = 0.5 (0.5\u20130.6) for PHAX and 2.9 (2.4\u20133.0) for propofol.", {"entities": [[5, 9, "GENE"], [127, 131, "GENE"], [5, 9, "GENE"], [127, 131, "GENE"]]}], ["The lowest median BIS reached was 27 to 28 for both agents with no significant differences between them for timing of onset and recovery of BIS.", {"entities": []}], ["The concomitant median changes in systolic and diastolic blood pressures were \u221211% vs \u221219% for systolic and \u221225% vs \u221237% for diastolic in PHAX- and propofol-treated subjects, respectively.", {"entities": []}], ["Nine of the 12 propofol-treated subjects and none of 12 PHAX-treated subjects required airway support.", {"entities": []}], ["For subjects reaching an equivalent BIS of \u226450: a Richmond Agitation and Sedation Scale score of 0 was reached at a median of 5 (IQR, 5\u201310) and 15 (IQR, 10\u201320) minutes after PHAX and propofol, respectively; BIS returned to 90 at a mean of 21 (SD, 10.1) and 21 (SD, 9.2) minutes after PHAX and propofol, respectively; and Digit Symbol Substitution Test scores returned to predrug injection values at median of 50 (IQR, 35\u201372.5) and 42.5 (IQR, 35\u201376.3) minutes after PHAX and propofol, respectively.", {"entities": [[174, 178, "GENE"], [284, 288, "GENE"], [465, 469, "GENE"], [174, 178, "GENE"], [284, 288, "GENE"], [465, 469, "GENE"], [174, 178, "GENE"], [284, 288, "GENE"], [465, 469, "GENE"]]}], ["There was no increase in C3 and C4 complement fractions after either drug.", {"entities": [[25, 27, "GENE"]]}], ["PHAX causes fast-onset, short-duration anesthesia with fast cognitive recovery similar to propofol, but with less cardiovascular depression, or airway obstruction and no pain on injection.", {"entities": [[0, 4, "GENE"]]}], ["Published ahead of print July 29, 2015", {"entities": []}], ["GTPase of immunity-associated protein 5 (Gimap5) is linked with lymphocyte survival, autoimmunity, and colitis, but its mechanisms of action are unclear.", {"entities": [[41, 47, "GENE"]]}], ["Here, we show that Gimap5 is essential for the inactivation of glycogen synthase kinase-3\u03b2 (GSK3\u03b2) following T cell activation.", {"entities": [[19, 25, "GENE"]]}], ["In the absence of Gimap5, constitutive GSK3\u03b2 activity constrains c-Myc induction and NFATc1 nuclear import, thereby limiting productive CD4 GIMAP5 loss-of-function mutation has lymphopenia and impaired T cell proliferation in vitro that can be rescued with GSK3 inhibitors.", {"entities": [[177, 188, "DISEASE"], [18, 24, "GENE"], [140, 146, "GENE"], [85, 91, "GENE"], [136, 139, "GENE"], [18, 24, "GENE"], [140, 146, "GENE"]]}], ["Given that the expression of Gimap5 is lymphocyte-restricted, we propose that its control of GSK3\u03b2 is an important checkpoint in lymphocyte proliferation.", {"entities": [[29, 35, "GENE"]]}], ["Loss of function GIMAP5 mutation is associated with lymphopenia, but how it mediates T cell homeostasis is unclear.", {"entities": [[52, 63, "DISEASE"], [17, 23, "GENE"]]}], ["Here the authors study Gimap5 GIMAP5 deficiency to show how this GTPAse negatively regulates GSK3\u03b2 activity to prevent DNA damage and cell death.", {"entities": [[23, 29, "GENE"], [30, 36, "GENE"], [23, 29, "GENE"], [30, 36, "GENE"]]}], ["Background .", {"entities": []}], ["Since the FEV1/FVC ratio declines with age, using the fixed ratio of 0.70 leads to overdiagnosis of COPD in older populations and underdiagnosis among young adults.", {"entities": []}], ["Objective .", {"entities": []}], ["To evaluate whether discordant obstructive cases (FEV1/FVC < 0.70 but \u2265LLN) are a healthy population or have clinical features that would place them at increased risk.", {"entities": []}], ["We used post-bronchodilator spirometry data from the population-based Austrian Burden of Obstructive Lung Disease (BOLD) study.", {"entities": []}], ["Those with post-bronchodilator FEV1/FVC ratio <LLN and <0.70 were defined as concordant obstructive cases .", {"entities": []}], ["Participants with post-bronchodilator FEV1/FVC ratio \u2265LLN but <0.70 were defined as discordant obstructive cases .", {"entities": []}], ["Discordant obstructive cases were more likely to be older, male and never-smokers.", {"entities": []}], ["Additionally they had less respiratory symptoms and less severe impairment of FEV1.", {"entities": []}], ["However, discordant obstructive cases reported significantly more often a diagnosis of heart disease than subjects with normal lung function (27.2% vs 7.3%, P = .015).", {"entities": [[87, 100, "DISEASE"]]}], ["Conclusion .", {"entities": []}], ["The clinical profile of discordant obstructive cases includes potentially important comorbid disease.", {"entities": []}], ["Anxiety and health related Quality of Life (HRQoL) have emerged as important mental health measures in obstetric care.", {"entities": []}], ["Few studies have systematically examined the longitudinal trajectories of anxiety and HRQoL in pregnancy.", {"entities": []}], ["Using a linear growth modeling strategy, we analyzed the course of State-Trait Anxiety Inventory (STAI)- and Short Form (36) Health Survey (SF-36) scores between the 12", {"entities": []}], ["Interferon regulatory factor 5 gene ( IRF5 ) polymorphisms are strongly associated with several diseases, including systemic lupus erythematosus (SLE).", {"entities": [[125, 144, "DISEASE"], [116, 144, "DISEASE"], [38, 42, "GENE"]]}], ["The association includes risk and protective components.", {"entities": []}], ["They could be due to combinations of functional polymorphisms and related to cis -regulation of IRF5 expression, but their mechanisms are still uncertain.", {"entities": [[96, 100, "GENE"]]}], ["We hypothesised that thorough testing of the relationships between IRF5 polymorphisms, expression data from multiple experiments and SLE-associated haplotypes might provide useful new information.", {"entities": [[67, 71, "GENE"]]}], ["Expression data from four published microarray hybridisation experiments with lymphoblastoid cell lines (57 to 181 cell lines) were retrieved.", {"entities": []}], ["Genotypes of 109 IRF5 polymorphisms, including four known functional polymorphisms, were considered.", {"entities": [[17, 21, "GENE"]]}], ["The best linear regression models accounting for the IRF5 expression data were selected by using a forward entry procedure.", {"entities": [[53, 57, "GENE"]]}], ["SLE-associated IRF5 haplotypes were correlated with the expression data and with the best cis -regulatory models.", {"entities": [[15, 19, "GENE"]]}], ["A large fraction of variability in IRF5 expression was accounted for by linear regression models with IRF5 polymorphisms, but at a different level in each expression data set.", {"entities": [[35, 39, "GENE"], [102, 106, "GENE"], [35, 39, "GENE"], [102, 106, "GENE"]]}], ["Also, the best models from each expression data set were different, although there was overlap between them.", {"entities": []}], ["The SNP introducing an early polyadenylation signal, rs10954213, was included in the best models for two of the expression data sets and in good models for the other two data sets.", {"entities": []}], ["The SLE risk haplotype was associated with high IRF5 expression in the four expression data sets.", {"entities": [[48, 52, "GENE"]]}], ["However, there was also a trend towards high IRF5 expression with some protective and neutral haplotypes, and the protective haplotypes were not associated with IRF5 expression.", {"entities": [[45, 49, "GENE"], [161, 165, "GENE"], [45, 49, "GENE"], [161, 165, "GENE"]]}], ["As a consequence, correlation between the cis -regulatory best models and SLE-associated haplotypes, regarding either the risk or protective component, was poor.", {"entities": []}], ["Our analysis indicates that although the SLE risk haplotype of IRF5 is associated with high expression of the gene, cis -regulation of IRF5 expression is not enough to fully account for IRF5 association with SLE susceptibility, which indicates the need to identify additional functional changes in this gene.", {"entities": [[63, 67, "GENE"], [135, 139, "GENE"], [186, 190, "GENE"], [63, 67, "GENE"], [135, 139, "GENE"], [186, 190, "GENE"], [63, 67, "GENE"], [135, 139, "GENE"], [186, 190, "GENE"]]}], ["Studies about formaldehyde (FA) published since the guideline of 0.1\u00a0mg/m p53 and K - Ras genes at \u226415\u00a0ppm neither increased cell proliferation, histopathological changes and changes in gene expression at 0.7\u00a0ppm.", {"entities": []}], ["Repeated controlled exposures (0.5\u00a0ppm with peaks at 1\u00a0ppm) did not increase micronucleus formation in human buccal cells or nasal tissue (0.7\u00a0ppm) or in vivo genotoxicity in peripheral blood lymphocytes (0.7\u00a0ppm), but higher occupational exposures were associated with genotoxicity in buccal cells and cultivated peripheral blood lymphocytes.", {"entities": []}], ["It is still valid that exposures not inducing nasal squamous cell carcinoma in rats will not induce nasopharyngeal cancer or lymphohematopoietic malignancies in humans.", {"entities": [[66, 75, "DISEASE"], [52, 75, "DISEASE"], [115, 121, "DISEASE"]]}], ["Reproductive and developmental toxicity are not considered relevant in the absence of sensory irritation.", {"entities": []}], ["In conclusion, the WHO guideline has been strengthened.", {"entities": []}], ["Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe hypersensitivity drug reaction involving the skin and multiple internal organ systems.", {"entities": [[19, 31, "DISEASE"]]}], ["The symptoms typically present with fever and skin rash, and rapidly progress to multiple organ failures.", {"entities": []}], ["Vancomycin is a rare drug to cause DRESS syndrome with 23 cases reported to date.", {"entities": [[41, 49, "DISEASE"]]}], ["We described a case of a 39\u00a0year-old man who was treated with vancomycin for osteomyelitis of the foot.", {"entities": [[77, 90, "DISEASE"]]}], ["The patient subsequently developed acute respiratory distress syndrome (ARDS) followed by rash and acute interstitial nephritis.", {"entities": [[105, 127, "DISEASE"], [62, 70, "DISEASE"], [118, 127, "DISEASE"]]}], ["These symptoms were improved by withdrawal of vancomycin and a pulsed corticosteroid regimen.", {"entities": []}], ["According to the European Registry of Severe Cutaneous Adverse Reaction Criteria (RegiSCAR) (Kardaun et al, British Journal of Dermatology, 169:1071-1080, 2013), the probability of vancomycin induced DRESS syndrome was scored as \u201cDefinite\u201d.", {"entities": [[206, 214, "DISEASE"]]}], ["A literature search of vancomycin induced DRESS syndrome was also performed and the overall pulmonary involvement was estimated as 5%.", {"entities": [[48, 56, "DISEASE"]]}], ["To our knowledge, this was the first case reported with pulmonary involvement as the initial symptom.", {"entities": []}], ["This is the first case to report pulmonary manifestation as the initial symptom in vancomycin induced DRESS syndrome.", {"entities": [[108, 116, "DISEASE"]]}], ["Prompt recognition of this entity can expedite proper treatment and hasten recovery.", {"entities": []}], ["The online version of this article (10.1186/s12890-017-0564-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Interstitial lung disease is a frequent complication in sickle cell disease and is characterized by vascular remodeling and interstitial fibrosis.", {"entities": [[0, 25, "DISEASE"], [13, 25, "DISEASE"]]}], ["Bone marrow-derived fibrocytes have been shown to contribute to the pathogenesis of other interstitial lung diseases.", {"entities": []}], ["The goal of this study was to define the contribution of fibrocytes to the pathogenesis of sickle cell lung disease.", {"entities": [[103, 115, "DISEASE"]]}], ["Fibrocytes were quantified and characterized in subjects with sickle cell disease or healthy controls, and in a model of sickle cell disease, the NY1DD mouse.", {"entities": []}], ["The role of the chemokine ligand CXCL12 in trafficking of fibrocytes and phenotype of lung disease was examined in the animal model.", {"entities": [[86, 98, "DISEASE"], [33, 39, "GENE"]]}], ["We found elevated concentration of activated fibrocytes in the peripheral blood of subjects with sickle cell disease, which increased further during vaso-occlusive crises.", {"entities": []}], ["There was a similar elevations in the numbers and activation phenotype of fibrocytes in the bone marrow, blood, and lungs of the NY1DD mouse, both at baseline and under conditions of hypoxia/re-oxygenation.", {"entities": []}], ["In both subjects with sickle cell disease and the mouse model, fibrocytes expressed a hierarchy of chemokine receptors, with CXCR4 expressed on most fibrocytes, and CCR2 and CCR7 expressed on a smaller subset of cells.", {"entities": [[125, 130, "GENE"], [165, 169, "GENE"], [174, 178, "GENE"]]}], ["Depletion of the CXCR4 ligand, CXCL12, in the mouse model resulted in a marked reduction of fibrocyte trafficking into the lungs, reduced lung collagen content and improved lung compliance and histology.", {"entities": [[17, 22, "GENE"], [31, 37, "GENE"]]}], ["These data support the notion that activated fibrocytes play a significant role in the pathogenesis of sickle cell lung disease.", {"entities": [[115, 127, "DISEASE"]]}], ["Objective quantification of emphysema using computerized tomography (CT) density measurements is rapidly gaining wide acceptance as an in vivo measurement tool.", {"entities": []}], ["However, some studies have suggested that abnormal lung function in the absence of emphysema can affect lung density, and the role of such measurements in identifying and monitoring the progression of emphysema is not clear.", {"entities": []}], ["To clarify the relationship between lung density measurements and pulmonary function.", {"entities": []}], ["CT measurements of the proportion of lung occupied by low density tissue (as percentage of lung area below predetermined Hounsfield unit [HU] thresholds) were obtained in a large random population (n = 739) and the association with detailed pulmonary function tests studied using factor analysis.", {"entities": []}], ["Density measurements showed a greater association with measures of hyperinflation and airflow obstruction than measures of gas transfer (correlation coefficient, high resolution scan, \u2212 950 HU threshold vs FEV 1 /FVC, RV, and DLCO/VA of \u2212 0.39, 0.22, and \u2212 0.15 respectively).", {"entities": [[206, 209, "GENE"]]}], ["The strongest lung density factor coefficients of 0.51 (standard resolution scan, \u2212 950 HU threshold) and 0.46 (high resolution scan, \u2212 910 HU threshold) were seen with factors predominantly consisting of measures of airflow obstruction and hyperinflation.", {"entities": []}], ["Most variation in lung density was not accounted for by lung function measurements (communality 0.21\u20130.34).", {"entities": []}], ["Lung density measurements associate most strongly with measures of airway disease that are not specific to emphysema.", {"entities": []}], ["Atherosclerosis, now regarded as a chronic inflammatory disease of the arterial wall, and its clinical manifestations have increasingly been associated with rheumatoid arthritis (RA), supporting the notion that autoimmune diseases and vascular disorders share common etiological features.", {"entities": [[0, 15, "DISEASE"], [157, 177, "DISEASE"], [168, 177, "DISEASE"]]}], ["Indeed, evidence pertaining to this matter indicates that inflammation and its multiple components are the driving force behind the pathogenesis of these disorders.", {"entities": []}], ["Interestingly, CD154 and its receptors have emerged as major players in the development of RA and atherosclerosis, which raises the possibility that this axis may represent an important biological link between both complications.", {"entities": [[98, 113, "DISEASE"]]}], ["Indeed, CD154 signaling elicits critical inflammatory responses that are common to the pathogenesis of both diseases.", {"entities": []}], ["Here, we provide an overview of the traditional and disease-related interrelations between RA and vascular abnormalities, while focusing on CD154 as a potential mediator in the development of atherosclerotic events in RA patients.", {"entities": []}], ["Th17 cells provide protective immunity to infections by fungi and extracellular bacteria as well as cancer but are also involved in chronic inflammation.", {"entities": [[100, 106, "DISEASE"]]}], ["The cells were first identified by their ability to produce interleukin 17A (IL-17A) and, subsequently, associated with chronic inflammation and autoimmunity.", {"entities": []}], ["Th17 cells have some gene profile similarity with stem cells and can remain dormant in mucosal tissues for long periods.", {"entities": []}], ["Indeed, recent studies suggest that functionally distinct subsets of pro- and anti-inflammatory Th17 cells can interchange phenotype and functions.", {"entities": []}], ["For development, Th17 cells require activation of the transcription factors STAT3 and ROR \u03b3 t while RUNX1, c-Maf, and Aiolos are involved in changes of phenotype/functions.", {"entities": [[76, 81, "GENE"], [100, 105, "GENE"]]}], ["Attempts to harness Th17 cells against pathogens and cancer using vaccination strategies are being explored.", {"entities": [[53, 59, "DISEASE"]]}], ["The cells gain protective abilities when induced to produce interferon \u03b3 (IFN \u03b3 ).", {"entities": []}], ["In addition, treatment with antibodies to IL-17 is effective in treating patients with psoriasis, psoriatic arthritis, and refectory rheumatoid arthritis.", {"entities": [[133, 153, "DISEASE"], [87, 96, "DISEASE"], [108, 117, "DISEASE"], [144, 153, "DISEASE"], [98, 117, "DISEASE"]]}], ["Moreover, since ROR \u03b3 t is a nuclear receptor, it is likely to be a potential future drug target for modulating Th17 functions.", {"entities": []}], ["This review explores pathways through which Th17 subsets are induced, the molecular basis of their plasticity, and potential therapeutic strategies for their modulation in diseases.", {"entities": []}], ["Evidence suggests that higher levels of vitamin D and calcium are associated with greater lung function and that vitamin D is inversely associated with atopic sensitisation.", {"entities": []}], ["It is unknown whether the associations of vitamin D and calcium with lung function are independent of each other or mediated by atopic sensitisation.", {"entities": []}], ["To study the associations of 25-hydroxyvitamin D [25(OH)D] and ionised calcium levels with lung function and specific allergen sensitisation in adolescents (12-19 years) and adults (20-59 years) and to assess whether the associations with lung function are due to altered atopic sensitisation.", {"entities": []}], ["Cross-sectional analysis of the data from the third National Health and Nutrition Examination Survey.", {"entities": []}], ["25(OH)D levels were positively associated with forced vital capacity in adolescents [0.035(95 %CI: 0.007-0.064) standard deviations;SD in model adjusted for multiple confounders].", {"entities": []}], ["This association and the previously reported association between higher serum levels of 25(OH)D and better lung function in adults were independent of serum calcium levels, which were not associated with lung function.", {"entities": []}], ["In adults, calcium was associated with sensitisation to grass allergens [OR per SD,1.17(1.03-1.32), 1.15(1.01-1.31) and 1.18 (1.06-1.32) for white oak, Bermuda grass and short ragweed, respectively] and peanut OR 1.21 (95%CI 1.02-1.43) after adjusting for age, gender and race/ethnicity, but these associations attenuated towards the null after adjusting for additional confounders.", {"entities": []}], ["The associations were independent of 25(OH)D levels, which were not associated with allergen sensitisation.", {"entities": []}], ["Circulating levels of 25(OH)D are positively associated with lung function and this does not appear to be driven by allergen sensitisation or influenced by calcium levels.", {"entities": []}], ["A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sparing of tenofovir and protease inhibitors.", {"entities": []}], ["However, data on use of this combination as a strategy of switch are limited.", {"entities": []}], ["Aims of the study were to assess the long-term efficacy and safety of this regimen.", {"entities": []}], ["Retrospective study on HIV-1 infected patients followed at the Infectious Disease Department of the San Raffaele Scientific Institute, HBsAg-negative, HLA B5701-negative, with no documented resistance to RPV, ABC and 3TC, with HIV-RNA<50 copies/mL who started RPV plus ABC/3TC from March 2013 to September 2015.", {"entities": [[151, 154, "GENE"]]}], ["The primary outcome was durability [no treatment failure (TF)].", {"entities": [[58, 60, "GENE"]]}], ["Secondary objectives were to evaluate changes in immunological, metabolic and other safety parameters.", {"entities": []}], ["TF was defined as the occurrence of virological failure (VF, 2 consecutive values >50 copies/mL) or discontinuation of any drug in the regimen for any reason.", {"entities": [[0, 2, "GENE"]]}], ["Patients\u2019 follow-up accrued from the date of RPV plus ABC/3TC initiation to the date of TF (VF or discontinuation of any drug in the regimen) or to the date of last available visit.", {"entities": [[88, 90, "GENE"]]}], ["Time to TF was evaluated by use of the Kaplan-Meier curves.", {"entities": [[8, 10, "GENE"]]}], ["Mixed linear models were applied to evaluate changes in immunological, metabolic and other safety parameters.", {"entities": []}], ["In this analysis, 100 patients starting RPV plus ABC/3TC were included.", {"entities": []}], ["By 12, 24 and 36 months after switching to RPV plus ABC/3TC, the proportions of individuals without TF were 88% [95% confidence interval (CI): 79%-93%], 82% (95% CI:73%-89%) and 78% (95% CI:68%-86%), respectively.", {"entities": [[100, 102, "GENE"]]}], ["Time to TF was not significantly influenced by CD4+ nadir (\u2264200 vs >200 cells/\u03bcl; log-rank test: p = 0.311) or pre-ART viral load (<100000 vs \u2265100000 copies/mL; log-rank test: p = 0.574) or the type of previous antiretroviral regimen (PI+2NRTIs vs NNRTI+2NRTIs vs Other; log-rank test: p = 0.942).", {"entities": [[8, 10, "GENE"]]}], ["Over a median follow-up of 2.9 years (IQR: 1.9\u20133.5), 26 subjects discontinued the treatment [10 due to toxicity, 7 for interactions with other drugs, 3 due to cardiovascular risk concern, 2 due to single viral blip, 1 due to VF, 1 for asthma, 1 patient\u2019s decision, 1 due to enrolment in a study protocol].", {"entities": [[235, 241, "DISEASE"]]}], ["In this retrospective study, long-term use of RPV plus ABC/3TC regimen is effective and safe.", {"entities": []}], ["Efficacy of this regimen was not found to be affected by low CD4+ nadir or high pre-ART viral load.", {"entities": []}], ["Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is an uncommon but potentially life threatening disease in children.", {"entities": [[47, 57, "DISEASE"]]}], ["Pulmonary hemorrhage (PH) is a well recognized but lethal complication.", {"entities": []}], ["The incidence of venous thromboembolism (VTE) is higher in patients with AAV, especially in those with active disease.", {"entities": []}], ["However, the simultaneous occurrence of both PH and VTE has rarely been reported.", {"entities": []}], ["Herein, we describe a 14-year-old female with AAV who developed concomitant deep vein thrombosis (DVT) and PH within 3\u00a0days after hospitalization.", {"entities": []}], ["She was successfully treated with timely plasmapheresis and methylprednisolone pulse therapy.", {"entities": []}], ["VTE did not occur during discontinuation of anticoagulant.", {"entities": []}], ["On reviewing the English literature, 5 AAV patients with coexisting VTE and PH have been reported.", {"entities": []}], ["When faced with PH, whether or not to keep anti-coagulation treatment is a dilemma.", {"entities": []}], ["Some of the patients kept receiving anti-coagulation treatment, whereas others undergoing inferior vena cava filter implantation.", {"entities": []}], ["Glucocorticoids and cyclophosphamide or other immunosuppressant agents were prescribed in all patients.", {"entities": []}], ["All of the cases survived after treatment for concurrent VTE and PH, and received short- or long-term anticoagulation treatment after discharge.", {"entities": []}], ["To the best of our knowledge, this is the first report of a pediatric patient with AAV presenting with coexistent VTE and PH.", {"entities": []}], ["VTE should be considered to be a sign of disease flare-up, and early plasmapheresis with immunosuppressant therapy can rescue this fatal complication.", {"entities": []}], ["Controversy has arisen regarding the effectiveness of neuraminidase inhibitors (NIs), especially against influenza-related complications.", {"entities": [[105, 114, "DISEASE"]]}], ["A literature search was performed to critically assess the evidence collected by the available systematic reviews (SRs) regarding the benefits and disadvantages of NIs (oseltamivir, zanamivir) compared to placebos in healthy and at-risk individuals of all ages for prophylaxis and treatment of seasonal influenza.", {"entities": [[303, 312, "DISEASE"]]}], ["A SR was done using the Cochrane Database of Systematic Reviews, Health Technology Assessment Database, Database of Abstracts of Reviews of Effects, and Medline (January 2006\u2013July 2012).", {"entities": []}], ["Two reviewers selected SRs based on randomized clinical trials, which were restricted to intention-to-treat results, and they assessed review (AMSTAR) and study quality indicators (GRADE).", {"entities": []}], ["The SRs included (N\u200a=\u200a9) were of high quality.", {"entities": []}], ["The efficacy of NIs in prophylaxis ranged from 64% (16\u201385) to 92% (37\u201399); the absolute risk reduction ranged from 1.2% to 12.1% (GRADE moderate to low).", {"entities": []}], ["Clinically relevant treatment benefits of NIs were small in healthy adults and children suffering from influenza-like illness (GRADE high to moderate).", {"entities": [[103, 112, "DISEASE"]]}], ["Oseltamivir reduced antibiotic usage in healthy adults according to one SR, but this was not confirmed by other reviews (GRADE low).", {"entities": []}], ["Zanamivir showed a preventive effect on antibiotic usage in children (95% (77\u201399);GRADE moderate) and on the occurrence of bronchitis in at-risk individuals (59% (30\u201376);GRADE moderate).", {"entities": [[123, 133, "DISEASE"]]}], ["No evidence was available on the treatment benefits of NIs in elderly and at-risk groups and their effects on hospitalization and mortality.", {"entities": []}], ["In oseltamivir trials, nausea, vomiting and diarrhea were significant side-effects.", {"entities": [[44, 52, "DISEASE"]]}], ["For zanamivir trials, no adverse effects have been reported.", {"entities": []}], ["The combination of diagnostic uncertainty, the risk for virus strain resistance, possible side effects and financial cost outweigh the small benefits of oseltamivir or zanamivir for the prophylaxis and treatment of healthy individuals.", {"entities": []}], ["No relevant benefits of these NIs on complications in at-risk individuals have been established.", {"entities": []}], ["Estimating COPD occurrence is perceived by the scientific community as a matter of increasing interest because of the worldwide diffusion of the disease.", {"entities": []}], ["We aimed to estimate COPD prevalence by using administrative databases from a city in central Italy for 2002\u20132006, improving both the sensitivity and the reliability of the estimate.", {"entities": []}], ["Multiple sources were used, integrating the hospital discharge register (HDR), clinical charts, spirometry and the cause-specific mortality register (CMR) in a longitudinal algorithm, to reduce underestimation of COPD prevalence.", {"entities": []}], ["Prevalence was also estimated on the basis of COPD cases confirmed through spirometry, to correct misclassification.", {"entities": []}], ["Estimating such prevalence relied on using coefficients of validation, derived as the positive predictive value (PPV) for being an actual COPD case from clinical and spirometric data at the Institute of Clinical Physiology of the National Research Council.", {"entities": []}], ["We found that sensitivity of COPD prevalence increased by 37%.", {"entities": []}], ["The highest estimate (4.43 per 100 residents) was observed in the 5-year period, using a 3-year longitudinal approach and combined data from three sources.", {"entities": []}], ["We found that 17% of COPD cases were misclassified.", {"entities": []}], ["The above estimate of COPD prevalence decreased (3.66 per 100 residents) when coefficients of validation were applied.", {"entities": []}], ["The PPV was 80% for the HDR, 82% for clinical diagnoses and 91% for the CMR.", {"entities": []}], ["Adjusting the COPD prevalence for both underestimation and misclassification of the cases makes administrative data more reliable for epidemiological purposes.", {"entities": []}], ["Tuberculosis (TB) control is based on early detection and complete treatment of infectious cases.", {"entities": [[0, 12, "DISEASE"]]}], ["Consequently, it is important that TB suspects and patients can readily access medical care.", {"entities": []}], ["This qualitative study investigated determinants of access to DOTS services as identified by patients, health providers and community members in four districts in Tajikistan.", {"entities": []}], ["Focus group discussions were conducted in order to investigate access to TB services.", {"entities": []}], ["A conceptual framework for access to care guided the analysis.", {"entities": []}], ["Thirteen focus group discussions involving a total of 97 informants were conducted.", {"entities": []}], ["Content analysis of discussions and a rating to quantify the relative importance of discussed factors were carried out.", {"entities": []}], ["The conceptual framework identifies five main components of access to which factors can be assigned: availability, adequacy, acceptability, accessibility and affordability.", {"entities": []}], ["Financial factors were considered the most important determinants of access to diagnosis and treatment of tuberculosis.", {"entities": [[106, 118, "DISEASE"]]}], ["Expenditure for drugs and consultations, for transport, and for special foods as well as lost income were identified as major barriers to treatment.", {"entities": []}], ["Stigma, doubts about curability and low perceived quality of care were not seen to be significant determinants of access to care for tuberculosis.", {"entities": [[133, 145, "DISEASE"]]}], ["Community members were well aware of symptoms of tuberculosis and of medical services.", {"entities": [[49, 61, "DISEASE"]]}], ["These findings were consistent between different respondent groups (community members, patients and providers).", {"entities": []}], ["They were also highly consistent between the open discussion and the confidential rating.", {"entities": []}], ["Illness-costs to households were identified as the main barrier to tuberculosis diagnosis and treatment.", {"entities": [[67, 79, "DISEASE"]]}], ["To improve access and ultimately adherence to tuberculosis treatment, effective mitigation strategies, e.g.", {"entities": [[46, 58, "DISEASE"]]}], ["changes in case management, food contributions or financial stimuli, need to be explored and implemented.", {"entities": []}], ["Olodaterol is a novel, inhaled long-acting \u03b2 2 -agonist (LABA) with >24-hour duration of action investigated in asthma and chronic obstructive pulmonary disease.", {"entities": [[123, 160, "DISEASE"], [112, 118, "DISEASE"]]}], ["Two multicentre studies examined the efficacy and safety of 4\u00a0weeks\u2019 once-daily (QD) olodaterol (2, 5, 10 and 20\u00a0\u03bcg, with background inhaled corticosteroids) in patients with asthma.", {"entities": [[175, 181, "DISEASE"]]}], ["One randomised, double-blind, parallel-group study (1222.6; 296 patients) administered treatment in the morning.", {"entities": []}], ["Pulmonary function tests (PFTs) were performed pre-dose (trough) and \u22643\u00a0hours post-dose (weeks 1 and 2), and \u22646\u00a0hours post-dose after 4\u00a0weeks; primary end point was trough forced expiratory volume in 1\u00a0second (FEV 1 ) response (change from baseline mean FEV 1 ) after 4\u00a0weeks.", {"entities": [[210, 213, "GENE"], [254, 257, "GENE"], [210, 213, "GENE"], [254, 257, "GENE"]]}], ["A second randomised, double-blind, placebo- and active-controlled (formoterol 12\u00a0\u03bcg twice-daily) incomplete-block crossover study (1222.27; 198 patients) administered QD treatments in the evening.", {"entities": []}], ["PFTs were performed over a 24-hour dosing interval after 4\u00a0weeks; primary end point was FEV 1 area under the curve from 0\u201324 hours (AUC 0\u201324 ) response (change from study baseline [mean FEV 1 ] after 4\u00a0weeks).", {"entities": [[88, 91, "GENE"], [186, 189, "GENE"], [88, 91, "GENE"], [186, 189, "GENE"]]}], ["Study 1222.6 showed a statistically significant increase in trough FEV 1 response with olodaterol 20\u00a0\u03bcg (0.147\u00a0L; 95\u00a0% confidence interval [CI]: 0.059, 0.234; p \u2009=\u20090.001) versus placebo, with more limited efficacy and no evidence of dose response compared to placebo across the other olodaterol doses (2, 5 and 10\u00a0\u03bcg).", {"entities": [[67, 70, "GENE"]]}], ["Study 1222.27 demonstrated increases in FEV 1 AUC 0\u201324 responses at 4\u00a0weeks with all active treatments ( p \u2009<\u20090.0001); adjusted mean (95\u00a0% CI) differences from placebo were 0.140 (0.097, 0.182), 0.182 (0.140, 0.224), 0.205 (0.163, 0.248) and 0.229 (0.186, 0.272) L for olodaterol 2, 5, 10 and 20\u00a0\u03bcg, respectively, and 0.169 (0.126, 0.211) for formoterol, providing evidence of increased efficacy with higher olodaterol dose.", {"entities": [[40, 43, "GENE"]]}], ["Olodaterol was generally well tolerated, with a few events associated with known sympathomimetic effects, mainly with 20\u00a0\u03bcg.", {"entities": []}], ["The LABA olodaterol has >24-hour duration of action.", {"entities": []}], ["In patients with asthma, evidence of bronchodilator efficacy was demonstrated with statistically and clinically significant improvements in the primary end point of trough FEV 1 response measured in clinics over placebo for the highest administered dose of 20\u00a0\u03bcg in Study 1222.6, and statistically and clinically significant improvements versus placebo in FEV 1 AUC 0\u201324 responses at 4\u00a0weeks for all doses tested in Study 1222.27, which also exhibited a dose response.", {"entities": [[17, 23, "DISEASE"], [172, 175, "GENE"], [356, 359, "GENE"], [172, 175, "GENE"], [356, 359, "GENE"]]}], ["Bronchodilator efficacy was seen over placebo for all olodaterol doses for morning and evening peak expiratory flow in both studies.", {"entities": []}], ["All doses were well tolerated.", {"entities": []}], ["NCT00467740 (1222.6) and NCT01013753 (1222.27).", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0249-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background: We examined whether the effect of maternal smoking during pregnancy on birthweight of the offspring was mediated by smoking-induced changes to DNA methylation in cord blood.", {"entities": []}], ["Methods: First, we used cord blood of 129 Dutch children exposed to maternal smoking vs 126 unexposed to maternal and paternal smoking (53% male) participating in the GECKO Drenthe birth cohort.", {"entities": []}], ["DNA methylation was measured using the Illumina HumanMethylation450 Beadchip.", {"entities": []}], ["We performed an epigenome-wide association study for the association between maternal smoking and methylation followed by a mediation analysis of the top signals [false-discovery rate (FDR)\u2009<\u20090.05].", {"entities": []}], ["We adjusted both analyses for maternal age, education, pre-pregnancy BMI, offspring\u2019s sex, gestational age and white blood cell composition.", {"entities": []}], ["Secondly, in 175 exposed and 1248 unexposed newborns from two independent birth cohorts, we replicated and meta-analysed results of eight cytosine-phosphate-guanine (CpG) sites in the GFI1 gene, which showed the most robust mediation.", {"entities": [[184, 188, "GENE"]]}], ["Finally, we performed functional network and enrichment analysis.", {"entities": []}], ["Results: We found 35 differentially methylated CpGs (FDR\u2009<\u20090.05) in newborns exposed vs unexposed to smoking, of which 23 survived Bonferroni correction ( P \u2009<\u20091\u2009\u00d7\u200910 AHRR, GFI1, MYO1G, CYP1A1, NEUROG1, CNTNAP2, FRMD4A and LRP5 .", {"entities": [[167, 171, "GENE"], [173, 177, "GENE"], [179, 184, "GENE"], [186, 192, "GENE"], [194, 201, "GENE"], [203, 210, "GENE"], [212, 218, "GENE"], [223, 227, "GENE"]]}], ["We observed partial confirmation as three of the eight CpGs in GFI1 replicated.", {"entities": [[63, 67, "GENE"]]}], ["These CpGs partly mediated the effect of maternal smoking on birthweight (Sobel P \u2009<\u20090.05) in meta-analysis of GECKO and the two replication cohorts.", {"entities": []}], ["Differential methylation of these three GFI1 CpGs explained 12\u201319% of the 202 g lower birthweight in smoking mothers.", {"entities": [[40, 44, "GENE"]]}], ["Functional enrichment analysis pointed towards activation of cell-mediated immunity.", {"entities": []}], ["Conclusions: Maternal smoking during pregnancy was associated with cord blood methylation differences.", {"entities": []}], ["We observed a potentially mediating role of methylation in the association between maternal smoking during pregnancy and birthweight of the offspring.", {"entities": []}], ["Functional network analysis suggested a role in activating the immune system.", {"entities": []}], ["Asthma is believed to be a risk factor for influenza infection, however little experimental evidence exists to directly demonstrate the impact of asthma on susceptibility to influenza infection.", {"entities": [[43, 52, "DISEASE"], [174, 183, "DISEASE"], [0, 6, "DISEASE"], [146, 152, "DISEASE"]]}], ["Using a mouse model, we now report that asthmatic mice are actually significantly more resistant to a lethal influenza virus challenge.", {"entities": [[109, 118, "DISEASE"]]}], ["Notably, the observed increased resistance was not attributable to enhanced viral clearance, but instead, was due to reduced lung inflammation.", {"entities": []}], ["Asthmatic mice exhibited a significantly reduced cytokine storm, as well as reduced total protein levels and cytotoxicity in the airways, indicators of decreased tissue injury.", {"entities": []}], ["Further, asthmatic mice had significantly increased levels of TGF-\u03b21 and the heightened resistance of asthmatic mice was abrogated in the absence of TGF-\u03b2 receptor II.", {"entities": []}], ["We conclude that a transient increase in TGF-\u03b2 expression following acute asthma can induce protection against influenza-induced immunopathology.", {"entities": [[111, 120, "DISEASE"], [74, 80, "DISEASE"]]}], ["Influenza and asthma represent the two major lung diseases in humans.", {"entities": [[0, 9, "DISEASE"], [14, 20, "DISEASE"]]}], ["While most studies have focused on exacerbation of asthma symptoms by influenza virus infection, the effects of asthma on susceptibility to influenza virus infections has been far less studied.", {"entities": [[70, 79, "DISEASE"], [140, 149, "DISEASE"], [51, 57, "DISEASE"], [112, 118, "DISEASE"]]}], ["Using a novel mouse model of asthma and influenza infection, we show that asthmatic mice are highly resistant to primary challenge with the 2009 influenza pandemic strain (CA04) compared to non-asthmatic mice.", {"entities": [[40, 49, "DISEASE"], [145, 154, "DISEASE"], [29, 35, "DISEASE"]]}], ["The increased resistance of asthmatic mice is not due to the enhanced T or B cell immunity but rather, to a strong anti-inflammatory TGF-beta response triggered by asthma.", {"entities": [[164, 170, "DISEASE"]]}], ["This study is the first to provide a mechanistic explanation for asthma-mediated protection during the 2009 influenza pandemic.", {"entities": [[108, 117, "DISEASE"], [65, 71, "DISEASE"]]}], ["Diary cards are useful for analyzing exacerbations in chronic obstructive pulmonary disease (COPD), although factors influencing the length and frequency of each episode are poorly understood.", {"entities": [[54, 91, "DISEASE"]]}], ["This study investigated factors that influence the features of exacerbations in patients with alpha-1 antitrypsin (AAT) deficiency (PiZ phenotype) and COPD.", {"entities": []}], ["Daily diary cards were collected over 2 years.", {"entities": []}], ["Patients had emphysema visualized and quantified by computed tomography scan, and had at least one documented exacerbation in the previous year.", {"entities": []}], ["The patients (n = 23) had a mean age of 52.5 years, forced expiratory volume in one second (FEV 1 ) of 1.2 L (38.4% predicted), corrected gas transfer (KCO) of 0.90 mmol/min/kPa/L (59.7% predicted), and 15th percentile lung density of 44.55 g/L.", {"entities": [[92, 95, "GENE"]]}], ["Two hundred and sixty-three exacerbations (164 treated) were identified.", {"entities": []}], ["The frequency of treated exacerbations correlated negatively with KCO% predicted (r = \u22120.432; P = 0.022).", {"entities": []}], ["Exacerbation length (determined for 17 of the patients for whom diary card data through the episode were available) correlated negatively with baseline 15th percentile lung density (r = \u22120.361; P = 0.003), and increased the longer treatment was delayed (r = 0.503; P < 0.001).", {"entities": []}], ["Treatment delay was shorter with higher day 1 symptom score, lower baseline FEV 1 , FEV 1 /forced vital capacity, and lower 15th percentile lung density (r = \u22120.368, 0.272, 0.461, and 0.786; P = 0.004, 0.036, <0.001, and <0.001, respectively).", {"entities": [[76, 79, "GENE"], [84, 87, "GENE"], [76, 79, "GENE"], [84, 87, "GENE"]]}], ["Time to resolution of exacerbation after treatment initiation was not affected by treatment delay, but correlated negatively with KCO% predicted (r = \u22120.647; P = 0.007).", {"entities": []}], ["In alpha-1 antitrypsin deficiency, the frequency and length of resolution of exacerbation were related to baseline gas transfer.", {"entities": []}], ["Treatment delay adversely affected exacerbation length, and lung density was the best independent predictor of delay in starting treatment.", {"entities": []}], ["To determine the long-term changes in the intraocular pressure (IOP) following vitrectomy for rhegmatogenous retinal detachment (RRD), epiretinal membrane (ERM), and macular hole (MH), and to investigate the relationship between the retinal disease and the incidence of late-onset IOP elevation.", {"entities": [[109, 127, "DISEASE"], [233, 248, "DISEASE"]]}], ["This was a retrospective, observational, comparative study.", {"entities": []}], ["We reviewed the medical records of 54 eyes of 54 RRD patients, 117 eyes of 117 ERM patients, and 75 eyes of 75 MH patients who underwent 20-, 23- or 25-gauge vitrectomy.", {"entities": []}], ["The IOPs before surgery and 1, 3, 6, and 12 months following vitrectomy, and also at the final visit (average, 23.95 months) were evaluated.", {"entities": []}], ["We defined a significant increase in the IOP as an increase of \u22654 mmHg from the preoperative IOP, and this increase was taken to be a \u2018death\u2019 event for the Kaplan-Meier survival analyses.", {"entities": []}], ["The mean follow-up period was not significantly different among the groups.", {"entities": []}], ["The mean IOP at 3 ( P = 0.001) and 12 ( P = 0.011) months following the vitrectomy and at the final visit ( P = 0.002) were significantly higher than that before the vitrectomy in the RRD group.", {"entities": []}], ["The mean IOP in the RRD group was significant higher than that in the ERM group at 1 ( P = 0.005), 3 ( P = 0.009), and 12 ( P = 0.013) months following vitrectomy, and at the final visit ( P = 0.032).", {"entities": []}], ["Kaplan-Meier survival analyses showed that the RRD group had a significantly higher risk of an IOP increase following vitrectomy than the other groups ( P <0.001 by log-rank test).", {"entities": []}], ["Multivariate logistic regression analyses showed that a preoperative diagnosis of RRD was the only risk factor that was significantly associated with a postoperative IOP elevation after excluding eyes with a low preoperative IOP (odds ratio, 3.208; P = 0.003).", {"entities": []}], ["A late-onset IOP elevation following vitrectomy was observed only in eyes that underwent RRD surgery.", {"entities": []}], ["The elevation was probably caused by the specific characteristics and surgical procedures of RRD.", {"entities": []}], ["Clinicians should pay more attention to the IOP elevation for long times after vitrectomy especially in eyes with RRD.", {"entities": []}], ["Acute respiratory infections are ubiquitous and may have long-term implications on respiratory health.", {"entities": []}], ["There are many scoring systems used to objectively measure severity of respiratory infections in clinical and research settings.", {"entities": []}], ["A respiratory severity score derived exclusively from physical exam components (RSS-HR) was studied as an objective measure of disease severity and was compared to a previously described score that uses pulse oximetry as a component of its score (RSS-SO).", {"entities": []}], ["A score was derived from 497 infants.", {"entities": []}], ["The RSS-HR median score was higher in infants that were hospitalized (8.0) versus outpatient (4.0, p\u00a0<\u00a00.001), and those with lower respiratory tract infections (LRTI) (6.5) versus upper respiratory infections (URI) (1.0, p\u00a0<\u00a00.001).", {"entities": []}], ["When discriminating upper versus LRTIs the concordance index of regression for RSS-HR was 0.91 and RSS-SO was 0.93.", {"entities": []}], ["RSS-HR distinguishes disease severity based on level of care, as well as LRTI versus URI.", {"entities": []}], ["Innate immunity has been extended to respond environmental pathogen other than microbial components.", {"entities": []}], ["Here we explore a novel pollen/TLR4 innate immunity in allergic inflammation.", {"entities": []}], ["In experimental allergic conjunctivitis induced by short ragweed (SRW) pollen, typical allergic signs, stimulated IL-33/ST2 signaling and overproduced Th2 cytokine were observed in ocular surface, cervical lymph nodes and isolated CD4 Tlr4-d ) or MyD88 knockout ( MyD88 Tlr4-d or MyD88", {"entities": [[16, 39, "DISEASE"], [25, 39, "DISEASE"], [231, 234, "GENE"], [247, 252, "GENE"], [264, 269, "GENE"], [280, 285, "GENE"], [247, 252, "GENE"], [264, 269, "GENE"], [280, 285, "GENE"], [247, 252, "GENE"], [264, 269, "GENE"], [280, 285, "GENE"]]}], ["Please cite this paper as: Khandaker et\u00a0al.", {"entities": []}], ["(2011) Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009.", {"entities": [[82, 91, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses DOI: 10.1111/j.1750\u20102659.2011.00199.x.", {"entities": [[0, 9, "DISEASE"]]}], ["The aim of this systematic review was to summarise the clinical and epidemiological features of the pandemic influenza A (H1N1) 2009.", {"entities": [[109, 118, "DISEASE"]]}], ["We did a systematic search of published literature reporting clinical features of laboratory\u2010confirmed pandemic influenza A (H1N1) 2009 from 1 April 2009 to 31 January 2010.", {"entities": [[112, 121, "DISEASE"]]}], ["Forty\u2010four articles met our inclusion criteria for the review.", {"entities": []}], ["The calculated weighted mean age of confirmed cases was 18\u00b71\u2003years, with the median ranging from 12 to 44\u2003years.", {"entities": []}], ["Cough (84\u00b79%), fever (84\u00b77%), headache (66\u00b75%), runny nose (60\u00b71%) and muscle pain (58\u00b71%) were the most common symptoms of confirmed cases.", {"entities": []}], ["One or more pre\u2010existing chronic medical conditions were found in 18\u00b74% of cases.", {"entities": []}], ["Almost two\u2010thirds (64%) of cases were aged between 10 and 29\u2003years, 5\u00b71% were aged over 50\u2003years and only 1\u00b71% were aged over 60\u2003years.", {"entities": []}], ["The confirmed case fatality ratio was 2\u00b79% (95% CI 0\u00b70\u20136\u00b77%), an extracted average from 12 of 42 studies reporting fatal cases (937 fatal cases among 31\u2003980 confirmed cases), which gives an overall estimated infected case fatality ratio of 0\u00b702%.", {"entities": []}], ["Early in the pandemic, disease occurred overwhelmingly in children and younger adults, with cough and fever as the most prevalent clinical symptoms of the confirmed cases.", {"entities": []}], ["A high infection rate in children and young adults, with sparing of the elderly population, has implications for pandemic influenza management and control policies.", {"entities": [[122, 131, "DISEASE"]]}], ["Decreased epinephrine (EPI) is an important underlying factor of bronchoconstriction in asthma.", {"entities": [[88, 94, "DISEASE"]]}], ["Exogenous \u03b2 2 -adrenergic receptor agonist is one of the preferred options to treat asthma.", {"entities": [[84, 90, "DISEASE"]]}], ["We previously showed that this phenomenon involved adrenal medullary chromaffin cell (AMCC) transformation to a neuron phenotype.", {"entities": []}], ["However, the underlying molecular mechanism is not fully understood.", {"entities": []}], ["To further explore this, an asthmatic model with unilateral adrenalectomy was established in this study.", {"entities": []}], ["Thirty-two rats were randomly into four groups (n\u200a=\u200a8 each) control rats (controls), unilateral adrenalectomy rats (surgery-control, s-control), asthmatic rats (asthma), unilateral adrenalectomy asthmatic rats (surgery-induced asthma, s-asthma).", {"entities": [[161, 167, "DISEASE"], [227, 233, "DISEASE"], [237, 243, "DISEASE"]]}], ["Asthmatic rats and s-asthmatic rats were sensitized and challenged with ovalbumin (OVA).", {"entities": []}], ["The pathological changes in adrenal medulla tissues were observed under microscopy.", {"entities": []}], ["EPI and its rate-limiting enzyme, phenylethanolamine N-methyl transferase (PNMT), were measured.", {"entities": [[75, 79, "GENE"]]}], ["Peripherin, a type III intermediate filament protein, was also detected in each group.", {"entities": []}], ["The asthmatic rats presented with decreased chromaffin granules and swollen mitochondria in AMCCs, and the s-asthmatic rats presented more serious pathological changes than those in asthmatic rats and s-control rats.", {"entities": []}], ["The expressions of EPI and PNMT in asthmatic rats were significantly decreased, as compared with levels in controls (P<0.05), and a further decline was observed in s-asthmatic rats (P<0.05).", {"entities": [[27, 31, "GENE"]]}], ["The expression of peripherin was higher in the asthmatic rats than in the controls, and the highest level was found in the s-asthmatic rats (P<0.05).", {"entities": []}], ["Compared with asthmatic rats and s-control rats, the transformation tendency of AMCCs to neurons is more obvious in the s-asthmatic rats.", {"entities": []}], ["Moreover, this phenotype alteration in the asthmatic rats is accompanied by reduced EPI and PNMT, and increased peripherin expression.", {"entities": [[92, 96, "GENE"]]}], ["This result provides further evidence to support the notion that phenotype alteration of AMCCs contributes to asthma pathogenesis.", {"entities": [[110, 116, "DISEASE"]]}], ["Several epidemiological and laboratory studies have evidenced the fact that atmospheric particulate matter (PM) increases the risk of respiratory morbidity.", {"entities": []}], ["It is well known that the smallest fraction of PM (PM1 - particulate matter having a diameter below 1\u00a0\u03bcm) penetrates the deepest into the airways.", {"entities": []}], ["The ratio of the different size fractions in PM is highly variable, but in industrial areas PM1 can be significant.", {"entities": []}], ["Despite these facts, the health effects of PM1 have been poorly investigated and air quality standards are based on PM10 and PM2.5 (PM having diameters below 10\u00a0\u03bcm and 2.5\u00a0\u03bcm, respectively) concentrations.", {"entities": []}], ["Therefore, this study aimed at determining whether exposure to ambient PM1 at a near alert threshold level for PM10 has respiratory consequences in rats.", {"entities": []}], ["Rats were either exposed for 6\u00a0weeks to 100\u00a0\u03bcg/m aw ) and respiratory tissue mechanics were measured.", {"entities": []}], ["Respiratory mechanics were measured under baseline conditions and following intravenous methacholine challenges to characterize the development of airway hyperresponsiveness (AH).", {"entities": []}], ["Bronchoalveolar lavage fluid (BALF) was analyzed and lung histology was performed.", {"entities": []}], ["No significant differences were detected in lung volume and mechanical parameters at baseline.", {"entities": []}], ["However, the exposed rats exhibited significantly greater MCh-induced responses in R aw , demonstrating the progression of AH.", {"entities": []}], ["The associated bronchial inflammation was evidenced by the accumulation of inflammatory cells in BALF and by lung histology.", {"entities": []}], ["Our findings suggest that exposure to concentrated ambient PM1 (mass concentration at the threshold level for PM10) leads to the development of mild respiratory symptoms in healthy adult rats, which may suggest a need for the reconsideration of threshold limits for airborne PM1.", {"entities": []}], ["Elemental characterization of fine particulate matter was undertaken at schools and residences in three low income neighborhoods in Quito, Ecuador.", {"entities": []}], ["The three zones were located in the northern (Cotocollao), south central (El Camal), and south east (Los Chillos) neighborhoods and were classified as zones 1\u20133, respectively.", {"entities": []}], ["Forty elements were quantified via ICP-MS analysis.", {"entities": []}], ["Amongst the geogenic elements, the concentration of Si was the most abundant followed by S, Al, and Ca.", {"entities": []}], ["Elements with predominantly anthropogenic sources such as Zn, V, and Ni were higher in zone 3 school followed by zone 2 and zone 1 schools.", {"entities": []}], ["Enrichment factors were calculated to study the role of crustal sources in the elemental concentrations.", {"entities": []}], ["Geogenic elements, except K, all had values <10 and anthropogenic elements such as Ni, V, Zn, Pb, As, Cr had >10.", {"entities": []}], ["Principal Component Analysis suggested that Ni and V concentrations were strongly attributable to pet coke and heavy oil combustion.", {"entities": []}], ["Strong associations between As and Pb could be attributed to traffic and other industrial emissions.", {"entities": []}], ["Resuspended dust, soil erosion, vehicular emissions (tailpipe, brake and tire wear, and engine abrasion), pet coke, heavy oil combustion, and heavy industrial operations were major contributors to air pollution.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is one of the most common inflammatory diseases resulting from habitual smoking.", {"entities": []}], ["Impaired clearance of apoptotic cell by airway macrophages contributes to lung inflammation.", {"entities": []}], ["Milk fat globule-EGF factor 8 (MFG-E8), as a link between apoptotic cells and phagocytes, facilitates clearance of apoptotic cells and attenuates inflammation.", {"entities": []}], ["We sought to investigate altered expression and potential role of MFG-E8 in COPD.", {"entities": []}], ["In this study, apoptosis was increased and the level of MFG-E8 was decreased while HMGB1 expression was increased in lung tissues of CS-exposed mice.", {"entities": [[83, 88, "GENE"]]}], ["Compared with CS-exposed WT mice, more apoptotic cells were accumulated in lung tissues of CS-exposed MFG-E8 deficiency mice.", {"entities": []}], ["Exposure of a range of macrophages to cigarette smoke extract (CSE) resulted in decreased MFG-E8 expression.", {"entities": []}], ["Administration of rmMFG-E8 ameliorated phagocytic ability of RAW264.7 cells and suppressed inflammatory response induced by CS-exposure.", {"entities": []}], ["10% CSE stimulation suppressed Rac1 membrane localization in RAW264.7 cells which was restored by administration of rmMFG-E8.", {"entities": [[31, 35, "GENE"]]}], ["MFG-E8 deficiency diminished uptake of apoptotic thymocytes by peritoneal macrophages upon CSE exposure.", {"entities": []}], ["Overall, the findings in current work provide a novel target for diagnosing and treating COPD.", {"entities": []}], ["The technological and clinical need for orthopedic replacement materials has led to significant advances in the field of nanomedicine, which embraces the breadth of nanotechnology from pharmacological agents and surface modification through to regulation and toxicology.", {"entities": []}], ["A variety of nanostructures with unique chemical, physical, and biological properties have been engineered to improve the functionality and reliability of implantable medical devices.", {"entities": []}], ["However, mimicking living bone tissue is still a challenge.", {"entities": []}], ["The scope of this review is to highlight the most recent accomplishments and trends in designing nanomaterials and their applications in orthopedics with an outline on future directions and challenges.", {"entities": []}], ["Atopic dermatitis (AD) is a common inflammatory skin disease with an increasingly significant prevalence.", {"entities": [[48, 60, "DISEASE"], [7, 17, "DISEASE"]]}], ["The prevalence of AD depends greatly on how its diagnosis is done.", {"entities": []}], ["The UK Working Party's diagnostic criteria for AD are simple and easy to apply without invasive laboratory tests.", {"entities": []}], ["This study assessed the clinical utility of these criteria in China.", {"entities": []}], ["Data were collected from 6208 patients at 31 tertiary hospitals in 13 Chinese provinces/municipalities from March 2014 to May 2014.", {"entities": []}], ["The agreement between the UK diagnostic criteria and the clinical records for AD was assessed by Cohen's kappa.", {"entities": []}], ["The overall agreement between the UK diagnostic criteria and clinical diagnosis was fair (kappa = 0.40).", {"entities": []}], ["A slightly better agreement was found in patients aged between 4 and 9 years (kappa = 0.48), while fair agreement was found in the group <4 years and the group \u226510 years (kappa = 0.27 and 0.39, respectively).", {"entities": []}], ["Using the UK party's criteria as the standard, the sensitivity, specificity, positive predictive value, and negative predictive value of the clinical diagnosis of AD were 62.3%, 89.2%, 38.0%, and 95.7%, respectively.", {"entities": []}], ["Our study indicates a modest ability among Chinese dermatologists to apply the UK Working Party's diagnostic criteria for AD, especially in patients aged <4 years and \u226510 years.", {"entities": []}], ["Since there is no gold standard for AD diagnosis, it is important to determine how AD is identified when evaluating a diagnostic tool.", {"entities": []}], ["Inhaler device errors are common and may impact the effectiveness of the delivered drug.", {"entities": []}], ["There is a paucity of up-to-date systematic reviews (SRs) or meta-analyses (MAs) of device errors in asthma and chronic obstructive pulmonary disease (COPD) patients.", {"entities": [[112, 149, "DISEASE"], [101, 107, "DISEASE"]]}], ["This SR and MA provides an estimate of overall error rates (both critical and non-critical) by device type and evaluates factors associated with inhaler misuse.", {"entities": []}], ["The following databases from inception to July 23, 2014 (Embase\u00ae, MEDLINE\u00ae, MEDLINE\u00ae In-Process and CENTRAL) were searched, using predefined search terms.", {"entities": []}], ["Studies in adult males and females with asthma or COPD, reporting at least one overall or critical error, using metered dose inhalers and dry powder inhalers were included.", {"entities": [[40, 46, "DISEASE"]]}], ["Random-effect MAs were performed to estimate device error rates and to compare pairs of devices.", {"entities": []}], ["Overall and critical error rates were high across all devices, ranging from 50\u2013100% and 14\u201392%, respectively.", {"entities": []}], ["However, between-study heterogeneity was also generally >90% (I-squared statistic), indicating large variability between studies.", {"entities": []}], ["A trend towards higher error rates with assessments comprising a larger number of steps was observed; however no consistent pattern was identified.", {"entities": []}], ["This SR and MA highlights the relatively limited body of evidence assessing device errors and the lack of standardised checklists.", {"entities": []}], ["There is currently insufficient evidence to determine differences in error rates between different inhaler devices and their impact on clinical outcomes.", {"entities": []}], ["A key step in improving our knowledge on this topic would be the development of standardised checklists for each device.", {"entities": []}], ["Researchers should adopt a standardised approach to investigate the incorrect use of inhalers and its associated clinical implications.", {"entities": []}], ["Henry Chrystyn at Plymouth University, together with scientists across the UK and the Netherlands, conducted a review of research related to inhaled medication errors made by patients with asthma or chronic obstructive pulmonary disease.", {"entities": [[199, 236, "DISEASE"], [189, 195, "DISEASE"]]}], ["It is widely acknowledged that many patients with lung conditions don\u2019t use their inhaler devices correctly, which affects drug effectiveness and disease control.", {"entities": []}], ["While Chrystyn\u2019s team found high critical error rates reported across all devices, their meta-analysis and systematic review highlighted significant gaps in knowledge regarding different inhalers and associated error rates, and how these affect clinical outcomes.", {"entities": []}], ["The researchers call for in-depth studies into device use, alongside standardised checklists and definitions for such studies to use to ensure consistency.", {"entities": []}], ["Type 2 diabetes is a worldwide disease that is associated with increased rates of obesity and reduced physical activity.", {"entities": [[82, 89, "DISEASE"]]}], ["Obesity\u2010associated insulin resistance in type 2 diabetes is a disorder in the balance between pro\u2010inflammatory and anti\u2010inflammatory signals.", {"entities": [[0, 7, "DISEASE"]]}], ["T cell immunoglobulin and mucin domain\u2010containing molecule 3 (Tim\u20103) has been reported as an important regulatory inflammation molecule, and plays a pivotal role in several inflammation\u2010related diseases.", {"entities": []}], ["Peripheral blood mononuclear cells were obtained from type 2 diabetes patients ( n = 31) and healthy donors ( n = 18), and Tim\u20103 expression on peripheral blood mononuclear cells was evaluated by flow cytometry.", {"entities": []}], ["We showed the downregulated expression of Tim\u20103 on CD 14 CD 4 CD 8 CD 14 CD 14 monocytes.", {"entities": []}], ["The present results suggest that Tim\u20103 might participate in the progression of type 2 diabetes by its negative regulation on these immune cells, and Tim\u20103 on CD 14", {"entities": []}], ["Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a multi-functional cytokine, which is involved in the pathophysiological processes of cardiovascular and metabolic diseases.", {"entities": []}], ["Previously, we demonstrated that TRAIL stimulated lipid uptake and foam cell formation in macrophages in vitro .", {"entities": []}], ["Several clinical studies have suggested that the serum concentration of TRAIL may be increased in humans with elevated blood cholesterol; however, the current data appear to be inconclusive in this regard.", {"entities": []}], ["In the present study, we examined the relationships between the serum TRAIL concentration and cholesterol levels in 352 generally healthy subjects undergoing the routine annual health check.", {"entities": []}], ["We showed that there were significant correlations between TRAIL concentration and levels of total and low-density lipoprotein cholesterols.", {"entities": []}], ["The level of TRAIL was significantly elevated in subjects with hypercholesterolemia, although this relationship might be also associated with changes of other metabolic factors.", {"entities": []}], ["Moreover, we showed that the level of blood cholesterol was significantly higher in subjects in the upper quartile of serum TRAIL.", {"entities": []}], ["In conclusion, our data demonstrate that the serum TRAIL concentration is elevated in people with hypercholesterolemia.", {"entities": []}], ["Nasal cytology is a very useful diagnostic tool in nasal disorders, being able to detect both the cellular modifications of the nasal epithelium caused by either allergen exposure or irritative stimuli (that may be physical or chemical, acute or chronic), or inflammation.", {"entities": []}], ["Over these past few years, nasal cytology has allowed to identify new disorders, such as the non-allergic rhinitis with eosinophils (NARES), the non-allergic rhinitis with mast cells (NARMA), the non-allergic rhinitis with neutrophils (NARNE), and the non-allergic rhinitis with eosinophils and mast cells (NARESMA).", {"entities": [[97, 114, "DISEASE"], [149, 166, "DISEASE"], [200, 217, "DISEASE"], [256, 273, "DISEASE"], [106, 114, "DISEASE"], [158, 166, "DISEASE"], [209, 217, "DISEASE"], [265, 273, "DISEASE"]]}], ["The rhinocytogram is actually able to distinguish the different forms of allergic rhinitis and to suggest the appropriate treatment, such as antinflammatory drugs or allergen immunotherapy.", {"entities": [[73, 90, "DISEASE"], [82, 90, "DISEASE"]]}], ["The technique is easy to perform and nasal cytology is therefore particularly suitable even for children.", {"entities": []}], ["Such a consideration suggests the utility of a systematic use of nasal cytology in the diagnostic work-up of nasal disorders in children, in order to reach a proper defined diagnosis and to set a rational therapeutic approach: in facts, these two elements are fundamental in order to prevent from complications and to improve the patient\u2019s quality of life.", {"entities": []}], ["The immune responses in patients with novel A(H1N1) virus infection (nvA(H1N1)) are incompletely characterized.", {"entities": []}], ["We investigated the profile of Th1 and Th17 mediators and interferon-inducible protein-10 (IP-10) in groups with severe and mild nvA(H1N1) disease and correlated them with clinical aspects.", {"entities": []}], ["Thirty-two patients hospitalized with confirmed nvA(H1N1) infection were enrolled in the study: 21 patients with nvA(H1N1)-acute respiratory distress syndrome (ARDS) and 11 patients with mild disease.", {"entities": [[150, 158, "DISEASE"]]}], ["One group of 20 patients with bacterial sepsis-ARDS and another group of 15 healthy volunteers were added to compare their cytokine levels with pandemic influenza groups.", {"entities": [[153, 162, "DISEASE"]]}], ["In the nvA(H1N1)-ARDS group, the serum cytokine samples were obtained on admission and 3 days later.", {"entities": []}], ["The clinical aspects were recorded prospectively.", {"entities": []}], ["In the nvA(H1N1)-ARDS group, obesity and lymphocytopenia were more common and IP-10, interleukin (IL)-12, IL-15, tumor necrosis factor (TNF)\u03b1, IL-6, IL-8 and IL-9 were significantly increased versus control.", {"entities": [[29, 36, "DISEASE"], [136, 139, "GENE"]]}], ["When comparing mild with severe nvA(H1N1) groups, IL-6, IL-8, IL-15 and TNF\u03b1 were significantly higher in the severe group.", {"entities": []}], ["In nonsurvivors versus survivors, IL-6 and IL-15 were increased on admission and remained higher 3 days later.", {"entities": []}], ["A positive correlation of IL-6, IL-8 and IL-15 levels with C-reactive protein and with > 5-day interval between symptom onset and admission, and a negative correlation with the PaO 2 :FiO 2 ratio, were found in nvA(H1N1) groups.", {"entities": []}], ["In obese patients with influenza disease, a significant increased level of IL-8 was found.", {"entities": [[23, 32, "DISEASE"]]}], ["When comparing viral ARDS with bacterial ARDS, the level of IL-8, IL-17 and TNF\u03b1 was significantly higher in bacterial ARDS and IL-12 was increased only in viral ARDS.", {"entities": []}], ["In our critically ill patients with novel influenza A(H1N1) virus infection, the hallmarks of the severity of disease were IL-6, IL-15, IL-8 and TNF\u03b1.", {"entities": [[42, 51, "DISEASE"]]}], ["These cytokines, except TNF\u03b1, had a positive correlation with the admission delay and C-reactive protein, and a negative correlation with the PaO 2 :FiO 2 ratio.", {"entities": []}], ["Obese patients with nvA(H1N1) disease have a significant level of IL-8.", {"entities": []}], ["There are significant differences in the level of cytokines when comparing viral ARDS with bacterial ARDS.", {"entities": []}], ["Numerous epidemiological studies have demonstrated adverse health effects of a sedentary life style, on the one hand, and of acute and chronic exposure to traffic-related air pollution, on the other.", {"entities": []}], ["Because physical exercise augments the amount of inhaled pollutants, it is not clear whether cycling to work in a polluted urban environment should be encouraged or not.", {"entities": []}], ["To address this conundrum we investigated if a bicycle journey along a busy commuting road would induce changes in biomarkers of pulmonary and systematic inflammation in a group of healthy subjects.", {"entities": []}], ["38 volunteers (mean age: 43 \u00b1 8.6 years, 26% women) cycled for about 20 minutes in real traffic near a major bypass road (road test; mean UFP exposure: 28,867 particles per cm Percentage of blood neutrophils increased significantly more (p = 0.004) after exercise in the road test (3.9%; 95% CI: 1.5 to 6.2%; p = 0.003) than after exercise in the clean room (0.2%; 95% CI: -1.8 to 2.2%, p = 0.83).", {"entities": []}], ["The pre/post-cycling changes in exhaled NO, plasma IL-6, platelet function, serum levels of Clara cell protein and number of total blood leukocytes did not differ significantly between the two scenarios.", {"entities": []}], ["Traffic-related exposure to particles during exercise caused a small increase in the distribution of inflammatory blood cells in healthy subjects.", {"entities": []}], ["The health significance of this isolated change is unclear.", {"entities": []}], ["The aim of this cross-sectional study was to evaluate whether interleukin 10 (IL10) and transforming growth factor \u03b21 (TGF\u03b21) gene polymorphisms were associated with persistent IgE-mediated cow's milk allergy in 50 Brazilian children.", {"entities": [[78, 82, "GENE"]]}], ["The diagnostic criteria were anaphylaxis triggered by cow's milk or a positive double-blind, placebo-controlled food challenge.", {"entities": []}], ["Tolerance was defined as the absence of a clinical response to a double-blind, placebo-controlled food challenge or cow's milk exposure.", {"entities": []}], ["The genomic DNA of the 50 patients and 224 healthy controls (HCs) was used to investigate five IL10 gene polymorphisms (-3575A/T, -2849A/G, -2763A/C, -1082G/A, -592C/A) and one TGF\u03b21 polymorphism (-509C/T).", {"entities": [[95, 99, "GENE"]]}], ["Among the five IL10 polymorphisms analyzed, homozygosis for the G allele at the -1082 position was significantly higher in the patients compared with the healthy controls ( p \u200a=\u200a0.027) and in the persistent cow's milk allergy group compared with the healthy controls ( p \u200a=\u200a0.001).", {"entities": [[15, 19, "GENE"]]}], ["Homozygosis for the G allele at the IL10 -1082G/A polymorphism is associated with the persistent form of cow's milk allergy.", {"entities": [[36, 40, "GENE"]]}], ["In 1998 Congress mandated expanded U.S. Environmental Protection Agency (U.S. EPA) health effects research on ambient air particulate matter (PM) and a National Research Council (NRC) committee to provide research oversight.", {"entities": []}], ["The U.S. EPA currently supports intramural and extramural PM research, including five academically based PM centers.", {"entities": []}], ["The PM centers in their first 2.5 years have initiated research directed at critical issues identified by the NRC committee, including collaborative activities, and sponsored scientific workshops in key research areas.", {"entities": []}], ["Through these activities, there is a better understanding of PM health effects and scientific uncertainties.", {"entities": []}], ["Future PM centers research will focus on long-term effects associated with chronic PM exposures.", {"entities": []}], ["This report provides a synopsis of accomplishments to date, short-term goals (during the next 2.5 years) and longer-term goals.", {"entities": []}], ["It consists of six sections: biological mechanisms, acute effects, chronic effects, dosimetry, exposure assessment, and the specific attributes of a coordinated PM centers program.", {"entities": []}], ["While adolescents\u2019 access and utilization of health services is critical for ensuring their health, very few seek care, and if they do, it is primarily from family members, friends, or other non-formal sources of care.", {"entities": []}], ["Examining the influence of the social context on adolescent health care seeking behaviors may provide us with a better understanding for how interventions can increase adolescents\u2019 utilization of formal health care services.", {"entities": []}], ["The study is based on qualitative and quantitative data collected as part of the Well Being of Adolescents in Vulnerable Environments (WAVE) study, one of the first global studies to focus on very disadvantaged urban adolescents (aged 15\u201319 years) across five diverse sites, which include: Baltimore (USA), Ibadan (Nigeria), Johannesburg (South Africa), New Delhi (India), and Shanghai (China).", {"entities": []}], ["Qualitative data was based on numerous methodologies, including key informant interviews, a Photovoice exercise, community mapping, focus groups and in-depth interviews.", {"entities": []}], ["Quantitative data was gathered from a cross-sectional Audio Computer Assisted Self Interview (ACASI) survey that was administered to approximately 450\u2013500 adolescents per site, yielding a total of 2,393 adolescents.", {"entities": []}], ["Respondent-driven sampling was used to ensure the sample include out-of-school youth and unstably housed youth who are often underrepresented in school-based or household-based samples.", {"entities": []}], ["While adolescents in Baltimore, New Delhi, and Johannesburg were more likely to seek health services if they felt illness symptoms, a fairly large proportion of adolescents indicated that even when they needed health care, they didn\u2019t seek it.", {"entities": []}], ["In Johannesburg, more than 30\u00a0% of adolescents did not seek care even when they knew it was needed.", {"entities": []}], ["Similarly, nearly a quarter of adolescents in Baltimore and in Shanghai indicated not seeking care when needed.", {"entities": []}], ["Qualitative data indicated that adolescents exhibited a general lack of trust in providers and often felt embarrassed or stigmatized for seeking services.", {"entities": []}], ["Multivariate analysis revealed that perceived fear and exposure to community violence was associated with a decreased likelihood of seeking care, while adult support from the home increased adolescents\u2019 likelihood to seek care in Baltimore and Johannesburg.", {"entities": []}], ["Adolescent health care seeking patterns vary substantially by setting and gender.", {"entities": []}], ["Neighborhood and family environments are important contexts in which health seeking behaviors are shaped.", {"entities": []}], ["Efforts to connect adolescents to health care will need to target neighborhood safety as well as trust and support among adults outside of provider settings.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-016-1597-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study provides secondhand smoke (SHS) exposure data in utero and after birth when children were at 18 months, 36 months and 66 months old, and it identifies risk factors for the early childhood SHS among 18-month-old infants living in smoker and non-smoker households.", {"entities": []}], ["The data come from the Taiwan Birth Cohort Study, a longitudinal survey of a birth cohort born in 2005.", {"entities": []}], ["This study used the survey wave when children were 18 months old (n=18\u2009845) for statistical analysis of early childhood SHS exposure.", {"entities": []}], ["Logistic regression was used to identify the risk factors of the SHS exposure.", {"entities": []}], ["Approximately 62% of the 18-month-old infants lived in a household with at least one smoker, with the father being the smoker in 84% of those households.", {"entities": []}], ["Among these infants living in a smoker household, 70% were exposed to SHS and 36% were exposed to heavy SHS in utero, and the prevalence was approximately 66% and 17% after birth for SHS and heavy SHS, respectively.", {"entities": []}], ["The number and the existence of smokers in the household, parents\u2019 smoking status, father\u2019s educational attainment and being a first-born baby are strong predictors of early childhood heavy SHS exposure.", {"entities": []}], ["Encouraging families to have a smoke-free home environment, empowering women to ensure their perspectives and rights are embedded into tobacco control efforts and educating families about the health risks from childhood SHS exposure, especially among people living in households with smokers, will protect non-smoking adults and children from SHS exposure.", {"entities": []}], ["The identification of biosignatures of aerosol exposure to pathogens has the potential to provide useful diagnostic information.", {"entities": []}], ["In particular, markers of exposure to different types of respiratory pathogens may yield diverse sets of markers that can be used to differentiate exposure.", {"entities": []}], ["We examine a mouse model of aerosol exposure to known Gram negative bacterial pathogens, Francisella tularensis novicida and Pseudomonas aeruginosa .", {"entities": []}], ["Mice were subjected to either a pathogen or control exposure and bronchial alveolar lavage fluid (BALF) was collected at four and twenty four hours post exposure.", {"entities": []}], ["Small protein and peptide markers within the BALF were detected by matrix assisted laser desorption/ionization (MALDI) mass spectrometry (MS) and analyzed using both exploratory and predictive data analysis methods; principle component analysis and degree of association.", {"entities": []}], ["The markers detected were successfully used to accurately identify the four hour exposed samples from the control samples.", {"entities": []}], ["This report demonstrates the potential for small protein and peptide marker profiles to identify aerosol exposure in a short post-exposure time frame.", {"entities": []}], ["Research into the effects of common activities during pregnancy is sparse and often contradictory.", {"entities": []}], ["To examine whether common activities are an acute trigger of pregnancy complications the prevalence of these activities are necessary to determine sample size estimates.", {"entities": []}], ["The aim of this study is to ascertain the prevalence of selected activities in any seven day period during pregnancy.", {"entities": []}], ["The study was conducted in the antenatal clinic of a teaching hospital with tertiary obstetric and neonatal care in Sydney, Australia between August 2008 and April 2009.", {"entities": []}], ["Women who were at least 20 weeks pregnant and able to read English completed a questionnaire to assess whether they had performed a list of activities in the seven days prior to survey completion.", {"entities": []}], ["Results were analysed using frequency tabulations, contingency table analyses and chi square tests.", {"entities": []}], ["A total of 766 surveys were completed, 29 surveys were excluded as the women completing them were less than 20 weeks pregnant, while 161 women completed the survey more than once.", {"entities": []}], ["Ninety seven per cent of women completed the survey when approached for the first time, while 87% completed the survey when approached a subsequent time.", {"entities": []}], ["In the week prior to completing the survey 82.6% of women had consumed a caffeinated beverage, 42.1% had had sexual intercourse, 32.7% had lifted something over 12 kilograms, 21.4% had consumed alcohol and 6.4% had performed vigorous exercise.", {"entities": []}], ["The weekly prevalence of heavy lifting was higher for multiparous women compared to nulliparous women.", {"entities": []}], ["The results of this study can be used to inform future research into activities as acute triggers of pregnancy complications.", {"entities": []}], ["Parents of children with food allergy, primary care physicians, and members of the general public play a critical role in the health and well-being of food-allergic children, though little is known about their knowledge and perceptions of food allergy.", {"entities": [[25, 37, "DISEASE"], [239, 251, "DISEASE"]]}], ["The purpose of this paper is to detail the development of the Chicago Food Allergy Research Surveys to assess food allergy knowledge, attitudes, and beliefs among these three populations.", {"entities": [[70, 82, "DISEASE"], [110, 122, "DISEASE"]]}], ["From 2006\u20132008, parents of food-allergic children, pediatricians, family physicians, and adult members of the general public were recruited to assist in survey development.", {"entities": []}], ["Preliminary analysis included literature review, creation of initial content domains, expert panel review, and focus groups.", {"entities": []}], ["Survey validation included creation of initial survey items, expert panel ratings, cognitive interviews, reliability testing, item reduction, and final validation.", {"entities": []}], ["National administration of the surveys is ongoing.", {"entities": []}], ["Nine experts were assembled to oversee survey development.", {"entities": []}], ["Six focus groups were held: 2/survey population, 4\u20139 participants/group; transcripts were reviewed via constant comparative methods to identify emerging themes and inform item creation.", {"entities": []}], ["At least 220 participants per population were recruited to assess the relevance, reliability, and utility of each survey item as follows: cognitive interviews, 10 participants; reliability testing \u2265 10; item reduction \u2265 50; and final validation, 150 respondents.", {"entities": []}], ["The Chicago Food Allergy Research surveys offer validated tools to assess food allergy knowledge and perceptions among three distinct populations: a 42 item parent tool, a 50 item physician tool, and a 35 item general public tool.", {"entities": [[12, 24, "DISEASE"], [74, 86, "DISEASE"]]}], ["No such tools were previously available.", {"entities": []}], ["Annual hibernation is an adaptation that helps many animals conserve energy during food shortage in winter.", {"entities": []}], ["This natural cycle is also accompanied by a remodeling of the intestinal immune system, which is an aspect of host biology that is both influenced by, and can itself influence, the microbiota.", {"entities": []}], ["In amphibians, the bacteria in the intestinal tract show a drop in bacterial counts.", {"entities": []}], ["The proportion of pathogenic bacteria is greater in hibernating frogs than that found in nonhibernating frogs.", {"entities": []}], ["This suggests that some intestinal gut microbes in amphibians can be maintained and may contribute to the functions in this closed ecosystem during hibernation.", {"entities": []}], ["However, these results were derived from culture-based approaches that only covered a small portion of bacteria in the intestinal tract.", {"entities": []}], ["In this study, we use a more comprehensive analysis, including bacterial appearance and functional prediction, to reveal the global changes in gut microbiota during artificial hibernation via high-throughput sequencing technology.", {"entities": []}], ["Our results suggest that artificial hibernation in the brown tree frog ( Polypedates megacephalus ) could reduce microbial diversity, and artificially hibernating frogs tend to harbor core operational taxonomic units that are rarely distributed among nonhibernating frogs.", {"entities": []}], ["In addition, artificial hibernation increased significantly the relative abundance of the red-leg syndrome-related pathogenic genus Citrobacter .", {"entities": [[98, 106, "DISEASE"]]}], ["Furthermore, functional predictions via PICRUSt and Tax4Fun suggested that artificial hibernation has effects on metabolism, disease, signal transduction, bacterial infection, and primary immunodeficiency.", {"entities": []}], ["We infer that artificial hibernation may impose potential effects on primary immunodeficiency and increase the risk of bacterial infections in the brown tree frog.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-016-3318-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A marked proliferation of synovial fibroblasts in joints leads to pannus formation in rheumatoid arthritis (RA).", {"entities": [[86, 106, "DISEASE"], [97, 106, "DISEASE"]]}], ["Various kinds of cytokines are produced in the pannus.", {"entities": []}], ["The purpose of this study is to elucidate the effects of phosphodiesterase 4 (PDE4) inhibitors in a new animal model for the evaluation of pannus formation and cytokine production in the pannus.", {"entities": []}], ["Mice sensitized with methylated bovine serum albumin (mBSA) were challenged by subcutaneous implantation of a membrane filter soaked in mBSA solution in the back of the mice.", {"entities": []}], ["Drugs were orally administered for 10 days.", {"entities": []}], ["The granuloma formed around the filter was collected on day 11.", {"entities": []}], ["It was chopped into pieces and cultured in vitro for 24 hr.", {"entities": [[56, 58, "GENE"]]}], ["The cytokines were measured in the supernatants.", {"entities": []}], ["The type of cytokines produced in the granuloma was quite similar to those produced in pannus in RA.", {"entities": []}], ["Both PDE4 inhibitors, KF66490 and SB207499, suppressed the production of IL-1 \u03b2 , TNF- \u03b1 , and IL-12, and the increase in myeloperoxidase activity, a marker enzyme for neutrophils and hydroxyproline content.", {"entities": []}], ["Compared to leflunomide, PDE4 inhibitors more strongly suppressed IL-12 production and the increase in myeloperoxidase activity.", {"entities": []}], ["PDE4 inhibitors also inhibited lipopolysaccharide-induced TNF- \u03b1 and IL-12 production from thioglycolate-induced murine peritoneal macrophages and the proliferation of rat synovial fibroblasts.", {"entities": []}], ["These results indicate this model makes it easy to evaluate the effect of drugs on various cytokine productions in a granuloma without any purification step and may be a relevant model for evaluating novel antirheumatic drugs on pannus formation in RA.", {"entities": []}], ["PDE4 inhibitors could have therapeutic effects on pannus formation in RA by inhibition of cytokine production by macrophages and synovial fibroblast proliferation.", {"entities": []}], ["A 14-kD protein was purified from human PMNs and its NH2-terminal sequence was determined.", {"entities": []}], ["Comparison of a portion of the NH2-terminal sequence of this protein to the recently reported NH2-terminal sequence of eosinophil major basic protein (MBP) showed them to be identical.", {"entities": [[151, 154, "GENE"]]}], ["To aid further characterization of the structural and functional properties of this molecule, we isolated from an HL-60 cDNA library a single class of cDNA clones whose sequence matched exactly the NH2- terminal amino acid sequence of the 14-kD polypeptide.", {"entities": []}], ["Northern analysis of HL-60 cells suggests that MBP is constitutively expressed in HL-60 cells and is highly transcribed from a single copy gene.", {"entities": [[47, 50, "GENE"]]}], ["The sequence of the full-length cDNA clones predicts that MBP is synthesized as a 23-kD precursor form (pro-MBP) which is subsequently cleaved to release the mature 14-kD MBP.", {"entities": [[58, 61, "GENE"], [108, 111, "GENE"], [171, 174, "GENE"], [58, 61, "GENE"], [108, 111, "GENE"], [171, 174, "GENE"]]}], ["The putative pro-MBP has a predicted pI of 6.0, but both the charged and the hydrophobic residues are asymmetrically distributed, creating a bipolar molecule.", {"entities": []}], ["The NH2- terminal half has a predicted pI of 3.7 and is hydrophilic, while the COOH-terminal half (corresponding to mature MBP) has a predicted pI of 11.1 and is hydrophobic.", {"entities": [[123, 126, "GENE"]]}], ["Respiratory syncytial virus (RSV) is a leading etiological agent of acute respiratory tract infections and hospitalizations in children.", {"entities": []}], ["However, little information is available regarding RSV infections in Latin American countries, particularly among adult patients.", {"entities": []}], ["To describe the epidemiology of RSV infection and to analyze the factors associated with severe infections in children and adults in Mexico.", {"entities": []}], ["Patients \u22651\u00a0month old, who presented with an influenza\u2010like illness (ILI) to six hospitals in Mexico, were eligible for participation in the study.", {"entities": [[45, 54, "DISEASE"]]}], ["Multiplex reverse\u2010transcriptase polymerase chain reaction identified viral pathogens in nasal swabs from 5629 episodes of ILI.", {"entities": []}], ["Patients in whom RSV was detected were included in this report.", {"entities": []}], ["Respiratory syncytial virus was detected in 399 children and 171 adults.", {"entities": []}], ["RSV A was detected in 413 cases and RSV B in 163, including six patients who had coinfection with both subtypes; 414 (72.6%) patients required hospital admission, including 96 (16.8%) patients that required admission to the intensive care unit.", {"entities": []}], ["Coinfection with one or more respiratory pathogens other than RSV was detected in 159 cases.", {"entities": []}], ["Young age (in children) and older age (in adults) as well as the presence of some underlying conditions were associated with more severe disease.", {"entities": []}], ["This study confirms that RSV is an important respiratory pathogen in children in Mexico.", {"entities": []}], ["In addition, a substantial number of cases in adults were also detected highlighting the relevance of this virus in all ages.", {"entities": []}], ["It is important to identify subjects at high risk of complications who may benefit from current or future preventive interventions.", {"entities": []}], ["Antivenom is the most effective method currently available for the treatment of poisonous snake bite.", {"entities": []}], ["Allergic reactions to antivenom have been reported in the past.", {"entities": []}], ["Here we shared a case of allergic reactions to antivenom in an old male patient who was bitten twice by the same snake (probably same one) at the same biting site within a month whereas the patient did not show any allergic disorder in the first bitten.", {"entities": []}], ["Envenomations twice in a short period time by the same kind of snake are very rare.", {"entities": []}], ["Physician should be alert to the occurrence of allergic reactions in treating this type of patients with antivenom.", {"entities": []}], ["The skin allergy test has a certain value in predicting the allergic response before the second use of antivenom.", {"entities": []}], ["Desensitization may reduce the incidence of allergic reactions, but this is insufficient.", {"entities": []}], ["Rather than non-IgE-mediated immediate hypersensitivity, patients receiving the second treatment of antivenom may develop IgE-mediated immediate hypersensitivity.", {"entities": []}], ["Once happened, the antivenom treatment should be stopped promptly and anti-allergy treatment should be given immediately.", {"entities": []}], ["The respiratory system is one of the most important body systems particularly from the viewpoint of occupational medicine because it is the major route of occupational exposure.", {"entities": []}], ["In 2013, there were significant changes in the specific criteria for the recognition of occupational diseases, which were established by the Enforcement Decree of the Industrial Accident Compensation Insurance Act (IACIA).", {"entities": []}], ["In this article, the authors deal with the former criteria, implications of the revision, and changes in the specific criteria in Korea by focusing on the 2013 amendment to the IACIA.", {"entities": []}], ["Before the 2013 amendment to the IACIA, occupational respiratory disease was not a category because the previous criteria were based on specific hazardous agents and their health effects.", {"entities": []}], ["Workers as well as clinicians were not familiar with the agent-based criteria.", {"entities": []}], ["To improve these criteria, a system-based structure was added.", {"entities": []}], ["Through these changes, in the current criteria, 33 types of agents and 11 types of respiratory diseases are listed under diseases of the respiratory system.", {"entities": []}], ["In the current criteria, there are no concrete guidelines for evaluating work-relatedness, such as estimating the exposure level, latent period, and detailed examination methods.", {"entities": []}], ["The results of further studies can support the formulation of detailed criteria.", {"entities": []}], ["Computing the genetic relationship between two humans is important to studies in genetics, genomics, genealogy, and forensics.", {"entities": []}], ["Relationship algorithms may be sensitive to noise, such as that arising from sequencing errors or imperfect reference genomes.", {"entities": []}], ["We developed an algorithm for estimation of genetic relationship by averaged blocks (GRAB) that is designed for whole-genome sequencing (WGS) data.", {"entities": []}], ["GRAB segments the genome into blocks, calculates the fraction of blocks sharing identity, and then uses a classification tree to infer 1st- to 5th- degree relationships and unrelated individuals.", {"entities": []}], ["We evaluated GRAB on simulated and real sequenced families, and compared it with other software.", {"entities": []}], ["GRAB achieves similar performance, and does not require knowledge of population background or phasing.", {"entities": []}], ["GRAB can be used in workflows for identifying unreported relationships, validating reported relationships in family-based studies, and detection of sample-tracking errors or duplicate inclusion.", {"entities": []}], ["The software is available at familygenomics.systemsbiology.net/grab.", {"entities": []}], ["Mesenchymal stem cells (MSCs) have been identified as a viable treatment for inflammatory bowel disease (IBD).", {"entities": [[77, 103, "DISEASE"]]}], ["MSCs derived from bone marrow (BM-MSCs) have predominated in experimental models whereas the majority of clinical trials have used MSCs derived from adipose tissue (AT-MSCs), thus there is little consensus on the optimal tissue source.", {"entities": []}], ["The therapeutic efficacies of these MSCs are yet to be compared in context of the underlying dysfunction of the enteric nervous system innervating the gastrointestinal tract concomitant with IBD.", {"entities": []}], ["This study aims to characterise the in vitro properties of MSCs and compare their in vivo therapeutic potential for the treatment of enteric neuropathy associated with intestinal inflammation.", {"entities": [[141, 151, "DISEASE"]]}], ["BM-MSCs and AT-MSCs were validated and characterised in vitro.", {"entities": []}], ["In in vivo experiments, guinea-pigs received either 2,4,6-trinitrobenzene-sulfonate acid (TNBS) for the induction of colitis or sham treatment by enema.", {"entities": []}], ["MSCs were administered at a dose of 1x10 in vivo was elucidated by immunohistochemistry and in vitro using a modified Boyden chamber assay.", {"entities": []}], ["Cells exhibited multipotency and a typical surface immunophenotype for validation as bona fide MSCs.", {"entities": []}], ["In vitro characterisation revealed distinct differences in growth kinetics, clonogenicity and cell morphology between MSC types.", {"entities": [[118, 121, "GENE"]]}], ["In vivo , BM-MSCs were comparatively more effective than AT-MSCs in attenuating leukocyte infiltration and neuronal loss in the myenteric plexus.", {"entities": []}], ["MSCs from both sources equally ameliorated body weight loss, gross morphological damage to the colon, changes in the neurochemical coding of neuronal subpopulations and the reduction in density of extrinsic and intrinsic nerve fibres innervating the colon.", {"entities": []}], ["MSCs from both sources migrated to the myenteric plexus in in vivo colitis and in an in vitro assay.", {"entities": []}], ["These data from in vitro experiments suggest that AT-MSCs are ideal for cellular expansion.", {"entities": []}], ["However, BM-MSCs were more therapeutic in the treatment of enteric neuropathy and plexitis.", {"entities": [[67, 77, "DISEASE"]]}], ["These characteristics should be considered when deciding on the MSC tissue source.", {"entities": [[64, 67, "GENE"]]}], ["Programmed cell death 5 (PDCD5) was first identified as an apoptosis-promoting protein and involved in some autoimmune diseases and inflammatory processes.", {"entities": [[25, 30, "GENE"]]}], ["Our previous study demonstrated greater expression of serum PDCD5 in asthmatic patients than controls.", {"entities": [[60, 65, "GENE"]]}], ["This study aimed to further explore the significance of PDCD5 in mice with induced allergic asthma.", {"entities": [[83, 98, "DISEASE"], [92, 98, "DISEASE"], [56, 61, "GENE"]]}], ["We divided 16 female mice into 2 groups: control ( n \u2009=\u20098) and allergen (ovalbumin, OVA)-challenged mice ( n \u2009=\u20098).", {"entities": []}], ["The modified ovalbumin inhalation method was used to generate the allergic asthma mouse model, and the impact of OVA was assessed by histology of lung tissue and morphometry.", {"entities": [[66, 81, "DISEASE"], [75, 81, "DISEASE"]]}], ["The number of cells in bronchoalveolar lavage fluid (BALF) was detected.", {"entities": []}], ["Pulmonary function was measured by pressure sensors.", {"entities": []}], ["PDCD5 and active caspase-3 levels were detected.", {"entities": [[0, 5, "GENE"]]}], ["The expression of PDCD5 was higher with OVA challenge than for controls ( p \u2009<\u20090.05).", {"entities": [[18, 23, "GENE"]]}], ["PDCD5 level was correlated with number of inflammatory cells in BALF and lung function.", {"entities": [[0, 5, "GENE"]]}], ["Moreover, active caspase-3 level was increased in the OVA-challenged mice ( p \u2009<\u20090.001) and correlated with PDCD5 level ( p \u2009=\u20090.000).", {"entities": [[108, 113, "GENE"]]}], ["These data demonstrate an association between level of PDCD5 and asthma severity and indicate that PDCD5 may play a role in allergic asthma.", {"entities": [[124, 139, "DISEASE"], [65, 71, "DISEASE"], [133, 139, "DISEASE"], [55, 60, "GENE"], [99, 104, "GENE"], [55, 60, "GENE"], [99, 104, "GENE"]]}], ["The online version of this article (doi:10.1186/s12890-016-0317-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We introduced domiciliary intravenous (IV) antibiotic therapy in patients with bronchiectasis to promote patient-centred domiciliary treatment instead of hospital inpatient treatment.", {"entities": [[79, 93, "DISEASE"]]}], ["To assess the efficacy and safety of domiciliary IV antibiotic therapy in patients with non-cystic fibrosis bronchiectasis.", {"entities": [[108, 122, "DISEASE"], [92, 107, "DISEASE"]]}], ["In this prospective study conducted over 5 years, we assessed patients\u2019 eligibility for receiving domiciliary treatment.", {"entities": []}], ["All patients received 14 days of IV antibiotic therapy and were monitored at baseline/day 7/day 14.", {"entities": []}], ["We assessed the treatment outcome, morbidity, mortality and 30-day readmission rates.", {"entities": []}], ["A total of 116 patients received 196 courses of IV antibiotics.", {"entities": []}], ["Eighty courses were delivered as inpatient treatment, 32 as early supported discharge (ESD) and 84 as domiciliary therapy.", {"entities": [[87, 90, "GENE"]]}], ["There was significant clinical and quality of life improvement in all groups, with resolution of infection in 76% in the inpatient group, 80% in the ESD group and 80% in the domiciliary group.", {"entities": [[149, 152, "GENE"]]}], ["Morbidity was recorded in 13.8% in the inpatient group, 9.4% in the ESD group and 14.2% in the domiciliary IV group.", {"entities": [[68, 71, "GENE"]]}], ["No mortality was recorded in either group.", {"entities": []}], ["Thirty-day readmission rates were 13.8% in the inpatient group, 12.5% in the ESD group and 14.2% in the domiciliary group.", {"entities": [[77, 80, "GENE"]]}], ["Total bed days saved was 1443.", {"entities": []}], ["Domiciliary IV antibiotic therapy in bronchiectasis is clinically effective and was safe in our cohort of patients.", {"entities": [[37, 51, "DISEASE"]]}], ["The cystic fibrosis transmembrane conductance regulator (CFTR) is a phosphorylation- and ATP-dependent chloride channel that modulates salt and water transport across lung and gut epithelia.", {"entities": [[4, 19, "DISEASE"], [57, 61, "GENE"]]}], ["The relationship between CFTR and oxidized forms of glutathione is of potential interest because reactive glutathione species are produced in inflamed epithelia where they may be modulators or substrates of CFTR.", {"entities": [[25, 29, "GENE"], [207, 211, "GENE"], [25, 29, "GENE"], [207, 211, "GENE"]]}], ["Here we show that CFTR channel activity in excised membrane patches is markedly inhibited by several oxidized forms of glutathione (i.e., GSSG, GSNO, and glutathione treated with diamide, a strong thiol oxidizer).", {"entities": [[18, 22, "GENE"]]}], ["Three lines of evidence indicate that the likely mechanism for this inhibitory effect is glutathionylation of a CFTR cysteine (i.e., formation of a mixed disulfide with glutathione): (a) channels could be protected from inhibition by pretreating the patch with NEM (a thiol alkylating agent) or by lowering the bath pH; (b) inhibited channels could be rescued by reducing agents (e.g., DTT) or by purified glutaredoxins (Grxs; thiol disulfide oxidoreductases) including a mutant Grx that specifically reduces mixed disulfides between glutathione and cysteines within proteins; and (c) reversible glutathionylation of CFTR polypeptides in microsomes could be detected biochemically under the same conditions.", {"entities": [[112, 116, "GENE"], [617, 621, "GENE"], [112, 116, "GENE"], [617, 621, "GENE"]]}], ["At the single channel level, the primary effect of reactive glutathione species was to markedly inhibit the opening rates of individual CFTR channels.", {"entities": [[136, 140, "GENE"]]}], ["CFTR channel inhibition was not obviously dependent on phosphorylation state but was markedly slowed when channels were first \u201clocked open\u201d by a poorly hydrolyzable ATP analogue (AMP-PNP).", {"entities": [[0, 4, "GENE"]]}], ["Consistent with the latter finding, we show that the major site of inhibition is cys-1344, a poorly conserved cysteine that lies proximal to the signature sequence in the second nucleotide binding domain (NBD2) of human CFTR.", {"entities": [[220, 224, "GENE"]]}], ["This region is predicted to participate in ATP-dependent channel opening and to be occluded in the nucleotide-bound state of the channel based on structural comparisons to related ATP binding cassette transporters.", {"entities": []}], ["Our results demonstrate that human CFTR channels are reversibly inhibited by reactive glutathione species, and support an important role of the region proximal to the NBD2 signature sequence in ATP-dependent channel opening.", {"entities": [[35, 39, "GENE"]]}], ["The EIP has expanded efforts to measure health inequities by using area-based socioeconomic analyses.", {"entities": []}], ["The Emerging Infections Program (EIP), a collaboration between (currently) 10 state health departments, their academic center partners, and the Centers for Disease Control and Prevention, was established in 1995.", {"entities": []}], ["The EIP performs active, population-based surveillance for important infectious diseases, addresses new problems as they arise, emphasizes projects that lead to prevention, and develops and evaluates public health practices.", {"entities": []}], ["The EIP has increasingly addressed the health equity challenges posed by Healthy People 2020.", {"entities": []}], ["These challenges include objectives to increase the proportion of Healthy People\u2013specified conditions for which national data are available by race/ethnicity and socioeconomic status as a step toward first recognizing and subsequently eliminating health inequities.", {"entities": []}], ["EIP has made substantial progress in moving from an initial focus on monitoring social determinants exclusively through collecting and analyzing data by race/ethnicity to identifying and piloting ways to conduct population-based surveillance by using area-based socioeconomic status measures.", {"entities": []}], ["Objective To determine whether mobile phone based monitoring improves asthma control compared with standard paper based monitoring strategies.", {"entities": [[70, 76, "DISEASE"]]}], ["Design Multicentre randomised controlled trial with cost effectiveness analysis.", {"entities": []}], ["Setting UK primary care.", {"entities": []}], ["Participants 288 adolescents and adults with poorly controlled asthma (asthma control questionnaire (ACQ) score \u22651.5) from 32 practices.", {"entities": [[63, 69, "DISEASE"], [71, 77, "DISEASE"]]}], ["Intervention Participants were centrally randomised to twice daily recording and mobile phone based transmission of symptoms, drug use, and peak flow with immediate feedback prompting action according to an agreed plan or paper based monitoring.", {"entities": []}], ["Main outcome measures Changes in scores on asthma control questionnaire and self efficacy (knowledge, attitude, and self efficacy asthma questionnaire (KASE-AQ)) at six months after randomisation.", {"entities": [[43, 49, "DISEASE"], [130, 136, "DISEASE"]]}], ["Assessment of outcomes was blinded.", {"entities": []}], ["Analysis was on an intention to treat basis.", {"entities": []}], ["Results There was no significant difference in the change in asthma control or self efficacy between the two groups (ACQ: mean change 0.75 in mobile group v 0.73 in paper group, mean difference in change \u22120.02 (95% confidence interval \u22120.23 to 0.19); KASE-AQ score: mean change \u22124.4 v \u22122.4, mean difference 2.0 (\u22120.3 to 4.2)).", {"entities": [[61, 67, "DISEASE"]]}], ["The numbers of patients who had acute exacerbations, steroid courses, and unscheduled consultations were similar in both groups, with similar healthcare costs.", {"entities": []}], ["Overall, the mobile phone service was more expensive because of the expenses of telemonitoring.", {"entities": []}], ["Conclusions Mobile technology does not improve asthma control or increase self efficacy compared with paper based monitoring when both groups received clinical care to guidelines standards.", {"entities": [[47, 53, "DISEASE"]]}], ["The mobile technology was not cost effective.", {"entities": []}], ["Trial registration Clinical Trials NCT00512837.", {"entities": []}], ["This study was performed to assess whether iterative reconstruction can reduce radiation dose while maintaining acceptable image quality, and to investigate whether perfusion parameters vary from conventional filtered back projection (FBP) at the low-tube-voltage (80-kVp) during whole-pancreas perfusion examination using a 256-slice CT. 76 patients with known or suspected pancreatic mass underwent whole-pancreas perfusion by a 256-slice CT. High- and low-tube-voltage CT images were acquired.", {"entities": []}], ["120-kVp image data (protocol A) and 80-kVp image data (protocol B) were reconstructed with conventional FBP, and 80-kVp image data were reconstructed with iDose In the quantitative study, protocol C reduced image noise by 36.8% compared to protocol B (P<0.001).", {"entities": []}], ["Protocol C yielded significantly higher CNR relative to muscle for the aorta, pancreas and liver compared to protocol B (P<0.001), and offered no significant difference compared to protocol A.", {"entities": []}], ["In the qualitative study, protocols C and A gained similar scores and protocol B gained the lowest score for overall image quality (P<0.001).", {"entities": []}], ["Mean effective doses were 23.37 mSv for protocol A and 10.81 mSv for protocols B and C. There were no significant differences in the normal pancreas perfusion values among three different protocols.", {"entities": []}], ["Low-tube-voltage and iDose", {"entities": []}], ["Exposure to cigarette smoking during foetal and early postnatal life may have implications for lung health.", {"entities": []}], ["The aim of this study was to assess the possible effects of such exposure in utero on lower respiratory disease in children up to two years of age.", {"entities": []}], ["A birth cohort of 4089 newborn infants was followed for two years using parental questionnaires.", {"entities": []}], ["When the infant was two months old the parents completed a questionnaire on various lifestyle factors, including maternal smoking during pregnancy and after birth.", {"entities": []}], ["At one and two years of age information was obtained by questionnaire on symptoms of allergic and respiratory diseases as well as on environmental exposures, particularly exposure to environmental tobacco smoke (ETS).", {"entities": []}], ["Adjustments were made for potential confounders.", {"entities": []}], ["When the mother had smoked during pregnancy but not after that, there was an increased risk of recurrent wheezing up to two years' age, OR adj = 2.2, (95% CI 1.3 \u2013 3.6).", {"entities": []}], ["The corresponding OR was 1.6, (95% CI 1.2 \u2013 2.3) for reported exposure to ETS with or without maternal smoking in utero.", {"entities": []}], ["Maternal smoking during pregnancy but no exposure to ETS also increased the risk of doctor's diagnosed asthma up to two years of age, OR adj = 2.1, (95% CI 1.2 \u2013 3.7).", {"entities": [[103, 109, "DISEASE"]]}], ["Exposure to maternal cigarette smoking in utero is a risk factor for recurrent wheezing, as well as doctor's diagnosed asthma in children up to two yearsof age.", {"entities": [[119, 125, "DISEASE"]]}], ["The development of laparoscopic cholecystectomy has allowed the introduction of outpatient surgery for biliary tract disease.", {"entities": [[103, 124, "DISEASE"]]}], ["However, there appears to be a wide variation of the interpretation of \u201coutpatient surgery,\u201d ranging from discharge the same day to keeping patients for overnight observation.", {"entities": []}], ["We prospectively reviewed the last 50 cholecystectomies performed at Spartanburg Regional Medical Center, a private teaching institution, and Upstate Carolina Medical Center, a private nonteaching hospital.", {"entities": []}], ["All cholecystectomies were performed by board certified surgeons or surgical residents under the supervision of board certified surgeons.", {"entities": []}], ["Spartanburg Regional Medical Center's standard was 23-hour observation with 9 patients (18%) being discharged home the day of surgery.", {"entities": []}], ["Upstate Carolina Medical Center's standard was discharge home (usually 4-8 hours after completion of the procedure) with 39 patients (78%) discharged the same day.", {"entities": []}], ["No patient discharged the same day presented back with any significant complication.", {"entities": []}], ["Comorbid disease, biliary pancreatitis, ascending cholangitis, gangrenous gallbladder, extreme age and living conditions and conversion to open were factors considered for admission.", {"entities": [[40, 61, "DISEASE"], [26, 38, "DISEASE"], [50, 61, "DISEASE"]]}], ["Intra-operative difficulty such as oozing, excessive adhesiolysis, postoperative nausea, vomiting or pain control were also indications for overnight admissions.", {"entities": []}], ["The extra 15 to 19 hours for routine observation did not change any treatment for any of the 41 patients and resulted in additional cost to the hospital of approximately $15,000.", {"entities": []}], ["We conclude that same day, outpatient laparoscopic cholecystectomy can be done safely with discharge home 4 to 8 hours postoperative without significant morbidity in selective patients.", {"entities": []}], ["When \u201cantipsychotic\u201d drugs were introduced into psychiatry in the 1950s, they were thought to work by inducing a state of neurological suppression, which reduced behavioral disturbance as well as psychotic symptoms.", {"entities": []}], ["This view was reflected in the name \u201cneuroleptic.\u201d Within a few years, however, the idea that the drugs were a disease-specific treatment for schizophrenia or psychosis, and that they worked by modifying the underlying pathology of the condition, replaced this earlier view, and they became known as \u201cantipsychotics.\u201d This transformation of views about the drugs\u2019 mode of action occurred with little debate or empirical evaluation in the psychiatric literature and obscured earlier evidence about the nature of these drugs.", {"entities": [[142, 155, "DISEASE"]]}], ["Drug advertisements in the British Journal of Psychiatry reflect the same changes, although the nondisease-specific view persisted for longer.", {"entities": []}], ["It is suggested that professional interests rather than scientific merit facilitated the rise of the disease-specific view of drug action.", {"entities": []}], ["The increasing popularity of atypical antipsychotics makes it important to examine the origins of the assumptions on which modern drug treatment is based.", {"entities": []}], ["Recent studies have indicated that patients are showing increased interest in playing a larger role in making decisions regarding their medical treatment.", {"entities": []}], ["Inflammatory bowel disease (IBD) is a chronic disease that manifests either as Crohn\u2019s disease (CD) or ulcerative colitis (UC).", {"entities": [[103, 121, "DISEASE"]]}], ["IBD treatment is multifaceted and dependent on patient-specific factors.", {"entities": []}], ["The selection of treatment options is mostly driven by physicians, and it is unclear to what degree patients are involved in shared decision-making (SDM).", {"entities": []}], ["The objective of the current study is to assess preferences among Japanese patients with IBD in regard to SDM during their treatment for IBD.", {"entities": []}], ["A nationwide web-based survey was performed in Japan during February 2016.", {"entities": []}], ["The patients were asked for their basic clinical characteristics, socioeconomic status, medical history, treatment details, and preferences regarding SDM in IBD treatment.", {"entities": []}], ["Differences were analyzed by chi-square, t tests, a multiple regression analysis, and ordered logistic regression analysis.", {"entities": []}], ["In response to the screening survey, a total of 1068 Japanese nationals met the inclusion criteria for this study of being patients diagnosed with IBD who are currently receiving treatment.", {"entities": []}], ["Of these, 235 had CD and 800 UC; 33 were not specified.", {"entities": []}], ["Overall, the majority of these patients felt that SDM was very important.", {"entities": []}], ["Furthermore, interest in SDM was strongly associated with certain disease comorbidities, surgical history, and current treatment, although there were some differences in the results between CD and UC.", {"entities": []}], ["The present study found that the majority of IBD patients in Japan wanted to have a role in their treatment plan.", {"entities": []}], ["The results indicate that the patient\u2019s preference in regard to SDM was driven by their perception of the severity or progression of their disease.", {"entities": []}], ["Janssen Pharmaceuticals.", {"entities": []}], ["Respiratory infections are responsible for a large global burden of disease.", {"entities": []}], ["We assessed the public and philanthropic investments awarded to UK institutions for respiratory infectious disease research to identify areas of underinvestment.", {"entities": []}], ["We aimed to identify projects and categorise them by pathogen, disease and position along the research and development value chain.", {"entities": []}], ["Institutions that host and carry out infectious disease research.", {"entities": []}], ["The total amount spent and number of studies with a focus on several different respiratory pathogens or diseases, and to correlate these against the global burden of disease; also the total amount spent and number of studies relating to the type of science, the predominant funder in each category and the mean and median award size.", {"entities": []}], ["We identified 6165 infectious disease studies with a total investment of \u00a32\u00b76 billion.", {"entities": []}], ["Respiratory research received \u00a3419 million (16.1%) across 1192 (19.3%) studies.", {"entities": []}], ["The Wellcome Trust provided greatest investment (\u00a3135.2 million; 32.3%).", {"entities": []}], ["Tuberculosis received \u00a3155 million (37.1%), influenza \u00a380 million (19.1%) and pneumonia \u00a327.8 million (6.6%).", {"entities": [[44, 53, "DISEASE"], [78, 87, "DISEASE"], [0, 12, "DISEASE"]]}], ["Despite high burden, there was relatively little investment in vaccine-preventable diseases including diphtheria (\u00a30.1 million, 0.03%), measles (\u00a35.0 million, 1.2%) and drug-resistant tuberculosis.", {"entities": [[136, 143, "DISEASE"], [102, 112, "DISEASE"], [184, 196, "DISEASE"]]}], ["There were 802 preclinical studies (67.3%) receiving \u00a3273 million (65.2%), while implementation research received \u00a381 million (19.3%) across 274 studies (23%).", {"entities": []}], ["There were comparatively few phase I\u2013IV trials or product development studies.", {"entities": []}], ["Global health research received \u00a368.3 million (16.3%).", {"entities": []}], ["Relative investment was strongly correlated with 2010 disease burden.", {"entities": []}], ["The UK predominantly funds preclinical science.", {"entities": []}], ["Tuberculosis is the most studied respiratory disease.", {"entities": [[0, 12, "DISEASE"]]}], ["The high global burden of pneumonia-related disease warrants greater investment than it has historically received.", {"entities": [[26, 35, "DISEASE"]]}], ["Other priority areas include antimicrobial resistance (particularly within tuberculosis), economics and proactive investments for emerging infectious threats.", {"entities": [[75, 87, "DISEASE"]]}], ["Arachidonic acid metabolism leads to the generation of key lipid mediators which play a fundamental role during inflammation.", {"entities": []}], ["The inhibition of enzymes involved in arachidonic acid metabolism has been considered as a synergistic anti-inflammatory effect with enhanced spectrum of activity.", {"entities": []}], ["A series of 1,3-diphenyl-2-propen-1-one derivatives were investigated for anti-inflammatory related activities involving inhibition of secretory phospholipase A 2 , cyclooxygenases, soybean lipoxygenase, and lipopolysaccharides-induced secretion of interleukin-6 and tumor necrosis factor-alpha in mouse RAW264.7 macrophages.", {"entities": []}], ["The results from the above mentioned assays exhibited that the synthesized compounds were effective inhibitors of pro-inflammatory enzymes and cytokines.", {"entities": []}], ["The results also revealed that the chalcone derivatives with 4-methlyamino ethanol substitution seem to be significant for inhibition of enzymes and cytokines.", {"entities": []}], ["Molecular docking experiments were carried out to elucidate the molecular aspects of the observed inhibitory activities of the investigated compounds.", {"entities": []}], ["Present findings increase the possibility that these chalcone derivatives might serve as a beneficial starting point for the design and development of improved anti-inflammatory agents.", {"entities": []}], ["Numerous studies suggest genetic influences on sleepiness and circadian rhythms.", {"entities": []}], ["The Sleep Heart Health Study collected questionnaire data on sleep habits and sleepiness from 2848 Framingham Heart Study Offspring Cohort participants.", {"entities": []}], ["More than 700 participants were genotyped using the Affymetrix 100K SNP GeneChip, providing a unique opportunity to assess genetic linkage and association of these traits.", {"entities": []}], ["Sleepiness (defined as the Epworth Sleepiness Scale score), usual bedtime and usual sleep duration were assessed by self-completion questionnaire.", {"entities": []}], ["Standardized residual measures adjusted for age, sex and BMI were analyzed.", {"entities": []}], ["Multipoint variance components linkage analysis was performed.", {"entities": []}], ["Association of SNPs to sleep phenotypes was analyzed with both population-based and family-based association tests, with analysis limited to 70,987 autosomal SNPs with minor allele frequency \u226510%, call rate \u226580%, and no significant deviation from Hardy-Weinberg equilibrium (p \u2265 0.001).", {"entities": []}], ["Heritability of sleepiness was 0.29, bedtime 0.22, and sleep duration 0.17.", {"entities": []}], ["Both genotype and sleep phenotype data were available for 749 subjects.", {"entities": []}], ["Linkage analysis revealed five linkage peaks of LOD >2: four to usual bedtime, one to sleep duration.", {"entities": []}], ["These peaks include several candidate sleep-related genes, including CSNK2A2 , encoding a known component of the circadian molecular clock, and PROK2 , encoding a putative transmitter of the behavioral circadian rhythm from the suprachiasmatic nucleus.", {"entities": [[69, 76, "GENE"], [144, 149, "GENE"]]}], ["Association tests identified an association of usual bedtime with a non-synonymous coding SNP in NPSR1 that has been shown to encode a gain of function mutation of the neuropeptide S receptor, whose endogenous ligand is a potent promoter of wakefulness.", {"entities": [[97, 102, "GENE"]]}], ["Each copy of the minor allele of this SNP was associated with a 15 minute later mean bedtime.", {"entities": []}], ["The lowest p value was for association of sleepiness with a SNP located in an intron of PDE4D , which encodes a cAMP-specific phosphodiesterase widely expressed in human brain.", {"entities": [[88, 93, "GENE"]]}], ["Full association results are posted at .", {"entities": []}], ["This analysis confirms prior reports of significant heritability of sleepiness, usual bedtime, and usual sleep duration.", {"entities": []}], ["Several genetic loci with suggestive linkage to these traits are identified, including linkage peaks containing circadian clock-related genes.", {"entities": []}], ["Association tests identify NPSR1 and PDE4D as possible mediators of bedtime and sleepiness.", {"entities": [[27, 32, "GENE"], [37, 42, "GENE"]]}], ["Administration of infliximab is associated with a well-recognised risk of infusion reactions.", {"entities": []}], ["Lack of a mechanism-based rationale for their prevention, and absence of adequate and well-controlled studies, has led to the use of diverse empirical administration protocols.", {"entities": []}], ["The aim of this study is to perform a systematic review of the evidence behind the strategies for preventing infusion reactions to infliximab, and for controlling the reactions once they occur.", {"entities": []}], ["We conducted extensive search of electronic databases of MEDLINE [PubMed] for reports that communicate various aspects of infusion reactions to infliximab in IBD patients.", {"entities": []}], ["We examined full texts of 105 potentially eligible articles.", {"entities": []}], ["No randomised controlled trials that pre-defined infusion reaction as a primary outcome were found.", {"entities": []}], ["Three RCTs evaluated infusion reactions as a secondary outcome; another four RCTs included infusion reactions in the safety evaluation analysis; and 62 additional studies focused on various aspects of mechanism/s, risk, primary and secondary preventive measures, and management algorithms.", {"entities": []}], ["Seven studies were added by a manual search of reference lists of the relevant articles.", {"entities": []}], ["A total of 76 original studies were included in quantitative analysis of the existing strategies.", {"entities": []}], ["There is still paucity of systematic and controlled data on the risk, prevention, and management of infusion reactions to infliximab.", {"entities": []}], ["We present working algorithms based on systematic and extensive review of the available data.", {"entities": []}], ["More randomised controlled trials are needed in order to investigate the efficacy of the proposed preventive and management algorithms.", {"entities": []}], ["Persons with Irritable bowel syndrome (IBS) are seriously affected in their everyday life.", {"entities": [[29, 37, "DISEASE"]]}], ["The effect across different cultural settings of IBS on their quality of life has been little studied.", {"entities": []}], ["The aim was to compare health-related quality of life (HRQOL) of individuals suffering from IBS in two different cultural settings; Crete, Greece and Link\u00f6ping, Sweden.", {"entities": []}], ["This study is a sex and age-matched case-control study, with n = 30 Cretan IBS cases and n = 90 Swedish IBS cases and a Swedish control group (n = 300) randomly selected from the general population.", {"entities": []}], ["Health-related quality of life, measured by SF-36 and demographics, life style indicators and co-morbidity, was measured.", {"entities": []}], ["Cretan IBS cases reported lower HRQOL on most dimensions of SF-36 in comparison to the Swedish IBS cases.", {"entities": []}], ["Significant differences were found for the dimensions mental health (p < 0.0001) and general health (p = 0.05) even after adjustments for educational level and co-morbidity.", {"entities": []}], ["Women from Crete with IBS scored especially low on the dimensions general health (p = 0.009) and mental health (p < 0.0001) in comparison with Swedish women with IBS.", {"entities": []}], ["The IBS cases, from both sites, reported significantly lower scores on all HRQOL dimensions in comparison with the Swedish control group.", {"entities": []}], ["The results from this study tentatively support that the claim that similar individuals having the same disease, e.g.", {"entities": []}], ["IBS, but living in different cultural environments could perceive their disease differently and that the disease might affect their everyday life and quality of life in a different way.", {"entities": []}], ["The Cretan population, and especially women, are more seriously affected mentally by their disease than Swedish IBS cases.", {"entities": []}], ["Coping with IBS in everyday life might be more problematic in the Cretan environment than in the Swedish setting.", {"entities": []}], ["The government of Ghana introduced the National Health Insurance Scheme (NHIS) in 2003 through an Act of Parliament (Act 650) as a strategy to improve financial access to quality basic health care services.", {"entities": []}], ["Although attendance at health facilities has increased since the introduction of the NHIS, there have been media reports of widespread abuse of the NHIS by scheme operators, service providers and insured persons.", {"entities": []}], ["The aim of the study was to document behaviors and practices of service providers and clients of the NHIS in the Kassena-Nankana District (KND) of Ghana that constitute moral hazards (abuse of the scheme) and identify strategies to minimize such behaviors.", {"entities": []}], ["Qualitative methods through 14 Focused Group Discussions (FGDs) and 5 individual in-depth interviews were conducted between December 2009 and January 2010.", {"entities": []}], ["Thematic analysis was performed with the aid of QSR NVivo 8 software.", {"entities": []}], ["Analysis of FGDs and in-depth interviews showed that community members, health providers and NHIS officers are aware of various behaviors and practices that constitute abuse of the scheme.", {"entities": []}], ["Behaviors such as frequent and \u2018frivolous\u2019 visits to health facilities, impersonation, feigning sickness to collect drugs for non-insured persons, over charging for services provided to clients, charging clients for services not provided and over prescription were identified.", {"entities": []}], ["Suggestions on how to minimize abuse of the NHIS offered by respondents included: reduction of premiums and registration fees, premium payments by installment, improvement in the picture quality of the membership cards, critical examination and verification of membership cards at health facilities, some ceiling on the number of times one can seek health care within a specified time period, and general education to change behaviors that abuse the scheme.", {"entities": []}], ["Attention should be focused on addressing the identified moral hazard behaviors and pursue cost containment strategies to ensure the smooth operation of the scheme and enhance its sustainability.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-1133-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We review the evidence that infectious agents, including those that become dormant within the host, have a major role to play in much of the etiology of rheumatoid arthritis and the inflammation that is its hallmark.", {"entities": [[153, 173, "DISEASE"], [164, 173, "DISEASE"]]}], ["This occurs in particular because they can produce cross-reactive (auto-)antigens, as well as potent inflammagens such as lipopolysaccharide that can themselves catalyze further inflammagenesis, including via \u03b2-amyloid formation.", {"entities": []}], ["A series of observables coexist in many chronic, inflammatory diseases as well as rheumatoid arthritis.", {"entities": [[82, 102, "DISEASE"], [93, 102, "DISEASE"]]}], ["They include iron dysregulation, hypercoagulability, anomalous morphologies of host erythrocytes, and microparticle formation.", {"entities": []}], ["Iron dysregulation may be responsible for the periodic regrowth and resuscitation of the dormant bacteria, with concomitant inflammagen production.", {"entities": []}], ["The present systems biology analysis benefits from the philosophical idea of \u201ccoherence,\u201d that reflects the principle that if a series of ostensibly unrelated findings are brought together into a self-consistent narrative, that narrative is thereby strengthened.", {"entities": []}], ["As such, we provide a coherent and testable narrative for the major involvement of (often dormant) bacteria in rheumatoid arthritis.", {"entities": [[111, 131, "DISEASE"], [122, 131, "DISEASE"]]}], ["IgE-mediated peanut allergy is a complex trait with strong heritability, but its genetic basis is currently unknown.", {"entities": []}], ["Loss-of-function mutations within the filaggrin gene are associated with atopic dermatitis and other atopic diseases; therefore, filaggrin is a candidate gene in the etiology of peanut allergy.", {"entities": [[73, 90, "DISEASE"], [80, 90, "DISEASE"]]}], ["To investigate the association between filaggrin loss-of-function mutations and peanut allergy.", {"entities": []}], ["Case-control study of 71 English, Dutch, and Irish oral food challenge\u2013positive patients with peanut allergy and 1000 non peanut-sensitized English population controls.", {"entities": []}], ["Replication was tested in 390 white Canadian patients with peanut allergy (defined by food challenge, or clinical history and skin prick test wheal to peanut \u22658 mm and/or peanut-specific IgE \u226515 kUL Filaggrin loss-of-function mutations showed a strong and significant association with peanut allergy in the food challenge\u2013positive patients ( P \u00a0= 3.0 \u00d7 10 P \u00a0= 5.4 \u00d7 10 P \u00a0= .0008) after controlling for coexistent atopic dermatitis.", {"entities": [[415, 432, "DISEASE"], [422, 432, "DISEASE"]]}], ["Filaggrin mutations represent a significant risk factor for IgE-mediated peanut allergy, indicating a role for\u00a0epithelial barrier dysfunction in the pathogenesis of\u00a0this\u00a0disease.", {"entities": []}], ["MiRNA expression profiling is being actively investigated as a clinical biomarker and diagnostic tool to detect multiple cancer types and stages as well as other complex diseases.", {"entities": [[121, 127, "DISEASE"]]}], ["Initial investigations, however, have not comprehensively taken into account genetic variability affecting miRNA expression and/or function in populations of different ethnic backgrounds.", {"entities": []}], ["Therefore, more complete surveys of miRNA genetic variability are needed to assess global patterns of miRNA variation within and between diverse human populations and their effect on clinically relevant miRNA genes.", {"entities": []}], ["Genetic variation in 1524 miRNA genes was examined using whole genome sequencing (60x coverage) in a panel of 69 unrelated individuals from 14 global populations, including European, Asian and African populations.", {"entities": []}], ["We identified 33 previously undescribed miRNA variants, and 31 miRNA containing variants that are globally population-differentiated in frequency between African and non-African populations (PD-miRNA).", {"entities": []}], ["The top 1% of PD-miRNA were significantly enriched for regulation of genes involved in glucose/insulin metabolism and cell division (p < 10 in vivo and subsequently breast cancer mortality.", {"entities": [[165, 178, "DISEASE"], [172, 178, "DISEASE"]]}], ["MiRNA expression profiles represent a promising new category of disease biomarkers.", {"entities": []}], ["However, population specific genetic variation can affect the prevalence and baseline expression of these miRNAs in diverse populations.", {"entities": []}], ["Consequently, miRNA genetic and expression level variation among ethnic groups may be contributing in part to health disparities observed in multiple forms of cancer, specifically breast cancer, and will be an essential consideration when assessing the utility of miRNA biomarkers for the clinic.", {"entities": [[180, 193, "DISEASE"], [159, 165, "DISEASE"], [187, 193, "DISEASE"]]}], ["Multimorbidity is common and associated with poor clinical outcomes and high health care costs.", {"entities": []}], ["Administrative data are a promising tool for studying the epidemiology of multimorbidity.", {"entities": []}], ["Our goal was to derive and apply a new scheme for using administrative data to identify the presence of chronic conditions and multimorbidity.", {"entities": []}], ["We identified validated algorithms that use ICD-9 CM/ICD-10 data to ascertain the presence or absence of 40 morbidities.", {"entities": []}], ["Algorithms with both positive predictive value and sensitivity \u226570% were graded as \u201chigh validity\u201d; those with positive predictive value \u226570% and sensitivity <70% were graded as \u201cmoderate validity\u201d.", {"entities": []}], ["To show proof of concept, we applied identified algorithms with high to moderate validity to inpatient and outpatient claims and utilization data from 574,409 people residing in Edmonton, Canada during the 2008/2009 fiscal year.", {"entities": []}], ["Of the 40 morbidities, we identified 30 that could be identified with high to moderate validity.", {"entities": []}], ["Approximately one quarter of participants had identified multimorbidity (2 or more conditions), one quarter had a single identified morbidity and the remaining participants were not identified as having any of the 30 morbidities.", {"entities": []}], ["We identified a panel of 30 chronic conditions that can be identified from administrative data using validated algorithms, facilitating the study and surveillance of multimorbidity.", {"entities": []}], ["We encourage other groups to use this scheme, to facilitate comparisons between settings and jurisdictions.", {"entities": []}], ["The online version of this article (doi:10.1186/s12911-015-0155-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We present an effective portable e-nose system that performs well even in noisy environments.", {"entities": []}], ["Considering the characteristics of the e-nose data, we use an image covariance matrix-based method for extracting discriminant features for vapor classification.", {"entities": []}], ["To construct composite vectors, primitive variables of the data measured by a sensor array are rearranged.", {"entities": []}], ["Then, composite features are extracted by utilizing the information about the statistical dependency among multiple primitive variables, and a classifier for vapor classification is designed with these composite features.", {"entities": []}], ["Experimental results with different volatile organic compounds data show that the proposed system has better classification performance than other methods in a noisy environment.", {"entities": []}], ["To compare the psychometric properties of the World Health Organization Quality of Life-BREF (WHOQOL-BREF) instrument and the St. George\u2019s Respiratory Questionnaire (SGRQ), and to examine the association between pulmonary function and domains and items of these questionnaires in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[294, 331, "DISEASE"]]}], ["The WHOQOL-BREF and the SGRQ were administered to 211 patients.", {"entities": []}], ["The reliability and validity of, and correlations among, the domain scores were examined.", {"entities": []}], ["Multiple regression analyses were performed to identify which items were independently associated with subjects\u2019 lung functions.", {"entities": []}], ["Both questionnaires showed good internal consistency (\u03b1\u00a0>\u00a00.8), except the SGRQ symptoms domain (\u03b1\u00a0=\u00a00.66), minimal ceiling and floor effects, and good item convergent and item discriminant validity.", {"entities": []}], ["There were moderate correlations between physical domain of the WHOQOL-BREF and activity, impacts and total domains of the SGRQ, and between psychological domain of the WHOQOL-BREF and impacts and total domains of the SGRQ.", {"entities": []}], ["Eighteen items were significantly associated with lung function, particularly those items relating to mobility/walking and activities of daily living (ADL).", {"entities": []}], ["Both the WHOQOL-BREF and the SGRQ showed comparable reliability and validity.", {"entities": []}], ["Items related to mobility/walking and ADL may be useful in clinical screening for lung function impairment.", {"entities": []}], ["Falls are one of the major health problems that effect the quality of life among older adults.", {"entities": []}], ["The aim of this study was to explore the relationship between quality of life (Short Form-12) and the risk factors of falls (balance, functional mobility, proprioception, muscle strength, flexibility and fear of falling) in older adults.", {"entities": []}], ["One hundred sixteen people aged 65 or older and living in the T.C.", {"entities": []}], ["Emekli Sandigi Narlidere nursing home participated in the study.", {"entities": []}], ["Balance (Berg Balance test), functional mobility (Timed Up and Go), proprioception (joint position sense), muscle strength (back/leg dynamometer), flexibility (sit and reach) and fear of falling (Visual Analogue Scale) were assessed as risk factors for falls.", {"entities": []}], ["The quality of life was measured by Short Form-12 (SF-12).", {"entities": []}], ["A strong positive correlation was observed between Physical Health Component Summary of SF-12, General Health Perception and balance, muscle strength.", {"entities": []}], ["Proprioception and flexibility did not correlated with SF-12 (p > 0.05).", {"entities": []}], ["There was negative correlation between Physical Health Component Summary of SF-12, General Health Perception and fear of falling, functional mobility (p < 0.05).", {"entities": []}], ["We concluded that the risk factors for falls (balance, functional mobility, muscle strength, fear of falling) in older adults are associated with quality of life while flexibility and proprioception are not.", {"entities": []}], ["A systematic review and meta-analysis of the association between alcohol consumption and risk of sleep apnoea in adults.", {"entities": []}], ["We searched Medline, EMBASE and Web of Science databases from 1985 to 2015 for comparative epidemiological studies assessing the relation between alcohol consumption and sleep apnoea.", {"entities": []}], ["Two authors independently screened and extracted data.", {"entities": []}], ["Random effects meta-analysis was used to estimate pooled effect sizes with 95% confidence intervals (CI).", {"entities": []}], ["Heterogeneity was quantified using I We identified 21 studies from which estimates of relative risk could be obtained.", {"entities": []}], ["Meta-analysis of these estimates demonstrated that higher levels of alcohol consumption increased the risk of sleep apnoea by 25% (RR 1.25, 95%CI 1.13\u20131.38, I These findings suggest that alcohol consumption is associated with a higher risk of sleep apnoea, further supporting evidence that reducing alcohol intake is of potential therapeutic and preventive value in this condition.", {"entities": []}], ["\u2022 Alcohol consumption increased the risk of sleep apnoea by 25%.", {"entities": []}], ["\u2022 Findings were robust to differences in definitions of alcohol consumption and sleep apnoea.", {"entities": []}], ["\u2022 Association appeared stronger low and middle income countries.", {"entities": []}], ["\u2022 Timing and regularity of alcohol consumption likely to be important to its effect on OSA.", {"entities": []}], ["\u2022 Recommend advising against alcohol in people with, or at risk of, OSA.", {"entities": []}], ["Alcohol consumption increased the risk of sleep apnoea by 25%.", {"entities": []}], ["Findings were robust to differences in definitions of alcohol consumption and sleep apnoea.", {"entities": []}], ["Association appeared stronger low and middle income countries.", {"entities": []}], ["Timing and regularity of alcohol consumption likely to be important to its effect on OSA.", {"entities": []}], ["Recommend advising against alcohol in people with, or at risk of, OSA.", {"entities": []}], ["Non-cystic fibrosis-related bronchiectasis is a chronic inflammatory lung disease, which is regarded as an \u201corphan\u201d lung disease, with little research devoted to the study of this condition.", {"entities": [[28, 42, "DISEASE"], [4, 19, "DISEASE"], [69, 81, "DISEASE"], [116, 128, "DISEASE"]]}], ["Bronchiectasis results in impaired quality of life and mortality if left untreated.", {"entities": [[0, 14, "DISEASE"]]}], ["The tools available in the armamentarium for the management of bronchiectasis entail antibiotic therapy traditionally used to treat exacerbations, stratagems to improve mucociliary clearance, and avoidance of toxins.", {"entities": [[63, 77, "DISEASE"]]}], ["Macrolides have been known for the last two decades to have not only anti-bacterial effects but immunomodulatory properties as well.", {"entities": []}], ["In cystic fibrosis, the use of macrolides is well documented in subjects colonized with Pseudomonas aeruginosa , to improve quality of life and lung function.", {"entities": [[3, 18, "DISEASE"]]}], ["There is currently emerging evidence to suggest the benefit of macrolides in subjects not colonized with Pseudomonas aeruginosa .", {"entities": []}], ["This beneficial effect has been less explored in the context of bronchiectasis from other causes.", {"entities": [[64, 78, "DISEASE"]]}], ["The purpose of this paper is to review the current literature on the use of macrolides in non-cystic fibrosis related bronchiectasis in paediatrics.", {"entities": [[118, 132, "DISEASE"], [94, 109, "DISEASE"]]}], ["Anaphylactoid reactions induced by preparations containing red ginseng have been reported.", {"entities": []}], ["The aim of this study is to evaluate the allergenicity and screen potential allergens in red ginseng extract thoroughly.", {"entities": []}], ["Red ginseng extract (RGE) and different fractions of RGE were prepared and evaluated by measuring the degranulation and viability of rat basophilic leukemia 2H3 (RBL-2H3) cells.", {"entities": [[148, 156, "DISEASE"]]}], ["Potential allergens were screened by RBL-2H3 cell extraction and allergenicity verified in RBL-2H3 cells, mouse peritoneal mast cells, Laboratory of Allergic Disease 2 (LAD2) human mast cells and mice, respectively.", {"entities": []}], ["80% ethanol extract of red ginseng extract induced mast cell degranulation with less cytotoxicity, but 40% ethanol extract could not.", {"entities": []}], ["Ginsenoside Rd and 20( S )-Rg3 could induce a significant increase in \u03b2-hexosaminidase release, histamine release and translocation of phosphatidylserine in RBL-2H3 cells.", {"entities": [[12, 14, "GENE"]]}], ["Ginsenoside Rd and 20( S )-Rg3 also increased \u03b2-hexosaminidase release and the intracellular Ca Ginsenoside Rd and 20( S )-Rg3 are potential allergens that induce the release of mediators associated with anaphylactoid reactions.", {"entities": [[12, 14, "GENE"], [108, 110, "GENE"], [12, 14, "GENE"], [108, 110, "GENE"]]}], ["Our study could guide optimization of methods associated with Rd/20( S )-Rg3-containing preparations and establishment of quality standards for safe application of Traditional Chinese Medicines.", {"entities": []}], ["Medical donation programs for drugs, other medical products, training and other supportive services can improve access to essential medicines in low- and middle-income countries (LMICs) and provide emergency and disaster relief.", {"entities": []}], ["The scope and extent to which medical donation programs evaluate their impact on recipients and health systems is not well documented.", {"entities": []}], ["We conducted a survey of the member organizations of the Partnership for Quality Medical Donations (PQMD), a global alliance of non-profit and corporate organizations, to identify evaluations conducted in conjunction with donation programs.", {"entities": []}], ["Twenty-five out of the 36 PQMD organizations that were members at the time of the survey participated in the study, for a response rate of 69\u00a0%.", {"entities": []}], ["PQMD members provided information on 34 of their major medical donation programs.", {"entities": []}], ["Half of the donation programs reported conducting trainings as a part of their donation program.", {"entities": []}], ["Twenty-six (76\u00a0%) programs reported that they conduct routine monitoring of their donation programs.", {"entities": []}], ["Less than 30\u00a0% of donation programs were evaluated for their impact on health.", {"entities": []}], ["Lack of technical staff and lack of funding were reported as key barriers to conducting impact evaluations.", {"entities": []}], ["Member organizations of PQMD provide a broad range of medical donations, targeting a wide range of public health issues and events.", {"entities": []}], ["While some level of monitoring and evaluation was conducted in nearly 80\u00a0% of the donation programs, a program\u2019s impact was infrequently evaluated.", {"entities": []}], ["Opportunities exist to develop consistent metrics for medical donation programs, develop a common framework for impact evaluations, and advocate for data collection and analysis plans that collect meaningful metrics.", {"entities": []}], ["The neurotoxicity of lead has been well established, and oxidative stress is strongly associated with lead-induced neurotoxicity.", {"entities": []}], ["Nrf2 is important for protection against oxidative stress in many disease models.", {"entities": []}], ["We applied t-BHQ, which is an Nrf2 activator, to investigate the possible role of Nrf2 in the protection against lead neurotoxicity.", {"entities": []}], ["t-BHQ significantly attenuated the oxidative stress in developmental rats by decreasing MDA level, as well as by increasing SOD activity and GSH content, in the hippocampus and frontal cortex.", {"entities": []}], ["Furthermore, neuronal apoptosis was detected by Nissl staining, and Bax expression was inhibited in the t-BHQ-treated group.", {"entities": [[68, 71, "GENE"]]}], ["Results showed that t-BHQ suppressed ROS production and caspase 3/7 activity but increased intracellular GSH content, in SH-SY5Y cells under lead exposure.", {"entities": []}], ["Moreover, in vivo and in vitro , t-BHQ enhanced the nuclear translocation of Nrf2 and binding to ARE areas but did not induce Nrf2 transcription.", {"entities": []}], ["These phenomena were confirmed using RT-PCR, EMSA, Western blot, and immunofluorescence analyses.", {"entities": []}], ["Subsequent upregulation of the expression of HO-1, NQO1, and GCLC was observed.", {"entities": [[51, 55, "GENE"], [61, 65, "GENE"]]}], ["However, knockdown of Nrf2 or HO-1 adversely affected the protective effects of t-BHQ against lead toxicity in SH-SY5Y cells.", {"entities": []}], ["Thus, t-BHQ can protect against lead neurotoxicity, depending on the Nrf2/HO-1 pathway.", {"entities": []}], ["Early disease detection with a minimally invasive screening test will significantly increase effectiveness and decrease the cost of treatment.", {"entities": []}], ["Here we propose a framework of a novel approach \u2013 Universal Screening Test (UST) for the detection of pathological processes in a particular organ system, organ, or tissue by RT-qPCR analysis of circulating cell-free miRNAs in plasma.", {"entities": []}], ["As the first step towards assessing the feasibility of this concept, the present study was designed to analyze whether the same microRNAs (miRNAs) can detect various diseases of a particular organ system.", {"entities": []}], ["RNA was extracted from plasma using Trizol treatment and silica binding.", {"entities": []}], ["Levels of miRNAs were measured by single target RT-qPCR.", {"entities": []}], ["The following innovations have been tested and proven effective: (i) the use of organ system/organ/tissue-enriched miRNAs; (ii) the use of miRNAs associated with broad disease categories, such as cancer and inflammation, in combination with the organ-enriched miRNAs; and (iii) the use of \u201cmiRNA pairs\u201d for selecting miRNA combinations with the highest sensitivity and specificity.", {"entities": [[196, 202, "DISEASE"]]}], ["Here we report biomarker miRNA pairs effectively differentiating (i) patients with pulmonary system diseases (asthma, pneumonia and non-small cell lung cancer) and gastrointestinal (GI) system diseases (Crohn\u2019s disease, stages I/II esophageal, gastric and colon cancers) from controls, each with 95% accuracy; (ii) patients with a pathology of the pulmonary system from patients with a pathology of the GI system with 94% accuracy; and (iii) cancer patients (stages I/II esophageal, gastric, colon cancers, or non-small cell lung cancer) from patients with inflammatory diseases (asthma, pneumonia, or Crohn\u2019s disease) with 93%-95% accuracy.", {"entities": [[147, 158, "DISEASE"], [525, 536, "DISEASE"], [118, 127, "DISEASE"], [588, 597, "DISEASE"], [110, 116, "DISEASE"], [580, 586, "DISEASE"], [152, 158, "DISEASE"], [442, 448, "DISEASE"], [530, 536, "DISEASE"]]}], ["The results obtained in the present study, along with the data reported by us and others previously, are encouraging and lay the ground for further investigation of the described approach for UST development.", {"entities": []}], ["Over the past decade there has been a significant shift to the use of murine models for investigations into the molecular basis of respiratory diseases, including asthma and chronic obstructive pulmonary disease.", {"entities": [[174, 211, "DISEASE"], [163, 169, "DISEASE"]]}], ["These models offer the exciting prospect of dissecting the complex interaction between cytokines, chemokines and growth related peptides in disease pathogenesis.", {"entities": []}], ["Furthermore, the receptors and the intracellular signalling pathways that are subsequently activated are amenable for study because of the availability of monoclonal antibodies and techniques for targeted gene disruption and gene incorporation for individual mediators, receptors and proteins.", {"entities": []}], ["However, it is clear that extrapolation from these models to the human condition is not straightforward, as reflected by some recent clinical disappointments.", {"entities": []}], ["This is not necessarily a problem with the use of mice itself, but results from our continued ignorance of the disease process and how to improve the modelling of complex interactions between different inflammatory mediators that underlie clinical pathology.", {"entities": []}], ["This review highlights some of the strengths and weaknesses of murine models of respiratory disease.", {"entities": []}], ["Exposure to second hand smoke (SHS) is one of the major causes of premature death and disease among children.", {"entities": []}], ["While socioeconomic inequalities exist for adult smoking, such evidence is limited for SHS exposure in children.", {"entities": []}], ["Thus, this study examined changes over time in socioeconomic inequalities in infants\u2019 SHS exposure in Japan.", {"entities": []}], ["This is a repeated cross-sectional study of 41,833 infants born in 2001 and 32,120 infants born in 2010 in Japan from nationally representative surveys using questionnaires.", {"entities": []}], ["The prevalence of infants\u2019 SHS exposure was determined and related to household income and parental education level.", {"entities": []}], ["The magnitudes of income and educational inequalities in infants\u2019 SHS exposure were estimated in 2001 and 2010 using both absolute and relative inequality indices.", {"entities": []}], ["The prevalence of SHS exposure in infants declined from 2001 to 2010.", {"entities": []}], ["The relative index of inequality increased from 0.85 (95% confidence interval [CI], 0.80 to 0.89) to 1.47 (95% CI, 1.37 to 1.56) based on income and from 1.22 (95% CI, 1.17 to 1.26) to 2.09 (95% CI, 2.00 to 2.17) based on education.", {"entities": []}], ["In contrast, the slope index of inequality decreased from 30.9 (95% CI, 29.3 to 32.6) to 20.1 (95% CI, 18.7 to 21.5) based on income and from 44.6 (95% CI, 43.1 to 46.2) to 28.7 (95% CI, 27.3 to 30.0) based on education.", {"entities": []}], ["Having only a father who smoked indoors was a major contributor to absolute income inequality in infants\u2019 SHS exposure in 2010, which increased in importance from 45.1% in 2001 to 67.0% in 2010.", {"entities": []}], ["The socioeconomic inequalities in infants\u2019 second hand smoke exposure increased in relative terms but decreased in absolute terms from 2001 to 2010.", {"entities": []}], ["Further efforts are needed to encourage parents to quit smoking and protect infants from second hand smoke exposure, especially in low socioeconomic households that include non-smoking mothers.", {"entities": []}], ["Self-reported screening questions are considered as an effective way to identify patients with limited health literacy.", {"entities": []}], ["Yet research has shown that individuals tend to over-report their reading level.", {"entities": []}], ["Moreover, the likelihood of over-reporting may differ between gender groups.", {"entities": []}], ["This study examined if systematic differences exist between men and women in their response to self-reported screening questions.", {"entities": []}], ["A national survey in Taiwan with participants selected using a multistage stratified, probability-proportional-to-size sampling strategy.", {"entities": []}], ["A total of 5682 Taiwanese adults aged 18 and older were sampled and recruited.", {"entities": []}], ["Of those adults, 3491 participated in the survey, resulting in a 62.1% response rate.", {"entities": []}], ["Both gender groups were equally represented in the final study sample.", {"entities": []}], ["Self-reported health literacy was assessed using two sets of questions that asked how difficult it was for the respondent to understand written health materials and how often the participant needed assistance from others to understand written health materials.", {"entities": []}], ["The objective level of health literacy was measured using the Mandarin Health Literacy Scale (MHLS).", {"entities": []}], ["A significant gender difference was observed among participants who had inadequate health literacy: while women's self-report was in line with the MHLS test result, men had a significant tendency to over-report their comprehension of health information.", {"entities": []}], ["In Taiwan, screening questions are prone to socially desirable response and may underidentify male patients with inadequate health literacy.", {"entities": []}], ["Development of a brief and easy-to-use health literacy test may be a more effective approach to health literacy screening in clinical settings.", {"entities": []}], ["Alternatively, clinicians can verify patient comprehension of health information via the \u2018teach back\u2019 or \u2018show me\u2019 technique in order to improve communication and patient care.", {"entities": []}], ["Research is needed to examine if gender differences in self-report of health literacy exist in other countries.", {"entities": []}], ["Persons with vertebral fracture may have reduced pulmonary function, but this association has not been much studied.", {"entities": []}], ["The aim of this cross-sectional study was therefore to examine the relationship between vertebral fracture and pulmonary function in a general, elderly population.", {"entities": []}], ["Vertebral morphometry was used for vertebral fracture assessment in 2132 elderly men (n\u2009=\u2009892) and women (n\u2009=\u20091240) aged 55 to 87\u00a0years in the population-based Troms\u00f8 Study 2007\u201308.", {"entities": []}], ["Pulmonary function was examined by spirometry.", {"entities": []}], ["Pulmonary function was expressed as FVC% predicted, FEV 1 % predicted, and FEV 1 /FVC% predicted values, adjusted FVC, FEV 1 , and FEV 1 /FVC, and obstructive and restrictive ventilatory impairment.", {"entities": [[52, 55, "GENE"], [75, 78, "GENE"], [119, 122, "GENE"], [131, 134, "GENE"], [52, 55, "GENE"], [75, 78, "GENE"], [119, 122, "GENE"], [131, 134, "GENE"], [52, 55, "GENE"], [75, 78, "GENE"], [119, 122, "GENE"], [131, 134, "GENE"], [52, 55, "GENE"], [75, 78, "GENE"], [119, 122, "GENE"], [131, 134, "GENE"]]}], ["Vertebral fracture was classified according to appearance, number, severity, and location of fractures.", {"entities": []}], ["Associations were analyzed using general linear and logistic models.", {"entities": []}], ["FVC% predicted and FEV 1 % predicted values were not associated with vertebral fracture (P\u2009>\u20090.05), whereas FEV 1 /FVC% predicted ratio was associated with both prevalent fracture, number of fractures, severity of fractures, and fracture site in men (P\u2009<\u20090.05), but not in women.", {"entities": [[19, 22, "GENE"], [108, 111, "GENE"], [19, 22, "GENE"], [108, 111, "GENE"]]}], ["When FVC, FEV 1 , and FEV 1 /FVC values were adjusted for multiple covariates, we found no significant association with vertebral fracture.", {"entities": [[10, 13, "GENE"], [22, 25, "GENE"], [10, 13, "GENE"], [22, 25, "GENE"]]}], ["Obstructive and restrictive ventilatory impairment was not associated with prevalent vertebral fracture.", {"entities": []}], ["In conclusion, this study did not confirm any clinically relevant associations between prevalent vertebral fracture and ventilatory impairment in elderly individuals.", {"entities": []}], ["The association between atopy and asthma is attenuated in non-affluent populations, an effect that may be explained by childhood infections such as geohelminths.", {"entities": [[34, 40, "DISEASE"]]}], ["To investigate the association between atopy and wheeze in schoolchildren living in urban and rural areas of Ecuador and examine the effects of geohelminths on this association.", {"entities": []}], ["We performed nested case\u2013control studies among comparable populations of schoolchildren living in rural communities and urban neighbourhoods in the Province of Esmeraldas, Ecuador.", {"entities": []}], ["We detected geohelminths in stool samples, measured recent wheeze and environmental exposures by parental questionnaire, and atopy by specific IgE (sIgE) and skin prick test (SPT) reactivity to aeroallergens.", {"entities": []}], ["Atopy, particularly sIgE to house dust mite (HDM), was more strongly associated with recent wheeze in urban than rural schoolchildren: (urban, adj.", {"entities": []}], ["OR 5.19, 95% CI 3.37\u20138.00, P\u00a0 < \u00a0 0.0001; rural, adj.", {"entities": []}], ["OR 1.81, 95%CI 1.09\u20132.99, P\u00a0 = \u00a0 0.02; interaction, P\u00a0 < \u00a0 0.001).", {"entities": []}], ["The population fractions of wheeze attributable to atopy were approximately two-fold greater in urban schoolchildren: SPT to any allergen (urban 23.5% vs. rural 10.1%), SPT to HDM (urban 18.5% vs. rural 9.6%), and anti-HDM IgE (urban 26.5% vs. rural 10.5%), while anti- Ascaris IgE was related to wheeze in a high proportion of rural (49.7%) and urban (35.4%) children.", {"entities": []}], ["The association between atopy and recent wheeze was attenuated by markers of geohelminth infections.", {"entities": []}], ["Our data suggest that urban residence modifies the association between HDM atopy and recent wheeze, and this effect is explained partly by geohelminth infections.", {"entities": []}], ["The role of influenza virus in patients presenting at ED during seasonal-epidemic periods has not previously been specified.", {"entities": [[12, 21, "DISEASE"]]}], ["Our objective was to determine its frequency according to clinical presentation.", {"entities": []}], ["This is a prospective observational study conducted during three-consecutive seasonal Influenza epidemics (2013\u20132015), including patients presenting i) community-acquired pneumonia (CAP); ii) severe acute symptoms (SAS): respiratory failure (RF), hemodynamic failure (HF), cardiac failure (CF), and miscellaneous symptoms (M); iii) symptoms suggesting influenza (PSSI).", {"entities": [[221, 240, "DISEASE"], [86, 95, "DISEASE"], [352, 361, "DISEASE"], [171, 180, "DISEASE"]]}], ["Patients were tested for influenza using specific PCR on naso-pharyngeal swabs.", {"entities": [[25, 34, "DISEASE"]]}], ["Of 1,239 patients, virological samples were taken from 784 (63.3%), 213 (27.2%) of whom were positive for the influenza virus: CAP 52/177 (29.4%), SAS 115/447 (25.7%) and PSSI 46/160 (28.8%) (p = 0.6).", {"entities": [[110, 119, "DISEASE"]]}], ["In the SAS group positivity rates were: RF 76/263 (28.9%), HF 5/29 (17.2%), CF 15/68 (22.1%), and M 19/87 (21.8%) (p = 0.3).", {"entities": []}], ["Among the major diagnostic categories, the influenza virus positivity rates were: asthma 60/231 (26%), acute exacerbation of chronic obstructive pulmonary disease 18/86 (20.9%), HIV 5/21 (23.8%) and cardiac failure 33/131 (25.2%).", {"entities": [[43, 52, "DISEASE"], [125, 162, "DISEASE"], [82, 88, "DISEASE"]]}], ["The positivity of the samples has not been associated (p>0.1) nor the presence of signs of severity or admission rate in medical ward nor intensive care unit.", {"entities": []}], ["Our results indicate that during seasonal influenza epidemics, Influenza virus-positivity rate is similar in patients attending ED for influenza-compatible clinical features, patients with acute symptoms including pneumonia, respiratory, hemodynamic and cardiac distress, and patients presenting for acute decompensation of chronic respiratory and cardiac diseases.", {"entities": [[42, 51, "DISEASE"], [63, 72, "DISEASE"], [135, 144, "DISEASE"], [214, 223, "DISEASE"]]}], ["An unusually high proportion of cases in Houston are caused by active transmission of endemic strains among US-born non-Hispanic blacks.", {"entities": []}], ["Tuberculosis (TB) rates in the United States are disproportionately high for certain ethnic minorities.", {"entities": [[0, 12, "DISEASE"]]}], ["Using univariate and multivariate analyses, we compared data for 1,318 US-born blacks with 565 US-born non-Hispanic whites who participated in the Houston TB Initiative (1995\u20132004).", {"entities": []}], ["All available Mycobacterium tuberculosis isolates underwent susceptibility and genotype testing (insertion sequence 6110 restriction fragment length polymorphism, spoligotyping, and genetic grouping).", {"entities": [[28, 40, "DISEASE"]]}], ["TB in blacks was associated with younger age, inner city residence, HIV seropositivity, and drug resistance.", {"entities": []}], ["TB cases clustered in 82% and 77% of blacks and whites, respectively (p = 0.46).", {"entities": []}], ["Three clusters had >100 patients each, including 1 cluster with a predominance of blacks.", {"entities": []}], ["Size of TB clusters was unexpectedly large, underscoring the ongoing transmission of TB in Houston, particularly among blacks.", {"entities": []}], ["The World Health Organization (WHO) conducted the World Health Survey (WHS) between 2002 and 2004 in 70 countries to provide cross-population comparable data on health, health-related outcomes and risk factors.", {"entities": []}], ["The aim of this study was to apply Grade of Membership (GoM) modelling as a means to condense extensive health information from the WHS into a set of easily understandable health profiles and to assign the degree to which an individual belongs to each profile.", {"entities": []}], ["This paper described the application of the GoM models to summarize population health status using World Health Survey data.", {"entities": []}], ["Grade of Membership analysis is a flexible, non-parametric, multivariate method, used to calculate health profiles from WHS self-reported health state and health conditions.", {"entities": []}], ["The WHS dataset was divided into four country economic categories based on the World Bank economic groupings (high, upper-middle, lower-middle and low income economies) for separate GoM analysis.", {"entities": []}], ["Three main health profiles were produced for each of the four areas: I.", {"entities": []}], ["Robust ; II.", {"entities": []}], ["Intermediate ; III.", {"entities": []}], ["Frail ; moreover population health, wealth and inequalities are defined for countries in each economic area as a means to put the health results into perspective.", {"entities": []}], ["These analyses have provided a robust method to better understand health profiles and the components which can help to identify healthy and non-healthy individuals.", {"entities": []}], ["The obtained profiles have described concrete levels of health and have clearly delineated characteristics of healthy and non-healthy respondents.", {"entities": []}], ["The GoM results provided both a useable way of summarising complex individual health information and a selection of intermediate determinants which can be targeted for interventions to improve health.", {"entities": []}], ["As populations' age, and with limited budgets for additional costs for health care and social services, applying the GoM methods may assist with identifying higher risk profiles for decision-making and resource allocations.", {"entities": []}], ["Reducing exposure to environmental agents indoors shown to increase asthma symptoms or lead to asthma exacerbations is an important component of a strategy to manage asthma for individuals.", {"entities": [[68, 74, "DISEASE"], [95, 101, "DISEASE"], [166, 172, "DISEASE"]]}], ["Numerous investigations have demonstrated that portable air cleaning devices can reduce concentrations of asthma triggers in indoor air; however, their benefits for breathing problems have not always been reproducible.", {"entities": [[106, 112, "DISEASE"]]}], ["The potential exposure benefits of whole house high efficiency in-duct air cleaners for sensitive subpopulations have yet to be evaluated.", {"entities": []}], ["We used an indoor air quality modeling system (CONTAM) developed by NIST to examine peak and time-integrated concentrations of common asthma triggers present in indoor air over a year as a function of natural ventilation, portable air cleaners, and forced air ventilation equipped with conventional and high efficiency filtration systems.", {"entities": [[134, 140, "DISEASE"]]}], ["Emission rates for asthma triggers were based on experimental studies published in the scientific literature.", {"entities": [[19, 25, "DISEASE"]]}], ["Forced air systems with high efficiency filtration were found to provide the best control of asthma triggers: 30\u201355% lower cat allergen levels, 90\u201399% lower risk of respiratory infection through the inhalation route of exposure, 90\u201398% lower environmental tobacco smoke (ETS) levels, and 50\u201375% lower fungal spore levels than the other ventilation/filtration systems considered.", {"entities": [[93, 99, "DISEASE"]]}], ["These results indicate that the use of high efficiency in-duct air cleaners provide an effective means of controlling allergen levels not only in a single room, like a portable air cleaner, but the whole house.", {"entities": []}], ["These findings are useful for evaluating potential benefits of high efficiency in-duct filtration systems for controlling exposure to asthma triggers indoors and for the design of trials of environmental interventions intended to evaluate their utility in practice.", {"entities": [[134, 140, "DISEASE"]]}], ["Intraoperative cardiac arrest (IOCA) is a lethal complication of noncardiac surgery.", {"entities": []}], ["According to several reports, immediate survival after IOCA is approximately 50%.", {"entities": []}], ["In this study, a retrospective case analysis was performed to determine the incidence of IOCA, the potential causes of cardiac arrest, and the risk factors of no resuscitation in patients undergoing tumorous surgery.", {"entities": []}], ["The medical records of surgery patients who experienced cardiac arrest during the intraoperative period between 2005 and 2014 were reviewed.", {"entities": []}], ["The general conditions of the patients with IOCA were compared between the successfully resuscitated group and the unresuscitated group.", {"entities": []}], ["Fifteen patients with IOCA among 142,853 patients undergoing tumorous surgery were reviewed during the study period.", {"entities": []}], ["Immediate survival after IOCA was 60%.", {"entities": []}], ["Hospital survival was 46.7%.", {"entities": []}], ["The incidence of IOCA decreased during 2010 to 2014 when compared with the rate during 2005 to 2009 ( P \u200a<\u200a.05).", {"entities": []}], ["The risk factors affecting the success of resuscitation after IOCA included American Society of Anesthesiologists Physical Status (ASA PS) classification\u200a\u2265\u200aIII ( P \u200a<\u200a.05) and preoperative tachycardia (heart rate \u2265100/min, P \u200a<\u200a.05).", {"entities": []}], ["The methods of anesthesia had no effects on the results of resuscitation.", {"entities": []}], ["The incidence of IOCA in patients undergoing tumorous surgery was 1.05 per 10,000 anesthesia.", {"entities": []}], ["The overall mortality of IOCA was 0.56/10,000.", {"entities": []}], ["The frequency of IOCA decreased within 10 years.", {"entities": []}], ["There was no cardiac arrest primarily attributable to anesthesia over this study period.", {"entities": []}], ["The risk factors leading to unsuccessful resuscitation after IOCA were ASA PS classification\u200a\u2265\u200aIII and preoperative tachycardia.", {"entities": []}], ["The p38\u03b1 mitogen\u2010activated protein kinase pathway not only regulates the production of inflammatory mediators, but also controls processes related to tissue homeostasis, such as cell proliferation, differentiation and survival, which are often disrupted during malignant transformation.", {"entities": []}], ["The versatility of this signaling pathway allows for the regulation of many specific functions depending on the cell type and context.", {"entities": []}], ["Here, we discuss mouse models that have been used to identify in\u00a0vivo functions of p38\u03b1 signaling in the pathogenesis of inflammatory diseases and cancer.", {"entities": [[147, 153, "DISEASE"]]}], ["Experiments using genetically modified mice and pharmacological inhibitors support that targeting the p38\u03b1 pathway could be therapeutically useful for some inflammatory diseases and tumor types.", {"entities": []}], ["In the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT), heart rate (HR) reduction with ivabradine was associated with improved survival and reduced hospitalizations in patients with heart failure (HF).", {"entities": [[100, 102, "GENE"]]}], ["The mechanisms by which elevated HR increases mortality are not fully understood.", {"entities": [[33, 35, "GENE"]]}], ["To assess the relationship of baseline HR with clinical, neurohormonal and cardiac sympathetic activity in patients with chronic HF and elevated HR.", {"entities": [[39, 41, "GENE"], [145, 147, "GENE"], [39, 41, "GENE"], [145, 147, "GENE"]]}], ["Patients with chronic HF who were in sinus rhythm and had resting HR>70 bpm despite optimal medical treatment were included in a randomized, double-blind study comparing ivabradine versus pyridostigmine.", {"entities": [[66, 68, "GENE"]]}], ["This report refers to the baseline data of 16 initial patients.", {"entities": []}], ["Baseline HR (before randomization to one of the drugs) was assessed, and patients were classified into two groups, with HR below or above mean values.", {"entities": [[9, 11, "GENE"], [120, 122, "GENE"], [9, 11, "GENE"], [120, 122, "GENE"]]}], ["Cardiac sympathetic activity was assessed by 123-iodine-metaiodobenzylguanidine myocardial scintigraphy.", {"entities": []}], ["Mean HR was 83.5\u00b111.5 bpm (range 72 to 104), and seven (43.7%) patients had HR above the mean.", {"entities": [[5, 7, "GENE"], [76, 78, "GENE"], [5, 7, "GENE"], [76, 78, "GENE"]]}], ["These patients had lower 6-min walk distance (292.3\u00b193 vs 465.2\u00b197.1 m, p=0.0029), higher values of N-Terminal-proBNP (median 708.4 vs 76.1, p=0.035) and lower late heart/mediastinum rate, indicating cardiac denervation (1.48\u00b10.12 vs 1.74\u00b10.09, p<0.001).", {"entities": []}], ["Elevated resting HR in patients with HF under optimal medical treatment was associated with cardiac denervation, worse functional capacity, and neurohormonal activation.", {"entities": [[17, 19, "GENE"]]}], ["Recently, many cases of vitamin K-dependent coagulopathy of unknown origin have been reported.", {"entities": []}], ["Such patients lack any relevant family history and have no systemic disease, raising suspicion of superwarfarin intoxication.", {"entities": []}], ["We evaluated individual risk factors causing coagulopathy and hemorrhagic symptoms in patients with suspected superwarfarin intoxication.", {"entities": []}], ["In addition, we determined how to effectively treat vitamin K-dependent coagulopathy caused by suspected superwarfarin intoxication.", {"entities": []}], ["Seven patients with suspected superwarfarin intoxication who lacked any definitive history of rodenticide ingestion were included.", {"entities": []}], ["Thirty-one patients initially diagnosed with rodenticide poisoning were also included.", {"entities": []}], ["We performed a retrospective chart review of all subjects and examined clinical data including patient demographics and medical histories.", {"entities": []}], ["Patients initially diagnosed with rodenticide poisoning were divided into two groups, one of which had a laboratory abnormality (prothrombin time [PT] > 13 seconds) and another group with PTs in the normal range.", {"entities": [[188, 191, "GENE"]]}], ["There was no significant difference between the two groups in any of age, gender, the extent of chronic alcohol consumption, the causative rodenticide, psychiatric problems, ingestion of drugs interacting with warfarin, the extent of intoxication, or the type of ingestion attempt.", {"entities": []}], ["The albumin level of the former group was significantly lower than that of the latter group ( p = 0.014).", {"entities": []}], ["Furthermore, a significant difference between the two groups was evident in terms of simultaneous ingestion of rodenticide and alcohol ( p = 0.023).", {"entities": []}], ["Most patients with superwarfarin poisoning did not exhibit any complication.", {"entities": []}], ["When such complications were evident, they were associated with serum albumin level and coingestion of rodenticide and alcohol.", {"entities": []}], ["Di-(2-ethylhexyl)phthalate (DEHP), the most commonly used plasticizer in flexible polyvinylchloride formulations, is a ubiquitous environmental contaminant.", {"entities": []}], ["To date, no information exists on the potential health hazards from exposure to DEHP and/or its main metabolite, mono-(2-ethylhexyl)phthalate (MEHP), in high-risk conditions, such as pregnancy and during the neonatal period.", {"entities": []}], ["The aim of this study was to evaluate prenatal exposure to DEHP and/or MEHP and its possible biologic effects.", {"entities": []}], ["We measured serum DEHP and MEHP concentrations in the cord blood of 84 consecutive newborns by high-performance liquid chromatography.", {"entities": []}], ["Relationships between DEHP/MEHP and infant characteristics were tested using Fisher's exact test, unpaired t-tests, and univariate linear regression analyses, and significant differences on univariate analysis were evaluated using multiple logistic regression analysis.", {"entities": []}], ["We found detectable cord blood DEHP and/or MEHP concentrations in 88.1% of the samples.", {"entities": []}], ["Either DEHP or MEHP was present in 65 of 84 (77.4%) of the examined samples.", {"entities": []}], ["Mean concentrations of DEHP and MEHP were 1.19 +/- 1.15 microg/mL [95% confidence interval (CI), 0.93-1.44, range = 0-4.71] and 0.52 +/- 0.61 microg/mL (95% CI, 0.39-0.66, range = 0-2.94), respectively.", {"entities": []}], ["MEHP-positive newborns showed a significantly lower gestational age compared with MEHP-negative infants (p = 0.033).", {"entities": []}], ["Logistic regression analysis results indicated a positive correlation between absence of MEHP in cord blood and gestational age at delivery (odds ratio = 1.50, 95% CI, 1.013-2.21; p = 0.043).", {"entities": []}], ["These findings confirm that human exposure to DEHP can begin in utero and suggest that phthalate exposure is significantly associated with a shorter pregnancy duration.", {"entities": []}], ["With the recent completion of the International HapMap Project, many tools are in hand for genetic association studies seeking to test the common variant/common disease hypothesis.", {"entities": []}], ["In contrast, very few tools and resources are in place for genotype\u2013phenotype studies hypothesizing that rare variation has a large impact on the phenotype of interest.", {"entities": []}], ["To create these tools for rare variant/common disease studies, much interest is being generated towards investing in re-sequencing either large sample sizes of random chromosomes or smaller sample sizes of patients with extreme phenotypes.", {"entities": []}], ["As a case study for rare variant discovery in random chromosomes, we have re-sequenced ~1,000 chromosomes representing diverse populations for the gene C-reactive protein ( CRP ).", {"entities": [[173, 176, "GENE"]]}], ["CRP is an important gene in the fields of cardiovascular and inflammation genetics, and its size (~2\u00a0kb) makes it particularly amenable medical or deep re-sequencing.", {"entities": [[0, 3, "GENE"]]}], ["With these data, we explore several issues related to the present-day candidate gene association study including the benefits of complete SNP discovery, the effects of tagSNP selection across diverse populations, and completeness of dbSNP for CRP .", {"entities": [[243, 246, "GENE"]]}], ["Also, we show that while deep re-sequencing uncovers potentially medically relevant coding SNPs, these SNPs are fleetingly rare when genotyped in a population-based survey of 7,000 Americans (NHANES III).", {"entities": []}], ["Collectively, these data suggest that several different types re-sequencing and genotyping approaches may be required to fully understand the complete spectrum of alleles that impact human phenotypes.", {"entities": []}], ["Supplementary material is available for this article at http://dx.doi.org/10.1007/s00439-006-0160-y and is accessible for authorized users.", {"entities": []}], ["Preeclampsia is one of the most commonly encountered hypertensive disorders of pregnancy.", {"entities": []}], ["For many years, obesity has been suggested to play a role in preeclampsia.", {"entities": [[16, 23, "DISEASE"]]}], ["However, the hypotheses have been diverse and often revealed inconsistent results.", {"entities": []}], ["This study has aimed to estimate the effect of obesity and dietary habits on preeclampsia in Bahir Dar City, north-western Ethiopia.", {"entities": [[47, 54, "DISEASE"]]}], ["A facility-based unmatched case-control study was conducted on 453 (151 cases and 302 controls) pregnant women, attending antenatal care or skilled delivery at Bahir Dar City.", {"entities": []}], ["Data were collected through face to face interviews and measurements of mid-upper-arm circumference (MUAC) at the time of the interviews.", {"entities": []}], ["Data were cleaned and entered into IBM SPSS version 20 and later analyzed using STATA version 12.", {"entities": []}], ["Univariate and multivariate logistic regression analyses were employed to estimate the effect of independent variables on preeclampsia.", {"entities": []}], ["Stratified analysis was conducted to check for presence of confounding and/or effect modification between covariates.", {"entities": []}], ["The odds of preeclampsia were higher among obese (MUAC \u226525\u00a0cm) women than their leaner counterparts (AOR\u2009=\u20093.33, 95 % CI: 1.87, 5.79).", {"entities": []}], ["Obesity was also found to have a similar magnitude of risk for late onset preeclampsia (AOR\u2009=\u20093.63, 95 % CI: 1.89, 6.97).", {"entities": [[0, 7, "DISEASE"]]}], ["When stratified by age, the effect of obesity on overall and late onset preeclampsia was significant among young (age\u2009<\u200935\u00a0years) women (COR\u2009=\u20091.81, 95 % CI: 1.11, 2.99) and (COR\u2009=\u20092.09, 95 % CI: 1.16, 3.86), respectively.", {"entities": [[38, 45, "DISEASE"]]}], ["As the age groups became more homogenous through adjusted stratification, obesity showed a particularly significant effect in women age \u226424 and 25\u201329 years; (AOR\u2009=\u20092.31, 95 % CI: 1.06, 5.12) and (AOR\u2009=\u20093.66, 95 % CI: 1.37, 10.87) respectively.", {"entities": [[74, 81, "DISEASE"]]}], ["Similarly, the effect of obesity on late onset preeclampsia was evident among younger women age \u226424 and 25\u201329 years; (AOR\u2009=\u20093.16, 95 % CI: 1.21, 8.24) and (AOR\u2009=\u20091.98, 95 % CI: 1.16, 3.40) respectively.", {"entities": [[25, 32, "DISEASE"]]}], ["However, obesity has no significant effect on early onset of preeclampsia (AOR\u2009=\u20091.98, 95 % CI: 0.79, 4.94).", {"entities": [[9, 16, "DISEASE"]]}], ["On the other hand, compliance to folate supplementation during pregnancy and fruit consumption were associated with reduced risk of preeclampsia.", {"entities": []}], ["Obesity in young age was found to be a risk factor for preeclampsia while compliance to folate supplement and adequate fruit consumption were found to be protective against preeclampsia.", {"entities": [[0, 7, "DISEASE"]]}], ["Promoting healthy life style, including body weight control, consumption of fruits and vegetables, and folate supplementation should be promoted to reduce the risk of preeclampsia.", {"entities": []}], ["Reduced level of arousal is commonly observed in medical admissions and may predict in-hospital mortality.", {"entities": []}], ["Delirium and reduced level of arousal are closely related.", {"entities": []}], ["We systematically reviewed and conducted a meta-analysis of studies in adult acute medical patients of the relationship between reduced level of arousal on admission and in-hospital mortality.", {"entities": []}], ["We conducted a systematic review (PROSPERO: CRD42016022048), searching MEDLINE and EMBASE.", {"entities": []}], ["We included studies of adult patients admitted with acute medical illness with level of arousal assessed on admission and mortality rates reported.", {"entities": []}], ["We performed meta-analysis using a random effects model.", {"entities": []}], ["From 23,941 studies we included 21 with 14 included in the meta-analysis.", {"entities": []}], ["Mean age range was 33.4 - 83.8 years.", {"entities": []}], ["Studies considered unselected general medical admissions (8 studies, n =13,039) or specific medical conditions (13 studies, n =38,882).", {"entities": []}], ["Methods of evaluating level of arousal varied.", {"entities": []}], ["The prevalence of reduced level of arousal was 3.1%-76.9% (median 13.5%).", {"entities": []}], ["Mortality rates were 1.7%-58% (median 15.9%).", {"entities": []}], ["Reduced level of arousal was associated with higher in-hospital mortality (pooled OR 5.71; 95% CI 4.21-7.74; low quality evidence: high risk of bias, clinical heterogeneity and possible publication bias).", {"entities": []}], ["Reduced level of arousal on hospital admission may be a strong predictor of in-hospital mortality.", {"entities": []}], ["Most evidence was of low quality.", {"entities": []}], ["Reduced level of arousal is highly specific to delirium, better formal detection of hypoactive delirium and implementation of care pathways may improve outcomes.", {"entities": []}], ["Future studies to assess the impact of interventions on in-hospital mortality should use validated assessments of both level of arousal and delirium.", {"entities": []}], ["The online version of this article (10.1186/s12877-017-0661-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although pneumococcal infection is a serious problem worldwide and has a high mortality rate, the molecular mechanisms underlying the lethality caused by pneumococcus remain elusive.", {"entities": []}], ["Here, we show that BLT2, a G protein-coupled receptor for leukotriene B 4 and 12(S)-hydroxyheptadecatrienoic acid (12-HHT), protects mice from lung injury caused by a pneumococcal toxin, pneumolysin (PLY).", {"entities": []}], ["Intratracheal injection of PLY caused lethal acute lung injury (ALI) in BLT2-deficient mice, with evident vascular leakage and bronchoconstriction.", {"entities": []}], ["Large amounts of cysteinyl leukotrienes (cysLTs), classically known as a slow reactive substance of anaphylaxis, were detected in PLY-treated lungs.", {"entities": []}], ["PLY-dependent vascular leakage, bronchoconstriction, and death were markedly ameliorated by treatment with a CysLT1 receptor antagonist.", {"entities": []}], ["Upon stimulation by PLY, mast cells produced cysLTs that activated CysLT1 expressed in vascular endothelial cells and bronchial smooth muscle cells, leading to lethal vascular leakage and bronchoconstriction.", {"entities": []}], ["Treatment of mice with aspirin or loxoprofen inhibited the production of 12-HHT and increased the sensitivity toward PLY, which was also ameliorated by the CysLT1 antagonist.", {"entities": []}], ["Thus, the present study identifies the molecular mechanism underlying PLY-dependent ALI and suggests the possible use of CysLT1 antagonists as a therapeutic tool to protect against ALI caused by pneumococcal infection.", {"entities": []}], ["DNA barcoding promises to be a useful tool to identify pest species assuming adequate representation of genetic variants in a reference library.", {"entities": []}], ["Here we examined mitochondrial DNA barcodes in a global urban pest, the American cockroach ( Periplaneta americana ).", {"entities": []}], ["Our sampling effort generated 284 cockroach specimens, most from New York City, plus 15 additional U.S. states and six other countries, enabling the first large-scale survey of P. americana barcode variation.", {"entities": []}], ["Periplaneta americana barcode sequences (n = 247, including 24 GenBank records) formed a monophyletic lineage separate from other Periplaneta species.", {"entities": []}], ["We found three distinct P. americana haplogroups with relatively small differences within (\u22640.6%) and larger differences among groups (2.4%\u20134.7%).", {"entities": []}], ["This could be interpreted as indicative of multiple cryptic species.", {"entities": []}], ["However, nuclear DNA sequences (n = 77 specimens) revealed extensive gene flow among mitochondrial haplogroups, confirming a single species.", {"entities": []}], ["This unusual genetic pattern likely reflects multiple introductions from genetically divergent source populations, followed by interbreeding in the invasive range.", {"entities": []}], ["Our findings highlight the need for comprehensive reference databases in DNA barcoding studies, especially when dealing with invasive populations that might be derived from multiple genetically distinct source populations.", {"entities": []}], ["Metastasis is the\u00a0leading cause of\u00a0death in breast cancer patients.", {"entities": [[44, 57, "DISEASE"], [51, 57, "DISEASE"]]}], ["However, the mechanisms underlying metastasis are not well understood and there is no effective treatment in the clinic.", {"entities": []}], ["Here, we demonstrate that in MMTV-PyMT,\u00a0a highly malignant spontaneous breast tumor model, IL-25 (also called IL-17E) was expressed by tumor-infiltrating CD4 The online version of this article (doi:10.1007/s13238-016-0345-7) contains supplementary material, which is available to authorized users.", {"entities": [[154, 157, "GENE"]]}], ["Retrospective analysis of surgico-pathologic data comparing total laparoscopic hysterectomy (TLH) with total abdominal hysterectomy (TAH) patients with uterine neoplasia We conducted a chart abstraction of all patients undergoing hysterectomy for uterine neoplasia from September 1996 to November 2004.", {"entities": []}], ["Patients were assigned to undergo the abdominal or laparoscopic approach based on established clinical safety criteria.", {"entities": []}], ["The study included 105 patients, 29 with TAH and 76 with TLH.", {"entities": []}], ["TAH patients were older (68 vs. 61, P =0.021); however, both groups had similar body mass indexes (31) and parities (1.6).", {"entities": []}], ["Controlling for age, surgical duration was similar (152 minutes).", {"entities": []}], ["Average blood loss was higher for TAH, (504 vs.138 mL, P <0.001).", {"entities": []}], ["Hospital stays were significantly longer for patients with TAH than for those with TLH (5.4 vs. 1.8 days, P <0.0001).", {"entities": []}], ["Uterine weight was greater (197 vs. 135 g, P =0.008) and myometrial invasion deeper in the TAH group (48% outer half vs. 17%, P =0.001).", {"entities": []}], ["More patients had Stage II or higher disease in the TAH group (35% vs. 17%, P =0.038).", {"entities": []}], ["More TAH patients needed node dissection (79% vs. 28%, P <.001).", {"entities": []}], ["Node yields from dissections of 23 TAH cases and 21 laparoscopic cases were similar (17 nodes).", {"entities": []}], ["Total and reoperative complications from TAH versus TLH were not statistically different in our small sample (14.3 vs. 5.2% total, NS; 10.3 vs. 2.6% reoperative).", {"entities": []}], ["One conversion was necessary from laparoscopy to laparotomy for unsuspected bulky metastatic disease.", {"entities": []}], ["Based on clinical selection criteria, TLH performed for endometrial pathology has few complications and is well tolerated by select patients.", {"entities": []}], ["The advantages are less blood loss and a shorter length of hospital stay for qualified patients.", {"entities": []}], ["Effects of antiinterleukin 13 therapies in patients with asthma remain inconsistent.", {"entities": [[57, 63, "DISEASE"]]}], ["Therefore, we aimed to further clarify the efficacy and safety of antiinterleukin 13 therapies in adult asthmatics by a systematic review and meta-analysis.", {"entities": []}], ["Randomized controlled trials which reported pulmonary functions, fraction of exhaled nitric oxide (FeNO), Asthma Control Questionnaire (ACQ), rescue use of short-acting-\u03b2-agonist (SABA), and rate of asthmatic exacerbation and adverse events were identified in Pubmed, Embase, Medline, Cochrane Central Register of Controlled Trials (CENTRAL), American College of Physician (ACP) Journal Club, and ISI Web of Science, reference lists and by manual searches.", {"entities": [[106, 112, "DISEASE"]]}], ["Randomized-effect models were used in meta-analysis to calculate pooled mean difference and relative risks (RR).", {"entities": []}], ["Eight studies with 957 patients were enrolled.", {"entities": []}], ["Systematic review showed that treatment with antiinterleukin 13 antibodies could significantly improve peak expiratory flow (PEF), decrease FeNO and asthmatic exacerbation, but could not decrease blood and sputum eosinophil levels, improve FEV 1 , inhibit methacholine PC 20 , or reduce ACQ scores.", {"entities": [[240, 243, "GENE"], [269, 271, "GENE"]]}], ["Two studies reported opposite results in reducing rescue use of SABA.", {"entities": []}], ["Meta-analysis showed that antiinterleukin 13 monoclonal therapies could significantly decrease asthmatic exacerbation (RR 0.55, 95% CI: 0.31\u20130.96, z \u200a=\u200a2.10, P \u200a=\u200a0.04), but did not significantly improve the FEV 1 (95% CI: \u22121.03 to 2.22, z \u200a=\u200a0.72, P \u200a=\u200a0.47) or increasing adverse events (RR 1.00, 95% CI: 0.91\u20131.10, z \u200a=\u200a0.00, P \u200a=\u200a1.00).", {"entities": [[208, 211, "GENE"]]}], ["Antiinterleukin 13 monoclonal therapies could be safely used to improve PEF, decrease FeNO and asthmatic exacerbation, and probably reduce rescue use of SABA, but could not decrease blood and sputum eosinophil levels, improve FEV 1 , inhibit methacholine PC 20 , or reduce ACQ scores.", {"entities": [[226, 229, "GENE"], [255, 257, "GENE"]]}], ["The mechanisms through which cytokine signals prevent the activation and mitochondrial targeting of the pro-apoptotic Bcl-2-associated X protein (Bax) are unclear.", {"entities": [[146, 149, "GENE"]]}], ["Here we showed, using primary human eosinophils, that in the absence of the pro-survival cytokines granulocyte macrophage-colony stimulating factor (GM-CSF) or interleukin 5, Bax spontaneously undergoes activation and initiates mitochondrial disruption.", {"entities": [[175, 178, "GENE"]]}], ["Bax inhibition reduced eosinophil apoptosis, even in the absence of cytokines.", {"entities": [[0, 3, "GENE"]]}], ["GM-CSF induced activation of Erk1/2, which phosphorylated Thr167 of Bax, which facilitated de novo interaction of Bax with the prolyl isomerase Pin1.", {"entities": [[68, 71, "GENE"], [114, 117, "GENE"], [68, 71, "GENE"], [114, 117, "GENE"], [144, 148, "GENE"]]}], ["Pin1 blockade led to Bax cleavage, mitochondrial translocation and caspase activation, irrespective of the presence of cytokines.", {"entities": [[0, 4, "GENE"], [21, 24, "GENE"]]}], ["Our findings indicate that Pin1 is a key mediator of pro-survival signaling and a regulator of Bax function.", {"entities": [[27, 31, "GENE"], [95, 98, "GENE"]]}], ["Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening, virus-triggered immune disease.", {"entities": []}], ["Hypersensitivity to mosquito bite (HMB), a presentation of Chronic Active Epstein-Barr Virus infection (CAEBV), may progress to HLH.", {"entities": []}], ["This study aimed to investigate the immunologic difference between the HMB episodes and the HLH episodes associated with EBV infection.", {"entities": []}], ["Immunologic changes of immunoglobulins, lymphocyte subsets, cytotoxicity, intracellular perforin and granzyme expressions, EBV virus load and known candidate genes for hereditary HLH were evaluated and compared.", {"entities": []}], ["In 12 HLH episodes (12 patients) and 14 HMB episodes (4 patients), there were both decreased percentages of CD4+ and CD8+ and increased memory CD4+ and activated (CD2+HLADR+) lymphocytes.", {"entities": []}], ["In contrast to HMB episodes that had higher IgE levels and EBV virus load predominantly in NK cells, those HLH episodes with virus load predominantly in CD3+ lymphocyte had decreased perforin expression and cytotoxicity that were recovered in the convalescence period.", {"entities": []}], ["However, there was neither significant difference of total virus load in these episodes nor candidate genetic mutations responsible for hereditary HLH.", {"entities": []}], ["In conclusion, decreased perforin expression in the HLH episodes with predominant-CD3+ EBV virus load is distinct from those HMB episodes with predominant-NK EBV virus load.", {"entities": []}], ["Whether the presence of non-elevated memory CD4+ cells or activated lymphocytes (CD2+HLADR+) increases the mortality rate in the HLH episodes remains to be further warranted through larger-scale studies.", {"entities": []}], ["Human immunodeficiency virus (HIV) infection significantly affect neurodevelopmental and behavioral outcomes.", {"entities": []}], ["We investigated whether alterations of gray matter organization and structural covariance networks with vertical HIV infection adolescents exist, by using the GAT toolbox.", {"entities": []}], ["MRI data were analysed from 25 HIV vertically infected adolescents and 33 HIV-exposed-uninfected control participants.", {"entities": []}], ["The gray matter volume (GMV) was calculated, and structural brain networks were reconstructed from gray matter co-variance.", {"entities": []}], ["Gray matter losses were pronounced in anterior cingulate cortex (ACC), right pallidum, right occipital lobe, inferior parietal lobe, and bilateral cerebellum crus.", {"entities": []}], ["The global brain network measures were not significantly different between the groups; however, the nodal alterations were most pronounced in frontal, temporal, basal ganglia, cerebellum, and temporal lobes.", {"entities": []}], ["Brain hubs in the HIV-infected subjects increased in number and tended to shift to sensorimotor and temporal areas.", {"entities": []}], ["In the HIV-infected subjects, decreased GMVs in ACC and bilateral cerebellum were related to lower Mini-Mental State Examination scores; the CD4 counts were positively related to the GMVs in ACC and sensorimotor areas.", {"entities": [[141, 144, "GENE"]]}], ["These findings suggest that focally reduced gray matter, disrupted nodal profiles of structural wirings, and a shift in hub distribution may represent neuroanatomical biomarkers of HIV infection on the developing brain.", {"entities": []}], ["To examine the relationship between socio-economic status (SES), functional recovery and long-term mortality following acute myocardial infarction (AMI).", {"entities": [[125, 146, "DISEASE"], [119, 146, "DISEASE"]]}], ["The extent to which SES mortality disparities are explained by differences in functional recovery following AMI is unclear.", {"entities": []}], ["We prospectively examined 1368 patients who survived at least one-year following an index AMI between 1999 and 2003 in Ontario, Canada.", {"entities": []}], ["Each patient was linked to administrative data and followed over 9.6 years to track mortality.", {"entities": []}], ["All patients underwent medical chart abstraction and telephone interviews following AMI to identify individual-level SES, clinical factors, processes of care (i.e., use of, and adherence, to evidence-based medications, physician visits, invasive cardiac procedures, referrals to cardiac rehabilitation), as well as changes in psychosocial stressors, quality of life, and self-reported functional capacity.", {"entities": []}], ["As compared with their lower SES counterparts, higher SES patients experienced greater functional recovery (1.80 ml/kg/min average increase in peak V02, P<0.001) after adjusting for all baseline clinical factors.", {"entities": []}], ["Post-AMI functional recovery was the strongest modifiable predictor of long-term mortality (Adjusted HR for each ml/kg/min increase in functional capacity: 0.91; 95% CI: 0.87\u20130.94, P<0.001) irrespective of SES (P\u200a=\u200a0.51 for interaction between SES, functional recovery, and mortality).", {"entities": [[101, 103, "GENE"]]}], ["SES-mortality associations were attenuated by 27% after adjustments for functional recovery, rendering the residual SES-mortality association no longer statistically significant (Adjusted HR: 0.84; 95% CI:0.70\u20131.00, P\u200a=\u200a0.05).", {"entities": [[188, 190, "GENE"]]}], ["The effects of functional recovery on SES-mortality associations were not explained by access inequities to physician specialists or cardiac rehabilitation.", {"entities": []}], ["Functional recovery may play an important role in explaining SES-mortality gradients following AMI.", {"entities": []}], ["Korea has industrialized since the 1970s.", {"entities": []}], ["Pneumoconiosis in coal miners was the most common occupational disease in the 1970s to 1980s.", {"entities": [[0, 14, "DISEASE"]]}], ["With the industrialization, the use of many chemicals have increased since the 1970s.", {"entities": []}], ["As a consequence, there were outbreaks of occupational diseases caused by poisonous chemicals, such as heavy metal poisoning, solvent poisoning and occupational asthma in the late 1980s and early 1990s with civil movement for democracy.", {"entities": [[161, 167, "DISEASE"]]}], ["Many actions have been taken for prevention by the government, employers and employees or unions.", {"entities": []}], ["In the 1990s most chemical related diseases and pneumoconiosis have rapidly decreased due to improving work environment.", {"entities": [[48, 62, "DISEASE"]]}], ["In the late 1990s, cerebro-cardiovascular diseases related to job stress or work overloads have abruptly increased especially after the economic crisis in 1998.", {"entities": []}], ["After the year 2000, musculoskeletal disorders became a major problem especially in assembly lines in the manufacturing industry and they were expanded to the service industry.", {"entities": []}], ["Mental diseases related to job stress have increased.", {"entities": []}], ["Infectious diseases increased in health care workers and afforestation workers.", {"entities": []}], ["Occupational cancers are increasing because of their long latency, although the use of carcinogenic substances are reduced, limited, and even banned.", {"entities": []}], ["Combinatorial therapy is a promising strategy for combating complex disorders due to improved efficacy and reduced side effects.", {"entities": []}], ["However, screening new drug combinations exhaustively is impractical considering all possible combinations between drugs.", {"entities": []}], ["Here, we present a novel computational approach to predict drug combinations by integrating molecular and pharmacological data.", {"entities": []}], ["Specifically, drugs are represented by a set of their properties, such as their targets or indications.", {"entities": []}], ["By integrating several of these features, we show that feature patterns enriched in approved drug combinations are not only predictive for new drug combinations but also provide insights into mechanisms underlying combinatorial therapy.", {"entities": []}], ["Further analysis confirmed that among our top ranked predictions of effective combinations, 69% are supported by literature, while the others represent novel potential drug combinations.", {"entities": []}], ["We believe that our proposed approach can help to limit the search space of drug combinations and provide a new way to effectively utilize existing drugs for new purposes.", {"entities": []}], ["The combination of distinct drugs in combinatorial therapy can help to improve therapeutic efficacy by overcoming the redundancy and robustness of pathogenic processes, or by lowering the risk of side effects.", {"entities": []}], ["However, identification of effective drug combinations is cumbersome, considering the possible search space with respect to the large number of drugs that could potentially be combined.", {"entities": []}], ["In this work, we explore various molecular and pharmacological features of drugs, and show that by utilizing combinations of such features it is possible to predict new drug combinations.", {"entities": []}], ["Benchmarking the approach using approved drug combinations demonstrates that these feature combinations are indeed predictive and can propose promising new drug combinations.", {"entities": []}], ["In addition, the enriched feature patterns provide insights into the mechanisms underlying drug combinations.", {"entities": []}], ["For example, they suggest that if two drugs share targets or therapeutic effects, they can be independently combined with a third common drug.", {"entities": []}], ["The ability to efficiently predict drug combinations should facilitate the development of more efficient drug therapies for a broader range of indications including hard-to-treat complex diseases.", {"entities": []}], ["Childhood asthma is a complex condition where many environmental factors are implicated in causation.", {"entities": [[10, 16, "DISEASE"]]}], ["The aim of this study was to complete a systematic review of the literature describing associations between environmental exposures and the development of asthma in young children.", {"entities": [[155, 161, "DISEASE"]]}], ["A systematic review of the literature up to November 2013 was conducted using key words agreed by the research team.", {"entities": []}], ["Abstracts were screened and potentially eligible papers reviewed.", {"entities": []}], ["Papers describing associations between exposures and exacerbation of pre-existing asthma were not included.", {"entities": [[82, 88, "DISEASE"]]}], ["Papers were placed into the following predefined categories: secondhand smoke (SHS), inhaled chemicals, damp housing/mould, inhaled allergens, air pollution, domestic combustion, dietary exposures, respiratory virus infection and medications.", {"entities": []}], ["Children aged up to 9\u2005years.", {"entities": []}], ["Diagnosed asthma and wheeze.", {"entities": [[10, 16, "DISEASE"]]}], ["14\u2005691 abstracts were identified, 207 papers reviewed and 135 included in the present review of which 15 were systematic reviews, 6 were meta-analyses and 14 were intervention studies.", {"entities": []}], ["There was consistent evidence linking exposures to SHS, inhaled chemicals, mould, ambient air pollutants, some deficiencies in maternal diet and respiratory viruses to an increased risk for asthma (OR typically increased by 1.5\u20132.0).", {"entities": [[190, 196, "DISEASE"]]}], ["There was less consistent evidence linking exposures to pets, breast feeding and infant dietary exposures to asthma risk, and although there were consistent associations between exposures to antibiotics and paracetamol in early life, these associations might reflect reverse causation.", {"entities": [[109, 115, "DISEASE"]]}], ["There was good evidence that exposures to house dust mites (in isolation) was not associated with asthma risk.", {"entities": [[98, 104, "DISEASE"]]}], ["Evidence from observational and intervention studies suggest that interactions between exposures were important to asthma causation, where the effect size was typically 1.5\u20133.0.", {"entities": [[115, 121, "DISEASE"]]}], ["There are many publications reporting associations between environmental exposures and modest changes in risk for asthma in young children, and this review highlights the complex interactions between exposures that further increase risk.", {"entities": [[114, 120, "DISEASE"]]}], ["Systematic reviews, a cornerstone of evidence-based medicine, are not produced quickly enough to support clinical practice.", {"entities": []}], ["The cost of production, availability of the requisite expertise and timeliness are often quoted as major contributors for the delay.", {"entities": []}], ["This detailed survey of the state of the art of information systems designed to support or automate individual tasks in the systematic review, and in particular systematic reviews of randomized controlled clinical trials, reveals trends that see the convergence of several parallel research projects.", {"entities": []}], ["We surveyed literature describing informatics systems that support or automate the processes of systematic review or each of the tasks of the systematic review.", {"entities": []}], ["Several projects focus on automating, simplifying and/or streamlining specific tasks of the systematic review.", {"entities": []}], ["Some tasks are already fully automated while others are still largely manual.", {"entities": []}], ["In this review, we describe each task and the effect that its automation would have on the entire systematic review process, summarize the existing information system support for each task, and highlight where further research is needed for realizing automation for the task.", {"entities": []}], ["Integration of the systems that automate systematic review tasks may lead to a revised systematic review workflow.", {"entities": []}], ["We envisage the optimized workflow will lead to system in which each systematic review is described as a computer program that automatically retrieves relevant trials, appraises them, extracts and synthesizes data, evaluates the risk of bias, performs meta-analysis calculations, and produces a report in real time.", {"entities": []}], ["Haemodialysis (HD) is critically dependent on the availability of adequate access to the systemic circulation, ideally via a native arteriovenous fistula (AVF).", {"entities": []}], ["The Primary failure rate of an AVF ranges between 20\u201354%, due to thrombosis or failure of maturation.", {"entities": []}], ["There remains limited evidence for the use of anti-platelet agents and uncertainty as to choice of agent(s) for the prevention of AVF thrombosis.", {"entities": []}], ["We present the study protocol for a randomised, double-blind, placebo-controlled, clinical trial examining whether the use of the anti-platelet agents, aspirin and omega-3 fatty acids, either alone or in combination, will effectively reduce the risk of early thrombosis in de novo AVF.", {"entities": []}], ["The study population is adult patients with stage IV or V chronic kidney disease (CKD) currently on HD or where HD is planned to start within 6 months in whom a planned upper or lower arm AVF is to be the primary HD access.", {"entities": [[66, 80, "DISEASE"]]}], ["Using a factorial-design trial, patients will be randomised to aspirin or matching placebo, and also to omega-3 fatty acids or matching placebo, resulting in four treatment groups (aspirin placebo/omega-3 fatty acid placebo, aspirin/omega-3 fatty acid placebo, aspirin placebo/omega-3 fatty acid, aspirin/omega-3 fatty acid).", {"entities": []}], ["Randomisation will be achieved using a dynamic balancing method over the two stratification factors of study site and upper versus lower arm AVF.", {"entities": []}], ["The medication will be commenced pre-operatively and continued for 3 months post surgery.", {"entities": []}], ["The primary outcome is patency of the AVF at three months after randomisation.", {"entities": []}], ["Secondary outcome measures will include functional patency at six and twelve months, primary patency time, secondary (assisted) patency time, and adverse events, particularly bleeding.", {"entities": []}], ["This multicentre Australian and New Zealand study has been designed to determine whether the outcome of surgery to create de novo AVF can be improved by the use of aspirin and/or omega-3 fatty acids.", {"entities": []}], ["Recently a placebo-controlled trial has shown that clopidogrel is effective in safely preventing primary AVF thrombosis, but ineffective at increasing functional patency.", {"entities": []}], ["Our study presents significant differences in the anti-platelet agents used, the study design, and surgical and patient demographics that should contribute further evidence regarding the efficacy of anti-platelet agents.", {"entities": []}], ["Australia & New Zealand Clinical Trials Register (ACTRN12607000569404).", {"entities": []}], ["We analyzed individual-level data on pandemic influenza A/H1N1pdm hospitalizations from the enhanced surveillance system of the Maricopa County Department of Public Health, AZ, USA from April 1st, 2009 to March 31st, 2010.", {"entities": [[46, 55, "DISEASE"]]}], ["We also assessed the the risk of death among A/H1N1 hospitalizations using multivariate logistic regression.", {"entities": []}], ["Hospitalization rates were significantly higher among Native Americans (risk ratio (RR) \u200a = \u200a 6.2; 95% CI: 6.15, 6.21), non-Hispanic Black (RR = 3.84; 95% CI: 3.8, 3.9), and Hispanics (RR = 2.0; 95% CI: 2.0, 2.01) compared to non-Hispanic Whites.", {"entities": []}], ["Throughout the spring, 59.2% of hospitalized patients received antiviral treatment; the proportion of patients treated increased significantly during the fall to 74.4% (Chi-square test, P < 0.0001).", {"entities": []}], ["In our best-fit logistic model, the adjusted risk of death among A/H1N1 inpatients was significantly higher during the fall wave (August 16, 2009 to March 31, 2010, OR = 3.94; 95% CI: 1.72, 9.03) compared to the spring wave (April 1, 2009 to August 15, 2009).", {"entities": []}], ["Moreover, chronic lung disease (OR = 3.5; 95% CI: 1.7, 7.4), cancer within the last 12 months (OR = 4.3; 95%CI: 1.3, 14.8), immuno-suppression (OR = 4.0; 95% CI: 1.84, 8.9), and admission delays (OR = 4.6; 95% CI: 2.2, 9.5) were significantly associated with an increased the risk of death among A/H1N1 inpatients.", {"entities": [[18, 30, "DISEASE"], [61, 67, "DISEASE"]]}], ["The purpose of this investigation was to identify when diagnostic testing and empirical antiviral therapy should be considered for adult patients requiring hospitalization during influenza seasons.", {"entities": [[179, 188, "DISEASE"]]}], ["During the 2007/8 influenza season, six acute care hospitals in the Greater Toronto Area participated in active surveillance for laboratory-confirmed influenza requiring hospitalization.", {"entities": [[18, 27, "DISEASE"], [150, 159, "DISEASE"]]}], ["Nasopharyngeal (NP) swabs were obtained from patients presenting with acute respiratory or cardiac illness, or with febrile illness without clear non-respiratory etiology.", {"entities": []}], ["Predictors of influenza were analyzed by multivariable logistic regression analysis and likelihoods of influenza infection in various patient groups were calculated.", {"entities": [[14, 23, "DISEASE"], [103, 112, "DISEASE"]]}], ["Two hundred and eighty of 3,917 patients were found to have influenza.", {"entities": [[60, 69, "DISEASE"]]}], ["Thirty-five percent of patients with influenza presented with a triage temperature \u226538.0\u00b0C, 80% had respiratory symptoms in the emergency department, and 76% were \u226565\u00a0years old.", {"entities": [[37, 46, "DISEASE"]]}], ["Multivariable analysis revealed a triage temperature \u226538.0\u00b0C (odds ratio [OR] 3.1; 95% confidence interval [CI] 2.3\u20134.1), the presence of respiratory symptoms (OR 1.7; 95% CI 1.2\u20132.4), admission diagnosis of respiratory infection (OR 1.8; 95% CI 1.3\u20132.4), admission diagnosis of exacerbation of chronic obstructive pulmonary disease (COPD)/asthma or respiratory failure (OR 2.3; 95% CI 1.6\u20133.4), and admission in peak influenza weeks (OR 4.2; 95% CI 3.1\u20135.7) as independent predictors of influenza.", {"entities": [[350, 369, "DISEASE"], [418, 427, "DISEASE"], [488, 497, "DISEASE"], [295, 332, "DISEASE"], [340, 346, "DISEASE"]]}], ["The likelihood of influenza exceeded 15% in patients with respiratory infection or exacerbation of COPD/asthma if the triage temperature was \u226538.0\u00b0C or if they were admitted in the peak weeks during the influenza season.", {"entities": [[18, 27, "DISEASE"], [203, 212, "DISEASE"], [104, 110, "DISEASE"]]}], ["During influenza season, diagnostic testing and empiric antiviral therapy should be considered in patients requiring hospitalization if respiratory infection or exacerbation of COPD/asthma are suspected and if either the triage temperature is \u226538.0\u00b0C or admission is during the weeks of peak influenza activity.", {"entities": [[7, 16, "DISEASE"], [292, 301, "DISEASE"], [182, 188, "DISEASE"]]}], ["Dengue virus (DENV) is the most widespread arbovirus with an estimated 100 million infections occurring every year.", {"entities": []}], ["Endemic in the tropical and subtropical areas of the world, dengue fever/dengue hemorrhagic fever (DF/DHF) is emerging as a major public health concern.", {"entities": [[73, 97, "DISEASE"]]}], ["The complex array of concurrent host physiologic changes has hampered a complete understanding of underlying molecular mechanisms of dengue pathogenesis.", {"entities": []}], ["Systems level characterization of serum metabolome and lipidome of adult DF patients at early febrile, defervescence, and convalescent stages of DENV infection was performed using liquid chromatography- and gas chromatography-mass spectrometry.", {"entities": []}], ["The tractability of following metabolite and lipid changes in a relatively large sample size ( n \u200a=\u200a44) across three prominent infection stages allowed the identification of critical physiologic changes that coincided with the different stages.", {"entities": []}], ["Sixty differential metabolites were identified in our metabolomics analysis and the main metabolite classes were free fatty acids, acylcarnitines, phospholipids, and amino acids.", {"entities": []}], ["Major perturbed metabolic pathways included fatty acid biosynthesis and \u03b2 -oxidation, phospholipid catabolism, steroid hormone pathway, etc., suggesting the multifactorial nature of human host responses.", {"entities": []}], ["Analysis of phospholipids and sphingolipids verified the temporal trends and revealed association with lymphocytes and platelets numbers.", {"entities": []}], ["These metabolites were significantly perturbed during the early stages, and normalized to control levels at convalescent stage, suggesting their potential utility as prognostic markers.", {"entities": []}], ["DENV infection causes temporally distinct serum metabolome and lipidome changes, and many of the differential metabolites are involved in acute inflammatory responses.", {"entities": []}], ["Our global analyses revealed early anti-inflammatory responses working in concert to modulate early pro-inflammatory processes, thus preventing the host from development of pathologies by excessive or prolonged inflammation.", {"entities": []}], ["This study is the first example of how an omic- approach can divulge the extensive, concurrent, and dynamic host responses elicited by DENV and offers plausible physiological insights to why DF is self limiting.", {"entities": []}], ["Dengue virus is the most widespread arbovirus and a major public health threat in the tropical and subtropical areas of the world.", {"entities": []}], ["As yet, little is known about the molecular mechanisms underlying infection, and there is no specific treatment or vaccine that is currently effective against the disease.", {"entities": []}], ["Metabolomics and lipidomics provide global views of metabolome and lipidome landscapes and implicate metabolic to disease phenotype.", {"entities": []}], ["We performed serum metabolic and lipidomic profiling on a cohort of dengue patients with three sampling time points at early febrile, defervescence, and convalescent stages via mass spectrometry-based analytical platforms.", {"entities": []}], ["Compared with healthy subjects, approximately two hundred metabolites showed significant difference in dengue patients, and 60 were identified.", {"entities": []}], ["This study revealed that in primary dengue infection, the host metabolome is tightly regulated, with active, early anti-inflammatory processes modulating the pro-inflammatory processes, suggesting the self-limiting phenotype of dengue fever.", {"entities": []}], ["Major perturbed metabolic pathways included fatty acid biosynthesis, fatty acid \u03b2 -oxidation, phospholipid catabolism, steroid hormone pathway, etc.", {"entities": []}], ["This represents a first report on the characterization of the serum metabolome and significantly advances our understanding on host and dengue virus interactions.", {"entities": []}], ["These differential metabolites have the potential as biomarkers for disease monitoring and evaluation of therapeutic interventions.", {"entities": []}], ["The indoor environment in four beauty salons located in Athens (Greece) was examined in order to investigate the occupational health exposure of cosmetologists to various chemical products typically used in their work.", {"entities": []}], ["Chemical substances chosen for investigation were volatile organic compounds (VOCs), formaldehyde, ozone and carbon dioxide.", {"entities": []}], ["Total VOCs levels measured showed significant variation (100\u20131,450 \u03bcg m etc .)", {"entities": []}], ["which are used as solvents in various beauty products; terpenes (pinene, limonene, camphor, menthenol) which have a particular odor and others like camphor which have specific properties.", {"entities": []}], ["Ozone concentrations measured in all salons were quite low (0.1 and 13.3 \u03bcg m", {"entities": []}], ["Neural tube defects (NTDs) are a group of severe congenital malformations, induced by the combined effects of genes and the environment.", {"entities": []}], ["The most valuable finding so far has been the protective effect of folic acid supplementation against NTDs.", {"entities": []}], ["However, many women do not take folic acid supplements until they are pregnant, which is too late to prevent NTDs effectively.", {"entities": []}], ["Long-term intake of folic acid\u2013fortified food is a good choice to solve this problem, and mandatory folic acid fortification should be further promoted, especially in Europe, Asia and Africa.", {"entities": []}], ["Vitamin B2, vitamin B-6, vitamin B-12, choline, betaine and n -3 polyunsaturated fatty acids (PUFAs) can also reduce the NTD risk by interacting with the one-carbon metabolism pathway.", {"entities": []}], ["This suggest that multivitamin B combined with choline, betaine and n -3 PUFAs supplementation may have a better protective effect against NTDs than folic acid alone.", {"entities": []}], ["Genetic polymorphisms involved in one-carbon metabolism are associated with NTD risk, and gene screening for women of childbearing age prior to pregnancy may help prevent NTDs induced by the risk allele.", {"entities": []}], ["In addition, the consumption of alcohol, tea and coffee, and low intakes of fruit and vegetable are also associated with the increased risk of NTDs, and should be avoided by women of childbearing age.", {"entities": []}], ["A systematic review was conducted for the association between animal feeding operations (AFOs) and the health of individuals living near AFOs.", {"entities": []}], ["The review was restricted to studies reporting respiratory, gastrointestinal and mental health outcomes in individuals living near AFOs in North America, European Union, United Kingdom, and Scandinavia.", {"entities": []}], ["From June to September 2008 searches were conducted in PUBMED, CAB, Web-of-Science, and Agricola with no restrictions.", {"entities": []}], ["Hand searching of narrative reviews was also used.", {"entities": []}], ["Two reviewers independently evaluated the role of chance, confounding, information, selection and analytic bias on the study outcome.", {"entities": []}], ["Nine relevant studies were identified.", {"entities": []}], ["The studies were heterogeneous with respect to outcomes and exposures assessed.", {"entities": []}], ["Few studies reported an association between surrogate clinical outcomes and AFO proximity.", {"entities": []}], ["A negative association was reported when odor was the measure of exposure to AFOs and self-reported disease, the measure of outcome.", {"entities": []}], ["There was evidence of an association between self-reported disease and proximity to AFO in individuals annoyed by AFO odor.", {"entities": []}], ["There was inconsistent evidence of a weak association between self-reported disease in people with allergies or familial history of allergies.", {"entities": []}], ["No consistent dose response relationship between exposure and disease was observable.", {"entities": []}], ["Global evaluation of influenza vaccination in children indicates that current recommendations are not followed.", {"entities": [[21, 30, "DISEASE"]]}], ["Most children at high risk for influenza-related complications do not receive the vaccine, and increased efforts are needed to protect them.", {"entities": [[31, 40, "DISEASE"]]}], ["Furthermore, immunizing healthy infants 6\u201323 months of age and their close contacts should be strongly encouraged.", {"entities": []}], ["Vaccinations are recommended for children with recurrent acute otitis media or recurrent respiratory tract infections and possibly for healthy daycare and school-age children because of the potential socioeconomic implications of influenza.", {"entities": [[63, 75, "DISEASE"], [230, 239, "DISEASE"]]}], ["Issues that need to be addressed include educating physicians and parents concerning influenza-related illness and complications, cost-effectiveness and safety of licensed vaccines, adequate vaccine supply, and availability of intranasal products.", {"entities": [[85, 94, "DISEASE"]]}], ["Electromagnetic navigation bronchoscopy (ENB) is an image-guided, minimally invasive approach that uses a flexible catheter to access pulmonary lesions.", {"entities": []}], ["NAVIGATE is a prospective, multicenter study of the superDimension\u2122 navigation system.", {"entities": []}], ["A prespecified 1-month interim analysis of the first 1,000 primary cohort subjects enrolled at 29 sites in the United States and Europe is described.", {"entities": []}], ["Enrollment and 24-month follow-up are ongoing.", {"entities": []}], ["ENB index procedures were conducted for lung lesion biopsy ( n \u2009=\u2009964), fiducial marker placement ( n \u2009=\u2009210), pleural dye marking ( n \u2009=\u200917), and/or lymph node biopsy ( n \u2009=\u2009334; primarily endobronchial ultrasound-guided).", {"entities": []}], ["Lesions were in the peripheral/middle lung thirds in 92.7%, 49.7% were <20\u00a0mm, and 48.4% had a bronchus sign.", {"entities": []}], ["Radial EBUS was used in 54.3% (543/1,000 subjects) and general anesthesia in 79.7% (797/1,000).", {"entities": []}], ["Among the 964 subjects (1,129 lesions) undergoing lung lesion biopsy, navigation was completed and tissue was obtained in 94.4% (910/964).", {"entities": []}], ["Based on final pathology results, ENB-aided samples were read as malignant in 417/910 (45.8%) subjects and non-malignant in 372/910 (40.9%) subjects.", {"entities": []}], ["An additional 121/910 (13.3%) were read as inconclusive.", {"entities": []}], ["One-month follow-up in this interim analysis is not sufficient to calculate the true negative rate or diagnostic yield.", {"entities": []}], ["Tissue adequacy for genetic testing was 80.0% (56 of 70 lesions sent for testing).", {"entities": []}], ["The ENB-related pneumothorax rate was 4.9% (49/1,000) overall and 3.2% (32/1,000) CTCAE Grade \u22652 (primary endpoint).", {"entities": [[16, 28, "DISEASE"]]}], ["The ENB-related Grade \u22652 bronchopulmonary hemorrhage and Grade \u22654 respiratory failure rates were 1.0 and 0.6%, respectively.", {"entities": [[66, 85, "DISEASE"]]}], ["One-month results of the first 1,000 subjects enrolled demonstrate low adverse event rates in a generalizable population across diverse practice settings.", {"entities": []}], ["Continued enrollment and follow-up are required to calculate the true negative rate and delineate the patient, lesion, and procedural factors contributing to diagnostic yield.", {"entities": []}], ["ClinicalTrials.gov NCT02410837 .", {"entities": []}], ["Registered 31 March 2015.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-017-0403-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background.", {"entities": []}], ["Severe falciparum malaria with human immunodeficiency virus (HIV) coinfection is common in settings with a high prevalence of both diseases, but there is little information on whether HIV affects the clinical presentation and outcome of severe malaria.", {"entities": [[18, 25, "DISEASE"], [244, 251, "DISEASE"]]}], ["HIV status was assessed prospectively in hospitalized parasitemic adults and children with severe malaria in Beira, Mozambique, as part of a clinical trial comparing parenteral artesunate versus quinine (ISRCTN50258054).", {"entities": [[98, 105, "DISEASE"]]}], ["Clinical signs, comorbidity, complications, and disease outcome were compared according to HIV status.", {"entities": []}], ["HIV-1 seroprevalence was 11% (74/655) in children under 15 years and 72% (49/68) in adults with severe malaria.", {"entities": [[103, 110, "DISEASE"]]}], ["Children with HIV coinfection presented with more severe acidosis, anemia, and respiratory distress, and higher peripheral blood parasitemia and plasma Plasmodium falciparum histidine-rich protein-2 ( Pf HRP2).", {"entities": [[67, 73, "DISEASE"]]}], ["During hospitalization, deterioration in coma score, convulsions, respiratory distress, and pneumonia were more common in HIV-coinfected children, and mortality was 26% (19/74) versus 9% (53/581) in uninfected children ( P \u00a0<\u00a0.001).", {"entities": [[92, 101, "DISEASE"]]}], ["In an age- and antimalarial treatment\u2013adjusted logistic regression model, significant, independent predictors for death were renal impairment, acidosis, parasitemia, and plasma Pf HRP2 concentration.", {"entities": []}], ["Conclusions.", {"entities": []}], ["Severe malaria in HIV-coinfected patients presents with higher parasite burden, more complications, and comorbidity, and carries a higher case fatality rate.", {"entities": [[7, 14, "DISEASE"]]}], ["Early identification of HIV coinfection is important for the clinical management of severe malaria.", {"entities": [[91, 98, "DISEASE"]]}], ["Eating disorders, which include anorexia nervosa and bulimia nervosa, are common in adolescent females and can have serious emotional and physical consequences, including death.", {"entities": []}], ["Despite our knowledge about the severity of these illnesses, previous research indicates that adolescent patients are not receiving the best available treatment with fidelity.", {"entities": []}], ["The main goal of this project is to reduce the knowledge gap between what research indicates is the best known treatment and what is actually delivered in clinical practice.", {"entities": []}], ["Informed by the National Implementation Research Network model and the Consolidated Framework for Implementation Research meta-theory, our primary study aim is to increase the capacity of Ontario-based therapists to provide family-based treatment, by providing training and ongoing supervision.", {"entities": []}], ["We will use a multi-site case study with a mixed method pre/post design to examine several implementation outcomes across four eating disorder treatment programs.", {"entities": [[127, 142, "DISEASE"]]}], ["We will provide a training workshop on family-based treatment as well as ongoing monthly supervision.", {"entities": []}], ["In addition, we will assemble implementation teams at each site and coach them by phone on a monthly basis regarding any process issues.", {"entities": []}], ["Our main outcomes include fidelity to the treatment model using quantitative evaluation of audio-recorded therapy sessions, as well as qualitative analysis of the perceptions of the implementation process using audio-recorded focus groups with all clinicians and administrators involved in the study.", {"entities": []}], ["To our knowledge, this is the first study to evaluate an implementation strategy for an evidence-based treatment for eating disorders.", {"entities": []}], ["Challenges to date include obtaining ethics approval at all sites, and recruitment.", {"entities": []}], ["This research will help to inform future studies on how to best implement evidence-based treatments in this field.", {"entities": []}], ["From May 2003 to May 2006, the Robert Koch Institute conducted the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).", {"entities": []}], ["Aim of this first nationwide interview and examination survey was to collect comprehensive data on the health status of children and adolescents aged 0 to 17 years.", {"entities": []}], ["Participants were enrolled in two steps: first, 167 study locations (sample points) were chosen; second, subjects were randomly selected from the official registers of local residents.", {"entities": []}], ["The survey involved questionnaires filled in by parents and parallel questionnaires for children aged 11 years and older, physical examinations and tests, and a computer assisted personal interview performed by study physicians.", {"entities": []}], ["A wide range of blood and urine testing was carried out at central laboratories.", {"entities": []}], ["A total of 17 641 children and adolescents were surveyed \u2013 8985 boys and 8656 girls.", {"entities": []}], ["The proportion of sample neutral drop-outs was 5.3%.", {"entities": []}], ["The response rate was 66.6%.", {"entities": []}], ["The response rate showed little variation between age groups and sexes, but marked variation between resident aliens and Germans, between inhabitants of cities with a population of 100 000 or more and sample points with fewer inhabitants, as well as between the old West German states and the former East German states.", {"entities": []}], ["By analysing the short non-responder questionnaires it was proven that the collected data give comprehensive and nationally representative evidence on the health status of children and adolescents aged 0 to 17 years.", {"entities": []}], ["The apical cytoplasm of airway epithelium (AE) contains abundant labile zinc (Zn) ions that are involved in the protection of AE from oxidants and inhaled noxious substances.", {"entities": []}], ["A major question is how dietary Zn traffics to this compartment.", {"entities": []}], ["In rat airways, in vivo selenite autometallographic (Se-AMG)-electron microscopy revealed labile Zn-selenium nanocrystals in structures resembling secretory vesicles in the apical cytoplasm.", {"entities": []}], ["This observation was consistent with the starry-sky Zinquin fluorescence staining of labile Zn ions confined to the same region.", {"entities": []}], ["The vesicular Zn transporter ZnT4 was likewise prominent in both the apical and basal parts of the epithelium both in rodent and human AE, although the apical pools were more obvious.", {"entities": []}], ["Expression of ZnT4 mRNA was unaffected by changes in the extracellular Zn concentration.", {"entities": []}], ["However, levels increased 3-fold during growth of cells in air liquid interface cultures and decreased sharply in the presence of retinoic acid.", {"entities": []}], ["When comparing nasal versus bronchial human AE cells, there were significant positive correlations between levels of ZnT4 from the same subject, suggesting that nasal brushings may allow monitoring of airway Zn transporter expression.", {"entities": []}], ["Finally, there were marked losses of both basally-located ZnT4 protein and labile Zn in the bronchial epithelium of mice with allergic airway inflammation.", {"entities": []}], ["This study is the first to describe co-localization of zinc vesicles with the specific zinc transporter ZnT4 in airway epithelium and loss of ZnT4 protein in inflamed airways.", {"entities": []}], ["Direct evidence that ZnT4 regulates Zn levels in the epithelium still needs to be provided.", {"entities": []}], ["We speculate that ZnT4 is an important regulator of zinc ion accumulation in secretory apical vesicles and that the loss of labile Zn and ZnT4 in airway inflammation contributes to AE vulnerability in diseases such as asthma.", {"entities": [[218, 224, "DISEASE"]]}], ["It has been recognized for a long time that engagement of B cell antigen receptors (BCRs) on immature B cells or mature B cells leads to completely opposite cell fate decisions.", {"entities": []}], ["The underlying mechanism remains unclear.", {"entities": []}], ["Here, we show that crosslinking of BCRs on human EU12 \u03bc HC \u03bc HC \u03bc HC \u03bc HC", {"entities": []}], ["To examine the quality of reports of complementary and alternative medicine (CAM) systematic reviews in the pediatric population.", {"entities": []}], ["We also examined whether there were differences in the quality of reports of a subset of CAM reviews compared to reviews using conventional interventions.", {"entities": []}], ["We assessed the quality of reports of 47 CAM systematic reviews and 19 reviews evaluating a conventional intervention.", {"entities": []}], ["The quality of each report was assessed using a validated 10-point scale.", {"entities": []}], ["Authors were particularly good at reporting: eligibility criteria for including primary studies, combining the primary studies for quantitative analysis appropriately, and basing their conclusions on the data included in the review.", {"entities": []}], ["Reviewers were weak in reporting: how they avoided bias in the selection of primary studies, and how they evaluated the validity of the primary studies.", {"entities": []}], ["Overall the reports achieved 43% (median = 3) of their maximum possible total score.", {"entities": []}], ["The overall quality of reporting was similar for CAM reviews and conventional therapy ones.", {"entities": []}], ["Evidence based health care continues to make important contributions to the well being of children.", {"entities": []}], ["To ensure the pediatric community can maximize the potential use of these interventions, it is important to ensure that systematic reviews are conducted and reported at the highest possible quality.", {"entities": []}], ["Such reviews will be of benefit to a broad spectrum of interested stakeholders.", {"entities": []}], ["Inguinal hernias have been treated traditionally with open methods of herniorrhaphy or hernioplasty.", {"entities": []}], ["But the trends have changed in the last decade with the introduction of minimal access surgery.", {"entities": []}], ["This study was a prospective descriptive study in patients presenting to Surgery Department of B. P. Koirala Institute of Health Sciences, Dharan, Nepal with reducible inguinal hernias from January 2011 to June 2012.", {"entities": []}], ["All patients >18 years of age presenting with inguinal hernias were given the choice of laparoscopic repair or open repair.", {"entities": []}], ["Those who opted for laparoscopic repair were included in the study.", {"entities": []}], ["There were 50 patients, age ranged from 18 to 71 years with 34 being median age at presentation.", {"entities": []}], ["In 41 patients, totally extraperitoneal repair was attempted.", {"entities": []}], ["Of these, 2 (4%) repairs were converted to transabdominal repair and 2 to open mesh repair (4%).", {"entities": []}], ["In 9 patients, transabdominal repair was done.", {"entities": []}], ["The median total hospital stay was 4 days (range 3-32 days), the mean postoperative stay was 3.38\u00b13.14 days (range 2-23 days), average time taken for full ambulation postoperatively was 2.05\u00b11.39 days (range 1-10 days), and median time taken to return for normal activity was 5 days (range 2-50 days).", {"entities": []}], ["One patient developed recurrence (2%).", {"entities": []}], ["None of the patients who had laparoscopic repair completed complained of neuralgias in the follow-up.", {"entities": []}], ["Laparoscopic repair of inguinal hernias could be contemplated safely both via totally extra peritoneal as well as transperitoneal route even in our setup of a developing country with modifications.", {"entities": []}], ["Various reports suggest a high contemporaneous prevalence of herb-drug use in both developed and developing countries.", {"entities": []}], ["The World Health Organisation indicates that 80% of the Asian and African populations rely on traditional medicine as the primary method for their health care needs.", {"entities": []}], ["Since time immemorial and despite the beneficial and traditional roles of herbs in different communities, the toxicity and herb-drug interactions that emanate from this practice have led to severe adverse effects and fatalities.", {"entities": []}], ["As a result of the perception that herbal medicinal products have low risk, consumers usually disregard any association between their use and any adverse reactions hence leading to underreporting of adverse reactions.", {"entities": []}], ["This is particularly common in developing countries and has led to a paucity of scientific data regarding the toxicity and interactions of locally used traditional herbal medicine.", {"entities": []}], ["Other factors like general lack of compositional and toxicological information of herbs and poor quality of adverse reaction case reports present hurdles which are highly underestimated by the population in the developing world.", {"entities": []}], ["This review paper addresses these toxicological challenges and calls for natural health product regulations as well as for protocols and guidance documents on safety and toxicity testing of herbal medicinal products.", {"entities": []}], ["The human immune system is responsible for protecting the host from infection.", {"entities": []}], ["However, in immunocompromised individuals the risk of infection increases substantially with possible drastic consequences.", {"entities": []}], ["In extreme, systemic infection can lead to sepsis which is responsible for innumerous deaths worldwide.", {"entities": []}], ["Amongst its causes are infections by bacteria and fungi.", {"entities": []}], ["To increase survival, it is mandatory to identify the type of infection rapidly.", {"entities": []}], ["Discriminating between fungal and bacterial pathogens is key to determine if antifungals or antibiotics should be administered, respectively.", {"entities": []}], ["For this, in situ experiments have been performed to determine regulation mechanisms of the human immune system to identify biomarkers.", {"entities": []}], ["However, these studies led to heterogeneous results either due different laboratory settings, pathogen strains, cell types and tissues, as well as the time of sample extraction, to name a few.", {"entities": []}], ["To generate a gene signature capable of discriminating between fungal and bacterial infected samples, we employed Mixed Integer Linear Programming (MILP) based classifiers on several datasets comprised of the above mentioned pathogens.", {"entities": []}], ["When combining the classifiers by a joint optimization we could increase the consistency of the biomarker gene list independently of the experimental setup.", {"entities": []}], ["An increase in pairwise overlap (the number of genes that overlap in each cross-validation) of 43% was obtained by this approach when compared to that of single classifiers.", {"entities": []}], ["The refined gene list was composed of 19 genes and ranked according to consistency in expression (up- or down-regulated)\u00a0and most of them were linked either directly or indirectly to the ERK-MAPK signalling pathway, which has been shown to play a key role in the immune response to infection.", {"entities": []}], ["Testing of the identified 12 genes on an unseen dataset yielded an average accuracy of 83%.", {"entities": []}], ["In conclusion, our method allowed the combination of independent classifiers and increased consistency and reliability of the generated gene signatures.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-017-4006-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Melanoma vaccines have not been optimized.", {"entities": []}], ["Adjuvants are added to activate dendritic cells (DCs) and to induce a favourable immunologic milieu, however, little is known about their cellular and molecular effects in human skin.", {"entities": []}], ["We hypothesized that a vaccine in incomplete Freund's adjuvant (IFA) would increase dermal Th1 and Tc1-lymphocytes and mature DCs, but that repeated vaccination may increase regulatory cells.", {"entities": []}], ["During and after 6 weekly immunizations with a multipeptide vaccine, immunization sites were biopsied at weeks 0, 1, 3, 7, or 12.", {"entities": []}], ["In 36 participants, we enumerated DCs and lymphocyte subsets by immunohistochemistry and characterized their location within skin compartments.", {"entities": []}], ["Mature DCs aggregated with lymphocytes around superficial vessels, however, immature DCs were randomly distributed.", {"entities": []}], ["Over time, there was no change in mature DCs.", {"entities": []}], ["Increases in T and B-cells were noted.", {"entities": []}], ["Th2 cells outnumbered Th1 lymphocytes after 1 vaccine 6.6:1.", {"entities": []}], ["Eosinophils and FoxP3 A multipeptide/IFA vaccine may induce a Th2-dominant microenvironment, which is reversed with repeat vaccination.", {"entities": [[16, 21, "GENE"]]}], ["However, repeat vaccination may increase FoxP3 ClinicalTrials.gov Identifier: NCT00705640", {"entities": [[41, 46, "GENE"]]}], ["Up to 50% of patients with chronic rhinosinusitis (CRS) have comorbid asthma, and we have reported that a subset of CRS patients who have nasal polyps (CRSwNP) have elevated autoantigen-specific antibodies within their nasal polyps (NP).", {"entities": [[70, 76, "DISEASE"]]}], ["While increases in the prevalence and/or severity of both asthma and autoimmunity in women are well characterized, it is not known whether CRSwNP is more severe or frequent in women than men.", {"entities": [[58, 64, "DISEASE"]]}], ["We sought to determine whether CRSwNP demonstrated sex-specific differences in frequency and/or severity.", {"entities": []}], ["Using a retrospectively collected database of tertiary care patients (n\u2009=\u20091393), we evaluated the distribution of sex in patients with CRSwNP with or without comorbid asthma or aspirin hypersensitivity.", {"entities": [[167, 173, "DISEASE"]]}], ["We further compared the severity of sinus disease between men and women with CRSwNP.", {"entities": []}], ["Although women comprised 55% of CRS patients without NP (CRSsNP), a significantly smaller proportion of CRSwNP patients were female (38%, P \u2009<\u20090.001).", {"entities": []}], ["Interestingly, women with CRSwNP were significantly more likely than men to have comorbid asthma ( P \u2009<\u20090.001), and 61% of patients with the most severe form of disease (aspirin-exacerbated respiratory disease (CRSwNP plus asthma plus aspirin sensitivity)) were women ( P \u2009<\u20090.05).", {"entities": [[90, 96, "DISEASE"], [223, 229, "DISEASE"]]}], ["Women with CRSwNP were significantly more likely to have taken oral steroids, and were more likely to have a history of revision surgeries ( P \u2009<\u20090.05) compared to men.", {"entities": []}], ["These data suggest that women with CRSwNP have more severe disease than men in a tertiary care setting.", {"entities": []}], ["Future studies are needed to elucidate the mechanisms that drive disease severity in men and women, paving the way for the development of personalized treatment strategies for CRSwNP based on sex.", {"entities": []}], ["Although previous studies have suggested that lavender oil promote wound healing, no study has examined the molecular mechanisms of its effect.", {"entities": []}], ["In this study, we investigated the effect of lavender oil on various steps of wound healing and its molecular mechanism, focusing on transforming growth factor-\u03b2 (TGF-\u03b2).", {"entities": []}], ["Circular full-thickness skin wounds were produced on rats.", {"entities": []}], ["Control solution or lavender oil was topically applied to the wounds on alternating days for 14\u00a0days.", {"entities": []}], ["The area of wounds topically treated with lavender oil was significantly decreased as compared to that of wounds of control rats at 4, 6, 8, and 10\u00a0days after wounding.", {"entities": []}], ["Topical application of lavender oil induced expression of type I and III collagen at 4\u00a0days after wounding, accompanied by an increased number of fibroblasts, which synthesize collagen.", {"entities": []}], ["Induced expression of type III collagen by topical application of lavender oil was reduced to control level at 7\u00a0days after wounding although increased expression of type I collagen still continued even at 7\u00a0days, suggesting rapid collagen replacement from type III to type I in wounds treated with lavender oil.", {"entities": []}], ["Importantly, expression of TGF-\u03b2 in wounds treated with lavender oil was significantly increased as compared to control.", {"entities": []}], ["Moreover, an increased number of myofibroblasts was observed in wounds treated with lavender oil at 4\u00a0days after wounding, suggesting promotion of differentiation of fibroblasts through induction of TGF-\u03b2, which is needed for wound contraction.", {"entities": []}], ["This study demonstrated that topical application of lavender oil promoted collagen synthesis and differentiation of fibroblasts, accompanied by up-regulation of TGF-\u03b2.", {"entities": []}], ["These data suggest that lavender oil has the potential to promote wound healing in the early phase by acceleration of formation of granulation tissue, tissue remodeling by collagen replacement and wound contraction through up-regulation of TGF-\u03b2.", {"entities": []}], ["The beneficial effect of lavender oil on wound healing may raise the possibility of new approaches as complementary treatment besides conventional therapy.", {"entities": []}], ["On passage through the lung vascular bed, prostaglandins are removed from the circulation by a transport carrier and subsequently inactivated by intracellular enzymes.", {"entities": []}], ["However, PGI2 is not inactivated by the lung in vivo.", {"entities": []}], ["Although PGI2 is an excellent substrate for the intracellular enzymes in vitro, PGI2 is not a substrate for the carrier system.", {"entities": []}], ["Thus, the transport carrier determines which circulating prostaglandin is inactivated by the pulmonary vascular bed.", {"entities": []}], ["Also, the lung has a high capacity for forming prostaglandins from arachidonic acid.", {"entities": []}], ["Considerable differences exist between species in relation to amount and specific prostaglandin formed as determined by incubation of 11C-PGH2 with pulmonary microsomes.", {"entities": []}], ["The pulmonary biosynthesis and metabolism of these prostaglandins and related substances are discussed.", {"entities": []}], ["Nerium oleander is traditionally used in various diseases because of its medicinal properties.", {"entities": []}], ["One of its uses is in musculoskeletal disorder.", {"entities": []}], ["The aim of the study was to evaluate the skeletal muscle relaxant activity of the aqueous extract of Nerium oleander flowers (AENOF) in albino rats in comparison with diazepam.", {"entities": []}], ["A total of 20 Swiss albino rats aged 6\u20137 weeks, of either sex, weighing about 100\u2013150 g, were taken, and after acute toxicity studies two different doses were selected.", {"entities": []}], ["The animals were divided into four different groups.", {"entities": []}], ["The first group was kept as the control (normal saline), second as the standard (diazepam) and the remaining two groups as Test I and Test II, and given different doses of the AENOF.", {"entities": []}], ["Skeletal muscle relaxant activity (motor coordination) on Rotarod and locomotor activity on photoactometer was performed.", {"entities": []}], ["Statistical analysis was carried out by using analysis of variance, followed by Dunnett's multiple comparison tests.", {"entities": []}], ["The result from the Actophotometer test and Rotarod test showed that the extract of AENOF significantly reduced ( P < 0.05) the motor coordination of the tested animals.", {"entities": []}], ["Our data indicates that AENOF possesses skeletal muscle relaxant activities.", {"entities": []}], ["Advances in knowledge of neurocellulars relations have provided new directions in the understanding and treatment of numerous conditions, including atopic dermatitis.", {"entities": [[148, 165, "DISEASE"], [155, 165, "DISEASE"]]}], ["It is known that emotional, physical, chemical or biological stimuli can generate more accentuated responses in atopic patients than in non-atopic individuals; however, the complex network of control covered by these influences, especially by neuropeptides and neurotrophins, and their genetic relations, still keep secrets to be revealed.", {"entities": []}], ["Itching and airway hyperresponsiveness, the main aspects of atopy, are associated with disruption of the neurosensory network activity.", {"entities": []}], ["Increased epidermal innervation and production of neurotrophins, neuropeptides, cytokines and proteases, in addition to their relations with the sensory receptors in an epidermis with poor lipid mantle, are the aspects currently covered for understanding atopic dermatitis.", {"entities": [[255, 272, "DISEASE"], [262, 272, "DISEASE"]]}], ["Oxidative stress, a state of imbalance in the production of reactive oxygen species and nitrogen, is induced by a wide variety of factors.", {"entities": []}], ["This biochemical state is associated with systemic diseases, and diseases affecting the central nervous system.", {"entities": []}], ["Epilepsy is a chronic neurological disorder with refractoriness to drug therapy at about 30%.", {"entities": []}], ["Currently, experimental evidence supports the involvement of oxidative stress in seizures, in the process of their generation, and in the mechanisms associated with refractoriness to drug therapy.", {"entities": []}], ["Hence, the aim of this review is to present information in order to facilitate the handling of this evidence and determine the therapeutic impact of the biochemical status for this pathology.", {"entities": []}], ["Fractures still present a significant burden to patients due to pain and periods of unproductivity.", {"entities": []}], ["Numerous growth factors have been identified to regulate bone remodeling.", {"entities": []}], ["However, to date, only the bone morphogenetic proteins (BMPs) are used to enhance fracture healing in clinical settings.", {"entities": []}], ["Activins are pleiotropic growth factors belonging to the TGF-\u03b2 superfamily.", {"entities": []}], ["We and others have recently shown that treatment with recombinant fusion proteins of activin receptors greatly increases bone mass in different animal models by trapping activins and other ligands thus inhibiting their signaling pathways.", {"entities": []}], ["However, their effects on fracture healing are less known.", {"entities": []}], ["Twelve-week old male C57Bl mice were subjected to a standardized, closed tibial fracture model.", {"entities": []}], ["Animals were divided into control and treatment groups and were administered either PBS control or a soluble activin type IIB receptor (ActRIIB-Fc) intraperitoneally once a week for a duration of two or four weeks.", {"entities": []}], ["There were no significant differences between the groups at two weeks but we observed a significant increase in callus mineralization in ActRIIB-Fc-treated animals by microcomputed tomography imaging at four weeks.", {"entities": []}], ["Bone volume per tissue volume was 60%, trabecular number 55% and bone mineral density 60% higher in the 4-week calluses of the ActRIIB-Fc-treated mice (p<0.05 in all).", {"entities": []}], ["Biomechanical strength of 4-week calluses was also significantly improved by ActRIIB-Fc treatment as stiffness increased by 64% and maximum force by 45% (p<0.05) compared to the PBS-injected controls.", {"entities": []}], ["These results demonstrate that ActRIIB-Fc treatment significantly improves healing of closed long bone fractures.", {"entities": []}], ["Our findings support the previous reports of activin receptors increasing bone mass but also demonstrate a novel approach for using ActRIIB-Fc to enhance fracture healing.", {"entities": []}], ["With cases of severe acute respiratory syndrome (SARS) occurring across geographic regions, data collection on the effectiveness of intervention strategies should be standardized to facilitate analysis.", {"entities": [[39, 47, "DISEASE"], [14, 47, "DISEASE"], [49, 53, "GENE"]]}], ["We propose a minimum dataset to capture data needed to examine the basic reproduction rate, case status and criteria, symptoms, and outcomes of SARS.", {"entities": [[144, 148, "GENE"]]}], ["Little is known about prognostic factors in epithelioid hemangioendothelioma (EHE).", {"entities": []}], ["We aimed to identify prognostic factors among various clinicopathologic and imaging features of thoracic EHEs.", {"entities": []}], ["Forty-two patients (male:female\u200a=\u200a20:22; median age, 49 years) of EHEs with (n\u200a=\u200a19) and without (n\u200a=\u200a23) thoracic involvement were included.", {"entities": []}], ["We reviewed electronic medical records for clinical information and computed tomography (CT) features for thoracic involvement.", {"entities": []}], ["Differences in demographics and survival outcomes of patients with and without thoracic involvement were assessed.", {"entities": []}], ["We also estimated overall survival.", {"entities": []}], ["The most common pattern of thoracic involvement was multiple pulmonary nodules (n\u200a=\u200a10), followed by parenchymal tumor with pleural invasion (n\u200a=\u200a4), reticulonodular opacities (n\u200a=\u200a3), and diffuse pleural thickening (n\u200a=\u200a2).", {"entities": []}], ["No significant difference in survival was found between the thoracic EHE group and nonthoracic EHE group ( P \u200a=\u200a0.68).", {"entities": []}], ["Among 4 different thoracic involvement types, the lung multinodular pattern tended to demonstrate longer median survival (8.5 months) than other patterns, whereas the shortest median survival (1 month) was observed for the nodule/mass with pleural involvement pattern ( P \u200a=\u200a0.038).", {"entities": []}], ["CT manifestations of thoracic EHEs are classified into 4 patterns, of which lung multinodular pattern is associated with longer survival.", {"entities": []}], ["Survival is not different between patients with and without thoracic involvement.", {"entities": []}], ["Inhaled corticosteroid/long-acting \u03b2 2 -agonist (ICS/LABA) fixed-dose combinations are recommended regular maintenance options for asthma.", {"entities": [[131, 137, "DISEASE"]]}], ["ICS/LABAs containing formoterol may also be indicated for single maintenance and reliever therapy (SMART).", {"entities": []}], ["This analysis evaluated the frequency of SMART dosing of budesonide/formoterol fixed-dose combination (BFC) in the United Kingdom.", {"entities": []}], ["Secondary objectives were to assess adherence and use of short-acting \u00df 2 -agonists (SABAs).", {"entities": []}], ["This was a descriptive analysis of treatment patterns using the UK Clinical Practice Research Datalink-GP OnLine Database data (2009\u20132013).", {"entities": []}], ["SMART dosing was determined when prescription instructions contained guidance for daily dosing plus \u2018and when required\u2019.", {"entities": []}], ["Treatment and prescription refill patterns of BFC and SABA were described in the year following the index date to identify adherence and SMART dosing instructions versus other dosing regimens.", {"entities": []}], ["Of 14,818 patients identified, 173 (1.2%) had evidence of prescriptions for SMART dosing at their index BFC prescription.", {"entities": []}], ["Despite being prescribed SMART dosing, 91 of 173 patients (53%) were additionally dispensed SABA in the year following the index date.", {"entities": []}], ["The mean number of BFC inhalers used was less than required for daily treatment for SMART and non-SMART dosing groups (4.7 and 4.8, respectively).This analysis suggests that SMART dosing is infrequent when examining dosing instructions.", {"entities": []}], ["Therefore, results of randomised clinical trials using SMART dosing may not translate to clinical practice in the United Kingdom because of the low level of SMART prescription, concurrent use of SABA, and inadequate refill persistence observed.", {"entities": []}], ["Further research is needed to understand SMART dosing in real-world clinical practice.", {"entities": []}], ["The level of human immunodeficiency virus (HIV), tuberculosis (TB) as well as the co-infection TB/HIV in South Africa is among the highest in the world.", {"entities": [[49, 61, "DISEASE"]]}], ["TB is curable while HIV is not, yet the combination of both is a growing feature in the world.", {"entities": []}], ["This study examined TB and HIV affecting people living in South Africa.", {"entities": []}], ["Analyses have been undertaken based on data from the General Household Survey of South Africa in 2006.", {"entities": []}], ["The study focused on respondents aged 15\u201349 years, corresponding to a total of 55,384 people composed of 25,859 males and 29,525 females.", {"entities": []}], ["Among this population, 5935 people suffered from illness/injury, including 2469 (41.6%) males and 3466 (58.4%) females.", {"entities": []}], ["Weighted multivariate logistic regression is performed on TB and/or HIV in association with the province, background characteristics of the target population, and selected socioeconomic and demographic variables included in the survey.", {"entities": []}], ["In this study we focus on variables of health status and whether subjects suffered from TB and/or HIV.", {"entities": []}], ["Findings of this investigation show that TB is the second most common cause of illness in the provinces of KwaZulu-Natal (KN) (9.1%), North West (5.4%) and Limpopo (4.2%).", {"entities": []}], ["People who are married have a 50% lower risk compared to those currently not married to suffer from TB and/or HIV.", {"entities": []}], ["Those with living spouses have a 5% lower risk to suffer from TB and/or HIV than those whose partners are not alive.", {"entities": []}], ["This study concluded that rapid action is needed to curb the spread of TB and/or HIV to produce a healthy population.", {"entities": []}], ["Therefore, follow-up care and special preventative measures are urgently needed in provinces with higher reported rates of TB and/or HIV such as KN.", {"entities": []}], ["\u2022 Patient registry is a valuable tool in international GNE myopathy research.", {"entities": [[59, 67, "DISEASE"], [55, 58, "GENE"]]}], ["\u2022 The registry expands the knowledge of GNE myopathy genetics and epidemiology.", {"entities": [[44, 52, "DISEASE"], [40, 43, "GENE"]]}], ["\u2022 The registry allows monitoring of the disease progression and discovering diversity.", {"entities": []}], ["\u2022 The data suggest possible genotype\u2013phenotype correlation in GNE myopathy.", {"entities": [[66, 74, "DISEASE"], [62, 65, "GENE"]]}], ["Patient registry is a valuable tool in international GNE myopathy research.", {"entities": [[57, 65, "DISEASE"], [53, 56, "GENE"]]}], ["The registry expands the knowledge of GNE myopathy genetics and epidemiology.", {"entities": [[42, 50, "DISEASE"], [38, 41, "GENE"]]}], ["The registry allows monitoring of the disease progression and discovering diversity.", {"entities": []}], ["The data suggest possible genotype\u2013phenotype correlation in GNE myopathy.", {"entities": [[64, 72, "DISEASE"], [60, 63, "GENE"]]}], ["GNE myopathy is a rare distal myopathy, caused by mutations in the GNE gene, affecting sialic acid synthesis.", {"entities": [[4, 12, "DISEASE"], [30, 38, "DISEASE"], [0, 3, "GENE"], [67, 70, "GENE"], [0, 3, "GENE"], [67, 70, "GENE"]]}], ["Clinical presentation varies from asymptomatic early stage patients to severely debilitating forms.", {"entities": []}], ["This first report describes clinical presentations and severity of the disease, using data of 150 patients collected via the on-line, patient-reported registry component of the GNE Myopathy Disease Monitoring Program (GNEM-DMP).", {"entities": [[181, 189, "DISEASE"], [177, 180, "GENE"]]}], ["Disease progression was prospectively analysed, over a 2-year period, using the GNE myopathy functional activity scale (GNEM-FAS).", {"entities": [[84, 92, "DISEASE"], [80, 83, "GENE"]]}], ["The average annual rates of decline in function were estimated at \u22129.6% and \u22123.2% in ambulant and non-ambulant patients respectively.", {"entities": []}], ["4.3% of participants became non-ambulant within one year.", {"entities": []}], ["The mean time from onset to required use of a wheelchair was 11.9 years.", {"entities": []}], ["Mean delay of genetic diagnosis from symptom onset was 5.2 years.", {"entities": []}], ["Mutation specific analysis demonstrated genotype\u2013phenotype relationships; i.e.", {"entities": []}], ["p.Ala662Val may be associated with a more severe phenotype, compared to p.Val727Met.", {"entities": []}], ["Patients with compound heterozygous mutation in epimerase and kinase domain appeared to have a more severe phenotype compared to patients with both mutations located within one domain.", {"entities": []}], ["Acknowledging the limitations of the study, these findings suggest that the severity of the GNE mutations affects disease severity.", {"entities": [[92, 95, "GENE"]]}], ["The GNEM-DMP is a useful data collection tool, prospectively measuring the progression of GNE myopathy, which could play an important role in translational and clinical research and further understanding of genotype\u2013phenotype correlations.", {"entities": [[94, 102, "DISEASE"], [90, 93, "GENE"]]}], ["A relationship between low levels of serum vitamin D and respiratory infections has been established.", {"entities": []}], ["No study has examined the frequency and clinical relevance of vitamin D deficiency in patients with primary ciliary dyskinesia (PCD).", {"entities": [[100, 126, "DISEASE"]]}], ["Vitamin D levels were measured in 22 PCD patients (7 females, 10.5\u00a0years, range, 2\u201334 years).", {"entities": []}], ["In PCD, pulmonary function tests (PFTs), sputum microbiology, self-reported physical activity (PA) level, and quality of life (QoL) by means of the Saint George\u2019s Respiratory Questionnaire (SGRQ), were also assessed.", {"entities": []}], ["Seventy-two percent of PCD patients were vitamin-D deficient-to-insufficient and 28% were sufficient.", {"entities": []}], ["No differences in PFTs parameters were found between vitamin D deficiency-to-insufficiency and sufficiency groups.", {"entities": []}], ["Patients with vitamin D deficiency-to-insufficiency had significantly higher SGRQ total scores, and thus poorer QoL ( p \u2009=\u20090.03).", {"entities": []}], ["Seventy-nine percent of PCD subjects had limitations in performing vigorous activities, and 53% performed less than 3\u00a0hours of PA per week.", {"entities": []}], ["Vitamin D deficiency-to-insufficiency and sufficiency groups did not show any differences in age at PCD diagnosis or at onset of respiratory symptoms, BMI, atopy, current asthma or bronchiectasis.", {"entities": [[181, 195, "DISEASE"], [171, 177, "DISEASE"]]}], ["However, 79% of patients with bronchiectasis had vitamin D deficiency-to-insufficiency.", {"entities": [[30, 44, "DISEASE"]]}], ["No differences were found in the rate of positive sputum cultures and in the number of antibiotic courses between the two groups.", {"entities": []}], ["Hypovitaminosis D is common in PCD patients, and is associated with poorer QoL.", {"entities": []}], ["We recommend the assessment and treatment of hypovitaminosis D to be included in the routine management of PCD.", {"entities": []}], ["Studies have consistently documented declines in respiratory health after 11 September 2001 (9/11) among surviving first responders and other World Trade Center (WTC) rescue, recovery, and clean-up workers.", {"entities": []}], ["The goal of this study was to describe the risk of newly diagnosed asthma among WTC site workers and volunteers and to characterize its association with WTC site exposures.", {"entities": [[67, 73, "DISEASE"]]}], ["We analyzed 2003\u20132004 interview data from the World Trade Center Health Registry for workers who did not have asthma before 9/11 ( n = 25,748), estimating the risk of newly diagnosed asthma and its associations with WTC work history, including mask or respirator use.", {"entities": [[110, 116, "DISEASE"], [183, 189, "DISEASE"]]}], ["Newly diagnosed asthma was reported by 926 workers (3.6%).", {"entities": [[16, 22, "DISEASE"]]}], ["Earlier arrival and longer duration of work were significant risk factors, with independent dose responses ( p < 0.001), as were exposure to the dust cloud and pile work.", {"entities": []}], ["Among workers who arrived on 11 September, longer delays in the initial use of masks or respirators were associated with increased risk of asthma; adjusted odds ratios ranged from 1.63 [95% confidence interval (CI), 1.03\u20132.56) for 1 day of delay to 3.44 (95% CI, 1.43\u20138.25) for 16\u201340 weeks delay.", {"entities": [[139, 145, "DISEASE"]]}], ["The rate of self-reported newly diagnosed asthma was high in the study population and significantly associated with increased exposure to the WTC disaster site.", {"entities": [[42, 48, "DISEASE"]]}], ["Although we could not distinguish appropriate respiratory protection from inappropriate, we observed a moderate protective effect of mask or respirator use.", {"entities": []}], ["The findings underscore the need for adequate and timely distribution of appropriate protective equipment and the enforcement of its use when other methods of controlling respiratory exposures are not feasible.", {"entities": []}], ["This case study investigates the effects of ventilation intervention on measured and perceived indoor air quality (IAQ) in a repaired school where occupants reported IAQ problems.", {"entities": []}], ["Occupants\u2019 symptoms were suspected to be related to the impurities leaked indoors through the building envelope.", {"entities": []}], ["The study\u2019s aim was to determine whether a positive pressure of 5\u20137 Pa prevents the infiltration of harmful chemical and microbiological agents from structures, thus decreasing symptoms and discomfort.", {"entities": []}], ["Ventilation intervention was conducted in a building section comprising 12 classrooms and was completed with IAQ measurements and occupants\u2019 questionnaires.", {"entities": []}], ["After intervention, the concentration of total volatile organic compounds (TVOC) and fine particulate matter (PM 2.5 ) decreased, and occupants\u2019 negative perceptions became more moderate compared to those for other parts of the building.", {"entities": []}], ["The indoor mycobiota differed in species composition from the outdoor mycobiota, and changed remarkably with the intervention, indicating that some species may have emanated from an indoor source before the intervention.", {"entities": []}], ["Rhinovirus infection is a major cause of asthma exacerbations.", {"entities": [[41, 47, "DISEASE"]]}], ["We studied nasal and bronchial mucosal inflammatory responses during experimental rhinovirus-induced asthma exacerbations.", {"entities": [[101, 107, "DISEASE"]]}], ["We used nasosorption on days 0, 2\u20135 and 7 and bronchosorption at baseline and day 4 to sample mucosal lining fluid to investigate airway mucosal responses to rhinovirus infection in patients with allergic asthma ( n \u00a0=\u00a028) and healthy non-atopic controls ( n \u00a0=\u00a011), by using a synthetic absorptive matrix and measuring levels of 34 cytokines and chemokines using a sensitive multiplex assay.", {"entities": [[196, 211, "DISEASE"], [205, 211, "DISEASE"]]}], ["Following rhinovirus infection asthmatics developed more upper and lower respiratory symptoms and lower peak expiratory flows compared to controls (all P \u00a0<\u00a00.05).", {"entities": []}], ["Asthmatics also developed higher nasal lining fluid levels of an anti-viral pathway (including IFN-\u03b3, IFN-\u03bb/IL-29, CXCL11/ITAC, CXCL10/IP10 and IL-15) and a type 2 inflammatory pathway (IL-4, IL-5, IL-13, CCL17/TARC, CCL11/eotaxin, CCL26/eotaxin-3) (area under curve day 0\u20137, all P \u00a0<\u00a00.05).", {"entities": []}], ["Nasal IL-5 and IL-13 were higher in asthmatics at day 0 ( P \u00a0<\u00a00.01) and levels increased by days 3 and 4 ( P \u00a0<\u00a00.01).", {"entities": []}], ["A hierarchical correlation matrix of 24 nasal lining fluid cytokine and chemokine levels over 7\u00a0days demonstrated expression of distinct interferon-related and type 2 pathways in asthmatics.", {"entities": []}], ["In asthmatics IFN-\u03b3, CXCL10/IP10, CXCL11/ITAC, IL-15 and IL-5 increased in bronchial lining fluid following viral infection (all P \u00a0<\u00a00.05).", {"entities": []}], ["Precision sampling of mucosal lining fluid identifies robust interferon and type 2 responses in the upper and lower airways of asthmatics during an asthma exacerbation.", {"entities": [[148, 154, "DISEASE"]]}], ["Nasosorption and bronchosorption have potential to define asthma endotypes in stable disease and at exacerbation.", {"entities": [[58, 64, "DISEASE"]]}], ["\u2022 Following rhinovirus infection asthmatics have increased interferons and type 2 inflammation in airway mucosal lining fluid.", {"entities": []}], ["\u2022 Nasosorption cytokines and chemokines showed distinct pathways of interferon and type 2 inflammation in asthma.", {"entities": [[106, 112, "DISEASE"]]}], ["\u2022 Precision mucosal sampling has potential for stratifying molecular endotypes of asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["\u2022 Validation of nasosorption and bronchosorption will be required for selection of asthmatics for therapy with biologics.", {"entities": []}], ["Following rhinovirus infection asthmatics have increased interferons and type 2 inflammation in airway mucosal lining fluid.", {"entities": []}], ["Nasosorption cytokines and chemokines showed distinct pathways of interferon and type 2 inflammation in asthma.", {"entities": [[104, 110, "DISEASE"]]}], ["Precision mucosal sampling has potential for stratifying molecular endotypes of asthma.", {"entities": [[80, 86, "DISEASE"]]}], ["Validation of nasosorption and bronchosorption will be required for selection of asthmatics for therapy with biologics.", {"entities": []}], ["Experimental human rhinovirus (HRV) infection causes more severe upper and lower respiratory tract symptoms in allergic asthmatics than in healthy controls.", {"entities": []}], ["There is greater induction of cytokines and chemokines in nasal and bronchial mucosal lining fluid (MLF) of asthmatics: with distinct pathways of type 2 and anti-viral/regulatory inflammation.", {"entities": []}], ["Subject to further validation, analysis of MLF may prove useful in stratification of patients with asthma, and the definition of molecular endotypes.", {"entities": [[99, 105, "DISEASE"]]}], ["Interpretation Nasosorption and bronchosorption are precision sampling methods with potential for widespread application in respiratory and other mucosal diseases ( e.g.", {"entities": []}], ["gastrointestinal diseases).", {"entities": []}], ["Biomarkers identified in nasosorption and bronchosorption samples will need to be validated compared to established airway sampling methods, in a range of asthma phenotypes, and with current and novel therapies.", {"entities": [[155, 161, "DISEASE"]]}], ["Aside from their role in hemostasis, coagulant and fibrinolytic proteases are important mediators of inflammation in diseases such as asthma, atherosclerosis, rheumatoid arthritis, and cancer.", {"entities": [[142, 157, "DISEASE"], [159, 179, "DISEASE"], [170, 179, "DISEASE"], [134, 140, "DISEASE"], [185, 191, "DISEASE"]]}], ["The blood circulating zymogens of these proteases enter damaged tissue as a consequence of vascular leak or rupture to become activated and contribute to extravascular coagulation or fibrinolysis.", {"entities": []}], ["The coagulants, factor Xa (FXa), factor VIIa (FVIIa), tissue factor, and thrombin, also evoke cell-mediated actions on structural cells (e.g., fibroblasts and smooth muscle cells) or inflammatory cells (e.g., macrophages) via the proteolytic activation of protease-activated receptors (PARs).", {"entities": []}], ["Plasmin, the principle enzymatic mediator of fibrinolysis, also forms toll-like receptor-4 (TLR-4) activating fibrin degradation products (FDPs) and can release latent-matrix bound growth factors such as transforming growth factor- \u03b2 (TGF- \u03b2 ).", {"entities": [[139, 143, "GENE"]]}], ["Furthermore, the proteases that convert plasminogen into plasmin (e.g., urokinase plasminogen activator) evoke plasmin-independent proinflammatory actions involving coreceptor activation.", {"entities": []}], ["Selectively targeting the receptor-mediated actions of hemostatic proteases is a strategy that may be used to treat inflammatory disease without the bleeding complications of conventional anticoagulant therapies.", {"entities": []}], ["The mechanisms by which proteases of the coagulant and fibrinolytic systems contribute to extravascular inflammation in disease will be considered in this review.", {"entities": []}], ["Veterans of Operation Desert Storm/Desert Shield \u2013 the 1991 Gulf War (GW) \u2013 are a unique population who returned from theater with multiple health complaints and disorders.", {"entities": []}], ["Studies in the U.S. and elsewhere have consistently concluded that approximately 25\u201332% of this population suffers from a disorder characterized by symptoms that vary somewhat among individuals and include fatigue, headaches, cognitive dysfunction, musculoskeletal pain, and respiratory, gastrointestinal and dermatologic complaints.", {"entities": []}], ["Gulf War illness (GWI) is the term used to describe this disorder.", {"entities": []}], ["In addition, brain cancer occurs at increased rates in subgroups of GW veterans, as do neuropsychological and brain imaging abnormalities.", {"entities": [[13, 25, "DISEASE"], [19, 25, "DISEASE"]]}], ["Chemical exposures have become the focus of etiologic GWI research because nervous system symptoms are prominent and many neurotoxicants were present in theater, including organophosphates (OPs), carbamates, and other pesticides; sarin/cyclosarin nerve agents, and pyridostigmine bromide (PB) medications used as prophylaxis against chemical warfare attacks.", {"entities": []}], ["Psychiatric etiologies have been ruled out.", {"entities": []}], ["This paper reviews the recent literature on the health of 1991 GW veterans, focusing particularly on the central nervous system and on effects of toxicant exposures.", {"entities": []}], ["In addition, it emphasizes research published since 2008, following on an exhaustive review that was published in that year that summarizes the prior literature ( We conclude that exposure to pesticides and/or to PB are causally associated with GWI and the neurological dysfunction in GW veterans.", {"entities": []}], ["Exposure to sarin and cyclosarin and to oil well fire emissions are also associated with neurologically based health effects, though their contribution to development of the disorder known as GWI is less clear.", {"entities": []}], ["Gene-environment interactions are likely to have contributed to development of GWI in deployed veterans.", {"entities": []}], ["The health consequences of chemical exposures in the GW and other conflicts have been called \u201ctoxic wounds\u201d by veterans.", {"entities": []}], ["This type of injury requires further study and concentrated treatment research efforts that may also benefit other occupational groups with similar exposure-related illnesses.", {"entities": []}], ["Mast cells play a critical role in allergic and inflammatory diseases, including exercise-induced bronchoconstriction (EIB) in asthma.", {"entities": [[127, 133, "DISEASE"]]}], ["The mechanism underlying EIB is probably related to increased airway fluid osmolarity that activates mast cells to the release inflammatory mediators.", {"entities": []}], ["These mediators then act on bronchial smooth muscle to cause bronchoconstriction.", {"entities": []}], ["In parallel, protective substances such as prostaglandin E 2 (PGE 2 ) are probably also released and could explain the refractory period observed in patients with EIB.", {"entities": []}], ["This study aimed to evaluate the protective effect of PGE 2 on osmotically activated mast cells, as a model of exercise-induced bronchoconstriction.", {"entities": []}], ["We used LAD2, HMC-1, CD34-positive, and human lung mast cell lines.", {"entities": []}], ["Cells underwent a mannitol challenge, and the effects of PGE 2 and prostanoid receptor (EP) antagonists for EP 1\u20134 were assayed on the activated mast cells.", {"entities": []}], ["Beta-hexosaminidase release, protein phosphorylation, and calcium mobilization were assessed.", {"entities": []}], ["Mannitol both induced mast cell degranulation and activated phosphatidyl inositide 3-kinase and mitogen-activated protein kinase (MAPK) pathways, thereby causing de novo eicosanoid and cytokine synthesis.", {"entities": []}], ["The addition of PGE 2 significantly reduced mannitol-induced degranulation through EP 2 and EP 4 receptors, as measured by beta-hexosaminidase release, and consequently calcium influx.", {"entities": []}], ["Extracellular-signal-regulated kinase 1/2, c-Jun N-terminal kinase, and p38 phosphorylation were diminished when compared with mannitol activation alone.", {"entities": []}], ["Our data show a protective role for the PGE 2 receptors EP 2 and EP 4 following osmotic changes, through the reduction of human mast cell activity caused by calcium influx impairment and MAP kinase inhibition.", {"entities": []}], ["Maritime transportation is a major source of climate change and air pollution.", {"entities": []}], ["Shipping emissions cause severe impacts on health and environment.", {"entities": []}], ["These effects of emissions are emerged especially in territorial waters, inland seas, canals, straits, bays, and port regions.", {"entities": []}], ["In this paper, exhaust gas emissions from ships in Izmir Port, which is one of the main ports in Turkey, are calculated by the ship activity-based methodology.", {"entities": []}], ["Total emissions from ships in the port is estimated as 1923\u2009ton y x , 1405\u2009ton y 2 , 82753\u2009ton y 2 , ton y", {"entities": []}], ["Elevation of serum IgE levels has long been associated with allergic diseases.", {"entities": []}], ["Many genes have been linked to IgE production, but few have been linked to the developmental aspects of genetic association with IgE production.", {"entities": []}], ["To clarify developmental genetic association, we investigated what genes and gene-gene interactions affect IgE levels among fetus, infancy and childhood in Taiwan individuals.", {"entities": []}], ["A birth cohort of 571 children with completion of IgE measurements from newborn to 1.5, 3, and 6 years of age was subject to genetic association analysis on the 384-customized SNPs of 159 allergy candidate genes.", {"entities": []}], ["Fifty-three SNPs in 37 genes on innate and adaptive immunity, and stress and response were associated with IgE production.", {"entities": []}], ["Polymorphisms of the IL13 , and the HLA-DPA1 and HLA-DQA1 were, respectively, the most significantly associated with the IgE production at newborn and 6 years of age.", {"entities": [[21, 25, "GENE"], [36, 44, "GENE"], [49, 57, "GENE"]]}], ["Analyses of gene-gene interactions indentified that the combination of NPSR1 , rs324981 TT with FGF1 , rs2282797 CC had the highest risk (85.7%) of IgE elevation at 1.5 years of age ( P \u200a=\u200a1.46\u00d710 IL13 , CYFIP2 and PDE2A was significantly associated with IgE elevation at 3 years of age ( P \u200a=\u200a5.98\u00d710 CLEC2D , COLEC11 and CCL2 was significantly associated with IgE elevation at 6 years of age ( P \u200a=\u200a6.65\u00d710", {"entities": [[71, 76, "GENE"], [96, 100, "GENE"], [197, 201, "GENE"], [204, 210, "GENE"], [215, 220, "GENE"], [302, 308, "GENE"], [311, 318, "GENE"], [323, 327, "GENE"]]}], ["Various transient receptor potential (TRP) channels in sensory neurons contribute to the transduction of mechanical stimuli in the colon.", {"entities": []}], ["Recently, even the cold-sensing menthol receptor TRPM(melastatin)8 was suggested to be involved in murine colonic mechano-nociception.", {"entities": []}], ["To analyze the roles of TRPM8, TRPA1 and TRPV4 in distension-induced colonic nociception and pain, TRP-deficient mice and selective pharmacological blockers in wild-type mice (WT) were used.", {"entities": [[24, 29, "GENE"], [31, 36, "GENE"], [41, 46, "GENE"]]}], ["Visceromotor responses (VMR) to colorectal distension (CRD) in vivo were recorded and distension/pressure-induced CGRP release from the isolated murine colon ex vivo was measured by EIA.", {"entities": []}], ["Distension-induced colonic CGRP release was markedly reduced in TRPA1 TRPA1 and TRPV4 mediate colonic distension pain and CGRP release and appear to govern a wide and congruent dynamic range of distensions.", {"entities": [[64, 69, "GENE"], [70, 75, "GENE"], [64, 69, "GENE"], [70, 75, "GENE"], [80, 85, "GENE"]]}], ["The role of TRPM8 seems to be confined to signaling extreme noxious distension, at least in the healthy colon.", {"entities": [[12, 17, "GENE"]]}], ["Interleukin (IL)-22", {"entities": []}], ["The nuclear factor erythroid\u2010derived two\u2010like 2\u2010antioxidant response element (Nrf2\u2010 ARE ) pathway and its downstream antioxidant enzyme heme oxygenase\u20101 ( HMOX 1 or HO \u20101) play essential roles in H 2 O 2 \u2010induced oxidative damage in human melanocytes.", {"entities": []}], ["However, the link between Nrf2 promoter polymorphisms and susceptibility to oxidative stress\u2010related diseases such as vitiligo is unknown.", {"entities": [[118, 126, "DISEASE"]]}], ["This study evaluated the association of the Nrf2 and HO \u20101 genes polymorphisms with vitiligo susceptibility.", {"entities": [[84, 92, "DISEASE"]]}], ["In this case\u2013control study of 1136 Han Chinese vitiligo patients and 1200 controls, Nrf2 (rs35652124 and rs6721961) and HO \u20101 (rs2071746) genes were genotyped by PCR \u2010restriction fragment length polymorphism analysis.", {"entities": [[47, 55, "DISEASE"]]}], ["Overall, a significantly decreased risk of vitiligo was found to be associated with Nrf2 rs35652124 CC and combined ( CT + CC ) genotypes [odds ratio ( OR ) 0.64, 95% confidence interval ( CI ) 0.50\u20130.83 and OR , 0.84, 95% CI 0.71\u20130.99, respectively], as well as among subgroups: female, onset age \u226420 and never smoker.", {"entities": [[43, 51, "DISEASE"]]}], ["We subsequently found that Nrf2 rs35652124 C allele had higher transcriptional activity in the luciferase reporter assay compared with Nrf2 rs35652124 T allele.", {"entities": []}], ["Furthermore, we investigated serum HO \u20101 activity was associated with the rs35652124 CT + CC genotype and lower in patients than in controls ( P = 0.024).", {"entities": []}], ["Logistic regression analysis showed a dose\u2013response relationship between lower vitiligo risk and increased HO \u20101 activity in rs35652124 CT + CC genotype carriers ( P trend < 0.05).", {"entities": [[79, 87, "DISEASE"]]}], ["These findings indicate that the C allele of rs35652124 located in the promoter region of Nrf2 gene is associated with protective effect on vitiligo in a Han Chinese population.", {"entities": [[140, 148, "DISEASE"]]}], ["High androgen receptor (AR) level in primary tumour predicts increased prostate cancer (PCa)-specific mortality.", {"entities": [[80, 86, "DISEASE"], [71, 86, "DISEASE"]]}], ["Furthermore, activations of the AR, PI3K, mTOR, NF\u03baB and Hedgehog (Hh) signaling pathways are involved in the fatal development of castration-resistant prostate cancer during androgen ablation therapy.", {"entities": [[161, 167, "DISEASE"], [152, 167, "DISEASE"], [42, 46, "GENE"]]}], ["MID1, a negative regulator of the tumor-suppressor PP2A, is known to promote PI3K, mTOR, NF\u03baB and Hh signaling.", {"entities": [[0, 4, "GENE"], [83, 87, "GENE"]]}], ["Here we investigate the interaction of MID1 and AR.", {"entities": [[39, 43, "GENE"]]}], ["AR and MID1 mRNA and protein levels were measured by qPCR, Western blot and immunohistochemistry.", {"entities": [[7, 11, "GENE"]]}], ["Co-immunoprecipitation followed by PCR and RNA-pull-down followed by Western blot was used to investigate protein-mRNA interaction, chromatin-immunoprecipitation followed by next-generation sequencing for identification of AR chromatin binding sites.", {"entities": []}], ["AR transcriptional activity and activity of promoter binding sites for AR were analyzed by reporter gene assays.", {"entities": []}], ["For knockdown or overexpression of proteins of interest prostate cancer cells were transfected with siRNA or expression plasmids, respectively.", {"entities": [[65, 71, "DISEASE"], [56, 71, "DISEASE"]]}], ["The microtubule-associated MID1 protein complex associates with AR mRNA via purine-rich trinucleotide repeats, expansions of which are known to correlate with ataxia and cancer.", {"entities": [[170, 176, "DISEASE"], [27, 31, "GENE"]]}], ["The level of MID1 directly correlates with the AR protein level in PCa cells.", {"entities": [[13, 17, "GENE"]]}], ["Overexpression of MID1 results in a several fold increase in AR protein and activity without major changes in mRNA-levels, whereas siRNA-triggered knockdown of MID1 mRNA reduces AR-protein levels significantly.", {"entities": [[18, 22, "GENE"], [160, 164, "GENE"], [18, 22, "GENE"], [160, 164, "GENE"]]}], ["Upregulation of AR protein by MID1 occurs via increased translation as no major changes in AR protein stability could be observed.", {"entities": [[30, 34, "GENE"]]}], ["AR on the other hand, regulates MID1 via several functional AR binding sites in the MID1 gene, and, in the presence of androgens, exerts a negative feedback loop on MID1 transcription.", {"entities": [[32, 36, "GENE"], [84, 88, "GENE"], [165, 169, "GENE"], [32, 36, "GENE"], [84, 88, "GENE"], [165, 169, "GENE"], [32, 36, "GENE"], [84, 88, "GENE"], [165, 169, "GENE"]]}], ["Thus, androgen withdrawal increases MID1 and concomitantly AR-protein levels.", {"entities": [[36, 40, "GENE"]]}], ["In line with this, MID1 is significantly over-expressed in PCa in a stage-dependent manner.", {"entities": [[19, 23, "GENE"]]}], ["Promotion of AR, in addition to enhancement of the Akt-, NF\u03baB-, and Hh-pathways by sustained MID1-upregulation during androgen deprivation therapy provides a powerful proliferative scenario for PCa progression into castration resistance.", {"entities": []}], ["Thus MID1 represents a novel, multi-faceted player in PCa and a promising target to treat castration resistant prostate cancer.", {"entities": [[120, 126, "DISEASE"], [111, 126, "DISEASE"], [5, 9, "GENE"]]}], ["Voltage-gated Kv1.3 and Ca Potassium channels are essential for modulating T-cell functions.", {"entities": []}], ["Here, by characterizing rat models and analysing human T cells, the authors identify differential requirements of two potassium channel proteins, Kv1.3 and KCa3.1, for the induction of conventional versus autoreactive T-cell responses.", {"entities": []}], ["Inadequate inhaled aerosol device demonstration and technique by health care professionals can lead to poor disease control.", {"entities": []}], ["The aims of this study were to develop and validate Knowledge of Aerosol Tool (KAT) among registered and unregistered pharmacists and to assess the pharmaceutical care practice among registered pharmacists.", {"entities": []}], ["The KAT and pharmaceutical care practice questionnaires were developed and modified from previous reports, then an observational cross-sectional study with a convenience sample size of 340 was carried out among registered and unregistered pharmacists.", {"entities": []}], ["The validation process included face validity and reliability, and item analysis was carried out.", {"entities": []}], ["The results showed good face validity and reliability with Cronbach\u2019s alpha test and Pearson\u2019s correlation coefficient for test\u2013retest of 0.637 and 0.440, respectively.", {"entities": []}], ["The KAT item difficulty index for most items was between 0.130 and 0.667.", {"entities": []}], ["The total KAT scores for registered and unregistered pharmacists were 10.13\u00b13.152 and 8.29\u00b12.930, respectively, which revealed inadequate pharmacist knowledge of inhaled aerosol device technique and therapies.", {"entities": []}], ["In addition, only 38.38% of the total sample was found to have a high KAT level score.", {"entities": []}], ["The results showed higher KAT scores among males, pharmacists with a family history of respiratory disease, and pharmacists with a master\u2019s degree.", {"entities": []}], ["For the registered pharmacists, there were positive correlations between the total KAT score and the total pharmaceutical care practice score and the average number of patients with a respiratory disease seen by the pharmacist weekly, respectively.", {"entities": []}], ["Moreover, there was a positive correlation between the total KAT score and its aerosol administration subscale with pharmacotherapy care and comorbid disease management practice care.", {"entities": []}], ["The KAT showed good validity and reliability, hence, it can be used for training or educational purposes.", {"entities": []}], ["This study showed that professional knowledge and pharmaceutical care are a major concern in Iraq.", {"entities": []}], ["KAT implementation depends on the whole educational process from undergraduate study to residence training.", {"entities": []}], ["Methamphetamine (MA) use during pregnancy is associated with many pregnancy complications, including preterm birth, small for gestational age, preeclampsia, and abruption.", {"entities": []}], ["Hawaii has lead the nation in MA use for many years, yet prior to 2007, did not have a comprehensive plan to care for pregnant substance-using women.", {"entities": []}], ["In 2006, the Hawaii State Legislature funded a pilot perinatal addiction clinic.", {"entities": []}], ["The Perinatal Addiction Treatment Clinic of Hawaii was built on a harm-reduction model, encompassing perinatal care, transportation, child-care, social services, family planning, motivational incentives, and addiction medicine.", {"entities": []}], ["We present the implementation model and results from our first one hundred three infants (103) seen over 3 years of operation of the program.", {"entities": []}], ["Referrals came from community health centers, hospitals, addiction treatment facilities, private physician offices, homeless outreach services and self-referral through word-of-mouth and bus ads.", {"entities": []}], ["Data to describe sample characteristics and outcome was obtained prospectively and retrospectively from chart abstraction and delivery data.", {"entities": []}], ["Drug use data was obtained from the women's self-report and random urine toxicology during the pregnancy, as well as urine toxicology at the time of birth on mothers, and urine and meconium toxicology on the infants.", {"entities": []}], ["Post-partum depression was measured in mothers with the Edinburgh Post-Partum depression scale.", {"entities": []}], ["Data from Path clinic patients were compared with a representative cohort of women delivering at Kapiolani Medical Center for Women and Children during the same time frame, who were enrolled in another study of pregnancy outcomes.", {"entities": []}], ["Ethical approval for this study was obtained through the University of Hawaii Committee for Human Studies.", {"entities": []}], ["Between April 2007 and August 2010, 213 women with a past or present history of addiction were seen, 132 were pregnant and 97 delivered during that time.", {"entities": []}], ["103 live-born infants were delivered.", {"entities": []}], ["There were 3 first-trimester Spontaneous Abortions, two 28-week intrauterine fetal deaths, and two sets of twins and 4 repeat pregnancies.", {"entities": []}], ["Over 50% of the women had lost custody of previous children due to substance use.", {"entities": []}], ["The majority of women who delivered used methamphetamine (86%), either in the year before pregnancy or during pregnancy.", {"entities": []}], ["Other drugs include marijuana (59.8%), cocaine (33%), opiates (9.6%), and alcohol (15.2%).", {"entities": []}], ["Of the women served, 85% smoked cigarettes upon enrollment.", {"entities": []}], ["Of the 97 women delivered during this period, all but 4 (96%) had negative urine toxicology at the time of delivery.", {"entities": []}], ["Of the 103 infants, 13 (12.6%) were born preterm, equal to the state and national average, despite having many risk factors for prematurity, including poverty, poor diet, smoking and polysubstance use.", {"entities": []}], ["Overwhelmingly, the women are parenting their children, > 90% retained custody at 8 weeks.", {"entities": []}], ["Long-term follow-up showed that women who maintained custody chose long-acting contraceptive methods; while those who lost custody had a very high (> 50%) repeat pregnancy rate at 9 months post delivery.", {"entities": []}], ["Methamphetamine use during pregnancy doesn't exist is isolation.", {"entities": []}], ["It is often combined with a multitude of other adverse circumstances, including poverty, interpersonal violence, psychiatric comorbidity, polysubstance use, nutritional deficiencies, inadequate health care and stressful life experiences.", {"entities": []}], ["A comprehensive harm reduction model of perinatal care, which aims to ameliorate some of these difficulties for substance-using women without mandating abstinence, provides exceptional birth outcomes and can be implemented with limited resources.", {"entities": []}], ["Epidemiological studies have shown that ambient air pollution is closely associated with increased respiratory inflammation and decreased lung function.", {"entities": []}], ["Particulate matters (PMs) are major components of air pollution that damages lung cells.", {"entities": []}], ["However, the mechanisms remain to be elucidated.", {"entities": []}], ["This study examines the effects of PMs on intercellular adhesion molecule-1 (ICAM-1) expression and the related mechanisms in vitro and in vivo.", {"entities": []}], ["The cytotoxicity, reactive oxygen species (ROS) generation, and monocyte adherence to A549 cells were more severely affected by treatment with O-PMs (organic solvent-extractable fraction of SRM1649b) than with W-PMs (water-soluble fraction of SRM1649b).", {"entities": []}], ["We observed a significant increase in ICAM-1 expression by O-PMs, but not W-PMs.", {"entities": []}], ["O-PMs also induced the phosphorylation of AKT, p65, and STAT3.", {"entities": [[56, 61, "GENE"]]}], ["Pretreating A549 cells with N-acetyl cysteine (NAC), an antioxidant, attenuated O-PMs-induced ROS generation, the phosphorylation of the mentioned kinases, and the expression of ICAM-1.", {"entities": []}], ["Furthermore, an AKT inhibitor (LY294002), NF-\u03baB inhibitor (BAY11\u20137082), and STAT3 inhibitor (Stattic) significantly down-regulated O-PMs-induced ICAM-1 expression as well as the adhesion of U937 cells to epithelial cells.", {"entities": [[76, 81, "GENE"]]}], ["Interleukin-6 (IL-6) was the most significantly changed cytokine in O-PMs-treated A549 cells according to the analysis of the cytokine antibody array.", {"entities": []}], ["The IL-6 receptor inhibitor tocilizumab (TCZ) and small interfering RNA for IL-6 significantly reduced ICAM-1 secretion and expression as well as the reduction of the AKT, p65, and STAT3 phosphorylation in O-PMs-treated A549 cells.", {"entities": [[181, 186, "GENE"]]}], ["In addition, the intratracheal instillation of PMs significantly increased the levels of the ICAM-1 and IL-6 in lung tissues and plasma in WT mice, but not in IL-6 knockout mice.", {"entities": []}], ["Pre-administration of NAC attenuated those PMs-induced adverse effects in WT mice.", {"entities": []}], ["Furthermore, patients with chronic obstructive pulmonary disease (COPD) had higher plasma levels of ICAM-1 and IL-6 compared to healthy subjects.", {"entities": [[27, 64, "DISEASE"]]}], ["These results suggest that PMs increase ICAM-1 expression in pulmonary epithelial cells in vitro and in vivo through the IL-6/AKT/STAT3/NF-\u03baB signaling pathway.", {"entities": []}], ["The online version of this article (10.1186/s12989-018-0240-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Concurrent helminth infections have been suggested to be associated with protection against cerebral malaria in humans, a condition characterised by systemic inflammation.", {"entities": [[92, 108, "DISEASE"], [101, 108, "DISEASE"]]}], ["Here we show that a concurrent chronic gastro-intestinal nematode infection does not alter the course of murine cerebral malaria.", {"entities": [[112, 128, "DISEASE"], [121, 128, "DISEASE"]]}], ["Mice infected with Heligmosomoides polygyrus , and co-infected with Plasmodium berghei ANKA 14 days later, developed malaria parasitemia, weight loss and anemia, at the same rate as mice without nematode infection.", {"entities": [[117, 124, "DISEASE"], [154, 160, "DISEASE"]]}], ["Both groups developed cerebral malaria around the same time point.", {"entities": [[22, 38, "DISEASE"], [31, 38, "DISEASE"]]}], ["The data suggest that a chronic helminth infection does not affect the development of cerebral malaria in a murine model.", {"entities": [[86, 102, "DISEASE"], [95, 102, "DISEASE"]]}], ["Experimental and epidemiological studies have reported associations between air pollution exposure, in particular related to vehicle exhaust, and cardiovascular disease.", {"entities": []}], ["A potential pathophysiological pathway is pollution-induced pulmonary oxidative stress, with secondary systemic inflammation.", {"entities": []}], ["Genetic polymorphisms in genes implicated in oxidative stress, such as GSTP1 , GSTT1 and GSTCD , may contribute to determining individual susceptibility to air pollution as a promoter of coronary vulnerability.", {"entities": [[71, 76, "GENE"], [79, 84, "GENE"], [89, 94, "GENE"]]}], ["We aimed to investigate effects of long-term traffic-related air pollution exposure, as well as variants in GSTP1 , GSTT1 and GSTCD , on risk of acute myocardial infarction (AMI) and hypertension.", {"entities": [[183, 195, "DISEASE"], [151, 172, "DISEASE"], [145, 172, "DISEASE"], [108, 113, "GENE"], [116, 121, "GENE"], [126, 131, "GENE"]]}], ["In addition, we studied whether air pollution effects were modified by the investigated genetic variants.", {"entities": []}], ["Genotype data at 7 single nucleotide polymorphisms (SNPs) in the GSTP1 gene, and one in each of the GSTT1 and GSTCD genes, as well as air pollution exposure estimates, were available for 119 AMI cases and 1310 randomly selected population controls.", {"entities": [[65, 70, "GENE"], [100, 105, "GENE"], [110, 115, "GENE"]]}], ["Population control individuals with systolic blood pressure \u2265140 mmHg, diastolic blood pressure \u226590 mmHg or on daily antihypertensive medication were defined as hypertensive (n\u200a=\u200a468).", {"entities": []}], ["Individual air pollution exposure levels were modeled as annual means of NO 2 (marker of vehicle exhaust pollutants) using central monitoring data and dispersion models, linking to participants' home addresses.", {"entities": []}], ["Air pollution was significantly associated with risk of AMI: OR 1.78 (95%CI 1.04\u20133.03) per 10 \u00b5g/m 2 exposure.", {"entities": []}], ["Three GSTP1 SNPs were significantly associated with hypertension.", {"entities": [[52, 64, "DISEASE"], [6, 11, "GENE"]]}], ["The effect of air pollution on risk of AMI varied by genotype strata, although the suggested interaction was not significant.", {"entities": []}], ["We saw no obvious interaction between genetic variants in the GST genes and air pollution exposure for hypertension.", {"entities": [[103, 115, "DISEASE"]]}], ["Air pollution exposure entails an increased risk of AMI, and this risk differed over genotype strata for variants in the GSTP1 , GSTT1 and GSTCD genes, albeit not statistically-significantly.", {"entities": [[121, 126, "GENE"], [129, 134, "GENE"], [139, 144, "GENE"]]}], ["Interferon-\u03b3 (IFN-\u03b3), a critical inflammatory cytokine, is primarily produced by T helper 1 (Th1) cells and accelerates the pathogenesis of inflammatory colitis.", {"entities": []}], ["Pharmacological suppression of IFN-\u03b3 production attenuates dysregulated inflammatory responses and may be beneficial for treating inflammatory disease.", {"entities": []}], ["In this study, we aimed to discover potent anti-inflammatory compounds that suppress IFN-\u03b3 production and found that the novel benzoxazole derivatives, 2-((3,4-dichlorophenyl) amino) benzo[d]xazol-5-ol (DCPAB) and 2-((3,4-hydroxyphenyl) amino) benzo[d]xazol-5-ol (HPAB), suppressed IFN-\u03b3 production by T cells.", {"entities": []}], ["Treatment of CD4+ T cells with DCPAB and HPAB selectively inhibited Th1 cell development, and DCPAB more potently suppressed IFN-\u03b3 than HPAB did.", {"entities": []}], ["Interestingly, DCPAB and HPAB significantly suppressed the expression of T-box containing protein expressed in T cells (T-bet) that activates IFN-\u03b3 gene transcription.", {"entities": []}], ["DCPAB additionally suppressed transcriptional activity of T-bet on IFN-\u03b3 gene promoter, whereas HPAB had no effect on T-bet activity.", {"entities": []}], ["IFN-\u03b3 suppressive activity of DCPAB and HPAB was impaired in the absence of T-bet but was retrieved by the restoration of T-bet in T-bet-deficient T cells.", {"entities": []}], ["Furthermore, DCPAB and HPAB attenuated inflammatory colitis development that was induced by CD4+ T cells in vivo .", {"entities": []}], ["We suggest that the novel benzoxazole derivatives, DCPAB and HPAB, may have therapeutic effects on inflammatory colitis.", {"entities": []}], ["Patient empowerment is viewed by policy makers and health care practitioners as a mechanism to help patients with long-term conditions better manage their health and achieve better outcomes.", {"entities": []}], ["However, assessing the role of empowerment is dependent on effective measures of empowerment.", {"entities": []}], ["Although many measures of empowerment exist, no measure has been developed specifically for patients with long-term conditions in the primary care setting.", {"entities": []}], ["This study presents preliminary data on the development and validation of such a measure.", {"entities": []}], ["We conducted two empirical studies.", {"entities": []}], ["Study one was an interview study to understand empowerment from the perspective of patients living with long-term conditions.", {"entities": []}], ["Qualitative analysis identified dimensions of empowerment, and the qualitative data were used to generate items relating to these dimensions.", {"entities": []}], ["Study two was a cross-sectional postal study involving patients with different types of long-term conditions recruited from general practices.", {"entities": []}], ["The survey was conducted to test and validate our new measure of empowerment.", {"entities": []}], ["Factor analysis and regression were performed to test scale structure, internal consistency and construct validity.", {"entities": []}], ["Sixteen predominately elderly patients with different types of long-term conditions described empowerment in terms of 5 dimensions (identity, knowledge and understanding, personal control, personal decision-making, and enabling other patients).", {"entities": []}], ["One hundred and ninety seven survey responses were received from mainly older white females, with relatively low levels of formal education, with the majority retired from paid work.", {"entities": []}], ["Almost half of the sample reported cardiovascular, joint or diabetes long-term conditions.", {"entities": []}], ["Factor analysis identified a three factor solution (positive attitude and sense of control, knowledge and confidence in decision making and enabling others), although the structure lacked clarity.", {"entities": []}], ["A total empowerment score across all items showed acceptable levels of internal consistency and relationships with other measures were generally supportive of its construct validity.", {"entities": []}], ["Initial analyses suggest that the new empowerment measure meets basic psychometric criteria.", {"entities": []}], ["Reasons concerning the failure to confirm the hypothesized factor structure are discussed alongside further developments of the scale.", {"entities": []}], ["Online health discussion forums are used by different patient groups for sharing advice and information.", {"entities": []}], ["Chronic cough is a common problem, and people with chronic cough use online health forums alongside formal medical therapies.", {"entities": []}], ["The objective of this study was to assess how chronic cough sufferers use online health forums, including the treatment advice they share with one another and the possible clinical uses of online forums in chronic cough.", {"entities": []}], ["Three open-access health forums were searched for threads related to chronic cough.", {"entities": []}], ["Identified threads were screened against inclusion and exclusion criteria adapted from the British Thoracic Society (BTS) Guidelines related to chronic cough diagnosis.", {"entities": []}], ["Included data were subjected to qualitative thematic analysis.", {"entities": []}], ["All study data were cross-validated by a second author and discrepancies were resolved.", {"entities": []}], ["In total, 96 threads were included in the analysis, consisting of posts by 223 forum users.", {"entities": []}], ["Three main themes were identified: the effect of chronic cough on the lives of patients, the treatment advice shared between users, and the provision of support within forums.", {"entities": []}], ["Chronic cough symptoms had impacts on multiple aspects of patients\u2019 health and well-being.", {"entities": []}], ["To try and combat these issues, forum users suggested a variety of treatments to one another, ranging from mainstream traditional therapies to odd alternative remedies.", {"entities": []}], ["The provision of support and empathy were also prominent themes in discussion threads.", {"entities": []}], ["Online forums themselves may provide increasing benefit to users through the addition of a moderator.", {"entities": []}], ["Royal jelly is a widely ingested supplement for health, but its effects on humans are not well known.", {"entities": []}], ["The objective was to evaluate the effects of long-term royal jelly ingestion on humans.", {"entities": []}], ["We conducted a randomized placebo-controlled, double-blind trial.", {"entities": []}], ["A total of 61 healthy volunteers aged 42-83 years were enrolled and were randomly divided into a royal jelly group (n = 31) and a control group (n = 30).", {"entities": []}], ["Three thousand mg of royal jelly (RJ) or a placebo in 100 ml liquid/day were ingested for 6 months.", {"entities": []}], ["The primary outcomes were changes in anthropometric measurements and biochemical indexes from baseline to 6 months after intervention.", {"entities": []}], ["Thirty subjects in the RJ group and 26 in the control group were included in the analysis of endpoints.", {"entities": []}], ["In an adjusted mean change of the variables from the baseline, significant differences between the two groups could be found in red blood cell counts (+0.16x10 P = 0.0134), hematocrit (+0.9% vs. -0.8%, P = 0.0251), log (fasting plasma glucose) (+0.01 \u00b1 0.01 log mg/dL vs. +0.05 \u00b1 0.01 log mg/dL, P = 0.0297), log (insulinogenic index) (+0.25 vs. -0.13, P = 0.0319), log dehydroepiandrosterone sulfate (DHEA-S) (+0.08 log \u03bcg/dL vs. +0.20 log \u03bcg/dL, P = 0.0483), log testosterone (T) (+0.12 \u00b1 0.04 log ng/mL vs. -0.02 \u00b1 0.05 log ng/mL, P = 0.0416), log T/DHEA-S ratio (+0.05 \u00b1 0.05 vs. -0.23 \u00b1 0.59, P = 0.0015), and in one of the SF-36 subscale scores, mental health (MH) (+4 vs. -7, P = 0.0276).", {"entities": []}], ["Six-month ingestion of RJ in humans improved erythropoiesis, glucose tolerance and mental health.", {"entities": []}], ["Acceleration of conversion from DHEA-S to T by RJ may have been observed among these favorable effects.", {"entities": []}], ["Use of helium-oxygen (He/O 2 ) mixtures in critically ill patients is supported by a reliable and well understood theoretical rationale and by numerous experimental observations.", {"entities": []}], ["Breathing He/O 2 can benefit critically ill patients with severe respiratory compromise mainly by reducing airway resistance in obstructive syndromes such as acute asthma and decompensated chronic obstructive pulmonary disease.", {"entities": [[189, 226, "DISEASE"], [164, 170, "DISEASE"]]}], ["However, the benefit from He/O 2 in terms of respiratory mechanics diminishes rapidly with increasing oxygen concentration in the gaseous mixture.", {"entities": []}], ["Safe use of He/O 2 in the intensive care unit requires specific equipment and supervision by adequately experienced personnel.", {"entities": []}], ["The available clinical data on inhaled He/O 2 mixtures are insufficient to prove that this therapy has benefit with respect to outcome variables.", {"entities": []}], ["For these reasons, He/O 2 is not currently a standard of care in critically ill patients with acute obstructive syndromes, apart from in some, well defined situations.", {"entities": []}], ["Its role in critically ill patients must be more precisely defined if we are to identify those patients who could benefit from this therapeutic approach.", {"entities": []}], ["Smoking is the main risk factor for chronic obstructive pulmonary disease (COPD).", {"entities": [[36, 73, "DISEASE"]]}], ["Women with COPD who smoke experienced a higher risk of hospitalization and worse decline of lung function.", {"entities": []}], ["Yet the mechanisms of these gender-related differences in clinical presentations in COPD remain unknown.", {"entities": []}], ["The aim of our study is to identify proteins and molecular pathways associated with COPD pathogenesis, with emphasis on elucidating molecular gender difference.", {"entities": []}], ["We employed shotgun isobaric tags for relative and absolute quantitation (iTRAQ) proteome analyses of bronchoalveolar lavage (BAL) cells from smokers with normal lung function ( n \u2009=\u200925) and early stage COPD patients ( n \u2009=\u200918).", {"entities": []}], ["Multivariate modeling, pathway enrichment analysis, and correlation with clinical characteristics were performed to identify specific proteins and pathways of interest.", {"entities": []}], ["More pronounced alterations both at the protein- and pathway- levels were observed in female COPD patients, involving dysregulation of the Fc\u03b3R-mediated phagocytosis-lysosomal axis and increase in oxidative stress.", {"entities": []}], ["Alterations in pathways of the phagocytosis-lysosomal axis associated with a female-dominated COPD phenotype correlated well with specific clinical features: Fc\u03b3R-mediated phagocytosis correlated with FEV 1 /FVC, the lysosomal pathway correlated with CT\u2009<\u2009\u2212950 Hounsfield Units (HU), and regulation of actin cytoskeleton correlated with FEV 1 and FEV1/FVC in female COPD patients.", {"entities": [[201, 204, "GENE"], [337, 340, "GENE"], [201, 204, "GENE"], [337, 340, "GENE"]]}], ["Alterations observed in the corresponding male cohort were minor.", {"entities": []}], ["The identified molecular pathways suggest dysregulation of several phagocytosis-related pathways in BAL cells in female COPD patients, with correlation to both the level of obstruction (FEV 1 /FVC) and disease severity (FEV 1 ) as well as emphysema (CT\u2009<\u2009\u2212950 HU) in women.", {"entities": [[186, 189, "GENE"], [220, 223, "GENE"], [186, 189, "GENE"], [220, 223, "GENE"]]}], [": NCT02627872 , retrospectively registered on December 9, 2015.", {"entities": []}], ["The online version of this article (10.1186/s12931-017-0699-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Non-melanoma skin cancer (NMSC) is an important cause of morbidity and long-term mortality in organ transplant recipients receiving immunosuppressive drugs such as azathioprine and cyclosporin, often combined with adrenocortical steroids (glucocorticoids).", {"entities": [[13, 24, "DISEASE"], [4, 12, "DISEASE"], [18, 24, "DISEASE"]]}], ["At lower doses, glucocorticoids alone are prescribed for other conditions including musculoskeletal, connective tissue and respiratory disorders.", {"entities": []}], ["Presently, it is unknown whether patients taking glucocorticoids are at an increased risk of skin malignances.", {"entities": []}], ["In a population-based case-control study in New Hampshire, USA, we compared use of glucocorticoids in 592 basal cell carcinoma (BCC) and 281 squamous cell carcinoma (SCC) cases and in 532 age and gender matched controls; neither cases nor controls had a history of organ transplantation.", {"entities": [[117, 126, "DISEASE"], [155, 164, "DISEASE"], [106, 126, "DISEASE"], [141, 164, "DISEASE"]]}], ["Participants underwent a structured personal interview regarding history of medication use and skin cancer risk factors.", {"entities": [[95, 106, "DISEASE"], [100, 106, "DISEASE"]]}], ["We used unconditional logistic regression analysis to compute odds ratios associated with glucocorticoid use for 1 month or longer while controlling for potential confounding factors.", {"entities": []}], ["Risk of SCC was increased among users of oral glucocorticoids (adjusted odds ratio = 2.31; 95% CI = 1.27, 4.18), and risk of BCC was elevated modestly (adjusted odds ratio = 1.49; 95% CI = 0.90, 2.47).", {"entities": []}], ["In contrast, risk of both SCC and BCC were unrelated to use of inhaled steroids.", {"entities": []}], ["Our data suggest that use of oral glucocorticoids may increase risk of NMSC, and SCC in particular, among patients other than organ transplant recipients.", {"entities": []}], ["We hypothesize that immunosuppression induced by oral glucocorticoids may allow these cancers to emerge from immunosurveillance.", {"entities": []}], ["\u00a9 2001 Cancer Research Campaign http://www.bjcancer.com", {"entities": [[7, 13, "DISEASE"]]}], ["To adapt a tailored short message service (SMS) text message smoking cessation intervention (MiQuit) for use without active health professional endorsement in routine antenatal care settings, to estimate \u2018real-world\u2019 uptake and test the feasibility of its use.", {"entities": [[43, 46, "GENE"]]}], ["Single-site service evaluation.", {"entities": []}], ["A Nottinghamshire (UK) antenatal clinic.", {"entities": []}], ["Pregnant women accessing the antenatal clinic (N=1750) over 6\u2005months.", {"entities": []}], ["A single-sheet A5 leaflet provided in the women's maternity notes folder describing the MiQuit text service.", {"entities": []}], ["Similar materials were left on clinic desks and noticeboards.", {"entities": []}], ["MiQuit activation requests and system interactions were logged for two time frames: 6\u2005months (strict) and 8\u2005months (extended).", {"entities": []}], ["Local hospital data were used to estimate the denominator of pregnant smokers exposed to the materials.", {"entities": []}], ["During the strict and extended time frames, 13 and 25 activation requests were received, representing 3% (95% CI 2% to 5%) and 4% (95% CI 3% to 6%) of estimated smokers, respectively.", {"entities": []}], ["Only 11 (44%) of the 25 requesting activation sent a correctly formatted initiation text.", {"entities": []}], ["Of those activating MiQuit, and invited to complete tailoring questions (used to tailor support), 6 (67%) completed all 12 questions by text or website and 5 (56%) texted a quit date to the system.", {"entities": []}], ["Of the 11 activating MiQuit, 5 (45%, 95% CI 21% to 72%) stopped the programme prematurely.", {"entities": []}], ["A low-intensity, cheap cessation intervention promoted at very low cost, resulted in a small but potentially impactful uptake rate by pregnant smokers.", {"entities": []}], ["Exposure to particulate matter (PM 2.5\u201310 ), including diesel exhaust particles (DEP) has been reported to induce lung injury and exacerbation of asthma and chronic obstructive pulmonary disease.", {"entities": [[157, 194, "DISEASE"], [146, 152, "DISEASE"]]}], ["Alveolar macrophages play a major role in the lung\u2019s response to inhaled particles and therefore, are a primary target for PM 2.5\u201310 effect.", {"entities": []}], ["The molecular and cellular events underlying DEP-induced toxicity in the lung, however, remain unclear.", {"entities": []}], ["To determine the effect of DEP on alveolar macrophages, RAW 264.7 cells were grown in RPMI 1640 with supplements until confluency.", {"entities": []}], ["RAW 264.7 cultures were exposed to Hank\u2019s buffered saline solution (vehicle), vehicle containing an NF-\u03baB inhibitor, BAY11-7082 (25\u03bcM with 11/2 hr pre-incubation), or vehicle containing DEP (250\u03bcg/ml) in the presence or absence of BAY11-7082 (25\u03bcM with 11/2 hr pre-incubation) for 4 hr and TNF-\u03b1 release was determined by enzyme-linked immunosorbent assay and confirmed by western blots.", {"entities": [[144, 146, "GENE"], [258, 260, "GENE"], [283, 285, "GENE"], [144, 146, "GENE"], [258, 260, "GENE"], [283, 285, "GENE"], [144, 146, "GENE"], [258, 260, "GENE"], [283, 285, "GENE"]]}], ["RAW 264.7 apoptotic response was determined by DNA fragmentation assays.", {"entities": []}], ["U937 cells treated with campothecin (4 \u03bcg/ml \u00d7 3 hr), an apoptosis-inducing agent, were used as positive control.", {"entities": [[49, 51, "GENE"]]}], ["We report that exposure to the carbonaceous core of DEP induces significant release of TNF-\u03b1 in a concentration-dependent fashion (31 \u00b1 4 pg/ml, n = 4, p = 0.08; 162 \u00b1 23 pg/ml, n = 4, p < 0.05; 313 \u00b1 31 pg/ml, n = 4, p < 0.05 at 25, 100, and 250 \u03bcg/ml, respectively).", {"entities": []}], ["DEP exposure, however, failed to induce any apoptotic response in RAW 264.7 cells.", {"entities": []}], ["Moreover, inhibition of NF-\u03baB binding activity has resulted in DEP-induced apoptotic response in alveolar macrophages, as demonstrated by the NF-\u03baB inhibitor, BAY11-7082 studies.", {"entities": []}], ["The results of the present study indicate that DEP induce the release of TNF-\u03b1 in alveolar macrophages, a primary target for inhaled particles effect.", {"entities": []}], ["DEP-induced TNF-\u03b1 gene expression is regulated at the transcriptional level by NF-\u03baB.", {"entities": []}], ["Furthermore, DEP-induced increase in NF-\u03baB-DNA binding activity appears to protect against apoptosis.", {"entities": []}], ["Interleukin-37 (IL-37) has been known to play an immunosuppressive role in various inflammatory disorders, but whether it participates in the regulation of pathogenesis of ankylosing spondylitis (AS) has not been investigated.", {"entities": [[183, 194, "DISEASE"], [172, 194, "DISEASE"]]}], ["Here, we examined the serum levels of IL-37 and its clinical association in AS, and explored the anti-inflammatory effects of IL-37 on peripheral blood mononuclear cells (PBMCs) from AS patients.", {"entities": []}], ["The mRNA levels of IL-37, TNF-\u03b1, IL-6, IL-17, and IL-23 in PBMCs and their serum concentrations from 46 AS patients were examined by real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunoassay (ELISA), respectively.", {"entities": []}], ["The correlations between serum IL-37 levels with disease activity, laboratory values and pro-inflammatory cytokines in AS were analyzed by Spearman correlation test.", {"entities": []}], ["PBMCs from 46 AS patients were stimulated with recombinant IL-37 protein, expressions of TNF-\u03b1, IL-6, IL-17 and IL-23 were determined by RT-PCR and ELISA.", {"entities": []}], ["Compared to healthy controls (HC), AS patients and active AS patients showed higher levels of IL-37 in PBMCs and serum respectively.", {"entities": []}], ["Strikingly, serum IL-37 levels were higher in AS patients with osteoporosis than those without.", {"entities": [[63, 75, "DISEASE"]]}], ["Serum levels of IL-37 were correlated with laboratory values as well as TNF-\u03b1, IL-6 and IL-17, but not IL-23 in patients with AS.", {"entities": []}], ["The productions of pro-inflammatory cytokines such as TNF-\u03b1, IL-6, IL-17, IL-23 in PBMCs from AS patients were obviously attenuated after recombinant IL-37 stimulation, but not in the HC.", {"entities": []}], ["The higher levels of IL-37 were found in AS patients, which were correlated with disease activity and AS related pro-inflammatory cytokines.", {"entities": []}], ["More importantly, IL-37 inhibits the expressions of the pro-inflammatory cytokines from PBMCs in AS patients, indicating the potential anti-inflammatory role of IL-37 in AS.", {"entities": []}], ["The online version of this article (doi:10.1186/s12967-015-0394-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Perfluorodecanoic acid (PFDA), a perfluorinated carboxylic acid, presents in the environment and accumulates in human blood and organs, but its association with tumor promotion are not clear.", {"entities": []}], ["Given that inflammation plays a significant role in the development of gastric malignancies, we evaluated the effects of PFDA on activation of the inflammasome and inflammation regulation in the gastric cell line AGS.", {"entities": []}], ["When added to cell cultures, PFDA significantly stimulated IL-1\u03b2 and IL18 secretion and their mRNA levels compared with control cells.", {"entities": [[69, 73, "GENE"]]}], ["By RT-PCR and western-blot we found that up-regulation of NLRP3 were associated with promotion of IL-1\u03b2 and IL-18 production.", {"entities": [[58, 63, "GENE"]]}], ["Then expression variation of cIAP1/2, c-Rel and p52 were analyzed, the results demonstrated raised mRNA expression in all the tested genes concomitant with enhanced inflammasome activity after exposure to PFDA.", {"entities": []}], ["Assays with cIAP2 siRNA and NF\u03baB reporter provided additional evidence that these genes were involved in PFDA-induced inflammasome assembly.", {"entities": []}], ["Furthermore, increased secretion of IL-1\u03b2 and IL-18 were detected in stomach of PFDA-treated mice, disorganized alignment of epithelial cells and inflammatory cell infiltration were also observed in the stomach tissues upon PFDA treatment.", {"entities": []}], ["This study reports for the first time that PFDA regulates inflammasome assembly in human cells and mice tissues.", {"entities": []}], ["Substance use is a globally devastating social problem.", {"entities": []}], ["Early maladaptive schemas (EMSs) are inefficient mechanisms leading directly or indirectly to psychological distress.", {"entities": []}], ["The current study aimed to assess the role of EMSs in predicting opioid use disorder.", {"entities": []}], ["The cross-sectional study was conducted in 2013 in Bojnurd at northeast of Iran on 60 male opioid users who received Methadone Maintenance Treatment (MMT) and 60 control males.", {"entities": []}], ["The opioid users were selected randomly from MMT clinics and control subjects were selected and matched with opioid users using demographic variables.", {"entities": []}], ["The subjects completed the Young Schema Questionnaire-Short Form (YSQ-SF).", {"entities": []}], ["Except for SS (self-sacrifice), EG (entitlement/grandiosity), US (unrelenting standards), and FA (Failure to Achieve), the mean of other maladaptive schemas in the opioid user group were significantly higher than that of the control group, adjusted for multiple comparisons.", {"entities": []}], ["Multivariate analysis of variance (MANOVA) indicated significant differences in maladaptive schemas between the two groups.", {"entities": []}], ["Logistic regression identified that Emotional Deprivation, Mistrust/Abuse, and Unrelenting Standards can predict opioid use.", {"entities": []}], ["As a result, the risk of opioid-related disorders in people with higher YSQ-SF scores in these schemas is higher.", {"entities": []}], ["The findings conclude that the existence of underlying EMS may constitute a vulnerability factor for developing opioid use disorders later on in life.", {"entities": []}], ["Provided the vast amount of scientific literature in evidence-based treatments focusing on EMSs, maladaptive schemas and related core beliefs can be detected and treated in adolescence to prevent the enactment of the schema and psychological distress likely to induce opioid use.", {"entities": []}], ["Prophylactic treatment is an important but under-utilised option for the management of migraine.", {"entities": [[87, 95, "DISEASE"]]}], ["Patients and physicians appear to have reservations about initiating this treatment option.", {"entities": []}], ["This paper explores the opinions, motives and expectations of patients regarding prophylactic migraine therapy.", {"entities": [[94, 102, "DISEASE"]]}], ["A qualitative focus group study in general practice in the Netherlands with twenty patients recruited from urban and rural general practices.", {"entities": []}], ["Three focus group meetings were held with 6-7 migraine patients per group (2 female and 1 male group).", {"entities": [[46, 54, "DISEASE"]]}], ["All participants were migraine patients according to the IHS (International Headache Society); 9 had experience with prophylactic medication.", {"entities": [[22, 30, "DISEASE"]]}], ["The focus group meetings were analysed using a general thematic analysis.", {"entities": []}], ["For patients several distinguished factors count when making a decision on prophylactic treatment.", {"entities": []}], ["The decision of a patient on prophylactic medication is depending on experience and perspectives, grouped into five categories, namely the context of being active or passive in taking the initiative to start prophylaxis; assessing the advantages and disadvantages of prophylaxis; satisfaction with current migraine treatment; the relationship with the physician and the feeling to be heard; and previous steps taken to prevent migraine.", {"entities": [[306, 314, "DISEASE"], [427, 435, "DISEASE"]]}], ["In addition to the functional impact of migraine, the decision to start prophylaxis is based on a complex of considerations from the patient's perspective (e.g.", {"entities": [[40, 48, "DISEASE"]]}], ["perceived burden of migraine, expected benefits or disadvantages, interaction with relatives, colleagues and physician).", {"entities": [[20, 28, "DISEASE"]]}], ["Therefore, when advising migraine patients about prophylaxis, their opinions should be taken into account.", {"entities": [[25, 33, "DISEASE"]]}], ["Patients need to be open to advice and information and intervention have to be offered at an appropriate moment in the course of migraine.", {"entities": [[129, 137, "DISEASE"]]}], ["The effect of various phospholipase A2 and protein kinase inhibitors on the arachidonic acid liberation in bovine platelets induced by the protein kinase activator 12-O-tetradecanoylphorbol-13-acetate (TPA) was studied.", {"entities": []}], ["TPA stimulates arachidonic acid release mainly by activating group IV cytosolic PLA2 (cPLA2), since inhibitors of this enzyme markedly inhibited arachidonic acid formation.", {"entities": []}], ["However, group VI Ca2+-independent PLA2 (iPLA2) seems to contribute to the arachidonic acid liberation too, since the relatively specific iPLA2 inhibitor bromoenol lactone (BEL) decreased arachidonic acid generation in part.", {"entities": []}], ["The pronounced inhibition of the TPA-induced arachidonic acid release by the protein kinase C (PKC) inhibitors GF 109203X and Ro 31-82220, respectively, and by the p38 MAP kinase inhibitor SB 202190 suggests that the activation of the PLA2s by TPA is mediated via PKC and p38 MAP kinase.", {"entities": []}], ["Ethanol (EtOH) is the world\u2019s most commonly used drug, and has been widely recognized as a risk factor for developing lung disorders.", {"entities": []}], ["Chronic EtOH exposure affects all of the organ systems in the body and increases the risk of developing pulmonary diseases such as acute lung injury and pneumonia, while exacerbating the symptoms and resulting in increased mortality in many other lung disorders.", {"entities": [[153, 162, "DISEASE"]]}], ["EtOH and its metabolites inhibit the immune response of alveolar macrophages (AMs), increase airway leakage, produce damaging reactive oxygen species (ROS), and disrupt the balance of antioxidants/oxidants within the lungs.", {"entities": []}], ["In this article, we review the role of EtOH exposure in the pathogenesis and progression of pulmonary disease.", {"entities": []}], ["We tested a dental health program in remote Aboriginal communities of Australia's Northern Territory, hypothesizing that it would reduce dental caries in preschool children.", {"entities": [[137, 150, "DISEASE"]]}], ["In this 2-year, prospective, cluster-randomized, concurrent controlled, open trial of the dental health program compared to no such program, 30 communities were allocated at random to intervention and control groups.", {"entities": []}], ["All residents aged 18\u201347 months were invited to participate.", {"entities": []}], ["Twice per year for 2 years in the 15 intervention communities, fluoride varnish was applied to children's teeth, water consumption and daily tooth cleaning with toothpaste were advocated, dental health was promoted in community settings, and primary health care workers were trained in preventive dental care.", {"entities": []}], ["Data from dental examinations at baseline and after 2 years were used to compute net dental caries increment per child (d 3 mfs).", {"entities": [[85, 98, "DISEASE"]]}], ["A multi-level statistical model compared d 3 mfs between intervention and control groups with adjustment for the clustered randomization design; four other models used additional variables for adjustment.", {"entities": []}], ["At baseline, 666 children were examined; 543 of them (82%) were re-examined 2 years later.", {"entities": []}], ["The adjusted d 3 mfs increment was significantly lower in the intervention group compared to the control group by an average of 3.0 surfaces per child (95% CI = 1.2, 4.9), a prevented fraction of 31%.", {"entities": []}], ["Adjustment for additional variables yielded caries reductions ranging from 2.3 to 3.5 surfaces per child and prevented fractions of 24\u201336%.", {"entities": []}], ["These results corroborate findings from other studies where fluoride varnish was efficacious in preventing dental caries in young children.", {"entities": [[107, 120, "DISEASE"]]}], ["The MYLK gene encodes the multifunctional enzyme, myosin light chain kinase (MLCK), involved in isoform-specific non-muscle and smooth muscle contraction and regulation of vascular permeability during inflammation.", {"entities": [[4, 8, "GENE"]]}], ["Three MYLK SNPs (P21H, S147P, V261A) alter the N-terminal amino acid sequence of the non-muscle isoform of MLCK (nmMLCK) and are highly associated with susceptibility to acute lung injury (ALI) and asthma, especially in individuals of African descent.", {"entities": [[198, 204, "DISEASE"], [6, 10, "GENE"]]}], ["To understand the functional effects of SNP associations, we examined the N-terminal segments of nmMLCK by in silico molecular modeling.", {"entities": []}], ["Both NMR analysis and molecular modeling indicated SNP localization to loops that connect the immunoglobulin-like domains of nmMLCK, consistent with minimal structural changes evoked by these SNPs.", {"entities": []}], ["Molecular modeling analysis identified protein-protein interaction motifs adversely affected by these MYLK SNPs including binding by the scaffold protein 14-3-3, results confirmed by immunoprecipitation and western blot studies.", {"entities": [[102, 106, "GENE"]]}], ["These structure-function studies suggest novel mechanisms for nmMLCK regulation, which may confirm MYLK as a candidate gene in inflammatory lung disease and advance knowledge of the genetic underpinning of lung-related health disparities.", {"entities": [[140, 152, "DISEASE"], [99, 103, "GENE"]]}], ["Growing evidence suggests that maternal exposures to endocrine disrupting chemicals during pregnancy may lead to poor pregnancy outcomes and increased fetal susceptibility to adult diseases.", {"entities": []}], ["Polybrominated diphenyl ethers (PBDEs), which are ubiquitously used flame-retardants, could leach into the environment; and become persistent organic pollutants via bioaccumulation.", {"entities": []}], ["In the United States, blood PBDE levels in adults range from 30\u2013100 ng/g- lipid but the alarming health concern revolves around children who have reported blood PBDE levels 3 to 9-fold higher than adults.", {"entities": []}], ["PBDEs disrupt endocrine, immune, reproductive and nervous systems.", {"entities": []}], ["However, the mechanism underlying its adverse health effect is not fully understood.", {"entities": []}], ["Epigenetics is a possible biological mechanism underlying maternal exposure-child health outcomes by regulating gene expression without changes in the DNA sequence.", {"entities": []}], ["We sought to examine the relationship between maternal exposure to environmental PBDEs and promoter methylation of a proinflammatory gene, tumor necrosis factor alpha ( TNF\u03b1 ).", {"entities": []}], ["We measured the maternal blood PBDE levels and cord blood TNF\u03b1 promoter methylation levels on 46 paired samples of maternal and cord blood from the Boston Birth Cohort (BBC).", {"entities": []}], ["We showed that decreased cord blood TNF\u03b1 methylation associated with high maternal PBDE47 exposure.", {"entities": []}], ["CpG site-specific methylation showed significantly hypomethylation in the girl whose mother has a high blood PBDE47 level.", {"entities": []}], ["Consistently, decreased TNF\u03b1 methylation associated with an increase in TNF\u03b1 protein level in cord blood.", {"entities": []}], ["In conclusion, our finding provided evidence that in utero exposure to PBDEs may epigenetically reprogram the offspring\u2019s immunological response through promoter methylation of a proinflammatory gene.", {"entities": []}], ["Several recent studies have suggested that 1 minus-forced expiratory volume expired in 3 seconds / forced vital capacity (1-FEV 3 /FVC) may be an indicator of distal airway obstruction and a promising measure to evaluate small airways dysfunction.", {"entities": []}], ["To investigate the associations of 1-FEV 3 /FVC with the spirometric measures and lung volumes that assess small airways dysfunction and reflects hyperinflation and air trapping.", {"entities": []}], ["Retrospective cross-sectional study.", {"entities": []}], ["Retrospective assessment of a total of 1110 cases who underwent body plethysmographic lung volume estimations between a time span from 2005 to 2012.", {"entities": []}], ["Patients were assigned into two groups: firstly by FEV 1 /FVC (FEV 1 /FVC <70% vs. FEV 1 /FVC \u226570%); secondly by FEV 3 /FVC < lower limits of normal (LLN) (FEV 3 /FVC < LLN vs. FEV 3 /FVC \u2265 LLN).", {"entities": [[51, 54, "GENE"], [63, 66, "GENE"], [83, 86, "GENE"], [113, 116, "GENE"], [156, 159, "GENE"], [177, 180, "GENE"], [51, 54, "GENE"], [63, 66, "GENE"], [83, 86, "GENE"], [113, 116, "GENE"], [156, 159, "GENE"], [177, 180, "GENE"], [51, 54, "GENE"], [63, 66, "GENE"], [83, 86, "GENE"], [113, 116, "GENE"], [156, 159, "GENE"], [177, 180, "GENE"], [51, 54, "GENE"], [63, 66, "GENE"], [83, 86, "GENE"], [113, 116, "GENE"], [156, 159, "GENE"], [177, 180, "GENE"], [51, 54, "GENE"], [63, 66, "GENE"], [83, 86, "GENE"], [113, 116, "GENE"], [156, 159, "GENE"], [177, 180, "GENE"], [51, 54, "GENE"], [63, 66, "GENE"], [83, 86, "GENE"], [113, 116, "GENE"], [156, 159, "GENE"], [177, 180, "GENE"]]}], ["Spirometric indices and lung volumes measured by whole-body plethysmography were compared in groups.", {"entities": []}], ["Also the correlation of spirometric indices with measured lung volumes were assessed in the whole-study population and in subgroups stratified according to FEV 1 /FVC and FEV 3 /FVC.", {"entities": [[156, 159, "GENE"], [171, 174, "GENE"], [156, 159, "GENE"], [171, 174, "GENE"]]}], ["Six hundred seven (54.7%) were male and 503 (45.3%) were female, with a mean age of 52.5\u00b115.6 years.", {"entities": []}], ["Mean FEV 3 /FVC and 1-FEV 3 /FVC were 87.05%, 12.95%, respectively.", {"entities": [[5, 8, "GENE"], [22, 25, "GENE"]]}], ["The mean 1-FEV 3 /FVC was 4.9% in the FEV 1 /FVC \u226570% group (n=644) vs. 24.1% in the FEV 1 /FVC <70% group (n=466).", {"entities": [[11, 14, "GENE"], [38, 41, "GENE"], [85, 88, "GENE"], [11, 14, "GENE"], [38, 41, "GENE"], [85, 88, "GENE"]]}], ["A positive correlation was found between 1-FEV 3 /FVC and residual volume (r=0.70; p<0.0001), functional residual capacity-pleth (r=0.61; p<0.0001), and total lung capacity (r=0.47; p<0.0001).", {"entities": []}], ["1-FEV 3 /FVC was negatively correlated with forced expiratory flow2 5-75 (r=\u22120.84; p<0.0001).", {"entities": []}], ["The upper limit of 95% confidence interval for 1-FEV 3 /FVC was 13.7%.", {"entities": []}], ["1-FEV 3 /FVC showed significant correlations with parameters of air trapping and hyperinflation measured by whole-body plethysmography.", {"entities": []}], ["Importantly, these correlations were higher in study participants with FEV 1 /FVC <70% or FEV 3 /FVC < LLN compared to those with FEV 1 /FVC \u226570% or FEV 3 /FVC \u2265 LLN, respectively.", {"entities": [[71, 74, "GENE"], [90, 93, "GENE"], [130, 133, "GENE"], [149, 152, "GENE"], [71, 74, "GENE"], [90, 93, "GENE"], [130, 133, "GENE"], [149, 152, "GENE"], [71, 74, "GENE"], [90, 93, "GENE"], [130, 133, "GENE"], [149, 152, "GENE"], [71, 74, "GENE"], [90, 93, "GENE"], [130, 133, "GENE"], [149, 152, "GENE"]]}], ["1-FEV 3 /FVC can be easily calculated from routine spirometric measurements.", {"entities": []}], ["1-FEV 3 /FVC is a promising marker of air trapping and hyperinflation.", {"entities": []}], ["We suggest that 1-FEV 3 /FVC is complementary to FEV 1 /FVC and recommend clinicians to routinely report and evaluate together with FEV 1 /FVC during spirometry.", {"entities": [[18, 21, "GENE"], [49, 52, "GENE"], [132, 135, "GENE"], [18, 21, "GENE"], [49, 52, "GENE"], [132, 135, "GENE"]]}], ["To help guide universal influenza vaccination efforts in the United States, it is important to know which demographic groups are currently at highest risk of costly complications of influenza infection.", {"entities": [[24, 33, "DISEASE"], [182, 191, "DISEASE"]]}], ["Few studies have examined the relationship between hospitalization with influenza and either socioeconomic status (SES) or sex.", {"entities": [[72, 81, "DISEASE"]]}], ["We examined associations between census tract-level SES and sex and incidence of influenza-related hospitalizations among adults.", {"entities": [[81, 90, "DISEASE"]]}], ["Descriptive analysis of data collected by active population-based surveillance for persons >18 years old hospitalized with laboratory confirmed influenza during the 2007\u20132008 through 2010\u20132011 influenza seasons.", {"entities": [[144, 153, "DISEASE"], [193, 202, "DISEASE"]]}], ["Case residential addresses were geocoded and linked to data from the 2006\u20132010 American Community Survey to obtain census-tract level (neighborhood) SES measures.", {"entities": []}], ["Census-tract level SES variables included measures of poverty, education, crowding, primary language, and median income.", {"entities": []}], ["Four levels were created for each.", {"entities": []}], ["New Haven, County, Connecticut.", {"entities": []}], ["Entire New Haven County population >18 years old.", {"entities": []}], ["Age-adjusted incidence of influenza hospitalizations and relative risk by sex and by each of five SES measures.", {"entities": [[26, 35, "DISEASE"]]}], ["Crude and age-adjusted incidence progressively increased with decreasing neighborhood SES for each measure both overall and for each influenza season.", {"entities": [[133, 142, "DISEASE"]]}], ["Female incidence was higher than male for each age group, and female age-adjusted incidence was higher for each SES level and influenza season.", {"entities": [[126, 135, "DISEASE"]]}], ["Female sex and lower neighborhood SES were independently and consistently associated with higher incidence of hospitalization of adults with influenza.", {"entities": [[141, 150, "DISEASE"]]}], ["If this is more broadly the case, these findings have implications for future influenza vaccination efforts.", {"entities": [[78, 87, "DISEASE"]]}], ["Analysis using census tract SES measures can provide additional perspective on health disparities.", {"entities": []}], ["Because of the ubiquitous nature of phthalates in the environment and the potential for adverse human health effects, an urgent need exists to identify the most important sources and pathways of exposure.", {"entities": []}], ["Using emissions of di(2-ethylhexyl) phthalate (DEHP) from vinyl flooring (VF) as an illustrative example, we describe a fundamental approach that can be used to identify the important sources and pathways of exposure associated with phthalates in indoor material.", {"entities": []}], ["We used a three-compartment model to estimate the emission rate of DEHP from VF and the evolving exposures via inhalation, dermal absorption, and oral ingestion of dust in a realistic indoor setting.", {"entities": []}], ["A sensitivity analysis indicates that the VF source characteristics (surface area and material-phase concentration of DEHP), as well as the external mass-transfer coefficient and ventilation rate, are important variables that influence the steady-state DEHP concentration and the resulting exposure.", {"entities": []}], ["In addition, DEHP is sorbed by interior surfaces, and the associated surface area and surface/air partition coefficients strongly influence the time to steady state.", {"entities": []}], ["The roughly 40-fold range in predicted exposure reveals the inherent difficulty in using biomonitoring to identify specific sources of exposure to phthalates in the general population.", {"entities": []}], ["The relatively simple dependence on source and chemical-specific transport parameters suggests that the mechanistic modeling approach could be extended to predict exposures arising from other sources of phthalates as well as additional sources of other semivolatile organic compounds (SVOCs) such as biocides and flame retardants.", {"entities": []}], ["This modeling approach could also provide a relatively inexpensive way to quantify exposure to many of the SVOCs used in indoor materials and consumer products.", {"entities": []}], ["We have investigated the effect of adhesion to fibronectin (Fn) on the survival of eosinophils in culture.", {"entities": []}], ["Peripheral blood eosinophils from normal human donors were separated by immunomagnetic selection and cultured in RPMI on Fn- (100 micrograms/ml) coated microtiter plates for up to 96 h. Survival was measured by trypan blue exclusion.", {"entities": []}], ["There was a significant enhancement of eosinophil survival with Fn as compared with both bovine serum albumin-coated and uncoated wells (p < 0.05-0.01).", {"entities": []}], ["Fn-induced eosinophil survival was comparable to that obtained with exogenous interleukin 3 (IL-3) or granulocyte/macrophage colony-stimulating factor (GM-CSF) and was inhibitable by antibodies against Fn, very late antigen 4 (VLA-4), IL-3, and GM-CSF.", {"entities": []}], ["Supernatants from Fn-, but not BSA-coated wells contained picogram amounts of IL-3 and GM-CSF, and eosinophils cultured on Fn for 24 h expressed mRNA for GM-CSF as determined by in situ hybridization.", {"entities": []}], ["Therefore, Fn prolongs eosinophil survival in culture by triggering autocrine generation of cytokines by eosinophils.", {"entities": []}], ["Since neutrophils lack VLA-4, this could provide a partial explanation for the preferential accumulation of eosinophils at sites of allergic inflammation, as well as the predominant tissue localization of eosinophils in healthy individuals.", {"entities": []}], ["Gene expression profiling of peripheral blood mononuclear cells (PBMCs) has revealed a crucial role for type I interferon (IFN) in the pathogenesis of systemic lupus erythematosus (SLE).", {"entities": [[160, 179, "DISEASE"], [151, 179, "DISEASE"]]}], ["However, it is unclear how particular leucocyte subsets contribute to the overall type I IFN signature of PBMCs and whole blood samples.Furthermore, a detailed analysis describing the differences in the IFN signature in autoimmune diseases from that observed after viral infection has not been performed to date.", {"entities": []}], ["Therefore, in this study, the transcriptional responses in peripheral T helper cells (CD4", {"entities": [[86, 89, "GENE"]]}], ["Decreased muscle strength can lead to adverse health outcomes in the elderly.", {"entities": []}], ["A potential association between phthalate exposure and muscle strength was suggested previously, but has not been investigated directly.", {"entities": []}], ["We hypothesized that phthalate exposure is associated with lower handgrip strength and that the association is modified by the dietary omega-6 to omega-3 ratio.", {"entities": []}], ["We analyzed 1,228 participants (\u226560\u00a0years of age) recruited in Seoul and Asan, Republic of Korea.", {"entities": []}], ["The study participants were surveyed up to three times between 2012 and 2015.", {"entities": []}], ["At every survey, we collected urine samples and measured handgrip strength twice for each hand.", {"entities": []}], ["The associations between urine phthalate metabolite concentrations and handgrip strength were evaluated using linear mixed models.", {"entities": []}], ["Based on dietary information from 391 individuals who participated in the first survey in Seoul, we evaluated the heterogeneity of the association for those with high and low omega-6 to omega-3 ratios, using 8.81 (the 75th quantile) as a cutoff value.", {"entities": []}], ["Log-transformed creatinine-adjusted concentrations of mono-(2-ethyl-5-oxohexyl phthalate (MEOHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), and mono-n-butyl phthalate (MnBP) were inversely associated with all measured handgrip strengths (\u03b2\u2009=\u2009\u22120.69 to \u22120.42, all p -values\u2009<\u20090.05).", {"entities": []}], ["Associations between phthalate biomarkers and handgrip strength did not differ by sex.", {"entities": []}], ["When the dietary subgroup was stratified by the omega-6 to omega-3 ratio, the associations were stronger among participants with high ratios.", {"entities": []}], ["We found inverse associations between phthalate biomarkers and handgrip strength in the elderly; this association was modified by the dietary omega-6 to omega-3 ratio.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-016-0176-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This subject concerns the complex interrelationship of a genetically determined protein deficiency, enzymes which are inhibited by that protein, environmental challenges such as cigarette smoke and industrial pollutants, and the occurrence of obstructive lung disease (Fig.", {"entities": [[243, 267, "DISEASE"], [255, 267, "DISEASE"]]}], ["Unequivocal establishment of an etiological role for AAT deficiency, especially of intermediate degree, has proven to be difficult.", {"entities": []}], ["Confounding variables such as enzyme concentration in PMN and PAMs, duration of exposure to potential environmental hazards, differences in laboratory methods utilized in measuring AAT and in studying pulmonary function all require investigation.", {"entities": []}], ["The definitive study, incorporating all of these and other factors, has yet to be conducted.", {"entities": []}], ["No single, clear-cut conclusion can be drawn from analysis of present studies.", {"entities": []}], ["In those circumstances in which heterozygotes appear to be predisposed to COPD, phenotypic screening of the population at potential risk, such as industrial workers may be appropriate.", {"entities": []}], ["Conversely, in conditions in which no association is demonstrated, such screening would not be justified.", {"entities": []}], ["Perhaps, the best one can do is to suggest a \"Scotch verdict\"; that is, the issue of causation is not proven.", {"entities": []}], ["Alveolar echinococcosis (AE) is a severe chronic parasitic disease which behaves like a slow-growing liver cancer.", {"entities": [[9, 23, "DISEASE"], [101, 113, "DISEASE"], [107, 113, "DISEASE"]]}], ["Clinical observations suggest that the parasite, Echinococcus multilocularis ( E. multilocularis ) influences liver homeostasis and hepatic cell metabolism.", {"entities": []}], ["However, this has never been analyzed during the time course of infection in the common model of secondary echinococcosis in experimental mice.", {"entities": [[107, 121, "DISEASE"]]}], ["Gene expression profiles were assessed using DNA microarray analysis, 1, 2, 3 and 6 months after injection of E. multilocularis metacestode in the liver of susceptible mice.", {"entities": []}], ["Data were collected at different time points to monitor the dynamic behavior of gene expression.", {"entities": []}], ["557 differentially expressed genes were identified at one or more time points, including 351 up-regulated and 228 down-regulated genes.", {"entities": []}], ["Time-course analysis indicated, at the initial stage of E. multilocularis infection (month 1\u20132), that most of up-regulated pathways were related to immune processes and cell trafficking such as chemokine-, mitogen-activated protein kinase (MAPK) signaling, and down-regulated pathways were related to xenobiotic metabolism; at the middle stage (month 3), MAPK signaling pathway was maintained and peroxisome proliferator-activated receptor (PPAR) signaling pathway emerged; at the late stage (month 6), most of up-regulated pathways were related to PPAR signaling pathway, complement and coagulation cascades, while down-regulated pathways were related to metabolism of xenobiotics by cytochrome P450.", {"entities": []}], ["Quantitative RT-PCR analysis of a random selection of 19 genes confirmed the reliability of the microarray data.", {"entities": []}], ["Immunohistochemistry analysis showed that proliferating cell nuclear antigen (PCNA) was increased in the liver of E. multilocularis infected mice from 2 months to 6 months.", {"entities": [[78, 82, "GENE"]]}], ["E. multilocularis metacestode definitely exerts a deep influence on liver homeostasis, by modifying a number of gene expression and metabolic pathways.", {"entities": []}], ["It especially promotes hepatic cell proliferation, as evidenced by the increased PCNA constantly found in all the experimental time-points we studied and by an increased gene expression of key metabolic pathways.", {"entities": [[81, 85, "GENE"]]}], ["Prolonged ventilation and failed extubation are associated with increased harm and cost.", {"entities": []}], ["The added value of heart and respiratory rate variability (HRV and RRV) during spontaneous breathing trials (SBTs) to predict extubation failure remains unknown.", {"entities": []}], ["We enrolled 721 patients in a multicenter (12 sites), prospective, observational study, evaluating clinical estimates of risk of extubation failure, physiologic measures recorded during SBTs, HRV and RRV recorded before and during the last SBT prior to extubation, and extubation outcomes.", {"entities": []}], ["We excluded 287 patients because of protocol or technical violations, or poor data quality.", {"entities": []}], ["Measures of variability (97 HRV, 82 RRV) were calculated from electrocardiogram and capnography waveforms followed by automated cleaning and variability analysis using Continuous Individualized Multiorgan Variability Analysis (CIMVA\u2122) software.", {"entities": []}], ["Repeated randomized subsampling with training, validation, and testing were used to derive and compare predictive models.", {"entities": []}], ["Of 434 patients with high-quality data, 51 (12%) failed extubation.", {"entities": []}], ["Two HRV and eight RRV measures showed statistically significant association with extubation failure ( P <0.0041, 5% false discovery rate).", {"entities": []}], ["An ensemble average of five univariate logistic regression models using RRV during SBT, yielding a probability of extubation failure (called WAVE score), demonstrated optimal predictive capacity.", {"entities": []}], ["With repeated random subsampling and testing, the model showed mean receiver operating characteristic area under the curve (ROC AUC) of 0.69, higher than heart rate (0.51), rapid shallow breathing index (RBSI; 0.61) and respiratory rate (0.63).", {"entities": []}], ["After deriving a WAVE model based on all data, training-set performance demonstrated that the model increased its predictive power when applied to patients conventionally considered high risk: a WAVE score >0.5 in patients with RSBI >105 and perceived high risk of failure yielded a fold increase in risk of extubation failure of 3.0 (95% confidence interval (CI) 1.2 to 5.2) and 3.5 (95% CI 1.9 to 5.4), respectively.", {"entities": []}], ["Altered HRV and RRV (during the SBT prior to extubation) are significantly associated with extubation failure.", {"entities": []}], ["A predictive model using RRV during the last SBT provided optimal accuracy of prediction in all patients, with improved accuracy when combined with clinical impression or RSBI.", {"entities": []}], ["This model requires a validation cohort to evaluate accuracy and generalizability.", {"entities": []}], ["ClinicalTrials.gov NCT01237886 .", {"entities": []}], ["Registered 13 October 2010.", {"entities": []}], ["At the core of the healthcare crisis is fundamental lack of actionable data.", {"entities": []}], ["Such data could stratify individuals within populations to predict which persons have which outcomes.", {"entities": []}], ["If baselines existed for all variations of all conditions, then managing health could be improved by matching the measuring of individuals to their cohort in the population.", {"entities": []}], ["The scale required for complete baselines involves effective National Surveys of Population Health (NSPH).", {"entities": []}], ["Traditionally, these have been focused upon acute medicine, measuring people to contain the spread of epidemics.", {"entities": []}], ["In recent decades, the focus has moved to chronic conditions as well, which require smaller measures over longer times.", {"entities": []}], ["NSPH have long utilized quality of life questionnaires.", {"entities": []}], ["Mobile Health Monitors, where computing technologies eliminate manual administration, provide richer data sets for health measurement.", {"entities": []}], ["Older technologies of telephone interviews will be replaced by newer technologies of smartphone sensors to provide deeper individual measures at more frequent timings across larger-sized populations.", {"entities": []}], ["Such continuous data can provide personal health records, supporting treatment guidelines specialized for population cohorts.", {"entities": []}], ["Evidence-based medicine will become feasible by leveraging hundreds of millions of persons carrying mobile devices interacting with Internet-scale services for Big Data Analytics.", {"entities": []}], ["Spouses tend to share habits and therefore have an increased risk of same diseases.", {"entities": []}], ["We followed all married couples in Sweden, born 1902 to 1942, in hospital records from 1987 to 2002, and found that individuals whose spouse had a hip fracture had an increased risk of hip fracture.", {"entities": []}], ["The purpose of this study was to determine whether spouses of hip fracture patients have an elevated risk of hip fracture.", {"entities": []}], ["We performed a retrospective cohort study of all couples married for at least 5\u00a0years in Sweden and born between 1902 and 1942 ( n \u2009=\u2009904,451) and all patients registered with a hip fracture ( n \u2009=\u2009218,285) in the National Inpatients Register in Sweden from 1987 to 2002.", {"entities": []}], ["During the period 1987 to 2002 hip fractures occurred among spouses in 4212 married couples.", {"entities": []}], ["The hazard ratio (HR) for hip fracture in a married woman following hip fracture in the husband was 1.11 (95\u00a0% confidence interval 1.07 to 1.16) compared to a woman whose husband did not have hip fracture.", {"entities": [[18, 20, "GENE"]]}], ["The corresponding HR for a married man was 1.20 (1.15 to 1.26) compared to a man whose wife did not have hip fracture.", {"entities": [[18, 20, "GENE"]]}], ["The risk was significantly elevated over the age range 60 to 90\u00a0years.", {"entities": []}], ["The increased risk for hip fracture among spouses remained after adjustments for income, education, geographical latitude and urbanisation.", {"entities": []}], ["In a common model with spouses and their siblings, the HR for spousal effect were 1.63 (1.01 to 2.64) and for sibling effect 2.18 (1.55 to 3.06) compared to married with spouse and sibling respectively without hip fracture.", {"entities": [[55, 57, "GENE"]]}], ["The novel finding of an increased risk for hip fracture among spouses provides evidence indicating that there is a homogamy effect due to common social and lifestyle factors but could also be due to assortative mating.", {"entities": []}], ["Autophagy has been linked with melanoma risk and survival, but no polymorphisms in autophagy\u2010related ( ATG ) genes have been investigated in relation to melanoma progression.", {"entities": [[31, 39, "DISEASE"], [153, 161, "DISEASE"]]}], ["We examined five single\u2010nucleotide polymorphisms ( SNP s) in three ATG genes ( ATG 5 ; ATG 10 ; and ATG 16L ) with known or suspected impact on autophagic flux in an international population\u2010based case\u2013control study of melanoma.", {"entities": [[219, 227, "DISEASE"]]}], ["DNA from 911 melanoma patients was genotyped.", {"entities": [[13, 21, "DISEASE"]]}], ["An association was identified between ( GG ) (rs2241880) and earlier stage at diagnosis ( OR 0.47; 95% Confidence Intervals ( CI )\u00a0=\u00a00.27\u20130.81, P\u00a0 = \u00a0 0.02) and a decrease in Breslow thickness ( P\u00a0 = \u00a0 0.03).", {"entities": []}], ["The ATG 16L heterozygous genotype ( AG ) (rs2241880) was associated with younger age at diagnosis ( P\u00a0 = \u00a0 0.02).", {"entities": []}], ["Two SNP s in ATG 5 were found to be associated with increased stage (rs2245214 CG , OR 1.47; 95% CI \u00a0=\u00a01.11\u20131.94, P\u00a0 = \u00a0 0.03; rs510432 CC , OR 1.84; 95% CI \u00a0=\u00a01.12\u20133.02, P\u00a0 = \u00a0 0.05).", {"entities": []}], ["Finally, we identified inverse associations between ATG 5 ( GG rs2245214) and melanomas on the scalp or neck ( OR 0.20, 95% CI = 0.05\u20130.86, P\u00a0 = \u00a0 0.03); ATG 10 ( CC ) (rs1864182) and brisk tumor infiltrating lymphocytes ( TIL s) ( OR 0.42; 95% CI \u00a0=\u00a00.21\u20130.88, P\u00a0 = \u00a0 0.02), and ATG 5 ( CC ) (rs510432) with nonbrisk TIL s ( OR 0.55; 95% CI \u00a0=\u00a00.34\u20130.87, P\u00a0 = \u00a0 0.01).", {"entities": []}], ["Our data suggest that ATG SNP s might be differentially associated with specific host and tumor characteristics including age at diagnosis, TIL s, and stage.", {"entities": []}], ["These associations may be critical to understanding the role of autophagy in cancer, and further investigation will help characterize the contribution of these variants to melanoma progression.", {"entities": [[172, 180, "DISEASE"], [77, 83, "DISEASE"]]}], ["To effectively manage environmental health risks, stakeholders often need to act collectively.", {"entities": []}], ["Stakeholders vary in their desire to act due to many factors, such as knowledge, risk perception, interests, and worldviews.", {"entities": []}], ["Understanding their perceptions of the issues at stake is crucial to support the risk governance process.", {"entities": []}], ["Even though concern assessment is a pivotal element of risk governance, few tools for rapid assessment are reported in the literature.", {"entities": []}], ["We tested a rapid and relatively cheap approach, taking the Dutch debate on Intensive Animal Production Systems (IAPS) and health as an example.", {"entities": []}], ["Dutch policy-oriented publications on IAPS and health and ten semi-structured in-depth interviews with a variety of stakeholders were analyzed to identify stakeholders and concerns involved in the Dutch debate about IAPS and health.", {"entities": []}], ["Concerns were mapped and a stakeholder network was derived.", {"entities": []}], ["Three classes of concerns were recognized in the discussions about IAPS and health: concerns related to health risks, concerns regarding the activity causing the risks (IAPS), and concerns about the process to control the risks.", {"entities": []}], ["The notions of \u2018trust\u2019 and \u2018scientific uncertainty\u2019 appeared as important themes in the discussions.", {"entities": []}], ["Argumentation based on concerns directly related to health risks, the activity causing the risk (IAPS), and its risk management can easily become muddled up in a societal debate, limiting the development of effective action perspectives.", {"entities": []}], ["Acknowledging these multiple stakeholder concerns can clarify the positions taken by stakeholders and allow for more and other action perspectives to develop.", {"entities": []}], ["Recombinant Bet v 1a (rBet v 1a) has been used in allergy research for more than three decades, including clinical application of so-called hypoallergens.", {"entities": []}], ["Quantitative IgE binding to rBet v 1a depends on its native protein conformation, which might be compromised upon heterologous expression, purification, or mutational engineering of rBet v 1a.", {"entities": []}], ["To correlate experimental/theoretical comparisons of IgE binding of defined molar ratios of folded/misfolded recombinant Bet v 1a variants and to determine accuracy and precision of immuno- and physicochemical assays routinely used to assess the quality of recombinant allergen preparations.", {"entities": []}], ["rBet v 1a and its misfolded variant rBet v 1a S112P/R145P were heterologously expressed and purified from Escherichia coli .", {"entities": []}], ["Structural integrities and oligomerisation of the recombinant allergens were evaluated by S112P/R145P was assessed using immunoblotting (IB), enzyme-linked immunosorbent assay (ELISA) and mediator release (MR) of humanized rat basophilic leukemia cells sensitized with serum IgE of subjects allergic to birch pollen.", {"entities": [[238, 246, "DISEASE"]]}], ["Experimental and theoretically expected results of the analyses were compared.", {"entities": []}], ["S112P/R145P demonstrate a native and highly disordered protein conformations, respectively.", {"entities": []}], ["The CD spectra suggested typical alpha-helical and beta-sheet secondary structure content of rBet v 1a and random coil for rBet v 1a S112P/R145P .", {"entities": []}], ["The hydrodynamic radii (R H ) of 2.49\u00a0\u00b1\u00a00.39 nm (rBet v 1a) and 3.1 \u00b1 0.56 nm (rBet v 1a S112P/R145P ) showed monomeric dispersion of both allergens in solution.", {"entities": []}], ["Serum IgE of birch pollen allergic subjects bound to 0.1% rBet v 1a in the presence of 99.9% of non-IgE binding rBet v 1a S112P/R145P .", {"entities": []}], ["Immunoblot analysis overestimated, whereas ELISA and mediator release assay underestimated the actual quantity of IgE-reactive rBet v 1a in mixtures of rBet v 1a/rBet v 1a S112P/R145P with a molar ratio of rBet v 1a \u2264 10%.", {"entities": []}], ["Valid conclusions on quantitative IgE binding of recombinant Bet v 1a preparations depend on the accuracy and precision of physico- and immunochemical assays with which natively folded allergen is detected.", {"entities": []}], ["Prostate cancer (PCa) is a heterogeneous trait for which several susceptibility loci have been implicated by genome-wide linkage and association studies.", {"entities": [[9, 15, "DISEASE"]]}], ["The genomic region 13q14 is frequently deleted in tumour tissues of both sporadic and familial PCa patients and is consequently recognised as a possible locus of tumour suppressor gene(s).", {"entities": []}], ["Deletions of this region have been found in many other cancers.", {"entities": []}], ["Recently, we showed that homozygous carriers for the T442C variant of the ARLTS1 gene (ADP-ribosylation factor-like tumour suppressor protein 1 or ARL11 , located at 13q14) are associated with an increased risk for both unselected and familial PCa.", {"entities": [[147, 152, "GENE"]]}], ["Furthermore, the variant T442C was observed in greater frequency among malignant tissue samples, PCa cell lines and xenografts, supporting its role in PCa tumourigenesis.", {"entities": []}], ["In this study, 84 PCa cases and 15 controls were analysed for ARLTS1 expression status in blood-derived RNA.", {"entities": []}], ["A statistically significant (p\u200a=\u200a0.0037) decrease of ARLTS1 expression in PCa cases was detected.", {"entities": []}], ["Regulation of ARLTS1 expression was analysed with eQTL (expression quantitative trait loci) methods.", {"entities": []}], ["Altogether fourteen significant cis -eQTLs affecting the ARLTS1 expression level were found.", {"entities": []}], ["In addition, epistatic interactions of ARLTS1 genomic variants with genes involved in immune system processes were predicted with the MDR program.", {"entities": []}], ["In conclusion, this study further supports the role of ARLTS1 as a tumour suppressor gene and reveals that the expression is regulated through variants localised in regulatory regions.", {"entities": []}], ["We conducted this study to estimate the correlates of current cigarette smoking among in-school adolescents in Jamaica 2006 and compare prevalence of smoking and associated factors between 2000 and 2006.", {"entities": []}], ["In 2006, 1854 participated of whom 49.5 were males and 50.5% females.", {"entities": []}], ["1752 adolescents, 48.8% male and 51.2% females participated in the 2000 survey.", {"entities": []}], ["Between 2000 and 2006, the prevalence of smoking among Jamaican school-going adolescents went up slightly from 15.2% to 16.7% but this was not statistically significant (p = 0.22).", {"entities": []}], ["The perception that smoking is not harmful increased from 10.9% to 15.9% while parental smoking decreased from 39.4% to 35.5%.", {"entities": []}], ["There was a decrease in the rates of adolescents exposed to tobacco adverts on billboards (p-value = 0.037) and in newspapers/magazine (p-value < 0.001).", {"entities": []}], ["The percentage of adolescents who reported having an item with a tobacco brand logo on it increased from 13.9% to 16.4%.", {"entities": []}], ["The perception that boys and girls who smoked had more friends increased between 2000 and 2006 (p-values = 0.016 and 0.004 respectively).", {"entities": []}], ["Current smoking was associated with male gender (OR = 1.55; 95% CI [1.09\u20132.19]), having smoking parents (OR = 1.75; 95% CI [1.23\u20132.50]), and smoking friends (OR = 14.94; 95% CI [8.61\u201325.92] for most or all friends smokers and OR = 4.38; 95% CI [2.93\u20136.56] for some friends smokers)).", {"entities": []}], ["Results from this study indicate smoking was positively associated with male gender, having smoking friends or parents.", {"entities": []}], ["We observed a slightly non significant increase in the prevalence of smoking between 2000 and 2006 among adolescents in Jamaica.", {"entities": []}], ["Although there was a decrease in the rates of adolescents exposed to advertisement, the percentage of those who had an item with a tobacco brand logo had increased.", {"entities": []}], ["The possible impact of the Jamaica's ratification of the Framework Convention on Tobacco control remains to be observed.", {"entities": []}], ["This study investigated associations between parenting stress in parents and self-reported stress in children with children's diurnal cortisol secretion and whether these associations are moderated by known stress-regulating capacities, namely child cognitive control.", {"entities": []}], ["Salivary cortisol concentrations were assessed from awakening to evening on two weekend days from 53 6-to-7-year-old children.", {"entities": []}], ["Children completed a cognitive control task and a self-report stress questionnaire with an experimenter, while parents completed a parenting stress inventory.", {"entities": []}], ["Hierarchical, linear mixed effects models revealed that higher parenting stress was associated with overall reduced cortisol secretion in children, and this effect was moderated by cognitive control.", {"entities": []}], ["Specifically, parenting stress was associated with reduced diurnal cortisol levels in children with lower cognitive control ability and not in children with higher cognitive control ability.", {"entities": []}], ["There were no effects of self-reported stress in children on their cortisol secretion, presumably because 6-to-7-year-old children cannot yet self-report on stress experiences.", {"entities": []}], ["Our results suggest that higher cognitive control skills may buffer the effects of parenting stress in parents on their children\u2019s stress regulation in middle childhood.", {"entities": []}], ["This could indicate that training cognitive control skills in early life could be a target to prevent stress-related disorders.", {"entities": []}], ["Chronic obstructive pulmonary disease risk is lower in black and south Asian people than white people, when adjusting for age, sex, deprivation and smoking status.", {"entities": [[0, 37, "DISEASE"]]}], ["The role of smoking intensity was assessed for its contribution to ethnic differences in chronic obstructive pulmonary disease risk, a relationship not previously investigated.", {"entities": [[89, 126, "DISEASE"]]}], ["This cross-sectional study included routinely collected primary care data from four multi-ethnic London boroughs.", {"entities": []}], ["Smoking intensity (estimated by cigarettes per day) was compared between ethnic groups.", {"entities": []}], ["Chronic obstructive pulmonary disease risk was compared between ethnic groups using multiple logistic regression, controlling for age, sex, deprivation, asthma and both smoking status and smoking intensity, examined independently.", {"entities": [[0, 37, "DISEASE"], [153, 159, "DISEASE"]]}], ["In all, 1,000,388 adults were included.", {"entities": []}], ["Smoking prevalence and intensity were significantly higher in the white British/Irish groups than other ethnic groups.", {"entities": []}], ["Higher smoking intensity was associated with higher chronic obstructive pulmonary disease risk.", {"entities": [[52, 89, "DISEASE"]]}], ["Chronic obstructive pulmonary disease risk was significantly lower in all ethnic groups compared with white British/Irish after adjustment for either smoking status or smoking intensity, with lowest risk in black Africans (odds ratio 0.33; confidence interval 0.28\u20130.38).", {"entities": [[0, 37, "DISEASE"]]}], ["Ethnic differences in chronic obstructive pulmonary disease risk were not explained in this study by ethnic differences in smoking prevalence or smoking intensity.", {"entities": [[22, 59, "DISEASE"]]}], ["Other causes of ethnic differences in chronic obstructive pulmonary disease risk should be sought, including ethnic differences in smoking behaviour, environmental factors, repeated respiratory infections, immigrant status, metabolism and addictiveness of nicotine and differential susceptibility to the noxious effects of cigarette smoke.", {"entities": [[38, 75, "DISEASE"]]}], ["Lower smoking intensity among blacks and south Asians does not explain their lower risk for chronic obstructive pulmonary disease (COPD).", {"entities": [[92, 129, "DISEASE"]]}], ["A UK team led by Alexander Gilkes from Kings College London analysed primary care data from more than a million people living in four multi-ethnic boroughs of the British capital.", {"entities": []}], ["The researchers found that smoking status and intensity (as measured by number of cigarettes smoked per day) were both significantly higher in white British or Irish groups than in other ethnic populations.", {"entities": []}], ["Even after statistically adjusting for smoking status or smoking intensity, however, the researchers couldn\u2019t account for the fact that people of south Asian or African descent had much lower prevalence rates of COPD, a lung disease linked to smoking.", {"entities": [[220, 232, "DISEASE"]]}], ["The findings suggest that other explanations of ethnic differences are still needed.", {"entities": []}], ["Protein kinase R (PKR) is a vital component of host innate immunity against viral infection.", {"entities": []}], ["However, the mechanism underlying inactivation of PKR by in\ufb02uenza A virus (IAV) remains elusive.", {"entities": []}], ["Here, we found that vault RNAs (vtRNAs) were greatly induced in A549 cells and mouse lungs after infection with IAV.", {"entities": []}], ["The viral NS1 protein was shown to be the inducer triggering the upregulation of vtRNAs.", {"entities": []}], ["Importantly, silencing vtRNA in A549 cells significantly inhibited IAV replication, whereas overexpression of vtRNAs markedly promoted the viral replication.", {"entities": []}], ["Furthermore, in vivo studies showed that disrupting vtRNA expression in mice significantly decreased IAV replication in infected lungs.", {"entities": []}], ["The vtRNA knockdown animals exhibited significantly enhanced resistance to IAV infection, as evidenced by attenuated acute lung injury and spleen atrophy and consequently increased survival rates.", {"entities": []}], ["Interestingly, vtRNAs promoted viral replication through repressing the activation of PKR and the subsequent antiviral interferon response.", {"entities": []}], ["In addition, increased expression of vtRNAs was required for efficient suppression of PKR by NS1 during IAV infection.", {"entities": []}], ["Moreover, vtRNAs were also significantly upregulated by infections of several other viruses and involved in the inactivation of PKR signaling by these viruses.", {"entities": []}], ["These results reveal a novel mechanism by which some viruses circumvent PKR-mediated innate immunity.", {"entities": []}], ["Glucocorticoids (GCS) remain one of the mainstay treatments in the management of ulcerative colitis (UC) but up to a third of patients will ultimately fail to respond and progress to a more severe and difficult to manage disease state.", {"entities": [[81, 99, "DISEASE"]]}], ["Previous clinical studies suggest that the Toll-Like Receptor 9 (TLR9) agonist DIMS0150 not only induces production of key anti-inflammatory cytokines as IL-10 but interestingly also enhances steroid sensitivity in steroid refractory UC patients.", {"entities": [[65, 69, "GENE"]]}], ["We investigated, in the context of a clinical study, whether a pre-selection of steroid response genes could identify steroid refractory UC subjects most likely to respond to DIMS0150 treatment.", {"entities": []}], ["In a non-interventional pilot study, blood from steroid refractory UC patients and healthy volunteers was taken and thirty-four previously described steroid response genes were analysed by real time PCR analysis.", {"entities": []}], ["To establish clinical utility of the identified biomarkers, a placebo controlled, randomized, double blinded study in active steroid dependent and steroid resistant UC patients on concomitant steroid therapies was used (EudraCT number: 2006-001846-15).", {"entities": []}], ["We identified three potential biomarkers CD163, TSP-1 and IL-1RII whose response to steroids was significantly enhanced when DIMS0150 was applied.", {"entities": [[41, 46, "GENE"]]}], ["Thirty-four subjects were randomized to receive a single rectal administration of placebo or 30\u00a0mg of DIMS0150.", {"entities": []}], ["Blood derived PBMCs were obtained prior to dosing and assayed for evidence of a steroid enhancing effect following steroid incubation in the presence of DIMS0150.", {"entities": []}], ["Comparison to established steroid sensitivity marker IL-6 confirmed that clinical responders are steroid refractory UC patients.", {"entities": []}], ["Upon study completion and un-blinding, the biomarker assay correctly predicted a clinical response in over 90% of the patients.", {"entities": []}], ["Using specific steroid response biomarkers, GCS refractory UC patients most likely to benefit from DIMS0150 treatment could be identified and illustrates the usefulness of a personalized treatment approach.", {"entities": []}], ["Intravenous glutamate reduced the risk of developing severe circulatory failure after isolated coronary artery bypass graft surgery (CABG) for acute coronary syndrome (ACS) in a double-blind randomised clinical trial (GLUTAMICS-ClinicalTrials.gov Identifier: NCT00489827 ).", {"entities": [[158, 166, "DISEASE"]]}], ["Here our aim was to study if glutamate was associated with reduced the use of inotropes.", {"entities": []}], ["Post-hoc analysis of 824 patients undergoing isolated CABG for ACS in the GLUTAMICS-trial.", {"entities": []}], ["ICU-records were retrospectively scrutinised including hourly registration of inotropic drug infusion, dosage and total duration during the operation and postoperatively.", {"entities": []}], ["ICU-records were found for 171 out of 177 patients who received inotropes perioperatively.", {"entities": []}], ["Only one fourth of the patients treated with inotropes fulfilled study criteria for postoperative heart failure at weaning from cardiopulmonary bypass (CPB) or later in the ICU.", {"entities": []}], ["Inotropes were mainly given preemptively to facilitate weaning from CPB or to treat postoperative circulatory instability (bleeding, hypovolaemia).", {"entities": []}], ["Except for a significantly lower use of epinephrine there were only trends towards lower need of other inotropes overall in the glutamate group.", {"entities": []}], ["In patients treated with inotropes (glutamate n \u2009=\u200917; placebo n \u2009=\u200913) who fulfilled study criteria for left ventricular failure at weaning from CPB the average duration of inotropic treatment (34\u2009\u00b1\u200920 v 80\u2009\u00b1\u200977\u00a0h; p \u2009=\u20090.014) and the number of inotropes used (1.35\u2009\u00b1\u20090.6 v 1.85\u2009\u00b1\u20090.7; p \u2009=\u20090.047) were lower in the glutamate group.", {"entities": []}], ["Intravenous glutamate was associated with a minor influence on inotrope use overall in patients undergoing CABG for ACS whereas a considerable and significant reduction was observed in patients with heart failure at weaning from CPB.", {"entities": []}], ["The online version of this article (doi:10.1186/s12871-016-0216-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Allergic conjunctivitis (AC) is a disease of various agents that affects the physical and mental health of children.", {"entities": [[0, 23, "DISEASE"], [9, 23, "DISEASE"]]}], ["Although the most effective therapy has not been found so far, it is essential to explore the considerable therapeutic method.", {"entities": []}], ["We compared the clinical efficacy of olopatadine, emedastine, loteprednol etabonate (LE), and vehicle for treating seasonal allergic conjunctivitis (SAC) in Chinese children.", {"entities": [[124, 147, "DISEASE"], [133, 147, "DISEASE"]]}], ["Eighty cases of 160 eyes aged from 5 to 10 years with SAC were available and those subjects were randomly distributed into 4 groups.", {"entities": []}], ["Both their eyes received olopatadine hydrochloride 0.1% twice a day, emedastine difumarate 0.05% twice a day, or LE 0.5% 4 times a day, respectively, whereas those of the control group received artificial tears (AT) 0.5% 3 times a day.", {"entities": []}], ["This study was conducted successfully and the observations were collected before treatment and on day 8 (\u00b11 day) and day 15 (\u00b12 days) afterward.", {"entities": []}], ["The principal measurement of efficacy was focused on the signs and symptoms of the subjects, evaluated before and after treatment, in addition to visual acuity (VA) and fundus oculi.", {"entities": []}], ["On day 8 (\u00b11 day) and day 15 (\u00b12 days), all the antiallergic agents were found to be more effective than vehicle ( p < 0.05) in terms of all the symptoms and signs.", {"entities": []}], ["However, there was no statistical significance ( p \u2265 0.05) shown among the treatment groups.", {"entities": []}], ["There were no evident changes in VA and no clinically significant changes were observed in fundus oculi.", {"entities": []}], ["After the treatment, the efficacy presented a similar distribution among the trial groups.", {"entities": []}], ["The inflammasome\u2013IL-1 axis and type I interferons (IFNs) have been shown to exert protective effects upon respiratory tract infections.", {"entities": []}], ["Conversely, IL-1 has also been implicated in inflammatory airway pathologies such as asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[96, 133, "DISEASE"], [85, 91, "DISEASE"]]}], ["OM-85 is a bacterial extract with proved efficacy against COPD and recurrent respiratory tract infections, a cause of co-morbidity in asthmatic patients.", {"entities": []}], ["We therefore asked whether OM-85 affects the above-mentioned innate immune pathways.", {"entities": []}], ["Here we show that OM-85 induced interferon-\u03b2 through the Toll-like receptor adaptors Trif and MyD88 in bone marrow-derived dendritic cells.", {"entities": [[94, 99, "GENE"]]}], ["Moreover, it exerted a dual role on IL-1 production; on the one hand, it upregulated proIL-1\u03b2 and proIL-1\u03b1 levels in a MyD88-dependent manner without activating the inflammasome.", {"entities": []}], ["On the other hand, it repressed IL-1\u03b2 secretion induced by alum, a well-known NLRP3 activator.", {"entities": [[78, 83, "GENE"]]}], ["In vivo , OM-85 diminished the recruitment of inflammatory cells in response to peritoneal alum challenge.", {"entities": []}], ["Our findings therefore suggest that OM-85 favors a protective primed state, while dampening inflammasome activation in specific conditions.", {"entities": []}], ["Taken together, these data bring new insights into the mechanisms of OM-85 action on innate immune pathways and suggest potential explanations for its efficacy in the treatment of virus-induced airway diseases.", {"entities": []}], ["Cigarette smoke, the major risk factor for COPD, is known to activate matrix metalloproteinases in airway epithelium.", {"entities": []}], ["We investigated whether metalloproteinases, particularly A Disintegrin and Metalloproteinase (ADAM)17, contribute to increased pro-inflammatory epithelial responses with respect to the release of IL-8 and TGF-\u03b1, cytokines implicated in COPD pathogenesis.", {"entities": []}], ["We studied the effects of cigarette smoke extract (CSE) and metalloproteinase inhibitors on TGF-\u03b1 and IL-8 release in primary bronchial epithelial cells (PBECs) from COPD patients, healthy smokers and non-smokers.", {"entities": []}], ["We observed that TGF-\u03b1 was mainly shed by ADAM17 in PBECs from all groups.", {"entities": [[42, 48, "GENE"]]}], ["Interestingly, IL-8 production occurred independently from ADAM17 and TGF-\u03b1 shedding, but was significantly inhibited by broad-spectrum metalloproteinase inhibitor TAPI-2.", {"entities": [[59, 65, "GENE"]]}], ["CSE did not induce ADAM17-dependent TGF-\u03b1 shedding, while it slightly augmented the production of IL-8.", {"entities": []}], ["This was accompanied by reduced endogenous inhibitor of metalloproteinase (TIMP)-3 levels, suggesting that CSE does not directly but rather indirectly alter activity of ADAM17 through the regulation of its endogenous inhibitor.", {"entities": [[169, 175, "GENE"]]}], ["Furthermore, whereas baseline TGF-\u03b1 shedding was lower in COPD PBECs, the early release of IL-8 (likely due to its shedding) was higher in PBECs from COPD than healthy smokers.", {"entities": []}], ["Importantly, this was accompanied by lower TIMP-2 levels in COPD PBECs, while baseline TIMP-3 levels were similar between groups.", {"entities": []}], ["Our data indicate that IL-8 secretion is regulated independently from ADAM17 activity and TGF-\u03b1 shedding and that particularly its early release is differentially regulated in PBECs from COPD and healthy smokers.", {"entities": [[70, 76, "GENE"]]}], ["Since TIMP-2-sensitive metalloproteinases could potentially contribute to IL-8 release, these may be interesting targets to further investigate novel therapeutic strategies in COPD.", {"entities": []}], ["Angiopoietin-1 (Ang-1) is the primary agonist for Tie2 tyrosine kinase receptor (Tie2), and the effect of Ang-1-Tie2 signalling is context-dependent.", {"entities": []}], ["Deficiency in either Ang-1 or Tie2 protein leads to severe microvascular defects and subsequent embryonic lethality in murine model.", {"entities": []}], ["Tie2 receptors are expressed in several cell types, including endothelial cells, smooth muscle cells, fibroblasts, epithelial cells, monocytes, neutrophils, eosinophils and glial cells.", {"entities": []}], ["Ang-1-Tie2 signalling induces a chemotactic effect in smooth muscle cells, neutrophils and eosinophils, and induces differentiation of mesenchymal cells to smooth muscle cells.", {"entities": []}], ["Additionally, this signalling pathway induces the secretion of serotonin, matrix metalloproteinases (MMPs) and plasmin.", {"entities": []}], ["Ang-1 inhibits the secretion of tissue inhibitor of matrix metalloproteinase (TIMPs).", {"entities": []}], ["Aberrant expression and activity of Tie2 in vascular and non-vascular cells may result in the development of rheumatoid arthritis, cancer, hypertension and psoriasis.", {"entities": [[139, 151, "DISEASE"], [109, 129, "DISEASE"], [156, 165, "DISEASE"], [120, 129, "DISEASE"], [131, 137, "DISEASE"]]}], ["Ang-1 has an anti-inflammatory effect, when co-localized with vascular endothelial growth factor (VEGF) in the vasculature.", {"entities": []}], ["Thus, Ang-1 could be potentially important in the therapy of various pathological conditions such as pulmonary hypertension, arteriosclerosis and diabetic retinopathy.", {"entities": [[146, 166, "DISEASE"], [111, 123, "DISEASE"], [101, 123, "DISEASE"], [125, 141, "DISEASE"]]}], ["In this article, we have summarized and critically reviewed the pathophysiological role of Ang-1-Tie2 signalling pathway.", {"entities": []}], ["In the last decade the role of environmental factors as modulators of disease activity and progression has received increasing attention.", {"entities": []}], ["In contrast to classical environmental modulators such as exposure to sun-light or fine dust pollution, nutrition is an ideal tool for a personalized human intervention.", {"entities": []}], ["Various studies demonstrate a key role of dietary factors in autoimmune diseases including Inflammatory Bowel Disease (IBD), rheumatoid arthritis or inflammatory central nervous system (CNS) diseases such as Multiple Sclerosis (MS).", {"entities": [[125, 145, "DISEASE"], [136, 145, "DISEASE"]]}], ["In this review we discuss the connection between diet and inflammatory processes via the gut\u2013CNS-axis.", {"entities": []}], ["This axis describes a bi-directional communication system and comprises neuronal signaling, neuroendocrine pathways and modulation of immune responses.", {"entities": []}], ["Therefore, the gut\u2013CNS-axis represents an emerging target to modify CNS inflammatory activity ultimately opening new avenues for complementary and adjunctive treatment of autoimmune diseases such as MS.", {"entities": []}], ["Systemic inflammation is observed in horses with heaves and could also be present in horses with a lesser degree of pulmonary inflammation.", {"entities": []}], ["It was hypothesized that racehorses with inflammatory airway disease ( IAD ) have increased concentration of circulating acute phase proteins.", {"entities": []}], ["The objective of this study was to compare serum acute phase proteins of racehorses with and without lower airway inflammation.", {"entities": []}], ["Serum from 21 client\u2010owned Standardbred racehorses with exercise intolerance and lower airway inflammation and serum from 10 client\u2010owned Standardbred racehorses with exercise intolerance without lower airway inflammation.", {"entities": []}], ["In a case \u2013 control study, serum samples from previously characterized horses presented for exercise intolerance with or without lower airway inflammation based on bronchoalveolar lavage fluid cytology were analyzed for serum amyloid A protein ( SAA ), C\u2010reactive protein ( CRP ), and haptoglobin using commercial ELISA s. There was no significant differences between groups for SAA (non\u2010 IAD versus IAD , median (range): 3.47 (0.06\u201334.94) versus 6.33 (0.06\u201380) \u03bcg/mL, P \u00a0=\u00a0.49), CRP (10.87 (2.05\u201329.03) versus 4.63 (0.02\u201331.81) \u03bcg/mL, P \u00a0=\u00a0.23) or haptoglobin (900.36 (607.99\u20132018.84) versus 749.54 (530.81\u20131076.95) \u03bcg/mL, P \u00a0=\u00a0.09).", {"entities": [[274, 277, "GENE"], [480, 483, "GENE"], [274, 277, "GENE"], [480, 483, "GENE"]]}], ["In this population of poorly performing racehorses in training, serum SAA , CRP , and haptoglobin were not helpful in distinguishing between horses with IAD from horses with exercise intolerance from other causes.", {"entities": [[76, 79, "GENE"]]}], ["Although ethnomedically and taxonomically guided searches for new medicinal plants can improve the percentage of plants found containing active compounds when compared to random sampling, ethnobotany has fulfilled little of its promise in the last few decades to deliver a bounty of new, laboratory-proven medicinal plants and compounds.", {"entities": []}], ["It is quite difficult to test, isolate, and elucidate the structure and mechanism of compounds from the plethora of new medicinal plant uses described each year with limited laboratory time and resources and the high cost of clinical trials of new drug candidates.", {"entities": []}], ["A new quantitative theoretical framework of mathematical formulas called \"relational efficacy\" is proposed that should narrow down this search for new plant-derived medicines based on the hypothesis that closely related plants used to treat closely related diseases in distantly related cultures have a higher probability of being effective because they are more likely to be independent discoveries of similar plant compounds and disease mechanisms.", {"entities": []}], ["A prerequisite to this hypothesis, the idea that empirical testing in traditional medicine will lead to choosing similar medicinal plants and therefore the medicinal flora of two distant cultures will prove to be more similar than their general flora, is tested using resampling statistics on cross-cultural field data of the plants used by the Malink\u00e9 of Mali and the Ash\u00e1ninka of Peru to treat the diseases malaria, African sleeping sickness, Chagas' disease, leishmaniasis, diabetes, eczema, asthma, and uterine fibroids.", {"entities": [[462, 475, "DISEASE"], [409, 416, "DISEASE"], [426, 443, "DISEASE"], [495, 501, "DISEASE"]]}], ["In this case, the similarity of the medicinal floras is found to be significantly greater than the similarity of the general floras, but only when the diseases in question are grouped into the categories of parasitic and autoimmune diseases.", {"entities": []}], ["If the central theoretical framework of this hypothesis is shown to be true, it will allow the synthesis of medicinal plant information from around the world to pinpoint the species with the highest potential efficacy to take into the laboratory and analyze further, ultimately saving much field and laboratory time and resources.", {"entities": []}], ["Spanish abstract Las b\u00fasquedas que utilizan la etnomedicina y la taxonom\u00eda para descubrir nuevas plantas medicinales, pueden aumentar la probabilidad de \u00e9xito de encontrar compuestos qu\u00edmicos activos en plantas, en comparaci\u00f3n con las b\u00fasquedas aleatorias.", {"entities": []}], ["A pesar de lo anterior, en las \u00faltimas d\u00e9cadas, la etnobot\u00e1nica no ha cumplido con las expectativas de proveer numerosas plantas medicinales y qu\u00edmicos nuevos una vez examinados en el laboratorio.", {"entities": []}], ["Cada a\u00f1o se describen una pl\u00e9tora de plantas medicinales y sus usos, sin embargo las limitaciones de tiempo y recursos en los laboratorios, unidos al alto coste de los ensayos cl\u00ednicos de las drogas potenciales, hacen muy dif\u00edcil probar, aislar, y elucidar la estructura y el mecanismo de los compuestos de estas plantas.", {"entities": []}], ["Se propone un nuevo marco te\u00f3rico cuantitativo cuyo fin es focalizar la b\u00fasqueda de nueva plantas medicinales.", {"entities": []}], ["Este marco te\u00f3rico est\u00e1 basado en la hip\u00f3tesis que las plantas cercanamente relacionadas, usadas para tratar enfermedades cercanamente relacionadas en culturas distantemente relacionadas, tienen una eficacia potencial m\u00e1s alta, debido a que es m\u00e1s probable que estos hallazgos sean descubrimientos independientes de compuestos qu\u00edmicos similares.", {"entities": []}], ["Parte de esta hip\u00f3tesis, que las escogencias racionales se hacen para elegir plantas medicinales similares y que la flora medicinal de dos culturas distantes es m\u00e1s similar que su flora general, se prob\u00f3 usando m\u00e9todos estad\u00edsticos de remuestreo con datos de campo de la comunidad Malink\u00e9 de Mal\u00ed y de la Ash\u00e1ninka de Per\u00fa, y las enfermedades de paludismo, enfermedad africana del sue\u00f1o, enfermedad de Chagas, leishmania, diabetes, eczema, asma, y fibromas uterinos.", {"entities": []}], ["Se encontr\u00f3, en este caso, que la similitud de las floras medicinales es significativamente mayor a la similitud de las floras generales, solamente cuando las enfermedades analizadas se agruparon en las categor\u00edas de enfermedades parasitarias y enfermedades autoinmunes.", {"entities": []}], ["Si se demostrara que las otras partes de esta hip\u00f3tesis son ciertas, se podr\u00eda sintetizar la informaci\u00f3n sobre plantas medicinales alrededor del mundo, para establecer as\u00ed las plantas potencialmente m\u00e1s eficaces para llevarlas al laboratorio y analizarlas m\u00e1s profundamente.", {"entities": []}], ["French abstract Par rapport aux recherches men\u00e9es de fa\u00e7on al\u00e9atoire, les recherches effectu\u00e9es par des crit\u00e8res ethnobotaniques et taxonomiques ont de meilleures chances \u00e0 d\u00e9couvrir de nouvelles plantes m\u00e9dicinales \u00e0 produit chimique actifs.", {"entities": [[100, 103, "GENE"]]}], ["Pendant les derni\u00e8res d\u00e9cennies pourtant, l'ethnobotanique a r\u00e9alis\u00e9 peu de ces promesses \u00e0 r\u00e9v\u00e9ler un grand nombre de plantes m\u00e9dicinales et de nouveaux produits chimiques, test\u00e9s au laboratoire.", {"entities": []}], ["Avec les ressources limit\u00e9es pour la recherche au laboratoire et le co\u00fbt \u00e9lev\u00e9 des \u00e9preuves cliniques pour trouver de nouveaux candidats aux m\u00e9dicaments, il est difficile d'\u00e9tudier, d'isoler et d'\u00e9lucider la structure et le m\u00e9canisme des produits chimiques de chacune des nombreuses plantes m\u00e9dicinales (et les utilisations de ces plantes) d\u00e9crites chaque ann\u00e9e.", {"entities": [[79, 82, "GENE"], [234, 237, "GENE"], [268, 271, "GENE"], [79, 82, "GENE"], [234, 237, "GENE"], [268, 271, "GENE"], [79, 82, "GENE"], [234, 237, "GENE"], [268, 271, "GENE"]]}], ["Nous proposons une nouvelle technique th\u00e9orique et quantitative pour pr\u00e9ciser la recherche de nouvelles plantes m\u00e9dicinales; elle est bas\u00e9e sur l'hypoth\u00e8se que les plantes \u00e9troitement apparent\u00e9es, employ\u00e9es pour traiter les maladies \u00e9troitement apparent\u00e9es dans les cultures tr\u00e8s \u00e9loign\u00e9es les unes des autres, ont une potentialit\u00e9 d'efficacit\u00e9 sup\u00e9rieure parce qu'elles repr\u00e9sentent la d\u00e9couverte ind\u00e9pendante des propri\u00e9t\u00e9s chimiques semblables des plantes.", {"entities": [[299, 302, "GENE"], [411, 414, "GENE"], [447, 450, "GENE"], [299, 302, "GENE"], [411, 414, "GENE"], [447, 450, "GENE"], [299, 302, "GENE"], [411, 414, "GENE"], [447, 450, "GENE"]]}], ["Une partie de cette hypoth\u00e8se-qui d\u00e9montre que la s\u00e9lection des plantes m\u00e9dicinales semblables est un choix rationnel et qu'il y a davantage de ressemblance dans la flore m\u00e9dicinale de deux cultures \u00e9loign\u00e9es que dans leur flore g\u00e9n\u00e9rale-est examin\u00e9e par un re-\u00e9chantillonnage des donn\u00e9es de recherches effectu\u00e9es parmi les Malink\u00e9 au Mali et les Ash\u00e1ninka au P\u00e9rou, en particulier sur la malaria, la maladie africaine du sommeil, la maladie de Chagas, la leishmania, le diab\u00e8te, l'ecz\u00e9ma, l'asthme et les fibromes ut\u00e9rins.", {"entities": [[389, 396, "DISEASE"], [60, 63, "GENE"], [277, 280, "GENE"], [60, 63, "GENE"], [277, 280, "GENE"]]}], ["Dans ces cas pr\u00e9cis, la similitude de la flore m\u00e9dicinale s'av\u00e8re sensiblement plus grande que la similitude de la flore g\u00e9n\u00e9rale, mais seulement quand les maladies en question sont regroup\u00e9es ensemble comme maladies parasitaires et auto-immunitaires.", {"entities": []}], ["Si cette hypoth\u00e8se est prouv\u00e9e, elle permettra la synth\u00e8se des informations recueillies sur les plantes m\u00e9dicinales du monde entier pour en s\u00e9lectionner de fa\u00e7on plus pr\u00e9cise celles qui sont les plus efficaces et qui m\u00e9ritent analyse plus approfondie au laboratoire.", {"entities": [[59, 62, "GENE"]]}], ["Ash\u00e1ninka abstract Aayiantyarori ir\u00f2pero aavintane, ontzimatye ancovacovatero ayotero ovaqueraripaye incashi iyoyetziri ashaninka, ayotzityaro aajatzi iyotane viracocha paitachari \"quimica\" ancantero aaca oshintsinka inchashipaye.", {"entities": []}], ["Atziri yotacotzirori cametsa, ishtoriajacotzirori iyotane ashaninkapaye te iro\u00f1\u00e0rantero maaroni ocaratzi yamenacotaqueri laboratorioki.", {"entities": []}], ["Aaviantyarori cametsa, ayotacotero aavintarontsiyetatsiri osamani antzimaventero ishtoriatacotaro, aajatzi osheki opinata ampinaventero aparopaye inchashi, acoviriqui ayotacotero, osaretsikipaye.", {"entities": []}], ["Tzimatsi ovaquerari quenquishiriantsitatsiri ero opinata osheki ashitoriatacotero aparopaye inchashi, asampiyetatyrey pashinipaye atziri saicatsiri intaina puitarika inchasshi yavintari, ajatzirica oshiyaro ayotzi aaca, quemetachari atziri saikatsiri nampitsiki malinke aajatzi ishiyari ashaninka saicatsiri peruki, tzimatsi inchashi aajatzi yaavintari osheki okam\u00e8tsatzi aririka anteri mantsiyarentsi icantaitziri ompetarentsi catsirentsi, pochokirentsi, patsarontsi(matatsi) ashipetate maaroni, ampochavathate, ancainikentsite, oncatsithakite tsinani.", {"entities": []}], ["Aririka a\u00f1aker aajatzi ahiyaro inchashi yaavintayetari pashinipaye atziri intainasatzi irdotake ahitoriatacoperoteri an\u00e0ashityard aavintarontsi ovamairiri shithanentsi, on\u00e0shitaavintarontsi tzicaacoventairi ero antane mantsiyarentsi.", {"entities": []}], ["Omanperotatyarica ir\u00f2perotzi avintarontsi, oshitovake laboratorioki aritaque iyoitanaquero maaroni quipatsiki iroperori avintarontsi.", {"entities": []}], ["Intravenous immunoglobulin (IVIg) is currently in clinical study for Alzheimer\u2019s disease (AD).", {"entities": []}], ["However, preclinical investigations are required to better understand AD-relevant outcomes of IVIg treatment and develop replacement therapies in case of unsustainable supply.", {"entities": []}], ["We investigated the effects of IVIg in the 3xTg-AD mouse model, which reproduces both A\u03b2 and tau pathologies.", {"entities": []}], ["Mice were injected twice weekly with 1.5\u00a0g/kg IVIg for 1 or 3\u00a0months.", {"entities": []}], ["IVIg induced a modest but significant improvement in memory in the novel object recognition test and attenuated anxiety-like behavior in 3xTg-AD mice.", {"entities": []}], ["We observed a correction of immunologic defects present in 3xTg-AD mice (\u221222% CD4/CD8 blood ratio; \u221217% IL-5/IL-10 ratio in the cortex) and a modulation of CX3CR1 The memory-enhancing effect of IVIg reported here suggests that A\u03b2 oligomers, effector T cells and the fractalkine pathway are potential pharmacological targets of IVIg in AD.", {"entities": [[156, 162, "GENE"]]}], ["Angiogenic imbalance contributes to the development of preeclampsia.", {"entities": []}], ["We evaluated the protein expression of the proangiogenic placental growth factor (PlGF) and transforming growth factor beta 1 (TGF-\u03b2 1 ) compared with the anti-angiogenic soluble fms-like tyrosine kinase receptor (sFlt1) and soluble endoglin (sEng) in HIV-infected normotensive and pre-eclamptic pregnancies.", {"entities": []}], ["Blood was obtained from 110 pregnant women, enrolled in four groups, namely, HIV-negative normotensives (27); HIV-positive normotensives (31); HIV-negative pre-eclamptics (27) and HIV-positive pre-eclamptics (25), and was used to measure PlGF, TGF-\u03b21, sFlt1 and sEng levels.", {"entities": []}], ["Increased sFlt1 and sEng levels were associated with the pre-eclamptics (HIV negative and positive) compared with their counterparts.", {"entities": []}], ["Decreased PlGF levels were observed between the HIV-negative pre-eclamptics versus HIV-negative normotensives, but levels differed significantly ( p = 0.02) among the normotensives (HIV negative and positive).", {"entities": []}], ["TGF-\u03b2 1 remained unchanged across all groups.", {"entities": []}], ["Higher sEng/TGF-\u03b2 1 ratios were associated with the pre-eclamptics (HIV negative and positive) compared with their counterparts.", {"entities": []}], ["This study demonstrated increased sFlt1 and sEng levels in pre-eclamptic compared with normotensive pregnancies, irrespective of the HIV status.", {"entities": []}], ["Mechanical stress, including blood pressure related factors, up-regulate expression of the pro-angiogenic extracellular matrix protein tenascin-C in skeletal muscle.", {"entities": []}], ["We hypothesized that increased capillarization of skeletal muscle with the repeated augmentation in perfusion during endurance training is associated with blood vessel-related expression of tenascin-C and would be affected by the single-nucleotide polymorphism (SNP) rs2104772, which characterizes the non-synonymous exchange of thymidine (T)-to-adenosine (A) in the amino acid codon 1677 of tenascin-C .", {"entities": []}], ["Sixty-one healthy, untrained, male white participants of Swiss descent performed thirty 30-min bouts of endurance exercise on consecutive weekdays using a cycling ergometer.", {"entities": []}], ["Genotype and training interactions were called significant at Bonferroni-corrected p-value of 5% (repeated measures ANOVA).", {"entities": []}], ["Endurance training increased capillary-to-fiber-ratio (+11%), capillary density (+7%), and mitochondrial volume density (+30%) in m .", {"entities": []}], ["vastus lateralis .", {"entities": []}], ["Tenascin-C protein expression in this muscle was confined to arterioles and venules (80% of cases) and increased after training in A-allele carriers.", {"entities": []}], ["Prior to training, volume densities of subsarcolemmal and myofibrillar mitochondria in m .", {"entities": []}], ["vastus lateralis muscle were 49% and 18%, respectively, higher in A/A homozygotes relative to T-nucleotide carriers (A/T and T/T).", {"entities": []}], ["Training specifically increased capillary-to-fiber ratio in A-nucleotide carriers but not in T/T homozygotes.", {"entities": []}], ["Genotype specific regulation of angiogenesis was reflected by the expression response of 8 angiogenesis-associated transcripts after exercise, and confirmed by training-induced alterations of the shear stress related factors, vimentin and VEGF A.", {"entities": []}], ["Our findings provide evidence for a negative influence of T/T homozygosity in rs2104772 on capillary remodeling with endurance exercise.", {"entities": []}], ["Pre-eclampsia (PE) is a serious multi-factorial disorder of human pregnancy.", {"entities": [[4, 13, "DISEASE"]]}], ["It is associated with changes in the expression of placental genes.", {"entities": []}], ["Recent transcription profiling of placental genes with microarray analyses have offered better opportunities to define the molecular pathology of this disorder.", {"entities": []}], ["However, the extent to which placental gene expression changes in PE is not fully understood.", {"entities": []}], ["We conducted a systematic review of published PE and normal pregnancy (NP) control placental RNA microarrays to describe the similarities and differences between NP and PE placental gene expression, and examined how these differences could contribute to the molecular pathology of the disease.", {"entities": []}], ["A total of 167 microarray samples were available for meta-analysis.", {"entities": []}], ["We found the expression pattern of one group of genes was the same in PE and NP.", {"entities": []}], ["The review also identified a set of genes (PE unique genes) including a subset, that were significantly (p < 0.05) down-regulated in pre-eclamptic placentae only.", {"entities": []}], ["Using class prediction analysis, we further identified the expression of 88 genes that were highly associated with PE (p < 0.05), 10 of which (LEP, HTRA4, SPAG4, LHB, TREM1, FSTL3, CGB, INHA, PROCR, and LTF) were significant at p < 0.001.", {"entities": [[143, 146, "GENE"], [148, 153, "GENE"], [155, 160, "GENE"], [162, 165, "GENE"], [167, 172, "GENE"], [174, 179, "GENE"], [181, 184, "GENE"], [186, 190, "GENE"], [192, 197, "GENE"], [203, 206, "GENE"]]}], ["Our review also suggested that about 30% of genes currently being investigated as possibly of importance in PE placenta were not consistently and significantly affected in the PE placentae.", {"entities": []}], ["We recommend further work to confirm the roles of the PE unique and associated genes, currently not being investigated in the molecular pathology of the disease.", {"entities": []}], ["Several association studies have shown that -844 G/A and HindIII C/G PAI-1 polymorphisms are related with increase of PAI-1 levels, obesity, insulin resistance, glucose intolerance, hypertension and dyslipidemia, which are components of metabolic syndrome.", {"entities": [[182, 194, "DISEASE"], [161, 180, "DISEASE"], [132, 139, "DISEASE"], [247, 255, "DISEASE"]]}], ["The aim of this study was to analyze the allele and genotype frequencies of these polymorphisms in PAI-1 gene and its association with metabolic syndrome and its components in a sample of Mexican mestizo children.", {"entities": [[145, 153, "DISEASE"]]}], ["This study included 100 children with an age range between 6-11 years divided in two groups: a) 48 children diagnosed with metabolic syndrome and b) 52 children metabolically healthy without any clinical and biochemical alteration.", {"entities": [[133, 141, "DISEASE"]]}], ["Metabolic syndrome was defined as the presence of three or more of the following criteria: fasting glucose levels \u2265 100 mg/dL, triglycerides \u2265 150 mg/dL, HDL-cholesterol < 40 mg/dL, obesity BMI \u2265 95 HindIII C/G PAI-1 polymorphisms were analyzed by PCR-RFLP.", {"entities": [[182, 189, "DISEASE"], [10, 18, "DISEASE"]]}], ["For the -844 G/A polymorphism, the G/A genotype (OR = 2.79; 95% CI, 1.11-7.08; p = 0.015) and the A allele (OR = 2.2; 95% CI, 1.10-4.43; p = 0.015) were associated with metabolic syndrome.", {"entities": [[179, 187, "DISEASE"]]}], ["The -844 G/A and A/A genotypes were associated with increase in plasma triglycerides levels (OR = 2.6; 95% CI, 1.16 to 6.04; p = 0.02), decrease in plasma HDL-cholesterol levels (OR = 2.4; 95% CI, 1.06 to 5.42; p = 0.03) and obesity (OR = 2.6; 95% CI, 1.17-5.92; p = 0.01).", {"entities": [[225, 232, "DISEASE"]]}], ["The C/G and G/G genotypes of the HindIII C/G polymorphism contributed to a significant increase in plasma total cholesterol levels (179 vs. 165 mg/dL; p = 0.02) in comparison with C/C genotype.", {"entities": []}], ["The -844 G/A PAI-1 polymorphism is related with the risk of developing metabolic syndrome, obesity and atherogenic dyslipidemia, and the HindIII C/G PAI-1 polymorphism was associated with the increase of total cholesterol levels in Mexican children.", {"entities": [[91, 98, "DISEASE"], [81, 89, "DISEASE"]]}], ["The notion that family support may buffer individuals under adversity from poor outcomes has been theorized to have important implications for mental and physical health, but little is known about the biological mechanisms that explain these links.", {"entities": []}], ["We hypothesized that adults who grew up in low socioeconomic status (SES) households but who experienced high levels of maternal warmth would be protected from the pro-inflammatory states typically associated with low SES.", {"entities": []}], ["53 healthy adults (ages 25\u201340) low in SES early in life were assessed on markers of immune activation and systemic inflammation.", {"entities": []}], ["Genome-wide transcriptional profiling also was conducted.", {"entities": []}], ["Low early life SES individuals who had mothers who expressed high warmth toward them exhibited less Toll-like receptor-stimulated production of interleukin 6, and reduced bioinformatic indications of pro-inflammatory transcription factor activity (NF-\u03baB) and immune activating transcription factor activity (AP-1) compared to those who were low SES early in life but experienced low maternal warmth.", {"entities": []}], ["To the extent that such effects are causal, they suggest the possibility that the detrimental immunologic effects of low early life SES environments may be partly diminished through supportive family climates.", {"entities": []}], ["The early inflammatory response to influenza virus infection contributes to severe lung disease and continues to pose a serious threat to human health.", {"entities": [[35, 44, "DISEASE"], [83, 95, "DISEASE"]]}], ["The mechanisms by which neutrophils gain entry to the respiratory tract and their role during pathogenesis remain unclear.", {"entities": []}], ["Here, we report that neutrophils significantly contributed to morbidity in a pathological mouse model of influenza virus infection.", {"entities": [[105, 114, "DISEASE"]]}], ["Using extensive immunohistochemistry, bone marrow transfers, and depletion studies, we identified neutrophils as the predominant pulmonary cellular source of the gelatinase matrix metalloprotease (MMP) 9, which is capable of digesting the extracellular matrix.", {"entities": []}], ["Furthermore, infection of MMP9-deficient mice showed that MMP9 was functionally required for neutrophil migration and control of viral replication in the respiratory tract.", {"entities": [[26, 30, "GENE"], [58, 62, "GENE"]]}], ["Although MMP9 release was toll-like receptor (TLR) signaling-dependent, MyD88-mediated signals in non-hematopoietic cells, rather than neutrophil TLRs themselves, were important for neutrophil migration.", {"entities": [[9, 13, "GENE"]]}], ["These results were extended using multiplex analyses of inflammatory mediators to show that neutrophil chemotactic factor, CCL3, and TNF\u03b1 were reduced in the Myd88 in vivo reduced neutrophil recruitment after infection.", {"entities": [[123, 127, "GENE"], [158, 163, "GENE"]]}], ["Innate recognition of influenza virus therefore provides the mechanisms to induce recruitment of neutrophils through chemokines and to enable their motility within the tissue via MMP9-mediated cleavage of the basement membrane.", {"entities": [[22, 31, "DISEASE"]]}], ["Our results demonstrate a previously unknown contribution of MMP9 to influenza virus pathogenesis by mediating excessive neutrophil migration into the respiratory tract in response to viral replication that could be exploited for therapeutic purposes.", {"entities": [[69, 78, "DISEASE"], [61, 65, "GENE"]]}], ["Influenza-associated morbidity and mortality due to yearly epidemics and sporadic, devastating pandemics are a significant health and economic burden.", {"entities": [[0, 9, "DISEASE"]]}], ["Severe complications arising from highly virulent viruses are associated with rapid, massive inflammatory cell infiltration.", {"entities": []}], ["Although neutrophils are the predominant cell population recruited to the lung in response to pandemic influenza viruses, the mechanisms by which they gain entry to the respiratory tract remain unclear.", {"entities": [[103, 112, "DISEASE"]]}], ["In this study, we show a previously unknown contribution of MMP9 to influenza pathogenesis by mediating excessive neutrophil migration into the lung, which not only controls viral replication, but also contributes to morbidity.", {"entities": [[68, 77, "DISEASE"], [60, 64, "GENE"]]}], ["The in vivo relevance of MMP9-derived enzymatic activity in neutrophils is controversial and understudied, but our data provide new evidence that innate recognition of influenza virus attracts neutrophils that secrete MMP9, which enables them to traverse the basement membrane of the lung by digesting the extracellular matrix.", {"entities": [[168, 177, "DISEASE"], [25, 29, "GENE"], [218, 222, "GENE"]]}], ["The dichotomy of MMP9 function in immunity versus pathology provides real challenges for targeting MMP9 for therapeutic purposes.", {"entities": [[17, 21, "GENE"], [99, 103, "GENE"], [17, 21, "GENE"], [99, 103, "GENE"]]}], ["Nevertheless, finding the balance to modulate neutrophil numbers following influenza virus infection will allow for innate immunity to be boosted whilst preventing pathology associated with pandemic strains.", {"entities": [[75, 84, "DISEASE"]]}], ["Long-term oxygen therapy (LTOT) has been shown to prolong survival and to improve quality of life in patients with chronic obstructive pulmonary disease (COPD) and in respiratory failure.", {"entities": [[167, 186, "DISEASE"], [115, 152, "DISEASE"]]}], ["In Northern Ireland oxygen concentrators have been available on prescription since August 1986, initially on a restricted basis from hospital physicians only.", {"entities": []}], ["This was followed by open prescribing from April 1989, when concentrators could be prescribed by general practitioners.", {"entities": []}], ["This study examined prescribing habits of LTOT during both periods, and patient survival.", {"entities": []}], ["Case notes of all prescriptions of oxygen concentrators in Northern Ireland (to April 1991) were reviewed.", {"entities": []}], ["Prescription criteria and advice regarding usage during both periods were analysed.", {"entities": []}], ["A questionnaire survey of subjects during open prescribing documented the advice given at the time of prescription and current usage.", {"entities": []}], ["164 charts of 178 total installations were available for review.", {"entities": []}], ["During both periods many concentrators were installed without adherence to the prescribing criteria at the time (75% restricted, 48% open).", {"entities": []}], ["The majority of these were on the advice of a consultant respiratory physician and only 14 were prescribed directly by GPs.", {"entities": []}], ["89 of 91 subjects receiving current LTOT during the study period completed questionnaires.", {"entities": []}], ["Of the subjects prescribed LTOT during the restricted period, 2 subjects are still alive (median survival 19 m, range 0-104).", {"entities": []}], ["From the open period, survival data was available on 107 of 129 subjects with 17 still alive (median survival 22 m, range 0-94).", {"entities": []}], ["This study documents an inadequate rate of prescribing and a lack of conformity to guidelines in the provision of LTOT in Northern Ireland.", {"entities": []}], ["We would suggest that familiarisation with the prescribing criteria, formal written advice at the time of prescription, appropriate follow up to ensure adequate supplementation and regular patient education on the use of LTOT would address these problems to a substantial degree.", {"entities": []}], ["High incidences of neck pain morbidity are challenging in various situations for populations based on their demographic, physiological and pathological characteristics.", {"entities": []}], ["Chinese proprietary herbal medicines, as Complementary and Alternative Medicine (CAM) products, are usually developed from well-established and long-standing recipes formulated as tablets or capsules.", {"entities": []}], ["However, good quantification and strict standardization are still needed for implementation of individualized therapies.", {"entities": []}], ["The Qishe pill was developed and has been used clinically since 2009.", {"entities": []}], ["The Qishe pill\u2019s personalized medicine should be documented and administered to various patients according to the ancient TCM system, a classification of personalized constitution types, established to determine predisposition and prognosis to diseases as well as therapy and life-style administration.", {"entities": []}], ["Therefore, we describe the population pharmacokinetic profile of the Qishe pill and compare its metabolic rate in the three major constitution types ( Qi- Deficiency, Yin -Deficiency and Blood- Stasis) to address major challenges to individualized standardized TCM.", {"entities": []}], ["Healthy subjects (N = 108) selected based on constitutional types will be assessed, and standardized pharmacokinetic protocol will be used for assessing demographic, physiological, and pathological data.", {"entities": []}], ["Laboratory biomarkers will be evaluated and blood samples collected for pharmacokinetics(PK) analysis and second-generation gene sequencing.", {"entities": []}], ["In single-dose administrations, subjects in each constitutional type cohort (N = 36) will be randomly divided into three groups to receive different Qishe pill doses (3.75, 7.5 and 15 grams).", {"entities": []}], ["Multiomics, including next generation sequencing, metabolomics, and proteomics, will complement the Qishe pill\u2019s multilevel assessment, with cytochrome P450 genes as targets.", {"entities": []}], ["In a comparison with the general population, a systematic population pharmacokinetic (PopPK) model for the Qishe pill will be established and verified.", {"entities": []}], ["This study is registered at ClinicalTrials.gov, NCT02294448 .15 November 2014.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-015-0568-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Indoor size-fractioned particulate matter (PM) was measured in seven schools in Milan, to characterize their concentration levels in classrooms, compare the measured concentrations with the recommended guideline values, and provide a preliminary assessment of the efficacy of the intervention measures, based on the guidelines developed by the Italian Ministry of Healthand applied to mitigate exposure to undesirable air pollutants.", {"entities": []}], ["Indoor sampling was performed from Monday morning to Friday afternoon in three classrooms of each school and was repeated in winter 2011\u20132012 and 2012\u20132013.", {"entities": []}], ["Simultaneously, PM 2.5 samples were also collected outdoors.", {"entities": []}], ["Two different photometers were used to collect the PM continuous data, which were corrected a posteriori using simultaneous gravimetric PM 2.5 measurements.", {"entities": []}], ["Furthermore, the concentrations of carbon dioxide (CO 2 ) were monitored and used to determine the Air Exchange Rates in the classrooms.", {"entities": []}], ["The results revealed poor IAQ in the school environment.", {"entities": []}], ["In several cases, the PM 2.5 and PM 10 24 h concentrations exceeded the 24 h guideline values established by the World Health Organization (WHO).", {"entities": []}], ["In addition, the indoor CO 2 levels often surpassed the CO 2 ASHRAE Standard.", {"entities": []}], ["Our findings confirmed that important indoor sources (human movements, personal clouds, cleaning activities) emitted coarse particles, markedly increasing the measured PM during school hours.", {"entities": []}], ["In general, the mean PM 2.5 indoor concentrations were lower than the average outdoor PM 2.5 levels, with I/O ratios generally <1.", {"entities": []}], ["Fine PM was less affected by indoor sources, exerting a major impact on the PM 1 \u20132.5 fraction.", {"entities": []}], ["Over half of the indoor fine particles were estimated to originate from outdoors.", {"entities": []}], ["To a first approximation, the intervention proposed to reduce indoor particle levels did not seem to significantly influence the indoor fine PM concentrations.", {"entities": []}], ["Conversely, the frequent opening of doors and windows appeared to significantly contribute to the reduction of the average indoor CO 2 levels.", {"entities": []}], ["We sought to assess whether the effects of mesenchymal stromal cells (MSC) on lung inflammation and remodeling in experimental emphysema would differ according to MSC source and administration route.", {"entities": [[70, 73, "GENE"], [163, 166, "GENE"], [70, 73, "GENE"], [163, 166, "GENE"]]}], ["Emphysema was induced in C57BL/6 mice by intratracheal (IT) administration of porcine pancreatic elastase (0.1 UI) weekly for 1\u00a0month.", {"entities": []}], ["After the last elastase instillation, saline or MSCs (1\u00d710", {"entities": []}], ["Little is known about using electronic medical records to identify patients with chronic obstructive pulmonary disease to improve quality of care.", {"entities": [[81, 118, "DISEASE"]]}], ["Our objective was to develop electronic medical record algorithms that can accurately identify patients with obstructive pulmonary disease.", {"entities": []}], ["A retrospective chart abstraction study was conducted on data from the Electronic Medical Record Administrative data Linked Database (EMRALD Researchers develop an algorithm that can accurately search through electronic health records to find patients with chronic lung disease.", {"entities": [[265, 277, "DISEASE"]]}], ["Mining population-wide data for information on patients diagnosed and treated with chronic obstructive pulmonary disease (COPD) in primary care could help inform future healthcare and spending practices.", {"entities": [[83, 120, "DISEASE"]]}], ["Theresa Lee at the University of Toronto, Canada, and colleagues used an algorithm to search electronic medical records and identify patients with COPD from doctors\u2019 notes, prescriptions and symptom histories.", {"entities": []}], ["They carefully adjusted the algorithm to improve sensitivity and predictive value by adding details such as specific medications, physician codes related to COPD, and different combinations of terminology in doctors\u2019 notes.", {"entities": []}], ["The team accurately identified 364 patients with COPD in a randomly-selected cohort of 5889 people.", {"entities": []}], ["Their results suggest opportunities for broader, informative studies of COPD in wider populations.", {"entities": []}], ["C57BL/6 mice have attenuated allergic airway hyperresponsiveness (AHR) when compared with Balb/c mice but the underlying mechanisms remain unclear.", {"entities": [[66, 69, "GENE"]]}], ["SP-D, an innate immune molecule with potent immunosuppressive activities may have an important modulatory role in the allergic airway response and the consequent physiological changes.", {"entities": []}], ["We hypothesized that an elevated SP-D production is associated with the impaired ability of C57BL/6 mice to develop allergic AHR.", {"entities": [[125, 128, "GENE"]]}], ["SP-D mRNA and protein expression was investigated during development of allergic airway changes in a model of Aspergillus fumigatus ( Af )-induced allergic inflammation.", {"entities": []}], ["To study whether strain dependency of allergic AHR is associated with different levels of SP-D in the lung, Balb/c and C57BL/6 mice were compared.", {"entities": [[47, 50, "GENE"]]}], ["Sensitization and exposure to Af induced significant airway inflammation in both mouse strains in comparison with na\u00efve controls.", {"entities": []}], ["AHR to acetylcholine however was significantly attenuated in C57BL/6 mice in spite of increased eosinophilia and serum IgE when compared with Balb/c mice (p < 0.05).", {"entities": [[96, 108, "DISEASE"], [0, 3, "GENE"]]}], ["Af challenge of sensitized C57BL/6 mice induced a markedly increased SP-D protein expression in the SA surfactant fraction (1,894 \u00b1 170% of na\u00efve controls) that was 1.5 fold greater than the increase in Balb/c mice (1,234 \u00b1 121% p < 0.01).", {"entities": []}], ["These changes were selective since levels of the hydrophobic SP-B and SP-C and the hydrophilic SP-A were significantly decreased following sensitization and challenge with Af in both strains.", {"entities": []}], ["Further, sensitized and exposed C57BL/6 mice had significantly lower IL-4 and IL-5 in the BAL fluid than that of Balb/c mice (p < 0.05).", {"entities": []}], ["These results suggest that enhanced SP-D production in the lung of C57BL/6 mice may contribute to an attenuated AHR in response to allergic airway sensitization.", {"entities": [[112, 115, "GENE"]]}], ["SP-D may act by inhibiting synthesis of Th2 cytokines.", {"entities": []}], ["There is interest among agencies and public health practitioners in the United States (USA) to estimate the future burden of climate-related health outcomes.", {"entities": []}], ["Calculating disease burden projections can be especially daunting, given the complexities of climate modeling and the multiple pathways by which climate influences public health.", {"entities": []}], ["Interdisciplinary coordination between public health practitioners and climate scientists is necessary for scientifically derived estimates.", {"entities": []}], ["We describe a unique partnership of state and regional climate scientists and public health practitioners assembled by the Florida Building Resilience Against Climate Effects (BRACE) program.", {"entities": []}], ["We provide a background on climate modeling and projections that has been developed specifically for public health practitioners, describe methodologies for combining climate and health data to project disease burden, and demonstrate three examples of this process used in Florida.", {"entities": []}], ["How the immune system senses aeroallergens and triggers an aberrant inflammation is poorly understood.", {"entities": []}], ["Dectin-2 is a house dust mite (HDM)-sensing pattern recognition receptor.", {"entities": []}], ["In a 3-week mouse model of repeated intranasal HDM challenge, anti-Dectin-2 potently attenuated the characteristic allergic inflammation and airway hyper-responsiveness.", {"entities": []}], ["Anti-Dectin-2 also prevented neutrophil influx following a single HDM challenge.", {"entities": []}], ["Interestingly, cysteinyl leukotrienes, but not chemokine and cytokine levels were inhibited by anti-Dectin-2 in this acute model, and in ex vivo challenge of cultured alveolar macrophages with HDM.", {"entities": []}], ["Furthermore in the single-challenge model, zileuton, an inhibitor of leukotriene production, produced a similar effect as Dectin-2 blockade.", {"entities": []}], ["Together these data suggest alveolar macrophage sensing of HDM by Dectin-2 elicits the production of cysteinyl leukotrienes, and this axis is key for the initiation of airway inflammation to this aeroallergen.", {"entities": []}], ["Finally, we found Dectin-2-positive infiltrating cells present in bronchial biopsies from asthmatic subjects.", {"entities": []}], ["Maintenance and repeated pulmonary rehabilitation programs (PRPs) for patients with COPD have attempted to prolong PRP benefits beyond 12\u201324 months.", {"entities": []}], ["However, there is limited evidence as to the magnitude of benefit or the ideal interval between repeating the program under \u201creal-world\u201d conditions in which patients are referred based on clinical necessity.", {"entities": []}], ["Therefore, we reviewed the effects of repeating PRP in a physician-referred cohort of patients with COPD.", {"entities": []}], ["A total of 141 individuals with COPD completed PRP twice and 35 completed PRP three times over a 12-year period.", {"entities": []}], ["We used linear mixed-effects models to quantify the magnitude and change in 6-minute walk distance (6MWD), St George\u2019s Respiratory Questionnaire (SGRQ), and Hospital Anxiety and Depression Scale (HADS) for each PRP.", {"entities": []}], ["One-way analysis of variance with Tukey\u2019s post hoc analysis compared the effects of different time intervals on 6MWD, SGRQ, and HADS between PRPs.", {"entities": []}], ["Despite 39 mL/year average decrease in forced expiratory volume in 1 second, overall 6MWD improved following each PRP (PRP1=58 m, P <0.0001; PRP2=42 m, P <0.0001; PRP3=32 m, P <0.003).", {"entities": []}], ["Mean SGRQ decreased after PRP1 (\u22127.0 units; P <0.001) and PRP2 (\u22124.9 units; P <0.0001) but not after PRP3 (\u22123.2 units; P =0.10).", {"entities": []}], ["HADS decreased after PRP1 (\u22121.9 units; P <0.0001) and PRP2 (\u22121.7 units; P =0.0001) but not after PRP3 (\u22120.4 units; P =0.63).", {"entities": []}], ["In physician-referred patients who underwent repeat PRP as clinically required, there were clear benefits in functional exercise capacity following each repeat PRP, which was not affected by the time interval between PRPs.", {"entities": []}], ["Health-related quality of life and mood improved after the first two PRPs, but not after a third.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) accounts for around 4% of all public hospital annual admissions in Hong Kong.", {"entities": []}], ["By year 2020, COPD will be ranked fifth among the conditions with the highest burden to the society.", {"entities": []}], ["This study identifies admission and unplanned readmission of COPD patients, factors affecting unplanned readmission, and estimates its cost burden on the public healthcare system in Hong Kong.", {"entities": []}], ["This is a retrospective study analyzing COPD admissions to all public hospitals in Hong Kong.", {"entities": []}], ["All admission episodes to acute medical wards with the principal diagnosis of COPD (ICD-9:490-492, 494-496) from January 2006 to December 2007 were captured.", {"entities": []}], ["Unplanned readmission was defined as an admission which followed a previous admission within 30 days.", {"entities": []}], ["In 2006 and 2007, 65497 (8.0%) of episodes from medical wards were identified as COPD admissions, and among these, 15882 (24.2%) were unplanned readmissions.", {"entities": []}], ["The mean age of COPD patients was 76.81 \u00b1 9.59 years and 77% were male.", {"entities": []}], ["Unplanned readmission was significantly associated with male gender, receiving public assistance and living in nursing homes while no association was found with the Charlson comorbidity index.", {"entities": []}], ["Patients who were readmitted unplanned had a significant longer acute length of stay (\u03b2 = 0.3894, P < 0.001) after adjustment for other covariates.", {"entities": []}], ["Unplanned readmission of COPD patients has a huge impact on the public healthcare system.", {"entities": []}], ["A systematic approach in programme provision and a good discharge planning process targeting on COPD patients who are at high risk of unplanned readmission are essential.", {"entities": []}], ["In severe humoral immunodeficiency the indication for antibody replacement therapy (ART) is clear, and supported by several large studies.", {"entities": []}], ["However, for milder forms of humoral immunodeficiency, the indication for ART is less clear.", {"entities": []}], ["This is a retrospective cohort study of 87 adults with recurrent respiratory tract infections who received ART.", {"entities": []}], ["The patients had severe or mild humoral immunodeficiency, and were followed up for a median of 62\u00a0months.", {"entities": []}], ["Infection frequency, pharmacy-registered antibiotics use and hospital admissions significantly decreased under ART compared to the year prior to starting ART (median 5.50 (anamnestically)\u20130.82 (physician-confirmed) infections/year, p \u00a0<\u00a00.001; median 4.00\u20132.05\u00a0antibiotics\u00a0courses/year, p \u00a0<\u00a00.001; mean 0.75\u20130.44\u00a0hospital\u00a0admissions/year, p \u00a0=\u00a00.009).", {"entities": []}], ["These beneficial effects of ART were seen in both severe and mild immunodeficiency.", {"entities": []}], ["Bronchiectasis was present in 27 patients when ART was started, but was not associated with clinical outcomes.", {"entities": []}], ["An increase in hospital admissions under ART, observed in some patients, was significantly associated with pulmonary emphysema and current smoking.", {"entities": [[107, 126, "DISEASE"]]}], ["In conclusion, this study shows that ART is a long-term effective therapy in adults with recurrent respiratory tract infections with severe as well as with milder forms of humoral immunodeficiency.", {"entities": []}], ["\u2022 Long-time follow up of 87 adult primary antibody deficiency patients treated with antibody replacement therapy is reported.", {"entities": []}], ["\u2022 Treatment leads to a significant decline in infection frequency, pharmacy-registered antibiotics use and hospital admissions.", {"entities": []}], ["\u2022 This beneficial effect was seen in both patients with severe and milder forms of immune deficiency.", {"entities": []}], ["Long-time follow up of 87 adult primary antibody deficiency patients treated with antibody replacement therapy is reported.", {"entities": []}], ["Treatment leads to a significant decline in infection frequency, pharmacy-registered antibiotics use and hospital admissions.", {"entities": []}], ["This beneficial effect was seen in both patients with severe and milder forms of immune deficiency.", {"entities": []}], ["Patients with recurrent respiratory tract infections can have a primary antibody deficiency, characterized by reduced specificities of circulating antibodies.", {"entities": []}], ["Antibody replacement therapy can prevent infections in these patients.", {"entities": []}], ["The evidence supporting antibody replacement therapy is weaker for mild than for severe primary antibody deficiency.", {"entities": []}], ["In this study of 87 patients with mild and severe primary antibody deficiency, antibody replacement therapy lead to a significant decrease in infections, antibiotics use and hospital admissions during a median follow up period of 62\u00a0months.", {"entities": []}], ["Thus, this study supports the use of antibody replacement therapy, also in patients with mild primary antibody deficiency.", {"entities": []}], ["Fatigue is a common complaint after stroke.", {"entities": []}], ["Reasons for higher prevalence are still unclear.", {"entities": []}], ["This study aimed to determine if fatigue prevalence in stroke patients is different to that of age and gender matched general population controls, and to explore whether early motor activity was associated with reduced likelihood of fatigue three months after stroke.", {"entities": []}], ["This was a prospective multicenter cohort study of stroke patients admitted to eleven regional Norwegian hospitals, within 14\u00a0days after stroke.", {"entities": []}], ["Stroke patients ( n \u2009=\u2009257) were age and gender matched to participants in a general population health survey (HUNT3-survey) carried out in a regional county of central Norway.", {"entities": []}], ["The single-item fatigue questionnaire from the HUNT3-survey was administered to both groups to compare prevalence.", {"entities": []}], ["The association between early motor activity ( time in bed, time sitting out of bed , and time upright) and fatigue at three months after stroke (Fatigue Severity Scale) was tested with logistic regression.", {"entities": []}], ["Simple models including each activity outcome, with adjustment for stroke severity and pre-stroke function, were tested, as well as a comprehensive model that included additional independent variables of depression, pain, pre-stroke fatigue, age and gender.", {"entities": []}], ["Prevalence was higher after stroke compared with the general population: 31.1\u00a0% versus 10.9\u00a0%.", {"entities": []}], ["In the simple regression models, none of the early motor activity categories were associated with fatigue three months after stroke.", {"entities": []}], ["In the comprehensive model, depression, pain and pre-stroke fatigue were significantly associated with post-stroke fatigue.", {"entities": []}], ["Time in bed through the daytime during hospital stay approached statistical significance ( p \u2009=\u20090.058) with an odds ratio for experiencing fatigue of 1.02 (95 % CI 1.00-1.04) for each additional 5.4\u00a0minutes in bed.", {"entities": []}], ["Stroke patients had higher prevalence of fatigue three months after stroke than the age and gender matched general population sample, which may be partly explained by the stroke population being in poorer health overall.", {"entities": []}], ["The relationship between early motor activity (and inactivity) and fatigue remains unclear.", {"entities": []}], ["Further research, which may help drive development of new treatments to target this challenging condition, is needed.", {"entities": []}], ["Pax6 is a key regulator of the entire cascade of ocular lens formation through specific binding to promoters and enhancers of batteries of target genes.", {"entities": [[0, 4, "GENE"]]}], ["The promoters and enhancers communicate with each other through DNA looping mediated by multiple protein\u2013DNA and protein\u2013protein interactions and are marked by specific combinations of histone posttranslational modifications (PTMs).", {"entities": [[226, 230, "GENE"]]}], ["Enhancers are distinguished from bulk chromatin by specific modifications of core histone H3, including H3K4me1 and H3K27ac, while promoters show increased H3K4me3 PTM.", {"entities": []}], ["Previous studies have shown the presence of Pax6 in as much as 1/8 of lens-specific enhancers but a much smaller fraction of tissue-specific promoters.", {"entities": [[44, 48, "GENE"]]}], ["Although Pax6 is known to interact with EP300/p300 histone acetyltransferase responsible for generation of H3K27ac, a potential link between Pax6 and histone H3K4 methylation remains to be established.", {"entities": [[9, 13, "GENE"], [141, 145, "GENE"], [9, 13, "GENE"], [141, 145, "GENE"]]}], ["Here we show that Pax6 co-purifies with H3K4 methyltransferase activity in lens cell nuclear extracts.", {"entities": [[18, 22, "GENE"]]}], ["Proteomic studies show that Pax6 immunoprecipitates with Set1a, Mll1, and Mll2 enzymes, and their associated proteins, i.e., Wdr5, Rbbp5, Ash2l, and Dpy30.", {"entities": [[28, 32, "GENE"], [74, 78, "GENE"], [125, 129, "GENE"], [131, 136, "GENE"], [138, 143, "GENE"], [149, 154, "GENE"]]}], ["ChIP-seq studies using chromatin prepared from mouse lens and cultured lens cells demonstrate that Pax6-bound regions are mostly enriched with H3K4me2 and H3K4me1 in enhancers and promoters, though H3K4me3 marks only Pax6-containing promoters.", {"entities": []}], ["The shRNA-mediated knockdown of Pax6 revealed down-regulation of a set of direct target genes, including Cap2 , Farp1 , Pax6 , Plekha1 , Prox1 , Tshz2 , and Zfp536 .", {"entities": [[32, 36, "GENE"], [120, 124, "GENE"], [105, 109, "GENE"], [112, 117, "GENE"], [32, 36, "GENE"], [120, 124, "GENE"], [127, 134, "GENE"], [137, 142, "GENE"], [145, 150, "GENE"]]}], ["Pax6 knockdown was accompanied by reduced H3K4me1 at enhancers and H3K4me3 at promoters, with little or no changes of the H3K4me2 modifications.", {"entities": [[0, 4, "GENE"]]}], ["These changes were prominent in Plekha1 , a gene regulated by Pax6 in both lens and retinal pigmented epithelium.", {"entities": [[32, 39, "GENE"], [62, 66, "GENE"]]}], ["Our study supports a general model of Pax6-mediated recruitment of histone methyltransferases Mll1 and Mll2 to lens chromatin, especially at distal enhancers.", {"entities": [[103, 107, "GENE"]]}], ["Genome-wide data in lens show that Pax6 binding correlates with H3K4me2, consistent with the idea that H3K4me2 PTMs correlate with the binding of transcription factors.", {"entities": [[35, 39, "GENE"], [111, 115, "GENE"]]}], ["Importantly, partial reduction of Pax6 induces prominent changes in local H3K4me1 and H3K4me3 modification.", {"entities": [[34, 38, "GENE"]]}], ["Together, these data open the field to mechanistic studies of Pax6, Mll1, Mll2, and H3K4me1/2/3 dynamics at distal enhancers and promoters of developmentally controlled genes.", {"entities": [[62, 66, "GENE"], [74, 78, "GENE"]]}], ["The online version of this article (doi:10.1186/s13072-016-0087-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["MicroRNAs (miRNAs) are a class of non-protein-coding genes that play a crucial regulatory role in mammalian development and disease.", {"entities": []}], ["Whereas a large number of miRNAs have been annotated at the structural level during the latest years, functional annotation is sparse.", {"entities": []}], ["Actinobacillus pleuropneumoniae (APP) causes serious lung infections in pigs.", {"entities": [[33, 36, "GENE"]]}], ["Severe damage to the lungs, in many cases deadly, is caused by toxins released by the bacterium and to some degree by host mediated tissue damage.", {"entities": []}], ["However, understanding of the role of microRNAs in the course of this infectious disease in porcine is still very limited.", {"entities": []}], ["In this study, the RNA extracted from visually unaffected and necrotic tissue from pigs infected with Actinobacillus pleuropneumoniae was subjected to small RNA deep sequencing.", {"entities": []}], ["We identified 169 conserved and 11 candidate novel microRNAs in the pig.", {"entities": []}], ["Of these, 17 were significantly up-regulated in the necrotic sample and 12 were down-regulated.", {"entities": []}], ["The expression analysis of a number of candidates revealed microRNAs of potential importance in the innate immune response.", {"entities": []}], ["MiR-155, a known key player in inflammation, was found expressed in both samples.", {"entities": [[0, 7, "GENE"]]}], ["Moreover, miR-664-5p, miR-451 and miR-15a appear as very promising candidates for microRNAs involved in response to pathogen infection.", {"entities": [[22, 29, "GENE"], [34, 41, "GENE"]]}], ["This is the first study revealing significant differences in composition and expression profiles of miRNAs in lungs infected with a bacterial pathogen.", {"entities": []}], ["Our results extend annotation of microRNA in pig and provide insight into the role of a number of microRNAs in regulation of bacteria induced immune and inflammatory response in porcine lung.", {"entities": []}], ["The aim was to compare the diagnosis of COPD among smokers according to different international guidelines and to compare the outcome when using slow (SVC) and forced vital capacity (FVC).", {"entities": []}], ["In order to find current smokers a questionnaire was sent to persons who had been on sick leave for more than two weeks.", {"entities": []}], ["Those who smoked more than 8 cigarettes per day were invited to perform a spirometry.", {"entities": []}], ["Totally 3,887 spirometries were performed.", {"entities": []}], ["In this sample 10.2% fulfilled the NICE COPD-criteria, 14.0% the GOLD COPD-criteria and 21.7% the ERS COPD criteria.", {"entities": []}], ["The diagnosis according to NICE and GOLD guidelines is based on FVC and in the ERS guidelines the best value of either SVC or FVC is used.", {"entities": []}], ["Thus, substantially more subjects with COPD were found when the best of either SVC or FVC was used.", {"entities": []}], ["Forced VC tended to be higher than SVC when lung function was normal and in those with mild obstruction prior to bronchodilatation whereas SVC exceeded FVC after bronchodilatation in those who had severe bronchial obstruction.", {"entities": []}], ["The diagnosis of COPD is highly depending on which guidelines are used for defining the disease.", {"entities": []}], ["If FVC and not the best of SVC and FVC is used when defining COPD the diagnosis will be missed in a substantial number of patients.", {"entities": []}], ["Lipopolysaccharide (endotoxin, LPS) is a strong inducer of the innate immune response.", {"entities": []}], ["It is widespread in our environment, e.g.", {"entities": []}], ["in house dust and contributes to asthma.", {"entities": [[33, 39, "DISEASE"]]}], ["Compared to humans, horses are even more sensitive to LPS.", {"entities": []}], ["However, data on LPS effects on the equine transcriptome are very limited.", {"entities": []}], ["Using RNA-seq we analysed LPS-induced differences in the gene expression in equine peripheral blood mononuclear cells at the gene and gene-network level in two half-sib families and one group of unrelated horses.", {"entities": []}], ["24\u00a0h-LPS challenge of equine immune cells resulted in substantial changes in the transcriptomic profile (1,265 differentially expressed genes) showing partial overlap with human data.", {"entities": []}], ["One of the half-sib families showed a specific response different from the other two groups of horses.", {"entities": []}], ["We also identified co-expressed gene modules that clearly differentiated 24\u00a0h-LPS- from non-stimulated samples.", {"entities": []}], ["These modules consisted of 934 highly interconnected genes and included genes involved in the immune response (e.g.", {"entities": []}], ["IL6 , CCL22 , CXCL6, CXCL2 ), however, none of the top ten hub genes of the modules have been annotated as responsive to LPS in gene ontology.", {"entities": [[0, 3, "GENE"], [6, 11, "GENE"], [14, 19, "GENE"], [21, 26, "GENE"]]}], ["Using weighted gene co-expression network analysis we identified ten co-expressed gene modules significantly regulated by in vitro stimulation with LPS.", {"entities": []}], ["Apart from 47 genes (5%) all other genes highly interconnected within the most up- and down-regulated modules were also significantly differentially expressed (FDR\u2009<\u20090.05).", {"entities": []}], ["The LPS-regulated module hub genes have not yet been described as having a role in the immune response to LPS (e.g.", {"entities": []}], ["VAT1 and TTC25 ).", {"entities": [[0, 4, "GENE"], [9, 14, "GENE"]]}], ["The online version of this article (doi:10.1186/s12864-016-3390-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Many studies have evaluated methicillin-resistant Staphylococcus aureus (MRSA) infections during single hospitalizations and subsequent readmissions to the same institution.", {"entities": []}], ["None have assessed the comprehensive burden of MRSA infection in the period after hospital discharge while accounting for healthcare utilization across institutions.", {"entities": []}], ["We conducted a retrospective cohort study of adult patients insured by Harvard Pilgrim Health Care who were newly-detected to harbor MRSA between January 1991 and December 2003 at a tertiary care medical center.", {"entities": []}], ["We evaluated all MRSA-attributable infections associated with hospitalization in the year following new detection, regardless of hospital location.", {"entities": []}], ["Data were collected on comorbidities, healthcare utilization, mortality and MRSA outcomes.", {"entities": []}], ["Of 591 newly-detected MRSA carriers, 23% were colonized and 77% were infected upon detection.", {"entities": []}], ["In the year following detection, 196 (33%) patients developed 317 discrete and unrelated MRSA infections.", {"entities": []}], ["The most common infections were pneumonia (34%), soft tissue (27%), and primary bloodstream (18%) infections.", {"entities": [[32, 41, "DISEASE"]]}], ["Infections occurred a median of 56 days post-detection.", {"entities": []}], ["Of all infections, 26% involved bacteremia, and 17% caused MRSA-attributable death.", {"entities": []}], ["During the admission where MRSA was newly-detected, 14% (82/576) developed subsequent infection.", {"entities": []}], ["Of those surviving to discharge, 24% (114/482) developed post-discharge infections in the year following detection.", {"entities": []}], ["Half (99/185, 54%) of post-discharge infections caused readmission, and most (104/185, 55%) occurred over 90 days post-discharge.", {"entities": []}], ["In high-risk tertiary care patients, newly-detected MRSA carriage confers large risks of infection and substantial attributable mortality in the year following acquisition.", {"entities": []}], ["Most infections occur post-discharge, and 18% of infections associated with readmission occurred in hospitals other than the one where MRSA was newly-detected.", {"entities": []}], ["Despite gains in reducing MRSA infections during hospitalization, the risk of MRSA infection among critically and chronically ill carriers persists after discharge and warrants targeted prevention strategies.", {"entities": []}], ["Human milk is an important source of bacteria for the developing infant and has been shown to influence the bacterial composition of the neonate, which in turn can affect disease risk later in life.", {"entities": []}], ["Very little is known about what factors shape the human milk microbiome.", {"entities": []}], ["The goal of the present study was to examine the milk microbiota from a range of women who delivered vaginally or by caesarean (C) section, who gave birth to males or females, at term or preterm.", {"entities": []}], ["Milk was collected from 39 Caucasian Canadian women, and microbial profiles were analyzed by 16S ribosomal RNA (rRNA) sequencing using the Illumina platform.", {"entities": []}], ["A diverse community of milk bacteria was found with the most dominant phyla being Proteobacteria and Firmicutes and at the genus level, Staphylococcus , Pseudomonas , Streptococcus and Lactobacillus .", {"entities": []}], ["Comparison of bacterial profiles between preterm and term births, C section (elective and non-elective) and vaginal deliveries, and male and female infants showed no statistically significant differences.", {"entities": []}], ["The study revealed the diverse bacterial types transferred to newborns.", {"entities": []}], ["We postulate that there may be a fail-safe mechanism whereby the mother is \u201cready\u201d to pass along her bacterial imprint irrespective of when and how the baby is born.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-015-0145-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Clinical documentation systems, such as templates, have been associated with process utilization.", {"entities": []}], ["The T-System emergency department (ED) templates are widely used but lacking are analyses of the templates association with processes.", {"entities": []}], ["This system is also unique because of the many different template options available, and thus the selection of the template may also be important.", {"entities": []}], ["We aimed to describe the selection of templates in ED dizziness presentations and to investigate the association between items on templates and process utilization.", {"entities": []}], ["Dizziness visits were captured from a population-based study of EDs that use documentation templates.", {"entities": []}], ["Two relevant process outcomes were assessed: head computerized tomography (CT) scan and nystagmus examination.", {"entities": []}], ["Multivariable logistic regression was used to estimate the probability of each outcome for patients who did or did not receive a relevant-item template.", {"entities": []}], ["Propensity scores were also used to adjust for selection effects.", {"entities": []}], ["The final cohort was 1,485 visits.", {"entities": []}], ["Thirty-one different templates were used.", {"entities": []}], ["Use of a template with a head CT item was associated with an increase in the adjusted probability of head CT utilization from 12.2% (95% CI, 8.9%-16.6%) to 29.3% (95% CI, 26.0%-32.9%).", {"entities": []}], ["The adjusted probability of documentation of a nystagmus assessment increased from 12.0% (95%CI, 8.8%-16.2%) when a nystagmus-item template was not used to 95.0% (95% CI, 92.8%-96.6%) when a nystagmus-item template was used.", {"entities": []}], ["The associations remained significant after propensity score adjustments.", {"entities": []}], ["Providers use many different templates in dizziness presentations.", {"entities": []}], ["Important differences exist in the various templates and the template that is used likely impacts process utilization, even though selection may be arbitrary.", {"entities": []}], ["The optimal design and selection of templates may offer a feasible and effective opportunity to improve care delivery.", {"entities": []}], ["Growth factor induced signaling cascades are key regulatory elements in tissue development, maintenance and regeneration.", {"entities": []}], ["Perturbations of these cascades have severe consequences, leading to developmental disorders and neoplastic diseases.", {"entities": []}], ["As a major function in signal transduction, activating mutations in RAF family kinases are the cause of human tumorigenesis, where B-RAF V600E has been identified as the prevalent mutant.", {"entities": []}], ["In order to address the oncogenic function of B-RAF V600E, we have generated transgenic mice expressing the activated oncogene specifically in lung alveolar epithelial type II cells.", {"entities": []}], ["Constitutive expression of B-RAF V600E caused abnormalities in alveolar epithelium formation that led to airspace enlargements.", {"entities": []}], ["These lung lesions showed signs of tissue remodeling and were often associated with chronic inflammation and low incidence of lung tumors.", {"entities": []}], ["The inflammatory cell infiltration did not precede the formation of the lung lesions but was rather accompanied with late tumor development.", {"entities": []}], ["These data support a model where the continuous regenerative process initiated by oncogenic B-RAF-driven alveolar disruption provides a tumor-promoting environment associated with chronic inflammation.", {"entities": []}], ["We investigated the efficacy and safety of AZD3199, a novel inhaled ultra-LABA, with the main aim of establishing a dose that would maintain 24-hour bronchodilation in patients with COPD.", {"entities": []}], ["Patients (n\u2009=\u2009329) were randomized to AZD3199 (200, 400 or 800 \u03bcg o.d.", {"entities": []}], ["), formoterol (9 \u03bcg b.i.d.)", {"entities": []}], ["or placebo via Turbuhaler\u00ae in a parallel group study.", {"entities": []}], ["The primary objective of the study was to compare the clinical efficacy of three doses of AZD3199 inhaled once daily with 9 \u03bcg formoterol twice daily and placebo, over a 4-week treatment period in adults with moderate-to-severe COPD.", {"entities": []}], ["After 4 weeks, peak (0\u20134 h) and trough (24\u201326 h) forced expiratory volume in 1 second (FEV 1 ) were assessed as the primary efficacy outcome variables.", {"entities": [[87, 90, "GENE"]]}], ["All AZD3199 doses significantly increased mean peak and trough FEV 1 versus placebo (106\u2013171 ml and 97\u2013110 ml increases, respectively), but with no clear dose\u2013response; the level of bronchodilation was comparable to or greater than that achieved with formoterol.", {"entities": [[63, 66, "GENE"]]}], ["Forced vital capacity (FVC) at peak bronchodilation also significantly increased with AZD3199 versus placebo (153\u2013204 ml).", {"entities": []}], ["COPD symptom scores and reliever use were reduced with AZD3199, while FEV 1 reversibility was unaltered.", {"entities": [[70, 73, "GENE"]]}], ["Adverse events were mild-to-moderate, with no safety concerns identified.", {"entities": []}], ["Drug exposure was dose-proportional, but lower than predicted from healthy volunteers.", {"entities": []}], ["All three doses of AZD3199 produced 24-hour bronchodilation, but with no clear dose\u2013response, suggesting that doses of 200 \u03bcg or less may be sufficient to maintain bronchodilation over 24 hours in patients with COPD.", {"entities": []}], ["No safety concerns were identified.", {"entities": []}], ["Further studies are required to determine the once-daily AZD3199 dose for COPD.", {"entities": []}], ["Clinicaltrials.gov, NCT00929708", {"entities": []}], ["Our objective was to assess the impact of obstetric mode of delivery, and in particular birth by Caesarean section (CS), on school performance in adolescents using a large, population-based cohort.", {"entities": [[116, 118, "GENE"]]}], ["We extracted data from the Swedish Medical Birth Register and National School Register.", {"entities": []}], ["We included all live singleton births in Sweden from 1982\u20131995 ( n \u2009=\u20091,489,925).", {"entities": []}], ["School grades were reported on a scale from 0 to 320, scores less than 160 (i.e.", {"entities": []}], ["\u201cpass\u201d) were considered to be \u201cpoor school performance.\u201d Mode of delivery was categorised as: unassisted vaginal delivery (VD), assisted VD, elective CS and emergency CS.", {"entities": [[150, 152, "GENE"], [167, 169, "GENE"], [150, 152, "GENE"], [167, 169, "GENE"]]}], ["We measured the association between mode of delivery and \u201cpoor school performance\u201d using logistic regression.", {"entities": []}], ["We then used quantile regression to assess the association between mode of delivery and school performance across the distribution of scores.", {"entities": []}], ["We adjusted for maternal age, parity, small and large for gestational age, gestational age, maternal country of birth, maternal depression, non-affective disorder or bipolar disorder, parental income at time of birth, and parental social welfare at time of birth.", {"entities": [[166, 182, "DISEASE"]]}], ["We also conducted sensitivity analyses to investigate the association further.", {"entities": []}], ["With logistic regression analysis, the adjusted odds ratio (aOR) of assisted VD and poor school performance, compared to unassisted VD, was 1.06 (95% CI: 1.03\u20131.08).", {"entities": []}], ["For elective CS it was 1.06 (95% CI:1.03-1.09) and for emergency CS it was 1.12 (95% CI: 1.09\u20131.15).", {"entities": [[13, 15, "GENE"], [65, 67, "GENE"], [13, 15, "GENE"], [65, 67, "GENE"]]}], ["With quantile regression, assisted VD showed little difference in scores, when compared to unassisted VD, at any point across the distribution.", {"entities": []}], ["Elective CS was associated with a 1\u20133 point decrease in scores, and emergency CS was associated with a 2\u20135 point decrease in scores.", {"entities": [[9, 11, "GENE"], [78, 80, "GENE"], [9, 11, "GENE"], [78, 80, "GENE"]]}], ["A slight association was found between birth by CS and school performance.", {"entities": [[48, 50, "GENE"]]}], ["However, the effect was quite small and given the complex nature of the relationship, should be interpreted with caution.", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-017-1304-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To examine recent time trends in the incidence of osteonecrosis (ON) in Denmark and to investigate different common comorbidities association with ON in a population-based setting.", {"entities": [[50, 63, "DISEASE"]]}], ["Using Danish medical databases, we included all patients with a first-time hospital diagnosis of ON during 1995\u20132012.", {"entities": []}], ["Each ON case was matched with 10 randomly selected population control subjects from general population.", {"entities": []}], ["For all participants, we obtained a complete hospital history of comorbidities included in the CharlsonComorbidity Index 5 years preceding the inclusion date.", {"entities": []}], ["4107 ON cases and 41\u2009063 controls were included.", {"entities": []}], ["The incidence of ON increased from 3.9 in 1995 to 5.5 in 2012 per 100\u2009000 inhabitants.", {"entities": []}], ["Solid cancer was the most common comorbidity, associated with an adjusted OR (aOR) for ON of 2.0 (95% CI 1.7 to 2.2).", {"entities": [[6, 12, "DISEASE"]]}], ["For advanced metastatic cancer, leukaemia and lymphoma, aORs of ON were 3.4 (95% CI 2.5 to 4.5), 4.3 (95% CI 2.7 to 7.0) and 5.8 (95% CI 4.3 to 7.8), respectively.", {"entities": [[46, 54, "DISEASE"], [24, 30, "DISEASE"]]}], ["Among other chronic conditions, aORs were 3.5 (95% CI 3.0 to 4.1) for connective tissue diseases and 2.3 (95% CI 2.0 to 2.7) for chronic pulmonary diseases.", {"entities": []}], ["aORs were also increased at 2.8 (95% CI 1.9 to 4.1) and 4.5 (95% CI 2.5 to 8.2) for mild and moderate-to-severe liver disease, respectively, and 4.2 (95% CI 3.4 to 5.2) for renal disease.", {"entities": [[112, 125, "DISEASE"]]}], ["This large population-based study provides evidence for an increasing ON incidence in the general population and documents an association between several common comorbid conditions and risk of ON.", {"entities": []}], ["The human microbiome is the collection of bacteria, viruses, and fungi that live on and in the human organism\u2019s skin, mucosa, and intestinal tract.", {"entities": []}], ["Re-examining commonly accepted ethical standards from the perspective of this new area of research provides an opportunity to reassess our current thinking about research regulations as well as the importance of some principles and distinctions.", {"entities": []}], ["In this commentary, I explain ethical issues illuminated by research on the human microbiome related to personal identity, privacy, property, research ethics, public health, and biobanks.", {"entities": []}], ["Heat shock proteins (HSPs) have been shown to modulate NF-\u03baB activation.", {"entities": []}], ["It is unknown whether HSP70 plays a role in modulating NF-\u03baB-mediated pro-inflammatory cytokines released from alveolar macrophage (AM) of patients with active pulmonary tuberculosis (TB).", {"entities": [[170, 182, "DISEASE"], [160, 182, "DISEASE"]]}], ["Peripheral blood monocytes (PBMs) and AM were sampled from nineteen active TB patients and 14 healthy individuals.", {"entities": []}], ["HSP70 expression was 3-fold higher in AMs of active TB patients than normal subjects, and declined after receiving 3-month anti-TB treatment.", {"entities": []}], ["Overexpression of HSP70 by transfection with HSP70 plasmid decreased p-I\u03baB\u03b1 and p65 NF-\u03baB activities.", {"entities": []}], ["Inhibition of NF-\u03baB activation using NF-\u03baB or MAPK inhibitors increased HSP70 expression in AM of TB patients.", {"entities": []}], ["Blocking p38- or ERK-MAPK decreased NF-\u03baB and I\u03baB activities, leading to up-regulated HSP70 expression.", {"entities": []}], ["Overexpression of HSP70 alone or with p38 or ERK inhibitors decreased TNF-\u03b1 (57%, 83% and 74%, respectively) and IL-6 (53%, 70%, and 67%, respectively) release from macrophages of TB patients.", {"entities": []}], ["In conclusion, HSP70 modulates NF-\u03baB activation in AM of TB patients, through inhibiting I\u03baB-\u03b1 phosphorylation or acting as a chaperon molecule to prevent NF-\u03baB binding to the target genes by facilitating degradation.", {"entities": []}], ["The upregulated HSP70 may suppress the release of pro-inflammatory cytokines during active PTB infection, and prevent overwhelming tissue damage.", {"entities": []}], ["Main study aim was as follows: (1) to explore the usefulness of the theory of planned behaviour (TPB) model in predicting Chinese hospital pharmacists' intention to provide clinical pharmacy services (CPSs), including auxiliary CPSs and core CPSs; (2) to identify the main factors affecting the Chinese hospital pharmacists' intention to provide core CPSs based on TPB quantitatively.", {"entities": []}], ["Cross-sectional questionnaire study.", {"entities": []}], ["The study was conducted in 22 general hospitals in seven cities located in the eastern and western part of China.", {"entities": []}], ["416 hospital pharmacists (292 (70.2%) female) entered and completed the study.", {"entities": []}], ["Quantitative responses with hospital pharmacists' intention, attitude, subjective norms (SNs) and perceived behavioural control (PBC) over provision of CPSs and their past behaviour (PB)-related CPSs.", {"entities": []}], ["The structural equation model analysis found that attitude (p=0.0079, \u03b2=0.12), SN (p=0.038, \u03b2=0.10) and the pharmacists' intention to provide auxiliary CPSs (p=0.0001, \u03b2=0.63) significantly predicted of their intention to provide core CPSs, accounting for 54.0% of its variance.", {"entities": []}], ["Attitude (p=0.0001, \u03b2=0.35), PBC (p=0.0182, \u03b2=0.12) and PB (p=0.0009, \u03b2=0.15) are significant predictors of pharmacists' intention, accounting for 21% of the variance in pharmacists' intention to provide auxiliary CPSs.", {"entities": []}], ["The TPB with the addition of PB is a useful framework for predicting pharmacists' intention to provide CPSs in Chinese hospital care context.", {"entities": []}], ["Strategies to improve hospital pharmacists' intention to provide CPSs should focus on helping the individuals related medical care see the value of CPSs, altering their perception of social pressure towards core CPSs and the removal of obstacles that impede the translation of intentions into behaviour.", {"entities": []}], ["Non-celiac gluten sensitivity (NCGS) or \u2018wheat sensitivity\u2019 (NCWS) is included in the spectrum of gluten-related disorders.", {"entities": []}], ["No data are available on the prevalence of low bone mass density (BMD) in NCWS.", {"entities": []}], ["Our study aims to evaluate the prevalence of low BMD in NCWS patients and search for correlations with other clinical characteristics.", {"entities": []}], ["This prospective observation study included 75 NCWS patients (63 women; median age 36\u00a0years) with irritable bowel syndrome (IBS)-like symptoms, 65 IBS and 50 celiac controls.", {"entities": [[98, 122, "DISEASE"], [114, 122, "DISEASE"]]}], ["Patients were recruited at two Internal Medicine Departments.", {"entities": []}], ["Elimination diet and double-blind placebo controlled (DBPC) wheat challenge proved the NCWS diagnosis.", {"entities": []}], ["All subjects underwent BMD assessment by Dual Energy X-Ray Absorptiometry (DXA), duodenal histology, HLA DQ typing, body mass index (BMI) evaluation and assessment for daily calcium intake.", {"entities": [[101, 104, "GENE"]]}], ["DBPC cow's milk proteins challenge showed that 30 of the 75 NCWS patients suffered from multiple food sensitivity.", {"entities": []}], ["Osteopenia and osteoporosis frequency increased from IBS to NCWS and to celiac disease (CD) ( P <0.0001).", {"entities": [[72, 86, "DISEASE"], [15, 27, "DISEASE"]]}], ["Thirty-five NCWS patients (46.6%) showed osteopenia or osteoporosis.", {"entities": [[55, 67, "DISEASE"]]}], ["Low BMD was related to low BMI and multiple food sensitivity.", {"entities": []}], ["Values of daily dietary calcium intake in NCWS patients were significantly lower than in IBS controls.", {"entities": []}], ["An elevated frequency of bone mass loss in NCWS patients was found; this was related to low BMI and was more frequent in patients with NCWS associated with other food sensitivity.", {"entities": []}], ["A low daily intake of dietary calcium was observed in patients with NCWS.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-014-0230-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We aim to determine 2012\u201313 seasonal influenza vaccination coverage.", {"entities": [[37, 46, "DISEASE"]]}], ["Data were analyzed by age group and by coexistence of concomitant chronic conditions.", {"entities": []}], ["Factors associated with vaccine uptake were identified.", {"entities": []}], ["We also analyze a possible trend in vaccine uptake in post pandemic seasons.", {"entities": []}], ["We used computerized immunization registries and clinical records of the entire population of the Autonomous Community of Madrid, Spain (6\u2009284\u2009128 persons) as data source.", {"entities": []}], ["A total of 871\u2009631 individuals were vaccinated (13.87%).", {"entities": []}], ["Coverage for people aged \u2265 65 years was 56.57%.", {"entities": []}], ["Global coverage in people with a chronic condition was 15.7% in children and 18.69% in adults aged 15\u201359 years.", {"entities": []}], ["The variables significantly associated with a higher likelihood of being vaccinated in the 2012\u201313 campaign for the age groups studied were higher age, being Spanish-born, higher number of doses of seasonal vaccine received in previous campaigns, uptake of pandemic vaccination, and having a chronic condition.", {"entities": []}], ["We conclude that vaccination coverage in persons aged &lt;60 years with chronic conditions is less than acceptable.", {"entities": [[55, 57, "GENE"]]}], ["The very low coverage among children with chronic conditions calls for urgent interventions.", {"entities": []}], ["Among those aged \u226560 years, uptake is higher but still far from optimal and seems to be descending in post-pandemic campaigns.", {"entities": []}], ["For those aged \u226565 years the mean percentage of decrease from the 2009/10 to the actual campaign has been 12%.", {"entities": []}], ["Computerized clinical and immunization registers are useful tools for providing rapid and detailed information about influenza vaccination coverage in the population.", {"entities": [[117, 126, "DISEASE"]]}], ["Social media is emerging as an insightful platform for studying health.", {"entities": []}], ["To develop targeted health interventions involving social media, we sought to identify the patient demographic and disease predictors of frequency of posting on Facebook.", {"entities": []}], ["The aims were to explore the language topics correlated with frequency of social media use across a cohort of social media users within a health care setting, evaluate the differences in the quantity of social media postings across individuals with different disease diagnoses, and determine if patients could accurately predict their own levels of social media engagement.", {"entities": []}], ["Patients seeking care at a single, academic, urban, tertiary care emergency department from March to October 2014 were queried on their willingness to share data from their Facebook accounts and electronic medical records (EMRs).", {"entities": []}], ["For each participant, the total content of Facebook posts was extracted.", {"entities": []}], ["Using the latent Dirichlet allocation natural language processing technique, Facebook language topics were correlated with frequency of Facebook use.", {"entities": []}], ["The mean number of Facebook posts over 6 months prior to enrollment was then compared across validated health outcomes in the sample.", {"entities": []}], ["A total of 695 patients consented to provide access to their EMR and social media data.", {"entities": []}], ["Significantly correlated language topics among participants with the highest quartile of posts contained health terms, such as \u201ccough,\u201d \u201cheadaches,\u201d and \u201cinsomnia.\u201d When adjusted for demographics, individuals with a history of depression had significantly higher posts (mean 38, 95% CI 28-50) than individuals without a history of depression (mean 22, 95% CI 19-26, P =.001).", {"entities": []}], ["Except for depression, across prevalent health outcomes in the sample (hypertension, diabetes, asthma), there were no significant posting differences between individuals with or without each condition.", {"entities": [[71, 83, "DISEASE"], [95, 101, "DISEASE"]]}], ["High-frequency posters in our sample were more likely to post about health and to have a diagnosis of depression.", {"entities": []}], ["The direction of causality between depression and social media use requires further evaluation.", {"entities": []}], ["Our findings suggest that patients with depression may be appropriate targets for health-related interventions on social media.", {"entities": []}], ["A myotonometer can objectively quantify changes in muscle tone.", {"entities": []}], ["The between-days intra-rater reliability in a ward setting for the acute stroke population remains unknown.", {"entities": []}], ["This study aimed to investigate the device\u2019s between-days intra-rater reliability when used in a ward setting for acute stroke participants.", {"entities": []}], ["Muscle tone of biceps brachii, brachioradialis, rectus femoris, and tibialis anterior was recorded in the ward at bedside by one physiotherapist on two consecutive days.", {"entities": []}], ["This study included participants who were within 1 month of their first stroke occurrence.", {"entities": []}], ["Participants who were medically unstable or who suffered from brain stem injury were excluded.", {"entities": []}], ["Reliability was assessed by the intraclass correlation coefficient (ICC), standard error of measurement (SEM), smallest real difference (SRD), and the Bland-Altman limits of agreement.", {"entities": []}], ["The results indicated excellent between-days intra-rater reliability (ICC\u2009>\u20090.75).", {"entities": []}], ["SEM and SRD show small differences between measurements.", {"entities": []}], ["The Bland-Altman analysis indicated a tendency of overestimation of the rectus femoris.", {"entities": []}], ["MyotonPRO demonstrated acceptable reliability when used in a ward setting in those patients with acute stroke.", {"entities": []}], ["However, results should be interpreted with caution, due to the limitations of the study and the varying level of consistency observed between different muscles.", {"entities": []}], ["Occult bronchial foreign body can be very difficult to diagnose early in an adult patient without acute symptoms.", {"entities": []}], ["This report describes a rare case of undetected Chinese medicine \u201cCoptis chinensis\u201d aspiration for 10 long years.", {"entities": []}], ["A case was reported that a female patient complained of a 10-year history of productive cough.", {"entities": []}], ["A battery of tests were given to confirm the diagnosis.", {"entities": []}], ["Chest computed tomography (CT) showed extensive bronchiectasis and multiple nodules, along with stenosis of left lower lobar bronchus.", {"entities": [[48, 62, "DISEASE"]]}], ["An extensive solid lesion with surrounding inflammatory granulation tissue was seen on her first bronchoscopy and biopsy revealed chronic mucosal inflammation.", {"entities": []}], ["A neglected history of Coptis chinensis regularly kept in-mouth while sleeping for the last 10 years in this patient provided clues for a final diagnosis.", {"entities": []}], ["Confirmatory diagnosis of bilateral tracheobronchial foreign bodies caused by recurrent inhalation of Coptis chinensis was made by a second bronchoscopy.", {"entities": []}], ["This case clearly demonstrates that a precise medical history is often overlooked.", {"entities": []}], ["A high index of suspicion, a precise medical history, radiographic features of chronic respiratory symptoms not explained by other conditions were keys to diagnosing this case.", {"entities": []}], ["Background: Childhood stunting usually begins in utero and continues after birth; therefore, its reduction must involve actions across different stages of early life.", {"entities": []}], ["Objective: We evaluated the efficacy of small-quantity, lipid-based nutrient supplements (SQ-LNSs) provided during pregnancy, lactation, and infancy on attained size by 18 mo of age.", {"entities": []}], ["Design: In this partially double-blind, individually randomized trial, 1320 women at \u226420 wk of gestation received standard iron and folic acid (IFA group), multiple micronutrients (MMN group), or SQ-LNS (LNS group) daily until delivery, and then placebo, MMNs, or SQ-LNS, respectively, for 6 mo postpartum; infants in the LNS group received SQ-LNS formulated for infants from 6 to 18 mo of age (endline).", {"entities": []}], ["The primary outcome was child length by 18 mo of age.", {"entities": []}], ["Results: At endline, data were available for 85% of 1228 infants enrolled; overall mean length and length-for-age z score (LAZ) were 79.3 cm and \u22120.83, respectively, and 12% of the children were stunted (LAZ <\u22122).", {"entities": []}], ["In analysis based on the intended treatment, mean \u00b1 SD length and LAZ for the LNS group (79.7 \u00b1 2.9 cm and \u22120.69 \u00b1 1.01, respectively) were significantly greater than for the IFA (79.1 \u00b1 2.9 cm and \u22120.87 \u00b1 0.99) and MMN (79.1 \u00b1 2.9 cm and \u22120.91 \u00b1 1.01) groups ( P = 0.006 and P = 0.009, respectively).", {"entities": []}], ["Differences were also significant for weight and weight-for-age z score but not head or midupper arm circumference, and the prevalence of stunting in the LNS group was 8.9%, compared with 13.7% in the IFA group and 12.9% in the MMN group ( P = 0.12).", {"entities": []}], ["In analysis based on actual supplement provided at enrollment, stunting prevalences were 8.9% compared with 15.1% and 11.5%, respectively ( P = 0.045).", {"entities": []}], ["Conclusion: Provision of SQ-LNSs to women from pregnancy to 6 mo postpartum and to their infants from 6 to 18 mo of age may increase the child\u2019s attained length by age 18 mo in similar settings.", {"entities": []}], ["This trial was registered at clinicaltrials.gov as NCT00970866.", {"entities": []}], ["The present study was aimed to evaluate the analgesic and anti-inflammatory properties of Castanospermum australe and to profile phytochemicals by GC-MS.", {"entities": []}], ["The ethanolic extracts were prepared by successive solvent extraction using Soxhlet apparatus.", {"entities": []}], ["The analgesic activity was analyzed by hot plate method and acetic acid-induced writhing test whereas anti-inflammatory study was done by carrageenan induced paw oedema model.", {"entities": []}], ["The acute toxicity study revealed that ethanol extracts of leaf and bark of C. australe were safe even at a higher dose of 2000\u2009mg/kg whereas ethanol extract of seed was toxic at the same dose.", {"entities": []}], ["In both hot plate method (5.85\u2009s) and acetic acid-induced writhing test (57%), the leaf ethanol extract exhibited significant analgesic activity ( P < 0.001) at a dose of 400\u2009mg/kg.", {"entities": []}], ["The anti-inflammatory activity of leaf extract was exhibited by the reduction in paw linear diameter by 64.76% at 400\u2009mg/kg in carrageenan induced paw oedema.", {"entities": []}], ["The GC-MS analysis of the ethanol extract of leaf revealed sixteen major compounds of which 1,7-dimethyl-4,10-dioxa-1,7-diazacyclododecane, (+)-N-methylephedrine, and permethylspermine were found to be pharmaceutically and the most important.", {"entities": []}], ["These findings justify that C. australe can be a valuable natural analgesic and anti-inflammatory source which seemed to provide potential phytotherapeutics against various ailments.", {"entities": []}], ["Maoto, a traditional Japanese Kampo medicine, has been used to treat various respiratory diseases, including respiratory infections and influenza.", {"entities": [[136, 145, "DISEASE"]]}], ["Ephedrine (EPD), the main ingredient in maoto, is also clinically used to treat respiratory diseases.", {"entities": []}], ["However, the pharmacokinetics and distribution of EPD in the lungs after the administration of maoto have not been demonstrated.", {"entities": []}], ["This study aimed to determine the concentrations, distribution, and pharmacokinetics of EPD and its precursor methylephedrine (MEPD) in the lungs of rats orally administered maoto (1 and 4\u2009g/kg).", {"entities": []}], ["We used liquid chromatography\u2013electrospray ionization-tandem mass spectrometry to measure the ingredient concentrations.", {"entities": []}], ["Both ingredients were detected in maoto-treated lung homogenates.", {"entities": []}], ["Next, we examined the distribution of both ingredients in lung sections by using matrix-assisted laser desorption/ionization-mass spectrometry imaging, a powerful tool for the visualization of the distribution of biological molecules.", {"entities": []}], ["The mass spectrometry imaging analysis detected only EPD and provided the first visual demonstration that EPD is distributed in the alveoli, bronchi, and bronchioles in the lungs of rats orally administered maoto (4\u2009g/kg, three times at 2-h intervals).", {"entities": []}], ["These results suggest that the pharmacological efficacy of maoto for the amelioration of respiratory symptoms is related to the distribution of EPD in the lung.", {"entities": []}], ["Particulate matter (PM) is a key indicator of air pollution and a significant risk factor for adverse health outcomes in humans.", {"entities": []}], ["PM is not a self-contained pollutant but a mixture of different compounds including chemical and biological fractions.", {"entities": []}], ["While several reviews have focused on the chemical components of PM and associated health effects, there is a dearth of review studies that holistically examine the role of biological and chemical components of inhalable and respirable PM in disease causation.", {"entities": []}], ["A literature search using various search engines and (or) keywords was done.", {"entities": []}], ["Articles selected for review were chosen following predefined criteria, to extract and analyze data.", {"entities": []}], ["The results show that the biological and chemical components of inhalable and respirable PM play a significant role in the burden of health effects attributed to PM.", {"entities": []}], ["These health outcomes include low birth weight, emergency room visit, hospital admission, respiratory and pulmonary diseases, cardiovascular disease, cancer, non-communicable diseases, and premature death, among others.", {"entities": [[150, 156, "DISEASE"]]}], ["This review justifies the importance of each or synergistic effects of the biological and chemical constituents of PM on health.", {"entities": []}], ["It also provides information that informs policy on the establishment of exposure limits for PM composition metrics rather than the existing exposure limits of the total mass of PM.", {"entities": []}], ["This will allow for more effective management strategies for improving outdoor air quality.", {"entities": []}], ["Kawasaki disease (KD) is a systemic vasculitis primarily affecting children < 5 years old.", {"entities": [[36, 46, "DISEASE"]]}], ["Genes significantly associated with KD mostly involve cardiovascular, immune, and inflammatory responses.", {"entities": []}], ["Recent studies have observed stronger associations for KD risk with multiple genes compared to individual genes.", {"entities": []}], ["Therefore, we investigated whether gene combinations influenced KD susceptibility or coronary artery lesion (CAL) formation.", {"entities": []}], ["We examined 384 single-nucleotide polymorphisms (SNPs) for 159 immune-related candidate genes in DNA samples from KD patients with CAL (n = 73), KD patients without CAL (n = 153), and cohort controls (n = 575).", {"entities": []}], ["Individual SNPs were first assessed by univariate analysis (UVA) and multivariate analysis (MVA).", {"entities": []}], ["We used multifactor dimensionality reduction (MDR) to examine individual SNPs in one-, two-, and three-locus best fit models.", {"entities": []}], ["UVA identified 53 individual SNPs that were significantly associated with KD risk or CAL formation ( p < 0.10), while 35 individual SNPs were significantly associated using MVA ( p \u2264 0.05).", {"entities": []}], ["Significant associations in MDR analysis were only observed for the two-locus models after permutation testing ( p \u2264 0.05).", {"entities": []}], ["In logistic regression, combined possession of PDE2A (rs341058) and CYFIP2 (rs767007) significantly increased KD susceptibility (OR = 3.54; p = 4.14 x 10 LOC100133214 (rs2517892) and IL2RA (rs3118470) significantly increased the risk of CAL in KD patients (OR = 5.35; p = 7.46 x 10", {"entities": [[47, 52, "GENE"], [68, 74, "GENE"], [183, 188, "GENE"]]}], ["Radiation-induced lung injury (RILI) is a common and unavoidable complication of thoracic radiotherapy.", {"entities": []}], ["The current study was conducted to evaluate the ability of clarithromycin (CLA) to prevent radiation-induced pneumonitis, oxidative stress, and lung fibrosis in an animal model.", {"entities": []}], ["C57BL/6J mice were assigned to control, irradiation only, irradiation plus CLA, and CLA only groups.", {"entities": []}], ["Test mice received single thoracic exposures to radiation and/or oral CLA (100 mg/kg/day).", {"entities": []}], ["Histopathologic findings and markers of inflammation, fibrosis, and oxidative stress were compared by group.", {"entities": []}], ["On a microscopic level, CLA inhibited macrophage influx, alveolar fibrosis, parenchymal collapse, consolidation, and epithelial cell changes.", {"entities": []}], ["The concentration of collagen in lung tissue was lower in irradiation plus CLA mice.", {"entities": []}], ["Radiation-induced expression of tumor necrosis factor (TNF)-\u03b1, TNF receptor 1, acetylated nuclear factor kappa B, cyclooxygenase 2, vascular cell adhesion molecule 1, and matrix metallopeptidase 9 were also attenuated by CLA.", {"entities": [[55, 58, "GENE"], [63, 66, "GENE"], [55, 58, "GENE"], [63, 66, "GENE"]]}], ["Expression levels of nuclear factor erythroid 2-related factor 2 and heme oxygenase 1, transforming growth factor-\u03b21, connective tissue growth factor, and type I collagen in radiation-treated lungs were also attenuated by CLA.", {"entities": []}], ["These findings indicate that CLA ameliorates the deleterious effects of thoracic irradiation in mice by reducing pulmonary inflammation, oxidative damage, and fibrosis.", {"entities": []}], ["The aim of this study was to investigate the protective effects of phospholipase A2 (PLA2) from bee venom against acetaminophen-induced hepatotoxicity through CD4", {"entities": [[159, 162, "GENE"]]}], ["The KB-Rank tool was developed to help determine the functions of proteins.", {"entities": []}], ["A user provides text query and protein structures are retrieved together with their functional annotation categories.", {"entities": []}], ["Structures and annotation categories are ranked according to their estimated relevance to the queried text.", {"entities": []}], ["The algorithm for ranking first retrieves matches between the query text and the text fields associated with the structures.", {"entities": []}], ["The structures are next ordered by their relative content of annotations that are found to be prevalent across all the structures retrieved.", {"entities": []}], ["An interactive web interface was implemented to navigate and interpret the relevance of the structures and annotation categories retrieved by a given search.", {"entities": []}], ["The aim of the KB-Rank tool is to provide a means to quickly identify protein structures of interest and the annotations most relevant to the queries posed by a user.", {"entities": []}], ["Informational and navigational searches regarding disease topics are described to illustrate the tool\u2019s utilities.", {"entities": []}], ["The tool is available at the URL http://protein.tcmedc.org/KB-Rank .", {"entities": []}], ["What is the central question of this study?", {"entities": []}], ["Does tuberous sclerosis complex 1\u2013mammalian target of rapamycin (mTOR) signalling regulate the synthesis of surfactant proteins A and B and, if so, can this contribute to the postnatal death of Fabp4-Tsc1 cKO mice?", {"entities": [[5, 23, "DISEASE"], [65, 69, "GENE"]]}], ["What is the main finding and its importance?", {"entities": []}], ["Our study reveals a novel mechanism for the regulation of alveolar surfactant proteins.", {"entities": []}], ["Tuberous sclerosis complex 1\u2013mTOR signalling contributes to the regulation of synthesis of surfactant proteins A and B.", {"entities": [[0, 18, "DISEASE"]]}], ["Deficiency of tuberous sclerosis complex 1 in alveolar epithelial cells may contribute to the postnatal death of Fabp4-Tsc1 cKO mice.", {"entities": [[14, 32, "DISEASE"]]}], ["Tuberous sclerosis complex 1 (TSC1) forms a heterodimmer with tuberous sclerosis complex 2, to inhibit signalling by the mammalian target of rapamycin (mTOR) complex 1 (mTORC1).", {"entities": [[0, 18, "DISEASE"], [62, 80, "DISEASE"], [30, 34, "GENE"], [152, 156, "GENE"]]}], ["The mTORC1 stimulates cell growth by promoting anabolic cellular processes, such as gene transcription and protein translation, in response to growth factors and nutrient signals.", {"entities": []}], ["Originally designed to test the role of TSC1 in adipocyte function, mice in which the gene for TSC1 was specifically deleted by the fatty acid binding protein 4 (FABP4)- Cre ( Fabp4-Tsc1 cKO mice) died prematurely within 48 h after birth.", {"entities": [[40, 44, "GENE"], [95, 99, "GENE"], [182, 186, "GENE"], [40, 44, "GENE"], [95, 99, "GENE"], [182, 186, "GENE"], [162, 167, "GENE"], [176, 181, "GENE"]]}], ["The Fabp4-Tsc1 cKO mouse revealed a much smaller phenotype relative to the wild-type littermates.", {"entities": []}], ["Maternal administration of rapamycin, a classical mTOR inhibitor, significantly increased the survival time of Fabp4-Tsc1 cKO mice for up to 23 days.", {"entities": [[50, 54, "GENE"]]}], ["Both macroscopic and microscopic haemorrhages were observed in the lungs of Fabp4-Tsc1 cKO mice, while other tissues showed no significant changes.", {"entities": []}], ["Levels of surfactant proteins A and B demonstrated a significant decrease in the Fabp4-Tsc1 cKO mice, which was rescued by maternal injection of rapamycin.", {"entities": []}], ["Co-localization of FABP4 or TSC1 with surfactant protein B was also detected in neonatal pulmonary tissues.", {"entities": [[19, 24, "GENE"], [28, 32, "GENE"]]}], ["Our study suggests that TSC1\u2013mTORC1 may be critical for the synthesis of surfactant proteins A and B.", {"entities": []}], ["A thorough genetic mapping study was performed to identify predisposing genes for alcoholism dependence using the Collaborative Study on the Genetics of Alcoholism (COGA) data.", {"entities": []}], ["The procedure comprised whole-genome linkage and confirmation analyses, single locus and haplotype fine mapping analyses, and gene \u00d7 environment haplotype regression.", {"entities": []}], ["Stratified analysis was considered to reduce the ethnic heterogeneity and simultaneously family-based and case-control study designs were applied to detect potential genetic signals.", {"entities": []}], ["By using different methods and markers, we found high linkage signals at D1S225 (253.7 cM), D1S547 (279.2 cM), D2S1356 (64.6 cM), and D7S2846 (56.8 cM) with nonparametric linkage scores of 3.92, 4.10, 4.44, and 3.55, respectively.", {"entities": []}], ["We also conducted haplotype and odds ratio analyses, where the response was the dichotomous status of alcohol dependence, explanatory variables were the inferred individual haplotypes and the three statistically significant covariates were age, gender, and max drink (the maximum number of drinks consumed in a 24-hr period).", {"entities": [[102, 120, "DISEASE"], [257, 260, "GENE"]]}], ["The final model identified important AD-related haplotypes within a candidate region of NRXN1 at 2p21 and a few others in the inter-gene regions.", {"entities": [[88, 93, "GENE"]]}], ["The relative magnitude of risks to the identified risky/protective haplotypes was elucidated.", {"entities": []}], ["We have developed a 12-week balance training program for older adults shown to improve fall-related concerns, gait speed, balance performance, and physical function.", {"entities": []}], ["We hypothesized that this balance training would also contribute to higher habitual physical activity (PA) levels and improved health-related quality of life (HRQoL).", {"entities": []}], ["The primary aim was to evaluate short- and long-term effects of the balance training program on objectively measured habitual PA in older adults with osteoporosis.", {"entities": [[150, 162, "DISEASE"]]}], ["Secondary aims were to assess the effects of the balance training on HRQoL, and to study whether any effects on PA were associated with changes in HRQoL, gait speed, balance performance, fall-related concerns, and physical function.", {"entities": []}], ["A randomized controlled trial with follow-up at 3, 9, and 15 months, including 91 participants with osteoporosis (75.6 \u00b1 5.4 years), compared a balance training group (n = 61) with a control group (n = 30).", {"entities": [[100, 112, "DISEASE"]]}], ["The primary outcome was effect on habitual PA measured as steps/day, dichotomized into less than 5000 or 5000 or more steps/day.", {"entities": []}], ["Physical activity was assessed with pedometers (Yamax) and accelerometers (Actigraph), HRQoL with the Short Form-36 (SF-36), gait with a GAITRite walkway, balance performance with Modified-Figure-Eight test and one-leg stance, fall-related concerns with Falls Efficacy Scale International, and physical function with the advanced lower extremity subscale of the questionnaire Late Life Function and Disability Instrument.", {"entities": []}], ["Statistical methods used were multivariate logistic regression and logistic generalized estimating equation.", {"entities": []}], ["Sixty-eight participants completed the short-term follow-up at 3 months, and 53 participants completed the long-term follow-up at 15 months.", {"entities": []}], ["Per-protocol analysis (n = 68) showed that the odds ratio for having a daily step count of 5000 or more at 3 months was 6.17 (95% confidence interval, 1.23-30.91), P = .027, for the intervention group compared with the control group.", {"entities": []}], ["The longitudinal analysis (n = 91) showed that the odds ratio for having a daily step count of 5000 or more at 15 months was 2.02 (95% confidence interval, 0.88-4.64), P = .096, for the intervention group compared with the control group.", {"entities": []}], ["The mental component sum of the SF-36 improved significantly from baseline to 3 months in the intervention group, and the physical component sum improved in both groups, but no statistically significant differences were found between groups.", {"entities": []}], ["No associations were found between PA and changes in covariates.", {"entities": []}], ["The short-term evaluation showed that balance training increased habitual PA in community-dwelling older adults with osteoporosis.", {"entities": [[117, 129, "DISEASE"]]}], ["A significantly higher proportion of participants in the intervention group reached a level of 5000 or more steps/day, which is important for overall health.", {"entities": []}], ["This effect was not associated with improvements in HRQoL, gait speed, balance performance, or fall-related concerns, and did not persist through the long-term follow-up.", {"entities": []}], ["To accomplish a sustained PA change, a prolonged intervention or more support regarding habitual PA may be required, such as reinforcement with personalized behavior change counseling or PA on prescription.", {"entities": []}], ["Internet-based surveillance systems to monitor influenza-like illness (ILI) have advantages over traditional (physician-based) reporting systems, as they can potentially monitor a wider range of cases (i.e.", {"entities": [[47, 56, "DISEASE"]]}], ["including those that do not seek care).", {"entities": []}], ["However, the requirement for participants to have internet access and to actively participate calls into question the representativeness of the data.", {"entities": []}], ["Such systems have been in place in a number of European countries over the last few years, and in July 2009 this was extended to the UK.", {"entities": []}], ["Here we present results of this survey with the aim of assessing the reliability of the data, and to evaluate methods to correct for possible biases.", {"entities": []}], ["Internet-based monitoring of ILI was launched near the peak of the first wave of the UK H1N1v influenza pandemic.", {"entities": [[94, 103, "DISEASE"]]}], ["We compared the recorded ILI incidence with physician-recorded incidence and an estimate of the true number of cases over the course of the epidemic.", {"entities": []}], ["We also compared overall attack rates.", {"entities": []}], ["The effect of using different ILI definitions and alternative denominator assumptions on incidence estimates was explored.", {"entities": []}], ["The crude incidence measured by the internet-based system appears to be influenced by individuals who participated only once in the survey and who appeared more likely to be ill.", {"entities": []}], ["This distorted the overall incidence trend.", {"entities": []}], ["Concentrating on individuals who reported more than once results in a time series of ILI incidence that matches the trend of case estimates reasonably closely, with a correlation of 0.713 (P-value: 0.0001, 95% CI: 0.435, 0.867).", {"entities": []}], ["Indeed, the internet-based system appears to give a better estimate of the relative height of the two waves of the UK pandemic than the physician-recorded incidence.", {"entities": []}], ["The overall attack rate is, however, higher than other estimates, at about 16% when compared with a model-based estimate of 6%.", {"entities": []}], ["Internet-based monitoring of ILI can capture the trends in case numbers if appropriate weighting is used to correct for differential response.", {"entities": []}], ["The overall level of incidence is, however, difficult to measure.", {"entities": []}], ["Internet-based systems may be a useful adjunct to existing ILI surveillance systems as they capture cases that do not necessarily contact health care.", {"entities": []}], ["However, further research is required before they can be used to accurately assess the absolute level of incidence in the community.", {"entities": []}], ["Severe sepsis and septic shock are frequent causes of the acute respiratory distress syndrome, and important sources of human mortality.", {"entities": [[85, 93, "DISEASE"]]}], ["Lipopolysaccharide (LPS), a component of Gram-negative bacterial cell walls, plays a major role in the pathogenesis of severe sepsis and septic shock.", {"entities": []}], ["LPS exposure induces the production of harmful reactive oxygen species, and the resultant oxidant injury has been implicated in the pathogenesis of both severe sepsis and ARDS.", {"entities": []}], ["We previously showed that the tyrosine kinase inhibitor imatinib increases lung endothelial antioxidant enzymes and protects against pulmonary endothelial antioxidant injury.", {"entities": []}], ["In the present study, we tested the hypothesis that imatinib would protect against lung injury and systemic inflammation caused by intravenous LPS in an intact mouse model of endotoxemia mimicking early sepsis.", {"entities": []}], ["We found that intravenous LPS induced a significant increase in the activity of lung xanthine oxidoreductase (XOR), an enzyme which is a major source of reactive oxygen species and implicated in the pathogenesis of acute lung injury.", {"entities": []}], ["Imatinib had no effect of LPS-induced XOR activity.", {"entities": []}], ["However, pretreatment of mice with imatinib increased lung catalase activity and decreased intravenous LPS-induced lung oxidant injury as measured by \u03b3 -H2AX, a marker of oxidant-induced DNA damage, lung apoptosis, and pulmonary edema.", {"entities": [[219, 234, "DISEASE"]]}], ["Imatinib also attenuated systemic cytokine expression after intravenous LPS exposure.", {"entities": []}], ["Finally, imatinib completely prevented mortality in an in\u00a0vivo, intravenous LPS mouse model of endotoxemia and lung injury.", {"entities": []}], ["These results support the testing of imatinib as a novel pharmacologic agent in the treatment of Gram-negative sepsis and sepsis-induced ARDS.", {"entities": []}], ["To test whether adding mobile application coaching and patient/provider web portals to community primary care compared with standard diabetes management would reduce glycated hemoglobin levels in patients with type 2 diabetes.", {"entities": []}], ["A cluster-randomized clinical trial, the Mobile Diabetes Intervention Study, randomly assigned 26 primary care practices to one of three stepped treatment groups or a control group (usual care).", {"entities": []}], ["A total of 163 patients were enrolled and included in analysis.", {"entities": []}], ["The primary outcome was change in glycated hemoglobin levels over a 1-year treatment period.", {"entities": []}], ["Secondary outcomes were changes in patient-reported diabetes symptoms, diabetes distress, depression, and other clinical (blood pressure) and laboratory (lipid) values.", {"entities": []}], ["Maximal treatment was a mobile- and web-based self-management patient coaching system and provider decision support.", {"entities": []}], ["Patients received automated, real-time educational and behavioral messaging in response to individually analyzed blood glucose values, diabetes medications, and lifestyle behaviors communicated by mobile phone.", {"entities": []}], ["Providers received quarterly reports summarizing patient\u2019s glycemic control, diabetes medication management, lifestyle behaviors, and evidence-based treatment options.", {"entities": []}], ["The mean declines in glycated hemoglobin were 1.9% in the maximal treatment group and 0.7% in the usual care group, a difference of 1.2% ( P < 0.001) over 12 months.", {"entities": []}], ["Appreciable differences were not observed between groups for patient-reported diabetes distress, depression, diabetes symptoms, or blood pressure and lipid levels (all P > 0.05).", {"entities": []}], ["The combination of behavioral mobile coaching with blood glucose data, lifestyle behaviors, and patient self-management data individually analyzed and presented with evidence-based guidelines to providers substantially reduced glycated hemoglobin levels over 1 year.", {"entities": []}], ["A laparoscopic approach to gastrointestinal stromal tumors (GISTs) of the small bowel seems to be a safe method even in the face of emergent surgery when open oncologic principles of bowel and tumor handling are followed.", {"entities": []}], ["Gastrointestinal stromal (GIST) tumors make < 1% of all gastrointestinal neoplasms and 20% of small bowel neoplasms.", {"entities": []}], ["The most common acute presenting symptom of these tumors is gastrointestinal hemorrhage with obstruction being rare.", {"entities": []}], ["We discuss our laparoscopic approach to 2 patients with small bowel GIST tumors that presented to our institution with obstruction of the small bowel.", {"entities": []}], ["Two patients presented to the emergency department with signs and symptoms of small bowel obstruction.", {"entities": []}], ["On workup, each was found to have a solid lesion either within or adjacent to the small bowel at the point of obstruction and both were emergently taken to the operating room.", {"entities": []}], ["The pathologic diagnosis of small bowel GIST tumor was the same in both cases, but the pathophysiologies of the obstructing tumors were different.", {"entities": []}], ["Both patients underwent laparoscopic surgery with successful resection of the lesions.", {"entities": []}], ["The details and crucial points of the laparoscopic approach to these tumors are described with specific attention to its appropriateness and safety in treating GIST tumors.", {"entities": []}], ["Attention to particular details of the manipulation and management of the bowel in the face of obstruction and removal of the lesions is described.", {"entities": []}], ["The laparoscopic approach to GIST tumors of the small bowel, even in the face of emergent surgery, is a safe method.", {"entities": []}], ["Exposure to household air pollution (HAP) from cooking with solid fuels affects 2.8 billion people in developing countries, including children and pregnant women.", {"entities": []}], ["The aim of this review is to propose intervention estimates for child survival outcomes linked to HAP.", {"entities": []}], ["Systematic reviews with meta-analysis were conducted for ages 0-59 months, for child pneumonia, adverse pregnancy outcomes, stunting and all-cause mortality.", {"entities": [[85, 94, "DISEASE"]]}], ["Evidence for each outcome was assessed against Bradford-Hill viewpoints, and GRADE used for certainty about intervention effect size for which all odds ratios (OR) are presented as protective effects.", {"entities": []}], ["Reviews found evidence linking HAP exposure with child ALRI, low birth weight (LBW), stillbirth, preterm birth, stunting and all-cause mortality.", {"entities": []}], ["Most studies were observational and rated low/very low in GRADE despite strong causal evidence for some outcomes; only one randomised trial was eligible.Intervention effect (OR) estimates of 0.64 (95% CI: 0.55, 0.75) for ALRI, 0.71 (0.65, 0.79) for LBW and 0.66 (0.54, 0.81) for stillbirth are proposed, specific outcomes for which causal evidence was sufficient.", {"entities": []}], ["Exposure-response evidence suggests this is a conservative estimate for ALRI risk reduction expected with sustained, low exposure.", {"entities": []}], ["Statistically significant protective ORs were also found for stunting [OR=0.79 (0.70, 0.89)], and in one study of pre-term birth [OR=0.70 (0.54, 0.90)], indicating these outcomes would also likely be reduced.", {"entities": []}], ["Five studies of all-cause mortality had an OR of 0.79 (0.70, 0.89), but heterogenity precludes a reliable estimate for mortality impact.", {"entities": []}], ["Although interventions including clean fuels and improved solid fuel stoves are available and can deliver low exposure levels, significant challenges remain in achieving sustained use at scale among low-income households.", {"entities": []}], ["Reducing exposure to HAP could substantially reduce the risk of several child survival outcomes, including fatal pneumonia, and the proposed effects could be achieved by interventions delivering low exposures.", {"entities": [[113, 122, "DISEASE"]]}], ["Larger impacts are anticipated if WHO air quality guidelines are met.", {"entities": []}], ["To achieve these benefits, clean fuels should be adopted where possible, and for other households the most effective solid fuel stoves promoted.", {"entities": []}], ["To strengthen evidence, new studies with thorough exposure assessment are required, along with evaluation of the longer-term acceptance and impacts of interventions.", {"entities": []}], ["Respiratory syncytial virus (RSV) is the most common pathogen identified in young children with acute lower respiratory infection (ALRI) as well as an important cause of hospital admission.", {"entities": []}], ["The high incidence of RSV infection and its potential severe outcome make it important to identify and prioritise children who are at higher risk of developing RSV\u2013associated ALRI.", {"entities": []}], ["We aimed to identify risk factors for RSV\u2013associated ALRI in young children.", {"entities": []}], ["We carried out a systematic literature review across 4 databases and obtained unpublished studies from RSV Global Epidemiology Network (RSV GEN) collaborators.", {"entities": []}], ["Quality of all eligible studies was assessed according to modified GRADE criteria.", {"entities": []}], ["We conducted meta\u2013analyses to estimate odds ratios with 95% confidence intervals (CI) for individual risk factors.", {"entities": []}], ["We identified 20 studies (3 were unpublished data) with \u201cgood quality\u201d that investigated 18 risk factors for RSV\u2013associated ALRI in children younger than five years old.", {"entities": []}], ["Among them, 8 risk factors were significantly associated with RSV\u2013associated ALRI.", {"entities": []}], ["The meta\u2013estimates of their odds ratio (ORs) with corresponding 95% confidence intervals (CI) are prematurity 1.96 (95% CI 1.44\u20132.67), low birth weight 1.91 (95% CI 1.45\u20132.53), being male 1.23 (95% CI 1.13\u20131.33), having siblings 1.60 (95% CI 1.32\u20131.95), maternal smoking 1.36 (95% CI 1.24\u20131.50), history of atopy 1.47 (95% CI 1.16\u20131.87), no breastfeeding 2.24 (95% CI 1.56\u20133.20) and crowding 1.94 (95% CI 1.29\u20132.93).", {"entities": []}], ["Although there were insufficient studies available to generate a meta\u2013estimate for HIV, all articles (irrespective of quality scores) reported significant associations between HIV and RSV\u2013associated ALRI.", {"entities": []}], ["This study presents a comprehensive report of the strength of association between various socio\u2013demographic risk factors and RSV\u2013associated ALRI in young children.", {"entities": []}], ["Some of these amenable risk factors are similar to those that have been identified for (all cause) ALRI and thus, in addition to the future impact of novel RSV vaccines, national action against ALRI risk factors as part of national control programmes can be expected to reduce burden of disease from RSV.", {"entities": []}], ["Further research which identifies, accesses and analyses additional unpublished RSV data sets could further improve the precision of these estimates.", {"entities": []}], ["Genome-wide association scans (GWASs) using single nucleotide polymorphisms (SNPs) have been completed successfully for several common disorders and have detected over 30 new associations.", {"entities": []}], ["Considering the large sample sizes and genome-wide SNP coverage of the scans, one might have expected many of the common variants underpinning the genetic component of various disorders to have been identified by now.", {"entities": []}], ["However, these studies have not evaluated the contribution of other forms of genetic variation, such as structural variation, mainly in the form of copy number variants (CNVs).", {"entities": []}], ["Known CNVs account for over 15% of the assembled human genome sequence.", {"entities": []}], ["Since CNVs are not easily tagged by SNPs, might have a wide range of copy number variability, and often fall in genomic regions not well covered by whole-genome arrays or not genotyped by the HapMap project, current GWASs have largely missed the contribution of CNVs to complex disorders.", {"entities": []}], ["In fact, some CNVs have already been reported to show association with several complex disorders using candidate gene/region approaches, underpinning the importance of regions not investigated in current GWASs.", {"entities": []}], ["This reveals the need for new generation arrays (some already in the market) and the use of tailored approaches to explore the full dimension of genome variability beyond the single nucleotide scale.", {"entities": []}], ["It is well known that asthma prevalence has been increasing all over the world in the last decades.", {"entities": [[22, 28, "DISEASE"]]}], ["However, few data are available on temporal trends of incidence and remission of asthma.", {"entities": [[81, 87, "DISEASE"]]}], ["To evaluate the rates of asthma incidence and remission in Italy from 1940 to 2010.", {"entities": [[25, 31, "DISEASE"]]}], ["The subjects were randomly sampled from the general Italian population between 1991 and 2010 in the three population-based multicentre studies: ECRHS, ISAYA, and GEIRD.", {"entities": []}], ["Individual information on the history of asthma (age at onset, age at the last attack, use of drugs for asthma control, co-presence of hay-fever) was collected on 35,495 subjects aged 20\u201384 and born between 1925\u20131989.", {"entities": [[41, 47, "DISEASE"], [104, 110, "DISEASE"]]}], ["Temporal changes in rates of asthma incidence and remission in relation to age, birth cohort and calendar period (APC) were modelled using Poisson regression and APC models.", {"entities": [[29, 35, "DISEASE"], [114, 117, "GENE"], [162, 165, "GENE"], [114, 117, "GENE"], [162, 165, "GENE"]]}], ["The average yearly rate of asthma incidence was 2.6/1000 (3,297 new cases among 1,263,885 person-years).", {"entities": [[27, 33, "DISEASE"]]}], ["The incidence rates have been linearly increasing, with a percentage increase of +3.9% (95%CI: 3.1\u20134.5), from 1940 up to the year 1995, when the rates begun to level off.", {"entities": []}], ["The stabilization of asthma incidence was mainly due to a decrease in the rates of atopic asthma after 1995, while non-atopic asthma has continued to increase.", {"entities": [[21, 27, "DISEASE"], [90, 96, "DISEASE"], [126, 132, "DISEASE"]]}], ["The overall rate of remission was 43.2/1000person-years, and it did not vary significantly across generations, but was associated with atopy, age at asthma onset and duration of the disease.", {"entities": [[149, 155, "DISEASE"]]}], ["After 50 years of a continuous upward trend, the rates of asthma incidence underwent a substantial stabilization in the late 90s.", {"entities": [[58, 64, "DISEASE"]]}], ["Despite remarkable improvements in the treatment of asthma, the rate of remission did not change significantly in the last seventy years.", {"entities": [[52, 58, "DISEASE"]]}], ["Some caveats are required in interpreting our results, given that our estimates are based on self-reported events that could be affected by the recall bias.", {"entities": []}], ["Hepatitis C virus (HCV) infection can be detected in virtually all patients with cryoglobulinemic vasculitis (CV) .", {"entities": [[98, 108, "DISEASE"]]}], ["Among its many effects, the virus is able to stimulate the production of thymic stromal lymphopoietin (TSLP) by infected hepatocytes.", {"entities": [[103, 107, "GENE"]]}], ["In this study, we assessed the systemic levels and tissue distribution of TSLP in 60 chronically HCV-infected patients, 36 with and 24 without CV.", {"entities": [[74, 78, "GENE"]]}], ["Serum TSLP levels were measured by an enzyme-linked immunosorbent assay (ELISA) method.", {"entities": [[6, 10, "GENE"]]}], ["TSLP mRNA was assessed in patient samples by real-time reverse transcriptase-polymerase chain reaction (RT-PCR).", {"entities": [[0, 4, "GENE"]]}], ["TSLP protein in liver and skin biopsy samples was revealed by indirect immunofluorescence.", {"entities": [[0, 4, "GENE"]]}], ["All other methods were carried out according to standardized procedures.", {"entities": []}], ["Serum TSLP levels were significantly higher in patients with than in those without CV and in healthy individuals.", {"entities": [[6, 10, "GENE"]]}], ["Higher TSLP levels paralleled specific mRNA expression and the up-regulation of TSLP protein in liver tissue.", {"entities": [[7, 11, "GENE"], [80, 84, "GENE"], [7, 11, "GENE"], [80, 84, "GENE"]]}], ["Compared with non-CV patients, higher TSLP levels in CV were accompanied by a higher frequency of circulating mono/oligoclonal B-cell expansions (8% vs. 92%, p\u2009<\u20090.0001) and a higher number of peripheral CD20 Overall, this study shows that TSLP secreted by hepatocytes and keratinocytes of HCV-infected patients with CV is involved in the pathogenesis of vasculitis and may possibly support the therapeutic use of TSLP-targeted monoclonal antibodies.", {"entities": [[355, 365, "DISEASE"], [38, 42, "GENE"], [240, 244, "GENE"], [414, 418, "GENE"], [38, 42, "GENE"], [240, 244, "GENE"], [414, 418, "GENE"]]}], ["To determine the possible genotoxic effect of exposure to the smoke generated by biomass burning on workers involved in manual sugar cane harvesting.", {"entities": []}], ["The frequency of micronuclei in exfoliated buccal cells and peripheral blood lymphocytes was determined in sugarcane workers in the Barretos region of Brazil, during the harvest season and compared to a control population, comprised of administrative employees of Barretos Cancer Hospital.", {"entities": []}], ["The frequency of micronuclei was higher in the sugar cane workers.", {"entities": []}], ["The mean frequency in blood lymphocytes (micronuclei/1000 cells) in the test group was 8.22 versus 1.27 in the control group.", {"entities": []}], ["The same effect was observed when exfoliated buccal cells were considered (22.75 and 9.70 micronuclei/1000 cells for sugar cane workers and controls, respectively).", {"entities": []}], ["Exposure to emissions produced by the burning of sugar cane during harvesting induces genomic instability in workers, indicating the necessity of adopting more advanced techniques of harvesting sugar cane to preserve human health.", {"entities": []}], ["Decision support systems linked to administrative databases provide a unique opportunity to monitor adherence to guidelines and target disease management strategies towards patients not receiving guideline-based therapy.", {"entities": []}], ["The objective of this study was to evaluate the discrepancy between actual asthma treatments prescribed by primary care physicians compared to those recommended by evidence-based guidelines using a decision support tool linked to a provincial health administrative database.", {"entities": [[75, 81, "DISEASE"]]}], ["The drug and medical services information of individuals with asthma was identified from the provincial health database and was pushed through an asthma decision support system (ADSS).", {"entities": [[62, 68, "DISEASE"], [146, 152, "DISEASE"], [178, 182, "GENE"]]}], ["Recommendations aimed at optimising asthma treatment were generated on two index dates, 15 September 2007 (index date 1) and 15 March 2008 (index date 2).", {"entities": [[36, 42, "DISEASE"]]}], ["Primary care settings in a large Canadian metropolitan area.", {"entities": []}], ["Individuals with asthma and provincial health insurance primary and secondary outcome measures: well controlled asthma.", {"entities": [[17, 23, "DISEASE"], [112, 118, "DISEASE"]]}], ["16\u2005803 eligible individuals were identified on index date 1, and 18\u2005103 on index date 2.", {"entities": []}], ["The distribution of recommendation categories was similar on both index dates.", {"entities": []}], ["94% were classified as well controlled and 7% as not well controlled.", {"entities": []}], ["Among well-controlled individuals, the largest proportion was in the maintain treatment category (63.8%), followed by the maintain/decrease treatment category (28.2%) and the decrease treatment category (2.7%).", {"entities": []}], ["Almost all individuals who were not well controlled had the recommendation to increase treatment (88%) with a small proportion in the refer category (1%).", {"entities": []}], ["The ADSS was able to identify subgroups of patients from an administrative database that could benefit from a medication review and possible change.", {"entities": [[4, 8, "GENE"]]}], ["Decision support systems linked to an administrative database can be used to identify individuals with uncontrolled asthma or prescriptions that deviate from recommended treatment.", {"entities": [[116, 122, "DISEASE"]]}], ["When connected to the point of care, this can provide an opportunity for physicians to intervene early.", {"entities": []}], ["Slovenia's national eHealth strategy aims to develop an efficient, flexible and modern health care informatics framework that would be comparable to the most successful EU countries.", {"entities": []}], ["To achieve this goal, the gap between availability and usage of information and communication technology by primary care physicians needs to be reduced.", {"entities": []}], ["As recent efforts show, consensus on information and communication technology purpose and usage in primary care needs to be established before any national information and communication technology solutions are developed.", {"entities": []}], ["The aim of this study was to identify the most appropriate measures in implementation of Slovene national eHealth strategy and to suggest an appropriate model for success by using the three round Delphi study.", {"entities": []}], ["An e-mail based, three-round Delphi study was undertaken to achieve consensus from a selected sample of nationally recognized experts from the fields of primary health care and medical informatics.", {"entities": []}], ["The aim of this study was to identify the most appropriate measures and key obstacles in implementation of eHealth in Slovene primary health care by using the Delphi study.", {"entities": []}], ["High levels of consensus on the majority of suggested measures were achieved among all study participants, as well as between the subgroups of experts from primary health care and medical informatics.", {"entities": []}], ["All aims of the three-round Delphi study on eHealth implementation in Slovenian primary health care were achieved.", {"entities": []}], ["The three round decision Delphi process has proven to be effective for developing outcomes, ranking key priorities in primary care eHealth development, and achieving consensus among the most influential experts in that field.", {"entities": []}], ["This consensus is an important contribution to future national eHealth strategies in the field of primary health care.", {"entities": []}], ["Multimorbidity and musculoskeletal conditions create substantial burden for people and health systems.", {"entities": []}], ["Quantifying the extent of co-occurring conditions is hampered by conceptual heterogeneity, imprecision and/or indecision about how multimorbidity is defined.", {"entities": []}], ["The purpose of this study is to examine the influence of different ways of operationalising multimorbidity on multimorbidity prevalence rates with a focus on working-age adults with musculoskeletal conditions.", {"entities": []}], ["Weighted population prevalence rates of multimorbidity among working-age Australians were estimated using data from the National Health Survey.", {"entities": []}], ["Two nominal thresholds (2+ or 3+ co-occurring conditions) and three operational definitions of multimorbidity (survey-, policy- and research-based) were examined.", {"entities": []}], ["Using logistic regression, we estimated the association between the prevalence of multimorbidity among persons with musculoskeletal conditions compared to persons with non-musculoskeletal conditions for each definition and threshold combination.", {"entities": []}], ["As few as 7.9% of working-age Australians have 2+ conditions using the research-based definition (95% CI 7.4\u20138.5%), compared to estimates of 15.3% (95% CI 14.3\u201316.2%) and 61.5% (95% CI 60.3\u201362.7%).", {"entities": []}], ["with the policy- and survey-based definitions, respectively.", {"entities": []}], ["Depending on definition, with the 3+ threshold multimorbidity prevalence ranged from 2.1% (research) to 41.9% (survey).", {"entities": []}], ["Among the sub-sample with musculoskeletal conditions, multimorbidity with the 2+ threshold ranged from 20.2 to 92.2%; and with 3+ threshold from 5.9 to 75.4%, again lowest with the research-definition and highest with the survey-definition.", {"entities": []}], ["When compared to any other condition (i.e.", {"entities": []}], ["non-musculoskeletal conditions), all musculoskeletal conditions were positively associated with multimorbidity, regardless of definition or threshold.", {"entities": []}], ["Depending on definition and threshold, multimorbidity is either rare or endemic in working-age Australians.", {"entities": []}], ["Irrespective of definition, musculoskeletal conditions are a near-ubiquitous feature of multimorbidity.", {"entities": []}], ["The online version of this article (doi:10.1186/s13104-017-2376-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["By tradition colloid solutions have been used to obtain fast circulatory stabilisation in shock, but high molecular weight hydroxyethyl starch (HES) may cause acute kidney failure in patients with severe sepsis.", {"entities": [[159, 179, "DISEASE"], [165, 179, "DISEASE"]]}], ["Now lower molecular weight HES 130/0.4 is the preferred colloid in Scandinavian intensive care units (ICUs) and 1 The 6S trial will randomise 800 patients with severe sepsis in 30 Scandinavian ICUs to masked fluid resuscitation using either 6% HES 130/0.4 in Ringer's acetate or Ringer's acetate alone.", {"entities": []}], ["The composite endpoint of 90-day mortality or end-stage kidney failure is the primary outcome measure.", {"entities": [[56, 70, "DISEASE"]]}], ["The secondary outcome measures are severe bleeding or allergic reactions, organ failure, acute kidney failure, days alive without renal replacement therapy or ventilator support and 28-day and 1/2- and one-year mortality.", {"entities": [[89, 109, "DISEASE"], [95, 109, "DISEASE"]]}], ["The sample size will allow the detection of a 10% absolute difference between the two groups in the composite endpoint with a power of 80%.", {"entities": []}], ["The 6S trial will provide important safety and efficacy data on the use of HES 130/0.4 in patients with severe sepsis.", {"entities": []}], ["The effects on mortality, dialysis-dependency, time on ventilator, bleeding and markers of resuscitation, metabolism, kidney failure, and coagulation will be assessed.", {"entities": [[118, 132, "DISEASE"]]}], ["ClinicalTrials.gov: NCT00962156", {"entities": []}], ["Long-term inhaled corticosteroids (ICS) may reduce growth velocity and final height of children with asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["We aimed to evaluate the association between ICS use of >12 months and growth.", {"entities": []}], ["We initially searched MEDLINE and EMBASE in July 2013, followed by a PubMed search updated to December 2014.", {"entities": []}], ["We selected RCTs and controlled observational studies of ICS use in patients with asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["We conducted random effects meta-analysis of mean differences in growth velocity (cm/year) or final height (cm) between groups.", {"entities": []}], ["Heterogeneity was assessed using the I We found 23 relevant studies (twenty RCTs and three observational studies) after screening 1882 hits.", {"entities": []}], ["Meta-analysis of 16 RCTs showed that ICS use significantly reduced growth velocity at one year follow-up (mean difference -0.48 cm/year (95% CI -0.66 to -0.29)).", {"entities": []}], ["There was evidence of a dose-response effect in three RCTs.", {"entities": []}], ["Final adult height showed a mean reduction of -1.20 cm (95% CI -1.90 cm to -0.50 cm) with budesonide versus placebo in a high quality RCT.", {"entities": []}], ["Meta-analysis of two lower quality observational studies revealed uncertainty in the association between ICS use and final adult height, pooled mean difference -0.85 cm (95% CI -3.35 to 1.65).", {"entities": []}], ["Use of ICS for >12 months in children with asthma has a limited impact on annual growth velocity.", {"entities": [[43, 49, "DISEASE"]]}], ["In ICS users, there is a slight reduction of about a centimeter in final adult height, which when interpreted in the context of average adult height in England (175 cm for men and 161 cm for women), represents a 0.7% reduction compared to non-ICS users.", {"entities": []}], ["Airway smooth muscle constriction induced by cholinergic agonists such as methacholine (MCh), which is typically increased in asthmatic patients, is regulated mainly by muscle muscarinic M3 receptors and negatively by vagal muscarinic M2 receptors.", {"entities": []}], ["Here we evaluated basal (intrinsic) and allergen-induced (extrinsic) airway responses to MCh.", {"entities": []}], ["We used two mouse lines selected to respond maximally (AIRmax) or minimally (AIRmin) to innate inflammatory stimuli.", {"entities": []}], ["We found that in basal condition AIRmin mice responded more vigorously to MCh than AIRmax.", {"entities": []}], ["Treatment with a specific M2 antagonist increased airway response of AIRmax but not of AIRmin mice.", {"entities": []}], ["The expression of M2 receptors in the lung was significantly lower in AIRmin compared to AIRmax animals.", {"entities": []}], ["AIRmax mice developed a more intense allergic inflammation than AIRmin, and both allergic mouse lines increased airway responses to MCh.", {"entities": []}], ["However, gallamine treatment of allergic groups did not affect the responses to MCh.", {"entities": []}], ["Our results confirm that low or dysfunctional M2 receptor activity is associated with increased airway responsiveness to MCh and that this trait was inherited during the selective breeding of AIRmin mice and was acquired by AIRmax mice during allergic lung inflammation.", {"entities": []}], ["The increasingly recognized importance of vitamin D has been discussed and vitamin D status among young children has attracted widespread attention in recent years.", {"entities": []}], ["However, study on vitamin D status in young children aged 1\u20133 y is limited in China.", {"entities": []}], ["To evaluate the nutritional vitamin D status of young children aged 1\u20133 y in Wuxi, southeastern China.", {"entities": []}], ["A large cohort of 5,571 young children aged 1\u20133 y were recruited in this study who visited the child health clinics at the Wuxi Maternity and Child Health Hospital (latitude 31.57\u00b0N) during January 2014 to January 2015.", {"entities": []}], ["Wuxi was located in southeastern China at a latitude of 31.57\u00b0N.", {"entities": []}], ["Finger-stick blood sampling was conducted in all the subjects and serum 25-Hydroxyvitamin D (25(OH)D) levels were measured to evaluate their vitamin D status.", {"entities": []}], ["In this study, serum 25(OH)D levels of young children at the age of 1\u20133 years ranged from 20.6\u2013132.9 nmol/L (Median: 71.5 nmol/L).", {"entities": []}], ["16.1% of the population had vitamin D deficiency (<50 nmol/L), while 38.8% of the subjects had a sufficient (50\u201374.9 nmol/L) vitamin D level.", {"entities": []}], ["An optimal vitamin D status (\u226575 nmol/L) was found in 45.1% of the young children.", {"entities": []}], ["The prevalence of vitamin D deficiency was higher in autumn (19.5%) than in summer (12.1%).", {"entities": []}], ["There was no significant difference in vitamin D status between genders.", {"entities": []}], ["The binary logistic regression analysis revealed that child age was strongly associated with vitamin D deficiency (adjusted OR: 1.173; 95%CI: 1.053\u20131.308; P = 0.004).", {"entities": []}], ["The prevalence of vitamin D deficiency was 16.1% among young children aged 1\u20133 y in Wuxi.", {"entities": []}], ["Season and child age were associated with their vitamin D status.", {"entities": []}], ["It is implied that young children should receive adequate amounts of vitamin D supplementation and spend more time outdoors to prolong the sunlight exposure when they grow older.", {"entities": []}], ["Sialodochitis fibrinosa is a rare disease which is characterized by recurring episodes of pain and swelling of the salivary glands due to the formation of mucofibrinous plugs.", {"entities": []}], ["Analytic studies ascertain elevated levels of eosinophils and immunoglobulin E (IgE).", {"entities": []}], ["Imaging studies such as magnetic resonance imaging (MRI) and sialography reveal dilation of the main salivary duct (duct ectasia).", {"entities": []}], ["Treatment is initially supportive, consisting of compressive massages, and use of antihistamines and/or corticosteroids.", {"entities": []}], ["In the following, 3 cases of sialodochitis fibrinosa are presented which were diagnosed in a third level hospital during the period of 2008 and 2016, as well as a literature review of all cases reported to our knowledge.", {"entities": []}], ["Of the 41 cases found, including the 3 of this article, 66% were women with an average age of 45 years old.", {"entities": []}], ["However, 75% of reported cases were of Japanese heritage.", {"entities": []}], ["Involvement of the parotid glands was more frequent than the submandibular glands.", {"entities": []}], ["In more than half of all cases treatment with compressive massages, antihistamines and/or corticosteroids was effective.", {"entities": []}], ["Clinicians should consider sialodochitis fibrinosa as a diagnostic possibility when presented with cases of recurring parotid and submandibular gland tumescence.", {"entities": []}], ["Thirty-day readmission rates after acute myocardial infarction (AMI) and heart failure are important patient outcome metrics.", {"entities": [[41, 62, "DISEASE"], [35, 62, "DISEASE"]]}], ["Early post-discharge physician follow-up has been promoted as a method of reducing 30-day readmission rates.", {"entities": []}], ["However, the relationship s between early post-discharge follow-up and 30-day readmission for AMI and heart failure are inconclusive.", {"entities": []}], ["We used nationwide population-based data to examine associations between 7-day physician follow-up and 30-day readmission, and further associations of 7-day same physician (during the index hospitalization and at follow-up) and cardiologist follow-up with 30-day readmission for non-ST-segment-elevation myocardial infarction (NSTEMI) or heart failure.", {"entities": [[304, 325, "DISEASE"]]}], ["We analyzed all patients 18 years or older with NSTEMI and heart failure and discharged from hospitals in 2010 in Taiwan through Taiwan\u2019s National Health Insurance Research Database.", {"entities": []}], ["Cox proportional hazard models with robust sandwich variance estimates and propensity score weighting were performed after adjustment for patient and hospital characteristics to test associations between 7-day physician follow-up and 30-day readmission.", {"entities": []}], ["The study population for NSTEMI and heart failure included 5,008 and 13,577 patients, respectively.", {"entities": []}], ["Early physician follow-up was associated with a lower hazard ratio of readmission compared with no early physician follow-up for patients with NSTEMI (hazard ratio [HR], 0.47; 95% confidence interval [CI], 0.39\u20130.57), and for patients with heart failure (HR, 0.54; 95% CI, 0.48\u20130.60).", {"entities": [[165, 167, "GENE"], [255, 257, "GENE"], [165, 167, "GENE"], [255, 257, "GENE"]]}], ["Same physician follow-up was associated with a reduced hazard ratio of readmission compared with different physician follow-up for patients with NSTEMI (HR, 0.56; 95% CI, 0.48\u20130.65), and for patients with heart failure (HR, 0.69; 95% CI, 0.62\u20130.76).", {"entities": [[153, 155, "GENE"], [220, 222, "GENE"], [153, 155, "GENE"], [220, 222, "GENE"]]}], ["For each condition, patients who have an outpatient visit with a physician within 7 days of discharge have a lower risk of 30-day readmission.", {"entities": []}], ["Moreover, patients who have an outpatient visit with the same physician within 7 days of discharge have a much lower risk of 30-day readmission.", {"entities": []}], ["The changes in the microbial community structure during acute exacerbations of severe chronic obstructive pulmonary disease (COPD) in hospitalized patients remain largely uncharacterized.", {"entities": [[86, 123, "DISEASE"]]}], ["Therefore, further studies focused on the temporal dynamics and structure of sputum microbial communities during acute exacerbation of COPD (AECOPD) would still be necessary.", {"entities": []}], ["In our study, the use of molecular microbiological techniques provided insight into both fungal and bacterial diversities in AECOPD patients during hospitalization.", {"entities": []}], ["In particular, we examined the structure and varieties of lung microbial community in 6 patients with severe AECOPD by amplifying 16S rRNA V4 hyper-variable and internal transcribed spacer (ITS) DNA regions using barcoded primers and the Illumina sequencing platform.", {"entities": []}], ["Sequence analysis showed 261 bacterial genera representing 20 distinct phyla, with an average number of genera per patient of >157, indicating high diversity.", {"entities": []}], ["Acinetobacter , Prevotella , Neisseria , Rothia , Lactobacillus , Leptotrichia , Streptococcus , Veillonella , and Actinomyces were the most commonly identified genera, and the average total sequencing number per sputum sample was >10000 18S ITS sequences.", {"entities": []}], ["The fungal population was typically dominated by Candia , Phialosimplex , Aspergillus , Penicillium , Cladosporium and Eutypella .", {"entities": []}], ["Our findings highlight that COPD patients have personalized structures and varieties in sputum microbial community during hospitalization periods.", {"entities": []}], ["Community development is a health promotion approach identified as having great potential to improve Indigenous health, because of its potential for extensive community participation.", {"entities": []}], ["There has been no systematic examination of the extent of community participation in community development projects and little analysis of their effectiveness.", {"entities": []}], ["This systematic review aims to identify the extent of community participation in community development projects implemented in Australian Indigenous communities, critically appraise the qualitative and quantitative methods used in their evaluation, and summarise their outcomes.", {"entities": []}], ["Ten electronic peer-reviewed databases and two electronic grey literature databases were searched for relevant studies published between 1990 and 2015.", {"entities": []}], ["The level of community participation and the methodological quality of the qualitative and quantitative components of the studies were assessed against standardised criteria.", {"entities": []}], ["Thirty one evaluation studies of community development projects were identified.", {"entities": []}], ["Community participation varied between different phases of project development, generally high during project implementation, but low during the evaluation phase.", {"entities": []}], ["For the majority of studies, methodological quality was low and the methods were poorly described.", {"entities": []}], ["Although positive qualitative or quantitative outcomes were reported in all studies, only two studies reported statistically significant outcomes.", {"entities": []}], ["Partnerships between researchers, community members and service providers have great potential to improve methodological quality and community participation when research\u00a0skills and community knowledge are integrated to design, implement and evaluate community development projects.", {"entities": []}], ["The methodological\u00a0quality of studies evaluating Australian Indigenous community development projects\u00a0is currently too weak to confidently determine the cost-effectiveness of community development projects in improving the health and wellbeing of Indigenous Australians.", {"entities": []}], ["Higher quality studies evaluating community\u00a0development projects would strengthen the evidence base.", {"entities": []}], ["Microdeletion of the chromosome 22q11.2 region is the most common genetic aberration among patients with velocardiofacial syndrome (VCFS) but a subset of subjects do not show alterations of this chromosome region.", {"entities": [[122, 130, "DISEASE"], [105, 130, "DISEASE"]]}], ["We analyzed 18 patients with VCFS-like features by comparative genomic hybridisation (aCGH) array and performed a face-to-face slide hybridization with two different arrays: a whole genome and a chromosome 22-specific BAC array.", {"entities": []}], ["Putative rearrangements were confirmed by FISH and MLPA assays.", {"entities": []}], ["One patient carried a combination of rearrangements on 1q21.1, consisting in a microduplication of 212 kb and a close microdeletion of 1.15 Mb, previously reported in patients with variable phenotypes, including mental retardation, congenital heart defects (CHD) and schizophrenia.", {"entities": [[267, 280, "DISEASE"], [140, 142, "GENE"]]}], ["While 326 control samples were negative for both 1q21.1 rearrangements, one of 73 patients carried the same 212-kb microduplication, reciprocal to TAR microdeletion syndrome.", {"entities": [[165, 173, "DISEASE"]]}], ["Also, we detected four copy number variants (CNVs) inherited from one parent (a 744-kb duplication on 10q11.22; a 160 kb duplication and deletion on 22q11.21 in two cases; and a gain of 140 kb on 22q13.2), not present in control subjects, raising the potential role of these CNVs in the VCFS-like phenotype.", {"entities": []}], ["Our results confirmed aCGH as a successful strategy in order to characterize additional submicroscopic aberrations in patients with VCF-like features that fail to show alterations in 22q11.2 region.", {"entities": []}], ["We report a 212-kb microduplication on 1q21.1, detected in two patients, which may contribute to CHD.", {"entities": []}], ["To evaluate the relationship between alcohol consumption and the risk of acute exacerbation of COPD (AECOPD).", {"entities": []}], ["We conducted a secondary analysis of data previously collected in a large, multicenter trial of daily azithromycin in COPD.", {"entities": []}], ["To analyze the relationship between amount of baseline self-reported alcohol consumption in the past 12 months and subsequent AECOPD, we categorized the subjects as minimal (<1 drink/month), light-to-moderate (1\u201360 drinks/month), or heavy alcohol users (>60 drinks/month).", {"entities": []}], ["The primary outcome was time to first AECOPD and the secondary outcome was AECOPD rate during the 1-year study period.", {"entities": []}], ["Of the 1,142 enrolled participants, 1,082 completed baseline alcohol questionnaires and were included in this analysis.", {"entities": []}], ["Six hundred and forty-five participants reported minimal alcohol intake, 363 reported light-to-moderate intake, and 74 reported heavy intake.", {"entities": []}], ["There were no statistically significant differences in median time to first AECOPD among minimal (195 days), light-to-moderate (241 days), and heavy drinkers (288 days) ( P =0.11).", {"entities": []}], ["The mean crude rate of AECOPD did not significantly differ between minimal (1.62 events per year) and light-to-moderate (1.44 events per year) ( P =0.095), or heavy drinkers (1.68 events per year) ( P =0.796).", {"entities": []}], ["There were no significant differences in hazard ratios for AECOPD after adjustment for multiple covariates.", {"entities": []}], ["Among persons with COPD at high risk of exacerbation, we found no significant relationship between self-reported baseline alcohol intake and subsequent exacerbations.", {"entities": []}], ["The number of patients reporting heavy alcohol intake was small and further study is needed to determine the effect of heavy alcohol intake on AECOPD risk.", {"entities": []}], ["Caring for a child with a chronic condition, such as sickle cell disease, can have a significant impact on parents and families.", {"entities": []}], ["In order to provide comprehensive care and support to these families, psychometrically sound instruments are needed as an initial step in measuring the impact of chronic diseases on parents and families.", {"entities": []}], ["We sought to evaluate the psychometric properties of the PedsQL\u2122 Family Impact Module in populations of children with and without sickle cell disease.", {"entities": []}], ["In addition, we sought to determine the correlation between parent's well being and their proxy report of their child's health-related quality of life (HRQL).", {"entities": []}], ["We conducted a cross-sectional study of parents of children with and without sickle cell disease who presented to an urban hospital-based sickle cell disease clinic and an urban primary care clinic.", {"entities": []}], ["We assessed the HRQL and family functioning of both groups of parents utilizing the PedsQL\u2122 Family Impact Module.", {"entities": []}], ["The reliability, validity and factor structure of the instrument were determined and scores from the instrument were correlated with scores from parent-proxy report of their child's HRQL using the PedsQL\u2122 4.0 Generic Core Scales.", {"entities": []}], ["Parents of 170 children completed the module (97 parents of children with sickle cell disease and 73 parents of children without sickle cell disease).", {"entities": []}], ["The Family Impact Module had high ceiling effects but was reliable (Cronbach's alpha > 0.80 in all scales).", {"entities": []}], ["The empirical factor structure was generally consistent with the theoretical factor structure and supported construct validity.", {"entities": []}], ["The Family Impact Module discriminated between parents of children with severe sickle cell disease from parents of children with mild disease or no disease in the areas of communication and worry.", {"entities": []}], ["There were no significant differences across any of the subscales between parents of children with mild sickle cell disease and those with no disease.", {"entities": []}], ["Parents with higher scores, representing better HRQL and family functioning, generally reported higher HRQL scores for their children.", {"entities": []}], ["The PedsQL\u2122 Family Impact module was reliable, however it displayed large ceiling effects and did not discriminate well between parents of children with and without sickle cell disease.", {"entities": []}], ["Future research to evaluate the psychometric properties of the Family Impact Module for parents of healthy children may be helpful.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a low grade systemic inflammatory disease characterized by dyspnea and exercise intolerance even under standard therapy.", {"entities": []}], ["Rhodiola crenulata (RC) has been shown to exert anti-inflammatory effects and to enhance exercise endurance, thereby having the potential to treat COPD.", {"entities": []}], ["In this 12-week, randomized, double-blind, placebo-controlled clinical trial, 57 patients with stable moderate-to-severe COPD aged 70\u00b18.8 years were given RC (250 mg twice/day) (n=38) or a placebo (250 mg twice/day) (n=19) in addition to their standard regimen.", {"entities": []}], ["There were no significant differences in anthropometrics, quality of life, lung function, six-minute walk and incremental exercise tests between the two groups at enrollment.", {"entities": []}], ["Over the 12 weeks, RC was well tolerated, significantly reduced triceps skin thickness (\u0394=-1 mm, p=.04), change of FEV1 (4.5%, p=.03), and improved workload (\u0394=10%, p=.01); although there were no significant differences in these factors between the two groups.", {"entities": []}], ["However, there were significant between-group differences in tidal volume and ventilation-CO 2 -output ratio at peak exercise (both p=.05), which were significantly related to peak work rate (both p<.0001).", {"entities": []}], ["RC tended to protect against acute exacerbation of COPD (p=.1) but not other measurements.", {"entities": []}], ["RC did not improve the six-minute walk test distance but significantly improved tidal breathing and ventilation efficiency, most likely through improvements in work rate.", {"entities": []}], ["Further studies with a larger patient population are needed in order to confirm these findings.", {"entities": []}], ["ClinicalTrials.gov number NCT02242461", {"entities": []}], ["Cluster immunotherapy represents an interesting alternative to conventional up-dosing schedules because it allows achieving the maintenance dose within a shorter time interval.", {"entities": []}], ["In this study, the efficacy and safety of cluster immunotherapy with a high polymerized allergen extract of a grass/rye pollen mixture have been evaluated in a randomized, double-blind, placebo-controlled, multicenter study.", {"entities": []}], ["In total, 121 patients with allergic rhinoconjunctivitis due to grass pollen were randomized 1\u00a0:\u00a01 to verum or placebo group.", {"entities": []}], ["A short cluster up-dosing schedule of only 1\u00a0week was applied to achieve the maintenance dose which was administered monthly during the study period of 1\u00a0year.", {"entities": []}], ["Total combined symptom and medication score (TCS) was defined as primary outcome parameter.", {"entities": []}], ["Secondary outcome parameters were individual symptom and medication scores, \u2018well days,\u2019 global improvement as well as immunological effects and nasal allergen challenge.", {"entities": []}], ["The safety profile was evaluated based on the European academy of allergy and clinical immunology grading system.", {"entities": []}], ["Significant reduction in the verum compared to the placebo group (intention-to-treat, population, verum: n \u00a0=\u00a055; placebo: n \u00a0=\u00a047) was found regarding TCS ( P \u00a0=\u00a00.005), rhinoconjunctivitis total symptom score (RTSS, P \u00a0=\u00a00.006), and total rescue medication score (TRMS, P \u00a0=\u00a00.002).", {"entities": []}], ["Additionally, secondary outcomes such as \u2018well days,\u2019 nasal challenge results, and increase of specific IgG4 were in favor of the active treatment.", {"entities": []}], ["All systemic adverse reactions (0.8% of all injections in the verum group) were of mild intensity.", {"entities": []}], ["No severe reactions related to the study medication were observed.", {"entities": []}], ["Cluster immunotherapy with high polymerized grass pollen extracts resulted in significant clinical efficacy and has been shown to be a safe treatment for grass pollen-allergic patients.", {"entities": []}], ["Patients with diabetes are at increased risk for depression, compounding the burden of disease.", {"entities": []}], ["When comorbid with diabetes, depression leads to poorer health outcomes and often complicates diabetes self-management .", {"entities": []}], ["Unfortunately, treatment options for these complex patients are limited and comprehensive services are rarely available for patients in rural settings.", {"entities": []}], ["A small open trial was conducted to test the acceptability, feasibility and preliminary outcomes of a telephone-delivered coaching intervention for rural-dwelling older adults with uncontrolled diabetes and comorbid, clinically significant depressive symptoms.", {"entities": []}], ["A total of eight older adults were enrolled in Healthy Outcomes through Patient Empowerment (HOPE), a 10-session (12-week), telephone-based coaching intervention.", {"entities": []}], ["Primary study constructs included measures of diabetes control (Hemoglobin [Hb] A1c), depressive symptoms (Patient Health Questionnaire-9 [PHQ-9]), and diabetes-related distress (Problem Areas in Diabetes Scale [PAID]).", {"entities": []}], ["Assessments were conducted at baseline, post-intervention, and 6-month follow-up.", {"entities": []}], ["Acceptability and feasibility were evaluated using patient surveys, focused exit interviews, and session attendance data.", {"entities": []}], ["Clinically significant improvements were realized post-intervention and at 6-month follow-up for outcomes related to diabetes and depression.", {"entities": []}], ["Effect sizes using Cohen's d were determined post-intervention and at 6-month follow-up, respectively, for HbA1c ( d= 0.36; d= 0.28), PHQ-9 ( d= 1.48; d= 1.67, and PAID ( d= 1.50; d= 1.06) scores.", {"entities": []}], ["Among study participants, HbA1c improved from baseline by a mean (M) of 1.13 (SD=1.70) post-intervention and M=0.84 (SD=1.62) at 6\u2009months.", {"entities": []}], ["Depression scores, measured by the PHQ-9, improved from baseline by M=5.14 (SD=2.27) post-intervention and M=7.03 (SD=4.43) at 6-month follow-up.", {"entities": []}], ["PAID scores also improved by M=17.68 (SD=10.7) post-intervention and M=20.42 (SD=20.66) from baseline to 6-month follow-up.", {"entities": []}], ["Case examples are provided for additional context and to more fully articulate salient intervention concepts.", {"entities": []}], ["Although preliminary, data from this small open trial suggest that HOPE holds the potential to improve both physical (diabetes) and emotional (diabetes distress, depression) health outcomes and that changes can be maintained over a 6-month time period.", {"entities": []}], ["As envisioned by the authors, HOPE may function as an extension of traditional primary care for rural-dwelling older adults with multiple comorbidities.", {"entities": []}], ["A future randomized clinical trial will test HOPE\u2019s broader effectiveness with rural-dwelling older adults.", {"entities": []}], ["NCT01274715", {"entities": []}], ["The oils of some unconventional oilseeds (hemp, radish, terebinth, stinging nettle, laurel) were obtained by a cold-press method in which the total oil content, fatty acids, tocopherol isomers, some metal contents (Ca, Mg, Fe, Cu), antioxidant activity and oxidative stability were determined.", {"entities": []}], ["The total oil content was determined ranging between 30.68 and 43.12%, and the oil samples had large amounts of unsaturated fatty acids, with oleic acid and linoleic acid.", {"entities": []}], ["Of all the oils, terebinth seed oil had the highest \u03b1-tocopherol content (102.21\u00a0\u00b1\u00a01.01\u00a0mg/kg oil).", {"entities": []}], ["Laurel oilseed had the highest antiradical activity in both the DPPH and ABTS assays.", {"entities": []}], ["The peroxide value of the non-oxidized oils ranged between 0.51 and 3.73\u00a0mequiv O 2 /kg oil.", {"entities": []}], ["The TBARS value of the non-oxidized oils ranged between 0.68\u00a0\u00b1\u00a00.02 and 6.43\u00a0\u00b1\u00a00.48\u00a0mmol MA equiv/g oil.", {"entities": []}], ["At 110\u00a0\u00b0C, the Rancimat induction period of the oils ranged between 1.32 and 43.44\u00a0h. The infrared spectra of the samples were recorded by FTIR spectroscopy.", {"entities": []}], ["The absorbance values of the spectrum bands were observed and it was determined that some of the chemical groups of oxidized oils caused changes in absorbance.", {"entities": []}], ["As a result of the present research, the analyzed oils could be evaluated as an alternative to traditionally consumed vegetable oils or as additives to them.", {"entities": []}], ["The glucocorticoid receptor (GR) is a ligand activated transcription factor, serving to regulate both energy metabolism and immune functions.", {"entities": []}], ["Factors that influence cellular sensitivity to glucocorticoids (GC) are therefore of great interest.", {"entities": [[64, 66, "GENE"]]}], ["The N-terminal of the GR contains numerous potential proline-directed phosphorylation sites, some of which can regulate GR transactivation.", {"entities": []}], ["Unrestricted proline isomerisation can be inhibited by adjacent serine phosphorylation and requires a prolyl isomerise, Pin1.", {"entities": [[120, 124, "GENE"]]}], ["Pin1 therefore determines the functional outcome of proline-directed kinases acting on the GR, as cis / trans isomers are distinct pools with different interacting proteins.", {"entities": [[0, 4, "GENE"]]}], ["We show that Pin1 mediates GR transactivation, but not GR trans-repression.", {"entities": [[13, 17, "GENE"]]}], ["Two N-terminal GR serines, S203 and S211, are targets for Pin1 potentiation of GR transactivation, establishing a direct link between Pin1 and the GR.", {"entities": [[58, 62, "GENE"], [134, 138, "GENE"], [58, 62, "GENE"], [134, 138, "GENE"]]}], ["We also demonstrate GC-activated co-recruitment of GR and Pin1 to the GILZ gene promoter.", {"entities": [[58, 62, "GENE"]]}], ["The Pin1 effect required both its WW and catalytic domains, and GR recruitment to its GRE was Pin1-dependent.", {"entities": [[4, 8, "GENE"], [94, 98, "GENE"]]}], ["Therefore, Pin1 is a selective regulator of GR transactivation, acting through N-terminal phospho-serine residues to regulate GR recruitment to its target sites in the genome.", {"entities": [[11, 15, "GENE"]]}], ["As Pin1 is dysregulated in disease states, this interaction may contribute to altered GC action in inflammatory conditions.", {"entities": [[3, 7, "GENE"], [86, 88, "GENE"]]}], ["Mast cells (MC) are key effector cells of allergic diseases and resistance to helminthic parasites and induce or amplify diverse innate and adaptive immune responses.", {"entities": []}], ["The signals controlling MC mobilization during inflammation are not fully understood.", {"entities": []}], ["Since anaphylatoxins are attractive candidates as MC chemoattractants, we investigated expression and function of anaphylatoxin receptors in murine MC.", {"entities": []}], ["Precursor cell-derived MC cultured with IL-3 in the presence or absence of SCF did not express significant amounts of surface C5a receptor (C5aR) or C3a receptor (C3aR).", {"entities": []}], ["MC required approximately 4 h of stimulation with Ag (DNP-albumin, following preincubation with IgE anti-DNP), ionomycin, or PMA to enable a strong chemotactic response towards C5a, paralleled by a distinct C5aR upregulation.", {"entities": []}], ["Likewise, C5a induced intracellular calcium fluxes solely in activated MC.", {"entities": []}], ["In contrast, C3a proved to be a weak MC chemotaxin and unable to increase intracellular calcium.", {"entities": []}], ["Primary peritoneal MC did not express detectable amounts of anaphylatoxin receptors, however, similar to precursor cell-derived MC, stimulation with Ag or ionomycin for 4 h induced a prominent surface expression of C5aR whereas C3aR remained undetectable.", {"entities": []}], ["Collectively, our results suggest that Ag-dependent as well as -independent activation induces an inflammatory MC phenotype which is distinguished by neoexpression of a functional C5aR as a novel effector mechanism in MC-mediated pathogenesis.", {"entities": []}], ["Human rIL-5 was found to selectively stimulate morphological changes and the function of human eosinophils.", {"entities": []}], ["This molecule is thus a prime candidate for the selective eosinophilia and eosinophil activation seen in disease.", {"entities": [[58, 70, "DISEASE"]]}], ["Chronic Beryllium (Be) Disease (CBD) is a granulomatous disorder that predominantly affects the lung.", {"entities": []}], ["The CBD is caused by Be exposure of individuals carrying the HLA-DP2 protein of the major histocompatibility complex class II (MHCII).", {"entities": []}], ["While the involvement of Be in the development of CBD is obvious and the binding site and the sequence of Be and peptide binding were recently experimentally revealed in silico modeling and predict the Be binding to be within the acidic pocket (Glu26, Glu68 and Glu69) present on the HLA-DP2 protein in accordance with the experimental work", {"entities": []}], ["Zinc (Zn) is an essential micronutrient for basic cell activities such as cell growth, differentiation, and survival.", {"entities": []}], ["Zn deficiency depresses both innate and adaptive immune responses.", {"entities": []}], ["However, the precise physiological mechanisms of the Zn-mediated regulation of the immune system have been largely unclear.", {"entities": []}], ["Zn homeostasis is tightly controlled by the coordinated activity of Zn transporters and metallothioneins, which regulate the transport, distribution, and storage of Zn.", {"entities": []}], ["There is growing evidence that Zn behaves like a signaling molecule, facilitating the transduction of a variety of signaling cascades in response to extracellular stimuli.", {"entities": []}], ["In this review, we highlight the emerging functional roles of Zn and Zn transporters in immunity, focusing on how crosstalk between Zn and immune-related signaling guides the normal development and function of immune cells.", {"entities": []}], ["Clinical use of chemotherapeutic drug, cisplatin is limited by its toxicity and drug resistance.", {"entities": []}], ["Therefore, efforts continue for the discovery of novel combination therapies with cisplatin, to increase efficacy and reduce its toxicity.", {"entities": []}], ["Here, we screened 16 medicinal plant extracts from Northeast part of India and found that leaf extract of Zanthoxylum armatum DC.", {"entities": []}], ["(ZALE) induced cytotoxicity as well as an effect on the increasing of the efficiency of chemotherapeutic drugs (cisplatin, mitomycin C and camptothecin).", {"entities": []}], ["This work shows detail molecular mechanism of anti-cancer activity of ZALE and its potential for combined treatment regimens to enhance the apoptotic response of chemotherapeutic drugs.", {"entities": [[51, 57, "DISEASE"]]}], ["ZALE induced cytotoxicity, nuclear blebbing and DNA fragmentation in HeLA cells suggesting apoptosis induction in human cervical cell line.", {"entities": []}], ["However, the apoptosis induced was independent of caspase 3 activation and poly ADP ribose polymerase (PARP) cleavage.", {"entities": []}], ["Further, ZALE activated Mitogen-activated protein kinases (MAPK) pathway as revealed by increased phosphorylation of extracellular-signal-regulated kinases (ERK), p38 and c-Jun N-terminal kinase (JNK).", {"entities": []}], ["Inhibition of ERK activation but not p38 or JNK completely blocked the ZALE induced apoptosis suggesting an ERK dependent apoptosis.", {"entities": []}], ["Moreover, ZALE generated DNA double strand breaks as suggested by the induction \u03b3H2AX foci formation.", {"entities": []}], ["Interestingly, pretreatment of certain cancer cell lines with ZALE, sensitized the cancer cells to cisplatin and other chemotherapeutic drugs.", {"entities": [[39, 45, "DISEASE"], [83, 89, "DISEASE"]]}], ["Enhanced caspase activation was observed in the synergistic interaction among chemotherapeutic drugs and ZALE.", {"entities": []}], ["Purification and identification of the bio-active molecules from the ZALE or as a complementary treatment for a sequential treatment of ZALE with chemotherapeutic drugs might be a new challenger to open a new therapeutic window for the novel anti-cancer treatment.", {"entities": [[247, 253, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s40659-015-0037-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cardiovascular diseases are highly represented in multimorbidity patterns.", {"entities": []}], ["Nevertheless, few studies have analysed the burden of these diseases in the population with multimorbidity.", {"entities": []}], ["The objective of this study was to identify and describe the cardiovascular diseases among the patients with multimorbidity.", {"entities": []}], ["We designed a cross-sectional study in patients \u226519\u00a0years old assigned to 251 primary health care centres in Catalonia, Spain.", {"entities": []}], ["The main outcome was cardiovascular morbidity burden, defined as the presence of one or more of 24 chronic cardiovascular diseases in multimorbid patients (\u22652 chronic conditions).", {"entities": []}], ["Two groups were defined, with and without multimorbidity; the multimorbidity group was further divided into cardiovascular and non-cardiovascular subgroups.", {"entities": []}], ["The secondary outcomes were: modifiable major cardiovascular risk factors (smoking, hypertension, hypercholesterolaemia, diabetes) and cardiovascular risk score (REGICOR, Registre Giron\u00ed del Cor ).", {"entities": [[84, 96, "DISEASE"]]}], ["Other variables analysed were: sex, age (19\u201324, 25\u201344, 45\u201364, 65\u201379, and 80+ years), number of chronic diseases, urban setting, active toxic habits (smoking and alcohol), physical parameters and laboratory tests.", {"entities": []}], ["A total of 1,749,710 individuals were included (mean age, 47.4\u00a0years [SD: 17.8]; 50.7\u00a0% women), of which nearly half (46.8\u00a0%) had multimorbidity (95\u00a0% CI: 46.9\u201347.1).", {"entities": []}], ["In patients with multimorbidity,, the cardiovascular burden was 54.1\u00a0% of morbidity (95\u00a0% CI: 54.0\u201354.2) and the four most prevalent cardiovascular diseases were uncomplicated hypertension (75.3\u00a0%), varicose veins of leg (20.6\u00a0%), \u201cother\u201d heart disease (10.5\u00a0%) and atrial fibrillation/flutter (6.7\u00a0%).", {"entities": [[176, 188, "DISEASE"], [239, 252, "DISEASE"], [199, 213, "DISEASE"]]}], ["In the cardiovascular morbidity subgroup, 38.2\u00a0% had more than one cardiovascular disease.", {"entities": []}], ["The most prevalent duet and triplet combinations were uncomplicated hypertension & lipid disorder (38.8\u00a0%) and uncomplicated hypertension & lipid disorder & non-insulin dependent diabetes (11.3\u00a0%), respectively.", {"entities": [[68, 80, "DISEASE"], [125, 137, "DISEASE"]]}], ["By age groups, the same duet was the most prevalent in patients aged 45\u201380 years and in men aged 25\u201344 years.", {"entities": []}], ["In women aged 19\u201344, varicose veins of leg & anxiety disorder/anxiety was the most prevalent; in men aged 19\u201324, it was uncomplicated hypertension & obesity.", {"entities": [[134, 146, "DISEASE"], [45, 61, "DISEASE"], [149, 156, "DISEASE"], [21, 35, "DISEASE"]]}], ["Patients with multimorbidity showed a higher cardiovascular risk profile than the non-multimorbidity group.", {"entities": []}], ["More than 50\u00a0% percent of patients with multimorbidity had cardiovascular diseases, the most frequent being hypertension.", {"entities": [[108, 120, "DISEASE"]]}], ["The presence of cardiovascular risk factors and the cardiovascular risk profile were higher in the multimorbidity group than the non-multimorbidity group.", {"entities": []}], ["Hypertension, diabetes and dyslipidaemia constituted the most prevalent multimorbidity pattern.", {"entities": [[0, 12, "DISEASE"]]}], ["Pain has a distinct sensory and affective (i.e., unpleasantness) component.", {"entities": []}], ["BreEStim, during which electrical stimulation is delivered during voluntary breathing, has been shown to selectively reduce the affective component of post-amputation phantom pain.", {"entities": []}], ["The objective was to examine whether BreEStim increases pain threshold such that subjects could have improved tolerance of sensation of painful stimuli.", {"entities": []}], ["Eleven pain-free healthy subjects (7 males, 4 females) participated in the study.", {"entities": []}], ["All subjects received BreEStim (100 stimuli) and conventional electrical stimulation (EStim, 100 stimuli) to two acupuncture points (Neiguan and Weiguan) of the dominant hand in a random order.", {"entities": []}], ["The two different treatments were provided at least three days apart.", {"entities": []}], ["Painful, but tolerable electrical stimuli were delivered randomly during EStim, but were triggered by effortful inhalation during BreEStim.", {"entities": []}], ["Measurements of tactile sensation threshold, electrical sensation and electrical pain thresholds, thermal (cold sensation, warm sensation, cold pain and heat pain) thresholds were recorded from the thenar eminence of both hands.", {"entities": []}], ["These measurements were taken pre-intervention and 10\u2212min post-intervention.", {"entities": []}], ["There was no difference in the pre-intervention baseline measurement of all thresholds between BreEStim and EStim.", {"entities": []}], ["The electrical pain threshold significantly increased after BreEStim (27.5\u00b16.7% for the dominant hand and 28.5\u00b110.8% for the non-dominant hand, respectively).", {"entities": []}], ["The electrical pain threshold significantly decreased after EStim (9.1\u00b12.8% for the dominant hand and 10.2\u00b14.6% for the non\u2013dominant hand, respectively) (F [1, 10] \u200a=\u200a30.992, p\u200a=\u200a.00024).", {"entities": []}], ["There was no statistically significant change in other thresholds after BreEStim and EStim.", {"entities": []}], ["The intensity of electrical stimuli was progressively increased, but no difference was found between BreEStim and EStim.", {"entities": []}], ["Voluntary breathing controlled electrical stimulation selectively increases electrical pain threshold, while conventional electrical stimulation selectively decreases electrical pain threshold.", {"entities": []}], ["This may translate into improved pain control.", {"entities": []}], ["The Ess1 prolyl isomerase from Saccharomyces cerevisiae and its human ortholog, Pin1, play critical roles in transcription by regulating RNA polymerase II.", {"entities": [[80, 84, "GENE"]]}], ["In human cells, Pin1 also regulates a variety of signaling proteins, and Pin1 misexpression is linked to several human diseases.", {"entities": [[16, 20, "GENE"], [73, 77, "GENE"], [16, 20, "GENE"], [73, 77, "GENE"]]}], ["To gain insight into Ess1 /Pin1 function, we carried out a synthetic genetic array screen to identify novel targets of Ess1 in yeast.", {"entities": []}], ["We identified potential targets of Ess1 in transcription, stress, and cell-cycle pathways.", {"entities": []}], ["We focused on the cell-cycle regulators Swi6 and Whi5 , both of which show highly regulated nucleocytoplasmic shuttling during the cell cycle.", {"entities": []}], ["Surprisingly, Ess1 did not control their transcription but instead was necessary for their nuclear localization.", {"entities": []}], ["Ess1 associated with Swi6 and Whi5 in vivo and bound directly to peptides corresponding to their nuclear localization sequences in vitro .", {"entities": []}], ["Binding by Ess1 was significant only if the Swi6 and Whi5 peptides were phosphorylated at Ser-Pro motifs, the target sites of cyclin-dependent kinases.", {"entities": []}], ["On the basis of these results, we propose a model in which Ess1 induces a conformational switch ( cis-trans isomerization) at phospho-Ser-Pro sites within the nuclear targeting sequences of Swi6 and Whi5 .", {"entities": []}], ["This switch would promote nuclear entry and/or retention during late M and G1 phases and might work by stimulating dephosphorylation at these sites by the Cdc14 phosphatase.", {"entities": []}], ["This is the first study to identify targets of Ess1 in yeast other than RNA polymerase II.", {"entities": []}], ["Cancer cachexia is a syndrome characterized by loss of skeletal muscle protein, depletion of lipid stores, anorexia, weakness, and perturbations of the hormonal homeostasis.", {"entities": [[21, 29, "DISEASE"], [0, 6, "DISEASE"]]}], ["Despite several therapeutic approaches described in the past, effective interventions countering cancer cachexia are still lacking.", {"entities": [[97, 103, "DISEASE"]]}], ["The present work was aimed to verify the ability of eicosapentaenoic acid (EPA) to prevent the muscle depletion in Lewis lung carcinoma-bearing mice and to test the ability of endurance exercise training to increase the EPA effect.", {"entities": [[126, 135, "DISEASE"], [121, 135, "DISEASE"]]}], ["EPA alone did not prevent the muscle loss induced by tumor growth while the combination with exercise induced a partial rescue of muscle strength and mass.", {"entities": []}], ["Moreover, the association of EPA and exercise reduced the dramatic PAX-7 accumulation and stimulated the increase of PCG-1 protein.", {"entities": []}], ["Overall, the present data suggest that exercise is an effective tool that should be added for combined therapeutic approaches against cancer cachexia.", {"entities": [[134, 140, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s13539-011-0028-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Device satisfaction and preference are important patient-reported outcomes to consider when choosing inhaled therapy.", {"entities": []}], ["A subset of adults (n = 153) with moderate or severe asthma participating in a randomized parallel-group, double-dummy trial that compared the efficacy and safety of 12 weeks\u2019 treatment with budesonide delivered via Respimat", {"entities": [[53, 59, "DISEASE"]]}], ["More than 800 000 people die every year from suicide, and about 20 times more attempt suicide.", {"entities": []}], ["In most countries, suicide risk is highest in older males, and risk of attempted suicide is highest in younger females.", {"entities": []}], ["The higher lethal level of suicidal acts in males is explained by the preference for more lethal methods, as well as other factors.", {"entities": []}], ["In the vast majority of cases, suicidal behavior occurs in the context of psychiatric disorders, depression being the most important one.", {"entities": []}], ["Improving the treatment of depression, restricting access to lethal means, and avoiding the Werther effect (imitation suicide) are central aspects of suicide prevention programs.", {"entities": []}], ["In several European regions, the four-level intervention concept of the European Alliance Against Depression (www.EAAD.net), simultaneously targeting depression and suicidal behavior, has been found to have preventive effects on suicidal behavior.", {"entities": []}], ["It has already been implemented in more than 100 regions in Europe.", {"entities": []}], ["Scientific evidence shows that cigarette price increases can significantly reduce smoking prevalence and smoking initiation among adolescents and young adults.", {"entities": []}], ["However, data are lacking regarding the effectiveness of increasing Pennsylvania\u2019s cigarette tax to reduce smoking and/or adverse health effects of smoking.", {"entities": []}], ["The objective of our study was to assess the impact of cigarette tax increases and resulting price increases on smoking prevalence, acute myocardial infarction (AMI) and asthma hospitalization rates, and sudden cardiac death (SCD) rates in Pennsylvania.", {"entities": [[138, 159, "DISEASE"], [132, 159, "DISEASE"], [170, 176, "DISEASE"], [226, 229, "GENE"]]}], ["We used segmented regression analyses of interrupted time series to evaluate the level and trend changes in Pennsylvania adults\u2019 current smoking prevalence, age-adjusted AMI and asthma hospitalization rates, age-specific asthma hospitalization rates, and age-adjusted SCD rates following 2 cigarette excise tax increases.", {"entities": [[178, 184, "DISEASE"], [221, 227, "DISEASE"], [268, 271, "GENE"]]}], ["After the first excise tax increase, no beneficial effects were noted on the outcomes of interest.", {"entities": []}], ["The second tax increase was associated with significant declines in smoking prevalence for people aged 18 to 39, age-adjusted AMI hospitalization rates for men, age-adjusted asthma hospitalizations rates, and SCD rates among men.", {"entities": [[174, 180, "DISEASE"], [209, 212, "GENE"]]}], ["Overall smoking prevalence declined by 5.2% ( P = .01), with a quarterly decrease of 1.4% ( P = .01) for people aged 18 to 39 years.", {"entities": []}], ["The age-adjusted AMI hospitalization rate for men showed a decline of 3.87/100,000 population ( P = .04).", {"entities": []}], ["The rate of age-adjusted asthma hospitalizations decreased by 10.05/100,000 population ( P < .001), and the quarterly trend decreased by 3.21/100,000 population ( P < .001).", {"entities": [[25, 31, "DISEASE"]]}], ["Quarterly SCD rates for men decreased by 1.34/100,000 population ( P < .001).", {"entities": [[10, 13, "GENE"]]}], ["An increase in the price of cigarettes to more than $4 per 20-cigarette pack was associated with a significant decrease in smoking among younger people (aged 18\u201339).", {"entities": []}], ["Decreases were also seen in asthma hospitalizations and men\u2019s age-adjusted AMI hospitalization and SCD rates.", {"entities": [[28, 34, "DISEASE"], [99, 102, "GENE"]]}], ["Further research and policy development regarding the effect of cigarette taxes on tobacco consumption should be cognizant of the psychological tipping points at which overall price affects smoking patterns.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) exhibit dominant features of chronic bronchitis, emphysema, and/or asthma, with a common phenotype of airflow obstruction.", {"entities": [[14, 51, "DISEASE"], [126, 132, "DISEASE"], [96, 106, "DISEASE"]]}], ["COPD pulmonary physiology reflects the sum of pathological changes in COPD, which can occur in large central airways, small peripheral airways, and the lung parenchyma.", {"entities": []}], ["Quantitative or high-resolution computed tomography is used as a surrogate measure for assessment of disease progression.", {"entities": []}], ["Different biological or molecular markers have been reported that reflect the mechanistic or pathogenic triad of inflammation, proteases, and oxidants and correspond to the different aspects of COPD histopathology.", {"entities": []}], ["Similar to the pathogenic triad markers, genetic variations or polymorphisms have also been linked to COPD-associated inflammation, protease\u2013antiprotease imbalance, and oxidative stress.", {"entities": []}], ["Furthermore, in recent years, there have been reports identifying aging-associated mechanistic markers as downstream consequences of the pathogenic triad in the lungs from COPD patients.", {"entities": []}], ["For this review, the authors have limited their discussion to a review of mechanistic markers and genetic variations and their association with COPD histopathology and disease status.", {"entities": []}], ["Glioma is the most common and believed to be one of the most aggressive tumors of the central nervous system (CNS) in humans.", {"entities": []}], ["Very little information is available on the etiology and pathogenesis of these tumors to date.", {"entities": []}], ["A significant gap remains in our current understanding of the molecular pathways involved in the genesis, progression and clinical behavior of these tumors.", {"entities": []}], ["Recently, several single nucleotide polymorphisms (SNPs) have been identified in cytokine gene sequences, particularly within the promoter region of these genes, and have been shown to be associated with the development of different types of brain tumors.", {"entities": []}], ["The present study investigates the association of C-33T SNP in the interleukin-4 (IL-4) gene with systemic IL-4 level and the S503P SNP in the IL-4R gene with the incidence of glioma.", {"entities": []}], ["Blood samples were collected from 100 histologically confirmed adult patients with glioma, and 30 apparently healthy individuals from the same area.", {"entities": []}], ["DNA was extracted from each blood sample, and the IL-4 and IL-4R genes were amplified using polymerase chain reaction (PCR) with gene-specific primers.", {"entities": []}], ["Systemic IL-4 concentration was assessed in serum samples from each participant by enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["We observed a negative association between the homozygous genotype (CC) of the SNP C-33T of the IL-4 gene with the incidence of glioma (OR=0.19, 95% CI=0.035-1.02), while the T allele of the SNP demonstrated a significant protective association against glioma.", {"entities": []}], ["Similarly, the heterozygous (CT) and homozygous mutant (CC) of the SNP S503P of the IL-4R gene demonstrated a significant association with glioma development (OR=0.405, 95% CI=0.17-0.969 and OR=0.147, 95% CI=0.036-0.6 respectively), while the C allele exhibited a highly significant association with protection from glioma formation.", {"entities": []}], ["These findings suggest that the T allele of the SNP C-33T in the IL-4 gene and the C allele of the SNP S503P in IL-4R may have a protective role against glioma development.", {"entities": []}], ["Background .", {"entities": []}], ["Very few studies investigate the role of the autonomic nervous system in allergic rhinitis.", {"entities": [[73, 90, "DISEASE"], [82, 90, "DISEASE"]]}], ["In this study, we evaluated the autonomic nervous system in allergic rhinitis patients using heart rate variability (HRV) analysis.", {"entities": [[60, 77, "DISEASE"], [69, 77, "DISEASE"]]}], ["Eleven patients with allergic rhinitis and 13 healthy controls, aged between 19 and 40 years old, were enrolled in the study.", {"entities": [[21, 38, "DISEASE"], [30, 38, "DISEASE"]]}], ["Diagnosis of allergic rhinitis was based on clinical history, symptoms, and positive Phadiatop test.", {"entities": [[13, 30, "DISEASE"], [22, 30, "DISEASE"]]}], ["Electrocardiographic recordings on the sitting and supine positions were obtained for HRV analysis.", {"entities": []}], ["In the supine position, there were no significant statistical differences in very-low-frequency power (VLF, \u22640.04\u2009Hz), low-frequency power (LF, 0.04\u20130.15\u2009Hz), high-frequency power (HF, 0.15\u20130.40\u2009Hz), and the ratio of LF to HF (LF/HF) between the patient and control groups.", {"entities": []}], ["The mean RR intervals significantly increased, while LF% and LF/HF significantly decreased in the patient group in the sitting position.", {"entities": []}], ["Moreover, mean RR intervals, LF, and LF/HF, which were significantly different between the two positions in the control group, did not show a significant change with the posture change in the patient group.", {"entities": []}], ["Conclusion .", {"entities": []}], ["These suggest that patients with allergic rhinitis may have poor sympathetic modulation in the sitting position.", {"entities": [[33, 50, "DISEASE"], [42, 50, "DISEASE"]]}], ["Autonomic dysfunction may therefore play a role in the pathophysiology of allergic rhinitis.", {"entities": [[74, 91, "DISEASE"], [83, 91, "DISEASE"]]}], ["Paranasal sinusitis is widespread and can lead to orbital complications, blindness, and death.", {"entities": [[73, 82, "DISEASE"], [10, 19, "DISEASE"]]}], ["However, the correlation between ophthalmological findings and disease staging remains unclear.", {"entities": []}], ["This study aimed to investigate the staging, acute ophthalmological manifestations, diagnosis, management, and outcomes of orbital complications of paranasal sinusitis during a 27-year period.", {"entities": [[158, 167, "DISEASE"]]}], ["We retrospectively reviewed the medical records of all patients with orbital complications of paranasal sinusitis hospitalized at the National Cheng Kung University Hospital, a medical center in Taiwan during 1988\u20132015.", {"entities": [[104, 113, "DISEASE"]]}], ["Sex, age, symptoms, history, ophthalmological findings, laboratory and imaging findings, treatments, and outcomes were analyzed by staging.", {"entities": []}], ["Eighty-three patients aged 9 days to 80 years had stage I (preseptal cellulitis, n = 39 patients), II (postseptal orbital cellulitis, n = 8), III (subperiosteal abscess, n = 16), IV (orbital abscess, n = 8), or V (intracranial involvement, n = 12) complications.", {"entities": [[69, 79, "DISEASE"], [122, 132, "DISEASE"], [114, 132, "DISEASE"]]}], ["Peak incidences occurred in patients aged 0\u201319 and 60\u201369 years.", {"entities": []}], ["Chronic sinusitis and diabetes mellitus were common preexisting diseases.", {"entities": [[8, 17, "DISEASE"], [22, 39, "DISEASE"]]}], ["Extraocular movement limitation and proptosis predicted postseptal (stage II or more) involvement.", {"entities": []}], ["The likelihood of elevated intraocular pressure increased with stage.", {"entities": []}], ["Reduced visual acuity and presence of relative afferent pupillary defect indicated consideration of magnetic resonance imaging to investigate possible intracranial extension.", {"entities": []}], ["Ipsilateral maxillary (81.7%) and ethmoidal (75.6%) sinuses were the most common sources of infection, and the most frequently implicated pathogens were coagulase-negative Staphylococcus spp.", {"entities": []}], ["(25.3%) and Staphylococcus aureus (20.5%).", {"entities": []}], ["All patients received intravenous antimicrobial therapy (multi-drug therapy in 88.0%), and 55.4% underwent surgery, most commonly endoscopic sinus surgery.", {"entities": []}], ["One (1.2%) diabetic man with stage V complications died of fungal sinusitis with intracranial invasion.", {"entities": [[66, 75, "DISEASE"]]}], ["Five (6.0%) patients, all stage V, lost vision despite intensive treatment.", {"entities": []}], ["The average length of hospital stay was 13.8 days (range 2\u201372 days), and significantly longer stays were associated with stages II\u2013V as compared to stage I. Orbital infection originating from paranasal sinusitis can cause vision loss and death due to intracranial extension.", {"entities": [[202, 211, "DISEASE"]]}], ["Acute ophthalmological findings predict staging and prognosis.", {"entities": []}], ["Cooperative consultation between ophthalmologists, otorhinolaryngologists, and neurologists is essential.", {"entities": []}], ["Urgent diagnostic studies and aggressive antimicrobial therapy are indicated, and surgery should be considered.", {"entities": []}], ["Objective .", {"entities": []}], ["Childhood asthma is a frequent cause of absenteeism that affects school performance.", {"entities": [[10, 16, "DISEASE"]]}], ["We aimed to investigate the impact of asthma on absenteeism and school performance level of elementary and high school students.", {"entities": [[38, 44, "DISEASE"]]}], ["Data about sociodemographics, absenteeism, and academic achievement were obtained from 1539 students attending 98 schools in Greece.", {"entities": []}], ["School performance was assessed for the last two years of school attendance using parents' and teachers' reports and grade point average promotion.", {"entities": []}], ["The mean of the days of absence of students with asthma was higher compared to the healthy students (6.2\u2009\u00b1\u200911.7 versus 0.3\u2009\u00b1\u20093.1, resp., P < 0.001).", {"entities": [[49, 55, "DISEASE"]]}], ["Students with reduced healthcare use presented less absenteeism than those with increased healthcare use for asthma (4.3\u2009\u00b1\u20098.6 versus 12.4\u2009\u00b1\u200917.0 days, resp., P < 0.001).", {"entities": [[109, 115, "DISEASE"]]}], ["Asthma and healthcare use for asthma accounted for an overall estimated variability in absence days of 13.8% and 9%, respectively.", {"entities": [[0, 6, "DISEASE"], [30, 36, "DISEASE"]]}], ["Absenteeism was associated with poor school performance for the last two years of school ( P = 0.002) and with lower grade point promotion in elementary school students ( P = 0.001) but not in high school students ( P = 0.316).", {"entities": []}], ["Higher level of parental education was associated with better school performance ( P < 0.001).", {"entities": []}], ["Asthma was associated with a decreased possibility for excellent performance (OR\u2009=\u20090.64, P = 0.049, 95%CI\u2009=\u20090.41\u20131.00) in elementary students.", {"entities": [[0, 6, "DISEASE"]]}], ["Students with asthma using inhalers were four times more likely to perform excellently in elementary school (OR\u2009=\u20094.3, P = 0.028, 95%CI\u2009=\u20091.17\u201315.95) than their asthmatic peers with alternative asthma treatments.", {"entities": [[14, 20, "DISEASE"], [194, 200, "DISEASE"]]}], ["Conclusions .", {"entities": []}], ["Asthma and increased healthcare use enhance school absenteeism.", {"entities": [[0, 6, "DISEASE"]]}], ["Inhaled steroid use and the higher parental education level were the most important predicting factors for good school performance in elementary school asthmatic children.", {"entities": []}], ["In this article, we review the cardiovascular responses to the inhalation of irritants and pollutants.", {"entities": []}], ["Many sensory receptors in the respiratory system, from nose to alveoli, respond to these irritants and set up powerful reflex changes, including those in the cardiovascular system.", {"entities": []}], ["Systemic hypotension or hypertension, pulmonary hypertension, bradycardia, tachycardia, and dysrhythmias have all been described previously.", {"entities": [[24, 36, "DISEASE"], [48, 60, "DISEASE"], [38, 60, "DISEASE"]]}], ["Most of the experiments have been acute and have been performed on anesthetized experimental animals.", {"entities": []}], ["Experiments on humans suggest we have similar sensory systems and reflex responses.", {"entities": []}], ["However, we must use caution when applying the animal results to humans.", {"entities": []}], ["Most animal experiments, unlike those with humans, have been performed using general anesthesia, with irritants administered in high concentrations, and often to a restricted part of the respiratory tract.", {"entities": []}], ["Species differences in the response to irritants are well established.", {"entities": []}], ["We must be even more careful when applying the results of acute experiments in animals to the pathophysiologic changes observed in prolonged exposure to environmental pollution in humans.", {"entities": []}], ["Objectives .", {"entities": []}], ["IL-33, a newly found cytokine which is involved in joint inflammation, could be blocked by a decoy receptor\u2014sST2.", {"entities": []}], ["The expression and correlation of IL-33 and sST2 in rheumatoid arthritis (RA) are of great interest.", {"entities": [[52, 72, "DISEASE"], [63, 72, "DISEASE"]]}], ["Synovial fluid (SF) was obtained from 120 RA and 30 osteoarthritis (OA) patients, and paired sera were collected from 54 of these RA patients.", {"entities": [[52, 66, "DISEASE"]]}], ["The levels of IL-33 and sST2 were measured by ELISA.", {"entities": []}], ["SF IL-33 was significantly higher in RA than in OA, which was correlated with disease activity score 28, erythrocyte sedimentation rate, rheumatoid factor (RF)-IgM, RF-IgG, glucose phosphate isomerase (GPI), and immunoglobulin.", {"entities": [[202, 205, "GENE"]]}], ["Serum IL-33 was correlated positively with SF IL-33 in RA.", {"entities": []}], ["Furthermore, it was correlated with RF-IgM and GPI.", {"entities": [[47, 50, "GENE"]]}], ["sST2 was partly detectable in RA (13 out of 54, 24.1%), while not in OA.", {"entities": []}], ["Serum sST2 in RA had no significant correlation with serum IL-33 or SF IL-33.", {"entities": []}], ["However, SFs from both RA and OA patients did not express sST2.", {"entities": []}], ["Conclusions .", {"entities": []}], ["This study supported that IL-33 played an important role in the local pathogenesis of RA.", {"entities": []}], ["Considering the tight correlation between IL-33 and clinical features, it may become a new target of local treatment.", {"entities": []}], ["To evaluate the impact of an educational strategy on potentially inappropriate medications (PIMs) and length of stay in hospitalized elderly patients.", {"entities": []}], ["An open study, with two cross-sectional surveys interspersed with an educational program (PRE phase and POST phase), has been performed in order to compare the PIMs number before and after the introduction of an educational strategy.", {"entities": []}], ["The study included 2 phases: PRE, in which patients were enrolled as control group; POST, in which an educational strategy on the PIMs use was introduced among physicians, and patients were enrolled as intervention group.", {"entities": []}], ["Italian residential rehabilitation Centre.", {"entities": []}], ["Inclusion criteria were \u22652 active chronic diseases and the current use of \u22654 medications.", {"entities": []}], ["The educational strategy consisted of a 3-day course on strategies to prevent PIMs and a computerized tool running on a Personal Digital Assistant (PDA) device to check for PIMs.", {"entities": []}], ["The primary was the PIMs number, the secondary the length of stay.", {"entities": []}], ["A total of 790 patients, 450 controls and 340 cases, were enrolled.", {"entities": []}], ["According to the Beers criteria, 52.3% of the study population received \u22651 PIMs, 18.73% \u22652, and 2.4% \u22654 PIMs.", {"entities": []}], ["A significant reduction of PIMs ( P \u200a=\u200a0.020) and length of stay ( P \u200a<\u200a0.0001) were seen in the intervention group.", {"entities": []}], ["At multivariate analysis, PIMs significantly correlated with age, drugs number, and the intervention, and the length of stay significantly correlated with disease count, comorbidities, and intervention.", {"entities": []}], ["These data suggest that our educative instrument may be useful in reducing the PIMs number and length of hospitalization in elderly with a high number of drugs and comorbidities.", {"entities": []}], ["The purpose of the study presented here was to simultaneously measure air quality and respiratory function and symptoms in populations living in the neighborhood of waste incinerators and to estimate the contribution of incinerator emissions to the particulate air mass in these neighborhoods.", {"entities": []}], ["We studied the residents of three communities having, respectively, a biomedical and a municipal incinerator, and a liquid hazardous waste-burning industrial furnace.", {"entities": []}], ["We compared results with three matched-comparison communities.", {"entities": []}], ["We did not detect differences in concentrations of particulate matter among any of the three pairs of study communities.", {"entities": []}], ["Average fine particulate (PM 2.5 ) concentrations measured for 35 days varied across study communities from 16 to 32 \u03bcg/m n = 6963) did not reveal consistent community differences in the prevalence of chronic or acute respiratory symptoms between incinerator and comparison communities, nor did we see a difference in baseline lung function tests or in the average peak expiratory flow rate measured over a period of 35 days.", {"entities": []}], ["Based on this analysis of the first year of our study, we conclude that we have no evidence to reject the null hypothesis of no acute or chronic respiratory effects associated with residence in any of the three incinerator communities.", {"entities": []}], ["There is limited information on the natural history of building occupants\u2019 health in relation to attempts to remediate moisture damage.", {"entities": []}], ["We examined changes in respiratory and non-respiratory symptoms in 1,175 office building occupants over seven years with multiple remediation attempts.", {"entities": []}], ["During each of four surveys, we categorized participants using a severity score: 0 = asymptomatic; 1 = mild, symptomatic in the last 12 months, but not frequently in the last 4 weeks; 2 = severe, symptomatic at least once weekly in the last 4 weeks.", {"entities": []}], ["Building-related symptoms were defined as improving away from the building.", {"entities": []}], ["We used random intercept models adjusted for demographics, smoking, building tenure, and microbial exposures to estimate temporal changes in the odds of building-related symptoms or severity scores independent of the effect of microbial exposures.", {"entities": []}], ["Trend analyses of combined mild/severe symptoms showed no changes in the odds of respiratory symptoms but significant improvement in non-respiratory symptoms over time.", {"entities": []}], ["Separate analyses showed increases in the odds of severe respiratory symptoms (odds ratio/year = 1.15\u20121.16, p-values<0.05) and severity scores (0.02/year, p-values<0.05) for wheezing and shortness of breath on exertion, due to worsening of participants in the mild symptom group.", {"entities": []}], ["For non-respiratory symptoms, we found no changes in the odds of severe symptoms but improvement in severity scores (-0.04\u2012-0.01/year, p-values<0.05) and the odds for mild fever and chills, excessive fatigue, headache, and throat symptoms (0.65\u20130.79/year, p-values<0.05).", {"entities": []}], ["Our study suggests that after the onset of respiratory and severe non-respiratory symptoms associated with dampness/mold, remediation efforts might not be effective in improving occupants\u2019 health.", {"entities": []}], ["Catgut implantation at acupoints has been used in China to treat allergic rhinitis (AR) for a long time.", {"entities": [[65, 82, "DISEASE"], [74, 82, "DISEASE"]]}], ["However, its efficacy and safety in the treatment of AR is controversial due to the poor quality of the clinical trial of this therapy.", {"entities": []}], ["This study aims to identify whether catgut implantation at acupoints is indeed an effective and safe treatment for patients with persistent or intermittent allergic rhinitis (PER or IAR) by comparing with sham catgut implantation treatment.", {"entities": [[156, 173, "DISEASE"], [165, 173, "DISEASE"]]}], ["This study compares real versus sham catgut implantation at acupoints in 242 patients with a history of PER or IAR and with a positive skin prick test (SPT).", {"entities": []}], ["The trial will be conducted in the Teaching Hospital of Chengdu University of Traditional Chinese Medicine.", {"entities": []}], ["In the study, patients will be randomly assigned by computer-generated randomization list into two groups and assessed prior to treatment.", {"entities": []}], ["Then, they will receive two sessions of treatments (once per 2\u00a0weeks) for 4 consecutive weeks and have a follow-up phase of 12\u00a0weeks.", {"entities": []}], ["The administration of catgut implantation (or sham-control) at acupoints follows the guidelines for clinical research on acupuncture (WHO Regional Publication, Western Pacific Series No.15, 1995), and is performed double-blindly by a well-trained physician in acupuncture.", {"entities": []}], ["The main outcome measures include the primary and secondary indicators.", {"entities": []}], ["Primary indicators are subjective symptoms scores evaluated by visual analogue scales (VAS) and Rhinoconjunctivitis Quality of Life Questionnaires (RQLQ).", {"entities": []}], ["The secondary indicators are the results of laboratory examinations, such as serum allergen-specific IgE, nasal inflammatory cells counts (mast cells, eosinophils, and T cells) and nitric oxide concentration in nasal excretion.", {"entities": []}], ["The use of anti-allergic medication will also be recorded as one of the secondary indicators.", {"entities": []}], ["Furthermore, adverse events will be recorded and analyzed.", {"entities": []}], ["If any participants withdraw from the trial, intention-to-treat analysis (ITT) and per-protocol (PP) analysis will be performed.", {"entities": []}], ["The important features of this trial include the randomization procedures, large sample, and a standardized protocol of catgut implantation at acupoints.", {"entities": []}], ["This trial will be the first study with a high evidence level in China in order to assess the efficacy and safety of catgut implantation at acupoints in treatment of AR following a randomized, double-blind sham-controlled method.", {"entities": []}], ["Chinese Clinical Trial Registry: ChiCTR-TRC-12002191", {"entities": []}], ["Older human immunodeficiency virus (HIV)-1 transgenic rats are a model for HIV-1 associated neurocognitive disorders (HAND).", {"entities": []}], ["They show behavioral changes, neuroinflammation, neuronal loss, and increased brain arachidonic acid (AA) enzymes.", {"entities": []}], ["Aspirin (acetylsalicylate, ASA) inhibits AA oxidation by cyclooxygenase (COX)-1 and COX-2.", {"entities": []}], ["Chronic low-dose ASA will downregulate brain AA metabolism in HIV-1 transgenic rats.", {"entities": []}], ["Nine month-old HIV-1 transgenic and wildtype rats were given 42 days of 10 mg/kg/day ASA or nothing in drinking water; eicosanoids were measured using ELISAs on microwaved brain extracts.", {"entities": []}], ["Brain 15-epi-lipoxin A4 and 8-isoprostane concentrations were significantly higher in HIV-1 transgenic than wildtype rats; these differences were prevented by ASA.", {"entities": []}], ["ASA reduced prostaglandin E 2 and leukotriene B 4 concentrations in HIV-1 Tg but not wildtype rats.", {"entities": [[74, 76, "GENE"]]}], ["Thromboxane B 2 , 15-HETE, lipoxin A 4 and resolvin D 1 concentrations were unaffected by genotype or treatment.", {"entities": []}], ["Chronic low-dose ASA reduces AA-metabolite markers of neuroinflammation and oxidative stress in a rat model for HAND.", {"entities": []}], ["Pneumonia is one of most prevalent infectious diseases worldwide and is associated with considerable mortality.", {"entities": [[0, 9, "DISEASE"]]}], ["In comparison to general population, schizophrenia patients hospitalized for pneumonia have poorer outcomes.", {"entities": [[37, 50, "DISEASE"], [77, 86, "DISEASE"]]}], ["We explored the risk factors of short-term mortality in this population because the information is lacking in the literature.", {"entities": []}], ["In a nationwide schizophrenia cohort, derived from the National Health Insurance Research Database in Taiwan, that was hospitalized for pneumonia between 2000 and 2008 (n\u200a=\u200a1,741), we identified 141 subjects who died during their hospitalizations or shortly after their discharges.", {"entities": [[16, 29, "DISEASE"], [136, 145, "DISEASE"]]}], ["Based on risk-set sampling in a 1\u22364 ratio, 468 matched controls were selected from the study cohort (i.e., schizophrenia cohort with pneumonia).", {"entities": [[107, 120, "DISEASE"], [133, 142, "DISEASE"]]}], ["Physical illnesses were categorized as pre-existing and incident illnesses that developed after pneumonia respectively.", {"entities": [[96, 105, "DISEASE"]]}], ["Exposures to medications were categorized by type, duration, and defined daily dose.", {"entities": []}], ["We used stepwise conditional logistic regression to explore the risk factors for short-term mortality.", {"entities": []}], ["Pre-existing arrhythmia was associated with short-term mortality (adjusted risk ratio [RR]\u200a=\u200a4.99, p<0.01).", {"entities": []}], ["Several variables during hospitalization were associated with increased mortality risk, including incident arrhythmia (RR\u200a=\u200a7.44, p<0.01), incident heart failure (RR\u200a=\u200a5.49, p\u200a=\u200a0.0183) and the use of hypoglycemic drugs (RR\u200a=\u200a2.32, p<0.01).", {"entities": []}], ["Furthermore, individual antipsychotic drugs (such as clozapine) known to induce pneumonia were not significantly associated with the risk.", {"entities": [[80, 89, "DISEASE"]]}], ["Incident cardiac complications following pneumonia are associated with increased short-term mortality.", {"entities": [[41, 50, "DISEASE"]]}], ["These findings have broad implications for clinical intervention and future studies are needed to clarify the mechanisms of the risk factors.", {"entities": []}], ["Protein kinase D (PKD) binds to a pool of diacylglycerol (DAG) in the TGN and undergoes a process of activation that involves heterotrimeric GTP-binding protein subunits \u03b2\u03b3 to regulate membrane fission.", {"entities": []}], ["This fission reaction is used to generate transport carriers at the TGN that are en route to the cell surface.", {"entities": []}], ["We now report that PKD is activated specifically by G protein subunit \u03b21\u03b32 and \u03b23\u03b32 via the Golgi apparatus\u2013associated PKC\u03b7.", {"entities": []}], ["Compromising the kinase activity of PKC\u03b7-inhibited protein transport from TGN to the cell surface.", {"entities": []}], ["Expression of constitutively activated PKC\u03b7 caused Golgi fragmentation, which was inhibited by a kinase inactive form of PKD.", {"entities": []}], ["Our findings reveal that \u03b2\u03b3, PKC\u03b7, and PKD act in series to generate transport carriers from the TGN and their overactivation results in complete vesiculation of the Golgi apparatus.", {"entities": []}], ["In animal experimental models, parasitic helminth infections can protect the host from auto-immune diseases.", {"entities": []}], ["We conducted a population-scale human study investigating the relationship between helminth parasitism and auto-reactive antibodies and the subsequent effect of anti-helminthic treatment on this relationship.", {"entities": []}], ["Levels of antinuclear antibodies (ANA) and plasma IL-10 were measured by enzyme linked immunosorbent assay in 613 Zimbabweans (aged 2\u201386 years) naturally exposed to the blood fluke Schistosoma haematobium .", {"entities": []}], ["ANA levels were related to schistosome infection intensity and systemic IL-10 levels.", {"entities": []}], ["All participants were offered treatment with the anti-helminthic drug praziquantel and 102 treated schoolchildren (5\u201316 years) were followed up 6 months post-antihelminthic treatment.", {"entities": []}], ["ANA levels were inversely associated with current infection intensity but were independent of host age, sex and HIV status.", {"entities": []}], ["Furthermore, after allowing for the confounding effects of schistosome infection intensity, ANA levels were inversely associated with systemic levels of IL-10.", {"entities": []}], ["ANA levels increased significantly 6 months after anti-helminthic treatment.", {"entities": []}], ["Our study shows that ANA levels are attenuated in helminth-infected humans and that anti-helminthic treatment of helminth-infected people can significantly increase ANA levels.", {"entities": []}], ["The implications of these findings are relevant for understanding both the aetiology of immune disorders mediated by auto-reactive antibodies and in predicting the long-term consequences of large-scale schistosomiasis control programs.", {"entities": [[202, 217, "DISEASE"]]}], ["The influence of co-existing atopy on the prognosis of juvenile systemic lupus erythematosus (JSLE) was assessed in this study.", {"entities": [[73, 92, "DISEASE"], [64, 92, "DISEASE"]]}], ["Patients diagnosed with JSLE between October 2005 and April 2016 were enrolled in a prospective study and followed up for 2 years.", {"entities": []}], ["Management of patients was evaluated using the systemic lupus erythematosus disease activity index 2000 (SLEDAI-2K) score and laboratory variables.", {"entities": [[56, 75, "DISEASE"], [47, 75, "DISEASE"]]}], ["Eighty JSLE patients were enrolled at diagnosis and divided into those with ( n = 35) and without (n = 45) atopy.", {"entities": []}], ["When compared with the non-atopic group, atopic patients showed higher SLEDAI-2K score at disease onset (16.09 vs .", {"entities": []}], ["11.18), higher erythrocyte sedimentation rate (52.89 vs .", {"entities": []}], ["38.27 mm/h), higher percentage of total B-cells (25.85 vs .", {"entities": []}], ["19.51%), lower percentage (7.26 vs .", {"entities": []}], ["9.03%) and cytotoxicity (9.92 vs .", {"entities": []}], ["11.32%) of natural killer cells, and lower complement C3 (0.51 vs .", {"entities": [[54, 56, "GENE"]]}], ["0.69 g/L) (all p <0.05).", {"entities": []}], ["At 1, 3, 6, 12, 18, and 24 months, JSLE patients with atopy reached higher SLEDAI-2K score and lower \u0394SLEDAI-2K improvement rate (at 1 month, 8.34 vs .", {"entities": []}], ["4.71 and 43.63 vs .", {"entities": []}], ["57.95%, respectively; at 3 months, 8.57 vs .", {"entities": []}], ["2.62 and 48.39 vs .", {"entities": []}], ["75.10%, respectively; at 6 months, 6.91 vs .", {"entities": []}], ["2.38 and 53.59 vs .", {"entities": []}], ["77.26%, respectively; at 12 months, 4.71 vs .", {"entities": []}], ["1.80 and 69.54 vs .", {"entities": []}], ["84.10%, respectively; at 18 months, 4.66 vs .", {"entities": []}], ["2.02 and 68.14 vs .", {"entities": []}], ["82.93%, respectively; at 24 months, 8.57 vs .", {"entities": []}], ["2.62 and 70.00 vs .", {"entities": []}], ["81.88%, respectively; all p <0.05).", {"entities": []}], ["During the 24 months of follow-up, the total number of disease flares was higher in JSLE patients with co-existing atopy (3.77 vs .", {"entities": []}], ["1.51, p <0.05), and the atopic group needed much more time to reach the stable condition of the disease (6.88 vs .", {"entities": []}], ["4.65 months, p <0.05).", {"entities": []}], ["JSLE patients combined with co-existing atopy had more severe disease at diagnosis and poorer outcomes than JSLE patients without atopy.", {"entities": []}], ["Although genome-wide association studies (GWAS) have identified many common variants associated with complex traits, low-frequency and rare variants have not been interrogated in a comprehensive manner.", {"entities": []}], ["Imputation from dense reference panels, such as the 1000 Genomes Project (1000G), enables testing of ungenotyped variants for association.", {"entities": []}], ["Here we present the results of imputation using a large, new population-specific panel: the Genome of The Netherlands (GoNL).", {"entities": []}], ["We benchmarked the performance of the 1000G and GoNL reference sets by comparing imputation genotypes with \u2018true' genotypes typed on ImmunoChip in three European populations (Dutch, British, and Italian).", {"entities": []}], ["GoNL showed significant improvement in the imputation quality for rare variants (MAF 0.05\u20130.5%) compared with 1000G.", {"entities": [[81, 84, "GENE"]]}], ["In Dutch samples, the mean observed Pearson correlation, r r r", {"entities": []}], ["The popularity of running continues to increase, which means that the incidence of running-related injuries will probably also continue to increase.", {"entities": []}], ["Little is known about risk factors for running injuries and whether they are sex-specific.", {"entities": []}], ["The aim of this study was to review information about risk factors and sex-specific differences for running-induced injuries in adults.", {"entities": []}], ["The databases PubMed, EMBASE, CINAHL and Psych-INFO were searched for relevant articles.", {"entities": []}], ["Longitudinal cohort studies with a minimal follow-up of 1 month that investigated the association between risk factors (personal factors, running/training factors and/or health and lifestyle factors) and the occurrence of lower limb injuries in runners were included.", {"entities": []}], ["Two reviewers\u2019 independently selected relevant articles from those identified by the systematic search and assessed the risk of bias of the included studies.", {"entities": []}], ["The strength of the evidence was determined using a best-evidence rating system.", {"entities": []}], ["Sex differences in risk were determined by calculating the sex ratio for risk factors (the risk factor for women divided by the risk factor for men).", {"entities": []}], ["Of 400 articles retrieved, 15 longitudinal studies were included, of which 11 were considered high-quality studies and 4 moderate-quality studies.", {"entities": []}], ["Overall, women were at lower risk than men for sustaining running-related injuries.", {"entities": []}], ["Strong and moderate evidence was found that a history of previous injury and of having used orthotics/inserts was associated with an increased risk of running injuries.", {"entities": []}], ["Age, previous sports activity, running on a concrete surface, participating in a marathon, weekly running distance (30\u201339 miles) and wearing running shoes for 4 to 6 months were associated with a greater risk of injury in women than in men.", {"entities": []}], ["A history of previous injuries, having a running experience of 0\u20132 years, restarting running, weekly running distance (20\u201329 miles) and having a running distance of more than 40 miles per week were associated with a greater risk of running-related injury in men than in women.", {"entities": []}], ["Previous injury and use of orthotic/inserts are risk factors for running injuries.", {"entities": []}], ["There appeared to be differences in the risk profile of men and women, but as few studies presented results for men and women separately, the results should be interpreted with caution.", {"entities": []}], ["Further research should attempt to minimize methodological bias by paying attention to recall bias for running injuries, follow-up time, and the participation rate of the identified target group.", {"entities": []}], ["Low-dose irradiation induces various stimulating effects, especially activation of the biological defense system including antioxidative and immune functions.", {"entities": []}], ["Oxidative stress induced by reactive oxygen species (ROS) can cause cell damage and death and can induce many types of diseases.", {"entities": []}], ["This paper reviews new insights into inhibition of ROS-related diseases with low-dose irradiation or radon inhalation.", {"entities": []}], ["X-irradiation (0.5 Gy) before or after carbon tetrachloride (CCl 4 ) treatment inhibits hepatopathy in mice.", {"entities": []}], ["X-irradiation (0.5 Gy) before ischemia-reperfusion injury or cold-induced brain injury also inhibits edema.", {"entities": [[30, 38, "DISEASE"]]}], ["These findings suggest that low-dose X-irradiation has antioxidative effects due to blocking the damage induced by free radicals or ROS.", {"entities": []}], ["Moreover, radon inhalation increases superoxide dismutase activity in many organs and inhibits CCl 4 -induced hepatic and renal damage and streptozotocin-induced type I diabetes.", {"entities": []}], ["These findings suggest that radon inhalation also has antioxidative effects.", {"entities": []}], ["This antioxidative effect against CCl 4 -induced hepatopathy is comparable to treatment with ascorbic acid (vitamin C) at a dose of 500 mg/kg weight, or \u03b1-tocopherol (vitamin E) treatment at a dose of 300 mg/kg weight, and is due to activation of antioxidative functions.", {"entities": []}], ["In addition, radon inhalation inhibits carrageenan-induced inflammatory paw edema, suggesting that radon inhalation has anti-inflammatory effects.", {"entities": []}], ["Furthermore, radon inhalation inhibits formalin-induced inflammatory pain and chronic constriction injury-induced neuropathic pain, suggesting that radon inhalation relieves pain.", {"entities": []}], ["Thus, low-dose irradiation very likely activates the defense systems in the body, and therefore, contributes to preventing or reducing ROS-related injuries, which are thought to involve peroxidation.", {"entities": []}], ["Supplemental Digital Content is available in the text.", {"entities": []}], ["Geographic rates of preventable hospitalization are used internationally as an indicator of accessibility and quality of primary care.", {"entities": []}], ["Much research has correlated the indicator with the supply of primary care services, yet multiple other factors may influence these admissions.", {"entities": []}], ["To quantify the relative contributions of the supply of general practitioners (GPs) and personal sociodemographic and health characteristics, to geographic variation in preventable hospitalization.", {"entities": []}], ["Self-reported questionnaire data for 267,091 participants in the 45 and Up Study, Australia, were linked with administrative hospital data to identify preventable hospitalizations.", {"entities": []}], ["Multilevel Poisson models, with participants clustered in their geographic area of residence, were used to explore factors that explain geographic variation in hospitalization.", {"entities": []}], ["GP supply, measured as full-time workload equivalents, was not a significant predictor of preventable hospitalization, and explained only a small amount (2.9%) of the geographic variation in hospitalization rates.", {"entities": []}], ["Conversely, more than one-third (36.9%) of variation was driven by the sociodemographic composition, health, and behaviors of the population.", {"entities": []}], ["These personal characteristics explained a greater amount of the variation for chronic conditions (37.5%) than acute (15.5%) or vaccine-preventable conditions (2.4%).", {"entities": []}], ["Personal sociodemographic and health characteristics, rather than GP supply, are major drivers of preventable hospitalization.", {"entities": []}], ["Their contribution varies according to condition, and if used for performance comparison purposes, geographic rates of preventable hospitalization should be reported according to individual condition or potential pathways for intervention.", {"entities": []}], ["Athletic performance is an important criteria used for the selection of superior horses.", {"entities": []}], ["However, little is known about exercise-related epigenetic processes in the horse.", {"entities": []}], ["DNA methylation is a key mechanism for regulating gene expression in response to environmental changes.", {"entities": []}], ["We carried out comparative genomic analysis of genome-wide DNA methylation profiles in the blood samples of two different thoroughbred horses before and after exercise by methylated-DNA immunoprecipitation sequencing (MeDIP-Seq).", {"entities": []}], ["Differentially methylated regions (DMRs) in the pre-and post-exercise blood samples of superior and inferior horses were identified.", {"entities": []}], ["Exercise altered the methylation patterns.", {"entities": []}], ["After 30 min of exercise, 596 genes were hypomethylated and 715 genes were hypermethylated in the superior horse, whereas in the inferior horse, 868 genes were hypomethylated and 794 genes were hypermethylated.", {"entities": []}], ["These genes were analyzed based on gene ontology (GO) annotations and the exercise-related pathway patterns in the two horses were compared.", {"entities": []}], ["After exercise, gene regions related to cell division and adhesion were hypermethylated in the superior horse, whereas regions related to cell signaling and transport were hypermethylated in the inferior horse.", {"entities": []}], ["Analysis of the distribution of methylated CpG islands confirmed the hypomethylation in the gene-body methylation regions after exercise.", {"entities": []}], ["The methylation patterns of transposable elements also changed after exercise.", {"entities": []}], ["Long interspersed nuclear elements (LINEs) showed abundance of DMRs.", {"entities": []}], ["Collectively, our results serve as a basis to study exercise-based reprogramming of epigenetic traits.", {"entities": []}], ["To investigate if nerve growth factor (NGF) might modulate toll-like receptor (TLR) 4 and 9 expression in primary cultures of vernal keratoconjunctivitis (VKC)-derived conjunctival epithelial cells (VKC-ECs).", {"entities": [[133, 153, "DISEASE"], [39, 42, "GENE"]]}], ["Primary cultures of ECs were established from VKC (n=7) and healthy-control (n=5) conjunctival specimens.", {"entities": []}], ["Primary untouched and short-term NGF-exposed VKC-ECs were analyzed for molecular (relative real-time PCR) and biochemical (confocal and fluorescence-activated cell sorting analysis of TLR4 and TLR9 expression.", {"entities": [[184, 188, "GENE"], [193, 197, "GENE"]]}], ["Data were compared to their untreated as well as stimulated healthy-control counterparts.", {"entities": []}], ["Conditioned media were analyzed for interferon (IFN)-\u03b3, interleukin (IL)-4, IL-10, and IL-12 p40 secretion.", {"entities": []}], ["Primary untouched VKC-ECs showed TLR4 increase and TLR9 decrease compared to their healthy-control counterparts.", {"entities": [[33, 37, "GENE"], [51, 55, "GENE"]]}], ["NGF exposure resulted in a strong upregulation of TLR4 and a moderate upregulation of TLR9 in few passages VKC-ECs.", {"entities": [[0, 3, "GENE"], [50, 54, "GENE"], [86, 90, "GENE"]]}], ["Both TLR4 and TLR9 upregulation occurred in a dose-dependent fashion and were supported by biochemical analysis.", {"entities": [[5, 9, "GENE"], [14, 18, "GENE"]]}], ["NGF triggered a dose-response release of IL-10 in VKC-ECs conditioned media, an effect not detected for IL-4, IL-12 p40, and IFN-\u03b3.", {"entities": [[0, 3, "GENE"]]}], ["Our data indicate that NGF is able to induce TLR4/TLR9 overexpression in VKC-ECs.", {"entities": [[23, 26, "GENE"]]}], ["These cells exhibited poor IL-4, IL-12 p40, and IFN-\u03b3 responses to NGF, while a significant IL-10 decreased secretion was detected.", {"entities": [[67, 70, "GENE"]]}], ["The different NGF-induced TLR response between VKC and healthy-control conjunctival ECs as well as the different cytokine response might reflect a different pattern of cell activation according to the state of VKC.", {"entities": []}], ["Lung function at the end of life depends on its peak and subsequent decline.", {"entities": []}], ["Because obesity is epidemic in young adulthood, we quantified age-related changes in lung function relative to body mass index (BMI).", {"entities": [[8, 15, "DISEASE"]]}], ["The Coronary Artery Risk Development in Young Adults (CARDIA) study in 1985\u201386 (year 0) recruited 5,115 black and white men and women, aged 18\u201330.", {"entities": []}], ["Spirometry testing was conducted at years 0, 2, 5 and 10.", {"entities": []}], ["We estimated 10 year change in FVC, FEV 1 and FEV 1 /FVC according to baseline BMI and change in BMI within birth cohorts with initial average ages 20, 24, and 28 years, controlling for race, sex, smoking, asthma, physical activity, and alcohol consumption.", {"entities": [[206, 212, "DISEASE"], [36, 39, "GENE"], [46, 49, "GENE"], [36, 39, "GENE"], [46, 49, "GENE"]]}], ["Participants with baseline BMI < 21.3 kg/m 1 and neither measure declined through age 38.", {"entities": []}], ["In contrast, participants with baseline BMI \u2265 26.4 kg/m 1 .", {"entities": []}], ["FEV 1 /FVC increased with increasing BMI.", {"entities": [[0, 3, "GENE"]]}], ["Weight gain was also associated with lung function.", {"entities": []}], ["Those who gained the most weight over 10 years had the largest decrease in FVC, but FVC increased with weight gain in those initially thinnest.", {"entities": []}], ["In contrast, FEV 1 decreased with increasing weight gain in all participants, with maximum decline in obese individuals who gained the most weight during the study.", {"entities": [[13, 16, "GENE"]]}], ["Among healthy young adults, increasing BMI in the initially thin participants was associated with increasing then stable lung function through age 38, but there were substantial lung function losses with higher and increasing fatness.", {"entities": []}], ["These results suggest that the obesity epidemic threatens the lung health of the general population.", {"entities": [[31, 38, "DISEASE"]]}], ["The present study aimed to investigate the effects of vitamin D (VD) on inflammatory responses in asthmatic mice and the underlying mechanism, providing a theoretical basis for clinical application of targeted drug therapy, and the development of novel drugs against asthma.", {"entities": [[267, 273, "DISEASE"]]}], ["Mouse models of asthma were established.", {"entities": [[16, 22, "DISEASE"]]}], ["Hematoxylin-eosin staining was performed to observe the pathological changes of the lung tissue.", {"entities": []}], ["Pulmonary function tests were conducted to determine airway resistance in asthmatic mice.", {"entities": []}], ["ELISA was performed to measure the serum levels of inflammatory factors.", {"entities": []}], ["Western blot analysis and reverse transcription-quantitative polymerase chain reaction were performed to determine the changes in apoptosis-inducing factors, and high mobility group box 1 protein (HMGB1)/Toll-like receptor-4 (TLR4)/nuclear factor (NF)-\u03baB signaling pathway-related proteins.", {"entities": [[197, 202, "GENE"], [226, 230, "GENE"]]}], ["VD reduced infiltrated inflammatory factors, attenuated the airway resistance of asthmatic mice, decreased serum levels of interleukin (IL)-1\u03b2, IL-6, tumor necrosis factor (TNF)-\u03b1, increased serum levels of IL-10, decreased apoptotic factor Bcl-2-associated X and caspase-3 expression, downregulated HMGB1 and TLR4, NF-\u03baB and phosphorylated-NF-\u03baB p65 expression.", {"entities": [[173, 176, "GENE"], [300, 305, "GENE"], [310, 314, "GENE"]]}], ["When TLR4 expression was inhibited, the anti-inflammatory effects of VD were attenuated, and HMGB1, TLR4, NF-\u03baB and p-NF-\u03baB p65 expression was increased.", {"entities": [[5, 9, "GENE"], [100, 104, "GENE"], [93, 98, "GENE"], [5, 9, "GENE"], [100, 104, "GENE"]]}], ["VD was able reduce the inflammatory response of asthmatic mice and apoptosis in lung tissue through the HMGB1/TLR4/NF-\u03baB signaling pathway.", {"entities": []}], ["HIF-1\u03b1 is a transcription factor that is activated during hypoxia and inflammation and is a key regulator of angiogenesis in vivo .", {"entities": []}], ["During the development of asthma, peribronchial angiogenesis is induced in response to aeroallergens and is thought to be an important feature of sustained chronic allergic inflammation.", {"entities": [[26, 32, "DISEASE"]]}], ["Recently, elevated HIF-1\u03b1 levels have been demonstrated in both the lung tissue and bronchoalveolar lavage of allergic patients, respectively.", {"entities": []}], ["Therefore, we investigated the role of HIF-1\u03b1 on the development of angiogenesis and inflammation following acute and chronic allergen exposure.", {"entities": []}], ["Our data shows that intranasal exposure to house dust mite (HDM) increases the expression of HIF-1\u03b1 in the lung, whilst reducing the expression of the HIF-1\u03b1 negative regulators, PHD1 and PHD3.", {"entities": []}], ["Blockade of HIF-1\u03b1 in vivo , significantly decreased allergic inflammation and eosinophilia induced by allergen, due to a reduction in the levels of IL-5 and Eotaxin-2.", {"entities": [[79, 91, "DISEASE"]]}], ["Importantly, HIF-1\u03b1 blockade significantly decreased levels of VEGF-A and CXCL1 in the lungs, which in turn led to a profound decrease in the recruitment of endothelial progenitor cells and a reduction of peribronchial angiogenesis.", {"entities": [[74, 79, "GENE"]]}], ["Furthermore, HDM or IL-4 treatment of primary lung macrophages resulted in significant production of both VEGF-A and CXCL1; inhibition of HIF-1\u03b1 activity abrogated the production of these factors via an up-regulation of PHD1 and PHD3.", {"entities": [[117, 122, "GENE"]]}], ["These findings suggest that novel strategies to reduce the expression and activation of HIF-1\u03b1 in lung macrophages may be used to attenuate allergen-induced airway inflammation and angiogenesis through the modulation of VEGF-A and CXCL1 expression.", {"entities": [[231, 236, "GENE"]]}], ["This study provides new insights into the role of HIF-1\u03b1 in the development of peribronchial angiogenesis and inflammation in a murine model of allergic airway disease.", {"entities": []}], ["These findings indicate that strategies to reduce activation of macrophage derived HIF-1\u03b1 may be used as a target to improve asthma pathology.", {"entities": [[125, 131, "DISEASE"]]}], ["Care for many chronic health conditions is delivered by both specialists and generalists.", {"entities": []}], ["Differences in patients\u2019 quality of care and management between generalists and specialists have been well documented for asthma, whereas a few studies for COPD reported no differences.", {"entities": [[122, 128, "DISEASE"]]}], ["The objective of this study is to compare consistency with Global initiative for chronic Obstructive Lung Disease guidelines, as well as rate, health care utilization, and hospital outcomes of severe acute exacerbation (AE) of COPD patients managed by pulmonologists and internists.", {"entities": []}], ["This is a 12-month prospective, comparative observational study among 208 COPD patients who were regularly managed by pulmonologists (Group A) and internists (Group B).", {"entities": []}], ["Clinical data, health care utilization, and hospital outcomes of the two groups were statistically compared.", {"entities": []}], ["Out of 208 enrolled patients, 137 (Group A) and 71 (Group B) were managed by pulmonologists and internists, respectively.", {"entities": []}], ["Pharmacological treatment corresponding to disease severity stages between the two groups was not statistically different.", {"entities": []}], ["Group A received care consistent with guidelines in terms of annual influenza vaccination (31.4% vs 9.9%, P <0.001) and pulmonary rehabilitation (24.1% vs 0%, P <0.001) greater than Group B.", {"entities": [[68, 77, "DISEASE"]]}], ["Group A had reduced rates (12.4% vs 23.9%, P =0.033) and numbers of severe AE (0.20\u00b10.63 person-years vs 0.41\u00b10.80 person-years, P =0.029).", {"entities": []}], ["Among patients with severe AE requiring mechanical ventilation, Group A had reduced mechanical ventilator duration (1.5 [1\u20137] days vs 5 [3\u201329] days, P =0.005), hospital length of stay (3.5 [1\u201320] days vs 16 [6\u201329] days, P =0.012), and total hospital cost ($863 [247\u20132,496] vs $2,095 [763\u20136,792], P =0.049) as compared with Group B.", {"entities": []}], ["This study demonstrated that pulmonologists followed national COPD guidelines more closely than internists.", {"entities": []}], ["The rates and frequencies of severe AE were significantly lower in patients managed by pulmonologists, and length of hospital stay and cost were significantly lower among the patients with severe AE who required mechanical ventilation.", {"entities": []}], ["In the absence in the major Australian administrative health record collections of a direct measure of the socioeconomic status of the individual about whom the event is recorded, analysis of the association between the health status, use of health services and socioeconomic status of the population relies an area-based measure of socioeconomic status.", {"entities": []}], ["This paper explores the reliability of the area of address (at the levels typically available in administrative data collections) as a proxy measure for socioeconomic disadvantage.", {"entities": []}], ["The Western Australian Data Linkage System was used to show the extent to which hospital inpatient separation rates for residents of Perth vary by socioeconomic status of area of residence, when calculated at various levels of aggregation of area, from smallest (Census Collection District) to largest (postcode areas and Statistical Local Areas).", {"entities": []}], ["Results are also provided of the reliability, over time, of the address as a measure of socioeconomic status.", {"entities": []}], ["There is a strong association between the socioeconomic status of the usual address of hospital inpatients at the smallest level in Perth, and weaker associations when the data are aggregated to larger areas.", {"entities": []}], ["The analysis also shows that a higher proportion of people from the most disadvantaged areas are admitted to hospital than from the most well-off areas (13% more), and that these areas have more separations overall (47% more), as a result of larger numbers of multiple admissions.", {"entities": []}], ["Of people admitted to hospital more than once in a five year period, four out of five had not moved address by the time of their second episode.", {"entities": []}], ["Of those who moved, the most movement was within, or between, areas of similar socioeconomic status, with people from the most well off areas being the least likely to have moved.", {"entities": []}], ["Postcode level and SLA level data provide a reliable, although understated, indication of socioeconomic disadvantage of area.", {"entities": []}], ["The majority of Perth residents admitted to hospital in Western Australia had the same address when admitted again within five years.", {"entities": []}], ["Of those who moved address, the majority had moved within, or between, areas of similar socioeconomic status.", {"entities": []}], ["Access to data about individuals from the Western Australian Data Linkage System shows that more people from disadvantaged areas are admitted to a hospital, and that they have more episodes of hospitalisation.", {"entities": []}], ["Were data to be available across Australia on a similar basis, it would be possible to undertake research of greater policy-relevance than is currently possible with the existing separations-based national database.", {"entities": []}], ["This study was performed to consider the association between Internet using time for non-educational purposes and adolescent health, and to examine how health status differs between Internet users and non-users.", {"entities": []}], ["We analyzed 2009 data from the Korea Adolescent Risk Behavior Web-Based Survey, conducted on a nationally representative sample of students in grades 7 to 12.", {"entities": []}], ["A total of 75 066 adolescents were categorized into four groups according to their Internet using time excluding using for educational purposes: non-Internet users (NIUs), occasional Internet users (OIUs) (<1 h/d), moderate Internet users (MIUs) (\u22651 and <2 h/d), and heavy Internet users (HIUs) (\u22652 h/d).", {"entities": []}], ["Health factors included eight health risk behavior indices, four mental health indices and six physical health indices.", {"entities": []}], ["The distribution of Internet use was as follows: NIUs 17.4%, OIUs 68.1%, MIUs 12.7%, and HIUs 1.7%.", {"entities": []}], ["In multivariate analysis, using OIUs as a reference, U- or J-shaped associations were observed for five health risk behavior indices (current smoking, current drinking, drug abuse, sexual intercourse, sedentary behavior on weekdays) and four mental health indices (stressed, depressed, suicidal ideation, attempted suicide) in both genders.", {"entities": []}], ["After removing confounding effects, including age, region, school type, subjective school record, subjective economic status, presence of parents, living with family, and sedentary behavior, these associations were still observed.", {"entities": []}], ["Health professionals should consider both Internet non-users (for non-educational purposes) and heavy users to be high-risk groups in terms of health status.", {"entities": []}], ["Also, more well-designed studies are needed to clarify what factors are working in these nonlinear associations.", {"entities": []}], ["Forced oscillation technique (FOT) is a method to characterize the mechanical properties of the respiratory system over a wide range of frequencies.", {"entities": []}], ["Its\u2019 most important advantage is to require minimal cooperation from the subject.", {"entities": []}], ["This study was performed to evaluate the usefulness of the FOT applications in patients with bronchial asthma by estimating the associations between asthma severity and FOT parameters, and the relationships between FOT and spirometry parameters.", {"entities": [[103, 109, "DISEASE"], [149, 155, "DISEASE"]]}], ["216 patients with asthma were enrolled in this study.", {"entities": [[18, 24, "DISEASE"]]}], ["Patients were classified into 3 different groups according to their symptoms and pulmonary functions.", {"entities": []}], ["Respiratory impedance, resistance (at 5 Hz, 20 Hz, 35 Hz) and resonant frequency were measured by FOT.", {"entities": []}], ["FEV 1 , FVC and MMEF were measured with conventional spirometry.", {"entities": [[0, 3, "GENE"]]}], ["There were significant differences of resonant frequency, resistance at 5 Hz and 20 Hz, resistance difference at 5 Hz and 20 Hz according to asthma severity (p<0.05, respectively).", {"entities": [[141, 147, "DISEASE"]]}], ["Resonant frequency, resistance at 5 Hz, and impedance were significantly correlated with FEV 1 (r = \u22120.55, \u22120.48, \u22120.49, p<0.05, respectively), and with MMEF in patients with normal pulmonary function (r = \u22120.37, \u22120.35, \u22120.34, p<0.05, respectively).", {"entities": [[89, 92, "GENE"]]}], ["Resistance at 5 Hz had similar reproducibility compared to FEV 1 (resistance at 5 Hz, r = 0.78 vs FEV 1 , r = 0.79).", {"entities": [[59, 62, "GENE"], [98, 101, "GENE"], [59, 62, "GENE"], [98, 101, "GENE"]]}], ["FOT is a useful and alternative method to evaluate the clinical status of bronchial asthma.", {"entities": [[84, 90, "DISEASE"]]}], ["Further studies will be needed to clarify its value for a wide range of clinical applications.", {"entities": []}], ["Children's exposure to secondhand smoke is associated with increased morbidity.", {"entities": []}], ["We estimated Medicaid expenditures for children living with smokers compared to those living with no smokers in the United States.", {"entities": []}], ["Data were overall and service-specific (i.e., inpatient, ambulatory, emergency department, prescription drug, and dental) annual Medicaid expenditures for children 0-11 years old from the 2000-2007 Medical Expenditures Panel Surveys.", {"entities": []}], ["Smokers' presence in households was determined by adult respondents' self reports.", {"entities": []}], ["There were 25,835 person-years of observation.", {"entities": []}], ["We used multivariate analyses to adjust for child, parent, and geographic characteristics.", {"entities": []}], ["Children with Medicaid expenditures were nearly twice as likely to live with a smoker as other children in the U.S. population.", {"entities": []}], ["Adjusted analyses revealed no detectable differences in children's overall Medicaid expenditures by presence of smokers in the household.", {"entities": []}], ["Medicaid children who lived with smokers on average had $10 (95% CI $3, $18) higher emergency department expenditures per year than those living with no smokers.", {"entities": []}], ["Living with at least one smoker (a proxy for secondhand smoke exposure) is unrelated to children's overall short-term Medicaid expenditures, but has a modest impact on emergency department expenditures.", {"entities": []}], ["Additional research is necessary to understand the relationship between secondhand smoke exposure and long-term health and economic outcomes.", {"entities": []}], ["A small-molecule agonist of the Toll-like receptor 1/2 signaling pathway does it by stabilizing heterodimeric associations.", {"entities": []}], ["Toll-like receptor (TLR) agonists activate both the innate and the adaptive immune systems.", {"entities": []}], ["These TLR agonists have been exploited as potent vaccine adjuvants and antitumor agents.", {"entities": []}], ["We describe the identification and characterization of a small molecule, N -methyl-4-nitro-2-(4-(4-(trifluoromethyl)phenyl)-1 H -imidazol-1-yl)aniline (CU-T12-9), that directly targets TLR1/2 to initiate downstream signaling.", {"entities": []}], ["CU-T12-9 specifically induces TLR1/2 activation, which can be blocked by either the anti-hTLR1 or the anti-hTLR2 antibody, but not the anti-hTLR6 antibody.", {"entities": []}], ["Using a variety of different biophysical assays, we have demonstrated the binding mode of CU-T12-9.", {"entities": []}], ["By binding to both TLR1 and TLR2, CU-T12-9 facilitates the TLR1/2 heterodimeric complex formation, which in turn activates the downstream signaling.", {"entities": [[19, 23, "GENE"], [59, 63, "GENE"], [28, 32, "GENE"]]}], ["Fluorescence anisotropy assays revealed competitive binding to the TLR1/2 complex between CU-T12-9 and Pam 3 CSK 4 with a half-maximal inhibitory concentration (IC 50 ) of 54.4 nM.", {"entities": [[109, 112, "GENE"]]}], ["Finally, we showed that CU-T12-9 signals through nuclear factor \u03baB (NF-\u03baB) and invokes an elevation of the downstream effectors tumor necrosis factor\u2013\u03b1 (TNF-\u03b1), interleukin-10 (IL-10), and inducible nitric oxide synthase (iNOS).", {"entities": []}], ["Thus, our studies not only provide compelling new insights into the regulation of TLR1/2 signaling transduction but also may facilitate future therapeutic developments.", {"entities": []}], ["Acute systemic inflammatory response syndrome arising from infection can lead to multiple organ failure and death, with greater susceptibility occurring in immunocompromised individuals.", {"entities": [[37, 45, "DISEASE"]]}], ["Moreover, sub-acute chronic inflammation is a contributor to the pathology of diverse degenerative diseases (Parkinson\u2019s disease, Alzheimer\u2019s disease and arthritis).", {"entities": [[154, 163, "DISEASE"]]}], ["Given the known limitations in Western medicine to treat a broad range of inflammatory related illness as well as the emergence of antibiotic resistance, there is a renewed interest in complementary and alternative medicines (CAMs) to achieve these means.", {"entities": []}], ["A high throughput (HTP) screening of >1400 commonly sold natural products (bulk herbs, cooking spices, teas, leaves, supplement components, nutraceutical food components, fruit and vegetables, rinds, seeds, polyphenolics etc.)", {"entities": []}], ["was conducted to elucidate anti-inflammatory substances in lipopolysaccharide (LPS) ( E. coli serotype O111:B4 ) monocytes: RAW 264.7 macrophages [peripheral], BV-2 microglia [brain]) relative to hydrocortisone, dexamethasone and L-N6-(1Iminoethyl)lysine (L-NIL).", {"entities": []}], ["HTP evaluation was also carried out for lethal kill curves against E.coli 0157:H7 1x10 The data show that activated BV-2 microglia cells (+ LPS 1\u03bcg/ml) release >10-fold greater IL-6, MIP1/2, RANTES and nitric oxide (NO2\u2013), where RAW 264.7 macrophages (+ LPS 1\u03bcg/ml) produced > 10-fold rise in sTNFR2, MCP-1, IL-6, GCSF, RANTES and NO2\u2013.", {"entities": []}], ["Data validation studies establish hydrocortisone and dexamethasone as suppressing multiple pro-inflammatory processes, where L-NIL suppressed NO2\u2013, but had no effect on iNOS expression or IL-6.", {"entities": []}], ["The screening results demonstrate relative few valid hits with anti-inflammatory effects at < 250\u03bcg/ml for the following: Bay Leaf ( Laurus nobilis ), Elecampagne Root ( Inula helenium ), Tansy ( Tanacetum vulgare ),Yerba ( Eriodictyon californicum ) and Centipeda ( Centipeda minima ), Ashwagandha ( Withania somnifera ), Feverfew ( Tanacetum parthenium ), Rosemary ( Rosmarinus officinalis ), Turmeric Root ( Curcuma Longa ), Osha Root ( Ligusticum porteri ), Green Tea ( Camellia sinensis ) and constituents: cardamonin, apigenin, quercetin, biochanin A, eupatorin, (-)-epigallocatechin gallate (EGCG) and butein.", {"entities": []}], ["Natural products lethal against [ E. coli 0157:H7 ] where the LC 50 < 100 \u03bcg/ml included bioactive silver hydrosol-Argentyn 23, green tea (its constituents EGCG > Polyphenon 60 > (-)-Gallocatechin > Epicatechin > (+)-Catechin), Grapeseed Extract ( Vitis vinifera ), Chinese Gallnut (its constituents gallic acid > caffeic acid) and gallic acid containing plants such as Babul Chall Bark ( Acacia Arabica ), Arjun ( Terminalia Arjuna ) and Bayberry Root Bark ( Morella Cerifera ) .", {"entities": []}], ["These findings emphasize and validate the previous work of others and identify the most effective CAM anti-inflammatory, antibacterial compounds using these models.", {"entities": []}], ["Future work will be required to evaluate potential combination strategies for long-term use to prevent chronic inflammation and possibly lower the risk of sepsis in immunocompromised at risk populations.", {"entities": []}], ["Statins are drugs that are used to lower plasma cholesterol levels.", {"entities": []}], ["Recently, contradictory claims have been made about possible additional effects of statins on progression of a variety of inflammatory disorders, including infections.", {"entities": []}], ["We therefore examined the clinical course of patients admitted to hospital with 2009 pandemic influenza A(H1N1), who were or weren't taking statins at time of admission.", {"entities": [[94, 103, "DISEASE"]]}], ["A retrospective case-control study was performed using the United Kingdom Influenza Clinical Information Network (FLU-CIN) database, containing detailed information on 1,520 patients admitted to participating hospitals with confirmed 2009 pandemic influenza A(H1N1) infection between April 2009 and January 2010.", {"entities": [[74, 83, "DISEASE"], [248, 257, "DISEASE"]]}], ["We confined our analysis to those aged over 34 years.", {"entities": []}], ["Univariate analysis was used to calculate unadjusted odds ratios (OR) and 95 percent confidence intervals (95%CI) for factors affecting progression to severe outcome (high dependency or intensive care unit level support) or death (cases); two multivariable logistic regression models were then established for age and sex, and for age, sex, obesity and \u201cindication for statin\u201d (e.g., heart disease or hypercholesterolaemia).", {"entities": [[384, 397, "DISEASE"], [341, 348, "DISEASE"]]}], ["We found no statistically significant association between pre-admission statin use and severity of outcome after adjustment for age and sex [adjusted OR: 0.81 (95% CI: 0.46\u20131.38); n\u200a=\u200a571].", {"entities": []}], ["After adjustment for age, sex, obesity and indication for statin, the association between pre-admission statin use and severe outcome was not statistically significant; point estimates are compatible with a small but clinically significant protective effect of statin use [adjusted OR: 0.72 (95% CI: 0.38\u20131.33)].", {"entities": [[31, 38, "DISEASE"]]}], ["In this group of patients hospitalized with pandemic influenza, a significant beneficial effect of pre-admission statin use on the in-hospital course of illness was not identified.", {"entities": [[53, 62, "DISEASE"]]}], ["Although the database from which these observations are derived represents the largest available suitable UK hospital cohort, a larger study would be needed to confirm whether there is any benefit in this setting.", {"entities": []}], ["Pulmonary tuberculosis (PTB) is a risk factor for COPD, but the clinical characteristics and the chest imaging features (emphysema and bronchiectasis) of COPD with previous PTB have not been studied well.", {"entities": [[135, 149, "DISEASE"], [10, 22, "DISEASE"]]}], ["The presence, distribution, and severity of emphysema and bronchiectasis in COPD patients with and without previous PTB were evaluated by high-resolution computed tomography (HRCT) and compared.", {"entities": [[58, 72, "DISEASE"]]}], ["Demographic data, respiratory symptoms, lung function, and sputum culture of Pseudomonas aeruginosa were also compared between patients with and without previous PTB.", {"entities": []}], ["A total of 231 COPD patients (82.2% ex- or current smokers, 67.5% male) were consecutively enrolled.", {"entities": []}], ["Patients with previous PTB (45.0%) had more severe ( p =0.045) and longer history ( p =0.008) of dyspnea, more exacerbations in the previous year ( p =0.011), and more positive culture of P. aeruginosa ( p =0.001), compared with those without PTB.", {"entities": []}], ["Patients with previous PTB showed a higher prevalence of bronchiectasis ( p <0.001), which was more significant in lungs with tuberculosis (TB) lesions, and a higher percentage of more severe bronchiectasis (Bhalla score \u22652, p =0.031), compared with those without previous PTB.", {"entities": [[57, 71, "DISEASE"], [192, 206, "DISEASE"], [126, 138, "DISEASE"]]}], ["The overall prevalence of emphysema was not different between patients with and without previous PTB, but in those with previous PTB, a higher number of subjects with middle ( p =0.001) and lower ( p =0.019) lobe emphysema, higher severity score ( p =0.028), higher prevalence of panlobular emphysema ( p =0.013), and more extensive centrilobular emphysema ( p =0.039) were observed.", {"entities": []}], ["Notably, in patients with TB lesions localized in a single lung, no difference was found in the occurrence and severity of emphysema between the 2 lungs.", {"entities": []}], ["COPD patients with previous PTB had unique features of bronchiectasis and emphysema on HRCT, which were associated with significant dyspnea and higher frequency of severe exacerbations.", {"entities": [[55, 69, "DISEASE"]]}], ["While PTB may have a local effect on bronchiectasis, its involvement in airspace damage in COPD may be extensive, probably through interactions with cigarette smoke.", {"entities": [[37, 51, "DISEASE"]]}], ["Toll like receptors (TLRs) are an essential part of the innate immune response.", {"entities": []}], ["So far, ten different TLRs were identified in humans.", {"entities": []}], ["They recognize a wide range of microbial and viral pathogens.", {"entities": []}], ["Infection by respiratory syncytial virus (RSV) is still a major health problem, about 2% of all children are hospitalised due to RSV bronchiolitis during their first 2 years of live.", {"entities": [[133, 146, "DISEASE"]]}], ["TLR4 has already been described in association with RSV associated diseases by us and others.", {"entities": [[0, 4, "GENE"]]}], ["Thus we were interested whether other TLRs are also involved in the genetics of severe RSV infection.", {"entities": []}], ["We genotyped 19 polymorphisms in the autosomal TLRs, these are TLR1, 2, 3, 5, 6, 9 and 10.", {"entities": [[63, 67, "GENE"]]}], ["Association analyses by the Armitage's Trend test revealed weak association of one TLR9 promoter polymorphism with RSV infection ( p = 0.013).", {"entities": [[83, 87, "GENE"]]}], ["In addition, association was found with TLR10 haplotypes ( p = 0.024).", {"entities": [[40, 45, "GENE"]]}], ["We conclude from our data \u2013 that \u2013 although we can not rule out a minor involvement of TLR9 polymorphism and TLR10 haplotypes \u2013 TLRs other than TLR4 do not play a major role in the genetics of severe RSV associated diseases.", {"entities": [[87, 91, "GENE"], [109, 114, "GENE"], [144, 148, "GENE"]]}], ["Future studies should focus on additional genes of the innate immune response.", {"entities": []}], ["Granulocyte-macrophage colony-stimulating factor (GM-CSF) has shown promising results as a cytokine adjuvant for antiviral vaccines and in various models of tumor gene therapy.", {"entities": []}], ["To explore whether the targeting of antigens to GM-CSF receptors on antigen-presenting cells enhances antigen-specific CD8 T-cell responses, fusion proteins of GM-CSF and ovalbumin (OVA) were expressed by DNA and adenoviral vector vaccines.", {"entities": []}], ["In addition, bicistronic vectors allowing independent expression of the antigen and the cytokine were tested in parallel.", {"entities": []}], ["In vitro , the GM-CSF ovalbumin fusion protein (GM-OVA) led to the better stimulation of OVA-specific CD8+ T cells by antigen-presenting cells than OVA and GM-CSF given as two separate proteins.", {"entities": []}], ["However, prime-boost immunizations of mice with DNA and adenoviral vector vaccines encoding GM-OVA suppressed CD8+ T-cell responses to OVA.", {"entities": []}], ["OVA-specific IgG2a antibody levels were also reduced, while the IgG1 antibody response was enhanced.", {"entities": []}], ["Suppression of CD8+ T cell responses by GM-OVA vaccines was associated with the induction of neutralizing antibodies to GM-CSF.", {"entities": []}], ["In contrast, the coexpression of GM-CSF and antigens in DNA prime adenoviral boost immunizations led to a striking expansion of polyfunctional OVA-specific CD8+ T cells without the induction of autoantibodies.", {"entities": []}], ["The induction of autoantibodies suggests a general note of caution regarding the use of highly immunogenic viral vector vaccines encoding fusion proteins between antigens and host proteins.", {"entities": []}], ["In contrast, the expansion of polyfunctional OVA-specific CD8+ T cells after immunizations with bicistronic vectors further support a potential application of GM-CSF as an adjuvant for heterologous prime-boost regimens with genetic vaccines.", {"entities": []}], ["Since DNA prime adenoviral vector boost regimenes are presently considered as one of the most efficient ways to induce CD8+ T cell responses in mice, non-human primates and humans, further enhancement of this response by GM-CSF is a striking observation.", {"entities": []}], ["Chemical irritation of airway mucosa elicits a variety of reflex responses such as coughing, apnea, and laryngeal closure.", {"entities": []}], ["Inhaled irritants can activate either chemosensitive free nerve endings, laryngeal taste buds or solitary chemosensory cells (SCCs).", {"entities": []}], ["The SCC population lies in the nasal respiratory epithelium, vomeronasal organ, and larynx, as well as deeper in the airway.", {"entities": []}], ["The objective of this study is to map the distribution of SCCs within the airways and to determine the elements of the chemosensory transduction cascade expressed in these SCCs.", {"entities": []}], ["We utilized a combination of immunohistochemistry and molecular techniques (rtPCR and in situ hybridization) on rats and transgenic mice where the Tas1R3 or TRPM5 promoter drives expression of green fluorescent protein (GFP).", {"entities": [[147, 153, "GENE"], [157, 162, "GENE"]]}], ["Epithelial SCCs specialized for chemoreception are distributed throughout much of the respiratory tree of rodents.", {"entities": []}], ["These cells express elements of the taste transduction cascade, including Tas1R and Tas2R receptor molecules, \u03b1-gustducin, PLC\u03b22 and TrpM5.", {"entities": [[133, 138, "GENE"]]}], ["The Tas2R bitter taste receptors are present throughout the entire respiratory tract.", {"entities": []}], ["In contrast, the Tas1R sweet/umami taste receptors are expressed by numerous SCCs in the nasal cavity, but decrease in prevalence in the trachea, and are absent in the lower airways.", {"entities": []}], ["Elements of the taste transduction cascade including taste receptors are expressed by SCCs distributed throughout the airways.", {"entities": []}], ["In the nasal cavity, SCCs, expressing Tas1R and Tas2R taste receptors, mediate detection of irritants and foreign substances which trigger trigeminally-mediated protective airway reflexes.", {"entities": []}], ["Lower in the respiratory tract, similar chemosensory cells are not related to the trigeminal nerve but may still trigger local epithelial responses to irritants.", {"entities": []}], ["In total, SCCs should be considered chemoreceptor cells that help in preventing damage to the respiratory tract caused by inhaled irritants and pathogens.", {"entities": []}], ["Although balloon sinus dilation is a treatment option for adults with chronic rhinosinusitis (CRS), there have been few studies performed in pediatric patients.", {"entities": []}], ["This study was designed as a prospective, multicenter, single\u2010arm investigation.", {"entities": []}], ["Children (2 to 21 years old) with CRS who had failed medical management were treated with balloon sinus dilation and followed to 6 months postprocedure.", {"entities": []}], ["Fifty children were treated at 4 centers; 33 participants were 2 to 12 years old (mean \u00b1 standard deviation age: 6.6 \u00b1 2.2 years) and 17 participants were >12 to 21 years (mean age: 15.7 \u00b1 2.5 years).", {"entities": []}], ["A total of 157 sinus dilations were attempted (98 maxillary, 30 frontal, and 29 sphenoid sinuses) and all were successful with no complications.", {"entities": []}], ["Significant improvement in the Sinus and Nasal Quality of Life Survey (SN\u20105) was seen for all children between baseline and 6 months (4.6 \u00b1 1.2 vs 1.7 \u00b1 0.8; p < 0.0001) and 92% improved by a minimal clinically important difference (MCID) of 1.0 or more.", {"entities": []}], ["Those children aged 2 to 12 years with standalone balloon dilation also showed significant SN\u20105 improvements between baseline and follow\u2010up (4.5 \u00b1 1.0 vs 1.9 \u00b1 0.8; p < 0.0001).", {"entities": []}], ["Multivariate regression analysis showed no differences or associations of SN\u20105 improvement at 6 months with the presence of allergy, asthma, or concomitant procedures.", {"entities": [[133, 139, "DISEASE"]]}], ["For adolescents, overall 22\u2010item Sino\u2010Nasal Outcome Test (SNOT\u201022) mean scores were also significantly improved at 6 months (42.2 \u00b1 19.2 vs 10.4 \u00b1 9.7; p < 0.0001).", {"entities": []}], ["Balloon sinus dilation is safe and appears effective for children with CRS aged 2 years and older.", {"entities": []}], ["Pulmonary fibrosis (PF) is a progressive and predominantly lethal form of several interstitial lung diseases with limited current therapeutics; it is, therefore, essential to develop a simple, homogeneous, and noninvasive disease model to investigate possible anti-fibrotic approaches.", {"entities": []}], ["The present study is designed to develop oropharyngeal aspiration (OPA) model of bleomycin (BLM)-induced PF as a simple and alternative to intratracheal (IT) administration of BLM in Swiss mice strain.", {"entities": [[92, 95, "GENE"], [176, 179, "GENE"], [92, 95, "GENE"], [176, 179, "GENE"]]}], ["Mice were divided into two groups, BLM-treated and normal control.", {"entities": []}], ["BLM via OPA (2 IU/kg) was used to induce PF.", {"entities": [[0, 3, "GENE"]]}], ["Water for injection was used as a vehicle in control animals.", {"entities": []}], ["Body weights were measured once in a week, and the study was continued for 21 days.", {"entities": []}], ["At the end of the study, animals were euthanized and bronchoalveolar lavage fluid was collected and subjected to lymphocytes count, estimation of albumin and protein levels.", {"entities": []}], ["Lung tissues were collected, and various biochemical assays (malondialdehyde, glutathione, nitric oxide, hydroxyproline) and molecular techniques including ELISA and Western blot were performed to investigate the effect of OPA-BLM.", {"entities": []}], ["Further, histopathology and Masson's trichrome staining techniques were performed in lung sections.", {"entities": []}], ["OPA administration of BLM in Swiss mice significantly induced PF, evident from lung index and morphology.", {"entities": [[22, 25, "GENE"]]}], ["Several oxidative stress parameters and hydroxyproline assay revealed the significant ( P < 0.05) induction of PF.", {"entities": []}], ["Further results obtained from histopathology, Masson's trichrome staining, ELISA, and Western blot confirmed the significant induction of PF via OPA-BLM.", {"entities": []}], ["BLM administration by OPA route in Swiss mice can be used as a simple, homogeneous, and noninvasive model of inducing PF and to investigate the effect of various anti-fibrotic agents as an alternative to IT-BLM.", {"entities": [[0, 3, "GENE"], [207, 210, "GENE"]]}], ["Patient: Female, 78 Final Diagnosis: Takotsubo cardiomyopathy Symptoms: Chest discomfort, chest pain, dyspnea, short of breath Medication: \u2014 Clinical Procedure: \u2014 Specialty: Cardiology Unusual or unexpected effect of treatment Takotsubo cardiomyopathy is an increasingly recognized cardiac condition that usually results from an acute stressor.", {"entities": [[47, 61, "DISEASE"], [237, 251, "DISEASE"]]}], ["Some medications are becoming recognized as possible stressors.", {"entities": []}], ["Albuterol is widely used in general medicine.", {"entities": []}], ["We report an unusual link between Takotsubo cardiomyopathy and albuterol.", {"entities": [[44, 58, "DISEASE"]]}], ["A 78-year-old woman presented to our emergency department for chest pain of 2-day duration.", {"entities": []}], ["The patient had been taking albuterol inhaler therapy for worsening shortness of breath followed by chest pain.", {"entities": []}], ["Her albuterol use was excessive.", {"entities": []}], ["There were no other acute stressors.", {"entities": []}], ["The electrocardiogram showed ST-elevations in the anterior and inferior leads.", {"entities": []}], ["Emergent coronary angiography showed noncritical coronary artery disease and left ventriculography showed apical ballooning.", {"entities": []}], ["When patients taking albuterol present with acute chest pain in the absence of other etiologies, beta-agonist-induced Takotsubo cardiomyopathy should be considered.", {"entities": [[128, 142, "DISEASE"]]}], ["Poly- \u03b3 -glutamic acid ( \u03b3 -PGA), naturally secreted from various strains of Bacillus , has anti-inflammatory activity.", {"entities": []}], ["In inflammatory bowel disease (IBD), inflammation is promoted and sustained by angiogenesis; however, the role played by \u03b3 -PGA in this condition is unclear.", {"entities": [[3, 29, "DISEASE"]]}], ["Therefore, we evaluated \u03b3 -PGA effects on angiogenesis and inflammation in a dextran sulfate sodium- (DSS-) induced mouse colitis model.", {"entities": []}], ["Experimental colitis was induced in male C57BL/6 mice by administering 3% DSS.", {"entities": []}], ["Disease activity index (DAI), histopathological scores, microvascular density, myeloperoxidase activity, and VEGF-A and VEGFR2 expression were compared among control mice, DSS-treated mice, and mice receiving 3% DSS along with \u03b3 -PGA at 50\u2009mg/kg body weight per day or 3% DSS with \u03b3 -PGA at 200\u2009mg/kg body weight per day.", {"entities": []}], ["We found that \u03b3 -PGA significantly attenuated weight loss, DAI, and colon shortening.", {"entities": []}], ["\u03b3 -PGA also significantly reduced histopathological evidence of injury.", {"entities": []}], ["Moreover, \u03b3 -PGA significantly attenuated DSS-induced blood vessel densities.", {"entities": []}], ["Furthermore, \u03b3 -PGA attenuated DSS-induced expression of VEGF-A and its receptor, VEGFR2.", {"entities": []}], ["In addition, \u03b3 -PGA treatment led to reduced recruitment of leukocytes to the inflamed colon.", {"entities": []}], ["Therefore, our results indicate that \u03b3 -PGA has potential application in conditions marked by inflammatory-driven angiogenesis and mucosal inflammation.", {"entities": []}], ["Hookah (narghile, shisha, \u201cwater-pipe\u201d) smoking is now seen by public health officials as a global tobacco epidemic.", {"entities": []}], ["Cigarette Environmental Tobacco Smoke (ETS) is classically understood as a combination of Side-Stream Smoke (SSS) and Exhaled Main-Stream Smoke (EMSS), both diluted and aged.", {"entities": []}], ["Some of the corresponding cigarette studies have served as the scientific basis for stringent legislation on indoor smoking across the world.", {"entities": []}], ["Interestingly, one of the distinctive traits of the hookah device is that it generates almost no SSS.", {"entities": []}], ["Indeed, its ETS is made up almost exclusively by the smoke exhaled by the smoker (EMSS), i.e.", {"entities": []}], ["which has been filtered by the hookah at the level of the bowl, inside the water, along the hose and then by the smoker\u2019s respiratory tract itself.", {"entities": []}], ["The present paper reviews the sparse and scattered scientific evidence available about hookah EMSS and the corresponding inferences that can be drawn from the composition of cigarette EMSS.", {"entities": []}], ["The reviewed literature shows that most of hookah ETS is made up of EMSS and that the latter qualitatively differs from MSS.", {"entities": []}], ["Keeping in mind that the first victim of passive smoking is the active smoker her/himself, the toxicity of hookah ETS for non-smokers should not be overestimated and hyped in an unscientific way.", {"entities": []}], ["Our objective was to investigate the impact of socioeconomic status and subjective social class on health-related quality of life (HRQOL) vs. overall quality of life (QOL).", {"entities": []}], ["We performed a longitudinal analysis using data regarding 8250 individuals drawn from the Korean Longitudinal Study of Aging (KLoSA).", {"entities": []}], ["We analyzed differences between HRQOL and QOL in individuals of various socioeconomic strata (high, middle, or low household income and education levels) and subjective social classes (high, middle, or low) at baseline (2009).", {"entities": []}], ["Individuals with low household incomes and of low subjective social class had the highest probability of reporting discrepant HRQOL and QOL scores (B: 4.796; P \u2009<\u20090.0001), whereas individuals with high household incomes and high subjective social class had the lowest probability of discrepant HRQOL and QOL scores (B: \u22123.625; P \u2009=\u20090.000).", {"entities": []}], ["Similar trends were seen when education was used as a proxy for socioeconomic status.", {"entities": []}], ["In conclusion, both household income/subjective social class and education/subjective social class were found to have an impact on the degree of divergence between QOL and HRQOL.", {"entities": []}], ["Therefore, in designing interventions, socioeconomic inequalities should be taken into account through the use of multi-dimensional measurement tools.", {"entities": []}], ["Exhaled nitric oxide (eNO) has been proposed as a noninvasive marker of airway inflammation in asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["In asthmatic patients, exhaled NO levels have been shown to relate with other markers of eosinophilic recruitment, which are detected in blood, sputum, bronchoalveolar lavage fluid and bronchial biopsy samples.", {"entities": []}], ["The purpose of this study was to assess the possible relationship between eNO and allergic inflammation or sensitization in childhood asthma and allergic rhinitis.", {"entities": [[145, 162, "DISEASE"], [154, 162, "DISEASE"], [134, 140, "DISEASE"]]}], ["Subjects consisted of 118 asthmatic children, 79 patients with allergic rhinitis, and 74 controls.", {"entities": [[63, 80, "DISEASE"], [72, 80, "DISEASE"]]}], ["Their age ranged from 6 to 15 yr old.", {"entities": []}], ["eNO level, peripheral blood eosinophil count, eosinophil cationic protein (ECP), serum total IgE level and specific IgE levels were measured.", {"entities": []}], ["Methacholine challenge test and allergic skin prick test for common allergens were performed in all subjects.", {"entities": []}], ["Atopic group (n = 206, 44.48 \u00b1 30.45 ppb) had higher eNO values than non-atopic group (n = 65, 20.54 \u00b1 16.57 ppb, P < 0.001).", {"entities": []}], ["eNO level was significantly higher in patients with asthma (42.84 \u00b1 31.92 ppb) and in those with allergic rhinitis (43.59 \u00b1 29.84 ppb) than in healthy controls (27.01 \u00b1 21.34 ppb, P < 0.001) but there was no difference between asthma and allergic rhinitis group.", {"entities": [[97, 114, "DISEASE"], [238, 255, "DISEASE"], [106, 114, "DISEASE"], [247, 255, "DISEASE"], [52, 58, "DISEASE"], [227, 233, "DISEASE"]]}], ["eNO also had significant positive correlations with Dermatophagoides pteronyssinus IgE level ( r = 0.348, P < 0.001), Dermatophagoides farinae IgE level ( r = 0.376, P < 0.001), and the number of positive allergens in skin prick test ( r = 0.329, P = 0.001).", {"entities": []}], ["eNO had significant positive correlations with peripheral blood eosinophil count ( r = 0.356, P < 0.001), serum total IgE level ( r = 0.221, P < 0.001), and ECP ( r = 0.436, P < 0.001).", {"entities": []}], ["This study reveals that eNO level is associated with allergic inflammation and the degree of allergic sensitization.", {"entities": []}], ["Adequate health literacy is important for people to maintain good health and manage diseases and injuries.", {"entities": []}], ["Educational text, either retrieved from the Internet or provided by a doctor\u2019s office, is a popular method to communicate health-related information.", {"entities": []}], ["Unfortunately, it is difficult to write text that is easy to understand, and existing approaches, mostly the application of readability formulas, have not convincingly been shown to reduce the difficulty of text.", {"entities": []}], ["To develop an evidence-based writer support tool to improve perceived and actual text difficulty.", {"entities": []}], ["To this end, we are developing and testing algorithms that automatically identify difficult sections in text and provide appropriate, easier alternatives; algorithms that effectively reduce text difficulty will be included in the support tool.", {"entities": []}], ["This work describes the user evaluation with an independent writer of an automated simplification algorithm using term familiarity.", {"entities": []}], ["Term familiarity indicates how easy words are for readers and is estimated using term frequencies in the Google Web Corpus.", {"entities": []}], ["Unfamiliar words are algorithmically identified and tagged for potential replacement.", {"entities": []}], ["Easier alternatives consisting of synonyms, hypernyms, definitions, and semantic types are extracted from WordNet, the Unified Medical Language System (UMLS), and Wiktionary and ranked for a writer to choose from to simplify the text.", {"entities": []}], ["We conducted a controlled user study with a representative writer who used our simplification algorithm to simplify texts.", {"entities": []}], ["We tested the impact with representative consumers.", {"entities": []}], ["The key independent variable of our study is lexical simplification, and we measured its effect on both perceived and actual text difficulty.", {"entities": []}], ["Participants were recruited from Amazon\u2019s Mechanical Turk website.", {"entities": []}], ["Perceived difficulty was measured with 1 metric, a 5-point Likert scale.", {"entities": []}], ["Actual difficulty was measured with 3 metrics: 5 multiple-choice questions alongside each text to measure understanding, 7 multiple-choice questions without the text for learning, and 2 free recall questions for information retention.", {"entities": []}], ["Ninety-nine participants completed the study.", {"entities": []}], ["We found strong beneficial effects on both perceived and actual difficulty.", {"entities": []}], ["After simplification, the text was perceived as simpler ( P <.001) with simplified text scoring 2.3 and original text 3.2 on the 5-point Likert scale (score 1: easiest).", {"entities": []}], ["It also led to better understanding of the text ( P <.001) with 11% more correct answers with simplified text (63% correct) compared to the original (52% correct).", {"entities": []}], ["There was more learning with 18% more correct answers after reading simplified text compared to 9% more correct answers after reading the original text ( P =.003).", {"entities": []}], ["There was no significant effect on free recall.", {"entities": []}], ["Term familiarity is a valuable feature in simplifying text.", {"entities": []}], ["Although the topic of the text influences the effect size, the results were convincing and consistent.", {"entities": []}], ["Quantitative studies of the skin-sensitizing antibodies, blocking antibodies, and hemagglutinins in sera of allergic human beings have been made.", {"entities": []}], ["A comparison of 12 maternal and the 12 corresponding cord sera by the method of passive transfer showed the human placenta to be impermeable to skin-sensitizing antibodies.", {"entities": []}], ["Direct skin tests and passive transfer studies of 6 infants at the ages of 3 to 6 months showed negative reactions to the antigens to which their mothers were sensitive.", {"entities": []}], ["The blocking antibody present in the sera of hay fever patients after treatment with pollen extract injections was also demonstrated in the cord sera.", {"entities": []}], ["The apparent placental transmission of this antibody gave further evidence that it was distinct from the skin-sensitizing antibody.", {"entities": []}], ["Infant sera obtained at the ages of 3 to 6 months showed no evidence of this immune antibody.", {"entities": []}], ["The cord sera from 4 of these cases were shown to contain the same isoagglutinins as the maternal sera, showing that the placentas were permeable to these antibodies.", {"entities": []}], ["The mothers and their offspring reacted alike to Schick testing.", {"entities": []}], ["Typhoid agglutinins were demonstrated in maternal and cord sera of an adult who previously received injections of triple typhoid vaccine, whereas the serum of the corresponding infant at the age of 3 months failed to show agglutinins.", {"entities": []}], ["Erythrocyte measures are heritable and have important health implications, yet their genetic determinants are largely unknown.", {"entities": []}], ["We performed genome-wide association analyses in 24,167 European-ancestry individuals for six erythrocyte traits and identified associations at 23 loci ( P values 5\u00d710 HBS1L/MYB, HFE, TMPRSS6, TFR2, SPTA1 ) and novel associations ( EPO, TFRC, SH2B3, and 15 other loci).", {"entities": [[179, 182, "GENE"], [184, 191, "GENE"], [193, 197, "GENE"], [199, 204, "GENE"], [232, 235, "GENE"], [237, 241, "GENE"], [243, 248, "GENE"]]}], ["This study has identified novel determinants of erythrocyte traits, offering insight into common variants underlying variation in erythrocyte measures.", {"entities": []}], ["Objective To evaluate the predictive value of alarm symptoms for specified non-cancer diagnoses and cancer diagnoses in primary care.", {"entities": [[79, 85, "DISEASE"], [100, 106, "DISEASE"]]}], ["Design Cohort study using the general practice research database.", {"entities": []}], ["Setting 128 general practices in the UK contributing data, 1994-2000.", {"entities": []}], ["Participants 762\u2009325 patients aged 15 or older.", {"entities": []}], ["Main outcome measures Up to 15 pre-specified, non-cancer diagnoses associated with four alarm symptoms (haematuria, haemoptysis, dysphagia, rectal bleeding) at 90 days and three years after the first recorded alarm symptom.", {"entities": [[50, 56, "DISEASE"]]}], ["For each outcome analyses were implemented separately in a time to event framework.", {"entities": []}], ["Data were censored if patients died, left the practice, or reached the end of the study period.", {"entities": []}], ["Results We analysed data on first episodes of haematuria (11\u2009108), haemoptysis (4812), dysphagia (5999), or rectal bleeding (15\u2009289).", {"entities": []}], ["Non-cancer diagnoses were common in patients who presented with alarm symptoms.", {"entities": [[4, 10, "DISEASE"]]}], ["The proportion diagnosed with either cancer or non-cancer diagnoses generally increased with age.", {"entities": [[37, 43, "DISEASE"], [51, 57, "DISEASE"]]}], ["In patients presenting with haematuria, the proportions diagnosed with either cancer or non-cancer diagnoses within 90 days were 17.5% (95% confidence interval 16.4% to 18.6%) in women and 18.3% (17.4% to 19.3%) in men.", {"entities": [[78, 84, "DISEASE"], [92, 98, "DISEASE"]]}], ["For the other symptoms the proportions were 25.7% (23.8% to 27.8%) and 24% (22.5% to 25.6%) for haemoptysis, 17.2% (16% to 18.5%) and 22.6% (21% to 24.3%) for dysphagia, and 14.5% (13.7% to 15.3%) and 16.7% (15.8% to 17.5%) for rectal bleeding.", {"entities": []}], ["Conclusion Clinically relevant diagnoses are made in a high proportion of patients presenting with alarm symptoms.", {"entities": []}], ["For every four to seven patients evaluated for haematuria, haemoptysis, dysphagia, or rectal bleeding, relevant diagnoses will be identified in one patient within 90 days.", {"entities": []}], ["Acute asthma attacks remain a frequent cause of emergency department (ED) visits and hospital admission.", {"entities": [[6, 12, "DISEASE"]]}], ["Many factors encourage patients to seek asthma treatment at the emergency department.", {"entities": [[40, 46, "DISEASE"]]}], ["These factors may be related to the patient himself or to a health system that hinders asthma control.", {"entities": [[87, 93, "DISEASE"]]}], ["The aim of this study was to identify the main factors that lead to the frequent admission of asthmatic patients to the ED.", {"entities": []}], ["A cross-sectional survey of all the patients who visited the emergency room with bronchial asthma attacks over a 9-month period was undertaken at two major academic hospitals.", {"entities": [[91, 97, "DISEASE"]]}], ["The following data were collected: demographic data, asthma control in the preceding month, where and by whom the patients were treated, whether the patient received education about asthma or its medication and the patients\u2019 reasons for visiting the ED.", {"entities": [[53, 59, "DISEASE"], [182, 188, "DISEASE"]]}], ["Four hundred fifty (N\u2009=\u2009450) patients were recruited, 39.1% of whom were males with a mean age of 42.3\u2009\u00b1\u200916.7.", {"entities": []}], ["The mean duration of asthma was 155.90\u2009\u00b1\u2009127.13 weeks.", {"entities": [[21, 27, "DISEASE"]]}], ["Approximately half of the patients did not receive any information about bronchial asthma as a disease, and 40.7% did not receive any education regarding how to use asthma medication.", {"entities": [[83, 89, "DISEASE"], [165, 171, "DISEASE"]]}], ["Asthma was not controlled or partially controlled in the majority (97.7%) of the patients preceding the admission to ED.", {"entities": [[0, 6, "DISEASE"]]}], ["The majority of the patients visited the ED to receive a bronchodilator by nebuliser (86.7%) and to obtain oxygen (75.1%).", {"entities": []}], ["Moreover, 20.9% of the patients believed that the ED managed them faster than the clinic, and 21.1% claimed that their symptoms were severe enough that they could not wait for a clinic visit.", {"entities": []}], ["No education about asthma and uncontrolled asthma are the major factors leading to frequent ED visits (three or more visits/year), p-value\u2009=\u20090.0145 and p-value\u2009=\u20090.0003, respectively.", {"entities": [[19, 25, "DISEASE"], [43, 49, "DISEASE"]]}], ["Asthma control also exhibited a significant relationship with inhaled corticosteroid ICS use (p-value =0.0401) and education about asthma (p-value =0.0117).", {"entities": [[0, 6, "DISEASE"], [131, 137, "DISEASE"]]}], ["This study demonstrates that many avoidable risk factors lead to uncontrolled asthma and frequent ED visits.", {"entities": [[78, 84, "DISEASE"]]}], ["Hepatocellular carcinoma is a common type of tumour worldwide with a high mortality rate and with low response to current cytotoxic and chemotherapeutic drugs.", {"entities": [[15, 24, "DISEASE"]]}], ["The prediction of activity spectra for the substances (PASS) software, which predicted that more than 300 pharmacological effects, biological and biochemical mechanisms based on the structural formula of the substance was efficiently used in this study to reveal new multitalented actions for Vitex negundo (VN) constituents.", {"entities": []}], ["Experimental studies based on antioxidant and antiproliferative assays verified the predictions obtained by the PASS-predicted design strategy.", {"entities": []}], ["Antioxidant activity of VN extract was studied using 1,1-diphenyl-2-picrylhydrazyl (DPPH) and Ferric reducing or antioxidant power (FRAP) assays.", {"entities": []}], ["The antiproliferative activity of VN extract against WRL68 and HepG2 was investigated based on methylthiazol tetrazolium (MTT) spectrophotometric assay.", {"entities": []}], ["VN extract showed 79.43% inhibition of DPPH stable radical with IC 50 13.31\u2009\u00b1\u20090.18\u00a0\u03bcg/ml.", {"entities": []}], ["This inhibition was too closed to butylated hydroxyl toluene (BHT) 82.53% (IC 50 13.8\u2009\u00b1\u20090.14) and gallic acid 89.51% (IC 50 3.1\u2009\u00b1\u20090.08).", {"entities": []}], ["VN extract exhibited the strongest free radical scavenging power compared with two commercial antioxidants, BHT and ascorbic acid.", {"entities": []}], ["VN increased the activities of antioxidant enzymes in normal embryonic liver cells (WRL68) including, superoxide dismutase (SOD) and glutathione peroxidase (GPX) compared with to H 2 O 2 group.", {"entities": []}], ["The ethanolic extract of VN showed cytotoxicity to HepG2 cells in a dose and time-dependent manner with IC 50 66.46\u00a0\u03bcg/ml, 57.36\u00a0\u03bcg/ml and 65.12\u00a0\u03bcg/ml at 24, 48, and 72-hours incubation respectively, with no sensitivity in WRL68 cells.", {"entities": []}], ["This was associated with significant elevation in lactate dehydrogenase (LDH) release in HepG2 cells.", {"entities": []}], ["In addition, the activation of caspase-3 enzyme suggesting that the observed cytotoxicity was mediated via an intrinsic apoptosis pathway.", {"entities": []}], ["PASS-predicted plant activity could efficiently help in selecting a promising pharmaceutical leads with high accuracy and required antioxidant and antiproliferative properties.", {"entities": []}], ["This is the first report on PASS-predicted VN activity.", {"entities": []}], ["To describe the clinical characteristics, lung function, radiological findings, and the inflammatory cell profile in induced sputum in children and adolescents with severe therapy-resistant asthma (STRA) treated at a referral center in southern Brazil.", {"entities": [[190, 196, "DISEASE"]]}], ["We retrospectively analyzed children and adolescents (3-18 years of age) with uncontrolled STRA treated with high-dose inhaled corticosteroids and long-acting \u00df 2 agonists.", {"entities": []}], ["We prospectively collected data on disease control, lung function, skin test reactivity to allergens, the inflammatory cell profile in induced sputum, chest CT findings, and esophageal pH monitoring results.", {"entities": []}], ["We analyzed 21 patients (mean age, 9.2 \u00b1 2.98 years).", {"entities": []}], ["Of those, 18 (86%) were atopic.", {"entities": []}], ["Most had uncontrolled asthma and near-normal baseline lung function.", {"entities": [[22, 28, "DISEASE"]]}], ["In 4 and 7, induced sputum was found to be eosinophilic and neutrophilic, respectively; the inflammatory cell profile in induced sputum having changed in 67% of those in whom induced sputum analysis was repeated.", {"entities": []}], ["Of the 8 patients receiving treatment with omalizumab (an anti-IgE antibody), 7 (87.5%) showed significant improvement in quality of life, as well as significant reductions in the numbers of exacerbations and hospitalizations.", {"entities": []}], ["Children with STRA present with near-normal lung function and a variable airway inflammatory pattern during clinical follow-up, showing a significant clinical response to omalizumab.", {"entities": []}], ["In children, STRA differs from that seen in adults, further studies being required in order to gain a better understanding of the disease mechanisms.", {"entities": []}], ["Descrever as principais caracter\u00edsticas cl\u00ednicas, a fun\u00e7\u00e3o pulmonar, as caracter\u00edsticas radiol\u00f3gicas e o perfil inflamat\u00f3rio do escarro induzido de crian\u00e7as e adolescentes com asma grave resistente a terapia (AGRT) tratados em um centro de refer\u00eancia do sul do Brasil.", {"entities": []}], ["Foram analisadas retrospectivamente crian\u00e7as e adolescentes de 3-18 anos com diagn\u00f3stico de AGRT n\u00e3o controlada acompanhados durante pelo menos 6 meses e tratados com doses elevadas de corticoide inalat\u00f3rio associado a um \u00df 2 -agonista de longa dura\u00e7\u00e3o.", {"entities": [[133, 137, "GENE"]]}], ["Foram coletados prospectivamente dados relativos ao controle da doen\u00e7a, fun\u00e7\u00e3o pulmonar, teste cut\u00e2neo para al\u00e9rgenos, perfil inflamat\u00f3rio do escarro induzido, TC de t\u00f3rax e pHmetria esof\u00e1gica.", {"entities": []}], ["Foram analisados 21 pacientes (m\u00e9dia de idade: 9,2 2,98 anos).", {"entities": []}], ["Dos 21, 18 (86%) eram at\u00f3picos.", {"entities": []}], ["A maioria apresentava asma n\u00e3o controlada e fun\u00e7\u00e3o pulmonar basal pr\u00f3xima do normal.", {"entities": []}], ["Em 4 e 7 pacientes, o escarro induzido revelou-se eosinof\u00edlico e neutrof\u00edlico, respectivamente, e 67% dos pacientes que repetiram o exame apresentaram mudan\u00e7a no perfil inflamat\u00f3rio.", {"entities": []}], ["Dos 8 pacientes que receberam omalizumabe (um anticorpo anti-IgE), 7 (87,5%) apresentaram melhora importante da qualidade de vida, com redu\u00e7\u00e3o importante das exacerba\u00e7\u00f5es e hospitaliza\u00e7\u00f5es.", {"entities": []}], ["Crian\u00e7as com AGRT apresentam fun\u00e7\u00e3o pulmonar pr\u00f3xima do normal e padr\u00e3o inflamat\u00f3rio das vias a\u00e9reas vari\u00e1vel durante o seguimento cl\u00ednico, com importante resposta cl\u00ednica ao omalizumabe.", {"entities": []}], ["A AGRT em crian\u00e7as difere da AGRT em adultos, e s\u00e3o necess\u00e1rios mais estudos para esclarecer os mecanismos da doen\u00e7a.", {"entities": []}], ["We performed linkage and linkage disequilibrium (LD) mapping analyses to compare the power between microsatellite and single nucleotide polymorphism (SNP) markers.", {"entities": []}], ["Chromosome-wide analyses were performed for a quantitative electrophysiological phenotype, ttth1, on chromosome 7.", {"entities": []}], ["Multipoint analysis of microsatellite markers using the variance component (VC) method showed the highest LOD score of 4.20 at 162 cM, near D7S509 (163.7 cM).", {"entities": []}], ["Two-point analysis of SNPs using the VC method yielded the highest LOD score of 3.98 in the Illumina SNP data and 3.45 in the Affymetrix SNP data around 152\u2013153 cM.", {"entities": []}], ["In family-based single SNP and SNP haplotype LD analysis, we identified seven SNPs associated with ttth1.", {"entities": []}], ["We searched for any potential candidate genes in the location of the seven SNPs.", {"entities": []}], ["The SNPs rs1476640 and rs768055 are located in the FLJ40852 gene (a hypothetical protein), and SNP rs1859646 is located in the TAS2R5 gene (a taste receptor).", {"entities": []}], ["The other four SNPs are not located in any known or annotated genes.", {"entities": []}], ["We found the high density SNP scan to be superior to microsatellites because it is effective in downstream fine mapping due to a better defined linkage region.", {"entities": []}], ["Our study proves the utility of high density SNP in genome-wide mapping studies.", {"entities": []}], ["Adenosine A 2A receptors (A2ARs) are thought to interact negatively with the dopamine D 2 receptor (D2R), so selective A2AR antagonists have attracted attention as novel treatments for Parkinson's disease (PD).", {"entities": []}], ["However, no information about the receptor in living patients with PD is available.", {"entities": []}], ["The purpose of this study was to investigate the relationship between A2ARs and the dopaminergic system in the striata of drug-na\u00efve PD patients and PD patients with dyskinesia, and alteration of these receptors after antiparkinsonian therapy.", {"entities": []}], ["We measured binding ability of striatal A2ARs using positron emission tomography (PET) with [7-methyl- E )-8-(3,4,5-trimethoxystyryl)-1,3,7-trimethylxanthine ([ post hoc test).", {"entities": []}], ["In the drug-na\u00efve patients, the binding ability of the A2ARs in the putamen, but not in the head of caudate nucleus, was significantly lower on the more affected side than on the less affected side (p<0.05, paired t -test).", {"entities": []}], ["In addition, the A2ARs were significantly increased after antiparkinsonian therapy in the bilateral putamen of the drug-na\u00efve patients (p<0.05, paired t -test) but not in the bilateral head of caudate nucleus.", {"entities": []}], ["Our study demonstrated that the A2ARs in the putamen were increased in the PD patients with dyskinesia, and also suggest that the A2ARs in the putamen compensate for the asymmetrical decrease of dopamine in drug-na\u00efve PD patients and that antiparkinsonian therapy increases the A2ARs in the putamen.", {"entities": []}], ["The A2ARs may play an important role in regulation of parkinsonism in PD.", {"entities": []}], ["By November 2013, a total of 125 clinical practice guidelines (CPGs) have been developed in Korea.", {"entities": []}], ["However, despite the high burden of diseases and the clinical importance of CPGs, most chronic diseases do not have available CPGs.", {"entities": []}], ["Merely 83 CPGs are related to chronic diseases, and only 40 guidelines had been developed in the last 5 yr.", {"entities": []}], ["Considering the rate of the production of new evidence in medicine and the worsening burden from chronic diseases, the need for developing CPGs for more chronic diseases is becoming increasingly pressing.", {"entities": []}], ["Since 2011, the Korean Academy of Medical Sciences and the Korea Centers for Disease Control and Prevention have been jointly developing CPGs for chronic diseases.", {"entities": []}], ["However, priorities have to be set and resources need to be allocated within the constraint of a limited funding.", {"entities": []}], ["This study identifies the chronic diseases that should be prioritized for the development of CPGs in Korea.", {"entities": []}], ["Through an objective assessment by using the analytic hierarchy process and a subjective assessment with a survey of expert opinion, high priorities were placed on ischemic heart disease, cerebrovascular diseases, Alzheimer's disease and other dementias, osteoarthritis, neck pain, chronic kidney disease, and cirrhosis of the liver.", {"entities": [[164, 186, "DISEASE"], [290, 304, "DISEASE"], [173, 186, "DISEASE"], [255, 269, "DISEASE"]]}], ["Surfactant protein D (SP-D) can regulate both innate and adaptive immunity.", {"entities": []}], ["Recently, SP-D has been shown to contribute to the pathogenesis of airway allergic inflammation and bleomycin-induced pulmonary fibrosis.", {"entities": [[118, 136, "DISEASE"]]}], ["However, in allergic airways disease, the role of SP-D in airway remodeling remains unknown.", {"entities": []}], ["The objective of this study was to determine the contribution of functional SP-D in regulating sub-epithelial fibrosis in a mouse chronic house dust mite model of allergic airways disease.", {"entities": []}], ["C57BL/6 wild-type (WT) and SP-D\u2212/\u2212 mice (C57BL/6 background) were chronically challenged with house dust mite antigen (Dermatophagoides pteronyssinus, Dp).", {"entities": []}], ["Studies with SP-D rescue and neutralization of TGF-\u03b2 were conducted.", {"entities": []}], ["Lung histopathology and the concentrations of collagen, growth factors, and cytokines present in the airspace and lung tissue were determined.", {"entities": []}], ["Cultured eosinophils were stimulated by Dp in presence or absence of SP-D. Dp-challenged SP-D\u2212/\u2212 mice demonstrate increased sub-epithelial fibrosis, collagen production, eosinophil infiltration, TGF-\u03b21, and IL-13 production, when compared to Dp-challenged WT mice.", {"entities": []}], ["By immunohistology, we detected an increase in TGF-\u03b21 and IL-13 positive eosinophils in SP-D\u2212/\u2212 mice.", {"entities": []}], ["Purified eosinophils stimulated with Dp produced TGF-\u03b21 and IL-13, which was prevented by co-incubation with SP-D. Additionally, treatment of Dp challenged SP-D\u2212/\u2212 mice with exogenous SP-D was able to rescue the phenotypes observed in SP-D\u2212/\u2212 mice and neutralization of TGF-\u03b21 reduced sub-epithelial fibrosis in Dp-challenged SP-D\u2212/\u2212 mice.", {"entities": []}], ["These data support a protective role for SP-D in the pathogenesis of sub-epithelial fibrosis in a mouse model of allergic inflammation through regulation of eosinophil-derived TGF-\u03b2.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-014-0143-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Respiratory tract infections are a major cause of outpatient visits, yet only a portion is tested to determine the etiologic organism.", {"entities": []}], ["Multiplex reverse transcriptase polymerase chain reaction (MRT-PCR) assays for detection of multiple viruses are being used increasingly in clinical settings.", {"entities": []}], ["During January\u2013April 2012, outpatients with acute respiratory illness (\u22647 days) were tested for influenza using singleplex RT-PCR (SRT-PCR).", {"entities": [[96, 105, "DISEASE"]]}], ["A subset was assayed for 18 viruses using MRT-PCR to compare detection of influenza and examine the distribution of viruses and characteristics of patients using multinomial logistic regression.", {"entities": [[74, 83, "DISEASE"]]}], ["Among 662 participants (6 months\u201382 years), detection of influenza was similar between the MRT-PCR and SRT-PCR (\u03ba = 0\u00b783).", {"entities": [[57, 66, "DISEASE"]]}], ["No virus was identified in 267 (40.3%) samples.", {"entities": []}], ["Commonly detected viruses were human rhinovirus (HRV, 15\u00b74%), coronavirus (CoV, 10\u00b74%), respiratory syncytial virus (RSV, 8\u00b74%), human metapneumovirus (hMPV, 8\u00b73%), and influenza (6%).", {"entities": [[169, 178, "DISEASE"]]}], ["Co-detections were infrequent (6\u00b79%) and most commonly occurred among those <18 years old.", {"entities": []}], ["In regression analyses, compared with non-viral illnesses, RSV and hMPV were significantly more frequent in children and less frequent in 18- to 49-year-olds than in those \u226550 years ( P = 0\u00b701), fever was more common in hMPV and influenza infections ( P = 0\u00b7008), nasal congestion was more frequent in CoV, HRV, hMPV, influenza and RSV infections ( P = 0\u00b7001), and body mass index was higher among those with influenza ( P = 0\u00b7036).", {"entities": [[229, 238, "DISEASE"], [318, 327, "DISEASE"], [409, 418, "DISEASE"]]}], ["Using MRT-PCR, a viral etiology was found in three-fifths of patients with medically attended outpatient visits for acute respiratory illness during the influenza season; co-detected viruses were infrequent.", {"entities": [[153, 162, "DISEASE"]]}], ["Symptoms varied by viral etiology.", {"entities": []}], ["The impressive correlation between cardiovascular disease and glucose metabolism alterations has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents.", {"entities": [[124, 139, "DISEASE"]]}], ["Inflammation is emerging as a conceivable etiologic mechanism for both.", {"entities": []}], ["Interleukins are regulatory proteins with ability to accelerate or inhibit inflammatory processes.", {"entities": []}], ["A novel interleukins classification is described, based on their role in diabetes and atherosclerosis, hypothesizing that each interleukin (IL) acts on both diseases in the same direction \u2013 regardless if harmful, favorable or neutral.", {"entities": [[86, 101, "DISEASE"]]}], ["The 29 known interleukins were clustered into three groups: noxious (the \"bad\" , 8 members), comprising IL-1, IL-2, IL-6, IL-7, IL-8, IL-15, IL-17 and IL-18; protective (the \"good\" , 5 members), comprising IL-4, IL-10, IL-11, IL-12 and IL-13; and \"aloof\" , comprising IL-5, IL-9, IL-14, IL-16 and IL-19 through IL-29 (15 members).", {"entities": []}], ["Each group presented converging effects on both diseases.", {"entities": []}], ["IL-3 was reluctant to clustering.", {"entities": []}], ["These observations imply that 1) favorable effects of a given IL on either diabetes or atherosclerosis predicts similar effects on the other; 2) equally, harmful IL effects on one disease can be extrapolated to the other; and 3) absence of influence of a given IL on one of these diseases forecasts lack of effects on the other.", {"entities": [[87, 102, "DISEASE"]]}], ["These facts further support the unifying etiologic theory of both ailments, emphasizing the importance of a cardiovascular diabetologic approach to interleukins for future research.", {"entities": []}], ["Pharmacologic targeting of these cytokines might provide an effective means to simultaneously control both atherosclerosis and diabetes.", {"entities": [[107, 122, "DISEASE"]]}], ["Lung cancer is one of the leading cancer malignancies with a five-year survival rate of only ~15%.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [34, 40, "DISEASE"]]}], ["We have developed a lentiviral vector mediated mouse model which allows generation of non-small cell lung cancer from less than one hundred alveolar epithelial cells, and investigated the role of IKK2 and NF-\u03baB in lung cancer development.", {"entities": [[101, 112, "DISEASE"], [214, 225, "DISEASE"], [106, 112, "DISEASE"], [219, 225, "DISEASE"]]}], ["IKK2 depletion in tumour cells significantly attenuated tumour proliferation and significantly prolonged mouse survival.", {"entities": []}], ["We identified Timp-1, one of the NF-\u03baB target genes, as a key mediator for tumour growth.", {"entities": []}], ["Activation of Erk signalling pathway and cell proliferation requires Timp-1 and its receptor CD63.", {"entities": [[93, 97, "GENE"]]}], ["Knockdown of either IKK2 or Timp-1 by shRNAs reduced tumour growth in both xenograft and lentiviral models.", {"entities": []}], ["Our results, thus suggest the possible application of IKK2 and Timp-1 inhibitors in treating lung cancer.", {"entities": [[93, 104, "DISEASE"], [98, 104, "DISEASE"]]}], ["A comfortable postoperative return to daily activities has increased the need to control inflammation after third molar surgery.", {"entities": []}], ["Anti-inflammatory drugs and analgesics are not exempt from adverse effects such as allergies and chronic gastritis, and they are not without cost.", {"entities": [[105, 114, "DISEASE"]]}], ["The association between low-level laser and auricular acupuncture can be an alternative when conventional drugs are contraindicated.", {"entities": []}], ["Among its advantages, we can mention the low risk of side effects, low cost and simplicity of application.", {"entities": []}], ["The objective of this study is to evaluate the efficiency of low-level laser at auriculotherapy points in reducing postoperative pain in lower third molar surgery.", {"entities": []}], ["Ninety bilateral, symmetrical lower third molar surgeries will be performed in 45 healthy patients.", {"entities": []}], ["Each patient will be their own control, through a split-mouth crossover study.", {"entities": []}], ["One side of the mouth will be randomly chosen and, immediately after surgery, will be treated with low-level laser.", {"entities": []}], ["After 21 days, the contralateral side will be operated on with low-level laser simulation used postoperatively.", {"entities": []}], ["This regimen (laser application or not) will be repeated at 24 and 48 h after surgery.", {"entities": []}], ["All patients will be requested to take analgesics (acetaminophen) if they have pain, i.e.", {"entities": []}], ["in case of pain.", {"entities": []}], ["Neither the surgeon nor the patients will know the assigned treatment.", {"entities": []}], ["The primary variable will be postoperative pain assessed using a Visual Analog Scale, and the secondary variables will be trismus, edema, local temperature, dysphagia, presence of infection and painkiller ingestion.", {"entities": []}], ["These variables will be assessed at baseline, 24 h, 48 h and 7 days after surgery.", {"entities": []}], ["Blood samples for systemic inflammatory cytokine (TNF-\u03b1, IL-1, IL-6 and IL-8) analysis will be assessed at baseline and 24 h after surgery.", {"entities": []}], ["Some authors believe that using a wavelength of 633 to 670 nm is a good option for laser therapy in the field of acupuncture.", {"entities": []}], ["This wavelength can penetrate biological tissue to a depth of about 3 mm.", {"entities": []}], ["However, for auriculotherapy points, the stimulus (mustard seeds, needles 1 to 2.5 mm) does not penetrate so deeply.", {"entities": []}], ["For this reason, we chose a laser wavelength of 660 nm (red wavelength).", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT02657174 , registered on 11 January 2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-016-1540-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Infancy and childhood are characterized by rapid growth and development, which largely determine health status and well-being across the lifespan.", {"entities": []}], ["Identification of modifiable risk factors and prognostic factors in critical periods of life will contribute to the development of effective prevention and intervention strategies.", {"entities": []}], ["The LucKi Birth Cohort Study was designed and started in 2006 to follow children from birth into adulthood on a wide range of determinants, disorders, and diseases.", {"entities": []}], ["During preschool and school years, the primary focus is on the etiology and prognosis of atopic diseases (eczema, asthma, and hay fever) and overweight/obesity.", {"entities": [[152, 159, "DISEASE"], [114, 120, "DISEASE"]]}], ["LucKi is an ongoing, dynamic, prospective birth cohort study, embedded in the Child and Youth Health Care (CYHC) practice of the \u2018Westelijke Mijnstreek\u2019 (a region in the southeast of the Netherlands).", {"entities": []}], ["Recruitment (1\u20132 weeks after birth) and follow-up (until 19\u00a0years) coincide with routine CYHC contact moments, during which the child\u2019s physical and psychosocial development is closely monitored, and anthropometrics are measured repeatedly in a standardised way.", {"entities": []}], ["Information gathered through CYHC is complemented with repeated parental questionnaires, and information from existing registries of pharmacy, hospital and/or general practice.", {"entities": []}], ["Since the start already more than 5,000 children were included in LucKi shortly after birth, reaching an average participation rate of ~65 %.", {"entities": []}], ["The LucKi Birth Cohort Study provides a framework in which children are followed from birth into adulthood.", {"entities": []}], ["Embedding LucKi in CYHC simplifies implementation, leads to low maintenance costs and high participation rates, and facilitates direct implementation of study results into CYHC practice.", {"entities": []}], ["Furthermore, LucKi provides opportunities to initiate new (experimental) studies and/or to establish biobanking in (part of) the cohort, and contributes relevant information on determinants and health outcomes to policy and decision makers.", {"entities": []}], ["Cohort details can be found on www.birthcohorts.net .", {"entities": []}], ["Background.", {"entities": []}], ["Monitoring changes in obesity prevalence by risk factors is relevant to public health programs that focus on reducing or preventing obesity.", {"entities": [[22, 29, "DISEASE"], [132, 139, "DISEASE"]]}], ["The purpose of this paper was to study trends in obesity odds ratios (ORs) for individuals aged 20 years and older in Iran by using a new statistical methodology.", {"entities": [[49, 56, "DISEASE"]]}], ["Data collected by the National Surveys in Iran, from 2000 through 2011.", {"entities": []}], ["Since responses of the member of each cluster are correlated, the quadratic inference functions (QIF) method was used to model the relationship between the odds of obesity and risk factors.", {"entities": [[164, 171, "DISEASE"]]}], ["During the study period, the prevalence rate of obesity increased from 12% to 22%.", {"entities": [[48, 55, "DISEASE"]]}], ["By using QIF method and a model selection criterion for performing stepwise regression analysis, we found that while obesity prevalence generally increased in both sexes, all ages, all employment, residence, and smoking levels, it seems to have changes in obesity ORs since 2000.", {"entities": [[117, 124, "DISEASE"], [256, 263, "DISEASE"]]}], ["Conclusions.", {"entities": []}], ["Because obesity is one of the main risk factors for many diseases, awareness of the differences by factors allows development of targets for prevention and early intervention.", {"entities": [[8, 15, "DISEASE"]]}], ["Analysis of virological and clinical outcomes from a randomized trial that was terminated early suggest that combined treatment of seasonal influenza in adult outpatients with oseltamivir plus zanamivir is no more effective than either oseltamivir or zanamivir monotherapy.", {"entities": [[140, 149, "DISEASE"]]}], ["Neuraminidase inhibitors are thought to be efficacious in reducing the time to alleviation of symptoms in outpatients with seasonal influenza.", {"entities": [[132, 141, "DISEASE"]]}], ["The objective of this study was to compare the short-term virological efficacy of oseltamivir-zanamivir combination versus each monotherapy plus placebo.", {"entities": []}], ["We conducted a randomized placebo-controlled trial with 145 general practitioners throughout France during the 2008\u20132009 seasonal influenza epidemic.", {"entities": [[130, 139, "DISEASE"]]}], ["Patients, general practitioners, and outcome assessors were all blinded to treatment assignment.", {"entities": []}], ["Adult outpatients presenting influenza-like illness for less than 36 hours and a positive influenza A rapid test diagnosis were randomized to oseltamivir 75 mg orally twice daily plus zanamivir 10 mg by inhalation twice daily (OZ), oseltamivir plus inhaled placebo (O), or zanamivir plus oral placebo (Z).", {"entities": [[29, 38, "DISEASE"], [90, 99, "DISEASE"]]}], ["Treatment efficacy was assessed virologically according to the proportion of patients with nasal influenza reverse transcription (RT)-PCR below 200 copies genome equivalent (cgeq)/\u00b5l at day 2 (primary outcome), and clinically to the time to alleviation of symptoms until day 14.", {"entities": [[97, 106, "DISEASE"]]}], ["Overall 541 patients (of the 900 planned) were included (OZ, n \u200a=\u200a192; O, n \u200a=\u200a176; Z, n \u200a=\u200a173), 49% male, mean age 39 years.", {"entities": []}], ["In the intention-to-treat analysis conducted in the 447 patients with RT-PCR-confirmed influenza A, 46%, 59%, and 34% in OZ ( n \u200a=\u200a157), O ( n \u200a=\u200a141), and Z ( n \u200a=\u200a149) arms had RT-PCR<200 cgeq/\u00b5l (\u221213.0%, 95% confidence interval [CI] \u221223.1 to \u22122.9, p \u200a=\u200a0.025; +12.3%, 95% CI 2.39\u201322.2, p \u200a=\u200a0.028 for OZ/O and OZ/Z comparisons).", {"entities": [[87, 96, "DISEASE"]]}], ["Mean day 0 to day 2 viral load decrease was 2.14, 2.49, and 1.68 log 10 cgeq/\u00b5l ( p \u200a=\u200a0.060, p \u200a=\u200a0.016 for OZ/O and OZ/Z).", {"entities": []}], ["Median time to alleviation of symptoms was 4.0, 3.0, and 4.0 days (+1.0, 95% CI 0.0\u20134.0, p \u200a=\u200a0.018; +0.0, 95% CI \u22123.0 to 3.0, p \u200a=\u200a0.960 for OZ/O and OZ/Z).", {"entities": []}], ["Four severe adverse events were observed.", {"entities": []}], ["Nausea and/or vomiting tended to be more frequent in the combination arm (OZ, n \u200a=\u200a13; O, n \u200a=\u200a4; and Z, n \u200a=\u200a5 patients, respectively).", {"entities": []}], ["In adults with seasonal influenza A mainly H3N2 virus infection, the oseltamivir-zanamivir combination appeared less effective than oseltamivir monotherapy, and not significantly more effective than zanamivir monotherapy.", {"entities": [[24, 33, "DISEASE"]]}], ["Despite the theoretical potential for the reduction of the emergence of antiviral resistance, the lower effectiveness of this combination calls for caution in its use in clinical practice.", {"entities": []}], ["www.ClinicalTrials.gov NCT00799760 Please see later in the article for the Editors' Summary In the last few years, use of the neuraminidase inhibitors, oseltamivir and zanamivir, has been considered a key strategy for limiting the impact of influenza both in individuals (by reducing morbidity and mortality) and collectively (by slowing the virus' spread to buy time for vaccine production, the cornerstone of influenza control).", {"entities": [[241, 250, "DISEASE"], [411, 420, "DISEASE"]]}], ["However, there are concerns that widespread use of a single antiviral drug may lead to resistant strains, which could dramatically reduce its effectiveness in future.", {"entities": []}], ["Theoretically, if well tolerated, and if producing at least additive antiviral activity, the combination of two antiviral agents could offer several advantages such as reducing disease severity and reducing the viral shedding period, which in turn could lead to lower infection rates and reduced resistance especially in immunocompromised patients.", {"entities": []}], ["Importantly, combining two drugs could ensure optimal treatment of all types of circulating influenza virus and subtypes or variants.", {"entities": [[92, 101, "DISEASE"]]}], ["The combination of two neuraminidase inhibitors is feasible as both oseltamivir and zanamivir are licensed for seasonal influenza and have different key mutations associated with resistance to each drug.", {"entities": [[120, 129, "DISEASE"]]}], ["As yet, there have been no robust randomized controlled trials that compare the effectiveness of monotherapy with either oseltamivir or zanamivir with the effectiveness of a oseltamivir-zanamivir combination.", {"entities": []}], ["Such a study would be important for influenza pandemic planning.", {"entities": [[36, 45, "DISEASE"]]}], ["The researchers conducted a randomized, placebo-controlled trial within 145 general practitioners throughout France during the seasonal influenza epidemic in 2008\u20132009.", {"entities": [[136, 145, "DISEASE"]]}], ["Adults who visited their general practitioner with symptoms of an influenza-like illness for less than 36 hours and who had a positive influenza A rapid test were randomized to one of three arms: (1) oral oseltamivir 75 mg twice daily plus zanamivir 10 mg by inhalation twice daily, (2) oral oseltamivir 75 mg twice daily plus inhaled placebo, or (3) zanamivir 10 mg by inhalation twice daily plus oral placebo.", {"entities": [[66, 75, "DISEASE"], [135, 144, "DISEASE"]]}], ["The effects of the drugs or combination of drugs was assessed virologically, by looking at the proportion of patients with nasal influenza reverse transcription (RT)-PCR below a particular level on day 2 of treatment.", {"entities": [[129, 138, "DISEASE"]]}], ["Clinical measures of effectiveness included the time to resolution of illness, the number of patients with alleviation of symptoms at the end of treatment, and the incidence of secondary complications of influenza such as otitis, bronchitis, sinusitis, and pneumonia.", {"entities": [[204, 213, "DISEASE"], [257, 266, "DISEASE"], [242, 251, "DISEASE"], [230, 240, "DISEASE"]]}], ["In the study, patients, general practitioners, and outcome assessors were all blinded to treatment assignments.", {"entities": []}], ["Due to the emergence of the H1N1 pandemic in 2009, the study's independent data-monitoring committee requested that the researchers terminate the trial early and analyze the results earlier than planned.", {"entities": []}], ["541 patients (of the 900 planned) were enrolled in the study (192 in group 1; 176 in group 2; and 173 in group 3) of whom 447 were infected with influenza A.", {"entities": [[145, 154, "DISEASE"]]}], ["Overall the oseltamivir-zanamivir combination was both virologically and clinically significantly less effective than the oseltamivir monotherapy.", {"entities": []}], ["In addition, the clinical effects of the oseltamivir-zanamivir combination on time to resolution of symptoms were not significantly different from that of zanamivir monotherapy, suggesting that oseltamivir does not add clinical benefit to zanamivir monotherapy.", {"entities": []}], ["The results of this study essentially show that in France during the Winter of 2009 prepandemic (of which 85% was due to of H3N2 virus), in adults with seasonal influenza A virus infection, the combination of oseltamivir and zanamivir was less effective than oseltamivir monotherapy and not significantly more effective than zanamivir monotherapy.", {"entities": [[161, 170, "DISEASE"]]}], ["These results call for caution in the use of the oseltamivir-zanamivir combination in treatment of adult outpatients.", {"entities": []}], ["In addition, as the clinical and virological effects of oseltamivir monotherapy over zanamivir monotherapy were superior in this trial, oseltamivir should be the recommended treatment during influenza seasons with predominant H3N2 viruses.", {"entities": [[191, 200, "DISEASE"]]}], ["However, the results of this study should be confirmed in the coming years on future circulating influenza viruses.", {"entities": [[97, 106, "DISEASE"]]}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1000362 .", {"entities": []}], ["Wikipedia has information on H3N3 influenza A virus (note that Wikipedia is a free online encyclopedia that anyone can edit; available in several languages) The World Health Organization has a global alert and response site on seasonal influenza Patient UK provides information about antivirals for influenza Answers.com has information about oseltamivir and about zanamivir", {"entities": [[34, 43, "DISEASE"], [236, 245, "DISEASE"], [299, 308, "DISEASE"]]}], ["To examine the trajectories of physical activity from preretirement to postretirement and to further clarify whether the changes in physical activity are associated with changes in body weight.", {"entities": []}], ["Prospective.", {"entities": []}], ["French national gas and electricity company (GAZEL cohort).", {"entities": []}], ["From the original sample of 20\u2008625 employees, only those retiring between 2001 and 2008 on a statutory basis were selected for the analyses (analysis 1: n=2711, 63% men; analysis 2: n=3812, 75% men).", {"entities": []}], ["Persons with data on at least one preretirement and postretirement measurement of the outcome were selected.", {"entities": []}], ["All outcome data were gathered by questionnaires.", {"entities": []}], ["In analysis 1, the annual prevalence of higher physical activity (walking \u22655\u2005km/week) 4\u2005years before and after retirement was analysed.", {"entities": []}], ["In analysis 2, changes in leisure-time sport activities (engagement, frequency and manner) from preretirement to postretirement were analysed with simultaneous changes in body weight (kilogram).", {"entities": []}], ["In analysis 1 (n=2711), prevalence estimates for 4\u2005years before and 4\u2005years after retirement showed that higher leisure-time physical activity (walking at least 5\u2005km/week) increased by 36% in men and 61% in women during the transition to retirement.", {"entities": []}], ["This increase was also observed among people at a higher risk of physical inactivity, such as smokers and those with elevated depressive symptoms.", {"entities": []}], ["In a separate sample (analysis 2, n=3812), change in weight as a function of preretirement and postretirement physical activity was analysed.", {"entities": []}], ["Weight gain preretirement to postretirement was 0.85 (95% CI 0.48 to 1.21) to 1.35 (0.79 to 1.90) kg greater among physically inactive persons (decrease in activity or inactive) compared with those physically active (p<0.001).", {"entities": []}], ["Retirement transition may be associated with beneficial changes in lifestyle and may thus be a good starting point to preventive interventions in various groups of individuals in order to maintain long-term changes.", {"entities": []}], ["The main focus of this article was to examine whether statutory retirement is associated with changes in physical activity.", {"entities": []}], ["Especially, we wanted to clarify what happens during the actual retirement transition (ie, the year of retirement \u00b11\u2005year).", {"entities": []}], ["Furthermore, we examined whether there were changes in body weight as a function of preretirement and postretirement physical activity level.", {"entities": []}], ["We were able to show that during a 9-year follow-up physical activity increased most during the retirement transition, both in men and women.", {"entities": []}], ["Beneficial changes were noticed also among those usually considered as low physical activity groups, such as smokers.", {"entities": []}], ["Physically inactive persons were most prone to gain weight during the follow-up.", {"entities": []}], ["The main strength of this study was yearly measurements of the outcome, which enabled us to get accurate estimates of physical activity during the actual retirement transition.", {"entities": []}], ["Large and stable occupational cohort, prospective study design, accurate register-based data on retirement and long follow-up both preretirement and postretirement were other strengths of this study.", {"entities": []}], ["The main limitation was the use of self-report data of the outcome.", {"entities": []}], ["In Tunisia, there is a paucity of population-based data on Chronic Obstructive Pulmonary Disease (COPD) prevalence.", {"entities": []}], ["To address this problem, we estimated the prevalence of COPD following the Burden of Lung Disease Initiative.", {"entities": []}], ["We surveyed 807 adults aged 40+ years and have collected information on respiratory history and symptoms, risk factors for COPD and quality of life.", {"entities": []}], ["Post-bronchodilator spirometry was performed and COPD and its stages were defined according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.", {"entities": []}], ["Six hundred and sixty one (661) subjects were included in the final analysis.", {"entities": []}], ["The prevalence of GOLD Stage I and II or higher COPD were 7.8% and 4.2%, respectively (Lower Limit of Normal modified stage I and II or higher COPD prevalence were 5.3% and 3.8%, respectively).", {"entities": []}], ["COPD was more common in subjects aged 70+ years and in those with a BMI < 20 kg/m", {"entities": []}], ["In idiopathic pulmonary fibrosis, the interaction of CXCL12 and CXC receptor 4 (CXCR4) plays a critical role in lung fibrosis.", {"entities": [[14, 32, "DISEASE"], [3, 32, "DISEASE"], [53, 59, "GENE"], [80, 85, "GENE"]]}], ["Connective tissue growth factor (CTGF) overexpression underlies the development of pulmonary fibrosis.", {"entities": [[83, 101, "DISEASE"], [33, 37, "GENE"]]}], ["Our previous report showed that the Rac1-dependent extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and activator protein (AP)-1 pathways are involved in CXCL12-generated CTGF expression in human lung fibroblasts (WI-38).", {"entities": [[198, 202, "GENE"]]}], ["In present study, we additionally inspected the involvement of mitogen-activated protein kinase kinase kinase 1 (MEKK1)/JNK-dependent SMAD3 in CXCL12-triggered CTGF expression in WI-38 cells.", {"entities": [[134, 139, "GENE"], [160, 164, "GENE"]]}], ["WI-38 cells were stimulated with CXCL12 in the absence or presence of specific inhibitors or small interfering RNAs (siRNAs).", {"entities": [[33, 39, "GENE"]]}], ["CTGF expression and signaling transduction molecules were assessed by Western blot, luciferase activity assay, or ChIP assay.", {"entities": [[0, 4, "GENE"]]}], ["CXCL-12-induced CTGF expression was attenuated by SIS3 (a SMAD3 inhibitor) and SMAD3 siRNA, but not by SB431542 (an activin receptor-like kinase 5, ALK5, inhibitor).", {"entities": [[16, 20, "GENE"], [58, 63, "GENE"], [79, 84, "GENE"], [58, 63, "GENE"], [79, 84, "GENE"]]}], ["CXCL12-stimulated CTGF expression was also attenuated by MEKK1 siRNA.", {"entities": [[18, 22, "GENE"]]}], ["Treatment of cells with CXCL12 caused an increase in SMAD3 phosphorylation at Ser208, translocation to nuclei, SMAD3-luciferase activity, and recruitment of SMAD3 to the CTGF promoter.", {"entities": [[24, 30, "GENE"], [53, 58, "GENE"], [111, 116, "GENE"], [157, 162, "GENE"], [53, 58, "GENE"], [111, 116, "GENE"], [157, 162, "GENE"], [170, 174, "GENE"]]}], ["Stimulation of cells with CXCL12 resulted in increase in JNK phosphorylation at Thr183/Tyr185 and MEKK1 phosphorylation at Thr261.", {"entities": [[26, 32, "GENE"]]}], ["Moreover, CXCL12-mediated SMAD3 phosphorylation or SMAD3-luciferase activity was inhibited by MEKK1 siRNA or SP600125.", {"entities": [[26, 31, "GENE"], [51, 56, "GENE"]]}], ["Finally, CXCL12-mediated JNK phosphorylation was attenuated by MEKK1 siRNA.", {"entities": []}], ["In conclusion, results of this study suggest that CXCL12 activates the MEKK1/JNK signaling pathway, which in turn initiates SMAD3 phosphorylation, its translocation to nuclei, and recruitment of SMAD3 to the CTGF promoter, which ultimately induces CTGF expression in human lung fibroblasts.", {"entities": [[50, 56, "GENE"], [124, 129, "GENE"], [195, 200, "GENE"], [124, 129, "GENE"], [195, 200, "GENE"], [208, 212, "GENE"], [248, 252, "GENE"], [208, 212, "GENE"], [248, 252, "GENE"]]}], ["Chronic airway diseases, like asthma or COPD, are characterized by excessive acetylcholine release and airway remodeling.", {"entities": [[30, 36, "DISEASE"]]}], ["The aim of this study was to investigate the long-term effect of muscarinic agonists on the phenotype and proliferation of rabbit tracheal airway smooth muscle cells (ASMCs).", {"entities": []}], ["ASMCs were serum starved before treatment with muscarinic agonists.", {"entities": []}], ["Cell phenotype was studied by optical microscopy and indirect immunofluorescence, using smooth muscle \u03b1-actin, desmin and SM-Myosin Heavy Chain (SM-MHC) antibodies.", {"entities": []}], ["[ N -methyl- 3 muscarinic receptor expression on isolated cell membranes.", {"entities": []}], ["Contractility studies were performed on isolated ASMCs treated with muscarinic agonists.", {"entities": []}], ["Proliferation was estimated using methyl-[ Prolonged culture of ASMCs with acetylcholine, carbachol or FBS, reduced the expression of \u03b1-actin, desmin and SM-MHC compared to cells cultured in serum free medium.", {"entities": []}], ["Treatment of ASMCs with muscarinic agonists for 3-15\u00a0days decreased muscarinic receptor expression and their responsiveness to muscarinic stimulation.", {"entities": []}], ["Acetylcholine and carbachol induced DNA synthesis and increased cell number, of ASMCs that had acquired a contractile phenotype by 7\u00a0day serum starvation.", {"entities": []}], ["This effect was mediated via a PI3K and MAPK dependent mechanism.", {"entities": []}], ["Prolonged exposure of rabbit ASMCs to muscarinic agonists decreases the expression of smooth muscle specific marker proteins, down-regulates muscarinic receptors and decreases ASMC contractile responsiveness.", {"entities": []}], ["Muscarinic agonists are mitogenic, via the PI3K and MAPK signalling pathways.", {"entities": []}], ["The African, Caribbean and Black communities have been found to be reluctant to participate in health research in North America.", {"entities": []}], ["This is partly attributed to historical experiences as well as their cultural beliefs.", {"entities": []}], ["Cultural beliefs about the uses of breast milk/fluids could further hinder the participation of African, Caribbean, and Black communities in research involving the collection of breast milk/fluids samples.", {"entities": []}], ["We conducted 17 in-depth interviews and three group interviews (n\u00a0=\u00a010) with HIV+ African, Caribbean and Black women living in Ontario, Canada to explore their cultural beliefs about breast milk/fluids and their acceptance of participating in research that involves the provision of breast fluid samples.", {"entities": []}], ["Qualitative study involving in-depth interviews.", {"entities": []}], ["Our respondents believed that breast milk/fluids should be used for infant feeding and for curative purposes for a variety of children\u2019s health ailments as well as ailments experienced by other family members.", {"entities": []}], ["The cultural belief that breast milk/fluids could be used to bewitch the baby and mother and the perception that it is intrusive (equating breast milk/fluids research to DNA testing), could prevent African, Caribbean and Black women from participating in research involving the collection of breast milk/fluids.", {"entities": []}], ["Despite these fears, some respondents expressed that they would participate if the research results would benefit them directly, for example, by finding a cure for HIV, enabling HIV+ mothers to breastfeed, or contributing to developing new drugs or vaccines for HIV.", {"entities": []}], ["Women\u2019s recommendations to facilitate successful recruitment included giving incentives to participants, and employing a recruiter who was trustworthy, informed, and culturally sensitive.", {"entities": []}], ["Cultural beliefs could present barriers to recruitment and participation of Africa, Caribbean and Black communities in health research involving breast milk/fluid samples.", {"entities": []}], ["Successful recruitment for future studies would necessitate researchers to be culturally aware of the beliefs held by African, Caribbean and Black women, to build trust, and use an appropriate recruiter.", {"entities": []}], ["While the findings relate to breast milk/fluids, the suggested recommendations for facilitating recruitment of research participants from these communities may be useful to consider when recruiting ethnically and culturally similar participants for research involving biological samples.", {"entities": []}], ["The online version of this article (doi:10.1186/s13104-016-2326-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A new study reveals distinctive metabolic changes that precede the development of type 1 diabetes (T1D), tossing a stone into the quiet waters of T1D immunology and genetics.", {"entities": []}], ["The causes of these metabolic changes and their relationship to autoimmunity and \u03b2 cell destruction are not yet known, but the identification of a metabolic phenotype linked to susceptibility to type I diabetes may help pave the way to a new era of investigation of T1D causality.", {"entities": []}], ["Young children are at increased risk of severe influenza disease and, thus, are good candidates for receiving annual vaccination.", {"entities": [[47, 56, "DISEASE"]]}], ["Nevertheless, the influenza vaccine is infrequently given to children in our region.", {"entities": [[18, 27, "DISEASE"]]}], ["The primary objectives of this study are to monitor the serologic immunities against influenza A and B viruses, and provide pediatric data that support the need for influenza vaccination in the community.", {"entities": [[85, 94, "DISEASE"], [165, 174, "DISEASE"]]}], ["Influenza A and B virus-specific IgG antibodies were measured in 294 children (median age 4.1\u00a0years; range 1.9\u201312.5\u00a0years) between July 2014 and September 2015.", {"entities": [[0, 9, "DISEASE"]]}], ["The percentage of children who were seropositive for influenza A IgG was 15.8%, equivocal 7.4%, and negative 76.8%.", {"entities": [[53, 62, "DISEASE"]]}], ["The corresponding values for influenza B IgG were 31.3, 9.6, and 59.1%, respectively.", {"entities": [[29, 38, "DISEASE"]]}], ["There was a higher seropositivity rate for influenza B than for influenza A in all age groups.", {"entities": [[43, 52, "DISEASE"], [64, 73, "DISEASE"]]}], ["The percentage of children who were seropositive for either influenza A or B IgG was 27.9% and for both was only 2.7%.", {"entities": [[60, 69, "DISEASE"]]}], ["Most of the studied children are serologically na\u00efve and, thus, are likely to acquire primary influenza disease.", {"entities": [[94, 103, "DISEASE"]]}], ["A national policy that endorses childhood influenza vaccination is highly advisable.", {"entities": [[42, 51, "DISEASE"]]}], ["Recommendations for secondary hyperparathyroidism (SHPT) consider that a \u201cone-size-fits-all\u201d target enables efficacy of care.", {"entities": [[20, 49, "DISEASE"], [30, 49, "DISEASE"]]}], ["In routine clinical practice, SHPT continues to pose diagnosis and treatment challenges.", {"entities": []}], ["One hypothesis that could explain these difficulties is that dialysis population with SHPT is not homogeneous.", {"entities": []}], ["EPHEYL is a prospective, multicenter, pharmacoepidemiological study including chronic dialysis patients (\u22653 months) with newly SHPT diagnosis, i.e.", {"entities": []}], ["parathyroid hormone (PTH) \u2265500 ng/L for the first time, or initiation of cinacalcet, or parathyroidectomy.", {"entities": [[21, 24, "GENE"]]}], ["Multiple correspondence analysis and ascendant hierarchical clustering on clinico-biological (symptoms, PTH, plasma phosphorus and alkaline phosphatase) and treatment of SHPT (cinacalcet, vitamin D, calcium, or calcium-free calcic phosphate binder) were performed to identify distinct phenotypes.", {"entities": [[104, 107, "GENE"]]}], ["305 patients (261 with incident PTH\u2009\u2265\u2009500 ng/L; 44 with cinacalcet initiation) were included.", {"entities": [[32, 35, "GENE"]]}], ["Their mean age was 67\u2009\u00b1\u200915 years, and 60% were men, 92% on hemodialysis and 8% on peritoneal dialysis.", {"entities": []}], ["Four subgroups of SHPT patients were identified: 1/ \u201cintermediate\u201d phenotype with hyperphosphatemia without hypocalcemia (n\u2009=\u2009113); 2/ younger patients with severe comorbidities, hyperphosphatemia and hypocalcemia, despite SHPT multiple medical treatments, suggesting poor adherence (n\u2009=\u200973); 3/ elderly patients with few cardiovascular comorbidities, controlled phospho-calcium balance, higher PTH, and few treatments (n\u2009=\u200975); 4/ patients who initiated cinacalcet (n\u2009=\u200943).", {"entities": [[82, 99, "DISEASE"], [179, 196, "DISEASE"], [395, 398, "GENE"]]}], ["The quality criterion of the model had a cut-off of 14 (>2), suggesting a relevant classification.", {"entities": []}], ["In real life, dialysis patients with newly diagnosed SHPT constitute a very heterogeneous population.", {"entities": []}], ["A \u201cone-size-fits-all\u201d target approach is probably not appropriate.", {"entities": []}], ["Therapeutic management needs to be adjusted to the 4 different phenotypes.", {"entities": []}], ["Respiratory and heart failure are conditions that can occur with little warning and may also be difficult to predict.", {"entities": []}], ["Therefore continuous monitoring of these bio-signals is advantageous for ensuring human health.", {"entities": []}], ["The car safety belt is mainly designed to secure the occupants of the vehicle in the event of an accident.", {"entities": []}], ["In the current research a prototype safety belt is developed, which is used to acquire respiratory and heart signals, under laboratory conditions.", {"entities": []}], ["The current safety belt is constructed using a copper ink based nonwoven material, which works based on the piezo-resistive effect due to the pressure exerted on the sensor as a result of expansion of the thorax/abdomen area of the body for respiration and due to the principle of ballistocardiography (BCG) in heart signal sensing.", {"entities": []}], ["In this research, the development of a theoretical model to qualitatively describe the piezo-resistive material is also presented in order to predict the relative change in the resistance of the piezo-resistive material due to the pressure applied.", {"entities": []}], ["In childbirth, most deliveries are low-risk, defined as spontaneous labor at full term without special high-risk facts or complications, especially in high-resource countries where maternal and perinatal mortality rates are very low.", {"entities": []}], ["Indeed, the majority of mothers and infants have no serious conditions during labor.", {"entities": []}], ["However, the quality of care provided is not assured, and performance may vary by birthing facility and provider.", {"entities": []}], ["The overuse of technology in childbirth in some parts of the world is almost certainly based on assumptions like, \u201csomething can go wrong at any minute.\u201d There is a need to assess the quality of care provided for mothers and infants in low-risk labor.", {"entities": []}], ["We aimed to develop specific quality indicators for low-risk labor care provided primarily by midwives in Japan.", {"entities": []}], ["We used a RAND-modified Delphi method, which integrates evidence review with expert consensus development.", {"entities": []}], ["The procedure comprises five steps: (1) literature review, including clinical practice guidelines, to extract and develop quality indicator candidates; (2) formation of a multidisciplinary panel; (3) independent panel ratings (Round 1); (4) panel meeting and independent panel ratings (Round 2); and (5) independent panel ratings (Round 3).", {"entities": []}], ["The three independent panel ratings (Rounds 1\u20133) were held between July and December 2012.", {"entities": []}], ["The assembled multidisciplinary panel comprised eight clinicians (two pediatricians, three obstetricians, and three midwives) and three mothers who were nonclinicians.", {"entities": []}], ["Evidentiary review extracted 166 key recommendations from 32 clinical practice guidelines, and 31 existing quality indicators were added.", {"entities": []}], ["After excluding duplicate recommendations and quality indicators, the panel discussed 25 candidate indicators.", {"entities": []}], ["Of these, 18 were adopted, one was modified, six were not adopted, and four were added during the meeting, respectively.", {"entities": []}], ["We established 23 quality indicators for low-risk labor care provided by midwives in labor units in Japan.", {"entities": []}], ["Eight candidate genes selected in this study were previously associated with gene-environment interactions in asthma in an urban area.", {"entities": [[110, 116, "DISEASE"]]}], ["These genes were analyzed in a familial collection from a founder and remote population (Saguenay\u2013Lac-Saint-Jean; SLSJ) located in an area with low air levels of ozone but with localized areas of relatively high air pollutant levels, such as sulphur dioxide, when compared to many urban areas.", {"entities": []}], ["Polymorphisms (SNPs) were extracted from the genome-wide association study (GWAS) performed on the SLSJ familial collection.", {"entities": []}], ["A transmission disequilibrium test (TDT) was performed using the entire family sample (1,428 individuals in 254 nuclear families).", {"entities": []}], ["Stratification according to the proximity of aluminium, pulp and paper industries was also analyzed.", {"entities": []}], ["Two genes were associated with asthma in the entire sample before correction ( CAT and NQO1 ) and one was associated after correction for multiple analyses ( CAT ).", {"entities": [[31, 37, "DISEASE"], [87, 91, "GENE"]]}], ["Two genes were associated when subjects were stratified according to the proximity of aluminium industries ( CAT and NQO1 ) and one according to the proximity of pulp and paper industries ( GSTP1 ).", {"entities": [[117, 121, "GENE"], [190, 195, "GENE"]]}], ["However, none of them resisted correction for multiple analyses.", {"entities": []}], ["Given that the spatial pattern of environmental exposures can be complex and inadequately represented by a few stationary monitors and that exposures can also come from sources other than the standard outdoor air pollution (e.g., indoor air, occupation, residential wood smoke), a new approach and new tools are required to measure specific and individual pollutant exposures in order to estimate the real impact of gene-environment interactions on respiratory health.", {"entities": []}], ["Antimicrobial resistance is a public health challenge supplemented by inappropriate prescribing, especially for an upper respiratory tract infection in primary care.", {"entities": []}], ["Patient/carer expectations have been identified as one of the main drivers for inappropriate antibiotics prescribing by primary care physicians.", {"entities": []}], ["The aim of this study was to understand who is more likely to expect an antibiotic for an upper respiratory tract infection from their doctor and the reasons underlying it.", {"entities": []}], ["This study used a sequential mixed methods approach: a nationally representative cross sectional survey ( n \u2009=\u20091509) and four focus groups.", {"entities": []}], ["The outcome of interest was expectation and demand for an antibiotic from a doctor when presenting with a cold or flu.", {"entities": []}], ["The study found 19.5\u00a0% of survey respondents reported that they would expect the doctor to prescribe antibiotics for a cold or flu.", {"entities": []}], ["People younger than 65\u00a0years of age, those who never attended university and those speaking a language other than English at home were more likely to expect or demand antibiotics for a cold or flu.", {"entities": []}], ["People who knew that \u2018antibiotics don\u2019t kill viruses\u2019 and agreed that \u2018taking an antibiotic when one is not needed means they won\u2019t work in the future\u2019 were less likely to expect or demand antibiotics.", {"entities": []}], ["The main reasons for expecting antibiotics were believing that antibiotics are an effective treatment for a cold or flu and that they shortened the duration and potential deterioration of their illness.", {"entities": []}], ["The secondary reason centered around the value or return on investment for visiting a doctor when feeling unwell.", {"entities": []}], ["Our study found that patients do not appear to feel they have a sufficiently strong incentive to consider the impact of their immediate use of antibiotics on antimicrobial resistance.", {"entities": []}], ["The issue of antibiotic resistance needs to be explained and reframed as a more immediate health issue with dire consequences to ensure the success of future health campaigns.", {"entities": []}], ["The online version of this article (doi:10.1186/s13756-016-0134-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["There is little knowledge about how oral and respiratory health is interrelated even though the mucosa of the oral cavity and airways constitutes a continuum and the exposures to these are partly similar.", {"entities": []}], ["To investigate whether gum bleeding is related to asthma, respiratory symptoms and self-reported COPD.", {"entities": [[50, 56, "DISEASE"]]}], ["A postal questionnaire including questions about respiratory and oral health was sent to general population samples in seven Northern European centres.", {"entities": []}], ["In 13,409 responders, gum bleeding when brushing teeth was reported always/often by 4% and sometimes by 20%.", {"entities": []}], ["Logistic regressions accounted for age, smoking, educational level, centre and gender.", {"entities": []}], ["Effects of BMI, cardio-metabolic diseases, early life factors, gastro-oesophageal reflux, dental hygiene, nasal congestion, and asthma medication were addressed.", {"entities": [[128, 134, "DISEASE"]]}], ["Gum bleeding always/often was significantly associated with \u22653 asthma symptoms (OR 2.58, 95% CI 2.10\u20133.18), asthma (1.62 [1.23\u20132.14]) and self-reported COPD (2.02 [1.28\u20133.18]).", {"entities": [[63, 69, "DISEASE"], [108, 114, "DISEASE"]]}], ["There was a dose-response relationship between respiratory outcomes and gum bleeding frequency (\u22653 symptoms: gum bleeding sometimes 1.42 [1.25\u20131.60], often/always 2.58 [2.10\u20133.18]), and there was no heterogeneity between centres (p heterogeneity = 0.49).", {"entities": []}], ["None of the investigated risk factors explained the associations.", {"entities": []}], ["The observed associations were significantly stronger among current smokers (p interaction = 0.004).", {"entities": []}], ["A consistent link between gum bleeding and obstructive airways disease was observed, not explained by common risk factors or metabolic factors.", {"entities": []}], ["We speculate that oral pathogens might have unfavourable impact on the airways, and that the direct continuity of the mucosa of the oral cavity and the airways reflects a pathway that might provide novel opportunities for interventions.", {"entities": []}], ["Tuberculosis and malnutrition are linked in a complex relationship.", {"entities": [[0, 12, "DISEASE"]]}], ["Tuberculosis may cause undernutrition through increased metabolic demands and decreased intake, and nutritional deficiencies may worsen the disease, or delay recovery by depressing important immune functions.", {"entities": [[0, 12, "DISEASE"]]}], ["At present, there is no evidence-based nutritional guidance for adults and children being treated for tuberculosis.", {"entities": [[102, 114, "DISEASE"]]}], ["To assess the effects of oral nutritional supplements in people being treated with antituberculous drug therapy for active tuberculosis.", {"entities": [[123, 135, "DISEASE"]]}], ["We searched the Cochrane Infectious Disease Group Specialized Register, Cochrane Central Register of Controlled Trials (CENTRAL; Issue 1, 2016), MEDLINE (from 1946 to 4 February 2016), EMBASE (from 1980 to 4 February 2016), LILACS (from 1982 to 4 February 2016), the meta Register of Controlled Trials ( m RCT), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), and the Indian Journal of Tuberculosis up to 4 February 2016, and checked the reference lists of all included studies.", {"entities": [[431, 443, "DISEASE"]]}], ["Randomized controlled trials that compared any oral nutritional supplement given for at least four weeks with no nutritional intervention, placebo, or dietary advice only for people being treated for active tuberculosis.", {"entities": [[207, 219, "DISEASE"]]}], ["The primary outcomes of interest were all-cause death, and cure at six and 12 months.", {"entities": []}], ["Two review authors independently selected trials for inclusion, and extracted data and assessed the risk of bias in the included trials.", {"entities": []}], ["We presented the results as risk ratios (RR) for dichotomous variables, and mean differences (MD) for continuous variables, with 95% confidence intervals (CIs).", {"entities": []}], ["Where appropriate, we pooled data from trials with similar interventions and outcomes.", {"entities": []}], ["We assessed the quality of the evidence using the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach.", {"entities": []}], ["Thirty-five trials, including 8283 participants, met the inclusion criteria of this review.", {"entities": []}], ["Macronutrient supplementation Six trials assessed the provision of free food, or high-energy supplements.", {"entities": []}], ["Only two trials measured total dietary intake, and in both trials the intervention increased calorie consumption compared to controls.", {"entities": []}], ["The available trials were too small to reliably prove or exclude clinically important benefits on mortality (RR 0.34, 95% CI 0.10 to 1.20; four trials, 567 participants, very low quality evidence ), cure (RR 0.91, 95% CI 0.59 to 1.41; one trial, 102 participants, very low quality evidence ), or treatment completion (data not pooled; two trials, 365 participants, very low quality evidence ).", {"entities": []}], ["Supplementation probably produces a modest increase in weight gain during treatment for active tuberculosis, although this was not seen consistently across all trials (data not pooled; five trials, 883 participants, moderate quality evidence ).", {"entities": [[95, 107, "DISEASE"]]}], ["Two small studies provide some evidence that quality of life may also be improved but the trials were too small to have much confidence in the result (data not pooled; two trials, 134 participants, low quality evidence ).", {"entities": []}], ["Micronutrient supplementation Six trials assessed multi-micronutrient supplementation in doses up to 10 times the dietary reference intake, and 18 trials assessed single or dual micronutrient supplementation.", {"entities": []}], ["Routine multi-micronutrient supplementation may have little or no effect on mortality in HIV-negative people with tuberculosis (RR 0.86, 95% CI 0.46 to 1.6; four trials, 1219 participants, low quality evidence ), or HIV-positive people who are not taking antiretroviral therapy (RR 0.92, 95% CI 0.69 to 1.23; three trials, 1429 participants, moderate quality evidence ).", {"entities": [[114, 126, "DISEASE"]]}], ["There is insufficient evidence to know if supplementation improves cure (no trials), treatment completion (RR 0.99, 95% CI 0.95 to 1.04; one trial, 302 participants, very low quality evidence ), or the proportion of people who remain sputum positive during the first eight weeks (RR 0.92, 95% CI 0.63 to 1.35; two trials, 1020 participants, very low quality evidence ).", {"entities": []}], ["However, supplementation may have little or no effect on weight gain during treatment (data not pooled; five trials, 2940 participants, low quality evidence ), and no studies have assessed the effect on quality of life.", {"entities": []}], ["Plasma levels of vitamin A appear to increase following initiation of tuberculosis treatment regardless of supplementation.", {"entities": [[70, 82, "DISEASE"]]}], ["In contrast, supplementation probably does improve plasma levels of zinc, vitamin D, vitamin E, and selenium, but this has not been shown to have clinically important benefits.", {"entities": []}], ["Of note, despite multiple studies of vitamin D supplementation in different doses, statistically significant benefits on sputum conversion have not been demonstrated.", {"entities": []}], ["There is currently insufficient research to know whether routinely providing free food, or energy supplements improves tuberculosis treatment outcomes, but it probably improves weight gain in some settings.", {"entities": [[119, 131, "DISEASE"]]}], ["Although blood levels of some vitamins may be low in people starting treatment for active tuberculosis, there is currently no reliable evidence that routinely supplementing above recommended daily amounts has clinical benefits.", {"entities": [[90, 102, "DISEASE"]]}], ["Nutritional supplements for people being treated for active tuberculosis Cochrane researchers conducted a review of the effects of nutritional supplements for people being treated for tuberculosis.", {"entities": [[60, 72, "DISEASE"], [184, 196, "DISEASE"]]}], ["After searching for relevant studies up to 4 February 2016, they included 35 relevant studies with 8283 participants.", {"entities": []}], ["Their findings are summarized below.", {"entities": []}], ["What is active tuberculosis and how might nutritional supplements work?", {"entities": [[15, 27, "DISEASE"]]}], ["Tuberculosis is a bacterial infection which most commonly affects the lungs.", {"entities": [[0, 12, "DISEASE"]]}], ["Most people who get infected never develop symptoms as their immune system manages to control the bacteria.", {"entities": []}], ["Active tuberculosis occurs when the infection is no longer contained by the immune system, and typical symptoms are cough, chest pain, fever, night sweats, weight loss, and sometimes coughing up blood.", {"entities": [[7, 19, "DISEASE"]]}], ["Treatment is with a combination of antibiotic drugs, which must be taken for at least six months.", {"entities": []}], ["People with tuberculosis are often malnourished, and malnourished people are at higher risk of developing tuberculosis as their immune system is weakened.", {"entities": [[12, 24, "DISEASE"], [106, 118, "DISEASE"]]}], ["Nutritional supplements could help people recover from the illness by strengthening their immune system, and by improving weight gain, and muscle strength, allowing them to return to an active life.", {"entities": []}], ["Good nutrition requires a daily intake of macronutrients (carbohydrate, protein, and fat), and micronutrients (essential vitamins and minerals).", {"entities": []}], ["What the research says Effect of providing nutritional supplements to people being treated for tuberculosis We currently don't know if providing free food to tuberculosis patients, as hot meals or ration parcels, reduces death or improves cure ( very low quality evidence ).", {"entities": [[95, 107, "DISEASE"], [158, 170, "DISEASE"]]}], ["However, it probably does improve weight gain in some settings ( moderate quality evidence ), and may improve quality of life ( low quality evidence ).", {"entities": []}], ["Routinely providing multi-micronutrient supplements may have little or no effect on deaths in HIV-negative people with tuberculosis ( low quality evidence ), or HIV-positive people who are not taking anti-retroviral therapy ( moderate quality evidence ).", {"entities": [[119, 131, "DISEASE"]]}], ["We currently don't know if micronutrient supplements have any effect on tuberculosis treatment outcomes ( very low quality evidence ), but they may have no effect on weight gain ( low quality evidence ).", {"entities": [[72, 84, "DISEASE"]]}], ["No studies have assessed the effect on quality of life.", {"entities": []}], ["Plasma levels of vitamin A appear to increase after starting tuberculosis treatment regardless of supplementation.", {"entities": [[61, 73, "DISEASE"]]}], ["In contrast, supplementation probably does improve plasma levels of zinc, vitamin D, vitamin E, and selenium, but this has not been shown to have clinically important benefits.", {"entities": []}], ["Despite multiple studies of vitamin D supplementation in different doses, statistically significant benefits on sputum conversion have not been demonstrated.", {"entities": []}], ["Authors' conclusions Food or energy supplements may improve weight gain during recovery from tuberculosis in some settings, but there is currently no evidence that they improve tuberculosis treatment outcomes.", {"entities": [[93, 105, "DISEASE"], [177, 189, "DISEASE"]]}], ["There is also currently no reliable evidence that routinely supplementing above recommended daily amounts has clinical benefits.", {"entities": []}], ["It is often stated that external validity is not sufficiently considered in the assessment of clinical studies.", {"entities": []}], ["Although tools for its evaluation have been established, there is a lack of awareness of their significance and application.", {"entities": []}], ["In this article, a comprehensive checklist is presented addressing these relevant criteria.", {"entities": []}], ["The checklist was developed by listing the most commonly used assessment criteria for clinical studies.", {"entities": []}], ["Additionally, specific lists for individual applications were included.", {"entities": []}], ["The categories of biases of internal validity (selection, performance, attrition and detection bias) correspond to structural, treatment-related and observational differences between the test and control groups.", {"entities": []}], ["Analogously, we have extended these categories to address external validity and model validity, regarding similarity between the study population/conditions and the general population/conditions related to structure, treatment and observation.", {"entities": []}], ["A checklist is presented, in which the evaluation criteria concerning external validity and model validity are systemised and transformed into a questionnaire format.", {"entities": []}], ["The checklist presented in this article can be applied to both planning and evaluating of clinical studies.", {"entities": []}], ["We encourage the prospective user to modify the checklists according to the respective application and research question.", {"entities": []}], ["The higher expenditure needed for the evaluation of clinical studies in systematic reviews is justified, particularly in the light of the influential nature of their conclusions on therapeutic decisions and the creation of clinical guidelines.", {"entities": []}], ["\"Fright\" is an English-speaking Caribbean idiom for an illness, or ethnomedical syndrome, of persistent distress.", {"entities": [[80, 88, "DISEASE"]]}], ["A parallel ethnopsychiatric idiom exists in the French Antilles as s\u00e9sisma.", {"entities": []}], ["Fright is distinct from susto among Hispanics, though both develop in the wake of traumatic events.", {"entities": []}], ["West Indian ethnophysiology (ethnoanatomy) theorizes that an overload of stressful emotions (fear, panic, anguish or worry) causes a cold humoral state in which blood coagulates causing prolonged distress and increased risks of other humorally cold illnesses.", {"entities": []}], ["Qualitative data on local explanatory models and treatment of fright were collected using participant-observation, informal key informant interviews and a village health survey.", {"entities": []}], ["Ethnobotanical and epidemiological data come from freelist (or \"free-list\") tasks, analyzed for salience, with nearly all adults (N = 112) of an eastern village in Dominica, and a village survey on medicinal plant recognition and use (N = 106).", {"entities": []}], ["Along with prayer and exercise, three herbs are salient fright treatments: Gossypium barbadense L., Lippia micromera Schauer, and, Plectranthus [Coleus] amboinicus [Loureiro] Sprengel.", {"entities": []}], ["The survey indicated that 27% of village adults had medicated themselves for fright.", {"entities": []}], ["Logistic regression of fright suffering onto demographic variables of age, education, gender, parental status and wealth measured in consumer goods found age to be the only significant predictor of having had fright.", {"entities": []}], ["The probability of having (and medicating for) fright thus increases with every year.", {"entities": []}], ["While sufferers are often uncomfortable recalling personal fright experiences, reporting use of medicinal plants is less problematic.", {"entities": []}], ["Inquiry on fright medical ethnobotany (or phytotherapies) serves as a proxy measurement for fright occurrence.", {"entities": []}], ["Cross-cultural and ethnopharmacology literature on the medicinal plants suggests probable efficacy in accord with Dominican ethnomedical notions of fright.", {"entities": []}], ["Further, the cultural salience and beliefs about these medicines may give these medications extra psychoneuroimmune (i.e.", {"entities": []}], ["mind-body) benefits, or placebo-like effects, for this stress-related folk illness.", {"entities": []}], ["To investigate the risk of emergency hospital admissions for violence (EHAV) associated with demographic and socioeconomic factors in Wales between 2007/2008 and 2013/2014, and to describe the site of injury causing admission.", {"entities": []}], ["Database analysis of 7\u2005years\u2019 hospital admissions using the Patient Episode Database for Wales (PEDW).", {"entities": []}], ["Wales, UK, successive annual populations \u223c2.8 million aged 0\u201374\u2005years.", {"entities": []}], ["The first emergency admission for violence in each year of the study, defined by the International Classification of Diseases V.10 (ICD-10) codes for assaults (X85-X99, Y00-Y09) in any coding position.", {"entities": []}], ["A total of 11\u2005033 admissions for assault.", {"entities": []}], ["The majority of admissions resulted from head injuries.", {"entities": []}], ["The overall crude admission rate declined over the study period, from 69.9 per 100\u2005000 to 43.2 per 100\u2005000, with the largest decrease in the most deprived quintile of deprivation.", {"entities": []}], ["A generalised linear count model with a negative binomial log link, adjusted for year, age group, gender, deprivation quintile and settlement type, showed the relative risk was highest in age group 18\u201319\u2005years (RR=6.75, 95% CI 5.88 to 7.75) compared with the reference category aged 10\u201314\u2005years.", {"entities": []}], ["The risk decreased with age after 25\u2005years.", {"entities": []}], ["Risk of admission was substantially higher in males (RR=4.55, 95% CI 4.31 to 4.81), for residents of the most deprived areas of Wales (RR=3.60, 95% CI 3.32 to 3.90) compared with the least deprived, and higher in cities (RR=1.37, 95% CI 1.27 to 1.49) and towns (RR=1.32, 95% CI 1.21 to 1.45) compared with villages.", {"entities": []}], ["Despite identifying a narrowing in the gap between prevalence of violence in richer and poorer communities, violence remains strongly associated with young men living in areas of socioeconomic deprivation.", {"entities": []}], ["There is potential for a greater reduction, given that violence is mostly preventable.", {"entities": []}], ["Recommendations for reducing inequalities in the risk of admission for violence are discussed.", {"entities": []}], ["Frailty is a state of increased vulnerability to disability, falls, and mortality.", {"entities": []}], ["The Fried frailty phenotype includes assessments of grip strength and gait speed, which are complex or require objective measurements and are challenging in routine primary care practice.", {"entities": []}], ["In this study, we aimed to develop a simple assessment tool based on self-reported information on the 5 Fried frailty components to identify older people at risk of incident disability, falls, and mortality.", {"entities": []}], ["Analyses are based on a prospective cohort comprising older British men aged 71\u201392\u00a0years in 2010\u20132012.", {"entities": []}], ["A follow-up questionnaire was completed in 2014.", {"entities": []}], ["The discriminatory power for incident disability and falls was compared with the Fried frailty phenotype using receiver operating characteristic-area under the curve (ROC-AUC); for incident falls it was additionally compared with the\u00a0FRAIL scale (fatigue, resistance, ambulation, illnesses, and loss of weight).", {"entities": []}], ["Predictive ability for mortality was assessed using age-adjusted Cox proportional hazard models.", {"entities": []}], ["A model including self-reported measures of slow walking speed, low physical activity, and exhaustion had a significantly increased ROC-AUC [0.68, 95% confidence interval (CI) 0.63\u20130.72] for incident disability compared with the Fried frailty phenotype (0.63, 95% CI 0.59\u20130.68; P value of \u0394AUC\u00a0=\u00a0.003).", {"entities": []}], ["A second model including self-reported measures of slow walking speed, low physical activity, and weight loss had a higher ROC-AUC (0.64, 95% CI 0.59\u20130.68) for incident falls compared with the Fried frailty phenotype (0.57, 95% CI 0.53\u20130.61; P value of \u0394AUC\u00a0<\u00a0.001) and the FRAIL scale (0.56, 95% CI 0.52\u20130.61; P value of \u0394AUC\u00a0=\u00a0.001).", {"entities": []}], ["This model was also associated with an increased risk of mortality (Harrell's C\u00a0=\u00a00.73, Somer's D\u00a0=\u00a00.45; linear trend P \u00a0<\u00a0.001) compared with the Fried phenotype (Harrell's C\u00a0=\u00a00.71; Somer's D\u00a0=\u00a00.42; linear trend P \u00a0<\u00a0.001) and the FRAIL scale (Harrell's C\u00a0=\u00a00.71, Somer's D\u00a0=\u00a00.42; linear trend P \u00a0<\u00a0.001).", {"entities": []}], ["Self-reported information on the Fried frailty components had superior discriminatory and predictive ability compared with the Fried frailty phenotype for all the adverse outcomes considered and with the FRAIL scale for incident falls and mortality.", {"entities": []}], ["These findings have important implications for developing interventions and health care policies as they offer a simple way to identify older people at risk of adverse outcomes associated with frailty.", {"entities": []}], ["The epithelial lining of the airway tract and allergen-specific IgE are considered essential controllers of inflammatory responses to allergens.", {"entities": []}], ["The human low affinity IgE receptor, CD23 (Fc\u03b5RII), is capable of transporting IgE or IgE-allergen complexes across the polarized human airway epithelial cell (AEC) monolayer in vitro .", {"entities": []}], ["However, it remains unknown whether the CD23-dependent IgE transfer pathway in AECs initiates and facilitates allergic inflammation in vivo , and whether inhibition of this pathway attenuates allergic inflammation.", {"entities": []}], ["To this end, we show that in wild-type (WT) mice, epithelial CD23 transcytosed both IgE and ovalbumin (OVA)-IgE complexes across the airway epithelial barrier, while neither type of transcytosis was observed in CD23 knockout (KO) mice.", {"entities": []}], ["In chimeric mice, OVA sensitization and aerosol challenge of WT/WT (bone-marrow transfer from the WT to WT) or CD23KO/WT (CD23KO to WT) chimeric mice, which express CD23 on radioresistant airway structural cells (mainly epithelial cells) resulted in airway eosinophilia, including collagen deposition and a significant increase in goblet cells, and increased airway hyperreactivity.", {"entities": [[257, 269, "DISEASE"]]}], ["In contrast, the absence of CD23 expression on airway structural or epithelial cells, but not on hematopoietic cells, in WT/CD23KO (the WT to CD23KO) chimeric mice significantly reduced OVA-driven allergic airway inflammation.", {"entities": []}], ["In addition, inhalation of the CD23-blocking B3B4 antibody in sensitized WT mice before or during airway challenge suppressed the salient features of asthma, including bronchial hyperreactivity.", {"entities": [[150, 156, "DISEASE"]]}], ["Taken together, these results identify a previously unproven mechanism in which epithelial CD23 plays a central role in the development of allergic inflammation.", {"entities": []}], ["Further, our study suggests that functional inhibition of CD23 in the airway is a potential therapeutic approach with which to inhibit the development of asthma.", {"entities": [[154, 160, "DISEASE"]]}], ["No optimal housekeeping genes (HKGs) have been identified for CD4 Three groups of subjects (Non-depressive asthmatic, NDA, n\u200a=\u200a10, Depressive asthmatic, DA, n\u200a=\u200a11, and Healthy control, HC, n\u200a=\u200a10 respectively) were studied.", {"entities": [[62, 65, "GENE"]]}], ["qPCR for 9 potential HKGs, namely RNA, 28S ribosomal 1 ( RN28S1 ), ribosomal protein, large, P0 ( RPLP0 ), actin, beta ( ACTB ), cyclophilin A ( PPIA ), glyceraldehyde-3-phosphate dehydrogenase ( GAPDH ), phosphoglycerate kinase 1 ( PGK1 ), beta-2-microglobulin ( B2M ), glucuronidase, beta ( GUSB ) and ribosomal protein L13a ( RPL13A ), was performed.", {"entities": [[98, 103, "GENE"], [121, 125, "GENE"], [145, 149, "GENE"], [196, 201, "GENE"], [233, 237, "GENE"], [264, 267, "GENE"], [293, 297, "GENE"], [329, 335, "GENE"]]}], ["Then the data were analyzed with three different applications namely BestKeeper, geNorm, and NormFinder.", {"entities": []}], ["The analysis of gene expression data identified B2M and RPLP0 as the most stable reference genes and showed that the level of PPIA was significantly different among subjects of three groups when the two best HKGs identified were applied.", {"entities": [[48, 51, "GENE"], [56, 61, "GENE"], [126, 130, "GENE"]]}], ["Post-hoc analysis by Student-Newman-Keuls correction shows that depressive asthmatics and non-depressive asthmatics exhibited lower expression level of PPIA than healthy controls ( p <0.05).", {"entities": [[152, 156, "GENE"]]}], ["B2M and RPLP0 were identified as the most optimal HKGs in gene expression studies involving human blood CD4 PPIA gene as the HKG for such studies was questioned due to its low expression in asthmatics.", {"entities": [[0, 3, "GENE"], [8, 13, "GENE"], [104, 107, "GENE"], [108, 112, "GENE"]]}], ["Emergency department (ED) studies often require follow-up with subjects to assess outcomes and adverse events.", {"entities": []}], ["Our objective was to identify baseline subject characteristics associated with successful contact at 3 time points after the index ED visit within a sample of cigarette smokers.", {"entities": []}], ["This study is a secondary analysis of a prospective cohort.", {"entities": []}], ["We recruited current adult smokers at 10 U.S. EDs and collected baseline demographics, smoking profile, substance abuse, health conditions, and contact information.", {"entities": [[104, 119, "DISEASE"]]}], ["Site investigators attempted contact at 2 weeks, 3 months, and 6 months to assess smoking prevalence and quit attempts.", {"entities": []}], ["Subjects were paid $20 for successful follow-up at each time point.", {"entities": []}], ["We analyzed data using logistic and Poisson regressions.", {"entities": []}], ["Of 375 recruited subjects, 270 (72%) were contacted at 2 weeks, 245 (65%) at 3 months, and 217 (58%) at 6 months.", {"entities": []}], ["Overall, 175 (47%) were contacted at 3 of 3, 71 (19%) at 2 of 3, 62 (17%) at 1 of 3, and 66 (18%) at 0 of 3 time points.", {"entities": []}], ["At 6 months, predictors of successful contact were: older age (adjusted odds ratio [AOR] 1.2 [95%CI, 0.99\u20131.5] per \u219110 years); female sex (AOR 1.7 [95%CI, 1.04\u20132.8]); non-Hispanic black (AOR 2.3 [95%CI, 1.2\u20134.5]) vs Hispanic; private insurance (AOR 2.0 [95%CI, 1.03\u20133.8]) and Medicare (AOR 5.7 [95%CI, 1.5\u201322]) vs no insurance; and no recreational drug use (AOR 3.2 [95%CI; 1.6\u20136.3]).", {"entities": []}], ["The characteristics independently predictive of the total number of successful contacts were: age (incidence rate ratio [IRR] 1.06 [95%CI, 1.00\u20131.13] per \u219110 years); female sex (IRR 1.18 [95%CI, 1.01\u20131.40]); and no recreational drug use (IRR 1.37 [95%CI, 1.07\u20131.74]).", {"entities": []}], ["Variables related to smoking cessation (e.g., cigarette packs-years, readiness to quit smoking) and amount of contact information provided were not associated with successful contact.", {"entities": []}], ["Successful contact 2 weeks after the ED visit was 72% but decreased to 58% by 6 months, despite modest financial incentives.", {"entities": []}], ["Older, female, and non-drug abusing participants were the most likely to be contacted.", {"entities": []}], ["Strategies to optimize longitudinal follow-up rates, with limited sacrifice of generalizability, remain an important challenge for ED-based research.", {"entities": []}], ["This is particularly true for studies on substance abusers and other difficult-to-reach populations.", {"entities": []}], ["Since the performance of the first laparoscopic cardiomyotomy for achalasia cardia in 1991, the popularity of the minimally invasive approach for this troublesome disease has been growing.", {"entities": [[66, 75, "DISEASE"]]}], ["We present our experience of 226 patients who underwent laparoscopic cardiomyotomy and discuss the relevant issues.", {"entities": []}], ["A retrospective analysis was carried out of 226 patients who have undergone laparoscopic cardiomyotomy since 1993.", {"entities": []}], ["The preoperative workup, surgical technique, and postoperative management are described.", {"entities": []}], ["Patients included 146 males and 80 females; average age was 36.4 years (range, 6 to 85).", {"entities": []}], ["Mean duration of symptoms was 1.4 years.", {"entities": []}], ["Nearly half of the patients (112) had undergone prior pneumatic dilatation.", {"entities": []}], ["In 20 patients, myotomy alone was done, 44 patients had a Dor's fundoplication, and 162 had Toupet's fundoplication.", {"entities": []}], ["The average operating time was 96 minutes.", {"entities": []}], ["Mean postoperative hospital stay was 2.2 days.", {"entities": []}], ["Dysphagia was eliminated in 88.9% of the patients with an overall morbidity of 4.4% and nil mortality over a mean follow-up of 4.3 years.", {"entities": []}], ["Laparoscopic cardiomyotomy with Toupet's fundoplication is a safe and effective treatment of achalasia cardia.", {"entities": [[93, 102, "DISEASE"]]}], ["Dor's fundoplication is done selectively, especially when suspicion is present of mucosal injury.", {"entities": []}], ["A temporary ileostomy may reduce symptoms from anastomotic leakage after rectal cancer resection.", {"entities": [[80, 86, "DISEASE"]]}], ["Earlier results of the EASY trial showed that early closure of the temporary ileostomy was associated with significantly fewer postoperative complications.", {"entities": []}], ["The aim of the present study was to compare health\u2010related quality of life (HRQOL) following early versus late closure of a temporary ileostomy.", {"entities": []}], ["Early closure of a temporary ileostomy (at 8\u201313 days) was compared with late closure (at more than 12 weeks) in a multicentre RCT (EASY) that included patients who underwent rectal resection for cancer.", {"entities": [[195, 201, "DISEASE"]]}], ["Inclusion of participants was made after index surgery.", {"entities": []}], ["Exclusion criteria were signs of anastomotic leakage, diabetes mellitus, steroid treatment, and signs of postoperative complications at clinical evaluation 1\u20134 days after rectal resection.", {"entities": [[54, 71, "DISEASE"]]}], ["HRQOL was evaluated at 3, 6 and 12 months after resection using the European Organisation for Research and Treatment of Cancer (EORTC) questionnaires QLQ\u2010C30 and QLQ\u2010CR29 and Short Form 36 (SF\u201036\u00ae).", {"entities": [[120, 126, "DISEASE"]]}], ["There were 112 patients available for analysis.", {"entities": []}], ["Response rates of the questionnaires were 82\u201395 per cent, except for EORTC QLQ\u2010C30 at 12 months, to which only 54\u201355 per cent of the patients responded owing to an error in questionnaire distribution.", {"entities": []}], ["There were no clinically significant differences in any questionnaire scores between the groups at 3, 6 or 12 months.", {"entities": []}], ["Although the randomized study found that early closure of the temporary ileostomy was associated with significantly fewer complications, this clinical advantage had no effect on the patients' HRQOL.", {"entities": []}], ["Registration number: NCT01287637 ( https://www.clinicaltrials.gov ).", {"entities": []}], ["No different after early ileostomy closure", {"entities": []}], ["Sarcoidosis is a systemic inflammatory disease of unknown etiology.", {"entities": [[0, 11, "DISEASE"]]}], ["Osteopontin (SPP1, OPN) is an extra cellular matrix glycoprotein and cytokine with a known role in granuloma formation and in autoimmune and inflammatory diseases.", {"entities": [[13, 17, "GENE"]]}], ["To determine whether plasma OPN levels are elevated in patients with sarcoidosis and compare the frequency of four single nucleotide polymorphism (SNPs) variants in the OPN gene in sarcoidosis patients compared to healthy controls.", {"entities": [[69, 80, "DISEASE"], [181, 192, "DISEASE"]]}], ["Demographic and clinical information, radiological studies and pulmonary function tests were evaluated in 113 patients with sarcoidosis and in 79 healthy controls.", {"entities": [[124, 135, "DISEASE"]]}], ["Blood samples were analyzed for SNPs of the OPN gene and for plasma OPN and CRP levels.", {"entities": [[76, 79, "GENE"]]}], ["Association between clinical features of disease and OPN levels as well as SNP frequencies was determined.", {"entities": []}], ["Plasma OPN levels were higher in sarcoidosis patients than in healthy subjects, (median: 217 vs 122ng/ml, p<0.001).", {"entities": [[33, 44, "DISEASE"]]}], ["Area under the curve for receiver operator curves (ROC) was 0.798 (0.686\u20130.909 95% CI.)", {"entities": []}], ["No differences were observed between sarcoidosis patients and controls in the frequency of any of the SNPs evaluated.", {"entities": [[37, 48, "DISEASE"]]}], ["Presence of lung parenchymal involvement was associated with SNP distribution at rs1126772 (p = 0.02).", {"entities": []}], ["We found no correlation between SNPs distribution and plasma OPN levels.", {"entities": []}], ["Osteopontin protein levels are elevated in sarcoidosis.", {"entities": [[43, 54, "DISEASE"]]}], ["We found no evidence for an association between SNPs on the osteopontin gene and plasma OPN levels or the presence of sarcoidosis, however, an association between genotype and several phenotypic clinical parameters of disease was observed.", {"entities": [[118, 129, "DISEASE"]]}], ["Self-management of chronic diseases has been a research focus for years.", {"entities": []}], ["Information and communication technologies (ICTs) have played a significant role in aiding patients and their families with that management task.", {"entities": []}], ["The recent dramatic increase in smartphone capabilities has expanded the potential of these technologies by facilitating the integration of features specific to cell phones with advanced capabilities that extend the reach of what type of information can be assessed and which services can be provided.", {"entities": []}], ["A recent review of the literature covering the use of ICTs in managing chronic diseases, including addiction, has examined the effectiveness of ICTs, with an emphasis on technologies tested in randomized controlled trials.", {"entities": []}], ["One example of an addiction-relapse prevention system currently being tested is the Alcohol Comprehensive Health Enhancement Support System (A-CHESS) Program.", {"entities": []}], ["Representative national data on disability are becoming increasingly important in helping policymakers decide on public health strategies.", {"entities": []}], ["We assessed the respective contribution of chronic health conditions to disability for three age groups (18\u201340, 40\u201365, and >65 years old) using data from the 2008\u20132009 Disability-Health Survey in France.", {"entities": []}], ["Data on 12 chronic conditions and on disability for 24,682 adults living in households were extracted from the Disability-Health Survey results.", {"entities": []}], ["A weighting factor was applied to obtain representative estimates for the French population.", {"entities": []}], ["Disability was defined as at least one restriction in activities of daily living (ADL), severe disability as the inability to perform at least one ADL alone, and self-reported disability as a general feeling of being disabled.", {"entities": []}], ["To account for co-morbidities, we assessed the contribution of each chronic disorder to disability by using the average attributable fraction (AAF).", {"entities": []}], ["We estimated that 38.8 million people in France (81.7% [95% CI 80.9;82.6]) had a chronic condition: 14.3% (14.0;14.6) considered themselves disabled, 4.6% (4.4;4.9) were restricted in ADL and 1.7% (1.5;1.8) were severely disabled.", {"entities": []}], ["Musculoskeletal and sensorial impairments contributed the most to self-reported disability (AAF 15.4% and 12.3%).", {"entities": []}], ["Neurological and musculoskeletal diseases had the largest impact on disability (AAF 17.4% and 16.4%, respectively).", {"entities": []}], ["Neurological disorders contributed the most to severe disability (AAF 31.0%).", {"entities": []}], ["Psychiatric diseases contributed the most to disability categories for patients 18\u201340 years old (AAFs 23.8%\u201340.3%).", {"entities": []}], ["Cardiovascular conditions were also among the top four contributors to disability categories (AAFs 8.5%\u201311.1%).", {"entities": []}], ["Neurological, musculoskeletal, and cardiovascular chronic disorders mainly contribute to disability in France.", {"entities": []}], ["Psychiatric impairments have a heavy burden for people 18\u201340 years old.", {"entities": []}], ["These findings should help policymakers define priorities for health-service delivery in France and perhaps other developed countries.", {"entities": []}], ["The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases.", {"entities": []}], ["To improve therapeutic efficacy, the heavy and light chains (HC and LC) of the three BoNT serotypes were targeted to achieve a synergistic effect (oligoclonal antibodies).", {"entities": []}], ["For antibody isolation, macaques were immunized with the recombinant and non-toxic BoNT/A, B or E, HC or LC, followed by the generation of immune phage-display libraries.", {"entities": []}], ["Antibodies were selected from these libraries against the holotoxin and further analyzed in in vitro and ex vivo assays.", {"entities": []}], ["For each library, the best ex vivo neutralizing antibody fragments were germline-humanized and expressed as immunoglobulin G (IgGs).", {"entities": []}], ["The IgGs were tested in vivo, in a standardized model of protection, and challenged with toxins obtained from collections of Clostridium strains.", {"entities": []}], ["Protective antibody combinations against BoNT/A and BoNT/B were evidenced and for BoNT/E, the anti-LC antibody alone was found highly protective.", {"entities": []}], ["The combination of these five antibodies as an oligoclonal antibody cocktail can be clinically and regulatorily developed while their high \u201chumanness\u201d predicts a high tolerance in humans.", {"entities": []}], ["To estimate the potential cost savings by following the current Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline recommendations in patients being treated for chronic obstructive pulmonary disease (COPD) with the combination of long-acting \u03b2 2 -agonist (LABA), long-acting muscarinic antagonist (LAMA) or inhaled corticosteroids (ICS).", {"entities": [[182, 219, "DISEASE"]]}], ["The Geisinger Health System (GHS) database was utilized to identify subjects between January 1, 2004 to March 12, 2007.", {"entities": []}], ["The index date was based on the first prescription of a LAMA plus LABA, LAMA plus LABA/ICS, or LABA plus ICS.", {"entities": []}], ["Patients were included in the study if they: had a COPD diagnosis; had data representative of treatment 12 months prior to and 12 months post index date; were 40 years of age or over; had no prior diagnosis for asthma; and had pulmonary function test (PFT) data.", {"entities": [[211, 217, "DISEASE"]]}], ["We examined the baseline characteristics of these patients along with their healthcare resource utilization.", {"entities": []}], ["Based on PFT data within 30 days of the index date, a subgroup was classified as adhering or non-adhering to GOLD guidelines.", {"entities": []}], ["A total of 364 subjects could be classified as adhering or non-adherent to current GOLD guidelines based on their PFT results.", {"entities": []}], ["The adherent subgroup received COPD medications consistent with current GOLD guidelines.", {"entities": []}], ["Of the LAMA plus LABA cohort, 25 patients adhered and 39 patients were non-adherent to current GOLD guidelines.", {"entities": []}], ["In the cohort of LABA plus ICS, 74 patients were adherent and 180 patients non-adherent to current GOLD guidelines.", {"entities": []}], ["In the cohort of LAMA plus LABA/ICS, 21 patients were adherent and 25 patients non-adherent to current GOLD guidelines.", {"entities": []}], ["GOLD adherence was associated with mean total cost of all services savings of $5,889 for LAMA plus LABA, $3,330 for LABA + ICS, and $10,217 for LAMA plus LABA/ICS cohorts.", {"entities": []}], ["Staging of COPD with a PFT and adherence to current GOLD guidelines was associated with lower costs in subjects with moderate to severe COPD.", {"entities": []}], ["Appropriate use of LAMA plus LABA, LABA plus ICS, and LAMA plus LABA/ICS has economic as well as clinical benefits for patients and payers.", {"entities": []}], ["African Americans suffer disproportionately from tobacco-related illness and have more difficulty quitting smoking than other racial/ethnic groups.", {"entities": []}], ["Previous research indicates that African American treatment-seekers are high utilizers of tobacco quitlines, yet cessation rates via quitlines are lower relative to whites.", {"entities": []}], ["The goal of the present study is to test the effectiveness of adding a culturally specific, video-based, adjunct to standard quitline care.", {"entities": []}], ["It is hypothesized that the integration of an evidence-based intervention ( Pathways to Freedom: Leading the Way to a Smoke-Free Community\u00a9; PTF ) into quitline services will increase cessation and treatment engagement compared to control conditions, and that effects will be moderated by sociocultural factors (e.g., culturally specific intervention expectancies, acculturation, and ethnic identity).", {"entities": []}], ["This study is a 3-arm semi-pragmatic randomized controlled trial (RCT).", {"entities": []}], ["Participants will be 1050 enrollees in the North Carolina State quitline (QuitlineNC) who self-identify as African American.", {"entities": []}], ["Usual quitline care includes up to 4 proactive quit coaching calls, website access, and two-weeks of nicotine patch therapy.", {"entities": []}], ["Eligible study participants will be randomized to receive (1) standard quitline services plus PTF (PTF) ; (2) quitline services plus a standard tobacco cessation DVD (attention control); or (3) quitline services alone (usual care).", {"entities": []}], ["Assessments will be conducted at baseline, 3 and 6-months post-enrollment.", {"entities": []}], ["The primary outcome will be biochemically verified 7\u00a0day ppa at 6-months.", {"entities": []}], ["Generalized linear mixed models (GLMMs) and hierarchical logistic regression will be used to assess the effects of treatment group on cessation outcomes and to test potential moderators.", {"entities": []}], ["This study will answer questions regarding the implementation and effectiveness of integrating a culturally specific video intervention into a real-world, population-level tobacco intervention.", {"entities": []}], ["It will also aid our understanding of individual-difference variables that are associated with success.", {"entities": []}], ["If an incremental benefit is found, this trial will have implications for increasing the responsiveness of tobacco quitlines for African Americans, reducing tobacco cessation disparities, and best practices for improving minority health.", {"entities": []}], ["In addition, the PTF intervention has the potential for widespread disseminated through quitlines, which are available across the United States.", {"entities": []}], ["Clinicaltrials.gov NCT03064971 .", {"entities": []}], ["Registered on February 22, 2017.", {"entities": []}], ["Multiple genetic variants have been associated with adult obesity and a few with severe obesity in childhood; however, less progress has been made to establish genetic influences on common early-onset obesity.", {"entities": [[58, 65, "DISEASE"], [88, 95, "DISEASE"], [201, 208, "DISEASE"]]}], ["We performed a North American-Australian-European collaborative meta-analysis of fourteen studies consisting of 5,530 cases (\u226595 P < 5\u00d710 P -value, namely near OLFM4 on 13q14 (rs9568856; P =1.82\u00d710 HOXB5 on 17q21 (rs9299; P =3.54\u00d710", {"entities": [[160, 165, "GENE"], [198, 203, "GENE"]]}], ["Respiratory syncytial virus (RSV) is the most common viral cause of severe lower respiratory tract illness in infants and children.", {"entities": []}], ["The virus replicates in polarized epithelial cells in the airway and, to a lesser extent, infects airway antigen-presenting cells, such as dendritic cells (DCs).", {"entities": []}], ["RSV possesses a number of expressed genes that antagonize the effect of type I interferons and other related host factor pathways that inhibit replication efficiency.", {"entities": []}], ["Virus infection alters host gene transcription and the translation of host transcripts through specific antagonism of the function of host proteins, through induction of RNA stress granules, and through induction of altered patterns of host gene expression.", {"entities": []}], ["In healthy cells, microRNAs (miRNAs) regulate gene expression by targeting the noncoding region of mRNA molecules to cause silencing or degradation of transcripts.", {"entities": []}], ["It is not known whether or not RSV infection alters the level of microRNAs in cells.", {"entities": []}], ["We profiled the pattern of expression of host cell microRNAs in RSV-infected epithelial cells or DCs and found that RSV did alter microRNA expression but in a cell-type-specific manner.", {"entities": []}], ["The studies showed that let-7b was upregulated in DCs, while let-7i and miR-30b were upregulated in epithelial cells in a process that required viral replication.", {"entities": [[24, 30, "GENE"], [61, 67, "GENE"], [72, 79, "GENE"]]}], ["Interestingly, we found that the RSV nonstructural genes NS1 and NS2 antagonized the upregulation of let-7i and miR-30b.", {"entities": [[101, 107, "GENE"], [112, 119, "GENE"]]}], ["RSV appears to manipulate host cell gene expression through regulation of expression of miRNAs related to the interferon response.", {"entities": []}], ["The data suggest a new mechanism of virus-host cell interactions for paramyxoviruses.", {"entities": []}], ["Respiratory syncytial virus (RSV) is the most common cause of serious lower respiratory tract illness in infants and children.", {"entities": []}], ["The human innate immune response inhibits RSV replication early after inoculation, principally through the effect of substances called interferons.", {"entities": []}], ["The virus, however, has developed several mechanisms for counteracting the host innate immune response.", {"entities": []}], ["It is not known whether or not RSV infection alters the expression of host microRNAs, which are short RNA sequences that are posttranscriptional regulators.", {"entities": []}], ["This paper shows that RSV does induce unique patterns of microRNA expression related to the NF-\u03baB pathway or interferon pathways.", {"entities": []}], ["The microRNA profiles differed depending on the cell type that was infected, airway cell or antigen-presenting cell.", {"entities": []}], ["Interestingly, the virus appears to counteract the microRNA response by expressing nonstructural viral genes in the cell that reduce microRNA induction.", {"entities": []}], ["The data suggest a new way in which paramyxoviruses regulate the host cell response to infection.", {"entities": []}], ["Being a transient carrier of genetic information, mRNA could be a versatile, flexible, and safe means for protein therapies.", {"entities": []}], ["While recent findings highlight the enormous therapeutic potential of mRNA, evidence that mRNA-based protein therapies are feasible beyond small animals such as mice is still lacking.", {"entities": []}], ["Previous studies imply that mRNA therapeutics require chemical nucleoside modifications to obtain sufficient protein expression and avoid activation of the innate immune system.", {"entities": []}], ["Here we show that chemically unmodified mRNA can achieve those goals as well by applying sequence-engineered molecules.", {"entities": []}], ["Using erythropoietin (EPO) driven production of red blood cells as the biological model, engineered Epo mRNA elicited meaningful physiological responses from mice to nonhuman primates.", {"entities": [[22, 25, "GENE"], [100, 103, "GENE"], [22, 25, "GENE"], [100, 103, "GENE"]]}], ["Even in pigs of about 20\u2009kg in weight, a single adequate dose of engineered mRNA encapsulated in lipid nanoparticles (LNPs) induced high systemic Epo levels and strong physiological effects.", {"entities": [[146, 149, "GENE"]]}], ["Our results demonstrate that sequence-engineered mRNA has the potential to revolutionize human protein therapies.", {"entities": []}], ["Anthropogenic release of pollutants into the environment is especially harmful to growing fetuses and young children.", {"entities": []}], ["These populations are at an increased risk of damage because exposure to pollutants during critical periods of development can cause many impairments.", {"entities": []}], ["Children\u2019s exposure to mixtures of metals could be responsible for the rising numbers of neurological disorders surfacing in Iraqi children.", {"entities": []}], ["Titanium (Ti) and magnesium (Mg) are heavily used in war industries.", {"entities": []}], ["Exposure to Ti and Mg has been linked to the dust in occupation soldiers\u2019 lungs.", {"entities": []}], ["Hair samples of children in Hawija, Iraq ( n \u2009=\u200913) contained significantly higher levels of Ti compared to Iranian children ( n \u2009=\u200913) living near the Iraqi border (2080\u2009\u00b1\u2009940 vs 707\u2009\u00b1\u2009421\u00a0\u03bcg/kg, p \u2009<\u20090.0001).", {"entities": []}], ["Magnesium was 1.7 times higher in Hawija children compared to Iranian children (115,763\u2009\u00b1\u2009118,155 vs 67,650\u2009\u00b1\u200946,729\u00a0\u03bcg/kg).", {"entities": []}], ["In samples from Hawija, Ti was 1.3 times higher in children with neurodevelopmental disorders (2198\u2009\u00b1\u20091108 vs 1942\u2009\u00b1\u2009779\u00a0\u03bcg/kg), and Mg was 1.9 times higher in children without neurodevelopmental disorders (155,618\u2009\u00b1\u2009140,791 vs 81,602\u2009\u00b1\u200991,940\u00a0\u03bcg/kg).", {"entities": []}], ["Lead, arsenic, and cadmium in Hawija children with neurodevelopmental disorders ( n \u2009=\u20096) were 2.5, 2.2, and 1.37 times higher compared to non-disabled children ( n \u2009=\u20097).", {"entities": []}], ["To get a clear understanding of the current status of neurodevelopmental disorders in Iraqi children and to determine the magnitude of this suspected global health issue, registries should be set up to compile and aggregate data from hospitals, clinics, and health centers across the country.", {"entities": []}], ["Functional registries can develop collaborations with researchers toward finding causes of these disorders in Iraqi children and toward preventing them.", {"entities": []}], ["Confidence in results from monitoring genetic end points in environmentally or occupationally exposed individuals can be improved with knowledge of the normal variability of changes in genetic end points in the general population.", {"entities": []}], ["Confounding effects can be determined, and study interpretation can be improved by correlation of this variability with various lifestyle factors such as sex and age, smoking and drinking habits, viral infections, exposure to diagnostic X-rays, etc.", {"entities": []}], ["Eight blood samples were taken from each of 24 male and 24 female volunteers over a period of 2 years.", {"entities": []}], ["Questionnaires pertaining to lifestyle were completed at the time of each sampling.", {"entities": []}], ["Whole blood was cultured and slides prepared for chromosome aberration (CA) or sister chromatid exchange (SCE) analysis.", {"entities": []}], ["Separated mononuclear cells were cultured with a range of phytohemagglutinin concentrations, and the maximum level of mitogen-induced blastogenesis was determined by measurement of [3H]thymidine uptake.", {"entities": []}], ["There was a significant effect of both year and season of sampling for all three end points.", {"entities": []}], ["Because there was no consistent pattern in 2 successive years, effects were thought to be independent of season.", {"entities": []}], ["No significant effects in any of the three end points were found with respect to sex or age nor any of the other lifestyle factors, although SCE frequency and mitogen-induced blastogenesis were nearly always higher in females than in males.", {"entities": []}], ["These results point to the need for concurrent sampling of controls with exposed populations.", {"entities": []}], ["Genetic factors explain a proportion of the inter-individual variation in the risk for atherosclerotic events, but the genetic basis of atherosclerosis and atherothrombosis in families with Mendelian forms of premature atherosclerosis is incompletely understood.", {"entities": [[136, 151, "DISEASE"], [219, 234, "DISEASE"]]}], ["We set out to unravel the molecular pathology in a large kindred with an autosomal dominant inherited form of premature atherosclerosis.", {"entities": [[120, 135, "DISEASE"]]}], ["Parametric linkage analysis was performed in a pedigree comprising 4 generations, of which a total of 11 members suffered from premature vascular events.", {"entities": []}], ["A parametric LOD-score of 3.31 was observed for a 4.4 Mb interval on chromosome 12.", {"entities": [[54, 56, "GENE"]]}], ["Upon sequencing, a non-synonymous variant in KERA (c.920C>G; p.Ser307Cys) was identified.", {"entities": [[45, 49, "GENE"]]}], ["The variant was absent from nearly 28,000 individuals, including 2,571 patients with premature atherosclerosis.", {"entities": [[95, 110, "DISEASE"]]}], ["KERA, a proteoglycan protein, was expressed in lipid-rich areas of human atherosclerotic lesions, but not in healthy arterial specimens.", {"entities": [[0, 4, "GENE"]]}], ["Moreover, KERA expression in plaques was significantly associated with plaque size in a carotid-collar Apoe mice (r A rare variant in KERA was identified in a large kindred with premature atherosclerosis.", {"entities": [[188, 203, "DISEASE"], [10, 14, "GENE"], [134, 138, "GENE"], [103, 107, "GENE"], [10, 14, "GENE"], [134, 138, "GENE"]]}], ["The identification of KERA in atherosclerotic plaque specimen in humans and mice lends support to its potential role in atherosclerosis.", {"entities": [[120, 135, "DISEASE"], [22, 26, "GENE"]]}], ["Allergic skin inflammation such as atopic dermatitis (AD), which is characterized by pruritus and inflammation, is regulated partly through the activity of regulatory T cells (Tregs).", {"entities": [[35, 52, "DISEASE"], [42, 52, "DISEASE"]]}], ["Tregs play key roles in the immune response by preventing or suppressing the differentiation, proliferation and function of various immune cells, including CD4 The ability of FFO and NFO to modulate the immune system was investigated using a mouse model of AD.", {"entities": [[156, 159, "GENE"]]}], ["Administration of FFO or NFO in the drinking water alleviated the allergic inflammation in the skin, and FFO was more effective than NFO.", {"entities": []}], ["FFO treatment did increase the expression of the immune-suppressive cytokines TGF-\u03b2 and IL-10.", {"entities": []}], ["In addition, ingestion of FFO increased Foxp3 expression and the number of CD4 These results suggest that the anti-allergic effect of FFO is associated with enrichment of CD4", {"entities": [[40, 45, "GENE"], [75, 78, "GENE"], [171, 174, "GENE"], [75, 78, "GENE"], [171, 174, "GENE"]]}], ["Prevention of the onset of depression in adolescence may prevent social dysfunction, teenage pregnancy, substance abuse, suicide, and mental health conditions in adulthood.", {"entities": [[104, 119, "DISEASE"]]}], ["New technologies allow delivery of prevention programs scalable to large and disparate populations.", {"entities": []}], ["To develop and test the novel mobile phone delivery of a depression prevention intervention for adolescents.", {"entities": []}], ["We describe the development of the intervention and the results of participants\u2019 self-reported satisfaction with the intervention.", {"entities": []}], ["The intervention was developed from 15 key messages derived from cognitive behavioral therapy (CBT).", {"entities": []}], ["The program was fully automated and delivered in 2 mobile phone messages/day for 9 weeks, with a mixture of text, video, and cartoon messages and a mobile website.", {"entities": []}], ["Delivery modalities were guided by social cognitive theory and marketing principles.", {"entities": []}], ["The intervention was compared with an attention control program of the same number and types of messages on different topics.", {"entities": []}], ["A double-blind randomized controlled trial was undertaken in high schools in Auckland, New Zealand, from June 2009 to April 2011.", {"entities": []}], ["A total of 1348 students (13\u201317 years of age) volunteered to participate at group sessions in schools, and 855 were eventually randomly assigned to groups.", {"entities": []}], ["Of these, 835 (97.7%) self-completed follow-up questionnaires at postprogram interviews on satisfaction, perceived usefulness, and adherence to the intervention.", {"entities": []}], ["Over three-quarters of participants viewed at least half of the messages and 90.7% (379/418) in the intervention group reported they would refer the program to a friend.", {"entities": []}], ["Intervention group participants said the intervention helped them to be more positive (279/418, 66.7%) and to get rid of negative thoughts (210/418, 50.2%)\u2014significantly higher than proportions in the control group.", {"entities": []}], ["Key messages from CBT can be delivered by mobile phone, and young people report that these are helpful.", {"entities": []}], ["Change in clinician-rated depression symptom scores from baseline to 12 months, yet to be completed, will provide evidence on the effectiveness of the intervention.", {"entities": []}], ["If proven effective, this form of delivery may be useful in many countries lacking widespread mental health services but with extensive mobile phone coverage.", {"entities": []}], ["Australia New Zealand Clinical Trials Registry (ACTRN): 12609000405213; http://www.anzctr.org.au/trial_view.aspx?ID=83667 (Archived by WebCite at http://www.webcitation.org/64aueRqOb)", {"entities": []}], ["Thrombocytosis has been associated with COPD prevalence and increased all-cause mortality in patients with acute exacerbation of COPD (AECOPD); but whether it is associated with morbidity in stable COPD is unknown.", {"entities": [[0, 14, "DISEASE"]]}], ["This study aims to determine the association of thrombocytosis with COPD morbidity including reported AECOPD, respiratory symptoms and exercise capacity.", {"entities": [[48, 62, "DISEASE"]]}], ["Participants with COPD were included from two multi-center observational studies (SPIROMICS and COPDGene).", {"entities": []}], ["Cross-sectional associations of thrombocytosis (platelet count \u2265350\u2009\u00d7\u200910 Thrombocytosis was present in 124/1820 (6.8%) SPIROMICS participants and 111/2185 (5.1%) COPDGene participants.", {"entities": [[32, 46, "DISEASE"], [73, 87, "DISEASE"]]}], ["In meta-analysis thrombocytosis was associated with any AECOPD (adjusted odds ratio [aOR] 1.5; 95% confidence interval [95% CI]: 1.1\u20132.0), severe AECOPD (aOR 1.5; 95% CI: 1.1\u20132.2), dyspnea (mMRC\u2009\u2265\u20092 aOR 1.4; 95% CI: 1.0\u20131.9), respiratory symptoms (CAT\u2009\u2265\u200910 aOR 1.6; 95% CI: 1.1\u20132.4), and higher SGRQ score (\u03b2 2.7; 95% CI: 0.5, 5).", {"entities": [[17, 31, "DISEASE"]]}], ["Thrombocytosis was also associated with classification into Global Initiative for Chronic Obstructive Lung Disease (GOLD) group D (aOR 1.7 95% CI: 1.2\u20132.4).", {"entities": [[0, 14, "DISEASE"]]}], ["Thrombocytosis was associated with higher likelihood of prior exacerbation and worse symptoms.", {"entities": [[0, 14, "DISEASE"]]}], ["Platelet count, a commonly measured clinical assay, may be a biomarker for moderate-severe COPD symptoms, guide disease classification and intensity of treatment.", {"entities": []}], ["Future longitudinal studies investigating the role of platelets in COPD progression may be warranted.", {"entities": []}], ["ClinicalTrials.gov: NCT01969344 (SPIROMICS) and NCT00608764 (COPDGene).", {"entities": []}], ["Several studies have shown an association between chronic obstructive pulmonary disease (COPD) and cognitive impairment.", {"entities": [[50, 87, "DISEASE"]]}], ["These studies have been limited by methodological issues such as diagnostic uncertainty, cross-sectional design, small sample size, or lack of appropriate referent group.", {"entities": []}], ["This study aimed to elucidate the association between COPD and the risk of cognitive impairment compared to referent subjects without COPD.", {"entities": []}], ["In patients with established COPD, we evaluated the impact of disease severity and impairment of respiratory physiology on cognitive impairment and the potential mitigating role of oxygen therapy.", {"entities": []}], ["We used the Function, Living, Outcomes and Work (FLOW) cohort study of adults with COPD (n = 1202) and referent subjects matched by age, sex, and race (n = 302) to study the potential risk factors for cognitive impairment among subjects with COPD.", {"entities": []}], ["Cognitive impairment was defined as a Mini-Mental State Exam score of <24 points.", {"entities": []}], ["Disease severity was using Forced Expiratory Volume in one second (FEV 1 ); the validated COPD Severity Score; and the BMI (Body Mass Index), Obstruction, Dyspnea, Exercise Capacity (BODE) Index.", {"entities": [[67, 70, "GENE"]]}], ["Multivariable analysis was used to control for confounding by age, sex, race, educational attainment, and cigarette smoking.", {"entities": []}], ["COPD was associated with a substantive risk of cognitive impairment compared to referent subjects (odds ratio [OR] 2.42; 95% confidence interval [CI] 1.043\u20136.64).", {"entities": []}], ["Among COPD patients, none of the COPD severity measures were associated with the risk of cognitive impairment ( P > 0.20 in all cases).", {"entities": []}], ["Low baseline oxygen saturation was related to increased risk of cognitive impairment (OR for oxygen saturation \u226488% (OR 5.45; 95% CI 1.014\u201329.2; P = 0.048).", {"entities": []}], ["Conversely, regular use of supplemental oxygen therapy decreased the risk for cognitive impairment (OR 0.14; 95% CI 0.07\u20130.27; P < 0.0001).", {"entities": []}], ["COPD is a major risk factor for cognitive impairment.", {"entities": []}], ["Among patients with COPD, hypoxemia is a major contributor and regular use of home oxygen is protective.", {"entities": []}], ["Health care providers should consider screening their COPD patients for cognitive impairment.", {"entities": []}], ["Age-related variations in genes and microRNAs expression and DNA methylation have been reported respectively; however, their interactions during aging are unclear.", {"entities": []}], ["We therefore investigated alterations in the transcriptomes, miRNAomes and DNA methylomes in the same CD4", {"entities": [[102, 105, "GENE"]]}], ["The purpose of this study was to compare the Korean COPD guideline to GOLD consensus report in terms of acute exacerbation.", {"entities": []}], ["A total of 361 patients were enrolled in this study, and 16.9% of them experienced acute exacerbation during the follow-up.", {"entities": []}], ["A total of 6.3% of patients in GOLD A, 9.5% in GOLD B, 7.7% in GOLD C and 17.0% of GOLD D experienced exacerbation during the first year of follow-up, respectively ( P =0.09).", {"entities": []}], ["There was no one who experienced exacerbation during the first year of follow-up in the Korean group 'ga'.", {"entities": []}], ["The 12-month exacerbation rates of Korean group 'na' and 'da' were 4.5% and 16.0%, respectively ( P <0.001).", {"entities": []}], ["We explore the experience of exacerbation in patients with change of their risk group after applying Korean COPD guideline.", {"entities": []}], ["A total of 16.0% of the patients who were reclassified from GOLD A to Korean group 'da' experienced acute exacerbation,and 15.3% from GOLD B to Korean group 'da' experienced acute exacerbation.", {"entities": []}], ["In summary, the Korean COPD guideline is useful to differentiate the high risk from low risk for exacerbation in terms of spirometry.", {"entities": []}], ["This indicates that application of Korean COPD guideline is appropriate to treat Korean COPD patients.", {"entities": []}], ["Due to the fact that some individuals are allergic to crustaceans, the presumed relationship between allergy and the presence of chitin in crustaceans has been investigated.", {"entities": []}], ["In vivo , chitin is part of complex structures with other organic and inorganic compounds: in arthropods chitin is covalently linked to proteins and tanned by quinones, in fungi it is covalently linked to glucans, while in bacteria chitin is diversely combined according to Gram(+/\u2212) classification.", {"entities": []}], ["On the other hand, isolated, purified chitin is a plain polysaccharide that, at the nano level, presents itself as a highly associated structure, recently refined in terms of regularity, nature of bonds, crystallinity degree and unusual colloidal behavior.", {"entities": []}], ["Chitins and modified chitins exert a number of beneficial actions, i.e.", {"entities": []}], [", (i) they stimulate macrophages by interacting with receptors on the macrophage surface that mediate the internalization of chitin particles to be degraded by lysozyme and N -acetyl-\u03b2-glucosaminidase (such as Nod-like, Toll-like, lectin, Dectin-1, leukotriene 134 and mannose receptors); (ii) the macrophages produce cytokines and other compounds that confer non-specific host resistance against bacterial and viral infections, and anti-tumor activity; (iii) chitin is a strong Th1 adjuvant that up-regulates Th1 immunity induced by heat-killed Mycobacterium bovis , while down- regulating Th2 immunity induced by mycobacterial protein; (iv) direct intranasal application of chitin microparticles into the lung was also able to significantly down-regulate allergic response to Dermatophagoids pteronyssinus and Aspergillus fumigatus in a murine model of allergy; (v) chitin microparticles had a beneficial effect in preventing and treating histopathologic changes in the airways of asthmatic mice; (vi) authors support the fact that chitin depresses the development of adaptive type 2 allergic responses.", {"entities": []}], ["Since the expression of chitinases, chitrotriosidase and chitinase-like proteins is greatly amplified during many infections and diseases, the common feature of chitinase-like proteins and chitinase activity in all organisms appears to be the biochemical defense of the host.", {"entities": []}], ["Unfortunately, conceptual and methodological errors are present in certain recent articles dealing with chitin and allergy, i.e.", {"entities": []}], [", (1) omitted consideration of mammalian chitinase and/or chitotriosidase secretion, accompanied by inactive chitinase-like proteins, as an ancestral defensive means against invasion, capable to prevent the insurgence of allergy; (2) omitted consideration of the fact that the mammalian organism recognizes more promptly the secreted water soluble chitinase produced by a pathogen, rather than the insoluble and well protected chitin within the pathogen itself; (3) superficial and incomplete reports and investigations on chitin as an allergen, without mentioning the potent allergen from crustacean flesh, tropomyosine; (4) limited perception of the importance of the chemical/biochemical characteristics of the isolated chitin or chitosan for the replication of experiments and optimization of results; and (5) lack of interdisciplinarity.", {"entities": []}], ["There is quite a large body of knowledge today on the use of chitosans as biomaterials, and more specifically as drug carriers for a variety of applications: the delivery routes being the same as those adopted for the immunological studies.", {"entities": []}], ["Said articles, that devote attention to the safety and biocompatibility aspects, never reported intolerance or allergy in individuals and animals, even when the quantities of chitosan used in single experiments were quite large.", {"entities": []}], ["Therefore, it is concluded that crab, shrimp, prawn and lobster chitins, as well as chitosans of all grades, once purified, should not be considered as \u201ccrustacean derivatives\u201d, because the isolation procedures have removed proteins, fats and other contaminants to such an extent as to allow them to be classified as chemicals regardless of their origin.", {"entities": []}], ["Chronic idiopathic urticaria (CIU) is a common cutaneous disorder but the influence of initial treatment modality on long-term control is not known.", {"entities": [[19, 28, "DISEASE"]]}], ["The aim of this study was to evaluate clinical features, and the influence of initial treatment modality on long-term control.", {"entities": []}], ["641 CIU patients were enrolled from the allergy clinic in a tertiary referral hospital.", {"entities": []}], ["Disease duration, aggravating factors and treatment modality at each visit were evaluated.", {"entities": []}], ["Times required to reach a controlled state were analyzed according to initial treatment modality, using Kaplan-Meier survival curves, the Cox proportional-hazards model, and propensity scores.", {"entities": []}], ["Female to male ratio was 1.7: 1; mean age at onset was 40.5 years.", {"entities": []}], ["The most common aggravating factors were food (33.5%), stress (31.5%) and fatigue (21.6%).", {"entities": []}], ["Most patients (82.2%) used H1-antihistamines alone as initial treatment while 17% used a combination treatment with oral corticosteroids.", {"entities": []}], ["There was no significant difference in the time taken to reach a controlled state between patients treated with single vs multiple H1-antihistamines or between those who received H1-antihistamine monotherapy vs. a combination therapy with oral corticosteroids.", {"entities": []}], ["The time required to control CIU is not reduced by use of multiple H1-antihistamines or oral corticosteroids in the initial treatment.", {"entities": []}], ["Due to a lack of an appropriate disease-specific patient-reported outcome (PRO) instrument for chronic heart failure including its social support and treatment aspects in China, this study was performed to develop a patient-reported outcome measure (PROM) for patients with chronic heart failure and evaluate its reliability, validity, and feasibility.", {"entities": []}], ["According to the standard PROM guidelines established by the Food and Drug Administration, an item pool was formed by reviewing a large amount of relevant literature and interviewing patients with chronic heart failure about their main symptoms.", {"entities": []}], ["Thus, the primary scale was created after adjusting the items and language with the help of patients and experts in the field.", {"entities": []}], ["Next, 155 patients from 8 hospitals in different districts were recruited for a pilot survey using questionnaires containing these items.", {"entities": []}], ["The patients\u2019 responses were analyzed using the classical test theory and item response theory to select high-quality items and determine the subdomains of the scale.", {"entities": []}], ["This was followed by a formal investigation in the same eight hospitals.", {"entities": []}], ["In total, 360 patients and 100 healthy subjects were included to evaluate the reliability, validity, and feasibility of the items.", {"entities": []}], ["Through this process, the final scale was established.", {"entities": []}], ["The final scale comprised 12 subdomains with 57 items related to physical, psychological, social, and therapeutic areas.", {"entities": []}], ["The data analysis results of the formal investigation showed that the PROM for chronic heart failure had good reliability, validity, and feasibility.", {"entities": []}], ["Reliability was verified by Cronbach\u2019s alpha coefficient, which was 0.913 for the total scale, 0.903 for the physical domain, 0.941 for the psychological domain, 0.827 for the social domain, and 0.839 for the therapeutic domain.", {"entities": []}], ["The construct validity results met the relative criteria of confirmatory factor analysis.", {"entities": []}], ["Discriminant validity was represented by score comparisons of nine subdomains.", {"entities": []}], ["The response rate and the effective rate of return of the CHF-PROM were 98.94% and 98.92%, respectively.", {"entities": []}], ["The final scale coincides with the theoretical framework and better reflects the overall quality of life of patients with chronic heart failure.", {"entities": []}], ["This scale can be used as a valid instrument to evaluate clinical treatment and clinical trials of chronic heart failure.", {"entities": []}], ["The online version of this article (10.1186/s12955-018-0874-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Computer-mediated educational applications can provide a self-paced, interactive environment to deliver educational content to individuals about their health condition.", {"entities": []}], ["These programs have been used to deliver health-related information about a variety of topics, including breast cancer screening, asthma management, and injury prevention.", {"entities": [[105, 118, "DISEASE"], [130, 136, "DISEASE"], [112, 118, "DISEASE"]]}], ["We have designed the Patient Education and Motivation Tool (PEMT), an interactive computer-based educational program based on behavioral, cognitive, and humanistic learning theories.", {"entities": [[60, 64, "GENE"]]}], ["The tool is designed to educate users and has three key components: screening, learning, and evaluation.", {"entities": []}], ["The objective of this tutorial is to illustrate a heuristic evaluation using a computer-based patient education program (PEMT) as a case study.", {"entities": [[121, 125, "GENE"]]}], ["The aims were to improve the usability of PEMT through heuristic evaluation of the interface; to report the results of these usability evaluations; to make changes based on the findings of the usability experts; and to describe the benefits and limitations of applying usability evaluations to PEMT.", {"entities": [[42, 46, "GENE"], [294, 298, "GENE"], [42, 46, "GENE"], [294, 298, "GENE"]]}], ["PEMT was evaluated by three usability experts using Nielsen\u2019s usability heuristics while reviewing the interface to produce a list of heuristic violations with severity ratings.", {"entities": [[0, 4, "GENE"]]}], ["The violations were sorted by heuristic and ordered from most to least severe within each heuristic.", {"entities": []}], ["A total of 127 violations were identified with a median severity of 3 (range 0 to 4 with 0 = no problem to 4 = catastrophic problem).", {"entities": []}], ["Results showed 13 violations for visibility (median severity = 2), 38 violations for match between system and real world (median severity = 2), 6 violations for user control and freedom (median severity = 3), 34 violations for consistency and standards (median severity = 2), 11 violations for error severity (median severity = 3), 1 violation for recognition and control (median severity = 3), 7 violations for flexibility and efficiency (median severity = 2), 9 violations for aesthetic and minimalist design (median severity = 2), 4 violations for help users recognize, diagnose, and recover from errors (median severity = 3), and 4 violations for help and documentation (median severity = 4).", {"entities": []}], ["We describe the heuristic evaluation method employed to assess the usability of PEMT, a method which uncovers heuristic violations in the interface design in a quick and efficient manner.", {"entities": [[80, 84, "GENE"]]}], ["Bringing together usability experts and health professionals to evaluate a computer-mediated patient education program can help to identify problems in a timely manner.", {"entities": []}], ["This makes this method particularly well suited to the iterative design process when developing other computer-mediated health education programs.", {"entities": []}], ["Heuristic evaluations provided a means to assess the user interface of PEMT.", {"entities": [[71, 75, "GENE"]]}], ["Patients with chronic obstructive pulmonary disease (COPD) often experience exacerbations of their disease, sometimes requiring hospital admission and being associated with increased mortality.", {"entities": [[14, 51, "DISEASE"]]}], ["Although previous studies have reported mortality from exacerbations of COPD, there is limited information about prediction of individual in-hospital mortality.", {"entities": []}], ["We therefore aimed to use data from a nationwide inpatient database in Japan to generate a nomogram for predicting in-hospital mortality from patients\u2019 characteristics on admission.", {"entities": []}], ["We retrospectively collected data on patients with COPD who had been admitted for exacerbations and been discharged between July 1, 2010 and March 31, 2013.", {"entities": []}], ["We performed multivariable logistic regression analysis to examine factors associated with in-hospital mortality and thereafter used these factors to develop a nomogram for predicting in-hospital prognosis.", {"entities": []}], ["The study comprised 3,064 eligible patients.", {"entities": []}], ["In-hospital death occurred in 209 patients (6.8%).", {"entities": []}], ["Higher mortality was associated with older age, being male, lower body mass index, disturbance of consciousness, severe dyspnea, history of mechanical ventilation, pneumonia, and having no asthma on admission.", {"entities": [[164, 173, "DISEASE"], [189, 195, "DISEASE"]]}], ["We developed a nomogram based on these variables to predict in-hospital mortality.", {"entities": []}], ["The concordance index of the nomogram was 0.775.", {"entities": []}], ["Internal validation was performed by a bootstrap method with 50 resamples, and calibration plots were found to be well fitted to predict in-hospital mortality.", {"entities": []}], ["We developed a nomogram for predicting in-hospital mortality of exacerbations of COPD.", {"entities": []}], ["This nomogram could help clinicians to predict risk of in-hospital mortality in individual patients with COPD exacerbation.", {"entities": []}], ["A new influenza A (H1N1) virus was first found in April 2009 and proceeded to cause a global pandemic.", {"entities": [[6, 15, "DISEASE"]]}], ["We compare the epidemiology and clinical presentation of seasonal influenza A (H1N1 and H3N2) and 2009 pandemic influenza A (H1N1) (pH1N1) using a prospective surveillance system for acute respiratory disease in Guatemala.", {"entities": [[66, 75, "DISEASE"], [112, 121, "DISEASE"]]}], ["Patients admitted to two public hospitals in Guatemala in 2008\u20132009 who met a pneumonia case definition, and ambulatory patients with influenza-like illness (ILI) at 10 ambulatory clinics were invited to participate.", {"entities": [[134, 143, "DISEASE"], [78, 87, "DISEASE"]]}], ["Data were collected through patient interview, chart abstraction and standardized physical and radiological exams.", {"entities": []}], ["Nasopharyngeal swabs were taken from all enrolled patients for laboratory diagnosis of influenza A virus infection with real-time reverse transcription polymerase chain reaction.", {"entities": [[87, 96, "DISEASE"]]}], ["We identified 1,744 eligible, hospitalized pneumonia patients, enrolled 1,666 (96%) and tested samples from 1,601 (96%); 138 (9%) had influenza A virus infection.", {"entities": [[134, 143, "DISEASE"], [43, 52, "DISEASE"]]}], ["Surveillance for ILI found 899 eligible patients, enrolled 801 (89%) and tested samples from 793 (99%); influenza A virus infection was identified in 246 (31%).", {"entities": [[104, 113, "DISEASE"]]}], ["The age distribution of hospitalized pneumonia patients was similar between seasonal H1N1 and pH1N1 ( P\u200a=\u200a 0.21); the proportion of pneumonia patients <1 year old with seasonal H1N1 (39%) and pH1N1 (37%) were similar ( P\u200a=\u200a 0.42).", {"entities": [[37, 46, "DISEASE"], [132, 141, "DISEASE"]]}], ["The clinical presentation of pH1N1 and seasonal influenza A was similar for both hospitalized pneumonia and ILI patients.", {"entities": [[48, 57, "DISEASE"], [94, 103, "DISEASE"]]}], ["Although signs of severity (admission to an intensive care unit, mechanical ventilation and death) were higher among cases of pH1N1 than seasonal H1N1, none of the differences was statistically significant.", {"entities": []}], ["Small sample sizes may limit the power of this study to find significant differences between seasonal influenza A and pH1N1.", {"entities": [[102, 111, "DISEASE"]]}], ["In Guatemala, influenza, whether seasonal or pH1N1, appears to cause severe disease mainly in infants; targeted vaccination of children should be considered.", {"entities": [[14, 23, "DISEASE"]]}], ["The analysis of gene expression in idiopathic epiretinal membranes (iERMs) may help elucidate ERM formation and its pathology.", {"entities": []}], ["Here, we conducted a case-control study, in order to determine the expression levels of cytokines and other genes in eyes with macular hole (MH) or iERM.", {"entities": []}], ["Twenty eyes, obtained from seven male and 13 female patients, were included in the study.", {"entities": []}], ["The average age of the study subjects was 69.1 \u00b1 7.67 years, and 15 eyes had iERM, while five eyes had MH.", {"entities": []}], ["Irrigation solution samples were collected during vitrectomy, centrifuged, and the levels of cytokine and other mRNAs in the sediment were assessed using real-time PCR.", {"entities": []}], ["The expression level of 11 cytokine genes, four transcription factor genes, two cytoskeletal genes, and genes encoding two extracellular matrix proteins in eyes with MH or iERM were determined and compared.", {"entities": []}], ["The expression levels of interleukin 6 ( IL6 ), tumor growth factor B2 ( TGFB2) , vascular endothelial growth factor A ( VEGFA ), chemokine C-X-C motif ligand 1 ( CXCL1 ), v-rel avian reticuloendotheliosis viral oncogene homolog A ( RELA ), glial fibrillary acidic protein ( GFAP ), and tenascin C ( TNC ) were significantly higher in eyes with iERM than in eyes with MH.", {"entities": [[41, 44, "GENE"], [73, 78, "GENE"], [121, 126, "GENE"], [163, 168, "GENE"], [233, 237, "GENE"], [275, 279, "GENE"], [300, 303, "GENE"]]}], ["The expression of these genes was not associated with the preoperative visual acuity of the investigated patients.", {"entities": []}], ["The obtained results indicate that real-time PCR analysis of irrigation solution samples collected during vitrectomy can help assess the expression levels of several genes, and that iERM is associated with the expression of pro-inflammatory genes and the genes expressed during angiogenesis and wound healing process ( IL6 , TGFB2 , VEGFA , CXCL1 , RELA , GFAP , and TNC ).", {"entities": [[319, 322, "GENE"], [325, 330, "GENE"], [333, 338, "GENE"], [341, 346, "GENE"], [349, 353, "GENE"], [356, 360, "GENE"], [367, 370, "GENE"]]}], ["Severe health risks caused by PM 10 (particulate matter with an aerodynamic diameter \u226410 \u03bcm) pollution have induced inevitable economic losses and have rendered pressure on the sustainable development of society as a whole.", {"entities": []}], ["In China, with the \u201cPolluters Pay Principle\u201d, polluters should pay for the pollution they have caused, but how much they should pay remains an intractable problem for policy makers.", {"entities": []}], ["This paper integrated an epidemiological exposure-response model with economics methods, including the Amended Human Capital (AHC) approach and the Cost of Illness (COI) method, to value the economic loss of PM 10 -related health risks in 16 districts and also 4 functional zones in Beijing from 2008 to 2012.", {"entities": []}], ["The results show that from 2008 to 2012 the estimated annual deaths caused by PM 10 in Beijing are around 56,000, 58,000, 63,000, 61,000 and 59,000, respectively, while the economic losses related to health damage increased from around 23 to 31 billion dollars that PM 10 polluters should pay for pollution victims between 2008 and 2012.", {"entities": []}], ["It is illustrated that not only PM 10 concentration but also many other social economic factors influence PM 10 -related health economic losses, which makes health economic losses show a time lag discrepancy compared with the decline of PM 10 concentration.", {"entities": []}], ["In conclusion, health economic loss evaluation is imperative in the pollution indemnity system establishment and should be considered for the urban planning and policy making to control the burgeoning PM 10 health economic loss.", {"entities": []}], ["Human rhinoviruses (HRVs) are the most frequently detected pathogens in acute respiratory tract infections (ARTIs) and yet little is known about the prevalence, recurrence, structure and clinical impact of individual members.", {"entities": []}], ["During 2007, the complete coding sequences of six previously unknown and highly divergent HRV strains were reported.", {"entities": []}], ["To catalogue the molecular and clinical features distinguishing the divergent HRV strains, we undertook, for the first time, in sili co analyses of all available polyprotein sequences and performed retrospective reviews of the medical records of cases in which variants of the prototype strain, HRV-QPM, had been detected.", {"entities": []}], ["Genomic analyses revealed that the six divergent strains, residing within a clade we previously called HRV A2, had the shortest polyprotein of all picornaviruses investigated.", {"entities": []}], ["Structure-based amino acid alignments identified conserved motifs shared among members of the genus Rhinovirus as well as substantive deletions and insertions unique to the divergent strains.", {"entities": []}], ["Deletions mostly affected regions encoding proteins traditionally involved in antigenicity and serving as HRV and HEV receptor footprints.", {"entities": []}], ["Because the HRV A2 strains cannot yet be cultured, we created homology models of predicted HRV-QPM structural proteins.", {"entities": []}], ["In silico comparisons confirmed that HRV-QPM was most closely related to the major group HRVs.", {"entities": []}], ["HRV-QPM was most frequently detected in infants with expiratory wheezing or persistent cough who had been admitted to hospital and required supplemental oxygen.", {"entities": []}], ["It was the only virus detected in 65% of positive individuals.", {"entities": []}], ["These observations contributed to an objective clinical impact ranging from mild to severe.", {"entities": []}], ["The divergent strains did not meet classification requirements for any existing species of the genus Rhinovirus or Enterovirus .", {"entities": []}], ["HRV A2 strains should be partitioned into at least one new species, putatively called Human rhinovirus C , populated by members detected with high frequency, from individuals with respiratory symptoms requiring hospital admission.", {"entities": []}], ["In this work, one of Zingiber officinale components, 10-shogaol, was tested with 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging, metal chelating ability, and reducing power to show antioxidant activity.", {"entities": []}], ["10-Shogaol promoted human normal epidermal keratinocytes and dermal fibroblasts cell growths.", {"entities": []}], ["10-Shogaol enhanced growth factor production in transforming growth factor-\u03b2 (TGF-\u03b2), platelet derived growth factor-\u03b1\u03b2 (PDGF-\u03b1\u03b2) and vascular endothelial growth factors (VEGF) of both cells.", {"entities": []}], ["In the in vitro wound healing assay for 12 or 24 h, with 10-shogaol, the fibroblasts and keratinocytes migrated more rapidly than the vehicle control group.", {"entities": []}], ["Thus, this study substantiates the target compound, 10-shogaol, as an antioxidant for human skin cell growth and a migration enhancer with potential to be a novel wound repair agent.", {"entities": []}], ["Since pathophysiologic evidence has been raised to suggest that obesity could facilitate an allergic reaction, obesity has been known as an independent risk factor for allergic disease such as asthma.", {"entities": [[64, 71, "DISEASE"], [111, 118, "DISEASE"], [193, 199, "DISEASE"]]}], ["However, the relationship between sedentary behavior and lifestyle which could lead to obesity, and those allergic diseases remains unclear.", {"entities": [[87, 94, "DISEASE"]]}], ["We analyzed the relations between physical activity, including sitting time for study, sitting time for leisure and sleep time, and obesity, asthma, allergic rhinitis, and atopic dermatitis using the Korea Youth Risk Behavior Web-based Survey, which was conducted in 2013.", {"entities": [[149, 166, "DISEASE"], [172, 189, "DISEASE"], [158, 166, "DISEASE"], [132, 139, "DISEASE"], [141, 147, "DISEASE"], [179, 189, "DISEASE"]]}], ["Total 53769 adolescent participants (12 through 18 years old) were analyzed using simple and multiple logistic regression analyses with complex sampling.", {"entities": []}], ["Longer sitting time for study and short sitting time for leisure were associated with allergic rhinitis.", {"entities": [[86, 103, "DISEASE"], [95, 103, "DISEASE"]]}], ["High physical activity and short sleep time were associated with asthma, allergic rhinitis, and atopic dermatitis.", {"entities": [[73, 90, "DISEASE"], [96, 113, "DISEASE"], [82, 90, "DISEASE"], [65, 71, "DISEASE"], [103, 113, "DISEASE"]]}], ["Underweight was negatively associated with atopic dermatitis, whereas overweight was positively correlated with allergic rhinitis and atopic dermatitis.", {"entities": [[112, 129, "DISEASE"], [43, 60, "DISEASE"], [134, 151, "DISEASE"], [121, 129, "DISEASE"], [50, 60, "DISEASE"], [141, 151, "DISEASE"]]}], ["High physical activity, and short sleep time were associated with asthma, allergic rhinitis, and atopic dermatitis.", {"entities": [[74, 91, "DISEASE"], [97, 114, "DISEASE"], [83, 91, "DISEASE"], [66, 72, "DISEASE"], [104, 114, "DISEASE"]]}], ["Long-acting beta-agonists were one of the first-choice bronchodilator agents for stable chronic obstructive pulmonary disease.", {"entities": [[88, 125, "DISEASE"]]}], ["But the impact of long-acting beta-agonists on mortality was not well investigated.", {"entities": []}], ["National Emphysema Treatment Trial provided the data.", {"entities": []}], ["Severe and very severe stable chronic obstructive pulmonary disease patients who were eligible for volume reduction surgery were recruited at 17 clinical centers in United States during 1988\u20132002.", {"entities": [[30, 67, "DISEASE"]]}], ["We used the 6\u201310 year follow-up data of patients randomized to non-surgery treatment.", {"entities": []}], ["Hazard ratios for death by long-acting beta-agonists were estimated by three models using Cox proportional hazard analysis and propensity score matching were measured.", {"entities": []}], ["The pre-matching cohort was comprised of 591 patients (50.6% were administered long-acting beta-agonists.", {"entities": []}], ["Age: 66.6\u2009\u00b1\u20095.3 year old.", {"entities": []}], ["Female: 35.4%.", {"entities": []}], ["Forced expiratory volume in one second (%predicted): 26.7\u2009\u00b1\u20097.1%.", {"entities": []}], ["Mortality during follow-up: 70.2%).", {"entities": []}], ["Hazard ratio using a multivariate Cox model in the pre-matching cohort was 0.77 (P\u2009=\u20090.010).", {"entities": []}], ["Propensity score matching was conducted (C-statics: 0.62.", {"entities": []}], ["No parameter differed between cohorts).", {"entities": []}], ["The propensity-matched cohort was comprised of 492 patients (50.0% were administered long-acting beta-agonists.", {"entities": []}], ["Age: 66.8\u2009\u00b1\u20095.1 year old.", {"entities": []}], ["Female: 34.8%.", {"entities": []}], ["Forced expiratory volume in one second (%predicted) 26.5\u2009\u00b1\u20096.8%.", {"entities": []}], ["Mortality during follow-up: 69.1%).", {"entities": []}], ["Hazard ratio using a univariate Cox model in the propensity-matched cohort was 0.77 (P\u2009=\u20090.017).", {"entities": []}], ["Hazard ratio using a multivariate Cox model in the propensity-matched cohort was 0.76 (P\u2009=\u20090.011).", {"entities": []}], ["Long-acting beta-agonists reduce mortality of severe and very severe chronic obstructive pulmonary disease patients.", {"entities": [[69, 106, "DISEASE"]]}], ["Decreasing traffic speeds increases the amount of time drivers have to react to road hazards, potentially averting collisions, and makes crashes that do happen less severe.", {"entities": []}], ["Boston\u2019s regional planning agency, the Metropolitan Area Planning Council (MAPC), in partnership with the Massachusetts Department of Public Health (MDPH), conducted a Health Impact Assessment (HIA) that examined the potential health impacts of a proposed bill in the state legislature to lower the default speed limits on local roads from 30 miles per hour (mph) to 25 mph.", {"entities": []}], ["The aim was to reduce vehicle speeds on local roads to a limit that is safer for pedestrians, cyclists, and children.", {"entities": []}], ["The passage of this proposed legislation could have had far-reaching and potentially important public health impacts.", {"entities": []}], ["Lower default speed limits may prevent around 18 fatalities and 1200 serious injuries to motorists, cyclists and pedestrians each year, as well as promote active transportation by making local roads feel more hospitable to cyclists and pedestrians.", {"entities": []}], ["While a lower speed limit would increase congestion and slightly worsen air quality, the benefits outweigh the costs from both a health and economic perspective and would save the state approximately $62 million annually from prevented fatalities and injuries.", {"entities": []}], ["Adipose-derived mesenchymal stem cells (ASCs) are a promising cell therapy to treat inflammatory and immune-mediated diseases.", {"entities": []}], ["Development of appropriate pre-clinical animal models is critical to determine safety and attain early efficacy data for the most promising therapeutic candidates.", {"entities": []}], ["Naturally occurring diseases in cats already serve as valuable models to inform human clinical trials in oncologic, cardiovascular, and genetic diseases.", {"entities": []}], ["The objective of this study was to complete a comprehensive side-by-side comparison of human and feline ASCs, with an emphasis on their immunomodulatory capacity and transcriptome.", {"entities": []}], ["Human and feline ASCs were evaluated for phenotype, immunomodulatory profile, and transcriptome.", {"entities": []}], ["Additionally, transwells were used to determine the role of cell-cell contact in ASC-mediated inhibition of lymphocyte proliferation in both humans and cats.", {"entities": []}], ["Similar to human ASCs, feline ASCs were highly proliferative at low passages and fit the minimal criteria of multipotent stem cells including a compatible surface protein phenotype, osteogenic capacity, and normal karyotype.", {"entities": []}], ["Like ASCs from all species, feline ASCs inhibited mitogen-activated lymphocyte proliferation in vitro, with or without direct ASC-lymphocyte contact.", {"entities": []}], ["Feline ASCs mimic human ASCs in their mediator secretion pattern, including prostaglandin E2, indoleamine 2,3 dioxygenase, transforming growth factor beta, and interleukin-6, all augmented by interferon gamma secretion by lymphocytes.", {"entities": []}], ["The transcriptome of three unactivated feline ASC lines were highly similar.", {"entities": []}], ["Functional analysis of the most highly expressed genes highlighted processes including: 1) the regulation of apoptosis; 2) cell adhesion; 3) response to oxidative stress; and 4) regulation of cell differentiation.", {"entities": []}], ["Finally, feline ASCs had a similar gene expression profile to noninduced human ASCs.", {"entities": []}], ["Findings suggest that feline ASCs modulate lymphocyte proliferation using soluble mediators that mirror the human ASC secretion pattern.", {"entities": []}], ["Uninduced feline ASCs have similar gene expression profiles to uninduced human ASCs, as revealed by transcriptome analysis.", {"entities": []}], ["These data will help inform clinical trials using cats with naturally occurring diseases as surrogate models for human clinical trials in the regenerative medicine arena.", {"entities": []}], ["The online version of this article (doi:10.1186/s13287-017-0528-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Basic and translational research on lung biology has discovered multiple progenitor cell types, specialized or facultative, responsible for turnover, renewal, and repair.", {"entities": []}], ["Isolation of populations of resident lung progenitor cells (LPCs) has been described by multiple protocols, and some have been successfully applied to healthy human lung tissue.", {"entities": []}], ["We aimed at understanding how different cell culture conditions may affect, in vitro, the phenotype of LPCs to create an ideal niche\u2010like microenvironment.", {"entities": []}], ["The influence of different substrates (i.e., fibronectin, gelatin, laminin) and the impact of a three\u2010dimensional/two\u2010dimensional (3D/2D) culture switch on the biology of LPCs isolated as lung spheroids (LSs) from normal adult human lung biopsy specimens were investigated.", {"entities": [[204, 207, "GENE"]]}], ["We applied a spheroid culture system as the selective/inductive step for progenitor cell culture, as described in many biological systems.", {"entities": []}], ["The data showed a niche\u2010like proepithelial microenvironment inside the LS, highly sensitive to the 3D culture system and significantly affecting the phenotype of adult LPCs more than culture substrate.", {"entities": []}], ["LSs favor epithelial phenotypes and LPC maintenance and contain cells more responsive to specific commitment stimuli than 2D monolayer cultures, while secreting a distinctive set of paracrine factors.", {"entities": [[0, 3, "GENE"]]}], ["We have shown for the first time, to our knowledge, how culture as 3D LSs can affect LPC epithelial phenotype and produce strong paracrine signals with a distinctive secretomic profile compared with 2D monolayer conditions.", {"entities": [[70, 73, "GENE"]]}], ["These findings suggest novel approaches to maintain ex vivo LPCs for basic and translational studies.", {"entities": []}], ["S tem C ells T ranslational M edicine 2017;6:767\u2013777", {"entities": []}], ["Little is known about how early postoperative complications after oesophagectomy for cancer influence healthcare utilisation in the long-term.", {"entities": [[85, 91, "DISEASE"]]}], ["We hypothesised that these complications also increase healthcare utilisation long after the recovery period.", {"entities": []}], ["This was a prospective, nationwide Swedish population-based cohort study of patients who underwent curatively intended oesophagectomy for cancer in 2001-2005 and survived at least 1 year postoperatively (n = 390).", {"entities": [[138, 144, "DISEASE"]]}], ["Total days of in-hospitalisation, number of hospitalisations and number of visits to the outpatient clinic within 5 years of surgery were analysed using quasi-Poisson models with adjustment for patient, tumour and treatment characteristics and are expressed as incidence rate ratios (IRR) and 95% confidence intervals (CI).", {"entities": []}], ["There was an increased in-hospitalisation period 1-5 years after surgery in patients with more than 1 complication (IRR 1.5, 95% CI 1.0-2.4).", {"entities": []}], ["The IRR for the number of hospitalisations by number of complications was 1.1 (95% CI 0.7-1.6), and 1.2 (95% CI 0.9-1.6) for number of outpatient visits in patients with more than 1 complication.", {"entities": []}], ["The IRR for in-hospitalisation period 1-5 years following oesophagectomy was 1.8 (95% CI 1.0-3.0) for patients with anastomotic insufficiency and 1.5 (95% CI 0.9-2.5) for patients with cardiovascular or cerebrovascular complications.", {"entities": []}], ["We found no association with number of hospitalisations (IRR 1.2, 95% CI 0.7-2.0) or number of outpatient visits (IRR 1.3, 95% CI 0.9-1.7) after anastomotic insufficiency, or after cardiovascular or cerebrovascular complications (IRR 1.2, 95% CI 0.7-1.9) and (IRR 1.1, 95% CI 0.8-1.5) respectively.", {"entities": []}], ["This study showed an increased total in-hospitalisation period 1-5 years after oesophagectomy for cancer in patients with postoperative complications, particularly following anastomotic insufficiency.", {"entities": [[98, 104, "DISEASE"]]}], ["The HADS (Hospital Anxiety and Depression Scale) aims to measure symptoms of anxiety (HADS Anxiety) and depression (HADS Depression).", {"entities": []}], ["The HADS is widely used but has shown ambiguous results both regarding the factor structure and sex differences in the prevalence of depressive symptoms.", {"entities": []}], ["There is also a lack of psychometric evaluations of the HADS in non-clinical samples of older people.", {"entities": []}], ["The aim of the study was to evaluate the factor structure of the HADS in a general population 65\u201380\u00a0years old and to exam possible presence of differential item functioning (DIF) with respect to sex.", {"entities": [[174, 177, "GENE"]]}], ["This study was based on data from a Swedish sample, randomized from the total population in the age group 65\u201380\u00a0years ( n \u00a0=\u00a06659).", {"entities": []}], ["Confirmatory factor analyses (CFA) were performed to examine the factor structure.", {"entities": []}], ["Ordinal regression analyses were conducted to detect DIF for sex.", {"entities": [[53, 56, "GENE"]]}], ["Reliability was examined by both ordinal as well as traditional Cronbach\u2019s alpha.", {"entities": []}], ["The CFA showed a two-factor model with cross-loadings for two items (7 and 8) had excellent model fit.", {"entities": []}], ["Internal consistency was good in both subscales, measured with ordinal and traditional alpha.", {"entities": []}], ["Floor effects were presented for all items.", {"entities": []}], ["No indication for meaningful DIF regarding sex was found for any of the subscales.", {"entities": [[29, 32, "GENE"]]}], ["HADS Anxiety and HADS Depression are unidimensional measures with acceptable internal consistency and are invariant with regard to sex.", {"entities": []}], ["Despite pronounced ceiling effects and cross-loadings for item 7 and 8, the hypothesized two-factor model of HADS can be recommended to assess psychological distress among a general population 65\u201380\u00a0years old.", {"entities": []}], ["Previous histological and imaging studies have shown the presence of variability in the degree of bronchoconstriction of airways sampled at different locations in the lung (i.e., heterogeneity).", {"entities": []}], ["Heterogeneity can occur at different airway generations and at branching points in the bronchial tree.", {"entities": []}], ["Whilst heterogeneity has been detected by previous experimental approaches, its spatial relationship either within or between airways is unknown.", {"entities": []}], ["In this study, distribution of airway narrowing responses across a portion of the porcine bronchial tree was determined in vitro .", {"entities": []}], ["The portion comprised contiguous airways spanning bronchial generations (#3-11), including the associated side branches.", {"entities": []}], ["We used a recent optical imaging technique, anatomical optical coherence tomography, to image the bronchial tree in three dimensions.", {"entities": []}], ["Bronchoconstriction was produced by carbachol administered to either the adventitial or luminal surface of the airway.", {"entities": []}], ["Luminal cross sectional area was measured before and at different time points after constriction to carbachol and airway narrowing calculated from the percent decrease in luminal cross sectional area.", {"entities": []}], ["When administered to the adventitial surface, the degree of airway narrowing was progressively increased from proximal to distal generations (r = 0.80 to 0.98, P < 0.05 to 0.001).", {"entities": []}], ["This 'serial heterogeneity' was also apparent when carbachol was administered via the lumen, though it was less pronounced.", {"entities": []}], ["In contrast, airway narrowing was not different at side branches, and was uniform both in the parent and daughter airways.", {"entities": []}], ["Our findings demonstrate that the bronchial tree expresses intrinsic serial heterogeneity, such that narrowing increases from proximal to distal airways, a relationship that is influenced by the route of drug administration but not by structural variations accompanying branching sites.", {"entities": []}], ["The aim of this study is to investigate the effects of fast-track surgery (FTS) on postoperative recovery, hospital stay, total medical costs, and the complications of pneumonectomy in patients with non-small cell lung cancer (NSCLC).", {"entities": [[214, 225, "DISEASE"], [219, 225, "DISEASE"]]}], ["Studies were performed between June 2012 and March 2014 in 17 patients received FTS and 18 patients given conventional management (control) after pneumonectomy in the Department of Thoracic Surgery, the Fourth Affiliated Hospital of Harbin Medical University.", {"entities": []}], ["Patients were evaluated based on their days to achieve the first postoperative flatus, C-reactive protein (CRP) at postoperative day (POD) 1\u20137, the length of hospital stay, the medical costs, and postoperative complications.", {"entities": [[107, 110, "GENE"]]}], ["The results showed that in the FTS group, latency to the first postoperative flatus (1.5\u2009\u00b1\u20090.6 versus 3.1\u2009\u00b1\u20090.8\u00a0s in controls, P \u2009<\u20090.0001), CRP (71.36\u2009\u00b1\u20095.48 versus 80.71\u2009\u00b1\u20098.32\u00a0mg/L in at POD 7, P \u2009<\u20090.0001), the length of hospital stay (18.1\u2009\u00b1\u20091.4 versus 27.4\u2009\u00b1\u20096.6\u00a0days, P \u2009<\u20090.0001), and the medical costs (29.9\u2009\u00b1\u20092.7 versus 37.2\u2009\u00b1\u20093.6 thousand Chinese Yuan, P \u2009<\u20090.0001) were significantly reduced compared to the group receiving conventional management.", {"entities": [[141, 144, "GENE"]]}], ["FTS group also had a relatively lower postoperative complication rate (23.5% of 17 versus 33.3% of 18 in control group) although it was statistically insignificant ( P \u2009=\u20090.711).", {"entities": []}], ["These results indicate that application of the FTS in NSCLC pneumonectomy efficiently accelerates postoperative recovery, shortens hospital stay, reduces the total medical costs of the patients and thus is more acceptable than conventional management.", {"entities": []}], ["The laparoscopic vertical sleeve gastrectomy (LSG) is derived from the biliopancreatic diversion with duodenal switch operation (Marceau et al., Obes Surg 3:29\u201335, The study is a nonrandomized retrospective analysis of 204 patients from a single surgeon operated between July 2006 and April 2010.", {"entities": []}], ["The study comprises of 155 women and 49 men with a mean age of 45\u00a0years (range, 19\u201370\u00a0years), a mean preoperative weight of 126.6\u00a0kg, and body mass index (BMI) of 45.7\u00a0kg/m The mean percent excess weight loss (%EWL) was 49.9% ( n \u2009=\u2009159), 64.2% ( n \u2009=\u2009138), 67.9% ( n \u2009=\u200977), 62.4% ( n \u2009=\u200934), and 62.2% ( n \u2009=\u20099) at 3, 6, 12, 24, and 36\u00a0months, respectively.", {"entities": []}], ["For patients with BMI \u226443.0, the mean postoperative %EWL was 58.9% ( n \u2009=\u200972), 74.1% ( n \u2009=\u200967), 75.8% ( n \u2009=\u200939), 72.1% ( n \u2009=\u200917), and 78.7% ( n \u2009=\u20095) at 3, 6, 12, 24, and 36\u00a0months, respectively.", {"entities": []}], ["Operative complications include leak (0.0%), abscess (0.5%), hemorrhage (1.0%), sleeve stricture (1.0%), and severe gastroesphogeal reflux disease with need to convert to laparoscopic Roux-en-Y gastric bypass (0.5%).", {"entities": []}], ["LSG yields excellent outcomes with low complication rates for morbidly obese patients.", {"entities": []}], ["We advocate LSG as a safe and effective stand-alone procedure, especially with the lower BMI population (BMI 35.0\u201343.0\u00a0kg/m", {"entities": []}], ["This study investigated skin characteristics in healthy Chinese children aged from 1 to 10\u00a0years and compared these findings with similar measures from the child\u2019s mothers.", {"entities": []}], ["Children aged 1, 2, 3, 4, 5, and 10\u00a0years ( n \u00a0=\u00a029\u201330 per age group) and the child\u2019s mothers were enrolled in a single-visit cross-sectional study.", {"entities": []}], ["Clinical parameters evaluated on the face, ventral forearm, and calf were softness, smoothness, erythema, edema, rash, dryness, and scaling.", {"entities": []}], ["Instrumental evaluations included transepidermal water loss, moisture content, and water-holding capacity.", {"entities": []}], ["The clinical evaluations indicated a general decrease in softness, smoothness, and overall skin condition with increased child age.", {"entities": []}], ["In general, the child\u2019s clinical scores were better than in adults.", {"entities": []}], ["Children had a more permeable skin barrier that matured to adult values by approximately 5\u00a0years of age.", {"entities": []}], ["Mothers had greater skin moisture than children.", {"entities": []}], ["Clinical and instrumental measures were consistent with skin being softer and smoother and in better overall condition in younger children.", {"entities": []}], ["As the skin matured with age, higher scores were observed.", {"entities": []}], ["Instrumental measures demonstrated a more permeable skin barrier in younger children compared with older children and with adults.", {"entities": []}], ["Previous studies suggest a role for eotaxin-3, TARC/CCL17 and IgG4 in newly- diagnosed patients with eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss) with highly active disease.", {"entities": []}], ["The role of these biomarkers in relapsing disease is unclear.", {"entities": []}], ["Serum levels of TARC/CCL17, eotaxin-3, IgG4, and IgG4/IgG ratio were determined in serum samples from a longitudinal cohort of patients with EGPA (105 visits of 25 patients).", {"entities": []}], ["Epidemiological, clinical and laboratory data were available for all visits.", {"entities": []}], ["At the first visit, 80% of patients were using glucocorticoids and 68% additional immunosuppressive drugs.", {"entities": []}], ["Disease flares were seen at 18 visits.", {"entities": []}], ["The median BVAS and BVAS/WG scores at time of relapse were 4 and 2, respectively.", {"entities": []}], ["None of the biomarkers tested were useful to discriminate between active disease and remission.", {"entities": []}], ["Patients treated with prednisone had lower eotaxin-3 and eosinophil levels compared to patients not taking glucocorticoids irrespective of disease activity.", {"entities": []}], ["Use of immunosuppressive agents was not associated with biomarker levels.", {"entities": []}], ["Serum levels of TARC/CCL17, eotaxin-3, IgG4, and IgG4/IgG ratio do not clearly differentiate active and inactive disease in established EGPA.", {"entities": []}], ["Defining biomarkers in EGPA remains a challenge especially during times of glucocorticoid use.", {"entities": []}], ["Missed abortion is a common occurrence for otherwise healthy women.", {"entities": []}], ["Immunological factor is one of the most important reasons.", {"entities": []}], ["Tumor necrosis factor-\u03b1-induced protein-8 like-2 (TIPE2) is a novel negative immune regulator related to several human diseases.", {"entities": []}], ["However, the expression level and clinical significance of TIPE2 in missed abortion remain unclear.", {"entities": []}], ["The expression of TIPE2 mRNA and protein in decidua and chorion from 36 missed abortion patients and 36 healthy controls was detected using quantitative real-time PCR, western blot and immunohistochemistry.", {"entities": []}], ["In addition, serum TNF-\u0251 and IL-10 levels were measured using flow cytometry.", {"entities": []}], ["Serum estradiol and progesterone levels were measured by radioimmunoassay test.", {"entities": []}], ["The correlations of TIPE2 protein levels with TNF-\u0251, IL-10, estradiol and progesterone were further analyzed.", {"entities": []}], ["TIPE2 protein levels were significantly lower in decidual tissues of missed abortion patients than those in healthy controls.", {"entities": []}], ["The patients with missed abortion had significantly higher levels of serum TNF-\u0251, and lower levels of serum IL-10, estradiol and progesterone compared with healthy controls.", {"entities": []}], ["The TIPE2 protein levels were positively related to serum IL-10 levels.", {"entities": []}], ["Our data indicate TIPE2 could play important roles in maintaining the maternal-fetal tolerance and decreased TIPE2 expression in the decidua may be related to the development of missed abortion.", {"entities": []}], ["Most cases of the 2009 influenza A (H1N1) infection are self-limited, but occasionally the disease evolves to a severe condition needing hospitalization.", {"entities": [[23, 32, "DISEASE"]]}], ["Here we describe the evolution of the respiratory compromise, ventilatory management and laboratory variables of patients with diffuse viral pneumonitis caused by pandemic 2009 influenza A (H1N1) admitted to the ICU.", {"entities": [[177, 186, "DISEASE"]]}], ["This was a multicenter, prospective inception cohort study including adult patients with acute respiratory failure requiring mechanical ventilation (MV) admitted to 20 ICUs in Argentina between June and September of 2009 during the influenza A (H1N1) pandemic.", {"entities": [[95, 114, "DISEASE"], [232, 241, "DISEASE"]]}], ["In a standard case-report form, we collected epidemiological characteristics, results of real-time reverse-transcriptase--polymerase-chain-reaction viral diagnostic tests, oxygenation variables, acid-base status, respiratory mechanics, ventilation management and laboratory tests.", {"entities": []}], ["Variables were recorded on ICU admission and at days 3, 7 and 10.", {"entities": []}], ["During the study period 178 patients with diffuse viral pneumonitis requiring MV were admitted.", {"entities": []}], ["They were 44 \u00b1 15 years of age, with Acute Physiology And Chronic Health Evaluation II (APACHE II) scores of 18 \u00b1 7, and most frequent comorbidities were obesity (26%), previous respiratory disease (24%) and immunosuppression (16%).", {"entities": [[154, 161, "DISEASE"]]}], ["Non-invasive ventilation (NIV) was applied in 49 (28%) patients on admission, but 94% were later intubated.", {"entities": []}], ["Acute respiratory distress syndrome (ARDS) was present throughout the entire ICU stay in the whole group (mean PaO 2 / FIO 2 170 \u00b1 25).", {"entities": [[27, 35, "DISEASE"]]}], ["Tidal-volumes used were 7.8 to 8.1 ml/kg (ideal body weight), plateau pressures always remained < 30 cmH 2 O, without differences between survivors and non-survivors; and mean positive end-expiratory pressure (PEEP) levels used were between 8 to 12 cm H 2 O.", {"entities": []}], ["Rescue therapies, like recruitment maneuvers (8 to 35%), prone positioning (12 to 24%) and tracheal gas insufflation (3%) were frequently applied.", {"entities": []}], ["At all time points, pH, platelet count, lactate dehydrogenase assay (LDH) and Sequential Organ Failure Assessment (SOFA) differed significantly between survivors and non-survivors.", {"entities": []}], ["Lack of recovery of platelet count and persistence of leukocytosis were characteristic of non-survivors.", {"entities": []}], ["Mortality was high (46%); and length of MV was 10 (6 to 17) days.", {"entities": []}], ["These patients had severe, hypoxemic respiratory failure compatible with ARDS that persisted over time, frequently requiring rescue therapies to support oxygenation.", {"entities": [[37, 56, "DISEASE"]]}], ["NIV use is not warranted, given its high failure rate.", {"entities": []}], ["Death and evolution to prolonged mechanical ventilation were common outcomes.", {"entities": []}], ["Persistence of thrombocytopenia, acidosis and leukocytosis, and high LDH levels found in non-survivors during the course of the disease might be novel prognostic findings.", {"entities": [[15, 31, "DISEASE"]]}], ["Decreasing exposure to airborne particulates was previously associated with reduced age-related decline in lung function.", {"entities": []}], ["However, whether the benefit from improved air quality depends on genetic background is not known.", {"entities": []}], ["Recent evidence points to the involvement of the genes p53 and p21 and of the cell cycle control gene cyclin D1 ( CCND1 ) in the response of bronchial cells to air pollution.", {"entities": [[114, 119, "GENE"]]}], ["We determined in 4,326 participants of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) whether four single-nucleotide polymorphisms in three genes [ CCND1 (rs9344 [P242P], rs667515), p53 (rs1042522 [R72P]), and p21 (rs1801270 [S31R])] modified the previously observed attenuation of the decline in the forced expiratory flow between 25% and 75% of the forced vital capacity (FEF 25\u201375 ) associated with improved air quality.", {"entities": [[190, 195, "GENE"]]}], ["Subjects of the prospective population-based SAPALDIA cohort were assessed in 1991 and 2002 by spirometry, questionnaires, and biological sample collection for genotyping.", {"entities": []}], ["We assigned spatially resolved concentrations of particulate matter with aerodynamic diameter \u2264 10 \u03bcm (PM 10 ) to each participant\u2019s residential history 12 months before the baseline and follow-up assessments.", {"entities": []}], ["The effect of diminishing PM 10 exposure on FEF 25\u201375 decline appeared to be modified by p53 R72P, CCND1 P242P, and CCND1 rs667515.", {"entities": [[99, 104, "GENE"], [116, 121, "GENE"], [99, 104, "GENE"], [116, 121, "GENE"]]}], ["For example, a 10-\u03bcg/m 10 exposure over an 11-year period attenuated the average annual decline in FEF 25\u201375 by 21.33 mL/year (95% confidence interval, 10.57\u201332.08) among participants homozygous for the CCND1 (P242P) GG genotype, by 13.72 mL/year (5.38\u201322.06) among GA genotypes, and by 6.00 mL/year (\u22124.54 to 16.54) among AA genotypes.", {"entities": [[203, 208, "GENE"]]}], ["Our results suggest that cell cycle control genes may modify the degree to which improved air quality may benefit respiratory function in adults.", {"entities": []}], ["Non-coding RNAs play major roles in the translational control of gene expression.", {"entities": []}], ["In order to identify disease-associated miRNAs in precursor lesions of lung cancer, RNA extracts from lungs of either c-Raf transgenic or wild-type (WT) mice were hybridized to the Agilent and Affymetrix miRNA microarray platforms, respectively.", {"entities": [[71, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["This resulted in the detection of a range of miRNAs varying between 111 and 267, depending on the presence or absence of the transgene, on the gender, and on the platform used.", {"entities": []}], ["Importantly, when the two platforms were compared, only 11\u201316% of the 586 overlapping genes were commonly detected.", {"entities": []}], ["With the Agilent microarray, seven miRNAs were identified as significantly regulated, of which three were selectively up-regulated in male transgenic mice.", {"entities": []}], ["Much to our surprise, when the same samples were analyzed with the Affymetrix platform, only two miRNAs were identified as significantly regulated.", {"entities": []}], ["Quantitative PCR performed with lung RNA extracts from WT and transgenic mice confirmed only partially the differential expression of significant regulated miRNAs and established that the Agilent platform failed to detect miR-433.", {"entities": [[222, 229, "GENE"]]}], ["Finally, bioinformatic analyses predicted a total of 152 mouse genes as targets of the regulated miRNAs of which 4 and 11 genes were significantly regulated at the mRNA level, respectively in laser micro-dissected lung dysplasia and lung adenocarcinomas of c-Raf transgenic mice.", {"entities": []}], ["Furthermore, for many of the predicted mouse target genes expression of the coded protein was also repressed in human lung cancer when the publically available database of the Human Protein Atlas was analyzed, thus supporting the clinical significance of our findings.", {"entities": [[118, 129, "DISEASE"], [123, 129, "DISEASE"]]}], ["In conclusion, a significant difference in a cross-platform comparison was observed that will have important implications for research into miRNAs.", {"entities": []}], ["The Internet and emergent telecommunications infrastructures are transforming the future of health care management.", {"entities": []}], ["The costs of health care delivery systems, products, and services continue to rise everywhere, but performance of health care delivery is associated with institutional and ideological considerations as well as availability of financial and technological resources.", {"entities": []}], ["To identify the effects of ideological differences on health care market infrastructures including the Internet and telecommunications technologies by a comparative case analysis of two large health care organizations: the British National Health Service and the California-based Kaiser Permanente health maintenance organization.", {"entities": []}], ["A qualitative comparative analysis focusing on the British National Health Service and the Kaiser Permanente health maintenance organization to show how system infrastructures vary according to market dynamics dominated by health care institutions (\"push\") or by consumer demand (\"pull\").", {"entities": []}], ["System control mechanisms may be technologically embedded, institutional, or behavioral.", {"entities": []}], ["The analysis suggests that telecommunications technologies and the Internet may contribute significantly to health care system performance in a context of ideological diversity.", {"entities": []}], ["The study offers evidence to validate alternative models of health care governance: the national constitution model, and the enterprise business contract model.", {"entities": []}], ["This evidence also suggests important questions for health care policy makers as well as researchers in telecommunications, organizational theory, and health care management.", {"entities": []}], ["Identification and treatment of abdominal aortic aneurysm (AAA) remain among the most prominent challenges in vascular medicine.", {"entities": [[32, 57, "DISEASE"], [42, 57, "DISEASE"]]}], ["MicroRNAs (miRNAs) are crucial regulators of cardiovascular pathology and represent intriguing targets to limit AAA expansion.", {"entities": []}], ["Here we show, by using two established murine models of AAA disease along with human aortic tissue and plasma analysis, that miR-24 is a key regulator of vascular inflammation and AAA pathology.", {"entities": [[125, 131, "GENE"]]}], ["In vivo and in vitro studies reveal chitinase 3-like 1 (Chi3l1) to be a major target and effector under the control of miR-24, regulating cytokine synthesis in macrophages as well as their survival, promoting aortic smooth muscle cell migration and cytokine production, and stimulating adhesion molecule expression in vascular endothelial cells.", {"entities": [[56, 62, "GENE"], [119, 125, "GENE"]]}], ["We further show that modulation of miR-24 alters AAA progression in animal models, and that miR-24 and CHI3L1 represent novel plasma biomarkers of AAA disease progression in humans.", {"entities": [[35, 41, "GENE"], [92, 98, "GENE"], [35, 41, "GENE"], [92, 98, "GENE"], [103, 109, "GENE"]]}], ["Abdominal aortic aneurysm (AAA) is a potentially fatal and often asymptomatic disease whose causes remain unclear.", {"entities": [[0, 25, "DISEASE"], [10, 25, "DISEASE"]]}], ["Here the authors show that a microRNA, miR-24, and its target, the glycoprotein chitinase 3-like 1, represent key regulators of AAA development.", {"entities": [[39, 45, "GENE"]]}], ["Background: Several studies have estimated associations between air pollution and birth outcomes, but few have evaluated potential effects on pregnancy complications.", {"entities": []}], ["Objective: We investigated whether low-level exposure to air pollution is associated with gestational diabetes and preeclampsia.", {"entities": [[90, 110, "DISEASE"]]}], ["Methods: High-quality registry information on 81,110 singleton pregnancy outcomes in southern Sweden during 1999\u20132005 was linked to individual-level exposure estimates with high spatial resolution.", {"entities": []}], ["Modeled exposure to nitrogen oxides (NO x ), expressed as mean concentrations per trimester, and proximity to roads of different traffic densities were used as proxy indicators of exposure to combustion-related air pollution.", {"entities": []}], ["The data were analyzed by logistic regression, with and without adjusting for potential confounders.", {"entities": []}], ["Results: The prevalence of gestational diabetes increased with each NO x quartile, with an adjusted odds ratio (OR) of 1.69 (95% CI: 1.41, 2.03) for the highest (> 22.7 \u00b5g/m x compared with the lowest.", {"entities": [[27, 47, "DISEASE"]]}], ["Both outcomes were associated with high traffic density, but ORs were significant for gestational diabetes only.", {"entities": [[86, 106, "DISEASE"]]}], ["Conclusion: NO x exposure during pregnancy was associated with gestational diabetes and preeclampsia in an area with air pollution levels below current air quality guidelines.", {"entities": [[63, 83, "DISEASE"]]}], ["Pulmonary fibrosis is the main cause of severe morbidity and mortality in idiopathic interstitial pneumonias (IIP).", {"entities": []}], ["In the past years, there has been major progress in the discovery of genetic factors that contribute to disease.", {"entities": []}], ["Genes with highly penetrant mutations or strongly predisposing common risk alleles have been identified in familial and sporadic IIP.", {"entities": []}], ["This review summarizes genes harbouring causative rare mutations and replicated common predisposing alleles.", {"entities": []}], ["To date, rare mutations in nine different genes and five risk alleles fulfil this criterion.", {"entities": []}], ["Mutated genes represent three genes involved in surfactant homeostasis and six genes involved in telomere maintenance.", {"entities": []}], ["We summarize gene function, gene expressing cells, and pathological consequences of genetic alterations associated with disease.", {"entities": []}], ["Consequences of the genetic alteration include dysfunctional surfactant processing, ER stress, immune dysregulation, and maintenance of telomere length.", {"entities": []}], ["Biological evidence shows that these processes point towards a central role for alveolar epithelial type II cell dysfunction.", {"entities": []}], ["However, tabulation also shows that function and consequence of most common risk alleles are not known.", {"entities": []}], ["Most importantly, the predisposition of the MUC5B risk allele to disease is not understood.", {"entities": [[44, 49, "GENE"]]}], ["We propose a mechanism whereby MUC5B decreases surface tension lowering capacity of alveolar surfactant at areas with maximal mechanical stress.", {"entities": [[31, 36, "GENE"]]}], ["Dialyzable leukocyte extracts (DLEs) contain molecules smaller than 10 kDa with biological activity in receptor organisms.", {"entities": []}], ["Primarily, they participate in the regulation of the Th1 immune response, which is essential for the control of several intracellular infections, such as toxoplasmosis.", {"entities": [[154, 167, "DISEASE"]]}], ["This disease is associated with congenital infection, encephalitis or systemic infections in immunocompromised individuals.", {"entities": [[54, 66, "DISEASE"]]}], ["The clinical course of this infection fundamentally depends on a well-regulated immune response and timely treatment with the appropriate drugs.", {"entities": []}], ["The aim of this study was to evaluate the effect of treatment with a leukocyte extract, derived from crocodile lymphoid tissue, on the histopathology and brain parasite load in NIH mice that had been infected with cysts of Toxoplasma gondii (ME-49 strain).", {"entities": []}], ["The treatment was applied during the acute and chronic stages of the infection.", {"entities": []}], ["Histopathological changes were evaluated in the ileum, liver and spleen at one, four and eight weeks after infection and in the brain at week 8.", {"entities": []}], ["The parasite load was evaluated by counting the cysts of T. gondii found in the brain.", {"entities": []}], ["Compared to the control mouse group, the mice infected with T. gondii and under treatment with DLE showed less tissue damage, mainly at the intestinal, splenic and hepatic levels.", {"entities": []}], ["In addition, a greater percentage of survival was observed, and there was a considerable reduction in the parasite load in the brain.", {"entities": []}], ["The results suggest that DLE derived from crocodile is a potential adjunctive therapy in the conventional treatment of toxoplasmosis.", {"entities": [[119, 132, "DISEASE"]]}], ["Sterile injury can cause a systemic inflammatory response syndrome (SIRS) that resembles the host response during sepsis.", {"entities": [[58, 66, "DISEASE"]]}], ["The inflammatory response following trauma comprises various systems of the human body which are cross-linked with each other within a highly complex network of inflammation.", {"entities": []}], ["Endogenous danger signals (danger-associated molecular patterns; DAMPs; alarmins) as well as exogenous pathogen-associated molecular patterns (PAMPs) play a crucial role in the initiation of the immune response.", {"entities": []}], ["With popularization of the \u201cdanger theory,\u201d numerous DAMPs and PAMPs and their corresponding pathogen-recognition receptors have been identified.", {"entities": []}], ["In this paper, we highlight the role of the DAMPs high-mobility group box protein 1 (HMGB1), interleukin-1 \u03b1 (IL-1 \u03b1 ), and interleukin-33 (IL-33) as unique dual-function mediators as well as mitochondrial danger signals released upon cellular trauma and necrosis.", {"entities": [[85, 90, "GENE"]]}], ["Most individuals prefer bicycling separated from motor traffic.", {"entities": []}], ["However, cycle tracks (physically separated bicycle-exclusive paths along roads, as found in The Netherlands) are discouraged in the USA by engineering guidance that suggests that facilities such as cycle tracks are more dangerous than the street.", {"entities": []}], ["The objective of this study conducted in Montreal (with a longstanding network of cycle tracks) was to compare bicyclist injury rates on cycle tracks versus in the street.", {"entities": []}], ["For six cycle tracks and comparable reference streets, vehicle/bicycle crashes and health record injury counts were obtained and use counts conducted.", {"entities": []}], ["The relative risk (RR) of injury on cycle tracks, compared with reference streets, was determined.", {"entities": []}], ["Overall, 2.5 times as many cyclists rode on cycle tracks compared with reference streets and there were 8.5 injuries and 10.5 crashes per million bicycle-kilometres.", {"entities": []}], ["The RR of injury on cycle tracks was 0.72 (95% CI 0.60 to 0.85) compared with bicycling in reference streets.", {"entities": []}], ["These data suggest that the injury risk of bicycling on cycle tracks is less than bicycling in streets.", {"entities": []}], ["The construction of cycle tracks should not be discouraged.", {"entities": []}], ["In India, Non Communicable Diseases (NCDs) and injuries account for an estimated 62% of the total age-standardized burden of forgone Disability Adjusted Life Years (DALYs).", {"entities": []}], ["Public and private financing of clinical services to reduce the NCD burden is a major challenge.", {"entities": []}], ["We used National Sample Survey Organization (NSSO) survey data from 1995-96 and 2004 covering nearly 200 thousand households to assess healthcare utilization patterns and out of pocket health spending by disease category.", {"entities": []}], ["For this purpose, self-reported diseases and conditions were categorized into NCDs and non-NCDs.", {"entities": []}], ["Survey data were used to assess how households financed their overall health expenditures and related this pattern to specific health conditions.", {"entities": []}], ["We measured catastrophic spending on NCD-related hospitalization, defined as occurring when health expenditures exceeded 40% of a household's ability to pay, that is, household consumption spending less combined survival consumption expenditure; and impoverishment when per capita expenditure within the household decreased to below the poverty line once health spending was netted out.", {"entities": []}], ["The share of NCDs in out of pocket health expenses incurred by households increased over time, from 31.6 percent in 1995-96 to 47.3 percent in 2004.", {"entities": []}], ["In both years, own savings and income were the most important source of financing for many health conditions, typically between 40-60 percent of all spending, whereas 30-35 percent was from borrowing.", {"entities": []}], ["The odds of catastrophic hospitalization expenditures for cancer was nearly 170% greater and for CVD and injuries 22 percent greater than the odds due to communicable diseases.", {"entities": [[58, 64, "DISEASE"]]}], ["Impoverishment patterns were similar.", {"entities": []}], ["Out of pocket expenses for treating NCDs rose sharply over the period from 1995-96 to 2004.", {"entities": []}], ["When NCDs are present, the financial risks to which Indians households are exposed are significant.", {"entities": []}], ["IgG4-related disease (IgG4-RD) is a fibroinflammatory condition characterized by serum IgG4 elevation and tissue infiltration of IgG4-positive plasma cells.", {"entities": []}], ["Substantial overlap between IgG4-RD and antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV) exists in terms of organ involvement and histopathological features.", {"entities": []}], ["A positive ANCA assay is regarded as a highly specific finding in favor of an AAV, and generally influences away from a diagnosis of IgG4-RD.", {"entities": []}], ["Recent reports, however, have raised the possibility that some patients with IgG4-RD are ANCA positive, thus suggesting reconsideration of the role of ANCA in the diagnostic workup.", {"entities": []}], ["In the present work, we describe the first case of concomitant biopsy-proven IgG4-RD and granulomatosis with polyangiitis (GPA), demonstrating antiproteinase 3 (PR3) ANCA of the IgG4 subclass in the patient's serum.", {"entities": []}], ["We also review the literature in order to provide clinicians with tools for interpreting ANCA positivity in IgG4-RD patients.", {"entities": []}], ["A 51-year-old woman was referred for left exopthalmos due to lacrimal gland enlargement and increased serum IgG4 concentration.", {"entities": []}], ["IgG4-RD was suspected and further imaging studies disclosed multiple pulmonary masses in the right lung.", {"entities": []}], ["Histological analysis of the left lacrimal gland was diagnostic for IgG4-RD, but lung biopsy showed typical features of GPA.", {"entities": []}], ["ANCA assay was positive for anti-PR3 antibodies.", {"entities": []}], ["Further immunofluorescence studies demonstrated anti-PR3 antibodies of IgG1 and IgG4 subclass.", {"entities": []}], ["Treatment with rituximab induced swift remission of both IgG4-RD and GPA manifestations.", {"entities": []}], ["We identified 9 other reports of patients with IgG4-RD and positive ANCA in the English literature, 5 cases with biopsy-proven IgG4-RD and 4 cases in whom IgG4-RD was diagnosed presumptively.", {"entities": []}], ["Four patients had also histological evidence of concomitant AAV.", {"entities": []}], ["The present work demonstrates that ANCA positivity in patients with biopsy-proven IgG4-RD should prompt the exclusion of a concomitant vasculitic process; a positive ANCA does not exclude the diagnosis of IgG4-RD; confirmation through immunoenzymatic assays of the ANCA specificity, clinical-pathological correlation, and histopathological evaluation remain crucial steps for the differential diagnosis between AAV and IgG4-RD.", {"entities": []}], ["Imatinib is a tyrosine-kinase inhibitor; for which there is limited information regarding its effects on AIDS Kaposi's sarcoma and none in patients with transplant-associated Kaposi's sarcoma.", {"entities": [[119, 126, "DISEASE"], [184, 191, "DISEASE"]]}], ["Sirolimus, an immunosuppressive drug used for kidney transplant, exhibits antiangiogenic activity related to impaired production of VEGF (vascular endothelial growth factor), clinical benefit has been reported in Kaposi's sarcoma associated with renal graft.", {"entities": [[222, 229, "DISEASE"]]}], ["Here we report a case of an 80 year old male, who developed Kaposi's Sarcoma nine months after receiving a living non-related donor kidney transplant at age 74.", {"entities": [[69, 76, "DISEASE"]]}], ["Three years after treatment with different chemotherapeutic agents for progressive cutaneous Kaposi's Sarcoma with no visceral involvement, he was prescribed Imatinib (200 mg/day for two weeks followed by 400 mg/day) after four weeks of treatment he developed anasarca, further progression of KS and agranulocytosis.", {"entities": [[300, 315, "DISEASE"], [102, 109, "DISEASE"]]}], ["Imatinib was discontinued and there was significant clinical recovery.", {"entities": []}], ["One year later his immunosuppressive therapy was changed to Sirolimus and regression of the Kaposi's sarcoma occurred.", {"entities": [[101, 108, "DISEASE"]]}], ["The lack of benefit and severe toxicity associated with the use of Imatinib in this patient should alert clinicians of potentially adverse consequence of its use in patients with transplant associated Kaposi's sarcoma.", {"entities": [[210, 217, "DISEASE"]]}], ["On the other hand the positive response seen in this patient to Sirolimus even after a long evolution of Kaposi's sarcoma, multiple chemotherapy regimens and extensive cutaneous disease further suggest it therapeutical utility for transplant associated Kaposi's sarcoma.", {"entities": [[114, 121, "DISEASE"], [262, 269, "DISEASE"]]}], ["Controversial findings have been reported regarding to the effect of the transporter associated with antigen processing 1 (TAP1) polymorphisms exerted on the atopic diseases susceptibility.", {"entities": [[123, 127, "GENE"]]}], ["To gain a better understanding of the effects of TAP1 polymorphisms on the risk of atopic diseases, a retrospective study was carried out to evaluate the association of the most common TAP1 polymorphisms, rs1057141 and rs1135216, with the risk of atopic diseases.", {"entities": [[49, 53, "GENE"], [185, 189, "GENE"], [49, 53, "GENE"], [185, 189, "GENE"]]}], ["From studies published in PubMed, Embase, and Web of Science up to July 2017, ten eligible studies were selected for meta-analysis.", {"entities": []}], ["The pooled results from rs1135216 polymorphism showed increased risk of atopic diseases in homozygote and recessive comparison.", {"entities": []}], ["From the subgroup analysis by ethnicity, it was found that rs1135216 polymorphism contributed to atopic diseases susceptibility among Africans in all the five genetic models.", {"entities": []}], ["Subgroup analysis by atopic types indicated significant association of TAP1 polymorphism rs1135216 with asthma in the allele, dominant and recessive models and with allergic rhinitis in the recessive model.", {"entities": [[165, 182, "DISEASE"], [174, 182, "DISEASE"], [104, 110, "DISEASE"], [71, 75, "GENE"]]}], ["As to rs1057141, increased risk of atopic disease in the allelic, dominant and heterozygous model was found in African population.", {"entities": []}], ["Overall, this meta-analysis study demonstrated that rs1135216 polymorphism may contribute to atopic diseases susceptibility in Asians and Africans as assessed in this study.", {"entities": []}], ["However, well designed large-scale case-control studies are needed to confirm such preliminary findings.", {"entities": []}], ["The \u03b22 family of integrins, CD11a, CD11b, CD11c, and \u03b1d, are expressed on most leukocytes.", {"entities": []}], ["We show that the newest member of this family, \u03b1d, is expressed on human eosinophils in peripheral blood, and surface expression can be upregulated within minutes by phorbol ester or calcium ionophore A23187.", {"entities": []}], ["Culture of eosinophils with interleukin 5 (IL-5) leads to a two- to fourfold increase in \u03b1d levels by 3\u20137 d without a change in \u03b14 integrin expression.", {"entities": []}], ["Eosinophils isolated from late phase bronchoalveolar lavage fluids express \u03b1d at levels similar to that seen after 3 d of IL-5 culture.", {"entities": []}], ["Regarding \u03b1d\u03b22 ligands, in both freshly isolated and IL-5\u2013cultured eosinophils, as well as \u03b1d\u03b22-transfected Chinese hamster ovary cells, \u03b1d\u03b22 can function as a ligand for vascular cell adhesion molecule 1 (VCAM-1).", {"entities": []}], ["This conclusion is based on the ability of monoclonal antibodies to \u03b1d, \u03b22, or VCAM-1 to block cell attachment in static adhesion assays.", {"entities": []}], ["In experiments with eosinophils, the relative contribution of \u03b1d\u03b22 integrin\u2013 mediated adhesion is enhanced after IL-5 culture.", {"entities": []}], ["These experiments demonstrate that \u03b1d\u03b22 is an alternative ligand for VCAM-1, and this integrin may play a role in eosinophil adhesion to VCAM-1 in states of chronic inflammation.", {"entities": []}], ["Airway remodeling is characterized by airway wall thickening, subepithelial fibrosis, increased smooth muscle mass, angiogenesis and increased mucous glands, which can lead to a chronic and obstinate asthma with pulmonary function depression.", {"entities": [[200, 206, "DISEASE"]]}], ["In the present study, we investigated whether the astragalus extract inhibits airway remodeling in a mouse asthma model and observed the effects of astragalus extract on the transforming growth factor-\u03b21 (TGF-\u03b21)/Smad signaling pathway in ovalbumin-sensitized mice.", {"entities": [[107, 113, "DISEASE"]]}], ["Mice were sensitized and challenged by ovalbumin to establish a model of asthma.", {"entities": [[73, 79, "DISEASE"]]}], ["Treatments included the astragalus extract and budesonide.", {"entities": []}], ["Lung tissues were obtained for hematoxylin and eosin staining and Periodic acid-Schiff staining after the final ovalbumin challenge.", {"entities": []}], ["Levels of TGF-\u03b21 were assessed by immunohistology and ELISA, levels of TGF-\u03b21 mRNA were measured by RT-PCR, and levels of P-Smad2/3 and T-Smad2/3 were assessed by western blotting.", {"entities": []}], ["Astragalus extract and budesonide reduced allergen-induced increases in the thickness of bronchial airway and mucous gland hypertrophy, goblet cell hyperplasia and collagen deposition.", {"entities": []}], ["Levels of lung TGF-\u03b21, TGF-\u03b21 mRNA and P-Smad2/3 were significantly reduced in mice treated with astragalus extract and budesonide.", {"entities": []}], ["Astragalus extract improved asthma airway remodeling by inhibiting the expression of the TGF-\u03b21/Smad signaling pathway, and may be a potential drug for the treatment of patients with a severe asthma airway.", {"entities": [[28, 34, "DISEASE"], [192, 198, "DISEASE"]]}], ["Caesarean section (CS) is a common surgical procedure.", {"entities": [[19, 21, "GENE"]]}], ["Although it has been performed in a modern context for about 100 years, there is no concise analysis of the international architecture of caesarean section research output available so far.", {"entities": []}], ["Therefore, the present study characterizes the global pattern of the related publications by using the NewQIS (New Quality and Quantity Indices in Science) platform, which combines scientometric methods with density equalizing mapping algorithms.", {"entities": []}], ["The Web of Science was used as a database.", {"entities": []}], ["12,608 publications were identified that originated from 131 countries.", {"entities": []}], ["The leading nations concerning research activity, overall citations and country-specific h-Index were the USA and the United Kingdom.", {"entities": []}], ["Relation of the research activity to epidemiologic data indicated that Scandinavian countries including Sweden and Finland were leading the field, whereas, in relation to economic data, countries such as Israel and Ireland led.", {"entities": []}], ["Semi-qualitative indices such as country-specific citation rates ranked Sweden, Norway and Finland in the top positions.", {"entities": []}], ["International caesarean section research output continues to grow annually in an era where caesarean section rates increased dramatically over the past decades.", {"entities": []}], ["With regard to increasing employment of scientometric indicators in performance assessment, these findings should provide useful information for those tasked with the improvement of scientific achievements.", {"entities": []}], ["Filamentous fungi occur widely in the environment, contaminating soil, air, food and other substrates.", {"entities": []}], ["Due to their wide distribution, they have medical and economic implications.", {"entities": []}], ["Regardless of their use as a source of antibiotics, vitamins and raw materials for various industrially important chemicals, most fungi and filamentous fungi produce metabolites associated with a range of health risks, both in humans and in animals.", {"entities": []}], ["The association of filamentous fungi and their metabolites to different negative health conditions in humans and animals, has contributed to the importance of investigating different health risks induced by this family of heterotrophs.", {"entities": []}], ["This review aims to discuss health risks associated with commonly occurring filamentous fungal species which belong to genera Aspergillus , Penicillium and Fusarium , as well as evaluating their pathogenicity and mycotoxic properties.", {"entities": []}], ["Cigarette smoke (CS) has a major impact on lung biology and may result in the development of lung diseases such as chronic obstructive pulmonary disease or lung cancer.", {"entities": [[156, 167, "DISEASE"], [115, 152, "DISEASE"], [161, 167, "DISEASE"], [17, 19, "GENE"]]}], ["To understand the underlying mechanisms of disease development, it would be important to examine the impact of CS exposure directly on lung tissues.", {"entities": [[111, 113, "GENE"]]}], ["However, this approach is difficult to implement in epidemiological studies because lung tissue sampling is complex and invasive.", {"entities": []}], ["Alternatively, tissue culture models can facilitate the assessment of exposure impacts on the lung tissue.", {"entities": []}], ["Submerged 2D cell cultures, such as normal human bronchial epithelial (NHBE) cell cultures, have traditionally been used for this purpose.", {"entities": []}], ["However, they cannot be exposed directly to smoke in a similar manner to the in vivo exposure situation.", {"entities": []}], ["Recently developed 3D tissue culture models better reflect the in vivo situation because they can be cultured at the air-liquid interface (ALI).", {"entities": []}], ["Their basal sides are immersed in the culture medium; whereas, their apical sides are exposed to air.", {"entities": []}], ["Moreover, organotypic tissue cultures that contain different type of cells, better represent the physiology of the tissue in vivo .", {"entities": []}], ["In this work, the utilization of an in vitro exposure system to expose human organotypic bronchial and nasal tissue models to mainstream CS is demonstrated.", {"entities": [[137, 139, "GENE"]]}], ["Ciliary beating frequency and the activity of cytochrome P450s (CYP) 1A1/1B1 were measured to assess functional impacts of CS on the tissues.", {"entities": [[123, 125, "GENE"]]}], ["Furthermore, to examine CS-induced alterations at the molecular level, gene expression profiles were generated from the tissues following exposure.", {"entities": []}], ["A slight increase in CYP1A1/1B1 activity was observed in CS-exposed tissues compared with air-exposed tissues.", {"entities": []}], ["A network-and transcriptomics-based systems biology approach was sufficiently robust to demonstrate CS-induced alterations of xenobiotic metabolism that were similar to those observed in the bronchial and nasal epithelial cells obtained from smokers.", {"entities": []}], ["Th2 cells drive protective immunity against most parasitic helminths, but few mechanisms have been demonstrated that facilitate pathogen clearance.", {"entities": []}], ["We show that IL-4 and IL-13 protect against intestinal lumen-dwelling worms primarily by inducing intestinal epithelial cells (IECs) to differentiate into goblet cells that secrete resistin-like molecule (RELM) \u03b2. RELM-\u03b2 is essential for normal spontaneous expulsion and IL-4\u2013induced expulsion of Nippostrongylus brasiliensis and Heligmosomoides polygyrus , which both live in the intestinal lumen, but it does not contribute to immunity against Trichinella spiralis , which lives within IEC.", {"entities": []}], ["RELM-\u03b2 is nontoxic for H. polygyrus in vitro but directly inhibits the ability of worms to feed on host tissues during infection.", {"entities": []}], ["This decreases H. polygyrus adenosine triphosphate content and fecundity.", {"entities": []}], ["Importantly, RELM-\u03b2\u2013driven immunity does not require T or B cells, alternative macrophage activation, or increased gut permeability.", {"entities": []}], ["Thus, we demonstrate a novel mechanism for host protection at the mucosal interface that explains how stimulation of epithelial cells by IL-4 and IL-13 contributes to protection against parasitic helminthes that dwell in the intestinal lumen.", {"entities": []}], ["Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental disorders characterized by impaired social interactions, communication deficits, and repetitive behavior.", {"entities": []}], ["Although the mechanisms underlying its etiology and manifestations are poorly understood, several lines of evidence from rodent and human studies suggest involvement of the evolutionarily highly-conserved oxytocin (OXT) and arginine-vasopressin (AVP), as these neuropeptides modulate various aspects of mammalian social behavior.", {"entities": [[215, 218, "GENE"], [246, 249, "GENE"]]}], ["As far as we know, there is no comprehensive review of the roles of the OXT and AVP systems in the development of ASD from the genetic aspect.", {"entities": [[72, 75, "GENE"], [80, 83, "GENE"]]}], ["In this review, we summarize the current knowledge regarding associations between ASD and single-nucleotide variants of the human OXT-AVP pathway genes OXT , AVP , AVP receptor 1a ( AVPR1a ), OXT receptor ( OXTR ), the oxytocinase/vasopressinase ( LNPEP ), and ADP-ribosyl cyclase ( CD38 ).", {"entities": [[130, 133, "GENE"], [152, 155, "GENE"], [192, 195, "GENE"], [134, 137, "GENE"], [158, 161, "GENE"], [164, 167, "GENE"], [134, 137, "GENE"], [158, 161, "GENE"], [164, 167, "GENE"], [182, 188, "GENE"], [130, 133, "GENE"], [152, 155, "GENE"], [192, 195, "GENE"], [207, 211, "GENE"], [248, 253, "GENE"], [283, 287, "GENE"]]}], ["Idiopathic interstitial pneumonias such as idiopathic pulmonary fibrosis or fibrotic nonspecific interstitial pneumonia are irreversible progressive pulmonary diseases that often have fatal outcomes.", {"entities": [[110, 119, "DISEASE"], [85, 119, "DISEASE"], [54, 72, "DISEASE"], [43, 72, "DISEASE"]]}], ["Although the etiology of idiopathic interstitial pneumonias is not yet fully understood, anti-fibrotic and anti-inflammatory agents have shown limited therapeutic effectiveness.", {"entities": []}], ["Reactive oxygen species and their cytotoxic effects on the lung epithelial cells have been reported to participate in the pathophysiology of the disease.", {"entities": []}], ["Because superoxide dismutase catalyzes the detoxification of reactive oxygen species, we developed lecithinized superoxide dismutase for the treatment of patients with idiopathic interstitial pneumonias.", {"entities": []}], ["A multicenter, randomized, placebo-controlled trial was conducted as a pilot study to investigate the safety and effectiveness of 40 or 80\u00a0mg lecithinized superoxide dismutase in patients with progressive idiopathic interstitial pneumonias who presented with either idiopathic pulmonary fibrosis or corticosteroid-resistant fibrotic nonspecific interstitial pneumonia and showed arterial oxygen tension compatible with stage III or IV on the Japanese severity grading scale for idiopathic interstitial pneumonias.", {"entities": [[358, 367, "DISEASE"], [333, 367, "DISEASE"], [277, 295, "DISEASE"], [266, 295, "DISEASE"]]}], ["Before and following infusion of lecithinized superoxide dismutase for 28\u00a0days, the primary endpoint of forced vital capacity and the secondary endpoints of lactate dehydrogenase, surfactant protein-A, surfactant protein-D and Krebs von den Lungen-6 levels were measured in the serum.", {"entities": []}], ["The primary endpoint of forced vital capacity did not improve significantly in the lecithinized superoxide dismutase groups in comparison with the placebo group.", {"entities": []}], ["The secondary endpoints of lactate dehydrogenase and surfactant protein-A levels were significantly attenuated by 28\u00a0days in the higher-dose (80\u00a0mg) group.", {"entities": []}], ["However, these changes returned to the baseline levels by 56\u00a0days after the cessation of lecithinized superoxide dismutase.", {"entities": []}], ["Adverse events and mortality in the drug-treated groups did not differ from those in the placebo group.", {"entities": []}], ["Treatment with lecithinized superoxide dismutase is safe and improves the levels of serum markers such as lactate dehydrogenase and surfactant protein-A in patients with advanced idiopathic interstitial pneumonias with severe respiratory dysfunction.", {"entities": []}], ["Considering the results of the current study, further investigations into the effects and treatment potential of long-term administration of lecithinized superoxide dismutase may be warranted.", {"entities": []}], ["University hospital Medical Information Network (UMIN) clinical trials registry no.", {"entities": []}], ["The contribution of the decline in thymic activity for the emergence of autoimmunity is still debatable.", {"entities": []}], ["Immune-competent adults submitted to complete thymectomy early in life provide a unique model to address this question.", {"entities": []}], ["We applied here strict criteria to identify adults lacking thymic activity based on sjTREC levels, to exclude thymic rebound and/or ectopic thymuses.", {"entities": []}], ["In agreement, they featured severe na\u00efve CD4 T-cell depletion and contraction of T-cell receptor diversity.", {"entities": [[41, 44, "GENE"]]}], ["Notwithstanding this, there was neither increased incidence of autoimmune disease in comparison with age-matched controls nor significant changes in their IgG/IgA/IgM/IgE autoreactivity profiles, as assessed through extensive arrays.", {"entities": []}], ["We reasoned that the observed relative preservation of the regulatory T-cell compartment, including maintenance of na\u00efve regulatory CD4 T-cells, may contribute to limit the emergence of autoimmunity upon thymectomy.", {"entities": [[132, 135, "GENE"]]}], ["Our findings have implications in other clinical settings with impaired thymic activity, and are particularly relevant to studies of autoimmunity in ageing.", {"entities": []}], ["The Hedgehog (HH) signaling pathway is critical for embryonic development and adult homeostasis.", {"entities": []}], ["Recent studies have identified regulatory roles for this pathway in certain cancers with mutations in the HH pathway genes.", {"entities": []}], ["The extent to which mutations of the HH pathway genes are involved in the pathogenesis of malignant mesothelioma (MMe) is unknown.", {"entities": [[90, 112, "DISEASE"], [114, 117, "GENE"]]}], ["Real-time PCR analysis of HH pathway genes PTCH1 , GLI1 and GLI2 were performed on 7 human MMe cell lines.", {"entities": [[43, 48, "GENE"], [51, 55, "GENE"], [60, 64, "GENE"], [91, 94, "GENE"]]}], ["Exon sequencing of 13 HH pathway genes was also performed in cell lines and human MMe tumors.", {"entities": [[82, 85, "GENE"]]}], ["In silico programs were used to predict the likelihood that an amino-acid substitution would have a functional effect.", {"entities": []}], ["GLI1 , GLI2 and PTCH1 were highly expressed in MMe cells, indicative of active HH signaling.", {"entities": [[0, 4, "GENE"], [7, 11, "GENE"], [16, 21, "GENE"], [47, 50, "GENE"]]}], ["PTCH1 , SMO and SUFU mutations were found in 2 of 11 MMe cell lines examined.", {"entities": [[0, 5, "GENE"], [8, 11, "GENE"], [16, 20, "GENE"], [53, 56, "GENE"]]}], ["A non-synonymous missense SUFU mutation (p.T411M) was identified in LO68 cells.", {"entities": [[26, 30, "GENE"]]}], ["In silico characterization of the SUFU mutant suggested that the p.T411M mutation might alter protein function.", {"entities": [[34, 38, "GENE"]]}], ["However, we were unable to demonstrate any functional effect of this mutation on Gli activity.", {"entities": []}], ["Deletion of exons of the PTCH1 gene was found in JU77 cells, resulting in loss of one of two extracellular loops implicated in HH ligand binding and the intracellular C-terminal domain.", {"entities": [[25, 30, "GENE"]]}], ["A 3-bp insertion (69_70insCTG) in SMO , predicting an additional leucine residue in the signal peptide segment of SMO protein was also identified in LO68 cells and a MMe tumour.", {"entities": [[34, 37, "GENE"], [114, 117, "GENE"], [34, 37, "GENE"], [114, 117, "GENE"], [166, 169, "GENE"]]}], ["We identified the first novel mutations in PTCH1 , SUFU and SMO associated with MMe.", {"entities": [[43, 48, "GENE"], [51, 55, "GENE"], [60, 63, "GENE"], [80, 83, "GENE"]]}], ["Although HH pathway mutations are relatively rare in MMe, these data suggest a possible role for dysfunctional HH pathway in the pathogenesis of a subgroup of MMe and help rationalize the exploration of HH pathway inhibitors for MMe therapy.", {"entities": [[53, 56, "GENE"], [159, 162, "GENE"], [229, 232, "GENE"], [53, 56, "GENE"], [159, 162, "GENE"], [229, 232, "GENE"], [53, 56, "GENE"], [159, 162, "GENE"], [229, 232, "GENE"]]}], ["Stress is thought to be one of the triggers of relapses in patients with inflammatory bowel disease (IBD).", {"entities": [[73, 99, "DISEASE"]]}], ["We examined the rate of relapse in IBD patients before and after the Great East Japan Earthquake.", {"entities": []}], ["A retrospective cohort study.", {"entities": []}], ["13 hospitals in Japan.", {"entities": []}], ["546 ulcerative colitis (UC) and 357 Crohn's disease (CD) patients who received outpatient and inpatient care at 13 hospitals located in the area that were seriously damaged by the earthquake.", {"entities": [[4, 22, "DISEASE"]]}], ["Data on patient's clinical characteristics, disease activity and deleterious effects of the earthquake were obtained from questionnaires and hospital records.", {"entities": []}], ["We evaluated the relapse rate (from inactive to active) across two consecutive months before and two consecutive months after the earthquake.", {"entities": []}], ["In this study, we defined \u2018active\u2019 as conditions with a partial Mayo score=2 or more (UC) or a Harvey-Bradshaw index=6 or more (CD).", {"entities": []}], ["Among the UC patients, disease was active in 167 patients and inactive in 379 patients before the earthquake.", {"entities": []}], ["After the earthquake, the activity scores increased significantly (p<0.0001).", {"entities": []}], ["A total of 86 patients relapsed (relapse rate=15.8%).", {"entities": []}], ["The relapse rate was about twice that of the corresponding period in the previous year.", {"entities": []}], ["Among the CD patients, 86 patients had active disease and 271 had inactive disease before the earthquake.", {"entities": []}], ["After the earthquake, the activity indices changed little.", {"entities": []}], ["A total of 25 patients experienced a relapse (relapse rate=7%).", {"entities": []}], ["The relapse rate did not differ from that of the corresponding period in the previous year.", {"entities": []}], ["Multivariate analyses revealed that UC, changes in dietary oral intake and anxiety about family finances were associated with the relapse.", {"entities": []}], ["Life-event stress induced by the Great East Japan Earthquake was associated with relapse in UC but not CD.", {"entities": []}], ["Epstein\u2013Barr virus (EBV) is a primary cause of infectious mononucleosis (IM) throughout the world, and the positive serology rate changes over time in infected individuals.", {"entities": [[47, 71, "DISEASE"]]}], ["The aim of this study was to explore the serological and clinical features among Chinese children with EBV infections.", {"entities": []}], ["A retrospective study of children suspected of having IM was conducted.", {"entities": []}], ["Peripheral blood samples were analyzed by indirect immunofluorescence to detect any EBV-specific antibodies.", {"entities": []}], ["Samples were classed as positive (+) or negative (\u2212) to immunoglobulins M (IgM) or G (IgG) to the viral capsid antigen (VCA) or EBV nuclear antigen (EBNA).", {"entities": []}], ["A standard medical history was taken, including epidemiological data and noting any clinical manifestations.", {"entities": []}], ["Of 317 children, 37 were aged <8 months; 10 of these were VCA-IgM+, and the youngest was aged 1 month; 280 were aged >8 months.", {"entities": []}], ["The EBV infection rate ranged from 21.4% among subjects aged 8\u201312 months to 84.2% in those aged >9 years.", {"entities": []}], ["Serologically, children who tested as VCA-IgM+ together with VCA-IgG and EBNA-IgG\u2013 had longer hospital stays with more palatal petechiae and lymphadenopathy, especially among those with an atypical lymphocyte count of >10%.", {"entities": []}], ["Children with the serological patterns [VCA-IgM\u2013, VCA-IgG+ and EBNA-IgG\u2013] and [VCA-IgM+ VCA-IgG+ and EBNA-IgG+] did not show specific clinical features.", {"entities": []}], ["Infants aged <8 months could be infected with EBV.", {"entities": []}], ["About 84% of these Chinese children aged >9 years had serological evidence of EBV infection, whereas IM peaked in patients aged 2\u20133 years.", {"entities": []}], ["The measurement of ventilation distribution is currently performed using inhaled tracer gases for multiple breath inhalation studies or imaging techniques to quantify spatial gas distribution.", {"entities": []}], ["Most tracer gases used for these studies have properties different from that of air.", {"entities": []}], ["The effect of gas density on regional ventilation distribution has not been studied.", {"entities": []}], ["This study aimed to measure the effect of gas density on regional ventilation distribution.", {"entities": []}], ["Ventilation distribution was measured in seven rats using electrical impedance tomography (EIT) in supine, prone, left and right lateral positions while being mechanically ventilated with either air, heliox (30% oxygen, 70% helium) or sulfur hexafluoride (20% SF 6 , 20% oxygen, 60% air).", {"entities": []}], ["The effect of gas density on regional ventilation distribution was assessed.", {"entities": []}], ["Gas density did not impact on regional ventilation distribution.", {"entities": []}], ["The non-dependent lung was better ventilated in all four body positions.", {"entities": []}], ["Gas density had no further impact on regional filling characteristics.", {"entities": []}], ["The filling characteristics followed an anatomical pattern with the anterior and left lung showing a greater impedance change during the initial phase of the inspiration.", {"entities": []}], ["It was shown that gas density did not impact on convection dependent ventilation distribution in rats measured with EIT.", {"entities": []}], ["Kaposi's sarcoma (KS) is an uncommon borderline vascular tumor involving mostly the cutaneous and mucosal sites of the body.", {"entities": [[9, 16, "DISEASE"]]}], ["Among the four distinctly clinicopathological presentations of KS, the iatrogenic form principally occurs in kidney transplant recipients receiving immunosuppressive therapy.", {"entities": []}], ["It rarely occurs in the head and neck region as primary site or in other groups of patients under immunosuppressive therapy.", {"entities": []}], ["We present of the case of a patient with right nose KS.", {"entities": []}], ["The patient had history of systemic lupus erythematosus (SLE) and was under immunosuppressive therapy.", {"entities": [[36, 55, "DISEASE"], [27, 55, "DISEASE"]]}], ["Once we keep KS in mind, the definite diagnosis can be made using routine histological examination and immunohistochemical study despite the rarity of the disease in this site.", {"entities": []}], ["Background and objective: Dysregulation of respiratory mucins, MUC5AC in particular, has been implicated in respiratory disease and MUC5AC expression is up-regulated in response to environmental challenges and inflammatory mediators.", {"entities": []}], ["The aim of this study was to examine the effect of genetic variation on susceptibility to common respiratory conditions.", {"entities": []}], ["Methods: The association of MUC5AC and the closely linked genes MUC2 and MUC5B with respiratory outcomes was tested in the MRC National Survey of Health and Development, a longitudinal birth cohort of men and women born in 1946.", {"entities": [[64, 68, "GENE"], [73, 78, "GENE"]]}], ["Also examined were the functional variants of the genes encoding inflammatory mediators, IL13, IL1B, IL1RN, TNFA and ERBB1 , for which there is a likely influence on MUC5AC expression and were explored potential gene-gene interactions with these inflammatory mediators.", {"entities": [[89, 93, "GENE"], [95, 99, "GENE"], [101, 106, "GENE"]]}], ["Results: Statistically significant associations between the 3'ter MUC5AC simple nucleotide polymorphism (SNP) rs1132440 and various non-independent respiratory outcomes (bronchitis, wheeze, asthma, hay fever) were reported while the adjacent loci show slight (but largely non-statistically significant) differences, presumably reflective of linkage disequilibrium (allelic association) across the region.", {"entities": [[190, 196, "DISEASE"], [170, 180, "DISEASE"]]}], ["A novel association between bronchitis and a non-synonymous functional ERBB1 SNP, rs2227983 (aka epidermal growth factor receptor:R497K, R521K) is also reported and evidence presented of interaction between MUC5AC and ERBB1 and between MUC5AC and IL1RN with respect to bronchitis.", {"entities": [[28, 38, "DISEASE"], [269, 279, "DISEASE"], [247, 252, "GENE"]]}], ["The ERBB1 result suggests a clear mechanism for a biological interaction in which the allelic variants of epidermal growth factor receptor differentially affect mucin expression.", {"entities": []}], ["Conclusions: The MUC5AC association and the interactions with inflammatory mediators suggest that genetically determined differences in MUC5AC expression alter susceptibility to respiratory disease.", {"entities": []}], ["SUMMARY AT A GLANCE This longitudinal cohort study shows occurrence of the common respiratory conditions bronchitis, wheeze, asthma and hay fever to be associated with genetic variation in a mucin gene, MUC5AC .", {"entities": [[125, 131, "DISEASE"], [105, 115, "DISEASE"]]}], ["Functional variation in the epidermal growth factor receptor (epidermal growth factor receptor encoded by ERBB1 ) is also associated with bronchitis and modulates the MUC5AC effect.", {"entities": [[138, 148, "DISEASE"]]}], ["There is growing evidence that the intrauterine environment can impact the neurodevelopment of the fetus through alterations in the functional epigenome of the placenta.", {"entities": []}], ["In the placenta, the HSD11B2 gene encoding the 11-beta hydroxysteroid dehydrogenase enzyme, which is responsible for the inactivation of maternal cortisol, is regulated by DNA methylation, and has been shown to be susceptible to stressors from the maternal environment.", {"entities": [[21, 28, "GENE"]]}], ["We examined the association between DNA methylation of the HSD11B2 promoter region in the placenta of 185 healthy newborn infants and infant and maternal characteristics, as well as the association between this epigenetic variability and newborn neurobehavioral outcome assessed with the NICU Network Neurobehavioral Scales.", {"entities": [[59, 66, "GENE"]]}], ["Controlling for confounders, HSD11B2 methylation extent is greatest in infants with the lowest birthweights (P\u200a=\u200a0.04), and this increasing methylation was associated with reduced scores of quality of movement (P\u200a=\u200a0.04).", {"entities": [[29, 36, "GENE"]]}], ["These results suggest that factors in the intrauterine environment which contribute to birth outcome may be associated with placental methylation of the HSD11B2 gene and that this epigenetic alteration is in turn associated with a prospectively predictive early neurobehavioral outcome, suggesting in some part a mechanism for the developmental origins of infant neurological health.", {"entities": [[153, 160, "GENE"]]}], ["Smoke-free legislation was implemented in Guangzhou on 1 September 2010.", {"entities": []}], ["However, the smoke-free policy did not cover all indoor areas and smoking rooms can be set in some public places.", {"entities": []}], ["This study aimed to assess changes in self-reported second-hand smoke (SHS) exposure in different types of venues and in homes, in order to evaluate the effectiveness of smoke-free legislation.", {"entities": []}], ["A repeated cross-sectional survey of representative participants was conducted in Guangzhou before and after the smoke-free legislation.", {"entities": []}], ["Logistic regression models were used to examine the effectiveness of smoke-free legislation.", {"entities": []}], ["Self-reported exposure to SHS,antitobacco advertisements and tobacco advertisements.", {"entities": []}], ["A total of 4900 participants before the ban and 5135 participants after the ban were selected using a multistage stratified design.", {"entities": []}], ["In full smoking ban places, overall self-reported SHS exposure has declined significantly from 58.8% to 50.3% (p<0.05) with greater drops in cultural venues, government offices and commercial venues.", {"entities": []}], ["The smoke-free policy did not alter SHS exposure in smokers\u2019 homes (39.6% in 2009 vs 40.0% in 2011; p=0.454).", {"entities": []}], ["Although a slight decrease in SHS exposure was observed in smoking rooms in hotels, workplaces, restaurants, cafes/bars/nightclubs and amusement parks, SHS continued to be high in those areas.", {"entities": []}], ["The implementation of smoke-free legislation was accompanied by an increase in antitobacco advertisements.", {"entities": []}], ["SHS exposure declines more significantly in full smoking ban places than in partial smoking ban places.", {"entities": []}], ["The smoke-free policy in public places does not lead to more SHS exposure in homes.", {"entities": []}], ["Therefore, it is recommended that Guangzhou should implement a 100% smoke-free policy in all public places and workplaces in the future.", {"entities": []}], ["By 2020, the child population is projected to have more racial and ethnic minorities make up the majority of the populations and health care organizations will need to have a system in place that collects accurate and reliable demographic data in order to monitor disparities.", {"entities": []}], ["The goals of this group were to establish sample practices, approaches and lessons learned with regard to race, ethnicity, language, and other demographic data collection in pediatric care setting.", {"entities": []}], ["A panel of 16 research and clinical professional experts working in 10 pediatric care delivery systems in the US and Canada convened twice in person for 3-day consensus development meetings and met multiple times via conference calls over a two year period.", {"entities": []}], ["Current evidence on adult demographic data collection was systematically reviewed and unique aspects of data collection in the pediatric setting were outlined.", {"entities": []}], ["Human centered design methods were utilized to facilitate theme development, facilitate constructive and innovative discussion, and generate consensus.", {"entities": []}], ["Group consensus determined six final data collection domains: 1) caregivers, 2) race and ethnicity, 3) language, 4) sexual orientation and gender identity, 5) disability, and 6) social determinants of health.", {"entities": []}], ["For each domain, the group defined the domain, established a rational for collection, identified the unique challenges for data collection in a pediatric setting, and developed sample practices which are based on the experience of the members as a starting point to allow for customization unique to each health care organization.", {"entities": []}], ["Several unique challenges in the pediatric setting across all domains include: data collection on caregivers, determining an age at which it is appropriate to collect data from the patient, collecting and updating data at multiple points across the lifespan, the limits of the electronic health record, and determining the purpose of the data collection before implementation.", {"entities": []}], ["There is no single approach that will work for all organizations when collecting race, ethnicity, language and other social determinants of health data.", {"entities": []}], ["Each organization will need to tailor their data collection based on the population they serve, the financial resources available, and the capacity of the electronic health record.", {"entities": []}], ["Vitamin D deficiency is well recognized in selected Middle Eastern countries, but neonatal vitamin D status is not well studied in Jordan and other nearby countries.", {"entities": []}], ["The aim of this study is to determine the prevalence of vitamin D deficiency in Jordanian newborns and risk factors associated with low levels.", {"entities": []}], ["This is a prospective cohort study of newborn infants who were delivered at the Al Bashir Government Hospital in Amman, Jordan, from January 31, 2010, to January 27, 2011.", {"entities": []}], ["Heel stick blood samples for 25-hydroxyvitamin D [25(OH)D] levels were obtained within 96 hours of birth.", {"entities": []}], ["Maternal dress pattern, vitamin supplementation, smoke exposure during pregnancy, mode of delivery, gestational age, and birth weight were documented.", {"entities": []}], ["Samples were obtained from 3,731 newborns.", {"entities": []}], ["Median gestational age was 39 weeks, median birth weight was 3.1 kilograms, median maternal age was 27 years, and median newborn 25(OH)D level was 8.6nmol/L.", {"entities": []}], ["A total of 3,512 newborns (94.1%) in this study were vitamin D deficient (< 50 nmol/L).", {"entities": []}], ["Lower gestational age, maternal smoke exposure, and birth during winter months were associated with lower infant vitamin D levels, while vitamin D supplementation and time spent outside during pregnancy were associated with higher vitamin D levels.", {"entities": []}], ["The prevalence of severely low vitamin D levels in newborn infants in Amman, Jordan, is substantial, even in newborns born during the spring and summer months.", {"entities": []}], ["Vitamin D supplementation is needed in this population.", {"entities": []}], ["We have developed a robust platform to generate and functionally characterize rabbit-derived antibodies using B cells from peripheral blood.", {"entities": []}], ["The rapid high throughput procedure generates a diverse set of antibodies, yet requires only few animals to be immunized without the need to sacrifice them.", {"entities": []}], ["The workflow includes (i) the identification and isolation of single B cells from rabbit blood expressing IgG antibodies, (ii) an elaborate short term B-cell cultivation to produce sufficient monoclonal antigen specific IgG for comprehensive phenotype screens, (iii) the isolation of VH and VL coding regions via PCR from B-cell clones producing antigen specific and functional antibodies followed by the sequence determination, and (iv) the recombinant expression and purification of IgG antibodies.", {"entities": []}], ["The fully integrated and to a large degree automated platform (demonstrated in this paper using IL1RL1 immunized rabbits) yielded clonal and very diverse IL1RL1-specific and functional IL1RL1-inhibiting rabbit antibodies.", {"entities": [[96, 102, "GENE"], [154, 160, "GENE"], [185, 191, "GENE"]]}], ["These functional IgGs from individual animals were obtained at a short time range after immunization and could be identified already during primary screening, thus substantially lowering the workload for the subsequent B-cell PCR workflow.", {"entities": []}], ["Early availability of sequence information permits one to select early-on function- and sequence-diverse antibodies for further characterization.", {"entities": []}], ["In summary, this powerful technology platform has proven to be an efficient and robust method for the rapid generation of antigen specific and functional monoclonal rabbit antibodies without sacrificing the immunized animal.", {"entities": []}], ["Advanced glycation end products (AGEs), inflammatory-associated macrophage migration and accumulation are crucial for initiation and progression of diabetic vascular complication.", {"entities": []}], ["Enzymatic activity of heparanase (HPA) is implicated strongly in dissemination of metastatic tumor cells and cells of the immune system.", {"entities": []}], ["In addition, HPA enhances the phosphorylation of selected signaling molecules including AKT pathway independent of enzymatic activity.", {"entities": []}], ["However, virtually nothing is presently known the role of HPA during macrophage migration exposed to AGEs involving signal pathway.", {"entities": []}], ["These studies were carried out in Ana-1 macrophages.", {"entities": []}], ["Macrophage viability was measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays.", {"entities": []}], ["HPA and AKT protein expression in macrophages are analysed by Western blotting and HPA mRNA expression by real time quantitative RT-PCR.", {"entities": []}], ["Release of HPA was determined by ELISA.", {"entities": []}], ["Macrophage migration was assessed by Transwell assays.", {"entities": []}], ["HPA protein and mRNA were found to be increased significantly in AGEs-treated macrophages.", {"entities": []}], ["Pretreatment with anti-HPA antibody which recognizes the nonenzymatic terminal of HPA prevented AGEs-induced AKT phosphorylation and macrophage migration.", {"entities": []}], ["LY294002 (PI3k/AKT inhibitor) inhibited AGEs-induced macrophage migration.", {"entities": []}], ["Furthermore, pretreatment with anti-receptor for advanced glycation end products (RAGE) antibody attenuated AGEs-induced HPA expression, AKT phosphorylation and macrophage migration.", {"entities": []}], ["These data indicate that AGEs-induced macrophage migration is dependent on HPA involving RAGE-HPA-PI3K/AKT pathway.", {"entities": []}], ["The nonenzymatic activity of HPA may play a key role in AGEs-induced macrophage migration associated with inflammation in diabetic vascular complication.", {"entities": []}], ["Glucocorticoid signaling regulates target genes by multiple mechanisms, including the repression of transcriptional activities of nuclear factor \u03ba-light-chain-enhancer of activated B cells (NF-\u03baB) though direct protein-protein interactions and subsequent O-GlcNAcylation of RNA polymerase II (pol II).", {"entities": []}], ["Recent studies have shown that overexpression of O -linked \u03b2- N -acetylglucosamine transferase (OGT), which adds an O -linked \u03b2- N -acetylglucosamine (O-GlcNAc) group to the C-terminal domain of RNA pol II, increases the transrepression effects of glucocorticoids (GC).", {"entities": [[96, 99, "GENE"], [265, 267, "GENE"]]}], ["As O -GlcNAcase (OGA) is an enzyme that removes O-GlcNAc from O-GlcNAcylated proteins, we hypothesized that the potentiation of GC effects following OGT overexpression could be similarly observed via the direct inhibition of OGA, inhibiting O-GlcNAc removal from pol II.", {"entities": [[128, 130, "GENE"], [149, 152, "GENE"]]}], ["Here we show that despite pharmacological evidence of target engagement by a selective small molecule inhibitor of OGA, there is no evidence for a sensitizing effect on glucocorticoid-mediated effects on TNF-\u03b1 promoter activity, or gene expression generally, in human cells.", {"entities": []}], ["Furthermore, inhibition of OGA did not potentiate glucocorticoid\u2013induced apoptosis in several cancer cell lines.", {"entities": [[94, 100, "DISEASE"]]}], ["Thus, despite evidence for O-GlcNAc modification of RNA pol II in GR-mediated transrepression, our data indicate that pharmacological inhibition of OGA does not potentiate or enhance glucocorticoid-mediated transrepression.", {"entities": []}], ["The aim of this study was to assess the frequency of use of dietary supplements (DS) among large sample of elite Finnish athletes and to describe possible changes in dietary supplement use between the years 2002 and 2009.", {"entities": []}], ["A prospective follow-up study was conducted on Olympic athletes.", {"entities": []}], ["The first survey was conducted on Olympic athletes in 2002 (N = 446) and the follow-up study was conducted between May 2008 and June 2009 (N = 372).", {"entities": []}], ["In 2002, a total of 81% of the athletes used dietary supplements (a mean of 3.37 \u00b1 3.06 DS per user) and in 2009, a total of 73% of the athletes (a mean of 2.60 \u00b1 2.69 per DS user) used them.", {"entities": []}], ["After adjusting for age-, sex- and sport type, the OR (95% confidence interval, CI) for use of any dietary supplement was significantly less in 2009 as compared with 2002 results (OR, 0.62; 95% CI, 0.43-0.90).", {"entities": []}], ["Decrease in DS use was observed in all supplement subgroups (vitamins, minerals, nutritional supplements).", {"entities": []}], ["Athletes in speed and power events and endurance events reported use of any dietary supplement significantly more often than team sport athletes both in 2002 and 2009.", {"entities": []}], ["In year 2009, the frequency of all dietary supplement use increased when athlete's age increased and the increase was significant in older age groups: of the athletes under 21 years 63%, 21-24 years 83% and over 24 years 90% consumed nutritional supplements.", {"entities": []}], ["Based in our study, there seems to be a lowering trend of dietary supplement use among elite Finnish athletes although differences between sport subgroups and age groups are considerable.", {"entities": []}], ["Parietaria pollen is one of the major causes of allergic reaction in southern Europe, affecting about 30% of all allergic patients in this area.", {"entities": []}], ["Specific immunotherapy is the only treatment able to modify the natural outcome of the disease by restoring a normal immunity against allergens.", {"entities": []}], ["The preparation of allergen-solid lipid nanoparticles as delivery vehicles for therapeutic proteins, P. judaica major allergen Par j 2, was investigated.", {"entities": []}], ["The Par j 2 allergen was expressed in a large amount in Escherichia coli and purified to homogeneity.", {"entities": []}], ["Its immunological properties were studied by western blotting and enzyme-linked immunosorbent assay inhibition.", {"entities": []}], ["Solid lipid nanoparticles were obtained by water-in-oil-in-water multiple emulsion method and characterized in terms of mean size and surface charge.", {"entities": []}], ["These systems (approximately 250 nm diameter and negative surface charge) incorporated recombinant Par j 2 with 40% or greater efficiency.", {"entities": []}], ["Moreover, the endotoxin level and anaphylactic activity of the empty solid lipid nanoparticles and recombinant Par j 2-loaded solid lipid nanoparticles were evaluated by looking at the overexpression of CD203c marker on human basophils.", {"entities": []}], ["These results demonstrate that recombinant Par j 2-nanoparticles could be proposed as safe compositions for the development of new therapeutic dosage forms to cure allergic reactions.", {"entities": []}], ["Dexamethasone has been shown to reduce mortality in patients with tuberculous meningitis but the long-term outcome of the disease is unknown.", {"entities": [[78, 88, "DISEASE"]]}], ["Vietnamese adults and adolescents with tuberculous meningitis recruited to a randomised, double-blind, placebo-controlled trial of adjunctive dexamethasone were followed-up at five years, to determine the effect of dexamethasone on long-term survival and neurological disability.", {"entities": [[51, 61, "DISEASE"]]}], ["545 patients were randomised to receive either dexamethasone (274 patients) or placebo (271 patients).", {"entities": []}], ["50 patients (9.2%) were lost to follow-up at five years.", {"entities": []}], ["In all patients two-year survival, probabilities tended to be higher in the dexamethasone arm (0.63 versus 0.55; p\u200a=\u200a0.07) but five-year survival rates were similar (0.54 versus 0.51, p\u200a=\u200a0.51) in both groups.", {"entities": []}], ["In patients with grade 1 TBM, but not with grade 2 or grade 3 TBM, the benefit of dexamethasone treatment tended to persist over time (five-year survival probabilities 0.69 versus 0.55, p\u200a=\u200a0.07) but there was no conclusive evidence of treatment effect heterogeneity by TBM grade (p\u200a=\u200a0.36).", {"entities": []}], ["The dexamethasone group had a similar proportion of severely disabled patients among survivors at five years as the placebo group (17/128, 13.2% vs. 17/116, 14.7%) and there was no significant association between dexamethasone treatment and disability status at five years (p\u200a=\u200a0.32).", {"entities": []}], ["Adjunctive dexamethasone appears to improve the probability of survival in patients with TBM, until at least two years of follow-up.", {"entities": []}], ["We could not demonstrate a five-year survival benefit of dexamethasone treatment which may be confined to patients with grade 1 TBM.", {"entities": []}], ["ClinicalTrials.gov NCT01317654 NCT01317654&quest;term&hairsp;&equals;&hairsp;tuberculous&plus;meningitis&amp;rank&hairsp;&equals;&hairsp;3", {"entities": [[94, 104, "DISEASE"]]}], ["The cellular infiltrates of certain inflammatory processes found in parasitic infection or in allergic diseases consist predominantly of eosinophilic granulocytes, often in association with activated T cells.", {"entities": []}], ["This suggests the existence of chemotactic agonists specific for eosinophils and lymphocyte subsets devoid of neutrophil-activating properties.", {"entities": []}], ["We therefore examined four members of the intercrine/chemokine superfamily of cytokines (monocyte chemotactic peptide 1 [MCP-1], RANTES, macrophage inflammatory protein 1 alpha [MIP- 1 alpha], and MIP-1 beta), which do not activate neutrophils, for their ability to affect different eosinophil effector functions.", {"entities": []}], ["RANTES strongly attracted normal human eosinophils by a chemotactic rather than a chemokinetic mechanism with a similar efficacy as the most potent chemotactic myeloid cell agonist, C5a.", {"entities": []}], ["MIP-1 alpha also induced eosinophil migration, however, with lower efficacy.", {"entities": []}], ["RANTES and MIP-1 alpha induced eosinophil cationic protein release in cytochalasin B- treated eosinophils, but did not promote leukotriene C4 formation by eosinophils, even after preincubation with interleukin 3 (IL-3), in contrast to other chemotactic agonists such as C5a and formyl-methionyl- leucyl-phenylalanine (FMLP).", {"entities": []}], ["RANTES, but not MIP-1 alpha, induced a biphasic chemiluminescence response, however, of lower magnitude than C5a.", {"entities": []}], ["RANTES and MIP-1 alpha both promoted identical transient changes in intracellular free calcium concentration ([Ca2+]i), with kinetics similar to those induced by chemotactic peptides known to interact with G protein-coupled receptors.", {"entities": []}], ["No cross-desensitization towards other peptide agonists (e.g., C5a, IL-8, FMLP) was observed, suggesting the presence of specific receptors.", {"entities": []}], ["Despite its weaker eosinophil- activating properties, MIP-1 alpha was at least 10 times more potent on a molar basis than RANTES at inducing [Ca2+]i changes.", {"entities": []}], ["Interestingly, RANTES deactivated the MIP-1 alpha-induced [Ca2+]i changes, while the RANTES response was preserved after MIP-1 alpha stimulation.", {"entities": []}], ["MCP-1, a potent monocyte chemoattractant and basophil agonist, as well as MIP-1 beta, a peptide with pronounced homology to MIP-1 alpha, did not activate the eosinophil functions tested.", {"entities": []}], ["Our results indicate that RANTES and MIP-1 alpha are crucial mediators of inflammatory processes in which eosinophils predominate.", {"entities": []}], ["Dicranopteris linearis (family Gleicheniaceae) has been reported to possess anti-inflammatory and antioxidant activities but no attempt has been made to study its hepatoprotective potential.", {"entities": []}], ["The aim of the present study was to determine the hepatoprotective effect of methanol extracts of D. linearis (MEDL) against carbon tetrachloride (CCl 4 )-induced acute liver injury in rats.", {"entities": []}], ["6 groups (n\u2009=\u20096) of rats received oral test solutions: 10% dimethyl sulfoxide (DMSO), 200\u00a0mg/kg silymarin, or MEDL (50, 250, and 500\u00a0mg/kg), once daily for 7 consecutive days, followed by hepatotoxicity induction with CCl 4 .", {"entities": []}], ["Blood and liver were collected for biochemical and microscopic analysis.", {"entities": []}], ["The extract was also subjected to antioxidant studies (e.g.", {"entities": []}], ["2, 2-diphenyl-1-picrylhydrazyl (DPPH)- and superoxide anion-radical scavenging assays, oxygen radical absorbance capacity (ORAC) test and total phenolic content (TPC) determination), phytochemical screening and HPLC analysis.", {"entities": []}], ["Pretreatment with MEDL and silymarin significantly (P\u2009<\u20090.05) reduced the serum levels of AST, ALT and ALP, which were increased significantly (P\u2009<\u20090.05) in DMSO-pretreated group following treatment with CCl 4 .", {"entities": []}], ["Histological analysis of liver tissues in groups pretreated with MEDL and silymarin showed mild necrosis and inflammation of the hepatocytes compared to the DMSO-pretreated group (negative control group).", {"entities": []}], ["The MEDL showed higher DPPH- and superoxide anion-radical scavenging activity as well as high TPC and ORAC values indicating high antioxidant activity.", {"entities": []}], ["MEDL exerts hepatoprotective activity that could be partly contributed by its antioxidant activity and high phenolic content, and hence demands further investigation.", {"entities": []}], ["Thirty-one cases of severe acute respiratory syndrome (SARS) occurred after exposure in the emergency room at the National Taiwan University Hospital.", {"entities": [[45, 53, "DISEASE"], [20, 53, "DISEASE"], [55, 59, "GENE"]]}], ["The index patient was linked to an outbreak at a nearby municipal hospital.", {"entities": []}], ["Three clusters were identified over a 3-week period.", {"entities": []}], ["The first cluster (5 patients) and the second cluster (14 patients) occurred among patients, family members, and nursing aids.", {"entities": []}], ["The third cluster (12 patients) occurred exclusively among healthcare workers.", {"entities": []}], ["Six healthcare workers had close contact with SARS patients.", {"entities": [[46, 50, "GENE"]]}], ["Six others, with different working patterns, indicated that they did not have contact with a SARS patient.", {"entities": [[93, 97, "GENE"]]}], ["Environmental surveys found 9 of 119 samples of inanimate objects to be positive for SARS coronavirus RNA.", {"entities": [[85, 89, "GENE"]]}], ["These observations indicate that although transmission by direct contact with known SARS patients was responsible for most cases, environmental contamination with the SARS coronavirus may have lead to infection among healthcare workers without documented contact with known hospitalized SARS patients.", {"entities": [[84, 88, "GENE"], [167, 171, "GENE"], [287, 291, "GENE"], [84, 88, "GENE"], [167, 171, "GENE"], [287, 291, "GENE"], [84, 88, "GENE"], [167, 171, "GENE"], [287, 291, "GENE"]]}], ["Viral surveillance programs or diagnostic labs occasionally obtain infectious samples that fail to be typed by available cell culture, serological, or nucleic acid tests.", {"entities": []}], ["Five such samples, originating from insect pools, skunk brain, human feces and sewer effluent, collected between 1955 and 1980, resulted in pathology when inoculated into suckling mice.", {"entities": []}], ["In this study, sequence-independent amplification of partially purified viral nucleic acids and small scale shotgun sequencing was used on mouse brain and muscle tissues.", {"entities": []}], ["A single viral agent was identified in each sample.", {"entities": []}], ["For each virus, between 16% to 57% of the viral genome was acquired by sequencing only 42\u2013108 plasmid inserts.", {"entities": []}], ["Viruses derived from human feces or sewer effluent belonged to the Picornaviridae family and showed between 80% to 91% amino acid identities to known picornaviruses.", {"entities": []}], ["The complete polyprotein sequence of one virus showed strong similarity to a simian picornavirus sequence in the provisional Sapelovirus genus.", {"entities": []}], ["Insects and skunk derived viral sequences exhibited amino acid identities ranging from 25% to 98% to the segmented genomes of viruses within the Reoviridae family.", {"entities": []}], ["Two isolates were highly divergent: one is potentially a new species within the orthoreovirus genus, and the other is a new species within the orbivirus genus.", {"entities": []}], ["We demonstrate that a simple, inexpensive, and rapid metagenomics approach is effective for identifying known and highly divergent new viruses in homogenized tissues of acutely infected mice.", {"entities": []}], ["Viral surveillance programs aim to identify circulating viruses to safeguard the public and livestock from viral outbreaks.", {"entities": []}], ["Occasionally, samples suspected of harboring a virus cause severe disease in laboratory animals, but the identity of the virus eludes researchers.", {"entities": []}], ["Here, we applied a simple viral discovery technique to identify viruses directly from the tissues of inoculated symptomatic mice and found a single virus in each sample using a rapid viral particle purification and random nucleic acid amplification method.", {"entities": []}], ["Two viruses appear to be closely related to the members of the Picornaviridae family.", {"entities": []}], ["In three other samples, originally collected from pools of crushed mosquitoes and the brain of a sick skunk, a known and novel viruses related to members of the Reoviridiae family were identified.", {"entities": []}], ["Reoviruses are considered major pathogens of livestock.", {"entities": []}], ["Our studies provide the groundwork for further analysis of the prevalence and pathogenesis of these divergent viruses and illustrate the ease with which new viral species can be identified in tissues of acutely infected animals.", {"entities": []}], ["Small-intestinal bacterial overgrowth (SIBO) is a frequent finding in patients with irritable bowel syndrome (IBS).", {"entities": [[84, 108, "DISEASE"], [100, 108, "DISEASE"]]}], ["Many patients with IBS also have abnormal intestinal permeability, which is probably due to low-grade inflammation in the intestinal mucosa.", {"entities": []}], ["Our aim was to verify the relationship between SIBO and small-intestinal permeability in IBS patients.", {"entities": []}], ["A cohort of 38 IBS patients (20 women and 18 men; age range 16-70 years; mean age 40.2 years) with symptoms that fulfilled Rome-II criteria, and 12 healthy controls (5 women and 7 men; age range 25-52 years; mean age: 37.8 years) were recruited.", {"entities": []}], ["All subjects underwent lactulose breath tests (LBTs) and intestinal permeability tests using the polyethylene glycol (PEG) 3350/400 retrieval ratio.", {"entities": []}], ["A positive LBT was found in 18.4% (7/38) of patients with IBS and 8.3% (1/12) of control subjects.", {"entities": []}], ["Intestinal permeability was significantly increased in patients with IBS compared with the normal controls (0.82\u00b10.09 vs 0.41\u00b10.05 [mean\u00b1SD], respectively; p<0.05).", {"entities": []}], ["However, the intestinal permeability did not differ significantly between IBS patients with a positive LBT and those with a negative LBT (0.90\u00b10.13 and 0.80\u00b10.11, respectively; p>0.05).", {"entities": []}], ["Intestinal permeability was increased in patients with IBS, but this finding did not correlated with the occurrence of SIBO.", {"entities": []}], ["Leukotriene B 4 (LTB 4 ) is a potent chemoattractant for neutrophils.", {"entities": [[17, 20, "GENE"]]}], ["Signalling of LTB 4 receptor type 1 (BLT 1 ) has pro-inflammatory functions through neutrophil recruitment.", {"entities": [[14, 17, "GENE"]]}], ["In this study, we investigated whether BLT 1 signalling plays a role in acetaminophen (APAP)-induced liver injury by affecting inflammatory responses including the accumulation of hepatic neutrophils.", {"entities": []}], ["BLT 1 -knockout (BLT 1 1 1 , displayed amplification of the injury, and similar results to those observed in BLT 1 1 1 -deficient neutrophils into WT mice aggravated the liver injury elicited by APAP.", {"entities": []}], ["These results demonstrate that BLT 1 signalling dampens the progression of APAP hepatotoxicity through inhibiting an excessive accumulation of activated neutrophils.", {"entities": []}], ["The development of a specific agonist for BLT 1 could be useful for the prevention of APAP hepatotoxicity.", {"entities": []}], ["There is growing interest in assisted living technologies to support independence at home.", {"entities": []}], ["Such technologies should ideally be designed \u2018in the wild\u2019 i.e.", {"entities": []}], ["taking account of how real people live in real homes and communities.", {"entities": []}], ["The ATHENE (Assistive Technologies for Healthy Living in Elders: Needs Assessment by Ethnography) project seeks to illuminate the living needs of older people and facilitate the co-production with older people of technologies and services.", {"entities": []}], ["This paper describes the development of a cultural probe tool produced as part of the ATHENE project and how it was used to support home visit interviews with elders with a range of ethnic and social backgrounds, family circumstances, health conditions and assisted living needs.", {"entities": []}], ["Thirty one people aged 60 to 98 were visited in their homes on three occasions.", {"entities": []}], ["Following an initial interview, participants were given a set of cultural probe materials, including a digital camera and the \u2018Home and Life Scrapbook\u2019 to complete in their own time for one week.", {"entities": []}], ["Activities within the Home and Life Scrapbook included maps (indicating their relationships to people, places and objects), lists (e.g.", {"entities": []}], ["likes, dislikes, things they were concerned about, things they were comfortable with), wishes (things they wanted to change or improve), body outline (indicating symptoms or impairments), home plan (room layouts of their homes to indicate spaces and objects used) and a diary.", {"entities": []}], ["After one week, the researcher and participant reviewed any digital photos taken and the content of the Home and Life Scrapbook as part of the home visit interview.", {"entities": []}], ["The cultural probe facilitated collection of visual, narrative and material data by older people, and appeared to generate high levels of engagement from some participants.", {"entities": []}], ["However, others used the probe minimally or not at all for various reasons including limited literacy, physical problems (e.g.", {"entities": []}], ["holding a pen), lack of time or energy, limited emotional or psychological resources, life events, and acute illness.", {"entities": []}], ["Discussions between researchers and participants about the materials collected (and sometimes about what had prevented them completing the tasks) helped elicit further information relevant to assisted living technology design.", {"entities": []}], ["The probe materials were particularly helpful when having conversations with non-English speaking participants through an interpreter.", {"entities": []}], ["Cultural probe methods can help build a rich picture of the lives and experiences of older people to facilitate the co-production of assisted living technologies.", {"entities": []}], ["But their application may be constrained by the participant\u2019s physical, mental and emotional capacity.", {"entities": []}], ["They are most effective when used as a tool to facilitate communication and development of a deeper understanding of older people\u2019s needs.", {"entities": []}], ["In recent years, there have been several sialome projects revealing transcripts expressed in the salivary glands of ticks, which are important vectors of several human diseases.", {"entities": []}], ["Here, we focused on the sialome of the European vector of Lyme disease, Ixodes ricinus .", {"entities": []}], ["In the attempt to describe expressed genes and their dynamics throughout the feeding period, we constructed cDNA libraries from four different feeding stages of Ixodes ricinus females: unfed, 24 hours after attachment, four (partially fed) and seven days (fully engorged) after attachment.", {"entities": []}], ["Approximately 600 randomly selected clones from each cDNA library were sequenced and analyzed.", {"entities": []}], ["From a total 2304 sequenced clones, 1881 sequences forming 1274 clusters underwent subsequent functional analysis using customized bioinformatics software.", {"entities": []}], ["Clusters were sorted according to their predicted function and quantitative comparison among the four libraries was made.", {"entities": []}], ["We found several groups of over-expressed genes associated with feeding that posses a secretion signal and may be involved in tick attachment, feeding or evading the host immune system.", {"entities": []}], ["Many transcripts clustered into families of related genes with stage-specific expression.", {"entities": []}], ["Comparison to Ixodes scapularis and I. pacificus transcripts was made.", {"entities": []}], ["In addition to a large number of homologues of the known transcripts, we obtained several novel predicted protein sequences.", {"entities": []}], ["Our work contributes to the growing list of proteins associated with tick feeding and sheds more light on the dynamics of the gene expression during tick feeding.", {"entities": []}], ["Additionally, our results corroborate previous evidence of gene duplication in the evolution of ticks.", {"entities": []}], ["Asthma is characterized by reversible airway narrowing, shortness of breath, wheezing, coughing, and other symptoms driven by chronic inflammatory processes, commonly triggered by allergens.", {"entities": [[0, 6, "DISEASE"]]}], ["In 90% of asthmatics, most of these symptoms can also be triggered by intense physical activities and severely exacerbated by environmental factors.", {"entities": []}], ["This condition is known as exercise-induced asthma (EIA).", {"entities": [[44, 50, "DISEASE"]]}], ["Current theories explaining EIA pathogenesis involve osmotic and/or thermal alterations in the airways caused by changes in respiratory airflow during exercise.", {"entities": []}], ["These changes, along with existing airway inflammatory conditions, are associated with increased cellular levels of reactive oxygen species (ROS) affecting important biomolecules including DNA, although the underlying molecular mechanisms have not been completely elucidated.", {"entities": []}], ["One of the most abundant oxidative DNA lesions is 8-oxoguanine (8-oxoG), which is repaired by 8-oxoguanine DNA glycosylase 1 (OGG1) during the base excision repair (BER) pathway.", {"entities": [[126, 130, "GENE"]]}], ["Whole-genome expression analyses suggest a cellular response to OGG1-BER, involving genes that may have a role in the pathophysiology of EIA leading to mast cell degranulation, airway hyperresponsiveness, and bronchoconstriction.", {"entities": []}], ["Accordingly, this review discusses a potential new hypothesis in which OGG1-BER-induced gene expression is associated with EIA symptoms.", {"entities": []}], ["The nucleotide-binding and oligomerization domain (NOD)-containing protein 1 (NOD1) plays the pivotal role in host-pathogen interface of innate immunity and triggers immune signalling pathways for the maturation and release of pro-inflammatory cytokines.", {"entities": [[78, 82, "GENE"]]}], ["Upon the recognition of iE-DAP, NOD1 self-oligomerizes in an ATP-dependent fashion and interacts with adaptor molecule receptor-interacting protein 2 (RIP2) for the propagation of innate immune signalling and initiation of pro-inflammatory immune responses.", {"entities": [[32, 36, "GENE"]]}], ["This interaction (mediated by NOD1 and RIP2) helps in transmitting the downstream signals for the activation of NF-\u03baB signalling pathway, and has been arbitrated by respective caspase-recruitment domains (CARDs).", {"entities": [[30, 34, "GENE"]]}], ["The so-called CARD-CARD interaction still remained contradictory due to inconsistent results.", {"entities": []}], ["Henceforth, to understand the mode and the nature of the interaction, structural bioinformatics approaches were employed.", {"entities": []}], ["MD simulation of modelled 1:1 heterodimeric complexes revealed that the type-Ia interface of NOD1", {"entities": [[93, 97, "GENE"]]}], ["Prior work suggests that asthma\u2013COPD overlap syndrome (ACOS) has a greater health burden than asthma alone or COPD alone.", {"entities": [[45, 53, "DISEASE"], [25, 31, "DISEASE"], [94, 100, "DISEASE"]]}], ["In the current study, we have further evaluated the health burden of ACOS in a nationally representative sample of the US population, focusing on patient-reported outcomes and health care utilization and on comparisons with asthma alone and COPD alone.", {"entities": [[224, 230, "DISEASE"]]}], ["Patient-reported outcomes are especially meaningful, as these include functional activities that are highly valued by patients and are the basis for patient-centered care.", {"entities": []}], ["Using data from the Medical Expenditure Panel Survey (MEPS), we evaluated patient-reported outcomes and health care utilization among participants who were aged 40\u201385 years and had self-reported, physician-diagnosed asthma or COPD.", {"entities": [[216, 222, "DISEASE"]]}], ["MEPS administered five rounds of interviews, at baseline and approximately every 6 months over 2.5 years.", {"entities": []}], ["Patient-reported outcomes included activities of daily living (ADLs), mobility, social/recreational activities, disability days in bed, and health status (Short Form 12, Version 2).", {"entities": []}], ["Health care utilization included outpatient and emergency department (ED) visits, and hospitalization.", {"entities": []}], ["Of 3,486 participants with asthma or COPD, 1,585 (45.4%) had asthma alone, 1,294 (37.1%) had COPD alone, and 607 (17.4%) had ACOS.", {"entities": [[27, 33, "DISEASE"], [61, 67, "DISEASE"]]}], ["Relative to asthma alone, ACOS was significantly associated with higher odds of prevalent disability in ADLs and limitations in mobility and social/recreational activities (adjusted odds ratios [adjORs]: 1.91\u20133.98), as well as with higher odds of incident limitations in mobility and social/recreational activities, disability days in bed, and respiratory-based outpatient and ED visits, and hospitalization (adjORs: 1.86\u20132.35).", {"entities": [[12, 18, "DISEASE"]]}], ["In addition, ACOS had significantly worse physical and mental health scores than asthma alone ( P -values <0.0001).", {"entities": [[81, 87, "DISEASE"]]}], ["Relative to COPD alone, ACOS was significantly associated with higher odds of prevalent limitations in mobility and social/recreational activities (adjORs: 1.68\u20132.06), as well as with higher odds of incident disability days in bed and respiratory-based outpatient and ED visits (adjORs: 1.48\u20131.74).", {"entities": []}], ["In addition, ACOS had a significantly worse physical health score, but similar mental health score, as compared with COPD alone ( P -values 0.0025 and 0.1578, respectively).", {"entities": []}], ["In the US, ACOS is associated with a greater health burden, including patient-reported outcomes and health care utilization, relative to asthma alone and COPD alone.", {"entities": [[137, 143, "DISEASE"]]}], ["Harmful effects of alcohol abuse are well documented for drinkers, and adverse effects are also reported for the physical and emotional well-being of family members, with evidence often originating from either drinkers or their families in clinic-based settings.", {"entities": [[19, 32, "DISEASE"]]}], ["This study evaluates intra-household associations between alcohol abuse in men, and depression and suicidal attempts in women, in community-based settings of Chennai, India.", {"entities": [[58, 71, "DISEASE"]]}], ["This community-based cross-sectional study of chronic disease risk factors and outcomes was conducted in n\u2009=\u2009259 households and n\u2009=\u20091053 adults (aged 15\u00a0years and above) in rural and urban Chennai.", {"entities": []}], ["The Alcohol Use Disorder Identification Test (AUDIT) score was used to classify alcohol consumption into \u2018low-risk', \u2018harmful\u2019, \u2018hazardous\u2019 and \u2018alcohol dependence\u2019 drinking and the Patient Health Questionnaire (PHQ-9) score to classify depression as \u2018mild\u2019, \u2018moderate\u2019, \u2018moderate-severe\u2019 and \u2018severe\u2019.", {"entities": [[145, 163, "DISEASE"]]}], ["Multivariate logistic regression models estimated the association of depression in women with men\u2019s drinking patterns in the same household.", {"entities": []}], ["A significant 2.5-fold increase in any depression (PHQ-9\u2009\u2265\u20095) was observed in men who were \u2018alcohol-dependent\u2019 compared to non-drinkers (OR\u2009=\u20092.53; 95\u00a0% CI: 1.26, 5.09).", {"entities": []}], ["However, there was no association between men\u2019s drinking behavior and depression in women of the same household, although suicidal attempts approached a significant dose\u2013response relationship with increasing hazard-level of men\u2019s drinking (p\u2009=\u20090.08).", {"entities": []}], ["No significant intra-household association was observed between men\u2019s alcohol consumption and women\u2019s depression, though an increasing (non-significant) trend was associated with suicidal attempts.", {"entities": []}], ["Complex relationships between suicidal attempts and depression in women and male abusive drinking require further exploration, with an emphasis on intra-household mechanisms and pathways.", {"entities": []}], ["Tissue-to-tissue coexpression networks between genes in hypothalamus, liver or adipose tissue enable identification of obesity-specific genes.", {"entities": [[119, 126, "DISEASE"]]}], ["Obesity is a particularly complex disease that at least partially involves genetic and environmental perturbations to gene-networks connecting the hypothalamus and several metabolic tissues, resulting in an energy imbalance at the systems level.", {"entities": [[0, 7, "DISEASE"]]}], ["To provide an inter-tissue view of obesity with respect to molecular states that are associated with physiological states, we developed a framework for constructing tissue-to-tissue coexpression networks between genes in the hypothalamus, liver or adipose tissue.", {"entities": [[35, 42, "DISEASE"]]}], ["These networks have a scale-free architecture and are strikingly independent of gene-gene coexpression networks that are constructed from more standard analyses of single tissues.", {"entities": []}], ["This is the first systematic effort to study inter-tissue relationships and highlights genes in the hypothalamus that act as information relays in the control of peripheral tissues in obese mice.", {"entities": []}], ["The subnetworks identified as specific to tissue-to-tissue interactions are enriched in genes that have obesity-relevant biological functions such as circadian rhythm, energy balance, stress response, or immune response.", {"entities": [[104, 111, "DISEASE"]]}], ["Tissue-to-tissue networks enable the identification of disease-specific genes that respond to changes induced by different tissues and they also provide unique details regarding candidate genes for obesity that are identified in genome-wide association studies.", {"entities": [[198, 205, "DISEASE"]]}], ["Identifying such genes from single tissue analyses would be difficult or impossible.", {"entities": []}], ["Dampness and mold have been shown in qualitative reviews to be associated with a variety of adverse respiratory health effects, including respiratory tract infections.", {"entities": []}], ["Several published meta-analyses have provided quantitative summaries for some of these associations, but not for respiratory infections.", {"entities": []}], ["Demonstrating a causal relationship between dampness-related agents, which are preventable exposures, and respiratory tract infections would suggest important new public health strategies.", {"entities": []}], ["We report the results of quantitative meta-analyses of published studies that examined the association of dampness or mold in homes with respiratory infections and bronchitis.", {"entities": [[164, 174, "DISEASE"]]}], ["For primary studies meeting eligibility criteria, we transformed reported odds ratios (ORs) and confidence intervals (CIs) to the log scale.", {"entities": []}], ["Both fixed and random effects models were applied to the log ORs and their variances.", {"entities": []}], ["Most studies contained multiple estimated ORs.", {"entities": []}], ["Models accounted for the correlation between multiple results within the studies analyzed.", {"entities": []}], ["One set of analyses was performed with all eligible studies, and another set restricted to studies that controlled for age, gender, smoking, and socioeconomic status.", {"entities": []}], ["Subgroups of studies were assessed to explore heterogeneity.", {"entities": []}], ["Funnel plots were used to assess publication bias.", {"entities": []}], ["The resulting summary estimates of ORs from random effects models based on all studies ranged from 1.38 to 1.50, with 95% CIs excluding the null in all cases.", {"entities": []}], ["Use of different analysis models and restricting analyses based on control of multiple confounding variables changed findings only slightly.", {"entities": []}], ["ORs (95% CIs) from random effects models using studies adjusting for major confounding variables were, for bronchitis, 1.45 (1.32-1.59); for respiratory infections, 1.44 (1.31-1.59); for respiratory infections excluding nonspecific upper respiratory infections, 1.50 (1.32-1.70), and for respiratory infections in children or infants, 1.48 (1.33-1.65).", {"entities": [[107, 117, "DISEASE"]]}], ["Little effect of publication bias was evident.", {"entities": []}], ["Estimated attributable risk proportions ranged from 8% to 20%.", {"entities": []}], ["Residential dampness and mold are associated with substantial and statistically significant increases in both respiratory infections and bronchitis.", {"entities": [[137, 147, "DISEASE"]]}], ["If these associations were confirmed as causal, effective control of dampness and mold in buildings would prevent a substantial proportion of respiratory infections.", {"entities": []}], ["The destruction of the World Trade Center (WTC) on 11 September 2001 in New York City resulted in the massive release of pulverized dust and combustion products.", {"entities": []}], ["The dust and smoke settled in the surrounding area, which encompassed a large residential community.", {"entities": []}], ["We hypothesized that previously normal residents in the community surrounding the former WTC would have an increased incidence of persistent respiratory symptoms and abnormalities in screening spirometry.", {"entities": []}], ["A hybrid cross-sectional and retrospective cohort study using a symptom-based questionnaire and onsite screening spirometry in residents in an exposed area and in a control area was performed 12 \u00b1 4 months after the collapse.", {"entities": []}], ["Surveys were analyzed from 2,812 residents.", {"entities": []}], ["New-onset respiratory symptoms were described by 55.8% of residents in the exposed area, compared with 20.1% in the control area after the event.", {"entities": []}], ["Persistent new-onset symptoms were identified in 26.4 versus 7.5% of residents in the exposed area versus control area, respectively.", {"entities": []}], ["No differences in screening spirometry between the groups were detected.", {"entities": []}], ["A small pilot study suggested the possibility of an increase in bronchial hyperresponsiveness in exposed participants with persistent symptoms.", {"entities": []}], ["The data demonstrate an increased rate of new-onset and persistent respiratory health effects in residents near the former WTC compared with a control population.", {"entities": []}], ["The aim of this study was to assess the role of European ambulatory pediatricians in caring for asthmatic children, especially in terms of their therapeutic education.", {"entities": []}], ["We developed a survey that was observational, declarative, retrospective and anonymous in nature.", {"entities": []}], ["436 ambulatory pediatricians in Belgium, France, Germany, Italy, Luxembourg and Slovenia were asked to participate in the survey providing information on three children over 6 years old suffering from persistent asthma, who had been followed for at least 6 months.", {"entities": [[212, 218, "DISEASE"]]}], ["We considered the pediatricians\u2019 profile, and their role in the therapeutic education of children.", {"entities": []}], ["277 pediatricians (64%) responded: 81% were primary care pediatricians; 46% participated in networks; 4% had specific training in Therapeutic Patient Education; 69% followed more than 5 asthmatic children per month, and over long periods (7 \u00b1 4 years).", {"entities": []}], ["The profiles of 684 children were assessed.", {"entities": []}], ["Answers diverged concerning the provision of a Personalized Action Plan (60\u201388%), training the child to measure and interpret his Peak Expiratory Flow (31\u201399%), and the prescription of pulmonary function tests during the follow-up programme of consultations (62\u201397%).", {"entities": []}], ["Answers converged on pediatricians\u2019 perception of their role in teaching children about their condition and its treatment (99%), about inhalation techniques (96%), and in improving the children\u2019s ability to take preventive measures when faced with risk situations (97%).", {"entities": []}], ["This study highlights the role of European pediatricians in caring for asthmatic children, and their lack of training in Therapeutic Patient Education.", {"entities": []}], ["Programmes and tools are required in order to train ambulatory pediatricians in Therapeutic Patient Education, and such resources should be integrated into primary health care, and harmonized at the European level.", {"entities": []}], ["In order to meet the challenges of caring for an injured person, caregivers need access to health information.", {"entities": []}], ["However, caregivers often feel that they lack adequate information.", {"entities": []}], ["Previous studies of caregivers have primarily focused on either their time and emotional burdens or their health outcomes, but the information needs of caregivers have not been thoroughly investigated.", {"entities": []}], ["The purpose of this investigation was to identify the preferred sources of health information for caregivers supporting individuals with injuries and to explore how access to this information could be improved.", {"entities": []}], ["A total of 32 caregivers participated in semistructured interviews, which were used in order to develop a more in-depth understanding of these caregivers\u2019 information needs.", {"entities": []}], ["Digital audio recordings of the interviews were used for analysis purposes.", {"entities": []}], ["These audio recordings were analyzed using a thematic analysis or qualitative content analysis.", {"entities": []}], ["All of participant\u2019s interviews were then coded using the qualitative analysis program, Nvivo 10 for Mac (QSR International).", {"entities": []}], ["The caregivers endorsed similar behaviors and preferences when seeking and accessing health information.", {"entities": []}], ["Medical professionals were the preferred source of information, while ease of access made the Internet the most common avenue to obtain information.", {"entities": []}], ["The challenges faced by participants were frequently a result of limited support.", {"entities": []}], ["In describing an ideal health system, participants expressed interest in a comprehensive care website offering support network resources, instructive services about the injury and caregiving, and injury-specific materials.", {"entities": []}], ["According to the participants, an ideal health information system would include a comprehensive care website that offered supportive network resources, instructive services about the injury and caregiving, and materials specific to the type of patient injury.", {"entities": []}], ["Progestational agents may reduce the risk of preterm birth in women with various risk factors.", {"entities": []}], ["We sought to test the hypothesis that a weekly dose of 17-hydroxyprogesterone caproate (17P) given to women with preterm rupture of the membranes (PROM) will prolong pregnancy and thereby reduce neonatal morbidity.", {"entities": []}], ["Double-blind, placebo-controlled randomized clinical trial.", {"entities": []}], ["Women with PROM at 23.0 to 31.9 weeks of gestation were randomly assigned to receive a weekly intramuscular injection of 17P (250 mg in 1 mL castor oil) or placebo (1 mL castor oil).", {"entities": []}], ["The primary outcome was the rate of continuing the pregnancy until 34.0 weeks of gestation or until documentation of fetal lung maturity at 32.0 to 33.9 weeks of gestation.", {"entities": []}], ["Planned secondary outcomes were duration of latency period and rate of composite neonatal morbidity.", {"entities": []}], ["Enrollment of 111 participants per group, 222 total, was planned to yield 80% power to detect an increase in the primary outcome from 30% with placebo to 50% with 17P.", {"entities": []}], ["Twelve women were enrolled of whom 4 were randomly assigned to receive 17P and 8 to receive placebo.", {"entities": []}], ["The trial was terminated prematurely because of two separate issues related to the supply of 17P.", {"entities": []}], ["No adverse events attributable to 17P were identified.", {"entities": []}], ["Because of premature termination, the trial does not have adequate statistical power to evaluate efficacy or safety of 17P in women with PROM.", {"entities": []}], ["Nonetheless, ethical principles dictate that we report the results, which may contribute to possible future metaanalyses and systematic reviews.", {"entities": []}], ["ClinicalTrials.gov: NCT01119963 Supported by a research grant from the Center for Research, Education, and Quality, Pediatrix Medical Group, Sunrise, FL", {"entities": []}], ["To influence the planning of the 2014 Commonwealth Games such that the positive impacts are maximized and the negative impacts are mitigated.", {"entities": []}], ["Participatory health impact assessment (HIA).", {"entities": []}], ["A participatory HIA was performed using standard World Health Organization methods.", {"entities": []}], ["A scoping event was held to involve decision makers in the process and to identify the key areas for consideration.", {"entities": []}], ["A large community engagement exercise and a systematic review were conducted as part of the evidence-gathering phase.", {"entities": []}], ["The results of the HIA were reported to the key decision makers involved in the Glasgow City Council legacy strategy.", {"entities": []}], ["The likely net health impact of hosting the Commonwealth Games was uncertain.", {"entities": []}], ["It was suggested that the main mechanisms through which impacts were likely to be felt were: the economy; civic pride; engagement in decision making; the provision of new infrastructure; and participation in cultural events.", {"entities": []}], ["A series of recommendations was produced in order to maximize positive health benefits and mitigate negative impacts.", {"entities": []}], ["HIA is a useful tool for engaging communities and decision makers in the public health agenda.", {"entities": []}], ["HIAs of major multi-sport events are limited by a lack of quality evidence and the inability to predict impacts reliably.", {"entities": []}], ["\u25ba The environment alters the immune response to an intradermal (i.d.)", {"entities": []}], ["TB subunit vaccine, Ad85A.", {"entities": []}], ["\u25ba Ad85A i.d.", {"entities": []}], ["induces a lung immune response but is less protective against Mtb than intranasal Ad85A.", {"entities": []}], ["\u25ba Oral administration of environmental mycobacteria reduces Ad85A i.d induced protection.", {"entities": []}], ["\u25ba In vivo depletion of CD25+ regulatory T cells abolishes the effect of oral mycobacteria.", {"entities": []}], ["Previously we have shown that intradermal (i.d.)", {"entities": []}], ["immunization with a recombinant adenovirus expressing antigen 85A (Ad85A) induced a strong splenic CD8\u00a0T cell response in BALB/c mice but a weak lung immune response and did not protect mice against challenge with Mycobacterium tuberculosis (Mtb) .", {"entities": [[228, 240, "DISEASE"]]}], ["After moving to a new animal house, the same i.d.", {"entities": []}], ["immunization induced a strong lung immune response and the mice were protected against Mtb challenge.", {"entities": []}], ["Increased numbers of antigen 85A-specific CD8 cells were present in lung tissue but were not recoverable by bronchoalveolar lavage (BAL).", {"entities": []}], ["Mycobacterial growth was inhibited 21 days after Mtb challenge.", {"entities": []}], ["In contrast, the effects of intranasal (i.n.)", {"entities": []}], ["immunization did not change between the animal houses; 85A-specific T cells were recovered by BAL and were able to inhibit Mtb growth early after challenge.", {"entities": []}], ["The effect of alterations to the environment was investigated by administering BCG or Mycobacterium abscessus in the drinking water, which induced protection against Mtb challenge, while Mycobacterium smegmatis did not.", {"entities": []}], ["However, when Ad85A was given i.d.", {"entities": []}], ["at the same time as BCG or M. abscessus , but not M. smegmatis , the protection induced by Ad85A was abolished.", {"entities": []}], ["Treatment of mice with a CD25 antibody during the challenge period, abolished the suppressive effect of oral mycobacterial administration, suggesting that regulatory T cells (T regs) were involved.", {"entities": []}], ["These results showed that exposure to environmental microorganisms can alter the protective immune response to a parenterally administered subunit vaccine, a result with important implications for the use of such vaccines in humans.", {"entities": []}], ["The purpose of this study was to identify whether the distribution of Hounsfield Unit (HU) values across the intracranial area in computed tomography (CT) images can be used as an effective diagnostic tool for determining the severity of cerebral edema in pediatric traumatic brain injury (TBI) patients.", {"entities": []}], ["CT images, medical records and radiology reports on 70 pediatric patients were collected.", {"entities": []}], ["Based on radiology reports and the Marshall classification, the patients were grouped as mild edema patients (n = 37) or severe edema patients (n = 33).", {"entities": []}], ["Automated quantitative analysis using unenhanced CT images was applied to eliminate artifacts and identify the difference in HU value distribution across the intracranial area between these groups.", {"entities": []}], ["The proportion of pixels with HU =17 to 24 was highly correlated with the existence of severe cerebral edema ( P <0.01).", {"entities": []}], ["This proportion was also able to differentiate patients who developed delayed cerebral edema from mild TBI patients.", {"entities": []}], ["A significant difference between deceased patients and surviving patients in terms of the HU distribution came from the proportion of pixels with HU = 19 to HU = 23 ( P <0.01).", {"entities": []}], ["The proportion of pixels with an HU value of 17 to 24 in the entire cerebral area of a non-enhanced CT image can be an effective basis for evaluating the severity of cerebral edema.", {"entities": []}], ["Based on this result, we propose a novel approach for the early detection of severe cerebral edema.", {"entities": []}], ["Bronchial thermoplasty (BT) is an emerging bronchoscopic intervention for the treatment of severe asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["The predictive factors for clinical response to BT are unknown.", {"entities": []}], ["We examined the relationship between the number of radiofrequency activations applied and the treatment response observed.", {"entities": []}], ["Data were collected from 24 consecutive cases treated at three Australian centres from June 2014 to March 2016.", {"entities": []}], ["The baseline characteristics were collated along with the activations delivered.", {"entities": []}], ["The primary response measure was change in the Asthma Control Questionnaire-5 (ACQ-5) score measured at 6\u00a0months post BT.", {"entities": [[47, 53, "DISEASE"]]}], ["The relationship between change in outcome parameters and the number of activations delivered was explored.", {"entities": []}], ["All patients met the ERS/ATS definition for severe asthma.", {"entities": [[51, 57, "DISEASE"]]}], ["At 6\u00a0months post treatment, mean ACQ-5 improved from 3.3\u00a0\u00b1\u00a01.1 to 1.5\u00a0\u00b1\u00a01.1, p \u00a0<\u00a00.001.", {"entities": []}], ["The minimal clinically significant improvement in ACQ-5 of \u22650.5 was observed in 21 out of 24 patients.", {"entities": []}], ["The only significant variable that differed between the 21 responders and the three non-responders was the number of activations delivered, with 139\u00a0\u00b1\u00a011 activations in the non-responders, compared to 221\u00a0\u00b1\u00a045 activations in the responders ( p \u00a0<\u00a00.01).", {"entities": []}], ["A significant inverse correlation was found between change in ACQ-5 score and the number of activations, r \u00a0=\u00a0\u22120.43 ( p \u00a0<\u00a00.05).", {"entities": []}], ["The number of activations delivered during BT has a role in determining clinical response to treatment.", {"entities": []}], ["We have previously found that reactive oxygen species (ROS) are involved in Pseudomonas aeruginosa lipopolysaccharide ( PA-LPS ) induced MUC5AC in airway epithelial cells.", {"entities": []}], ["Dual oxidase1 (Duox1), a member of NADPH oxidase(Nox), is known to be responsible for ROS production in respiratory tract epithelial cells.", {"entities": [[15, 20, "GENE"]]}], ["Our aim was to clarify whether Duox1 was also involved in the PA-LPS -induced MUC5AC and calcium dependent chloride channel 3(Clca3), another recognized marker of goblet cell hyperplasia and mucus hyper-production.", {"entities": [[31, 36, "GENE"]]}], ["PA-LPS -induced Duox1 mRNA levels were examined in A549 cells, primary mouse tracheal epithelial cells (mTECS) and lung tissues of mice.", {"entities": [[16, 21, "GENE"]]}], ["Nox inhibitors diphenyleneiodonium chloride (DPI) and Duox1 siRNA were used to investigate whether Duox1 is involved in PA-LPS -induced MUC5AC and Clca3 expression both in vitro and in vivo.", {"entities": [[54, 59, "GENE"], [99, 104, "GENE"], [54, 59, "GENE"], [99, 104, "GENE"]]}], ["Duox1 is induced by PA-LPS in A549 cells, primary mTECs and lung tissues of mice.", {"entities": [[0, 5, "GENE"]]}], ["DPI significantly inhibited PA-LPS -induced up-regulation of Duox1, Muc5ac and Clca3 in primary mouse trachea epithelial cells and lung tissues of mice.", {"entities": [[61, 66, "GENE"]]}], ["Knockdown of Duox1 markedly inhibited PA-LPS -induced MUC5AC expression via a ROS-TGF-\u03b1 cascade in A549 cells.", {"entities": [[13, 18, "GENE"]]}], ["Furthermore, DPI significantly inhibited PA-LPS -induced increases in inflammatory cells accumulated in mouse lungs.", {"entities": []}], ["We demonstrate for the first time that PA-LPS -induced MUC5AC and Clca3 expression is partly through Duox1, and provide supportive evidence for Duox1 as a potential target in treatments of mucin over-production diseases.", {"entities": [[101, 106, "GENE"], [144, 149, "GENE"], [101, 106, "GENE"], [144, 149, "GENE"]]}], ["The cardiovascular safety of inhaled long-acting \u03b2 2 -agonists (LABAs) in patients with chronic obstructive pulmonary disease (COPD) is a controversial problem.", {"entities": [[88, 125, "DISEASE"]]}], ["Certain studies have suggested that inhaled LABAs lead to an increased risk of cardiovascular events in patients with COPD.", {"entities": []}], ["This meta-analysis aimed to assess the cardiovascular safety of inhaled LABAs in COPD.", {"entities": []}], ["A meta-analysis of randomized, double-blind, parallel-group, placebo-controlled trials for LABA treatment of COPD with at least 3 months of follow-up was performed.", {"entities": []}], ["The fixed-effects model was used to evaluate the effects of LABAs on fatal cardiovascular adverse events.", {"entities": []}], ["Adverse events were collected for each trial, and the relative risk (RR) and 95% confidence intervals (CI) for LABA/placebo were estimated.", {"entities": []}], ["There were 24 trials included in this meta-analysis.", {"entities": []}], ["Compared with placebo, inhaled LABAs significantly decreased fatal cardiovascular adverse events in COPD patients (RR 0.65, 95% CI 0.50 to 0.86, P = 0.002).", {"entities": []}], ["In sensitivity analysis, there was still no increased risk of fatal cardiovascular events (RR 0.68, 95%CI 0.46 to 1.01, P = 0.06) after excluding the trial with the largest weight.", {"entities": []}], ["Among the different types of LABAs, only salmeterol had a significant effect (RR 0.64, 95% CI 0.46 to 0.90).", {"entities": []}], ["In subgroup analyses, inhaled LABAs were able to significantly decrease fatal cardiovascular events in long-term trials (RR 0.64, 95% CI 0.47 to 0.87) and in trials with severe COPD patients (RR 0.69, 95% CI 0.50 to 0.96).", {"entities": []}], ["Inhaled LABAs do not increase the risk of fatal cardiovascular events in COPD patients.", {"entities": []}], ["In data commonly used for health services research, a number of relevant variables are unobservable.", {"entities": []}], ["These include population lifestyle and socio-economic status, physician practice behaviors, population tendency to use health care resources, and disease prevalence.", {"entities": []}], ["These variables may be considered latent constructs of many observed variables.", {"entities": []}], ["Using health care data from South Carolina, we show an application of spatial structural equation modeling to identify how these latent constructs are associated with access to primary health care, as measured by hospitalizations for ambulatory care sensitive conditions.", {"entities": []}], ["We applied the confirmatory factor analysis approach, using the Bayesian paradigm, to identify the spatial distribution of these latent factors.", {"entities": []}], ["We then applied cluster detection tools to identify counties that have a higher probability of hospitalization for each of the twelve adult ambulatory care sensitive conditions, using a multivariate approach that incorporated the correlation structure among the ambulatory care sensitive conditions into the model.", {"entities": []}], ["For the South Carolina population ages 18 and over, we found that counties with high rates of emergency department visits also had less access to primary health care.", {"entities": []}], ["We also observed that in those counties there are no community health centers.", {"entities": []}], ["Locating such clusters will be useful to health services researchers and health policy makers; doing so enables targeted policy interventions to efficiently improve access to primary care.", {"entities": []}], ["Early discharge from the ICU is desirable because it shortens time in the ICU and reduces care costs, but can also increase the likelihood of ICU readmission and post-discharge unanticipated death if patients are discharged before they are stable.", {"entities": []}], ["We postulated that, using e ICU\u00ae Research Institute ( e RI) data from >400 ICUs, we could develop robust models predictive of post-discharge death and readmission that may be incorporated into future clinical information systems (CIS) to assist ICU discharge planning.", {"entities": []}], ["Retrospective, multi-center, exploratory cohort study of ICU survivors within the e RI database between 1/1/2007 and 3/31/2011.", {"entities": []}], ["Exclusion criteria: DNR or care limitations at ICU discharge and discharge to location external to hospital.", {"entities": []}], ["Patients were randomized (2\u22361) to development and validation cohorts.", {"entities": []}], ["Multivariable logistic regression was performed on a broad range of variables including: patient demographics, ICU admission diagnosis, admission severity of illness, laboratory values and physiologic variables present during the last 24 hours of the ICU stay.", {"entities": []}], ["Multiple imputation was used to address missing data.", {"entities": []}], ["The primary outcomes were the area under the receiver operator characteristic curves (auROC) in the validation cohorts for the models predicting readmission and death within 48 hours of ICU discharge.", {"entities": []}], ["469,976 and 234,987 patients representing 219 hospitals were in the development and validation cohorts.", {"entities": []}], ["Early ICU readmission and death was experienced by 2.54% and 0.92% of all patients, respectively.", {"entities": []}], ["The relationship between predictors and outcomes (death vs readmission) differed, justifying the need for separate models.", {"entities": []}], ["The models for early readmission and death produced auROCs of 0.71 and 0.92, respectively.", {"entities": []}], ["Both models calibrated well across risk groups.", {"entities": []}], ["Our models for death and readmission after ICU discharge showed good to excellent discrimination and good calibration.", {"entities": []}], ["Although prospective validation is warranted, we speculate that these models may have value in assisting clinicians with ICU discharge planning.", {"entities": []}], ["Only a small amount of research has focused on the relationship between socio-economic status (SES) and geographic access to prescription medications at community pharmacies in North America and Europe.", {"entities": []}], ["To examine the relationship between a community\u2019s socio-economic context and its residents\u2019 geographic access to common medications in pharmacies, we hypothesized that differences are present in access to pharmacies across communities with different socio-economic environments, and in availability of commonly prescribed medications within pharmacies located in communities with different socio-economic status.", {"entities": []}], ["We visited 408 pharmacies located in 168 socio-economically diverse communities to assess the availability of commonly prescribed medications.", {"entities": []}], ["We collected the following information at each pharmacy visited: hours of operation, pharmacy type, in-store medication availability, and the cash price of the 13 most commonly prescribed medications.", {"entities": []}], ["We calculated descriptive statistics for the sample and fitted a series of hierarchical linear models to test our hypothesis that the in-stock availability of medications differs by the socio-economic conditions of the community.", {"entities": []}], ["This was accomplished by modeling medication availability in pharmacies on the socio-economic factors operating at the community level in a socio-economically devise urban area.", {"entities": []}], ["Pharmacies in poor communities had significantly higher odds of medications being out of stock, OR=1.24, 95% CI [1.02, 1.52].", {"entities": []}], ["There was also a significant difference in density of smaller, independent pharmacies with very limited stock and hours of operation, and larger, chain pharmacies in poor communities as compared to the middle and low-poverty communities.", {"entities": []}], ["The findings suggest that geographic access to a neighborhood pharmacy, the type of pharmacy, and availability of commonly prescribed medications varies significantly across communities.", {"entities": []}], ["In extreme cases, entire communities could be deemed \u201cmedication deserts\u201d because geographic access to pharmacies and the availability of the most prescribed medications within them were very poor.", {"entities": []}], ["To our knowledge, this study is first to report on the relationship between SES and geographic access to medications using small area econometric analysis techniques.", {"entities": []}], ["Our findings should be reasonably generalizable to other urban areas in North America and Europe and suggest that more research is required to better understand the relationship of socio-economic environments and access to medications to develop strategies to achieve equitable medication access.", {"entities": []}], ["The main function of the lymphatic system is to control and maintain fluid homeostasis, lipid transport, and immune cell trafficking.", {"entities": []}], ["In recent years, the pathological roles of lymphangiogenesis, the generation of new lymphatic vessels from preexisting ones, in inflammatory diseases and cancer progression are beginning to be elucidated.", {"entities": [[154, 160, "DISEASE"]]}], ["Sphingosine-1-phosphate (S1P), a bioactive lipid, mediates multiple cellular events, such as cell proliferation, differentiation, and trafficking, and is now known as an important mediator of inflammation and cancer.", {"entities": [[209, 215, "DISEASE"]]}], ["In this review, we will discuss recent findings showing the emerging role of S1P in lymphangiogenesis, in inflammation, and in cancer.", {"entities": [[127, 133, "DISEASE"]]}], ["Drinking water contaminated with inorganic arsenic is associated with increased risk for different types of cancer.", {"entities": [[108, 114, "DISEASE"]]}], ["Paradoxically, arsenic trioxide can also be used to induce remission in patients with acute promyelocytic leukemia (APL) with a success rate of approximately 80%.", {"entities": [[106, 114, "DISEASE"]]}], ["A comprehensive study examining the mechanisms and potential signaling pathways contributing to the anti-tumor properties of arsenic trioxide has not been carried out.", {"entities": []}], ["Here we applied a systems biology approach to identify gene biomarkers that underlie tumor cell responses to arsenic-induced cytotoxicity.", {"entities": []}], ["The baseline gene expression levels of 14,500 well characterized human genes were associated with the GI 50 data of the NCI-60 tumor cell line panel from the developmental therapeutics program (DTP) database.", {"entities": []}], ["Selected biomarkers were tested in vitro for the ability to influence tumor susceptibility to arsenic trioxide.", {"entities": []}], ["A significant association was found between the baseline expression levels of 209 human genes and the sensitivity of the tumor cell line panel upon exposure to arsenic trioxide.", {"entities": []}], ["These genes were overlayed onto protein-protein network maps to identify transcriptional networks that modulate tumor cell responses to arsenic trioxide.", {"entities": []}], ["The analysis revealed a significant enrichment for the oxidative stress response pathway mediated by nuclear factor erythroid 2-related factor 2 (NRF2) with high expression in arsenic resistant tumor cell lines.", {"entities": []}], ["The role of the NRF2 pathway in protecting cells against arsenic-induced cell killing was validated in tumor cells using shRNA-mediated knock-down.", {"entities": []}], ["In this study, we show that the expression level of genes in the NRF2 pathway serve as potential gene biomarkers of tumor cell responses to arsenic trioxide.", {"entities": []}], ["Importantly, we demonstrate that tumor cells that are deficient for NRF2 display increased sensitivity to arsenic trioxide.", {"entities": []}], ["The results of our study will be useful in understanding the mechanism of arsenic-induced cytotoxicity in cells, as well as the increased applicability of arsenic trioxide as a chemotherapeutic agent in cancer treatment.", {"entities": [[203, 209, "DISEASE"]]}], ["Cholesterol gallstone disease (CGD) is a multifactorial and multistep disease.", {"entities": []}], ["Apart from female gender and increasing age being the documented non-modifiable risk factor for gallstones the pathobiological mechanisms underlying the phenotypic expression of CGD appear to be rather complex, and one or more variations in genes could play critical roles in the diverse pathways further progressing to cholesterol crystal formation.", {"entities": []}], ["In the present study we performed genotyping score, Multifactor dimensionality reduction (MDR) and Classification and Regression Tree analysis (CART) to identify combinations of alleles among the hormonal, hepatocanalicular transporter and adipogenesis differentiation pathway genes in modifying the risk for CGD.", {"entities": []}], ["The present case-control study recruited total of 450 subjects, including 230 CGD patients and 220 controls.", {"entities": []}], ["We analyzed common ESR1, ESR2, PGR, ADRB3, ADRA2A, ABCG8, SLCO1B1, PPAR\u03b32, and SREBP2 gene polymorphisms to find out combinations of genetic variants contributing to CGD risk, using multi-analytical approaches (G-score, MDR, and CART).", {"entities": [[19, 23, "GENE"], [25, 29, "GENE"], [31, 34, "GENE"], [36, 41, "GENE"], [43, 49, "GENE"], [51, 56, "GENE"], [58, 65, "GENE"]]}], ["Single locus analysis by logistic regression showed association of ESR1 IVS1-397C>T (rs2234693), IVS1-351A>G (rs9340799) PGR ins/del (rs1042838) ADRB3 -190 T>C (rs4994) ABCG8 D19H (rs11887534), SLCO1B1 Exon4 C>A (rs11045819) and SREBP2 1784G>C (rs2228314) with CGD risk.", {"entities": [[67, 71, "GENE"], [121, 124, "GENE"], [145, 150, "GENE"], [169, 174, "GENE"], [194, 201, "GENE"]]}], ["However, the MDR and CART analysis revealed ESR1 IVS1-397C>T (rs2234693) ADRB3 -190 T>C (rs4994) and ABCG8 D19H (rs11887534) polymorphisms as the best polymorphic signature for discriminating between cases and controls.", {"entities": [[44, 48, "GENE"], [73, 78, "GENE"], [101, 106, "GENE"]]}], ["The overall odds ratio for the applied multi-analytical approaches ranged from 4.33 to 10.05 showing an incremental risk for cholesterol crystal formation.", {"entities": []}], ["In conclusion, our muti-analytical approach suggests that, ESR1, ADRB3, in addition to ABCG8 genetic variants confer significant risk for cholesterol gallstone disease.", {"entities": [[59, 63, "GENE"], [65, 70, "GENE"], [87, 92, "GENE"]]}], ["Sleep is a state of quiescence that facilitates the significant restorative processes that enhance individuals\u2019 physiological and psychological well-being.", {"entities": []}], ["Patients admitted to the intensive care unit (ICU) experience substantial sleep disturbance.", {"entities": []}], ["Despite the biological importance of sleep, sleep monitoring does not form part of standard clinical care for critically ill patients.", {"entities": []}], ["There exists an unmet need to assess the feasibility and accuracy of a range of sleep assessment techniques that have the potential to allow widespread implementation of sleep monitoring in the ICU.", {"entities": []}], ["The coprimary outcome measures of this study are to: determine the accuracy and feasibility of motion accelerometer monitoring (ie, actigraphy) and subjective assessments of sleep (nursing-based observations and patient self-reports) to the gold standard of sleep monitoring (ie, polysomnography) in evaluating sleep continuity and disturbance.", {"entities": []}], ["The secondary outcome measures of the study will include: (1) the association between sleep disturbance and environmental factors (eg, noise, light and clinical interactions) and (2) to describe the sleep architecture of intensive care patients.", {"entities": []}], ["A prospective, single centre observational design with a within subjects\u2019 assessment of sleep monitoring techniques.", {"entities": []}], ["The sample will comprise 80 adults (aged 18 years or more) inclusive of ventilated and non-ventilated patients, admitted to a tertiary ICU with a Richmond Agitation-Sedation Scale score between +2 (agitated) and \u22123 (moderate sedation) and an anticipated length of stay >24\u2009hours.", {"entities": []}], ["Patients\u2019 sleep quality, total sleep time and sleep fragmentations will be continuously monitored for 24\u2009hours using polysomnography and actigraphy.", {"entities": []}], ["Behavioural assessments (nursing observations) and patients\u2019 self-reports of sleep quality will be assessed during the 24-hour period using the Richards-Campbell Sleep Questionnaire, subjective sleepiness evaluated via the Karolinska Sleepiness Scale, along with a prehospital discharge survey regarding patients\u2019 perception of sleep quality and disturbing factors using the Little Sleep Questionnaire will be undertaken.", {"entities": []}], ["Associations between sleep disturbance, noise and light levels, and the frequency of clinical interactions will also be investigated.", {"entities": []}], ["Sound and luminance levels will be recorded at 1\u2009s epochs via Extech SDL600 and SDL400 monitoring devices.", {"entities": []}], ["Clinical interactions will be logged via the electronic patient record system Metavision which documents patient monitoring and clinical care.", {"entities": []}], ["The relevant institutions have approved the study protocol and consent procedures.", {"entities": []}], ["The findings of the study will contribute to the understanding of sleep disturbance, and the ability to implement sleep monitoring methods within ICUs.", {"entities": []}], ["Understanding the contribution of a clinical environment on sleep disturbance may provide insight into the need to address clinical environmental issues that may positively influence patient outcomes, and could dispel notions that the environment is a primary factor in sleep disturbance.", {"entities": []}], ["The research findings will be disseminated via presentations at national and international conferences, proceedings and published articles in peer-reviewed journals.", {"entities": []}], ["ACTRN12615000945527; Pre-results .", {"entities": []}], ["Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characterized by excessive neutrophil infiltration which contributes to RSV induced pathology.", {"entities": [[34, 47, "DISEASE"]]}], ["The cytokine IL-17A enhances neutrophil infiltration into virus infected lungs.", {"entities": []}], ["IL-17A is however best known as an effector of adaptive immune responses.", {"entities": []}], ["The role of IL-17A in early immune modulation in RSV infection is unknown.", {"entities": []}], ["We aimed to elucidate whether local IL-17A facilitates the innate neutrophil infiltration into RSV infected lungs prior to adaptive immunity.", {"entities": []}], ["To this end, we studied IL-17A production in newborns that were hospitalized for severe RSV bronchiolitis.", {"entities": [[92, 105, "DISEASE"]]}], ["In tracheal aspirates we measured IL-17A concentration and neutrophil counts.", {"entities": []}], ["We utilized cultured human epithelial cells to test if IL-17A regulates RSV infection-induced IL-8 release as mediator of neutrophil recruitment.", {"entities": []}], ["In mice we investigated the cell types that are responsible for early innate IL-17A production during RSV infection.", {"entities": []}], ["Using IL-17A neutralizing antibodies we tested if IL-17A is responsible for innate neutrophil infiltration in mice.", {"entities": []}], ["Our data show that increased IL-17A production in newborn RSV patient lungs correlates with subsequent neutrophil counts recruited to the lungs.", {"entities": []}], ["IL-17A potentiates RSV-induced production of the neutrophil-attracting chemokine IL-8 by airway epithelial cells in vitro.", {"entities": []}], ["Various lung-resident lymphocytes produced IL-17A during early RSV infection in Balb/c mice, of which a local population of CD4 T cells stood out as the predominant RSV-induced cell type.", {"entities": [[124, 127, "GENE"]]}], ["By removing IL-17A during early RSV infection in mice we showed that IL-17A is responsible for enhanced innate neutrophil infiltration in vivo.", {"entities": []}], ["Using patient material, in vitro studies, and an animal model of RSV infection, we thus show that early local IL-17A production in the airways during RSV bronchiolitis facilitates neutrophil recruitment with pathologic consequences to infant lungs.", {"entities": [[154, 167, "DISEASE"]]}], ["There are long-standing concerns about adverse effects of gas appliances on respiratory health.", {"entities": []}], ["However, the potential adverse effect of low-NO x (nitrogen oxide) unflued gas heaters on children\u2019s health has not been assessed.", {"entities": []}], ["Our goal was to compare the respiratory health effects and air quality consequences of exposure to low-NO x unflued gas heaters with exposure to non\u2013indoor-air-emitting flued gas heaters in school classrooms.", {"entities": []}], ["We conducted a double-blind, cluster-randomized, crossover study in 400 primary school students attending 22 schools in New South Wales, Australia.", {"entities": []}], ["Children measured their lung function and recorded symptoms and medication use twice daily.", {"entities": []}], ["Nitrogen dioxide (NO 2 ) and formaldehyde concentrations were measured in classrooms using passive diffusion badges.", {"entities": []}], ["NO 2 concentrations were, on average, 1.8 times higher [95% confidence interval (CI), 1.6\u20132.1] and formaldehyde concentrations were, on average, 9.4 ppb higher (95% CI, 5.7\u201313.1) during exposure to unflued gas versus flued gas heaters.", {"entities": []}], ["Exposure to the unflued gas heaters was associated with increased cough reported in the evening [odds ratio (OR) = 1.16; 95% CI, 1.01\u20131.34] and wheeze reported in the morning (OR = 1.38; 95% CI, 1.04\u20131.83).", {"entities": []}], ["The association with wheeze was greater in atopic subjects.", {"entities": []}], ["There was no evidence of an adverse effect on lung function.", {"entities": []}], ["We conclude that classroom exposure to low-NO x unflued gas heaters causes increased respiratory symptoms, particularly in atopic children, but is not associated with significant decrements in lung function.", {"entities": []}], ["It is important to seek alternative sources of heating that do not have adverse effects on health.", {"entities": []}], ["Young adulthood is a critical life period for health and health behaviours.", {"entities": []}], ["Related measurements collected before and after birth, and during childhood and adolescence can provide a life-course analysis of important factors that contribute to health and behaviour in young adulthood.", {"entities": []}], ["The Western Australian Pregnancy Cohort (Raine) Study has collected a large number of such measurements during the fetal, perinatal, infancy, childhood and adolescence periods and plans to relate them to common health issues and behaviours in young adults, including spinal pain, asthma, sleep disorders, physical activity and sedentary behaviour and, work absenteeism and presenteeism.", {"entities": [[280, 286, "DISEASE"]]}], ["The aim of this paper is to describe the rationale, design and methods of the 22\u00a0year follow-up of the Raine Study cohort.", {"entities": []}], ["The Raine Study is a prospective cohort study.", {"entities": []}], ["Participants still active in the cohort ( n \u2009=\u20092,086) were contacted around the time of their 22nd birthday and invited to participate in the 22\u00a0year follow-up.", {"entities": []}], ["Each was asked to complete a questionnaire, attend a research facility for physical assessment and an overnight sleep study, wear activity monitors for a week, and to maintain a sleep and activity diary over this week.", {"entities": []}], ["The questionnaire was broad and included questions related to sociodemographics, medical history, quality of life, psychological factors, lifestyle factors, spinal pain, respiratory, sleep, activity and work factors.", {"entities": []}], ["Physical assessments included anthropometry, blood pressure, back muscle endurance, tissue sensitivity, lung function, airway reactivity, allergic status, 3D facial photographs, cognitive function, and overnight polysomnography.", {"entities": []}], ["Describing the prevalence of these health issues and behaviours in young adulthood will enable better recognition of the issues and planning of health care resources.", {"entities": []}], ["Providing a detailed description of the phenotype of these issues will provide valuable information to help educate health professionals of the needs of young adults.", {"entities": []}], ["Understanding the life-course risk factors of health issues and behaviours in young adulthood will have important health planning implications, supporting the development of targeted interventions to improve current health status and reduce the onset and development of further ill-health across adulthood.", {"entities": []}], ["Human adenovirus 55 (HAdV-55) has caused recent outbreaks of acute respiratory disease (ARD) among adults and military trainees.", {"entities": []}], ["The active surveillance for HAdV infections was sparse in China, and current knowledge on the HAdV-type distributions and its molecular evolution is lacking.", {"entities": []}], ["To acquire better understanding on the prevalence and molecular evolution of HAdV-55 strains in China, for an informed strategy for disease control and prevention.", {"entities": []}], ["Nasopharyngeal aspirates were collected from hospitalized children with ARTI in Chongqing during 2009\u20132012.", {"entities": []}], ["The genotype of HAdV isolates were determined by sequencing the partial hexon and fiber genes.", {"entities": []}], ["Whole genome sequences of HAdV-55 were obtained for molecular evolution analysis.", {"entities": []}], ["About 191 (8\u00b755%) HAdV were detected in 2234 children, including 92 (48\u00b72%) with HAdV-7, 72 (37\u00b77%) with HAdV-3, 6 (3\u00b71%) with HAdV-55, 5 (2\u00b76%) with HAdV-5, 4 (2\u00b71%) with HAdV-1, 1 (0\u00b75%) with HAdV-2, and 11(5\u00b78%) with untyped HAdV.", {"entities": []}], ["Four of these children developed pneumonia, two of whom were diagnosed with severe pneumonia and/or encephalopathy.", {"entities": [[33, 42, "DISEASE"], [83, 92, "DISEASE"]]}], ["HAdV-55 isolates clustered with HAdV-11 sequences based on the hexon gene and clustered with HAdV-14 sequences based on the fiber gene and the whole genome.", {"entities": []}], ["The overall evolutionary rates of hexon gene, fiber gene, and whole genome of HAdV-55 were estimated at 6\u00b72 \u00d7 10 This study suggested HAdV-55 as an emerging infectious disease pathogen has conserved genetic structure and is closely related to each other.", {"entities": []}], ["Further molecular investigation based on HAdV-55 of wider origin might facilitate understanding its diversity, dissemination, and transmission in China.", {"entities": []}], ["Acute lymphoblast leukemia (ALL) is characterized by overproduction of immature white blood cells in the bone marrow.", {"entities": [[18, 26, "DISEASE"]]}], ["ALL is most common in the childhood and has high (>80%) cure rate.", {"entities": []}], ["In contrast, acute myeloid leukemia (AML) has far greater mortality rate than the ALL and is most commonly affecting older adults.", {"entities": [[19, 35, "DISEASE"], [13, 35, "DISEASE"], [27, 35, "DISEASE"]]}], ["However, AML is a leading cause of childhood cancer mortality.", {"entities": [[45, 51, "DISEASE"]]}], ["In this study, we compare gene expression and molecular pathway activation patterns in three normal blood, seven pediatric ALL and seven pediatric AML bone marrow samples.", {"entities": []}], ["We identified 172/94 and 148/31 characteristic gene expression/pathway activation signatures, clearly distinguishing pediatric ALL and AML cells, respectively, from the normal blood.", {"entities": []}], ["The pediatric AML and ALL cells differed by 139/34 gene expression/pathway activation biomarkers.", {"entities": []}], ["For the adult 30 AML and 17 normal blood samples, we found 132/33 gene expression/pathway AML-specific features, of which only 7/2 were common for the adult and pediatric AML and, therefore, age-independent.", {"entities": []}], ["At the pathway level, we found more differences than similarities between the adult and pediatric forms.", {"entities": []}], ["These findings suggest that the adult and pediatric AMLs may require different treatment strategies.", {"entities": []}], ["The transient receptor potential ankyrin 1 (TRPA1) channel, localized to airway sensory nerves, has been proposed to mediate airway inflammation evoked by allergen and cigarette smoke (CS) in rodents, via a neurogenic mechanism.", {"entities": [[44, 49, "GENE"], [185, 187, "GENE"]]}], ["However the limited clinical evidence for the role of neurogenic inflammation in asthma or chronic obstructive pulmonary disease raises an alternative possibility that airway inflammation is promoted by non-neuronal TRPA1.", {"entities": [[91, 128, "DISEASE"], [81, 87, "DISEASE"], [216, 221, "GENE"]]}], ["By using Real-Time PCR and calcium imaging, we found that cultured human airway cells, including fibroblasts, epithelial and smooth muscle cells express functional TRPA1 channels.", {"entities": [[164, 169, "GENE"]]}], ["By using immunohistochemistry, TRPA1 staining was observed in airway epithelial and smooth muscle cells in sections taken from human airways and lung, and from airways and lung of wild-type, but not TRPA1-deficient mice.", {"entities": [[31, 36, "GENE"], [199, 204, "GENE"]]}], ["In cultured human airway epithelial and smooth muscle cells and fibroblasts, acrolein and CS extract evoked IL-8 release, a response selectively reduced by TRPA1 antagonists.", {"entities": [[90, 92, "GENE"], [156, 161, "GENE"]]}], ["Capsaicin, agonist of the transient receptor potential vanilloid 1 (TRPV1), a channel co-expressed with TRPA1 by airway sensory nerves, and acrolein or CS (TRPA1 agonists), or the neuropeptide substance P (SP), which is released from sensory nerve terminals by capsaicin, acrolein or CS), produced neurogenic inflammation in mouse airways.", {"entities": [[68, 73, "GENE"], [104, 109, "GENE"], [156, 161, "GENE"], [152, 154, "GENE"], [284, 286, "GENE"], [104, 109, "GENE"], [156, 161, "GENE"], [152, 154, "GENE"], [284, 286, "GENE"]]}], ["However, only acrolein and CS, but not capsaicin or SP, released the keratinocyte chemoattractant (CXCL-1/KC, IL-8 analogue) in bronchoalveolar lavage (BAL) fluid of wild-type mice.", {"entities": [[27, 29, "GENE"]]}], ["This effect of TRPA1 agonists was attenuated by TRPA1 antagonism or in TRPA1-deficient mice, but not by pharmacological ablation of sensory nerves.", {"entities": [[15, 20, "GENE"], [48, 53, "GENE"], [71, 76, "GENE"], [15, 20, "GENE"], [48, 53, "GENE"], [71, 76, "GENE"]]}], ["Our results demonstrate that, although either TRPV1 or TRPA1 activation causes airway neurogenic inflammation, solely TRPA1 activation orchestrates an additional inflammatory response which is not neurogenic.", {"entities": [[46, 51, "GENE"], [55, 60, "GENE"], [118, 123, "GENE"], [55, 60, "GENE"], [118, 123, "GENE"]]}], ["This finding suggests that non-neuronal TRPA1 in the airways is functional and potentially capable of contributing to inflammatory airway diseases.", {"entities": [[40, 45, "GENE"]]}], ["5.8 M living Americans have experienced a stroke at some time in their lives, 780K had either their first or a recurrent stroke this year, and 150K died from strokes this year.", {"entities": []}], ["Stroke costs about $66B annually in the US, and also results in serious, long-term disability.", {"entities": []}], ["Therefore, it is prudent to identify all possible risk factors and their effects so that appropriate intervention points may be targeted.", {"entities": []}], ["Baseline (1993\u20131994) interview data from the nationally representative Survey on Assets and Health Dynamics among the Oldest Old (AHEAD) were linked to 1993\u20132005 Medicare claims.", {"entities": []}], ["Participants were 5,511 self-respondents \u2265 70 years old.", {"entities": []}], ["Two ICD9-CM case-identification approaches were used.", {"entities": []}], ["Two approaches to stroke case-identification based on ICD9-CM codes were used, one emphasized sensitivity and the other emphasized specificity.", {"entities": []}], ["Participants were censored at death or enrollment into managed Medicare.", {"entities": []}], ["Baseline risk factors included sociodemographic, socioeconomic, place of residence, health behavior, disease history, and functional and cognitive status measures.", {"entities": []}], ["A time-dependent marker reflecting post-baseline non-stroke hospitalizations was included to reflect health shocks, and sensitivity analyses were conducted to identify its peak effect.", {"entities": []}], ["Competing risk, proportional hazards regression was used.", {"entities": []}], ["Post-baseline strokes occurred for 545 (9.9%; high sensitivity approach) and 374 (6.8%; high specificity approach) participants.", {"entities": []}], ["The greatest static risks involved increased age, being widowed or never married, living in multi-story buildings, reporting a baseline history of diabetes, hypertension, or stroke, and reporting difficulty picking up a dime, refusing to answer the delayed word recall test, or having poor cognition.", {"entities": [[157, 169, "DISEASE"]]}], ["Risks were similar for both case-identification approaches and for recurrent and first-ever vs. only first-ever strokes.", {"entities": []}], ["The time-dependent health shock (recent hospitalization) marker did not alter the static model effect estimates, but increased stroke risk by 200% or more.", {"entities": []}], ["The effect of our health shock marker (a time-dependent recent hospitalization indicator) was large and did not mediate the effects of the traditional risk factors.", {"entities": []}], ["This suggests an especially vulnerable post-hospital transition period from adverse effects associated with both their underlying health shock (the reasons for the recent hospital admission) and the consequences of their treatments.", {"entities": []}], ["Immune globulins for IgG supplementation have been produced for over 35\u00a0years with essentially no differentiating features regarding their specific antibody composition.", {"entities": []}], ["Furthermore, the compositions of plasma donor pools used for IG manufacturing are not standardized.", {"entities": []}], ["While all immune globulin products meet the specifications set by the US FDA for antibodies to pathogens like measles and polio, they have variable levels of antibodies to other important viruses and infectious pathogens, particularly respiratory syncytial virus (RSV).", {"entities": [[110, 117, "DISEASE"]]}], ["An IVIG was developed that satisfies the requirements for treating patients with primary immune deficiency disease (PIDD) and also has standardized elevated levels of RSV neutralizing antibodies (RI-002).", {"entities": []}], ["Plasma donors who have naturally occurring high circulating levels of neutralizing anti-RSV antibody were selected as the source for manufacturing IVIG to treat patients with PIDD to prevent serious bacterial infections.", {"entities": []}], ["While the introduction of the monoclonal antibody Palivizumab has had a dramatic impact in diminishing the burden of RSV disease in the pediatric population, it does not meet the standards for replacing the deficient immune compartments of patients with PIDD.", {"entities": []}], ["Fifty-nine patients with PIDD at 9 different sites across the US were enrolled in this study and received regular infusions of RI-002 over the course of 1\u00a0year.", {"entities": []}], ["There were zero serious bacterial infections, thus meeting the primary endpoint for this trial.", {"entities": []}], ["The secondary endpoints including days missed from work due to infection, unscheduled visits to the physician, and days of hospitalization due to infection compared favorably to published reports of other IVIG products.", {"entities": []}], ["The ability of Notch signaling to regulate T helper cell development and differentiation has been widely accepted.", {"entities": []}], ["Fringe, O-fucose-\u03b21,3-N -acetylglucosaminyltransferases modulate Notch receptor expression and promote the Notch signaling pathway through receptor-ligand binding.", {"entities": []}], ["In this study, we assayed the expression levels of three Fringe homologs in naive CD4", {"entities": [[82, 85, "GENE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a common disease, associated with cardiovascular disease.", {"entities": []}], ["Many patients use (long-acting) bronchodilators, whilst they continue smoking alongside.", {"entities": []}], ["We hypothesised an interaction between bronchodilators and smoking that enhances smoke exposure, and hence cardiovascular disease.", {"entities": []}], ["In this paper, we report our study protocol that explores the fundamental interaction, i.e.", {"entities": []}], ["smoke retention.", {"entities": []}], ["The design consists of a double-blinded, placebo-controlled, randomised crossover trial, in which 40 COPD patients smoke cigarettes during both undilated and maximal bronchodilated conditions.", {"entities": []}], ["Our primary outcome is the retention of cigarette smoke, expressed as tar and nicotine weight.", {"entities": []}], ["The inhaled tar weights are calculated from the correlated extracted nicotine weights in cigarette filters, whereas the exhaled weights are collected on Cambridge filters.", {"entities": []}], ["We established the inhaled weight calculations by a pilot study, that included paired measurements from several smoking regimes.", {"entities": []}], ["Our study protocol is approved by the local accredited medical review ethics committee.", {"entities": []}], ["Our study is currently in progress.", {"entities": []}], ["The pilot study revealed valid equations for inhaled tar and nicotine, with an R ClinicalTrials.gov: NCT00981851", {"entities": []}], ["Due to recently proposed changes in the Common Rule regarding the collection of research preferences, there is an increased need for efficient methods to document opt-in research preferences at a population level.", {"entities": []}], ["Previously, our institution developed an opt-out paper-based workflow that could not be utilized for research in a scalable fashion.", {"entities": []}], ["This project was designed to demonstrate the feasibility of implementing an electronic health record (EHR)-based active opt-in research preferences program.", {"entities": []}], ["The first phase of implementation required creating and disseminating a patient questionnaire through the EHR portal to populate discreet fields within the EHR indicating patients\u2019 preferences for future research study contact (contact) and their willingness to allow anonymised use of excess tissue and fluid specimens (biobank).", {"entities": []}], ["In the second phase, the questionnaire was presented within a clinic nurse intake workflow in an obstetrical clinic.", {"entities": []}], ["These permissions were tabulated in registries for use by investigators for feasibility studies and recruitment.", {"entities": []}], ["The registry was also used for research patient contact management using a new EHR encounter type to differentiate research from clinical encounters.", {"entities": []}], ["The research permissions questionnaire was sent to 59,670 patients via the EHR portal.", {"entities": []}], ["Within four months, 21,814 responses (75% willing to participate in biobanking, and 72% willing to be contacted for future research) were received.", {"entities": []}], ["Each response was recorded within a patient portal encounter to enable longitudinal analysis of responses.", {"entities": []}], ["We obtained a significantly lower positive response from the 264 females who completed the questionnaire in the obstetrical clinic (55% volunteers for biobank and 52% for contact).", {"entities": []}], ["We demonstrate that it is possible to establish a research permissions registry using the EHR portal and clinic-based workflows.", {"entities": []}], ["This patient-centric, population-based, opt-in approach documents preferences in the EHR, allowing linkage of these preferences to health record information.", {"entities": []}], ["In this study, we aimed to identify characteristics of (unscheduled) revisits and its optimal time frame after Emergency Department (ED) discharge.", {"entities": []}], ["Children with fever, dyspnea, or vomiting/diarrhea (1\u00a0month\u201316\u00a0years) who attended the ED of Erasmus MC-Sophia, Rotterdam (2010\u20132013), the Netherlands, were prospectively included.", {"entities": [[42, 50, "DISEASE"]]}], ["Three days after ED discharge, we applied standardized telephonic questionnaires on disease course and revisits.", {"entities": []}], ["Multivariable logistic regression analysis was used to identify independent characteristics of revisits.", {"entities": []}], ["Young age, parental concern, and alarming signs and symptoms (chest wall retractions, ill appearance, clinical signs of dehydration, and tachypnea) were associated with revisits ( n \u2009=\u2009527) in children at risk for serious infections discharged from the ED ( n \u2009=\u20091765).", {"entities": []}], ["Children revisited the ED within a median of 2\u00a0days (IQR 1.0\u20133.0), but this was proven to be shorter in children with vomiting/diarrhea (1.0\u00a0day (IQR 1.0\u20132.0)) compared to children with fever or dyspnea (2.0 (IQR 1.0\u20133.0)).", {"entities": [[127, 135, "DISEASE"]]}], ["Conclusion : Young age, parental concern, and alarming signs and symptoms (chest wall retractions, ill appearance, clinical signs of dehydration, and tachypnea) were associated with emergency health care revisits in children with fever, dyspnea, and vomiting/diarrhea.", {"entities": [[259, 267, "DISEASE"]]}], ["These characteristics could help to define targeted review of children during post-discharge period.", {"entities": []}], ["We observed a disease specific and differential timing of control revisits after ED discharge.", {"entities": []}], ["The online version of this article (10.1007/s00431-018-3095-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Genome-wide association studies (GWAS) led to the identification of numerous novel loci for a number of complex diseases.", {"entities": []}], ["Pathway-based approaches using genotypic data provide tangible leads which cannot be identified by single marker approaches as implemented in GWAS.", {"entities": []}], ["The available pathway analysis approaches mainly differ in the employed databases and in the applied statistics for determining the significance of the associated disease markers.", {"entities": []}], ["So far, pathway-based approaches using GWAS data failed to consider the overlapping of genes among different pathways or the influence of protein\u2013interactions.", {"entities": []}], ["We performed a multistage integrative pathway (MIP) analysis on three common diseases - Crohn's disease (CD), rheumatoid arthritis (RA) and type 1 diabetes (T1D) - incorporating genotypic, pathway, protein- and domain-interaction data to identify novel associations between these diseases and pathways.", {"entities": [[110, 130, "DISEASE"], [121, 130, "DISEASE"], [47, 50, "GENE"]]}], ["Additionally, we assessed the sensitivity of our method by studying the influence of the most significant SNPs on the pathway analysis by removing those and comparing the corresponding pathway analysis results.", {"entities": []}], ["Apart from confirming many previously published associations between pathways and RA, CD and T1D, our MIP approach was able to identify three new associations between disease phenotypes and pathways.", {"entities": [[102, 105, "GENE"]]}], ["This includes a relation between the influenza-A pathway and RA, as well as a relation between T1D and the phagosome and toxoplasmosis pathways.", {"entities": [[121, 134, "DISEASE"], [37, 46, "DISEASE"]]}], ["These results provide new leads to understand the molecular underpinnings of these diseases.", {"entities": []}], ["The developed software herein used is available at http://www.cogsys.cs.uni-tuebingen.de/software/GWASPathwayIdentifier/index.htm .", {"entities": []}], ["Multiple sclerosis, the clinical features and pathological correlate for which were first described by Charcot, is a chronic neuroinflammatory disease with unknown etiology and variable clinical evolution.", {"entities": [[0, 18, "DISEASE"]]}], ["Although neuroinflammation is a descriptive denominator in multiple sclerosis based on histopathological observations, namely the penetration of leukocytes into the central nervous system, the clinical symptoms of relapses, remissions and progressive paralysis are the result of losses of myelin and neurons.", {"entities": [[59, 77, "DISEASE"]]}], ["In the absence of etiological factors as targets for prevention and therapy, the definition of molecular mechanisms that form the basis of inflammation, demyelination and toxicity for neurons have led to a number of treatments that slow down disease progression in specific patient cohorts, but that do not cure the disease.", {"entities": []}], ["Current therapies are directed to block the immune processes, both innate and adaptive, that are associated with multiple sclerosis.", {"entities": [[113, 131, "DISEASE"]]}], ["In this review, we analyze the role of cytokines in the multiple sclerosis pathogenesis and current/future use of them in treatments of multiple sclerosis.", {"entities": [[56, 74, "DISEASE"], [136, 154, "DISEASE"]]}], ["The congenital long QT syndrome (LQTS) is an inherited channelopathy known for its electrocardiographic manifestations of QT prolongation and its hallmark arrhythmia, torsades de pointes (TdP).", {"entities": [[23, 31, "DISEASE"]]}], ["TdP can lead to syncope or sudden death and is often precipitated by triggers such as physical exertion or emotional stress.", {"entities": []}], ["Given that athletes may be at particular risk for adverse outcomes, those suspected of having LQTS should be evaluated, risk stratified, treated, and receive appropriate counseling by providers with sufficient expertise according to the latest guidelines.", {"entities": []}], ["The following keywords were used to query MEDLINE and PubMed through 2016: LQTS, LQT1, LQT2, LQT3, long QT, long QTc, prolonged QT, prolonged QTc, QT interval, QTc interval, channelopathy, channelopathies, athletes, torsades de pointes , and sudden cardiac death .", {"entities": []}], ["Selected articles within this primary search, in addition to relevant references from those articles, were reviewed for relevant information and data.", {"entities": []}], ["Articles with pertinent information regarding pathophysiology, evaluation, diagnosis, genetic testing, treatment, and guidelines for athletes were included, particularly those published in the prior 2 decades.", {"entities": []}], ["Clinical review.", {"entities": []}], ["Diagnosis of LQTS involves eliciting the patient\u2019s family history, clinical history, and evaluation of electrocardiographic findings.", {"entities": []}], ["Genetic testing for common mutations can confirm suspected cases.", {"entities": []}], ["\u03b2-Blockers represent the mainstay of treatment, though interventions such as implantable cardioverter-defibrillator placement or left cardiac sympathetic denervation may be required.", {"entities": []}], ["Properly evaluated and treated athletes with LQTS have a low risk of cardiac events.", {"entities": []}], ["Detection and management of LQTS in the athletic population is crucial given the possibility of adverse outcomes with the stress of athletic participation.", {"entities": []}], ["Preparticipation screening examinations should include a thorough clinical and family history.", {"entities": []}], ["Screening electrocardiograms may display key findings consistent with LQTS while genetic testing can confirm the diagnosis.", {"entities": []}], ["Formerly considered a strict contraindication to athletic participation, LQTS is now an increasingly manageable entity with proper evaluation and treatment by qualified and experienced providers.", {"entities": []}], ["Patients with HIV not only have to deal with the challenges of living with an incurable disease but also with the dilemma of whether or not to disclose their status to their partners, families and friends.", {"entities": []}], ["This study explores the extent to which sub-Saharan African (SSA) migrant women in Belgium disclose their HIV positive status, reasons for disclosure/non-disclosure and how they deal with HIV disclosure.", {"entities": []}], ["A qualitative study consisting of interviews with twenty-eight SSA women with HIV/AIDS was conducted.", {"entities": []}], ["Thematic content analysis was employed to identify themes as they emerged.", {"entities": []}], ["Our study reveals that these women usually only disclose their status to healthcare professionals because of the treatment and care they need.", {"entities": []}], ["This selective disclosure is mainly due to the taboo of HIV disease in SSA culture.", {"entities": []}], ["Stigma, notably self-stigma, greatly impedes HIV disclosure.", {"entities": []}], ["Techniques to systematically incorporate HIV disclosure into post-test counseling and primary care services are highly recommended.", {"entities": []}], ["Polyunsaturated fatty acids (PUFAs) are considered to be critical nutrients to regulate human health and development, and numerous fatty acid desaturases play key roles in synthesizing PUFAs.", {"entities": []}], ["Given the lack of delta-12 and -15 desaturases and the low levels of conversion to PUFAs, humans must consume some omega-3 and omega-6 fatty acids in their diet.", {"entities": []}], ["Many studies on fatty acid desaturases as well as PUFAs have shown that fatty acid desaturase genes are closely related to different human physiological conditions.", {"entities": []}], ["Since the first front-end desaturases from cyanobacteria were cloned, numerous desaturase genes have been identified and animals and plants have been genetically engineered to produce PUFAs such as eicosapentaenoic acid and docosahexaenoic acid.", {"entities": []}], ["Recently, a biotechnological approach has been used to develop clinical treatments for human physiological conditions, including cancers and neurogenetic disorders.", {"entities": []}], ["Thus, understanding the functions and regulation of PUFAs associated with human health and development by using biotechnology may facilitate the engineering of more advanced PUFA production and provide new insights into the complexity of fatty acid metabolism.", {"entities": []}], ["Statins are commonly prescribed worldwide and recent evidence suggests that they may increase the risk of herpes zoster ( HZ ).", {"entities": [[106, 119, "DISEASE"]]}], ["To quantify the effect of statin exposure on the risk of HZ in the U.K. A matched case\u2013control study was conducted using data from U.K. primary care and hospital records.", {"entities": []}], ["Patients > 18 years with an incident diagnosis of HZ were matched to up to four controls for age, sex and general practice.", {"entities": []}], ["Patients were included in the statin exposure group if they had ever used a statin, and the daily dosage of the most recent statin prescription and the time since the most recent statin prescription were also recorded.", {"entities": []}], ["The primary outcome was an incident diagnosis of HZ .", {"entities": []}], ["Odds ratios ( OR s) were estimated from conditional logistic regression and adjusted for potential confounders.", {"entities": []}], ["A total of 144 959 incident cases of HZ were matched to 549 336 controls.", {"entities": []}], ["Adjusted analysis suggested strong evidence for an increase in the risk of HZ related to statin exposure ( OR 1\u00b713, 95% confidence interval 1\u00b711\u20131\u00b715).", {"entities": []}], ["There was also an increased risk when dosages were increased for patients who were currently or had recently been receiving statin treatment ( P trend < 0\u00b7001), and we found an attenuation of the increased risk of HZ in previous statin users as the time since last statin exposure increased ( P trend < 0\u00b7001).", {"entities": []}], ["These findings are consistent with the hypothesis that statin therapy leads to an increase in the risk of HZ .", {"entities": []}], ["What's already known about this topic?", {"entities": []}], ["Studies in both Canada and Taiwan have recently reported a small but significantly increased risk of herpes zoster ( HZ ) in patients receiving statin treatment.", {"entities": [[101, 114, "DISEASE"]]}], ["As statins are one of the most widely prescribed drugs in the U.K., with around 45 million prescriptions every year, any adverse effects will have substantial public health implications.", {"entities": []}], ["Studies in both Canada and Taiwan have recently reported a small but significantly increased risk of herpes zoster ( HZ ) in patients receiving statin treatment.", {"entities": [[101, 114, "DISEASE"]]}], ["As statins are one of the most widely prescribed drugs in the U.K., with around 45 million prescriptions every year, any adverse effects will have substantial public health implications.", {"entities": []}], ["What does this study add?", {"entities": []}], ["In this large matched case\u2013control study, statin exposure was associated with a modest increase in the risk of HZ .", {"entities": []}], ["A dose\u2013response relationship was observed, and there was an attenuation of the increased risk over time among people who stopped statin therapy, indicating that the increased risk is consistent with a causal effect.", {"entities": []}], ["There may be extra motivation to maximize HZ vaccine uptake among eligible patients receiving a statin.", {"entities": []}], ["In this large matched case\u2013control study, statin exposure was associated with a modest increase in the risk of HZ .", {"entities": []}], ["A dose\u2013response relationship was observed, and there was an attenuation of the increased risk over time among people who stopped statin therapy, indicating that the increased risk is consistent with a causal effect.", {"entities": []}], ["There may be extra motivation to maximize HZ vaccine uptake among eligible patients receiving a statin.", {"entities": []}], ["Linked Comment: Shalom and Cohen.", {"entities": []}], ["Br J Dermatol 2016; 175 :1137\u20131138 .", {"entities": []}], ["Supplemental Digital Content is available in the text Nonasthmatic eosinophilic bronchitis (NAEB) is characterized by chronic cough and airway eosinophilic inflammation.", {"entities": [[80, 90, "DISEASE"]]}], ["Airway and systemic inflammation cytokine profile have not been comprehensively described in patients with NAEB.", {"entities": []}], ["The aim of the study was to identify the cytokine profile in sputum and serum of NAEB patients.", {"entities": []}], ["Furthermore, the relationship between cytokines and clinical features would be evaluated.", {"entities": []}], ["Induced sputum and serum were collected from untreated NAEB patients and healthy subjects.", {"entities": []}], ["The cytokine profile in sputum and serum was analyzed by a bead-based multiplex cytokine assay including 21 cytokines.", {"entities": []}], ["The levels of EGF, eotaxin, GM-CSF, GRO, IFN-\u03b3, IL-1\u03b2, IL-4, IL-6, IL-17A, IP-10, MIP-1\u03b1, and TNF-\u03b1 in sputum were significantly higher in NAEB patients than that in healthy subjects (all P \u200a<\u200a0.05).", {"entities": [[14, 17, "GENE"]]}], ["Values of area under the receiver operating characteristic curve (AUROC) of these cytokines were all above 0.750.", {"entities": []}], ["The concentrations of eotaxin and IL-4 were positively correlated with sputum eosinophil percentage ( r \u200a=\u200a0.726, P \u200a=\u200a0.002; r \u200a=\u200a0.511, P \u200a=\u200a0.043; respectively).", {"entities": []}], ["No significant correlations between other cytokines (EGF, GM-CSF, GRO, IFN-\u03b3, IL-1\u03b2, IL-6, IL-17A, IP-10, MIP-1\u03b1, and TNF-\u03b1) in sputum and sputum eosinophil percentage were found.", {"entities": [[53, 56, "GENE"]]}], ["The level of IL-4 in serum was slightly higher in NAEB patients than in healthy subjects.", {"entities": []}], ["However, there was no correlation between serum IL-4 levels and sputum eosinophil percentage.", {"entities": []}], ["We identified the cytokine profile in sputum and serum from NAEB patients.", {"entities": []}], ["Sputum eotaxin and IL-4 could have the potential to become the biomarkers for NAEB and might be useful to assist in the diagnosis of NAEB.", {"entities": []}], ["Bacillus Calmette Guerin (BCG) is the only available vaccine for tuberculosis (TB).", {"entities": [[65, 77, "DISEASE"]]}], ["Low grade complications in healthy recipients and disseminated vaccine associated complications among immuno-suppressed individuals were noticed globally after administration.", {"entities": []}], ["Recently a series of clinically suspected BCG associated suppurative and non-suppurative lymphadenitis cases were reported from different regions of Saudi Arabia.", {"entities": [[77, 102, "DISEASE"], [89, 102, "DISEASE"]]}], ["However a molecular confirmative analysis was lacking to prove these claims.", {"entities": []}], ["During 2009\u20132010, 42 Mycobacterium bovis BCG suspected clinical isolates from children diagnosed with suppurative lymphadenitis from different provinces of the country were collected and subjected to 24 loci based MIRU-VNTR typing, spoligotyping and first line anti-TB drugs susceptibility testing.", {"entities": [[102, 127, "DISEASE"], [114, 127, "DISEASE"]]}], ["Of the total 42 cases, 41 (97.6%) were Saudi nationals and particularly male (64.3%).", {"entities": []}], ["Majority of the cases were aged below 6 months (83.3%) with a median of age 4 months.", {"entities": []}], ["All the enrolled subjects showed left axillary mass which suppurated in a median of 4 months after vaccination.", {"entities": []}], ["Among the study subjects, 1 (2.4%) case was reactive to HIV antigen and 2 (4.8%) case had severe combined immunodeficiency.", {"entities": [[90, 122, "DISEASE"]]}], ["Genotyping results showed that, 41 (97.6%) isolates were identical to the vaccine strain Danish 1331 and one to Tokyo 172-1.", {"entities": []}], ["Phylogenetic analysis revealed all the Danish 1331 isolates in a single cluster.", {"entities": []}], ["Elevated proportion of suppurative lymphadenitis caused by M. bovis BCG reported in the country recently is majorly related to the vaccine strain Danish 1331.", {"entities": [[23, 48, "DISEASE"], [35, 48, "DISEASE"]]}], ["However lack of nationwide data on real magnitude of BCG related adverse events warrants population centric, long term future studies.", {"entities": []}], ["Migraine is increasingly understood to be a disorder of the brain.", {"entities": [[0, 8, "DISEASE"]]}], ["In susceptible individuals, a variety of \u201ctriggers\u201d may influence altered central excitability, resulting in the activation and sensitization of trigeminal nociceptive afferents surrounding blood vessels (i.e., the trigeminovascular system), leading to migraine pain.", {"entities": [[253, 261, "DISEASE"]]}], ["Transient receptor potential (TRP) channels are expressed in a subset of dural afferents, including those containing calcitonin gene related peptide (CGRP).", {"entities": []}], ["Activation of TRP channels promotes excitation of nociceptive afferent fibers and potentially lead to pain.", {"entities": []}], ["In addition to pain, allodynia to mechanical and cold stimuli can result from sensitization of both peripheral afferents and of central pain pathways.", {"entities": []}], ["TRP channels respond to a variety of endogenous conditions including chemical mediators and low pH.", {"entities": []}], ["These channels can be activated by exogenous stimuli including a wide range of chemical and environmental irritants, some of which have been demonstrated to trigger migraine in humans.", {"entities": [[165, 173, "DISEASE"]]}], ["Activation of TRP channels can elicit CGRP release, and blocking the effects of CGRP through receptor antagonism or antibody strategies has been demonstrated to be effective in the treatment of migraine.", {"entities": [[194, 202, "DISEASE"]]}], ["Identification of approaches that can prevent activation of TRP channels provides an additional novel strategy for discovery of migraine therapeutics.", {"entities": [[128, 136, "DISEASE"]]}], ["Ozone is a common environmental air pollutant leading to respiratory illness.", {"entities": []}], ["The mechanisms regulating ozone-induced airway inflammation remain poorly understood.", {"entities": []}], ["We hypothesize that ozone-triggered inflammasome activation and interleukin (IL)-1 production regulate neutrophilic airway inflammation through IL-17A.", {"entities": []}], ["Pulmonary neutrophilic inflammation was induced by extended (72\u2009h) low-dose (0.7\u2009ppm) exposure to ozone.", {"entities": []}], ["IL-1 receptor 1 (Il1r1) Il17a in vivo studies.", {"entities": [[17, 22, "GENE"], [24, 29, "GENE"]]}], ["Cellular inflammation and protein levels in bronchial alveolar lavage fluid (BALF), cytokines, and IL-17A-producing \u03b3\u03b4T-cells, as well as mitochondrial reactive oxygen species (ROS), mitochondrial DNA (mtDNA) release, and inflammasome activation in lung macrophages were analyzed.", {"entities": []}], ["Ozone-induced neutrophilic airway inflammation, accompanied an increased production of IL-1\u03b2, IL-18, IL-17A, Granulocyte-colony stimulating factor (G-CSF), Interferon-\u03b3 inducible protein 10 (IP-10) and BALF protein in the lung.", {"entities": []}], ["Ozone-induced IL-17A production was predominantly in \u03b3\u03b4T-cells, and Il17a -knockout mice exhibited reduced airway inflammation.", {"entities": [[68, 73, "GENE"]]}], ["Lung macrophages from ozone-exposed mice exhibited higher levels of mitochondrial ROS, enhanced cytosolic mtDNA, increased caspase-1 activation, and higher production of IL-1\u03b2.", {"entities": []}], ["Il1r1 -knockout mice or treatment with Ac-YVAD-cmk decreased the IL-17A production and subsequent airway inflammation.", {"entities": [[0, 5, "GENE"]]}], ["Taken together, we demonstrate that ozone-induced IL-17A and neutrophilic airway inflammation is orchestrated by the caspase-1-IL-1 cascade.", {"entities": []}], ["Acoustic pharyngometry is a relatively new noninvasive method that quantifies geometrically complexed pharyngeal dimensions.", {"entities": []}], ["Our study aimed to investigate the predictability and usefulness of acoustic pharyngometry in diagnosis of obstructive sleep apnea (OSA), and we developed a prospective clinical trial in 16 subjects without apnea and 54 subjects with apnea.", {"entities": []}], ["All seventy subjects received polysomnography (PSG) to assess the sleep architecture, including breathing and the degree of apnea hypopnea index.", {"entities": []}], ["Acoustic pharyngometry was performed in four body positions (sitting, supine, right and left lateral) while awake with tidal breathing in addition to morphometric measurements (Kushida index) of oral cavity.", {"entities": []}], ["This study shows that the cross-sectional area and volume of the upper airway is smaller in the supine position than any other positions.", {"entities": []}], ["As well, the oropharyngeal junction area of the supine position is the most predictive parameter to discriminate between subjects with or without OSA.", {"entities": []}], ["Acoustic pharyngometry can be a clinically useful tool for localizing the narrowed portion of the upper airway and predicting obstructive sleep apnea.", {"entities": []}], ["Paediatric cut-off values for serum allergen-specific IgE (sIgE) using the Siemens IMMULITE\u00ae 2000 system to diagnose allergic rhinoconjunctivitis have not been established.", {"entities": []}], ["We aimed to determine cut-off levels for sIgE for 10 common inhalant allergens and to study the relationship between sIgE, total IgE and fractional exhaled nitric oxide (FE NO ).", {"entities": []}], ["We enrolled 243 schoolchildren, including 164 with allergic rhinoconjunctivitis.", {"entities": []}], ["Parental interviews, skin prick tests, sIgE, total IgE, FE NO measurements, spirometry and exercise tests were performed.", {"entities": []}], ["Cut-off values with the best combined sensitivity and specificity were above the detection limit of the assay for seven of the ten allergens (0.23\u20131.1\u00a0kU/L).", {"entities": []}], ["The overall accuracy of the IMMULITE\u00ae in detecting allergic rhinoconjunctivitis was good.", {"entities": []}], ["sIgE was superior to total IgE and FE NO in predicting allergic rhinoconjunctivitis to timothy, birch, mugwort, cat, dog and house dust mite.", {"entities": []}], ["FE NO was elevated in children with allergic rhinoconjunctivitis, irrespective of asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["Cut-off values for sIgE were dependent on the allergic phenotype and were above the IMMULITE\u00ae detection limit for seven of ten inhalant allergens.", {"entities": []}], ["Consequently, using the detection limit for sIgE as the decision point would result in over-diagnosing allergic rhinoconjunctivitis.", {"entities": []}], ["When measuring elevated FE NO in children, allergic rhinoconjunctivitis should be suspected.", {"entities": []}], ["Selection bias is a systematic error in epidemiologic studies that may seriously distort true measures of associations between exposure and disease.", {"entities": []}], ["Observational studies are highly susceptible to selection bias, and researchers should therefore always examine to what extent selection bias may be present in their material and what characterizes the bias in their material.", {"entities": []}], ["In the present study we examined long-term participation and consequences of loss to follow-up in the studies Respiratory Health in Northern Europe (RHINE), Italian centers of European Community Respiratory Health Survey (I-ECRHS), and the Italian Study on Asthma in Young Adults (ISAYA).", {"entities": [[257, 263, "DISEASE"]]}], ["Logistic regression identified predictors for follow-up participation.", {"entities": []}], ["Baseline prevalence of 9 respiratory symptoms (asthma attack, asthma medication, combined variable with asthma attack and/or asthma medication, wheeze, rhinitis, wheeze with dyspnea, wheeze without cold, waking with chest tightness, waking with dyspnea) and 9 exposure-outcome associations (predictors sex, age and smoking; outcomes wheeze, asthma and rhinitis) were compared between all baseline participants and long-term participants.", {"entities": [[152, 160, "DISEASE"], [352, 360, "DISEASE"], [47, 53, "DISEASE"], [62, 68, "DISEASE"], [104, 110, "DISEASE"], [125, 131, "DISEASE"], [341, 347, "DISEASE"]]}], ["Bias was measured as ratios of relative frequencies and ratios of odds ratios (ROR).", {"entities": []}], ["Follow-up response rates after 10\u00a0years were 75% in RHINE, 64% in I-ECRHS and 53% in ISAYA.", {"entities": []}], ["After 20\u00a0years of follow-up, response was 53% in RHINE and 49% in I-ECRHS.", {"entities": []}], ["Female sex predicted long-term participation (in RHINE OR (95% CI) 1.30(1.22, 1.38); in I-ECRHS 1.29 (1.11, 1.50); and in ISAYA 1.42 (1.25, 1.61)), as did increasing age.", {"entities": []}], ["Baseline prevalence of respiratory symptoms were lower among long-term participants (relative deviations compared to total baseline population 0-15% (RHINE), 0-48% (I-ECRHS), 3-20% (ISAYA)), except rhinitis which had a slightly higher prevalence.", {"entities": [[198, 206, "DISEASE"]]}], ["Most exposure-outcome associations did not differ between long-term participants and all baseline participants, except lower OR for rhinitis among ISAYA long-term participating smokers (relative deviation 17% (smokers) and 44% (10\u201320 pack years)).", {"entities": [[132, 140, "DISEASE"]]}], ["We found comparable patterns of long-term participation and loss to follow-up in RHINE, I-ECRHS and ISAYA.", {"entities": []}], ["Baseline prevalence estimates for long-term participants were slightly lower than for the total baseline population, while exposure-outcome associations were mainly unchanged by loss to follow-up.", {"entities": []}], ["In spite of its positive repercussions on nutrition and environment, faba bean still remains an underutilized crop due to the presence of some undesired compounds.", {"entities": []}], ["The pyrimidine glycosides vicine and convicine are precursors of the aglycones divicine and isouramil, the main factors of favism, a genetic condition which may lead to severe hemolysis after faba bean ingestion.", {"entities": [[123, 129, "DISEASE"]]}], ["The reduction of vicine and convicine has been targeted in several studies but little is known about their degradation.", {"entities": []}], ["In this study, the hydrolysis kinetics of vicine and convicine and their derivatives during fermentation with L. plantarum DPPMAB24W was investigated.", {"entities": []}], ["In particular, a specific HPLC method coupled to ESI-MS and MS/MS analysis, including the evaluation procedure of the results, was set up as the analytical approach to monitor the compounds.", {"entities": []}], ["The degradation of the pyrimidine glycosides in the fermented flour was complete after 48\u2009h of incubation and the aglycone derivatives could not be detected in any of the samples.", {"entities": []}], ["The toxicity of the fermented faba bean was established through ex-vivo assays on human blood, confirming the experimental findings.", {"entities": []}], ["Results indicate that mild and cost effective bioprocessing techniques can be applied to detoxify faba bean also for industrial applications.", {"entities": []}], ["Instillation of highly soluble nanoparticles (NPs) into the lungs of rodents can cause acute eosinophilia without any previous sensitizations by the role of dissolved ions.", {"entities": [[93, 105, "DISEASE"], [46, 49, "GENE"]]}], ["However, whether gradually dissolving NPs can cause the same type of eosinophilia remains to be elucidated.", {"entities": [[69, 81, "DISEASE"], [38, 41, "GENE"]]}], ["We selected nickel oxide (NiO) as a gradually dissolving NP and evaluated the time course pulmonary inflammation pattern as well as its mechanisms.", {"entities": []}], ["NiO NPs were intratracheally instilled into female Wistar rats at various concentrations (50, 100, and 200\u00a0cm 2 and the ovalbumin-induced allergic airway inflammation model was applied.", {"entities": [[4, 7, "GENE"]]}], ["NiCl 2 was instilled at 171.1\u00a0\u03bcg Ni/rat, which is equivalent nickel concentration of 200\u00a0cm NiO NPs produced acute neutrophilic inflammation throughout the study.", {"entities": [[96, 99, "GENE"]]}], ["However, eosinophils were recruited at 3 and 4\u00a0days post-instillation of NiO NPs and the magnitude and pattern of inflammation was similar with NiCl 2 at 24\u00a0h post-instillation.", {"entities": [[77, 80, "GENE"]]}], ["The eosinophil recruitment by NiO NPs was not related with either the levels of total IgE or anaphylatoxins.", {"entities": [[34, 37, "GENE"]]}], ["The lysis of alveolar macrophages and normal lung tissue showed high levels of intracellular eotaxin and the levels of LDH showed positive correlation with the levels of eotaxin.", {"entities": []}], ["Instillation of NiO NPs produced neutrophilia at 1 and 2\u00a0days after instillation, while the mixed type of neutrophilic and eosinophilic inflammation was produced at 3 and 4\u00a0days post-instillation, which was consistent with NiCl 2 .", {"entities": [[20, 23, "GENE"]]}], ["The mechanism of the eosinophilia involves the direct release of intracellular eotaxin due to the rupture of cells by the accumulated solubilized nickel ions in the phagolysosome.", {"entities": [[21, 33, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12989-016-0142-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In the literature there are discussions on the choice of outcome and the need for more longitudinal studies of musculoskeletal disorders.", {"entities": []}], ["The general aim of this longitudinal study was to analyze musculoskeletal neck pain, in a group of young adults.", {"entities": []}], ["Specific aims were to determine whether psychosocial factors, computer use, high work/study demands, and lifestyle are long-term or short-term factors for musculoskeletal neck pain, and whether these factors are important for developing or ongoing musculoskeletal neck pain.", {"entities": []}], ["Three regression models were used to analyze the different outcomes.", {"entities": []}], ["Pain at present was analyzed with a marginal logistic model, for number of years with pain a Poisson regression model was used and for developing and ongoing pain a logistic model was used.", {"entities": []}], ["Presented results are odds ratios and proportion ratios (logistic models) and rate ratios (Poisson model).", {"entities": []}], ["The material consisted of web-based questionnaires answered by 1204 Swedish university students from a prospective cohort recruited in 2002.", {"entities": []}], ["Perceived stress was a risk factor for pain at present (PR = 1.6), for developing pain (PR = 1.7) and for number of years with pain (RR = 1.3).", {"entities": []}], ["High work/study demands was associated with pain at present (PR = 1.6); and with number of years with pain when the demands negatively affect home life (RR = 1.3).", {"entities": []}], ["Computer use pattern (number of times/week with a computer session \u2265 4 h, without break) was a risk factor for developing pain (PR = 1.7), but also associated with pain at present (PR = 1.4) and number of years with pain (RR = 1.2).", {"entities": []}], ["Among life style factors smoking (PR = 1.8) was found to be associated to pain at present.", {"entities": []}], ["The difference between men and women in prevalence of musculoskeletal pain was confirmed in this study.", {"entities": []}], ["It was smallest for the outcome ongoing pain (PR = 1.4) compared to pain at present (PR = 2.4) and developing pain (PR = 2.5).", {"entities": []}], ["By using different regression models different aspects of neck pain pattern could be addressed and the risk factors impact on pain pattern was identified.", {"entities": []}], ["Short-term risk factors were perceived stress, high work/study demands and computer use pattern (break pattern).", {"entities": []}], ["Those were also long-term risk factors.", {"entities": []}], ["For developing pain perceived stress and computer use pattern were risk factors.", {"entities": []}], ["Corneal diseases exhibit a high prevalence and are prone to cause blindness; furthermore, maintaining the morphology and ionic transporter expression in corneal endothelial cells (CECs) is crucial for treatment of these diseases.", {"entities": [[66, 75, "DISEASE"]]}], ["This study aimed to investigate the effects of the novel Rho associated coiled-coil containing protein kinase (ROCK) inhibitor, thiazovivin (2,4-disubstituted thiazole, TZV), on human corneal endothelial-to-mesenchymal transition/epithelial-to-mesenchymal transition (EndMT/EMT), cell morphology, junction proteins and ionic transporter expression in human CECs (HCECs) in vitro and then to clarify the mechanisms of action of TZV.", {"entities": []}], ["In the present study, primary HCECs were cultured in vitro and passaged.", {"entities": []}], ["The expression levels of adhesion proteins (E-cadherin and N-cadherin), the EndMT/EMT marker, \u03b1 smooth muscle actin (\u03b1-SMA), the tight junction protein, Zonula occludens-1 (ZO-1), and the ionic transporter, Na Snail , was examined by RT-PCR.", {"entities": []}], ["The protein expression levels of ROCK1/2 were evaluated by western blot analysis.", {"entities": []}], ["The HCECs were cultured with TZV at various concentrations (2, 4, or 6 \u00b5 M) for different periods of time (24 or 48 h).", {"entities": []}], ["We found that the the cell states of the HCECs co-cultured with 4 \u00b5 M TZV for 48 h reached the optimum, and corneal EndMT/EMT was inhibited, as evidenced by the significantly upregulated expression of ZO-1 and E-cadherin, and the markedly downregulated expression of N-cadherin and \u03b1-SMA.", {"entities": []}], ["Furthermore, the cells exhibited a normal, tightly connected hexagonal or pentagonal morphology.", {"entities": []}], ["Additionally, the protein expression of ROCK1/2 and the mRNA expression of Snail were significantly decreased.", {"entities": []}], ["However, there was no significant difference between the TZV-treated and the control groups as regards HCEC proliferative ability.", {"entities": []}], ["These findings suggested that the ROCK inhibitor, TZV (4 \u00b5 M), was effective in improving the morphology, cell junctions and ionic transporter expression of HCECs by inhibiting EndMT/EMT, but had no effect on HCEC proliferation.", {"entities": []}], ["Acute pancreatitis is the most common major complication after endoscopic retrograde cholangiopancreatography (ERCP).", {"entities": [[6, 18, "DISEASE"], [0, 18, "DISEASE"]]}], ["Many drugs have been evaluated for prophylaxis, including nonsteroidal anti-inflammatory drugs (NSAIDs), which are potent inhibitors of phospholipase A 2 and play a role in the pathogenesis of acute pancreatitis.", {"entities": [[199, 211, "DISEASE"], [193, 211, "DISEASE"]]}], ["Rectal NSAIDs have been shown in prospective studies to decrease the incidence of this complication, but the indication is not generalized in clinical practice.", {"entities": []}], ["The aim of this study was to evaluate the efficacy of rectal administration of indomethacin in reducing the incidence of post-ERCP pancreatitis in high-risk patients.", {"entities": [[131, 143, "DISEASE"]]}], ["This was a controlled clinical trial where patients with an elevated risk of developing post-ERCP pancreatitis were assigned to receive 100\u00a0mg of rectal indomethacin or a 2.6\u00a0g suppository of glycerin immediately after ERCP, without placement of a pancreatic stent.", {"entities": [[98, 110, "DISEASE"]]}], ["The patients were determined to be at high risk based on validated patient- and procedure-related risk factors.", {"entities": []}], ["Post-ERCP pancreatitis was defined as the presence of new upper abdominal pain, hyperamylasemia/hyperlipasemia (at least three times the upper limit) 2\u00a0hours after the procedure and hospitalization at least 48\u00a0hours because of the complication.", {"entities": [[10, 22, "DISEASE"]]}], ["Pancreatitis severity was defined according to Cotton\u2019s criteria.", {"entities": [[0, 12, "DISEASE"]]}], ["One hundred sixty-six patients were included; 82 in the study group and 84 in the placebo group.", {"entities": []}], ["Patients had at least one major and/or two minor risk factors for developing post-ERCP pancreatitis.", {"entities": [[87, 99, "DISEASE"]]}], ["The incidence of the complication was 4.87\u00a0% (4/82) in the study group and 20.23\u00a0% (17/84) in the placebo group; this difference was significant ( P \u2009=\u20090.01).", {"entities": []}], ["According to Cotton\u2019s criteria, 17 patients (80.9\u00a0%) developed mild pancreatitis and 4 (19.1\u00a0%) had moderate pancreatitis; 3 of these 4 patients belonged to the placebo group ( P \u2009=\u20090.60).", {"entities": [[68, 80, "DISEASE"], [109, 121, "DISEASE"]]}], ["Based on these results, an absolute risk reduction of 0.15 (15\u00a0%), a relative risk reduction of 0.75 (75\u00a0%) and a number needed to treat of 6.5 patients were calculated to prevent an episode of post-ERCP pancreatitis.", {"entities": [[204, 216, "DISEASE"]]}], ["There was no mortality.", {"entities": []}], ["Rectal indomethacin reduced the incidence of post-ERCP pancreatitis among patients at high risk of developing this complication.", {"entities": [[55, 67, "DISEASE"]]}], ["National Clinical Trials NCT02110810 .", {"entities": []}], ["Date April 7, 2014.", {"entities": []}], ["This post hoc analysis of TIOtropium Safety and Performance In Respimat (TIOSPIR) evaluated safety and exacerbation efficacy in patients with stable (\u22652\u2005months) use of tiotropium HandiHaler 18\u2005\u00b5g (HH18) prior to study entry, to evaluate whether there was a difference in risk for patients who switched from HH18 to tiotropium Respimat 2.5\u2005\u00b5g (R2.5) or 5\u2005\u00b5g (R5).", {"entities": []}], ["TIOSPIR (n=17\u2005135) was an international, Phase IIIb/IV, randomised, double-blind, parallel-group, event-driven trial.", {"entities": []}], ["Patients from TIOSPIR with chronic obstructive pulmonary disease (COPD) and postbronchodilator ratio of forced expiratory volume in 1\u2005s to forced vital capacity \u22640.70, receiving HH18 before study entry, were analysed (n=2784).", {"entities": [[27, 64, "DISEASE"]]}], ["Patients were randomised to once-daily tiotropium R2.5 (n=914), R5 (n=918) or HH18 (n=952) for 2\u20133\u2005years.", {"entities": []}], ["Primary outcomes: time to death (safety) and time to first COPD exacerbation (efficacy).", {"entities": []}], ["Secondary outcomes: number of exacerbations and time to first major adverse cardiovascular event (MACE).", {"entities": []}], ["Baseline characteristics were similar in all groups.", {"entities": []}], ["Respimat had a similar mortality risk versus HH18 (vital status follow-up, HR; 95% CI R2.5: 0.87; 0.64 to 1.17; R5: 0.79; 0.58 to 1.07) with no significant differences in the risk and rates of exacerbations and severe exacerbations across treatment groups.", {"entities": [[75, 77, "GENE"]]}], ["Risk of MACE and fatal MACE was similar for Respimat versus HH18 (HR; 95% CI MACE R2.5: 0.73; 0.47 to 1.15; R5: 0.69; 0.44 to 1.08; fatal MACE R2.5: 0.57; 0.27 to 1.19; R5: 0.67; 0.33 to 1.34).", {"entities": [[66, 68, "GENE"]]}], ["Overall risk of a fatal event (on treatment) was lower for R5 versus HH18 (HR; 95% CI R2.5: 0.78; 0.55 to 1.09; R5: 0.62; 0.43 to 0.89).", {"entities": [[75, 77, "GENE"]]}], ["This analysis indicates that it is safe to switch patients from tiotropium HandiHaler to tiotropium Respimat, and that the efficacy is maintained over the switch.", {"entities": []}], ["NCT01126437; Post-results.", {"entities": []}], ["We demonstrate that Pneumocystis reaches a >90% prevalence peak at 3\u20135 months of age and associates with increased mucus (MUC5AC), suggesting airway epithelium stimulation in infants during this age range.", {"entities": []}], ["Host ability to clear mucus would determine pathogenic expression.", {"entities": []}], ["Background.", {"entities": []}], ["Pneumocystis without obvious accompanying pathology is occasionally reported in autopsied infant lungs.", {"entities": []}], ["Its prevalence and significance are unknown.", {"entities": []}], ["Interestingly, this mild infection induces a strong activation of mucus secretion\u2013related genes in young immunocompetent rodents that has not been explored in infants.", {"entities": []}], ["Excess mucus is induced by multiple airway offenders through nonspecific pathways and would explain a cofactor role of Pneumocystis in respiratory disease.", {"entities": []}], ["We undertook characterization of the prevalence of Pneumocystis and associated mucus in infant lungs.", {"entities": []}], ["Samples from 128 infants (mean age, 101 days) who died suddenly and unexpectedly in Santiago during 1999\u20132004 were examined for Pneumocystis using nested polymerase chain reaction (nPCR) amplification of the P. jirovecii mtLSU ribosomal RNA gene and immunofluorescence microscopy (IF).", {"entities": []}], ["Pneumocystis -negative infants 28 days and older and their age-closest positives were studied for MUC5AC expression and Pneumocystis burden by Western blot and quantitative PCR, respectively.", {"entities": []}], ["Pneumocystis DNA was detected by nPCR in 105 of the 128 infants (82.0%) and Pneumocystis organisms were visualized by IF in 99 (94.3%) of the DNA-positive infants.", {"entities": []}], ["The infection was commonest at 3\u20134 months with 40 of 41 (97.6%) infants of that age testing positive.", {"entities": []}], ["MUC5AC was significantly increased in Pneumocystis- positive tissue specimens ( P = .013).", {"entities": []}], ["Death was unexplained in 113 (88.3%) infants; Pneumocystis was detected in 95 (84.0%) of them vs 10 of 15 (66.7%) with explained death ( P = .28).", {"entities": []}], ["Conclusions.", {"entities": []}], ["A highly focal Pneumocystis infection associated to increased mucus expression is almost universally present in the lungs of infants dying unexpectedly in the community regardless of autopsy diagnosis.", {"entities": []}], ["BACKGROUND: Low-dose and long-term administration of macrolide antibiotics into patients with chronic airway inflammatory diseases could favorably modify their clinical conditions.", {"entities": []}], ["However, the therapeutic mode of action of macrolides is not well understood.", {"entities": []}], ["Free oxygen radicals, including nitric oxide (NO), are well recognized as the important final effector molecules in the development and the maintenance of inflammatory diseases.", {"entities": []}], ["PURPOSE: The influence of macrolide antibiotics on NO generation was examined in vivo.", {"entities": []}], ["METHODS: Male ICR mice, 5 weeks of age, were orally administered with either roxithromycin, clarithromycin, azithromycin or josamycin once a day for 2-4 weeks.", {"entities": []}], ["The mice were then injected intraperitoneally with 5.0 mg/kg lipopolysaccharide (LPS) and the plasma NO level was examined 6 h later.", {"entities": []}], ["RESULTS: Although pre-treatment of mice with macrolide antibiotics for 2 weeks scarcely affected NO generation by LPS injection, the administration of macrolide antibiotics, except for josamycin, for 4 weeks significantly inhibited LPS-induced NO generation.", {"entities": []}], ["The data in the present study also showed that pre-treatment of mice with macrolide antibiotics for 4 weeks significantly suppresses not only production of pro-inflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha, but also inducible nitric oxide synthase mRNA expressions, which are enhanced by LPS injection.", {"entities": []}], ["CONCLUSION: These results strongly suggest that suppressive activity of macrolide antibiotics on NO generation in response to LPS stimulation in vivo may, in part, account for the clinical efficacy of macrolides on chronic inflammatory diseases.", {"entities": []}], ["Adrenomedullin (AM), a 52-amino acid ringed-structure peptide with C-terminal amidation, was originally isolated from human pheochromocytoma.", {"entities": []}], ["AM are widely distributed in various tissues and acts as a local vasoactive hormone in various conditions.", {"entities": []}], ["In the present study, we investigated the efficacy of AM on the animal model of bleomycin (BLM)-induced lung injury.", {"entities": [[91, 94, "GENE"]]}], ["Mice were subjected to intratracheal administration of BLM and were assigned to receive AM daily by an intraperitoneal injection of 200 ngr/kg.", {"entities": [[55, 58, "GENE"]]}], ["Myeloperoxidase activity, lung histology, immunohistochemical analyses for cytokines and adhesion molecules expression, inducible nitric oxide synthase (iNOS), nitrotyrosine, and poly (ADP-ribose) polymerase (PARP) were performed one week after fibrosis induction.", {"entities": []}], ["Lung histology and transforming growth factor beta (TGF-\u03b2) were performed 14 and 21 days after treatments.", {"entities": []}], ["After bleomycin administration, AM-treated mice exhibited a reduced degree of lung damage and inflammation compared with BLM-treated mice, as shown by the reduction of (1) myeloperoxidase activity (MPO), (2) cytokines and adhesion molecules expression, (3) nitric oxide synthase expression, (4) the nitration of tyrosine residues, (5) poly (ADP-ribose) (PAR) formation, a product of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (6) transforming growth factor beta (TGF-\u03b2) (7)and the degree of lung injury.", {"entities": [[198, 201, "GENE"]]}], ["Our results indicate that AM administration is able to prevent bleomycin induced lung injury through the down regulation of proinflammatory factors.", {"entities": []}], ["Passage of the Patient Protection and Affordable Care Act (ACA) increased the roles hospitals and health systems play in care delivery and led to a wave of consolidation of medical groups and hospitals.", {"entities": []}], ["As such, the traditional patient interaction with an independent medical provider is becoming far less common, replaced by frequent interactions with integrated medical groups and health systems.", {"entities": []}], ["It is thus increasingly important for these organizations to have an effective social media presence.", {"entities": []}], ["Moreover, in the age of the informed consumer, patients desire a readily accessible, electronic interface to initiate contact, making a well-designed website and social media strategy critical features of the modern health care organization.", {"entities": []}], ["The purpose of this study was to assess the Web presence of hospitals and their health systems on five dimensions: accessibility, content, marketing, technology, and usability.", {"entities": []}], ["In addition, an overall ranking was calculated to identify the top 100 hospital and health system websites.", {"entities": []}], ["A total of 2407 unique Web domains covering 2785 hospital facilities or their parent organizations were identified and matched against the 2009 American Hospital Association (AHA) Annual Survey.", {"entities": []}], ["This is a four-fold improvement in prior research and represents what the authors believe to be a census assessment of the online presence of US hospitals and their health systems.", {"entities": []}], ["Each of the five dimensions was investigated with an automated content analysis using a suite of tools.", {"entities": []}], ["Scores on the dimensions are reported on a range from 0 to 10, with a higher score on any given dimension representing better comparative performance.", {"entities": []}], ["Rankings on each dimension and an average ranking are provided for the top 100 hospitals.", {"entities": []}], ["The mean score on the usability dimension, meant to rate overall website quality, was 5.16 (SD 1.43), with the highest score of 8 shared by only 5 hospitals.", {"entities": []}], ["Mean scores on other dimensions were between 4.43 (SD 2.19) and 6.49 (SD 0.96).", {"entities": []}], ["Based on these scores, rank order calculations for the top 100 websites are presented.", {"entities": []}], ["Additionally, a link to raw data, including AHA ID, is provided to enable researchers and practitioners the ability to further explore relationships to other dynamics in health care.", {"entities": []}], ["This census assessment of US hospitals and their health systems provides a clear indication of the state of the sector.", {"entities": []}], ["While stakeholder engagement is core to most discussions of the role that hospitals must play in relation to communities, management of an online presence has not been recognized as a core competency fundamental to care delivery.", {"entities": []}], ["Yet, social media management and network engagement are skills that exist at the confluence of marketing and technical prowess.", {"entities": []}], ["This paper presents performance guidelines evaluated against best-demonstrated practice or independent standards to facilitate improvement of the sector\u2019s use of websites and social media.", {"entities": []}], ["The commercial drug paclitaxel (Taxol) may introduce hypersensitivity reactions associated with the polyethoxylated castor oil-ethanol solvent.", {"entities": []}], ["To overcome these problems, we developed a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation, known as Lipusu.", {"entities": []}], ["In this study, we performed in vitro and in vivo experiments to compare the safety profiles of Lipusu and Taxol, with special regard to hypersensitivity reactions.", {"entities": []}], ["First, Swiss mice were used to determine the lethal dosages, and then to evaluate hypersensitivity reactions, followed by histopathological examination and enzyme-linked immunosorbent assays (ELISAs) of serum SC5b-9 and lung histamine.", {"entities": []}], ["Additionally, healthy human serum was used to analyze in vitro complement activation.", {"entities": []}], ["Finally, an MTT assay was used to determine the in vitro anti-proliferation activity.", {"entities": []}], ["Our data clearly showed that Lipusu displayed a much higher safety margin and did not induce hypersensitivity or hypersensitivity-related lung lesions, which may be associated with the fact that Lipusu did not activate complement or increase histamine release in vivo .", {"entities": []}], ["Moreover, Lipusu did not promote complement activation in healthy human serum in vitro , and demonstrated anti-proliferative activity against human cancer cells, similar to that of Taxol.", {"entities": [[148, 154, "DISEASE"]]}], ["Therefore, the improved formulation of paclitaxel, which exhibited a much better safety profile and comparable cytotoxic activity to Taxol, may bring a number of benefits to cancer patients.", {"entities": [[174, 180, "DISEASE"]]}], ["Human metapneumovirus (HMPV) has an important etiological role in acute lower respiratory infections in children under five years.", {"entities": []}], ["Our objectives were to estimate the relative contribution of HMPV to hospitalization in children with acute respiratory infection, to define the clinical and epidemiological features of HMPV single and multiple infections, and to compare HMPV infections with respiratory syncytial virus (HRSV), rhinovirus (HRV), adenovirus and human bocavirus infections in the same population.", {"entities": []}], ["A prospective study performed on all children less than 14 years of age with a respiratory tract disease admitted to a secondary hospital between September 2005- June 2014.", {"entities": []}], ["Clinical characteristics of patients were analyzed.", {"entities": []}], ["Nasopharyngeal aspirate was taken at admission for viral study with polymerase chain reaction for 16 respiratory viruses.", {"entities": []}], ["A total of 3,906 children were included.", {"entities": []}], ["At least one respiratory virus was detected in 75.2% of them.", {"entities": []}], ["The most common identified virus was HRSV, followed by HRV.", {"entities": []}], ["HMPV was detected in 214 cases (5.5%); 133 (62%) were single infections and the remaining were detected in coinfection with other viruses.", {"entities": []}], ["90.7% cases were detected between February and May.", {"entities": []}], ["Children\u2019s mean age was 13.83 \u00b1 18 months.", {"entities": []}], ["Fever was frequent (69%), and bronchiolitis (27%), and recurrent wheezing (63%) were the main clinical diagnosis.", {"entities": [[30, 43, "DISEASE"]]}], ["Hypoxia was present in 65% of the patients and 47% of them had an infiltrate in X-ray.", {"entities": []}], ["Only 6 (2.8%) children were admitted to the intensive care unit.", {"entities": []}], ["Only the duration of the hospitalization was different, being longer in the coinfections group (p <0.05).", {"entities": []}], ["There were many differences in seasonality and clinical characteristics between HMPV and other respiratory viruses being more similar to HRSV.", {"entities": []}], ["HMPV infections accounted for 5.5% of total viral infections in hospitalized children.", {"entities": []}], ["The clinical characteristics were similar to HRSV infections, but seasonality and clinical data were different from other viral infections.", {"entities": []}], ["Long-term maintenance therapy for COPD is evolving rapidly.", {"entities": []}], ["Dual bronchodilation with new long-acting muscarinic antagonist and long-acting beta-agonist (LAMA/LABA) fixed dose combination inhalers were introduced over the past 2 years.", {"entities": []}], ["In clinical trials, these inhalers significantly improved lung function (trough forced expiratory volume in 1 second), patient-reported outcomes, and quality of life measures compared with placebo, their respective monocomponents, and tiotropium.", {"entities": []}], ["The recorded adverse events of these new inhalers were also similar to those of their monocomponents or placebo.", {"entities": []}], ["There are concerns regarding long-term complications (weight gain, osteoporosis, cataract) and increased risk of community-acquired pneumonia with the use of inhaled corticosteroids (ICS).", {"entities": [[81, 89, "DISEASE"], [132, 141, "DISEASE"], [67, 79, "DISEASE"]]}], ["The new LAMA/LABA inhalers could potentially reduce the use of ICS as part and parcel of maintenance therapy in COPD.", {"entities": []}], ["Recent studies compared these LAMA/LABA inhalers with ICS/LABA combination inhalers in moderate-to-severe COPD.", {"entities": []}], ["The results are promising and favor the LAMA/LABA inhalers, especially in the longer duration trials.", {"entities": []}], ["Furthermore, there is a clearer picture emerging as to the subgroup of COPD patients who may be able to successfully switch from their current ICS/LABA therapy to these new LAMA/LABA inhalers.", {"entities": []}], ["Due to the increasing prevalence of childhood obesity, the association between classroom furniture and energy expenditure as well as physical activity was examined using a standing-desk intervention in three central-Texas elementary schools.", {"entities": [[46, 53, "DISEASE"]]}], ["Of the 480 students in the 24 classrooms randomly assigned to either a seated or stand-biased desk equipped classroom, 374 agreed to participate in a week-long data collection during the fall and spring semesters.", {"entities": []}], ["Each participant\u2019s data was collected using Sensewear p < 0.0001) in the fall semester, and a higher EE by 0.08 kcal/min ( p = 0.0092) in the spring semester.", {"entities": []}], ["Despite aggressive antimicrobial therapy, many respiratory pathogens persist in the lung, underpinning the chronic inflammation and eventual lung decline that are characteristic of respiratory disease.", {"entities": []}], ["Recently, bile acid aspiration has emerged as a major comorbidity associated with a range of lung diseases, shaping the lung microbiome and promoting colonisation by Pseudomonas aeruginosa in Cystic Fibrosis (CF) patients.", {"entities": []}], ["In order to uncover the molecular mechanism through which bile modulates the respiratory microbiome, a combination of global transcriptomic and phenotypic analyses of the P. aeruginosa response to bile was undertaken.", {"entities": []}], ["Bile responsive pathways responsible for virulence, adaptive metabolism, and redox control were identified, with macrolide and polymyxin antibiotic tolerance increased significantly in the presence of bile.", {"entities": []}], ["Bile acids, and chenodeoxycholic acid (CDCA) in particular, elicited chronic biofilm behaviour in P. aeruginosa , while induction of the pro-inflammatory cytokine Interleukin-6 (IL-6) in lung epithelial cells by CDCA was Farnesoid X Receptor (FXR) dependent.", {"entities": []}], ["Microbiome analysis of paediatric CF sputum samples demonstrated increased colonisation by P. aeruginosa and other Proteobacterial pathogens in bile aspirating compared to non-aspirating patients.", {"entities": []}], ["Together, these data suggest that bile acid signalling is a leading trigger for the development of chronic phenotypes underlying the pathophysiology of chronic respiratory disease.", {"entities": []}], ["30\u00a0day mortality in patients with Acute Respiratory Failure (ARF) is approximately 30%, defined as patients requiring ventilator support for more than 6\u00a0hours.", {"entities": []}], ["Novel biomarkers are needed to predict patient outcomes and to guide potential future therapies.", {"entities": []}], ["The activins A and B, members of the Transforming Growth Factor \u03b2 family of proteins, and their binding protein, follistatin, have recently been shown to be important regulators of inflammation and fibrosis but no substantial data are available concerning their roles in ARF.", {"entities": []}], ["Our objectives were to evaluate whether the serum levels of activin A, B and follistatin are elevated in 518 patients with ARF from the FINNALI study compared the concentrations in 138 normal subjects that form a reference range.", {"entities": []}], ["Specific assays for activin A, B and follistatin were used and the results analyzed according to diagnostic groups as well as according to standard measures in intensive care.", {"entities": []}], ["Multivariable logistic regression was used to create a model to predict death at 90\u00a0days and 12\u00a0months from the onset of the ARF.", {"entities": []}], ["Serum activin A and B were significantly elevated in most patients and in most of the diagnostic groups.", {"entities": []}], ["Patients who had activin A and/or B concentrations above the reference maximum were significantly more likely to die in the 12\u00a0months following admission [either activin A or B above reference maximum: Positive Likelihood Ratio [LR+] 1.65 [95% CI 1.28-2.12, P \u2009=\u20090.00013]; both activin A and B above reference maximum: LR\u2009+\u20092.78 [95% CI 1.96-3.95, P \u2009<\u20090.00001].", {"entities": []}], ["The predictive model at 12\u00a0months had an overall accuracy of 80.2% [95% CI 76.6-83.3%].", {"entities": []}], ["The measurement of activin A and B levels in these patients with ARF would have assisted in predicting those at greatest risk of death.", {"entities": []}], ["Given the existing data from animal studies linking high activin A levels to significant inflammatory challenges, the results from this study suggest that approaches to modulate activin A and B bioactivity should be explored as potential therapeutic agents.", {"entities": []}], ["It has been recognized that patients with non-small cell lung cancer who are lifelong never-smokers constitute a distinct clinical entity.", {"entities": [[57, 68, "DISEASE"], [62, 68, "DISEASE"]]}], ["The aim of this study was to assess clinical risk factors for survival among never-smokers with non-small cell lung cancer.", {"entities": [[111, 122, "DISEASE"], [116, 122, "DISEASE"]]}], ["All consecutive non-small cell lung cancer patients diagnosed (n\u200a=\u200a285) between May 2005 and May 2009 were included.", {"entities": [[31, 42, "DISEASE"], [36, 42, "DISEASE"]]}], ["The clinical characteristics of never-smokers and ever-smokers (former and current) were compared using chi-squared or Student's t tests.", {"entities": []}], ["Survival curves were calculated using the Kaplan-Meier method, and log-rank tests were used for survival comparisons.", {"entities": []}], ["A Cox proportional hazards regression analysis was evaluated by adjusting for age (continuous variable), gender (female vs. male), smoking status (never- vs. ever-smoker), the Karnofsky Performance Status Scale (continuous variable), histological type (adenocarcinoma vs. non-adenocarcinoma), AJCC staging (early vs. advanced staging), and treatment (chemotherapy and/or radiotherapy vs. the best treatment support).", {"entities": [[253, 267, "DISEASE"], [276, 290, "DISEASE"]]}], ["Of the 285 non-small cell lung cancer patients, 56 patients were never-smokers.", {"entities": [[26, 37, "DISEASE"], [31, 37, "DISEASE"]]}], ["Univariate analyses indicated that the never-smoker patients were more likely to be female (68% vs. 32%) and have adenocarcinoma (70% vs. 51%).", {"entities": [[114, 128, "DISEASE"]]}], ["Overall median survival was 15.7 months (95% CI: 13.2 to 18.2).", {"entities": []}], ["The never-smoker patients had a better survival rate than their counterpart, the ever-smokers.", {"entities": []}], ["Never-smoker status, higher Karnofsky Performance Status, early staging, and treatment were independent and favorable prognostic factors for survival after adjusting for age, gender, and adenocarcinoma in multivariate analysis.", {"entities": [[187, 201, "DISEASE"]]}], ["Epidemiological differences exist between never- and ever-smokers with lung cancer.", {"entities": [[71, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["Overall survival among never-smokers was found to be higher and independent of gender and histological type.", {"entities": []}], ["Osteoporosis is a well-known comorbidity in COPD.", {"entities": [[0, 12, "DISEASE"]]}], ["It is associated with poor health status and prognosis.", {"entities": []}], ["Although the exact pathomechanisms are unclear, osteoporosis is suggested to be either a comorbidity due to shared risk factors with COPD or a systematic effect of COPD with a cause\u2013effect relationship.", {"entities": [[48, 60, "DISEASE"]]}], ["This study aimed to evaluate whether progression of osteoporosis is synchronized with that of COPD.", {"entities": [[52, 64, "DISEASE"]]}], ["Data from 103 patients with COPD included in the Hokkaido COPD cohort study were analyzed.", {"entities": []}], ["Computed tomography (CT) attenuation values of thoracic vertebrae 4, 7, and 10 were measured using custom software, and the average value (average bone density; ABD 4,7,10 ) was calculated.", {"entities": []}], ["The percentage of low attenuation volume (LAV%) for each patient was also calculated for evaluation of emphysematous lesions.", {"entities": []}], ["Annual change in thoracic vertebral CT attenuation, which is strongly correlated with dual-energy X-ray absorptiometry-measured bone mineral density, was compared with that in FEV 1.0 or emphysematous lesions.", {"entities": [[176, 179, "GENE"]]}], ["In the first CT data set, ABD 4,7,10 was significantly correlated with age ( \u03c1 =\u22120.331; p =0.0006), body mass index (BMI; \u03c1 =0.246; p =0.0136), St George\u2019s Respiratory Questionnaire (SGRQ) activity score ( \u03c1 =\u22120.248; p =0.0115), eosinophil count ( \u03c1 =0.229; p =0.0198), and LAV% ( \u03c1 =\u22120.372; p =0.0001).", {"entities": []}], ["However, ABD 4,7,10 was not associated with FEV 1.0 .", {"entities": [[44, 47, "GENE"]]}], ["After adjustment for age, BMI, SGRQ activity score, and eosinophil count, no significant relationship was found between ABD 4,7,10 and LAV%.", {"entities": []}], ["Annual change in ABD 4,7,10 was not associated with annual change in LAV% or FEV 1.0 .", {"entities": [[77, 80, "GENE"]]}], ["Progression of osteoporosis and that of COPD are not directly related or synchronized with each other.", {"entities": [[15, 27, "DISEASE"]]}], ["There is significant evidence arising from experimental models that autoantibodies play a key role in the pathogenesis of inflammatory arthritis.", {"entities": [[135, 144, "DISEASE"]]}], ["In addition to autoantibody production, B cells efficiently present antigen to T cells, produce soluble factors, including cytokines and chemokines, and form B cell aggregates in the target organ of rheumatoid arthritis.", {"entities": [[199, 219, "DISEASE"], [210, 219, "DISEASE"]]}], ["In this review we analyze the multifaceted role that B cells play in the pathogenesis of rheumatoid arthritis and discuss how this information can be used to guide more specific targeting of B cells for the therapy of this disease.", {"entities": [[89, 109, "DISEASE"], [100, 109, "DISEASE"]]}], ["Exacerbations of non-cystic fibrosis bronchiectasis cause significant morbidity but there are few detailed data on their clinical course and associated physiological changes.", {"entities": [[37, 51, "DISEASE"], [21, 36, "DISEASE"]]}], ["The biology of an exacerbation has not been previously described.", {"entities": []}], ["The purpose of this study was to describe changes in lung function, symptoms, health status and inflammation during the development and recovery from community-treated exacerbations.", {"entities": []}], ["This was a prospective observational cohort study of 32 outpatients with non-cystic fibrosis bronchiectasis conducted between August 2010 and August 2012.", {"entities": [[93, 107, "DISEASE"], [77, 92, "DISEASE"]]}], ["Patients completed a symptom diary card and measured their peak expiratory flow rate (PEFR) daily.", {"entities": []}], ["Exacerbations were defined as oral antibiotic treatment taken for a worsening of respiratory symptoms.", {"entities": []}], ["Symptoms and peak flow at exacerbation were analysed, and further measurements including the COPD Assessment Test (CAT) and inflammatory markers were also compared to baseline values.", {"entities": []}], ["At baseline, health status was significantly related to lung function, prognostic severity and systemic inflammation.", {"entities": []}], ["51 exacerbations occurred in 22 patients.", {"entities": []}], ["Exacerbation symptoms began a median (interquartile range) of 4 (2, 7) days before treatment started and the median exacerbation duration was 16 (10, 29) days.", {"entities": []}], ["16% had not recovered by 35 days.", {"entities": []}], ["At exacerbation, mean PEFR dropped by 10.6% (95% confidence interval 6.9-14.2, p\u2009<\u20090.001) and mean CAT score increased by 6.3 units (3.6-9.1, p\u2009=\u20090.001), median symptom count by 4 (2.25, 6, p\u2009<\u20090.001), and mean CRP by 9.0mg/L (2.3-15.8, p\u2009=\u20090.011).", {"entities": [[211, 214, "GENE"]]}], ["Exacerbations where PEFR fell by \u226510% were longer with more symptoms at onset.", {"entities": []}], ["Exacerbations of non-CF bronchiectasis are inflammatory events, with worsened symptoms, lung function and health status, and a prolonged recovery period.", {"entities": [[24, 38, "DISEASE"]]}], ["Symptom diary cards, PEFR and CAT scores are responsive to changes at exacerbation and may be useful tools for their detection and monitoring.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0167-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Arab-American (AA) populations in the US are exposed to discrimination and acculturative stress\u2014two factors that have been associated with higher suicide risk.", {"entities": []}], ["However, prior work suggests that socially oriented norms and behaviors, which characterize recent immigrant ethnic groups, may be protective against suicide risk.", {"entities": []}], ["Here we explored suicide rates and their determinants among AAs in Michigan, the state with the largest proportion of AAs in the US.", {"entities": []}], ["ICD-9/10 underlying cause of death codes were used to identify suicide deaths from among all deaths in Michigan between 1990 and 2007.", {"entities": []}], ["Data from the 2000 U.S. Census were collected for population denominators.", {"entities": []}], ["Age-adjusted suicide rates among AAs and non-ethnic whites were calculated by gender using the direct method of standardization.", {"entities": []}], ["We also stratified by residence inside or outside of Wayne County (WC), the county with the largest AA population in the state.", {"entities": []}], ["Suicide rates were 25.10 per 100,000 per year among men and 6.40 per 100,000 per year among women in Michigan from 1990 to 2007.", {"entities": []}], ["AA men had a 51% lower suicide rate and AA women had a 33% lower rate than non-ethnic white men and women, respectively.", {"entities": []}], ["The suicide rate among AA men in WC was 29% lower than in all other counties, while the rate among AA women in WC was 20% lower than in all other counties.", {"entities": []}], ["Among non-ethnic whites, the suicide rate in WC was higher compared to all other counties among both men (12%) and women (16%).", {"entities": []}], ["Suicide rates were higher among non-ethnic white men and women compared to AA men and women in both contexts.", {"entities": []}], ["Arab ethnicity may protect against suicide in both sexes, but more so among men.", {"entities": []}], ["Additionally, ethnic density may protect against suicide among Arab-Americans.", {"entities": []}], ["Sulforaphane (SFN), a naturally occurring isothiocyanate found in cruciferous vegetables, is implicated as a possible therapy for airway inflammation via induction of the transcription factor NF-E2-related factor 2 (NRF2).", {"entities": [[14, 17, "GENE"]]}], ["In this proof-of-concept clinical study, we show that supplementation of SFN with broccoli sprout homogenate in healthy human subjects did not induce expression of antioxidant genes or protect against neutrophilic airway inflammation in an ozone-exposure model.", {"entities": [[73, 76, "GENE"]]}], ["Therefore, dietary sulforaphane supplementation is not a promising candidate for larger scale clinical trials targeting airway inflammation.", {"entities": []}], ["Trial registration: NCT01625130 .", {"entities": []}], ["Registered 19 June, 2012.", {"entities": []}], ["Physician implicit (unconscious, automatic) bias has been shown to contribute to racial disparities in medical care.", {"entities": []}], ["The impact of medical education on implicit racial bias is unknown.", {"entities": []}], ["To examine the association between change in student implicit racial bias towards African Americans and student reports on their experiences with 1) formal curricula related to disparities in health and health care, cultural competence, and/or minority health; 2) informal curricula including racial climate and role model behavior; and 3) the amount and favorability of interracial contact during school.", {"entities": []}], ["Prospective observational study involving Web-based questionnaires administered during first (2010) and last (2014) semesters of medical school.", {"entities": []}], ["A total of 3547 students from a stratified random sample of 49 U.S. medical schools.", {"entities": []}], ["Change in implicit racial attitudes as assessed by the Black-White Implicit Association Test administered during the first semester and again during the last semester of medical school.", {"entities": []}], ["In multivariable modeling, having completed the Black-White Implicit Association Test during medical school remained a statistically significant predictor of decreased implicit racial bias (\u22125.34, p\u2009\u2264\u20090.001: mixed effects regression with random intercept across schools).", {"entities": []}], ["Students' self-assessed skills regarding providing care to African American patients had a borderline association with decreased implicit racial bias (\u22122.18, p \u2009=\u20090.056).", {"entities": []}], ["Having heard negative comments from attending physicians or residents about African American patients (3.17, p \u2009=\u20090.026) and having had unfavorable vs. very favorable contact with African American physicians (18.79, p \u2009=\u20090.003) were statistically significant predictors of increased implicit racial bias.", {"entities": []}], ["Medical school experiences in all three domains were independently associated with change in student implicit racial attitudes.", {"entities": []}], ["These findings are notable given that even small differences in implicit racial attitudes have been shown to affect behavior and that implicit attitudes are developed over a long period of repeated exposure and are difficult to change.", {"entities": []}], ["Production of Annexin A1 (ANXA1), a protein that mediates the anti-inflammatory action of glucocorticoids, is altered in obesity, but its role in modulation of adiposity has not yet been investigated.", {"entities": [[121, 128, "DISEASE"], [26, 31, "GENE"]]}], ["The objective of this study was to investigate modulation of ANXA1 in adipose tissue in murine models of obesity and to study the involvement of ANXA1 in diet-induced obesity in mice.", {"entities": [[105, 112, "DISEASE"], [167, 174, "DISEASE"], [61, 66, "GENE"], [145, 150, "GENE"], [61, 66, "GENE"], [145, 150, "GENE"]]}], ["Significant induction of ANXA1 mRNA was observed in adipose tissue of both C57BL6 and Balb/c mice with high fat diet (HFD)-induced obesity versus mice on chow diet.", {"entities": [[131, 138, "DISEASE"], [25, 30, "GENE"]]}], ["Upregulation of ANXA1 mRNA was independent of leptin or IL-6, as demonstrated by use of leptin-deficient ob/ob mice and IL-6 KO mice.", {"entities": [[16, 21, "GENE"]]}], ["Compared to WT mice, female Balb/c ANXA1 KO mice on HFD had increased adiposity, as indicated by significantly elevated body weight, fat mass, leptin levels, and adipocyte size.", {"entities": [[35, 40, "GENE"]]}], ["Whereas Balb/c WT mice upregulated expression of enzymes involved in the lipolytic pathway in response to HFD, this response was absent in ANXA1 KO mice.", {"entities": [[139, 144, "GENE"]]}], ["A significant increase in fasting glucose and insulin levels as well as development of insulin resistance was observed in ANXA1 KO mice on HFD compared to WT mice.", {"entities": [[122, 127, "GENE"]]}], ["Elevated plasma corticosterone levels and blunted downregulation of 11-beta hydroxysteroid dehydrogenase type 1 in adipose tissue was observed in ANXA1 KO mice compared to diet-matched WT mice.", {"entities": [[146, 151, "GENE"]]}], ["However, no differences between WT and KO mice on either chow or HFD were observed in expression of markers of adipose tissue inflammation.", {"entities": []}], ["These data indicate that ANXA1 is an important modulator of adiposity in mice, with female ANXA1 KO mice on Balb/c background being more susceptible to weight gain and diet-induced insulin resistance compared to WT mice, without significant changes in inflammation.", {"entities": [[25, 30, "GENE"], [91, 96, "GENE"], [25, 30, "GENE"], [91, 96, "GENE"]]}], ["Before the advent of genome-wide association studies (GWAS), ADAM33, ADRB2, CD14, MS4A2 (alias FCER1B ), IL13, IL4, IL4R , and TNF constituted the most replicated non- HLA candidate genes with asthma and related traits.", {"entities": [[193, 199, "DISEASE"], [61, 67, "GENE"], [69, 74, "GENE"], [76, 80, "GENE"], [82, 87, "GENE"], [105, 109, "GENE"], [111, 114, "GENE"], [116, 120, "GENE"], [127, 130, "GENE"], [168, 171, "GENE"]]}], ["However, except for the IL13-IL4 region, none of these genes have been found in close proximity of genome-wide significant hits among GWAS for asthma or related traits.", {"entities": [[143, 149, "DISEASE"]]}], ["Here we aimed to assess the reproducibility of these asthma associations and to test if associations were more evident considering the effect of age at diagnosis.", {"entities": [[53, 59, "DISEASE"]]}], ["We systematically evaluated 286 common single nucleotide polymorphisms (SNPs) of these 8 genes in a sample of 1,865 unrelated Spanish individuals (606 asthmatics and 1,259 controls).", {"entities": []}], ["We found that variants at MS4A2 , IL4R and ADAM33 genes demonstrated varying association effects with the age at diagnosis of asthma, with 10 SNPs showing study-wise significance after the multiple comparison adjustment.", {"entities": [[126, 132, "DISEASE"], [26, 31, "GENE"], [34, 38, "GENE"], [43, 49, "GENE"]]}], ["In addition, in silico replication with GWAS data supported the association of IL4R .", {"entities": [[79, 83, "GENE"]]}], ["Our results support the important role of MS4A2 , IL4R and ADAM33 genes in asthma and/or atopy susceptibility.", {"entities": [[75, 81, "DISEASE"], [42, 47, "GENE"], [50, 54, "GENE"], [59, 65, "GENE"]]}], ["However, additional studies in larger samples sets are needed to firmly implicate these genes in asthma susceptibility, and also to identify the causal variation underlying the associations found.", {"entities": [[97, 103, "DISEASE"]]}], ["Health related quality of life (HRQoL) is an important subjectively evaluated outcome of adolescents physical, mental, and social functioning.", {"entities": []}], ["It gives us the possibility to assess the disease impact on life of adolescents, and to sort out target groups of adolescents for future psychological interventions.", {"entities": []}], ["The objective of this cross-sectional survey was to study HRQoL in 173 adolescents with chronic physical illness (CPI - diabetes, asthma, and epilepsy), and to find HRQoL predictors in each disease group.", {"entities": [[130, 136, "DISEASE"]]}], ["Disease-specific questionnaires were completed by each adolescent recruited from the local outpatient clinic; mothers answered the questions on socioeconomic status (SES); and the patients\u2019 clinicians evaluated the severity of the disease.", {"entities": []}], ["A high proportion of adolescents in each disease specific sample reported moderate to high levels of HRQoL.", {"entities": []}], ["Gender was the most prominent predictor of HRQoL in all three studied groups, while disease severity predicted HRQoL in the diabetic group and to some extent in the asthma group.", {"entities": [[165, 171, "DISEASE"]]}], ["Our results provide evidence that adolescents with diabetes, asthma, and epilepsy in northern Russia maintain relatively moderate to high levels of HRQoL.", {"entities": [[61, 67, "DISEASE"]]}], ["The domains affecting HRQoL were related to both disease-specific (severity) and non-disease factors (gender and SES).", {"entities": []}], ["Our study suggests that future psychosocial interventions should focus on aspects of CPI impacting adolescents in gendered ways, furthermore taking into account disease specific factors.", {"entities": []}], ["Enhanced activity of neutrophil elastase leads to a protease\u2013antiprotease imbalance, and plays an essential pathogenic role in acute lung injury (ALI) and acute respiratory distress syndrome.", {"entities": [[182, 190, "DISEASE"]]}], ["We assayed the pharmacological effects and mechanisms of the action of sirtinol in human neutrophils, and in neutrophil elastase (HNE)-induced paw edema and lipopolysaccharide (LPS)-mediated ALI in mice.", {"entities": []}], ["Sirtinol significantly inhibited the activity of HNE from human neutrophils in response to various stimulators.", {"entities": []}], ["The inhibitory effects on HNE activity were not mediated through protein kinase A, calcium, extracellular-regulated kinase, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase, Akt, or Src family kinases.", {"entities": [[195, 198, "GENE"]]}], ["Analysis of enzymatic activities showed that sirtinol inhibited HNE activity in a concentration-dependent manner.", {"entities": []}], ["These results demonstrate that sirtinol does not affect neutrophil function and is an HNE inhibitor.", {"entities": []}], ["In addition, administration of sirtinol significantly inhibited HNE-induced paw edema, and attenuated the myeloperoxidase activity and reduced pulmonary wet/dry weight ratio in the LPS-induced ALI mouse model.", {"entities": []}], ["Our study indicates that sirtinol has anti-inflammatory effects through direct inhibition of HNE activity and attenuates HNE-induced and LPS-mediated tissue or organ injury in vivo.", {"entities": []}], ["Sirtinol is a novel HNE inhibitor and may have the potential for clinical application in the treatment of inflammatory lung diseases.", {"entities": []}], ["Pandemic influenza A (H1N1) virus has spread rapidly and prompt diagnosis is needed for successful treatment and prevention of transmission.", {"entities": [[9, 18, "DISEASE"]]}], ["We investigated clinical predictors, validated the use of previous criteria with laboratory tests, and evaluated the clinical criteria for H1N1 infection in the Korean population.", {"entities": []}], ["We analyzed clinical and laboratory evaluation data from outpatient clinics at Severance Hospital in Seoul, Korea between November 11 and December 5, 2009.", {"entities": []}], ["This analysis included a total of 828 patients.", {"entities": []}], ["Of these, 372 (44.9%) patients were confirmed with H1N1 infection by real-time reverse transcriptase-polymerase chain reaction (RT-PCR).", {"entities": []}], ["The most common and predictive symptom was cough (90.3%, OR 8.87, 95% CI 5.89-13.38) and about 40% of H1N1-positive patients were afebrile.", {"entities": []}], ["The best predictive model of H1N1 infection was cough plus fever or myalgia.", {"entities": []}], ["The sensitivities, specificities, positive predictive values, and negative predictive values of our suggested criteria were 73.9%, 69.5%, 66.4%, and 76.6%, respectively.", {"entities": []}], ["Cough was the most common independent symptom in patients with laboratory-confirmed H1N1 infection, and while not perfect, the combination of cough plus fever or myalgia is suggested as clinical diagnostic criteria.", {"entities": []}], ["Health care providers in Korea should suspect a cough without fever to be an early symptom of H1N1 infection.", {"entities": []}], ["Despite effective pharmacotherapy, asthma continues to impair quality of life for most patients.", {"entities": [[35, 41, "DISEASE"]]}], ["Non-pharmacological approaches, including breathing retraining, are therefore of great interest to patients.", {"entities": []}], ["However, clinicians rarely advocate breathing retraining and access to this intervention is restricted for most patients due to the limited availability of suitable physiotherapists and poor integration of breathing retraining into standard care.", {"entities": []}], ["We aimed to assess the effectiveness of a digital self-guided breathing retraining intervention.", {"entities": []}], ["In this randomised controlled trial, we recruited patients from 34 general practices in the UK.", {"entities": []}], ["Eligibility criteria for patients with asthma were broad, comprising a physician diagnosis of asthma, age of 16\u201370 years, receipt of at least one anti-asthma medication in the previous year, and impaired asthma-related quality of life (Asthma Quality of Life Questionnaire [AQLQ] score of <5\u00b75).", {"entities": [[39, 45, "DISEASE"], [94, 100, "DISEASE"], [151, 157, "DISEASE"], [204, 210, "DISEASE"], [236, 242, "DISEASE"]]}], ["We developed a self-guided intervention, which was delivered as a DVD plus a printed booklet (DVDB).", {"entities": []}], ["Participants were randomly assigned to receive either the DVDB intervention, three face-to-face breathing retraining sessions, or standard care, in a 2:1:2 ratio, for 12 months.", {"entities": []}], ["Randomisation was achieved using the Southampton Clinical Trials Unit telephone randomisation service by use of random number generators.", {"entities": []}], ["The primary outcome was the AQLQ score in the intention-to-treat population at 12 months.", {"entities": []}], ["The trial was powered to show equivalence between the two active intervention groups, and superiority of both intervention groups over usual care.", {"entities": []}], ["Secondary outcomes included patient-reported and physiological measures of asthma control, patient acceptability, and health-care costs.", {"entities": [[75, 81, "DISEASE"]]}], ["This trial was registered with International Standard Randomised Controlled Trial Number registry, number ISRCTN88318003.", {"entities": []}], ["Between Nov 5, 2012 and Jan 28, 2014, invitations to participate in the study were sent to 15\u2008203 patients with general practitioner-diagnosed asthma, of whom 655 were recruited into the study.", {"entities": [[143, 149, "DISEASE"], [8, 11, "GENE"]]}], ["AQLQ scores at 12 months were significantly higher in the DVDB group (mean 5\u00b740, SD 1\u00b714) than in the usual care group (5\u00b712, SD 1\u00b717; adjusted mean difference 0\u00b728, 95% CI 0\u00b711 to 0\u00b744), and in the face-to-face group (5\u00b733, SD 1\u00b706) than in the usual care group (adjusted mean difference 0\u00b724, 95% CI 0\u00b704 to 0\u00b744); AQLQ scores were similar between the DVDB group and the face-to-face group (0\u00b704, 95% CI \u22120\u00b716 to 0\u00b724).", {"entities": []}], ["There were no significant differences between the randomisation groups in FEV1 or fraction of exhaled nitric oxide.", {"entities": []}], ["744 adverse events occurred in 272 patients: 101 (39%) of 261 patients in the DVDB group, 55 (42%) of 132 patients in the face-to-face group, and 132 (50%) of 262 in the usual care group, with patients reporting one or more event.", {"entities": []}], ["11 (4%) patients in the DVDB group, four (3%) patients in the face-to-face group, and 20 (8%) patients in the usual care group had a serious adverse event.", {"entities": []}], ["Breathing retraining programmes improve quality of life in patients with incompletely controlled asthma despite having little effect on lung function or airway inflammation.", {"entities": [[97, 103, "DISEASE"]]}], ["Such programmes can be delivered conveniently and cost-effectively as a self-guided digital audiovisual programme, so might also reduce health-care costs.", {"entities": []}], ["UK National Institute of Health Research.", {"entities": []}], ["Human \u03b2-defensin (hBD)-2, antimicrobial peptide primarily induced in epithelial cells, is a key factor in the innate immune response of the respiratory tract.", {"entities": [[18, 21, "GENE"]]}], ["Several studies showed increased defensin levels in both inflammatory lung diseases, such as cystic fibrosis, diffuse panbronchiolitis, idiopathic pulmonary fibrosis and acute respiratory distress syndrome, and infectious diseases.", {"entities": [[197, 205, "DISEASE"], [93, 108, "DISEASE"], [147, 165, "DISEASE"], [136, 165, "DISEASE"]]}], ["Recently, epidemiologic studies have demonstrated acute and serious adverse effects of particulate air pollution on respiratory health, especially in people with pre-existing inflammatory lung disease.", {"entities": [[188, 200, "DISEASE"]]}], ["To elucidate the effect of diesel exhaust particles (DEP) on pulmonary innate immune response, we investigated the hBD-2 and interleukin-8 (IL-8) expression to DEP exposure in interleukin-1 beta (IL-1\u03b2)-stimulated A549 cells.", {"entities": []}], ["IL-1\u03b2 markedly up-regulated the hBD-2 promoter activity, and the subsequent DEP exposure increased dose-dependently the expression of hBD-2 and inflammatory cytokine IL-8 at the transcriptional level.", {"entities": []}], ["In addition, DEP further induced the NF-\u03baB activation in IL-1\u03b2-stimulated A549 cells more rapidly than in unstimulated control cells, which was showed by nuclear translocation of p65 NF-\u03baB and degradation of I\u03baB-\u03b1.", {"entities": []}], ["The experiment using two NF-\u03baB inhibitors, PDTC and MG132, confirmed that this increase of hBD-2 expression following DEP exposure was regulated through NF-\u03baB-mediated pathway.", {"entities": []}], ["These results demonstrated that DEP exposure increases the expression of antimicrobial peptide and inflammatory cytokine at the transcriptional level in IL-1\u03b2-primed A549 epithelial cells and suggested that the increase is mediated at least partially through NF-\u03baB activation.", {"entities": []}], ["Therefore, DEP exposure may contribute to enhance the airway-responsiveness especially on the patients suffering from chronic respiratory disease.", {"entities": []}], ["Despite considerable evidence showing the importance of the nursing and midwifery workforce, there are no systematic reviews outlining how these cadres are best supported to provide universal access and reduce health care disparities at the primary health care (PHC) level.", {"entities": []}], ["This review aims to identify nursing and midwifery policy, staffing, education and training interventions, collaborative efforts and strategies that have improved the quantity, quality and relevance of the nursing and midwifery workforce leading to health improvements for vulnerable populations.", {"entities": []}], ["We undertook a structured search of bibliographic databases for peer-reviewed research literature using a focused review question and inclusion/exclusion criteria.", {"entities": []}], ["The quality of retrieved papers was appraised using standard tools.", {"entities": []}], ["The characteristics of screened papers were described, and a deductive qualitative content analysis methodology was applied to analyse the interventions and findings of included studies using a conceptual framework.", {"entities": []}], ["Thirty-six papers were included in the review, the majority (25) from high-income countries and nursing settings (32).", {"entities": []}], ["Eleven papers defined leadership and governance approaches that had impacted upon the health outcomes of disadvantaged groups including policies at the national and state level that had led to an increased supply and coverage of nursing and midwifery staff and scope of practice.", {"entities": []}], ["Twenty-seven papers outlined human resource management strategies to support the expansion of nurse\u2019s and midwives\u2019 roles that often involved task shifting and task sharing.", {"entities": []}], ["These included approaches to managing staffing supply, distribution and skills mix; workloads; supervision; performance management; and remuneration, financial incentives and staffing costs.", {"entities": []}], ["Education and training activities were described in 14 papers to assist nurses and midwives to perform new or expanded roles and prepare nurses for inclusive practice.", {"entities": []}], ["This review identified collaboration between nurses and midwives and other health providers and organizations, across sectors, and with communities and individuals that resulted in improved health care and outcomes.", {"entities": []}], ["The findings of this review confirm the importance of a conceptual framework for understanding and planning leadership and governance approaches, management strategies and collaboration and education and training efforts to scale up and support nurses and midwives in existing or expanded roles to improve access to PHC for vulnerable populations.", {"entities": []}], ["Over the last decades survival after acute coronary syndrome (ACS) has improved, leading to an increasing number of patients returning to work, but little is known about factors that may influence their labour market affiliation.", {"entities": [[52, 60, "DISEASE"]]}], ["This study examines the impact of gender, co-morbidity and socio-economic position on subsequent labour market affiliation and transition between various social services in patients admitted for the first time with ACS.", {"entities": []}], ["From 2001 to 2009 all first-time hospitalisations for ACS were identified in the Danish National Patient Registry (n\u200a=\u200a79,714).", {"entities": []}], ["For this population, data on sick leave, unemployment and retirement were obtained from an administrative register covering all citizens.", {"entities": []}], ["The 21,926 patients, aged 18\u201363 years, who had survived 30 days and were part of the workforce at the time of diagnosis were included in the analyses where subsequent transition between the above labour market states was examined using Kaplan-Meier estimates and Cox proportional hazards models.", {"entities": []}], ["A total of 37% of patients were in work 30 days after first ACS diagnosis, while 55% were on sick leave and 8% were unemployed.", {"entities": []}], ["Seventy-nine per cent returned to work once during follow-up.", {"entities": []}], ["This probability was highest among males, those below 50 years, living with a partner, the highest educated, with higher occupations, having specific events (NSTEMI, and percutaneous coronary intervention) and with no co-morbidity.", {"entities": []}], ["During five years follow-up, 43% retired due to disability or voluntary early pension.", {"entities": []}], ["Female gender, low education, basic occupation, co-morbidity and having a severer event (invasive procedures) and receiving sickness benefits or being unemployed 30 days after admission were associated with increased probability of early retirement.", {"entities": []}], ["About half of patients with first-time ACS stay in or return to work shortly after the event.", {"entities": []}], ["Women, the socially disadvantaged, those with presumed severer events and co-morbidity have lower rates of return.", {"entities": []}], ["Omalizumab depletes free IgE in the blood and interstitial space and inhibits IgE binding to Fc \u03b5 RI on basophils, mast cells, and dendritic cells.", {"entities": []}], ["We stopped omalizumab treatment after four years.", {"entities": []}], ["Recurrences of urticaria symptoms were found to be higher in patients with chronic urticaria than recurrences of asthmatic symptoms in severe persistent asthma patients.", {"entities": [[15, 24, "DISEASE"], [83, 92, "DISEASE"], [153, 159, "DISEASE"]]}], ["For the very first time, we used omalizumab in symptomatic therapy of recurrent laryngeal oedema and urticaria attacks in a patient with postoperative pulmonary carcinoid tumor for eight months.", {"entities": [[101, 110, "DISEASE"]]}], ["During the four years of follow-up, no recurrence was noted in pulmonary carcinoid tumor.", {"entities": []}], ["Control PET CT results revealed normal findings.", {"entities": []}], ["After omalizumab treatment, laryngeal oedema and urticaria symptoms were decreased.", {"entities": [[49, 58, "DISEASE"]]}], ["The most common adverse reaction from omalizumab is injection site induration, injection site itching, injection site pain, and bruising but the package insert contains warnings regarding parasitic infections.", {"entities": []}], ["While there are no reports of fatal anaphylaxis as a result of omalizumab, some cases have been serious and potentially life-threatening.", {"entities": []}], ["Therefore, the FDA requires that people receiving omalizumab be monitored in the physician's office for a period of time after their injections.", {"entities": []}], ["Supplemental Digital Content is available in the text.", {"entities": []}], ["To evaluate the contemporary practice, outcomes, and costs related to mechanical ventilation among ICUs in China.", {"entities": []}], ["A prospective observational cohort study.", {"entities": []}], ["Fourteen ICUs among 13 hospitals in Beijing, China.", {"entities": []}], ["Seven hundred ninety-three patients who received at least 24 hours of mechanical ventilation within the first 48 hours of ICU stay.", {"entities": []}], ["The mean age was 64 years.", {"entities": []}], ["Sixty-three percent were male.", {"entities": []}], ["New acute respiratory failure accounted for 85.5% of mechanical ventilation cases.", {"entities": [[10, 29, "DISEASE"]]}], ["Only 4.7% of the patients received mechanical ventilation for acute exacerbation of chronic obstructive pulmonary disease.", {"entities": [[84, 121, "DISEASE"]]}], ["The most widely used ventilation mode was the combination of synchronized intermittent mandatory ventilation and pressure support (43.6%).", {"entities": []}], ["Use of lung-protective ventilation is widespread with tidal volumes of 7.1\u2009mL/kg (2.1\u2009mL/kg).", {"entities": []}], ["The ICU/hospital mortality was 27.6%/29.3%, respectively (8.5%/9.7% for surgical patients and 41.3%/43.2% for medical patients, respectively).", {"entities": []}], ["The mean level of ICU/hospital cost per patient was $15,271 (18,940)/$22,946 (25,575), respectively.", {"entities": []}], ["The mean daily ICU cost per patient was $1,212.", {"entities": []}], ["For the first time, we obtained a preliminary epidemiology data of mechanical ventilation in Beijing, China, through the study.", {"entities": []}], ["Compared with the other nations, our patients are older, predominantly male, and treated according to prevailing international guidelines yet at a relatively high cost and high mortality.", {"entities": []}], ["The expanding elderly population predicts increase demand for mechanical ventilation that must be met by continuous improvement in quality and efficiency of critical care services.", {"entities": []}], ["The aim of this study was to verify the benefits and limitations of repeated bedside echocardiographic examinations in children during mechanical ventilation.", {"entities": []}], ["For the purposes of this study, we selected the data of over a time period from 2006 to 2010.", {"entities": []}], ["A total of 235 children, average age 3.21 (SD 1.32) years were included into the study and divided into etiopathogenic groups.", {"entities": []}], ["High-risk groups comprised: Acute lung injury and acute respiratory distress syndrome (ALI/ARDS), return of spontaneous circulation after cardiopulmonary resuscitation (ROSC), bronchopulmonary dysplasia (BPD), cardiomyopathy (CMP) and cardiopulmonary disease (CPD).", {"entities": [[210, 224, "DISEASE"], [77, 85, "DISEASE"], [260, 263, "GENE"]]}], ["Transthoracic echocardiography was carried out during mechanical ventilation.", {"entities": []}], ["The following data were collated for statistical evaluation: right and left ventricle myocardial performance indices (RV MPI; LV MPI), left ventricle shortening fraction (SF), cardiac output (CO), and the mitral valve ratio of peak velocity of early wave (E) to the peak velocity of active wave (A) as E/A ratio.", {"entities": [[121, 124, "GENE"], [129, 132, "GENE"], [121, 124, "GENE"], [129, 132, "GENE"]]}], ["The data was processed after a period of recovery, i.e.", {"entities": []}], ["one hour after the introduction of invasive lines (time-1) and after 72 hours of comprehensive treatment (time-2).", {"entities": []}], ["The overall development of parameters over time was compared within groups and between groups using the distribution-free Wilcoxons and two-way ANOVA tests.", {"entities": []}], ["A total of 870 echocardiographic examinations were performed.", {"entities": []}], ["At time-1 higher average values of RV MPI (0.34, SD 0.01 vs. 0.21, SD 0.01; p < 0.001) were found in all groups compared with reference values.", {"entities": [[38, 41, "GENE"]]}], ["Left ventricular load in the high-risk groups was expressed by a higher LV MPI (0.39, SD 0.13 vs. 0.29, SD 0.02; p < 0.01) and lower E/A ratio (0.95, SD 0.36 vs. 1.36, SD 0.64; p < 0.001), SF (0.37, SD 0.11 vs. 0.47, SD 0.02; p < 0.01) and CO (1.95, SD 0.37 vs. 2.94, SD 1.03; p < 0.01).", {"entities": [[75, 78, "GENE"]]}], ["At time-2 RV MPI were lower (0.25, SD 0.02 vs. 0.34, SD 0.01; p < 0.001), but remained higher compared with reference values (0.25, SD 0.02 vs. 0.21, SD 0.01; p < 0.05).", {"entities": [[13, 16, "GENE"]]}], ["Other parameters in high-risk groups were improved, but remained insignificantly different compared with reference values.", {"entities": []}], ["Echocardiography complements standard monitoring of valuable information regarding cardiac load in real time.", {"entities": []}], ["Chest excursion during mechanical ventilation does not reduce the quality of the acquired data.", {"entities": []}], ["Patient preferences regarding characteristics associated with the treatment of chronic obstructive pulmonary disease (COPD) must be determined to increase the compatibility between the patients and the treatments, but as yet no studies have been performed regarding these characteristics.", {"entities": [[79, 116, "DISEASE"]]}], ["Here, we evaluate the preferred characteristics associated with the treatment of patients with COPD.", {"entities": []}], ["The expectations of patients receiving COPD therapy were assessed in six categories: time allocated by the physician to listen to patients\u2019 complaints, treatment to be applied, estimated adverse effect frequency concerning the therapy, ability of patients to visit the same physician each time, integral approach of the physician to the treatment of the patient, and therapy cost.", {"entities": []}], ["These groups were divided into categories of therapy indicating 25 alternative treatment methods, using conjoint analysis.", {"entities": []}], ["Patients were sorted to the 25 types of treatment with regard to their preferences.", {"entities": []}], ["The major expectation of conjoint analysis associated with the treatment of COPD patients is for the therapy to allow the patients to completely recover from their complaints.", {"entities": []}], ["The order preferred by patients of other treatment expectations is from sufficient time to be allowed by the physician to listen to the patient, to no cost for the treatment, to minimum adverse effects resulting from the treatment, to each follow-up to be performed by the same physician, and to the physician performing an assessment of the patient\u2019s well-being, rather than examining only the areas of complaint.", {"entities": []}], ["The major expectation of COPD patients regarding treatment was to completely recover with the help of the therapy.", {"entities": []}], ["Considering the expectations of the patient may help improve the compatibility of the patient with the treatment.", {"entities": []}], ["In favor of their outgrowth, cancer cells must resist immune surveillance and edit the immune response.", {"entities": [[29, 35, "DISEASE"]]}], ["Cancer immunoediting is characterized by fundamental changes in the cellular composition and the inflammatory cytokine profiles in the microenvironment of the primary tumor and metastatic niches, with an ever increasing complexity of interactions between tumor cells and the immune system.", {"entities": [[0, 6, "DISEASE"]]}], ["Recent data suggest that genetic instability and immunoediting are not necessarily disparate processes.", {"entities": []}], ["Increasing mutational load may be associated with multiple neoepitopes expressed by the tumor cells and thus increased chances for the immune system to recognize and combat these cells.", {"entities": []}], ["At the same time the immune system is more and more suppressed and exhausted by this process.", {"entities": []}], ["Consequently, immune checkpoint modulation may have the potential to be most successful in genetically highly altered and usually extremely unfavorable types of cancer.", {"entities": [[161, 167, "DISEASE"]]}], ["Moreover, the fact that epitopes recognized by the immune system are preferentially encoded by passenger gene mutations opens windows of synergy in targeting cancer-specific signaling pathways by small molecules simultaneously with antibodies modifying T-cell activation or exhaustion.", {"entities": [[158, 164, "DISEASE"]]}], ["This review covers some aspects of the current understanding of the immunological basis necessary to understand the rapidly developing therapeutic endeavours in cancer treatment, the clinical achievements made, and raises some burning questions for translational research in this field.", {"entities": [[161, 167, "DISEASE"]]}], ["Neurokinin A and B are putative inflammatory mediators.", {"entities": []}], ["We assessed their ability to alter prenodal lymphatic resistance.", {"entities": []}], ["Intralymphatic neurokinin A (3.0 \u00d7 10", {"entities": []}], ["The specific component responsible and the mechanistic pathway for increased human morbidity and mortality after cigarette smoking are yet to be delineated.", {"entities": []}], ["We propose that 1) injury and disease following cigarette smoking are associated with exposure to and retention of particles produced during smoking and 2) the biological effects of particles associated with cigarette smoking share a single mechanism of injury with all particles.", {"entities": []}], ["Smoking one cigarette exposes the human respiratory tract to between 15,000 and 40,000 \u03bcg particulate matter; this is a carbonaceous product of an incomplete combustion.", {"entities": []}], ["There are numerous human exposures to other particles, and these vary widely in composition, absolute magnitude, and size of the particle.", {"entities": []}], ["Individuals exposed to all these particles share a common clinical presentation with a loss of pulmonary function, increased bronchial hyperresponsiveness, pathologic changes of emphysema and fibrosis, and comorbidities, including cardiovascular disease, cerebrovascular disease, peripheral vascular disease, and cancers.", {"entities": [[255, 278, "DISEASE"], [291, 307, "DISEASE"], [280, 307, "DISEASE"]]}], ["Mechanistically, all particle exposures produce an oxidative stress, which is associated with a series of reactions, including an activation of kinase cascades and transcription factors, release of inflammatory mediators, and apoptosis.", {"entities": []}], ["If disease associated with cigarette smoking is recognized to be particle related, then certain aspects of the clinical presentation can be predicted; this would include worsening of pulmonary function and progression of pathological changes and comorbidity (eg, emphysema and carcinogenesis) after smoking cessation since the particle is retained in the lung and the exposure continues.", {"entities": []}], ["The aim of this study was to identify the challenges faced by primary care physicians (PCPs) when prescribing medications for patients with chronic diseases in a teaching hospital in Malaysia.", {"entities": []}], ["3 focus group discussions were conducted between July and August 2012 in a teaching primary care clinic in Malaysia.", {"entities": []}], ["A topic guide was used to facilitate the discussions which were audio-recorded, transcribed verbatim and analysed using a thematic approach.", {"entities": []}], ["PCPs affiliated to the primary care clinic were purposively sampled to include a range of clinical experience.", {"entities": []}], ["Sample size was determined by thematic saturation of the data.", {"entities": []}], ["14 family medicine trainees and 5 service medical officers participated in this study.", {"entities": []}], ["PCPs faced difficulties in prescribing for patients with chronic diseases due to a lack of communication among different healthcare providers.", {"entities": []}], ["Medication changes made by hospital specialists, for example, were often not communicated to the PCPs leading to drug duplications and interactions.", {"entities": []}], ["The use of paper-based medical records and electronic prescribing created a dual record system for patients\u2019 medications and became a problem when the 2 records did not tally.", {"entities": []}], ["Patients sometimes visited different doctors and pharmacies for their medications and this resulted in the lack of continuity of care.", {"entities": []}], ["PCPs also faced difficulties in addressing patients\u2019 concerns, and dealing with patients\u2019 medication requests and adherence issues.", {"entities": []}], ["Some PCPs lacked time and knowledge to advise patients about their medications and faced difficulties in managing side effects caused by the patients\u2019 complex medication regimen.", {"entities": []}], ["PCPs faced prescribing challenges related to patients, their own practice and the local health system when prescribing for patients with chronic diseases.", {"entities": []}], ["These challenges must be addressed in order to improve chronic disease management in primary care and, more importantly, patient safety.", {"entities": []}], ["We examined factors associated with high-grade squamous intraepithelial lesions (HSIL) and cervical cancer among human papillomavirus (HPV)-infected women in a prevalent case\u2013control study conducted within a population-based cohort of 10\u2008077 women in Costa Rica.", {"entities": [[100, 106, "DISEASE"], [91, 106, "DISEASE"]]}], ["We compared 146 women with HPV-positive HSIL or cancer (HSIL/CA) against 843 HPV-positive women without evidence of HSIL/CA.", {"entities": [[48, 54, "DISEASE"]]}], ["Subjects completed a risk factor questionnaire.", {"entities": []}], ["We evaluated the associations between exposures and HSIL/CA among women positive for any HPV and restricted to those positive for high-risk HPV types.", {"entities": []}], ["Risk of HSIL/CA increased with increasing number of live births ( P trend = 0.04).", {"entities": []}], ["Women who smoked 6+ cigarettes/day had a RR for HSIL/CA of 2.7 (95% CI = 1.1\u20136.7) compared to non-smokers.", {"entities": []}], ["Current use of barrier contraceptives was associated with a reduction in risk of HSIL/CA (RR = 0.39; 95% CI = 0.16\u20130.96).", {"entities": []}], ["Sexual behaviour and a self-reported history of sexually transmitted diseases (STDs) other than HPV were not associated with HSIL/CA.", {"entities": []}], ["Oral contraceptive use was associated with HSIL/CA among women with <3 pregnancies.", {"entities": []}], ["Effects were similar in analysis restricted to women positive for high-risk HPV types.", {"entities": []}], ["Among women positive for high-risk HPV types, 44% of HSIL/CA could be attributed to multiparity (\u22653 pregnancies) and/or smoking.", {"entities": []}], ["Among HPV-positive women, multiparity and smoking are risk factors for HSIL/CA.", {"entities": []}], ["Oral contraceptive use may be associated with HSIL/CA in subgroups of women.", {"entities": []}], ["\u00a9 2001 Cancer Research Campaign http://www.bjcancer.com", {"entities": [[7, 13, "DISEASE"]]}], ["Little is known about how combinations of chronic conditions in adults affect total health care expenditures.", {"entities": []}], ["Our objective was to estimate the annual average total expenditures and out-of-pocket spending burden among US adults by combinations of conditions.", {"entities": []}], ["We conducted a cross-sectional study using 2009 and 2011 data from the Medical Expenditure Panel Survey.", {"entities": []}], ["The sample consisted of 9,296 adults aged 21 years or older with at least 2 of the following 4 highly prevalent chronic conditions: arthritis, diabetes mellitus, heart disease, and hypertension.", {"entities": [[181, 193, "DISEASE"], [162, 175, "DISEASE"], [132, 141, "DISEASE"], [143, 160, "DISEASE"]]}], ["Unadjusted and adjusted regression techniques were used to examine the association between chronic condition combinations and log-transformed total expenditures.", {"entities": []}], ["Logistic regressions were used to analyze the relationship between chronic condition combinations and high out-of-pocket spending burden.", {"entities": []}], ["Among adults with chronic conditions, adults with all 4 conditions had the highest average total expenditures ($20,016), whereas adults with diabetes/hypertension had the lowest annual total expenditures ($7,116).", {"entities": [[150, 162, "DISEASE"]]}], ["In adjusted models, adults with diabetes/hypertension and hypertension/arthritis had lower health care expenditures than adults with diabetes/heart disease ( P < .001).", {"entities": [[41, 53, "DISEASE"], [58, 70, "DISEASE"], [142, 155, "DISEASE"], [71, 80, "DISEASE"]]}], ["In adjusted models, adults with all 4 conditions had higher expenditures compared with those with diabetes and heart disease.", {"entities": [[111, 124, "DISEASE"]]}], ["However, the difference was only marginally significant ( P = .04).", {"entities": []}], ["Among adults with arthritis, diabetes, heart disease, and hypertension, total health care expenditures differed by type of chronic condition combinations.", {"entities": [[58, 70, "DISEASE"], [39, 52, "DISEASE"], [18, 27, "DISEASE"]]}], ["For individuals with multiple chronic conditions, such as heart disease and diabetes, new models of care management are needed to reduce the cost burden on the payers.", {"entities": [[58, 71, "DISEASE"]]}], ["Haemophilus influenzae is commonly isolated from the airways of COPD patients.", {"entities": []}], ["Antibiotic treatment may cause the emergence of resistant H. influenzae strains, particularly ampicillin-resistant strains, including \u03b2-lactamase-negative ampicillin resistance (BLNAR) strains.", {"entities": []}], ["Genetic identification using ftsI sequencing is the optimum method for identifying mutations within BLNAR strains.", {"entities": []}], ["The prevalence of BLNAR in COPD patients during the stable state has not been reported.", {"entities": []}], ["We investigated the antibiotic resistance patterns of H. influenzae present in the sputum of stable COPD patients, focusing on ampicillin resistance; the prevalence of enzyme and non-enzyme-mediated ampicillin resistance was determined.", {"entities": []}], ["A subset of patients was followed up longitudinally to study H. influenzae strain switching and antibiotic sensitivity changes.", {"entities": []}], ["Sputum sampling was performed in 61 COPD patients, with 42 samples obtained at baseline; H. influenzae was detected by polymerase chain reaction in 28 samples.", {"entities": []}], ["In all, 45 patients completed the follow-up for 2 years; 24 H. influenzae isolates were obtained.", {"entities": []}], ["Disk diffusion showed the highest antibiotic resistance in the penicillin antibiotic group (eg, 67% for ampicillin) and macrolides (eg, 46% for erythromycin), whereas all isolates were susceptible to quinolones.", {"entities": []}], ["Of the 16 isolates resistant to ampicillin, 9 (56%) were \u03b2-lactamase positive.", {"entities": []}], ["The \u03b2-lactamase-negative isolates were further investigated; none of these fulfilled the phenotypic BLNAR classification criteria of ampicillin minimum inhibitory concentration >1 \u00b5g/mL, and only one demonstrated an ftsI mutation.", {"entities": []}], ["Frequent H. influenzae strain switching was confirmed using multilocus sequence typing and was associated with changes in the antibiotic sensitivity pattern.", {"entities": []}], ["We observed an overidentification of ampicillin resistance by disk diffusion.", {"entities": []}], ["The majority of ampicillin resistance was due to enzyme production.", {"entities": []}], ["H. influenzae strain changes during the stable state may be associated with a change in antibiotic sensitivity; this has implications for empirical antibiotic prescribing.", {"entities": []}], ["We aimed to study the impact by running 5 km, at maximal speed, on the normal variations of metabolic variables related to glucose, insulin, insulin sensitivity, cortisol, glucagon, Troponin T and metabolic rate.", {"entities": []}], ["Five women and 12 men 25.7\u00b15.2 years of age with a body-mass-index of 22.5\u00b12.3 kg/m Insulin and cortisol levels were higher, and insulin sensitivity was lower, on the race-day compared with the day of rest (linear mixed model: p<0.0001 for all three analyses).", {"entities": []}], ["However, glucose levels and metabolic rate did not differ between the two trial days (p = 0.29 and p = 0.53, respectively).", {"entities": []}], ["When analyzing specific time-points we found that glucose increased from 5.01\u00b10.37 mmol/l to 6.36 \u00b1 1.3 mmol/l, p<0.0001, by running, while serum insulin concomitantly increased from 42\u00b121 to 90\u00b154 pmol/l, p<0.0001.", {"entities": []}], ["In accordance, the QUICKI index of serum sensitivity, 1/(log 10 insulin+log 10 glucose), was lowered post-race, p<0.0001.", {"entities": []}], ["Serum cortisol levels increased from 408\u00b1137 nmol/l to 644\u00b1171 nmol/l, p<0.0001, post-race while serum glucagon levels were unaffected.", {"entities": []}], ["Troponin T was detectable in serum post-race in 12 out of the 17 participants and reached or surpassed the clinical reference level of 15 ng/l in three subjects.", {"entities": []}], ["Post-race electrocardiograms displayed no pathologies.", {"entities": []}], ["Relatively short running-races can apparently induce a reduction in insulin sensitivity that is not fully compensated by concomitantly increased insulin secretion intended to ensure euglycemia.", {"entities": []}], ["Since also Troponin T was detected in plasma in a majority of the participants, our data suggest that it is possible to induce considerable metabolic stress by running merely 5 km, when striving for maximal speed.", {"entities": []}], ["This article reviews the role of the French schools in the development of psychiatric nosology.", {"entities": []}], ["Boissier de Sauvages published the first French treatise on medical nosology in 1763.", {"entities": []}], ["Until the 1880s, French schools held a pre-eminent position in the development of psychiatric concepts.", {"entities": []}], ["From the 1880s until World War I, German-speaking schools exerted the most influence, featuring the work of major figures such as Emil Kraepelin and Eugen Bleuler.", {"entities": []}], ["French schools were probably hampered by excessive administrative and cultural centralization.", {"entities": []}], ["Between the 1880s and the 1930s, French schools developed diagnostic categories that set them apart from international classifications.", {"entities": []}], ["The main examples are Bouff\u00e9e D\u00e9lirante, and the complex set of chronic delusional psychoses (CDPs), including chronic hallucinatory psychosis.", {"entities": []}], ["CDPs were distinguished from schizophrenia by the lack of cognitive deterioration during evolution.", {"entities": [[29, 42, "DISEASE"]]}], ["Modern French psychiatry is now coming into line with international classification, such as DSM-5 and the upcoming ICD-11 .", {"entities": []}], ["Although well established, the association between socioeconomic position and health and health behaviour is not clearly understood, and it has been speculated that familial factors, for example, dispositional factors or exposures in the rearing environment, may be underlying the association.", {"entities": []}], ["The objective was to compare prescription fillings within twin pairs who are partly or fully genetically identical and share childhood exposures.", {"entities": []}], ["Twin cohort study.", {"entities": []}], ["Data from the Danish Twin Registry were linked to registers in Statistics Denmark and the Danish Registry of Medicinal Product statistics.", {"entities": []}], ["A total of 8582 monozygotic (MZ) and 15\u2005788 dizygotic same sex (DZSS) twins were included.", {"entities": []}], ["Number of prescription fillings during follow-up (1995\u20132005) was analysed according to education and income.", {"entities": []}], ["Results of unpaired and intrapair analyses were compared.", {"entities": []}], ["An inverse social gradient in filling of prescriptions for all-purpose and system-specific drugs was observed in the unpaired analyses.", {"entities": []}], ["In the intrapair analyses, associations were attenuated some in DZSS and more in MZ twins.", {"entities": []}], ["Filling of drugs targeting the nervous system was still strongly associated with income in the intrapair analyses.", {"entities": []}], ["Familial factors seem to account for part of the observed social inequality in filling of prescription medicine.", {"entities": []}], ["To explore the association between maternal disability as measured by the presence of a limiting longstanding illness (LLI) 9\u2005months postpartum and subsequent child health at the age of 7\u2005years.", {"entities": []}], ["Nationally representative prospective longitudinal study.", {"entities": []}], ["England, Scotland, Wales and Northern Ireland.", {"entities": []}], ["Secondary analysis of data on 11\u2005807 mother\u2013child pairs recruited to the UK Millennium Cohort Study.", {"entities": []}], ["Baseline interviews with mothers were carried out in 2001\u20132002.", {"entities": []}], ["When the children were 7\u2005years old, the follow-up survey included questions about limiting longstanding health conditions in the child.", {"entities": []}], ["Any longstanding condition that was reported to limit the children's activities in any way.", {"entities": []}], ["Nearly 7% of all children were reported to have an LLI at the age of 7\u2005years.", {"entities": []}], ["The majority (88.1%, 95% CI 85.6% to 90.2%) of children whose mother was disabled did not have an LLI themselves.", {"entities": []}], ["The children of disabled mothers, however, had higher odds of LLI (OR=1.9, 95% CI 1.5 to 2.5) independently of different maternal, pregnancy and birth characteristics and breast feeding duration.", {"entities": []}], ["Inclusion of poverty measures in the model did not significantly affect the odds (OR=1.8, 95% CI 1.4 to 2.4), suggesting that maternal LLI around the time of birth increases the odds of child LLI at the age of 7\u2005years independently of starting life in poverty.", {"entities": []}], ["There is a strong positive association between maternal and child LLI.", {"entities": []}], ["Health professionals should work together with social care and other relevant service providers to identify the individual needs of disabled parents and provide adequate support throughout the pregnancy and after the child is born.", {"entities": []}], ["Further research is important to clarify the exact nature of the associations for different types of maternal and child disability.", {"entities": []}], ["Ventilator-associated pneumonia (VAP) is a nosocomial infection occurring in the intensive care unit (ICU).", {"entities": [[22, 31, "DISEASE"]]}], ["The diagnostic standard is based on clinical criteria and bronchoalveolar lavage (BAL).", {"entities": []}], ["Exhaled breath analysis is a promising non-invasive method for rapid diagnosis of diseases and contains volatile organic compounds (VOCs) that can differentiate diseased from healthy individuals.", {"entities": []}], ["The aim of this study was to determine whether analysis of VOCs in exhaled breath can be used as a non-invasive monitoring tool for VAP.", {"entities": []}], ["One hundred critically ill patients with clinical suspicion of VAP underwent BAL.", {"entities": []}], ["Before BAL, exhaled air samples were collected and analysed by gas chromatography time-of-flight mass spectrometry (GC- tof- MS).", {"entities": []}], ["The clinical suspicion of VAP was confirmed by BAL diagnostic criteria in 32 patients [VAP(+)] and rejected in 68 patients [VAP(\u2212)].", {"entities": []}], ["Multivariate statistical comparison of VOC profiles between VAP(+) and VAP(\u2212) revealed a subset of 12 VOCs that correctly discriminated between those two patient groups with a sensitivity and specificity of 75.8% \u00b1 13.5% and 73.0% \u00b1 11.8%, respectively.", {"entities": []}], ["These results suggest that detection of VAP in ICU patients is possible by examining exhaled breath, enabling a simple, safe and non-invasive approach that could diminish diagnostic burden of VAP.", {"entities": []}], ["Stanton Glantz and colleagues analyzed previously secret tobacco industry documents and peer-reviewed published results of Philip Morris' Project MIX about research on cigarette additives, and show that this research on the use of cigarette additives cannot be taken at face value.", {"entities": []}], ["In 2009, the promulgation of US Food and Drug Administration (FDA) tobacco regulation focused attention on cigarette flavor additives.", {"entities": []}], ["The tobacco industry had prepared for this eventuality by initiating a research program focusing on additive toxicity.", {"entities": []}], ["The objective of this study was to analyze Philip Morris' Project MIX as a case study of tobacco industry scientific research being positioned strategically to prevent anticipated tobacco control regulations.", {"entities": []}], ["We analyzed previously secret tobacco industry documents to identify internal strategies for research on cigarette additives and reanalyzed tobacco industry peer-reviewed published results of this research.", {"entities": []}], ["We focused on the key group of studies conducted by Phillip Morris in a coordinated effort known as \u201cProject MIX.\u201d Documents showed that Project MIX subsumed the study of various combinations of 333 cigarette additives.", {"entities": []}], ["In addition to multiple internal reports, this work also led to four peer-reviewed publications (published in 2001).", {"entities": []}], ["These papers concluded that there was no evidence of substantial toxicity attributable to the cigarette additives studied.", {"entities": []}], ["Internal documents revealed post hoc changes in analytical protocols after initial statistical findings indicated an additive-associated increase in cigarette toxicity as well as increased total particulate matter (TPM) concentrations in additive-modified cigarette smoke.", {"entities": []}], ["By expressing the data adjusted by TPM concentration, the published papers obscured this underlying toxicity and particulate increase.", {"entities": []}], ["The animal toxicology results were based on a small number of rats in each experiment, raising the possibility that the failure to detect statistically significant changes in the end points was due to underpowering the experiments rather than lack of a real effect.", {"entities": []}], ["The case study of Project MIX shows tobacco industry scientific research on the use of cigarette additives cannot be taken at face value.", {"entities": []}], ["The results demonstrate that toxins in cigarette smoke increase substantially when additives are put in cigarettes, including the level of TPM.", {"entities": []}], ["In particular, regulatory authorities, including the FDA and similar agencies elsewhere, could use the Project MIX data to eliminate the use of these 333 additives (including menthol) from cigarettes.", {"entities": []}], ["Please see later in the article for the Editors' Summary The tobacco industry in the United States has recognized that regulation of its products was inevitable as early as 1963 and devoted increasing attention to the likelihood of regulation by the US Food and Drug Administration in the mid-1990s, which finally became law in 2009.", {"entities": []}], ["In addition, the World Health Organization (WHO) Framework Convention on Tobacco Control (WHO FCTC), which came into force in June 2003, includes provisions addressing the regulation of the contents of tobacco products and the regulation of tobacco product disclosures.", {"entities": []}], ["Although these steps represent progress in tobacco control, the events of the past few decades show the determination of the tobacco industry to avoid regulation, including the regulation of additives.", {"entities": []}], ["In the United States, executives of the tobacco company Philip Morris (PM) recognized the inevitability of regulation and responded by initiating efforts to shape legislation and regulation by reorganizing its internal scientific activities and conducting scientific research that could be used to shape any proposed regulations.", {"entities": []}], ["For example, the company conducted \u201cProject MIX,\u201d a study of chemical constituents in and toxicity of smoke produced by burning cigarettes containing three different combinations of 333 cigarette additives that \u201cwere constructed to resemble typical commercial blended cigarettes.\u201d The resulting four papers published in Food and Chemical Toxicology in January 2002 concluded that there was no evidence of substantial toxicity attributable to the cigarette additives studied.", {"entities": []}], ["The use of cigarette additives is an important concern of the WHO, FDA, and similar national regulatory bodies around the world.", {"entities": []}], ["Philip Morris has used the published Project MIX papers to assert the safety of individual additives and other cigarette companies have done similar studies that reached similar conclusions.", {"entities": []}], ["In this study, the researchers used documents made public as a result of litigation against the tobacco industry to investigate the origins and design of Project MIX and to conduct their own analyses of the results to assess the reliability of the conclusions in the papers published in Food and Chemical Toxicology .", {"entities": []}], ["The researchers systematically examined tobacco industry documents in the University of California San Francisco Legacy Tobacco Documents Library (then about 60 million pages made publicly available as a result of litigation) and used an iterative process of searching, analyzing, and refining to identify and review in detail 500 relevant documents.", {"entities": []}], ["The researchers found that in the original Project MIX analysis, the published papers obscured findings of toxicity by adjusting the data by total particulate matter (TPM) concentration.", {"entities": []}], ["When the researchers conducted their own analysis by studying additives per cigarette (as was specified in the original Project MIX protocol), they found that 15 carcinogenic chemicals increased by 20%.", {"entities": []}], ["The researchers also reported that, for unexplained reasons, Philip Morris deemphasized 19 of the 51 chemicals tested in the presentation of results, including nine that were substantially increased in smoke on a per cigarette basis of additive-added cigarettes, compared to smoke of control cigarettes.", {"entities": []}], ["The researchers explored the possibility that the failure of Project MIX to detect statistically significant changes in the toxicity of the smoke from cigarettes containing the additives was due to underpowered experiments rather than lack of a real effect by conducting their own statistical analysis.", {"entities": []}], ["This analysis suggests that a better powered study would have detected a much broader range of biological effects associated with the additives than was identified in Philip Morris' published paper, suggesting that it substantially underestimated the toxic potential of cigarette smoke and additives.", {"entities": []}], ["The researchers also found that Food and Chemical Toxicology , the journal in which the four Project MIX papers were published, had an editor and 11 of its International Editorial Board with documented links to the tobacco industry.", {"entities": []}], ["The scientist and leader of Project MIX Edward Carmines described the process of publication as \u201can inside job.\u201d These findings show that the tobacco industry scientific research on the use of cigarette additives cannot be taken at face value: the results demonstrate that toxins in cigarette smoke increase substantially when additives are put in cigarettes.", {"entities": []}], ["In addition, better powered studies would probably have detected a much broader range of adverse biological effects associated with the additives than identified to those identified in PM's published papers suggesting that the published papers substantially underestimate the toxic potential combination of cigarette smoke and additives.", {"entities": []}], ["Regulatory authorities, including the FDA and similar agencies elsewhere who are implementing WHO FCTC, should conduct their own independent analysis of Project MIX data, which, analyzed correctly, could provide a strong evidence base for the elimination of the use of the studied additives (including menthol) in cigarettes on public health grounds.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001145 .", {"entities": []}], ["For PLoS Medicin e's own policy on publishing papers sponsored by the tobacco industry see http://www.plosmedicine.org/static/policies.action#funders The World Health Organization (WHO) provides information on the Framework Convention on Tobacco Control (FCTC) The documents that the researchers reviewed in this paper can be found at the Legacy Tobacco Documents Library", {"entities": []}], ["This study aimed to investigate the effects of weekly singings classes on pulmonary function parameters and quality of life (QoL) of COPD patients.", {"entities": []}], ["Forty-three patients were randomized to weekly classes of singing practice, or handcraft work.", {"entities": []}], ["They performed spirometry and completed maximal respiratory pressure measurements, evaluations of dyspnea, and the Saint George\u2019s Respiratory Questionnaire, before and after 24 training classes.", {"entities": []}], ["A functional evaluation, immediately after 10 minutes of singing practice, was also performed at the end of the study.", {"entities": []}], ["Fifteen subjects completed the study in each group.", {"entities": []}], ["In comparison to controls the singing group exhibited transitory elevations on the dyspnea Borg scale (p = 0.02), and inspiratory capacity (p = 0.01), and decreases of expiratory reserve volume (p = 0.03), just after a short session of singing.", {"entities": []}], ["There was a significant difference on changes of maximal expiratory pressures in the comparison between groups at the end of training.", {"entities": []}], ["While the control group showed deterioration of maximal expiratory pressure, the singing group exhibited a small improvement (p = 0.05).", {"entities": []}], ["Both groups showed significant improvements of QoL in within group comparisons.", {"entities": []}], ["We have concluded that singing classes are a well tolerated activity for selected subjects with COPD.", {"entities": []}], ["Regular practice of singing may improve QoL, and preserve the maximal expiratory pressure of these patients.", {"entities": []}], ["Increasing demand for hospital services by older people is a major concern for Australian health care providers.", {"entities": []}], ["To date there has been little in-depth research that encompasses contextual and systems factors contributing to hospital admissions.", {"entities": []}], ["The objective of this study was to determine the reasons why older patients experienced unplanned hospital admissions to a major public hospital.", {"entities": []}], ["A retrospective qualitative study using a Root Cause Analysis (RCA) methodology was conducted in a major public hospital in Adelaide, South Australia and surrounding community.", {"entities": []}], ["Community dwelling older people admitted to the hospital who were well enough to give informed consent and be interviewed were invited to take part in the study.", {"entities": []}], ["With patients consent, family members, general practitioners (GPs) and specialists were also interviewed and patient hospital records reviewed.", {"entities": []}], ["Using a purposive sampling technique to obtain maximum variability, thirty-six older people (aged 70\u00a0years and older) participated in the study.", {"entities": []}], ["GPs ( n \u2009=\u200917), family members ( n \u2009=\u200914), and other healthcare providers ( n \u2009=\u200912) involved in their care were also interviewed.", {"entities": []}], ["Cases were then analysed according to a standardized protocol to determine the root cause of admission.", {"entities": []}], ["Root causes were then assigned to broader categories using thematic analysis.", {"entities": []}], ["The root causes of unplanned admissions were identified and categorised into six causal groups: a consequence of minimal care, progression of disease, home care accessibility, high complexity, clinical error, and delayed care-seeking by the patient.", {"entities": []}], ["RCA can be effectively applied to determine the causes of unplanned hospital admissions although the process is time consuming.", {"entities": []}], ["Four categories of admission (minimal care, clinical error, home care access, delayed care-seeking) were deemed potentially preventable.", {"entities": []}], ["This methodology and classification approach may assist in designing interventions to prevent future hospitalisations in this high-risk population.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-1170-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To obtain utility estimates suitable for use in economic models for chronic spontaneous (idiopathic) urticaria (CSU).", {"entities": [[101, 110, "DISEASE"]]}], ["Patient-level data from three randomized clinical trials\u2014ASTERIA\u00a0I, ASTERIA\u00a0II and GLACIAL\u2014were analysed.", {"entities": []}], ["Health states were derived from the Urticaria Activity Score over 7\u00a0days (UAS7); higher scores denote greater activity.", {"entities": [[36, 45, "DISEASE"]]}], ["The health state score ranges were urticaria free: 0; well-controlled urticaria: 1\u20136; mild urticaria: 7\u201315; moderate urticaria: 16\u201327; and severe urticaria: 28\u201342.", {"entities": [[35, 44, "DISEASE"], [70, 79, "DISEASE"], [91, 100, "DISEASE"], [117, 126, "DISEASE"], [146, 155, "DISEASE"]]}], ["The mean EQ-5D utilities were calculated for each health state.", {"entities": []}], ["A mixed model was used to predict the EQ-5D according to UAS7 health states in a pooled data set containing all treatment arms and time points from the three trials.", {"entities": []}], ["Pooled trial data were validated through visual comparisons and interaction terms.", {"entities": []}], ["Fixed and random effects for trials and patients were included, along with the following covariates: UAS7 health state at baseline (moderate or severe); presence of angioedema at baseline and during follow-up; duration of CSU; number of previous CSU medications; visit; current treatment; and patient age and sex.", {"entities": [[165, 175, "DISEASE"]]}], ["There was a consistent improvement in EQ-5D utilities as urticaria activity decreased.", {"entities": [[57, 66, "DISEASE"]]}], ["The mean utilities ranged from 0.710 (severe urticaria) to 0.780 (moderate urticaria), 0.829 (mild urticaria), 0.862 (well-controlled urticaria) and 0.894 (urticaria free).", {"entities": [[45, 54, "DISEASE"], [75, 84, "DISEASE"], [99, 108, "DISEASE"], [134, 143, "DISEASE"], [156, 165, "DISEASE"]]}], ["Sensitivity and subgroup analyses confirmed the robustness of the results.", {"entities": []}], ["The results suggest that EQ-5D utility scores increase with decreasing urticaria activity.", {"entities": [[71, 80, "DISEASE"]]}], ["EQ-5D utility scores enable the health-related quality of life of CSU patients to be compared with that of patients with other diseases.", {"entities": []}], ["The online version of this article (doi:10.1007/s40273-015-0375-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Multimorbidity is now acknowledged as a research priority in primary care.", {"entities": []}], ["The identification of risk factors and people most at risk is an important step in guiding prevention and intervention strategies.", {"entities": []}], ["The aim of this study was to examine the relationship between literacy and multimorbidity while controlling for potential confounders.", {"entities": []}], ["Participants were adult patients attending the family medicine clinic of a regional health centre in Saguenay (Quebec), Canada.", {"entities": []}], ["Literacy was measured with the Newest Vital Sign (NVS).", {"entities": []}], ["Multimorbidity was measured with the Disease Burden Morbidity Assessment (DBMA) by self-report.", {"entities": []}], ["Information on potential confounders (age, sex, education and family income) was also collected.", {"entities": []}], ["The association between literacy (independent variable) and multimorbidity was examined in bivariate and multivariate analyses.", {"entities": []}], ["Two operational definitions of multimorbidity were used successively as the dependent variable; confounding variables were introduced into the model as potential predictors.", {"entities": []}], ["One hundred three patients (36 men) 19\u201383 years old were recruited; 41.8% had completed 12 years of school or less.", {"entities": []}], ["Forty-seven percent of patients provided fewer than four correct answers on the NVS (possible low literacy) whereas 53% had four correct responses or more.", {"entities": []}], ["Literacy and multimorbidity were associated in bivariate analyses (p\u2009<\u20090.01) but not in multivariate analyses, including age and family income.", {"entities": []}], ["This study suggests that there is no relationship between literacy and multimorbidity when controlling for age and family income.", {"entities": []}], ["Schistosomiasis is a serious health problem especially in developing countries and affects more than 243 million people.", {"entities": [[0, 15, "DISEASE"]]}], ["Only few anthelmintic drugs are available up to now.", {"entities": []}], ["A major obstacle for drug treatment is the different developmental stages and the varying host compartments during worm development.", {"entities": []}], ["Anthelmintic drugs have been tested mainly on adult schistosomes or freshly transformed cercariae.", {"entities": []}], ["Knowledge concerning the larval stages is lacking.", {"entities": []}], ["In this study, we used in vitro -grown schistosomula (aged between 2 to 14 days) to investigate drug effects of the three anthelmintics praziquantel, artemether, and oxamniquine.", {"entities": []}], ["Further, we analyzed the antibody accessibility of two exemplary schistosome antigens SmCD59a and SmKK7, before and after drug treatment.", {"entities": []}], ["Our results demonstrated that praziquantel applied at a concentration of 1 \u03bcM inhibited development of all life stages.", {"entities": []}], ["Application of 10 \u03bcM praziquantel led to dramatic morphological changes of all schistosomula.", {"entities": []}], ["Artemether at 1 and 10 \u03bcM had differential effects depending on whether it was applied to 2-day as compared to 7- and 14-day schistosomula.", {"entities": []}], ["While 2-day schistosomula were not killed but inhibited from further development, severe morphological damage was seen in 7- and 14-day schistosomula.", {"entities": []}], ["Oxamniquine (1 and 10 \u03bcM) led to severe morphological impairment in all life stages.", {"entities": []}], ["Analyzing the accessibility of the antigens SmCD59a and SmKK7 before drug treatment showed no antibody binding on living intact schistosomula.", {"entities": []}], ["However, when schistosomula were treated with anthelmintics, both antigens became exposed on the larvae.", {"entities": []}], ["Oxamniquine turned out to be most effective in promoting antibody binding to all schistosomula stages.", {"entities": []}], ["This study has revealed marked differences in anthelmintic drug effects against larvae.", {"entities": []}], ["Drug treatment increases surface antigen presentation and renders larvae accessible to antibody attack.", {"entities": []}], ["Schistosomiasis is one of the major parasitic diseases in developing countries and still causes 200,000 deaths per year.", {"entities": [[0, 15, "DISEASE"]]}], ["Mass drug administration programs with praziquantel, the drug of choice against schistosomiasis, are currently undertaken in Sub-Saharan Africa.", {"entities": [[80, 95, "DISEASE"]]}], ["Praziquantel, although efficient against adult worms, fails to cure early infection.", {"entities": []}], ["The complex developmental stages of schistosomes and migration through varying host compartments with different local drug concentration are a challenge for drug treatment.", {"entities": []}], ["After infecting their mammalian host, schistosomula traverse through skin and the vasculature of lung, liver and intestines.", {"entities": []}], ["During their migration, they develop from larvae to paired adults in approximately 4 to 5 weeks.", {"entities": []}], ["So far, drug effects have been analyzed on adult worms or freshly transformed schistosomula only.", {"entities": []}], ["Information about the effects on the larval stages is lacking.", {"entities": []}], ["We were able to transfer the larval development of the first three weeks into the culture dish.", {"entities": []}], ["This tool can be used for the analysis of drug effects against schistosomula and for investigation of the accessibility, expression and localization of antigens.", {"entities": []}], ["Rendering the parasite\u2019s larvae vulnerable to the host\u2019s immune system by increasing antigen presentation is an important aspect of drug activity.", {"entities": []}], ["We demonstrate on in vitro -cultured Schistosoma mansoni larvae, that SmCD59a and SmKK7, as examples for hidden antigens, become accessible to antibodies following drug treatment.", {"entities": []}], ["The ability to measure 25-hydroxyvitamin D (25OHD) levels from blood spot cards can simplify sample collection versus samples obtained by venipuncture, particularly in populations in whom it is difficult to draw blood.", {"entities": []}], ["We sought to validate the use of blood spot samples for the measurement of 25OHD compared to serum or whole blood samples and correlate the measured levels with intake estimated from dietary recall.", {"entities": []}], ["Utilizing 109 biological mothers of infants enrolled in the Tennessee Children's Respiratory Initiative cohort, we measured 25OHD levels through highly selective liquid chromatography\u2013tandem mass spectrometry on samples from blood spot cards, serum, and whole blood collected at enrollment.", {"entities": []}], ["Dietary questionnaires (n\u200a=\u200a65) were used to assess 25OHD intake by dietary recall.", {"entities": []}], ["Sample collection measures were assessed for agreement and 25OHD levels for association with dietary 25OHD intake.", {"entities": []}], ["The mean absolute differences (95%CI) in 25OHD levels measured between whole blood and blood spot (n\u200a=\u200a50 pairs) or serum and blood spot (n\u200a=\u200a20) were 3.2 (95%CI:1.6, 4.8) ng/ml and 1.5 (95%CI:\u22120.5,3.4) ng/mL.", {"entities": []}], ["Intake by dietary recall was marginally associated with 25OHD levels after adjustment for current smoking and race in linear regression.", {"entities": []}], ["25OHD levels determined by mass spectrometry from blood spot cards, serum and whole blood show relatively good agreement, although 25OHD levels are slightly lower when measured by blood spot cards.", {"entities": []}], ["Blood spot samples are a less invasive means of obtaining 25OHD measurements, particularly in large population-based samples, or among children when venipuncture may decrease study participation.", {"entities": []}], ["It has been suggested that maternal vitamin D status in pregnancy influences the risk of asthma and atopy in the offspring.", {"entities": [[89, 95, "DISEASE"]]}], ["The epidemiological evidence to support these claims is conflicting and may reflect chance findings and differences in how vitamin D was assessed.", {"entities": []}], ["To examine the association between blood total maternal 25-hydroxy vitamin D (25(OH)D) concentrations in pregnancy and offspring asthma, atopy and lung function in the largest birth cohort study to date.", {"entities": [[129, 135, "DISEASE"]]}], ["Participants were largely of white European origin and resident in the South West of England.", {"entities": []}], ["We examined the associations of maternal 25(OH)D concentrations in pregnancy with the following outcomes in the offspring: wheeze, asthma, atopy, eczema, hayfever, at mean age 7.5 years ( n = 3652\u20134696 depending on outcome), IgE at 7 years ( n = 2915) and lung function and bronchial responsiveness at mean age 8.7 years ( n = 3728\u20133784).", {"entities": [[131, 137, "DISEASE"]]}], ["Sixty-eight per cent of mothers had sufficient (> 50 nmol/L) concentrations of 25(OH)D, 27% were insufficient (27.5\u201349.99 nmol/L) and 5% were deficient (< 27.5 nmol/L).", {"entities": []}], ["There was no evidence to suggest that maternal 25(OH)D concentration in pregnancy was associated with any respiratory or atopic outcome in the offspring.", {"entities": []}], ["These findings remained after adjustment for season of measurement and for potential confounders.", {"entities": []}], ["There was also no evidence that these relationships followed a non-linear form and no evidence that either deficient or high concentrations of maternal 25(OH)D were associated with atopic or respiratory outcomes.", {"entities": []}], ["We found no evidence that maternal blood 25(OH)D concentration in pregnancy is associated with childhood atopic or respiratory outcomes.", {"entities": []}], ["Eosinophilic esophagitis (EoE) is an allergic disorder characterized by eosinophil-predominant esophageal inflammation, which can be ameliorated by food antigen restriction.", {"entities": [[13, 24, "DISEASE"]]}], ["Though recent studies suggest that changes in dietary composition may alter the distal gut microbiome, little is currently known about the impact of a restricted diet upon microbial communities of the oral and esophageal microenvironments in the context of EoE.", {"entities": []}], ["We hypothesize that the oral and esophageal microbiomes of EoE patients are distinct from non-EoE controls, that these differences correspond to changes in esophageal inflammation, and that targeted therapeutic dietary intervention may influence community structure.", {"entities": []}], ["Using 16S rRNA gene sequencing, we characterized the bacterial composition of the oral and esophageal microenvironments using oral swabs and esophageal biopsies from 35 non-EoE pediatric controls and compared this cohort to samples from 33 pediatric EoE subjects studied in a longitudinal fashion before and after defined dietary changes.", {"entities": []}], ["Firmicutes were more abundant in esophageal samples compared to oral.", {"entities": []}], ["Proportions of bacterial communities were significantly different comparing all EoE esophageal microbiota to non-EoE controls, with enrichment of Proteobacteria, including Neisseria and Corynebacterium in the EoE cohort, and predominance of the Firmicutes in non-EoE control subjects.", {"entities": []}], ["We detected a statistically significant difference between actively inflamed EoE biopsies and non-EoE controls.", {"entities": []}], ["Overall, though targeted dietary intervention did not lead to significant differences in either oral or esophageal microbiota, reintroduction of highly allergenic foods led to enrichment in Ganulicatella and Campylobacter genera in the esophagus.", {"entities": []}], ["In conclusion, the esophageal microbiome in EoE is distinct from that of non-EoE controls, with maximal differences observed during active allergic inflammation.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-015-0085-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Bronchial epithelial cells represent the first line of defense against microorganisms and allergens in the airways and play an important role in chronic inflammatory processes such as asthma.", {"entities": [[184, 190, "DISEASE"]]}], ["In an experimental model, both RvD1 and AT-RvD1, lipid mediators of inflammation resolution, ameliorated some of the most important phenotypes of experimental asthma.", {"entities": [[159, 165, "DISEASE"]]}], ["Here, we extend these results and demonstrate the effect of AT-RvD1 on bronchial epithelial cells (BEAS-2B) stimulated with IL-4.", {"entities": []}], ["AT-RvD1 (100\u2009nM) decreased both CCL2 and CXCL-8 production, in part by decreasing STAT6 and NF- \u03ba B pathways.", {"entities": [[32, 36, "GENE"], [82, 87, "GENE"]]}], ["Furthermore, the effects of AT-RvD1 were ALX/FRP2 receptor dependent, as the antagonist of this receptor (BOC1) reversed the inhibition of these chemokines by AT-RvD1.", {"entities": []}], ["In addition, AT-RvD1 decreased SOCS1 and increased SOCS3 expression, which play important roles in Th1 and Th17 modulation, respectively.", {"entities": [[31, 36, "GENE"], [51, 56, "GENE"]]}], ["In conclusion, AT-RvD1 demonstrated significant effects on the IL-4-induced activation of bronchial epithelial cells and consequently the potential to modulate neutrophilic and eosinophilic airway inflammation in asthma.", {"entities": [[213, 219, "DISEASE"]]}], ["Taken together, these findings identify AT-RvD1 as a potential proresolving therapeutic agent for allergic responses in the airways.", {"entities": []}], ["To develop a self-administered short questionnaire to assess patient satisfaction with medical treatment for hand eczema (dermatitis) with good psychometric properties.", {"entities": [[122, 132, "DISEASE"]]}], ["The content of the questionnaire was determined on the basis of clinical consultation with groups of patients, from studying the existing instruments, and from discussions with a panel of seven experts.", {"entities": []}], ["A first draft version containing 38 items organised in six dimensions was tested on a pilot sample of patients to assess its legibility.", {"entities": []}], ["The extended version was then tested on a sample of 217 patients of both genders enrolled at 18 hospitals representative of the national distribution.", {"entities": []}], ["The questionnaire was supplied together with the Morisky-Green compliance questionnaire, the health-related quality of life (HRQL) SF-12 questionnaire, and a visual analogue scale (VAS) of perceived health status to assess concurrent validity.", {"entities": []}], ["The dimensionality was reduced by means of exploratory factor analysis, and reliability was evaluated on the basis of internal consistency and two halves reliability estimates.", {"entities": []}], ["Item discriminant capability and questionnaire discriminant validity with respect to known groups of patients (by gender, principal diagnosis, age, disease severity and treatment) were also assessed.", {"entities": []}], ["The reduction and validation sample was composed of 54% women and 46% men, of various educational levels with an average age of 43 years (SD = 13.7).", {"entities": []}], ["Of those who responded, 26% were diagnosed with hyperkeratotic dermatitis of the palms and 27% of the fingertips, and 47% with recurring palmar dyshidrotic eczema.", {"entities": [[63, 73, "DISEASE"]]}], ["The questionnaire was shortened to a version containing 17 items grouped in six dimensions: effectiveness, convenience, impact on HRQL, medical follow-up, side effects, and general opinion.", {"entities": []}], ["Cronbach's alpha coefficient reached a value of 0.9.", {"entities": []}], ["The dimensions showed different degrees of correlation, and the scores had a normal distribution with an average of 58.4 points (SD = 18.01).", {"entities": []}], ["Treatment satisfaction scores attained correlations between 0.003 and 0.222 with the HRQL measures, and showed higher correlations with the effectiveness (r = 0.41) and tolerability (0.22) measures, but very low correlation with compliance (r = 0.015).", {"entities": []}], ["Significant differences were observed between some diagnoses and treatments.", {"entities": []}], ["The shortened questionnaire proved to have good psychometric properties, providing excellent reliability, satisfactorily reproducing the proposed structure and supplying evidence of validity.", {"entities": []}], ["To identify motivational factors linked to child health status that affected the likelihood of parents\u2019 allowing their child to participate in pediatric research.", {"entities": []}], ["Parents were invited to return their completed questionnaires anonymously to assess motivational factors and factors that might improve participation in pediatric research.", {"entities": []}], ["Of 573 eligible parents, 261 returned the completed questionnaires.", {"entities": []}], ["Of these, 126 were parents of healthy children (group 1), whereas 135 were parents of sick children who were divided into two groups according to the severity of their pathology, i .", {"entities": []}], ["e ., 99 ambulatory children (group 2) and 36 nonambulatory children (group 3).", {"entities": []}], ["The main factor motivating participation in a pediatric clinical research study was \u201cdirect benefits for their child\u201d (87.7%, 100%, and 100% for groups 1, 2, and 3, respectively).", {"entities": []}], ["The other factors differed significantly between the three groups, depending on the child\u2019s health status (all p \u2009<\u20090.05).", {"entities": []}], ["Factors that might have a positive impact on parental consent to the participation of their child in a pediatric clinical research study differed significantly (\u03c7 p \u2264 0.04), depending on the child\u2019s health status.", {"entities": []}], ["The main factor was \u201ca better understanding of the study and its regulation\u201d for the healthy children and ambulatory sick children groups (31.2% and 82.1%, respectively), whereas this was the third factor for the nonambulatory sick children group (50%).", {"entities": []}], ["Innovative strategies should be developed based on a child\u2019s health status to improve information provision when seeking a child\u2019s participation in pediatric research.", {"entities": []}], ["Parents would like to spend more time in discussions with investigators.", {"entities": []}], ["Cystic fibrosis (CF) clinically manifests with various levels of severity, which are thought to be modulated by mutations in the cystic fibrosis transmembrane conductance regulator gene ( CFTR) , modifier genes, and the environment.", {"entities": [[0, 15, "DISEASE"], [129, 144, "DISEASE"], [188, 192, "GENE"]]}], ["This study verified whether polymorphisms in modifier genes associated with glutathione (GSH) metabolism influence CF severity.", {"entities": []}], ["A cross-sectional study of 180 CF patients was carried out from 2011 to 2012.", {"entities": []}], ["We analyzed CFTR mutations, polymorphisms ( GSTM1 and GSTT1 deletions, GSTP1 \u2009+\u2009313A > G, GCLC -129C > T, and GCLC -3506A > G) in modifier genes and CF clinical severity as assessed by 28 clinical and laboratory variables.", {"entities": [[12, 16, "GENE"], [44, 49, "GENE"], [54, 59, "GENE"], [71, 76, "GENE"], [90, 94, "GENE"], [110, 114, "GENE"], [90, 94, "GENE"], [110, 114, "GENE"]]}], ["Significant associations were found between modifier gene polymorphisms and particular phenotypes or genotype changes.", {"entities": []}], ["These included GCLC-129C > T with a higher frequency of the Pseudomonas aeruginosa mucoid to CC genotype ( p \u2009=\u20090.044), and GCLC -3506A > G with a higher frequency of the no-mucoid P. aeruginosa (NMPA) to AA genotype ( p \u2009=\u20090.012).", {"entities": [[15, 19, "GENE"], [124, 128, "GENE"]]}], ["The GSTT1 deletion was associated with a higher frequency of the NMPA to homozygous deletion ( p \u2009=\u20090.008), GSTP1 \u2009+\u2009313A > G with a minor risk of osteoporosis ( p \u2009=\u20090.036), and patient age\u2009\u2264\u2009154\u00a0months ( p \u2009=\u20090.044) with the AA genotype.", {"entities": [[147, 159, "DISEASE"], [4, 9, "GENE"], [108, 113, "GENE"]]}], ["The Bhalla score was associated with GCLC -3506A > G ( p \u2009=\u20090.044) and GSTM1 / GSTT1 deletion polymorphisms ( p \u2009=\u20090.02), while transcutaneous hemoglobin oxygen saturation levels were associated with GSTT1 deletions ( p \u2009=\u20090.048).", {"entities": [[37, 41, "GENE"], [71, 76, "GENE"], [79, 84, "GENE"], [200, 205, "GENE"], [79, 84, "GENE"], [200, 205, "GENE"]]}], ["CF severity is associated with polymorphisms in GSH pathways and CFTR mutations.", {"entities": [[65, 69, "GENE"]]}], ["Objective To assess evidence from randomised clinical trials about the effectiveness of extracts of Boswellia serrata (frankincense).", {"entities": []}], ["Design Systematic review.", {"entities": []}], ["Data sources Electronic searches on Medline, Embase, Cinahl, Amed, and Cochrane Library.", {"entities": []}], ["Hand searches of conference proceedings, bibliographies, and departmental files.", {"entities": []}], ["Review methods All randomised clinical trials of B serrata extract as a treatment for any human medical condition were included and studies of B serrata preparations combined with other ingredients were excluded.", {"entities": []}], ["Titles and abstracts of all retrieved articles were read and hard copies of all relevant articles were obtained.", {"entities": []}], ["Selection of studies, data extraction and validation were done by the author.", {"entities": []}], ["The Jadad score was used to evaluate the methodological quality of all included trials.", {"entities": []}], ["Results Of 47 potentially relevant studies, seven met all inclusion criteria (five placebo controlled, two with active controls).", {"entities": []}], ["The included trials related to asthma, rheumatoid arthritis, Crohn\u2019s disease, osteoarthritis, and collagenous colitis.", {"entities": [[39, 59, "DISEASE"], [50, 59, "DISEASE"], [78, 92, "DISEASE"], [31, 37, "DISEASE"]]}], ["Results of all trials indicated that B serrata extracts were clinically effective.", {"entities": []}], ["Three studies were of good methodological quality.", {"entities": []}], ["No serious safety issues were noted.", {"entities": []}], ["Conclusions The evidence for the effectiveness of B serrata extracts is encouraging but not compelling.", {"entities": []}], ["Direct exposure to camels, diabetes mellitus, heart disease, and smoking were independently associated with this illness.", {"entities": [[46, 59, "DISEASE"], [27, 44, "DISEASE"]]}], ["Risk factors for primary Middle East respiratory syndrome coronavirus (MERS-CoV) illness in humans are incompletely understood.", {"entities": [[49, 57, "DISEASE"]]}], ["We identified all primary MERS-CoV cases reported in Saudi Arabia during March\u2013November 2014 by excluding those with history of exposure to other cases of MERS-CoV or acute respiratory illness of unknown cause or exposure to healthcare settings within 14 days before illness onset.", {"entities": []}], ["Using a case\u2013control design, we assessed differences in underlying medical conditions and environmental exposures among primary case-patients and 2\u20134 controls matched by age, sex, and neighborhood.", {"entities": []}], ["Using multivariable analysis, we found that direct exposure to dromedary camels during the 2 weeks before illness onset, as well as diabetes mellitus, heart disease, and smoking, were each independently associated with MERS-CoV illness.", {"entities": [[151, 164, "DISEASE"], [132, 149, "DISEASE"]]}], ["Further investigation is needed to better understand animal-to-human transmission of MERS-CoV.", {"entities": []}], ["Acute ozone (O 3 ) exposure has known deleterious effects on the respiratory system and has been linked with respiratory disease and infection.", {"entities": []}], ["Inflammatory lung disease induced by air pollution has demonstrated greater severity and poorer prognosis in women vs. men.", {"entities": [[13, 25, "DISEASE"]]}], ["Both severe damage to the bronchial-alveolar epithelium and malfunctioning of bronchial-blood barrier have been largely attributed to the pathobiology of O 3 -induced inflammatory response, but the associated mechanisms in the male and female lung remain unknown.", {"entities": []}], ["Here, we investigated sex-based differential regulation of lung interleukin-6 (IL-6) and its downstream signaling pathways JAK2/STAT3 and AKT1/NF-\u03baB in response to O 3 exposure in a mouse model.", {"entities": []}], ["We exposed male and female mice (in different stages of the estrous cycle) to 2\u00a0ppm of O 3 or filtered air (FA) for 3\u00a0h, and we harvested lung tissue for protein expression analysis by Western blot.", {"entities": []}], ["We found significant up-regulation of IL-6 and IL-6R in females and IL-6 in males in response to O 3 vs. FA.", {"entities": []}], ["Ozone exposure induced a significant increase in STAT3-Y705 phosphorylation in both females and males.", {"entities": []}], ["Males exposed to O 3 had decreased levels of JAK2, but increased JAK2 (Y1007+Y1008) phosphorylation, while females exposed to O 3 showed significant up-regulation of both proteins.", {"entities": [[45, 49, "GENE"], [65, 69, "GENE"], [45, 49, "GENE"], [65, 69, "GENE"]]}], ["Both NF-\u03baB (p105/p50) and AKT1 protein levels were significantly increased only in females exposed to O 3 .", {"entities": [[26, 30, "GENE"]]}], ["In addition, females exposed to O 3 during proestrus displayed increased expression of selected genes when compared to females exposed to O 3 in other estrous cycle stages.", {"entities": []}], ["Together, our observations indicate a sex-based and estrous cycle-dependent differential lung inflammatory response to O 3 and involvement of two converging JAK2/STAT3 and AKT1/NF-\u03baB pathways.", {"entities": []}], ["To our knowledge, this is the first study specifically addressing the impact of the estrous cycle in O 3 -associated lung inflammatory pathways.", {"entities": []}], ["The online version of this article (doi:10.1186/s13293-016-0069-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Generalists such as general practitioners and district nurses have been the main actors in community palliative care in Norway.", {"entities": []}], ["Specialised oncology nurses with postgraduate palliative training are increasingly becoming involved.", {"entities": []}], ["There is little research on their contribution.", {"entities": []}], ["This study explores how general practitioners (GPs) and oncology nurses (ONs) experience their collaboration in primary palliative care.", {"entities": []}], ["A qualitative focus group and interview study in rural Northern Norway, involving 52 health professionals.", {"entities": []}], ["Five uni-professional focus group discussions were followed by five interprofessional discussions and six individual interviews.", {"entities": []}], ["Transcripts were analysed thematically.", {"entities": []}], ["The ideal cooperation between GPs and ONs was as a \u201cmeeting of experts\u201d with complementary competencies.", {"entities": []}], ["GPs drew on their generalist backgrounds, including their often long-term relationship with and knowledge of the patient.", {"entities": []}], ["The ONs contributed longitudinal clinical observations and used their specialised knowledge to make treatment suggestions.", {"entities": []}], ["While ONs were often experienced and many had developed a form of pattern recognition, they needed GPs\u2019 competencies for complex clinical judgements.", {"entities": []}], ["However, ONs sometimes lacked timely advice from GPs, and could feel left alone with sick patients.", {"entities": []}], ["To avoid this, some ONs bypassed GPs and contacted palliative specialists directly.", {"entities": []}], ["While traditional professional hierarchies were not a barrier, we found that organization, funding and remuneration were significant barriers to cooperation.", {"entities": []}], ["GPs often did not have time to meet with ONs to discuss shared patients.", {"entities": []}], ["We also found that ONs and GPs had different strategies for learning.", {"entities": []}], ["While ONs belonged to a networking nursing collective aiming for continuous quality improvement, GPs learned mostly from their individual experience of caring for patients.", {"entities": []}], ["The complementary competences and autonomous roles of a specialised nurse and a general practitioner represented a good match for primary palliative care.", {"entities": []}], ["When planning high-quality teamwork in primary care, organizational barriers to cooperation and different cultures for learning need consideration.", {"entities": []}], ["The online version of this article (10.1186/s12913-018-2955-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cardiac asthma is common, but has been poorly investigated.", {"entities": [[8, 14, "DISEASE"]]}], ["The objective was to compare the characteristics and outcome of cardiac asthma with that of classical congestive heart failure (CHF) in elderly patients.", {"entities": [[102, 126, "DISEASE"], [72, 78, "DISEASE"]]}], ["Prospective study in an 1,800-bed teaching hospital.", {"entities": []}], ["Two hundred and twelve consecutive patients aged \u2265 65 years presenting with dyspnea due to CHF (mean age of 82 \u00b1 8 years) were included.", {"entities": []}], ["Findings of cardiac echocardiography and natriuretic peptides levels were used to confirm CHF.", {"entities": []}], ["Cardiac asthma patients were defined as a patient with CHF and wheezing reported by attending physician upon admission to the emergency department.", {"entities": [[8, 14, "DISEASE"]]}], ["The CHF group (n = 137) and the cardiac asthma group (n = 75), differed for tobacco use (34% vs. 59%, p < 0.05), history of chronic obstructive pulmonary disease (16% vs. 47%, p < 0.05), peripheral arterial disease (10% vs. 24%, p < 0.05).", {"entities": [[124, 161, "DISEASE"], [40, 46, "DISEASE"]]}], ["Patients with cardiac asthma had a significantly lower pH (7.38 \u00b1 0.08 vs. 7.43 \u00b1 0.06, p < 0.05), and a higher PaCO 2 (47 \u00b1 15 vs. 41 \u00b1 11 mmHg, p < 0.05) at admission.", {"entities": [[22, 28, "DISEASE"]]}], ["In the cardiac asthma group, patients had greater distal airway obstruction: forced expiratory volume in 1 second of 1.09 vs. 1.33 Liter (p < 0.05), and a forced expiratory flow at 25% to 75% of vital capacity of 0.76 vs. 0.99 Liter (p < 0.05).", {"entities": [[15, 21, "DISEASE"]]}], ["The in-hospital (23% vs. 19%) and one year mortality (48% vs. 43%) rates were similar.", {"entities": []}], ["Patients with cardiac asthma represented one third of CHF in elderly patients.", {"entities": [[22, 28, "DISEASE"]]}], ["They were more hypercapnic and experienced more distal airway obstruction.", {"entities": []}], ["However, outcomes were similar.", {"entities": []}], ["We have shown previously that acute infection with the respiratory pathogen, pneumonia virus of mice (PVM), results in local production of the proinflammatory chemokine, CCL3, and that neutrophil recruitment in response to PVM infection is reduced dramatically in CCL3 -/- mice.", {"entities": [[77, 86, "DISEASE"], [170, 174, "GENE"], [264, 268, "GENE"], [170, 174, "GENE"], [264, 268, "GENE"]]}], ["In this work, we demonstrate that CCL3-mediated neutrophil recruitment is coordinated by interferon-gamma (IFN\u03b3).", {"entities": []}], ["Neutrophil recruitment in response to PVM infection was diminished five-fold in IFN\u03b3 receptor gene-deleted mice, although neutrophils from IFN\u03b3R -/- mice expressed transcripts for the CCL3 receptor, CCR1 and responded functionally to CCL3 ex vivo .", {"entities": [[184, 188, "GENE"], [234, 238, "GENE"], [199, 203, "GENE"], [184, 188, "GENE"], [234, 238, "GENE"]]}], ["Similarly, in the absence of PVM infection, CCL3 overexpression alone could not elicit neutrophil recruitment in the absence of IFN\u03b3.", {"entities": [[44, 48, "GENE"]]}], ["Interestingly, although supplemental IFN\u03b3 restored neutrophil recruitment and resulted in a sustained weight loss among CCL3-overexpressing IFN\u03b3 -/- mice, CCL3-mediated neutrophil recruitment alone did not result in the pulmonary edema or respiratory failure characteristic of severe viral infection, suggesting that CCL3 and IFN-\u03b3 together are sufficient to promote neutrophil recruitment but not pathologic activation.", {"entities": [[239, 258, "DISEASE"], [220, 235, "DISEASE"], [120, 124, "GENE"], [155, 159, "GENE"], [317, 321, "GENE"]]}], ["Our findings reveal a heretofore unrecognized hierarchical interaction between the IFN\u03b3 and CCL3, which demonstrate that IFN\u03b3 is crucial for CCL3-mediated neutrophil recruitment in vivo .", {"entities": [[92, 96, "GENE"], [141, 145, "GENE"]]}], ["Measurement of self-efficacy requires carefully developed and validated instruments.", {"entities": []}], ["It is currently unclear whether available self-efficacy instruments for chronic diseases fulfill these requirements.", {"entities": []}], ["Our aim was to systematically identify all existing self-efficacy scales for five major chronic diseases and to assess their development and validation process.", {"entities": []}], ["We conducted a systematic literature search in electronic databases (MEDLINE, PSYCHINFO, and EMBASE) to identify studies describing the development and/or validation process of self-efficacy instruments for the five chronic diseases diabetes, chronic obstructive pulmonary disease (COPD), asthma, arthritis, and heart failure.", {"entities": [[243, 280, "DISEASE"], [297, 306, "DISEASE"], [289, 295, "DISEASE"]]}], ["Two members of the review team independently selected articles meeting inclusion criteria.", {"entities": []}], ["The self-efficacy instruments were evaluated in terms of their development (aim of instrument, a priori considerations, identification of items, selection of items, development of domains, answer options) and validation (test-retest reliability, internal consistency reliability, validity, responsiveness) process.", {"entities": []}], ["Of 584 potentially eligible papers we included 25 (13 for diabetes, 5 for asthma, 4 for arthritis, 3 for COPD, 0 for heart failure) which covered 26 different self-efficacy instrument versions.", {"entities": [[88, 97, "DISEASE"], [74, 80, "DISEASE"]]}], ["For 8 instruments (30.8%), the authors described the aim before the scales were developed whereas for the other instruments the aim was unclear.", {"entities": []}], ["In one study (3.8%) a priori considerations were specified.", {"entities": []}], ["In none of the studies a systematic literature search was carried out to identify items.", {"entities": []}], ["The item selection process was often not clearly described (38.5%).", {"entities": []}], ["Test-retest reliability was assessed for 9 instruments (34.6%), validity using a correlational approach for 18 (69.2%), and responsiveness to change for 3 (11.5%) instruments.", {"entities": []}], ["The development and validation process of the majority of the self-efficacy instruments had major limitations.", {"entities": []}], ["The aim of the instruments was often not specified and for most instruments, not all measurement properties that are important to support the specific aim of the instrument (for example responsiveness for evaluative instruments) were assessed.", {"entities": []}], ["Researchers who develop and validate self-efficacy instruments should adhere more closely to important methodological concepts for development and validation of patient-reported outcomes and report their methods more transparently.", {"entities": []}], ["We propose a systematic five step approach for the development and validation of self-efficacy instruments.", {"entities": []}], ["Human bone marrow mesenchymal stem cells (hBM-MSCs) hold promise for treating incurable diseases and repairing of damaged tissues.", {"entities": []}], ["However, hBM-MSCs face the disadvantages of painful invasive isolation and limited cell numbers.", {"entities": []}], ["In this study we assessed characteristics of MSCs isolated from residual human bone marrow transplantation material and expanded to clinically relevant numbers at passages 3-4 and 6-7.", {"entities": []}], ["Results indicated that early passage hBM-MSCs are genomically stable and retain identity and high proliferation capacity.", {"entities": []}], ["Despite the chromosomal stability, the cells became senescent at late passages, paralleling the slower proliferation, altered morphology and immunophenotype.", {"entities": []}], ["By qRT-PCR array profiling, we revealed 13 genes and 33 miRNAs significantly differentially expressed in late passage cells, among which 8 genes and 30 miRNAs emerged as potential novel biomarkers of hBM-MSC aging.", {"entities": []}], ["Functional analysis of genes with altered expression showed strong association with biological processes causing cellular senescence.", {"entities": []}], ["Altogether, this study revives hBM as convenient source for cellular therapy.", {"entities": []}], ["Potential novel markers provide new details for better understanding the hBM-MSC senescence mechanisms, contributing to basic science, facilitating the development of cellular therapy quality control, and providing new clues for human disease processes since senescence phenotype of the hematological patient hBM-MSCs only very recently has been revealed.", {"entities": []}], ["Genome-wide association studies have identified several genetic risk loci for severe chronic obstructive pulmonary disease (COPD) and emphysema.", {"entities": [[85, 122, "DISEASE"]]}], ["However, these studies do not fully explain disease heritability and in most cases, fail to implicate specific genes.", {"entities": []}], ["Integrative methods that combine gene expression data with GWAS can provide more power in discovering disease-associated genes and give mechanistic insight into regulated genes.", {"entities": []}], ["We applied a recently described method that imputes gene expression using reference transcriptome data to genome-wide association studies for two phenotypes (severe COPD and quantitative emphysema) and blood and lung tissue gene expression datasets.", {"entities": []}], ["We further tested the potential causality of individual genes using multi-variant colocalization.", {"entities": []}], ["We identified seven genes significantly associated with severe COPD, and five genes significantly associated with quantitative emphysema in whole blood or lung.", {"entities": []}], ["We validated results in independent transcriptome databases and confirmed colocalization signals for PSMA4 , EGLN2 , WNT3 , DCBLD1 , and LILRA3 .", {"entities": [[101, 106, "GENE"], [109, 114, "GENE"], [117, 121, "GENE"], [137, 143, "GENE"]]}], ["Three of these genes were not located within previously reported GWAS loci for either phenotype.", {"entities": []}], ["We also identified genetically driven pathways, including those related to immune regulation.", {"entities": []}], ["An integrative analysis of GWAS and gene expression identified novel associations with severe COPD and quantitative emphysema, and also suggested disease-associated genes in known COPD susceptibility loci.", {"entities": []}], ["NCT00608764 , Registry: ClinicalTrials.gov, Date of Enrollment of First Participant: November 2007, Date Registered: January 28, 2008 (retrospectively registered); NCT00292552 , Registry: ClinicalTrials.gov, Date of Enrollment of First Participant: December 2005, Date Registered: February 14, 2006 (retrospectively registered).", {"entities": []}], ["The online version of this article (10.1186/s12931-018-0744-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Exacerbations of COPD (ECOPD) are a frequent cause of emergency room (ER) visits.", {"entities": []}], ["Predictors of early outcome could help clinicians in orientation decisions.", {"entities": []}], ["In the current study, we investigated whether mid-regional pro-adrenomedullin (MR-proADM) and copeptin, in addition to clinical evaluation, could predict short-term outcomes.", {"entities": []}], ["This prospective blinded observational study was conducted in 20 French centers.", {"entities": []}], ["Patients admitted to the ER for an ECOPD were considered for inclusion.", {"entities": []}], ["A clinical risk score was calculated, and MR-proADM and copeptin levels were determined from a venous blood sample.", {"entities": []}], ["The composite primary end point comprised 30-day death or transfer to the intensive care unit or a new ER visit.", {"entities": []}], ["A total of 379 patients were enrolled in the study, of whom 277 were eventually investigated for the primary end point that occurred in 66 (24%) patients.", {"entities": []}], ["In those patients, the median (interquartile range [IQR]) MR-proADM level was 1.02 nmol/L (0.77\u20131.48) versus 0.83 nmol/L (0.63\u20131.07) in patients who did not meet the primary end point ( P =0.0009).", {"entities": []}], ["In contrast, copeptin levels were similar in patients who met or did not meet the primary end point ( P =0.23).", {"entities": []}], ["MR-proADM levels increased with increasing clinical risk score category: 0.74 nmol/L (0.57\u20130.89), 0.83 nmol/L (0.62\u20131.12) and 0.95 nmol/L (0.75\u20131.29) for the low-, intermediate- and high-risk categories, respectively ( P <0.001).", {"entities": []}], ["MR-proADM was independently associated with the primary end point (odds ratio, 1.65; 95% confidence interval [CI], 1.10\u20132.48; P =0.015).", {"entities": []}], ["MR-proADM predicted the occurrence of primary end point with a sensitivity of 46% (95% CI, 33%\u201358%) and a specificity of 79% (95% CI, 74\u201384).", {"entities": []}], ["MR-proADM but not copeptin was significantly associated with outcomes at 30 days, even after adjustment for clinical risk category.", {"entities": []}], ["Overall, MR-proADM, alone or combined with the clinical risk score, was a moderate strong predictor of short-term outcomes.", {"entities": []}], ["BACKGROUND: Increased secretion of mucus is a hallmark of many respiratory diseases and contributes significantly to the airflow limitation experienced by many patients.", {"entities": []}], ["While the current pharmacological approach to reducing mucus and sputum production in patients is limited, clinical studies have suggested that drugs which inhibit the cyclooxygenase and/or 5-lipoxygenase enzymatic pathways may reduce secretory activity in patients with airway disease.", {"entities": []}], ["AIM: This study was performed to investigate the effects of indomethacin (cyclooxygenase inhibitor) and Bay x 1005 (5-lipoxygenase inhibitor) on MUC5AC release from human airways in vitro.", {"entities": []}], ["METHODS: An immunoradiometric assay was used to determine the quantities of MUC5AC present in the biological fluids derived from human airways in vitro.", {"entities": []}], ["The measurements were made with a mixture of eight monoclonal antibodies (MAbs; PM8) of which the 21 M1 MAb recognized a recombinant M1 mucin partially encoded by the MUC5AC gene.", {"entities": []}], ["RESULTS: The quantities of MUC5AC detected in the biological fluids derived from human bronchial preparations were not modified after treatment with indomethacin (cyclooxygenase inhibitor) and/or an inhibitor of the 5-lipoxygenase metabolic pathway (BAY x 1005).", {"entities": []}], ["CONCLUSION: These results suggest that the cyclooxygenase and 5-lipoxygenase metabolic pathways play little or no role in the release of MUC5AC from human airways.", {"entities": []}], ["The human airway epithelium consists of 4 major cell types: ciliated, secretory, columnar and basal cells.", {"entities": []}], ["During natural turnover and in response to injury, the airway basal cells function as stem/progenitor cells for the other airway cell types.", {"entities": []}], ["The objective of this study is to better understand human airway epithelial basal cell biology by defining the gene expression signature of this cell population.", {"entities": []}], ["Bronchial brushing was used to obtain airway epithelium from healthy nonsmokers.", {"entities": []}], ["Microarrays were used to assess the transcriptome of basal cells purified from the airway epithelium in comparison to the transcriptome of the differentiated airway epithelium.", {"entities": []}], ["This analysis identified the \u201chuman airway basal cell signature\u201d as 1,161 unique genes with >5-fold higher expression level in basal cells compared to differentiated epithelium.", {"entities": []}], ["The basal cell signature was suppressed when the basal cells differentiated into a ciliated airway epithelium in vitro .", {"entities": []}], ["The basal cell signature displayed overlap with genes expressed in basal-like cells from other human tissues and with that of murine airway basal cells.", {"entities": []}], ["Consistent with self-modulation as well as signaling to other airway cell types, the human airway basal cell signature was characterized by genes encoding extracellular matrix components, growth factors and growth factor receptors, including genes related to the EGF and VEGF pathways.", {"entities": [[263, 266, "GENE"]]}], ["Interestingly, while the basal cell signature overlaps that of basal-like cells of other organs, the human airway basal cell signature has features not previously associated with this cell type, including a unique pattern of genes encoding extracellular matrix components, G protein-coupled receptors, neuroactive ligands and receptors, and ion channels.", {"entities": []}], ["The human airway epithelial basal cell signature identified in the present study provides novel insights into the molecular phenotype and biology of the stem/progenitor cells of the human airway epithelium.", {"entities": []}], ["Sulfur dioxide, formed during the combustion of fossil fuels, is a major air pollutant near large cities.", {"entities": []}], ["Its two ionized forms in aqueous solution, sulfite and (bi)sulfite, are widely used as preservatives and antioxidants to prevent food and beverage spoilage.", {"entities": []}], ["(Bi)sulfite can be oxidized by peroxidases to form the very reactive sulfur trioxide anion radical ( 3 3 SOO 4 To explore the critical role of these radical intermediates in further oxidizing biomolecules, we examined the ability of copper,zinc-superoxide dismutase (Cu,Zn-SOD) to initiate this radical chain reaction, using human serum albumin (HSA) as a model target.", {"entities": []}], ["We used electron paramagnetic resonance, optical spectroscopy, oxygen uptake, and immuno-spin trapping to study the protein oxidations driven by sulfite-derived radicals.", {"entities": []}], ["We found that when Cu,Zn-SOD reacted with (bi)sulfite, 3 N -oxide (DMPO) spin-trapped HSA radicals.", {"entities": []}], ["The present study suggests that protein oxidative damage resulting from (bi)sulfite oxidation promoted by Cu,Zn-SOD could be involved in oxidative damage and tissue injury in (bi)sulfite-exacerbated allergic reactions.", {"entities": []}], ["Our aim was to systematically summarize the evidence on whether prenatal, birth and early life factors up to 6\u00a0years of age predict sedentary behavior in young people (\u226418\u00a0years).", {"entities": []}], ["PRISMA guidelines were followed, and searches were conducted in PubMed, SPORTDiscus, EMBASE and Web of Science up to December 1, 2015.", {"entities": []}], ["We included observational (non-intervention) and longitudinal studies, that reported data on the association between one or more of the potential predictors and objectively or subjectively measured sedentary behavior.", {"entities": []}], ["Study quality was assessed using a formal checklist and data extraction was performed using standardized forms independently by two researchers.", {"entities": []}], ["More than 18,000 articles were screened, and 16 studies, examining 10 different predictors, were included.", {"entities": []}], ["Study quality was variable (0.36-0.95).", {"entities": []}], ["Two studies suggest that heritability and BMI in children aged 2\u20136 years were significant predictors of sedentary behavior later in life, while four and seven studies suggest no evidence for an association between gestational age, birth weight and sedentary behavior respectively.", {"entities": []}], ["There was insufficient evidence whether other prenatal, birth and early life factors act as predictors of later sedentary behavior in young people.", {"entities": []}], ["The results suggest that heritability and early childhood BMI may predict sedentary behavior in young people.", {"entities": []}], ["However, small number of studies included and methodological limitations, including subjective and poorly validated sedentary behavior assessment, limits the conclusions.", {"entities": []}], ["The systematic review is registered in the International Prospective Register of Systematic Reviews, PROSPERO, 17.10.2014 ( CRD42014014156 ).", {"entities": []}], ["The online version of this article (doi:10.1186/s12966-016-0389-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["During sedated esophagogastroduodenoscopy (EGD), patients may not be able to perform inspiration, which is necessary to examine the esophagogastric junction.", {"entities": []}], ["Therefore sedation may affect diagnosis of gastroesophageal reflux-related findings.", {"entities": []}], ["The aim of our study was to investigate the effect of sedation on diagnosis of gastroesophageal reflux-related findings during EGD.", {"entities": []}], ["This retrospective study evaluated 28914 patients older than 20 years who underwent EGD at our institution between January 2011 and December 2011.", {"entities": []}], ["Ultimately, 1546 patients indicated for EGD for health check-up and symptom evaluation were included.", {"entities": []}], ["There were 18546 patients who had diagnostic EGD: 10471 patients (56%) by non-sedated EGD and 8075 patients (43%) by sedated EGD.", {"entities": []}], ["After statistical adjustment for age, sex, and body mass index, minimal change esophagitis, and hiatal hernia were significantly less frequently observed in the sedated EGD group [odds ratio (OR), 0.651; 95% confidence interval (CI), 0.586 to 0.722 and OR, 0.699; 95% CI, 0.564 to 0.866].", {"entities": [[79, 90, "DISEASE"]]}], ["Nevertheless, there was no significant difference in other findings at the gastroesophageal junction, such as reflux esophagitis with Los Angeles classification A, B, C, and D or Barrett's esophagus, between the two groups.", {"entities": [[117, 128, "DISEASE"]]}], ["Similarly, there were no differences in early gastric cancer, advanced gastric cancer, and gastric ulcer occurrence.", {"entities": [[91, 104, "DISEASE"], [54, 60, "DISEASE"], [79, 85, "DISEASE"]]}], ["Sedation can impede the detection of minimal change esophagitis and hiatal hernia, but does not influence detection of reflux esophagitis of definite severity and Barrett's esophagus.", {"entities": [[52, 63, "DISEASE"], [126, 137, "DISEASE"]]}], ["Some people have a lower threshold to seek care for certain symptoms than others.", {"entities": []}], ["This study aims to investigate what factors are associated with patients\u2019 propensity to seek care.", {"entities": []}], ["In addition, this study explores whether patients\u2019 propensity to seek care is associated with their actual health care utilization.", {"entities": []}], ["We hypothesized that higher scores for propensity to seek care will lead to more general practitioners (GP) consultations, but to lower rates of avoidable hospitalization.", {"entities": []}], ["Propensity to seek care and GP utilization were measured by the Patient Experience Questionnaire of the QUALICOPC study, a survey among 61,931 patients that recently visited GP services in 34 countries.", {"entities": []}], ["Propensity to seek care was estimated by two questions: one question focusing on health care seeking behavior for serious symptoms and the other question focused minor complaints.", {"entities": []}], ["Data on country level rates of avoidable hospitalization for CHF, COPD, asthma and diabetes were obtained from the OECD health care quality indicators project.", {"entities": [[72, 78, "DISEASE"]]}], ["Beside patient characteristics, various organizational factors, such as better accessible and continuous primary care, and better experienced communication between patient and GPs was associated with a higher propensity to seek care for both severe and minor complaints.", {"entities": []}], ["A higher propensity to seek care was associated with a slightly higher health care utilization in terms of GP visits, with no differences between the severity of the experienced symptoms (OR 1.08 for severe complaints and OR 1.05 for minor complaints).", {"entities": []}], ["At country level, no association was found between propensity to seek care and rates of avoidable hospitalization for CHF, COPD, asthma and diabetes, possibly due to low statistical power at country level.", {"entities": [[129, 135, "DISEASE"]]}], ["The organization of primary care and patients\u2019 perceived communication with their GP were found to be highly correlated with patients\u2019 decision to seek health care for minor or severe complaints, suggesting that characteristics of healthcare systems directly influence patients\u2019 care seeking behavior, potentially leading to overuse or underuse of health services.", {"entities": []}], ["However, we also observed that patients\u2019 propensity to seek care is only weakly associated with more GP use.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-1119-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The measurement of Interferon gamma or Interferon gamma inducible protein (IP)-10 in antigen stimulated blood samples is suggested as an alternative method for latent tuberculosis (TB) diagnosis.", {"entities": [[167, 179, "DISEASE"]]}], ["Nonetheless, their role in active TB diagnosis, particularly in TB endemic settings is yet to be defined.", {"entities": []}], ["In this study, the sensitivities and specificities of Interferon gamma release assay (IGRA), IP-10 assay and tuberculin skin test (TST) in detecting active TB cases were assessed in human immunodeficiency virus (HIV) sero-negative TB patients and healthy controls respectively.", {"entities": []}], ["A total of 177 adult TB patients and 100 healthy controls were included for this study.", {"entities": []}], ["QuantiFERON-TB Gold In-tube (QFT-IT) method was used to analyze the sensitivity and specificity of IGRA.", {"entities": []}], ["QFT-IT, IP-10 and TST yielded the diagnostic sensitivities of 90.6% (95%CI: 86.3%\u201394.9%), 92.5% (95%CI: 88.6%\u201396.4%) and 68.9% (95%CI: 60.6%\u201377.2%) and specificities of 55% (95% CI: 35.2%\u201354.8%), 48% (95% CI: 38.2%\u201357.8%) and 75.5% (95% CI: 66.8%\u201384.2%), respectively.", {"entities": []}], ["The extent of pulmonary involvement or presence of diabetes mellitus did not appear to influence the sensitivities of any of these tests.", {"entities": [[51, 68, "DISEASE"]]}], ["The combination of any of the two tests among QFT-IT, IP-10 and TST showed >98% sensitivity among smear negative cases and particularly the combination of IP-10, TST and smear microscopy showed 100% sensitivity, however, the specificity was decreased to 44.8%.", {"entities": []}], ["QFT-IT and IP-10 were highly sensitive in detecting active TB cases.", {"entities": []}], ["The combination with TST improved the sensitivity of QFT-IT and IP-10 significantly.", {"entities": []}], ["Although the higher sensitivity of combination of QFT-IT/IP-10 and TST may be useful in active TB diagnosis, they are limited by their poor specificity due to the high prevalence of latent TB in our settings.", {"entities": []}], ["Chronic kidney disease (CKD) is a serious public health problem in Taiwan and the world.", {"entities": [[8, 22, "DISEASE"]]}], ["The most effective, affordable treatments involve early prevention/detection/intervention, requiring screening.", {"entities": []}], ["Successfully implementing CKD programs requires good patient participation, affected by patient perceptions of screening service quality.", {"entities": []}], ["Service quality improvements can help make such programs more successful.", {"entities": []}], ["Thus, good tools for assessing service quality perceptions are important.", {"entities": []}], ["Aim: to investigate using a modified SERVQUAL questionnaire in assessing patient expectations, perceptions, and loyalty towards kidney disease screening service quality.", {"entities": [[128, 142, "DISEASE"]]}], ["1595 kidney disease screening program patients in Taichung City were requested to complete and return a modified kidney disease screening SERVQUAL questionnaire.", {"entities": [[5, 19, "DISEASE"], [113, 127, "DISEASE"]]}], ["1187 returned them.", {"entities": []}], ["Incomplete ones (102) were culled and 1085 were chosen as effective for use.", {"entities": []}], ["Paired t-tests, correlation tests, ANOVA, LSD test, and factor analysis identified the characteristics and factors of service quality.", {"entities": []}], ["The paired t-test tested expectation score and perception score gaps.", {"entities": []}], ["A structural equation modeling system examined satisfaction-based components' relationships.", {"entities": []}], ["The effective response rate was 91.4%.", {"entities": []}], ["Several methods verified validity.", {"entities": []}], ["Cronbach's alpha on internal reliability was above 0.902.", {"entities": []}], ["On patient satisfaction, expectation scores are high: 6.50 (0.82), but perception scores are significantly lower 6.14 (1.02).", {"entities": []}], ["Older patients' perception scores are lower than younger patients'.", {"entities": []}], ["Expectation and perception scores for patients with different types of jobs are significantly different.", {"entities": []}], ["Patients higher on education have lower scores for expectation (r = -0.09) and perception (r = -0.26).", {"entities": []}], ["Factor analysis identified three factors in the 22 item SERVQUAL form, which account for 80.8% of the total variance for the expectation scores and 86.9% of the total variance for the satisfaction scores.", {"entities": []}], ["Expectation and perception score gaps in all 22 items are significant.", {"entities": []}], ["The goodness-of-fit summary of the SEM results indicates that expectations and perceptions are positively correlated, perceptions and loyalty are positively correlated, but expectations and loyalty are not positively correlated.", {"entities": []}], ["The results of this research suggest that the SERVQUAL instrument is a useful measurement tool in assessing and monitoring service quality in kidney disease screening services, enabling the staff to identify where service improvements are needed from the patients' perspectives.", {"entities": [[142, 156, "DISEASE"]]}], ["Free nitric oxide (NO) reacts with sulphydryl residues to form S-nitrosothiols, which act as NO reservoirs.", {"entities": []}], ["We sought to determine whether thiol-preserving agents and antioxidants, such as dithiothreitol (DTT) and vitamin C, induce NO release from S-nitrosylated proteins in endothelial cell cultures to promote angiogenesis.", {"entities": []}], ["NO release was measured directly in cell supernatants using a Sievers NO Analyser, and in vitro angiogenesis was assessed by quantifying capillary-like tube network formation of porcine aortic endothelial cells (PAEC) on growth factor-reduced Matrigel.", {"entities": []}], ["Incubation of PAEC with DTT or vitamin C significantly increased NO release in a concentration-dependent manner.", {"entities": []}], ["However, the nitric oxide synthase (NOS) inhibitors, L-NNA and L-NIO, had no effect on DTT- or vitamin C-induced NO release, and there was no concomitant increase in the phosphorylation of endothelial NOS at serine-1177 following DTT or vitamin C treatment.", {"entities": []}], ["DTT and vitamin C increased capillary-like tube network formation by nine- and two-fold, respectively, and the addition of copper ions doubled the effect of vitamin C. Surprisingly, DTT maintained endothelial tube networks for up to one month under serum-free conditions, and selective inhibitors of guanylyl cyclase (ODQ) and PKG (KT-5823) blocked this, demonstrating the requirement of cyclic GMP and PKG in this process.", {"entities": []}], ["Both DTT and vitamin C are capable of releasing sufficient NO from S-nitrosothiols to induce capillary morphogenesis.", {"entities": []}], ["This study provides the first evidence that increased denitrosylation leads to increased bioavailability of NO, independent of NOS activity, to promote sustained angiogenesis.", {"entities": []}], ["Central venous catheters play an important role in patient care.", {"entities": []}], ["Real-time ultrasound-guided subclavian central venous (SCV) cannulation may reduce the incidence of complications and the time between skin penetration and the aspiration of venous blood into the syringe.", {"entities": []}], ["Ultrasonic diagnosis of catheter misplacement and pneumothorax related to central venous catheterization is rapid and accurate.", {"entities": [[50, 62, "DISEASE"]]}], ["It is unclear, however, whether ultrasound real-time guidance and examination can reduce procedure times and complication rates when compared with landmark guidance and radiographic examination for SCV catheterization.", {"entities": []}], ["The Subclavian Central Venous Catheters Guidance and Examination by UltraSound (SUBGEUS) study is an investigator-initiated single center, randomized, controlled two-arm trial.", {"entities": []}], ["Three hundred patients undergoing SCV catheter placement will be randomized to ultrasound real-time guidance and examination or landmark guidance and radiographic examination.", {"entities": []}], ["The primary outcome is the time between the beginning of the procedure and control of the catheter.", {"entities": []}], ["Secondary outcomes include the times required for the six components of the total procedure, the occurrence of complications (pneumothorax, hemothorax, or misplacement), failure of the technique and occurrence of central venous catheter infections.", {"entities": [[126, 138, "DISEASE"]]}], ["The SUBGEUS trial is the first randomized controlled study to investigate whether ultrasound real-time guidance and examination for SCV catheter placement reduces all procedure times and the rate of complications.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT01888094", {"entities": []}], ["The objective was to determine the repeatability and stability of capnography interfaced with human exposure facility.", {"entities": []}], ["Capnographic wave signals were obtained from five healthy volunteers exposed to particle-free, filtered air during two consecutive 5 min intervals, 10 min apart, within the open and then the sealed and operational human exposure facility (HEF).", {"entities": []}], ["Using a customized setup comprised of the Oridion Microcap TE ) were recorded before and after capnographic recording and then averaged.", {"entities": []}], ["Each capnographic tracing was analyzed for acceptable waves.", {"entities": []}], ["From each recorded interval, 8 to 19 acceptable waves were selected and measured.", {"entities": []}], ["The following wave parameters were obtained: total length and length of phase II and III, slope of phase II and III, area under the curve and area under phase III.", {"entities": []}], ["In addition, we recorded signal measures including the mean, standard deviation, mode, minimum, maximum \u2013 which equals end-tidal CO 2 (EtCO 2 ), zero-corrected maximum and true RMS.", {"entities": []}], ["Statistical analysis using a paired t-test for means showed no statistically significant changes of any wave parameters and wave signal measures, corrected for RR and V TE , comparing the measures when the HEF was open vs. sealed and operational.", {"entities": []}], ["The coefficients of variation of the zero-corrected and uncorrected EtCO 2 , phase II absolute difference, signal mean, standard deviation and RMS were less than 10% despite a sub-atmospheric barometric pressure, and slightly higher temperature and relative humidity within the HEF when operational.", {"entities": []}], ["We showed that a customized setup for the acquisition and processing of the capnographic wave signal, interfaced with HEF was stable and repeatable.", {"entities": []}], ["Thus, we expect that analysis of capnographic waves in controlled human air pollution exposure studies is a feasible tool for characterization of cardio-pulmonary effects of such exposures.", {"entities": []}], ["Laparoscopic anti-reflux surgery has been shown to be superior to medical management for treatment of complicated gastroesophageal reflux disease (GERD).", {"entities": [[114, 145, "DISEASE"]]}], ["This study encompasses 100 consecutive patients undergoing laparoscopic Nissen-Rossetti or Toupet fundoplications for GERD refractory to medical management.", {"entities": []}], ["All 100 patients had failed maximum medical management (behavioral and dietary modifications, antacids, and H2 and acid PUMP blockers).", {"entities": []}], ["All patients underwent esophagogastroduodenoscopy with biopsy prior to surgery.", {"entities": []}], ["Ninety-eight patients had esophageal manometry to evaluate the lower esophageal sphincter pressures and determine the amplitude of contractions of the body of the esophagus.", {"entities": []}], ["Twenty-four hour pH studies were used selectively when the preceding studies were equivocal.", {"entities": []}], ["All 100 patients' surgeries were accomplished laparoscopically.", {"entities": []}], ["The mortality rate was zero.", {"entities": []}], ["The post-operative complication rate was 2%.", {"entities": []}], ["The average hospital stay was 1.85 days.", {"entities": []}], ["Follow-up was achieved in 98%.", {"entities": []}], ["The mean follow-up was 17.6 months.", {"entities": []}], ["All patients had significant improvement of their symptoms.", {"entities": []}], ["No patients have long-term dysphagia.", {"entities": []}], ["The study demonstrates that laparoscopic anti-reflux surgery can be safely and effectively accomplished in the community hospital setting.", {"entities": []}], ["An efficient synthesis of novel 2,3-dihydro-4H-pyrido[1,2-a]pyrimidin-4-ones has been reported.", {"entities": []}], ["Inexpensive and readily available substrates, environmentally benign reaction condition, and product formation up to quantitative yield are the key features of this methodology.", {"entities": []}], ["Products are formed by the aza-Michael addition followed by intramolecular acyl substitution in a domino process.", {"entities": []}], ["The polar nature and strong hydrogen bond donor capability of 1,1,1,3,3,3-hexafluoropropan-2-ol is pivotal in this cascade protocol.", {"entities": []}], ["The CD26-associated enzymatic activity of dipeptidyl peptidase-4 (DPP4) as well as the recruitment of CD26", {"entities": [[66, 70, "GENE"]]}], ["Autoimmune diseases and other inflammatory conditions are characterized by large lymphocytic tissue infiltrates in which T and B cells can be found in close contact.", {"entities": []}], ["Here, using a murine airway inflammation model, we compare antigen-specific T and B cells in lung tissue versus lung-draining lymph node.", {"entities": []}], ["In the lung we identify a B-cell population exhibiting a classical germinal centre phenotype without being organized into ectopic lymphoid tissue.", {"entities": []}], ["By contrast, classical CXCR5 In secondary lymphoid organs T follicular helper (Tfh) cells help B cells to develop into memory B and plasma cells.", {"entities": [[23, 28, "GENE"]]}], ["Here, the authors show that inflamed lung becomes a reservoir of activated B cells with a germinal centre phenotype, and T cells that exhibit Tfh-like properties despite not expressing classical Tfh markers.", {"entities": []}], ["Fibronectin is a mechanically sensitive protein which is organized in the extracellular matrix as a network of interacting fibrils.", {"entities": []}], ["The lung tumor stroma is enriched for fibronectin which is thought to contribute to metastasis and drug resistance.", {"entities": []}], ["Fibronectin is an elastic, multi-modular protein made up of individually folded domains, some of which can stretch in response to increased mechanical tension.", {"entities": []}], ["Very little is known about the relationship of fibronectin\u2019s unfolded domains to lung cancer resistance to chemotherapy.", {"entities": [[81, 92, "DISEASE"], [86, 92, "DISEASE"]]}], ["In the present study, we evaluated the impact of unfolding the first Type III domain of fibronectin (FnIII-1c) on TNF-related apoptosis inducing ligand (TRAIL) resistance.", {"entities": []}], ["NCI-H460 non-small cell lung cancer cells were treated with FnIII-1c then assessed for TRAIL-induced apoptosis.", {"entities": [[24, 35, "DISEASE"], [29, 35, "DISEASE"]]}], ["Subsequent analysis of FnIII-1c-mediated signaling pathways was also completed.", {"entities": []}], ["Human non-small cell lung cancer tissue sections were assessed for the expression of vitronectin by immunohistochemistry.", {"entities": [[21, 32, "DISEASE"], [26, 32, "DISEASE"]]}], ["FnIII-1c inhibited TRAIL-induced activation of caspase 8 and subsequent apoptosis in NCI-H460 lung cancer cells.", {"entities": [[94, 105, "DISEASE"], [99, 105, "DISEASE"]]}], ["FnIII-1c treatment was associated with the activation of the phosphatidylinositol-3-kinase/alpha serine/threonine kinase (PI3K/Akt) pathway and the \u03b1v\u03b25 integrin receptor for vitronectin, both of which were required for TRAIL resistance.", {"entities": []}], ["Immunohistochemical staining of sections from non-small cell lung cancers showed that vitronectin was localized around blood vessels and in the tumor-stroma interface.", {"entities": []}], ["Unfolding of Type III domains within the fibronectin matrix may promote TRAIL resistance through the activation of a PI3K/Akt/\u03b1v\u03b25 signaling axis and point to a novel mechanism by which changes in secondary structure of fibronectin contribute to cancer cell resistance to apoptosis.", {"entities": [[246, 252, "DISEASE"]]}], ["Although several systematic reviews investigated the safety of long-acting beta\u2013agonists (LABAs) in asthma, they mainly addressed randomized clinical trials while evidence from non-randomized studies has been mostly neglected.", {"entities": [[100, 106, "DISEASE"]]}], ["We aim to assess the risk of serious adverse events in adults and children with asthma treated with LABAs and Inhaled Corticosteroids (ICs), compared to patients treated only with ICs, from published non-randomized studies.", {"entities": [[80, 86, "DISEASE"]]}], ["The protocol registration number was CRD42012003387 ( http://www.crd.york.ac.uk/Prospero ).", {"entities": []}], ["Literature search for articles published since 1990 was performed in MEDLINE and EMBASE.", {"entities": []}], ["Two authors selected studies independently for inclusion and extracted the data.", {"entities": []}], ["A third reviewer resolved discrepancies.", {"entities": []}], ["To assess the risk of serious adverse events, meta-analyses were performed calculating odds ratio summary estimators using random effect models when heterogeneity was found, and fixed effect models otherwise.", {"entities": []}], ["Of 4,415 candidate articles, 1,759 abstracts were reviewed and 220 articles were fully read.", {"entities": []}], ["Finally, 19 studies met the inclusion criteria.", {"entities": []}], ["Most of them were retrospective observational cohorts.", {"entities": []}], ["Sample sizes varied from 50 to 514,216.", {"entities": []}], ["The meta-analyses performed (69,939-624,303 participants according to the outcome considered) showed that odds ratio of the LABAs and ICs combined treatment when compared with ICs alone was: 0.88 (95% CI 0.69-1.12) for asthma-related hospitalization; 0.75 (95% CI 0.66-0.84) for asthma-related emergency visits; 1.02 (95% CI 0.94-1.10) for systemic corticosteroids; and 0.95 (95% CI 0.9-1.0) for the combined outcome.", {"entities": [[219, 225, "DISEASE"], [279, 285, "DISEASE"]]}], ["Evidence from observational studies shows that the combined treatment of LABAs and ICs is not associated with a higher risk of serious adverse events, compared to ICs alone.", {"entities": []}], ["Major gaps identified were prospective design, paediatric population and inclusion of mortality as a primary outcome.", {"entities": []}], ["Noninvasive measurement of the distribution and oxygenation state of hemoglobin (Hb) inside the tissue is strongly required to analyze the tumor-associated vasculatures.", {"entities": []}], ["We developed a photoacoustic imaging (PAI) system with a hemispherical-shaped detector array (HDA).", {"entities": []}], ["Here, we show that PAI system with HDA revealed finer vasculature, more detailed blood-vessel branching structures, and more detailed morphological vessel characteristics compared with MRI by the use of breast shape deformation of MRI to PAI and their fused image.", {"entities": []}], ["Morphologically abnormal peritumoral blood vessel features, including centripetal photoacoustic signals and disruption or narrowing of vessel signals, were observed and intratumoral signals were detected by PAI in breast cancer tissues as a result of the clinical study of 22 malignant cases.", {"entities": [[214, 227, "DISEASE"], [221, 227, "DISEASE"]]}], ["Interestingly, it was also possible to analyze anticancer treatment-driven changes in vascular morphological features and function, such as improvement of intratumoral blood perfusion and relevant changes in intravascular hemoglobin saturation of oxygen.", {"entities": []}], ["This clinical study indicated that PAI appears to be a promising tool for noninvasive analysis of human blood vessels and may contribute to improve cancer diagnosis.", {"entities": [[148, 154, "DISEASE"]]}], ["Calprotectin is a calcium and zinc binding protein, abundant in neutrophils and is extremely stable in faeces.", {"entities": []}], ["Faecal calprotectin is used as a non-specific marker for gastrointestinal inflammation.", {"entities": []}], ["It has a good diagnostic precision to distinguish between irritable bowel syndrome and inflammatory bowel disease.", {"entities": [[87, 113, "DISEASE"], [58, 82, "DISEASE"], [74, 82, "DISEASE"]]}], ["Studies have established normal concentrations in healthy children; all these studies have been performed in high-income countries.", {"entities": []}], ["The objective of this study was to determine the concentration of faecal calprotectin in apparently healthy children aged 0-12 years in urban Kampala, Uganda.", {"entities": []}], ["We tested 302 apparently healthy children aged, age 0-12 years (162 female, 140 male) in urban Kampala, Uganda.", {"entities": []}], ["The children were recruited consecutively by door-to-door visits.", {"entities": []}], ["Faecal calprotectin was analyzed using a quantitative enzyme-linked immunosorbent assay.", {"entities": []}], ["Faeces were also tested for Helicobacter pylori (H. pylori) antigen, for growth of enteropathogens and microscopy was performed to assess protozoa and helminths.", {"entities": []}], ["A short standardized interview with socio-demographic information and medical history was obtained to assess health status of the children.", {"entities": []}], ["In the different age groups the median faecal calprotectin concentrations were 249 mg/kg in 0 < 1 year (n = 54), 75 mg/kg in 1 < 4 years (n = 89) and 28 mg/kg in 4 < 12 years (n = 159).", {"entities": []}], ["There was no significant difference in faecal calprotectin concentrations and education of female caretaker, wealth index, gender, habits of using mosquito nets, being colonized with H. pylori or having other pathogens in the stool.", {"entities": []}], ["Concentrations of faecal calprotectin among healthy children, living in urban Ugandan, a low-income country, are comparable to those in healthy children living in high-income countries.", {"entities": []}], ["In children older than 4 years, the faecal calprotectin concentration is low.", {"entities": []}], ["In healthy infants faecal calprotectin is high.", {"entities": []}], ["The suggested cut-off concentrations in the literature can be used in apparently healthy Ugandan children.", {"entities": []}], ["This finding also shows that healthy children living under poor circumstances do not have a constant inflammation in the gut.", {"entities": []}], ["We see an opportunity to use this relatively inexpensive test for further understanding and investigations of gut inflammation in children living in low-income countries.", {"entities": []}], ["The term myeloproliferative neoplasms (MPN) refers to a heterogeneous group of diseases including not only polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), but also chronic myeloid leukemia (CML), and systemic mastocytosis (SM).", {"entities": [[205, 229, "DISEASE"], [175, 188, "DISEASE"], [107, 124, "DISEASE"], [250, 262, "DISEASE"], [107, 119, "DISEASE"], [213, 229, "DISEASE"], [221, 229, "DISEASE"], [241, 262, "DISEASE"]]}], ["Despite the clinical and biological differences between these diseases, common pathophysiological mechanisms have been identified in MPN.", {"entities": []}], ["First, aberrant tyrosine kinase signaling due to somatic mutations in certain driver genes is common to these MPN.", {"entities": []}], ["Second, alterations of the bone marrow microenvironment are found in all MPN types and have been implicated in the pathogenesis of the diseases.", {"entities": []}], ["Finally, elevated levels of proinflammatory and microenvironment-regulating cytokines are commonly found in all MPN-variants.", {"entities": []}], ["In this paper, we review the effects of MPN-related oncogenes on cytokine expression and release and describe common as well as distinct pathogenetic mechanisms underlying microenvironmental changes in various MPN.", {"entities": []}], ["Furthermore, targeting of the microenvironment in MPN is discussed.", {"entities": []}], ["Such novel therapies may enhance the efficacy and may overcome resistance to established tyrosine kinase inhibitor treatment in these patients.", {"entities": []}], ["Nevertheless, additional basic studies on the complex interplay of neoplastic and stromal cells are required in order to optimize targeting strategies and to translate these concepts into clinical application.", {"entities": []}], ["We examined the controversial relationship between obesity and depression among Chinese people aged 45 and over using data from the 2013 follow-up survey of the China Health and Retirement Longitudinal Study (CHARLS).", {"entities": [[51, 58, "DISEASE"]]}], ["Depressive symptoms were measured using the CES-D 10; overweight and obesity were defined using WHO, Asian and Chinese criteria.", {"entities": [[69, 76, "DISEASE"]]}], ["The proportion of depressive symptoms was 19.9% and 33.2% in men and women, respectively.", {"entities": []}], ["Depressive symptoms decreased as BMI increased in both men and women (P\u2009<\u20090.05).", {"entities": []}], ["Obese women were less likely to suffer from depressive symptoms than normal weight women according to WHO, Asian and Chinese criteria (P\u2009<\u20090.05).", {"entities": []}], ["Obese men were less likely to suffer from depressive symptoms than normal weight men under the Chinese criteria (P\u2009<\u20090.05).", {"entities": []}], ["The results indicate that there is an inverse association between obesity and depressive symptoms among Chinese men and women, supporting the \u201cjolly fat\u201d hypothesis in China, and suggest that individuals and medical providers should pay attention to underweight as well as obesity.", {"entities": [[66, 73, "DISEASE"], [273, 280, "DISEASE"]]}], ["In addition, our study illustrates the importance of establishing appropriate obesity cut-off points for individual countries.", {"entities": [[78, 85, "DISEASE"]]}], ["Lung function measures are used in the diagnosis of chronic obstructive pulmonary disease.", {"entities": [[52, 89, "DISEASE"]]}], ["In 38,199 European ancestry individuals, we studied genome-wide association of forced expiratory volume in 1\u2009s (FEV 1 ), forced vital capacity (FVC) and FEV 1 /FVC with 1000 Genomes Project (phase 1)-imputed genotypes and followed up top associations in 54,550 Europeans.", {"entities": [[112, 115, "GENE"], [153, 156, "GENE"], [112, 115, "GENE"], [153, 156, "GENE"]]}], ["We identify 14 novel loci ( P <5 \u00d7 10 ENSA , RNU5F-1 , KCNS3 , AK097794 , ASTN2 , LHX3 , CCDC91 , TBX3 , TRIP11 , RIN3 , TEKT5 , LTBP4 , MN1 and AP1S2 , and two novel signals at known loci NPNT and GPR126 , providing a basis for new understanding of the genetic determinants of these traits and pulmonary diseases in which they are altered.", {"entities": [[38, 42, "GENE"], [55, 60, "GENE"], [74, 79, "GENE"], [82, 86, "GENE"], [89, 95, "GENE"], [98, 102, "GENE"], [105, 111, "GENE"], [114, 118, "GENE"], [121, 126, "GENE"], [129, 134, "GENE"], [137, 140, "GENE"], [145, 150, "GENE"], [189, 193, "GENE"], [198, 204, "GENE"]]}], ["Genetic and environmental factors impact on lung function, important in the diagnosis of pulmonary diseases.", {"entities": []}], ["Here the authors use imputation of genotypes to the 1000 Genomes Project reference panel to identify novel, low frequency variants associated with lung function.", {"entities": []}], ["Canadians\u2019 health care-seeking behaviour for physical and mental health issues was examined using the international Quality and Cost of Primary Care (QUALICOPC) survey that was conducted in 2013 in Canada.", {"entities": []}], ["This study used the cross-sectional Patient Experiences Survey collected from 7260 patients in 759 practices across 10 Canadian provinces as part of the QUALICOPC study.", {"entities": []}], ["A Responsive Care Scale (RCS) was constructed to reflect the degree of health care-seeking behaviour across 11 health conditions.", {"entities": []}], ["Using several patient characteristics as independent variables, four multiple regression analyses were conducted.", {"entities": []}], ["Patients\u2019 self-reports indicated that there were gender differences in health care-seeking behaviour, with women reporting they visited their primary care provider to a greater extent than did men for both physical and mental health concerns.", {"entities": []}], ["Overall, patients were less likely to seek care for mental health concerns in comparison to physical health concerns.", {"entities": []}], ["For both women and men, the results of the regressions indicated that age, illness prevention, trust in physicians and chronic conditions were important factors when explaining health care-seeking behaviours for mental health concerns.", {"entities": []}], ["This study confirms the gender differences in health care-seeking behaviour advances previous research by exploring in detail the variables predicting differences in health care-seeking behaviour for men and women.", {"entities": []}], ["The variables were better predictors of health care-seeking behaviour in response to mental health concerns than physical health concerns, likely reflecting greater variation among those seeking mental health care.", {"entities": []}], ["This study has implications for those working to improve barriers to health care access by identifying those more likely to engage in health care-seeking behaviours and the variables predicting health care-seeking.", {"entities": []}], ["Consequently, those who are not accessing primary care can be targeted and policies can be developed and put in place to promote their health care-seeking behavior.", {"entities": []}], ["A nine-year prospective study (2002\u20132010) on the prevalence of Candida dubliniensis among Candida bloodstream isolates is presented.", {"entities": []}], ["The germ tube positive isolates were provisionally identified as C. dubliniensis by presence of fringed and rough colonies on sunflower seed agar.", {"entities": []}], ["Subsequently, their identity was confirmed by Vitek2 Yeast identification system and/or by amplification and sequencing of the ITS region of rDNA.", {"entities": []}], ["In all, 368 isolates were identified as C. dubliniensis ; 67.1% came from respiratory specimens, 11.7% from oral swabs, 9.2% from urine, 3.8% from blood, 2.7% from vaginal swabs and 5.4% from other sources.", {"entities": []}], ["All C. dubliniensis isolates tested by Etest were susceptible to voriconazole and amphotericin B.", {"entities": []}], ["Resistance to fluconazole (\u22658 \u00b5g/ml) was observed in 2.5% of C. dubliniensis isolates, 7 of which occurred between 2008\u20132010.", {"entities": []}], ["Of note was the diagnosis of C. dubliniensis candidemia in 14 patients, 11 of them occurring between 2008\u20132010.", {"entities": []}], ["None of the bloodstream isolate was resistant to fluconazole, while a solitary isolate showed increased MIC to 5-flucytosine (>32 \u00b5g/ml) and belonged to genotype 4.", {"entities": []}], ["A review of literature since 1999 revealed 28 additional cases of C. dubliniensis candidemia, and 167 isolates identified from blood cultures since 1982.", {"entities": []}], ["In conclusion, this study highlights a greater role of C. dubliniensis in bloodstream infections than hitherto recognized.", {"entities": []}], ["To examine the relationship between health conditions and the risk for membership in longitudinal trajectories of productivity loss.", {"entities": []}], ["Trajectories of productivity loss from the ages of 25 to 44 years, previously identified in the National Longitudinal Survey of Youth (NLSY79), were combined with information on health conditions from the age 40 years health module in the NLSY79.", {"entities": []}], ["Multinomial logistic regression was used to examine the relative risk of being in the low-risk, early-onset increasing risk, late-onset increasing risk, or high-risk trajectories compared with the no-risk trajectory for having various health conditions.", {"entities": []}], ["The trajectories with the greatest probability of productivity loss longitudinally had a greater prevalence of the individual health conditions and a greater total number of health conditions experienced.", {"entities": []}], ["Health conditions are associated with specific longitudinal patterns of experiencing productivity loss.", {"entities": []}], ["Despite the growing interest in assessing the quality of care for depression, there is little evidence to support measurement of the quality of primary care for depression.", {"entities": []}], ["This study identified evidence-based quality indicators for monitoring, evaluating and improving the quality of care for depression in primary care settings.", {"entities": []}], ["Ovid MEDLINE and Ovid PsycINFO databases, and grey literature, including relevant organizational websites, were searched from 2000 to 2015.", {"entities": []}], ["Two reviewers independently selected studies if (1) the study methodology combined a systematic literature search with assessment of quality indicators by an expert panel and (2) quality indicators were applicable to assessment of care for adults with depression in primary care settings.", {"entities": []}], ["Included studies were appraised using the Appraisal of Indicators through Research and Evaluation (AIRE) instrument, which contains four domains and 20 items.", {"entities": []}], ["A narrative synthesis was used to combine the indicators within themes.", {"entities": []}], ["Quality indicators applicable to care for adults with depression in primary care settings were extracted using a structured form.", {"entities": []}], ["The extracted quality indicators were categorized according to Donabedian\u2019s \u2018structure-process-outcome\u2019 framework.", {"entities": []}], ["The search revealed 3838 studies.", {"entities": []}], ["Four additional publications were identified through grey literature searching.", {"entities": []}], ["Thirty-nine articles were reviewed in detail and seven met the inclusion criteria.", {"entities": []}], ["According to the AIRE domains, all studies were clear on purpose and stakeholder involvement, while formal endorsement and usage of indicators in practice were scarcely described.", {"entities": []}], ["A total of 53 quality indicators were identified from the included studies, many of which overlap conceptually or in content: 15 structure, 33 process and four outcome indicators.", {"entities": []}], ["This study identified quality indicators for evaluating primary care for depression among adult patients.", {"entities": []}], ["The identified set of indicators address multiple dimensions of depression care and provide an excellent starting point for further development and use in primary care settings.", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-017-0530-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objectives.", {"entities": []}], ["We aimed to explore the impact of gut microbiota in coronary heart disease (CHD) patients through high-throughput sequencing.", {"entities": [[61, 74, "DISEASE"], [52, 74, "DISEASE"]]}], ["A total of 29 CHD in-hospital patients and 35 healthy volunteers as controls were included.", {"entities": []}], ["Nucleic acids were extracted from fecal samples, followed by \u03b1 diversity and principal coordinate analysis (PCoA).", {"entities": []}], ["Based on unweighted UniFrac distance matrices, unweighted-pair group method with arithmetic mean (UPGMA) trees were created.", {"entities": []}], ["After data optimization, an average of 121312 \u00b1 19293 reads in CHD patients and 234372 \u00b1 108725 reads in controls was obtained.", {"entities": []}], ["Reads corresponding to 38 phyla, 90 classes, and 584 genera were detected in CHD patients, whereas 40 phyla, 99 classes, and 775 genera were detected in controls.", {"entities": []}], ["The proportion of phylum Bacteroidetes (56.12%) was lower and that of phylum Firmicutes was higher (37.06%) in CHD patients than those in the controls (60.92% and 32.06%, P < 0.05).", {"entities": []}], ["PCoA and UPGMA tree analysis showed that there were significant differences of gut microbial compositions between the two groups.", {"entities": []}], ["Conclusion.", {"entities": []}], ["The diversity and compositions of gut flora were different between CHD patients and healthy controls.", {"entities": []}], ["The incidence of CHD might be associated with the alteration of gut microbiota.", {"entities": []}], ["Statins, which are revolutionized cholesterol-lowing agents, have been reported to have unfavorable effects on the liver.", {"entities": []}], ["Inflammatory stress is a susceptibility factor for drug-induced liver injury.", {"entities": []}], ["This study investigated whether inflammatory stress sensitized the liver to statin-induced toxicity in mice and explored the underlying mechanisms.", {"entities": []}], ["We used casein injection in ApoE-/- mice to induce inflammatory stress.", {"entities": []}], ["Half of the mice were orally administered atorvastatin (10mg/kg/d) for 8 weeks.", {"entities": []}], ["The results showed that casein injection increased the levels of serum pro-inflammatory cytokines (IL-6 and TNF\u03b1).", {"entities": []}], ["Atorvastatin treatment increased serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in casein injection mice.", {"entities": []}], ["Moreover, atorvastatin treatment exacerbated hepatic steatosis, inflammation and fibrosis, as well as increased hepatic reactive oxygen species (ROS) and malondialdehyde in casein injection mice.", {"entities": []}], ["However, above changes were not observed in atorvastatin treated alone mice.", {"entities": []}], ["The protein expression of liver nuclear factor erythroid 2-related factor 2 (Nrf2) and the mRNA expressions of Nrf2 target genes were increased, together with the enhancement of activities of hepatic catalase and superoxide dismutase in atorvastatin treated alone mice, but these antioxidant responses were lost in mice treated with atorvastatin under inflammatory stress.", {"entities": []}], ["This study demonstrates that atorvastatin exacerbates the liver injury under inflammatory stress, which may be associated with the loss of adaptive antioxidant response mediated by Nrf2.", {"entities": []}], ["It has been reported that the composition of human gut microbiota changes with age; however, few studies have used molecular techniques to investigate the long-term, sequential changes in gut microbiota composition.", {"entities": []}], ["In this study, we investigated the sequential changes in gut microbiota composition in newborn to centenarian Japanese subjects.", {"entities": []}], ["Fecal samples from 367 healthy Japanese subjects between the ages of 0 and 104\u00a0years were analyzed by high-throughput sequencing of amplicons derived from the V3-V4 region of the 16S rRNA gene.", {"entities": []}], ["Analysis based on bacterial co-abundance groups (CAGs) defined by Kendall correlations between genera revealed that certain transition types of microbiota were enriched in infants, adults, elderly individuals and both infant and elderly subjects.", {"entities": []}], ["More positive correlations between the relative abundances of genera were observed in the elderly-associated CAGs compared with the infant- and adult-associated CAGs.", {"entities": []}], ["Hierarchical Ward\u2019s linkage clustering based on the abundance of genera indicated five clusters, with median (interquartile range) ages of 3 (0\u201335), 33 (24\u201345), 42 (32\u201362), 77 (36\u201384) and 94 (86\u201398) years.", {"entities": []}], ["Subjects were predominantly clustered with their matched age; however, some of them fell into mismatched age clusters.", {"entities": []}], ["Furthermore, clustering based on the proportion of transporters predicted by phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) showed that subjects were divided into two age-related groups, the adult-enriched and infant/elderly-enriched clusters.", {"entities": []}], ["Notably, all the drug transporters based on Kyoto Encyclopedia of Genes and Genomes (KEGG) Orthology groups were found in the infant/elderly-enriched cluster.", {"entities": []}], ["Our results indicate some patterns and transition points in the compositional changes in gut microbiota with age.", {"entities": []}], ["In addition, the transporter property prediction results suggest that nutrients in the gut might play an important role in changing the gut microbiota composition with age.", {"entities": []}], ["The online version of this article (doi:10.1186/s12866-016-0708-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to establish ethnic- and gender-specific cut-off values of triglycerides and glucose index (TyG index) for clinical usefulness in a representative sample of Mexican American, Non-Hispanic White, Non-Hispanic Black, and Korean adolescents.", {"entities": []}], ["The data were collected from datasets of the National Health and Nutrition Examination Survey between 1999 and 2012, and the Korean National Health and Nutrition Examination Survey between 2005 and 2013.", {"entities": []}], ["Receiver operating characteristic curve analysis was used to find valid cut-off values of the TyG index for metabolic syndrome.", {"entities": [[118, 126, "DISEASE"]]}], ["The total number of eligible participants was 3,164 in the US and 4,873 in Korea.", {"entities": []}], ["The optimal cut-off value with the Cook et al.", {"entities": []}], ["definition revealed 8.55 in Mexican American, 8.55 in Non-Hispanic White, 8.35 in Non-Hispanic Black, and 8.45 in Korean, respectively.", {"entities": []}], ["The cut-off value with the de Ferranti et al.", {"entities": []}], ["definition was 8.45, 8.45, 8.15, and 8.35, and the cut-off value with the International Diabetes Federation definition was 8.65, 8.65, 8.15, and 8.55, respectively.", {"entities": []}], ["These findings may be clinically useful for evaluating insulin resistance for determining metabolic abnormalities in adolescents.", {"entities": []}], ["Group 2 allergens (Der p2) have been reported to be a major cause of the human immune response to dust mite allergens.", {"entities": []}], ["In this study, we have demonstrated for the first time the effective differentiation between haplotype mutation and normal genes in the MD-2 gene promoter using a nanostructured biosensor.", {"entities": []}], ["A 70-mer gene fragment containing the haplotype of two single nucleotide polymorphisms in the MD-2 gene promoter region was used as a probe to detect haplotype mutations associated with Der p2-induced allergy.", {"entities": []}], ["Discrimination was achieved using electrochemical impedance spectroscopy.", {"entities": []}], ["The discrimination experiments employed 30 haplotype mutation samples and 30 normal target samples.", {"entities": []}], ["The haplotype mutation samples and normal target samples could be clearly discriminated, even using samples produced by a five-cycle polymerase chain reaction process.", {"entities": []}], ["The time and cost of sample preparation for the polymerase chain reaction process in the clinical setting can thus be reduced.", {"entities": []}], ["Chitinase-3-like-1 (Chi3l1) is known to play a significant role in the pathogenesis of Type 2 inflammation and cancer.", {"entities": [[111, 117, "DISEASE"], [20, 26, "GENE"]]}], ["However, the function of Chi3l1 in T cell and its clinical implications are largely unknown.", {"entities": [[25, 31, "GENE"]]}], ["Here we show that Chi3l1 expression was increased in activated T cells, especially in Th2 cells.", {"entities": [[18, 24, "GENE"]]}], ["In addition, Chi3l1-deficient T cells are hyper-responsive to TcR stimulation and are prone to differentiating into Th1 cells.", {"entities": []}], ["Chi3l1-deficient Th1 cells show increased expression of anti-tumor immunity genes and decreased Th1 negative regulators.", {"entities": []}], ["Deletion of Chi3l1 in T cells in mice show reduced melanoma lung metastasis with increased IFN\u03b3 and TNF\u03b1-producing T cells in the lung.", {"entities": [[51, 59, "DISEASE"], [12, 18, "GENE"]]}], ["Furthermore, silencing of Chi3l1 expression in the lung using peptide-siRNA complex (dNP2-siChi3l1) efficiently inhibit lung metastasis with enhanced Th1 and CTL responses.", {"entities": [[26, 32, "GENE"]]}], ["Collectively, this study demonstrates Chi3l1 is a regulator of Th1 and CTL which could be a therapeutic target to enhance anti-tumor immunity.", {"entities": [[38, 44, "GENE"]]}], ["Chitinase-3-like-1 (Chi3l1) has been involved in inflammation and pulmonary metastasis.", {"entities": [[20, 26, "GENE"]]}], ["Here the authors show that Chi3l1 inhibits the\u00a0T cell response by negatively regulating their activation and that, in a mouse model of melanoma, T cell-targeted silencing of Chi3l1 results in reduced lung metastasis.", {"entities": [[135, 143, "DISEASE"], [27, 33, "GENE"], [174, 180, "GENE"], [27, 33, "GENE"], [174, 180, "GENE"]]}], ["Human respiratory syncytial virus (HRSV) is a major cause of pediatric lower respiratory tract disease to which there is no vaccine or efficacious chemotherapeutic strategy.", {"entities": [[71, 102, "DISEASE"]]}], ["Although RNA synthesis and virus assembly occur in the cytoplasm, HRSV is known to induce nuclear responses in the host cell as replication alters global gene expression.", {"entities": []}], ["Quantitative proteomics was used to take an unbiased overview of the protein changes in transformed human alveolar basal epithelial cells infected with HRSV.", {"entities": []}], ["Underpinning this was the use of stable isotope labeling with amino acids in cell culture coupled to LC-MS/MS, which allowed the direct and simultaneous identification and quantification of both cellular and viral proteins.", {"entities": []}], ["To reduce sample complexity and increase data return on potential protein localization, cells were fractionated into nuclear and cytoplasmic extracts.", {"entities": []}], ["This resulted in the identification of 1,140 cellular proteins and six viral proteins.", {"entities": []}], ["The proteomics data were analyzed using Ingenuity Pathways Analysis to identify defined canonical pathways and functional groupings.", {"entities": []}], ["Selected data were validated using Western blot, direct and indirect immunofluorescence confocal microscopy, and functional assays.", {"entities": []}], ["The study served to validate and expand upon known HRSV-host cell interactions, including those associated with the antiviral response and alterations in subnuclear structures such as the nucleolus and ND10 (promyelocytic leukemia bodies).", {"entities": [[222, 230, "DISEASE"]]}], ["In addition, novel changes were observed in mitochondrial proteins and functions, cell cycle regulatory molecules, nuclear pore complex proteins and nucleocytoplasmic trafficking proteins.", {"entities": []}], ["These data shed light into how the cell is potentially altered to create conditions more favorable for infection.", {"entities": []}], ["Additionally, the study highlights the application and advantage of stable isotope labeling with amino acids in cell culture coupled to LC-MS/MS for the analysis of virus-host interactions.", {"entities": []}], ["Prolonged weaning from mechanical ventilation has a major impact on ICU bed occupancy and patient outcome, and has significant cost implications.", {"entities": []}], ["There is evidence in patients around the period of extubation that helium-oxygen leads to a reduction in the work of breathing.", {"entities": []}], ["Therefore breathing helium-oxygen during weaning may be a useful adjunct to facilitate weaning.", {"entities": []}], ["We hypothesised that breathing helium-oxygen would reduce carbon dioxide production during the weaning phase of mechanical ventilation.", {"entities": []}], ["We performed a prospective randomised controlled single blinded cross-over trial on 19 adult intensive care patients without significant airways disease who fulfilled criteria for weaning with CPAP.", {"entities": []}], ["Patients were randomised to helium-oxygen and air-oxygen delivered during a 2 hour period of CPAP ventilation.", {"entities": []}], ["Carbon dioxide production (VCO 2 ) was measured using a near patient main stream infrared carbon dioxide sensor and fixed orifice pneumotachograph.", {"entities": []}], ["Compared to air-oxygen, helium-oxygen significantly decreased VCO 2 production at the end of the 2 hour period of CPAP ventilation; there was a mean difference in CO 2 production of 48.9 ml/min (95% CI 18.7-79.2 p = 0.003) between the groups.", {"entities": []}], ["There were no significant differences in other respiratory and haemodynamic parameters.", {"entities": []}], ["This study shows that breathing a helium-oxygen mixture during weaning reduces carbon dioxide production.", {"entities": []}], ["This physiological study supports the need for a clinical trial of helium-oxygen mixture during the weaning phase of mechanical ventilation with duration of weaning as the primary outcome.", {"entities": []}], ["ISRCTN56470948", {"entities": []}], ["Electronic noses are composites of nanosensor arrays.", {"entities": []}], ["Numerous studies showed their potential to detect lung cancer from breath samples by analysing exhaled volatile compound pattern (\u201cbreathprint\u201d).", {"entities": [[50, 61, "DISEASE"], [55, 61, "DISEASE"]]}], ["Expiratory flow rate, breath hold and inclusion of anatomic dead space may influence the exhaled levels of some volatile compounds; however it has not been fully addressed how these factors affect electronic nose data.", {"entities": []}], ["Therefore, the aim of the study was to investigate these effects.", {"entities": []}], ["37 healthy subjects (44\u2009\u00b1\u200914\u00a0years) and 27 patients with lung cancer (60\u2009\u00b1\u200910\u00a0years) participated in the study.", {"entities": [[57, 68, "DISEASE"], [62, 68, "DISEASE"]]}], ["After deep inhalation through a volatile organic compound filter, subjects exhaled at two different flow rates (50\u00a0ml/sec and 75\u00a0ml/sec) into Teflon-coated bags.", {"entities": []}], ["The effect of breath hold was analysed after 10\u00a0seconds of deep inhalation.", {"entities": []}], ["We also studied the effect of anatomic dead space by excluding this fraction and comparing alveolar air to mixed (alveolar\u2009+\u2009anatomic dead space) air samples.", {"entities": []}], ["Exhaled air samples were processed with Cyranose 320 electronic nose.", {"entities": []}], ["Expiratory flow rate, breath hold and the inclusion of anatomic dead space significantly altered \u201cbreathprints\u201d in healthy individuals (p\u2009<\u20090.05), but not in lung cancer (p\u2009>\u20090.05).", {"entities": [[158, 169, "DISEASE"], [163, 169, "DISEASE"]]}], ["These factors also influenced the discrimination ability of the electronic nose to detect lung cancer significantly.", {"entities": [[90, 101, "DISEASE"], [95, 101, "DISEASE"]]}], ["We have shown that expiratory flow, breath hold and dead space influence exhaled volatile compound pattern assessed with electronic nose.", {"entities": []}], ["These findings suggest critical methodological recommendations to standardise sample collections for electronic nose measurements.", {"entities": []}], ["In many countries, short-acting \u03b2 2 -agonist inhalers have traditionally been coloured blue.", {"entities": []}], ["This inhaled therapy has also conventionally been known as a \u2018reliever\u2019 by patients and healthcare professionals (HCPs), in comparison with \u2018preventer\u2019 medications (inhaled steroids).", {"entities": []}], ["With the rapidly changing market in inhaled therapy for COPD and asthma and growing numbers of devices, there has been some concern that the erosion of traditional colour conventions is leading to patients (and HCPs) becoming confused about the role of different therapies.", {"entities": [[65, 71, "DISEASE"]]}], ["In order to assess whether there was concern over the perceived changing colour conventions, the UK Inhaler Group carried out a large online survey of patients and HCPs.", {"entities": []}], ["The aim was to determine how patients and HCPS identify and describe inhaled drugs, and how this might impact on use of medicines and safety.", {"entities": []}], ["The results of the survey highlighted the importance of the term \u2018blue inhaler\u2019 for patients with only 11.3% never referring to the colour when referring to their inhaler.", {"entities": []}], ["For HCPs, 95% felt colour conventions were important when referring to reliever medication.", {"entities": []}], ["In addition, HCPs appear to refer to inhalers mainly by colour when talking to patients.", {"entities": []}], ["Our conclusions were that the concept of a \u2018blue inhaler\u2019 remains important to patients and healthcare professionals.", {"entities": []}], ["These results add to the debate about the need to formalise the colour coding of inhaled therapies, in particular using the colour blue for inhalers for rapid relief of symptoms, as this convention may be an important measure and contributor to patient safety.", {"entities": []}], ["Our survey should provide impetus for all interested parties to discuss and agree a formal industry-wide approach to colour coding of inhaled therapies for the benefit of patients and carers and HCPs.", {"entities": []}], ["This study relies on knowledge regarding the neuroplasticity of dual-system components that govern addiction and excessive behavior and suggests that alterations in the grey matter volumes, i.e., brain morphology, of specific regions of interest are associated with technology-related addictions.", {"entities": []}], ["Using voxel based morphometry (VBM) applied to structural Magnetic Resonance Imaging (MRI) scans of twenty social network site (SNS) users with varying degrees of SNS addiction, we show that SNS addiction is associated with a presumably more efficient impulsive brain system, manifested through reduced grey matter volumes in the amygdala bilaterally (but not with structural differences in the Nucleus Accumbens).", {"entities": []}], ["In this regard, SNS addiction is similar in terms of brain anatomy alterations to other (substance, gambling etc.)", {"entities": []}], ["addictions.", {"entities": []}], ["We also show that in contrast to other addictions in which the anterior-/ mid- cingulate cortex is impaired and fails to support the needed inhibition, which manifests through reduced grey matter volumes, this region is presumed to be healthy in our sample and its grey matter volume is positively correlated with one\u2019s level of SNS addiction.", {"entities": []}], ["These findings portray an anatomical morphology model of SNS addiction and point to brain morphology similarities and differences between technology addictions and substance and gambling addictions.", {"entities": []}], ["More so than the traditional socioeconomic indicators, such as education and income, wealth reflects the accumulation of resources and makes socioeconomic ranking manifest and explicitly visible to the outside world.", {"entities": []}], ["While the lack of basic goods, such as a refrigerator, may affect health directly, via biological pathways, the lack of luxury goods, such as an LCD television, may affect health indirectly through psychosocial mechanisms.", {"entities": []}], ["We set out to examine, firstly, the relevance of both basic and luxury goods in explaining health-related dysfunction in older persons, and, secondly, the extent to which these associations are independent of traditional socioeconomic indicators.", {"entities": []}], ["Cross-sectional and longitudinal data from 2067 men and women aged 55 years and older who participated in the Study on Medical Information and Lifestyles Eindhoven (SMILE) were gathered.", {"entities": []}], ["Logistic regression analyses were used to study the relation between a lack of basic and luxury goods and health-related function, assessed with two sub-domains of the SF-36.", {"entities": []}], ["The lack of basic goods was closely related to incident physical (OR = 2.32) and mental (OR = 2.12) dysfunction, even when the traditional measures of socioeconomic status, i.e.", {"entities": []}], ["education or income, were taken into account.", {"entities": []}], ["Cross-sectional analyses, in which basic and luxury goods were compared, showed that the lack of basic goods was strongly associated with mental dysfunction.", {"entities": []}], ["Lack of luxury goods was, however, not related to dysfunction.", {"entities": []}], ["Even in a relatively wealthy country like the Netherlands, the lack of certain basic goods is not uncommon.", {"entities": []}], ["More importantly, lack of basic goods, as an indicator of wealth, was strongly related to health-related dysfunction also when traditional measures of socioeconomic status were taken into account.", {"entities": []}], ["In contrast, no effects of luxury goods on physical or mental dysfunction were found.", {"entities": []}], ["Future longitudinal research is necessary to clarify the precise mechanisms underlying these effects.", {"entities": []}], ["Monocyte exposure to mitochondrial Danger Associated Molecular Patterns (DAMPs), including mitochondrial DNA (mtDNA), induces a transient state in which these cells are refractory to further endotoxin stimulation.", {"entities": []}], ["In this context, IRAK-M up-regulation and impaired p65 activity were observed.", {"entities": []}], ["This phenomenon, termed endotoxin tolerance (ET), is characterized by decreased production of cytokines in response to the pro-inflammatory stimulus.", {"entities": []}], ["We also show that monocytes isolated from patients with myocardial infarction (MI) exhibited high levels of circulating mtDNA, which correlated with ET status.", {"entities": [[56, 77, "DISEASE"]]}], ["Moreover, a significant incidence of infection was observed in those patients with a strong tolerant phenotype.", {"entities": []}], ["The present data extend our current understanding of the implications of endotoxin tolerance.", {"entities": []}], ["Furthermore, our data suggest that the levels of mitochondrial antigens in plasma, such as plasma mtDNA, should be useful as a marker of increased risk of susceptibility to nosocomial infections in MI and in other pathologies involving tissue damage.", {"entities": []}], ["Self-reports of sensitive, socially stigmatized or illegal behavior are common in STI/HIV research, but can raise challenges in terms of data reliability and validity.", {"entities": []}], ["The use of electronic data collection tools, including ecological momentary assessment (EMA), can increase the accuracy of this information by allowing a participant to self-administer a survey or diary entry, in their own environment, as close to the occurrence of the behavior as possible.", {"entities": []}], ["In this paper, we evaluate the feasibility of using cell phone-based EMA as a tool for understanding sexual risk and STI among adult men and women.", {"entities": []}], ["As part of a larger prospective clinical study on sexual risk behavior and incident STI in clinically recruited adult men and women, using study-provided cell phones, participants (N\u2009=\u2009243) completed thrice\u2013daily EMA diaries monitoring individual and partner-specific emotional attributes, non-sexual activities, non-coital or coital sexual behaviors, and contraceptive behaviors.", {"entities": []}], ["Using these data, we assess feasibility in terms of participant compliance, behavior reactivity, general method acceptability and method efficacy for capturing behaviors.", {"entities": []}], ["Participants were highly compliant with diary entry protocol and schedule: over the entire 12 study weeks, participants submitted 89.7% (54,914/61,236) of the expected diary entries, with an average of 18.86 of the 21 expected diaries (85.7%) each week.", {"entities": []}], ["Submission did not differ substantially across gender, race/ethnicity and baseline sexually transmitted infection status.", {"entities": []}], ["A sufficient volume and range of sexual behaviors were captured, with reporting trends in different legal and illegal behaviors showing small variation over time.", {"entities": []}], ["Participants found the methodology to be acceptable, enjoyed and felt comfortable participating in the study.", {"entities": []}], ["Achieving the correct medium of data collection can drastically improve, or degrade, the timeliness and quality of an individual\u2019s self-reported sexual risk behavior, which in turn, is a key factor in the success of intervention or education programs relying on this information.", {"entities": []}], ["Our findings demonstrate that completion of electronic diaries via cellular phone is feasible way to describe STI/HIV risk among clinically recruited adult men and women.", {"entities": []}], ["Increased oxidative stress has an important role in asthmatic airway inflammation and remodeling.", {"entities": []}], ["A potent methyl donor, S-adenosylmethionine (SAMe), is known to protect against tissue injury and fibrosis through modulation of oxidative stress.", {"entities": []}], ["The aim of this study was to evaluate the effect of SAMe on airway inflammation and remodeling in a murine model of chronic asthma.", {"entities": [[124, 130, "DISEASE"]]}], ["A mouse model was generated by repeated intranasal challenge with ovalbumin and Aspergillus fungal protease twice a week for 8 weeks.", {"entities": []}], ["SAMe was orally administered every 24\u2009h for 8 weeks.", {"entities": []}], ["We performed bronchoalveolar lavage (BAL) fluid analysis and histopathological examination.", {"entities": []}], ["The levels of various cytokines and 4-hydroxy-2-nonenal (HNE) were measured in the lung tissue.", {"entities": []}], ["Cultured macrophages and fibroblasts were employed to evaluate the underlying anti-inflammatory and antifibrotic mechanisms of SAMe.", {"entities": []}], ["The magnitude of airway inflammation and fibrosis, as well as the total BAL cell counts, were significantly suppressed in the SAMe-treated groups.", {"entities": []}], ["A reduction in T helper type 2 pro-inflammatory cytokines and HNE levels was observed in mouse lung tissue after SAMe administration.", {"entities": []}], ["Macrophages cultured with SAMe also showed reduced cellular oxidative stress and pro-inflammatory cytokine production.", {"entities": []}], ["Moreover, SAMe treatment attenuated transforming growth factor-\u03b2 (TGF-\u03b2)-induced fibronectin expression in cultured fibroblasts.", {"entities": []}], ["SAMe had a suppressive effect on airway inflammation and fibrosis in a mouse model of chronic asthma, at least partially through the attenuation of oxidative stress and TGF-\u03b2-induced fibronectin expression.", {"entities": [[94, 100, "DISEASE"]]}], ["The results of this study suggest a potential role for SAMe as a novel therapeutic agent in chronic asthma.", {"entities": [[100, 106, "DISEASE"]]}], ["Financial incentives are utilised in healthcare systems in a number of countries to improve quality of care delivered to patients by rewarding practices or practitioners for achieving set targets.", {"entities": []}], ["To systematically review the evidence investigating the impact of financial incentives for implementation of supported self-management on quality of care including: organisational process outcomes, individual behavioural outcomes, and health outcomes for individuals with asthma or diabetes; both conditions with an extensive evidence base for self-management.", {"entities": [[272, 278, "DISEASE"]]}], ["We followed Cochrane methodology, using a PICOS search strategy to search eight databases in November 2015 (updated May 2017) including a broad range of implementation methodologies.", {"entities": []}], ["Studies were weighted by robustness of methodology, number of participants and the quality score.", {"entities": []}], ["We used narrative synthesis due to heterogeneity of studies.", {"entities": []}], ["We identified 2,541 articles; 12 met our inclusion criteria.", {"entities": []}], ["The articles were from the US (n = 7), UK (n = 4) and Canada (n = 1).", {"entities": []}], ["Measured outcomes were HbA1c tests undertaken and/or the level achieved (n = 10), written action plans for asthma (n = 1) and hospital/emergency department visits (n = 1).", {"entities": [[107, 113, "DISEASE"]]}], ["Three of the studies were part of a larger incentive scheme including many conditions; one focused on asthma; eight focussed on diabetes.", {"entities": [[102, 108, "DISEASE"]]}], ["In asthma, the proportion receiving \u2018perfect care\u2019 (including providing a written action plan) increased from 4% to 88% in one study, and there were fewer hospitalisations/emergency department visits in another study.", {"entities": [[3, 9, "DISEASE"]]}], ["Across the diabetes studies, quality-of-care/GP performance scores improved in three, were unchanged in six and deteriorated in one.", {"entities": []}], ["Results for the impact of financial incentives for the implementation of self-management were mixed.", {"entities": []}], ["The evidence in diabetes suggests no consistent impact on diabetic control.", {"entities": []}], ["There was evidence from a single study of improved process and health outcomes in asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["Further research is needed to confirm these findings and understand the process by which financial incentives may impact (or not) on care.", {"entities": []}], ["Protocol registration number: CRD42016027411", {"entities": []}], ["The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) is a brief measure of global disability originally developed for adults, which has since been implemented among samples of children and youth.", {"entities": []}], ["However, evidence of its validity for use among youth, particularly measurement invariance, is lacking.", {"entities": []}], ["Investigations of measurement invariance assess the extent to which the psychometric properties of observed items in a measure are generalizable across samples.", {"entities": []}], ["Satisfying the assumption of measurement invariance is critical for any inferences about between-group differences.", {"entities": []}], ["The objective of this paper was to empirically assess the measurement invariance of the 12-item interview version of the WHODAS 2.0 measure in an epidemiological sample of youth (15 to 17 years) and adults (\u2265 18 years) in Canada.", {"entities": []}], ["Multiple-group confirmatory factor analysis using a categorical variable framework allowed for the sequential testing of increasingly restrictive models to evaluate measurement invariance of the WHODAS 2.0 between adults and youth.", {"entities": []}], ["Findings provided evidence for full measurement invariance of the WHODAS 2.0 in youth aged 15 to 17 years.", {"entities": []}], ["The final model fit the data well: \u03c7 p < .001; CFI = 0.950, TLI = 0.958, RMSEA (90% CI) = 0.055 [0.051, 0.059].", {"entities": [[47, 50, "GENE"]]}], ["Results from this study build on previous work supporting the validity of the WHODAS 2.0.", {"entities": []}], ["Findings indicate that the WHODAS 2.0 is valid for making substantive comparisons of disability among youth as young as 15 years of age.", {"entities": []}], ["Pediatric asthma is a serious public health problem in Chicago and has been designated a high priority concern by residents of Chicago's Humboldt Park, a diverse community area with a large number of Puerto Rican, African American, and Mexican American families.", {"entities": [[10, 16, "DISEASE"]]}], ["In May 2009, following the principles of community-based participatory research, a cross-sectional asthma screening survey was administered to adult caregivers of children attending two Humboldt Park elementary schools.", {"entities": [[99, 105, "DISEASE"]]}], ["Data were analyzed to determine the prevalence of diagnosed and probable asthma as well as the degree of asthma control among affected children; associations between asthma outcomes and mutable triggers were evaluated.", {"entities": [[73, 79, "DISEASE"], [105, 111, "DISEASE"], [166, 172, "DISEASE"]]}], ["Surveys from 494 children were evaluated.", {"entities": []}], ["Physician-diagnosed asthma was reported for 24.9% of children and probable asthma identified in an additional 16.2% of children.", {"entities": [[20, 26, "DISEASE"], [75, 81, "DISEASE"]]}], ["Asthma was poorly or moderately controlled in 60.0% of diagnosed children.", {"entities": [[0, 6, "DISEASE"]]}], ["Smoking occurred inside 25.0% of households and 75.0% of caregivers reported idling of vehicles in their community.", {"entities": []}], ["Report of general stress among caregivers, stress due to community crime, and/or an inability to cope with everyday life were significantly and positively associated with poor asthma morbidity and control among affected children.", {"entities": [[176, 182, "DISEASE"]]}], ["Despite high prevalence rates and poor asthma morbidity and control in Humboldt Park, the association of these measures with mutable variables is promising.", {"entities": [[39, 45, "DISEASE"]]}], ["A community-based asthma intervention to address the issues identified in this study is needed to affect positive change.", {"entities": [[18, 24, "DISEASE"]]}], ["Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders that are mediated by pathogenic Th1 and Th17 cells.", {"entities": []}], ["Previous studies have demonstrated that taheebo water extract (TWE) derived from Tabebuia avellanedae Lorentz ex Griseb ., as folk remedy, has been used to treat various inflammatory diseases.", {"entities": []}], ["Although TWE has been previously shown to display anti-inflammatory activities, the in vivo effects of TWE on mucosal immune responses remain unclear.", {"entities": []}], ["We examined the anti-inflammatory effects of TWE on innate immune cells such as dendritic cells (DCs) and macrophages and also on the differentiation of T helper cells.", {"entities": []}], ["Lastly, adopting a method for dextran sulfate sodium (DSS)-induced colitis, we investigated whether the oral administration of TWE can modulate mucosal inflammatory responses.", {"entities": []}], ["We found that TWE could activate DCs to produce immunosuppressive IL10 and polarize macrophages toward an anti-inflammatory phenotype in the mesenteric lymph node (MLN).", {"entities": [[66, 70, "GENE"], [164, 167, "GENE"]]}], ["Such alterations in DCs and macrophages resulted in a significant increase in anti-inflammatory Th2 and Foxp3 Taken together, these data suggest that TWE is an excellent natural product with therapeutic effects to help improve inflammatory disorders such as colitis.", {"entities": [[104, 109, "GENE"]]}], ["We reply to the Ioannidis's paper \"Effectiveness of antidepressants; an evidence based myth constructed from a thousand controlled trials.\"", {"entities": []}], ["We disagree that antidepressants have no greater efficacy than placebo.", {"entities": []}], ["We present the efficacy from hundreds of trials in terms of the percentage of patients with a substantial clinical response (a 50% improvement or more symptomatic reduction).", {"entities": []}], ["This meta-analysis finds that 42-70% of depressed patients improve with drug and 21%-39% improve with placebo.", {"entities": []}], ["The response benefit of antidepressant treatment is 33%-11% greater than placebo.", {"entities": []}], ["Ioannidis argues that it would be vanishingly smaller because systematic biasing in these clinical trials would reduce the drug-placebo difference to zero.", {"entities": []}], ["Ioannidis' argument that antidepressants have no benefit is eroded by his failures of logic because he does not present any evidence that there are a large number of studies where placebo is substantially more effective than drug.", {"entities": []}], ["(To reduce to zero, one would also have to show that some of the unpublished studies find placebo better than drug and have substantial systematic or methodological bias).", {"entities": []}], ["We also present the empirical evidence showing that these methodological concerns generally have the opposite effect of what Ioannidis argues, supporting our contention that the measured efficacy of antidepressants likely underestimates true efficacy.", {"entities": []}], ["Our most important criticism is Ioannidis\u2019 basic underlying argument about antidepressants that if the existing evidence is imperfect and methods can be criticized, then this proves that antidepressant are not efficacious.", {"entities": []}], ["He presents no credible evidence that antidepressants have zero effect size.", {"entities": []}], ["Valid arguments can point out difficulties with the data but do not prove that a given drug had no efficacy.", {"entities": []}], ["Indeed better evidence might prove it was more efficacious that originally found.", {"entities": []}], ["We find no empirical or ethical reason why psychiatrists should not try to help depressed patients with drugs and/or with psychotherapeutic/behavioral treatments given evidence of efficacy even though our treatment knowledge has limitations.", {"entities": []}], ["The immense suffering of patients with major depression leads to ethical, moral, professional and legal obligations to treat patients with the best available tools at our disposal, while diligently and actively monitoring for adverse effects and actively revising treatment components as necessary.", {"entities": []}], ["Monitoring clinical disease status in cystic fibrosis frequently requires invasive collection of clinical samples.", {"entities": [[38, 53, "DISEASE"]]}], ["Due to its noninvasive collection process and direct anatomic relationship with the lower airway, saliva shows great potential as a biological fluid for cystic fibrosis monitoring.", {"entities": [[153, 168, "DISEASE"]]}], ["To measure the levels of multiple protein markers in human saliva supernatants and investigate the possibility of utilizing them to provide a more quantitative measure of disease state for use in research and monitoring of patients with cystic fibrosis clinically.", {"entities": [[237, 252, "DISEASE"]]}], ["Whole saliva samples were collected and processed from cystic fibrosis patients at two distinct time points (2010 and 2013) and measured by two separate platforms.", {"entities": [[55, 70, "DISEASE"]]}], ["In this cross sectional study, a convenience sample of 71 participants were recruited with samples measured by multiplexed fluorescence microarray (fiber microarray) and another 117 participant samples were measured by an automated, point-of-care, analyzer (SDReader) using a microsphere-based array via fluorescence sandwich immunoassay.", {"entities": []}], ["For comparison, saliva from 56 and 50 healthy subjects were collected, respectively.", {"entities": []}], ["The levels of six target proteins were quantified.", {"entities": []}], ["Various demographic and clinical data, including spirometry, medical history, and clinicians\u2019 assessments were also collected from patients with cystic fibrosis on the day of saliva collection.", {"entities": [[145, 160, "DISEASE"]]}], ["Similar trends were observed with both platforms and compared with healthy subjects, cystic fibrosis patients had significantly elevated levels of VEGF, IP-10, IL-8, and EGF as well as lower levels of MMP-9 ( P \u2264 0.005) using fiber microarray and significantly elevated levels of IP-10, IL-8 with lower levels of MMP-9 and IL-1 \u03b2 ( P \u2264 0.02) using the SDReader.", {"entities": [[85, 100, "DISEASE"], [170, 173, "GENE"]]}], ["The levels of the six proteins correlated with each other significantly, and in some cases, biomarker levels could be used to differentiate between subgroups of patients with different clinical presentations.", {"entities": []}], ["For example, IP-10 levels significantly correlated with FEV 1 and disease severity (as evaluated by clinicians) with both platforms ( P < 0.05).", {"entities": [[56, 59, "GENE"]]}], ["Significant variations of the levels of six proteins in saliva supernatants, and the correlations of these levels with clinical assessments, demonstrated the potential of saliva for cystic fibrosis research and monitoring.", {"entities": [[182, 197, "DISEASE"]]}], ["Paracoccidioidomycosis (PCM), an endemic systemic mycosis caused by the fungus Paracoccidioides brasiliensis (Pb) , usually results in severe lung damage in patients.", {"entities": [[41, 57, "DISEASE"]]}], ["Considering the difficulties to sequentially study the infection in humans, this work was done in mice inoculated intranasally with infective Pb- conidia.", {"entities": []}], ["Lungs of control and Pb -infected mice were studied after 2-hours, 4, 8, 12 and 16-weeks post-infection (p.i) in order to define histopathologic patterns of pulmonary lesions, multiplex-cytokine profiles and their dynamics during the course of this mycosis.", {"entities": []}], ["Besides the nodular/granulomatous lesions previously informed, results revealed additional non-formerly described lung abnormalities, such as periarterial sheath inflammation and pseudotumoral masses.", {"entities": []}], ["The following chronologic stages occurring during the course of the experimental infection were defined: Stage one (2-hours p.i): mild septal infiltration composed by neutrophils and macrophages accompanied by an intense \u201ccytokine burst\u201d represented by significant increases in IL-1\u03b1, IL-1\u03b2, IL-4, IL-5, IL-6, IL-10, IL12p70, IL-13, IL-17, Eotaxin, G-CSF, MCP1, MIP1\u03b1, GM-CSF, IFN-\u03b3, MIP1\u03b2 and TNF\u03b1 levels.", {"entities": []}], ["Stage two (4-weeks p.i): presence of nodules, evidence of incipient periarterial- and intense but disperse parenchymal- inflammation, abnormalities that continued to be accompanied by hyper-secretion of those cytokines and chemokines mentioned in the first stage of infection.", {"entities": []}], ["Stages three and four (8 and 12-weeks p.i.", {"entities": []}], ["): fungal proliferation, inflammation and collagenesis reached their highest intensity with particular involvement of the periarterial space.", {"entities": []}], ["Paradoxically, lung cytokines and chemokines were down-regulated with significant decreases in IL-2,IL-3,IL-5,IL-9,IL-13,IL-15,GM-CSF,IFN-\u03b3,MIP1\u03b2 and TNF\u03b1.", {"entities": []}], ["Stage five (16-weeks p.i.", {"entities": []}], ["): inflammation decreased becoming limited to the pseudotumoral masses and was accompanied by a \u201csilent\u201d cytokine response, except for PDGF, MIG, RANTES and IL12p40 which remained up-regulated for the duration of the experiment.", {"entities": []}], ["Results of this study identified both classic and novel patterns corresponding to histopathologic and immunologic responses occurring during the course of experimental PCM.", {"entities": []}], ["Paracoccidioidomycosis (PCM), an endemic fungal infection of pulmonary origin resulting in severe disseminated disease, occurs in rural areas of most South American countries and presents several clinical forms.", {"entities": []}], ["The infection is acquired by inhalation of specific fungal propagules, called conidia.", {"entities": []}], ["Considering the difficulties encountered when studying the infection in humans, this work was done in mice infected by inhalation of infective fungal conidia thus mimicking the human natural infection.", {"entities": []}], ["The lungs of mice were sequentially studied by histopathological and multiplex cytokine methods from 2 h to 16 weeks after infection to verify the course of the disease.", {"entities": []}], ["The mycosis presented different morphologic aspects during the course of time, affecting several pulmonary compartments.", {"entities": []}], ["Otherwise and based on the analysis of 30 cytokines, the immune response also showed heterogeneous responses, which were up or down regulated depending on the time of infection.", {"entities": []}], ["By recognizing the different stages that correspond to the evolution of pulmonary lesions, the severity (benign, chronic or fibrotic) of the disease could be predicted and the probable prognosis of the illness be inferred.", {"entities": []}], ["Previous studies have suggested that IL4, IL13, and IL4R are associated with serum IgE levels and allergies, and common variants of these genes may alter cancer risk.", {"entities": [[154, 160, "DISEASE"], [37, 40, "GENE"], [42, 46, "GENE"], [52, 56, "GENE"]]}], ["To clarify these associations, we conducted a meta-analysis to investigate the associations of IL4 , IL13 , and IL4R polymorphisms with gastrointestinal cancer risk.", {"entities": [[153, 159, "DISEASE"], [95, 98, "GENE"], [101, 105, "GENE"], [112, 116, "GENE"]]}], ["We used 27 eligible case\u2013control studies describing the associations of six polymorphisms of IL4 , IL13 , and IL4R with gastrointestinal cancer risk to calculate summary odds ratios (ORs) and 95% confidence intervals (CIs) using five different genetic models.", {"entities": [[137, 143, "DISEASE"], [93, 96, "GENE"], [99, 103, "GENE"], [110, 114, "GENE"]]}], ["The Q-statistic and I The IL4 rs2070874 T allele seems to be associated with an increased risk of gastrointestinal cancer (OR 1.11; 95% CI, 1.00\u20131.24 for T allele vs .", {"entities": [[115, 121, "DISEASE"], [26, 29, "GENE"]]}], ["This association was significant in studies conducted outside of Asia (OR 1.28; 95% CI, 1.03\u20131.58 for T allele vs .", {"entities": []}], ["C allele) and in studies investigating the association with gastric cancer (OR 1.17; 95% CI, 1.03\u20131.34 for T allele vs .", {"entities": [[68, 74, "DISEASE"]]}], ["However, the IL4R rs1801275 heterozygote seems to be associated with a reduced risk of gastrointestinal cancer (OR 0.79; 95% CI, 0.65\u20130.96 for AG vs .", {"entities": [[104, 110, "DISEASE"], [13, 17, "GENE"]]}], ["Other polymorphisms did not show any significant associations with gastrointestinal cancer risk in any of the genetic models and subgroup analyses.", {"entities": [[84, 90, "DISEASE"]]}], ["Our results suggest that certain polymorphisms of IL4 and IL4R may affect susceptibility to gastrointestinal cancer.", {"entities": [[109, 115, "DISEASE"], [50, 53, "GENE"], [58, 62, "GENE"]]}], ["However, further studies are required to confirm these findings.", {"entities": []}], ["\u2022 This meta-analysis included 27 eligible case\u2013control studies.", {"entities": []}], ["\u2022 IL4 rs2070874\u00a0T allele may increase the risk of gastrointestinal cancer.", {"entities": [[67, 73, "DISEASE"], [2, 5, "GENE"]]}], ["\u2022 IL4R rs1801275 variant may reduce the risk of gastrointestinal cancer.", {"entities": [[65, 71, "DISEASE"], [2, 6, "GENE"]]}], ["\u2022 Polymorphisms in IL4 and IL4R may affect susceptibility to gastrointestinal cancer.", {"entities": [[78, 84, "DISEASE"], [19, 22, "GENE"], [27, 31, "GENE"]]}], ["This meta-analysis included 27 eligible case\u2013control studies.", {"entities": []}], ["IL4 rs2070874\u00a0T allele may increase the risk of gastrointestinal cancer.", {"entities": [[65, 71, "DISEASE"], [0, 3, "GENE"]]}], ["IL4R rs1801275 variant may reduce the risk of gastrointestinal cancer.", {"entities": [[63, 69, "DISEASE"], [0, 4, "GENE"]]}], ["Polymorphisms in IL4 and IL4R may affect susceptibility to gastrointestinal cancer.", {"entities": [[76, 82, "DISEASE"], [17, 20, "GENE"], [25, 29, "GENE"]]}], ["It is well known that the disease progression in cystic fibrosis (CF) patients may be diverse in subjects with identical mutation in CFTR gene.", {"entities": [[49, 64, "DISEASE"], [133, 137, "GENE"]]}], ["It is quite possible that such heterogeneity is associated with TNF - \u03b1 and/or LT - \u03b1 gene polymorphisms since their products play a key role in inflammation.", {"entities": [[64, 67, "GENE"], [79, 81, "GENE"]]}], ["The aim of the study was to investigate the possible roles of TNF gene polymorphisms in CF disease phenotype and progression.", {"entities": [[62, 65, "GENE"]]}], ["198 CF patients and 130 control subjects were genotyped for both TNF - \u03b1 \u2013 308GA and LT - \u03b1 \u2009+\u2009 252AG polymorphisms.", {"entities": [[65, 68, "GENE"], [85, 87, "GENE"]]}], ["The carriers of the TNF - \u03b1 \u2013 308A allele more frequently had asthma as compared to patients homozygous for the TNF - \u03b1 \u2013 308 G allele.", {"entities": [[62, 68, "DISEASE"], [20, 23, "GENE"], [112, 115, "GENE"], [20, 23, "GENE"], [112, 115, "GENE"]]}], ["In 9 of 108 (8.3%) of LT\u03b1 \u2009+\u2009 252AA carriers, tuberculosis infection has been documented, whereas there was no case of tuberculosis among patients, either homozygous or heterozygous for LT\u03b1 + 252 G alleles ( p \u2009=\u20090.01).", {"entities": [[46, 58, "DISEASE"], [119, 131, "DISEASE"]]}], ["We never observed virus hepatitis among LT\u03b1 \u2009+\u2009 252GA carriers.", {"entities": [[24, 33, "DISEASE"]]}], ["The genotypes TNF - \u03b1 \u2013 308GG \u2013 LT - \u03b1 \u2009+\u2009 252AA and TNF - \u03b1 \u2013 308GA \u2013 LT - \u03b1 \u2009+\u2009 252AG were unfavorable with regard to liver disease development (both p \u2009<\u20090.05).", {"entities": [[120, 133, "DISEASE"], [14, 17, "GENE"], [53, 56, "GENE"], [32, 34, "GENE"], [71, 73, "GENE"], [14, 17, "GENE"], [53, 56, "GENE"], [32, 34, "GENE"], [71, 73, "GENE"]]}], ["It was also shown that neutrophil elastase activity was higher in sputum specimens from high TNF producers with genotypes TNF - \u03b1 \u2013 308GA or LT - \u03b1 \u2009+\u2009 252GG .", {"entities": [[93, 96, "GENE"], [122, 125, "GENE"], [93, 96, "GENE"], [122, 125, "GENE"], [141, 143, "GENE"]]}], ["In addition the carriers of such genotypes demonstrated a higher risk of osteoporosis development ( p values were 0.011 and 0.017, respectively).", {"entities": [[73, 85, "DISEASE"]]}], ["The carriers of genotypes, which are associated with higher TNF-\u03b1 production, demonstrated increased frequency of asthma, higher levels of neutrophil elastase, and decrease of bone density.", {"entities": [[114, 120, "DISEASE"]]}], ["On the contrary, the carriers of genotypes associated with low TNF-\u03b1 production showed a higher frequency of tuberculosis infection.", {"entities": [[109, 121, "DISEASE"]]}], ["Confounding due to cellular heterogeneity represents one of the foremost challenges currently facing Epigenome-Wide Association Studies (EWAS).", {"entities": []}], ["Statistical methods leveraging the tissue-specificity of DNA methylation for deconvoluting the cellular mixture of heterogenous biospecimens offer a promising solution, however the performance of such methods depends entirely on the library of methylation markers being used for deconvolution.", {"entities": []}], ["Here, we introduce a novel algorithm for Id entifying O ptimal L ibraries ( IDOL ) that dynamically scans a candidate set of cell-specific methylation markers to find libraries that optimize the accuracy of cell fraction estimates obtained from cell mixture deconvolution.", {"entities": []}], ["Application of IDOL to training set consisting of samples with both whole-blood DNA methylation data (Illumina HumanMethylation450 BeadArray (HM450)) and flow cytometry measurements of cell composition revealed an optimized library comprised of 300 CpG sites.", {"entities": []}], ["When compared existing libraries, the library identified by IDOL demonstrated significantly better overall discrimination of the entire immune cell landscape ( p = 0.038), and resulted in improved discrimination of 14 out of the 15 pairs of leukocyte subtypes.", {"entities": []}], ["Estimates of cell composition across the samples in the training set using the IDOL library were highly correlated with their respective flow cytometry measurements, with all cell-specific R RMSE s) ranging from [0.97 % to 1.33 %] across leukocyte subtypes.", {"entities": []}], ["Independent validation of the optimized IDOL library using two additional HM450 data sets showed similarly strong prediction performance, with all cell-specific R R M S E <4.00 % .", {"entities": []}], ["In simulation studies, adjustments for cell composition using the IDOL library resulted in uniformly lower false positive rates compared to competing libraries, while also demonstrating an improved capacity to explain epigenome-wide variation in DNA methylation within two large publicly available HM450 data sets.", {"entities": []}], ["Despite consisting of half as many CpGs compared to existing libraries for whole blood mixture deconvolution, the optimized IDOL library identified herein resulted in outstanding prediction performance across all considered data sets and demonstrated potential to improve the operating characteristics of EWAS involving adjustments for cell distribution.", {"entities": []}], ["In addition to providing the EWAS community with an optimized library for whole blood mixture deconvolution, our work establishes a systematic and generalizable framework for the assembly of libraries that improve the accuracy of cell mixture deconvolution.", {"entities": []}], ["The online version of this article (doi:10.1186/s12859-016-0943-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Atopic dermatitis (AD) is a major inflammatory condition of the skin caused by inherited skin barrier deficiency,\u00a0with mutations in the filaggrin gene predisposing to development of AD.", {"entities": [[7, 17, "DISEASE"]]}], ["Support for barrier deficiency initiating AD came from flaky tail mice, which have a frameshift mutation in Flg and also carry an unknown gene, matted , causing a matted hair phenotype.", {"entities": [[108, 111, "GENE"]]}], ["We sought to identify the matted mutant gene in mice and further define whether mutations in the human gene were associated with AD.", {"entities": []}], ["A mouse genetics approach was used to separate the matted and Flg mutations to produce congenic single-mutant strains for genetic and immunologic analysis.", {"entities": [[62, 65, "GENE"]]}], ["Next-generation sequencing was used to identify the matted gene.", {"entities": []}], ["Five independently recruited AD case collections were analyzed to define associations between single nucleotide polymorphisms (SNPs) in the human gene and AD.", {"entities": []}], ["The matted phenotype in flaky tail mice is due to a mutation in the Tmem79/Matt gene, with no expression of the encoded protein mattrin in the skin of mutant mice.", {"entities": []}], ["Matt MATT gene has a small but significant association with AD.", {"entities": []}], ["In mice mutations in Matt cause a defective skin barrier and spontaneous dermatitis and atopy.", {"entities": [[73, 83, "DISEASE"]]}], ["A\u00a0common SNP in MATT has an association with AD in human subjects.", {"entities": []}], ["Health Insurance and Review Assessment (HIRA) in South Korea, also called National Health Insurance (NHI) data, is a repository of claims data collected in the process of reimbursing healthcare providers.", {"entities": [[40, 44, "GENE"]]}], ["Under the universal coverage system, having fee-for-services covering all citizens in South Korea, HIRA contains comprehensive and rich information pertaining to healthcare services such as treatments, pharmaceuticals, procedures, and diagnoses for almost 50 million beneficiaries.", {"entities": [[99, 103, "GENE"]]}], ["This corpus of HIRA data, which constitutes a large repository of data in the healthcare sector, has enormous potential to create value in several ways: enhancing the efficiency of the healthcare delivery system without compromising quality of care; adding supporting evidence for a given intervention; and providing the information needed to prevent (or monitor) adverse events.", {"entities": [[15, 19, "GENE"]]}], ["In order to actualize this potential, HIRA data need to actively be utilized for research.", {"entities": [[38, 42, "GENE"]]}], ["Thus understanding this data would greatly enhance this potential.", {"entities": []}], ["We introduce HIRA data as an important source for health research and provide guidelines for researchers who are currently utilizing HIRA, or interested in doing so, to answer their research questions.", {"entities": [[13, 17, "GENE"], [133, 137, "GENE"], [13, 17, "GENE"], [133, 137, "GENE"]]}], ["We present the characteristics and structure of HIRA data.", {"entities": [[48, 52, "GENE"]]}], ["We discuss strengths and limitations that should be considered in conducting research with HIRA data and suggest strategies for optimal utilization of HIRA data by reviewing published research using HIRA data.", {"entities": [[91, 95, "GENE"], [151, 155, "GENE"], [199, 203, "GENE"], [91, 95, "GENE"], [151, 155, "GENE"], [199, 203, "GENE"], [91, 95, "GENE"], [151, 155, "GENE"], [199, 203, "GENE"]]}], ["Differences in asthma severity may be related to inflammation in the airways.", {"entities": [[15, 21, "DISEASE"]]}], ["The lower airway microbiota has been associated with clinical features such as airway obstruction, symptom control, and response to corticosteroids.", {"entities": []}], ["To assess the relationship between local airway inflammation, severity of disease, and the lower airway microbiota in atopic asthmatics.", {"entities": []}], ["A cohort of young adult, atopic asthmatics with intermittent or mild/moderate persistent symptoms (n = 13) were assessed via bronchoscopy, lavage, and spirometry.", {"entities": []}], ["These individuals were compared to age matched non-asthmatic controls (n = 6) and to themselves after six weeks of treatment with fluticasone propionate (FP).", {"entities": []}], ["Inflammation of the airways was assessed via a cytokine and chemokine panel.", {"entities": []}], ["Lower airway microbiota composition was determined by metagenomic shotgun sequencing.", {"entities": []}], ["Unsupervised clustering of cytokines and chemokines prior to treatment with FP identified two asthmatic phenotypes (AP), termed AP1 and AP2, with distinct bronchoalveolar lavage inflammatory profiles.", {"entities": []}], ["AP2 was associated with more obstruction, compared to AP1.", {"entities": []}], ["After treatment with FP reduced MIP-1\u03b2 and TNF-\u03b1 and increased IL-2 was observed.", {"entities": []}], ["A module of highly correlated cytokines that include MIP-1\u03b2 and TNF-\u03b1 was identified that negatively correlated with pulmonary function.", {"entities": []}], ["Independently, IL-2 was positively correlated with pulmonary function.", {"entities": []}], ["The airway microbiome composition correlated with asthmatic phenotypes.", {"entities": []}], ["AP2, prior to FP treatment, was enriched with Streptococcus pneumoniae .", {"entities": []}], ["Unique associations between IL-2 or the cytokine module and the microbiota composition of the airways were observed in asthmatics subjects prior to treatment but not after or in controls.", {"entities": []}], ["The underlying inflammation in atopic asthma is related to the composition of microbiota and is associated with severity of airway obstruction.", {"entities": [[38, 44, "DISEASE"]]}], ["Treatment with inhaled corticosteroids was associated with changes in the airway inflammatory response to microbiota.", {"entities": []}], ["Improvements in mobile telecommunication technologies have enabled clinicians to collect patient-reported outcome (PRO) data more frequently, but there is as yet limited evidence regarding the frequency with which PRO data can be collected via smartphone applications (apps) in breast cancer patients receiving chemotherapy.", {"entities": [[278, 291, "DISEASE"], [285, 291, "DISEASE"]]}], ["The primary objective of this study was to determine the feasibility of an app for sleep disturbance-related data collection from breast cancer patients receiving chemotherapy.", {"entities": [[130, 143, "DISEASE"], [137, 143, "DISEASE"], [75, 78, "GENE"]]}], ["A secondary objective was to identify the variables associated with better compliance in order to identify the optimal subgroups to include in future studies of smartphone-based interventions.", {"entities": []}], ["Between March 2013 and July 2013, patients who planned to receive neoadjuvant chemotherapy for breast cancer at Asan Medical Center who had access to a smartphone app were enrolled just before the start of their chemotherapy and asked to self-report their sleep patterns, anxiety severity, and mood status via a smartphone app on a daily basis during the 90-day study period.", {"entities": [[95, 108, "DISEASE"], [102, 108, "DISEASE"], [163, 166, "GENE"], [323, 326, "GENE"], [163, 166, "GENE"], [323, 326, "GENE"]]}], ["Push notifications were sent to participants daily at 9 am and 7 pm.", {"entities": []}], ["Data regarding the patients\u2019 demographics, interval from enrollment to first self-report, baseline Beck\u2019s Depression Inventory (BDI) score, and health-related quality of life score (as assessed using the EuroQol Five Dimensional [EQ5D-3L] questionnaire) were collected to ascertain the factors associated with compliance with the self-reporting process.", {"entities": []}], ["A total of 30 participants (mean age 45 years, SD 6; range 35-65 years) were analyzed in this study.", {"entities": []}], ["In total, 2700 daily push notifications were sent to these 30 participants over the 90-day study period via their smartphones, resulting in the collection of 1215 self-reporting sleep-disturbance data items (overall compliance rate=45.0%, 1215/2700).", {"entities": []}], ["The median value of individual patient-level reporting rates was 41.1% (range 6.7-95.6%).", {"entities": []}], ["The longitudinal day-level compliance curve fell to 50.0% at day 34 and reached a nadir of 13.3% at day 90.", {"entities": []}], ["The cumulative longitudinal compliance curve exhibited a steady decrease by about 50% at day 70 and continued to fall to 45% on day 90.", {"entities": []}], ["Women without any form of employment exhibited the higher compliance rate.", {"entities": []}], ["There was no association between any of the other patient characteristics (ie, demographics, and BDI and EQ5D-3L scores) and compliance.", {"entities": []}], ["The mean individual patient-level reporting rate was higher for the subgroup with a 1-day lag time, defined as starting to self-report on the day immediately after enrollment, than for those with a lag of 2 or more days (51.6%, SD 24.0 and 29.6%, SD 25.3, respectively; P =.03).", {"entities": []}], ["The 90-day longitudinal collection of daily self-reporting sleep-disturbance data via a smartphone app was found to be feasible.", {"entities": [[99, 102, "GENE"]]}], ["Further research should focus on how to sustain compliance with this self-reporting for a longer time and select subpopulations with higher rates of compliance for mobile health care.", {"entities": []}], ["Classroom ventilation rates often do not meet building standards, although it is considered to be important to improve indoor air quality.", {"entities": []}], ["Poor indoor air quality is thought to influence both children\u2019s health and performance.", {"entities": []}], ["Poor ventilation in The Netherlands most often occurs in the heating season.", {"entities": []}], ["To improve classroom ventilation a tailor made mechanical ventilation device was developed to improve outdoor air supply.", {"entities": []}], ["This paper studies the effect of this intervention.", {"entities": []}], ["The FRESH study (Forced-ventilation Related Environmental School Health) was designed to investigate the effect of a CO 2 controlled mechanical ventilation intervention on classroom CO 2 levels using a longitudinal cross-over design.", {"entities": []}], ["Target CO 2 concentrations were 800 and 1200 parts per million (ppm), respectively.", {"entities": []}], ["The study included 18 classrooms from 17 schools from the north-eastern part of The Netherlands, 12 experimental classrooms and 6 control classrooms.", {"entities": []}], ["Data on indoor levels of CO 2 , temperature and relative humidity were collected during three consecutive weeks per school during the heating seasons of 2010\u20132012.", {"entities": []}], ["Associations between the intervention and weekly average indoor CO 2 levels, classroom temperature and relative humidity were assessed by means of mixed models with random school-effects.", {"entities": []}], ["At baseline, mean CO 2 concentration for all schools was 1335\u00a0ppm (range: 763\u20132000\u00a0ppm).", {"entities": []}], ["The intervention was able to significantly decrease CO 2 levels in the intervention classrooms (F (2,10)\u2009=\u200917.59, p\u2009<\u20090.001), with a mean decrease of 491\u00a0ppm.", {"entities": []}], ["With the target set at 800\u00a0ppm, mean CO 2 was 841\u00a0ppm (range: 743\u2013925\u00a0ppm); with the target set at 1200\u00a0ppm, mean CO 2 was 975\u00a0ppm (range: 887\u20131077\u00a0ppm).", {"entities": []}], ["Although the device was not capable of precisely achieving the two predefined levels of CO 2 , our study showed that classroom CO 2 levels can be reduced by intervening on classroom ventilation using a CO 2 controlled mechanical ventilation system.", {"entities": []}], ["Health literacy is commonly associated with many of the antecedents of health disparities.", {"entities": []}], ["Yet the precise nature of the relationship between health literacy and disparities remains unclear.", {"entities": []}], ["A systematic review was conducted to better understand in how far the relationship between health literacy and health disparities has been systematically studied and which potential relationships and pathways have been identified.", {"entities": []}], ["Five databases, including PubMed/MEDLINE and CINAHL, were searched for peer-reviewed studies.", {"entities": []}], ["Publications were included in the review when they (1) included a valid measure of health literacy, (2) explicitly conceived a health disparity as related to a social disparity, such as race/ethnicity or education and (3) when results were presented by comparing two or more groups afflicted by a social disparity investigating the effect of health literacy on health outcomes.", {"entities": []}], ["Two reviewers evaluated each study for inclusion and abstracted relevant information.", {"entities": []}], ["Findings were ordered according to the disparities identified and the role of health literacy in explaining them.", {"entities": []}], ["36 studies were included in the final synthesis.", {"entities": []}], ["Most of the studies investigated racial/ethnic disparities, followed by some few studies that systematically investigated educational disparities.", {"entities": []}], ["Some evidence was found on the mediating function of health literacy on self-rated health status across racial/ethnic and educational disparities, as well as on the potential effect of health literacy and numeracy on reducing racial/ethnic disparities in medication adherence and understanding of medication intake.", {"entities": []}], ["Overall the evidence on the relationship between health literacy and disparities is still mixed and fairly limited.", {"entities": []}], ["Studies largely varied with regard to health(-related) outcomes under investigation and the health literacy assessments used.", {"entities": []}], ["Further, many studies lacked a specific description of the nature of the disparity that was explored and a clear account of possible pathways tested.", {"entities": []}], ["Hospital readmissions are a leading topic of healthcare policy and practice reform because they are common, costly, and potentially avoidable events.", {"entities": []}], ["Hospitals face the prospect of reduced or eliminated reimbursement for an increasing number of preventable readmissions under nationwide cost savings and quality improvement efforts.", {"entities": []}], ["To meet the current changes and future expectations, organizations are looking for potential strategies to reduce readmissions.", {"entities": []}], ["We undertook a systematic review of the literature to determine what factors are associated with preventable readmissions.", {"entities": []}], ["We conducted a review of the English language medicine, health, and health services research literature (2000 to 2009) for research studies dealing with unplanned, avoidable, preventable, or early readmissions.", {"entities": []}], ["Each of these modifying terms was included in keyword searches of readmissions or rehospitalizations in Medline, ISI, CINAHL, The Cochrane Library, ProQuest Health Management, and PAIS International.", {"entities": []}], ["Results were limited to US adult populations.", {"entities": []}], ["The review included 37 studies with significant variation in index conditions, readmitting conditions, timeframe, and terminology.", {"entities": []}], ["Studies of cardiovascular-related readmissions were most common, followed by all cause readmissions, other surgical procedures, and other specific-conditions.", {"entities": []}], ["Patient-level indicators of general ill health or complexity were the commonly identified risk factors.", {"entities": []}], ["While more than one study demonstrated preventable readmissions vary by hospital, identification of many specific organizational level characteristics was lacking.", {"entities": []}], ["The current literature on preventable readmissions in the US contains evidence from a variety of patient populations, geographical locations, healthcare settings, study designs, clinical and theoretical perspectives, and conditions.", {"entities": []}], ["However, definitional variations, clear gaps, and methodological challenges limit translation of this literature into guidance for the operation and management of healthcare organizations.", {"entities": []}], ["We recommend that those organizations that propose to reward reductions in preventable readmissions invest in additional research across multiple hospitals in order to fill this serious gap in knowledge of great potential value to payers, providers, and patients.", {"entities": []}], ["To assess the effect of a customised, structured cardiovascular disease (CVD) medication health literacy programme on medication knowledge among Indigenous people with, or at high risk of, CVD.", {"entities": []}], ["Intervention trial with premeasures and postmeasures at multiple time points.", {"entities": []}], ["Indigenous primary care services in Australia, Canada and New Zealand.", {"entities": []}], ["171 Indigenous people aged \u226520 years of age who had at least one clinical diagnosis of a CVD event, or in Canada and Australia had a 5-year CVD risk \u226515%, and were prescribed at least two of the following CVD medication classes: statin, aspirin, ACE inhibitors and beta blockers.", {"entities": []}], ["An education session delivered on three occasions over 1\u2009month by registered nurses or health educators who had received training in health literacy and principles of adult education.", {"entities": []}], ["An interactive tablet application was used during each session and an information booklet and pill card provided to participants.", {"entities": []}], ["Knowledge about the CVD medications assessed before and after each session.", {"entities": []}], ["Knowledge at baseline (presession 1) was low, with the mean per cent correct answers highest for statins (34.0% correct answers), 29.4% for aspirin, 26.0% for beta blockers and 22.7% for ACE inhibitors.", {"entities": []}], ["Adjusted analyses showed highly significant (P<0.001) increases in knowledge scores between preassessments and postassessments at all three time points for all medication classes.", {"entities": []}], ["For the four medications, the absolute increases in adjusted per cent correct items from presession 1 to postsession 3 assessments were 60.1% for statins, 76.8% for aspirin, 71.4% for ACE inhibitor and 69.5% for beta blocker.", {"entities": []}], ["The intervention was highly effective in contextually diverse Indigenous primary healthcare services in Australia, Canada and New Zealand.", {"entities": []}], ["The findings from this study have important implications for health services working with populations with low health literacy more generally.", {"entities": []}], ["ACTRN12612001309875.", {"entities": []}], ["The principals of therapeutic recreation underpin a camping program for children and adolescents living with chronic disease.", {"entities": []}], ["This study aimed to evaluate the campers' health-related quality of life (HRQoL) before and after the program.", {"entities": []}], ["We used the Hungarian version of Kidscreen-52 questionnaire to assess HRQoL.", {"entities": []}], ["The study sample (n = 115) consisted of children and adolescents aged 10-18 (Mean Age: 13,34; SD: 2,20) collected two months before and two months after camp with the following illnesses: oncology patients (n = 32), diabetes (n = 55) and juvenile immune arthritis (JIA) (n = 28).", {"entities": [[254, 263, "DISEASE"]]}], ["Repeated measures of multivariate analysis of variance (MANOVA) evaluated pre and post camp changes.", {"entities": []}], ["We used the Reliable Change Index (RCI) to calculate all the 10 subscales of clinically significant changes.", {"entities": []}], ["The Self-perception subscale showed significant positive change from pre camp to post camp with small effect size.", {"entities": []}], ["Autonomy scores showed time related decline as well as significant time and age group interaction: children under 14 years of age showed a significant moderate effect size decrease on the Autonomy subscale.", {"entities": []}], ["32 children (27.8%) showed clinically significant improvement (RCI > 1.96) at least on one subscale.", {"entities": []}], ["All positive changes were independent of the type of disease, age, gender, and previous camp experience.", {"entities": []}], ["The therapeutic recreation camping program had a positive impact on HRQoL of children and adolescents living with cancer, diabetes mellitus and JIA.", {"entities": [[114, 120, "DISEASE"], [122, 139, "DISEASE"]]}], ["The experience enhanced their self-perception in all age groups and reduced the autonomy of children under 14 years of age.", {"entities": []}], ["This study is an innovative use of the KIDSCREEN-52 questionnaire to measure the outcome effectiveness of a psychosocial rehabilitation program and to assess and compare HRQoL of children living with different chronic diseases.", {"entities": []}], ["To identify practice strategies associated with higher flu vaccination rates in primary care.", {"entities": []}], ["Logistic regression analysis of data from a cross-sectional online questionnaire.", {"entities": []}], ["795 general practices across England.", {"entities": []}], ["569 practice managers, 335 nursing staff and 107 general practitioners.", {"entities": []}], ["Flu vaccination rates achieved by each practice in different groups of at-risk patients.", {"entities": []}], ["7 independent factors associated with higher vaccine uptake were identified.", {"entities": []}], ["Having a lead staff member for planning the flu campaign and producing a written report of practice performance predicted an 8% higher vaccination rate for at-risk patients aged <65\u2005years (OR 1.37, 95% CI 1.10 to 1.71).", {"entities": []}], ["These strategies, plus sending a personal invitation to all eligible patients and only stopping vaccination when Quality and Outcomes Framework targets are reached, predicted a 7% higher vaccination rate (OR 1.45, 95% CI 1.10 to 1.92) in patients aged \u226565\u2005years.", {"entities": []}], ["Using a lead member of staff for identifying eligible patients, with either a modified manufacturer's or in-house search programme for interrogating the practice IT system, independently predicted a 4% higher vaccination rate in patients aged \u226565\u2005years (OR 1.22, 95% CI 1.06 to 1.41/OR 1.20, 95% CI 1.03 to 1.40).", {"entities": []}], ["The provision of flu vaccine by midwives was associated with a 4% higher vaccination rate in pregnant women (OR 1.19, 95% CI 1.02 to 1.40).", {"entities": []}], ["Clear leadership, effective communication about performance and methods used to identify and contact eligible patients were independently associated with significantly higher rates of flu vaccination.", {"entities": []}], ["Financial targets appear to incentivise practices to work harder to maximise seasonal influenza vaccine uptake.", {"entities": [[86, 95, "DISEASE"]]}], ["The strategies identified here could help primary care providers to substantially increase their seasonal flu vaccination rates towards or even above the Chief Medical Officer's targets.", {"entities": []}], ["Uptake of seasonal influenza vaccination in the UK's at-risk population is below the national and international target of 75%.", {"entities": [[19, 28, "DISEASE"]]}], ["Evidence-based guidance, to advise practices how to optimise all aspects of their flu vaccination campaigns and maximise their likelihood of protecting at-risk patients against flu and its serious sequelae, is greatly needed.", {"entities": []}], ["This study sought to identify which strategies and procedures were associated with higher rates of flu vaccine uptake.", {"entities": []}], ["This study has identified seven key strategies that were significantly associated with the success of practices' seasonal flu vaccination campaigns.", {"entities": []}], ["If widely implemented by general practices, average vaccination rates would be predicted to rise by 7%\u20138% (thereby exceeding WHO target in patients aged >65\u2005years).", {"entities": []}], ["The study sample was large and representative, despite a participation rate of only 27.5%.", {"entities": []}], ["Outcome measures (vaccination rates) were objective and corrected for practice size.", {"entities": []}], ["Strategies used to provide and encourage vaccination were self-reported.", {"entities": []}], ["T lymphocytes and eosinophils are important components of the inflammatory cell infiltrate in bronchial mucosa in asthma.", {"entities": [[114, 120, "DISEASE"]]}], ["Because activated lymphocytes migrate through the thoracic duct and the general circulation to remote glandular and mucosal sites, we initiated this study to evaluate pathological abnormalities and immunoreactivity for interleukin (IL) 3, IL-5, and granulocyte/macrophage colony-stimulating factor (GM-CSF) of intestinal mucosa in bronchial asthma.", {"entities": [[341, 347, "DISEASE"]]}], ["15 asthmatic patients, 8 nonasthmatic patients with chronic obstructive pulmonary disease, 6 atopic nonasthmatic healthy controls, and 6 nonatopic healthy controls were studied.", {"entities": [[52, 89, "DISEASE"]]}], ["Duodenal biopsies were performed by endoscopy.", {"entities": []}], ["A significantly increased number of intraepithelial lymphocytes and eosinophils and a significant accumulation of mononuclear cells (lymphocytes and mast cells) and eosinophils in the lamina propria were detected in asthmatics and atopic controls.", {"entities": []}], ["Immunostaining with antibodies directed against IL-3, IL-5, and GM-CSF was positive in asthmatics and atopic controls, whereas no staining was observed in nonatopic controls and chronic obstructive pulmonary disease.", {"entities": [[178, 215, "DISEASE"]]}], ["Combined ultrastructural study and immunogold labeling demonstrated that IL-3, IL-5, and GM-CSF were localized in eosinophils and mast cells.", {"entities": []}], ["Although devoid of gastrointestinal symptoms, asthmatics and asymptomatic atopics had duodenal pathological abnormalities mimicking those observed in the bronchial mucosa in asthma, suggesting that the whole mucosal immune system is involved in bronchial asthma.", {"entities": [[174, 180, "DISEASE"], [255, 261, "DISEASE"]]}], ["Bronchopulmonary dysplasia is one of the most serious complications observed in premature infants.", {"entities": []}], ["Thanks to microarray technique, expression of nearly all human genes can be reliably evaluated.", {"entities": []}], ["To compare whole genome expression in the first month of life in groups of infants with and without bronchopulmonary dysplasia.", {"entities": []}], ["111 newborns were included in the study.", {"entities": []}], ["The mean birth weight was 1029g (SD:290), and the mean gestational age was 27.8 weeks (SD:2.5).", {"entities": []}], ["Blood samples were drawn from the study participants on the 5th, 14th and 28th day of life.", {"entities": []}], ["The mRNA samples were evaluated for gene expression with the use of GeneChip\u00ae Human Gene 1.0 ST microarrays.", {"entities": []}], ["The infants were divided into two groups: bronchopulmonary dysplasia (n=68) and control (n=43).", {"entities": []}], ["Overall 2086 genes were differentially expressed on the day 5, only 324 on the day 14 and 3498 on the day 28.", {"entities": []}], ["Based on pathway enrichment analysis we found that the cell cycle pathway was up-regulated in the bronchopulmonary dysplasia group.", {"entities": []}], ["The activation of this pathway does not seem to be related with the maturity of the infant.", {"entities": []}], ["Four pathways related to inflammatory response were continuously on the 5 The results of the whole genome expression study revealed alteration of the expression of nearly 10% of the genome in bronchopulmonary dysplasia patients.", {"entities": []}], ["The studied respiratory syndromes are suitable for syndromic surveillance because they reflect respiratory pathogen activity patterns Syndromic surveillance is increasingly used to signal unusual illness events.", {"entities": []}], ["To validate data-source selection, we retrospectively investigated the extent to which 6 respiratory syndromes (based on different medical registries) reflected respiratory pathogen activity.", {"entities": []}], ["These syndromes showed higher levels in winter, which corresponded with higher laboratory counts of Streptococcus pneumoniae , respiratory syncytial virus, and influenza virus.", {"entities": [[160, 169, "DISEASE"]]}], ["Multiple linear regression models indicated that most syndrome variations (up to 86%) can be explained by counts of respiratory pathogens.", {"entities": [[54, 62, "DISEASE"]]}], ["Absenteeism and pharmacy syndromes might reflect nonrespiratory conditions as well.", {"entities": []}], ["We also observed systematic syndrome elevations in the fall, which were unexplained by pathogen counts but likely reflected rhinovirus activity.", {"entities": [[28, 36, "DISEASE"]]}], ["Earliest syndrome elevations were observed in absenteeism data, followed by hospital data (+1 week), pharmacy/general practitioner consultations (+2 weeks), and deaths/laboratory submissions (test requests) (+3 weeks).", {"entities": [[9, 17, "DISEASE"]]}], ["We conclude that these syndromes can be used for respiratory syndromic surveillance, since they reflect patterns in respiratory pathogen activity.", {"entities": []}], ["Airway remodelling is a feature of asthma including fragmentation of elastic fibres observed in the superficial elastin network of the airway wall.", {"entities": [[35, 41, "DISEASE"]]}], ["Fibered confocal fluorescence microscopy (FCFM) is a new and non-invasive imaging technique performed during bronchoscopy that may visualize elastic fibres, as shown by in vitro spectral analysis of elastin powder.", {"entities": []}], ["We hypothesized that FCFM images capture in vivo elastic fibre patterns within the airway wall and that such patterns correspond with airway histology.", {"entities": []}], ["We aimed to establish the concordance between the bronchial elastic fibre pattern in histology and FCFM.", {"entities": []}], ["Second, we examined whether elastic fibre patterns in histology and FCFM were different between asthmatic subjects and healthy controls.", {"entities": []}], ["Finally, the association between these patterns and lung function parameters was investigated.", {"entities": []}], ["In a cross-sectional study comprising 16 subjects (8 atopic asthmatic patients with controlled disease and 8 healthy controls) spirometry and bronchoscopy were performed, with recording of FCFM images followed by endobronchial biopsy at the airway main carina.", {"entities": []}], ["Elastic fibre patterns in histological sections and FCFM images were scored semi-quantitatively.", {"entities": []}], ["Agreement between histology and FCFM was analysed using linearly weighted kappa \u03ba w .", {"entities": []}], ["The patterns observed in histological sections and FCFM images could be divided into 3 distinct groups.", {"entities": []}], ["There was good agreement between elastic fibre patterns in histology and FCFM patterns (\u03ba w 0.744).", {"entities": []}], ["The semi-quantitative pattern scores were not different between asthmatic patients and controls.", {"entities": []}], ["Notably, there was a significant difference in post-bronchodilator FEV 1 %predicted between the different patterns by histology (p = 0.001) and FCFM (p = 0.048), regardless of asthma or atopy.", {"entities": [[176, 182, "DISEASE"], [67, 70, "GENE"]]}], ["FCFM captures the elastic fibre pattern within the airway wall in humans in vivo .", {"entities": []}], ["The association between post-bronchodilator FEV 1 %predicted and both histological and FCFM elastic fibre patterns points towards a structure-function relationship between extracellular matrix in the airway wall and lung function.", {"entities": [[44, 47, "GENE"]]}], ["Netherlands Trial Register NTR1306", {"entities": []}], ["Nuclear receptors (NR) impact a myriad of physiological processes including homeostasis, reproduction, development, and metabolism.", {"entities": []}], ["NRs are regulated by post-translational modifications (PTM) that markedly impact receptor function.", {"entities": []}], ["Recent studies have identified NR PTMs that are involved in the onset and progression of human diseases, including cancer.", {"entities": [[115, 121, "DISEASE"], [34, 38, "GENE"]]}], ["The majority of evidence linking NR PTMs with disease has been demonstrated for phosphorylation, acetylation and sumoylation of androgen receptor (AR), estrogen receptor \u03b1 (ER\u03b1), glucocorticoid receptor (GR) and peroxisome proliferator activated receptor \u03b3 (PPAR\u03b3).", {"entities": [[36, 40, "GENE"]]}], ["Phosphorylation of AR has been associated with hormone refractory prostate cancer and decreased disease-specific survival.", {"entities": [[75, 81, "DISEASE"], [66, 81, "DISEASE"]]}], ["AR acetylation and sumoylation increased growth of prostate cancer tumor models.", {"entities": [[60, 66, "DISEASE"], [51, 66, "DISEASE"]]}], ["AR phosphorylation reduced the toxicity of the expanded polyglutamine AR in Kennedy\u2019s Disease as a consequence of reduced ligand binding.", {"entities": []}], ["A comprehensive evaluation of ER\u03b1 phosphorylation in breast cancer revealed several sites associated with better clinical outcome to tamoxifen therapy, whereas other phosphorylation sites were associated with poorer clinical outcome.", {"entities": [[53, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["ER\u03b1 acetylation and sumoylation may also have predictive value for breast cancer.", {"entities": [[67, 80, "DISEASE"], [74, 80, "DISEASE"]]}], ["GR phosphorylation and acetylation impact GR responsiveness to glucocorticoids that are used as anti-inflammatory drugs.", {"entities": []}], ["PPAR\u03b3 phosphorylation can regulate the balance between growth and differentiation in adipose tissue that is linked to obesity and insulin resistance.", {"entities": [[118, 125, "DISEASE"]]}], ["Sumoylation of PPAR\u03b3 is linked to repression of inflammatory genes important in patients with inflammatory diseases.", {"entities": []}], ["NR PTMs provide an additional measure of NR function that can be used as both biomarkers of disease progression, and predictive markers for patient response to NR-directed treatments.", {"entities": [[3, 7, "GENE"]]}], ["Guolin Qigong is a combination of meditation, controlled breathing and physical movement designed to control the vital energy (qi) of the body and consequently to improve spiritual, physical and mental health.", {"entities": []}], ["Practice of Qigong has been reported to alter immunological function, but there have been few studies of its effects on cytokines, the key regulators of immunity.", {"entities": []}], ["Numbers of peripheral blood cytokine-secreting cells were determined by ELISPOT in 19 healthy volunteers aged 27 \u2013 55, before they were taught the practice of Qigong and after 3, 7 and 14 weeks of daily practice.", {"entities": []}], ["The effect of Qigong on blood cortisol was also examined.", {"entities": []}], ["Numbers of IL4 and IL12-secreting cells remained stable.", {"entities": [[11, 14, "GENE"]]}], ["IL6 increased at 7 weeks and TNF\u03b1 increased in unstimulated cultures at 3 and 7 weeks but decreased at these times in LPS and SAC-stimulated cultures.", {"entities": [[0, 3, "GENE"]]}], ["Of particular interest, IFN\u03b3-secreting cells increased and IL10-secreting cells decreased in PHA-stimulated cultures, resulting in significant increases in the IFN\u03b3:IL10 ratio.", {"entities": [[59, 63, "GENE"], [165, 169, "GENE"]]}], ["Cortisol, a known inhibitor of type 1 cytokine production, was reduced by practicing Qigong.", {"entities": []}], ["These preliminary studies in healthy subjects, although not necessarily representative of a randomized healthy population and not including a separate control group, have indicated that blood levels of the stress-related hormone cortisol may be lowered by short-term practice of Qigong and that there are concomitant changes in numbers of cytokine-secreting cells.", {"entities": []}], ["Further studies of the effect of Qigong in patients with clinical diseases known to be associated with type 2 cytokine predominance are merited.", {"entities": []}], ["Multimorbidity has a high prevalence in the primary care context and it is frequently associated with worse health-related quality of life (HRQoL).", {"entities": []}], ["Few studies evaluated the variables that could have a potential effect on HRQoL of primary care patients with multimorbidity.", {"entities": []}], ["The purpose of this study, the first of its kind ever undertaken in Portugal, is to analyse the relationship between multimorbidity, health-related quality of life, perceived family support and unmet health needs in adult patients attending primary care.", {"entities": []}], ["Multicentre, cross-sectional survey conducted among primary care patients with multimorbidity.", {"entities": []}], ["It included 521 participants (64.1\u00a0% females) who met the inclusion criteria.", {"entities": []}], ["HRQoL was evaluated using the Portuguese Short Form-12 Health Status Questionnaire.", {"entities": []}], ["The Portuguese Family APGAR was used to measure the perceived family support.", {"entities": []}], ["A patients\u2019 unmet health needs questionnaire was used.", {"entities": []}], ["The unmet needs for medical, surgical and dental care; prescription medications; mental healthcare or counselling; and eyeglasses or other technical aid was assessed.", {"entities": []}], ["Descriptive and multivariate analyses were performed.", {"entities": []}], ["The sample had an overall average of 4.5 chronic health problems.", {"entities": []}], ["Increased multimorbidity levels were linked to worse health-related quality of life, particularly the physical health.", {"entities": []}], ["Some variables were confirmed as playing a role on health-related quality of life.", {"entities": []}], ["Male patients with high monthly incomes and highly functional families had better physical and mental health.", {"entities": []}], ["High levels of education and the presence of asthma were also associated with better physical health.", {"entities": [[45, 51, "DISEASE"]]}], ["Contrariwise, elderly patients with high levels of multimorbidity and with osteoarthritis had lower physical health.", {"entities": [[75, 89, "DISEASE"]]}], ["The majority of the patients did not have unmet health needs.", {"entities": []}], ["When health needs were stated they were mostly for generalist medical care, dental care, and eyeglasses/other technical aid.", {"entities": []}], ["Financial insufficiency was the primary reason for not fulfilling their health needs.", {"entities": []}], ["To improve the quality of life of multimorbid patients, within primary care practices and health delivery systems, one should take into special account the sex of the patient, the perceived family support and the self-perceived economic status because of their relationship with both physical and mental health.", {"entities": []}], ["Limitations and recommendations are discussed.", {"entities": []}], ["Thymic stromal lymphopoietin (TSLP) is a cytokine with pleiotropic functions in the immune system.", {"entities": [[30, 34, "GENE"]]}], ["It has been associated with allergic reactions in the skin and lungs but also homeostatic tolerogenic responses in the thymus and gut.", {"entities": []}], ["In human subjects TSLP is present in 2 isoforms, short and long.", {"entities": [[18, 22, "GENE"]]}], ["Here we wanted to investigate the differential expression of the TSLP isoforms and discern their biological implications under homeostatic or inflammatory conditions.", {"entities": [[65, 69, "GENE"]]}], ["We evaluated the expression of TSLPs in tissues from healthy subjects, patients with ulcerative colitis, patients with celiac disease, and patients with atopic dermatitis and on epithelial cells and keratinocytes under steady-state conditions or after stimulation.", {"entities": [[153, 170, "DISEASE"], [119, 133, "DISEASE"], [85, 103, "DISEASE"], [160, 170, "DISEASE"]]}], ["We then tested the immune activity of TSLP isoforms both in\u00a0vitro and in\u00a0vivo .", {"entities": [[38, 42, "GENE"]]}], ["We showed that TSLP isoforms are responsible for 2 opposite immune functions.", {"entities": [[15, 19, "GENE"]]}], ["The short isoform is expressed under steady-state conditions and exerts anti-inflammatory activities by affecting the capacity of PBMCs and dendritic cells to produce inflammatory cytokines.", {"entities": []}], ["Moreover, the short isoform TSLP ameliorates experimental colitis in mice and prevents endotoxin shock.", {"entities": [[28, 32, "GENE"]]}], ["The long isoform of TSLP is proinflammatory and is only expressed during inflammation.", {"entities": [[20, 24, "GENE"]]}], ["The isoforms are differentially regulated by pathogenic bacteria, such as Salmonella species and adhesive-invasive Escherichia coli .", {"entities": []}], ["We have solved the dilemma of TSLP being both homeostatic and inflammatory.", {"entities": [[30, 34, "GENE"]]}], ["The TSLP isoform ratio is altered during several inflammatory disorders, with strong implications in disease treatment and prevention.", {"entities": [[4, 8, "GENE"]]}], ["Indeed, targeting of the long isoform of TSLP at the C-terminal portion, which is common to both isoforms, might lead to unwanted side effects caused by neutralization of the homeostatic short isoform.", {"entities": [[41, 45, "GENE"]]}], ["To examine whether non-psychiatric hospitalizations rates were higher in those with mental disorders.", {"entities": []}], ["In a cohort of 15 811 employees, aged 35\u201350 years in 1989, mental disorder status was defined from 1989 to 2000.", {"entities": []}], ["Hospitalizations for all-causes, myocardial infarction (MI), stroke, and cancer, were recorded yearly from 2001 to 2011.", {"entities": [[33, 54, "DISEASE"], [73, 79, "DISEASE"]]}], ["Negative binomial regression models were used to estimate hospitalization rates over the follow-up.", {"entities": []}], ["After controlling for baseline sociodemographic factors, health-related behaviors, self-rated health, and self-reported medical conditions, participants with a mental disorder had significantly higher rates of all-cause hospitalization [incidence rate ratio, IRR = 1.20 (95%, 1.14\u20131.26)], as well as hospitalization due to MI [IRR = 1.44 (95%, 1.12\u20131.85)].", {"entities": []}], ["For stroke, the IRR did not reach statistical significance [IRR = 1.37 (95%, 0.95\u20131.99)] and there was no association with cancer [IRR = 1.01 (95%, 0.86\u20131.19)].", {"entities": [[123, 129, "DISEASE"]]}], ["A similar trend was observed when mental disorders groups were considered (no mental disorder, depressive disorder, mental disorders due to psychoactive substance use, other mental disorders, mixed mental disorders, and severe mental disorder).", {"entities": []}], ["In this prospective cohort of employees with stable employment as well as universal access to healthcare, we found participants with mental disorders to have higher rates of non-psychiatric hospitalizations.", {"entities": []}], ["It is well known that increased airflow limitation as measured by spirometry is associated with the risk of exacerbation in patients with COPD.", {"entities": []}], ["The forced oscillation technique (FOT) is a noninvasive method used to assess respiratory impedance (resistance and reactance) with minimal patient cooperation required.", {"entities": []}], ["The clinical utility of the FOT in assessing the risk of exacerbations of COPD is yet to be determined.", {"entities": []}], ["We examined the relationship between respiratory impedance as measured by FOT and exacerbations in patients with COPD.", {"entities": []}], ["Among 310 patients with COPD (Global Initiative for Chronic Obstructive Lung Disease stages I\u2013IV) who presented at the outpatient clinic of the Showa University Hospital from September 2014 through January 2015, 119 were collected and assigned into 2 groups according to their history of exacerbation: exacerbators and nonexacerbators.", {"entities": []}], ["Respiratory resistance components and respiratory reactance components, as measured by FOT, were compared between the two groups.", {"entities": []}], ["Exacerbators were significantly older and had a higher white blood cell count than nonexacerbators.", {"entities": []}], ["Resistance at 20 Hz, reactance at 5 Hz (X5), resonant frequency (Fres), and area of low reactance (ALX) differed significantly between the two groups.", {"entities": []}], ["In addition, among patients with stage II COPD, there were significant differences in X5, Fres, and ALX between the two groups despite no significant differences in respiratory function as assessed by spirometry.", {"entities": []}], ["Finally, receiver operating characteristic curve analysis revealed that the reactance components rather than the resistance components were associated with the risk of exacerbation.", {"entities": []}], ["There were significant differences in respiratory impedance between exacerbators and nonexacerbators in patients with moderate COPD.", {"entities": []}], ["FOT is a promising tool for assessing future exacerbations in patients with COPD.", {"entities": []}], ["Objective .", {"entities": []}], ["To evaluate the effect of anti-TNF agents plus synthetic disease modifying antirheumatic drugs (DMARDs) versus DMARDs alone for ankylosing spondylitis (AS) with reduced pulmonary function vital capacity (FVC%).", {"entities": [[139, 150, "DISEASE"], [128, 150, "DISEASE"]]}], ["In an observational study, we included AS who had FVC% <80% at baseline.", {"entities": []}], ["Twenty patients were taking DMARDs and 16 received anti-TNF + DMARDs.", {"entities": []}], ["Outcome measures: changes in FVC%, BASDAI, BASFI, 6-minute walk test (6MWT), Borg scale after 6MWT, and St. George's Respiratory Questionnaire at 24 months.", {"entities": []}], ["Both DMARDs and anti-TNF + DMARDs groups had similar baseline values in FVC%.", {"entities": []}], ["Significant improvement was achieved with anti-TNF + DMARDs in FVC%, at 24 months, when compared to DMARDs alone ( P = 0.04).", {"entities": []}], ["Similarly, patients in anti-TNF + DMARDs group had greater improvement in BASDAI, BASFI, Borg scale, and 6MWT when compared to DMARDs alone.", {"entities": []}], ["After 2 years of follow-up, 14/16 (87.5%) in the anti-TNF + DMARDs group achieved the primary outcome: FVC% \u226580%, compared with 11/20 (55%) in the DMARDs group ( P = 0.04).", {"entities": []}], ["Conclusions .", {"entities": []}], ["Patients with anti-TNF + DMARDs had a greater improvement in FVC% and cardiopulmonary scales at 24 months compared with DMARDs.", {"entities": []}], ["This preliminary study supports the fact that anti-TNF agents may offer additional benefits compared to DMARDs in patients with AS who have reduced FVC%.", {"entities": []}], ["Processing Web-based health information can be difficult, especially for people with low health literacy.", {"entities": []}], ["Presenting health information in an audiovisual format, such as animation, is expected to improve understanding among low health literate audiences.", {"entities": []}], ["The aim of this paper is to investigate what features of spoken health animations improve information recall and attitudes and whether there are differences between health literacy groups.", {"entities": []}], ["We conducted an online experiment among 231 participants aged 55 years or older with either low or high health literacy.", {"entities": []}], ["A 2 (spoken vs written text) x 2 (illustration vs animation) design was used.", {"entities": []}], ["Participants were randomly exposed to one of the four experimental messages, all providing the same information on colorectal cancer screening.", {"entities": [[115, 132, "DISEASE"], [126, 132, "DISEASE"]]}], ["The results showed that, among people with low health literacy, spoken messages about colorectal cancer screening improved recall ( P =.03) and attitudes ( P =.02) compared to written messages.", {"entities": [[86, 103, "DISEASE"], [97, 103, "DISEASE"]]}], ["Animations alone did not improve recall, but when combined with spoken text, they significantly improved recall in this group ( P =.02).", {"entities": []}], ["When exposed to spoken animations, people with low health literacy recalled the same amount of information as their high health literate counterparts ( P =.12), whereas in all other conditions people with high health literacy recalled more information compared to low health literate individuals.", {"entities": []}], ["For people with low health literacy, positive attitudes mediated the relationship between spoken text and the intention to have a colorectal cancer screening ( b =.12; 95% CI 0.02-0.25).", {"entities": [[130, 147, "DISEASE"], [141, 147, "DISEASE"]]}], ["We conclude that spoken animation is the best way to communicate complex health information to people with low health literacy.", {"entities": []}], ["This format can even bridge the information processing gap between audiences with low and high health literacy as the recall differences between the two groups are eliminated.", {"entities": []}], ["As animations do not negatively influence high health literate audiences, it is concluded that information adapted to audiences with low health literacy suits people with high health literacy as well.", {"entities": []}], ["Pulmonary arterial hypertension (PAH) is a rare progressive pulmonary vascular disorder associated with vascular remodeling and right heart failure.", {"entities": [[19, 31, "DISEASE"]]}], ["Vascular remodeling involves numerous signaling cascades governing pulmonary arterial smooth muscle cell (PASMC) proliferation, migration and differentiation.", {"entities": []}], ["Glycogen synthase kinase 3beta (GSK3\u00df) is a serine/threonine kinase and can act as a downstream regulatory switch for numerous signaling pathways.", {"entities": []}], ["Hence, we hypothesized that GSK3\u00df plays a crucial role in pulmonary vascular remodeling.", {"entities": []}], ["All experiments were done with lung tissue or isolated PASMCs in a well-established monocrotaline (MCT)-induced PAH rat model.", {"entities": []}], ["The mRNA expression of Wnt ligands (Wnt1, Wnt3a, Wnt5a), upstream Wnt signaling regulator genes (Frizzled Receptors 1, 2 and secreted Frizzled related protein sFRP-1) and canonical Wnt intracellular effectors (GSK3\u00df, Axin1) were assessed by real-time polymerase chain reaction and protein levels of GSK3\u00df, phospho-GSK3\u00df (ser 9) by western blotting and localization by immunohistochemistry.", {"entities": [[36, 40, "GENE"], [42, 47, "GENE"], [49, 54, "GENE"], [217, 222, "GENE"]]}], ["The role of GSK3\u00df in PASMCs proliferation was assessed by overexpression of wild-type GSK3\u00df (WT) and constitutively active GSK3\u00df S9A by [ Increased levels of total and phosphorylated GSK3\u00df (inhibitory phosphorylation) were observed in lungs and PASMCs isolated from MCT-induced PAH rats compared to controls.", {"entities": []}], ["Further, stimulation of MCT-PASMCs with growth factors induced GSK3\u00df inactivation.", {"entities": []}], ["Most importantly, treatment with the PDGFR inhibitor, Imatinib, attenuated PDGF-BB and FCS induced GSK3\u00df phosphorylation.", {"entities": []}], ["Increased expression of GSK3\u00df observed in lungs and PASMC isolated from MCT-induced PAH rats was confirmed to be clinically relevant as the same observation was identified in human iPAH lung explants.", {"entities": []}], ["Overexpression of GSK3\u00df significantly increased MCT-PASMCs proliferation by regulating ERK phosphorylation.", {"entities": []}], ["Constitutive activation of GSK3\u00df (GSK3\u00df S9A, 9th serine replaced to alanine) inhibited MCT-PASMCs proliferation by decreasing ERK phosphorylation.", {"entities": []}], ["This study supports a central role for GSK3\u00df in vascular remodeling processes and suggests a novel therapeutic opportunity for the treatment of PAH.", {"entities": []}], ["Evaluations of the impact of interventions for resource allocation purposes commonly focus on health status.", {"entities": []}], ["There is, however, also concern about broader impacts on wellbeing and, increasingly, on a person's capability.", {"entities": []}], ["This study aims to compare the impact on health status and capability of seven major health conditions, and highlight differences in treatment priorities when outcomes are measured by capability as opposed to health status.", {"entities": []}], ["The study was a cross-sectional four country survey (n = 6650) of eight population groups: seven disease groups with: arthritis, asthma, cancer, depression, diabetes, hearing loss, and heart disease and one health population \u2018comparator\u2019 group.", {"entities": [[185, 198, "DISEASE"], [118, 127, "DISEASE"], [129, 135, "DISEASE"], [137, 143, "DISEASE"]]}], ["Two simple self-complete questionnaires were used to measure health status (EQ-5D-5L) and capability (ICECAP-A).", {"entities": []}], ["Individuals were classified by illness severity using condition-specific questionnaires.", {"entities": []}], ["Effect sizes were used to estimate: (i) the difference in health status and capability for those with conditions, relative to a healthy population; and (ii) the impact of the severity of the condition on health status and capability within each disease group.", {"entities": []}], ["5248 individuals were included in the analysis.", {"entities": []}], ["Individuals with depression have the greatest mean reduction in both health (effect size, 1.26) and capability (1.22) compared to the healthy population.", {"entities": []}], ["The effect sizes for capability for depression are much greater than for all other conditions, which is not the case for health.", {"entities": []}], ["For example, the arthritis group effect size for health (1.24) is also high and similar to that of depression, whereas for the same arthritis group, the effect size for capability is much lower than that for depression (0.55).", {"entities": [[17, 26, "DISEASE"], [132, 141, "DISEASE"]]}], ["In terms of severity within disease groups, individuals categorised as 'mild' have similar capability levels to the healthy population (effect sizes <0.2, excluding depression) but lower health status than the healthy population (\u22650.4).", {"entities": []}], ["Significant differences exist in the relative effect sizes across diseases when measured by health status and capability.", {"entities": []}], ["In terms of treating morbidity, a shift in focus from health gain to capability gain would increase funding priorities for patients with depression specifically and severe illnesses more generally.", {"entities": []}], ["The improvement in sickle cell anemia (SCA) care resulted in the emergence of a large population of adults living with this disease.", {"entities": [[19, 37, "DISEASE"], [31, 37, "DISEASE"]]}], ["The mechanisms of lung injury in this new population are largely unknown.", {"entities": []}], ["The forced oscillation technique (FOT) represents the current state-of-the-art in the assessment of lung function.", {"entities": []}], ["The present work uses the FOT to improve our knowledge about the respiratory abnormalities in SCA, evaluates the associations of FOT with the functional exercise capacity and investigates the early detection of respiratory abnormalities.", {"entities": []}], ["Spirometric classification of restrictive abnormalities resulted in three categories: controls (n = 23), patients with a normal exam (n = 21) and presenting pulmonary restriction (n = 24).", {"entities": []}], ["FOT analysis showed that, besides restrictive changes (reduced compliance; p<0.001), there is also an increase in respiratory resistance (p<0.001) and ventilation heterogeneity (p<0.01).", {"entities": []}], ["FOT parameters are associated with functional exercise capacity (R = -0.38), pulmonary diffusion (R = 0.66), respiratory muscle performance (R = 0.41), pulmonary volumes (R = 0.56) and airway obstruction (R = 0.54).", {"entities": []}], ["The diagnostic accuracy was evaluated by investigating the area under the receiver operating characteristic curve (AUC).", {"entities": []}], ["A combination of FOT and machine learning (ML) classifiers showed adequate diagnostic accuracy in the detection of early respiratory abnormalities (AUC = 0.82).", {"entities": []}], ["In this study, the use of FOT showed that adults with SCA develop a mixed pattern of respiratory disease.", {"entities": []}], ["Changes in FOT parameters are associated with functional exercise capacity decline, abnormal pulmonary mechanics and diffusion.", {"entities": []}], ["FOT associated with ML methods accurately diagnosed early respiratory abnormalities.", {"entities": []}], ["This suggested the potential utility of the FOT and ML clinical decision support systems in the identification of respiratory abnormalities in patients with SCA.", {"entities": []}], ["In 1991, treasure hunters found skeletal remains in an area close to the destroyed country residence of former Nazi leader Hermann G\u00f6ring in northeastern Berlin.", {"entities": []}], ["The remains, which were believed to belong to Carin G\u00f6ring, who was buried at the site, were examined to determine whether it was possible to make a positive identification.", {"entities": []}], ["The anthropological analysis showed that the remains come from an adult woman.", {"entities": []}], ["The DNA analysis of several bone elements showed female sex, and a reference sample from Carin's son revealed mtDNA sequences identical to the remains.", {"entities": []}], ["The profile has one nucleotide difference from the Cambridge reference sequence (rCRS), the common variant 263G.", {"entities": []}], ["A database search resulted in a frequency of this mtDNA sequence of about 10% out of more than 7,000 European haplotypes.", {"entities": []}], ["The mtDNA sequence found in the ulna, the cranium and the reference sample is, thus, very common among Europeans.", {"entities": []}], ["Therefore, nuclear DNA analysis was attempted.", {"entities": []}], ["The remains as well as a sample from Carin's son were successfully analysed for the three nuclear markers TH01, D7S820 and D8S1179.", {"entities": []}], ["The nuclear DNA analysis of the two samples revealed one shared allele for each of the three markers, supporting a mother and son relationship.", {"entities": []}], ["This genetic information together with anthropological and historical files provides an additional piece of circumstantial evidence in our efforts to identify the remains of Carin G\u00f6ring.", {"entities": []}], ["It is unknown if young children\u2019s parent-reported physical activity and sedentary time are correlated with direct measures.", {"entities": []}], ["The study objectives were to compare parent-reported physical and sedentary activity versus directly measured accelerometer data in early childhood.", {"entities": []}], ["From 2013 to 2014, 117 healthy children less than 6\u00a0years of age were recruited to wear Actical accelerometers for 7\u00a0days.", {"entities": []}], ["Accelerometer data and questionnaires were available on 87 children (74\u00a0%).", {"entities": []}], ["Average daily physical activity was defined as the sum of activity \u2265100 counts per minute, and sedentary time as the sum of activity <100 counts per minute during waking hours.", {"entities": []}], ["Parents reported daily physical activity (unstructured free play in and out of school, and organized activities) and selected sedentary behaviors (screen time, stroller time, time in motor vehicle).", {"entities": []}], ["Spearman correlation coefficients and Bland\u2013Altman plots were used to assess the validity of parent-reported measures compared to accelerometer data.", {"entities": []}], ["Total physical activity was significantly greater when measured by accelerometer than parent-report; the median difference was 131\u00a0min/day (p\u00a0<\u00a00.001).", {"entities": []}], ["Parent-reported child physical activity was weak to moderately correlated with directly measured total physical activity (r\u00a0=\u00a00.39, 95\u00a0% CI 0.19, 0.56).", {"entities": []}], ["The correlations between types of physical activity (unstructured free play in and outside of school/daycare, and organized structured activity) and accelerometer were r\u00a0=\u00a00.30 (95\u00a0% CI 0.09, 0.49); r\u00a0=\u00a00.42 (95\u00a0% CI 0.23, 0.58); r\u00a0=\u00a00.26 (95\u00a0% CI 0.05, 0.46), respectively.", {"entities": []}], ["There was no correlation between parent-reported and accelerometer-measured total sedentary time in children (r\u00a0=\u00a00.10, 95\u00a0% CI \u22120.12, 0.33).", {"entities": []}], ["When the results were stratified by age group (<18, 18\u201347, and 48\u201370\u00a0months of age) no statistically significant correlations were observed and some inverse associations were observed.", {"entities": []}], ["The correlation between parent-report of young children\u2019s physical activity and accelerometer-measured activity was weak to moderate depending on type of activity and age group.", {"entities": []}], ["Parent-report of children\u2019s sedentary time was not correlated with accelerometer-measured sedentary time.", {"entities": []}], ["Additional validation studies are needed to determine if parent-reported measures of physical activity and sedentary time are valid among children less than 6\u00a0years of age and across these young age groups.", {"entities": []}], ["The online version of this article (doi:10.1186/s13104-015-1648-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The initial steps in chlamydial infection involve adhesion and internalization into host cells and, most importantly, modification of the nascent inclusion to establish the intracellular niche.", {"entities": []}], ["Here, we show that Chlamydia pneumoniae enters host cells via EGFR-dependent endocytosis into an early endosome with a phosphatidylinositol 3-phosphate (PI3P) membrane identity.", {"entities": []}], ["Immediately after entry, the early chlamydial inclusion acquires early endosomal Rab GTPases including Rab4, Rab5, Rab7, as well as the two recycling-specific Rabs Rab11 and Rab14.", {"entities": [[174, 179, "GENE"]]}], ["While Rab5, Rab11 and Rab14 are retained in the vesicular membrane, Rab4 and Rab7 soon disappear.", {"entities": [[22, 27, "GENE"]]}], ["Loss of Rab7 enables the C .", {"entities": []}], ["pneumoniae inclusion to escape delivery to, and degradation in lysosomes.", {"entities": []}], ["Loss of Rab4 and retention of Rab11/ Rab14 designates the inclusion as a slowly recycling endosome\u2014that is protected from degradation.", {"entities": [[37, 42, "GENE"]]}], ["Furthermore, we show that the Rab11/ Rab14 adaptor protein Rab11-Fip2 (Fip2) is recruited to the nascent inclusion upon internalization and retained in the membrane throughout infection.", {"entities": [[37, 42, "GENE"]]}], ["siRNA knockdown of Fip2 demonstrated that the protein is essential for internalization and infection, and expression of various deletion variants revealed that Fip2 regulates the intracellular positioning of the inclusion.", {"entities": []}], ["Additionally, we show that binding to Rab11 and Fip2 recruits the unconventional actin motor protein myosin Vb to the early inclusion and that together they regulate the relocation of the nascent inclusion from the cell periphery to the perinuclear region, its final destination.", {"entities": []}], ["Here, we characterize for the first time inclusion identity and inclusion-associated proteins to delineate how C .", {"entities": []}], ["pneumoniae establishes the intracellular niche essential for its survival.", {"entities": []}], ["Here, we show for the first time how Chlamydia pneumoniae an obligate intracellular pathogen establishes its intracellular niche.", {"entities": []}], ["After EGFR-dependent endocytosis into host cells, the nascent chlamydial inclusion acquires early endosomal membrane identity and the Rab GTPases Rab4, Rab5 and Rab7, as well as the recycling-specific Rab11 and Rab14.", {"entities": [[211, 216, "GENE"]]}], ["We show that Rab5, Rab11 and Rab14 are retained in the vesicular membrane, while Rab4 and Rab7 subsequently disappear.", {"entities": [[29, 34, "GENE"]]}], ["pneumoniae escapes lysosomal degradation by hiding in a recycling endosome vesicle.", {"entities": []}], ["Furthermore, we show that the Rab11/Rab14 adaptor protein Rab11-Fip2 (Fip2), together with the unconventional actin motor protein myosin Vb, is recruited to the nascent inclusion.", {"entities": []}], ["Both are essential for internalization and infection, as they regulate the intracellular positioning of the inclusion, which is essential for intracellular transport from the cell periphery to the perinuclear region.", {"entities": []}], ["Here, we characterize for the first time inclusion identity and inclusion-associated proteins to understand how C .", {"entities": []}], ["pneumoniae establishes the intracellular niche, which is essential for its survival.", {"entities": []}], ["Oxidized low-density lipoprotein (oxLDL) is a well-recognized proatherogenic particle that functions in atherosclerosis.", {"entities": [[104, 119, "DISEASE"]]}], ["In this study, we established conditions to generate human oxLDL, characterized according to the grade of lipid and protein oxidation, particle size and oxylipin content.", {"entities": []}], ["The induction effect of the cellular proatherogenic response was assessed in foam cells by using an oxLDL-macrophage interaction model.", {"entities": []}], ["Uptake of oxLDL, reactive oxygen species production and expression of oxLDL receptors (CD36, SR-A and LOX-1) were significantly increased in THP-1 macrophages.", {"entities": [[87, 91, "GENE"]]}], ["Analyses of 35 oxylipins revealed that isoprostanes (IsoP) and prostaglandins (PGs) derived from the oxidation of arachidonic, dihomo gamma-linolenic and eicosapentaenoic acids were strongly and significantly induced in macrophages stimulated with oxLDL.", {"entities": []}], ["Importantly, the main metabolites responsible for the THP1-macrophage response to oxLDL exposure were the oxidative stress markers 5- epi -5-F 2t -IsoP, 15-E 1t -IsoP, 8-F 3t -IsoP and 15-keto-15-F 2t -IsoP as well as inflammatory markers PGDM, 17- trans -PGF 3\u03b1 , and 11\u03b2-PGF 2\u03b1 , all of which are reported here, for the first time, to function in the interaction of oxLDL with THP-1 macrophages.", {"entities": []}], ["By contrast, a salvage pathway mediated by anti-inflammatory PGs (PGE 1 and 17- trans -PGF 3\u03b1 ) was also identified, suggesting a response to oxLDL-induced injury.", {"entities": []}], ["In conclusion, when THP-1 macrophages were treated with oxLDL, a specific induction of biomarkers related to oxidative stress and inflammation was triggered.", {"entities": []}], ["This work contributes to our understanding of initial atherogenic events mediated by oxLDL-macrophage interactions and helps to generate new approaches for their modulation.", {"entities": []}], ["fx1 \u2022 OxLDL has a potent impact on the oxylipin profiles in THP-1 human macrophages.", {"entities": []}], ["\u2022 OxLDL induces biomarkers of oxidation and inflammation in THP-1 human macrophages.", {"entities": []}], ["\u2022 Human Macrophages produce anti-inflammatory prostaglandins after oxLDL exposure.", {"entities": []}], ["OxLDL has a potent impact on the oxylipin profiles in THP-1 human macrophages.", {"entities": []}], ["OxLDL induces biomarkers of oxidation and inflammation in THP-1 human macrophages.", {"entities": []}], ["Human Macrophages produce anti-inflammatory prostaglandins after oxLDL exposure.", {"entities": []}], ["Like CD1d-restricted i NKT cells, mucosal-associated invariant T cells (MAITs) are \u201cinnate\u201d T cells that express a canonical TCR\u03b1 chain, have a memory phenotype, and rapidly secrete cytokines upon TCR ligation.", {"entities": []}], ["Unlike i NKT cells, MAIT cells require the class Ib molecule MHC-related protein I (MR1), B cells, and gut flora for development and/or expansion, and they preferentially reside in the gut lamina propria.", {"entities": []}], ["Evidence strongly suggests that MAIT cell activation is ligand-dependent, but the nature of MR1 ligand is unknown.", {"entities": []}], ["In this study, we define a mechanism of endogenous antigen presentation by MR1 to MAIT cells.", {"entities": []}], ["MAIT cell activation was dependent neither on a proteasome-processed ligand nor on the chaperoning by the MHC class I peptide loading complex.", {"entities": []}], ["However, MAIT cell activation was enhanced by overexpression of MHC class II chaperones Ii and DM and was strikingly diminished by silencing endogenous Ii.", {"entities": []}], ["Furthermore, inhibiting the acidification of the endocytic compartments reduced MR1 surface expression and ablated MAIT cell activation.", {"entities": []}], ["The importance of the late endosome for MR1 antigen presentation was further corroborated by the localization of MR1 molecules in the multivesicular endosomes.", {"entities": []}], ["These findings demonstrate that MR1 traffics through endocytic compartments, thereby allowing MAIT cells to sample both endocytosed and endogenous antigens.", {"entities": []}], ["Evidence from recent literature shows that protocol-directed extubation is a useful approach to liberate patients from mechanical ventilation (MV).", {"entities": []}], ["However, research evidence does not necessarily provide guidance on how to implement changes in individual intensive care units (ICUs).", {"entities": []}], ["We conducted the present study to determine whether such an evidence-based strategy can be implemented safely and effectively using a multidisciplinary team (MDT) approach.", {"entities": []}], ["We designed a MDT-driven extubation protocol.", {"entities": []}], ["Multiple meetings were held to encourage constructive criticism of the design by attending physicians, nurses and respiratory care practitioners (RCPs), in order to define a protocol that was evidence based and acceptable to all clinical staff involved in the process of extubation.", {"entities": []}], ["It was subsequently implemented and evaluated in our medical/ surgical ICU.", {"entities": []}], ["Outcomes included response of the MDT to the initiative, duration of MV and stay in the ICU, as well as reintubation rate.", {"entities": []}], ["The MDT responded favourably to the design and implementation of this MDT-driven extubation protocol, because it provided greater autonomy to the staff.", {"entities": []}], ["Outcomes reported in the literature and in the historical control group were compared with those in the protocol group, and indicated similar durations of MV and ICU stay, as well as reintubation rates.", {"entities": []}], ["No adverse events were documented.", {"entities": []}], ["An MDT approach to protocol-directed extubation can be implemented safely and effectively in a multidisciplinary ICU.", {"entities": []}], ["Such an effort is viewed favourably by the entire team and is useful in enhancing team building.", {"entities": []}], ["Immigrants from undeveloped countries are a growing problem in Europe.", {"entities": []}], ["Spain has become a frequent destination for immigrants (20% of whom are children) because of its geographic location and its historic and cultural links with Africa and Latin America.", {"entities": []}], ["Eosinophilia is frequent in adult immigrants, travelers and expatriates coming from tropical areas.", {"entities": [[0, 12, "DISEASE"]]}], ["However, there are few studies that focus on the incidence and causes of tropical eosinophilia and hyper-IgE in immigrant children.", {"entities": [[82, 94, "DISEASE"]]}], ["We evaluated, prospectively, the prevalence and causes of eosinophilia and hyper-immunoglobulin E (IgE) in 362 immigrant children coming from Sub-Saharan Africa, Northern Africa and Latin America to Salamanca, Spain, between January 2007 and December 2011.", {"entities": [[58, 70, "DISEASE"]]}], ["Absolute eosinophilia and hyper-IgE were present in 22.9% and 56.8% of the analyzed children, respectively.", {"entities": [[9, 21, "DISEASE"]]}], ["The most frequent causes of absolute eosinophilia were filariasis (52.6%), strongyloidiasis (46.8%) and schistosomiasis (28.9%).", {"entities": [[55, 65, "DISEASE"], [75, 91, "DISEASE"], [37, 49, "DISEASE"], [104, 119, "DISEASE"]]}], ["Filariasis (41.9%), strongyloidiasis (29.6%) and schistosomiasis (22.2%) were the most frequent causes of increased levels of IgE.", {"entities": [[0, 10, "DISEASE"], [20, 36, "DISEASE"], [49, 64, "DISEASE"]]}], ["The area under the ROC curve showed similar values between eosinophil count and IgE levels in the diagnosis of helminthiasis (69% [95% confidence interval (CI) 63%\u201374%] vs 67% [95% CI 60%\u201372%], P \u200a=\u200a0.24) .", {"entities": []}], ["Eosinophilia and hyper-IgE have a high value as biomarkers of helminthiasis in children coming from tropical and subtropical areas.", {"entities": [[0, 12, "DISEASE"]]}], ["There is evidence from existing literature that ambient air pollutant exposure in early childhood likely plays an important role in asthma exacerbation and other respiratory symptoms, with greater effect among asthmatic children.", {"entities": [[132, 138, "DISEASE"]]}], ["However, there is inconclusive evidence on the role of ambient air pollutant exposures in relation to increasing asthma prevalence as well as asthma induction in children.", {"entities": [[113, 119, "DISEASE"], [142, 148, "DISEASE"]]}], ["At the population level, little is known about the potential synergistic effects between pollen allergens and air pollutants since this type of association poses challenges in uncontrolled real life settings.", {"entities": []}], ["In particular, data from sub-Sahara Africa is scarce and virtually absent among populations residing in informal residential settlements.", {"entities": []}], ["A prospective cohort study of 600 school children residing in four informal settlement areas with varying potential ambient air pollutant exposure levels in the Western Cape in South Africa is carried-out.", {"entities": []}], ["The study has two follow-up periods of at least six-months apart including an embedded panel study in summer and winter.", {"entities": []}], ["The exposure assessment component models temporal and spatial variability of air quality in the four study areas over the study duration using land-use regression modelling (LUR).", {"entities": []}], ["Additionally, daily pollen levels (mould spores, tree, grass and weed pollen) in the study areas are recorded.", {"entities": []}], ["In the panel study asthma symptoms and serial peak flow measurements is recorded three times daily to determine short-term serial airway changes in relation to varying ambient air quality and pollen over 10-days during winter and summer.", {"entities": [[19, 25, "DISEASE"]]}], ["The health outcome component of the cohort study include; the presence of asthma using a standardised ISAAC questionnaire, spirometry, fractional exhaled nitric-oxide (FeNO) and the presence of atopy (Phadiatop).", {"entities": [[74, 80, "DISEASE"]]}], ["This research applies state of the art exposure assessment approaches to characterize the effects of ambient air pollutants on childhood respiratory health, with a specific focus on asthma and markers of airway inflammation (FeNO) in South African informal settlement areas by considering also pollen counts and meteorological factors.", {"entities": [[182, 188, "DISEASE"]]}], ["The study will generate crucial data on air pollution and asthma in low income settings in sub-Sahara Africa that is lacking in the international literature.", {"entities": [[58, 64, "DISEASE"]]}], ["The present study aimed to estimate the age and cause-specific mortality in Ballabgarh Health and Demographic Surveillance System (HDSS) site for the years 2009 to 2012, using a probabilistic model (InterVA-4).", {"entities": []}], ["All Deaths in Ballabgarh HDSS from January 1, 2009, to December 31, 2012, were included in the study.", {"entities": []}], ["InterVA-4 model (version 4.02) was used for assigning cause of death (COD).", {"entities": []}], ["Data from the verbal autopsy (VA) tool were extracted and processed with the InterVA-4 model.", {"entities": []}], ["Cause-specific mortality rate (CSMR) per 1,000 person-years was calculated.", {"entities": []}], ["A total of 2,459 deaths occurred in the HDSS during the year 2009 to 2012.", {"entities": []}], ["Among them, 2,174 (88.4%) valid VA interviews were conducted.", {"entities": []}], ["Crude death rate ranged from 7.1 (2009) to 6.4 (2012) per 1,000 population.", {"entities": []}], ["The CSMR per 1,000 person-years over the years (2009\u20132012) for non-communicable diseases, communicable diseases, trauma, neoplasm, and maternal and neonatal diseases were 1.78, 1.68, 0.68, 0.49, and 0.48, respectively.", {"entities": []}], ["The most common causes of death among children, adults, and the elderly were infectious diseases, trauma, and non-communicable diseases, respectively.", {"entities": []}], ["Overall, non-communicable diseases constituted the largest proportion of mortality, whereas trauma was the most common COD among adults at Ballabgarh HDSS.", {"entities": []}], ["Policy-makers ought to focus on prevention of premature CODs, especially prevention of infectious diseases in children, and intentional self-harm and road traffic accidents in the adult population.", {"entities": []}], ["Stories may be an effective tool to communicate with patients because of their ability to engage the reader.", {"entities": []}], ["Our objective was to evaluate the effectiveness of story booklets compared to standard information sheets for parents of children attending the emergency department (ED) with a child with croup.", {"entities": [[188, 193, "DISEASE"]]}], ["Parents were randomized to receive story booklets (n=208) or standard information sheets (n=205) during their ED visit.", {"entities": []}], ["The primary outcome was change in anxiety between triage to ED discharge as measured by the State-Trait Anxiety Inventory.", {"entities": []}], ["Follow-up telephone interviews were conducted at 1 and 3 days after discharge, then every other day until 9 days (or until resolution of symptoms), and at 1 year.", {"entities": []}], ["Secondary outcomes included: expected future anxiety, event impact, parental knowledge, satisfaction, decision regret, healthcare utilization, time to symptom resolution.", {"entities": []}], ["There was no significant difference in the primary outcome of change in parental anxiety between recruitment and ED discharge (change of 5 points for the story group vs. 6 points for the comparison group, p=0.78).", {"entities": []}], ["The story group showed significantly greater decision regret regarding their decision to go to the ED (p<0.001): 6.7% of the story group vs. 1.5% of the comparison group strongly disagreed with the statement \u201cI would go for the same choice if I had to do it over again\u201d.", {"entities": []}], ["The story group reported shorter time to resolution of symptoms (mean 3.7 days story group vs. 4.0 days comparison group, median 3 days both groups; log rank test, p=0.04).", {"entities": []}], ["No other outcomes were different between study groups.", {"entities": []}], ["Stories about parent experiences managing a child with croup did not reduce parental anxiety.", {"entities": [[55, 60, "DISEASE"]]}], ["The story group showed significantly greater decision regret and quicker time to resolution of symptoms.", {"entities": []}], ["Further research is needed to better understand whether stories can be effective in improving patient-important outcomes.", {"entities": []}], ["Current Controlled Trials, ISRCTN39642997 ( http://www.controlled-trials.com/ISRCTN39642997 )", {"entities": []}], ["This review summarizes current knowledge of macrophages in helminth infections, with a focus not only on delineating the striking similarities in macrophage phenotype between diverse infections but also on highlighting the differences.", {"entities": []}], ["Findings from many different labs illustrate that macrophages in helminth infection can act as anti-parasite effectors but can also act as powerful immune suppressors.", {"entities": []}], ["The specific role for their alternative (Th2-mediated) activation in helminth killing or expulsion versus immune regulation remains to be determined.", {"entities": []}], ["Meanwhile, the rapid growth in knowledge of alternatively activated macrophages will require an even more expansive view of their potential functions to include repair of host tissue and regulation of host metabolism.", {"entities": []}], ["The aim of this research was to examine the occupational risk factors for Chronic Obstructive Pulmonary Diseases (COPD) in a range of occupations.", {"entities": []}], ["Eleven occupations involving different types of exposure were observed in this multicenter case-control study.", {"entities": []}], ["Controls and cases were matched for sex, age and smoking.", {"entities": []}], ["Multiple logistic regression analyses were used to estimate odds ratios (ORs).", {"entities": []}], ["A total of 1,519 participants were initially recruited between September 2004 and September 2012.", {"entities": []}], ["After matching, 547 pairs were obtained.", {"entities": []}], ["The mean age was 56.3 +/- 10.4 years.", {"entities": []}], ["Smelter workers were the only ones with an increased risk of COPD in this study (OR = 7.6, p < 0.0001, 95% CI [4.5, 12.9]).", {"entities": []}], ["Physical activity was protective (OR = 0.7), while living in the city was a risk (OR = 1.6).", {"entities": []}], ["The main used metals were cast iron, aluminum and alloys.", {"entities": []}], ["Molds and cores were mainly made from sand and synthetic resins.", {"entities": []}], ["Machine maintenance (65.2%), molding (49.6%), finishing (41.1%) and casting (41.0%) were the most common activities.", {"entities": []}], ["Almost all workers (95.1%) cleaned the floors and machines with a brush or compressed air.", {"entities": []}], ["This study demonstrates the importance of occupational factors in the genesis of COPD, especially among smelter workers.", {"entities": []}], ["As with the fight against smoking-related disease, the removal or substitution of recognized hazardous agents is the best way of preventing the onset of COPD.", {"entities": []}], ["This is why it is essential to continue research on its occupational risk factors.", {"entities": []}], ["Regulatory agencies, including the U.S. Environmental Protection Agency (US EPA) and state authorities like the California Air Resources Board (CARB), have sought to address the concerns of environmental justice (EJ) advocates who argue that chemical-by-chemical and source-specific assessments of potential health risks of environmental hazards do not reflect the multiple environmental and social stressors faced by vulnerable communities.", {"entities": []}], ["We propose an Environmental Justice Screening Method (EJSM) as a relatively simple, flexible and transparent way to examine the relative rank of cumulative impacts and social vulnerability within metropolitan regions and determine environmental justice areas based on more than simply the demographics of income and race.", {"entities": []}], ["We specifically organize 23 indicator metrics into three categories: (1) hazard proximity and land use; (2) air pollution exposure and estimated health risk; and (3) social and health vulnerability.", {"entities": []}], ["For hazard proximity, the EJSM uses GIS analysis to create a base map by intersecting land use data with census block polygons, and calculates hazard proximity measures based on locations within various buffer distances.", {"entities": []}], ["These proximity metrics are then summarized to the census tract level where they are combined with tract centroid-based estimates of pollution exposure and health risk and socio-economic status (SES) measures.", {"entities": []}], ["The result is a cumulative impacts (CI) score for ranking neighborhoods within regions that can inform diverse stakeholders seeking to identify local areas that might need targeted regulatory strategies to address environmental justice concerns.", {"entities": []}], ["An elevated level of the cytokine TL1A is known to be associated with several autoimmune diseases, e.g.", {"entities": []}], ["rheumatoid arthritis and inflammatory bowel disease.", {"entities": [[25, 51, "DISEASE"], [0, 20, "DISEASE"], [11, 20, "DISEASE"]]}], ["However, the mode of action of TL1A remains elusive.", {"entities": []}], ["In this study, we investigated the role of TL1A in a pro-inflammatory setting, using human leukocytes purified from healthy donors.", {"entities": []}], ["We show that TL1A, together with IL-12, IL-15 and IL-18, directly induces the production of IL-6 and TNF-\u03b1 from leukocytes.", {"entities": []}], ["Interestingly, TL1A-induced IL-6 was not produced by CD14", {"entities": [[53, 57, "GENE"]]}], ["The Health and Environmental Sciences Institute (HESI) Developmental and Reproductive Toxicology Technical Committee sponsored a pharmaceutical industry survey on current industry practices for contraception use during clinical trials.", {"entities": []}], ["The objectives of the survey were to improve our understanding of the current industry practices for contraception requirements in clinical trials, the governance processes set up to promote consistency and/or compliance with contraception requirements, and the effectiveness of current contraception practices in preventing pregnancies during clinical trials.", {"entities": []}], ["Opportunities for improvements in current practices were also considered.", {"entities": []}], ["The survey results from 12 pharmaceutical companies identified significant variability among companies with regard to contraception practices and governance during clinical trials.", {"entities": []}], ["This variability was due primarily to differences in definitions, areas of scientific uncertainty or misunderstanding, and differences in company approaches to enrollment in clinical trials.", {"entities": []}], ["The survey also revealed that few companies collected data in a manner that would allow a retrospective understanding of the reasons for failure of birth control during clinical trials.", {"entities": []}], ["In this article, suggestions are made for topics where regulatory guidance or scientific publications could facilitate best practice.", {"entities": []}], ["These include provisions for a pragmatic definition of women of childbearing potential, guidance on how animal data can influence the requirements for male and female birth control, evidence-based guidance on birth control and pregnancy testing regimes suitable for low- and high-risk situations, plus practical methods to ascertain the risk of drug-drug interactions with hormonal contraceptives.", {"entities": []}], ["Literature on the disease profile of prisoners that differentiates by age and gender remains sparse.", {"entities": []}], ["This study aimed to describe the health of correctional inmates in terms of substance abuse problems and mental and somatic health conditions, and compare it by gender and age.", {"entities": [[76, 91, "DISEASE"]]}], ["This study examined cross-sectional data from the Canton of Vaud in Switzerland on the health conditions of detainees who were in prison on January 1, 2011 or entered prison in 2011.", {"entities": []}], ["Health conditions validated by physician examination were reported using the International Classification of Diseases (ICD) version 10.", {"entities": []}], ["The analyses were descriptive by groups of prisoners: the entire sample (All), Men, Older adults and Women.", {"entities": []}], ["A total of 1,664 individuals were included in the analysis.", {"entities": []}], ["Men comprised 91.5\u00a0% of the sample and had a mean age of 33\u00a0years.", {"entities": []}], ["The other 8.5\u00a0% were women and had an average age of 39.", {"entities": []}], ["Older adults (i.e., age 50 and older) represented 7\u00a0% of the total sample.", {"entities": []}], ["Overall, 80\u00a0% of inmates were non-Swiss citizens, but the proportion of Swiss prisoners was higher among the older adults (51\u00a0%) and women (29\u00a0%).", {"entities": []}], ["Overall, 41\u00a0% of inmates self-reported substance abuse problems.", {"entities": [[39, 54, "DISEASE"]]}], ["Of those, 27\u00a0% were being treated by psychiatrists for behavioral disorders related to substance abuse.", {"entities": [[87, 102, "DISEASE"]]}], ["Chronic infectious diseases were found in 9\u00a0% of the prison population.", {"entities": []}], ["In addition, 27\u00a0% of detainees suffered from serious mental health conditions.", {"entities": []}], ["Gender and age had an influence on the disease profile of this sample: compared to the entire prison population, the older inmates were less likely to misuse illegal drugs and to suffer from communicable infections but exhibited more problems with alcohol and a higher burden of chronic health conditions.", {"entities": []}], ["Female prisoners were more disposed to mental health problems (including drug abuse) and infectious diseases.", {"entities": []}], ["In terms of chronic diseases, women suffered from the same conditions as men, but the diseases were more prevalent in women.", {"entities": []}], ["It is important to understand the different disease profiles of prisoners by gender and age, as it helps identify the needs of different groups and tailor age-and gender-specific interventions.", {"entities": []}], ["Bovine viral diarrhea virus (BVDV) is one of the most important pathogens in cattle.", {"entities": [[13, 21, "DISEASE"]]}], ["Previously, BVDV sub-genotypes of 1b, 1c, 1d, and 1\u00a0m were detected in China.", {"entities": []}], ["However, isolation of BVDV type 1a from cattle has not been reported in China.", {"entities": []}], ["In 2010, twenty nasal swabs and blood samples were collected from the cattle suspected BVDV infection in Henan province, China.", {"entities": []}], ["A BVDV isolate was isolated using cell culture, and the pathogenesis of the virus isolate was studied.", {"entities": []}], ["Virus isolation was performed on MDBK cells.", {"entities": []}], ["The virus identification was conducted by RT-PCR, neutralization test and immunofluorescence assay.", {"entities": []}], ["In order to determine the genotype of the newly isolated virus, the 5\u2032 un-translated region (5\u2032UTR) of the virus isolate was cloned, sequenced and phylogenetically analyzed.", {"entities": []}], ["To evaluate the virulence of the virus isolate, four BVDV sero-negative calves were intranasally inoculated with the virus suspension.", {"entities": []}], ["Rectal temperatures and clinical signs were recorded daily.", {"entities": []}], ["Blood samples were analyzed for changes in white blood cell counts, and tissue samples were taken for histopathology analysis.", {"entities": []}], ["A new isolate of bovine viral diarrhea virus (BVDV), named HN01, was isolated from the nasal swabs using MDBK cell culture.", {"entities": [[30, 38, "DISEASE"]]}], ["The HN01 strain caused cytopathic effect (CPE) in MDBK cell cultures after two passages.", {"entities": [[42, 45, "GENE"]]}], ["The virus specifically reacted to BVDV1-specific monoclonal antibody in an immunofluorescence assay.", {"entities": []}], ["A fragment of 288\u00a0bp of genome from this isolate was amplified by the RT-PCR.", {"entities": []}], ["Phylogenetic analysis of 5\u2032UTR indicated that the virus was BVDV 1a.", {"entities": []}], ["In the pathogenesis study, four calves experimentally infected with the BVDV strain developed depression, cough and other clinical signs.", {"entities": []}], ["Calves showed high temperature over 40\u00b0C, and white blood cell counts dropped more than 40%.", {"entities": []}], ["A new subgenotype 1a strain of BVDV was firstly isolated from dairy cattle in China.", {"entities": []}], ["The experimental infection showed that the virus was moderate pathogenic to cattle and can be used as a BVDV challenge virus to evaluate the efficacy of BVDV vaccines in the target animals.", {"entities": []}], ["Oxidative stress enhances inflammation and reduces the effectiveness of corticosteroids, but the inflammatory signalling pathways induced by oxidants remain ill-defined.", {"entities": []}], ["Phosphorylation of histone 3 at serine 10 (H3-Pser10) marks out a subset of inflammatory genes for transcription, several of which are induced in oxidant-associated inflammation.", {"entities": []}], ["However, the influence of oxidants or of corticosteroids on this modification remains unknown.", {"entities": []}], ["We assessed the regulation of H3-Pser10 by oxidants and lipopolysaccharide (LPS) in human blood monocytes and lung macrophages and the effectiveness of its abolition in controlling inflammatory gene expression in cells from asthmatic subjects compared to corticosteroids alone.", {"entities": []}], ["Both oxidants and LPS promoted the induction of H3-Pser10 which was unaffected by corticosteroids.", {"entities": []}], ["The induction of H3-Pser10 was mediated through p38\u03b1 mitogen-activated protein kinase (MAPK) and I\u03baB kinase 2 (IKK-2) signalling.", {"entities": []}], ["Consequently, inhibitors of p38\u03b1 MAPK or IKK-2 used in combination with dexamethasone were more effective at controlling inflammatory gene expression from monocytes and lung macrophages from asthmatic patients than the corticosteroid alone.", {"entities": []}], ["Therefore, reduction of H3-Pser10 by inhibition of p38\u03b1 MAPK or of IKK-2 may provide greater anti-inflammatory control than corticosteroids alone in oxidant-associated inflammation such as severe asthma.", {"entities": [[196, 202, "DISEASE"]]}], ["Asthma is a multifactorial disease composed of endotypes with varying risk profiles and outcomes.", {"entities": [[0, 6, "DISEASE"]]}], ["African Americans experience a high burden of asthma and of psychosocial stress, including racial discrimination.", {"entities": [[46, 52, "DISEASE"]]}], ["It is unknown which endotypes of asthma are vulnerable to racial/ethnic discrimination.", {"entities": [[33, 39, "DISEASE"]]}], ["We examined the association between self-reported racial/ethnic discrimination and bronchodilator response (BDR) among African American youth with asthma ages 8 to 21 years (n = 576) and whether this association varies with tumor necrosis factor alpha (TNF-\u03b1) level.", {"entities": [[147, 153, "DISEASE"]]}], ["Self-reported racial/ethnic discrimination was assessed by a modified Experiences of Discrimination questionnaire as none or any.", {"entities": []}], ["Using spirometry, BDR was specified as the mean percentage change in forced expiratory volume in one second before and after albuterol administration.", {"entities": []}], ["TNF-\u03b1 was specified as high/low levels based on our study population mean.", {"entities": []}], ["Linear regression was used to examine the association between self-reported racial/ethnic discrimination and BDR adjusted for selected characteristics.", {"entities": []}], ["An interaction term between TNF-\u03b1 levels and self-reported racial/ethnic discrimination was tested in the final model.", {"entities": []}], ["Almost half of participants (48.8%) reported racial/ethnic discrimination.", {"entities": []}], ["The mean percent BDR was higher among participants reporting racial/ethnic discrimination than among those who did not (10.8 versus 8.9, p = 0.006).", {"entities": []}], ["After adjustment, participants reporting racial/ethnic discrimination had a 1.7 (95% CI: 0.36\u20133.03) higher BDR mean than those not reporting racial/ethnic discrimination.", {"entities": []}], ["However, we found heterogeneity of this association according to TNF-\u03b1 levels (p-interaction = 0.040): Among individuals with TNF-\u03b1 high level only, we observed a 2.78 higher BDR mean among those reporting racial/ethnic discrimination compared with those not reporting racial/ethnic discrimination (95%CI: 0.79\u20134.77).", {"entities": []}], ["We found BDR to be increased in participants reporting racial/ethnic discrimination and this association was limited to African American youth with TNF-\u03b1 high asthma, an endotype thought to be resistant to traditional asthma medications.", {"entities": [[159, 165, "DISEASE"], [218, 224, "DISEASE"]]}], ["These results support screening for racial/ethnic discrimination in those with asthma as it may reclassify disease pathogenesis.", {"entities": [[79, 85, "DISEASE"]]}], ["Cyclooxygenase-2 (COX-2) and adipokines have been implicated in breast cancer.", {"entities": [[64, 77, "DISEASE"], [71, 77, "DISEASE"]]}], ["This study investigated a possible link between COX-2 and adipokines in the development of mammary tumors.", {"entities": []}], ["A model of environmental enrichment (EE), known to reduce tumor growth was used for a syngeneic murine model of mammary carcinoma.", {"entities": [[120, 129, "DISEASE"]]}], ["3-week-old, female C57BL/6 mice were housed in standard environment (SE) or EE cages for 9 weeks and transplanted orthotopically with syngeneic EO771 adenocarcinoma cells into the right inguinal mammary fat pad.", {"entities": [[150, 164, "DISEASE"]]}], ["EE housing influenced mammary gland development with a decrease in COX-2 expressing cells and enhanced side-branching and advanced development of alveolar structures of the mammary gland.", {"entities": []}], ["Tumor volume and weight were decreased in EE housed mice and were associated with a reduction in COX-2 and Ki67 levels, and an increase in caspase-3 levels.", {"entities": []}], ["In tumors of SE mice, high COX-2 expression correlated with enhanced leptin detection.", {"entities": []}], ["Non-tumor-bearing EE mice showed a significant increase in adiponectin levels but no change in those of leptin, F 2 -isoprostanes, PGF 2\u03b1 , IL-6, TNF-\u03b1, PAI-1, and MCP-1 levels.", {"entities": [[131, 134, "GENE"]]}], ["Both tumor-bearing groups (SE and EE housing) had increased resistin, IL-6, TNF-\u03b1, PAI-1 and MCP-1 levels irrespective of the different housing environment demonstrating higher inflammatory response due to the presence of the tumor.", {"entities": []}], ["This study demonstrates that EE housing influenced normal mammary gland development and inhibited mammary tumor growth resulting in a marked decrease in intratumoral COX-2 activity and an increase in the plasma ratio of adiponectin/leptin levels.", {"entities": []}], ["YKL-40 is a secreted inflammatory protein that its overexpression has been reported to correlate with poor outcome of various malignant diseases, especially in cancer.", {"entities": [[160, 166, "DISEASE"]]}], ["However, the function of this protein is still unclear.", {"entities": []}], ["The clinical prognosis of non-small cell lung cancers (NSCLC) patients and their clinical YKL-40 expressions were obtained from the Prognoscan database.", {"entities": []}], ["The expressions of YKL-40 in patient samples were determined by Western Blotting assay.", {"entities": []}], ["YKL-40 gene knockdown and overexpression were performed on NSCLC cancer cells (CL1-1 and CL1-5).", {"entities": [[65, 71, "DISEASE"]]}], ["The cells were investigated for their epithelial\u2013mesenchymal transition (EMT) markers gene modulation through Western Blotting and RT-PCR.", {"entities": []}], ["Further cell metastatic abilities were assessed by transwell migration and invasion assay.", {"entities": []}], ["In this study, YKL-40 was observed to be highly expressed in NSCLC specimens.", {"entities": []}], ["Furthermore, determined by the PrognoScan database analysis, patients with high expression levels of YKL-40 were found with poor prognosis.", {"entities": []}], ["In the in vitro study, different characteristics of NSCLC cell lines (CL1-1, H23, H838, CL1-5, and H2009) were used as study models, where YKL-40 expression levels were determined to correlate with the phenotypic characteristics of cancer metastasis.", {"entities": [[232, 238, "DISEASE"]]}], ["In this study,YKL-40 was demonstrated to regulate EMT marker expressions such as Twist, Snail, Slug, N-cadherin, Vimentin, and E-cadherin.", {"entities": []}], ["The protein\u2019s affects in cancer cell migration and invasion were also observed in YKL-40 overexpression or knock down NSCLC cell lines.", {"entities": [[25, 31, "DISEASE"]]}], ["All of results from this study suggest that YKL-40 is a major factor in NSCLC metastasis.", {"entities": []}], ["Thus, YKL-40 may serve as therapeutic targets for NSCLC patients in the future.", {"entities": []}], ["This study forms part of the first complete characterization of the dose\u2013response curve for glycopyrrolate (GP) delivered using Co-Suspension\u2122 Delivery Technology via a metered dose inhaler (MDI).", {"entities": []}], ["We examined the lower GP MDI dose range to determine an optimal dose for patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).", {"entities": [[106, 143, "DISEASE"]]}], ["This randomized, double-blind, chronic-dosing, balanced incomplete-block, placebo-controlled, crossover study compared six doses of GP MDI (18, 9, 4.6, 2.4, 1.2, and 0.6\u00a0\u03bcg, twice daily [BID]) with placebo MDI BID and open-label tiotropium dry powder inhaler (18\u00a0\u03bcg, once daily [QD]) in patients with moderate-to-severe COPD.", {"entities": []}], ["Patients were randomized into 1 of 120 treatment sequences.", {"entities": []}], ["Each sequence included 4 of 8 treatments administered for 14-day periods separated by 7- to 21-day washout periods.", {"entities": []}], ["The primary efficacy endpoint was change from baseline in forced expiratory volume in 1\u00a0s area under the curve from 0 to 12 h (FEV 1 AUC 0\u201312 ) on Day 14.", {"entities": [[127, 130, "GENE"]]}], ["Secondary efficacy endpoints included peak change from baseline (post-dose) in FEV 1 and inspiratory capacity (IC) on Days 1, 7, and 14; change from baseline in morning pre-dose trough FEV 1 on Days 7 and 14; change from baseline in 12-h post-dose trough FEV 1 on Day 14; time to onset of action (\u226510\u00a0% improvement in mean FEV 1 ) and the proportion of patients achieving \u226512\u00a0% improvement in FEV 1 on Day 1; and pre-dose trough IC on Days 7 and 14.", {"entities": [[79, 82, "GENE"], [185, 188, "GENE"], [255, 258, "GENE"], [323, 326, "GENE"], [393, 396, "GENE"], [79, 82, "GENE"], [185, 188, "GENE"], [255, 258, "GENE"], [323, 326, "GENE"], [393, 396, "GENE"], [79, 82, "GENE"], [185, 188, "GENE"], [255, 258, "GENE"], [323, 326, "GENE"], [393, 396, "GENE"], [79, 82, "GENE"], [185, 188, "GENE"], [255, 258, "GENE"], [323, 326, "GENE"], [393, 396, "GENE"], [79, 82, "GENE"], [185, 188, "GENE"], [255, 258, "GENE"], [323, 326, "GENE"], [393, 396, "GENE"]]}], ["Safety and tolerability were also assessed.", {"entities": []}], ["GP MDI 18, 9, 4.6, and 2.4\u00a0\u03bcg demonstrated statistically significant and clinically relevant increases in FEV 1 AUC 0\u201312 compared with placebo MDI following 14\u00a0days of treatment (modified intent-to-treat population\u2009=\u2009120).", {"entities": [[106, 109, "GENE"]]}], ["GP MDI 18\u00a0\u03bcg was non-inferior to open-label tiotropium for peak change in FEV 1 on Day 1 and morning pre-dose trough FEV 1 on Day 14.", {"entities": [[74, 77, "GENE"], [117, 120, "GENE"], [74, 77, "GENE"], [117, 120, "GENE"]]}], ["All doses of GP MDI were well tolerated with no unexpected safety findings.", {"entities": []}], ["These efficacy and safety results support GP MDI 18\u00a0\u03bcg BID as the most appropriate dose for evaluation in Phase III trials in patients with moderate-to-severe COPD.", {"entities": []}], ["ClinicalTrials.gov NCT01566773 .", {"entities": []}], ["Registered 27 March 2012.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0426-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Limited research exists that investigates hospital admissions for ambulatory care sensitive conditions (ACSCs) among the homeless, who frequently lack a usual source of care.", {"entities": []}], ["This study profiled ACSC admissions for homeless patients.", {"entities": []}], ["Bivariate analyses and logistic regression were completed to investigate ACSC and non-ACSC admissions among homeless patients using the 2010 California State Inpatient Database.", {"entities": []}], ["Homeless patients admitted for an ACSC were mostly male, non-Hispanic white, and on average 49.9\u00a0years old.", {"entities": []}], ["In the predictive model, the odds of an ACSC admission among homeless patients increased when they were black, admitted to the emergency department or transferred from another health facility.", {"entities": []}], ["Having Medicare was associated with a decreased odds of an ACSC admission.", {"entities": []}], ["Specific characteristics are associated with a greater likelihood of an ACSC admission.", {"entities": []}], ["Research should examine how these characteristics contribute to ACSC hospitalizations and findings should be linked to programs designed to serve as a safety-net for homeless patients to reduce hospitalizations.", {"entities": []}], ["Matching on the propensity score is a commonly used analytic method for estimating the effects of treatments on outcomes.", {"entities": []}], ["Commonly used propensity score matching methods include nearest neighbor matching and nearest neighbor caliper matching.", {"entities": []}], ["Rosenbaum (1991) proposed an optimal full matching approach, in which matched strata are formed consisting of either one treated subject and at least one control subject or one control subject and at least one treated subject.", {"entities": []}], ["Full matching has been used rarely in the applied literature.", {"entities": []}], ["Furthermore, its performance for use with survival outcomes has not been rigorously evaluated.", {"entities": []}], ["We propose a method to use full matching to estimate the effect of treatment on the hazard of the occurrence of the outcome.", {"entities": []}], ["An extensive set of Monte Carlo simulations were conducted to examine the performance of optimal full matching with survival analysis.", {"entities": []}], ["Its performance was compared with that of nearest neighbor matching, nearest neighbor caliper matching, and inverse probability of treatment weighting using the propensity score.", {"entities": []}], ["Full matching has superior performance compared with that of the two other matching algorithms and had comparable performance with that of inverse probability of treatment weighting using the propensity score.", {"entities": []}], ["We illustrate the application of full matching with survival outcomes to estimate the effect of statin prescribing at hospital discharge on the hazard of post\u2010discharge mortality in a large cohort of patients who were discharged from hospital with a diagnosis of acute myocardial infarction.", {"entities": [[269, 290, "DISEASE"], [263, 290, "DISEASE"]]}], ["Optimal full matching merits more widespread adoption in medical and epidemiological research.", {"entities": []}], ["\u00a9 2015 The Authors.", {"entities": []}], ["Statistics in Medicine Published by John Wiley & Sons Ltd.", {"entities": []}], ["Decreased heart rate variability (HRV) is associated with adverse outcomes in cardiovascular diseases and has been observed in patients with systemic lupus erythematosus (SLE).", {"entities": [[150, 169, "DISEASE"], [141, 169, "DISEASE"]]}], ["We examined the relationship of HRV with SLE disease activity and selected cytokine pathways.", {"entities": []}], ["Fifty-three patients from the Oklahoma Lupus Cohort were evaluated at two visits each.", {"entities": []}], ["Clinical assessments included the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), British Isles Lupus Assessment Group (BILAG) index, physician global assessment (PGA), and Safety of Estrogens in Lupus Erythematosus National Assessment-SLEDAI Flare Index.", {"entities": [[43, 62, "DISEASE"], [210, 229, "DISEASE"], [34, 62, "DISEASE"]]}], ["HRV was assessed with a 5-minute electrocardiogram, and the following HRV parameters were calculated: square root of the mean of the squares of differences between adjacent NN intervals (RMSSD), percentage of pairs of adjacent NN intervals differing by more than 50 milliseconds (pNN50), high-frequency power (HF power), and low frequency to high frequency (LF/HF) ratio, which reflects sympathetic/vagal balance.", {"entities": []}], ["Plasma cytokine levels were measured with a multiplex, bead-based immunoassay.", {"entities": []}], ["Serum B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) were measured with an enzyme-linked immunosorbent assay.", {"entities": []}], ["Linear regression analysis was applied.", {"entities": []}], ["Baseline HRV (pNN50, HF power, LF/HF ratio) was inversely related to disease activity (BILAG, PGA) and flare.", {"entities": []}], ["Changes in RMSSD between visits were inversely related to changes in SLEDAI ( p \u2009=\u20090.007).", {"entities": []}], ["Age, caffeine, tobacco and medication use had no impact on HRV.", {"entities": []}], ["Plasma soluble tumor necrosis factor receptor II (sTNFRII) and monokine induced by interferon gamma (MIG) were inversely related with all baseline measures of HRV ( p \u2009=\u20090.039 to <0.001).", {"entities": []}], ["Plasma stem cell factor (SCF), interleukin (IL)-1 receptor antagonist (IL-1RA), and IL-15 showed similar inverse relationships with baseline HRV, and weaker trends were observed for interferon (IFN)-\u03b1, interferon gamma-induced protein (IP)-10, and serum BLyS.", {"entities": []}], ["Changes in the LF/HF ratio between visits were also associated with changes in sTNFRII ( p \u2009=\u20090.021), MIG ( p \u2009=\u20090.003), IFN-\u03b1 ( p \u2009=\u20090.012), SCF ( p \u2009=\u20090.001), IL-1RA ( p \u2009=\u20090.023), and IL-15 ( p \u2009=\u20090.010).", {"entities": []}], ["On the basis of multivariate linear regression, MIG was an independent predictor of baseline HRV after adjusting for plasma IL-1RA, SCF, IFN-\u03b1, IP-10, and serum BLyS.", {"entities": []}], ["In a similar model, the sTNFRII impact remained significant after adjusting for the same variables.", {"entities": []}], ["Impaired HRV, particularly the LF/HF ratio, is associated with lupus disease activity and several cytokines related to IFN type II and TNF pathways.", {"entities": [[135, 138, "GENE"]]}], ["The strongest association was with MIG and sTNFRII, expanding previous immune connections of vagal signaling.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-016-1087-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["That a definite change in the reactivity of the skin takes place during the transition from infancy to childhood has been repeatedly noted.", {"entities": []}], ["Rolly (5), working with a variety of bacterial toxins, found that infants did not react, but that reactions occurred with advancing age.", {"entities": []}], ["Similarly Tenner (6), using Witte's peptone, colon bacilli, and tuberculin observed that at about the period that the skin of children became increasingly sensitive to tuberculin, a corresponding reactivity was manifest toward the other antigens.", {"entities": []}], ["It seems possible to us that this phenomenon is related to the alteration in the ferments of the skin that takes place during the transition period.", {"entities": []}], ["Thus while the protease of the adult type of skin causes a definite autolysis, that of the fetal skin does not, the synthetic potential evidently predominating.", {"entities": []}], ["Of greater significance seems to be the fact that the skin of the young animal contains peptidase to a considerable amount, while the adult skin seems to be without this ferment activity.", {"entities": []}], ["If we assume that the disintegration of the native protein of the antigen is essential in eliciting certain skin tests, it would seem probable that the splitting would be less apt to take place in the young skin in which the lytic effects of the ferments are relatively suppressed.", {"entities": []}], ["On the other hand, the young skin, containing peptidase, would be able to digest rapidly any antigen consisting of partially hydrolyzed proteins\u2014as tuberculin\u2014and in this way detoxicate and remove the noxious material.", {"entities": []}], ["From these considerations the undoubted alteration of the skin reactivity taking place after infancy seems definitely correlated with changes in the proteolytic ferments.", {"entities": []}], ["In how far they enter into and alter the specific reactions cannot be determined from the limited data so far available.", {"entities": []}], ["Of the other ferments, the lipases, as pointed out by Porter, are possibly of importance in the resistance of the skin to tuberculous infection.", {"entities": []}], ["It will be observed from the table that the activity of these skin ferments is less manifest in their action as esterases, on ethyl butyrate, than on the neutral fats used, oleic oil and butter fat, in this way differing from the activity of the serum.", {"entities": []}], ["The relative resistance of the skin to tuberculous infection can, however, hardly be due to the activity of the lipase alone, for it must be kept in mind that the lepra bacillus, also rich in lipoids, is enabled to proliferate well within the epithelial tissues.", {"entities": []}], ["Please cite this paper as: Maurer et\u00a0al.", {"entities": []}], ["(2012) Who knew?", {"entities": []}], ["Awareness of being recommended for influenza vaccination among US adults.", {"entities": [[35, 44, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(4), 284\u2013290.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Starting with the 2010\u20132011 influenza season, the Advisory Committee on Immunization Practices at the US Centers for Disease Control and Prevention recommends annual influenza vaccination to all people aged 6\u2003months and older unless contraindicated.", {"entities": [[40, 49, "DISEASE"], [178, 187, "DISEASE"]]}], ["Objectives\u2002 To measure perceived influenza vaccination recommendation status among US adults ( n \u2003=\u20032122) and its association with socio\u2010demographic characteristics and recommendation status during the 2009\u20132010 pandemic influenza season.", {"entities": [[33, 42, "DISEASE"], [221, 230, "DISEASE"]]}], ["Methods\u2002 We analyze nationally representative data from longitudinal Internet surveys of US adults conducted in November\u2013December 2009 and September\u2013October 2010.", {"entities": []}], ["Results\u2002 During the 2010\u20132011 vaccination season, 46\u00b72 percent (95%\u2010CI: 43\u00b73\u201349\u00b71%) of US adults correctly reported to be covered by a government recommendation for influenza vaccination.", {"entities": [[165, 174, "DISEASE"]]}], ["Awareness of being covered by a government influenza vaccination recommendation was statistically significantly higher among non\u2010working adults and adults who had been recommended for seasonal vaccination or both seasonal and H1N1 vaccination during the 2009\u20132010 pandemic influenza vaccination season.", {"entities": [[43, 52, "DISEASE"], [273, 282, "DISEASE"]]}], ["Conclusion\u2002 Our results highlight that a majority of US adults do not know that they are recommended for annual influenza vaccination by the government.", {"entities": [[112, 121, "DISEASE"]]}], ["The fraction of adults who are unaware of their recommendation status is especially large among newly recommended healthy young adults.", {"entities": []}], ["The universal vaccination recommendations will only be successful if they reach both patients and physicians and lead to changing vaccination practices.", {"entities": []}], ["The universal nature of the new recommendation simplifies vaccination\u2010related outreach and compliance with government vaccination guidelines considerably, as it does not require any identification of specific recommendation groups based on complex personal or health risk factors.", {"entities": []}], ["In preparation for a cluster-randomized controlled trial of a community intervention to increase the demand for measles vaccination in Lasbela district of Pakistan, a balance sheet summarized published evidence on benefits and possible adverse effects of measles vaccination.", {"entities": [[112, 119, "DISEASE"], [255, 262, "DISEASE"]]}], ["The balance sheet listed: 1) major health conditions associated with measles; 2) the risk among the unvaccinated who contract measles; 3) the risk among the vaccinated; 4) the risk difference between vaccinated and unvaccinated; and 5) the likely net gain from vaccination for each condition.", {"entities": [[69, 76, "DISEASE"], [126, 133, "DISEASE"]]}], ["Two models revealed very different projections of net gain from measles vaccine.", {"entities": [[64, 71, "DISEASE"]]}], ["A Lasbela-specific combination of low period prevalence of measles among the unvaccinated, medium vaccination coverage and low vaccine efficacy rate, as revealed by the baseline survey, resulted in less-than-expected gains attributable to vaccination.", {"entities": [[59, 66, "DISEASE"]]}], ["Modelled on estimates where the vaccine had greater efficacy, the gains from vaccination would be more substantial.", {"entities": []}], ["Specific local conditions probably explain the low rates among the unvaccinated while the high vaccine failure rate is likely due to weaknesses in the vaccination delivery system.", {"entities": []}], ["Community perception of these realities may have had some role in household decisions about whether to vaccinate, although the major discouraging factor was inadequate access.", {"entities": []}], ["The balance sheet may be useful as a communication tool in other circumstances, applied to up-to-date local evidence.", {"entities": []}], ["Bronchiectasis (BE) is a chronic and heterogeneous respiratory disease that requires a multidimensional scoring system to properly assess severity.", {"entities": []}], ["The aim of this study was to compare the severity stratification by 2 validated scores (BSI and FACED) in a BE cohort and to determine their predictive capacity for exacerbations and hospitalizations.", {"entities": []}], ["Moreover, we proposed a modified version of FACED which was created to better predict the risk of exacerbations in clinical practice.", {"entities": []}], ["We performed a prospective cohort study including BE patients >18 years old with a follow-up period of 1-year.", {"entities": []}], ["One-hundred eighty-two patients (40% males; mean age 68) were studied.", {"entities": []}], ["Patients were stratified according to the number of exacerbations during the follow-up, and according to BSI and FACED scores.", {"entities": []}], ["BSI classified most of our patients as severe 99 (54.4%) or moderate 47 (25.8%), while FACED mainly classified as mild 108 (59.3%) or moderate 61 (33.5%).", {"entities": []}], ["BSI and FACED showed an area under ROC curve (AUC) for exacerbations of 0.808 and 0.734; and for hospitalizations (due to BE exacerbations) of 0.893 and 0.809, respectively.", {"entities": []}], ["Subsequently, we modified FACED by adding previous exacerbations (Exa-FACED) and this new score classified patients as mild 48.4%, moderate 34.6% and severe 17.0%, with an improved AUC for exacerbations (0.760) and hospitalizations (0.820).", {"entities": []}], ["Despite previous validations of BSI and FACED, they classified our patients very differently.", {"entities": []}], ["As expected, FACED showed poor prognostic capacity for exacerbations.", {"entities": []}], ["We support the Exa-FACED score to predict the risk future exacerbations for been easy to use in clinical practice.", {"entities": []}], ["COPD is a multifactorial disease caused by environmental determinants as well as genetic risk factors.", {"entities": []}], ["The prevalence and mortality of COPD continue to increase, and underdiagnosis of COPD remains a critical issue.", {"entities": []}], ["Previous reports investigated promising microRNAs (miRNAs) to reveal the molecular mechanism for the development of COPD; however, diagnostic and therapeutic markers for COPD have not yet been found.", {"entities": []}], ["For this study, 20 representative COPD patients were separated into four groups based on increasing severity (A, B, C, and D) and compared to six healthy controls.", {"entities": []}], ["Small RNA profiles of peripheral leukocytes were differentially expressed miRNAs (analyzed via next-generation sequencing) were validated via quantitative reverse transcriptase-polymerase chain reaction.", {"entities": []}], ["Compared to healthy controls, 19 differentially expressed miRNAs were found in COPD patients.", {"entities": []}], ["For all COPD groups, miR-3177-3p was downregulated, while 17 miRNAs were upregulated.", {"entities": []}], ["Furthermore, the results revealed 21 differentially expressed miRNAs, of which miR-183-5p was continually downregulated from A to B to D. Between respective bronchodilator reversibility positive and negative groups of COPD different groups (A, B, C, and D), 10 miRNAs were differentially expressed, while miR-100-5p was upregulated in the negative groups.", {"entities": []}], ["In conclusion, miR-106b-5p, miR-125a-5p, miR-183-5p, and miR-100-5p are central for the development of COPD.", {"entities": [[28, 39, "GENE"]]}], ["The severity of COPD was attenuated by miR-106b-5p, thus suggesting this miRNA as potential target for disease treatment.", {"entities": []}], ["Different tissues contain diverse and dynamic cellular niches, providing distinct signals to tissue-resident or migratory infiltrating immune cells.", {"entities": []}], ["Hedgehog (Hh) proteins are secreted inter-cellular signalling molecules, which are essential during development and are important in cancer, post-natal tissue homeostasis and repair.", {"entities": [[133, 139, "DISEASE"]]}], ["Hh signalling mediated by the Hh-responsive transcription factor Gli2 also has multiple roles in T-lymphocyte development and differentiation.", {"entities": [[65, 69, "GENE"]]}], ["Here, we investigate the function of Gli2 in T-cell signalling and activation.", {"entities": [[37, 41, "GENE"]]}], ["Gene transcription driven by the Gli2 transcriptional activator isoform (Gli2A) attenuated T-cell activation and proliferation following T-cell receptor (TCR) stimulation.", {"entities": [[33, 37, "GENE"]]}], ["Expression of Gli2A in T-cells altered gene expression profiles, impaired the TCR-induced Ca", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a heterogeneous syndrome characterized by varying degrees of airflow limitation and diffusion impairment.", {"entities": [[64, 72, "DISEASE"]]}], ["There is increasing evidence to suggest that COPD is also characterized by systemic inflammation.", {"entities": []}], ["The primary goal of this study was to identify soluble proteins in plasma that associate with the severity of airflow limitation in a COPD cohort with stable disease.", {"entities": []}], ["A secondary goal was to assess whether unique markers associate with diffusion impairment, based on diffusion capacity of carbon monoxide (DLCO), independent of the forced expiratory volume in 1 second (FEV 1 ).", {"entities": [[203, 206, "GENE"]]}], ["A cross sectional study of 73 COPD subjects was performed in order to examine the association of 25 different plasma proteins with the severity of lung function impairment, as defined by the baseline measurements of the % predicted FEV 1 and the % predicted DLCO.", {"entities": [[232, 235, "GENE"]]}], ["Plasma protein concentrations were assayed using multiplexed immunobead-based cytokine profiling.", {"entities": []}], ["Associations between lung function and protein concentrations were adjusted for age, gender, pack years smoking history, current smoking, inhaled corticosteroid use, systemic corticosteroid use and statin use.", {"entities": []}], ["Plasma concentrations of CCL2/monocyte chemoattractant protein-1 (CCL2/MCP-1), CCL4/macrophage inflammatory protein-1\u03b2 (CCL4/MIP -1\u03b2), CCL11/eotaxin, and interleukin-13 (IL-13) were inversely associated with the % FEV 1 .", {"entities": [[214, 217, "GENE"]]}], ["Plasma concentrations of soluble Fas were associated with the % DLCO, whereas CXCL9/monokine induced by interferon-\u03b3 (CXCL9/Mig), granulocyte- colony stimulating factor (G-CSF) and IL-13 showed inverse relationships with the % DLCO.", {"entities": [[33, 36, "GENE"]]}], ["Systemic inflammation in a COPD cohort is characterized by cytokines implicated in inflammatory cell recruitment and airway remodeling.", {"entities": []}], ["Plasma concentrations of IL-13 and chemoattractants for monocytes, T lymphocytes, and eosinophils show associations with increasing severity of disease.", {"entities": []}], ["Soluble Fas, G-CSF and CXCL9/Mig may be unique markers that associate with disease characterized by disproportionate abnormalities in DLCO independent of the FEV 1 .", {"entities": [[8, 11, "GENE"], [158, 161, "GENE"]]}], ["The primary objective of this study was to explore whether general practitioners (GPs) in Norway, Sweden, and Denmark make similar or different decisions regarding sick leave for patients with severe subjective health complaints (SHC).", {"entities": []}], ["The secondary objective was to investigate if patient diagnoses, the reasons attributed for patient complaints, and GP demographics could explain variations in sick leave decisions.", {"entities": []}], ["A cross-sectional study.", {"entities": []}], ["Video vignettes of GP consultations with nine different patients.", {"entities": []}], ["126 GPs in Norway, Sweden, and Denmark.", {"entities": []}], ["Primary care in Norway, Sweden, and Denmark.", {"entities": []}], ["Sick leave decisions made by GPs.", {"entities": []}], ["\u201cPsychological\u201d diagnoses in Sweden were related to lower odds ratio (OR) of granting sick leave than in Norway (OR = 0.07; 95% CI = 0.01\u20130.83) Assessments of patient health, the risk of deterioration, and their ability to work predicted sick leave decisions.", {"entities": []}], ["Specialists in general medicine grant significantly fewer sick leaves than non-specialists.", {"entities": []}], ["Sick-leave decisions made by GPs in the three countries were relatively similar.", {"entities": []}], ["However, Swedish GPs were more reluctant to grant sick leave for patients with \u201cpsychological\u201d diagnoses.", {"entities": []}], ["Assessments regarding health-related factors were more important than diagnoses in sick-leave decisions.", {"entities": []}], ["Specialist training may be of importance for sick-leave decisions.", {"entities": []}], ["The objective of the study is to develop a scoring system for predicting a 90-day re-exacerbation in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).", {"entities": [[151, 188, "DISEASE"]]}], ["A total of 176 consecutive hospitalized patients with AECOPD were included.", {"entities": []}], ["The sociodemographic characteristics, status before acute exacerbation (AE), presentations of and treatment for the current AE, and the re-exacerbation in 90 days after discharge from hospital were collected.", {"entities": []}], ["The re-exacerbation rate in 90 days was 48.9% (86 out of 176).", {"entities": []}], ["It was associated with the degree of lung function impairment (Global initiative for chronic Obstructive Lung Disease [GOLD] grades), frequency of AE in the previous year, and parameters of the current AE, including pleural effusion, use of accessory respiratory muscles, inhaled long-acting \u03b2-2-agonists, inhaled corticosteroids, controlled oxygen therapy, noninvasive mechanical ventilation, and length of hospital stay, but was not associated with body mass index, modified Medical Research Council scale, or chronic obstructive pulmonary disease assessment test.", {"entities": [[512, 549, "DISEASE"]]}], ["A subgroup of ten variables was selected and developed into the re-exacerbation index scoring system (age grades, GOLD grades, AE times in the previous year, pleural effusion, use of accessory respiratory muscles, noninvasive mechanical ventilation, controlled oxygen therapy, inhaled long-acting \u03b2-2-agonists and inhaled corticosteroids, and length of hospital stay).", {"entities": []}], ["The re-exacerbation index showed good discrimination for re-exacerbation, with a C -statistic of 0.750 ( P <0.001).", {"entities": []}], ["A comprehensive assessment integrating parameters of stable chronic obstructive pulmonary disease, clinical presentations at exacerbation, and treatment showed a strong predictive capacity for short-term outcome in patients with AECOPD.", {"entities": [[60, 97, "DISEASE"]]}], ["Further studies are required to verify these findings.", {"entities": []}], ["\u2022 The effects of maternal smoking on the term placental proteome was studied.", {"entities": []}], ["\u2022 Maternal smoking significantly affected 18% of protein spots.", {"entities": []}], ["\u2022 Maternal smoking affects systems controlling the development and function of placenta.", {"entities": []}], ["\u2022 The observed placental changes may contribute to the lowered birth weights.", {"entities": []}], ["The effects of maternal smoking on the term placental proteome was studied.", {"entities": []}], ["Maternal smoking significantly affected 18% of protein spots.", {"entities": []}], ["Maternal smoking affects systems controlling the development and function of placenta.", {"entities": []}], ["The observed placental changes may contribute to the lowered birth weights.", {"entities": []}], ["Detrimental effects of maternal smoking on the term placental proteome and steroid-metabolizing activities, and maternal hormone levels, were studied by using seven non-smoker and seven smoker placentae.", {"entities": []}], ["Smoking significantly affected 18% of protein spots.", {"entities": []}], ["The functional networks affected were i) cell morphology, cellular assembly and organization, cellular compromise (15 hits) and ii) DNA replication, recombination, and repair, energy production, nucleic acid metabolism (6 hits).", {"entities": []}], ["Smoking significantly up-regulated such proteins as, SERPINA1, EFHD1 and KRT8; and down-regulated SERPINB2, FGA and HBB.", {"entities": [[53, 61, "GENE"], [63, 68, "GENE"], [73, 77, "GENE"], [98, 106, "GENE"], [108, 111, "GENE"], [116, 119, "GENE"]]}], ["Although maternal plasma steroids were not significantly altered, the catalytic activity of CYP1A1 was increased whereas CYP19A1 activity was reduced by smoking.", {"entities": [[92, 98, "GENE"], [121, 128, "GENE"]]}], ["Furthermore, transcript expression of CYP1A1 and CYP4B1 were induced while HSD17B2, NFKB and TGFB1 were repressed by smoking.", {"entities": [[38, 44, "GENE"], [49, 55, "GENE"], [75, 82, "GENE"], [93, 98, "GENE"]]}], ["The observed smoking induced wide-spread changes on placental proteome and transcript levels may contribute to the lowered birth weights of the new-born child and placenta.", {"entities": []}], ["Management of aortic root aneurysm or dissection has been the subject of much discussion that has led to some modifications.", {"entities": []}], ["The current trend is a valve-sparing root replacement.", {"entities": []}], ["We compared the outcome following valve sparing root repair with Bentall procedure.", {"entities": []}], ["We retrospectively evaluated 70 patients who underwent root replacement for aneurysm or dissection and compared the outcomes of valve-sparing root replacement with those of the Bentall procedure from January 2007 to December 2011 at our institution.", {"entities": []}], ["Twenty-five patients had valve-sparing aortic root replacement (VSR, including reimplantation or remodeling) (23 males and 2 females), and 45 patients had the Bentall procedure (34 males and 11 females).", {"entities": []}], ["Patients who underwent a VSR were younger with a mean age of 55.4 \u00b1 14.8 years compared to those who underwent the Bentall procedure with a mean age of 60.6 \u00b1 12.7 ( P =ns).", {"entities": []}], ["The preoperative aortic insufficiency (AI) in the VSR group was moderate in 8 (32%) patients, and severe in 6 (24%).", {"entities": []}], ["Preoperative creatinine was 1 \u00b1 0.35 mg/dl in the VSR group and 1.1 \u00b1 0.87 mg/dl in the Bentall group.", {"entities": []}], ["In the VSR group, 3 (12%) patients had emergency surgery; by contrast, in the Bentall group, 8 (17%) patients had emergent surgery.", {"entities": []}], ["Concomitant coronary artery bypass grafting (excluding coronary reimplantation) was performed in 8 (32%) patients in the VSR group and in 12 (26.6%) patients in the Bentall group ( P =0.78); additional valve procedures were performed in 2 (8%) patients in the VSR group and in 11 (24.4%) patients in the Bentall group.", {"entities": []}], ["The perioperative mortality was 8% (n=2) and 13.3% (n=6), for the VSR and Bentall procedures, respectively ( P =0.7, ns).", {"entities": []}], ["The total duration of intensive care unit stay was 116.6 \u00b1 106 hours for VSR patients and 152.5 \u00b1 218.2 hours for Bentall patients ( P =0.5).", {"entities": []}], ["The overall length of stay in the hospital was 10 \u00b1 8.1 days for VSR and 11 \u00b1 9.52 days for Bentall ( P =0.89).", {"entities": []}], ["The one-year survival was 92% for the VSR group and 79.0% for the Bentall group.", {"entities": []}], ["The seven-year survival for the VSR group was 92% and 79% for the Bentall group (95% CI [1.215 to 0.1275], P =0.1).", {"entities": []}], ["Aortic valve-sparing root replacement can be performed with acceptable morbidity and mortality with a comparable long-term survival to the Bentall procedure.", {"entities": []}], ["Interest is rapidly growing around the role of the human gut microbiota in facilitating beneficial health effects associated with consumption of dietary fiber.", {"entities": []}], ["An evidence map of current research activity in this area was created using a newly developed database of dietary fiber intervention studies in humans to identify studies with the following broad outcomes: (1) modulation of colonic microflora; and/or (2) colonic fermentation/short-chain fatty acid concentration.", {"entities": []}], ["Study design characteristics, fiber exposures, and outcome categories were summarized.", {"entities": []}], ["A sub-analysis described oligosaccharides and bacterial composition in greater detail.", {"entities": []}], ["One hundred eighty-eight relevant studies were identified.", {"entities": []}], ["The fiber categories represented by the most studies were oligosaccharides (20%), resistant starch (16%), and chemically synthesized fibers (15%).", {"entities": []}], ["Short-chain fatty acid concentration (47%) and bacterial composition (88%) were the most frequently studied outcomes.", {"entities": []}], ["Whole-diet interventions, measures of bacterial activity, and studies in metabolically at-risk subjects were identified as potential gaps in the evidence.", {"entities": []}], ["This evidence map efficiently captured the variability in characteristics of expanding research on dietary fiber, gut microbiota, and physiological health benefits, and identified areas that may benefit from further research.", {"entities": []}], ["We hope that this evidence map will provide a resource for researchers to direct new intervention studies and meta-analyses.", {"entities": []}], ["Recent advances have shown that the abnormal inflammatory response observed in CD involves an interplay among intestinal microbiota, host genetics and environmental factors.", {"entities": []}], ["The escalating consumption of fat and sugar in Western countries parallels an increased incidence of CD during the latter 20 E. coli population.", {"entities": []}], ["The HF/HS diet created a specific inflammatory environment in the gut, correlated with intestinal mucosa dysbiosis characterized by an overgrowth of pro-inflammatory Proteobacteria such as E. coli , a decrease in protective bacteria, and a significantly decreased of SCFA concentrations.", {"entities": []}], ["The expression of GPR43, a SCFA receptor was reduced in mice treated with a HF/HS diet and reduced in CD patients compared with controls.", {"entities": []}], ["Interestingly, mice treated with an agonist of GPR43 were protected against DSS-induced colitis.", {"entities": []}], ["Finally, the transplantation of feces from HF/HS treated mice to GF mice increased susceptibility to AIEC infection.", {"entities": []}], ["Together, our results demonstrate that a Western diet could aggravate the inflammatory process and that the activation of the GPR43 receptor pathway could be used as a new strategy to treat CD patients.", {"entities": []}], ["The objective of this study was to provide information on the effect of disparities in material deprivation, access to health care services, and lifestyle on the likelihood of undergoing screening for disease prevention.", {"entities": []}], ["We used data from a probability sample (N = 10,726) of the Montreal population aged 15 years or older and assessed 6 dependent variables (screening for breast cancer, cervical cancer, colon cancer, blood glucose, and high blood pressure and receipt of the seasonal influenza vaccination), and 3 independent variables (disparities in material deprivation, access to health care services, and personal lifestyle habits).", {"entities": [[265, 274, "DISEASE"], [152, 165, "DISEASE"], [184, 196, "DISEASE"], [159, 165, "DISEASE"], [176, 182, "DISEASE"], [190, 196, "DISEASE"], [167, 182, "DISEASE"]]}], ["We used logistic regression to analyze data and determine associations.", {"entities": []}], ["Use of preventive health services increased as material deprivation declined, access to health care improved, and lifestyle habits became healthier.", {"entities": []}], ["The combined effect of household income, an individual measure, and the material deprivation index (consisting of quintiles representing a range from the most privileged [quintile 1: best education, employment, and income] to the most deprived [quintile 5: least education, employment, and income]) an ecological measure, showed that having a Papanicolaou test was significantly associated with high annual household income (\u2265$40,000) even if the woman resided in a deprived neighborhood (quintiles 4 and 5 of the material deprivation index) (odds ratio [OR], 1.38; 95% confidence interval [CI], 1.04\u20131.84), whereas odds of having a mammogram or influenza vaccination were significantly associated with living in a privileged neighborhood (quintiles 1, 2, and 3 of the material deprivation index) even among people with a low annual household income (<$40,000) (mammogram: OR, 1.54; 95% CI, 1.00\u20132.38; influenza vaccination: OR, 1.31; 95% CI, 1.04\u20131.66).", {"entities": [[646, 655, "DISEASE"], [902, 911, "DISEASE"]]}], ["In addition to influencing lifestyle habits and access to health care services, disparities in material deprivation influence whether a person uses preventive health services.", {"entities": []}], ["Public health professionals need to establish screening outreach programs in socioeconomically disadvantaged neighborhoods to enhance public participation in disease prevention programs and reduce disparities in health.", {"entities": []}], ["The seeds of Vigna genus are important food resources and there have already been many reports regarding their bioactivities.", {"entities": []}], ["In our preliminary bioassay, the chloroform layer of methanol extracts of V. vexillata demonstrated significant anti-inflammatory bioactivity.", {"entities": []}], ["Therefore, the present research is aimed to purify and identify the anti-inflammatory principles of V. vexillata .", {"entities": []}], ["One new sterol ( 1 ) and two new isoflavones ( 2 , 3 ) were reported from the natural sources for the first time and their chemical structures were determined by the spectroscopic and mass spectrometric analyses.", {"entities": []}], ["In addition, 37 known compounds were identified by comparison of their physical and spectroscopic data with those reported in the literature.", {"entities": []}], ["Among the isolates, daidzein ( 23 ), abscisic acid ( 25 ), and quercetin ( 40 ) displayed the most significant inhibition of superoxide anion generation and elastase release.", {"entities": []}], ["Cytokine-hormone network deregulations underpin pathologies ranging from autoimmune disorders to cancer, but our understanding of these networks in physiological/pathophysiological states remains patchy.", {"entities": [[97, 103, "DISEASE"]]}], ["We employed Bayesian networks to analyze cytokine-hormone interactions in vivo using murine lactation as a dynamic, physiological model system.", {"entities": []}], ["Circulatory levels of estrogen, progesterone, prolactin and twenty-three cytokines were profiled in post partum mice with/without pups.", {"entities": []}], ["The resultant networks were very robust and assembled about structural hubs, with evidence that interleukin (IL)-12 (p40), IL-13 and monocyte chemoattractant protein (MCP)-1 were the primary drivers of network behavior.", {"entities": []}], ["Network structural conservation across physiological scenarios coupled with the successful empirical validation of our approach suggested that in silico network perturbations can predict in vivo qualitative responses.", {"entities": []}], ["In silico perturbation of network components also captured biological features of cytokine interactions (antagonism, synergy, redundancy).", {"entities": []}], ["These findings highlight the potential of network-based approaches in identifying novel cytokine pharmacological targets and in predicting the effects of their exogenous manipulation in inflammatory/immune disorders.", {"entities": []}], ["The online version of this article (doi:10.1186/s12918-015-0226-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Nutrition has been suggested as an important environmental factor other than viruses and chemicals in the pathogenesis of type 1 diabetes (T1D).", {"entities": []}], ["Whereas various maternal dietary nutritional elements have been suggested and examined in T1D of both humans and experimental animals, the results largely remain controversial.", {"entities": []}], ["In a series of studies using T1D model nonobese diabetic (NOD) mice, maternal dietary n-6/n-3 essential fatty acid ratio during pregnancy and lactation period, that is, early life stages of the offspring, has been shown to affect pathogenesis of insulitis and strongly prevent overt T1D of the offspring, which is consistent with its preventive effects on other allergic diseases.", {"entities": []}], ["Streptococcus pneumoniae (Spn) is a major causative organism of empyema, an inflammatory condition occurring in the pleural sac.", {"entities": [[26, 29, "GENE"]]}], ["In this study, we used human and Spn cDNA microarrays to characterize the transcriptional responses occurring during initial contact between Spn and a human pleural mesothelial cell line (PMC) in vitro .", {"entities": [[33, 36, "GENE"], [141, 144, "GENE"], [33, 36, "GENE"], [141, 144, "GENE"]]}], ["Using stringent filtering criteria, 42 and 23 Spn genes were up-and down-regulated respectively.", {"entities": [[46, 49, "GENE"]]}], ["In particular, genes encoding factors potentially involved in metabolic processes and Spn adherence to eukaryotic cells were up-regulated e.g.", {"entities": [[86, 89, "GENE"]]}], ["glnQ , glnA , aliA , psaB , lytB and nox .", {"entities": []}], ["After Spn initial contact, 870 human genes were differentially regulated and the largest numbers of significant gene expression changes were found in canonical pathways for eukaryotic initiation factor 2 signaling (60 genes out of 171), oxidative phosphorylation (32/103), mitochondrial dysfunction (37/164), eIF4 and p70S6K signaling (28/142), mTOR signaling (27/182), NRF2-mediated oxidative stress response (20/177), epithelial adherens junction remodeling (11/66) and ubiquitination (22/254).", {"entities": [[6, 9, "GENE"], [345, 349, "GENE"]]}], ["The cellular response appeared to be directed towards host cell survival and defense.", {"entities": []}], ["Spn did not activate NF-kB or phosphorylate p38 MAPK or induce cytokine production from PMC.", {"entities": [[0, 3, "GENE"]]}], ["Moreover, Spn infection of TNF-\u03b1 pre-stimulated PMC inhibited production of IL-6 and IL-8 secretion by >50% (p<0.01).", {"entities": [[10, 13, "GENE"]]}], ["In summary, this descriptive study provides datasets and a platform for examining further the molecular mechanisms underlying the pathogenesis of empyema.", {"entities": []}], ["We examined the extent to which disability mediates the observed associations of common mental and physical conditions with perceived health.", {"entities": []}], ["WHO World Mental Health (WMH) Surveys carried out in 22 countries worldwide (n\u200a=\u200a51,344 respondents, 72.0% response rate).", {"entities": []}], ["We assessed nine common mental conditions with the WHO Composite International Diagnostic Interview (CIDI), and ten chronic physical with a checklist.", {"entities": []}], ["A visual analog scale (VAS) score (0, worst to 100, best) measured perceived health in the previous 30 days.", {"entities": []}], ["Disability was assessed using a modified WHO Disability Assessment Schedule (WHODAS), including: cognition, mobility, self-care, getting along, role functioning (life activities), family burden, stigma, and discrimination.", {"entities": []}], ["Path analysis was used to estimate total effects of conditions on perceived health VAS and their separate direct and indirect (through the WHODAS dimensions) effects.", {"entities": []}], ["Twelve-month prevalence was 14.4% for any mental and 51.4% for any physical condition.", {"entities": []}], ["31.7% of respondents reported difficulties in role functioning, 11.4% in mobility, 8.3% in stigma, 8.1% in family burden and 6.9% in cognition.", {"entities": []}], ["Other difficulties were much less common.", {"entities": []}], ["Mean VAS score was 81.0 (SD\u200a=\u200a0.1).", {"entities": []}], ["Decrements in VAS scores were highest for neurological conditions (9.8), depression (8.2) and bipolar disorder (8.1).", {"entities": [[94, 110, "DISEASE"]]}], ["Across conditions, 36.8% (IQR: 31.2\u201351.5%) of the total decrement in perceived health associated with the condition were mediated by WHODAS disabilities (significant for 17 of 19 conditions).", {"entities": []}], ["Role functioning was the dominant mediator for both mental and physical conditions.", {"entities": []}], ["Stigma and family burden were also important mediators for mental conditions, and mobility for physical conditions.", {"entities": []}], ["More than a third of the decrement in perceived health associated with common conditions is mediated by disability.", {"entities": []}], ["Although the decrement is similar for physical and mental conditions, the pattern of mediation is different.", {"entities": []}], ["Research is needed on the benefits for perceived health of targeted interventions aimed at particular disability dimensions.", {"entities": []}], ["In the context of health-related quality of life (HrQoL) assessment in pediatric short stature, the present study aimed to examine the levels of agreement/disagreement between parents\u2019 and children\u2019s reports of generic and condition-specific HrQoL, and to identify socio-demographic, clinical and psychosocial variables associated with the extent and direction of parent-child discrepancies.", {"entities": []}], ["This study was part of the retest phase of the QoLISSY project, which was a multicenter study conducted simultaneously in France, Germany, Spain, Sweden and UK.", {"entities": []}], ["The sample comprised 137 dyads of children/adolescents between 8 and 18\u00a0years of age, diagnosed with growth hormone deficiency (GHD) or idiopathic short stature (ISS), and one of their parents.", {"entities": []}], ["The participants completed child- and parent-reported questionnaires on generic (KIDSCREEN-10 Index) and condition-specific HrQoL (QoLISSY Core Module).", {"entities": []}], ["Children/adolescents also reported on social support (Oslo 3-items Social Support Scale) and parents assessed the parent-child relationships (Parental Role subscale of the Social Adjustment Scale) and burden of short stature on parents (QoLISSY- additional module).", {"entities": []}], ["The parent-child agreement on reported HrQoL was strong (intraclass correlation coefficients between .59 and .80).", {"entities": []}], ["The rates of parent-child discrepancies were 61.5\u00a0% for generic and 35.2\u00a0% for condition-specific HrQoL, with the parents being more prone to report lower generic (42.3\u00a0%) and condition-specific HrQoL (23.7\u00a0%) than their children.", {"entities": []}], ["The extent of discrepancies was better explained by family and social relationships than by clinical and socio-demographic variables: poorer parent-child relationships and better children\u2019s social support were associated with larger discrepancies in generic HrQoL, while more parental burden was associated with larger discrepancies in condition-specific HrQoL reports.", {"entities": []}], ["Regarding the direction of discrepancies, higher parental burden was significantly associated with parents\u2019 underrating, and better children\u2019s social support was significantly associated with parents\u2019 overrating of condition-specific HrQoL.", {"entities": []}], ["Routine assessment of pediatric HrQoL in healthcare and research contexts should include child- and parent-reported data as complementary sources of information, and also consider the family and social context.", {"entities": []}], ["The developed world is undergoing a demographic transition with greater numbers of older adults and higher rates of chronic disease.", {"entities": []}], ["Most elder care is now provided by primary care physicians, who prescribe the majority of medications taken by these patients.", {"entities": []}], ["Despite these significant trends, little is known about population-level prescribing patterns to primary care patients aged 65+.", {"entities": []}], ["We conducted a population-based retrospective cohort study to examine 10-year prescribing trends among family physicians providing care to patients aged 65+ in Ontario, Canada.", {"entities": []}], ["Both crude number of prescription claims and prescription rates (i.e., claims per person) increased dramatically over the 10-year study period.", {"entities": []}], ["The greatest change was in prescribing patterns for females aged 85+.", {"entities": []}], ["Dramatic increases were observed in the prescribing of preventive medications, such as those to prevent osteoporosis (+2,347%) and lipid-lowering agents (+697%).", {"entities": [[104, 116, "DISEASE"]]}], ["And lastly, the number of unique classes of medications prescribed to older persons has increased, with the proportion of older patients prescribed more than 10 classes of medications almost tripling during the study period.", {"entities": []}], ["Prescribing to older adults by family physicians increased substantially during the study period.", {"entities": []}], ["This raises important concerns regarding quality of care, patient safety, and cost sustainability.", {"entities": []}], ["It is evident that further research is urgently needed on the health outcomes (both beneficial and harmful) associated with these dramatic increases in prescribing rates.", {"entities": []}], ["Coronary artery disease (CAD) is an immune-mediated chronic inflammatory disease mainly caused by atherosclerosis.", {"entities": [[98, 113, "DISEASE"]]}], ["The aims of this study were to investigate the role of interleukin-27 (IL-27) in patients with CAD and the severity of coronary artery lesions, which was evaluated by Gensini score and to investigate the biosynthesis of IL-27 and oxidized low-density lipoprotein (ox-LDL) in vitro using monocyte-derived dendritic cells (DCs).", {"entities": []}], ["To this aim, plasma levels of IL-27, ox-LDL, and Gensini score were analyzed in patients with CAD ( n = 136) and normal subjects (controls, n = 29).", {"entities": []}], ["IL-27 concentration of the supernatant and the mRNA expression levels of p28 and ebi3, subunits of IL-27, from cultured immature DCs incubated with different concentrations of ox-LDL for 24 h were also analyzed.", {"entities": [[81, 85, "GENE"]]}], ["We found that circulating IL-27 levels were significantly elevated in patients with CAD than in controls ( P < 0.01), and positively correlated to ox-LDL and Gensini score.", {"entities": []}], ["ox-LDL dose-dependently upregulated expression of both IL-27 protein and IL-27 (p28 and EBI3) mRNA in vitro, indicating that ox-LDL can stimulate DCs to produce IL-27.", {"entities": [[88, 92, "GENE"]]}], ["These results demonstrate that IL-27 might regulate the network of immunity and inflammation in the pathogenesis of atherosclerosis.", {"entities": [[116, 131, "DISEASE"]]}], ["Hyperinsulinemia is a hallmark of insulin resistance\u2010associated metabolic disorders.", {"entities": []}], ["Under physiological conditions, insulin maintains a balance between nitric oxide ( NO ) and, the potent vasoconstrictor, endothelin\u20101 ( ET \u20101).", {"entities": []}], ["We tested the hypothesis that acute hyperinsulinemia will preferentially augment ET \u20101 protein expression, disrupt the equilibrium between ET \u20101 expression and endothelial NO synthase ( eNOS ) activation, and subsequently impair flow\u2010induced dilation ( FID ) in human skeletal muscle arterioles.", {"entities": []}], ["Skeletal muscle biopsies were performed on 18 lean, healthy controls ( LHC s) and 9 older, obese, type 2 diabetics (T2 DM ) before and during (120\u00a0min) a 40\u00a0mU/m ET \u20101, eNOS , phosphorylated eNOS (p\u2010 eNOS ), and ET \u20101 receptor type A ( ETAR ) and B ( ETBR ) expression.", {"entities": []}], ["In a subset of T2 DM ( n\u00a0 = \u00a0 6) and LHC s ( n \u00a0=\u00a05), FID of isolated skeletal muscle arterioles was measured.", {"entities": []}], ["Experimental hyperinsulinemia impaired FID (% of dilation at \u220660 pressure gradient) in LHC s (basal: 74.2\u00a0\u00b1\u00a02.0; insulin: 57.2\u00a0\u00b1\u00a03.3, P \u00a0=\u00a00.003) and T2 DM (basal: 62.1\u00a0\u00b1\u00a03.6; insulin: 48.9\u00a0\u00b1\u00a03.6, P \u00a0=\u00a00.01).", {"entities": []}], ["Hyperinsulinemia increased ET \u20101 protein expression in LHC s (0.63\u00a0\u00b1\u00a00.04) and T2 DM (0.86\u00a0\u00b1\u00a00.06) compared to basal conditions ( LHC s: 0.44\u00a0\u00b1\u00a00.05, P \u00a0=\u00a00.007; T2 DM : 0.69\u00a0\u00b1\u00a00.06, P \u00a0=\u00a00.02).", {"entities": []}], ["Insulin decreased p\u2010 eNOS (serine 1177) only in T2 DM (basal: 0.28\u00a0\u00b1\u00a00.07; insulin: 0.17\u00a0\u00b1\u00a00.04, P \u00a0=\u00a00.03).", {"entities": []}], ["In LHC s, hyperinsulinemia disturbed the balance between ETAR and ETBR receptors known to mediate vasoconstrictor and vasodilator actions of ET \u20101, respectively.", {"entities": []}], ["Moreover, hyperinsulinemia markedly impaired plasma NO concentration in both LHC s and T2 DM .", {"entities": []}], ["These data suggest that hyperinsulinemia disturbs the vasomotor balance in human skeletal muscle favoring vasoconstrictive pathways, eventually impairing arteriolar vasodilation.", {"entities": []}], ["In the context of population aging, multimorbidity has emerged as a growing concern in public health.", {"entities": []}], ["However, little is known about multimorbidity patterns and other issues surrounding chronic diseases.", {"entities": []}], ["The aim of our study was to examine multimorbidity patterns, the relationship between physical and mental conditions and the distribution of multimorbidity in the Spanish adult population.", {"entities": []}], ["Data from this cross-sectional study was collected from the COURAGE study.", {"entities": []}], ["A total of 4,583 participants from Spain were included, 3,625 aged over 50.", {"entities": []}], ["An exploratory factor analysis was conducted to detect multimorbidity patterns in the population over 50 years of age.", {"entities": []}], ["Crude and adjusted binary logistic regressions were performed to identify individual associations between physical and mental conditions.", {"entities": []}], ["Three multimorbidity patterns rose: \u2018cardio-respiratory\u2019 (angina, asthma, chronic lung disease), \u2018mental-arthritis\u2019 (arthritis, depression, anxiety) and the \u2018aggregated pattern\u2019 (angina, hypertension, stroke, diabetes, cataracts, edentulism, arthritis).", {"entities": [[187, 199, "DISEASE"], [105, 114, "DISEASE"], [117, 126, "DISEASE"], [242, 251, "DISEASE"], [66, 72, "DISEASE"], [82, 94, "DISEASE"]]}], ["After adjusting for covariates, asthma, chronic lung disease, arthritis and the number of physical conditions were associated with depression.", {"entities": [[62, 71, "DISEASE"], [32, 38, "DISEASE"], [48, 60, "DISEASE"]]}], ["Angina and the number of physical conditions were associated with a higher risk of anxiety.", {"entities": []}], ["With regard to multimorbidity distribution, women over 65 years suffered from the highest rate of multimorbidity (67.3%).", {"entities": []}], ["Multimorbidity prevalence occurs in a high percentage of the Spanish population, especially in the elderly.", {"entities": []}], ["There are specific multimorbidity patterns and individual associations between physical and mental conditions, which bring new insights into the complexity of chronic patients.", {"entities": []}], ["There is need to implement patient-centered care which involves these interactions rather than merely paying attention to individual diseases.", {"entities": []}], ["Occurrence of chronic physical pain is increasingly identified among youth, and medically unsupervised analgesic use is a possible risk factor for opioid dependence and other mental diseases in later life.", {"entities": []}], ["Therefore, the present study was carried out in young student population in Sikkim, India, to explore predictors (including current chronic pain and current analgesic use) of low QoL in youth to identify a subset of population vulnerable to substance use and mental diseases in later life.", {"entities": []}], ["The study was conducted in a health university setting in Sikkim, North East India.", {"entities": []}], ["In this cross-sectional study, 156 participants were enrolled with almost equal number of males and females.", {"entities": []}], ["Generic instruments for demographics and current analgesic use and SF - 36, for assessment of quality of life (QoL), were used.", {"entities": []}], ["QoL was measured in general, physical and emotional domains.", {"entities": []}], ["Presence of chronic physical pain during past four weeks was captured using SF - 36.", {"entities": []}], ["Almost two-third participants reported presence of current physical pain (69%, n=108); and (14%, n=22) reported current analgesic use for pain.", {"entities": []}], ["In logistic regression model controlled for age, ethnicity, gender and residence, higher body mass index (BMI) (\u03b2=-0.16, P =0.02) and current analgesic use (\u03b2=1.6, P =0.006) predicted low QoL in emotional domain (less accomplishment due to emotional problem).", {"entities": []}], ["Current analgesic use also predicted low QoL in another measure of emotional domain (depressed \u03b2=2.0, P =0.001).", {"entities": []}], ["This study identified a subset of participants in their youth with low QoL in emotional domain predicted by current analgesic use and possible overweight problem.", {"entities": []}], ["Low QoL in more than one emotional domain also identifies possibility of later psychiatric impairment.", {"entities": []}], ["However, chronic pain did not emerge as a significant predictor of low QoL in emotional domain.", {"entities": []}], ["A number of open questions in human evolutionary genetics would become tractable if we were able to directly measure evolutionary fitness.", {"entities": []}], ["As a step towards this goal, we developed a method to examine whether individual genetic variants, or sets of genetic variants, currently influence viability.", {"entities": []}], ["The approach consists in testing whether the frequency of an allele varies across ages, accounting for variation in ancestry.", {"entities": []}], ["We applied it to the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort and to the parents of participants in the UK Biobank.", {"entities": []}], ["Across the genome, we found only a few common variants with large effects on age-specific mortality: tagging the APOE \u03b54 allele and near CHRNA3 .", {"entities": [[113, 117, "GENE"], [137, 143, "GENE"]]}], ["These results suggest that when large, even late-onset effects are kept at low frequency by purifying selection.", {"entities": []}], ["Testing viability effects of sets of genetic variants that jointly influence 1 of 42 traits, we detected a number of strong signals.", {"entities": []}], ["In participants of the UK Biobank of British ancestry, we found that variants that delay puberty timing are associated with a longer parental life span ( P ~6.2 \u00d7 10 P ~2.0 \u00d7 10 P ~1.4 \u00d7 10 CHRNA3 locus, and variants associated with risk of CAD and cholesterol levels.", {"entities": [[190, 196, "GENE"]]}], ["Beyond our findings, the analysis serves as a proof of principle for how upcoming biomedical data sets can be used to learn about selection effects in contemporary humans.", {"entities": []}], ["Our global understanding of adaptation in humans is limited to indirect statistical inferences from patterns of genetic variation, which are sensitive to past selection pressures.", {"entities": []}], ["We introduced a method that allowed us to directly observe ongoing selection in humans by identifying genetic variants that affect survival to a given age (i.e., viability selection).", {"entities": []}], ["We applied our approach to the GERA cohort and parents of the UK Biobank participants.", {"entities": []}], ["We found viability effects of variants near the APOE and CHRNA3 genes, which are associated with the risk of Alzheimer disease and smoking behavior, respectively.", {"entities": [[48, 52, "GENE"], [57, 63, "GENE"]]}], ["We also tested for the joint effect of sets of genetic variants that influence quantitative traits.", {"entities": []}], ["We uncovered an association between longer life span and genetic variants that delay puberty timing and age at first birth.", {"entities": []}], ["We also detected detrimental effects of higher genetically predicted cholesterol levels, body mass index, risk of coronary artery disease (CAD), and risk of asthma on survival.", {"entities": [[157, 163, "DISEASE"]]}], ["Some of the observed effects differ between males and females, most notably those at the CHRNA3 gene and variants associated with risk of CAD and cholesterol levels.", {"entities": [[89, 95, "GENE"]]}], ["Beyond this application, our analysis shows how large biomedical data sets can be used to study natural selection in humans.", {"entities": []}], ["Several genetic association studies have examined the relationships between single nucleotide polymorphisms (SNPs) in the IL13 gene and eczema, and have provided contradictory results.", {"entities": [[122, 126, "GENE"]]}], ["We investigated the relationship between the IL13 SNPs rs1800925 and rs20541 and the risk of eczema in Japanese young adult women.", {"entities": [[45, 49, "GENE"]]}], ["Included were 188 cases who met the criteria of the International Study of Asthma and Allergies in Childhood (ISAAC) for eczema.", {"entities": [[75, 81, "DISEASE"]]}], ["Control subjects were 1,082 women without eczema according to the ISAAC criteria, who had not been diagnosed with atopic eczema by a doctor and who had no current asthma as defined by the European Community Respiratory Health Survey criteria.", {"entities": [[163, 169, "DISEASE"]]}], ["Adjustment was made for age, region of residence, number of children, smoking, and education.", {"entities": []}], ["The minor TT genotype of SNP rs1800925 was significantly associated with an increased risk of eczema in the co-dominant model: the adjusted odds ratio was 2.19 (95% confidence interval: 1.03-4.67).", {"entities": []}], ["SNP rs20541 was not related to eczema.", {"entities": []}], ["None of the haplotypes were significantly associated with eczema.", {"entities": []}], ["Compared with women with the CC or CT genotype of SNP rs1800925 who had never smoked, those with the TT genotype who had ever smoked had a 2.85-fold increased risk of eczema, though the adjusted odds ratio was not statistically significant, and neither multiplicative nor additive interaction was statistically significant.", {"entities": []}], ["Our findings suggest that the IL13 SNP rs1800925 is significantly associated with eczema in Japanese young adult women.", {"entities": [[30, 34, "GENE"]]}], ["We could not find evidence for an interaction between SNP rs1800925 and smoking with regard to eczema.", {"entities": []}], ["Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe inflammatory lung diseases.", {"entities": [[55, 63, "DISEASE"]]}], ["Methylprednisolone (MP) is a common drug against inflammation in clinic.", {"entities": []}], ["In this study, we aim to investigate the protective effect of MP on ALI and potential mechanisms.", {"entities": []}], ["Male BABL/c mice were injected through tail vein using lipopolysaccharide (LPS, 5\u00a0mg/kg) with or without 5\u00a0mg/kg MP.", {"entities": []}], ["Lung mechanics, tissue injury and inflammation were examined.", {"entities": []}], ["Macrophage subsets in the lung were identified by flow cytometry.", {"entities": []}], ["Macrophages were cultured from bone marrow of mice with or without MP.", {"entities": []}], ["Then, we analyzed and isolated the subsets of macrophages.", {"entities": []}], ["These isolated macrophages were then co-cultured with CD4 Respiratory physiologic function was significantly improved by MP treatment.", {"entities": [[54, 57, "GENE"]]}], ["Tissue injury and inflammation were ameliorated in the MP-treated group.", {"entities": []}], ["After MP treatment, the number of M1 decreased and M2 increased in the lung.", {"entities": []}], ["In in vitro experiment, MP promoted M2 polarization rather than M1.", {"entities": []}], ["We then induced M1, M2a and M2c from bone marrow cells.", {"entities": []}], ["M1 induced more Th17 while M2 induced more CD4 In conclusion, MP ameliorated ALI by promoting M2 polarization.", {"entities": [[43, 46, "GENE"]]}], ["M2, especially M2c, induced Tregs without any influence on Tregs immunosuppression function.", {"entities": []}], ["Observational studies have associated metformin use with a decreased risk of lung cancer incidence in patients with type 2 diabetes, but the studies had important methodological shortcomings.", {"entities": [[77, 88, "DISEASE"], [82, 88, "DISEASE"]]}], ["The objective of this study was to determine whether metformin use is associated with a decreased risk of lung cancer in patients with type 2 diabetes, while avoiding previous biases.", {"entities": [[106, 117, "DISEASE"], [111, 117, "DISEASE"]]}], ["Using the U.K. General Practice Research Database, we assembled a cohort of patients newly treated with oral hypoglycemic agents (OHAs) between 1988 and 2009.", {"entities": []}], ["A nested case\u2013control analysis was conducted, where case subjects with lung cancer occurring during follow-up were matched with up to 10 control subjects for age, sex, calendar time, and duration of follow-up.", {"entities": [[71, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["Conditional logistic regression was used to estimate adjusted rate ratios of lung cancer associated with ever use of metformin, along with measures of duration and cumulative dose.", {"entities": [[77, 88, "DISEASE"], [82, 88, "DISEASE"]]}], ["Models were adjusted for potential confounders, which included smoking.", {"entities": []}], ["The cohort included 115,923 new users of OHAs, with 1,061 patients diagnosed with lung cancer during follow-up (rate 2.0/1,000 person-years).", {"entities": [[82, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["Metformin use was not associated with a decreased rate of lung cancer (rate ratio 0.94 [95% CI 0.76\u20131.17]).", {"entities": [[58, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["No dose-response was observed by number of prescriptions received, cumulative duration of use, and dose.", {"entities": []}], ["Metformin use is not associated with a decreased risk of lung cancer in patients with type 2 diabetes.", {"entities": [[57, 68, "DISEASE"], [62, 68, "DISEASE"]]}], ["The decreased risk reported in other observational studies is likely due to bias from methodological shortcomings.", {"entities": []}], ["Nonetheless, greater consideration should be given to clarify inconsistencies between experimental models and population studies.", {"entities": []}], ["The EQ-5D has been extensively used to assess patient utility in trials of new treatments within the cardiovascular field.", {"entities": []}], ["The aims of this study were to review evidence of the validity and reliability of the EQ-5D, and to summarise utility scores based on the use of the EQ-5D in clinical trials and in studies of patients with cardiovascular disease.", {"entities": []}], ["A structured literature search was conducted using keywords related to cardiovascular disease and EQ-5D.", {"entities": []}], ["Original research studies of patients with cardiovascular disease that reported EQ-5D results and its measurement properties were included.", {"entities": []}], ["Of 147 identified papers, 66 met the selection criteria, with 10 studies reporting evidence on validity or reliability and 60 reporting EQ-5D responses (VAS or self-classification).", {"entities": []}], ["Mean EQ-5D index-based scores ranged from 0.24 (SD 0.39) to 0.90 (SD 0.16), while VAS scores ranged from 37 (SD 21) to 89 (no SD reported).", {"entities": []}], ["Stratification of EQ-5D index scores by disease severity revealed that scores decreased from a mean of 0.78 (SD 0.18) to 0.51 (SD 0.21) for mild to severe disease in heart failure patients and from 0.80 (SD 0.05) to 0.45 (SD 0.22) for mild to severe disease in angina patients.", {"entities": []}], ["The published evidence generally supports the validity and reliability of the EQ-5D as an outcome measure within the cardiovascular area.", {"entities": []}], ["This review provides utility estimates across a range of cardiovascular subgroups and treatments that may be useful for future modelling of utilities and QALYs in economic evaluations within the cardiovascular area.", {"entities": []}], ["Primary headaches among children and adolescents have a substantial impact on quality of life, daily activities, social interaction, and school performance in combination with psychopathological symptoms.", {"entities": []}], ["The main purpose of the present paper is to summarize clinical and epidemiological evidence for psychiatric comorbidity among children and adolescents with headaches, to describe how evidence in headache research suggest different pathways involved in the development and maintenance of these comorbid conditions, and finally suggest some elements professionals may find helpful to assess the scope of complaints, related functional impairment, and potential precipitating factors in planning of more targeted treatments.", {"entities": []}], ["Nanotechnology and engineered nanomaterials (ENM) are here to stay.", {"entities": []}], ["Recent evidence suggests that exposure to environmental particulate matter exacerbates symptoms of asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["In the present study we investigated the modulatory effects of titanium dioxide particle exposure in an experimental allergic asthma.", {"entities": [[117, 132, "DISEASE"], [126, 132, "DISEASE"]]}], ["Nonallergic (healthy) and ovalbumin-sensitized (asthmatic) mice were exposed via inhalation to two different sizes of titanium dioxide particles, nanosized (nTiO 2 ) and fine (fTiO 2 ), for 2 hours a day, three days a week, for four weeks at a concentration of 10 mg/m Healthy mice elicited pulmonary neutrophilia accompanied by significantly increased chemokine CXCL5 expression when exposed to nTiO 2 .", {"entities": [[363, 368, "GENE"]]}], ["Surprisingly, allergic pulmonary inflammation was dramatically suppressed in asthmatic mice which were exposed to nTiO 2 or fTiO 2 particles - i.e.", {"entities": []}], ["the levels of leucocytes, cytokines, chemokines and antibodies characteristic to allergic asthma were substantially decreased.", {"entities": [[81, 96, "DISEASE"], [90, 96, "DISEASE"]]}], ["Our results suggest that repeated airway exposure to TiO 2 particles modulates the airway inflammation depending on the immunological status of the exposed mice.", {"entities": []}], ["Interleukin (IL)-38, a novel member of the IL-1 cytokine family, is homologous to IL-1 receptor antagonist (IL-1Ra) and IL-36Ra, and has been reported to act as an antagonist.", {"entities": []}], ["IL-38 expression is found in tonsil, placenta, and spleen, and recent studies suggest an association between IL-38 and autoimmune diseases.", {"entities": []}], ["However, whether IL-38 plays a role in carcinogenesis or cancer growth is unclear.", {"entities": [[57, 63, "DISEASE"]]}], ["In the present study, we identified increases in IL-38 expression by immunohistochemistry in multiple types of cancer cells.", {"entities": [[111, 117, "DISEASE"]]}], ["In the examination of 417 surgically resected primary lung adenocarcinomas, Fisher\u2019s exact tests showed significant associations between high IL-38 expression and high tumor grades, an advanced T status, advanced N status, advanced stage, and the presence of pleural and vessel invasions.", {"entities": []}], ["Survival analyses by the Kaplan-Meier method showed that patients with high expression of IL-38 had significantly shorter disease-free survival and shorter overall survival after surgery than patients with low expression of IL-38 (log-rank test: P = 0.0021 and P = 0.0035, respectively).", {"entities": []}], ["Moreover, programmed cell death-ligand 1 (PD-L1)-positive cases showed higher expression of IL-38 than PD-L1-negative cases (Wilcoxon rank-sum test: P < 0.0001).", {"entities": []}], ["In conclusion, IL-38 was expressed in tumor cells of various cancers, and IL-38 expression was associated with poor survival of lung adenocarcinoma patients.", {"entities": [[133, 147, "DISEASE"], [128, 147, "DISEASE"]]}], ["IL-38 may affect host immunity or the tumor microenvironment, and contribute to the progression of lung adenocarcinoma.", {"entities": [[104, 118, "DISEASE"], [99, 118, "DISEASE"]]}], ["Bacillus anthracis , similar to other bacterial pathogens, has evolved effective immune evasion strategies to prolong its survival in the host, thus ensuring the unchecked spread of the infection.", {"entities": []}], ["This function is subserved by lethal (LT) and edema (ET) toxins, two exotoxins produced by vegetative anthrax bacilli following germination of the spores.", {"entities": [[38, 40, "GENE"]]}], ["The structure of these toxins and the mechanism of cell intoxication are topics covered by other reviews in this issue.", {"entities": []}], ["Here we shall discuss how B. anthracis uses LT and ET to suppress the immune defenses of the host, focusing on T lymphocytes, the key players in adaptive immunity.", {"entities": [[44, 46, "GENE"]]}], ["We shall also summarize recent findings showing that, depending on its concentration, ET has the ability not only to suppress T cell activation but also to promote the polarization of CD4", {"entities": [[184, 187, "GENE"]]}], ["We attempted to investigate the prevalence of atopic dermatitis (AD) in Korea by using national statistics.", {"entities": [[46, 63, "DISEASE"], [53, 63, "DISEASE"]]}], ["Data on AD patients who received medical service at least once a year from 2003 through 2008 were collected from health insurance research team of National Health Insurance Corporation.", {"entities": []}], ["Data of estimated populations during the same period were obtained from the Statistics Korea.", {"entities": []}], ["In 2008, the prevalence of AD was 26.5% in aged 12-23 months and decreased substantially to 7.6% at age 6 yr, 3.4% at age 12 yr and to 2.4% at age 18 yr.", {"entities": []}], ["In males, the prevalence was higher than females until 2 yr of age, while the opposite was shown in children aged 2 yr or older.", {"entities": []}], ["In children aged less than 24 months, the prevalence of AD has increased from 19.8% to 23.8% between the years 2003 and 2008, while the prevalence showed no increase in the older age group.", {"entities": []}], ["In conclusion, the prevalence of AD in 2008 peaked during infancy up to 26.5% and decreased thereafter.", {"entities": []}], ["Our findings also suggest that increasing prevalence of AD in children less than 24 months might be responsible for the recent increase in the prevalence of AD in Korean children.", {"entities": []}], ["Few studies of air pollutants address morbidity in preschool children.", {"entities": []}], ["In this study we evaluated bronchitis in children from two Czech districts: Teplice, with high ambient air pollution, and Prachatice, characterized by lower exposures.", {"entities": [[27, 37, "DISEASE"]]}], ["Our goal was to examine rates of lower respiratory illnesses in preschool children in relation to ambient particles and hydrocarbons.", {"entities": []}], ["Air monitoring for particulate matter < 2.5 \u03bcm in diameter (PM 2.5 ) and polycyclic aromatic hydrocarbons (PAHs) was conducted daily, every third day, or every sixth day.", {"entities": []}], ["Children born May 1994 through December 1998 were followed to 3 or 4.5 years of age to ascertain illness diagnoses.", {"entities": []}], ["Mothers completed questionnaires at birth and at follow-up regarding demographic, lifestyle, reproductive, and home environmental factors.", {"entities": []}], ["Longitudinal multivariate repeated-measures analysis was used to quantify rate ratios for bronchitis and for total lower respiratory illnesses in 1,133 children.", {"entities": [[90, 100, "DISEASE"]]}], ["After adjustment for season, temperature, and other covariates, bronchitis rates increased with rising pollutant concentrations.", {"entities": [[64, 74, "DISEASE"]]}], ["Below 2 years of age, increments in 30-day averages of 100 ng/m 2.5 resulted in rate ratios (RRs) for bronchitis of 1.29 [95 % confidence interval (CI), 1.07\u20131.54] and 1.30 (95% CI, 1.08\u20131.58), respectively; from 2 to 4.5 years of age, these RRs were 1.56 (95% CI, 1.22\u20132.00) and 1.23 (95% CI, 0.94\u20131.62), respectively.", {"entities": [[102, 112, "DISEASE"]]}], ["Ambient PAHs and fine particles were associated with early-life susceptibility to bronchitis.", {"entities": [[82, 92, "DISEASE"]]}], ["Associations were stronger for longer pollutant-averaging periods and, among children > 2 years of age, for PAHs compared with fine particles.", {"entities": []}], ["Preschool-age children may be particularly vulnerable to air pollution\u2013induced illnesses.", {"entities": []}], ["To study the association between bilateral oophorectomy and the rate of accumulation of multimorbidity.", {"entities": []}], ["In this historical cohort study, the Rochester Epidemiology Project records-linkage system was used to identify all premenopausal women who underwent bilateral oophorectomy before age 50 years between January 1, 1988, and December 31, 2007, in Olmsted County, Minnesota.", {"entities": []}], ["Each woman was randomly matched to a referent woman born in the same year (\u00b1 1 year) who had not undergone bilateral oophorectomy.", {"entities": []}], ["We studied the rate of accumulation of 18 common chronic conditions over a median of approximately 14 years of follow-up.", {"entities": []}], ["Although women who underwent bilateral oophorectomy already had a higher multimorbidity burden at the time of oophorectomy, they also experienced a significantly increased risk of subsequent multimorbidity ( P =.XX).", {"entities": []}], ["After adjustments for 18 chronic conditions present at baseline, race/ethnicity, education, body mass index, smoking, age at baseline, and calendar year at baseline, women who underwent oophorectomy before age 46 years experienced an increased risk of depression, hyperlipidemia, cardiac arrhythmias, coronary artery disease, arthritis, asthma, chronic obstructive pulmonary disease, and osteoporosis.", {"entities": [[345, 382, "DISEASE"], [388, 400, "DISEASE"], [326, 335, "DISEASE"], [337, 343, "DISEASE"]]}], ["In addition, they experienced an accelerated rate of accumulation of the 18 chronic conditions considered together (hazard ratio, 1.22; 95% CI, 1.14\u20131.31; P <.001).", {"entities": []}], ["Several of these associations were reduced in women who received estrogen therapy.", {"entities": []}], ["Bilateral oophorectomy is associated with a higher risk of multimorbidity, even after adjustment for conditions present at baseline and for several possible confounders.", {"entities": []}], ["However, several of these associations were reduced in women who received estrogen therapy.", {"entities": []}], ["A novel chitin-degrading aerobe, Chitinibacter tainanensis , was isolated from a soil sample from southern Taiwan, and was proved to produce N -acetyl glucosamine (NAG).", {"entities": []}], ["Chitin degrading factors (CDFs) were proposed to be the critical factors to degrade chitin in this work.", {"entities": []}], ["When C. tainanensis was incubated with chitin, CDFs were induced and chitin was converted to NAG.", {"entities": []}], ["CDFs were found to be located on the surface of C. tainanensis.", {"entities": []}], ["N -Acetylglucosaminidase (NAGase) and endochitinase activities were found in the debris, and the activity of NAGase was much higher than that of endochitinase.", {"entities": []}], ["The optimum pH of the enzymatic activity was about 7.0, while that of NAG production by the debris was 5.3.", {"entities": []}], ["These results suggested that some factors in the debris, in addition to NAGase and endochitinase, were crucial for chitin degradation.", {"entities": []}], ["Given the complex nature of symptom presentation and medication regimens, psychiatric clinics may benefit from additional tools to personalize treatments.", {"entities": []}], ["Utilizing pharmacogenetic information may be helpful in assessing unique responses to therapy.", {"entities": []}], ["We report herein a case of wearing-off phenomena during treatment with aripiprazole long-acting injectable (LAI) and a proof of concept strategy of how pharmacogenetic information may be used to assess possible genetic factors and also hypothesize potential mechanisms for further study.", {"entities": []}], ["A 51-year-old African American male with schizoaffective disorder was referred to a psychiatric clinic for medication management.", {"entities": [[41, 65, "DISEASE"]]}], ["After unsuccessful trials of multiple antipsychotics, oral aripiprazole was initiated (up to 30\u00a0mg/day) and transitioned to aripiprazole LAI with symptom improvement.", {"entities": []}], ["At a high dose of aripiprazole LAI (400\u00a0mg Q3wks), the patient experienced breakthrough symptoms approximately 3\u00a0days prior to his next injection.", {"entities": []}], ["Various considerations were examined to explain his atypical dose requirements, including but not limited to pharmacogenetic influences.", {"entities": []}], ["Pharmacogenetic testing ruled out genetic influences on drug metabolism but noted a -141C Del variant in the dopamine-D2 receptor ( DRD2 ) gene associated in prior studies of poor-response to antipsychotics.", {"entities": [[132, 136, "GENE"]]}], ["At this time, a new formulation, aripiprazole lauroxil, was explored due to its availability in higher dose options.", {"entities": []}], ["Transition to the new formulation (882\u00a0mg Q4wks) greatly improved and stabilized the patient\u2019s symptoms with no breakthrough psychosis.", {"entities": []}], ["Comparable daily dose equivalents were achieved with two different formulations due to the Q3wks vs Q4wks dosing strategies, although the two agents have some differences in pharmacokinetic profiles.", {"entities": []}], ["We report a case of a patient experiencing wearing-off symptoms with aripiprazole LAI who benefited from switching to aripiprazole lauroxil.", {"entities": []}], ["Pharmacogenetic testing revealed normal activity for relevant metabolism pathways but a DRD2 -141C variant that may influence brain D2 expression and antipsychotic responsiveness.", {"entities": [[88, 92, "GENE"]]}], ["The clinical utility of DRD2 information and what to do with genotyping results has not been previously addressed, despite availability on clinical test panels.", {"entities": [[24, 28, "GENE"]]}], ["Our case report suggests further investigations of altered dosing strategies and receptor genotype sensitivities to pharmacokinetic factors may be helpful in understanding symptom re-emergence observed in some patients taking LAI antipsychotics.", {"entities": []}], ["Atopic march refers to the typical transition from a food allergy in early childhood to allergic asthma in older children and adults.", {"entities": [[88, 103, "DISEASE"], [53, 65, "DISEASE"], [97, 103, "DISEASE"]]}], ["However the precise interplay of events involving gut, skin and pulmonary inflammation in this process is not completely understood.", {"entities": []}], ["To develop a mouse model of mixed food and respiratory allergy mimicking the atopic march and better understand the impact of food allergies on asthma.", {"entities": [[144, 150, "DISEASE"]]}], ["Food allergy to ovalbumin (OVA) was induced through intra-peritoneal sensitization and intra-gastric challenge, and/or a respiratory allergy to house dust mite (HDM) was obtained through percutaneous sensitization and intra-nasal challenges with dermatophagoides farinae (Der f) extract.", {"entities": [[0, 12, "DISEASE"]]}], ["Digestive, respiratory and systemic parameters were analyzed.", {"entities": []}], ["OVA-mediated gut allergy was associated with an increase in jejunum permeability, and a worsening of Der f-induced asthma with stronger airway hyperresponsiveness and pulmonary cell infiltration, notably eosinophils.", {"entities": [[115, 121, "DISEASE"]]}], ["There was overproduction of the pro-eosinophil chemokine RANTES in broncho-alveolar lavages associated with an enhanced Th2 cytokine secretion and increased total and Der f-specific IgE when the two allergies were present.", {"entities": []}], ["Both AHR and lung inflammation increased after a second pulmonary challenge.", {"entities": [[5, 8, "GENE"]]}], ["Gut sensitization to OVA amplifies Der f-induced asthma in mice.", {"entities": [[49, 55, "DISEASE"]]}], ["Lipoxygenases (LOXs) are non-heme iron containing dioxygenases involved in the oxygenation of polyunsaturated fatty acids (PUFAs) such as arachidonic acid (AA).", {"entities": []}], ["Depending on the position of insertion of oxygen, LOXs are classified into 5-, 8-, 9-, 12- and 15-LOX.", {"entities": []}], ["Among these, 5-LOX is the most predominant isoform associated with the formation of 5-hydroperoxyeicosatetraenoic acid (5-HpETE), the precursor of non-peptido (LTB 4 ) and peptido (LTC 4 , LTD 4 , and LTE 4 ) leukotrienes.", {"entities": [[160, 163, "GENE"]]}], ["LTs are involved in inflammatory and allergic diseases like asthma, ulcerative colitis, rhinitis and also in cancer.", {"entities": [[88, 96, "DISEASE"], [60, 66, "DISEASE"], [109, 115, "DISEASE"], [68, 86, "DISEASE"]]}], ["Consequently 5-LOX has become target for the development of therapeutic molecules for treatment of various inflammatory disorders.", {"entities": []}], ["Zileuton is one such inhibitor of 5-LOX approved for the treatment of asthma.", {"entities": [[70, 76, "DISEASE"]]}], ["In the recent times, computer aided drug design (CADD) strategies have been applied successfully in drug development processes.", {"entities": []}], ["A comprehensive review on structure based drug design strategies in the development of novel 5-LOX inhibitors is presented in this article.", {"entities": []}], ["Since the crystal structure of 5-LOX has been recently solved, efforts to develop 5-LOX inhibitors have mostly relied on ligand based rational approaches.", {"entities": []}], ["The present review provides a comprehensive survey on these strategies in the development of 5-LOX inhibitors.", {"entities": []}], ["Phosphodiesterases (PDEs) are important enzymes that hydrolyze the cyclic nucleotides adenosine 3\u20325\u2032-cyclic monophosphate (cAMP) and guanosine 3\u20325\u2032-cyclic mono-phosphate (cGMP) to their inactive 5\u2032 monophosphates.", {"entities": []}], ["They are highly conserved across species and as well as their role in signal termination, they also have a vital role in intracellular localization of cyclic nucleotide signaling and integration of the cyclic nucleotide pathways with other signaling pathways.", {"entities": []}], ["Because of their pivotal role in intracellular signaling, they are now of considerable interest as therapeutic targets in a wide variety diseases, including COPD where PDE inhibitors may have bronchodilator, anti-inflammatory and pulmonary vasodilator actions.", {"entities": []}], ["This review examines the diversity and cellular localization of the isoforms of PDE, the known and speculative relevance of this to the treatment of COPD, and the range of PDE inhibitors in development together with a discussion of their possible role in treating COPD.", {"entities": []}], ["Exhaled, endogenous particles are formed from the epithelial lining fluid in small airways, where surfactant protein A (SP-A) plays an important role in pulmonary host defense.", {"entities": []}], ["Based on the knowledge that chronic obstructive pulmonary disease (COPD) starts in the small airway epithelium, we hypothesized that chronic inflammation modulates peripheral exhaled particle SP-A and albumin levels.", {"entities": [[28, 65, "DISEASE"]]}], ["The main objective of this explorative study was to compare the SP-A and albumin contents in exhaled particles from patients with COPD and healthy subjects and to determine exhaled particle number concentrations.", {"entities": []}], ["Patients with stable COPD ranging from moderate to very severe (n = 13), and healthy non-smoking subjects (n = 12) were studied.", {"entities": []}], ["Subjects performed repeated breath maneuvers allowing for airway closure and re-opening, and exhaled particles were optically counted and collected on a membrane using the novel PExA COPD patients exhibited significantly lower SP-A mass content of the exhaled particles (2.7 vs. 3.9 weight percent, p = 0.036) and lower particle number concentration (p<0.0001) than healthy subjects.", {"entities": []}], ["Albumin mass contents were similar for both groups.", {"entities": []}], ["Decreased levels of SP-A may lead to impaired host defense functions of surfactant in the airways, contributing to increased susceptibility to COPD exacerbations.", {"entities": []}], ["SP-A in exhaled particles from small airways may represent a promising non-invasive biomarker of disease in COPD patients.", {"entities": []}], ["Lung cancer consists of two main subtypes: small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) that are classified according to their physiological phenotypes.", {"entities": [[0, 11, "DISEASE"], [54, 65, "DISEASE"], [92, 103, "DISEASE"], [5, 11, "DISEASE"], [59, 65, "DISEASE"], [97, 103, "DISEASE"]]}], ["In this study, we have developed a network-based approach to identify molecular biomarkers that can distinguish SCLC from NSCLC.", {"entities": []}], ["By identifying positive and negative coexpression gene pairs in normal lung tissues, SCLC, or NSCLC samples and using functional association information from the STRING network, we first construct a lung cancer-specific gene association network.", {"entities": [[199, 210, "DISEASE"], [204, 210, "DISEASE"]]}], ["From the network, we obtain gene modules in which genes are highly functionally associated with each other and are either positively or negatively coexpressed in the three conditions.", {"entities": []}], ["Then, we identify gene modules that not only are differentially expressed between cancer and normal samples, but also show distinctive expression patterns between SCLC and NSCLC.", {"entities": [[82, 88, "DISEASE"]]}], ["Finally, we select genes inside those modules with discriminating coexpression patterns between the two lung cancer subtypes and predict them as candidate biomarkers that are of diagnostic use.", {"entities": [[104, 115, "DISEASE"], [109, 115, "DISEASE"]]}], ["Allosteric mechanisms are widely used in nature to control the rates of enzymatic reactions, but little is known about RNA catalysts controlled by these principles.", {"entities": []}], ["The only natural allosteric ribozyme reported to date catalyzes an RNA cleavage reaction, and so do almost all artificial systems.", {"entities": []}], ["RNA has, however, been shown to accelerate a much wider range of chemical reactions.", {"entities": []}], ["Here we report that RNA catalysts for organic reactions can be put under the stringent control of effector molecules by straight-forward rational design.", {"entities": []}], ["This approach uses known RNA sequences with catalytic and ligand-binding properties, and exploits weakly conserved sequence elements and available structural information to induce the formation of alternative, catalytically inactive structures.", {"entities": []}], ["The potential and general applicability is demonstrated by the design of three different systems in which the rate of a catalytic carbon\u2013carbon bond forming reaction is positively regulated up to 2100-fold by theophylline, tobramycin and a specific mRNA sequence, respectively.", {"entities": []}], ["Although smaller in size than a tRNA, all three ribozymes show typical features of allosteric metabolic enzymes, namely high rate acceleration and tight allosteric regulation.", {"entities": []}], ["Not only do these findings demonstrate RNA's power as a catalyst, but also highlight on RNA's capabilities as signaling components in regulatory networks.", {"entities": []}], ["Glycyrrhizic acid (GA) is a triterpene glycoside found in the roots of licorice plants ( Glycyrrhiza glabra ).", {"entities": []}], ["GA is the most important active ingredient in the licorice root, and possesses a wide range of pharmacological and biological activities.", {"entities": []}], ["GA coupled with glycyrrhetinic acid and 18-beta-glycyrrhetic acid was developed in China or Japan as an anti-inflammatory, antiviral, and antiallergic drug for liver disease.", {"entities": [[160, 173, "DISEASE"]]}], ["This review summarizes the current biological activities of GA and its medical applications in liver diseases.", {"entities": []}], ["The pharmacological actions of GA include inhibition of hepatic apoptosis and necrosis; anti-inflammatory and immune regulatory actions; antiviral effects; and antitumor effects.", {"entities": []}], ["This paper will be a useful reference for physicians and biologists researching GA and will open the door to novel agents in drug discovery and development from Chinese herbs.", {"entities": []}], ["With additional research, GA may be more widely used in the treatment of liver diseases or other conditions.", {"entities": []}], ["To assess pediatricians' attitudes toward & practice of Complementary/Alternative Medicine (CAM) including their knowledge, experience, & referral patterns for CAM therapies.", {"entities": []}], ["An anonymous, self-report, 27-item questionnaire was mailed nationally to fellows of the American Academy of Pediatrics in July 2004.", {"entities": []}], ["648 of 3500 pediatricians' surveyed responded (18%).", {"entities": []}], ["The median age ranged from 46\u201359 yrs; 52% female, 81% Caucasian, 71% generalists, & 85% trained in the US.", {"entities": []}], ["Over 96% of pediatricians' responding believed their patients were using CAM.", {"entities": []}], ["Discussions of CAM use were initiated by the family (70%) & only 37% of pediatricians asked about CAM use as part of routine medical history.", {"entities": []}], ["Majority (84%) said more CME courses should be offered on CAM and 71% said they would consider referring patients to CAM practitioners.", {"entities": []}], ["Medical conditions referred for CAM included; chronic problems (headaches, pain management, asthma, backaches) (86%), diseases with no known cure (55.5%) or failure of conventional therapies (56%), behavioral problems (49%), & psychiatric disorders (47%).", {"entities": [[92, 98, "DISEASE"]]}], ["American born, US medical school graduates, general pediatricians, & pediatricians who ask/talk about CAM were most likely to believe their patients used CAM (P < 0.01).", {"entities": []}], ["Pediatricians' have a positive attitude towards CAM.", {"entities": []}], ["Majority believe that their patients are using CAM, that asking about CAM should be part of routine medical history, would consider referring to a CAM practitioner and want more education on CAM.", {"entities": []}], ["To evaluate the diseases pattern among pilgrims attending the 2 Holy Mosque (Haram) Health Care Centers during the Hajj season 2013 (Hijra 1434).", {"entities": []}], ["In this cross-sectional study, data was collected from 2 medical centers located in the Holy Mosque in Makkah city, Saudi Arabia, from the first of Dhul-Hijjah to sixteenth Dhul-Hijjah 1434.", {"entities": []}], ["The present study was completed in 16 days (6th October to 21st October 2013).", {"entities": []}], ["Over 16 days, 1008 patients attended the medical centers during Hajj 1434, (2013), out of which 554 (55%) were males and 454 (45%) were females.", {"entities": []}], ["Most of the patients were Egyptians (n=242, 24%), followed by Saudis (n=116, 11.5%), Pakistani (n=114, 11.3%), Turkish (n=50, 5%), and other nationalities (n=404).", {"entities": []}], ["According to age distribution, mostly were in the 51-60 years age group (n=237, 23.5%), followed by other age groups.", {"entities": []}], ["Out of 1008 patients, 842 (83.5%) patients were treated and subsequently discharged, while 166 patients (16.5%) were referred to the tertiary centers.", {"entities": []}], ["According to the diseases pattern, most of the patients were suffering from respiratory problems (n=177, 17.6%) followed by skin diseases (n=158, 15.7%), gastrointestinal tract (GIT) diseases (n=133, 13.2%), and others.", {"entities": []}], ["Most of the patients were suffering from respiratory problems followed by skin and GIT diseases, and <25% of patients were referred to tertiary care centers.", {"entities": []}], ["Allergic rhinitis (AR) is especially prevalent among the population of large cities.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["Immunologically, the airway epithelium is a region where the population of allergen-presenting cells concentrates.", {"entities": []}], ["These cells actively express a group of receptors of the innate immune system.", {"entities": []}], ["A specific cytokine profile is its representation.", {"entities": []}], ["The study was aimed at evaluating the cytokine profile in patients with seasonal and perennial allergic rhinitis.", {"entities": [[95, 112, "DISEASE"], [104, 112, "DISEASE"]]}], ["The cytokine profile of nasal secretion and blood serum of 44 patients with AR was studied.", {"entities": []}], ["24 of them had seasonal allergic rhinitis (SAR), and 20 patients suffered from perennial allergic rhinitis (PAR).", {"entities": [[24, 41, "DISEASE"], [89, 106, "DISEASE"], [33, 41, "DISEASE"], [98, 106, "DISEASE"]]}], ["The patients' age ranged from 4 to 60 years.", {"entities": []}], ["It was determined in our study that the activation of the GM-CSF production retained in patients with PAR sensitized to mite allergen components ( Dermatophagoides pteronyssinus ).", {"entities": []}], ["There was a higher production profile of TNF- \u03b1 and TSLP in nasal secretion in the patients with perennial allergic rhinitis and additional high sensitization to SEs.", {"entities": [[107, 124, "DISEASE"], [116, 124, "DISEASE"], [52, 56, "GENE"]]}], ["Sensitization to mold fungal allergen components significantly increases in patients with seasonal allergic rhinitis.", {"entities": [[99, 116, "DISEASE"], [108, 116, "DISEASE"]]}], ["They demonstrated high level of sensitization to the Aspergillus fumigatus component m3.", {"entities": []}], ["Thus, along with other clinical trials, the study performed would clarify some aspects of molecular pathogenesis of human allergic rhinitis.", {"entities": [[122, 139, "DISEASE"], [131, 139, "DISEASE"]]}], ["Human leukotriene C 4 synthase (hLTC 4 S) is an integral membrane enzyme that conjugates leukotriene (LT) A 4 with glutathione to form LTC 4 , a precursor to the cysteinyl leukotrienes (LTC 4 , LTD 4 , and LTE 4 ) that are involved in the pathogenesis of human bronchial asthma.", {"entities": [[271, 277, "DISEASE"], [102, 104, "GENE"]]}], ["From the crystal structure of hLTC 4 S, Arg-104 and Arg-31 have been implicated in the conjugation reaction.", {"entities": []}], ["Here, we used site-directed mutagenesis, UV spectroscopy, and x-ray crystallography to examine the catalytic role of Arg-104 and Arg-31.", {"entities": []}], ["Exchange of Arg-104 with Ala, Ser, Thr, or Lys abolished 94.3\u201399.9% of the specific activity against LTA 4 .", {"entities": [[101, 104, "GENE"]]}], ["Steady-state kinetics of R104A and R104S revealed that the K m for GSH was not significantly affected.", {"entities": []}], ["UV difference spectra of the binary enzyme-GSH complex indicated that GSH ionization depends on the presence of Arg-104 because no thiolate signal, with \u03bb max at 239 nm, could be detected using R104A or R104S hLTC 4 S. Apparently, the interaction of Arg-104 with the thiol group of GSH reduces its p K a to allow formation of a thiolate anion and subsequent nucleophilic attack at C6 of LTA 4 .", {"entities": [[155, 158, "GENE"], [381, 383, "GENE"], [387, 390, "GENE"]]}], ["On the other hand, exchange of Arg-31 with Ala or Glu reduced the catalytic activity of hLTC 4 S by 88 and 70%, respectively, without significantly affecting the k cat / K m values for GSH, and a crystal structure of R31Q hLTC 4 S (2.1 \u212b) revealed a Gln-31 side chain pointing away from the active site.", {"entities": []}], ["We conclude that Arg-104 plays a critical role in the catalytic mechanism of hLTC 4 S, whereas a functional role of Arg-31 seems more elusive.", {"entities": []}], ["Because Arg-104 is a conserved residue, our results pertain to other homologous membrane proteins and represent a structure-function paradigm probably common to all microsomal GSH transferases.", {"entities": []}], ["TLR and complement activation ensures efficient clearance of infection.", {"entities": []}], ["Previous studies documented synergism between TLRs and the receptor for the pro-inflammatory complement peptide C5a (C5aR/CD88), and regulation of TLR-induced pro-inflammatory responses by C5aR, suggesting crosstalk between TLRs and C5aR.", {"entities": []}], ["However, it is unclear whether and how TLRs modulate C5a-induced pro-inflammatory responses.", {"entities": []}], ["We demonstrate a marked positive modulatory effect of TLR activation on cell sensitivity to C5a in vitro and ex vivo and identify an underlying mechanistic target.", {"entities": []}], ["Pre-exposure of PBMCs and whole blood to diverse TLR ligands or bacteria enhanced C5a-induced pro-inflammatory responses.", {"entities": []}], ["This effect was not observed in TLR4 signalling-deficient mice.", {"entities": [[32, 36, "GENE"]]}], ["TLR-induced hypersensitivity to C5a did not result from C5aR upregulation or modulation of C5a-induced Ca", {"entities": []}], ["The aim of the study was to describe the sociodemographic and clinical features of the mothers and their offspring staying with them in prison.", {"entities": []}], ["The study was planned as a cross-sectional, single-center study of mothers residing in Tarsus Closed Women\u2019s Prison of Turkish Ministry of Justice along with their 0 to 6 years old offspring.", {"entities": []}], ["Mothers were evaluated via Structured Clinical Interview for DSM-IV Axis I Disorders.", {"entities": []}], ["A psychologist blind to maternal evaluations applied the Denver Developmental Screening Test II (DII-DST).", {"entities": []}], ["Children/mothers were also evaluated by a child and adolescent psychiatrist via K-SADS-PL.", {"entities": []}], ["Twenty-four mothers with a mean age of 29.3 years were included.", {"entities": []}], ["Most common diagnoses in mothers were nicotine abuse (n\u2009=\u200917, 70.8%), specific phobia (n\u2009=\u20098, 33.3%), alcohol abuse (n\u2009=\u20097, 29.2%) and substance abuse (n\u2009=\u20095, 20.8%).", {"entities": [[135, 150, "DISEASE"], [70, 85, "DISEASE"], [102, 115, "DISEASE"]]}], ["Twenty-six children (53.9% female) were living with their mothers in prison, and the mean age of those was 26.3 months.", {"entities": []}], ["Results of the D-II-DST were abnormal in 33.3% of the children.", {"entities": []}], ["Most common diagnoses in children were adjustment disorder (n\u2009=\u20097, 26.9%) separation anxiety disorder (n\u2009=\u20093, 11.5%) and conduct disorder (n\u2009=\u20092, 7.7%).", {"entities": [[39, 58, "DISEASE"], [121, 137, "DISEASE"], [85, 101, "DISEASE"], [74, 101, "DISEASE"]]}], ["A multi-center study is necessary to reach that neglected/under-served population and address the inter-generational transmission of abuse, neglect, and psychopathology.", {"entities": []}], ["Although it is often acknowledged that social and environmental factors interact to produce racial and ethnic environmental health disparities, it is still unclear how this occurs.", {"entities": []}], ["Despite continued controversy, the environmental justice movement has provided some insight by suggesting that disadvantaged communities face greater likelihood of exposure to ambient hazards.", {"entities": []}], ["The exposure\u2013disease paradigm has long suggested that differential \u201cvulnerability\u201d may modify the effects of toxicants on biological systems.", {"entities": []}], ["However, relatively little work has been done to specify whether racial and ethnic minorities may have greater vulnerability than do majority populations and, further, what these vulnerabilities may be.", {"entities": []}], ["We suggest that psychosocial stress may be the vulnerability factor that links social conditions with environmental hazards.", {"entities": []}], ["Psychosocial stress can lead to acute and chronic changes in the functioning of body systems (e.g., immune) and also lead directly to illness.", {"entities": []}], ["In this article we present a multidisciplinary framework integrating these ideas.", {"entities": []}], ["We also argue that residential segregation leads to differential experiences of community stress, exposure to pollutants, and access to community resources.", {"entities": []}], ["When not counterbalanced by resources, stressors may lead to heightened vulnerability to environmental hazards.", {"entities": []}], ["Design and execution of immunotherapy trials for seasonal allergies may be complicated by numerous factors including variable allergy testing methods, pollen levels, and timing and intensity of other seasonal allergens.", {"entities": []}], ["We evaluated grass allergy immunotherapy tablet (AIT) treatment in North American adults with grass pollen-induced allergic rhinitis with or without conjunctivitis (AR/C), with/without asthma.", {"entities": [[115, 132, "DISEASE"], [124, 132, "DISEASE"], [149, 163, "DISEASE"], [185, 191, "DISEASE"]]}], ["Subjects age 18\u201365 with clinical history of grass pollen\u2013induced AR/C, with/without asthma were randomized 1:1 to once-daily 2800 BAU Timothy grass AIT (oral lyophilisate, Phleum pratense , 75,000 SQ-T, containing approximately 15\u00a0\u03bcg of Phl p 5) or placebo.", {"entities": [[84, 90, "DISEASE"]]}], ["The AR/C symptom and medication scores were recorded daily.", {"entities": []}], ["The primary end point was the average AR/C daily symptom score (DSS) during the entire grass pollen season (GPS).", {"entities": []}], ["Ranked key secondary end points were Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score, daily medication score (DMS), and percentage of well days, all over entire GPS.", {"entities": []}], ["Safety was monitored through adverse event reporting.", {"entities": []}], ["Efficacy analysis included 289 subjects.", {"entities": []}], ["Over the entire GPS, mean DSS was 6% lower with AIT versus placebo (5.69 vs. 6.06), but this difference was not statistically significant (p\u2009=\u20090.3475) despite significantly higher immunological response in the grass AIT group.", {"entities": []}], ["No significant between-group differences were seen for key secondary end points.", {"entities": []}], ["In general, DSS was high before GPS began and no clear relationship between DSS and grass pollen counts was seen during GPS.", {"entities": []}], ["In post hoc analysis of subjects with pre-seasonal DSS \u22643, mean DSS and DMS were both significantly lower with grass AIT versus placebo (27%; p\u2009=\u20090.0327 and 68%; p\u2009=\u20090.0060, respectively).", {"entities": []}], ["In this subgroup a relationship between DSS and grass pollen counts was observed.", {"entities": []}], ["Grass AIT was generally well tolerated, with no events of anaphylactic shock or respiratory compromise.", {"entities": []}], ["In this trial, 2800 BAU grass AIT did not demonstrate significant symptom improvement versus placebo.", {"entities": []}], ["Lack of relationship between pollen count and symptom score in the study population, and post hoc findings among subjects with low pre-seasonal symptoms, suggest that the symptoms reported in this study were not primarily reflective of the effects of grass pollen exposure.", {"entities": []}], ["NCT00421655", {"entities": []}], ["Many public health interventions based on apparently sound evidence from randomised controlled trials encounter difficulties when being scaled up within health systems.", {"entities": []}], ["Even under the best of circumstances, implementation is exceedingly difficult.", {"entities": []}], ["In this paper we will describe the implementation salvage experiences from the Melbourne Diabetes Prevention Study, which is a randomised controlled trial of the effectiveness and cost-effectiveness nested in the state-wide Life!", {"entities": []}], ["Taking Action on Diabetes program in Victoria, Australia.", {"entities": []}], ["The Melbourne Diabetes Prevention Study sits within an evolving larger scale implementation project, the Life!", {"entities": []}], ["Changes that occurred during the roll-out of that program had a direct impact on the process of conducting this trial.", {"entities": []}], ["The issues and methods of recovery the study team encountered were conceptualised using an implementation salvage strategies framework.", {"entities": []}], ["The specific issues the study team came across included continuity of the state funding for Life!", {"entities": []}], ["program and structural changes to the Life!", {"entities": []}], ["program which consisted of adjustments to eligibility criteria, referral processes, structure and content, as well as alternative program delivery for different population groups.", {"entities": []}], ["Staff turnover, recruitment problems, setting and venue concerns, availability of potential participants and participant characteristics were also identified as evaluation roadblocks.", {"entities": []}], ["Each issue and corresponding salvage strategy is presented.", {"entities": []}], ["The experiences of conducting such a novel trial as the preliminary Melbourne Diabetes Prevention Study have been invaluable.", {"entities": []}], ["The lessons learnt and knowledge gained will inform the future execution of this trial in the coming years.", {"entities": []}], ["We anticipate that these results will also be beneficial to other researchers conducting similar trials in the public health field.", {"entities": []}], ["We recommend that researchers openly share their experiences, barriers and challenges when conducting randomised controlled trials and implementation research.", {"entities": []}], ["We encourage them to describe the factors that may have inhibited or enhanced the desired outcomes so that the academic community can learn and expand the research foundation of implementation salvage.", {"entities": []}], ["The neuropeptide S (NPS) receptor system modulates neuronal circuit activity in the amygdala in conjunction with fear, anxiety and the expression and extinction of previously acquired fear memories.", {"entities": [[20, 23, "GENE"]]}], ["Using in vitro brain slice preparations of transgenic GAD67-GFP (\u0394neo) mice, we investigated the effects of NPS on neural activity in the lateral amygdala as a key region for the formation and extinction of fear memories.", {"entities": [[108, 111, "GENE"]]}], ["We are able to demonstrate that NPS augments excitatory glutamatergic synaptic input onto both projection neurons and interneurons of the lateral amygdala, resulting in enhanced spike activity of both types of cells.", {"entities": [[32, 35, "GENE"]]}], ["These effects were at least in part mediated by presynaptic mechanisms.", {"entities": []}], ["In turn, inhibition of projection neurons by local interneurons was augmented by NPS, and subthreshold oscillations were strengthened, leading to their shift into the theta frequency range.", {"entities": [[81, 84, "GENE"]]}], ["These data suggest that the multifaceted effects of NPS on amygdaloid circuitry may shape behavior-related network activity patterns in the amygdala and reflect the peptide's potent activity in various forms of affective behavior and emotional memory.", {"entities": [[52, 55, "GENE"]]}], ["Adequate dietary intake is essential to maintain good health.", {"entities": []}], ["This is particularly true for the elderly.", {"entities": []}], ["This study investigated the dietary intakes of seniors residing in Newfoundland and Labrador (NL) and assessed the adequacy of nutrients which they consumed as food.", {"entities": []}], ["Between November 2012 and January 2013, we recruited senior residents in NL, aged 65\u00a0years or older Participants were required to complete two questionnaires, one food-frequency questionnaire (FFQ) and one general health questionnaire (GHQ).", {"entities": []}], ["Macro- and micro- nutrients in foods consumed were estimated using the Elizabeth Stewart Hands and Associations (ESHA) nutrient analysis software.", {"entities": []}], ["The nutrient intakes were compared with appropriate components of the dietary reference intakes (DRIs) adopted by Health Canada to determine adequacy.", {"entities": []}], ["Various descriptive statistical analyses were performed using SPSS.", {"entities": []}], ["One hundred-and-eleven participants (69 females and 42 males) completed the surveys and were included in the analysis.", {"entities": []}], ["A considerable portion of subjects were overweight (41.7%) or obese (25%), and had at least one chronic illness (86.5%).", {"entities": []}], ["Many seniors studied did not meet the daily recommendations for dietary intakes of nutrients supported by Health Canada, notably vitamin E (84.7%) and vitamin D (68.5%).", {"entities": []}], ["Our study also suggests that about 40% of participants consumed more dietary energy as fat than is recommended.", {"entities": []}], ["The present study revealed an inadequate consumption of essential nutrients from foods in a noninstitutionalized senior population of NL.", {"entities": []}], ["The study of expressed proteins in neoplasia is undergoing a revolution with the advent of proteomic analysis.", {"entities": []}], ["Unlike genomic studies where individual changes may have no functional significance, protein expression is closely aligned with cellular activity.", {"entities": []}], ["This perspective will review proteomics as a method of detecting markers of neoplasia with a particular emphasis on lung cancer and the potential to sample the lung by exhaled breath condensate (EBC).", {"entities": [[116, 127, "DISEASE"], [121, 127, "DISEASE"]]}], ["EBC collection is a simple, new, and noninvasive technique, which allows sampling of lower respiratory tract fluid.", {"entities": []}], ["EBC enables the study of a wide variety of biological markers from low molecular weight mediators to macromolecules, such as proteins, in a range of pulmonary diseases.", {"entities": []}], ["EBC may be applied to the detection of lung cancer where it could be a tool in early diagnosis.", {"entities": [[39, 50, "DISEASE"], [44, 50, "DISEASE"]]}], ["This perspective will explore the potential of applying proteomics to the EBC from lung cancer patients as an example of detecting potential biomarkers of disease and progression.", {"entities": [[83, 94, "DISEASE"], [88, 94, "DISEASE"]]}], ["An increasing number of US states and localities have implemented comprehensive policies prohibiting tobacco smoking in all indoor areas of public places and worksites.", {"entities": []}], ["However, private settings such as homes and vehicles remain a major source of exposure to secondhand smoke (SHS) for many people.", {"entities": []}], ["This study assessed the prevalence and correlates of voluntary smoke-free rules and SHS exposure in homes and vehicles among US adults.", {"entities": []}], ["We obtained data from the 2009\u20132010 National Adult Tobacco Survey, a landline and cellular-telephone survey of adults aged 18 years or older residing in the 50 US states or the District of Columbia.", {"entities": []}], ["We calculated national and state estimates of smoke-free rules and past-7-day SHS exposure in homes and vehicles and examined national estimates by sex, age, race/ethnicity, and education.", {"entities": []}], ["The national prevalence of voluntary smoke-free home rules was 81.1% (state range, 67.9%\u201392.9%), and the prevalence of household smoke-free vehicle rules was 73.6% (state range, 58.6%\u201385.8%).", {"entities": []}], ["Among nonsmokers, the prevalence of SHS exposure was 6.0% in homes (state range, 2.4%\u201313.0%) and 9.2% in vehicles (state range, 4.8%\u201313.7%).", {"entities": []}], ["SHS exposure among nonsmokers was greatest among men, younger adults, non-Hispanic blacks, and those with a lower level of education.", {"entities": []}], ["Most US adults report having voluntary smoke-free home and vehicle rules; however, millions of people remain exposed to SHS in these environments.", {"entities": []}], ["Disparities in exposure also exist among certain states and subpopulations.", {"entities": []}], ["Efforts are needed to warn about the dangers of SHS and to promote voluntary smoke-free home and vehicle rules.", {"entities": []}], ["We present a gas sensitive thin-film transistor (TFT) based on an amorphous Indium\u2013Gallium\u2013Zinc\u2013Oxide (a-IGZO) semiconductor as the sensing layer, which is fabricated on a free-standing flexible polyimide foil.", {"entities": []}], ["The photo-induced sensor response to NO 2 gas at room temperature and the cross-sensitivity to humidity are investigated.", {"entities": []}], ["We combine the advantages of a transistor based sensor with flexible electronics technology to demonstrate the first flexible a-IGZO based gas sensitive TFT.", {"entities": []}], ["Since flexible plastic substrates prohibit the use of high operating temperatures, the charge generation is promoted with the help of UV-light absorption, which ultimately triggers the reversible chemical reaction with the trace gas.", {"entities": []}], ["Furthermore, the device fabrication process flow can be directly implemented in standard TFT technology, allowing for the parallel integration of the sensor and analog or logical circuits.", {"entities": []}], ["A series of epidemiologic studies have identified the fungus Alternaria as a major risk factor for asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["The airway epithelium plays a critical role in the pathogenesis of allergic asthma.", {"entities": [[67, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["These reports suggest that activated airway epithelial cells can produce cytokines such as IL-25, TSLP and IL-33 that induce Th2 phenotype.", {"entities": [[98, 102, "GENE"]]}], ["However the epithelium-derived products that mediate the pro-asthma effects of Alternaria are not well characterized.", {"entities": [[61, 67, "DISEASE"]]}], ["We hypothesized that exposure of the airway epithelium to Alternaria releasing cytokines that can induce Th2 differentiation.", {"entities": []}], ["We used ELISA to measure human and mouse cytokines.", {"entities": []}], ["Alternaria extract (ALT-E) induced rapid release of IL-18, but not IL-4, IL-9, IL-13, IL-25, IL-33, or TSLP from cultured normal human bronchial epithelial cells; and in the BAL fluids of na\u00efve mice after challenge with ALT-E.", {"entities": [[103, 107, "GENE"]]}], ["Both microscopic and FACS indicated that this release was associated with necrosis of epithelial cells.", {"entities": []}], ["ALT-E induced much greater IL-18 release compared to 19 major outdoor allergens.", {"entities": []}], ["Culture of na\u00efve CD4 cells with rmIL-18 induced Th2 differentiation in the absence of IL-4 and STAT6, and this effect was abrogated by disrupting NF- \u03baB p50 or with a NEMO binding peptide inhibitor.", {"entities": [[17, 20, "GENE"], [95, 100, "GENE"]]}], ["Rapid and specific release of IL-18 from Alternaria-exposed damaged airway epithelial cells can directly initiate Th2 differentiation of na\u00efve CD4", {"entities": [[143, 146, "GENE"]]}], ["Several studies have demonstrated that long-acting \u03b2 2 -agonists such as salmeterol are beneficial in chronic obstructive pulmonary disease (COPD).", {"entities": [[102, 139, "DISEASE"]]}], ["A meta-analysis was therefore conducted to review studies in COPD to provide pooled estimates of the effect of salmeterol 50 mcg taken twice daily in addition to usual therapy on several clinically relevant endpoints, when compared with placebo/usual therapy.", {"entities": []}], ["An extensive search of literature and clinical trial databases was conducted using the terms salmeterol, COPD, chronic, obstructive, bronchitis and emphysema.", {"entities": [[133, 143, "DISEASE"]]}], ["Nine randomized, double-blind, parallel-group, placebo-controlled trials of \u226512 week duration with salmeterol 50 mcg bid treatment in COPD were included (>3500 patients), with a further 14 trials excluded due to study design or reporting timelines.", {"entities": []}], ["All patients were included, and a sub-group of subjects (84%) with poorly reversible COPD were considered separately.", {"entities": []}], ["Statistical testing was carried out at the 5% level, except for interaction testing which was carried out at the 10% level.", {"entities": []}], ["Patients treated with salmeterol over 12 months were less likely to withdraw early from the studies (19% patients compared with 25% on their current usual therapy, p < 0.001), less likely to suffer a moderate/severe exacerbation (34% compared with 39%, p < 0.0001) and had a greater increase in average FEV 1 (73 mL difference vs placebo/usual therapy, p < 0.0001).", {"entities": [[303, 306, "GENE"]]}], ["Similar differences were found at 3 and 6 months.", {"entities": []}], ["At all time points, more patients experienced an improvement in health status and also a greater change with salmeterol than with placebo/usual therapy (p < 0.002).", {"entities": []}], ["There was no evidence of tachyphylaxis to salmeterol over 12 months.", {"entities": []}], ["The meta-analysis confirmed clinically and statistically significant, sustained and consistent superiority of salmeterol 50 mcg bid over placebo/usual therapy on a broad range of outcome measures.", {"entities": []}], ["Medication-related burden (MRB) is a negative experience with medicine, which may impact on psychological, social, physical and financial well-being of an individual.", {"entities": []}], ["This study describes the development and initial validation of an instrument specifically designed to measure MRB on functioning and well-being\u2014the Medication-Related Burden Quality of Life (MRB-QoL) tool.", {"entities": []}], ["An initial pool of 76-items for MRB-QoL was generated.", {"entities": []}], ["The link to MRB-QoL survey was sent to a sample of consumers living with at least one chronic medical condition and taking \u22653\u2009prescription medicines on a regular basis.", {"entities": []}], ["Exploratory factor analysis (EFA) was used to determine the underlining factor structure.", {"entities": []}], ["Internal consistency (Cronbach\u2019s \u03b1) and construct validity were examined.", {"entities": []}], ["The latter was examined through correlation with Medication Regimen Complexity Index (MRCI), Drug Burden Index (DBI) and Charlson\u2019s Comorbidity Index (CCI).", {"entities": [[112, 115, "GENE"]]}], ["367 consumers completed the survey (51.2% male).", {"entities": []}], ["EFA resulted in a 31-item, five-factor solution explaining 72% of the total variance.", {"entities": []}], ["The five subscales were labelled as \u2018Routine and Regimen Complexity\u2019 (11 items), \u2018Psychological Burden\u2019 (six items), \u2018Functional and Role Limitation\u2019 (seven items), \u2018Therapeutic Relationship\u2019 (three items) and \u2018Social Burden\u2019 (four items).", {"entities": []}], ["All subscales showed good internal consistency (Cronbach\u2019s \u03b1 0.87 to 0.95).", {"entities": []}], ["Discriminant validity of MRB-QoL was demonstrated via its correlations with MRCI (Spearman\u2019s r \u22120.16 to 0.08), DBI (r 0.12 to 0.28) and CCI (r \u22120.23 to \u22120.15).", {"entities": [[111, 114, "GENE"]]}], ["Correlation between DBI and \u2018Functional and Role Limitation\u2019 subscale (r 0.36) indicated some evidence of convergent validity.", {"entities": [[20, 23, "GENE"]]}], ["Patients with polypharmacy, multiple morbidity and DBI >0 had higher median scores of MRB-QoL providing evidence for known group validity.", {"entities": [[51, 54, "GENE"]]}], ["The MRB-QoL V.1 has good construct validity and internal consistency.", {"entities": []}], ["The MRB-QoL may be a useful humanistic measure for evaluating the impact of pharmaceutical care interventions on patients\u2019 quality of life.", {"entities": []}], ["Future research is warranted to further examine additional psychometric properties of MRB-QoL V.1 and its utility in patient care.", {"entities": []}], ["Poor symptom control and impaired quality of life are common in adults with asthma, and breathing retraining exercises may be an effective method of self-management.", {"entities": [[76, 82, "DISEASE"]]}], ["This study aimed to explore the experiences of participants in the intervention arms of the BREATHE trial, which investigated the effectiveness of breathing retraining as a mode of asthma management.", {"entities": [[181, 187, "DISEASE"]]}], ["Sixteen people with asthma (11 women, 8 per group) who had taken part in the intervention arms of the BREATHE trial (breathing retraining delivered by digital versatile disc (DVD) or face-to-face sessions with a respiratory physiotherapist) took part in semi-structured telephone interviews about their experiences.", {"entities": [[20, 26, "DISEASE"]]}], ["Interviews were analysed using thematic analysis.", {"entities": []}], ["Breathing retraining was perceived positively as a method of asthma management.", {"entities": [[61, 67, "DISEASE"]]}], ["Motivations for taking part included being asked, to enhance progress in research, to feel better/reduce symptoms, and to reduce medication.", {"entities": []}], ["Participants were positive about the physiotherapist, liked having the materials tailored, found meetings motivational, and liked the DVD and booklet.", {"entities": []}], ["The impact of breathing retraining following regular practice included increased awareness of breathing and development of new habits.", {"entities": []}], ["Benefits of breathing retraining included increased control over breathing, reduced need for medication, feeling more relaxed, and improved health and quality of life.", {"entities": []}], ["Problems included finding time to practice the exercises, and difficulty mastering techniques.", {"entities": []}], ["Breathing retraining was acceptable and valued by almost all participants, and many reported improved wellbeing.", {"entities": []}], ["Face to face physiotherapy was well received.", {"entities": []}], ["However, some participants in the DVD group mentioned being unable to master techniques.", {"entities": []}], ["Patients with asthma taught how to change their unconscious breathing patterns generally like non-pharmacological interventions.", {"entities": [[14, 20, "DISEASE"]]}], ["Researchers in the UK, led by Mike Thomas from the University of Southampton, interviewed 16 people about their experiences in a trial that tested breathing retraining exercises delivered by DVD or face-to-face sessions with a respiratory physiotherapist.", {"entities": []}], ["Overwhelmingly, trial participants reported that breathing retraining sessions gave them greater control over their symptoms, helped them relax, improved their quality of life and reduced the need for medications.", {"entities": []}], ["Some participants who received DVD instruction said they had trouble mastering the techniques, and many in both groups found it hard to find time to practice the exercises.", {"entities": []}], ["Overall, however, patients were positive about the experience.", {"entities": []}], ["The authors conclude that breathing exercises are likely to be a well-received method of asthma management.", {"entities": [[89, 95, "DISEASE"]]}], ["Although more emphasis has been given to the genetic and environmental factors that determine host vulnerability to malaria, other factors that might have a crucial role in burdening the disease have not been evaluated yet.", {"entities": [[116, 123, "DISEASE"]]}], ["Therefore, this study was designed to assess the effect of khat chewing on the incidence of severe malaria syndromes and immune responses during malaria infection in an area where the two problems co-exist.", {"entities": [[99, 106, "DISEASE"], [145, 152, "DISEASE"]]}], ["Clinical, physical, demographic, hematological, biochemical and immunological data were collected from Plasmodium falciparum mono-infected malaria patients (age \u2265 10 years) seeking medication in Halaba Kulito and Jimma Health Centers.", {"entities": [[139, 146, "DISEASE"]]}], ["In addition, incidences of severe malaria symptoms were assessed.", {"entities": [[34, 41, "DISEASE"]]}], ["The data were analyzed using SPSS (version 20) software.", {"entities": []}], ["Prevalence of current khat chewer malaria patients was 57.38% (95%CI =53-61.56%).", {"entities": [[34, 41, "DISEASE"]]}], ["Malaria symptoms such as hyperpyrexia, prostration and hyperparasitemia were significantly lower (P<0.05) among khat chewer malaria patients.", {"entities": [[0, 7, "DISEASE"], [124, 131, "DISEASE"]]}], ["However, relative risk to jaundice and renal failure were significantly higher (P<0.05) in khat chewers than in non-khat chewer malaria patients.", {"entities": [[128, 135, "DISEASE"]]}], ["Longer duration of khat use was positively associated with incidence of anemia.", {"entities": [[72, 78, "DISEASE"]]}], ["IgM and IgG antibody titers were significantly higher (P<0.05) among khat chewer malaria patients than among malaria positive non-chewers.", {"entities": [[81, 88, "DISEASE"], [109, 116, "DISEASE"]]}], ["Although levels of IgG subclasses in malaria patients did not show significant differences (P>0.05), IgG3 antibody was significantly higher (P<0.001) among khat chewer malaria patients.", {"entities": [[37, 44, "DISEASE"], [168, 175, "DISEASE"]]}], ["Moreover, IgM, IgG, IgG1and IgG3 antibodies had significant negative association (P<0.001) with parasite burden and clinical manifestations of severe malaria symptoms, but not with severe anemia and hypoglycemia.", {"entities": [[150, 157, "DISEASE"], [199, 211, "DISEASE"], [188, 194, "DISEASE"]]}], ["Additionally, a significant increment (P<0.05) in CD4", {"entities": [[50, 53, "GENE"]]}], ["Involuntary inhalation of tobacco smoke has been shown to aggravate the allergic response.", {"entities": []}], ["Antibodies to fungal antigens such as Aspergillus fumigatus (Af) cause an allergic lung disease in humans.", {"entities": [[83, 95, "DISEASE"]]}], ["This study was carried out to determine the effect of environmental tobacco smoke (ETS) on a murine model of allergic bronchopulmonary aspergillosis (ABPA).", {"entities": [[135, 148, "DISEASE"], [109, 148, "DISEASE"]]}], ["BALB/c mice were exposed to aged and diluted sidestream cigarette smoke to simulate 'second-hand smoke'.", {"entities": []}], ["The concentration was consistent with that achieved in enclosed public areas or households where multiple people smoke.", {"entities": []}], ["During exposure, mice were sensitized to Af antigen intranasally.", {"entities": []}], ["Mice that were sensitized to Af antigen and exposed to ETS developed significantly greater airway hyperreactivity than did mice similarly sensitized to Af but housed in ambient air.", {"entities": []}], ["The effective concentration of aerosolized acetylcholine needed to double pulmonary flow resistance was significantly lower in Af + ETS mice compared to the Af + AIR mice.", {"entities": []}], ["Immunological data that supports this exacerbation of airway hyperresponsiveness being mediated by an enhanced type 1 hypersensitivity response include: eosinophilia in peripheral blood and lung sections.", {"entities": [[153, 165, "DISEASE"]]}], ["All Af sensitized mice produced elevated levels of IL4, IL5 and IL10 but no IFN-\u03b3 indicating a polarized Th2 response.", {"entities": [[51, 54, "GENE"], [56, 59, "GENE"], [64, 68, "GENE"]]}], ["Thus, ETS can cause exacerbation of asthma in ABPA as demonstrated by functional airway hyperresponsiveness and elevated levels of blood eosinophilia.", {"entities": [[137, 149, "DISEASE"], [36, 42, "DISEASE"]]}], ["For genome-wide association studies in family-based designs, we propose a powerful two-stage testing strategy that can be applied in situations in which parent-offspring trio data are available and all offspring are affected with the trait or disease under study.", {"entities": []}], ["In the first step of the testing strategy, we construct estimators of genetic effect size in the completely ascertained sample of affected offspring and their parents that are statistically independent of the family-based association/transmission disequilibrium tests (FBATs/TDTs) that are calculated in the second step of the testing strategy.", {"entities": []}], ["For each marker, the genetic effect is estimated (without requiring an estimate of the SNP allele frequency) and the conditional power of the corresponding FBAT/TDT is computed.", {"entities": []}], ["Based on the power estimates, a weighted Bonferroni procedure assigns an individually adjusted significance level to each SNP.", {"entities": []}], ["In the second stage, the SNPs are tested with the FBAT/TDT statistic at the individually adjusted significance levels.", {"entities": []}], ["Using simulation studies for scenarios with up to 1,000,000 SNPs, varying allele frequencies and genetic effect sizes, the power of the strategy is compared with standard methodology (e.g., FBATs/TDTs with Bonferroni correction).", {"entities": []}], ["In all considered situations, the proposed testing strategy demonstrates substantial power increases over the standard approach, even when the true genetic model is unknown and must be selected based on the conditional power estimates.", {"entities": []}], ["The practical relevance of our methodology is illustrated by an application to a genome-wide association study for childhood asthma, in which we detect two markers meeting genome-wide significance that would not have been detected using standard methodology.", {"entities": [[125, 131, "DISEASE"]]}], ["The current state of genotyping technology has enabled researchers to conduct genome-wide association studies of up to 1,000,000 SNPs, allowing for systematic scanning of the genome for variants that might influence the development and progression of complex diseases.", {"entities": []}], ["One of the largest obstacles to the successful detection of such variants is the multiple comparisons/testing problem in the genetic association analysis.", {"entities": []}], ["For family-based designs in which all offspring are affected with the disease/trait under study, we developed a methodology that addresses this problem by partitioning the family-based data into two statistically independent components.", {"entities": []}], ["The first component is used to screen the data and determine the most promising SNPs.", {"entities": []}], ["The second component is used to test the SNPs for association, where information from the screening is used to weight the SNPs during testing.", {"entities": []}], ["This methodology is more powerful than standard procedures for multiple comparisons adjustment (i.e., Bonferroni correction).", {"entities": []}], ["Additionally, as only one data set is required for screening and testing, our testing strategy is less susceptible to study heterogeneity.", {"entities": []}], ["Finally, as many family-based studies collect data only from affected offspring, this method addresses a major limitation of previous methodologies for multiple comparisons in family-based designs, which require variation in the disease/trait among offspring.", {"entities": []}], ["Upregulated arginase activity, which competes with nitric oxide synthase (NOS), impairs nitric oxide production and has been implicated in various metabolic disorders.", {"entities": []}], ["This study examined whether circulating amino acid metabolite ratios are associated with arginase and NOS activities and whether arginine bioavailability is associated with metabolic syndrome (MetS).", {"entities": [[183, 191, "DISEASE"]]}], ["Data related to arginase and NOS activities were collected from non-diabetic Koreans without cardiovascular disease ( n = 1998) in the Ansan\u2013Ansung cohorts (2005\u20132006).", {"entities": []}], ["Subsequently, correlation and multivariate logistic regression analyses were performed.", {"entities": []}], ["With the increase in the number of MetS risk factors, ratios of circulating amino acid metabolites, such as those of ornithine/citrulline, proline/citrulline, and ornithine/arginine, also significantly increased, whereas arginine bioavailability significantly decreased.", {"entities": []}], ["These metabolite ratios and arginase bioavailability were also significantly correlated with MetS risk-related parameters, which remained significant after adjusting for covariates.", {"entities": []}], ["In addition, logistic regression analysis revealed that high ratios of circulating metabolites and low arginine bioavailability, which indicated increased arginase activity, were significantly associated with a high MetS risk.", {"entities": []}], ["This study demonstrated that altered ratios of circulating amino acid metabolites indicates increased arginase activity and decreased arginine bioavailability, both of which can be potential markers for MetS risk.", {"entities": []}], ["Adenovirus are the important pathogen of pediatric severe pneumonia.", {"entities": [[58, 67, "DISEASE"]]}], ["The aim of this study is to analyze the infection, subtype and distribution of adenovirus in autopsied pulmonary tissue of fatal pneumonia in infants and children, and the relationships between adenovirus infection and respiratory illness in South China.", {"entities": [[129, 138, "DISEASE"]]}], ["Nested PCR was performed on DNA extracted from autopsied lung tissue from patients who died of severe pneumonia, and the positive nested PCR products were cloned and sequenced.", {"entities": [[102, 111, "DISEASE"]]}], ["The adenovirus in autopsied pulmonary tissue was also analyzed by immunohistochemistry assay in a blind way.", {"entities": []}], ["In the 175 autopsied pulmonary tissues, the positive percentage of adenovirus was 9.14% (16/175) and 2.29% (4/175) detected with nested PCR and immunohistochemistry, respectively.", {"entities": []}], ["There are three cases of adenovirus serotype 3, twelve cases of adenovirus serotype 4 and one case of serotype 41 determined by sequencing of the cloned positive nested PCR products.", {"entities": []}], ["Adenovirus is an important cause of severe pneumonia, and these data suggest that adenovirus serotype 4 might be an important pathogen responsible for the fatal pneumonia in Guangzhou, South China.", {"entities": [[43, 52, "DISEASE"], [161, 170, "DISEASE"]]}], ["A high number of elderly people with multiple comorbidities are exposed to the risk of polypharmacy and prescription of potentially inappropriate medication (PIM).", {"entities": []}], ["The purpose of this study was to determine the prevalence and patterns of PIM prescription in Korean older adults according to the 2012 Beers Criteria.", {"entities": []}], ["A retrospective study was conducted using data from the Korean Health Insurance Review and Assessment (KHIRA) database of outpatient prescription claims collected from January 1, 2009 to December 31, 2011.", {"entities": []}], ["A total of 523,811 elderly subjects aged 65\u00a0years and older were included in the study, and several covariates related to the prescription of PIMs were obtained from the KHIRA database.", {"entities": []}], ["These covariates were analyzed using Student\u2019s t test and the chi-square test; furthermore, multivariate logistic regression analysis was used to evaluate the risk factors associated with the prescription of PIMs.", {"entities": []}], ["A total of 80.96\u00a0% subjects were prescribed at least one PIM independent of their diagnosis or condition according to the 2012 Beers Criteria.", {"entities": []}], ["The most commonly prescribed medication class was first-generation antihistamines with anticholinergic properties (52.33\u00a0%).", {"entities": []}], ["Pain medications (43.04\u00a0%) and benzodiazepines (42.53\u00a0%) were next in line.", {"entities": []}], ["When considering subjects\u2019 diagnoses or conditions, subjects diagnosed with central nervous system conditions were most often prescribed PIMs.", {"entities": []}], ["Female sex, severity of comorbidities, and polypharmacy were significant risk factors for PIM prescriptions.", {"entities": []}], ["This study confirmed that PIM prescription is common among elderly Koreans.", {"entities": []}], ["A clinical decision support system should be developed to decrease the prevalence of PIM prescriptions.", {"entities": []}], ["The online version of this article (doi:10.1186/s12877-016-0285-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Admission of infants to hospital with bronchiolitis consumes considerable healthcare resources each winter.", {"entities": [[38, 51, "DISEASE"]]}], ["We report an analysis of hospital admissions in England over five decades.", {"entities": []}], ["Data were analysed from the Hospital In-Patient Enquiry (HIPE, 1968\u20131985), Hospital Episode Statistics (HES, 1989\u20132011), Oxford Record Linkage Study (ORLS, 1963\u20132011) and Paediatric Intensive Care Audit Network (PICANet, 2003\u20132012).", {"entities": []}], ["Cases were identified using International Classification of Diseases (ICD) codes in discharge records.", {"entities": []}], ["Bronchiolitis was given a separate code in ICD9 (used in England from 1979).", {"entities": [[0, 13, "DISEASE"]]}], ["Geographical variation was analysed using Local Authority area boundaries.", {"entities": []}], ["Maternal and perinatal risk factors associated with bronchiolitis and subsequent admissions for asthma were analysed using record-linkage.", {"entities": [[96, 102, "DISEASE"], [52, 65, "DISEASE"]]}], ["All-England HIPE and HES data recorded 468\u2005138 episodes of admission for bronchiolitis in infants aged <1\u2005year between 1979 and 2011.", {"entities": [[73, 86, "DISEASE"]]}], ["In 2011 the estimated annual hospital admission rate was 46.1 (95% CI 45.6 to 46.6) per 1000 infants aged <1\u2005year.", {"entities": []}], ["Between 2004 and 2011 the rates rose by an average of 1.8% per year in the all-England HES data, whereas admission rates to paediatric intensive care changed little (1.3 to 1.6 per 1000 infants aged <1\u2005year).", {"entities": []}], ["A fivefold geographical variation in hospital admission rates was observed.", {"entities": []}], ["Young maternal age, low social class, low birth weight and maternal smoking were among factors associated with an increased risk of hospital admission with bronchiolitis.", {"entities": [[156, 169, "DISEASE"]]}], ["Hospital admissions for infants with bronchiolitis have increased substantially in recent years.", {"entities": [[37, 50, "DISEASE"]]}], ["However, cases requiring intensive care have changed little since 2004.", {"entities": []}], ["To test the feasibility of running a randomised controlled trial of a preconsultation web-based intervention (Presenting Asking Checking Expressing (PACE-D)) to improve the quality of care and clinical outcomes in patients with diabetes.", {"entities": []}], ["A feasibility study (with randomisation) conducted at outpatient diabetes clinics at two secondary care hospitals in Devon, UK.", {"entities": []}], ["People with diabetes (type 1 and type 2) attending secondary care general diabetes outpatient clinics.", {"entities": []}], ["The PACE-D, a web-based tool adapted for patients with diabetes to use before their consultation to generate an agenda of topics to discuss with their diabetologist.", {"entities": []}], ["The percentage of eligible patients who were recruited and the percentage of participants for whom routine glycosylated haemoglobin (HbA1c) data (the putative primary outcome) could be extracted from medical notes and who completed secondary outcome assessments via questionnaire at follow-up were reported.", {"entities": []}], ["In contrast with the planned recruitment of 120 participants, only 71 participants were randomised during the 7-month recruitment period.", {"entities": []}], ["This comprised 18.7% (95% CI 14.9% to 23.0%) of those who were eligible.", {"entities": []}], ["Mean (SD) age of the participants was 56.5 (12.4) years and 66.2% had type 1 diabetes.", {"entities": []}], ["Thirty-eight patients were randomised to the intervention arm and 33 to the control arm.", {"entities": []}], ["HbA1c data were available for only 73% (95% CI 61% to 83%) of participants at the 6\u2005months follow-up.", {"entities": []}], ["The questionnaire-based data were collected for 66% (95% CI 54% to 77%) of the participants at 6\u2005months follow-up.", {"entities": []}], ["Participants reported that the PACE-D tool was easy to use.", {"entities": []}], ["A randomised controlled trial of the preconsultation web-based intervention as set out in our current protocol is not feasible without significant modification to improve recruitment and follow-up of participants.", {"entities": []}], ["The study also provides insights into the feasibility and challenges of conducting complex intervention trials in everyday clinical practice.", {"entities": []}], ["ISRCTN75070242.", {"entities": []}], ["Asthma comorbidity has been correlated with poor asthma control, increased health services use, and decreased quality of life.", {"entities": [[0, 6, "DISEASE"], [49, 55, "DISEASE"]]}], ["Managing it improves these outcomes.", {"entities": []}], ["Little is known about the amount of different types of comorbidity associated with asthma and how they vary by age.", {"entities": [[83, 89, "DISEASE"]]}], ["The authors conducted a population study using health administrative data on all individuals living in Ontario, Canada (population 12 million).", {"entities": []}], ["Types of asthma comorbidity were quantified by comparing physician health care claims between individuals with and without asthma in each of 14 major disease categories; results were adjusted for demographic factors and other comorbidity and stratified by age.", {"entities": [[9, 15, "DISEASE"], [123, 129, "DISEASE"]]}], ["Compared to those without asthma, individuals with asthma had higher rates of comorbidity in most major disease categories.", {"entities": [[26, 32, "DISEASE"], [51, 57, "DISEASE"]]}], ["Most notably, they had about fifty percent or more physician health care claims for respiratory disease (other than asthma) in all age groups; psychiatric disorders in individuals age four and under and age 18 to 44; perinatal disorders in individuals 17 years and under, and metabolic and immunity, and hematologic disorders in children four years and under.", {"entities": [[116, 122, "DISEASE"]]}], ["Asthma appears to be associated with significant rates of various types of comorbidity that vary according to age.", {"entities": [[0, 6, "DISEASE"]]}], ["These results can be used to develop strategies to recognize and address asthma comorbidity to improve the overall health of individuals with asthma.", {"entities": [[73, 79, "DISEASE"], [142, 148, "DISEASE"]]}], ["Melanoacanthoma denotes a rare variant of pigmented seborrheic keratosis.", {"entities": [[52, 72, "DISEASE"], [63, 72, "DISEASE"]]}], ["A 65-year-old male farmer had pigmented, verrucous, itchy, highly painful, progressively growing irregularly oval plaque on left side of lower back for the past five years.", {"entities": []}], ["The indurated lesion, measuring maximum diameter 10 cm \u00d7 5 cm, had no discharge, bleeding, ulceration, or associated lymphadenopathy.", {"entities": []}], ["Dermoscopy showed regular pigmentary network and cribiform pattern of ridges without any feature of malignant melanoma.", {"entities": [[110, 118, "DISEASE"]]}], ["Histopathology showed well-defined islands of basaloid cells interspersed with large and richly dendritic melanocytes.", {"entities": []}], ["The lesion was totally excised followed by skin grafting.", {"entities": []}], ["Our patient was unique in its massive size and clinical resemblance with malignant melanoma.", {"entities": [[83, 91, "DISEASE"]]}], ["The diagnosis was confirmed by dermoscopy and skin biopsy.", {"entities": []}], ["There has been growing interest among exposure assessors, epidemiologists, and policymakers in the concept of \"hot spots\", or more broadly, the \"spatial extent\" of impacts from traffic-related air pollutants.", {"entities": []}], ["This review attempts to quantitatively synthesize findings about the spatial extent under various circumstances.", {"entities": []}], ["We include both the peer-reviewed literature and government reports, and focus on four significant air pollutants: carbon monoxide, benzene, nitrogen oxides, and particulate matter (including both ultrafine particle counts and fine particle mass).", {"entities": []}], ["From the identified studies, we extracted information about significant factors that would be hypothesized to influence the spatial extent within the study, such as the study type (e.g., monitoring, air dispersion modeling, GIS-based epidemiological studies), focus on concentrations or health risks, pollutant under study, background concentration, emission rate, and meteorological factors, as well as the study's implicit or explicit definition of spatial extent.", {"entities": []}], ["We supplement this meta-analysis with results from some illustrative atmospheric dispersion modeling.", {"entities": []}], ["We found that pollutant characteristics and background concentrations best explained variability in previously published spatial extent estimates, with a modifying influence of local meteorology, once some extreme values based on health risk estimates were removed from the analysis.", {"entities": []}], ["As hypothesized, inert pollutants with high background concentrations had the largest spatial extent (often demonstrating no significant gradient), and pollutants formed in near-source chemical reactions (e.g., nitrogen dioxide) had a larger spatial extent than pollutants depleted in near-source chemical reactions or removed through coagulation processes (e.g., nitrogen oxide and ultrafine particles).", {"entities": []}], ["Our illustrative dispersion model illustrated the complex interplay of spatial extent definitions, emission rates, background concentrations, and meteorological conditions on spatial extent estimates even for non-reactive pollutants.", {"entities": []}], ["Our findings indicate that, provided that a health risk threshold is not imposed, the spatial extent of impact for mobile sources reviewed in this study is on the order of 100\u2013400 m for elemental carbon or particulate matter mass concentration (excluding background concentration), 200\u2013500 m for nitrogen dioxide and 100\u2013300 m for ultrafine particle counts.", {"entities": []}], ["First, to allow for meaningful comparisons across studies, it is important to state the definition of spatial extent explicitly, including the comparison method, threshold values, and whether background concentration is included.", {"entities": []}], ["Second, the observation that the spatial extent is generally within a few hundred meters for highway or city roads demonstrates the need for high resolution modeling near the source.", {"entities": []}], ["Finally, our findings emphasize that policymakers should be able to develop reasonable estimates of the \"zone of influence\" of mobile sources, provided that they can clarify the pollutant of concern, the general site characteristics, and the underlying definition of spatial extent that they wish to utilize.", {"entities": []}], ["Evaluate the impact of stress on sugar cane cutters and the prevalence of physical and psychological symptoms before and after harvest.", {"entities": []}], ["We studied 114 sugarcane cutters and 109 urban workers in the pre-harvest and 102 sugar cane cutters and 81 urban workers in the post-harvest period in the city of Mendon\u00e7a, SP, Southeastern Brazil, in 2009.", {"entities": []}], ["Data analysis was based on the frequency and percentage of the assessed symptoms of stress, using the Lipp-ISSL test (Symptoms of Stress for Adults).", {"entities": []}], ["The data were analyzed using descriptive statistics.", {"entities": []}], ["The Fisher Test was used to compare the variable of stress between pre- and post-harvest within the sugar cane cutter and urban worker groups.", {"entities": []}], ["P values below 0.05 were considered significant.", {"entities": []}], ["Stress in sugar cane cutters increased after harvesting (34.2% pre-harvest and 46.1% post-harvest); in urban workers, stress decreased from 44.0% pre-harvest to 42.0% post-harvest.", {"entities": []}], ["There was prevalence of the phase of resistance to stress for both groups with signs more apparent from the near-exhaustion and exhaustion phases for sugar cane cutters.", {"entities": []}], ["After harvest, there was a tendency for the number of sugar cane cutters with symptoms of near-exhaustion (6.4%) and exhaustion (10.6%) to increase.", {"entities": []}], ["After harvest there was a trend for the number of sugar cane cutters with physical symptoms (pre-harvest = 20.5%, post-harvest = 25.5%) and psychological symptoms (pre-harvest = 64.1%; post-harvest = 70.2%) to increase.", {"entities": []}], ["For both groups, predominantly psychological symptoms occurred in both phases (70.2% versus 64.7%).", {"entities": []}], ["The work process of cutting cane can cause stress.", {"entities": []}], ["Individual factors such as cognitive perception of the experience, self-efficacy beliefs and expectations of the employee regarding their performance can influence the understanding of the reactions in their body in face of the work.", {"entities": []}], ["Vitiligo usually presented as asymptomatic depigmented macules and patches.", {"entities": [[0, 8, "DISEASE"]]}], ["Little is known regarding itch in vitiligo.", {"entities": [[34, 42, "DISEASE"]]}], ["This study aimed to evaluate the prevalence and characteristics of itch in vitiligo patients.", {"entities": [[75, 83, "DISEASE"]]}], ["A cross-sectional study was conducted on vitiligo patients.", {"entities": [[41, 49, "DISEASE"]]}], ["Itch character and intensity were determined through questionnaires.", {"entities": []}], ["Evaluation was also made by dermatologists to define vitiligo subtype, body surface area, Koebner phenomenon (KP), and so on.", {"entities": [[53, 61, "DISEASE"]]}], ["Data were assessed by computer software.", {"entities": []}], ["Results were considered statistically significant if p < 0.05.", {"entities": []}], ["Among 402 patients, itch on vitiliginous lesion presented in 20.2%.", {"entities": []}], ["Prevalence of itch was most common in focal vitiligo (29.4%), followed by segmental vitiligo (20.3%) and nonsegmental vitiligo (19.6%), respectively.", {"entities": [[44, 52, "DISEASE"], [84, 92, "DISEASE"], [118, 126, "DISEASE"]]}], ["Tingling sensation was the most common itch-related symptom (82.7%).", {"entities": []}], ["The median itch intensity is 5 by 10-point visual analog scale.", {"entities": []}], ["Daily activity and sleep disturbance were observed in 60.5% and 39.5% of patients who experience itch.", {"entities": []}], ["Itch occurred approximately 3 days prior to the development of lesions in 48.1% of patients.", {"entities": []}], ["Thirty-two patients (78.1%) with both itch and KP type IIb had active disease.", {"entities": []}], ["Itch in vitiligo is not uncommon.", {"entities": [[8, 16, "DISEASE"]]}], ["The presence of itch with KP type IIb may warrant the active vitiligo.", {"entities": [[61, 69, "DISEASE"]]}], ["The aim of this substudy of the ghrelin treatment, multicenter, randomized, double-blind, placebo-controlled trial was to investigate the effects of ghrelin administration on exercise capacity and the underlying mechanisms in underweight patients with chronic obstructive pulmonary disease (COPD) using cardiopulmonary exercise testing.", {"entities": [[252, 289, "DISEASE"]]}], ["Twenty underweight COPD patients were randomized to pulmonary rehabilitation with intravenous ghrelin (2 \u03bcg/kg, n = 10) or placebo (n = 10) twice daily for 3 weeks in a double-blind fashion.", {"entities": []}], ["The primary outcome was changes in peak oxygen uptake V \u2022 o 2 .", {"entities": []}], ["Secondary outcomes included changes in exertional cardio-respiratory functions: O 2 -pulse, physiologic dead space/tidal volume-ratio (V D /V T ), ventilatory equivalent for oxygen V \u2022 E / V \u2022 o 2 , and ventilatory equivalent for carbon dioxide V \u2022 E / V \u2022 c o 2 .", {"entities": []}], ["With incremental exercise, at peak exercise, there was a significant difference in the mean difference (ghrelin minus placebo), i.e., treatment effect in: i) peak V \u2022 o 2 (1.2 mL/kg/min, 95% CI: 0.2-2.3 mL/kg/min, between-group p = 0.025); ii) V \u2022 E / V \u2022 o 2 (-4.2, 95% CI: -7.9 to -0.5, between-group p = 0.030); iii) V \u2022 E / V \u2022 c o 2 (-4.1, 95% CI: -8.2 to -0.1, between-group p = 0.045); iv) V D /V T (-0.04, 95% CI: -0.08 to -0.00, between-group p = 0.041); and v) O 2 -pulse (0.7 mL/beat, 95% CI: 0.3 to 1.2 mL/beat, between-group p = 0.003).", {"entities": []}], ["Additionally, repeated-measures analysis of variance (ANOVA) indicated a significant time-course effect of ghrelin versus placebo in the peak V \u2022 o 2 (p = 0.025).", {"entities": []}], ["Ghrelin administration was associated with improved exertional capacity and improvements in ventilatory-cardiac parameters.", {"entities": []}], ["UMIN (University Hospital Medical Information Network in Japan) C000000061", {"entities": []}], ["Lymphangioleiomyomatosis is an uncommon progressive disease characterized by hamartomatous smooth muscle proliferation of the airways within the lungs as well as the lymph nodes, lymphatics, and blood vessels of the lungs, mediastinum, and abdomen.", {"entities": [[0, 24, "DISEASE"]]}], ["The most common manifestations of lymphangioleiomyomatosis are pulmonary symptoms.", {"entities": [[34, 58, "DISEASE"]]}], ["Primary abdominal lymphangioleiomyomatosis without any pathological changes in the respiratory system is extremely unusual.", {"entities": [[18, 42, "DISEASE"]]}], ["We report a case of primary abdominal lymphangioleiomyomatosis located between the left hepatic and gastric antrum of a 29-year-old woman.", {"entities": [[38, 62, "DISEASE"]]}], ["The patient had no typical symptoms of lymphangioleiomyomatosis (dyspnea, pneumothorax) or abdominal pain.", {"entities": [[39, 63, "DISEASE"], [74, 86, "DISEASE"]]}], ["All physical examination findings were normal.", {"entities": []}], ["Laboratory test results, including routine blood examination, liver and kidney function, tumor markers, blood coagulation function, and urine and stool examinations, were all normal.", {"entities": []}], ["She found abdominal cyst in an annual medical examination by ultrasonography and confirmed by computed tomography.", {"entities": []}], ["For a clear diagnosis, a laparoscopic abdominal mass resection was performed.", {"entities": []}], ["The postoperative pathohistological examination findings allowed for the definitive diagnosis.", {"entities": []}], ["This case report may advance the understanding of primary peritoneal lymphatic leiomyoma and reduce the number of mistakenly diagnosed patients.", {"entities": [[79, 88, "DISEASE"]]}], ["Molecular logic gates, designs constructed with biological and chemical molecules, have emerged as an alternative computing approach to silicon-based logic operations.", {"entities": []}], ["These molecular computers are capable of receiving and integrating multiple stimuli of biochemical significance to generate a definitive output, opening a new research avenue to advanced diagnostics and therapeutics which demand handling of complex factors and precise control.", {"entities": []}], ["In molecularly gated devices, Boolean logic computations can be activated by specific inputs and accurately processed via bio-recognition, bio-catalysis, and selective chemical reactions.", {"entities": []}], ["In this review, we survey recent advances of the molecular logic approaches to practical applications of biosensors, including designs constructed with proteins, enzymes, nucleic acids, nanomaterials, and organic compounds, as well as the research avenues for future development of digitally operating \u201csense and act\u201d schemes that logically process biochemical signals through networked circuits to implement intelligent control systems.", {"entities": []}], ["Food allergy is a serious health concern among infants and young children.", {"entities": [[0, 12, "DISEASE"]]}], ["Although immunological mechanism of food allergy is well documented, the molecular mechanism(s) involved in food allergen sensitization have not been well characterized.", {"entities": [[36, 48, "DISEASE"]]}], ["Therefore, the present study analyzed the mesenteric lymph node (MLN) transcriptome profiles of BALB/c mice in response to three common food allergens.", {"entities": [[65, 68, "GENE"]]}], ["Microarray analysis identified a total of 1361, 533 and 488 differentially expressed genes in response to \u03b2-lactoglobulin (BLG) from cow's milk, ovalbumin (OVA) from hen's egg white and peanut agglutinin (PNA) sensitizations, respectively (p < 0.05).", {"entities": []}], ["A total of 150 genes were commonly expressed in all antigen sensitized groups.", {"entities": []}], ["The expression of seven representative genes from microarray experiment was validated by real-time RT-PCR.", {"entities": []}], ["All allergens induced significant ear swelling and serum IgG1 concentrations, whereas IgE concentrations were increased in BLG- and PNA-treated mice (p < 0.05).", {"entities": []}], ["Treatment with OVA and PNA significantly induced plasma histamine concentrations (p < 0.05).", {"entities": []}], ["The PCA demonstrated the presence of allergen-specific IgE in the serum of previously sensitized and challenged mice.", {"entities": []}], ["Immunological profiles indicate that the allergen dosages used are sufficient to sensitize the BALB/c mice and to conduct transcriptome profiling.", {"entities": []}], ["Microarray studies identified several differentially expressed genes in the sensitization phase of the food allergy.", {"entities": [[103, 115, "DISEASE"]]}], ["These findings will help to better understand the underlying molecular mechanism(s) of food allergen sensitizations and may be useful in identifying the potential biomarkers of food allergy.", {"entities": [[177, 189, "DISEASE"]]}], ["The aim of this study was to develop and conduct preliminary validation of the Perceived Impact of Problem Profile (PIPP).", {"entities": []}], ["Based on the biopsychosocial model of health and functioning, the PIPP was intended as a generic research and clinical measurement tool to assess the impact and distress of health conditions from the individuals' perspective.", {"entities": []}], ["The ICF classification system was used to guide the structure of the PIPP with subscales included to assess impact on self-care, mobility, participation, relationships and psychological well-being.", {"entities": []}], ["While the ICF focuses on the classification of objective health and health related status, the PIPP broadens this focus to address the individuals' subjective experience of their health condition.", {"entities": []}], ["An item pool of 23 items assessing both impact and distress on five key domains was generated.", {"entities": []}], ["These were administered to 169 adults with mobility impairment.", {"entities": []}], ["Rasch analysis using RUMM2020 was conducted to assess the psychometric properties of each set of items.", {"entities": []}], ["Preliminary construct validation of the PIPP was performed using the EQ5D.", {"entities": []}], ["For both the Impact and Distress scales of the PIPP, the five subscales (Self-care, Mobility, Participation, Relationships, and Psychological Well-being) showed adequate psychometric properties, demonstrating fit to the Rasch model.", {"entities": []}], ["All subscales showed adequate person separation reliability and no evidence of differential item functioning for sex, age, educational level or rural vs urban residence.", {"entities": []}], ["Preliminary validity testing using the EQ5D items provided support for the subscales.", {"entities": []}], ["This preliminary study, using a sample of adults with mobility impairment, provides support for the psychometric properties of the PIPP as a potential clinical and research measurement tool.", {"entities": []}], ["The PIPP provides a brief, but comprehensive means to assess the key ICF components, focusing on the individuals' perspective of the impact and distress caused by their health condition.", {"entities": []}], ["Further validation of its use across different health conditions and varying cultural settings is required.", {"entities": []}], ["Inflammation plays a considerable role in the progression of Duchenne Muscular Dystrophy (DMD), a severe muscle disease caused by a mutation in the dystrophin gene.", {"entities": [[70, 88, "DISEASE"], [90, 93, "GENE"]]}], ["We previously showed that genetic ablation of Protein Kinase C \u03b8 (PKC\u03b8) in mdx , the mouse model of DMD, improves muscle healing and regeneration, preventing massive inflammation.", {"entities": [[100, 103, "GENE"]]}], ["To establish whether pharmacological targeting of PKC\u03b8 in DMD can be proposed as a therapeutic option, in this study we treated young mdx mice with the PKC\u03b8 inhibitor Compound 20 (C20).", {"entities": [[58, 61, "GENE"]]}], ["We show that C20 treatment led to a significant reduction in muscle damage associated with reduced immune cells infiltration, reduced inflammatory pathways activation, and maintained muscle regeneration.", {"entities": []}], ["Importantly, C20 treatment is efficient in recovering muscle performance in mdx mice, by preserving muscle integrity.", {"entities": []}], ["Together, these results provide proof of principle that pharmacological inhibition of PKC\u03b8 in DMD can be considered an attractive strategy to modulate immune response and prevent the progression of the disease.", {"entities": [[94, 97, "GENE"]]}], ["Duchenne muscular dystrophy (DMD) is a severe muscle disease affecting 1:3500 male births.", {"entities": [[9, 27, "DISEASE"], [29, 32, "GENE"]]}], ["DMD is caused by a mutation in dystrophin gene, coding for a protein required for skeletal and cardiac muscle integrity.", {"entities": [[0, 3, "GENE"]]}], ["Lack of a functional dystrophin is primarily responsible for the muscle eccentric contraction-induced muscle damage, observed in dystrophic muscle.", {"entities": []}], ["However, inflammation plays a considerable role in the progression of DMD.", {"entities": [[70, 73, "GENE"]]}], ["Glucocorticoids, which have anti-inflammatory properties, are being used to treat DMD with some success; however, long term treatment with these drugs induces muscle atrophy and wasting, outweighing their benefit.", {"entities": [[82, 85, "GENE"]]}], ["The identification of specific targets for anti-inflammatory therapies is one of the ongoing therapeutic options.", {"entities": []}], ["Although blunting inflammation would not be a \u201ccure\u201d for the disease, the emerging clue is that multiple strategies, addressing different aspects of the pathology, which may eventually converge, may be successful.", {"entities": []}], ["In this context, we previously showed that genetic ablation of Protein Kinase C \u03b8 (PKC\u03b8), an enzyme known to be involved in immune response, in mdx , the mouse model of DMD, improves muscle healing and regeneration, preventing massive inflammation.", {"entities": [[169, 172, "GENE"]]}], ["To establish whether pharmacological targeting of PKC\u03b8 in DMD can be proposed as a therapeutic option, in this study we treated young mdx mice with the PKC\u03b8 inhibitor Compound 20 (C20).", {"entities": [[58, 61, "GENE"]]}], ["We show that C20 treatment led to a significant reduction in muscle damage associated with reduced immune cells infiltration, reduced inflammatory pathways activation, and maintained muscle regeneration.", {"entities": []}], ["Importantly, C20 treatment is efficient in recovering muscle performance in mdx mice, by preserving muscle integrity.", {"entities": []}], ["Together, these results provide proof of principle that pharmacological inhibition of PKC\u03b8 in DMD can be considered an attractive strategy to modulate immune response and prevent the progression of the disease.", {"entities": [[94, 97, "GENE"]]}], ["Image 1 \u2022 Immune-cell intrinsic PKC\u03b8 activity might play a hitherto unrecognized role of in the development of DMD.", {"entities": [[111, 114, "GENE"]]}], ["\u2022 Mdx dystrophic mice were treated with the PKC\u03b8 inhibitor C20.", {"entities": []}], ["\u2022 C20 treatment prevents damage and inflammation in dystrophic muscle, while improving muscle regeneration.", {"entities": []}], ["\u2022 C20 treatment prevents drop in force and ameliorates fatigue resistance in dystrophic mice.", {"entities": []}], ["Immune-cell intrinsic PKC\u03b8 activity might play a hitherto unrecognized role of in the development of DMD.", {"entities": [[101, 104, "GENE"]]}], ["Mdx dystrophic mice were treated with the PKC\u03b8 inhibitor C20.", {"entities": []}], ["C20 treatment prevents damage and inflammation in dystrophic muscle, while improving muscle regeneration.", {"entities": []}], ["C20 treatment prevents drop in force and ameliorates fatigue resistance in dystrophic mice.", {"entities": []}], ["Connective tissue growth factor (CTGF) has been recognized as a central mediator and promising therapeutic target in hepatic fibrosis.", {"entities": [[33, 37, "GENE"]]}], ["In this study, we generated a novel virus-like particle (VLP) CTGF vaccine by inserting the 138\u2013159 amino acid (aa) fragment of CTGF into the central c/e1 epitope of C-terminus truncated hepatitis B virus core antigen (HBc, aa 1\u2013149) using a prokaryotic expression system.", {"entities": [[187, 196, "DISEASE"], [62, 66, "GENE"], [128, 132, "GENE"], [62, 66, "GENE"], [128, 132, "GENE"]]}], ["Immunization of BALB/c mice with the VLP vaccine efficiently elicited the production of anti-CTGF neutralizing antibodies.", {"entities": []}], ["Vaccination with this CTGF vaccine significantly protected BALB/c mice from carbon tetrachloride (CCl 4 )-induced hepatic fibrosis, as indicated by decreased hepatic hydroxyproline content and lower fibrotic score.", {"entities": [[22, 26, "GENE"]]}], ["CCl 4 intoxication-induced hepatic stellate cell activation was inhibited by the vaccination, as indicated by decreased \u03b1-smooth muscle actin expression and Smad2 phosphorylation.", {"entities": [[157, 162, "GENE"]]}], ["Vaccination against CTGF also attenuated the over-expression of some profibrogenic factors, such as CTGF, transforming growth factor-\u03b21, platelet-derived growth factor-B and tissue inhibitor of metalloproteinase-1 in the fibrotic mouse livers, decreased hepatocyte apoptosis and accelerated hepatocyte proliferation in the fibrotic mouse livers.", {"entities": [[20, 24, "GENE"], [100, 104, "GENE"], [20, 24, "GENE"], [100, 104, "GENE"]]}], ["Our results clearly indicate that vaccination against CTGF inhibits fibrogenesis, alleviates hepatocyte apoptosis and facilitate hepatic regeneration.", {"entities": [[54, 58, "GENE"]]}], ["We suggest that the vaccine should be developed into an effective therapeutic measure for hepatic fibrosis.", {"entities": []}], ["Leukotriene B4 (LTB 4 ) is a potent pro-inflammatory eicosanoid that is derived from arachidonic acid, and its signaling is known to have a tumor-promoting role in several cancer types.", {"entities": [[172, 178, "DISEASE"], [16, 19, "GENE"]]}], ["In this study, we investigated whether enhanced LTB 4 signaling confers resistance to the cytostatic transforming growth factor-\u03b21 (TGF-\u03b21) response.", {"entities": [[48, 51, "GENE"]]}], ["We found that LTB 4 pretreatment or ectopic expression of BLT1, a high affinity LTB 4 receptor, fully abrogated TGF-\u03b21-induced cell cycle arrest and expression of p15 4 -mediated suppression of TGF-\u03b21-induced Smad3 activation and growth inhibition was due to enhanced phosphorylation of Smad3 linker region (pSmad3L) through activation of BLT1-NAD(P)H oxidase (NOX)-reactive oxygen species (ROS)-epidermal growth factor receptor (EGFR)-phosphatidylinositol 3-kinase (PI3-K)-extracellular signal-activated kinase1/2 (ERK1/2)-linked signaling cascade.", {"entities": [[14, 17, "GENE"], [80, 83, "GENE"], [14, 17, "GENE"], [80, 83, "GENE"], [209, 214, "GENE"], [287, 292, "GENE"], [209, 214, "GENE"], [287, 292, "GENE"], [430, 434, "GENE"]]}], ["Furthermore, the LTB 4 /BLT1 signaling pathway leading to pSmad3L was constitutively activated in breast cancer cells and was correlated with TGF-\u03b21-resistant growth of the cells in vitro and in vivo .", {"entities": [[98, 111, "DISEASE"], [105, 111, "DISEASE"], [17, 20, "GENE"]]}], ["In human breast cancer tissues, the expression level of pSmad3L (Thr179) had a positive correlation with BLT1 expression.", {"entities": [[9, 22, "DISEASE"], [16, 22, "DISEASE"]]}], ["Collectively, our data demonstrate for the first time that the induction of pSmad3L through BLT1-NOX-ROS-EGFR-PI3K-ERK1/2 signaling pathway is a key mechanism by which LTB 4 blocks the anti-proliferative responses of TGF-\u03b21, providing a novel mechanistic insight into the connection between enhanced inflammatory signal and cancer cell growth.", {"entities": [[324, 330, "DISEASE"], [168, 171, "GENE"]]}], ["Research examining the impact of neighborhoods on asthma has shown an increased interest in the role of the psychosocial environment.", {"entities": [[50, 56, "DISEASE"]]}], ["We examined the associations between various measures of neighborhood safety, individual and family characteristics, and asthma outcomes among children in Los Angeles.", {"entities": [[121, 127, "DISEASE"]]}], ["Multilevel logistic regression models were used to analyze data on 3,114 children across 65 neighborhoods from Wave 1 of the Los Angeles Family and Neighborhood Survey (2000 to 2002).", {"entities": []}], ["Primary caregivers reported asthma outcome and all individual covariates; home environmental characteristics were observed by the interviewer.", {"entities": [[28, 34, "DISEASE"]]}], ["In fully adjusted models, parents who reported their neighborhood fairly safe or somewhat dangerous had lower odds of reported lifetime asthma compared to those who reported their neighborhood completely safe (OR 0.71; 95% CI 0.52\u20130.96 and OR 0.60; 95% CI 0.42\u20130.88 respectively).", {"entities": [[136, 142, "DISEASE"]]}], ["Conversely, parents who reported they could not trust their neighbors to keep their children safe had a nearly 40% increase in lifetime asthma compared to those who reported they could trust their neighbors to keep their children safe (OR 1.39; 95% CI 1.07\u20131.81).", {"entities": [[136, 142, "DISEASE"]]}], ["The study demonstrates a complex pattern between various measures of neighborhood safety and asthma and suggests that these relationships may operate differently in Los Angeles.", {"entities": [[93, 99, "DISEASE"]]}], ["As an increasing proportion of children are growing up in newer Western and Southwestern cities, which have different physical layouts and residential segregation patterns compared to Northeast and Midwestern cities, future studies should continue to examine neighborhood psychosocial stressors and asthma in diverse contexts.", {"entities": [[299, 305, "DISEASE"]]}], ["Slow transmural tissue necrosis may occur after an electrosurgical Bovie injury and lead to eventual bowel perforation.", {"entities": []}], ["Bowel injury during laparoscopic surgery is a rare but serious complication.", {"entities": []}], ["A Bovie injury to the bowel can cause delayed perforation of the viscus, thus increasing the possibility of a preventable morbidity.", {"entities": []}], ["Patients presenting with perforation peritonitis within 24 hours and up to 2 to 3 weeks after laparoscopic Bovie injury to the bowel have been reported in the literature.", {"entities": [[37, 48, "DISEASE"]]}], ["Description: A 74-year-old woman underwent a laparoscopic ventral hernia mesh repair.", {"entities": []}], ["Intraoperatively, a small area of superficial Bovie injury to the small bowel was repaired with Lembert sutures and tissue glue.", {"entities": []}], ["Postoperatively, the patient recovered well, but she presented with perforation peritonitis 3 months after surgery.", {"entities": [[80, 91, "DISEASE"]]}], ["An exploratory laparotomy showed a jejunal perforation in the same area that was injured with cautery and repaired during the previous surgery.", {"entities": []}], ["The patient was only using inhaled steroids for asthma on and off but had a remote history of chemotherapy and radiation for colorectal cancer.", {"entities": [[125, 142, "DISEASE"], [48, 54, "DISEASE"], [136, 142, "DISEASE"]]}], ["Bovie injury to the bowel has a hidden depth, causing a slow transmural tissue necrosis, and it might also impair local healing and eventually lead to perforation.", {"entities": []}], ["Thus, the patient may present later than the usual period for wound healing and remodeling as previously reported.", {"entities": []}], ["Given the disastrous consequence, it is imperative to perform a good surgical repair of even a minor Bovie injury to the bowel.", {"entities": []}], ["This is the first report of a delayed presentation (>1 month) of a Bovie injury of the bowel.", {"entities": []}], ["Kawasaki disease (KD) is an autoimmune disease preferentially attacking children younger than five years worldwide.", {"entities": []}], ["So far, the principal treatment to KD is the administration of Intravenous immunoglobulin (IVIG).", {"entities": []}], ["Although DNA methylation plays important regulation roles in diseases, few studies investigated the regulation roles of DNA methylation in KD.", {"entities": []}], ["In this study, we focused not only on the DNA methylation alterations resulted from KD onset but also on DNA methylation alterations resulted from IVIG administration.", {"entities": []}], ["To do so, we investigated the effects of KD\u2019s onset and IVIG administration on CpG marker\u2019s methylation alterations.", {"entities": []}], ["We first found that DNA methylation alterations reflecting disease onset or IVIG administration are contributed mainly by the CpG markers on autosomes.", {"entities": []}], ["In addition, we also demonstrated that some CpG markers carry methylation alteration among samples, forcing the expression abundance of the downstream genes to be also altered and negatively correlated with methylation profile.", {"entities": []}], ["Finally, compared with KD\u2019s onset, IVIG administration brings stronger impact on methylation alteration.", {"entities": []}], ["And, such alterations were conducted mainly by hyper-methylating CpG markers, forcing the corresponding genes to keep lower expression levels.", {"entities": []}], ["Moreover, the genes regulated by the altered CpG markers with IVIG administration are enriched in the pathways associated with inflammatory immune response.", {"entities": []}], ["In summary, our result provides researchers with another way into the regulation mechanism through which IVIG represses excessive inflammatory responses.", {"entities": []}], ["Intersectoral costs and benefits (ICBs), i.e.", {"entities": []}], ["costs and benefits of healthcare interventions outside the healthcare sector, can be a crucial component in economic evaluations from the societal perspective.", {"entities": []}], ["Pivotal to their estimation is the existence of sound resource-use measurement (RUM) instruments; however, RUM instruments for ICBs in the education or criminal justice sectors have not yet been systematically collated or their psychometric quality assessed.", {"entities": []}], ["This review aims to fill this gap.", {"entities": []}], ["To identify relevant instruments, the Database of Instruments for Resource Use Measurement (DIRUM) was searched.", {"entities": []}], ["Additionally, a systematic literature review was conducted in seven electronic databases to detect instruments containing ICB items used in economic evaluations.", {"entities": []}], ["Finally, studies evaluating the psychometric quality of these instruments were searched.", {"entities": []}], ["Twenty-six unique instruments were included.", {"entities": []}], ["Most frequently, ICB items measured school absenteeism, tutoring, classroom assistance or contacts with legal representatives, police custody/prison detainment and court appearances, with the highest number of items listed in the Client Service Receipt Inventory/Client Sociodemographic and Service Receipt Inventory/Client Service Receipt Inventory\u2013Children\u2019s Version (CSRI/CSSRI/CSRI-C), Studying the Scope of Parental Expenditures (SCOPE) and Self-Harm Intervention, Family Therapy (SHIFT) instruments.", {"entities": []}], ["ICBs in the education sector were especially relevant for age-related developmental disorders and chronic diseases, while criminal justice resource use seems more important in mental health, including alcohol-related disorders or substance abuse.", {"entities": [[230, 245, "DISEASE"]]}], ["Evidence on the validity or reliability of ICB items was published for two instruments only.", {"entities": []}], ["With a heterogeneous variety of ICBs found to be relevant for several disease areas but many ICB instruments applied in one study only (21/26 instruments), setting-up an international task force to, for example, develop an internationally adaptable instrument is recommended.", {"entities": []}], ["The online version of this article (doi:10.1007/s40273-017-0522-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The use of computerized clinical decision support systems may improve the diagnosis and ongoing management of chronic diseases, which requires recurrent visits to multiple health professionals, disease and medication monitoring and modification of patient behavior.", {"entities": []}], ["The aim of this review was to systematically review randomized controlled trials evaluating the effectiveness of computerized clinical decision systems (CCDSS) in the care of people with asthma and COPD.", {"entities": [[187, 193, "DISEASE"]]}], ["Randomized controlled trials published between 2003 and 2013 were searched using multiple electronic databases Medline, EMBASE, CINAHL, IPA, Informit, PsychINFO, Compendex, and Cochrane Clinical Controlled Trials Register databases.", {"entities": []}], ["To be included, RCTs had to evaluate the role of the CCDSSs for asthma and/or COPD in primary care.", {"entities": [[64, 70, "DISEASE"]]}], ["Nineteen studies representing 16 RCTs met our inclusion criteria.", {"entities": []}], ["The majority of the trials were conducted in patients with asthma.", {"entities": [[59, 65, "DISEASE"]]}], ["Study quality was generally high.", {"entities": []}], ["Meta-analysis was not conducted because of methodological and clinical heterogeneity.", {"entities": []}], ["The use of CCDSS improved asthma and COPD care in 14 of the 19 studies reviewed (74%).", {"entities": [[26, 32, "DISEASE"]]}], ["Nine of the nineteen studies showed statistically significant (p < 0.05) improvement in the primary outcomes measured.", {"entities": []}], ["The majority of the studies evaluated health care process measures as their primary outcomes (10/19).", {"entities": []}], ["Evidence supports the effectiveness of CCDSS in the care of people with asthma.", {"entities": [[72, 78, "DISEASE"]]}], ["However there is very little information of its use in COPD care.", {"entities": []}], ["Although there is considerable improvement in the health care process measures and clinical outcomes through the use of CCDSSs, its effects on user workload and efficiency, safety, costs of care, provider and patient satisfaction remain understudied.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2466-14-189) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Leukocyte extravasation is mediated by multiple interactions of adhesive surface structures with ligands on endothelial cells and matrix components.", {"entities": []}], ["The functional role of beta 1 (CD29) integrins (or very late antigen [VLA] proteins) in eosinophil migration across polycarbonate filters was examined under several in vitro conditions.", {"entities": []}], ["Eosinophil migration induced by the chemoattractant C5a or platelet- activating factor was fully inhibited by monoclonal antibody (mAb) 8A2, a recently characterized \"activating\" CD29 mAb.", {"entities": []}], ["However, inhibition by mAb 8A2 was observed only under filter conditions that best reflected the in vivo situation, i.e., when the eosinophils migrated over filters preincubated with the extracellular matrix (ECM) protein fibronectin (FN), or when the filters were covered with confluent monolayers of cultured human umbilical vein endothelial cells (HUVEC).", {"entities": []}], ["When bare untreated filters were used, mAb 8A2 had no effect, whereas the C5a- directed movement was prevented by CD18 mAb.", {"entities": []}], ["Studies with alpha-subunit (CD49)-specific mAbs indicated that the integrins VLA-4 and -5 mediated migration across FN-preincubated filters, and VLA-2, -4, -5, and -6 were involved in eosinophil migration through filters covered with HUVEC.", {"entities": []}], ["In contrast with the activating CD29 mAb 8A2, a combination of blocking CD49 mAbs or the nonactivating but blocking CD29 mAb AIIB2 failed to inhibit completely eosinophil migration over FN-preincubated or HUVEC-covered filters.", {"entities": []}], ["mAb 8A2 stimulated binding to FN but not to HUVEC.", {"entities": []}], ["Moreover, eosinophil migration over FN-preincubated or HUVEC- covered filters was significantly inhibited by anti-connecting segment 1 (CS-1) mAbs, as well as the soluble CS-1 peptide (unlike migration across bare untreated filters).", {"entities": []}], ["Thus, inhibition of eosinophil migration by mAb 8A2 depended upon the presence of ECM proteins and not upon the presence of HUVEC per se.", {"entities": []}], ["In conclusion, \"freezing\" adhesion receptors of the beta 1 integrin family into their high-avidity binding state by the activating CD29 mAb 8A2 results in a complete inhibition of eosinophil migration under physiological conditions.", {"entities": []}], ["Hence, activation of beta 1 integrin-mediated cell adhesion may represent a new approach to prevent influx of inflammatory cells.", {"entities": []}], ["Long-acting muscarinic antagonist (LAMA) and long-acting \u03b2 2 -agonist (LABA) bronchodilators are key to the pharmacologic treatment of chronic obstructive pulmonary disease (COPD).", {"entities": [[135, 172, "DISEASE"]]}], ["This Phase IIb study investigated the safety and efficacy of four doses of the LAMA glycopyrronium (GP) delivered using co-suspension delivery technology via metered dose inhaler (MDI).", {"entities": []}], ["The study was part of a wider clinical trial program performed to determine the optimal dose of GP MDI, the LABA formoterol fumarate dihydrate (FF) MDI, and glycopyrronium/formoterol fumarate dihydrate (GFF) MDI fixed-dose combination to be taken forward into Phase III studies.", {"entities": []}], ["In this randomized, double-blind, 7-day chronic-dosing, three-period incomplete block, cross-over study, patients with moderate-to-severe COPD received two of the four doses of GP MDI (28.8\u00a0\u03bcg, 14.4\u00a0\u03bcg, 7.2\u00a0\u03bcg, and 3.6\u00a0\u03bcg) twice daily (BID), and either placebo MDI BID or open-label ipratropium MDI 34\u00a0\u03bcg four times daily.", {"entities": []}], ["The primary efficacy endpoint was forced expiratory volume in 1\u00a0s (FEV 1 ) area under the curve from 0 to 12\u00a0h (AUC 0\u201312 ) relative to baseline on Day 7.", {"entities": [[67, 70, "GENE"]]}], ["Secondary and exploratory efficacy endpoints were assessed on Days 1 and 7.", {"entities": []}], ["Safety and tolerability were evaluated throughout the study.", {"entities": []}], ["All GP MDI treatments were superior to placebo MDI for the primary efficacy endpoint (all p \u2009<\u20090.0001).", {"entities": []}], ["However, only GP MDI 28.8\u00a0\u03bcg and 14.4\u00a0\u03bcg demonstrated statistical superiority to placebo MDI for all secondary efficacy endpoints analyzed in this study, with the exception of GP MDI 14.4\u00a0\u03bcg versus placebo MDI for the proportion of patients achieving \u226512% improvement in FEV 1 .", {"entities": [[271, 274, "GENE"]]}], ["No nominally significant differences were observed between GP MDI 28.8\u00a0\u03bcg and GP MDI 14.4\u00a0\u03bcg for any of the endpoints.", {"entities": []}], ["All doses of GP MDI were well tolerated, with no unexpected safety findings.", {"entities": []}], ["This study indicated that there was no advantage of GP MDI 28.8\u00a0\u03bcg compared with GP MDI 14.4\u00a0\u03bcg.", {"entities": []}], ["It therefore added to the evidence from the Phase I/II clinical trial program, which identified GP MDI 14.4\u00a0\u03bcg as the most appropriate dose for use in the Phase III clinical studies.", {"entities": []}], ["ClinicalTrials.gov (NCT01350128).", {"entities": []}], ["Registered May 09, 2011.", {"entities": []}], ["Mucins are the major components of mucus and their genes share a common, centrally-located region of sequence that encodes tandem repeats.", {"entities": []}], ["Mucins are well known genes with respect to their specific expression levels; however, their genomic levels are unclear because of complex genomic properties.", {"entities": []}], ["In this study, we identified eight novel minisatellites from the entire MUC2 region and investigated how allelic variation in these minisatellites may affect susceptibility to gastrointestinal cancer.", {"entities": [[193, 199, "DISEASE"], [72, 76, "GENE"]]}], ["We analyzed genomic DNA from the blood of normal healthy individuals and multi-generational family groups.", {"entities": []}], ["Six of the eight minisatellites exhibited polymorphism and were transmitted meiotically in seven families, following Mendelian inheritance.", {"entities": []}], ["Furthermore, a case-control study was performed that compared genomic DNA from 457 cancer-free controls with DNA from individuals with gastric (455), colon (192) and rectal (271) cancers.", {"entities": [[83, 89, "DISEASE"]]}], ["A statistically significant association was identified between rare exonic MUC2 -MS6 alleles and the occurrence of gastric cancer: odds ratio (OR), 2.56; 95% confidence interval (CI), 1.31\u20135.04; and p\u200a=\u200a 0.0047.", {"entities": [[123, 129, "DISEASE"], [75, 79, "GENE"]]}], ["We focused on an association between rare alleles and gastric cancer.", {"entities": [[62, 68, "DISEASE"]]}], ["Rare alleles were divided into short (40, 43 and 44) and long (47, 50 and 54), according to their TR (tandem repeats) lengths.", {"entities": []}], ["Interestingly, short rare alleles were associated with gastric cancer (OR\u200a=\u200a5.6, 95% CI: 1.93\u201316.42; p\u200a=\u200a 0.00036).", {"entities": [[63, 69, "DISEASE"]]}], ["Moreover, hypervariable MUC2 minisatellites were analyzed in matched blood and cancer tissue from 28 patients with gastric cancer and in 4 cases of MUC2- MS2, minisatellites were found to have undergone rearrangement.", {"entities": [[79, 85, "DISEASE"], [123, 129, "DISEASE"], [24, 28, "GENE"], [148, 152, "GENE"]]}], ["Our observations suggest that the short rare MUC2 -MS6 alleles could function as identifiers for risk of gastric cancer.", {"entities": [[113, 119, "DISEASE"], [45, 49, "GENE"]]}], ["Additionally, we suggest that minisatellite instability might be associated with MUC2 function in cancer cells.", {"entities": [[98, 104, "DISEASE"], [81, 85, "GENE"]]}], ["The Gram-positive bacterium Streptococcus pneumoniae causes life-threatening infections, especially among immunocompromised patients.", {"entities": []}], ["The host's immune system senses S. pneumoniae via different families of pattern recognition receptors, in particular the Toll-like receptor (TLR) family that promotes immune cell activation.", {"entities": []}], ["Yet, while single TLRs are dispensable for initiating inflammatory responses against S. pneumoniae , the central TLR adapter protein myeloid differentiation factor 88 (MyD88) is of vital importance, as MyD88-deficient mice succumb rapidly to infection.", {"entities": [[168, 173, "GENE"], [202, 207, "GENE"]]}], ["Since MyD88 is ubiquitously expressed in hematopoietic and non-hematopoietic cells, the extent to which MyD88 signaling is required in different cell types to control S. pneumoniae is unknown.", {"entities": [[6, 11, "GENE"], [104, 109, "GENE"], [6, 11, "GENE"], [104, 109, "GENE"]]}], ["Therefore, we used novel conditional knockin mice to investigate the necessity of MyD88 signaling in distinct lung-resident myeloid and epithelial cells for the initiation of a protective immune response against S. pneumoniae .", {"entities": [[82, 87, "GENE"]]}], ["Here, we show that MyD88 signaling in lysozyme M (LysM)\u2013 and CD11c-expressing myeloid cells, as well as in pulmonary epithelial cells, is critical to restore inflammatory cytokine and antimicrobial peptide production, leading to efficient neutrophil recruitment and enhanced bacterial clearance.", {"entities": [[19, 24, "GENE"]]}], ["Overall, we show a novel synergistic requirement of compartment-specific MyD88 signaling in S. pneumoniae immunity.", {"entities": [[73, 78, "GENE"]]}], ["Idiopathic pulmonary fibrosis is a type of chronic fibrosing interstitial pneumonia, of unknown etiology, which is associated with a progressive decrease in pulmonary function and with high mortality rates.", {"entities": [[74, 83, "DISEASE"], [11, 29, "DISEASE"], [0, 29, "DISEASE"]]}], ["Interest in and knowledge of this disorder have grown substantially in recent years.", {"entities": []}], ["In this review article, we broadly discuss distinct aspects related to the diagnosis and treatment of idiopathic pulmonary fibrosis.", {"entities": [[113, 131, "DISEASE"], [102, 131, "DISEASE"]]}], ["We list the current diagnostic criteria and describe the therapeutic approaches currently available, symptomatic treatments, the action of new drugs that are effective in slowing the decline in pulmonary function, and indications for lung transplantation.", {"entities": []}], ["A fibrose pulmonar idiop\u00e1tica \u00e9 um tipo de pneumonia intersticial cr\u00f4nica fibrosante, de causa desconhecida, associada \u00e0 piora funcional respirat\u00f3ria progressiva e taxas elevadas de mortalidade.", {"entities": [[43, 52, "DISEASE"]]}], ["Em anos recentes, o interesse e os conhecimentos sobre essa mol\u00e9stia t\u00eam aumentado substancialmente.", {"entities": []}], ["O presente artigo de revis\u00e3o aborda de maneira ampla aspectos relacionados ao diagn\u00f3stico e tratamento da doen\u00e7a.", {"entities": []}], ["Nele s\u00e3o listados os crit\u00e9rios atuais para o diagn\u00f3stico e s\u00e3o discutidos as diferentes abordagens terap\u00eauticas agora dispon\u00edveis, o tratamento sintom\u00e1tico, a a\u00e7\u00e3o de novas drogas eficazes em reduzir o ritmo de deteriora\u00e7\u00e3o funcional pulmonar e as indica\u00e7\u00f5es para transplante pulmonar.", {"entities": []}], ["Perturbations of mammalian organisms including diseases, drug treatments and gene perturbations in mice affect organ systems differently.", {"entities": []}], ["Some perturbations impair relatively few organ systems while others lead to highly heterogeneous or systemic effects.", {"entities": []}], ["Organ System Heterogeneity DB ( http://mips.helmholtz-muenchen.de/Organ_System_Heterogeneity/ ) provides information on the phenotypic effects of 4865 human diseases, 1667 drugs and 5361 genetically modified mouse models on 26 different organ systems.", {"entities": []}], ["Disease symptoms, drug side effects and mouse phenotypes are mapped to the System Organ Class (SOC) level of the Medical Dictionary of Regulatory Activities (MedDRA).", {"entities": []}], ["Then, the organ system heterogeneity value, a measurement of the systemic impact of a perturbation, is calculated from the relative frequency of phenotypic features across all SOCs.", {"entities": []}], ["For perturbations of interest, the database displays the distribution of phenotypic effects across organ systems along with the heterogeneity value and the distance between organ system distributions.", {"entities": []}], ["In this way, it allows, in an easy and comprehensible fashion, the comparison of the phenotypic organ system distributions of diseases, drugs and their corresponding genetically modified mouse models of associated disease genes and drug targets.", {"entities": []}], ["The Organ System Heterogeneity DB is thus a platform for the visualization and comparison of organ system level phenotypic effects of drugs, diseases and genes.", {"entities": []}], ["In February 2012 Italy was hit by an exceptional cold spell with extremely low temperatures and heavy snowfall.", {"entities": []}], ["The aim of this work is to estimate the impact of the cold spell on health in the Italian cities using data from the rapid surveillance systems.", {"entities": []}], ["In Italy, a national mortality surveillance system has been operational since 2004 in 34 cities for the rapid monitoring of daily mortality.", {"entities": []}], ["Data from this system were used to evaluate the impact of the February 2012 cold spell on mortality shortly after the occurrence of the event.", {"entities": []}], ["Furthermore, a cause-specific analysis was conducted in Roma using the Regional Mortality Registry and the emergency visits (ER) surveillance system.", {"entities": []}], ["Cold spell episodes were defined as days when mean temperatures were below the 10", {"entities": []}], ["Objective : Correct inhaler technique is central to effective delivery of asthma therapy.", {"entities": [[74, 80, "DISEASE"]]}], ["The study aim was to identify factors associated with serious inhaler technique errors and their prevalence among primary care patients with asthma using the Diskus dry powder inhaler (DPI).", {"entities": [[141, 147, "DISEASE"]]}], ["Methods : This was a historical, multinational, cross-sectional study (2011\u20132013) using the iHARP database, an international initiative that includes patient- and healthcare provider-reported questionnaires from eight countries.", {"entities": []}], ["Patients with asthma were observed for serious inhaler errors by trained healthcare providers as predefined by the iHARP steering committee.", {"entities": [[14, 20, "DISEASE"]]}], ["Multivariable logistic regression, stepwise reduced, was used to identify clinical characteristics and asthma-related outcomes associated with \u22651 serious errors.", {"entities": [[103, 109, "DISEASE"]]}], ["Results : Of 3681 patients with asthma, 623 (17%) were using a Diskus (mean [SD] age, 51 [14]; 61% women).", {"entities": [[32, 38, "DISEASE"]]}], ["A total of 341 (55%) patients made \u22651 serious errors.", {"entities": []}], ["The most common errors were the failure to exhale before inhalation, insufficient breath-hold at the end of inhalation, and inhalation that was not forceful from the start.", {"entities": []}], ["Factors significantly associated with \u22651 serious errors included asthma-related hospitalization the previous year (odds ratio [OR] 2.07; 95% confidence interval [CI], 1.26\u20133.40); obesity (OR 1.75; 1.17\u20132.63); poor asthma control the previous 4 weeks (OR 1.57; 1.04\u20132.36); female sex (OR 1.51; 1.08\u20132.10); and no inhaler technique review during the previous year (OR 1.45; 1.04\u20132.02).", {"entities": [[179, 186, "DISEASE"], [65, 71, "DISEASE"], [214, 220, "DISEASE"]]}], ["Conclusions : Patients with evidence of poor asthma control should be targeted for a review of their inhaler technique even when using a device thought to have a low error rate.", {"entities": [[45, 51, "DISEASE"]]}], ["Data regarding osteoporosis in COPD patients in Taiwan remain limited.", {"entities": [[15, 27, "DISEASE"]]}], ["The primary end point of this study was to evaluate the prevalence and risk factors of osteoporosis in COPD patients in Taiwan.", {"entities": [[87, 99, "DISEASE"]]}], ["The secondary end point was to examine the association between osteoporosis and health-related quality of life (HRQL) in COPD patients.", {"entities": [[63, 75, "DISEASE"]]}], ["This prospective cross-sectional study enrolled 125 COPD patients (mean age 73.6 years, forced expiratory volume in 1 second [FEV 1 ] 1.19\u00b10.43 L) who had bone mineral-density measurements performed consecutively.", {"entities": [[126, 129, "GENE"]]}], ["Demographic data, lung function, and HRQL including modified Medical Research Council dyspnea scale, St George\u2019s Respiratory Questionnaire, oxygen-cost diagram, Center for Epidemiologic Studies \u2013 depression scale, and COPD Assessment Test scores were recorded.", {"entities": []}], ["A total of 50 (40%) participants were diagnosed as having osteoporosis.", {"entities": [[58, 70, "DISEASE"]]}], ["In a multivariate logistic regression model including age, smoking amount (pack-year), body mass index (BMI), and FEV 1 , only BMI (odds ratio 0.824, 95% confidence interval 0.73\u20130.93; P =0.002) and FEV 1 (odds ratio 0.360, 95% confidence interval 0.13\u20130.98; P =0.046) were negatively associated with an increased risk of osteoporosis in COPD patients.", {"entities": [[322, 334, "DISEASE"], [114, 117, "GENE"], [199, 202, "GENE"], [114, 117, "GENE"], [199, 202, "GENE"]]}], ["In addition, COPD patients with osteoporosis had significantly higher modified Medical Research Council dyspnea scale scores (1.7\u00b10.8 vs 1.4\u00b10.8, P =0.046), St George\u2019s Respiratory Questionnaire scores (36.6 vs 28.0, P =0.01), and COPD Assessment Test scores (14.7\u00b18 vs 11.5\u00b17, P =0.019), and lower oxygen-cost diagram score (4.8\u00b11.8 vs 5.4\u00b11.6, P =0.045) than patients without osteoporosis.", {"entities": [[32, 44, "DISEASE"], [378, 390, "DISEASE"]]}], ["The prevalence of osteoporosis in COPD patients was high at a community hospital in Taiwan.", {"entities": [[18, 30, "DISEASE"]]}], ["BMI and FEV 1 were the independent risk factors for osteoporosis in COPD.", {"entities": [[52, 64, "DISEASE"], [8, 11, "GENE"]]}], ["In addition, COPD patients with osteoporosis had worse HRQL than those without osteoporosis.", {"entities": [[32, 44, "DISEASE"], [79, 91, "DISEASE"]]}], ["The classification of rhinitis in adults is missing in epidemiological studies.", {"entities": [[22, 30, "DISEASE"]]}], ["To identify phenotypes of adult rhinitis using an unsupervised approach ( data-driven ) compared with a classical hypothesis-driven approach.", {"entities": [[32, 40, "DISEASE"]]}], ["983 adults of the French Epidemiological Study on the Genetics and Environment of Asthma (EGEA) were studied.", {"entities": [[82, 88, "DISEASE"]]}], ["Self-reported symptoms related to rhinitis such as nasal symptoms, hay fever, sinusitis, conjunctivitis, and sensitivities to different triggers (dust, animals, hay/flowers, cold air\u2026) were used.", {"entities": [[34, 42, "DISEASE"], [78, 87, "DISEASE"], [89, 103, "DISEASE"]]}], ["Allergic sensitization was defined by at least one positive skin prick test to 12 aeroallergens.", {"entities": []}], ["Mixture model was used to cluster participants, independently in those without (Asthma-, n = 582) and with asthma (Asthma+, n = 401).", {"entities": [[80, 86, "DISEASE"], [107, 113, "DISEASE"], [115, 121, "DISEASE"]]}], ["Three clusters were identified in both groups: 1) Cluster A (55% in Asthma-, and 22% in Asthma+) mainly characterized by the absence of nasal symptoms, 2) Cluster B (23% in Asthma-, 36% in Asthma+) mainly characterized by nasal symptoms all over the year, sinusitis and a low prevalence of positive skin prick tests, and 3) Cluster C (22% in Asthma-, 42% in Asthma+) mainly characterized by a peak of nasal symptoms during spring, a high prevalence of positive skin prick tests and a high report of hay fever, allergic rhinitis and conjunctivitis.", {"entities": [[510, 527, "DISEASE"], [519, 527, "DISEASE"], [256, 265, "DISEASE"], [532, 546, "DISEASE"], [68, 74, "DISEASE"], [88, 94, "DISEASE"], [173, 179, "DISEASE"], [189, 195, "DISEASE"], [342, 348, "DISEASE"], [358, 364, "DISEASE"]]}], ["The highest rate of polysensitization (80%) was found in participants with comorbid asthma and allergic rhinitis.", {"entities": [[95, 112, "DISEASE"], [104, 112, "DISEASE"], [84, 90, "DISEASE"]]}], ["This cluster analysis highlighted three clusters of rhinitis with similar characteristics than those known by clinicians but differing according to allergic sensitization, and this whatever the asthma status.", {"entities": [[52, 60, "DISEASE"], [194, 200, "DISEASE"]]}], ["These clusters could be easily rebuilt using a small number of variables.", {"entities": []}], ["Infant colic (IC) is defined as recurrent and prolonged crying without an obvious cause or evidence of failure to thrive or illness.", {"entities": []}], ["It is a common problem with a prevalence of 5%\u201325%.", {"entities": []}], ["The unknown aetiology results in a wide variety in interventions and use of heterogeneous outcome measures across therapeutic trials.", {"entities": []}], ["Our aim was to develop a core outcome set (COS) for IC to facilitate and improve evidence synthesis.", {"entities": []}], ["Prospective study design; primary, secondary and tertiary care.", {"entities": []}], ["The COS was developed using a modified Delphi technique.", {"entities": []}], ["First, healthcare professionals (HCPs) and parents of infants with IC were asked to list up to five outcomes they considered relevant in the treatment of IC.", {"entities": []}], ["Outcomes mentioned by >10% of participants were forwarded to a shortlist.", {"entities": []}], ["In the second round, outcomes on this shortlist were rated and prioritised.", {"entities": []}], ["The final COS was defined in a face-to-face expert meeting of paediatricians.", {"entities": []}], ["F of invited stakeholders (133 HCPs and 55 parents of infants with IC) completed both Delphi rounds.", {"entities": []}], ["Duration of crying, family stress, sleeping time of infant, quality of life (of family), discomfort of infant and hospital admission/duration were rated as most important outcomes in IC, framing the final COS.", {"entities": []}], ["The use of this COS should serve as a minimum of outcomes to be measured and reported.", {"entities": []}], ["This will benefit evidence synthesis, by enhancing homogeneity of outcomes, and enable evaluation of success in therapeutic trials on IC.", {"entities": []}], ["Researchers are strongly encouraged to use this COS when setting up a clinical trial in primary, secondary and/or tertiary care or performing a systematic review on IC.", {"entities": []}], ["The ability to drive is important for ensuring quality of life for many older adults.", {"entities": []}], ["Glaucoma is prevalent in this age group and may affect driving.", {"entities": [[0, 8, "DISEASE"]]}], ["The purpose of this study is to determine if glaucoma and glaucomatous visual field (VF) loss are associated with driving cessation, limitations, and deference to another driver in older adults.", {"entities": [[45, 53, "DISEASE"]]}], ["Cross-sectional study.", {"entities": []}], ["Eighty-one glaucoma subjects and 58 glaucoma suspect controls between age 60 and 80 reported if they had ceased driving, limited their driving in various ways, or preferred another to drive.", {"entities": [[11, 19, "DISEASE"], [36, 44, "DISEASE"]]}], ["Twenty-three percent of glaucoma subjects and 6.9% of suspects had ceased driving (p\u2009=\u20090.01).", {"entities": [[24, 32, "DISEASE"]]}], ["Glaucoma subjects also had more driving limitations than suspects (2.0 vs. 1.1, p\u2009=\u20090.007).", {"entities": [[0, 8, "DISEASE"]]}], ["In multivariable models, driving cessation was more likely for glaucoma subjects as compared to suspects (OR\u2009=\u20094.0; 95% CI\u2009=\u20091.1-14.7; p\u2009=\u20090.03).", {"entities": [[63, 71, "DISEASE"]]}], ["The odds of driving cessation doubled with each 5 decibel (dB) decrement in the better-eye VF mean deviation (MD) (OR\u2009=\u20092.0; 95% CI\u2009=\u20091.4-2.9; p\u2009<\u20090.001).", {"entities": []}], ["Glaucoma subjects were also more likely than suspects to report a greater number of driving limitations (OR\u2009=\u20094.7; 95% CI\u2009=\u20091.3-16.8; p\u2009=\u20090.02).", {"entities": [[0, 8, "DISEASE"]]}], ["The likelihood of reporting more limitations increased with the VF loss severity (OR\u2009=\u20091.6 per 5 dB decrement in the better-eye VF MD; 95% CI\u2009=\u20091.1-2.4; p\u2009=\u20090.02).", {"entities": []}], ["Neither glaucoma nor VF MD was associated with other driver preference (p\u2009>\u20090.1 for both).", {"entities": [[8, 16, "DISEASE"]]}], ["Glaucoma and glaucomatous VF loss are associated with greater likelihood of driving cessation and greater limitation of driving in the elderly.", {"entities": [[0, 8, "DISEASE"]]}], ["Further prospective study is merited to assess when and why people with glaucoma change their driving habits, and to determine if their observed self-regulation of driving is adequate to ensure safety.", {"entities": [[72, 80, "DISEASE"]]}], ["The aetiology of acute exacerbations of COPD (AECOPD) is incompletely understood.", {"entities": []}], ["Understanding the relationship between chronic bacterial airway infection and viral exposure may explain the incidence and seasonality of these events.", {"entities": []}], ["In this prospective, observational cohort study (NCT01360398), patients with COPD aged 40\u201385\u2005years underwent sputum sampling monthly and at exacerbation for detection of bacteria and viruses.", {"entities": []}], ["Results are presented for subjects in the full cohort, followed for 1\u2005year.", {"entities": []}], ["Interactions between exacerbation occurrence and pathogens were investigated by generalised estimating equation and stratified conditional logistic regression analyses.", {"entities": []}], ["The mean exacerbation rate per patient-year was 3.04 (95% CI 2.63 to 3.50).", {"entities": []}], ["At AECOPD, the most common bacterial species were non-typeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis , and the most common virus was rhinovirus.", {"entities": []}], ["Logistic regression analyses (culture bacterial detection) showed significant OR for AECOPD occurrence when M. catarrhalis was detected regardless of season (5.09 (95% CI 2.76 to 9.41)).", {"entities": []}], ["When NTHi was detected, the increased risk of exacerbation was greater in high season (October\u2013March, OR 3.04 (1.80 to 5.13)) than low season (OR 1.22 (0.68 to 2.22)).", {"entities": []}], ["Bacterial and viral coinfection was more frequent at exacerbation (24.9%) than stable state (8.6%).", {"entities": []}], ["A significant interaction was detected between NTHi and rhinovirus presence and AECOPD risk (OR 5.18 (1.92 to 13.99); p=0.031).", {"entities": []}], ["AECOPD aetiology varies with season.", {"entities": []}], ["Rises in incidence in winter may be driven by increased pathogen presence as well as an interaction between NTHi airway infection and effects of viral infection.", {"entities": []}], ["Results, NCT01360398.", {"entities": []}], ["The interferons are a complex group of virally induced proteins produced by activated macrophages and lymphocytes, which have become the mainstay of therapy for hepatitis C infection.", {"entities": [[161, 170, "DISEASE"]]}], ["Sustained viral response (SVR) rates in noncirrhotic patients vary from 40\u201380% with interferon-based therapy.", {"entities": []}], ["This, along with transplantation, has drastically changed the course of hepatitis C virus (HCV) infection over the last two decades.", {"entities": [[72, 81, "DISEASE"]]}], ["Numerous side effects associated with interferon therapy have been reported.", {"entities": []}], ["These range from transient flu-like symptoms to serious effects such as cardiac arrhythmias, cardiomyopathy, renal and liver failure, polyneuropathy, and myelosuppression.", {"entities": [[93, 107, "DISEASE"], [134, 148, "DISEASE"]]}], ["Pulmonary side effects including pneumonitis, pulmonary fibrosis, and reversible pulmonary hypertension have been reported.", {"entities": [[91, 103, "DISEASE"], [81, 103, "DISEASE"], [46, 64, "DISEASE"]]}], ["Herein, we present four cases in which irreversible pulmonary hypertension was diagnosed after prolonged treatment with interferon alpha.", {"entities": [[62, 74, "DISEASE"], [52, 74, "DISEASE"]]}], ["In each case, other causes of pulmonary hypertension were systematically eliminated.", {"entities": [[40, 52, "DISEASE"], [30, 52, "DISEASE"]]}], ["Pulmonary artery hypertension, which may be irreversible, should be considered in patients being treated with interferon alpha who present with exertional dyspnea and do not have a readily identifiable inflammatory or thromboembolic cause.", {"entities": [[17, 29, "DISEASE"]]}], ["Pregnancy-related (PR) deaths are often a result of direct obstetric complications occurring at childbirth.", {"entities": []}], ["To estimate the burden of and characterize risk factors for PR mortality, we evaluated deaths that occurred between 2003 and 2008 among women of childbearing age (15 to 49 years) using Health and Demographic Surveillance System data in rural western Kenya.", {"entities": []}], ["WHO ICD definition of PR mortality was used: \u201cthe death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the cause of death\u201d.", {"entities": []}], ["In addition, symptoms and events at the time of death were examined using the WHO verbal autopsy methodology.", {"entities": []}], ["Deaths were categorized as either (i) directly PR: main cause of death was ascribed as obstetric, or (ii) indirectly PR: main cause of death was non-obstetric.", {"entities": []}], ["Of 3,223 deaths in women 15 to 49 years, 249 (7.7%) were PR.", {"entities": []}], ["One-third (34%) of these were due to direct obstetric causes, predominantly postpartum hemorrhage, abortion complications and puerperal sepsis.", {"entities": []}], ["Two-thirds were indirect; three-quarters were attributable to human immunodeficiency virus (HIV/AIDS), malaria and tuberculosis.", {"entities": [[115, 127, "DISEASE"], [103, 110, "DISEASE"]]}], ["Significantly more women who died in lower socio-economic groups sought care from traditional birth attendants (p\u200a=\u200a0.034), while less impoverished women were more likely to seek hospital care (p\u200a=\u200a0.001).", {"entities": []}], ["The PR mortality ratio over the six years was 740 (95% CI 651\u2013838) per 100,000 live births, with no evidence of reduction over time (\u03c7 These data supplement current scanty information on the relationship between infectious diseases and poor maternal outcomes in Africa.", {"entities": []}], ["They indicate low uptake of maternal health interventions in women dying during pregnancy and postpartum, suggesting improved access to and increased uptake of skilled obstetric care, as well as preventive measures against HIV/AIDS, malaria and tuberculosis among all women of childbearing age may help to reduce pregnancy-related mortality.", {"entities": [[245, 257, "DISEASE"], [233, 240, "DISEASE"]]}], ["Recent studies have raised controversy regarding the association between cesarean section and later obesity in the offspring.", {"entities": [[100, 107, "DISEASE"]]}], ["The purpose of this study was to assess the association of cesarean section with increased body mass index (BMI) and obesity in school children from two Brazilian cities with distinct socioeconomic backgrounds.", {"entities": [[117, 124, "DISEASE"]]}], ["Two birth cohorts respectively born in 1994 in Ribeirao Preto, a wealthy city in Southeast, and in 1997/98 in Sao Luis, a less wealthy city in Northeast of Brasil, were evaluated.", {"entities": []}], ["After birth, 2,846 pairs of mothers-newborns were evaluated in Ribeirao Preto and 2,542 in Sao Luis.", {"entities": []}], ["In 2004/05, 790 children aged 10/11\u00a0years were randomly reassessed in Ribeirao Preto and 673 at 7/9\u00a0years in Sao Luis.", {"entities": []}], ["Information on type of delivery, maternal and child characteristics, socioeconomic position and anthropometric measurements were collected after birth and at school age.", {"entities": []}], ["Obesity was defined as BMI\u2009\u2265\u200995th percentile at school age.", {"entities": [[0, 7, "DISEASE"]]}], ["Obesity rate was 13.0% in Ribeirao Preto and 2.1% in Sao Luis.", {"entities": [[0, 7, "DISEASE"]]}], ["Cesarean section was associated with obesity and remained significant after adjustment only in Ribeirao Preto [OR\u2009=\u20091.74 (95% CI: 1.04; 2.92)].", {"entities": [[37, 44, "DISEASE"]]}], ["The association between cesarean section and BMI remained significant after adjustment for maternal schooling, maternal smoking during pregnancy, duration of breastfeeding, gender, birth weight and gestational age, type of school and, only in Sao Luis, pre-pregnancy maternal weight.", {"entities": []}], ["In Ribeirao Preto children born by cesarean section had BMI 0.31\u00a0kg/m A positive association between cesarean section and increased BMI z-score was demonstrated in areas with different socioeconomic status in a middle-income country.", {"entities": []}], ["Dysfunctional regulation of airway smooth muscle tone is a feature of obstructive airway diseases such as asthma and chronic obstructive pulmonary disease.", {"entities": [[117, 154, "DISEASE"], [106, 112, "DISEASE"]]}], ["Airway smooth muscle contraction is directly associated with changes in the phosphorylation of myosin light chain (MLC), which is increased by Rho and decreased by Rac.", {"entities": []}], ["Although cyclic adenosine monophosphate (cAMP)-elevating agents are believed to relieve bronchoconstriction mainly via activation of protein kinase A (PKA), here we addressed the role of the novel cAMP-mediated exchange protein Epac in the regulation of airway smooth muscle tone.", {"entities": []}], ["Isometric tension measurements showed that specific activation of Epac led to relaxation of guinea pig tracheal preparations pre-contracted with methacholine, independently of PKA.", {"entities": []}], ["In airway smooth muscle cells, Epac activation reduced methacholine-induced MLC phosphorylation.", {"entities": []}], ["Moreover, when Epac was stimulated, we observed a decreased methacholine-induced RhoA activation, measured by both stress fibre formation and pull-down assay whereas the same Epac activation prevented methacholine-induced Rac1 inhibition measured by pull-down assay.", {"entities": [[81, 85, "GENE"], [222, 226, "GENE"]]}], ["Epac-driven inhibition of both methacholine-induced muscle contraction by Toxin B-1470, and MLC phosphorylation by the Rac1-inhibitor NSC23766, were significantly attenuated, confirming the importance of Rac1 in Epac-mediated relaxation.", {"entities": [[119, 123, "GENE"], [204, 208, "GENE"]]}], ["Importantly, human airway smooth muscle tissue also expresses Epac, and Epac activation both relaxed pre-contracted human tracheal preparations and decreased MLC phosphorylation.", {"entities": []}], ["Collectively, we show that activation of Epac relaxes airway smooth muscle by decreasing MLC phosphorylation by skewing the balance of RhoA/Rac1 activation towards Rac1.", {"entities": [[140, 144, "GENE"], [164, 168, "GENE"]]}], ["Therefore, activation of Epac may have therapeutical potential in the treatment of obstructive airway diseases.", {"entities": []}], ["Patients recovering from critical illness have been shown to be at risk of developing Post Traumatic Stress disorder (PTSD).", {"entities": []}], ["This study was to evaluate whether a prospectively collected diary of a patient's intensive care unit (ICU) stay when used during convalescence following critical illness will reduce the development of new onset PTSD.", {"entities": []}], ["Intensive care patients with an ICU stay of more than 72 hours were recruited to a randomised controlled trial examining the effect of a diary outlining the details of the patients ICU stay on the development of acute PTSD.", {"entities": []}], ["The intervention patients received their ICU diary at 1 month following critical care discharge and the final assessment of the development of acute PTSD was made at 3 months.", {"entities": []}], ["352 patients were randomised to the study at 1 month.", {"entities": []}], ["The incidence of new cases of PTSD was reduced in the intervention group compared to the control patients (5% versus 13%, P = 0.02).", {"entities": []}], ["The provision of an ICU diary is effective in aiding psychological recovery and reducing the incidence of new PTSD.", {"entities": []}], ["NCT00912613.", {"entities": []}], ["Epidemiological data on asthma among adults in sub-Saharan Africa are sparse.", {"entities": [[24, 30, "DISEASE"]]}], ["To determine the prevalence of and factors associated with asthma among adults in Kinshasa.", {"entities": [[59, 65, "DISEASE"]]}], ["A previously validated asthma questionnaire was administered to an adult population aged \u226518 years in urban and peri-urban suburbs of Kinshasa.", {"entities": [[23, 29, "DISEASE"]]}], ["A random stratified multi-stage sampling plan was used to select the study participants.", {"entities": []}], ["Logistic regression was used to identify factors associated with asthma.", {"entities": [[65, 71, "DISEASE"]]}], ["The mean age of respondents was 36.7 (SD 15.36) years, 75% lived in an urban environment, and 57% were women.", {"entities": []}], ["The prevalence of asthma-ever was 6.9% (95% CI: 5.4\u20138.4).", {"entities": [[18, 24, "DISEASE"]]}], ["Among asthmatic patients, intermittent asthma was estimated at 75.7% and severe asthma at 9.3%.", {"entities": [[39, 45, "DISEASE"], [80, 86, "DISEASE"]]}], ["Family atopy (OR: 3.97; 95% CI: 2.42\u20136.50; p<0.001), and the presence of a cat in the house (OR: 1.82; 95% CI: 1.01\u20133.28; p = 0.045) were associated with self-reported asthma.", {"entities": [[168, 174, "DISEASE"]]}], ["Asthma is relatively frequent in adults in Kinshasa, a prevalence similar to those reported elsewhere in Africa.", {"entities": [[0, 6, "DISEASE"]]}], ["Family atopy and the presence of a cat in the house could be the most common determinants to be confirmed with national survey in order to design guidelines for the control of asthma.", {"entities": [[176, 182, "DISEASE"]]}], ["The aim of this paper is to determine the modulatory effects of Lactobacillus acidophilus on the IL-23/Th17 immune axis in experimental colitis.", {"entities": []}], ["DSS-induced mouse models of UC were to be saline, hormones, and different concentrations of Lactobacillus acidophilus intervention.", {"entities": []}], ["The expression of interleukin- (IL-) 17, tumor necrosis factor \u03b1 (TNF \u03b1 ), IL-23, transforming growth factor \u03b2 1 (TGF \u03b2 1), signal transducer and activator of transcription 3 (STAT3), and phosphorylated (p)-STAT3 was examined by RT-PCR, Western blotting, and immunohistochemical analysis.", {"entities": [[66, 69, "GENE"], [176, 181, "GENE"], [207, 212, "GENE"]]}], ["And the results showed that administration of L. acidophilus suppressed Th17 cell-mediated secretion of proinflammatory cytokine IL-17 through downregulation of IL-23 and TGF \u03b2 1 expression and downstream phosphorylation of p-STAT3.", {"entities": []}], ["Immunological cross talk between mucosal tissues such as the intestine and the lung is poorly defined during homeostasis and disease.", {"entities": []}], ["Here, we show that a low-dose infection with the intestinally restricted helminth parasite Trichuris muris results in the production of Th1 cell-dependent gamma interferon (IFN-\u03b3) and myeloid cell-derived interleukin-10 (IL-10) in the lung without causing overt airway pathology.", {"entities": []}], ["This cross-mucosal immune response in the lung inhibits the development of papain-induced allergic airway inflammation, an innate cell-mediated type 2 airway inflammatory disease.", {"entities": []}], ["Thus, we identify convergent and nonredundant roles of adaptive and innate immunity in mediating cross-mucosal suppression of type 2 airway inflammation during low-dose helminth-induced intestinal inflammation.", {"entities": []}], ["These results provide further insight in identifying novel intersecting immune pathways elicited by gut-to-lung mucosal cross talk.", {"entities": []}], ["We report on a 6-year-old Turkish boy with profound sensorineural deafness, balance disorder, severe disorder of oral motor function, and mild developmental delay.", {"entities": []}], ["Further findings included scaphocephaly, plagiocephaly, long palpebral fissures, high narrow palate, low-set posteriorly rotated ears, torticollis, hypoplastic genitalia and faulty foot posture.", {"entities": []}], ["Parents were consanguineous.", {"entities": []}], ["Computed tomography and magnetic resonance imaging showed bilateral single widened cochlear turn, narrowing of the internal auditory canal, and bilateral truncation of the vestibulo-cochlear nerve.", {"entities": []}], ["Microarray analysis and next generation sequencing showed a homozygous deletion of chromosome 5q31.1 spanning 115.3 kb and including three genes: NEUROG1 (encoding neurogenin 1), DCNP1 (dendritic cell nuclear protein 1, C5ORF20 ) and TIFAB (TIFA-related protein).", {"entities": [[146, 153, "GENE"], [220, 227, "GENE"]]}], ["The inability to chew and swallow, deafness and balance disorder represented congenital palsies of cranial nerves V (trigeminal nerve) and VIII (vestibulo-cochlear nerve) and thus a congenital cranial dysinnervation disorder.", {"entities": []}], ["Based on reported phenotypes of neurog1 null mutant mice and other vertebrates, we strongly propose NEUROG1 as the causative gene in this boy.", {"entities": [[32, 39, "GENE"], [100, 107, "GENE"], [32, 39, "GENE"], [100, 107, "GENE"]]}], ["The human NEUROG1 resides within the DFNB60 locus for non-syndromic autosomal recessive deafness on chromosome 5q22-q31, but linkage data have excluded it from being causative in the DFNB60 patients.", {"entities": [[10, 17, "GENE"]]}], ["Given its large size (35 Mb, >100 genes), the 5q22-q31 area could harbor more than one deafness gene.", {"entities": [[25, 27, "GENE"]]}], ["We propose NEUROG1 as a new gene for syndromic autosomal recessive hearing loss and congenital cranial dysinnervation disorder including cranial nerves V and VIII.", {"entities": [[11, 18, "GENE"]]}], ["The mechanisms underlying asthmatic airway epithelial injury are not clear.", {"entities": []}], ["12/15-lipoxygenase (an ortholog of human 15-LOX-1), which is induced by IL-13, is associated with mitochondrial degradation in reticulocytes at physiological conditions.", {"entities": []}], ["In this study, we showed that 12/15-LOX expressed in nonepithelial cells caused epithelial injury in asthma pathogenesis.", {"entities": [[101, 107, "DISEASE"]]}], ["While 12/15-LOX overexpression or IL-13 administration to na\u00efve mice showed airway epithelial injury, 12/15-LOX knockout/knockdown in allergic mice reduced airway epithelial injury.", {"entities": []}], ["The constitutive expression of 15-LOX-1 in bronchial epithelia of normal human lungs further indicated that epithelial 15-LOX-1 may not cause epithelial injury.", {"entities": []}], ["12/15-LOX expression is increased in various inflammatory cells in allergic mice.", {"entities": []}], ["Though non-epithelial cells such as macrophages or fibroblasts released 12/15-LOX metabolites upon IL-13 induction, bronchial epithelia didn't release.", {"entities": []}], ["Further 12-S-HETE, arachidonic acid metabolite of 12/15-LOX leads to epithelial injury.", {"entities": []}], ["These findings suggested 12/15-LOX expressed in non-epithelial cells such as macrophages and fibroblasts leads to bronchial epithelial injury.", {"entities": []}], ["Supplemental Digital Content is Available in the Text.", {"entities": []}], ["To evaluate effectiveness of a community health worker (CHW) program designed to address client objectives among frequent emergency department (ED) users.", {"entities": []}], ["Program evaluation using secondary analysis of client objectives from program records.", {"entities": []}], ["Client objectives were characterized according to the World Health Organization's social determinants of health framework.", {"entities": []}], ["Hierarchical generalized linear modeling was used to assess factors associated with objective achievement.", {"entities": []}], ["An ED and the surrounding community in an economically disadvantaged area of Buffalo, New York.", {"entities": []}], ["A total of 1600 adults over age 18 eligible for Medicaid and/or Medicare and who had at least 2 ED visits in the prior year.", {"entities": []}], ["Clients worked with CHWs in the community to identify diverse needs and objectives.", {"entities": []}], ["Community health workers provided individualized services to help achieve objectives.", {"entities": []}], ["Achievement of client-focused objectives.", {"entities": []}], ["Most objectives pertained to linkage to community resources and health care navigation, emphasizing chronic medical conditions and connection to primary care.", {"entities": []}], ["Clients and CHWs together achieved 43% of total objectives.", {"entities": []}], ["Objective achievement was positively associated with greater client engagement in CHW services.", {"entities": []}], ["Low objective achievement may stem from system- and policy-level barriers, such as lack of affordable housing and access to primary care.", {"entities": []}], ["Strategies for improving client engagement in CHW services are needed.", {"entities": []}], ["Community health workers and their clients were most successful in areas in which public health policies and systems made resources easy to access or where the program had formalized relationships with resources, such as primary care.", {"entities": []}], ["Long-term occupational exposure to cotton dust that contains endotoxin is associated with chronic respiratory symptoms and excessive decline in forced expiratory volume in 1 sec (FEV 1 ), but the mechanisms of endotoxin-related chronic airflow obstruction remain unclear.", {"entities": [[179, 182, "GENE"]]}], ["In the current study, we examined temporal aspects of the exposure\u2013response relationship between airborne endotoxin exposure, longitudinal change in FEV 1 , and respiratory symptoms in a cohort of Chinese cotton textile workers.", {"entities": [[149, 152, "GENE"]]}], ["This prospective cohort study followed 447 cotton textile workers from 1981 to 2006.at approximately 5-year intervals.", {"entities": []}], ["We used a generalized estimating equations approach to model FEV 1 level and respiratory symptoms as a function of past exposure (cumulative exposure up to the start of the most recent 5-year survey interval) and cumulative exposure (within the most recent interval) to endotoxins, after adjusting for other covariates.", {"entities": [[61, 64, "GENE"]]}], ["Models were stratified by active versus retired work status and by years employed before the baseline survey (< 5 and \u2265 5 years).", {"entities": []}], ["Past exposure to endotoxin was associated with reduced FEV 1 level among retired cotton workers.", {"entities": [[55, 58, "GENE"]]}], ["Among all cotton workers, past exposure was more strongly associated with reduced FEV 1 for those hired < 5 years before baseline than for those who were hired \u2265 5 years after baseline.", {"entities": [[82, 85, "GENE"]]}], ["Recent endotoxin exposure was significantly associated with byssinosis, chronic bronchitis, and chronic cough.", {"entities": [[60, 70, "DISEASE"], [80, 90, "DISEASE"]]}], ["Background .", {"entities": []}], ["The objective of this study was to conduct a systematic review of literature evaluating human resistin expression as a diagnostic factor in osteoarthritis development and to quantify the overall diagnostic effect.", {"entities": [[140, 154, "DISEASE"]]}], ["Relevant studies were identified and evaluated for quality through multiple search strategies.", {"entities": []}], ["Studies analyzing resistin expression in the development of OA were eligible for inclusion.", {"entities": []}], ["Data from eligible studies were extracted and included into the meta-analysis using a random-effects model.", {"entities": []}], ["Four case-control studies consisting of a total of 375 OA patients and 214 controls as well as three sex-stratified analyses composed of 53 males and 104 females were incorporated into our meta-analysis.", {"entities": []}], ["Our results revealed that resistin levels were significantly higher in male OA subjects and OA patients overall.", {"entities": []}], ["Country-stratified analysis yielded significantly different estimates in resistin levels between male OA subjects and female OA subjects in the Canadian subgroup but not among the French and USA subgroups.", {"entities": []}], ["Based on the resistin levels in OA cases and controls, resistin levels were heightened in OA patients in the Dutch population.", {"entities": []}], ["Conclusion .", {"entities": []}], ["These results support the hypothesis that high expression of resistin represents a significant and reproducible marker of poor progression in OA patients, especially in males.", {"entities": []}], ["The impact on patients suffering from chronic hand eczema (CHE) is enormous, as no licensed systemic treatment option with proven efficacy for CHE is available.", {"entities": []}], ["Alitretinoin is a novel agent which showed high clinical efficacy in patients with severe, refractory CHE.", {"entities": []}], ["We assessed the cost-effectiveness of alitretinoin for CHE patient treatment from a Swiss third party payer perspective.", {"entities": []}], ["A further objective of this study was to determine the burden of disease in Switzerland.", {"entities": []}], ["A long-term Markov cohort simulation model was used to estimate direct medical costs (\u20ac) and clinical effectiveness (quality adjusted life years, QALYs) of treating severe CHE patients with alitretinoin.", {"entities": []}], ["Comparison was against the standard treatment of supportive care (optimised emollient therapy).", {"entities": []}], ["Information on response rates were derived from a randomized controlled clinical trial.", {"entities": []}], ["Costs were considered from the perspective of the Swiss health system.", {"entities": []}], ["Swiss epidemiological data was derived from official Swiss Statistic institutions.", {"entities": []}], ["Annual costs of alitretinoin treatment accounted for \u20ac2'212.", {"entities": []}], ["After a time horizon of 22.4 years, average remaining long-term costs accounted for \u20ac42'208 or \u20ac38'795 in the alitretinoin and the standard treatment arm, respectively.", {"entities": []}], ["Compared with the standard therapy, the addition of alitretinoin yielded an average gain of 0.230 QALYs at the end of the simulation.", {"entities": []}], ["Accordingly, the incremental cost-effectiveness ratio resulted in \u20ac14'816/QALY gained.", {"entities": []}], ["These results were robust to changes in key model assumptions.", {"entities": []}], ["The therapy for CHE patients is currently insufficient.", {"entities": []}], ["In our long-term model we identified the treatment with alitretinoin as a cost-effective alternative for the therapy of CHE patients in Switzerland.", {"entities": []}], ["CD103+ and CD11b+ populations of CD11c+MHCIIhi murine dendritic cells (DCs) have been shown to carry antigens from the lung through the afferent lymphatics to mediastinal lymph nodes (MLN).", {"entities": [[184, 187, "GENE"]]}], ["We compared the responses of these two DC populations in neonatal and adult mice following intranasal infection with respiratory syncytial virus.", {"entities": []}], ["The response in neonates was dominated by functionally-limited CD103+ DCs, while CD11b+ DCs were diminished in both number and function compared to adults.", {"entities": []}], ["Infecting mice at intervals through the first three weeks of life revealed an evolution in DC phenotype and function during early life.", {"entities": []}], ["Using TCR transgenic T cells with two different specificities to measure the ability of CD103+ DC to induce epitope-specific CD8+ T cell responses, we found that neonatal CD103+ DCs stimulate proliferation in a pattern distinct from adult CD103+ DCs.", {"entities": []}], ["Blocking CD28-mediated costimulatory signals during adult infection demonstrated that signals from this costimulatory pathway influence the hierarchy of the CD8+ T cell response to RSV, suggesting that limited costimulation provided by neonatal CD103+ DCs is one mechanism whereby neonates generate a distinct CD8+ T cell response from that of adults.", {"entities": []}], ["Respiratory syncytial virus (RSV) infection is most severe in infants under six months and the most common cause of hospitalization for lower respiratory tract infection in children under five years.", {"entities": []}], ["Disease is a consequence of virus- and T-cell-mediated pathology.", {"entities": []}], ["Adaptive immune responses to viral respiratory infections are initiated by dendritic cells (DCs) that traffic to lymph nodes from the infected lungs.", {"entities": []}], ["We compared the phenotype and function of two lung-migratory DC populations, identified by high expression of MHC Class II and CD103+ (CD103+DCs) or CD11b+ (CD11b+DCs), in mice infected in early life or as adults.", {"entities": []}], ["We found that DC subsets undergo dramatic quantitative and qualitative changes during the first weeks of life, and CD103+DCs from neonatal mediastinal lymph nodes induced a fundamentally different CD8+ T-cell response profile than CD103+DCs from adults.", {"entities": []}], ["The adult response pattern required CD28-mediated costimulatory signals, which is a limiting functional property of neonatal CD103+DCs.", {"entities": []}], ["Thus, the ability of neonatal CD103+DCs to provide sufficient costimulation to neonatal CD8+ T-cells can influence the immunodominance hierarchy and functional properties of neonatal CD8+ T-cell responses compared to those of adults.", {"entities": []}], ["A better understanding of deficiencies in early life immunity will guide vaccine approaches that induce disease-sparing immune responses in infants.", {"entities": []}], ["Acid fog is complex and contains multiple stimuli that may be capable of inducing bronchoconstriction.", {"entities": []}], ["These stimuli include sulfuric and niric acids, the principal inorganic acids present; sulfites, formed in the atmosphere as a reaction product of sulfur dioxide and water droplets; fog water itself, a hypoosmolar aerosol; the organic acid hydroxymethanesulfonate, the bisulfite adduct of formaldehyde; and gaseous pollutants, e.g., sulfur dioxide, oxides of nitrogen, ozone.", {"entities": []}], ["Given this complexity, evaluation of the respiratory health effects of naturally occurring acid fog requires assessment of the bronchoconstrictor potency of each component stimulus and possible interactions among these stimuli.", {"entities": []}], ["We summarize the results of three studies that involve characterization of the bronchoconstrictor potency of acid fog stimuli and/or their interaction in subjects with asthma.", {"entities": [[168, 174, "DISEASE"]]}], ["The results of the first study indicate that titratable acidity appears to be a more important stimulus to bronchoconstriction than is pH.", {"entities": []}], ["The results of the second study demonstrate that sulfite species are capable of inducing bronchoconstriction, especially when inhaled at acid pH.", {"entities": []}], ["The results of the third study suggest that acidity can potentiate hypoosmolar fog-induced bronchoconstriction.", {"entities": []}], ["There is an ongoing debate concerning the risk benefit ratio of psychopharmacologic compounds.", {"entities": []}], ["With respect to the benefit, recent reports and meta-analyses note only small effect sizes with comparably high placebo response rates in the psychiatric field.", {"entities": []}], ["These reports together with others lead to a wider, general critique on psychotropic drugs in the scientific community and in the lay press.", {"entities": []}], ["In a recently published article, Leucht and his colleagues compare the efficacy of psychotropic drugs with the efficacy of common general medicine drugs in different indications according to results from reviewed meta-analyses.", {"entities": []}], ["The authors conclude that, overall, the psychiatric drugs were generally not less effective than most other medical drugs.", {"entities": []}], ["This article will highlight some of the results of this systematic review and discuss the limitations and the impact of this important approach on the above mentioned debate.", {"entities": []}], ["Mazindol has been proposed as a potential treatment of children with attention deficit/hyperactivity disorder (ADHD).", {"entities": []}], ["The purpose of this pilot study was to assess its pharmacokinetics, short-term efficacy, and safety.", {"entities": []}], ["A total of 24 children (aged 9\u201312 years) with ADHD (according to the Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition, text-revision criteria) received a daily dose of 1 mg for 7 days and were followed for 3 additional weeks.", {"entities": []}], ["Pharmacokinetic samples were collected after the first administration.", {"entities": []}], ["ADHD symptoms were assessed using the ADHD Rating Scale (RS)-IV, Conners\u2019 Parent Rating Scale \u2013 Revised: Long (CPRS-R:L) at screening, baseline, and the end of the study.", {"entities": []}], ["The Clinical Global Impression \u2013 Severity (CGI-S) scale was assessed at baseline, and the CGI \u2013 Improvement (CGI-I) scale was assessed at subsequent visits.", {"entities": []}], ["Twenty-one subjects (aged 10\u00b11 years) were analyzed.", {"entities": []}], ["Pharmacokinetic data were described by a one-compartment model with first-order absorption, elimination, and lag time.", {"entities": []}], ["The typical apparent clearance and apparent volume of distribution were 27.9 L/h and 234 L, and increased with fat-free mass and age, respectively.", {"entities": []}], ["The mean change in score in ADHD RS-IV after 1 week of mazindol was \u221224.1 ( P <0.0001), greater than a 90% improvement from baseline.", {"entities": []}], ["Reduction of CPRS-R:L and CGI-S scores were \u221252.1 ( P <0.0001) and \u22122.5 ( P <0.01), respectively.", {"entities": []}], ["Adverse events were mild to moderate, decreased appetite and upper abdominal pain being the most common.", {"entities": []}], ["This preliminary study shows that mazindol might be an effective, well-tolerated, and long-acting (more than 8 hours) agent for the treatment of ADHD in children.", {"entities": []}], ["Drug expenditures are responsible for an increasing proportion of health costs, accounting for $1.1 trillion in annual expenditure worldwide.", {"entities": []}], ["As hundreds of billions of dollars are being spent each year on overtreatment with prescribed medications that are either unnecessary or are in excess of lowest cost-effective therapy, programs are needed that optimize fiscally appropriate use.", {"entities": []}], ["We evaluated whether providing physicians with information on the patient out-of-pocket payment consequences of prescribing decisions that were in excess of lowest cost-effective therapy would alter prescribing decisions using the treatment of uncomplicated hypertension as an exemplar.", {"entities": [[258, 270, "DISEASE"]]}], ["A single-blind cluster randomized trial was conducted over a 60-month follow-up period in 76 primary care physicians in Quebec, Canada, and their patients with uncomplicated hypertension who were using the MOXXI integrated electronic health record for drug and health problem management.", {"entities": [[174, 186, "DISEASE"]]}], ["Physicians were randomized to an out-of-pocket expenditure module that provided alerts for comparative out-of-payment costs, thiazide diuretics as recommended first-line therapy, and tools to monitor blood pressure targets and medication compliance, or alternatively the basic MOXXI system.", {"entities": []}], ["System software and prescription claims were used to analyze the impact of the intervention on treatment choice, adherence, and overall and out-of-pocket payment costs using generalized estimating equations.", {"entities": []}], ["Three thousand five-hundred ninety-two eligible patients with uncomplicated hypertension were enrolled, of whom 1261 (35.1%) were newly started (incident patient) on treatment during follow-up.", {"entities": [[76, 88, "DISEASE"]]}], ["There was a statistically significant increase in the prescription of diuretics in the newly treated intervention (26.6%) compared to control patients (19.8%) (RR 1.65, 95% CI 1.17 to 2.33).", {"entities": []}], ["For patients already treated (prevalent patient), there was a statistically significant interaction between the intervention and patient age, with older patients being less likely to be switched to a diuretic.", {"entities": []}], ["Among the incident patients, physicians with less than 15\u00a0years of experience were much more likely to prescribe a diuretic (OR 10.69; 95% CI 1.49 to 76.64) than physicians with 15 to 25\u00a0years (OR 0.67; 95%CI 0.25 to 1.78), or more than 25\u00a0years of experience (OR 1.80; 95% CI 1.23 to 2.65).", {"entities": []}], ["There was no statistically significant effect of the intervention on adherence or out-of-pocket payment cost.", {"entities": []}], ["The provision of comparative information on patient out-of-pocket payments for treatment of uncomplicated hypertension had a statistically significant impact on increasing the initiation of diuretics in incident patients and switching to diuretics in younger prevalent patients.", {"entities": [[106, 118, "DISEASE"]]}], ["The impact of interventions to improve the cost-effectiveness of prescribing may be enhanced by also targeting patients with tools to participate in treatment decision-making and by providing physicians with comparative out-of-pocket information on all evidence-based alternatives that would enhance clinical decision-making.", {"entities": []}], ["ISRCTN96253624", {"entities": []}], ["In this retrospective cohort study using the Clinical Practice Research Datalink (CPRD), patients with sarcoidosis have an increased risk of clinical vertebral fractures and when on recent treatment with oral glucocorticoids, also an increased risk of any fractures and osteoporotic fractures.", {"entities": [[103, 114, "DISEASE"]]}], ["Sarcoidosis is a chronic inflammatory disease, in which fragility fractures have been reported despite normal BMD.", {"entities": [[0, 11, "DISEASE"]]}], ["The aim of this study was to assess whether patients with sarcoidosis have an increased risk of clinical fractures compared to the general population.", {"entities": [[58, 69, "DISEASE"]]}], ["A retrospective cohort study was conducted using the CPRD.", {"entities": []}], ["All patients with a CPRD code for sarcoidosis between January 1987 and September 2012 were included.", {"entities": [[34, 45, "DISEASE"]]}], ["Cox proportional hazards models were used to derive adjusted relative risks (RRs) of fractures in all sarcoidosis patients compared to matched controls, and within the sarcoidosis group according to use and dose of systemic glucocorticoids.", {"entities": [[102, 113, "DISEASE"], [168, 179, "DISEASE"]]}], ["Five thousand seven hundred twenty-two sarcoidosis patients (mean age 48.0\u00a0years, 51\u00a0% females, mean follow-up 6.7\u00a0years) were identified.", {"entities": [[39, 50, "DISEASE"]]}], ["Compared to 28,704 matched controls, the risk of any fracture was not different in patients with sarcoidosis.", {"entities": [[97, 108, "DISEASE"]]}], ["However, the risk of clinical vertebral fractures was significantly increased (adj RR 1.77; 95\u00a0% CI 1.06\u20132.96) and the risk of non-vertebral fractures was decreased although marginally significant (adj RR 0.87; 95\u00a0% CI 0.77\u20130.99).", {"entities": []}], ["Compared to sarcoidosis patients not taking glucocorticoids, recent use of systemic glucocorticoids was associated with an increased risk of any fracture (adj RR 1.50; 95\u00a0% CI 1.20\u20131.89) and of an osteoporotic fracture (adj RR 1.47; 95\u00a0% CI 1.07\u20132.02).", {"entities": [[12, 23, "DISEASE"]]}], ["Patients with sarcoidosis have an increased risk of clinical vertebral fractures, and when using glucocorticoid therapy, an increased risk of any fractures and osteoporotic fractures.", {"entities": [[14, 25, "DISEASE"]]}], ["In contrast, the risk of non-vertebral fractures maybe decreased.", {"entities": []}], ["Further investigation is needed to understand the underlying mechanisms of these contrasting effects on fracture risk.", {"entities": []}], ["The body first encounters deleterious inhaled substances, such as allergens, industrial particles, pollutants, and infectious agents, at the airway epithelium.", {"entities": []}], ["When this occurs, the epithelium and its resident inflammatory cells respond defensively by increasing production of cytokines, mucus, and reactive oxygen and nitrogen species (ROS/RNS).", {"entities": []}], ["As inflammation in the airway increases, additional infiltrating cells increase the level of these products.", {"entities": []}], ["Recent interest has focused on ROS/RNS as potential modulators of the expression of inflammation-associated genes important to the pathogenesis of various respiratory diseases.", {"entities": []}], ["ROS/RNS appear to play a variety of roles that lead to changes in expression of genes such as interleukin-6 and intercellular adhesion molecule 1.", {"entities": []}], ["By controlling this regulation, the reactive species can serve as exogenous stimuli, as intercellular signaling molecules, and as modulators of the redox state in epithelial cells.", {"entities": []}], ["Unraveling the molecular mechanisms affected by ROS/RNS acting in these capacities should aid in the understanding of how stimulated defense mechanisms within the airway can lead to disease.", {"entities": []}], ["Human MDA5 deficiency features recurrent severe human rhinovirus (HRV) infections.", {"entities": []}], ["MDA5 serves a protective and nonredundant role in protecting against HRV in the respiratory tract, through its effects on virus sensing and triggering of antiviral IFN signaling.", {"entities": []}], ["MDA5 is a cytosolic sensor of double-stranded RNA (ds)RNA including viral byproducts and intermediates.", {"entities": []}], ["We studied a child with life-threatening, recurrent respiratory tract infections, caused by viruses including human rhinovirus (HRV), influenza virus, and respiratory syncytial virus (RSV).", {"entities": [[134, 143, "DISEASE"]]}], ["We identified in her a homozygous missense mutation in IFIH1 that encodes MDA5.", {"entities": [[55, 60, "GENE"]]}], ["Mutant MDA5 was expressed but did not recognize the synthetic MDA5 agonist/(ds)RNA mimic polyinosinic-polycytidylic acid.", {"entities": []}], ["When overexpressed, mutant MDA5 failed to drive luciferase activity from the IFNB1 promoter or promoters containing ISRE or NF-\u03baB sequence motifs.", {"entities": [[77, 82, "GENE"]]}], ["In respiratory epithelial cells or fibroblasts, wild-type but not knockdown of MDA5 restricted HRV infection while increasing IFN-stimulated gene expression and IFN-\u03b2/\u03bb.", {"entities": []}], ["However, wild-type MDA5 did not restrict influenza virus or RSV replication.", {"entities": [[41, 50, "DISEASE"]]}], ["Moreover, nasal epithelial cells from the patient, or fibroblasts gene-edited to express mutant MDA5, showed increased replication of HRV but not influenza or RSV.", {"entities": [[146, 155, "DISEASE"]]}], ["Thus, human MDA5 deficiency is a novel inborn error of innate and/or intrinsic immunity that causes impaired (ds)RNA sensing, reduced IFN induction, and susceptibility to the common cold virus.", {"entities": [[175, 186, "DISEASE"]]}], ["Although it is known that patients with chronic obstructive pulmonary disease (COPD) generally do have an increased heart rate, the effects on both mortality and non-fatal pulmonary complications are unclear.", {"entities": [[40, 77, "DISEASE"]]}], ["We assessed whether heart rate is associated with all-cause mortality, and non-fatal pulmonary endpoints.", {"entities": []}], ["A prospective cohort study of 405 elderly patients with COPD was performed.", {"entities": []}], ["All patients underwent extensive investigations, including electrocardiography.", {"entities": []}], ["Follow-up data on mortality were obtained by linking the cohort to the Dutch National Cause of Death Register and information on complications (exacerbation of COPD or pneumonia) by scrutinizing patient files of general practitioners.", {"entities": [[168, 177, "DISEASE"]]}], ["Multivariable cox regression analysis was performed.", {"entities": []}], ["During the follow-up 132 (33%) patients died.", {"entities": []}], ["The overall mortality rate was 50/1000 py (42\u201359).", {"entities": []}], ["The major causes of death were cardiovascular and respiratory.", {"entities": []}], ["The relative risk of all-cause mortality increased with 21% for every 10 beats/minute increase in heart rate (adjusted HR: 1.21 [1.07\u20131.36], p\u200a=\u200a0.002).", {"entities": [[119, 121, "GENE"]]}], ["The incidence of major non-fatal pulmonary events was 145/1000 py (120\u2013168).", {"entities": []}], ["The risk of a non-fatal pulmonary complication increased non-significantly with 7% for every 10 beats/minute increase in resting heart rate (adjusted HR: 1.07 [0.96\u20131.18], p\u200a=\u200a0.208).", {"entities": [[150, 152, "GENE"]]}], ["Increased resting heart rate is a strong and independent risk factor for all-cause mortality in elderly patients with COPD.", {"entities": []}], ["An increased resting heart rate did not result in an increased risk of exacerbations or pneumonia.", {"entities": [[88, 97, "DISEASE"]]}], ["This may indicate that the increased mortality risk of COPD is related to non-pulmonary causes.", {"entities": []}], ["Future randomized controlled trials are needed to investigate whether heart-rate lowering agents are worthwhile for COPD patients.", {"entities": []}], ["Parental smoking and prone sleep positioning are recognized causal features of Sudden Infant Death.", {"entities": []}], ["This study quantifies the relationship between prenatal smoking and infant death over the time period of the Back to Sleep campaign in the United States, which encouraged parents to use a supine sleeping position for infants.", {"entities": []}], ["This retrospective cohort study utilized the Colorado Birth Registry.", {"entities": []}], ["All singleton, normal birth weight infants born from 1989 to 1998 were identified and linked to the Colorado Infant Death registry.", {"entities": []}], ["Multivariable logistic regression was used to analyze the relationship between outcomes of interest and prenatal maternal cigarette use.", {"entities": []}], ["Potential confounders analyzed included infant gender, gestational age, and birth year as well as maternal marital status, ethnicity, pregnancy interval, age, education, and alcohol use.", {"entities": []}], ["We analyzed 488,918 birth records after excluding 5835 records with missing smoking status.", {"entities": []}], ["Smokers were more likely to be single, non-Hispanic, less educated, and to report alcohol use while pregnant (p < 0.001).", {"entities": []}], ["The study included 598 SIDS cases of which 172 occurred in smoke-exposed infants.", {"entities": []}], ["Smoke exposed infants were 1.9 times (95% CI 1.6 to 2.3) more likely to die of SIDS.", {"entities": []}], ["The attributed risk associating smoking and SIDS increased during the study period from approximately 50% to 80%.", {"entities": []}], ["During the entire study period 59% (101/172) of SIDS deaths in smoke-exposed infants were attributed to maternal smoking.", {"entities": []}], ["Due to a decreased overall rate of SIDS likely due to changing infant sleep position, the attributed risk associating maternal smoking and SIDS has increased following the Back to Sleep campaign.", {"entities": []}], ["Mothers should be informed of the 2-fold increased rate of SIDS associated with maternal cigarette consumption.", {"entities": []}], ["Children with sickle cell disease (SCD) are susceptible to recurrent infections, which are often life threatening and necessitate frequent vaccinations.", {"entities": [[35, 38, "GENE"]]}], ["Given the altered baseline immunity and proinflammatory state associated with SCD, we sought to determine the relative safety and efficacy of vaccination in transgenic SCD mice.", {"entities": [[78, 81, "GENE"], [168, 171, "GENE"], [78, 81, "GENE"], [168, 171, "GENE"]]}], ["Eight week-old SCD mice were vaccinated with ovalbumin (OVA) and aluminum hydroxide weekly for three weeks by the intraperitoneal (IP) or intramuscular (IM) route.", {"entities": [[15, 18, "GENE"]]}], ["One week after the third vaccination, serum cytokines/chemokines, immunoglobulins, and bronchoalveolar lavage (BAL) fluid cytokines were measured.", {"entities": []}], ["Only SCD mice were prone to mortality associated with vaccination as 40% of the animals died after the IP vaccinations and 50% died after the IM vaccinations.", {"entities": [[5, 8, "GENE"]]}], ["Serum IgG2b and IgM were significantly lower in SCD than C57Bl/6 mice after vaccination, but OVA-specific IgE was significantly higher.", {"entities": [[48, 51, "GENE"]]}], ["Serum interleukin 1 alpha (IL-1\u03b1), IL-2, IL-5, macrophage inflammatory protein 1 alpha (MIP-1\u03b1), and granulocyte macrophage-colony stimulating factor (GM-CSF) were significantly lower in SCD mice than C57Bl/6 mice after vaccination, whereas BAL fluid IL-1\u03b2 and IL-6 were elevated.", {"entities": [[187, 190, "GENE"]]}], ["Mice with SCD appear to have a dysregulated immune response to vaccination.", {"entities": [[10, 13, "GENE"]]}], ["Thus, the relative safety and immunogenicity of vaccination should be studied in greater detail in the context of SCD.", {"entities": [[114, 117, "GENE"]]}], ["This study was performed to evaluate the antimicrobial activities of extracts of Bidens pilosa, Galinsoga ciliata, and Eryngium foetidum against 6 clinical strains of Helicobacter pylori in vitro and in vivo .", {"entities": []}], ["Broth microdilution method was used in vitro .", {"entities": []}], ["In vivo , Swiss mice were inoculated with H .", {"entities": []}], ["pylori and divided into 5 groups; the control group received the vehicle and the four others received 125, 250, and 500\u2009mg/kg of methanol extract of Eryngium foetidum and ciprofloxacin (500\u2009mg/kg) for 7 days, respectively.", {"entities": []}], ["Helicobacter pylori colonization and number of colonies in gastric biopsies culture were assessed on days 1 and 7 after treatment.", {"entities": []}], ["The lowest MIC value (64\u2009 \u03bc g/mL) and the best spectrum of bactericidal effect (MBC/MIC = 1) were obtained with the methanol extract of Eryngium foetidum .", {"entities": []}], ["The number of H .", {"entities": []}], ["pylori infected animals was 17% (plant-extract) and 0% (ciprofloxacin) compared to 100% for the infected untreated group.", {"entities": []}], ["Plant-extract (381.9 \u00b1 239.5\u2009CFU) and ciprofloxacin (248 \u00b1 153.2\u2009CFU) significantly reduced bacterial load in gastric mucosa compared to untreated, inoculated mice (14350 \u00b1 690\u2009CFU).", {"entities": []}], ["Conclusion .", {"entities": []}], ["The present data provided evidence that methanol extract of Eryngium foetidum could be a rich source of metabolites with antimicrobial activity to fight Helicobacter pylori infections.", {"entities": []}], ["Delayed patient admission to the intensive care unit (ICU) due to lack of bed availability is a common problem, but the effect on patient outcome is not fully known.", {"entities": []}], ["A retrospective study was performed using departmental computerised records to determine the effect of delayed ICU admission and temporary management within the operating theatre suite on patient outcome.", {"entities": []}], ["Emergency surgical and medical patients admitted to the ICU (2003 to 2007) were divided into delay (more than three hours from referral to admission) and no-delay (three or fewer hours from referral to admission) groups.", {"entities": []}], ["Our primary outcome measure was length of ICU stay.", {"entities": []}], ["Secondary outcome measures were mortality rates and duration of organ support.", {"entities": []}], ["A total of 1,609 eligible patients were included and 149 (9.3%) had a delayed admission.", {"entities": []}], ["The delay and no-delay groups had similar baseline characteristics.", {"entities": []}], ["Median ICU stay was 5.1 days (delay) and 4.5 days (no-delay) ( P = 0.55) and ICU mortality was 26.8% (delay) and 24.2% (no-delay) ( P = 0.47).", {"entities": []}], ["Following adjustment for demographic and baseline characteristics there was no difference in either length of ICU stay or mortality rates between groups.", {"entities": []}], ["ICU admission delay was associated with both an increased requirement for advanced respiratory support (92.3% delay vs. 76.4% no-delay, P <0.01) and a longer time spent ventilated (median four days delay vs. three days no-delay, P = 0.04).", {"entities": []}], ["No significant difference in length of ICU stay or mortality rate was demonstrated between the delay and no-delay cohorts.", {"entities": []}], ["Patients within the delay group had a significantly greater requirement for advanced respiratory support and spent a longer time ventilated.", {"entities": []}], ["Recent trials demonstrate increased pneumonia risk in chronic obstructive pulmonary disease patients treated with the inhaled corticosteroid (ICS) fluticasone propionate (FP).", {"entities": [[36, 45, "DISEASE"], [54, 91, "DISEASE"]]}], ["There is limited work describing FP effects on host defenses against bacterial pneumonia.", {"entities": [[79, 88, "DISEASE"], [69, 88, "DISEASE"]]}], ["C57BL/6 mice received daily, nose-only exposure to nebulized FP or vehicle for 8\u2009days, followed by pulmonary challenge with Klebsiella pneumoniae .", {"entities": []}], ["Bacterial burden, phagocytosis, leukocyte recruitment, cytokine expression, nitric oxide release, and survival were measured.", {"entities": []}], ["Inhaled FP increased bacterial burden in lungs and blood 48\u2009h after infection but affected neither in vivo phagocytosis of bacteria by alveolar macrophages (AM) nor alveolar neutrophil recruitment.", {"entities": []}], ["AM from FP-treated mice showed impaired expression of infection induced TNF-alpha, IP-10 (CXCL-10), and interleukin 6 (IL-6), and AM also showed a trend towards impaired intracellular pathogen control following in vivo infection.", {"entities": []}], ["In vitro FP treatment resulted in a dose-dependent impairment of cytokine expression by AM.", {"entities": []}], ["Furthermore, infection-induced nitric oxide (but not hydrogen peroxide) production was impaired by FP in vivo and in vitro.", {"entities": []}], ["FP decreased survival in this model.", {"entities": []}], ["Exposure to inhaled FP impairs pulmonary clearance of K. pneumoniae in mice, an effect associated with greater systemic bacteremia and death.", {"entities": []}], ["Decreased AM cytokine and nitric oxide expression parallel the failure to control infection.", {"entities": []}], ["These results support the study of ICS effects on human pulmonary host defenses.", {"entities": []}], ["Non-invasive ventilation (NIV) has been used for decades in treatment of exacerbations of chronic obstructive pulmonary disease (COPD).", {"entities": [[90, 127, "DISEASE"]]}], ["The impact of the changing use of assisted ventilation in acute exacerbations on outcomes has not been fully elucidated and we aimed to describe these changes in the Danish population and describe their consequences for mortality.", {"entities": []}], ["A register-based study was conducted of a cohort of 12,847 patients admitted for acute exacerbation of COPD (AECOPD) from 2004 through 2011, treated with invasive mechanical ventilation (IMV) or NIV for the first time.", {"entities": []}], ["Age, sex, in-hospital mortality rates, time to death or readmission for AECOPD were established and changes over time tracked.", {"entities": []}], ["The number of admissions for AECOPD where assisted ventilation was used was 1,130 in 2004 and had increased by 145% in 2011.", {"entities": []}], ["First time ventilations increased by 88%.", {"entities": []}], ["This was mainly due to an increase in use of NIV accounting for 36% of the total number of assisted ventilations in 2004 and 67% in 2011.", {"entities": []}], ["The number of IMV with or without NIV treatments remained constant.", {"entities": []}], ["The mean age of NIV patients increased from 71.5 to 73.6 years, but remained constant at 70.0 years in IMV patients.", {"entities": []}], ["Mortality rates both in hospital and after discharge for patients receiving NIV remained constant throughout the period.", {"entities": []}], ["In-hospital mortality following IMV increased from 30% to 38%, but mortality after discharge remained stable.", {"entities": []}], ["Assisted ventilation has been increasingly used in a broader spectrum of AECOPD patients since the introduction of NIV.", {"entities": []}], ["The changes in treatment strategies have been followed by shifts in in-hospital mortality rates following IMV.", {"entities": []}], ["The current lack of pharmacological treatments for cannabis use disorder (CUD) warrants novel approaches and further investigation of promising pharmacotherapy.", {"entities": []}], ["We previously showed that nabiximols (27 mg/ml \u0394 Subjects participated in a double blind randomized clinical trial, with as-needed nabiximols up to 113.4 mg THC/105 mg CBD or placebo daily for 12 weeks, concurrently with Motivational Enhancement Therapy and Cognitive Behavioral Therapy (MET/CBT).", {"entities": []}], ["Primary outcome measures were tolerability and abstinence, secondary outcome measures were days and amount of cannabis use, withdrawal, and craving scores.", {"entities": []}], ["Participants received up to CDN$ 855 in compensation for their time.", {"entities": []}], ["Medication was well tolerated and no serious adverse events (SAEs) were observed.", {"entities": []}], ["Rates of adverse events did not differ between treatment arms (F 1,39 = 0.205, NS).", {"entities": []}], ["There was no significant change in abstinence rates at trial end.", {"entities": []}], ["Participants were not able to differentiate between subjective effects associated with nabiximols or placebo treatments (F 1,40 = 0.585, NS).", {"entities": []}], ["Cannabis use was reduced in the nabiximols (70.5%) and placebo groups (42.6%).", {"entities": []}], ["Nabiximols reduced cannabis craving but no significant differences between the nabiximols and placebo groups were observed on withdrawal scores.", {"entities": []}], ["Nabiximols in combination with MET/CBT was well tolerated and allowed for reduction of cannabis use.", {"entities": []}], ["Future clinical trials should explore the potential of high doses of nabiximols for cannabis dependence.", {"entities": [[84, 103, "DISEASE"]]}], ["The research and development of new electronic-nose applications in the biomedical field has accelerated at a phenomenal rate over the past 25 years.", {"entities": []}], ["Many innovative e-nose technologies have provided solutions and applications to a wide variety of complex biomedical and healthcare problems.", {"entities": []}], ["The purposes of this review are to present a comprehensive analysis of past and recent biomedical research findings and developments of electronic-nose sensor technologies, and to identify current and future potential e-nose applications that will continue to advance the effectiveness and efficiency of biomedical treatments and healthcare services for many years.", {"entities": []}], ["An abundance of electronic-nose applications has been developed for a variety of healthcare sectors including diagnostics, immunology, pathology, patient recovery, pharmacology, physical therapy, physiology, preventative medicine, remote healthcare, and wound and graft healing.", {"entities": []}], ["Specific biomedical e-nose applications range from uses in biochemical testing, blood-compatibility evaluations, disease diagnoses, and drug delivery to monitoring of metabolic levels, organ dysfunctions, and patient conditions through telemedicine.", {"entities": []}], ["This paper summarizes the major electronic-nose technologies developed for healthcare and biomedical applications since the late 1980s when electronic aroma detection technologies were first recognized to be potentially useful in providing effective solutions to problems in the healthcare industry.", {"entities": []}], ["Regulatory T (Treg) cells, which suppress autoimmunity and other inflammatory states, are characterized by a distinct set of genetic elements controlling their gene expression.", {"entities": []}], ["However, the extent of genetic and associated epigenetic variation in the Treg cell lineage and its possible relation to disease states in humans remain unknown.", {"entities": []}], ["We explored evolutionary conservation of regulatory elements and natural human inter-individual epigenetic variation in Treg cells to identify the core transcriptional control program of lineage specification.", {"entities": []}], ["Analysis of single nucleotide polymorphisms in core lineage-specific enhancers revealed disease associations, which were further corroborated by high-resolution genotyping to fine map causal polymorphisms in lineage-specific enhancers.", {"entities": []}], ["Our findings suggest that a small set of regulatory elements specify the Treg lineage and that genetic variation in Treg cell-specific enhancers may alter Treg cell function contributing to polygenic disease.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.07571.001 The immune system protects the body from infection.", {"entities": []}], ["Key to this protection is the ability to mount an immune response that is sufficient to deal with the threat, but is not so large that the damage it causes to the body exceeds its immediate benefit.", {"entities": []}], ["Immune cells called regulatory T cells (or Treg cells for short) help to shut down the immune response after a threat has been successfully destroyed.", {"entities": []}], ["They also prevent the immune system from attacking the body's own cells, a phenomenon known as autoimmunity.", {"entities": []}], ["All cells in the body carry the same set of genes, but the activity of these genes varies between cell types to enable the cells to perform their different jobs.", {"entities": []}], ["This is possible because our DNA contains regions called regulatory elements that can control the expression of particular genes.", {"entities": []}], ["These regions can be activated in specific types of cells, which results in specific chemical modifications to DNA that only affect gene activity in those cells.", {"entities": []}], ["The DNA sequences of these regulatory elements vary between individuals.", {"entities": []}], ["This \u2018genetic variation\u2019 can lead to differences in the chemical modifications that occur to DNA, which is known as epigenetic variation.", {"entities": []}], ["This means that Treg cells in one person may work in a different way to those in another individual, which could make some individuals more susceptible to autoimmune diseases than others.", {"entities": []}], ["However, it was not clear how much genetic and epigenetic variation exists in Treg cells.", {"entities": []}], ["Here, Arvey et al.", {"entities": []}], ["examined Treg and other immune cells from human and mouse donors.", {"entities": []}], ["The experiments show that some of the epigenetic modifications present in many individuals only in Treg cells, which indicates that they may be important for the activity of the Treg cells.", {"entities": []}], ["Unexpectedly, most of the epigenetic modifications were specific to either mice or humans, but Arvey et al.", {"entities": []}], ["identified a core set of genes that had been modified only in Treg cells in both species.", {"entities": []}], ["In the human cells, Arvey et al.", {"entities": []}], ["also identified genetic differences in regulatory elements that are associated with autoimmune diseases.", {"entities": []}], ["Arvey et al.", {"entities": []}], ["'s findings suggest that a small set of regulatory elements are crucial to the role of Treg cells in the immune system.", {"entities": []}], ["Furthermore, genetic variation in these elements can lead to epigenetic changes in Treg cells that contribute to autoimmune diseases in humans.", {"entities": []}], ["Further study may lead to the development of new treatments for these diseases.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.07571.002", {"entities": []}], ["Developing novel uses of approved drugs, called drug repositioning, can reduce costs and times in traditional drug development.", {"entities": []}], ["Network-based approaches have presented promising results in this field.", {"entities": []}], ["However, even though various types of interactions such as activation or inhibition exist in drug-target interactions and molecular pathways, most of previous network-based studies disregarded this information.", {"entities": []}], ["We developed a novel computational method, Prediction of Drugs having Opposite effects on Disease genes (PDOD), for identifying drugs having opposite effects on altered states of disease genes.", {"entities": []}], ["PDOD utilized drug-drug target interactions with \u2018effect type\u2019, an integrated directed molecular network with \u2018effect type\u2019 and \u2018effect direction\u2019, and disease genes with regulated states in disease patients.", {"entities": []}], ["With this information, we proposed a scoring function to discover drugs likely to restore altered states of disease genes using the path from a drug to a disease through the drug-drug target interactions, shortest paths from drug targets to disease genes in molecular pathways, and disease gene-disease associations.", {"entities": []}], ["We collected drug-drug target interactions, molecular pathways, and disease genes with their regulated states in the diseases.", {"entities": []}], ["PDOD is applied to 898 drugs with known drug-drug target interactions and nine diseases.", {"entities": []}], ["We compared performance of PDOD for predicting known therapeutic drug-disease associations with the previous methods.", {"entities": []}], ["PDOD outperformed other previous approaches which do not exploit directional information in molecular network.", {"entities": []}], ["In addition, we provide a simple web service that researchers can submit genes of interest with their altered states and will obtain drugs seeming to have opposite effects on altered states of input genes at http://gto.kaist.ac.kr/pdod/index.php/main .", {"entities": []}], ["Our results showed that \u2018effect type\u2019 and \u2018effect direction\u2019 information in the network based approaches can be utilized to identify drugs having opposite effects on diseases.", {"entities": []}], ["Our study can offer a novel insight into the field of network-based drug repositioning.", {"entities": []}], ["The online version of this article (doi:10.1186/s12918-015-0243-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["High altitude pulmonary edema (HAPE) affects individuals and is characterized by alveolar flooding with protein-rich edema as a consequence of blood-gas barrier disruption.", {"entities": [[14, 29, "DISEASE"]]}], ["In this study, we hypothesized that aquaporin 5 (AQP5) which is one kind of water channels may play a role in preservation of alveolar epithelial barrier integrity in high altitude pulmonary edema (HAPE).", {"entities": [[181, 196, "DISEASE"], [49, 53, "GENE"]]}], ["Therefore, we established a model in Wildtype mice and AQP5 \u2212/\u2212 mice were assingned to normoxic rest (NR), hypoxic rest (HR) and hypoxic exercise (HE) group.", {"entities": [[55, 59, "GENE"], [121, 123, "GENE"]]}], ["Mice were produced by training to walk at treadmill for exercising and chamber pressure was reduced to simulate climbing an altitude of 5000\u00a0m for 48\u00a0hours.", {"entities": []}], ["Studies using BAL in HAPE mice to demonstrated that edema is caused leakage of albumin proteins and red cells across the alveolarcapillary barrier in the absence of any evidence of inflammation.", {"entities": []}], ["In this study, the Lung wet/dry weight ratio and broncholalveolar lavage protein concentrations were slightly increased in HE AQP5 \u2212/\u2212 mice compared to wildtype mice.", {"entities": [[126, 130, "GENE"]]}], ["And histologic evidence of hemorrhagic pulmonary edema was distinctly shown in HE group.", {"entities": [[39, 54, "DISEASE"]]}], ["The lung Evan\u2019s blue permeability of HE group was showed slightly increased compare to the wildtype groups, and HR group was showed a medium situation from normal to HAPE development compared with NR and HE group.", {"entities": [[112, 114, "GENE"]]}], ["Deletion of AQP5 slightly increased lung edema and lung injury compared to wildtype mice during HAPE development, which suggested that the AQP5 plays an important role in HAPE formation induced by high altitude simulation.", {"entities": [[12, 16, "GENE"], [139, 143, "GENE"], [12, 16, "GENE"], [139, 143, "GENE"]]}], ["Exposure to flour dust can be found in the food industry and animal feed production.", {"entities": []}], ["It may result in various adverse health outcomes from conjunctivitis to baker's asthma.", {"entities": [[54, 68, "DISEASE"], [80, 86, "DISEASE"]]}], ["In this paper, flour dust exposure in the above-mentioned occupational environments is characterized and its health effects are discussed.", {"entities": []}], ["A peer-reviewed literature search was carried out and all available published materials were included if they provided information on the above-mentioned elements.", {"entities": []}], ["The hitherto conducted studies show that different components of flour dust like enzymes, proteins and baker's additives can cause both non-allergic and allergic reactions among exposed workers.", {"entities": []}], ["Moreover, the problem of exposure to cereal allergens present in flour dust can also be a concern for bakers\u2019 family members.", {"entities": []}], ["Appreciating the importance of all these issues, the exposure assessment methods, hygienic standards and preventive measures are also addressed in this paper.", {"entities": []}], ["Despite being legally available in India since 1971, barriers to safe and legal abortion remain, and unsafe and/or illegal abortion continues to be a problem.", {"entities": []}], ["Community health workers have been involved in improving access to health information and care for maternal and child health in resource poor settings, but their role in facilitating accurate information about and access to safe abortion has been relatively unexplored.", {"entities": []}], ["A qualitative study was conducted in Rajasthan, India to study acceptability, perspectives and preferences of women and community health workers, regarding the involvement of community health workers in medical abortion referrals.", {"entities": []}], ["In-depth interviews were conducted with 24 women seeking early medical abortion at legal abortion facilities or presenting at these facilities for a follow-up assessment after medical abortion.", {"entities": []}], ["Ten community health workers who were trained to assess eligibility for early medical abortion and/or to assess whether women needed a follow-up visit after early medical abortion were also interviewed.", {"entities": []}], ["The transcripts were coded using ATLAS-ti 7 (version 7.1.4) in the local language and reports were generated for all the codes, emerging themes were identified and the findings were analysed.", {"entities": []}], ["Community health workers (CHWs) were willing to play a role in assessing eligibility for medical abortion and in identifying women who are in need of follow-up care after early medical abortion, when provided with appropriate training, regular supplies and job aids.", {"entities": []}], ["Women however had apprehensions about contacting CHWs in relation to abortions.", {"entities": []}], ["Important barriers that prevented women from seeking information and assistance from community health workers were fear of breach of confidentiality and a perception that they would be pressurised to undergo sterilisation.", {"entities": []}], ["Our findings support a potential for greater role of CHWs in making safe abortion information and services accessible to women, while highlighting the need to address women\u2019s concerns about approaching CHWs in case of unwanted pregnancy.", {"entities": []}], ["Further intervention research would be needed to shed light on the effectiveness of role of CHWs in facilitating access to safe abortion and to outline specific components in a programme setting.", {"entities": []}], ["Not applicable.", {"entities": []}], ["Objectives: The U.S. Environmental Protection Agency is working toward gaining a better understanding of the human health impacts of exposure to complex air pollutant mixtures and the key features that drive the toxicity of these mixtures, which can then be used for future scientific and risk assessments.", {"entities": []}], ["Data sources: A public workshop was held in Chapel Hill, North Carolina, 22\u201324 February 2011, to discuss scientific issues and data gaps related to adopting multipollutant science and risk assessment approaches, with a particular focus on the criteria air pollutants.", {"entities": []}], ["Expert panelists in the fields of epidemiology, toxicology, and atmospheric and exposure sciences led open discussions to encourage workshop participants to think broadly about available and emerging scientific evidence related to multipollutant approaches to evaluating the health effects of air pollution.", {"entities": []}], ["Synthesis: Although there is clearly a need for novel research and analytical approaches to better characterize the health effects of multipollutant exposures, much progress can be made by using existing scientific information and statistical methods to evaluate the effects of single pollutants in a multipollutant context.", {"entities": []}], ["This work will have a direct impact on the development of a multipollutant science assessment and a conceptual framework for conducting multipollutant risk assessments.", {"entities": []}], ["Conclusions: Transitioning to a multipollutant paradigm can be aided through the adoption of a framework for multipollutant science and risk assessment that encompasses well-studied and ubiquitous air pollutants.", {"entities": []}], ["Successfully advancing methods for conducting these assessments will require collaborative and parallel efforts between the scientific and environmental regulatory and policy communities.", {"entities": []}], ["Care for patients with complex chronic conditions such as diabetes requires a coordinated and collaborative team working in partnership with the patient.", {"entities": []}], ["Israel has taken important steps forward with the development of structured diabetes follow-up by Clalit Health Services, including several measures of diabetes care in the National Program for Quality Indicators in Community Healthcare, and efforts to develop health information exchange and measures of continuity between hospital and community-based care.", {"entities": []}], ["Achieving even better results will require purposeful development of health care teams to meet the needs of patients with single and multiple chronic conditions, including robust interprofessional education programs for the next generation of health professionals, and developing partnerships between the teams and the patients.", {"entities": []}], ["Frailty, a validated measure of physiologic reserve, predicts adverse health outcomes among adults with end-stage renal disease.", {"entities": []}], ["Frailty typically is not measured clinically; instead, a surrogate\u2014perceived frailty\u2014is used to inform clinical decision-making.", {"entities": []}], ["Because correlations between perceived and measured frailty remain unknown, the aim of this study was to assess their relationship.", {"entities": []}], ["146 adults undergoing hemodialysis were recruited from a single dialysis center in Baltimore, Maryland.", {"entities": []}], ["Patient characteristics associated with perceived (reported by nephrologists, nurse practitioners (NPs), or patients) or measured frailty (using the Fried criteria) were identified using ordered logistic regression.", {"entities": [[99, 102, "GENE"]]}], ["The relationship between perceived and measured frailty was assessed using percent agreement, kappa statistic, Pearson\u2019s correlation coefficient, and prevalence of misclassification of frailty.", {"entities": []}], ["Patient characteristics associated with misclassification were determined using Fisher\u2019s exact tests, t-tests, or median tests.", {"entities": []}], ["Older age (adjusted OR [aOR]\u2009=\u20091.36, 95%CI:1.11-1.68, P\u2009=\u20090.003 per 5-years older) and comorbidity (aOR\u2009=\u20091.49, 95%CI:1.27-1.75, P\u2009<\u20090.001 per additional comorbidity) were associated with greater likelihood of nephrologist-perceived frailty.", {"entities": []}], ["Being non-African American was associated with greater likelihood of NP- (aOR\u2009=\u20095.51, 95%CI:3.21-9.48, P\u2009=\u20090.003) and patient- (aOR\u2009=\u20094.20, 95%CI:1.61-10.9, P\u2009=\u20090.003) perceived frailty.", {"entities": []}], ["Percent agreement between perceived and measured frailty was poor (nephrologist, NP, and patient: 64.1%, 67.0%, and 55.5%).", {"entities": []}], ["Among non-frail participants, 34.4%, 30.0%, and 31.6% were perceived as frail by a nephrologist, NP, or themselves.", {"entities": []}], ["Older adults (P\u2009<\u20090.001) were more likely to be misclassified as frail by a nephrologist; women (P\u2009=\u20090.04) and non-African Americans (P\u2009=\u20090.02) were more likely to be misclassified by an NP.", {"entities": []}], ["Neither age, sex, nor race was associated with patient misclassification.", {"entities": []}], ["Perceived frailty is an inadequate proxy for measured frailty among patients undergoing hemodialysis.", {"entities": []}], ["Throughout the centuries, scientific observers have endeavoured to extend their knowledge of the interrelationships between the brain and its regulatory control of human emotions and behaviour.", {"entities": []}], ["Since the time of physicians such as Aristotle and Galen and the more recent observations of clinicians and neuropathologists such as Broca, Papez, and McLean, the field of affective neuroscience has matured to become the province of neuroscientists, neuropsychologists, neurologists, and psychiatrists.", {"entities": []}], ["It is accepted that the prefrontal cortex, amygdala, anterior cingulate cortex, hippocampus, and insula participate in the majority of emotional processes.", {"entities": []}], ["New imaging technologies and molecular biology discoveries are expanding further the frontiers of knowledge in this arena.", {"entities": []}], ["The advancements of knowledge on the interplay between the human brain and emotions came about as the legacy of the pioneers mentioned in this field.", {"entities": []}], ["The aim of this paper is to describe the historical evolution of the scientific understanding of interconnections between the human brain, behaviour, and emotions.", {"entities": []}], ["In this commentary, recent papers covering pandemic influenza, acute respiratory distress syndrome and cardiovascular issues are discussed.", {"entities": [[52, 61, "DISEASE"], [90, 98, "DISEASE"]]}], ["Assessment of thromboembolic risk is crucial for proper management of atrial fibrillation (AF) patients.", {"entities": []}], ["Currently used risk score base only on scarce clinical data and do not take into consideration parameters including echocardiographic findings.", {"entities": []}], ["The aim of this study was to evaluate if left atrium (LA) enlargement is associated with higher thromboembolic risk assessed by CHADS 2 and CHA 2 DS 2 -VASc scores in a cohort of unselected non-valvular AF patients.", {"entities": []}], ["Data from 582 AF hospitalizations occurring between November 2012 and January 2014 were analyzed.", {"entities": []}], ["All patients underwent a standard transthoracic echocardiography and had their thromboembolic risk assessed in both CHADS 2 and CHA 2 DS 2 -VASc scores.", {"entities": []}], ["In 494 enrolled patients (48.5\u00a0% male; mean age 73.4\u00a0\u00b1\u00a011.5\u00a0years) AF was classified as paroxysmal in 233 (47.3\u00a0%), as persistent in 109 (22.1\u00a0%), and as permanent in 151 (30.6\u00a0%) patients.", {"entities": []}], ["LA was enlarged in 426 (86.2\u00a0%) patients.", {"entities": []}], ["Enlargement was classified as mild in 99 (20.0\u00a0%) patients, as moderate in 130 (26.3\u00a0%) patients, and as severe in 196 (39.7\u00a0%) patients.", {"entities": []}], ["Patients with enlarged LA had higher mean CHADS 2 score (2.0\u00a0\u00b1\u00a01.5 vs. 2.6\u00a0\u00b1\u00a01.3; p \u00a0=\u00a00.0005) and CHA 2 DS 2 -VASc (3.8\u00a0\u00b1\u00a02.0 vs. 4.4\u00a0\u00b1\u00a01.8; p \u00a0=\u00a00.02) score than patients with normal LA.", {"entities": []}], ["The both mean scores rose along with rising LA diameter.", {"entities": []}], ["LA enlargement is highly prevalent in AF patients.", {"entities": []}], ["Higher thromboembolic risk assessed by both CHADS 2 and CHA 2 DS 2 -VASc scores is associated with presence of LA enlargement.", {"entities": []}], ["Echocardiographically assessed LA size may be an additional parameter useful in thromboembolic risk stratification of AF patients.", {"entities": []}], ["The prevention of recurrent hospitalizations in the frail elderly requires the implementation of high-intensity interventions such as case management.", {"entities": []}], ["In order to be practically and financially sustainable, these programs require a method of identifying those patients most at risk for hospitalization, and therefore most likely to benefit from an intervention.", {"entities": []}], ["The goal of this study is to demonstrate the use of an electronic medical record to create an administrative index which is able to risk-stratify this heterogeneous population.", {"entities": []}], ["We conducted a retrospective cohort study at a single tertiary care facility in Rochester, Minnesota.", {"entities": []}], ["Patients included all 12,650 community-dwelling adults age 60 and older assigned to a primary care internal medicine provider on January 1, 2005.", {"entities": []}], ["Patient risk factors over the previous two years, including demographic characteristics, comorbid diseases, and hospitalizations, were evaluated for significance in a logistic regression model.", {"entities": []}], ["The primary outcome was the total number of emergency room visits and hospitalizations in the subsequent two years.", {"entities": []}], ["Risk factors were assigned a score based on their regression coefficient estimate and a total risk score created.", {"entities": []}], ["This score was evaluated for sensitivity and specificity.", {"entities": []}], ["The final model had an AUC of 0.678 for the primary outcome.", {"entities": []}], ["Patients in the highest 10% of the risk group had a relative risk of 9.5 for either hospitalization or emergency room visits, and a relative risk of 13.3 for hospitalization in the subsequent two year period.", {"entities": []}], ["It is possible to create a screening tool which identifies an elderly population at high risk for hospital and emergency room admission using clinical and administrative data readily available within an electronic medical record.", {"entities": []}], ["It remains an open question whether falls are related with social relations, covering subjective (e.g., perceived loneliness) and more objective dimensions (e.g., number of important individuals in regular contact).", {"entities": []}], ["Consequently, we aimed at examining the association between falls and social ties comprehensively, including loneliness, social exclusion and the number of important people in regular contact.", {"entities": []}], ["Cross-sectional data were used from a population-based sample of community-dwelling individuals aged 40 and over ( n \u00a0=\u00a07808) in Germany.", {"entities": []}], ["Self-rated loneliness was quantified using a short version of the De Jong Gierveld Loneliness Scale.", {"entities": []}], ["Perceived social exclusion was measured using a scale developed by Bude and Lantermann.", {"entities": []}], ["Furthermore and in contrast to the subjective outcome measures, the more objective number of important people in regular contact was also used as outcome variable.", {"entities": []}], ["The experience of a fall in the preceding 12\u00a0months (yes; no) was assessed.", {"entities": []}], ["Controlling for various possible confounding variables, linear regressions showed that experiencing a fall in the past 12\u00a0months was associated with higher social exclusion (\u03b2\u00a0=\u00a0.08, p \u00a0<\u00a0.001), and increased loneliness (\u03b2\u00a0=\u00a0.08, p \u00a0<\u00a0.001), whereas it was not associated with the number of important people in regular contact.", {"entities": []}], ["Findings stress the relation between falls and feelings of loneliness and social exclusion, whereas falls were unrelated to the more objective measure of number of important people in regular contact, suggesting that falls are particularly related to subjective measures of social ties and relations.", {"entities": []}], ["This underlines the importance of interventions to prevent falls.", {"entities": []}], ["Preventing falls in turn might help to prevent loneliness and social exclusion.", {"entities": []}], ["Rhesus-positive and Rhesus-negative persons differ in the presence-absence of highly immunogenic RhD protein on the erythrocyte membrane.", {"entities": [[97, 100, "GENE"]]}], ["The biological function of the RhD molecule is unknown.", {"entities": [[31, 34, "GENE"]]}], ["Its structure suggests that the molecular complex with RhD protein transports NH 3 or CO 2 molecules across the erythrocyte cell membrane.", {"entities": [[55, 58, "GENE"]]}], ["Some data indicate that RhD positive and RhD negative subjects differ in their tolerance to certain biological factors, including, Toxoplasma infection, aging and fatique.", {"entities": [[24, 27, "GENE"], [41, 44, "GENE"], [24, 27, "GENE"], [41, 44, "GENE"]]}], ["Present cross sectional study performed on 3,130 subjects) showed that Rhesus negative subjects differed in many indices of their health status, including incidences of many disorders.", {"entities": []}], ["Rhesus negative subjects reported to have more frequent allergic, digestive, heart, hematological, immunity, mental health, and neurological problems.", {"entities": []}], ["On the population level, a Rhesus-negativity-associated burden could be compensated for, for example, by the heterozygote advantage, but for Rhesus negative subjects this burden represents a serious problem.", {"entities": []}], ["The Second Kitasato Symposium: New Prospects for Cytokines brought together researchers and rheumatologists to consider the essential role of cytokines in health and their contributions to autoimmunity.", {"entities": []}], ["Topics addressed during the Symposium - which was held in Berlin, Germany from 27 to 29 May 2010 - included established and new cytokine targets in arthritis and autoimmunity and innovative aspects of osteoimmunology as well as current perspectives from translational and clinical studies.", {"entities": [[148, 157, "DISEASE"]]}], ["The keynote lecture, delivered by George Kollias, focused on insights gained from animal models into the mechanisms of TNF function in chronic inflammation and autoimmunity.", {"entities": [[119, 122, "GENE"]]}], ["The presentations at the Symposium resulted in productive discussions regarding potential new targets for the treatment of rheumatoid arthritis and other autoimmune disorders.", {"entities": [[123, 143, "DISEASE"], [134, 143, "DISEASE"]]}], ["Children exposed to maternal smoking during pregnancy exhibit increased risk for many adverse health effects.", {"entities": []}], ["Maternal smoking influences methylation in newborns at specific CpG sites (CpGs).", {"entities": []}], ["Here, we extend evaluation of individual CpGs to gene-level and pathway-level analyses among 1062 participants in the Norwegian Mother and Child Cohort Study (MoBa) using the Illumina 450\u00a0K platform to measure methylation in newborn DNA and maternal smoking in pregnancy, assessed using the biomarker, plasma cotinine.", {"entities": []}], ["We used novel implementations of bioinformatics tools to collapse epigenome-wide methylation data into gene- and pathway-level effects to test whether exposure to maternal smoking in utero differentially methylated CpGs in genes enriched in biologic pathways.", {"entities": []}], ["Unlike most pathway analysis applications, our approach allows replication in an independent cohort.", {"entities": []}], ["Data on 485,577 CpGs, mapping to a total of 20,199 genes, were used to create gene scores that were tested for association with maternal plasma cotinine levels using Sequence Kernel Association Test (SKAT), and 15 genes were found to be associated ( q \u2009<\u20090.25).", {"entities": []}], ["Six of these 15 genes ( GFI1 , MYO1G , CYP1A1 , RUNX1 , LCTL , and AHRR) contained individual CpGs that were differentially methylated with regards to cotinine levels ( p \u2009<\u20091.06\u2009\u00d7\u200910 FCRLA , MIR641 , SLC25A24, TRAK1 , C1orf180 , ITLN2 , GLIS1 , LRFN1 , and MIR451) were associated with cotinine at the gene-level ( q \u2009<\u20090.25) but had no genome-wide significant individual CpGs ( p \u2009>\u20091.06\u2009\u00d7\u200910 q \u2009<\u20090.05).", {"entities": [[24, 28, "GENE"], [31, 36, "GENE"], [39, 45, "GENE"], [48, 53, "GENE"], [56, 60, "GENE"], [67, 71, "GENE"], [184, 189, "GENE"], [201, 209, "GENE"], [211, 216, "GENE"], [230, 235, "GENE"], [238, 243, "GENE"], [246, 251, "GENE"]]}], ["Of those 32 replicated in an independent cohort, which clustered into six groups.", {"entities": []}], ["The largest cluster consisted of pathways related to cancer, cell cycle, ER\u03b1 receptor signaling, and angiogenesis.", {"entities": [[53, 59, "DISEASE"]]}], ["The second cluster, organized into five smaller pathway groups, related to immune system function, such as T-cell regulation and other white blood cell related pathways.", {"entities": []}], ["Here we use novel implementations of bioinformatics tools to determine biological pathways impacted through epigenetic changes in utero by maternal smoking in 1062 participants in the MoBa, and successfully replicate these findings in an independent cohort.", {"entities": []}], ["The results provide new insight into biological mechanisms that may contribute to adverse health effects from exposure to tobacco smoke in utero .", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-016-3310-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cone-rod dystrophy (CRD) is an inherited progressive retinal dystrophy affecting the function of cone and rod photoreceptors.", {"entities": []}], ["By autozygosity mapping, we identified null mutations in the ADAM metallopeptidase domain 9 ( ADAM9 ) gene in four consanguineous families with recessively inherited early-onset CRD.", {"entities": [[94, 99, "GENE"]]}], ["We also found reduced photoreceptor responses in Adam9 knockout mice, previously reported to be asymptomatic.", {"entities": [[49, 54, "GENE"]]}], ["In 12-month-old knockout mice, photoreceptors appear normal, but the apical processes of the retinal pigment epithelium (RPE) cells are disorganized and contact between photoreceptor outer segments (POSs) and the RPE apical surface is compromised.", {"entities": [[121, 124, "GENE"], [213, 216, "GENE"], [121, 124, "GENE"], [213, 216, "GENE"]]}], ["In 20-month-old mice, there is clear evidence of progressive retinal degeneration with disorganized POS and thinning of the outer nuclear layer (ONL) in addition to the anomaly at the POS-RPE junction.", {"entities": [[61, 81, "DISEASE"]]}], ["RPE basal deposits and macrophages were also apparent in older mice.", {"entities": [[0, 3, "GENE"]]}], ["These findings therefore not only identify ADAM9 as a CRD gene but also identify a form of pathology wherein retinal disease first manifests at the POS-RPE junction.", {"entities": [[109, 124, "DISEASE"], [43, 48, "GENE"]]}], ["The hepatotoxicity of some Chinese herbs has been a cause for concern in recent years.", {"entities": []}], ["However, some herbs, such as rhubarb, have been documented as having both therapeutic and toxic effects on the liver, leading to the complex problem of distinguishing the benefits from the risks of using this herb.", {"entities": []}], ["To comparatively analyze the dose-response relationship between rhubarb and hepatic health, we administrated total rhubarb extract(RE) to normal and carbon tetrachloride(CCl 4 )-treated rats for 12 weeks at 4 dosage levels(2.00, 5.40, 14.69 and 40.00 g\u00b7kg 4 -treated rats was mainly expressed as a decrease in the extent of cellular injury.", {"entities": []}], ["The hepatoprotective mechanism of RE might be related to its antioxidant effect, the antagonism of the free radical damage to hepatocytes caused by CCl 4 .", {"entities": []}], ["By contrast, the RE-induced liver damage was mainly expressed as a significant increase in the amount of fibrosis in both normal rats at all dosage levels and CCl 4 -treated rats at the two highest dosage levels.", {"entities": []}], ["Therefore, the hepatotoxic potential of RE could be attributable to the liver cell fibrosis induced by high doses of the herb.", {"entities": []}], ["This study illustrates the bidirectional potential of rhubarb and demonstrates the feasibility of using factor analysis to study the dose-response relationships between herbal medicines and hepatotoxicity or the healing effects of these herbs by extracting the underlying interrelationships among a number of functional bio-indices in a holistic manner.", {"entities": []}], ["Arsenic is globally infamous for inducing immunosuppression associated with prevalence of opportunistic infection in exposed population, although the mechanism remains elusive.", {"entities": []}], ["In this study, we investigate the effect of arsenic exposure on thymocyte lineage commitment and the involvement of regulatory T cells (T reg ) in arsenic-induced immunosuppression.", {"entities": []}], ["Male Balb/c mice were exposed to 0.038, 0.38 and 3.8\u2009ppm sodium arsenite for 7, 15 and 30 days through oral gavage.", {"entities": []}], ["Arsenic exposure promoted CD4 lineage commitment in a dose dependent manner supported by the expression of ThPOK in thymus.", {"entities": [[26, 29, "GENE"]]}], ["Arsenic also increased splenic CD4 reg cells.", {"entities": [[31, 34, "GENE"]]}], ["In parallel,\ufeff arsenic exposure induced immunosuppression characterized by low cytokine secretion from splenocytes and increased susceptibility to Mycobacterium fortuitum ( M. fortuitum ) infection.", {"entities": []}], ["Therefore, we linked arsenic-induced rise in T reg cells with suppressed T h 1 and T h 2 related cytokines, which has been reversed by inhibition of T reg cells in-vivo using wortmannin.", {"entities": []}], ["Other parameters like body weight, kidney and liver function, histoanatomy of thymus and spleen as well as thymocyte and splenocytes viability were unaltered by arsenic exposure.", {"entities": []}], ["Taken together our findings indicated that environmentally relevant dose of arsenic enhanced differentiation of T reg cells which in turn induce immunosuppression in experimental animals.", {"entities": []}], ["Current studies of gene \u00d7 air pollution interaction typically seek to identify unknown heritability of common complex illnesses arising from variability in the host\u2019s susceptibility to environmental pollutants of interest.", {"entities": []}], ["Accordingly, a single component generalized linear models are often used to model the risk posed by an environmental exposure variable of interest in relation to a priori determined DNA variants.", {"entities": []}], ["However, reducing the phenotypic heterogeneity may further optimize such approach, primarily represented by the modeled DNA variants.", {"entities": []}], ["Here, we reduce phenotypic heterogeneity of asthma severity, and also identify single nucleotide polymorphisms (SNP) associated with phenotype subgroups.", {"entities": [[44, 50, "DISEASE"]]}], ["Specifically, we first apply an unsupervised learning algorithm method and a non-parametric regression to find a biclustering structure of children according to their allergy and asthma severity.", {"entities": [[179, 185, "DISEASE"]]}], ["We then identify a set of SNPs most closely correlated with each sub-group.", {"entities": []}], ["We subsequently fit a logistic regression model for each group against the healthy controls using benzo[ a ]pyrene (B[ a ]P) as a representative airborne carcinogen.", {"entities": []}], ["Application of such approach in a case-control data set shows that SNP clustering may help to partly explain heterogeneity in children\u2019s asthma susceptibility in relation to ambient B[ a ]P concentration with greater efficiency.", {"entities": [[137, 143, "DISEASE"]]}], ["In order to know the effect of pre-existing Trichinella spiralis infection on experimentally induced intestinal inflammation and immune responses, we induced colitis in T. spiralis -infected mice and observed the severity of colitis and the levels of Th1, Th2, and regulatory cytokines and recruitment of CD4 reg ) cells.", {"entities": [[305, 308, "GENE"]]}], ["Female C57BL/6 mice were infected with 250 muscle larvae; after 4 weeks, induction of experimental colitis was performed using 3% dextran sulfate sodium (DSS).", {"entities": []}], ["During the induction period, we observed severity of colitis, including weight loss and status of stool, and evaluated the disease activity index (DAI).", {"entities": []}], ["A significantly low DAI and degree of weight loss were observed in infected mice, compared with uninfected mice.", {"entities": []}], ["In addition, colon length in infected mice was not contracted, compared with uninfected mice.", {"entities": []}], ["We also observed a significant increase in production of pro-inflammatory cytokines, IL-6 and IFN-\u03b3, in spleen lymphocytes treated with DSS; however, such an increase was not observed in infected mice treated with DSS.", {"entities": []}], ["Of particular interest, production of regulatory cytokines, IL-10 and transforming growth factor (TGF)-\u03b2, in spleen lymphocytes showed a significant increase in mice infected with T. spiralis .", {"entities": []}], ["A similar result was observed in mesenteric lymph nodes (MLN).", {"entities": [[57, 60, "GENE"]]}], ["Subsets of the population of T reg cells in MLN and spleen showed significant increases in mice infected with T. spiralis .", {"entities": [[44, 47, "GENE"]]}], ["In conclusion, T. spiralis infection can inhibit the DSS-induced colitis in mice by enhancing the regulatory cytokine and T reg cells recruitment.", {"entities": []}], ["The association studies on human complex traits are admittedly propitious to identify deleterious genetic markers.", {"entities": []}], ["Compared to single-trait analyses, multiple-trait analyses can arguably make better use of the information on both traits and markers, and thus improve statistical power of association tests prominently.", {"entities": []}], ["Principal component analysis (PCA) is a well-known useful tool in multivariate analysis and can be applied to this task.", {"entities": []}], ["Generally, PCA is first performed on all traits and then a certain number of top principal components (PCs) that explain most of the trait variations are selected to construct the test statistics.", {"entities": []}], ["However, under some situations, only utilizing these top PCs would lead to a loss of important evidences from discarded PCs and thus makes the capability compromised.", {"entities": []}], ["To overcome this drawback while keeping the advantages of using the top PCs, we propose a group accumulated test evidence (GATE) procedure.", {"entities": []}], ["By dividing the PCs which is sorted in the descending order according to the corresponding eigenvalues into a few groups, GATE integrates the information of traits at the group level.", {"entities": []}], ["Simulation studies demonstrate the superiority of the proposed approach over several existing methods in terms of statistical power.", {"entities": []}], ["Sometimes, the increase of power can reach 25%.", {"entities": []}], ["These methods are further illustrated using the Heterogeneous Stock Mice data which is collected from a quantitative genome-wide association study.", {"entities": []}], ["Overall, GATE provides a powerful test for pleiotropic genetic associations.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-017-3928-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chronic exposure to high levels of ozone induces emphysema and chronic inflammation in mice.", {"entities": []}], ["We determined the recovery from ozone-induced injury and whether an antioxidant, N-acetylcysteine (NAC), could prevent or reverse the lung damage.", {"entities": []}], ["Mice were exposed to ozone (2.5 ppm, 3 hours/12 exposures, over 6 weeks) and studied 24 hours (24h) or 6 weeks (6W) later.", {"entities": []}], ["Nac (100 mg/kg, intraperitoneally) was administered either before each exposure (preventive) or after completion of exposure (therapeutic) for 6 weeks.", {"entities": []}], ["After ozone exposure, there was an increase in functional residual capacity, total lung volume, and lung compliance, and a reduction in the ratio of forced expiratory volume at 25 and 50 milliseconds to forced vital capacity (FEV 25 /FVC, FEV 50 /FVC).", {"entities": [[226, 229, "GENE"], [239, 242, "GENE"], [226, 229, "GENE"], [239, 242, "GENE"]]}], ["Mean linear intercept (L m ) and airway hyperresponsiveness (AHR) to acetylcholine increased, and remained unchanged at 6W after cessation of exposure.", {"entities": [[61, 64, "GENE"]]}], ["Preventive NAC reduced the number of BAL macrophages and airway smooth muscle (ASM) mass.", {"entities": []}], ["Therapeutic NAC reversed AHR, and reduced ASM mass and apoptotic cells.", {"entities": [[25, 28, "GENE"]]}], ["Emphysema and lung function changes were irreversible up to 6W after cessation of ozone exposure, and were not reversed by NAC.", {"entities": []}], ["The beneficial effects of therapeutic NAC may be restricted to the ASM.", {"entities": []}], ["Cutaneous lymphocyte-associated antigen (CLA)-expressing CD8 CD8 Our results revealed higher frequency and increased expression of perforin and granzyme-B in peripheral CD8 The attenuated inhibitory ability of Tregs on hyper-activated autologous CD8", {"entities": []}], ["Uridine has earlier been show to down modulate inflammation in models of lung inflammation.", {"entities": []}], ["The aim of this study was to evaluate the anti-inflammatory effect of uridine in arthritis.", {"entities": [[81, 90, "DISEASE"]]}], ["Arthritis was induced by intra-articular injection of mBSA in the knee of NMRI mice pre-immunized with mBSA.", {"entities": [[0, 9, "DISEASE"]]}], ["Uridine was either administered locally by direct injection into the knee joint or systemically.", {"entities": []}], ["Systemic treatment included repeated injections or implantation of a pellet continuously releasing uridine during the entire experimental procedure.", {"entities": []}], ["Anti-mBSA specific immune responses were determined by ELISA and cell proliferation and serum cytokine levels were determined by Luminex.", {"entities": []}], ["Immunohistochemistry was used to identify cells, study expression of cytokines and adhesion molecules in the joint.", {"entities": []}], ["Local administration of 25\u2013100 mg/kg uridine at the time of arthritis onset clearly prevented development of joint inflammation.", {"entities": [[60, 69, "DISEASE"]]}], ["In contrast, systemic administration of uridine (max 1.5 mg uridine per day) did not prevent development of arthritis.", {"entities": [[108, 117, "DISEASE"], [49, 52, "GENE"]]}], ["Protection against arthritis by local administration of uridine did not affect the anti-mBSA specific immune response and did not prevent the rise in serum levels of pro-inflammatory cytokines associated with the triggering of arthritis.", {"entities": [[19, 28, "DISEASE"], [227, 236, "DISEASE"]]}], ["In contrast, local uridine treatment efficiently inhibited synovial expression of ICAM-1 and CD18, local cytokine production and recruitment of leukocytes to the synovium.", {"entities": []}], ["Local, but not systemic administration of uridine efficiently prevented development of antigen-induced arthritis.", {"entities": [[103, 112, "DISEASE"]]}], ["The protective effect did not involve alteration of systemic immunity to mBSA but clearly involved inhibition of synovial expression of adhesion molecules, decreased TNF and IL-6 production and prevention of leukocyte extravasation.", {"entities": [[166, 169, "GENE"]]}], ["Further, uridine is a small, inexpensive molecule and may thus be a new therapeutic option to treat joint inflammation in RA.", {"entities": []}], ["A causal link between increased intake of omega-6 ( n -6) polyunsaturated fatty acids (PUFAs) and increased incidence of allergic disease has been suggested.", {"entities": []}], ["This is supported by biologically plausible mechanisms, related to the roles of eicosanoid mediators produced from the n -6 PUFA arachidonic acid.", {"entities": []}], ["Fish and fish oils are sources of long chain omega-3 ( n -3) PUFAs.", {"entities": []}], ["These fatty acids act to oppose the actions of n -6 PUFAs particularly with regard to eicosanoid synthesis.", {"entities": []}], ["Thus, n -3 PUFAs may protect against allergic sensitisation and allergic manifestations.", {"entities": []}], ["Epidemiological studies investigating the association between maternal fish intake during pregnancy and allergic outcomes in infants/children of those pregnancies suggest protective associations, but the findings are inconsistent.", {"entities": []}], ["Fish oil provision to pregnant women is associated with immunologic changes in cord blood.", {"entities": []}], ["Studies performed to date indicate that provision of fish oil during pregnancy may reduce sensitisation to common food allergens and reduce prevalence and severity of atopic eczema in the first year of life, with a possible persistence until adolescence.", {"entities": []}], ["A recent study reported that fish oil consumption in pregnancy reduces persistent wheeze and asthma in the offspring at ages 3 to 5 years.", {"entities": [[93, 99, "DISEASE"]]}], ["Eating oily fish or fish oil supplementation in pregnancy may be a strategy to prevent infant and childhood allergic disease.", {"entities": []}], ["Soluble-lymphocyte subsets (sCD19\u2009+\u2009CD23+ B cells and sCD4\u2009+\u2009CD25+ T cells), soluble-adhesion molecules (sE-selectin) and interleukin-12 (sIL-12) were assayed to evaluate the pathogenesis of steroid sensitive nephrotic syndrome in 48 patients diagnosed with steroid sensitive nephrotic syndrome (SSNS) in active (AS) and remission stages (RS).", {"entities": [[209, 227, "DISEASE"], [276, 294, "DISEASE"], [219, 227, "DISEASE"], [286, 294, "DISEASE"]]}], ["The ratios of soluble CD19 and sCD19\u2009+\u2009CD23 increased in patients with AS with respect to the patients with RS and controls (p\u2009<\u20090.05).", {"entities": [[22, 26, "GENE"]]}], ["Increased sCD19\u2009+\u2009CD23 ratios were preserved in the patients with RS when compared with the controls (p\u2009<\u20090.05).", {"entities": []}], ["Moreover, the ratios of sCD4\u2009+\u2009CD25 lymphocyte subsets were not significantly different among the groups.", {"entities": []}], ["Similarly, serum sIL-12 levels were not considerably disparate between the AS and RS.", {"entities": []}], ["Serum sE-selectin levels were higher in the patients with AS relative to the controls (p\u2009<\u20090.01) and RS (p\u2009<\u20090.05).", {"entities": []}], ["No significant correlations were noted between sE-selectin and lymphocyte subset ratios, serum sIL-12 and immunoglobulin levels.", {"entities": []}], ["There was a positive correlation between sE-selectin, triglyceride (r\u2009=\u20090.757, p\u2009<\u20090.0001) and cholesterol (r\u2009=\u20090.824, p\u2009<\u20090.0001) levels in patients with the AS.", {"entities": []}], ["The present results indicate that the patients with SSNS appear to have abnormalities in sCD23\u2009+\u2009CD19+ cells, defect in T regulatory cell activity, and injury in endothelial cells as indicated by the presence high sE-selectin.", {"entities": []}], ["These abnormalities might play a role in the pathogenesis of nephrotic syndrome.", {"entities": [[61, 79, "DISEASE"], [71, 79, "DISEASE"]]}], ["sIL-12 seems to have no role in pathogenesis of nephrotic syndrome reflecting normal Th1 response.", {"entities": [[48, 66, "DISEASE"], [58, 66, "DISEASE"]]}], ["Genetic studies have to date identified 43 genome wide significant coeliac disease susceptibility (CD) loci comprising over 70 candidate genes.", {"entities": []}], ["However, how altered regulation of such disease associated genes contributes to CD pathogenesis remains to be elucidated.", {"entities": []}], ["Recently there has been considerable emphasis on characterising cell type specific and stimulus dependent genetic variants.", {"entities": []}], ["Therefore in this study we used RNA sequencing to profile over 70 transcriptomes of CD4+ T cells, a cell type crucial for CD pathogenesis, in both stimulated and resting samples from individuals with CD and unaffected controls.", {"entities": []}], ["We identified extensive transcriptional changes across all conditions, with the previously established CD gene IFNy the most strongly up-regulated gene (log2 fold change 4.6; P adjusted = 2.40x10 adjusted = 0.002), and 21 CD candidate susceptibility genes are differentially expressed under one or more of the conditions used in this study.", {"entities": []}], ["Pathway analysis revealed significant enrichment of immune related processes.", {"entities": []}], ["Co-expression network analysis identified several modules of coordinately expressed CD genes.", {"entities": []}], ["Two modules were particularly highly enriched for differentially expressed genes (P<2.2x10 adjusted = 3.6x10", {"entities": []}], ["There is growing recognition of the role of diet and other environmental factors in modulating the composition and metabolic activity of the human gut microbiota, which in turn can impact health.", {"entities": []}], ["This narrative review explores the relevant contemporary scientific literature to provide a general perspective of this broad area.", {"entities": []}], ["Molecular technologies have greatly advanced our understanding of the complexity and diversity of the gut microbial communities within and between individuals.", {"entities": []}], ["Diet, particularly macronutrients, has a major role in shaping the composition and activity of these complex populations.", {"entities": []}], ["Despite the body of knowledge that exists on the effects of carbohydrates there are still many unanswered questions.", {"entities": []}], ["The impacts of dietary fats and protein on the gut microbiota are less well defined.", {"entities": []}], ["Both short- and long-term dietary change can influence the microbial profiles, and infant nutrition may have life-long consequences through microbial modulation of the immune system.", {"entities": []}], ["The impact of environmental factors, including aspects of lifestyle, on the microbiota is particularly poorly understood but some of these factors are described.", {"entities": []}], ["We also discuss the use and potential benefits of prebiotics and probiotics to modify microbial populations.", {"entities": []}], ["A description of some areas that should be addressed in future research is also presented.", {"entities": []}], ["Understanding the causes of low engagement in healthcare is a pre-requisite for improving health services\u2019 contribution to tackling health inequalities.", {"entities": []}], ["Low engagement includes missing healthcare appointments.", {"entities": []}], ["Serially (having a pattern of) missing general practice (GP) appointments may provide a risk marker for vulnerability and poorer health outcomes.", {"entities": []}], ["A proof of concept pilot using GP appointment data and a focus group with GPs informed the development of missed appointment categories: patients can be classified based on the number of appointments missed each year.", {"entities": []}], ["The full study, using a retrospective cohort design, will link routine health service and education data to determine the relationship between GP appointment attendance, health outcomes, healthcare usage, preventive health activity and social circumstances taking a life course approach and using data from the whole journey in the National Health Service (NHS) healthcare.", {"entities": [[357, 360, "GENE"]]}], ["172 practices will be recruited (\u223c900\u2005000 patients) across Scotland.", {"entities": []}], ["The statistical analysis will focus on 2 key areas: factors that predict patients who serially miss appointments, and serial missed appointments as a predictor of future patient outcomes.", {"entities": []}], ["Regression models will help understand how missed appointment patterns are associated with patient and practice characteristics.", {"entities": []}], ["We shall identify key factors associated with serial missed appointments and potential interactions that might predict them.", {"entities": []}], ["The results of the project will inform debates concerning how best to reduce non-attendance and increase patient engagement within healthcare systems.", {"entities": []}], ["Significant non-academic beneficiaries include governments, policymakers and medical practitioners.", {"entities": []}], ["Results will be disseminated via a combination of academic outputs (papers, conferences), social media and through collaborative public health/policy fora.", {"entities": []}], ["Human exposure to lead is a substantial public health hazard worldwide and is particularly problematic in the Republic of South Africa given the country\u2019s late cessation of leaded petrol.", {"entities": []}], ["Lead exposure is associated with a number of serious health issues and diseases including developmental and cognitive deficiency, hypertension and heart disease.", {"entities": [[130, 142, "DISEASE"], [147, 160, "DISEASE"]]}], ["Understanding the distribution of lifetime lead burden within a given population is critical for reducing exposure rates.", {"entities": []}], ["Femoral bone from 101 deceased adult males living in urban Transvaal Province (now Gauteng Province), South Africa between 1960 and 1998 were analyzed for lead concentration by Inductively Coupled Plasma Mass Spectrometry (ICP-MS).", {"entities": []}], ["Of the 72 black and 29 white individuals sampled, chronic lead exposure was apparent in nearly all individuals.", {"entities": []}], ["White males showed significantly higher median bone lead concentration (ME\u200a=\u200a10.04 \u00b5g\u00b7g", {"entities": []}], ["Neuropathic pain can have a major effect on quality of life but current therapies are often inadequate.", {"entities": []}], ["Growing evidence suggests that neuropathic pain induced by nerve damage is caused by chronic inflammation.", {"entities": []}], ["Upon nerve injury, damaged cells secrete pro-inflammatory molecules that activate cells in the surrounding tissue and recruit circulating leukocytes to the site of injury.", {"entities": []}], ["Among these, the most abundant cell type is macrophages, which produce several key molecules involved in pain enhancement, including cytokines and chemokines.", {"entities": []}], ["Given their central role in the regulation of peripheral sensitization, macrophage-derived cytokines and chemokines could be useful targets for the development of novel therapeutics.", {"entities": []}], ["Inhibition of key pro-inflammatory cytokines and chemokines prevents neuroinflammation and neuropathic pain; moreover, recent studies have demonstrated the effectiveness of pharmacological inhibition of inflammatory (M1) macrophages.", {"entities": []}], ["Nicotinic acetylcholine receptor ligands and T helper type 2 cytokines that reduce M1 macrophages are able to relieve neuropathic pain.", {"entities": []}], ["Future translational studies in non-human primates will be crucial for determining the regulatory mechanisms underlying neuroinflammation-associated neuropathic pain.", {"entities": []}], ["In turn, this knowledge will assist in the development of novel pharmacotherapies targeting macrophage-driven neuroinflammation for the treatment of intractable neuropathic pain.", {"entities": []}], ["IL-28 (IFN-\u03bb) cytokines exhibit potent antiviral and antitumor function but their full spectrum of activities remains largely unknown.", {"entities": []}], ["Recently, IL-28 cytokine family members were found to be profoundly down-regulated in allergic asthma.", {"entities": [[86, 101, "DISEASE"], [95, 101, "DISEASE"]]}], ["We now reveal a novel role of IL-28 cytokines in inducing type 1 immunity and protection from allergic airway disease.", {"entities": []}], ["Treatment of wild-type mice with recombinant or adenovirally expressed IL-28A ameliorated allergic airway disease, suppressed Th2 and Th17 responses and induced IFN-\u03b3.", {"entities": []}], ["Moreover, abrogation of endogenous IL-28 cytokine function in IL-28R\u03b1 in vivo through the modulation of lung CD11c", {"entities": []}], ["The Internet is a major source of information for professionals and the general public, especially in the field of health.", {"entities": []}], ["However, despite ever-increasing connection rates, a digital divide persists in the industrialised countries.", {"entities": []}], ["The objective of this study was to assess the determinants involved in: 1) having or not having Internet access; and 2) using or not using the Internet to obtain health information.", {"entities": []}], ["A cross-sectional survey of a representative random sample was conducted in the Paris metropolitan area, France, in the fall of 2005 (n = 3023).", {"entities": []}], ["Close to 70% of the adult population had Internet access, and 49% of Internet users had previously searched for medical information.", {"entities": []}], ["Economic and social disparities observed in online health information seeking are reinforced by the economic and social disparities in Internet access, hence a double divide.", {"entities": []}], ["While individuals who reported having a recent health problem were less likely to have Internet access (odds ratio (OR): 0.72, 95% confidence interval (CI): 0.53\u20130.98), it is they who, when they have Internet access, are the most likely to search for health information (OR = 1.44, 95% CI = 1.11\u20131.87).", {"entities": []}], ["In the French context of universal health insurance, access to the Internet varies according to social and socioeconomic status and health status, and its use for health information seeking varies also with health beliefs, but not to health insurance coverage or health-care utilisation.", {"entities": []}], ["Certain economic and social inequalities seem to impact cumulatively on Internet access and on the use of the Internet for health information seeking.", {"entities": []}], ["It is not obvious that the Internet is a special information tool for primary prevention in people who are the furthest removed from health concerns.", {"entities": []}], ["However, the Internet appears to be a useful complement for secondary prevention, especially for better understanding health problems or enhancing therapeutic compliance.", {"entities": []}], ["Continuous \u03b2-cell rest with diazoxide preserves residual endogenous insulin production in type 1 diabetes.", {"entities": []}], ["However, side effects have hampered therapeutic usefulness.", {"entities": []}], ["In a double-blind study, we tested whether lower, intermittent dosing of diazoxide had beneficial effects on insulin production, metabolic control, and autoimmunity markers in the absence of side effects.", {"entities": []}], ["Forty-one newly diagnosed type 1 diabetic patients were randomized to 6 months of treatment with placebo or 100 mg diazoxide at bedtime.", {"entities": []}], ["A1C, C-peptide (fasting and glucagon stimulated), and FoxP3 Of six dropouts, three were due to perceived side effects; one subject in the diazoxide group experienced rash, another dizziness, and one in the placebo group sleep disturbance.", {"entities": [[54, 59, "GENE"]]}], ["Adverse effects in others were absent.", {"entities": []}], ["Diazoxide treatment reduced A1C from 8.6% at baseline to 6.0% at 6 months and 6.5% at 12 months.", {"entities": []}], ["Corresponding A1C value in the placebo arm were 8.3, 7.3, and 7.5% ( P < 0.05 for stronger reduction in the diazoxide group).", {"entities": []}], ["Fasting and stimulated C-peptide decreased during 12 months similarly in both arms (mean \u22120.30 and \u22120.18 nmol/l in the diazoxide arm and \u22120.08 and \u22120.09 nmol/l in the placebo arm).", {"entities": []}], ["The proportion of Tregs was similar in both arms and remained stable during intervention but was significantly lower compared with nondiabetic subjects.", {"entities": []}], ["Six months of low-dose diazoxide was without side effects and did not measurably affect insulin production but was associated with improved metabolic control.", {"entities": []}], ["The present study has aimed to identify the perceptions of apprentice welders about physical, chemical, biological, and physiological risk factors to which they are exposed; identify types of occupational accidents involving apprentice welders; and report the development of a socioenvironmental education intervention as a tool for risk communication for apprentice welders.", {"entities": []}], ["A quantitative study was performed with 161 apprentice welders in Southern Brazil in 2011.", {"entities": []}], ["Data collection was performed via structured interviews with the apprentice welders about risk perception, occupational accidents, and time experienced in welding.", {"entities": []}], ["The data were analyzed using SPSS 19.0.", {"entities": []}], ["The participants identified the following risk types: physical (96.9%), chemical (95%), physiological (86.3%), and biological (51.5%).", {"entities": []}], ["In this sample, 39.7% of apprentice welders reported occupational accidents and 27.3% reported burning.", {"entities": []}], ["The inferential analysis showed that the frequency of risk perception factors increases with the length of experience, and apprentice welders who have experienced accidents during welding activity perceive a higher amount of risk factors than those who have never experienced them.", {"entities": []}], ["It is concluded that apprentice welders perceive risks and that they tend to relate risks with the occurrence of occupational accidents as an indicator of the dangerous nature of their activity.", {"entities": []}], ["We analysed the association between economic incentives and diagnostic coding practice in the Norwegian public health care system.", {"entities": []}], ["Data included 3,180,578 hospital discharges in Norway covering the period 1999\u20132008.", {"entities": []}], ["For reimbursement purposes, all discharges are grouped in diagnosis-related groups (DRGs).", {"entities": []}], ["We examined pairs of DRGs where the addition of one or more specific diagnoses places the patient in a complicated rather than an uncomplicated group, yielding higher reimbursement.", {"entities": []}], ["The economic incentive was measured as the potential gain in income by coding a patient as complicated, and we analysed the association between this gain and the share of complicated discharges within the DRG pairs.", {"entities": []}], ["Using multilevel linear regression modelling, we estimated both differences between hospitals for each DRG pair and changes within hospitals for each DRG pair over time.", {"entities": []}], ["Over the whole period, a one-DRG-point difference in price was associated with an increased share of complicated discharges of 14.2 (95\u00a0% confidence interval [CI] 11.2\u201317.2) percentage points.", {"entities": []}], ["However, a one-DRG-point change in prices between years was only associated with a 0.4 (95\u00a0% CI \\documentclass[12pt]{minimal} \t\t\t\t\\usepackage{amsmath} \t\t\t\t\\usepackage{wasysym} \t\t\t\t\\usepackage{amsfonts} \t\t\t\t\\usepackage{amssymb} \t\t\t\t\\usepackage{amsbsy} \t\t\t\t\\usepackage{mathrsfs} \t\t\t\t\\usepackage{upgreek} \t\t\t\t\\setlength{\\oddsidemargin}{-69pt} \t\t\t\t\\begin{document}$$-1.1$$\\end{document} - 1.1 to 1.8) percentage point change of discharges into the most complicated diagnostic category.", {"entities": []}], ["Although there was a strong increase in complicated discharges over time, this was not as closely related to price changes as expected.", {"entities": []}], ["Objective To study the association between wheezy symptoms in young children and the presence of bacteria in the airways.", {"entities": []}], ["Design Birth cohort study.", {"entities": []}], ["Setting Clinical research unit in Copenhagen.", {"entities": []}], ["Participants Children of asthmatic mothers, from age 4 weeks to 3 years, with planned visits and acute admissions to the research clinic.", {"entities": []}], ["Main outcome measure Frequency of bacteria and virus carriage in airway aspirates during wheezy episodes and at planned visits without respiratory symptoms.", {"entities": []}], ["Results 984 samples (361 children) were analysed for bacteria, 844 (299 children) for viruses, and 696 (277 children) for both viruses and bacteria.", {"entities": []}], ["Wheezy episodes were associated with both bacterial infection (odds ratio 2.9, 95% confidence interval 1.9 to 4.3; P<0.001) and virus infection (2.8, 1.7 to 4.4; P<0.001).", {"entities": []}], ["The associations of bacteria and viruses were independent of each other.", {"entities": []}], ["Conclusion Acute wheezy episodes in young children were significantly associated with bacterial infections similar to but independent of the association with virus infections.", {"entities": []}], ["Intrauterine growth restriction (IUGR) leads to development of type 2 diabetes (T2D) in adulthood.", {"entities": []}], ["The mechanisms underlying this phenomenon have not been fully elucidated.", {"entities": []}], ["Inflammation is associated with T2D; however, it is unknown whether inflammation is causal or secondary to the altered metabolic state.", {"entities": []}], ["Here we show that the mechanism by which IUGR leads to the development of T2D in adulthood is via transient recruitment of T-helper 2 (Th) lymphocytes and macrophages in fetal islets resulting in localized inflammation.", {"entities": []}], ["Although this immune response is short-lived, it results in a permanent reduction in islet vascularity and impaired insulin secretion.", {"entities": []}], ["Neutralizing interleukin-4 antibody therapy given only in the newborn period ameliorates inflammation and restores vascularity and \u03b2-cell function into adulthood, demonstrating a novel role for Th2 immune responses in the induction and progression of T2D.", {"entities": []}], ["In the neonatal stage, inflammation and vascular changes are reversible and may define an important developmental window for therapeutic intervention to prevent adult-onset diabetes.", {"entities": []}], ["Children make up about 20% of the UK population and caring for them is an important part of a general practitioner\u2019s (GP\u2019s) workload.", {"entities": []}], ["However, the UK Quality Outcomes Framework (pay-for-performance system) largely ignores children \u2013 less than 3% of the quality markers relate to them.", {"entities": []}], ["As no previous research has investigated whether GPs would support or oppose the introduction of child-specific quality markers, we sought their views on this important question.", {"entities": []}], ["Qualitative interview study with 20 GPs from four primary care trusts in Thames Valley, England.", {"entities": []}], ["Semi-structured interviews explored GPs\u2019 viewpoints on quality markers and childhood conditions that could be developed into markers in general practice.", {"entities": []}], ["Interviews were audiotaped and transcribed verbatim.", {"entities": []}], ["Analysis was thematic and used constant comparative method to look for anticipated and emergent themes as the analysis progressed.", {"entities": []}], ["All the GPs interviewed supported the development of \u2018benchmarks\u2019 or \u2018standards\u2019 to measure and improve quality of care for children.", {"entities": []}], ["However no consensus was expressed about the clinical conditions for which quality markers should be developed.", {"entities": []}], ["Many participants reflected on their concerns about unmet health care needs and felt there may be opportunities to improve proactive care in \u2018at risk\u2019 groups.", {"entities": []}], ["Some expressed feelings of powerlessness that important child-relevant outcomes such as emergency department visits and emergency admissions were out of their control and more directly related to public health, school and parents/carers.", {"entities": []}], ["The importance of access was a recurrent theme; access to urgent general practice appointments for children and GP access to specialists when needed.", {"entities": []}], ["The GPs expressed support for the development of quality markers for the care of children in UK general practice.", {"entities": []}], ["However, they flagged up a number of important challenges which need to be addressed if markers are to be developed that are measureable, targeted and within the direct control of primary care.", {"entities": []}], ["Easy access to primary and secondary care appointments may be an important benchmark for commissioners of care.", {"entities": []}], ["Objective To investigate the incidence of preterm delivery in the Belgian population after implementation of smoke-free legislation in three phases (in public places and most workplaces January 2006, in restaurants January 2007, and in bars serving food January 2010).", {"entities": []}], ["Design Logistic regression analyses on routinely collected birth data from January 2002 to December 2011.", {"entities": []}], ["Setting Flanders, Belgium.", {"entities": []}], ["Population All live born singleton births delivered at 24\u201344 weeks of gestation (n=606\u00a0877, with n=448\u00a0520 spontaneous deliveries).", {"entities": []}], ["Main outcome measures Preterm birth (gestational age <37 weeks).", {"entities": []}], ["Results We found reductions in the risk of preterm birth after the introduction of each phase of the smoking ban.", {"entities": []}], ["No decreasing trend was evident in the years or months before the bans.", {"entities": []}], ["We observed a step change in the risk of spontaneous preterm delivery of \u22123.13% (95% CI \u22124.37% to \u22121.87%; P<0.01) on 1 January 2007 (ban on smoking in restaurants), and an annual slope change of \u22122.65% (\u22125.11% to \u22120.13%; P=0.04) after 1 January 2010 (ban on smoking in bars serving food).", {"entities": []}], ["The analysis for all births gave similar results: a step change of \u22123.18% (\u22125.38% to \u22120.94%; P<0.01) on 1 January 2007, and an annual slope change of \u22123.50% (\u22126.35% to \u22120.57%; P=0.02) after 1 January 2010.", {"entities": []}], ["These changes could not be explained by personal factors (infant sex, maternal age, parity, socioeconomic status, national origin, level of urbanisation); time related factors (underlying trends, month of the year, day of the week); or population related factors (public holidays, influenza epidemics, and short term changes in apparent temperature and particulate air pollution).", {"entities": [[281, 290, "DISEASE"]]}], ["Conclusion Our study shows a consistent pattern of reduction in the risk of preterm delivery with successive population interventions to restrict smoking.", {"entities": []}], ["This finding is not definitive but it supports the notion that smoking bans have public health benefits from early life.", {"entities": []}], ["Hazelnuts are rich in monounsaturated fatty acids and antioxidant bioactive substances: their consumption has been associated with a decreased risk of cardiovascular disease events.", {"entities": []}], ["A systematic review and a meta-analysis was performed to combine the results from several trials and to estimate the pooled (overall) effect of hazelnuts on blood lipids and body weight outcomes.", {"entities": []}], ["Specifically, a Bayesian random effect meta-analysis of mean differences of \u0394-changes from baseline across treatment (MD\u0394) (i.e., hazelnut-enriched diet vs. control diet) has been conducted.", {"entities": []}], ["Nine studies representing 425 participants were included in the analysis.", {"entities": []}], ["The intervention diet lasted 28\u201384 days with a dosage of hazelnuts ranging from 29 to 69 g/day.", {"entities": []}], ["Out of nine studies, three randomized studies have been meta-analyzed showing a significant reduction in low-density lipoprotein (LDL) cholesterol (pooled MD\u0394 = \u22120.150 mmol/L; 95% highest posterior density interval (95%HPD) = \u22120.308; \u22120.003) in favor of a hazelnut-enriched diet.", {"entities": [[219, 222, "GENE"]]}], ["Total cholesterol showed a marked trend toward a decrease (pooled MD\u0394 = \u22120.127 mmol/L; 95%HPD = \u22120.284; 0.014) and high-density lipoprotein (HDL) cholesterol remained substantially stable (pooled MD\u0394 = 0.002 mmol/L; 95%HPD = \u22120.140; 0.147).", {"entities": [[90, 93, "GENE"], [219, 222, "GENE"], [90, 93, "GENE"], [219, 222, "GENE"]]}], ["No effects on triglycerides (pooled MD\u0394 = 0.045 mmol/L; 95%HPD = \u22120.195; 0.269) and body mass index (BMI) (pooled MD\u0394 = 0.062 kg/m", {"entities": [[59, 62, "GENE"]]}], ["Well-characterized cell lines represent useful scientific tools to study the pathophysiology of human disease.", {"entities": []}], ["Chronic rhinosinusitis (CRS) is a very common condition, though the number of CRS cell lines is limited, as are data showing how closely they resemble primary cells.", {"entities": []}], ["Searches for available human cell lines were performed using the American Type Culture Collection (ATCC) and European Collection of Cell Cultures (ECACC).", {"entities": []}], ["Identified cells were cultured and characterized with tinctorial and immunohistochemical staining and ELISA to assess their response to common, disease-relevant inflammatory stimuli.", {"entities": []}], ["Carefully phenotyped CRS patients were recruited with informed consent.", {"entities": []}], ["Primary nasal epithelial cell (PNEC) brushings were harvested, cultured, and compared to the available cell lines.", {"entities": []}], ["Searches identified 1 relevant CRS sino-nasal cell line, RPMI 2650.", {"entities": []}], ["Cultured PNECs showed strong expression of epithelial markers while being negative for mesenchymal markers.", {"entities": []}], ["However, RPMI 2650 cells show an atypical mixed epithelial/mesenchymal phenotype.", {"entities": []}], ["When stimulated by pro-inflammatory ligands, PNECs responded in a dose-dependent manner, whereas RPMI 2650 cells showed limited response.", {"entities": []}], ["The number and availability of cell lines to study the pathophysiology of CRS greatly underrepresent the disease burden.", {"entities": []}], ["Additionally, the sole commercially available cell line appears to have a different phenotype and behavior to primary patient-derived cells.", {"entities": []}], ["The development of further reproducible cell lines would be beneficial in our understanding of CRS.", {"entities": []}], ["There is a number of research work in the literature that have applied sEMG biofeedback as an instrument for muscle rehabilitation.", {"entities": []}], ["Therefore, sEMG is a good tool for this research work and is used to record the myoelectric activity in the paraspinal muscles of those with AIS during habitual standing and sitting.", {"entities": []}], ["After the sEMG evaluation, the root-mean-square (RMS) sEMG values of the paraspinal muscles in the habitual postures reflect the spinal curvature situation of the PUMC Type Ia and IIc subjects.", {"entities": []}], ["Both groups have a stronger average RMS sEMG value on the convex side of the affected muscle regions.", {"entities": []}], ["Correction to posture as instructed by the physiotherapist has helped the subjects to achieve a more balanced RMS sEMG ratio in the trapezius and latissimus dorsi regions; the erector spinae in the thoracic region and/or erector spinae in the lumbar region.", {"entities": []}], ["It is, therefore, considered that with regular practice of the suggested positions, those with AIS can use motor learning to achieve a more balanced posture.", {"entities": []}], ["Consequently, the findings can be used in less intrusive early orthotic intervention and provision of care to those with AIS.", {"entities": []}], ["In Malaysia, the number of reported cases of dengue fever demonstrates an increasing trend.", {"entities": []}], ["Since dengue fever has no vaccine or antiviral treatment available, it has become a burden.", {"entities": []}], ["Complementary and alternative medicine (CAM) has become one of the good alternatives to treat the patients with dengue fever.", {"entities": []}], ["There is limited study on the use of CAM among patients with dengue fever, particularly in hospital settings.", {"entities": []}], ["This study aims to determine the prevalence, types, reasons, expenditure, and resource of information on CAM use among patients with dengue fever.", {"entities": []}], ["This is a descriptive, cross-sectional study of 306 patients with dengue fever, which was carried out at the dengue clinic of three hospitals.", {"entities": []}], ["Data were analysed using IBM SPSS Statistics version 21.0 and logistic regression analysis was used to determine the factors associated with CAM use.", {"entities": []}], ["The prevalence of CAM use was 85.3\u00a0% among patients with dengue fever.", {"entities": []}], ["The most popular CAMs were isotonic drinks (85.8\u00a0%), crab soup (46.7\u00a0%) and papaya leaf extract (22.2\u00a0%).", {"entities": []}], ["The most common reason for CAM use was a good impression of CAM from other CAM users (33.3\u00a0%).", {"entities": []}], ["The main resource of information on CAM use among patients with dengue fever was family (54.8\u00a0%).", {"entities": []}], ["In multiple logistic regression analysis, dengue fever patients with a tertiary level are more likely to use CAM 5.8 (95\u00a0% confidence interval (CI 1.62\u201320.45) and 3.8 (95\u00a0% CI 1.12\u201312.93) times than secondary level and primary and below respectively.", {"entities": []}], ["CAM was commonly used by patients with dengue fever.", {"entities": []}], ["The predictor of CAM use was a higher level of education.", {"entities": []}], ["The online version of this article (doi:10.1186/s12906-016-1017-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["There is growing awareness of the need to explore patient reported outcomes in clinical trials.", {"entities": []}], ["In the Scandinavian Surgical Outcomes Research Group we are conducting several clinical trials in cooperation between Danish and Swedish surgical researchers, and we use questionnaires aimed at patients from both countries.", {"entities": []}], ["In relation to this and similar international cooperation, the validity and reliability of translated questionnaires are central aspects.", {"entities": []}], ["The purpose of this study was to explore which methodological measures were used in studies reporting translation of questionnaires.", {"entities": []}], ["Furthermore, we wanted to make some methodological suggestions for clinical researchers who are faced with having to translate a questionnaire.", {"entities": []}], ["We designed a research study based on a survey of the literature and extracted data from published studies reporting the methodological process when translating questionnaires on health related quality of life for different diseases.", {"entities": []}], ["We retrieved 187 studies and out of theses we included 52 studies.", {"entities": []}], ["The psychometric properties of the translated versions were validated using different tests.", {"entities": []}], ["The focus was on internal validity (96%), reliability (67%) criterion validity (81%), and construct validity (62%).", {"entities": []}], ["For internal validity Cronbach's alpha was used in 94% of the studies.", {"entities": []}], ["This study shows that there seems to be a consensus regarding the translation process (especially for internal validity) although most researchers did not use a translation guide.", {"entities": []}], ["Moreover, we recommended that clinical researchers should consider three steps covering the process of translation, the qualitative validation as well as the quantitative validation.", {"entities": []}], ["The major risk factor for the development of COPD is cigarette smoking.", {"entities": []}], ["Smoking causes activation of resident cells and the recruitment of inflammatory cells into the lungs, which leads to release of pro-inflammatory cytokines, chemotactic factors, oxygen radicals and proteases.", {"entities": []}], ["In the present study evidence is found for a new cellular mechanism that refers to a link between smoking and inflammation in lungs.", {"entities": []}], ["Employing human monocyte-derived macrophages, different techniques including FACS analysis, Cytometric Bead Array Assay and ELISA were achieved to evaluate the effects of CS on pro-inflammatory cytokine secretion including IL-8.", {"entities": [[171, 173, "GENE"]]}], ["Then, Toll-like receptor neutralization was performed to study the involvement of Toll-like receptor-4 in IL-8 production.", {"entities": []}], ["Finally, signaling pathways in macrophages after exposure to CS medium were investigated performing ELISA and Western analysis.", {"entities": [[61, 63, "GENE"]]}], ["We demonstrate that especially human monocytes are sensitive to produce IL-8 upon cigarette smoke stimulation compared to lymphocytes or neutrophils.", {"entities": []}], ["Moreover, monocyte-derived macrophages produce high amounts of the cytokine.", {"entities": []}], ["The IL-8 production is dependent on Toll-like receptor 4 stimulation and LPS is not involved.", {"entities": []}], ["Further research resolved the cellular mechanism by which cigarette smoke induces cytokine production in monocyte-derived macrophages.", {"entities": []}], ["Cigarette smoke causes subsequently a concentration-dependent phosphorylation of IRAK and degradation of TRAF6.", {"entities": [[105, 110, "GENE"]]}], ["Moreover, I\u03baB\u03b1 was phosphorylated which suggests involvement of NF-\u03baB.", {"entities": []}], ["In addition, NF\u03baB -inhibitor blocked cigarette smoke-induced IL-8 production.", {"entities": []}], ["These findings link cigarette smoke to inflammation and lead to new insights/therapeutic strategies in the pathogenesis of lung emphysema.", {"entities": []}]]